<SEC-DOCUMENT>0001022079-22-000027.txt : 20220228
<SEC-HEADER>0001022079-22-000027.hdr.sgml : 20220228
<ACCEPTANCE-DATETIME>20220228161337
ACCESSION NUMBER:		0001022079-22-000027
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		112
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220228
DATE AS OF CHANGE:		20220228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		22689674

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>dgx-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:c829db2e-c850-44b9-90d1-7027e34dc7fe,g:892aaabe-58ca-45ff-95da-140e039c9f49,d:b4001cf8768244cca3f772bfc08f865b--><html xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dgx="http://questdiagnostics.com/20211231" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:srt="http://fasb.org/srt/2021-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dgx-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl80L2ZyYWc6MDM0MmEzYzIwYTdkNDZiYjhjNWI4MGU0ZmIyNjE2OTMvdGFibGU6M2ZhYTlhNzMxNzVlNDdmYTkwODY1OWRlZTBhNGFiZTQvdGFibGVyYW5nZTozZmFhOWE3MzE3NWU0N2ZhOTA4NjU5ZGVlMGE0YWJlNF8yLTEtMS0xLTIwOTI1_3881cce3-b3e0-4df8-a0f1-ef487d2bc10f">0001022079</ix:nonNumeric><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl80L2ZyYWc6MDM0MmEzYzIwYTdkNDZiYjhjNWI4MGU0ZmIyNjE2OTMvdGFibGU6M2ZhYTlhNzMxNzVlNDdmYTkwODY1OWRlZTBhNGFiZTQvdGFibGVyYW5nZTozZmFhOWE3MzE3NWU0N2ZhOTA4NjU5ZGVlMGE0YWJlNF80LTEtMS0xLTIwOTI1_7dc9861d-dfe8-4565-9fd3-e68de7c56b57">2021</ix:nonNumeric><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl80L2ZyYWc6MDM0MmEzYzIwYTdkNDZiYjhjNWI4MGU0ZmIyNjE2OTMvdGFibGU6M2ZhYTlhNzMxNzVlNDdmYTkwODY1OWRlZTBhNGFiZTQvdGFibGVyYW5nZTozZmFhOWE3MzE3NWU0N2ZhOTA4NjU5ZGVlMGE0YWJlNF81LTEtMS0xLTIwOTI1_b25c1880-da3a-41c9-b5c6-2be5192925f5">FY</ix:nonNumeric><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl80L2ZyYWc6MDM0MmEzYzIwYTdkNDZiYjhjNWI4MGU0ZmIyNjE2OTMvdGFibGU6M2ZhYTlhNzMxNzVlNDdmYTkwODY1OWRlZTBhNGFiZTQvdGFibGVyYW5nZTozZmFhOWE3MzE3NWU0N2ZhOTA4NjU5ZGVlMGE0YWJlNF82LTEtMS0xLTIwOTI1_b9d8da9f-f7db-4947-863a-95738f749636">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i2807cd7680bc4bb4925dda96c4f03f1e_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1MDYw_1d199ab7-3192-43a9-a2e6-2c9e9839ee94">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i31a2f97bd63f4c42b34883f22a329ad2_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1Mjcw_88e6f6e4-a789-4494-8767-bda409fe0bc3">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i5e3f8aa3f21c4630b2c2d3a505ba4881_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE5MTMy_22152b9e-6ae5-4ec5-ae0f-101ca8483d0a">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="iba7313c4a10443ea84ad938944fb4263_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODEvZnJhZzo2OWM0NWUzNGM5OTE0YmIyOGMwZDExOWQzYjllZjg0Zi90YWJsZTphZWRiNTBjODNlZWE0ODJhYjU5MmVhNWEwZTkzZDAzNy90YWJsZXJhbmdlOmFlZGI1MGM4M2VlYTQ4MmFiNTkyZWE1YTBlOTNkMDM3XzEtMS0xLTEtMjA5MjU_ad17d72e-12ff-4028-a9b3-6cb270168a3d">31.5</ix:nonNumeric><ix:nonNumeric contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_50c95c33-a401-4066-8573-e62f6ca75cd3">http://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAsset</ix:nonNumeric><ix:nonNumeric contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_6f7e233a-96d4-4732-aa53-9f719523830d">http://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAsset</ix:nonNumeric><ix:nonNumeric contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_1997e471-5c97-4a99-87d8-0ad010e8dfa3">http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_2b9b9016-510b-480e-96bb-962223d0e820">http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_375a58c6-c5ec-4296-b7ed-b111e088fff7">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_b44b257f-98c9-4e44-912d-5c75a894370c">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_0ffa204f-63da-4cb5-97eb-2b95e023c547">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_47976c32-56f0-4b24-a8fa-f838f8d5f156">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i9a2973ec261740218274bc1cb13b32b6_D20160901-20160930" name="dgx:AgreementtoOutsourceBillingandCollectionFunction" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzExMzc_708f737c-5f7e-406e-a9c5-dbbc99a6dcd3">P10Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dgx-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93ead1399e2e4ac494b71ed2bb631561_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i4d0e2c71efc94e228f2767bcedc33dd0_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib618186b3e3648a0a5c22c9e567fe03f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i4a05287b4f02418c82cd5f2e6e79c6dc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37a9f450d5fc42bd8a4cedc5a182bb1d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93a20c5e9811442496e0ddbc0d32b35f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30f9993ad61e49b8889d85cebdd9a0ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb3cd0ebcab8404c8e2d53703218de07_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d0d6530dd894b1c87f220eb4e22a87b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i751cd9d2a9c24eeb80a337f22c577eed_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b6f2cccffed48a8b1dceaea5ff25de2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idda5f95daad049caab9cbe2bfb827136_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5299549fc0c64e619315ae69e3a2d208_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aab3fa36e3d4c9784c83bb58dbc0467_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f2e5616f9864fd5b5916bfd56220c6d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1066f069691a446899ccc794445c6f7e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88b348bf53ef45a6b79322e9729d0498_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1c4749bcaac4d619fd98fd7d8f56cf3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i267bcc57d1894a25886a84780745fe3f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie209ef77b3d74e11bcf8556dd3482d4a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3be5ad04ae5542ecb8f3b50fb4e30464_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf54f2e101be444fae80a5c5c2d3c804_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae81071de369404b8afd4d5fc92817db_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67c2565c4020431eab3d950ad045cb6d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if98d4882c785427cb6359a1c4887bd59_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb7782dfdbdd41bcb0c2a7ce6d9fc4e9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7887c43e3ff4c0eaa862aa8feccb3a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7109a9f8e79b43adaac841ce00ee330f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i100aacd303a1475289f1b48d599c5544_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i873b50b7201e479895a613c8644d45a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a6dfcd580714f519c23752e3e04312e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0aa4482609c643a18d09f0c105d38575_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b3040c4c16442589b2b35eb56972716_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib47828d248b649a69973dd77b69d8e47_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ed179caf3f3462791e29a68b26fdab2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf17d00ced53485da1e88eb50e730ada_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84e35541023d468e8cb0c202d383eddc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b11d3e18df649ec889a7fa850cc7e67_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7215d41c21ea4fbdb2f7240f3cc276ee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i184e53e381dc4d5bb40497f1d9fc9b8d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecc4fcf7570e403c98d584e438978f0c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6174bff25adb42cdbd66e7fb9ff9c37d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38edfda579db45e2b38455c17b62991c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6273937e3079404bac24531420de0b6c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id617ebe9e53c430eab235ef5b09c5eb1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie250c2a689ff4ef885295f77abd96941_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7d076d028664d249c58ef5ec036b46f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23a7255d9f5c4ffa878e62ba379a4038_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ef869edccf349a68f85c65c81e97770_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice911685201a460b8af3f58815059f82_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i641831615df34b538199d475b2c51f92_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89f3081e1b5445c6bfec2edf60f2f909_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5e542d0dfea43e2af9118d20432c274_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5d364f684594c5783514a961ba1cb23_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2807cd7680bc4bb4925dda96c4f03f1e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentAndFurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb8e5cfafc1a42d58d6cad9058f4760e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentAndFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31a2f97bd63f4c42b34883f22a329ad2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b00f7e1bf43453099ed71ff43d6717f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e3f8aa3f21c4630b2c2d3a505ba4881_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i972899ce7ba6442aaf147d47867cd482_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id22911e2cc294cebbfc441d94dfaf441_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba604be725684156a3eb0ffeedf8b741_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6abd46db2a6b4225801b044e7620dd70_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba7313c4a10443ea84ad938944fb4263_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a090f7f88f3481086c45baf1ec6dabd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice4e3139e0ba4820be8e5d8cf02f15fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb62d67015ba418c9bcc8c4ca149ca60_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie799399ba4554af3b75c1e5d805f52c7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88dd508f2a244b859dab8f3eb925f23a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dd2fa8993ba4765a061aa8753907429_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i886f4c78cd9c49dda5f59730477bd7a8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7db216ea09e4faf817a70826756f79f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b66d5c815234d649c202faa47b0836f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceca007bdcd64d67a3cfc72359b58092_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24c4e46338874112b41b05ba07c69b13_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e8e2db9ab7a4c3c8b0971c8eb34874d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bed9502f4964d15af65cfe68d0a3389_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7008d482a62245bb9875f7b05fec3156_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bb294ef9720428da49024b4cc1c015e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58580a51b19549c984bf823f6103da97_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3c0596ed88949319f741c4098014adc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53e0c40604dc436dac0d5316b6aa3124_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17c7defe77e94feca925988ab94659bc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if59d0382710d43bd95feee9461a26bdc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c17eb1dddb643999d1956c1832f752a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b5e5b177ae448c083554c9494be58aa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a09d850f846426d9dfd70228809d98a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i101444f4d55c4f7face8b6cbb4ad8c7c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67a12fbdd2794793bdbac9d69717453a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i842c67659a084bca972b57a09beab75c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0bd2018f1ae4210af8adb65d7d4adec_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6815212460d4587af042592f64aaf60_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id22f162e49514311adf2fd36a699bba9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d589ca3abf844d78f270902170a0189_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41ddf51214fb499e84fddd91bbb595d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62d8cd061af34ddda090b2a1ed70a859_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2add5ec575124eaa815d9e79f4d20f0e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia36c52a54f80476e9f66b1b0b7134265_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if86384a0f5614da3a89e030848de8448_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47fc543fa62f457495efbed248f47831_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i618e3edc7d0e472db6505e306cf617c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc63d78467b4990a09bb4edf33bc0d9_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbd86fbda26d4940870279bbf2723a39_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aee2bd26ebb41528a08b0155d7985b1_I20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaade8f13b4c24c27921a397d61fbbfce_I20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ede7ec3a11842568aa070ef6416d46f_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15009b0e1117479090ce699335523d61_D20211213-20211213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-13</xbrli:startDate><xbrli:endDate>2021-12-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81a78a06e59d4de0972e28a1dee3dbe4_I20211213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f1113940444a80a3c10cf968e6c6ce_D20211213-20211213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-13</xbrli:startDate><xbrli:endDate>2021-12-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3246f22b780495da5706a912cfe9e8f_D20200121-20200121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-21</xbrli:startDate><xbrli:endDate>2020-01-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9011e0276964d49be24c92eb49f6aab_I20200121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba6f3990b67144cba1d435606505c8f4_D20200121-20200121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-21</xbrli:startDate><xbrli:endDate>2020-01-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic51e744f4f2e4bcaa5294155d679de88_D20200121-20200121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-21</xbrli:startDate><xbrli:endDate>2020-01-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b68dc1052845acade8ae63bf8e6344_D20200406-20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-06</xbrli:startDate><xbrli:endDate>2020-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4617473021984d69adc99b7ffdf6247a_I20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8776f0149dc24a4fb8b364ad4db1ebb4_I20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e2e808f5d17421891028da702156879_D20200406-20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-06</xbrli:startDate><xbrli:endDate>2020-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91ecb9e9aa0543a9b24df0457649804e_I20200801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f962685f1e94c24ad92c8ab20b848a9_D20200801-20200801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e0666473465402491e5adb9a61aa8a9_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6481d3eb8e74ecb8e9190ad66be0074_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45f309f68fd843a48e8af03cd2f2fd0f_D20200801-20200801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dgx:OtherIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4508da7ee96473cacb0e8b34be9019b_I20200801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3555bc8ae0b4b1cbeefc4ba15b1ff96_D20200801-20200801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic42d65a53e2e4f8caac33c19b3fe9550_D20190211-20190211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-11</xbrli:startDate><xbrli:endDate>2019-02-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf8a6d03f13d4234a113977f48f0640c_I20190211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30539b4ef73742fd917103c75f8a131d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0443eda130d94868aa628f929fc4e6bd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i423ce88d5a4046c7b9394f997e1e0db6_I20190211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7356ad2d38bf4e7e85b6c706c139d415_I20190211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f33c5e991148e899c59f925d85d5b1_D20190211-20190211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-11</xbrli:startDate><xbrli:endDate>2019-02-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c1e96cb7a8540ba9373cdf8a930af85_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff8c10fa9efa4acb8369a234686c91ff_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e96757089434161b4f6a911623f3a76_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b20ad37382b4dbd949a4bd8cd17fa6c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:ForeignCurrencyTranslationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0766501a28ea42ae98034d9409e0ed9d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib83ba03755a844f2aacb5ab477db26dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ad83b4de96747abb8cb8781622ee947_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81f60e6780e640a694005a30b6a5abe5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38f5b3d3498744299e5a0aef9e2f770b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i073fd4818f044aef89256b4a52dcbf2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie17bd574ae9c4ff8ae0d21265f27f20e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i434a8ab4e7b34865bb3ce497565a2bf6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i617406ef61a34f3aa8f1d1f3c8941262_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dgx:MeasurementInputComparableCompanyRevenueVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i124355337c804541809469ff7ef7f47f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66a58a0ecc1d462f851c119a2540a972_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc94c6adc50e45d1a843a6310b57c833_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67b969149f9b4fee96f681a629e8e1bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i021bad29b33a4e059cf6ee59d7e0df44_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c47ea6a797a43599cb7fc4368a7daa1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10c8c1d0f30246589418e5588a96ce94_I20150701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41d87f6d82ea49589aa5d33a9546d817_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20d31ae01df141748e29ec7263dbe9c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c9bfd94887a4b799eb75fdf00ff90c6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaadd96b316f4fe3aa85d0828713bc7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83edf4f54cea471cb6078513f0ebb62d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie38bc8aadde34be2a92c9c3930883626_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b96d806bd364953ade441ac89234392_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fe0a4d10c264c40b9e40c8f509f7adc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee54bfafa2142ab925140ee00165fea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95334650a7794ede9d0240487ccf5b99_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d5ebce76e5d403e9298f0728ff53d6e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82c68c29716a45b6ae635ee994106a2f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b876c41bbc04618b47e5868c157a986_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib69a77afcc7848b9bcdb721d263b8590_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dc448c5c6a4434ca848bbf1bcbbdbab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0550e1e6602405196f7a86f02932b05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i850a9e2e7a37450487c5434158c02aec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3445b8f4bd484038bb1c8dba887da7aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9051075426f64d9fb6d5c2874af92f58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i703f397efc54465491f61111e9d00225_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75cf772afd4440dbabbaa7a8d8609ebd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie440f7efd91b4288b67e34da88f9d851_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b6430db74f74cdba668c4da15ce72f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19172532941b40db90a9673c0a833751_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ac379b1564746b29091a6803b4e237e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic96f44c6128f47809c839fe1a70df50d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01eaebddea0d433ea24e6c5ef38bd564_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8c4fd41a16d47c691063b053f0f15a1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id49dc7dd9f1c473ba5418fbddca06d3f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf12734ab0ab46498369e1f89b24439b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i662626ed24964bfba9dc3b27519b5804_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a7ac3e799d44879aad973d51eb36f14_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0367af741674c3fb7c7d805734fd8e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a08e02b7c23441cb6f556cdb634cb88_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97af82c328c645e99f19d0e2e6ce85e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05d194442c87432d9686414335afe7cf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1456547e481a4de1a93ec35f388b1295_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70b2a42da95c4ef2a98b0f15b9f4b9c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5164e43d9194c4eb7704645ad2ab56a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb21621cd5b4062b5cb405b6542855f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0594f257da04350b8a4a4b497e30e2e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourpointtwofivepercentSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c6fef0c959f4836b6be1689a5919adf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourpointtwofivepercentSeniorNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fadb78c01474e89b32f31ed14c21f18_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8b7492430de4dbfa02f30eb630168d1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5202c6f3e7cf486b94bb890d000fb968_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFourFivePercentSeniorNotesdueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82cb0de9768a4944bc7de354bb2821b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFourFivePercentSeniorNotesdueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5df62b2adde478ea217430cd360e7e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointTwoZeroPercentSeniorNotesdueJune2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida0ded49fab44741b80d31af3ba70aae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointTwoZeroPercentSeniorNotesdueJune2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i766f928a9c9346038b77495a2d20fb42_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointNineFivePercentSeniorNotesdueJune2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc060a500fe64aac9a2a927778e50857_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointNineFivePercentSeniorNotesdueJune2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i378672f20c0d4618a6b6e81143b6720a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88cc643b6da843ffa1c10a9f855203c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4ce1f1f310449c2b6c89c7e62ade9b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:SixPointNineFivePercentSeniorNotesDue2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5df76549d2994abd97388a4720896161_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:SixPointNineFivePercentSeniorNotesDue2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b9881c9daf746ff96ea2d9b6927e946_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FivePointSevenFivePercentSeniorNotesDue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82a4a8a3b9d14622adefe38f6d57418f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FivePointSevenFivePercentSeniorNotesDue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09bbac6d7bf04160afe3a6e074127aba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdueMarch2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic73df93e889f4d69ac6970fe52f080ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdueMarch2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a32e3b91ca84b89b38c8ba51a6735ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FinanceLeaseObligationsandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72472dddee4a401c94ec4e9a3d939bc5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FinanceLeaseObligationsandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife8fa0dbace2463781c162f0d572554e_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f138175e3a44f5ebf659b1a78903b5d_D20211001-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8413e7af478b4f60b3be63a14fc02040_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoanCommitmentMaturingOctober2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7273399a8b249109c5141327f9e2f70_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoanCommitmentMaturingOctober2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0f0ea4be7af4410af0e10d2186e1e37_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5bd74de8e5d42bd9ceb6ea699aa16ca_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1730f3f4c2874eff9f3ca20705fbdfce_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90044be8ca1a4466aea5fb0404e36a2d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e4a6015d1ef460f9e8ae76bf0c3381f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3d6de33f3ed4d19a2ec16d2ece3dab0_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaa60f894264418b86cad34928e740c7_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae8c124c79124e13a5f8a65b35a85a2d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f48d5ae19c347f5a146cb05e040a26f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8194949fa694c51b9a86b2aa1a10860_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i754db448c4a141e587eb41b3530387d7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dgx:OtherIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i088cf7af90a4499da82634db3e749425_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b611f9fb71a4871a95107ddf00e5972_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11c302abd9aa427ba7d0156fe01460ec_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cc5031c24924569b75aea0f1da108a1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i003a13fe51aa4e869629249e6bbb90d5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8afa4ad788744a6a80595836c35781a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia36018d33c604038aa1aa14c366c4dd2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia85aba486145433bbe90c96b488714b9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f78e9964d4545d0b470900cf41790eb_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaf3d2d6da574aad843e8c47db812bde_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e6f13795fa643d4a934ef2779cf20c8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icedac86dbdd94e328db0b81523eb9490_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i172b86f75b754578b0023e98bbdbb60a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i854a8c819539479993d7ec23a433969f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee641cc51754d1cb00d4f664780d7e8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9be9b6bedf67403391fbe4666a7b7789_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46c2e1b5de824befa49ed510987e9918_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i586f4c60ec0941b798835a56c0a9126d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d895060707c4feab2cdb2374be33e9e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20f21fbe58224ed6b3cf27749d03f137_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i823d173be3fb47b8a4246a64c03b0a01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aa0eae48f174f9b9a05ca9da0eab655_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcd6a47fcc964ce4a5dc370e77b30cbe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i455a47bd993d476393c8224860c4376d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2ea7757788d44a2a8005c4e5c5e5d8d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a589942e02b472d8d4555b653f21c8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e3a08874f20424ebeb0772967620d16_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia329d4330d184f4db61e55f388db1e37_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib08a3f5f05e8446a81e70c779986707e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b0ee439d5e042c0ad07cb7eea297ef4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i131d1f6ef78b4ccda288b254ef8513eb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i614f87384bc04f7eb3b659a197d00719_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8c928ba4d594c0d8a8bc43cc0eaff7a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i172575bb71684d5b977ed5b5efb382cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6be47c24890a4321b9eab67a24b8a937_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie014908da8a24f6e98f6bd987c799a93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i037da802480a40f1aceb3032d77fd42d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc7daa98ed14443ba924d16779e53a1b_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46b7967df9714e9abdb47bd55a82bb99_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i256fbf2ceee847e3a69e9615a1382681_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c85169bb26d4f7487f2139697536c87_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80051b14fe464495a4d017e6d935f7b4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75da353bc1d84ecf943ea64892e87557_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a65b7fef56742dfa223a86fcbbc87ed_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i920aa1cda167443c8b0444671613bbf4_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieda553b13ff74c3c8adddf0770a90cb1_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea6463b11ecf4c00a41fca1508914f0f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83a23412d4724363966c8ea6e44ab909_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bc256f3969842e6a0da1ee27ff4d814_I20220203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab2af8571ad549cc8ca5ad0958512f11_D20220203-20220203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-03</xbrli:startDate><xbrli:endDate>2022-02-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27c3f506bf6b40788ce7094bb62e2e2d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bbace4627094c78b2e45eaf382e646d_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23fa7d555abb409cb510e5e698113fc5_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f71fea2861045d2bc904b3d6d15ea55_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dafd9b95c6842e2b8662b418c9af1b3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i069088e9e79e44e78b230470438a9c05_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:EmployeeLongTermIncentivePlanEltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34ff8916a5f444ccb368b1089fe044ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:EmployeeLongTermIncentivePlanEltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89212b0997f444118e64670ec656f232_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57198eacfa274bdda46d180bc4e3f05d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad5bf5052c604fa2982645d51ef2f9bf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b1d357b32ce4113917ff628a45e0a1b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30b7bc67e7bb4a52a97e03ff7b345782_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie07834d81a9d4a88aaf80835b2bb5156_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0edf8a3dee0e4be4a7970782a11e919b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic601ee56a8d64d41a238221625b7f525_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d3304ab3de4fac88d8ba9dc1cdc015_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic50d104c1f2e4df4a4f6e3d9ae3c0287_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeeaf4706c6e49b7a86e967f2bd3443a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58ae2069c994411b8ad5cf3e9fd7f728_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i152aaa9d36b34e3496329cdd1df55d76_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i186f5b12f07149329dc5f3bd351174d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaf57f30a4d148c7832fab56a16d3c67_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i133ed156b2ae4c0cb1ccbd97cc19199f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if54829fa59064ad3adf7093c5e760b0e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i946d409692054dddb8d20bf8697e64db_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33d716f8929d432d844c17e2ba676a0b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fc7b757284449cebf65a284bd73bd8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e961edb5fcd410ea3ec16b2c6c74476_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i037161dc8162495a912293e3e9a40ec4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61c9407736c741d0ab822ef30250f2a8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8095617a570e4c32b5ffb3c1434f3dc7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb5c138d0e66484badc0c6cfaeb41e0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i041613d64bbb4a13a8721a2ee2352a92_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a2973ec261740218274bc1cb13b32b6_D20160901-20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-01</xbrli:startDate><xbrli:endDate>2016-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>dgx:claim</xbrli:measure></xbrli:unit><xbrli:context id="id980e16d89514f7aa100a29c06e97763_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i744ee99a69fd4003b8a54a40eb3c8813_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if013d02c91354f9286988eda03c628e0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bb108bc797e4252abac7baa59a2e9d4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cd1adca053c4d6580c37c9b0bff2f37_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73cec06921db4ba883aa7b2610ace433_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3764f252b9f84910a98e8576a15f1852_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98112ec95e1d4aab9f4cde79cf53b385_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc9427fc9d114228a3d3efa6bcb432e9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i208fa7e6f0334944b10d285de0b70711_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f08a738c5804d11b70644f0148c895c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib527ecaf883c4b36bb71ff0a85b4d81a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i338f15fece2f4712847fd4e04333fc1d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i975831888a86459eb1bac2b48531332d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19a2acf57ffa4509ab771b661fcea999_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c039428d6d84b189717417daf0d8fe3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a494abcac9c47fca32926023c31eae6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f07a6ecd11b4fb5b1eaf5f119c9eb51_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4766ba2728754ca5b737ca40088cd12b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5343cf8aa45f4acc956a10119ecd34d5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5096412349bf441a965c02745c0985c1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3694f852a462494f91d7c0a3b1211df9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:NidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7331c77972481e85855c53b18546a4_D20220201-20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a6f1832ce5e4035a5b9b14f52d94a3f_I20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbfee6ac293a4d0693346eada0d23f20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38a07547d99340ac959c9e338dbbd36c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2934d884c7734d478ccf8f3700348ced_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66fc5387af244c48b34e4b6ff0662c58_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c6d71b26c14be794b19fdcba867621_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33dd72fa523b4d1d80a0eabd16074f43_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6f1ed6fbd9646ca9077dc5312767b5f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib4001cf8768244cca3f772bfc08f865b_1"></div><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM5_221131c2-498a-416c-9a89-8846878f29ab">10-K</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">           </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTMz_afc0af55-20be-4816-a97a-d0d88b7c9003">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the Fiscal Year Ended <ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8yMTM_4cec85ae-179e-488e-9454-4fdeff021d55"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8yMTM_6594aa33-2814-4f15-ad14-2269aed98556">December 31</ix:nonNumeric>, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Or</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">           </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM0_9f43e3ad-5402-444a-9c9f-bbbc811b3705">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from __________ to __________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM1_973e38ff-51dc-49f6-bfe4-d4a8b8fcfff6">001-12215</ix:nonNumeric> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM2_3aa4867d-7a27-443e-8e5e-3621f53a1b56">Quest Diagnostics Inc</ix:nonNumeric>orporated</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8wLTAtMS0xLTIwOTI1_a4613d5c-b362-4b78-a7bd-45c008763fb3">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8wLTUtMS0xLTIwOTI1_0438ce41-21dd-41b1-ad3b-baf9524bbdd5">16-1387862</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(State of Incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8yLTAtMS0xLTIwOTI1_c86cb1ca-6bbe-4c96-bb8b-bd6b2e9d2cc1">500 Plaza Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8zLTAtMS0xLTIwOTI1_550d5f5d-3d62-4417-a506-88f760777a98">Secaucus,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8zLTEtMS0xLTIwOTI1_d6b9d029-2343-43d8-93e9-bc105222fc0b">NJ</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8zLTItMS0xLTIwOTI1_48797348-d80c-4fe5-bea4-d1876e89d23e">07094</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF80LTAtMS0xLTIwOTI1_93fcf354-264c-4bcb-a7c8-df0fb2fea603">(973)</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF80LTEtMS0xLTIwOTI1_d65a1af5-fe3a-4709-838a-06d21a8b5937">520-2700</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Title of Each Class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NTExYTE5NjM5NjlmNGIxNWFmYjAzYjE3MDhjMzRkNjAvdGFibGVyYW5nZTo1MTFhMTk2Mzk2OWY0YjE1YWZiMDNiMTcwOGMzNGQ2MF8yLTAtMS0xLTIwOTI1_a889e080-9fb1-446e-8ac0-d89441899e6d">Common Stock, $.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NTExYTE5NjM5NjlmNGIxNWFmYjAzYjE3MDhjMzRkNjAvdGFibGVyYW5nZTo1MTFhMTk2Mzk2OWY0YjE1YWZiMDNiMTcwOGMzNGQ2MF8yLTEtMS0xLTIwOTI1_69c7724a-5bf5-43fb-8326-ff0c8b50c21c">DGX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NTExYTE5NjM5NjlmNGIxNWFmYjAzYjE3MDhjMzRkNjAvdGFibGVyYW5nZTo1MTFhMTk2Mzk2OWY0YjE1YWZiMDNiMTcwOGMzNGQ2MF8yLTItMS0xLTIwOTI1_a2fbaf3b-2afe-4f05-9bfe-2eecb3d9548e">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:49.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(g) of the Act:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">None</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTQw_e39059ee-60c4-4e46-b165-259a6eef7ede">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;X&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTQx_97c4a37d-26c0-4d08-ab57-dad3c3c74e78">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;X&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTQy_55a947d4-eddc-4d99-b49f-01117bfcb506">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;X&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM3_5d51d477-ea84-41b2-a1d1-d8891cc30f95">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;X&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:42.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6ZWRiNmIzZGNlZmQxNGRkYzk1M2MwOWUzNTgxOWUxNmUvdGFibGVyYW5nZTplZGI2YjNkY2VmZDE0ZGRjOTUzYzA5ZTM1ODE5ZTE2ZV8wLTAtMS0xLTIwOTI1_02ff7340-2af8-424d-87a9-c999d2163c1f">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6ZWRiNmIzZGNlZmQxNGRkYzk1M2MwOWUzNTgxOWUxNmUvdGFibGVyYW5nZTplZGI2YjNkY2VmZDE0ZGRjOTUzYzA5ZTM1ODE5ZTE2ZV8xLTMtMS0xLTIwOTI1_939f9b22-0468-4cb4-9aa7-dac4be8c864c">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6ZWRiNmIzZGNlZmQxNGRkYzk1M2MwOWUzNTgxOWUxNmUvdGFibGVyYW5nZTplZGI2YjNkY2VmZDE0ZGRjOTUzYzA5ZTM1ODE5ZTE2ZV8yLTMtMS0xLTIwOTI1_4b34e5c1-b0be-41ab-b56c-90bf32fda4a7">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [&#9744; ]</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  [<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTMy_2ff3a872-ad04-46af-93ec-12ff19614d3a">&#9746;</ix:nonNumeric>]</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes <ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM4_0171e31e-608e-4d17-afb3-3d3c01214dbd">&#9744;</ix:nonNumeric>    No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;X&#160;&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June 30, 2021, the aggregate market value of the approximately 122&#160;million shares of voting and non-voting common equity held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i93ead1399e2e4ac494b71ed2bb631561_I20210630" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8yNzU1_c4a7645e-d708-443f-927c-d08ff37ff3ff">16.1</ix:nonFraction> billion, based on the closing price on such date of the registrant's Common Stock on the New York Stock Exchange.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of January&#160;31, 2022, there were outstanding <ix:nonFraction unitRef="shares" contextRef="i4d0e2c71efc94e228f2767bcedc33dd0_I20220131" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8yODk3_dff6546a-fc0b-4ca7-8c00-c2c837479e36">119,454,781</ix:nonFraction> shares of the registrant&#8217;s common stock, $.01 par value.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.298%"><tr><td style="width:1.0%"></td><td style="width:78.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.366%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Documents Incorporated by Reference</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part of Form 10-K into</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">which incorporated</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6YzdmNWY1ZjI0MGZiNDg4Nzg1Yzc2YmQ3YTZiMGI0NTQvdGFibGVyYW5nZTpjN2Y1ZjVmMjQwZmI0ODg3ODVjNzZiZDdhNmIwYjQ1NF8yLTAtMS0xLTIwOTI1_607fc369-c11c-4fd5-97d3-943ae8b64d4e" escape="true">Portions of the registrant's Proxy Statement to be filed by April&#160;30, 2022</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part III</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Such Proxy Statement, except for the portions thereof which have been specifically incorporated by reference, shall not be deemed &#8220;filed&#8221; as part of this report on Form 10-K.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_7"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> TABLE OF CONTENTS</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:10.764%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">&#160;Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_16">Introduction</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_19">Our Strategy</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_22">Our Strengths</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_22">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_25">Business Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_25">12</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_28">The Clinical Testing Industry</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_28">15</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_31">General</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_31">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_34">Regulation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_34">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_37">Available Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_37">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_40">Information about Our Executive Officers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_40">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_43">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_43">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_58">Cautionary Factors That May Affect Future Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_58">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_61">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_61">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_64">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_64">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_67">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_67">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_70">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_70">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_76">Market for Registrant's Common Stock, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_76">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_79">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_79">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_82">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_82">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_85">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_85">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_88">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_88">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_91">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_91">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_94">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_94">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_97">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_97">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_2192">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_2192">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_103">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_103">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_106">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_106">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_109">Security Ownership of Certain Beneficial Owners and Management and Related Stockholders' Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_109">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_112">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_112">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_115">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_115">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_121">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_121">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_124">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_124">54</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_133">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_133">57</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_148">Report of Management on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_148">75</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_151">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_151">1</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_154">Consolidated Financial Statements and Related Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_154">3</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_244">Schedule II - Valuation Accounts and Reserves</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_244">44</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The discussion in Item 1 below includes several defined terms:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACO - Accountable Care Organization</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAP - The College of American Pathologists</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CLIA - Clinical Laboratory Improvement Act</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS - Centers for Medicare and Medicaid Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DCE - Direct Contract Entity</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA - U.S. Food and Drug Administration</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FQHC - Federally Qualified Health Center</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HHS - U. S. Department of Health and Human Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IDN - Independent Delivery Network (including hospitals and hospital health systems)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPA - Independent Physician Association</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LDT - Laboratory-Developed Test</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAMA - The Protecting Access to Medicare Act of 2014</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The discussion also includes several tables, indexed in the following guide. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:81.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#828282;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Guide to Tables</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #828282;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services Portfolio </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #828282;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 1</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #828282;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approaches to Accelerate Growth</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 2</span></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key Professional Laboratory Services Offerings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 3</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer-Centric Initiatives</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 4</span></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer-Initiated Testing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 5</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major Themes to Drive Operational Excellence</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 6</span></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our Strengths </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 7</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets and Capabilities</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 8</span></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Franchises</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 9</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Net Revenues</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 10</span></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key Trends</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 11</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reducing Healthcare Costs and Improving Care</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 12</span></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customers</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 13</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential Factors Considered When Selecting a Diagnostics Information Services Provider</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 14</span></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Medicare and Medicaid Revenues as % of Consolidated Net Revenues                                                                                                                                                                                                                                                                                          </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 15</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key Regulatory Schemes</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 16</span></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information Available at Our Corporate Governance Webpage</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 17</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information Available at Our Corporate Responsibility Webpage</span></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 18</span></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Officers</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 19</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1. Business</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTRODUCTION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated is the world's leading provider of diagnostic information services.  We play a crucial role in the healthcare ecosystem, empowering people to take action to improve health outcomes.  Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  In the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics was incorporated in Delaware in 1990; its predecessor companies date back to 1967.  We conduct business through our headquarters in Secaucus, New Jersey, and our laboratories, patient service centers, offices and other facilities around the United States and in selected locations outside the United States.  Unless the context otherwise requires, the terms &#8220;Quest Diagnostics,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; and &#8220;our&#8221; mean Quest Diagnostics Incorporated and its consolidated subsidiaries.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The patients we serve comprise approximately one-third of the adult population of the United States annually, and approximately one-half of the adult population in the United States over a three-year period.  We estimate that annually we serve approximately half of the physicians and half of the hospitals in the United States. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2021, we generated net revenues of $10.8 billion.  Additional financial information concerning Quest Diagnostics for each of the years ended December&#160;31, 2021, 2020 and 2019 is included in the consolidated financial statements and notes thereto in &#8220;Financial Statements and Supplementary Data&#8221; in Part II, Item 8.</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our vision, aspirational goals and values are set forth below.&#160;&#160;&#160;&#160;</span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span><br/></span></div><div style="text-align:center"><img src="dgx-20211231_g1.jpg" alt="dgx-20211231_g1.jpg" style="height:476px;margin-bottom:5pt;vertical-align:text-bottom;width:277px"/></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that our vision, aspirational goals and strategy align very well with, and our strong value proposition supports, the triple aim of healthcare: improving medical quality and the patient experience while reducing the cost of care.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics is at the forefront of the response to the COVID-19 pandemic, playing a pivotal role to broaden access to laboratory insights to help people lead healthier and safer lives.  We provide both molecular diagnostic and antibody serology tests to aid in the diagnosis of COVID-19 and the detection of immune response to the virus, and have performed approximately 63 million of these tests.  We have built up and maintain the testing capacity to handle surges in COVID-19 testing demands, including using our national courier, air fleet and logistics network to balance volume across approximately two dozen COVID-19 testing laboratories, and also through our laboratory referral partner program. We are working with federal, state and local governments, healthcare organizations, payers, suppliers, retailers, trade associations and other laboratories in the effort to bring as much COVID-19 testing as possible to the American people.  We are also providing data on COVID-19 testing that we conduct to federal, state and local public health authorities, including the federal Centers for Disease Control and Prevention, and participate in studies with government and private institutions, aiding COVID-19 public health response and research.  All of our employees, including our dedicated laboratory professionals, phlebotomists, air fleet team, and couriers take tremendous pride in the role we play and work tirelessly to help patients and communities access quality COVID-19 testing.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have seen how underserved communities are being disproportionately impacted by COVID-19 with tragic consequences.  With the Quest Diagnostics Foundation, we launched Quest for Health Equity, an initiative to reduce health disparities in underserved communities in the U.S.  This initiative is providing a combination of testing services, education programs, alliances and financial support to efforts to address health disparities.  Since its inception, we have launched over 25 programs across the U.S. and Puerto Rico, including supporting COVID-19 testing and vaccination events, educating young students on healthy nutrition choices and expanding research and mentorship opportunities for black and Hispanic scholars.      </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our approach to fighting the COVID-19 pandemic has been rooted in our vision of empowering better health through diagnostic insights.  We believe that the challenges we are facing from the COVID-19 pandemic have brought us together, made us a stronger company and will help us capture the substantial opportunities in front of us.  </span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR STRATEGY </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have a two-point business strategy, reviewed by our Board of Directors, to achieve our vision and our goals.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="dgx-20211231_g2.jpg" alt="dgx-20211231_g2.jpg" style="height:261px;margin-bottom:5pt;vertical-align:text-bottom;width:440px"/></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accelerate Growth</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our strategy to accelerate revenue growth is based on the Company&#8217;s portfolio of services.</span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="12" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Services Portfolio (Table 1)</span></td></tr><tr><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Activity</span></td><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Key Characteristics</span></td><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">At A Glance</span></td><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #acacac;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Quest Value Proposition</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Diagnostics</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Testing services generating strong cash flows and steady growth </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Routine and non-routine testing services</span></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Largest revenue stream</span></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Essential portion of healthcare delivery</span></div></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Scale<br/>&#8226; Operational excellence<br/>&#8226; Access and convenience<br/></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #d8d8d8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Diagnostics</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-top:1pt solid #d8d8d8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Testing services targeting faster growth through innovation testing model</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-top:1pt solid #d8d8d8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Genetic and advanced molecular testing services </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; An important part of precision medicine</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Innovation-based competitors</span></div></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #d8d8d8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Rich clinical, scientific and medical innovation expertise<br/>&#8226; Quality and reliability of new assays<br/>&#8226; Ability to manage potential new regulatory requirements</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Services</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and data-related healthcare opportunities targeting faster growth</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Enables partners to deliver healthcare more efficiently (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, risk assessment; Professional Laboratory Services; Employer Population Health)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Services to support population health (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, data analytics; extended care services)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Extensive diagnostic capability<br/>&#8226; Large and growing database and analytics expertise<br/>&#8226; Partnerships with industry leaders across healthcare landscape</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have identified the following five approaches to accelerate growth.</span></div></td></tr><tr><td colspan="3" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approaches to Accelerate Growth (Table 2)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1. Delivering annual revenue growth of more than 2% through accretive, strategic acquisitions</span></td></tr><tr><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plus organic growth through:</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2. Capitalizing on increased health plan access </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3. Increasing share with IDNs </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4. Growing Advanced Diagnostics  </span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5. Building consumer-initiated testing</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;1. Growing through acquisitions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We endeavor to grow revenue each year by more than 2% through accretive, strategic acquisitions (our target is based on our revenues excluding the revenues from our COVID -19 testing).  Acquisition opportunities may include IDN outreach businesses, regional laboratory consolidation and businesses that will provide us with new capabilities.  Our approach to acquisitions, and the key acquisitions we consummated during 2021, are discussed below under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deliver disciplined capital deployment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2. Capitalizing on increased health plan access.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We are focused on opportunities to partner with health plans.  We strengthen our relationships with health plans and increase the volume of our services for their members by focusing on driving value and providing strong value propositions for members and clinicians. This includes working with payers to reduce the cost of care, improve the customer experience and drive better outcomes for populations.  For example, we strive to build information platforms to help health plans manage utilization and population health, keep laboratory testing in network and provide an alternative to high-cost labs.  We also offer extended care services to help close gaps in care designed to be attractive to payers, for example through our Quest HealthConnect offerings.  In 2021, we made progress with value-based programs with UnitedHealthcare and broadened redirection and network leakage efforts with Anthem.  We also renewed our longstanding </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relationships with Aetna (remaining a preferred laboratory provider and partner in Aetna's network) and EmblemHealth (one of the nation's largest non-profit health insurers).  In addition, we expanded access, including with Highmark Delaware and other plans.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;3.  Increasing share with IDNs.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the growing market challenges faced by IDNs, including continued consolidation, price transparency, cost and utilization pressure, evolving healthcare payment models, capital needs, changing technology and limited resources, provide us with an opportunity to partner with them more effectively as they consider their laboratory testing strategy and drive demand for our expertise.   We have deployed a dedicated team to strengthen our relationships with IDNs, including with respect to their reference testing.  We target three specific segments: reference testing, outreach testing and lab management.  We provide reference testing for approximately half of the hospitals in the U.S. and are a leading provider of this testing in the country.  Our industry-leading Professional Laboratory Services, highlighted in Table 3, provides a suite of solutions to help IDNs build and execute their laboratory strategy, improve quality, reduce the cost of care and focus on core competencies.  We purchase outreach testing businesses from IDNs that decide to exit that business.  In 2021, we recorded our highest level of Professional Laboratory Services revenues to date and, as discussed below under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deliver disciplined capital deployment,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> acquired the outreach testing business of Mercy. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Professional Laboratory Services Offerings (Table 3)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab management outsourcing</span></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced data solutions</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test menu optimization and spend consolidation</span></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reference testing, including advanced diagnostics</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supply chain management and purchasing</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood utilization management</span></td></tr></table></div><div style="padding-left:54pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Growing Advanced Diagnostics.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We are a leading provider of Advanced Diagnostics, with an array of offerings across the spectrum.  We aim to accelerate the growth of our Advanced Diagnostics offerings to a growth rate of at least 8% per year.  We have been investing in our Advanced Diagnostics offerings, including to enhance our innovation capabilities and to strengthen our service offering and sales force, to make our Advanced Diagnostics offerings more attractive and accessible to IDNs and clinicians.  In addition, we have invested in reducing the cost of next-generation sequencing and combining that with the power of our Blueprint Genetics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> data analytics capabilities.  We are seeking to apply the capabilities gained by these efforts to other areas where we can make a meaningful difference in health care, including consumer genetics and offerings to pharmaceutical companies, IDNs and health plans.  In 2021, we expanded our offerings with the addition of Biocept Inc.'s liquid biopsy test for non-small cell lung cancer.  We also saw strong growth in non-invasive prenatal testing and a solid contribution in specialty genetics from Blueprint Genetics.   </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">               </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Building consumer-initiated testing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  For many years, we have been focused on the consumer, and have taken strong steps to be recognized as the consumer-friendly provider of choice of diagnostic information services.  Our strong consumer focus is highlighted in Table 4.  We will continue to focus on improving the consumer experience, including through improved digitization and other enhancements of our operations.  For example, in 2021 we improved the functionality of our MyQuest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> app, taking into account consumer feedback.   </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increasing consumer expectations inform our design for our consumer experience. </span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consumer-Centric Initiatives (Table 4)</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connectivity and access to information</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; &gt;21.5 million registered users in our MyQuest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> health portal and mobile connectivity solution, up nearly 7 million from a year ago.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;  Quest lab results available for Android users through the CommonHealth app.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; MyQuest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> supports Health Records using the Apple Health app.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Using MyQuest,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">consumers can manage healthcare for a group of individuals. </span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reminders</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Consumers whose physicians have ordered a test for them electronically can receive email reminders to complete the test.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Consumers who have made appointments can receive appointment reminders via text messaging.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enhanced experience</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Electronic check-in at patient service centers.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Improved on-line pre-registration and appointment scheduling.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Real-time payment determination for payers.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convenient access </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Partnerships with Walmart and Safeway to expand convenient access to testing services at select Walmart and Safeway locations across the United States (approximately 230 locations at year end).</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expanded access to basic healthcare services</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Partnership with Walmart to expand access to basic healthcare services.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Self-collection technology</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Proprietary, consumer-friendly self-collection technology offered to consumers at home. </span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Satisfaction</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; We are measuring consumer satisfaction, including Net Promoter Score.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2018, we launched QuestDirect</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, our consumer-initiated testing offering that permits consumers to request their own lab tests, to allow consumers to take control of their health and to better understand their own health through access to personal diagnostic information.  In an evolving healthcare environment, consumers are increasingly engaged in their health care and want control, a dynamic experience and convenience.  We believe that by building on the foundation of our strong consumer focus we can capture growing opportunities in consumer-initiated testing.  In 2021, we continued the strong growth in QuestDirect</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and launched our comprehensive consumer health profile, which offers consumers a picture of their own health through a battery of tests and biometric measurements that provides a personalized health quotient score that can be used to track health progress over time.  We also are extensively engaged with telehealth providers, supporting their offerings as a diagnostic information services provider.     </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are focusing on consumer interest to experience health care in a different way <br/>and empowering consumers to make important decisions about their health </span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consumer-Initiated Testing (Table 5)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer-initiated testing </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Consumers can choose from approximately 50 different test packages focused on consumer interests, such as general health, men's and women's health, digestive health, heart health, infectious disease, sexually transmitted disease, COVID-19 and Lyme disease.  In 2021, we expanded our offerings to include Insure</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> ONE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for colorectal cancer screening.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Self-collection technology</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; In 2021, we expanded our proprietary, consumer-friendly self-collection technology offered to consumers at home. </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convenient access </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Access to services in our patient service centers and in select Walmart stores</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convenient payment</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Introduced flexible payment options in 2021 </span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Drive operational excellence</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We strive to enhance operational excellence and improve our quality and efficiency across every portion of our value chain and operations, from the time that we interact with a potential customer until the time we receive payment.</span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Major Themes to Drive Operational Excellence (Table 6)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduce denials and patient concessions </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standardize and automate</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digitize the customer experience</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optimize</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Improving our operations will yield many benefits, including: enhancing customer experience; improving our quality and competitiveness; strengthening our foundation for growth; and increasing employee engagement and shareholder value.  We are building a superior experience, at lower cost, for all of our customers, including consumers, health plans, IDNs and clinicians.  We endeavor to improve our processes and effectiveness at the same time.  We are guided by a service dashboard that focuses throughout our operations on quality for consumers, healthcare providers and employees, including medical quality, on-time delivery, competitive costs and employee safety. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2021, we made strong progress on our improvement initiatives.  We completed the consolidation and integration of Northeast U.S. regional operations into our new 250,000 square foot, highly automated, flagship laboratory in Clifton, New Jersey.  We also commenced consolidation of our urinalysis testing onto a new highly automated platform that we expect will generate substantial savings once implemented.  We are taking advantage of robotic process automation technologies.  In addition, we also increased patient use of appointment scheduling, reduced payor denials and improved patient collection at the time of service.  We also are seeing increased patient and physician acceptance of the digitization of our service offerings, with more self-service options and a greater percentage of our volume moving to digital, paperless transactions.    </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our cost excellence program, Invigorate, includes structured plans to drive savings and improve productivity across the value chain, including in such areas as revenue services, information technology and procurement.  We currently aim annually to achieve savings and productivity improvements of 3% of our costs.  In 2021, we exceeded our goal. </span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_22"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR STRENGTHS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We offer high value diagnostic information services and diagnostic solutions that are attractive to our customers.  </span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Our Strengths (Table 7)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Strong Operating Principles</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets and Capabilities to Deliver Value </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Information Technology Solutions and <br/>Information Assets</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Innovation</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical and Scientific Expertise</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Focus</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our goal is to provide every patient with services and products of superior quality.  We strive to accomplish that through commitment, leadership, and establishing rigorous processes which we measure and continually seek to improve, and by using the Quest Management System, which provides best-in-class business performance tools to create and implement effective and sustainable quality processes.  The Quest Diagnostics Quality Program includes policies and procedures to document, measure and monitor the effectiveness of our laboratory operations in providing and improving quality and meeting applicable regulatory requirements.  The Quality Program is designed so that the quality of laboratory services is monitored objectively and evaluated systematically to deliver superior quality care, identify opportunities to improve patient care and resolve identified problems.  To help achieve our goal of becoming recognized as the undisputed quality leader in the diagnostics information services industry, we have implemented our Quality System Framework, which serves as a reference </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guide for our employees and describes our Quality System Elements, which provide the structure for each laboratory to achieve and maintain quality processes.   We also have a robust Supplier Quality Program designed to ensure we have a high-quality supplier network and to raise the bar of quality expectations across that network.  Being chosen by UnitedHealthcare as a participant in the UnitedHealthcare Preferred Lab Network reflects the strength of our quality.  For additional information about our commitment to quality, see "General - Quality Assurance" on page 25.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strong operating principles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have a foundation of three strong operating principles: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strengthen organizational capabilities; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">remain focused on diagnostic information services; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">deliver disciplined capital deployment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strengthen organizational capabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We continuously strive to strengthen our organizational capabilities to support our two-point strategy, enable growth and productivity, better focus on our customers, speed decision-making and empower employees.  Highlights include:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Align for Growth, Execution and Efficiency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Our organization is designed to align around future growth opportunities, coordinate business units for seamless execution and leverage our company-wide infrastructure to gain more capability, value and efficiency. We relied on this organizational design to allow us to develop a coordinated and sustained strategy to respond to the unprecedented challenges we face responding to the COVID-19 pandemic.  The value creation side of our business includes product and commercial marketing and is organized by clinical franchise and focuses on customer solutions for the marketplace, including new test development and diagnostic insights.  The value delivery side includes sales, laboratory operations, field operations, logistics and client services.   </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Quest Management System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This system provides a foundation for day-to-day management, and includes best-in-class business performance tools to help develop new capabilities to improve our Company.  The system enables us to run the Company with a common language, approach and philosophy, and supports our efforts to maintain a high-performance culture, with employees focused on behaviors to foster our agility, transparency, customer focus, collaboration and performance orientation.  </span></div><div style="padding-left:54pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remain focused on diagnostic information services.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We maintain a sharp focus on providing diagnostic information services.  During 2021, we sold to IQVIA Holdings Inc. our 40% minority stake in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> our clinical trials central laboratory services joint venture, and in connection with the sale we entered a multi-year agreement to continue to support Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions as its strategic preferred laboratory partner. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deliver disciplined capital deployment.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disciplined capital deployment framework includes investment in our business, dividends and share repurchases.  The framework is grounded in maintaining an investment grade credit rating.  We expect to return a majority of our free cash flow to investors through a combination of dividends and share repurchases.  Consistent with that expectation, in February 2022 we announced that we increased our quarterly common stock cash dividend by approximately 6.5%, from $0.62 per common share to $0.66 per common share.  This represents our eleventh increase in the dividend since 2011.  For many years, we have maintained a common stock repurchase program.  Since the beginning of 2013, we have returned approximately $5.7 billion to stockholders through repurchases of our common stock.  Our share repurchases, dividends and capital expenditures in each of the last three years are presented in our consolidated financial statements (Part II, Item&#160;8 of this Report).  </span></div><div style="padding-left:54pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's strategy includes generating growth through value-creating, strategically-aligned acquisitions using disciplined investment criteria.  We screen potential acquisitions using guidelines that assess strategic fit and financial considerations, including value creation, return on invested capital and impact on our earnings.  In 2021, we consummated the acquisition of the outreach laboratory services business of Mercy, one of the most highly-integrated, multi-state health care systems, with operations serving providers and patients in Arkansas, Kansas, Missouri and Oklahoma.  We also acquired assets of Labtech Diagnostics LLC, an independent clinical laboratory serving physicians and patients primarily in South Carolina, North Carolina, Georgia and Florida, and a couple of other small independent regional labs.  Our significant acquisitions in each of the last three years are further discussed in Note 5 to the audited consolidated financial statements (Part II, Item&#160;8 of this Report).</span></div><div style="padding-left:54pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will continue to invest in our business in a disciplined manner, including focusing on enhancing our solid foundation of strategic assets and capabilities, accelerating growth and driving operational excellence.  Our near-term investments in growth are likely to focus on the approaches to accelerate growth set forth in table 2 above.  Our near-term investments to drive operational excellence are likely to focus on improving the customer experience and gaining efficiency, systems standardization, digital enablement of our processes and footprint optimization. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets and capabilities to deliver value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We use our unmatched size, scale and capabilities to deliver a very attractive value proposition to our customers.</span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets and Capabilities (Table 8)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Connectivity </span></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Provide healthcare connectivity solutions to &gt;445,000 clinician and IDN accounts and interface with  &gt;800 electronic health records systems</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Data  </span></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   The largest private database of de-identifiable laboratory test results: &gt;60 billion patient data points </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Logistics  </span></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Strong logistics capabilities </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    make &gt;75,000 stops daily</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    approximately 4,000 courier vehicles</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   &gt;20 aircraft serving the U.S.</span></div><div style="padding-left:9pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Medical and Scientific Staff </span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    One of the largest medical and scientific staffs in the industry to provide interpretive consultation </span></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    &gt;650 M.D.s and Ph.D.s, many of whom are recognized leaders in their field </span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Genetic counselors</span></div><div style="padding-left:9pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Healthcare Professionals  </span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Approximately 24,000 phlebotomists, paramedics, nurses and other health and wellness professionals</span></div><div style="padding-left:9pt;text-indent:-13.5pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Consumer Access </span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   &gt;7,100 patient access points, including phlebotomists in physician offices and the most extensive patient service center network in the U.S. with &gt;2,100 locations </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Health Plan Participation</span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Access to approximately 90% of U.S. insured lives</span></div><div style="padding-left:9pt;text-indent:-13.5pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Processing Volume</span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Processed approximately 218 million test requisitions in 2021</span></div><div style="padding-left:9pt;text-indent:-13.5pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Range of Testing  </span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Industry-leading test menu across clinical sub-specialty areas and diagnostic technologies </span></div><div style="padding-left:9pt;text-indent:-13.5pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Patents</span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Own or control approximately 1,100 issued and over 450 pending patents worldwide in 2021</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Innovation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are a leading innovator in diagnostic information services.  We develop and introduce new tests, including many with a focus on personalized and targeted medicine, and new services.  Our capabilities include discovery, technology development and clinical validation of diagnostic tests.  We also partner with other developers of new technologies, services and tests to transfer their innovations to the marketplace, using our in-house expertise (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, strength in assay development and commercialization of testing services).  These developers include large commercial manufacturers, the academic community, pharmaceutical and biotechnology firms, emerging medical technology companies and others that develop and commercialize novel diagnostics, pharmaceutical and device technologies.  We maintain relationships with advisers and consultants who are leaders in key fields of science and medicine.  As the industry leader with the largest and broadest U.S. network, we believe we are the distribution channel of choice for developers of new solutions.       </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.674%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our clinical franchises enable us to perform like a boutique while maintaining our scale advantages, and work with our research and development and commercial organizations to identify/deliver new and improved solutions.</span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Clinical Franchises (Table 9)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular, Metabolic and Endocrinology</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer Diagnostics</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Health and Wellness</span></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drug Monitoring and Toxicology</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Diseases and Immunology</span></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sports Science and Human Performance</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurology</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women&#8217;s and Reproductive Health</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek innovations and solutions that help healthcare providers, IDNs, health plans and other healthcare market participants care for their patients through better testing for predisposition, screening, monitoring, diagnosis, prognosis and treatment choices, and that deliver high clinical value to the medical community and reduce the overall cost of healthcare.  Starting with a clinical focus on a specific disease state or clinical problem, we take advantage of advanced technology for more precise, comprehensive and actionable information.  We seek to develop innovations and solutions that help to determine a patient's genotype or gene expression profile relative to a particular disease and its potential therapies, because they can help healthcare providers to determine a patient's susceptibility to disease or to tailor medical care to an individual's needs.  This would include determining if a medication might be an optimum choice for a particular person, or tailoring the right dosage once the proper medicine is prescribed.  We endeavor to improve test processes, including through increased automation.  In addition, we aim to develop holistic solutions responsive to challenges that healthcare providers and patients face, by developing solutions of tests, information and services focused on specific clinical challenges, and taking advantage of the latest healthcare data capabilities.   We also look for innovations and solutions that are less invasive than currently available options, and to increase the choices that healthcare providers and patients have for the collection of diagnostic samples.  We seek innovation in the ways we bring solutions to customers, and in the customer experience, including enhanced services and end-to-end solutions for convenience and support. We make innovative solutions available to community physicians through our connectivity solutions, operational footprint and by making complex results actionable.  We plan to expand our innovative solutions through research and development, as well as partnerships with academic institutions, other technology and healthcare leaders and public health agencies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Since the beginning of the COVID-19 pandemic, we have secured an Emergency Use Authorization from the FDA for pooled specimen testing in connection with molecular diagnostic COVID-19 testing.  With government and private sector partners, we developed and built "pop-up" COVID-19 testing sites that offered a new, efficient model for consumer access to testing at a critical time.  During 2021, we introduced a new COVID-19 semi-quantitative serology test service that aids in providing insight into an individual's immune response as a result of a recent or prior infection with SARS-CoV-2, including assessing blood levels of antibodies.  In addition, we licensed the patented ceramide-analysis technology of Zora Biosciences Oy and announced plans to develop, and offer through our Cardiometabolic Center of Excellence at Cleveland Heartlab, a test service as an aid in identifying patients at risk for cardiovascular-related disease and death.  These initiatives, along with other developments highlighted below under the headings "Collaboration," Medical and Scientific Expertise," and "Healthcare Information Technology Solutions and Information Assets," demonstrate our agility and strength in innovation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that strategic relationships, including with healthcare providers, public health authorities, consumer-focused entities and others, can position us for growth at the center of healthcare and that healthcare companies that can partner effectively with others will be successful in the long term.  We collaborate with partners that can help us to achieve our vision of empowering better health through diagnostic insights and have relationships across the spectrum of healthcare, including with world class healthcare and consumer-focused leaders, to foster important advances in healthcare, including in precision medicine and healthcare delivery.  We plan to continue to pursue strategic relationships to help accelerate growth and drive operational excellence.  In 2021, we announced our collaboration with Paige to unlock the potential of artificial intelligence to improve and speed the diagnosis of cancer and other diseases that rely on pathologic assessment.   We also collaborated with CIC Health, Ginko Bioworks and Battelle Memorial Institute to develop solutions to make testing easy, fast and affordable for school systems and other group settings (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., the travel and entertainment industry) across the country.   </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical and Scientific Expertise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;We have strong medical and scientific expertise and aspire to be a trusted authority in diagnostic medicine, provide insights and tools to support public and personal health, lead and facilitate scientific discussion and inspire innovation.  Our medical and scientific experts regularly provide presentations, symposia and webinars regarding diagnostic testing and participate on scientific committees determining guidelines for diagnostic usage.  They also publish research that demonstrates the clinical value and importance of diagnostic testing, including in connection with our research and development efforts, in peer-reviewed journals, textbooks and other publications.  For over 30 years, the Company has published the Quest Diagnostics Drug Testing Index,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a series of reports on national workplace drug positivity trends based on the Company's employer workplace drug testing data, that is widely cited by employers, the federal government and the media to help identify and quantify drug abuse among the nation's workforce.  The Company also publishes Quest Diagnostics Health Trends,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> a series of scientific reports that provide insights into health topics, based on analysis of objective clinical laboratory data, to empower better patient care, population health management and public health policy.  Our role at the forefront of the response to the COVID-19 pandemic demonstrated this strength.  We have secured over 20 Emergency Use Authorizations from the FDA for innovations in connection with COVID-19 testing and specimen collection, including regarding unobserved nasal specimen self-collection, combined COVID-19 and respiratory virus tests, COVID-19 at-home specimen collection by consumers, and methods to increase testing capacity and expand the testing supply base.  In addition to a Health Trends</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> report on children in the U.S. with detectable levels of lead in their blood, we published numerous Health Trends</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> reports on COVID-19, including during 2021 additional reports addressing the "hidden pandemic": signs of addiction missed during the pandemic; the sharp decline in cancer diagnoses during the first year of the pandemic; decreases in hepatitis C testing and treatment during the first months of the pandemic; and Blacks and Hispanic/Latinx less confident in their ability to access COVID-19 vaccines, treatment and healthcare than white Americans.  We also expanded our engagement with the Centers for Disease Control and Prevention to provide genomic sequencing of emerging COVID-19 variants, to aid public health response to COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Information Technology Solutions and Information Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have a history of providing leading information technology for diagnostic information services, including for patients, clinicians and healthcare organizations.   We were the first national diagnostic information services provider to offer online patient appointment scheduling and a patient connectivity solution.  Our MyQuest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patient healthcare portal, with 21.5 million registered users at year-end 2021, enables patients to manage healthcare and medical information for themselves and a circle of others and, among other things, use their smartphone or computer to order a test, find a Quest Diagnostics location, schedule appointments, receive appointment reminders, and receive and archive their test resul</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ts. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the COVID-19 pandemic, we collaborated with CLEAR to integrate CLEAR's safe and secure "Health Pass" technology with the Company's advanced COVID-19 testing capabilities to foster safer public environments and help reduce public health risk.  We also are a founding member of the Synaptic Healthcare Alliance, which is working to create a platform, powered by blockchain technology, that enables a culture of innovation, removes friction and solves shared challenges impacting constituents across healthcare today.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also have significant information assets and offer a robust portfolio of powerful analytics that inspire action and deliver value to an array of customers.  We offer an array of Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> solutions based on data insights, including retrospective analytics solutions for healthcare professionals and practices, health plans, IDNs, pharmaceutical companies and public health organizations.  We believe that solutions can tap the potential of large amounts of clinical information to: enhance the customer experience; deliver more precise, comprehensive solutions and actionable information; provide increased and interactive insights and analytics; foster greater adherence to clinical and reimbursement guidelines; and advance the development of precision medicine.  We believe that the breadth and depth of our data, combined with our powerful analytics capabilities, enables us to take advantage of important data-based opportunities in diagnostics, and provides us a competitive advantage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Focus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our brand idea -- Action from Insight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-- reflects our commitment to a superior customer experience.  The customer is at the center of everything we do; we strive to give them reason to put their trust in us.&#160; We use customer insights in developing our approach, listening to the voice of customers to identify and implement solutions and processes that will result in a superior customer experience.&#160; We also maintain our Everyday Excellence program, which includes guiding principles to support a superior customer experience, inspiring our employees to be their best every day, with every person and with every customer interaction. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11 </span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is made up of two businesses:  Diagnostic Information Services and Diagnostic Solutions.  Our Diagnostic Information Services business develops and delivers diagnostic information services, providing insights that empower and enable a broad range of customers, including those discussed in table 13.  Our Diagnostic Solutions group includes our risk assessment services business, which offers solutions for insurers, and our healthcare information technology businesses, which offers solutions for healthcare providers.  Our services primarily are provided under the Quest Diagnostics brand, but we also provide services under other brands, including AmeriPath,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dermpath Diagnostics,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ExamOne,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Quanum.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are the leading provider in the United States, where we conduct substantially all of our business, of clinical laboratory and anatomic pathology testing, and related services.  We see opportunities to bring our experience and expertise in diagnostic information services to markets outside the United States, including leveraging existing facilities to serve new markets.  We have laboratory facilities in Finland, Mexico and Puerto Rico.  We are a founding member, with other leading diagnostic laboratories outside the United States, of the Global Diagnostics Network,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a strategic working group of diagnostic laboratories committed to unleashing and sharing local innovation to increase global access to diagnostic science, information and services and generating enhanced diagnostic insights to improve the delivery of global healthcare.  The Company and fellow members of the Network are focused on response to the COVID-19 pandemic and preparedness for future global infectious diseases.  </span></div><div><span><br/></span></div><div style="text-align:center"><img src="dgx-20211231_g3.jpg" alt="dgx-20211231_g3.jpg" style="height:228px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Information Services&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background - clinical testing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   Clinical testing is an essential element in the delivery of healthcare services.  Clinical testing is used for predisposition, screening, monitoring, diagnosis, prognosis and treatment choices of diseases and other medical conditions.  Clinical testing is generally categorized as clinical laboratory testing and anatomic pathology services.   Anatomic pathology involves the diagnosis of cancer and other diseases and medical conditions through examination of tissue and cell samples taken from patients. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Clinical laboratory testing, which can be characterized as routine, non-routine or advanced, generally is performed on whole blood, serum, plasma and other body fluids, such as urine, and specimens such as microbiology samples.  Clinical laboratory tests which can be performed by most clinical laboratories are considered routine.  Routine testing measures various important bodily health parameters such as the functions of the kidney, heart, liver, thyroid and other organs.  Commonly ordered routine tests include blood chemistries, urinalysis, allergy tests and complete blood cell counts.  Non-routine tests may require professional &#8220;hands-on&#8221; attention from highly-skilled technical personnel, generally require more sophisticated data analysis, technology, equipment or materials, may be performed less frequently than routine tests and may be reimbursed at higher levels than routine tests.  It may not be practical, from a cost-effectiveness or infrastructure perspective, for many IDNs, ACOs, DCEs, commercial laboratories or physician office laboratories to develop and perform a broad menu of non-routine tests, or to perform low-volume non-routine testing in-house.  Such tests generally are outsourced to a clinical testing laboratory which can perform these non-routine tests.  Some non-routine tests are advanced.  Advanced tests include procedures in the areas of molecular diagnostics (including next-generation sequencing), oncology, neurology, companion diagnostics and non-invasive pre-natal and other germline genetic testing. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our services. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the world's leading provider of diagnostic information services.  We provide information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  We have strong testing capabilities, including services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases, and offer advanced tests in many fields, including endocrinology, immunology, neurology and oncology.  Increasingly, we are focused on providing solutions and insights to our customers, based on the testing that we perform, the data that we gather and our extensive medical, information and connectivity assets.  We believe that offering services, solutions and insights based on a full range of tests, information assets and other capabilities strengthens our market offering, market position and reputation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer the broadest access in the United States to clinical testing.  We maintain a nationwide network of laboratories, including advanced laboratories (such as our world-renowned Quest Diagnostics Nichols Institute</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) as well as rapid response laboratories (smaller facilities where we can quickly perform an abbreviated menu of routine tests for customers that require rapid turnaround times).  We operate 24 hours a day, 365 days a year.  Our nationwide network also includes patient service centers, phlebotomists in physician offices, and our connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  Our large in-house staff of medical and scientific experts, including medical directors, scientific directors, genetic counselors and board-certified geneticists, provide medical and scientific consultation to healthcare providers and patients regarding our tests and test results, and help them best utilize our services to improve outcomes and enhance satisfaction.   We also provide testing (including anatomic pathology) services and medical director services at IDN laboratories.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  We are a leading provider of diagnostic information services for infectious disease, such as COVID-19 (including molecular diagnostic and serology antibody offerings), tuberculosis (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our T.SPOT.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Quantiferon offerings) and tick-borne disease (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our Accutix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> offering).  We strive to be the first to provide diagnostic solutions for emerging infectious diseases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., our offerings for Zika, West Nile Virus, SARS and Influenza A H1N1).  We have leading positions in drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., our CardioIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Cleveland HeartLab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offerings through our Cardiometabolic Center of Excellence</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), and in cancer diagnostics (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., our QuestVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Med Fusion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> offerings).  We are a leader in providing testing for the detection of employee use of drugs of abuse, offering a full range of solutions, including urine, hair, blood and oral fluid tests.  We are the largest workplace drug testing provider certified by the U.S. Department of Health and Human Services to perform drug testing using electronic custody and control forms for federally-mandated, safety-sensitive workers.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are a leading provider of employer population health services, including biometric screenings, flu shots and related preventative services that leverage clinical data to improve population health outcomes and reduce healthcare spend.  Our solutions enable employers to leverage screening insights to identify chronic disease risks, connect employees to needed in-network care, and empower better health.  Our offerings include connecting participants to the right care at the right time, such as (i) a program designed to prevent diabetes and other chronic conditions, (ii) a program that enables participants to engage with a board-certified physician about their results and to be guided about actions based on those results and (iii) a mental health assessment program that links participants to virtual support.  We also collaborate with Catapult Health, the leading national provider of employer-sponsored preventative checkups, to help organizations facilitate virtual telehealth access to clinical services for their employees and adult dependents, with emphasis on reducing risks related to preventable chronic diseases.  These services are sold directly to employers and through reseller partnerships with health plans. In response to the COVID-19 pandemic, we developed and offered COVID-19 return to work services, to assist organizations as they developed plans for safer workplaces. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">health information technology solutions, including our products and national healthcare provider network, to help healthcare organizations and clinicians empower better health by leveraging the power of our significant information assets, including many years of test result data, and our technology prowess, including our history of providing leading information technology for diagnostic information services.  Our portfolio of offerings is designed to address analytic, clinical and financial needs.  The solutions help healthcare organizations and clinicians analyze and put in context data, and enable them to connect across the healthcare system and engage with their stakeholders.  They can enter, share and access clinical information without costly information technology implementation or significant workflow disruption.  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer an array of population health solutions to clinicians, health plans, and IDNs.  Our services build on the power of our information assets and data capabilities and help our customers deliver better care to their patient populations by identifying gaps in care in a population, providing clinical solutions to close the gaps and fostering consumer engagement with a solution.  For example, Quest Lab Stewardship</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> employs machine learning to help optimize medically-appropriate laboratory test utilization.  Our extended care services, including home-based health risk assessments and related services, help deliver better care to their patient populations by identifying and filling gaps in care for their patient populations and by enabling them to deliver the most effective healthcare to the right populations and individuals.  These services leverage the power of our assets (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., our extensive clinical data and data analytics services) and capabilities (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., call centers, patient service centers and mobile workforce, including professionals) and focus on extending the reach of clinician offices beyond their traditional four walls to assess the health of their populations, and doing so when and where it is convenient for consumers.  Once gaps are identified, we engage patients in our retail sites, in home or by telephone, including through our call centers and our mobile base capabilities, including highly-trained healthcare professionals.  We also offer services such as diabetic retinopathy and bone density examinations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer services to pharmaceutical companies, including clinical trials testing.  We have expertise in developing laboratory tests for FDA submission as companion diagnostics and laboratory developed tests for complementary diagnostics, and offer an array of assets and services to support the development of companion diagnostics, including our robust data set and patient services network. For example, in 2021, we introduced Ki-67 IHC MIB-1 pharmDx, the first companion diagnostic for Eli Lilly and Company's Verzenio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  (abemaciclib), a CDK4/6 inhibitor for certain people with HR+HER2- High Risk early breast cancer.  We also offer Quest Clinical Trials Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to help accelerate clinical trials (and thus the speed of drugs to market) through better patient recruitment, involvement and management, and improved physician outreach. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also offer sports teams, including at the professional and collegiate levels, our BluePrint for Athletes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> performance tools, based on biomarker testing, designed to optimize high-level athletic performance through actionable insights.  This service provides the context for athletes to consider performance variables holistically, including nutritional education and intervention, maximum fitness, injury assessment and training load monitoring as well as sophisticated biometric analysis.  During the COVID-19 pandemic, we also expanded our test offerings for athletes to include COVID-19 testing, to foster the country's return to athletic fields.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Solutions </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Assessment Services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ExamOne</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the largest provider of risk assessment services to the life insurance industry in North America.  Our risk assessment services comprise underwriting support services, including data gathering, paramedical examinations and clinical laboratory testing and analytics, designed to assist life insurance companies objectively to evaluate the mortality risks of applicants.  Most specimen collections and paramedical examinations are performed by our network of paramedical examiners at the applicant's home or workplace, but they also are offered at hundreds of Company patient service centers and hundreds of additional North American locations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Information Technology. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We offer healthcare organizations and clinicians robust health information technology solutions.  Our healthcare information technology offerings, including Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Practice Solutions, our Electronic Health Record, Practice Management and Revenue Cycle Management Solutions for healthcare providers, and our award-winning Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Enterprise Content Solutions for IDNs, connect data to decision-making and help clinicians advance clinical and operational strategies.  Healthcare organizations use Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Enterprise Content Solutions at over 375 sites in North America.  Our Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Electronic Health Record is a cloud-based, mobile-accessible offering that enables clinicians to generate a complete record of a clinical patient encounter, automates and streamlines the clinician's workflow, provides clinical decision support tools, captures patient encounter notes and lab and radiology results and enables secure communication with patients and other clinicians.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CLINICAL TESTING INDUSTRY</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Trends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The healthcare system in the United States is evolving; significant change is taking place in the system.   We expect that the evolution of the healthcare industry, including impacts of the COVID-19 pandemic, which include the increased adoption of telemedicine, will continue, and that industry change is likely to be extensive.  There are a number of key trends that are having, and that we expect will continue to have, a significant impact on the diagnostic information services business in the United States and on our business.  These trends, discussed in the table below, present both opportunities and risks.  We believe that several of the trends, including consolidation, price transparency and consumerization, are favorable to our business.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Because diagnostic information services is an essential healthcare service and because of the key trends discussed below, we believe that the industry will continue to grow over the long term.  In addition, we believe that the clinical testing market continued with fundamental changes in 2021.  First, we believe that PAMA-driven reimbursement pressure is a catalyst for structural change in the market.  Second, we believe that health plans increasingly are focusing on driving better value in laboratory testing services.  Third, we believe that ongoing consumerization in healthcare, with increased cost being borne by consumers, is changing consumption of healthcare services.  We believe that these changing market fundamentals will benefit lower-cost, high-value providers like Quest and that we are well positioned to grow from the changing market conditions and benefit from the long-term growth expected in the industry.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Trends (Table 11)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">PAMA-driven reimbursement pressure</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to PAMA, reimbursement rates for many clinical laboratory tests provided under Medicare were reduced during 2018 - 2020.  PAMA calls for further revision of the Medicare Clinical Laboratory Fee Schedule for years after 2020, based on future surveys of market rates; reimbursement rate reduction from 2023-25 is capped by PAMA at 15% annually. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PAMA's next data collection and reporting period have been delayed, most recently by federal legislation adopted in December 2021, which further delayed the reimbursement rate reductions and reporting requirements until January 1, 2023.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The American Clinical Laboratory Association, of which the Company is a member, initiated a lawsuit charging that in implementing PAMA, CMS failed to follow a Congressional directive to implement a market-based laboratory payment system.  The lawsuit is pending. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/><br/></span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Health plans driving value in lab spending</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDNs, which provide outreach testing and may encourage clinicians to send their outreach testing volume to the IDN's laboratory, historically were able to negotiate higher reimbursement rates with health plans than commercial clinical laboratories for comparable services.   In addition, health plans generally reimburse non-participating laboratory testing providers at higher out-of-network rates.  We are finding increased interest among health plans in driving better value in spending for laboratory testing.  Health plans increasingly are taking steps to encourage the movement of testing volume to high value, lower cost providers like our Company, including by identifying preferred provider partners, plan design changes (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., zero-dollar out-of-pocket costs for members using preferred providers) and better aligning reimbursement rates for IDN-based providers and independent commercial laboratories.  The UnitedHealthcare Preferred Lab Network, which chose us to participate, is a recent example of a health plan taking these steps.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health plans also are increasingly adopting policies, practices and procedures based on requirements imposed by government payers such as Medicare and Medicaid in order to influence the utilization and reimbursement of testing services.  These policies, practices and procedures are subject to change without notice.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Consumerization</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumers are our customers.  Increasingly, consumers are engaged and interested in, and empowered to manage and take direct responsibility for, their own healthcare.  As a result, they are more sophisticated in their understanding of their healthcare needs and their expectations of healthcare providers.  Some consumers are interested in selecting their own diagnostics tests, rather than relying upon a healthcare professional to select the tests.  In addition, consumers often are bearing increased financial responsibility for their healthcare (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., high deductible health plans; rising deductibles).  In our experience, consumers are more focused on transparency, ease of doing business and understanding diagnostics information services than they have been in the past.  Consumers increasingly are demanding convenience; a superior and personalized experience relevant to their needs; and to be empowered to make their own healthcare decisions.  During the COVID-19 pandemic, we are seeing consumers increase their use of telemedicine capabilities, increase their responsibility for their own healthcare (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, increased consumer-initiated testing; increased specimen self-collection) and increase their openness to new delivery channels (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., retail; convenient "pop-up" test centers).  In addition, consumers are seeking prompt, direct access to their test results.  Increasingly, consumers are motivated to find high quality service providers with strong digital experience delivery engines, accessible customer service and lower prices, like our Company.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Prevention and wellness</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We believe that the value of detection, prevention, wellness and personalized care is well recognized. Government agencies and other customers discussed in table 13 increasingly focus on helping the healthy stay healthy, detecting symptoms among those at risk and providing preventive insight and care that helps avoid disease. </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Medical innovation</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical advances allow for more accurate and earlier diagnosis and treatment of diseases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing advances in genomics and proteomics are expected to yield new, more sophisticated and specialized diagnostic tests. These advances also are spurring interest in and demand for precision medicine, which relies on diagnostic and prognostic testing and in which data information services and strategies are used to deliver the most effective healthcare to the right populations and individuals. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacogenomic testing increasingly is used as a parameter to help speed drug approval processes and to better focus therapy based on patient and tumor-specific genetic markers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demand also is growing toward comprehensive care management solutions that serve patients, payers and healthcare providers by improving clinical decision support and access to patient data, and by increasing patient participation in care management and population health management.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Innovation also includes making healthcare services, including laboratory testing services, more convenient for populations and consumers to access, including at home (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., telehealth) or in retail settings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There is increasing focus on access to patient data and data-driven insights.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Healthcare industry evolution</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customers discussed in table 13 and other healthcare system participants have been consolidating, converging and diversifying. For example, a number of IDNs are considering establishing or have established health insurance plans, and health insurance providers are considering providing or are providing healthcare services.   In recent years, a leading provider of retail medical clinics and pharmacy benefits management services has acquired a leading health insurance provider, a leading health insurance provider has acquired a leading pharmacy benefits manager, and the corporate parent of a leading health insurance company provides a wide array of healthcare services through its non-insurance company subsidiaries.   Health plans are entering agreements with other providers of healthcare services, including laboratory testing services providers, to partner on value-based approaches to delivering healthcare to populations.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidation is increasing pricing transparency and bargaining power, and may encourage internalization of clinical testing.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians frequently now are employed by IDNs, ACOs, DCEs or large group practices integrated with IDNs, instead of organizing physician-owned practices, which is impacting the dynamics for whether clinical testing is performed in or outside of an IDN.  Physicians and other clinicians also increasingly are being employed by health plans or their affiliates.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-based reimbursement is contributing to changes in the healthcare system.  ACOs, DCEs and patient-centered medical homes have grown as a means to deliver patient care.  Healthcare services increasingly are being provided by non-traditional providers (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, physician assistants), in non-traditional venues (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., retail medical clinics, urgent care centers) and using new technologies (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, telemedicine, digital pathology).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes are taking place in the way that some healthcare services are purchased and delivered in the United States.  IDNs are under significant pressure, and are evolving.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pricing transparency</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There has been a trend toward greater pricing transparency in healthcare, including in the laboratory testing marketplace.  Several states have taken action to foster greater pricing transparency in healthcare.  For example, Massachusetts launched a website to help consumers understand the wide variation in healthcare costs.  Federal laws effective January 1, 2022 require health care providers to provide good faith estimates of costs to self-pay patients, and provide rights and protections for consumers against surprise billing or balance billing.  In addition, the federal government requires providers of COVID-19 testing to post on their websites information regarding test pricing, and has adopted new legislation and issued new regulations designed to increase transparency regarding pricing and quality in healthcare, including requiring providers, group health plans and insurers to disclose cost information to consumers in advance of care being provided.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increased price transparency, combined with increased patient financial responsibility for medical care, is enhancing purchasing sophistication and fostering changes in behavior in the healthcare marketplace.  We believe that increased price transparency should benefit lower cost, high value providers like our Company.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Competition</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The diagnostic information services industry remains fragmented, is highly competitive and is subject to new competition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Competition is emerging from new technologies (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., digital pathology) and growing from non-traditional competitors (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., a government agency or an employer establishing its own clinical laboratory for testing; providers of consumer-initiated testing).  Increased IDN acquisitions of physician practices may enhance clinician ties to IDN-affiliated laboratories and may strengthen their competitive position.  However, in light of other trends, including continued reimbursement pressure, IDNs may change their approach to providing clinical testing services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New industry entrants with extensive resources may make acquisitions or expand into our traditional areas of operations.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Healthcare utilization<br/></span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare utilization in the United States has fluctuated based on a number of factors.  These factors include, without limitation, the economy, healthcare benefits design, patients delaying medical care (e.g., due to the COVID-19 pandemic), and increased consumer financial responsibility for, interest in and control of their healthcare.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reimbursement pressure; affordability</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There is a strong focus in the United States on controlling the overall cost of healthcare. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare market participants, including governments, are focused on controlling costs. Examples of cost control approaches include reducing reimbursement for healthcare services, changing reimbursement for healthcare services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., shift from fee for service to capitation), changing medical coverage policies (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., healthcare benefits design), denying coverage for services, requiring preauthorization of laboratory testing, requiring co-pays, introducing laboratory spend management utilities and payment and patient care innovations such as ACOs, DCEs and patient-centered medical homes.  CMS has set goals for value-based reimbursement to be achieved in Medicare.  There is increased market activity regarding alternative payment models, including bundled payment models.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Health Transformation Alliance, a group of over 50 major U.S. companies, was formed to improve and reform the healthcare system in the United States.  The rising cost of healthcare in the United States was a key driver for the formation of this alliance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">While pressure to control healthcare costs poses a risk to our Company, it also creates opportunities, such as an opportunity for increased proper utilization of testing as an efficient means to manage the total cost of healthcare.  We believe that it also creates greater opportunities for consolidation and gaining share for high value, lower-cost providers, like our Company, as compared to other providers.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Legislative, regulatory and policy environment</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government oversight of and attention to the healthcare industry in the United States is significant and increasing; healthcare payment reform and cost transparency are significant issues.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legislation introduced in Congress would enable the FDA to regulate LDTs, in vitro diagnostics, software and other items used in the diagnosis of disease.  If the legislation becomes law, the FDA could regulate diagnostic tests and components and platforms used as part of these tests.  The FDA and HHS also have expressed views regarding the regulation of LDTs. Either new law or a revised approach to regulation of LDTs could have a significant impact on the clinical laboratory testing industry, including regulating LDTs in new ways, while creating avenues of opportunity and competition regarding clinical laboratory testing.  New competitors may enter the industry, and competition may come in new forms. </span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Use of healthcare data; technology </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The increased availability of healthcare data, including data made available as a result of next generation DNA sequencing, and the increased ability to effectively analyze that data at population and patient levels, is impacting healthcare practices.  It is anticipated that the increased use of data in healthcare, coupled with mobile healthcare IT solutions for doctors and patients, will help to improve patient outcomes and reduce overall healthcare costs.  We provide automated next generation genetic sequencing, which will enable genetic screening faster and at lower cost.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Use of healthcare data, including integrated diagnostic and decision support solutions, predictive analytics, and healthcare information technology, is spurring advances in precision medicine, including medical decision making and value, for populations and individuals.  The increased focus on data and its use is increasing focus on maintaining the privacy of patient data.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There is a need for technology solutions to harness these opportunities.  In addition, new technology, social media and mobile technology are changing the way that healthcare markets interact with each other, and the expectations that they have about how services are provided, what services are provided, and other capabilities of healthcare market participants.  These developments are creating new opportunities and new challenges and disrupting the healthcare environment. For example, during the COVID-19 pandemic, telemedicine practices became more commonly used; digital pathology is an emerging technology that may change the practice of pathology.  Information technology that includes self-learning or "artificial intelligence" features is growing and may impact the healthcare industry. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare market participants, including many of our customers discussed in table 13, are striving to leverage interoperability and healthcare data analysis to positively influence the health of patient populations while maintaining patient privacy.<br/></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chronic diseases and conditions; gaps in care</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We believe that the cost and challenges of identifying, treating and controlling chronic diseases and conditions such as diabetes and heart disease are now well recognized.    <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a result of multiple factors, including increased focus on population health management and pressure to reduce the systemic costs associated with such diseases and conditions, there is increased focus on better identifying and attempting to reduce or eliminate the gaps in care historically associated with these diseases and conditions.  Healthcare market participants are developing new approaches for this purpose.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a result of the COVID-19 pandemic, there has been an increase in delays in diagnosis and treatment of chronic diseases and conditions, particularly in underserved communities, increasing potential gaps in care.  The COVID-19 pandemic called attention to gaps in care of these conditions in underserved populations; we believe that there also is increased focus on reducing or eliminating these gaps in care.  </span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Healthcare services delivery </span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare delivery is moving out of hospitals, clinician offices and other traditional locations in which it had been provided.  Care is increasingly being provided in new settings, such as outpatient, consumer-focused and home settings.  In response to the COVID-19 pandemic, telemedicine practices became more commonly used.  In addition, see the discussion of Emerging Retail Healthcare Providers in table 13.  This dynamic offers new opportunities and challenges for healthcare providers and reflects not only efforts to take advantage of new technologies, but also the trends of consumerization and affordability, each of which are discussed above in this table.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Value of Diagnostic Information Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There is an increased focus on the affordability of healthcare and on a disease-oriented approach to diagnostics, treatment and management. Healthcare providers, consumers and payers increasingly recognize the value of diagnostic information services as a means to improve health and reduce the overall cost of healthcare through early detection, prevention and treatment.  Healthcare providers increasingly rely on diagnostic information services to help identify risk for a disease, to detect the symptoms of disease earlier, to aid in the choice of therapeutic regimen, to monitor patient compliance and to evaluate treatment results.  Table 12 highlights how diagnostic information services contribute to improving care and reducing healthcare costs. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reducing Healthcare Costs and Improving Care (Table 12)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Identifying patients at risk for disease before they require urgent care, hospital treatment or expensive therapies</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Helping clinicians to target the right medicines for the right patients at the right time</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Identifying treatment-related side effects</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Assessing early the efficacy of a therapy, enabling changes or discontinuation of ineffective therapies</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Enabling population health management by identifying gaps in care and delivery of targeted solutions to individuals who need care</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Identifying and proactively managing individuals at risk for chronic diseases, to decrease progression and associated costs and morbidity</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Providing telemedicine services along with laboratory testing to help individuals interpret and obtain appropriate advice and referrals into needed care</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We provide diagnostic information services to a broad range of customers, including those discussed in table 13.  As discussed in table 11 above, customers are consolidating, converging and diversifying.  In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or a Medicaid program.  Increasingly, patients are bearing greater responsibility for some portion of the payment for the services we provide to them, even if a third party is primarily responsible for payment.  In addition, consumers are more frequently taking advantage of offerings like the Company's QuestDirect</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> offering, and requesting and paying for tests themselves.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Customers (Table 13)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Health plans including managed care organizations and other health insurance providers</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">These customers typically reimburse us as a contracted (or out-of-network) provider for services rendered to their members.  In certain locations, health plans may delegate to IPAs or other alternative delivery systems (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., physician IDN organizations, ACOs, DCEs, patient-centered medical homes) the ability to negotiate for diagnostic information services on behalf of certain members.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health plans and IPAs often require that diagnostic information services providers accept discounted fee structures or assume all or a portion of the financial risk associated with providing such services through capitated payment arrangements. Under capitated payment arrangements, we provide services at a predetermined monthly reimbursement rate for each covered member, generally regardless of the number or cost of services provided by us.  Under some capitated programs, we may provide certain services on a negotiated fee-for-service basis.  Reimbursement under programs that do not provide for capitated payments is typically negotiated on a fee-for-service basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursement from our five largest health plans totaled approximately 20%, and no one health plan accounted for 10%, of our consolidated net revenues in 2021.  Health plans typically negotiate directly or indirectly with a number of diagnostic information services providers, and represent approximately one-half of our total clinical testing volume and approximately 43% of our net revenues from diagnostic information services.  There has been a trend of consolidation among health plans.  Some health plans also have narrowed their provider networks.  In addition, some health plans have established "preferred provider" networks within their broader networks (e.g., UnitedHealthcare's Preferred Lab Network), in effect distinguishing among contracted providers.   </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are also sometimes a member of a &#8220;complementary network.&#8221; A complementary network generally is a set of contractual arrangements that a third party maintains with various providers that provide discounted fees for the benefit of its customers. A member of a health plan may choose to access a non-contracted provider that is a member of a complementary network; if so, the provider will be reimbursed at a rate negotiated by the complementary network.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We offer to health plans services and programs that leverage our Company's expertise and resources, including our superior patient access, extensive test menu, medical staff, data, information technology solutions, and wellness and population health management capabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Since the beginning of 2019, the Company has had access to a very high percentage of the insured lives in the U.S., including very strong access in key high-population states.  We believe that this strong access increases our attractiveness to other customer groups, including clinicians, patients and employers.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Clinicians</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinicians, including primary care physicians, specialists and physician assistants, requiring diagnostic information services for patients are the primary referral source for our services when patients choose their diagnostic information services provider. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In recent years, there has been a marked increase in the number of physician practices owned by IDNs.  There also has been a notable increase in some branches of medicine of the establishment of very large "rolled-up" specialty physician practice groups.  IDNs that own physician practices may encourage or require the practices to refer outreach testing to the IDN's affiliated laboratory.  Large specialty physician groups may encourage their members to refer testing to other members of the group.  In each case, referrals to independent diagnostic services providers may be reduced.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinicians determine which laboratory to recommend or use based on a variety of factors, including those set forth in table 14.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">IDNs</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We believe that we are an industry leader in servicing hospitals.  We provide services to IDNs throughout the United States, including advanced testing services, in some cases managing or serving as the medical directors of their laboratories (including through our industry-leading Professional Lab Services offering discussed in table 3 above).  IDNs generally maintain an on-site laboratory to perform the significant majority of clinical testing for their patients (inpatients and outpatients) and refer certain testing to outside service providers, which typically charge the IDNs on a negotiated fee-for-service basis. Fee schedules for IDN reference testing services often are negotiated on behalf of IDNs by group purchasing organizations. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We also have joint venture arrangements with leading IDNs in several metropolitan areas.  These joint venture arrangements, which provide diagnostic information services for affiliated IDNs as well as for unaffiliated clinicians and other local healthcare providers, serve as our principal facilities in their service areas.  Typically, we have either a majority ownership interest in, or day-to-day management responsibilities for, our joint venture relationships. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In light of continued pressure to reduce systemic healthcare costs, IDNs may change their approach to providing clinical testing services, including by insourcing tests, seeking ways to improve profitability or to better utilize their laboratory capacity.  We believe that our combination of services positions us to be an attractive partner for IDNs, offering a full range of strategic relationships.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;ACOs and DCEs </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An ACO is a network of providers and facilities that share financial risk in providing or arranging for the provision of healthcare.  A DCE is a healthcare provider that is contracted directly with Medicare and agrees to assume some level of financial risk for providing Medicare services.  ACOs and DCEs have increased in number; their impact on the provision of healthcare services to date has varied. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACOs and DCEs may exercise operational and financial control over providers across the continuum of care, and may function as a payer.  Thus, they may be able to manage the health of a population group within a defined geography, and also may be able to influence the cost and quality of healthcare delivery.  They may be encouraged to consider exclusive arrangements with healthcare providers, or to limit service providers.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are actively engaging with ACOs and DCEs to demonstrate the value of our services.  </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Employers</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employers use tests for drugs of abuse to determine an individual's employability and his or her &#8220;fitness for duty.&#8221;  Companies with high levels of employee hiring, safety conscious environments or regulatory testing requirements provide the highest volumes of testing. Factors such as the general economy, the job market and changes in the legal environment (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., marijuana decriminalization) can impact the utilization of drugs-of-abuse testing. Some employers retain third party administrators to handle such testing and related services; we support the needs of third party administrators as well as employers who retain us directly.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employers also are investing in population health services.  We meet their needs by providing nationwide access to our customizable services (discussed above at page 13), directly and through health plan and health improvement providers.  These services help employers, employees and others manage healthcare costs, capitalize on trends in personalized health and improve health outcomes.  In response to the COVID-19 pandemic, we expanded our offerings to employers to assist their pandemic response to create safer workplaces (discussed above at page 13). </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We seek to grow our employer business through offering new and innovative programs to help them with their goals of (1) maintaining a safe and productive workplace, (2) improving healthcare for employees and (3) lowering healthcare costs for employees and employers. </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Consumers </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are well positioned to provide information and insights to patients to help them take actions to improve their healthcare.  The changing expectations of patients about their healthcare and their healthcare transactions are influencing our services and the way we provide them.  See the discussions of our consumer strategy at page 5 and consumerization above in table 11.  </span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">FQHCs</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federally Qualified Health Centers offer a broad array of healthcare services, including to historically underserved populations.  We strive to offer an attractive array of services to FQHCs to demonstrate the value of our services.  </span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Emerging Retail Healthcare Providers</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In recent years, as the healthcare sector changes, retail providers of healthcare services have emerged and are growing.  These providers include "big-box" retailers, pharmacy chains, supermarkets, urgent care centers and Internet-based service providers.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are taking advantage of opportunities to work with these providers, not only to offer new access partners (e.g., CVS retail locations) and new access points for our services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., our collaboration with Safeway), but also to grow our business by expanding our service offerings (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., our joint venture with Walmart).  See the discussion of our consumer strategy at page 5.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;Government Agencies</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We provide services on a fee-for-service basis to federal, state and local governmental agencies.<br/>Historically, most Medicare and Medicaid beneficiaries were covered under the traditional Medicare and Medicaid programs administered by the federal government.  Over the last several years, the federal government has expanded its contracts with private health insurance plans for Medicare beneficiaries and has encouraged such beneficiaries to switch from the traditional programs to the private programs, called &#8220;Medicare Advantage&#8221; programs.  There has been growth of health insurance providers offering Medicare Advantage programs and of beneficiary enrollment in these programs.  States also have mandated that Medicaid beneficiaries enroll in private managed care arrangements.  During the COVID-19 pandemic, we provided additional services to and in conjunction with government agencies across the United States in connection with the COVID-19 pandemic. </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pharmaceutical companies</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have expertise with laboratory developed tests for companion and complementary diagnostics, and offer an array of assets and services to support the development of companion diagnostics, including our robust data set and patient services network. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We also offer Quest Clinical Trials Connect,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to help accelerate clinical trials (and thus the speed of drugs to market) through better patient recruitment, involvement and management, and improved physician outreach.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Laboratories</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We provide services on a fee-for-service basis to other commercial clinical laboratories.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> While there has been consolidation in the diagnostic information services industry in recent years, our industry remains fragmented and highly competitive.  We primarily compete with three types of clinical testing providers: commercial clinical laboratories, IDN-affiliated laboratories and physician-office laboratories.  Our largest commercial clinical laboratory competitor is Laboratory Corporation of America Holdings, Inc.  In addition, we compete with many smaller regional and local commercial clinical laboratories, specialized advanced laboratories and providers of consumer-initiated testing.  In anatomic pathology, we compete with anatomic pathology practices, including those in academic institutions and large physician group practices, and providers of emerging digital pathology solutions.  There also has been a trend among specialty physician practices to establish their own histology laboratory capabilities and/or bring pathologists into their practices, thereby reducing referrals from these practices and increasing the competitive position of these practices.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.673%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare providers consider a number of factors when selecting a diagnostic information services provider.</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Potential Factors Considered When Selecting a Diagnostic Information Services Provider (Table 14)</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Service capability and quality</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Reputation in the medical community</span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Accuracy, timeliness and consistency in reporting test results</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Healthcare information technology solutions, including connectivity options</span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Access to medical/scientific thought leaders for consultation</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Patient access, including the number, convenience and geographic coverage of patient service centers</span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Patient insurance coverage and experience</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Ability to develop new and useful tests and services</span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Number and type of tests performed</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Qualifications of its staff</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Pricing and overall value</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Provider office workflow </span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Real time payment determination</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Capabilities to support population health initiatives </span></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div style="padding-left:54pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that providing the most attractive service offering in the industry, including the most comprehensive test menu, innovative test offerings, a positive customer experience, a staff including medical and scientific experts, strong quality, unparalleled access and distribution, and data-powered integrated information technology solutions provide us with a competitive advantage.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that large diagnostic information services providers have a competitive advantage due to their large networks and lower cost structures.  These advantages should enable larger providers to serve customers more effectively.  In addition, we believe that consolidation in the diagnostic information services industry will continue.  However, a significant portion of clinical testing is likely to continue to be performed by IDNs, which generally have affiliations with community clinicians and may have more, or more convenient, locations in a market.  As a result, we compete against IDN-affiliated laboratories primarily on the basis of service capability, quality and pricing.  In addition, market activity may increase the competitive environment.  For example, IDN ownership of physician practices may enhance the ties of the clinicians to IDN-affiliated laboratories, enhancing the competitive position of IDN-affiliated laboratories.  ACOs and DCEs and their approach to contracts with healthcare providers also may impact competition to provide diagnostic information services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The diagnostic information services industry is faced with changing technology, new product introductions and new service offerings. Competitors may compete using advanced technology, including technology that enables more convenient or cost-effective testing.  Digital pathology, still in an emerging state, is an example of this.  Competitors also may compete on the basis of new service offerings.  Competitors also may offer testing to be performed outside of a commercial clinical laboratory, such as (1) point-of-care testing that can be performed by physicians in their offices; (2) testing that can be performed by IDNs in their own laboratories; and (3) home testing that can be carried out without requiring the services of outside providers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The risk assessment and healthcare information technology industries are highly competitive.  We have many competitors, some of which have much more extensive experience in these industries and some of which have greater resources.  We compete in the risk assessment business by seeking to provide a wider array of quality, integrated services than our competitors, faster services completion and a superior applicant experience.  We compete in the healthcare information technology industry by offering solutions that foster better patient care and improve performance for healthcare providers, including smaller and medium sized physician practices.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_31"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Creating an inspiring workplace is one of our three corporate goals, and this goal drives our approach to human capital management.  Effectively managing our human capital resources is a priority with key components that include culture, safety and well-being programs, employee engagement, and training, development and succession planning.  Our Board of Directors actively engages in oversight of our human capital management, including by receiving management reports on key areas, strategies and initiatives.  Additional information about our human capital management strategies and initiatives is available in our annual corporate responsibility report. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December 31, 2021, we have approximately 49,000 employees, of whom approximately 40,000 are full-time and the remainder are part-time or on-call.   Our employee population is more diverse than the U.S. workforce, taken as a whole.  Approximately 71% of our employees globally identify as women; approximately 51% of our U.S. employees identify as people of color.  A majority of our employees work directly with our customers or in our laboratories.  Fewer than 1% of our employees are represented by a union.  We believe that our overall relations with our employees are good.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Culture</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  We strive to foster a strong culture, built on our Code of Ethics, which reinforces our commitment to integrity and aligns with our vision, values, goals and brand.  Our Quest Management System, discussed above at page 8, supports our effort to maintain a focus on high performance.  We also focus on building and maintaining a collaborative, diverse and inclusive culture in which all employees are empowered to raise and discuss difficult issues and valued for their strengths, experience and unique perspectives (our focus on diversity and inclusion is discussed further below).  We encourage our employees to actively participate in their communities, and support their participation, including offering incentives for participation.  Our Everyday Excellence program includes guiding principles for our entire organization to support a superior customer experience and inspire employees to be their best every day, with every person and with every customer interaction; the program is integrated into performance assessments and frontline employee behavioral standards.  Our Recognition Quest Program reinforces our commitment to recognize above and beyond contributions and to demonstrating how much we value, care for and appreciate one another by regularly celebrating and rewarding one another as we work together.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Safety and Well-Being</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The health and safety of our employees is of paramount concern.  We use a systematic, risk-based approach to develop tailored incident prevention and response programs designed to keep our employees safe in each of our diverse functional areas, and use data insights and a detailed audit program to foster the effectiveness of our programs. We have a comprehensive curriculum of annual safety training, as well as training for new employees.  During the COVID-19 pandemic, our cross-functional Safely Working Together Steering Committee designed and implemented tactics, techniques and procedures to enable our colleagues to continue to work safely.  As part of our comprehensive and competitive compensation and benefits program, we also offer innovative initiatives to support the well-being of our employees and their </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">families through our HealthyQuest program.  The cornerstone of HealthyQuest is our Blueprint for Wellness program, which empowers our employees and their dependents with health insights based on lab and biometric data and invites them each year to take the initiative to improve their physical and mental health.  We also offer other programs designed to engage employees in managing their health, including access to medical expertise and support programs tailored to their individual needs, helping them to adopt healthier behaviors and access better care at lower costs.  These include customized programs for conditions such as type 2 diabetes management, chronic kidney disease, cardiovascular disease, zero-cost lab testing and specialty drugs, and special support for orthopedic surgery and for cancer and other serious diagnoses.   For 2022, we enhanced our mental health offering for employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inclusion and Diversity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  We understand the need to create an environment where employees can bring their whole selves to work.  We aim to harness the unique mix of capabilities, talents, cultures, beliefs and experience of our employees and create a workforce that is demographically diverse at all levels of the organization.  Through our CTC Framework (focusing on Culture, Talent and Community), we prioritize diversity across the entire talent lifecycle, with the goals of supporting employees throughout their careers at Quest, ensuring transparency and identifying opportunities for action.  In 2021, we continued to focus on inclusion and diversity issues through additional training for leaders and other employees.   We also continued, with the Quest Diagnostics Foundation, Quest for Health Equity, our initiative to help reduce health disparities in underserved communities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engagement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Since 1997, we have sought to foster the engagement and enablement of our employees, and have regularly surveyed our employees to assess their engagement.  Employee engagement has been a metric in the annual incentive plan for our executive officers since 2013.  In 2020, we launched a new strategy for gathering employee feedback that utilizes more frequent employee surveys.  This approach is designed to build an agile culture, based on continuous feedback that fuels ongoing conversations about priorities, performance, opportunities and growth, to result in a higher performing organization and committed employees.  In addition, throughout the COVID-19 pandemic, we have held weekly or bi-weekly meetings among hundreds of company leaders to foster increased communication across the company regarding topics of concern to employees.      </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Training, Development and Succession Planning</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  We provide training on a wide array of topics to our employees through live and online formats, including opportunities that can be accessed through their mobile devices.  We also offer a number of development opportunities for our employees, such as mentoring and education programs, including a higher education tuition reimbursement or assistance program.  In addition, we provide leadership training opportunities for employees at all levels, including a manager essentials curriculum, our Leading Quest Supervisor and Manager Core Program, coaching programs and trainings to strengthen critical leadership skills.  We also deliver a number of programs tailored to specific functions to drive a high-performance culture and sharpen the capabilities needed to lead our organization (e.g., our Commercial, Finance, Pathology, R&amp;D, and Product Management Leadership Programs).  We have a robust talent assessment and succession planning process to promote business continuity, including at the most senior levels; this planning is linked to our engagement and inclusion and diversity initiatives, to foster those efforts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Sales and Marketing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Our Diagnostic Information Services business has a unified commercial organization focused on the sale of most of our services.  It coordinates closely with our clinical franchises (discussed above under the heading I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">nnovation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and marketing organization.  The commercial organization is centrally led, and is organized regionally, in conjunction with our operations organization, to focus on local customer needs and to ensure aligned delivery for our customers.  Our commercial organization employs world-class processes and tools and strong management discipline.  We provide industry-leading training and development, focus on opportunities with IDNs and specialty physicians, and foster a customer-focused, performance-driven culture.   We also maintain distinct sales and marketing organizations for our offerings in Diagnostic Solutions and our employer drugs-of-abuse testing services.  In 2021, we launched a new marketing campaign designed to remind customers of the value that we bring to healthcare.  Our "Powering Affordable Care" campaign speaks about our leadership in clinical innovation, our ability to enable better clinical outcomes, our improved patient experience and our ability to reduce the cost of care.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Information Technology.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We use information systems extensively in virtually all aspects of our business, including clinical testing, test ordering and reporting, billing, customer service, logistics and management of medical data.  We endeavor to establish systems that create value and efficiencies for our Company and customers.  The successful delivery of our services depends, in part, on the continued and uninterrupted performance of our information technology systems.  We take precautionary measures to prevent problems that could affect our information technology systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some of our historic growth has come through acquisitions and, as a result, we continue to use multiple information systems.  We have made significant progress implementing common systems in our regional laboratories, and we continue to standardize laboratory information and billing systems across our operations.  We expect that our standardization efforts will </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">take several more years to complete, and will result in significantly more centralized systems, improved operating efficiency, more positive customer experiences and enhanced control over our operational environment.  Even after we complete our efforts to standardize our legacy systems, we will need to focus on standardizing systems in connection with future business acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Quality Assurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  As discussed further under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quality </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on page 7, our goal is to provide every patient with services and products of superior quality, and to meet that goal we employ the Quest Management System.  Employing root cause analysis, process improvements and rigorous tracking and measuring, we continuously seek to enhance quality, reduce defects, further increase the efficacy and efficiency of our operations and processes, eliminate waste and help standardize operations across our Company.&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our laboratory operations, our quality assurance efforts focus on pre-analytic, analytic and post-analytic processes, including positive patient identification of specimens, appropriate specimen transport, analysis and report accuracy, reference interval establishment and review, statistical process control and personnel training for all of our laboratories and patient service centers.  As part of our quality assurance program, we utilize internal proficiency testing, comprehensive quality control and rigorous process audits.  We have introduced comprehensive and digitized data analytics software that implements advanced automated quality control procedures, offering both real-time and post-analytic analysis of data at the laboratory and corporate level.  We monitor test results to identify trends, biases, instrument failures and population shifts through digitization and data analytics.  We also focus on the licensing, credentialing, training and competence of our professional and technical staff.  For example, our cytotechnologists and pathologists participate in an internal peer-review evaluation and one or more external individual proficiency testing programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have accreditation or licenses for our clinical laboratory operations from various regulatory agencies or accrediting organizations, such as CMS, CAP and certain states.  All of our laboratories participate in external quality surveillance programs, including proficiency testing programs administered by CAP and several state agencies. CAP is an independent, nongovernmental organization of board-certified pathologists approved by CMS to inspect clinical laboratories to determine compliance with the standards required by CLIA.  CAP offers an accreditation program to which clinical laboratories may voluntarily subscribe. All of our major laboratories, including our laboratories outside the U.S., and a number of our rapid response laboratories, are accredited by CAP.  Accreditation includes on-site inspections and participation in the CAP (or equivalent) proficiency testing program.  In addition, some of our laboratories also have International Organization for Standardization (ISO) certification for their quality management systems. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;We maintain a robust Supplier Quality Program designed to ensure a high quality supplier network and to raise the bar of quality expectation across that network.  We expect suppliers to provide the highest quality products and services and to embrace an ethic of transparent quality collaboration.  In our program, we aim to ensure and improve the quality of purchased products and services.  Our suppliers are expected to operate under quality management principles that meet industry standards, strive for zero defect manufacturing, use statistical analysis to reduce variation and meet applicable regulatory standards.  In choosing suppliers, we evaluate their quality systems and quality performance metrics. Our supplier qualification process is risk-based, with assessments and on-site audits based on risk tiers. Contracts with our suppliers include specific quality, compliance, and change management provisions as appropriate. We use supplier quality engineers who are trained to audit on ISO standards and FDA regulations applicable to suppliers&#8217; processes, and a procurement engineering team to assist with qualification and validation of new supplies and products. We actively manage supplier performance, utilizing a problem reporting and resolution process designed to drive to root cause and corrective actions. We maintain a continuous improvement dialogue with our suppliers, and with operationally critical suppliers deliver a supplier scorecard that supports continuous improvement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;We also maintain quality assurance programs for IDN laboratories that we manage, and for our services offerings outside laboratories. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Intellectual Property Rights.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  We own significant intellectual property, including patents, patent applications, technology, trade secrets, know-how, copyrights and trademarks in the United States and other countries.  From time to time, we also license patents, patent applications, technology, trade secrets, know-how, copyrights or trademarks owned by others; we also may license our intellectual property to others. In the aggregate, our intellectual property assets and licenses are of material importance to our business.  We believe, however, that no single patent, technology, trademark, intellectual property asset or license is material to our business as a whole.  Our approach is to manage our intellectual property assets, to safeguard them and to maximize their value to our enterprise.  We actively defend our important intellectual property assets and pursue protection of our products, processes and other intellectual property where possible.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enterprise Risk Management Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  We maintain an enterprise risk management program designed to promote a culture of risk awareness throughout the Company's key business, operations and support functions.  Our program, which is </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">integrated with the Company&#8217;s governance, performance management and internal control frameworks, entails a formal continuous process that identifies, assesses, mitigates and manages the risks from both internal and external conditions that could significantly impact the Company and influence its business strategy and performance.  The program is based on the most recent framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, which focuses on the following risk types:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operational risk - risks arising from systems, processes, people and external events that affect the Company&#8217;s operational objectives or fundamental reason for its existence, including: product life-cycle and execution; service quality and performance; information management and data protection and security, including cybersecurity; supply chain and business disruption; and other risks, including human capital and reputation.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Financial risk - risks arising from the Company&#8217;s ability to meet its financial obligations pursuant to its strategic and operational objectives, including exposure to broad market and more specific industry risk that could impact liquidity, interest rate, credit, pricing and reimbursement, and also to internal and external financial reporting.   </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Legal and compliance risk - risks arising from the regulatory and enforcement environment, legal proceedings and adherence to ethics and compliance policies and procedures.   </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strategic risk - risks that will impede the Company&#8217;s plan to achieve its mission and vision and apply its core values, including changes in the broad market and Company's industry, business development and restructuring activities, competitive threats and practices, technology and product innovation, and public policy.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As part of our program, we routinely assess our enterprise level risks, emerging risks, overall Company-level risk tolerance and the effectiveness of risk management, and monitor the progress of and resources applied to risk mitigation; our Board of Directors actively oversees our program.  Our primary risk factors are discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> beginning on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_43">32</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Billing; Government Reimbursement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We generally bill for diagnostic information services on a fee-for-service basis under one of two types of fee schedules; fees may be negotiated or discounted.  The types of fee schedules are:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Client&#8221; fees charged to physicians, IDNs and institutions for which services are performed on a wholesale basis and which are billed on a monthly basis.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Patient&#8221; fees charged to individual patients and certain third-party payers on a claim-by-claim basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Billing for diagnostic information services is very complicated.  Our customers, discussed in table 13, have different billing requirements. Some billing arrangements require us to bill multiple payers, and there are several other factors that complicate billing (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., disparity in coverage and information requirements among payers; incomplete or inaccurate billing information provided by ordering clinicians; and lack of access to patients before testing).  We maintain compliance policies and procedures for our billing practices, and we audit our practices for compliance with applicable laws and regulations and internal policies and procedures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With regard to the clinical testing services performed on behalf of Medicare beneficiaries, we generally must bill Medicare directly and must accept the Medicare carrier's fee schedule amount for covered services as payment in full.  In addition, state Medicaid programs are prohibited from paying more (and in most instances, pay significantly less) than Medicare.  Currently, Medicare does not require the beneficiary to pay a co-payment for diagnostic testing services reimbursed under the Clinical Laboratory Fee Schedule, but generally does require a patient deductible and co-insurance for anatomic pathology services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Part B of the Medicare program contains fee schedule payment methodologies for clinical testing services performed for covered patients, including a national ceiling on the amount that carriers could pay under their local Medicare clinical testing fee schedules.  Historically, the Medicare Clinical Laboratory Fee Schedule and the Medicare Physician Fee Schedule established under that program have been subject to change, including each year.  Pursuant to PAMA, reimbursement rates for many clinical laboratory tests provided under Medicare were reduced from 2018 - 2020.  PAMA calls for further revision of the Medicare Clinical Laboratory Fee Schedule for years after 2020, based on future surveys of market rates; reimbursement reduction from 2023-25 is capped by PAMA at 15% annually.  PAMA's next data collection and reporting period have been delayed, most recently by federal legislation adopted in December 2021, which further delayed the reimbursement rate reductions and reporting requirements until January 1, 2023. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><img src="dgx-20211231_g4.jpg" alt="dgx-20211231_g4.jpg" style="height:289px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our net revenues reimbursed under Medicare and Medicaid in 2021 were lower as a percentage of our consolidated net revenues than in recent years (excluding 2020, when we also experienced significant COVID-19 testing).  Excluding revenues attributable to COVID-19 testing, approximately 13% of our net revenues were reimbursed under Medicare and Medicaid in 2021, compared to approximately 15% in 2019.  &#160;&#160;&#160;&#160;</span></div><div id="ib4001cf8768244cca3f772bfc08f865b_34"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGULATION </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are subject to extensive and frequently changing laws and regulations in the United States (at both the federal and state levels) and other jurisdictions in which we conduct business, and to government inspections and audits. </span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Regulatory Schemes (Table 16)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CLIA and State Clinical Laboratory Licensing</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CLIA regulates the operations of virtually all clinical laboratories, requiring that they be certified by the federal government and that they comply with various technical, operational, personnel and quality requirements intended to ensure that the services provided are accurate, reliable and timely.  </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State laws may require additional personnel qualifications or licenses, quality control, record maintenance, proficiency testing or detailed review of our scientific method validations and technical procedures for certain tests. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Medicare and Medicaid; Fraud and Abuse</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic testing services provided under Medicare and Medicaid programs are subject to complex, evolving, stringent and frequently ambiguous federal and state laws and regulations, including those relating to billing, coverage and reimbursement.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-kickback laws and regulations prohibit making payments or furnishing other benefits to influence the referral of tests billed to Medicare, Medicaid or certain other federal or state healthcare programs.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, federal and state anti-self-referral laws generally prohibit Medicare and Medicaid payments for clinical tests referred by physicians who have an ownership or investment interest in, or a compensation arrangement with, the testing laboratory, unless specific exceptions are met.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Some states have similar laws that are not limited in applicability to only Medicare and Medicaid referrals and could also affect tests that are paid for by health plans and other non-governmental payers. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs. </span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The FDA has regulatory responsibility over, among other areas, instruments, software, test kits, reagents and other devices used by clinical laboratories to perform diagnostic testing in the United States.  The FDA also regulates drugs-of-abuse testing for employers and insurers, testing for blood bank purposes and testing of donors of human cells for purposes such as in vitro fertilization. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A number of advanced tests we develop internally are offered as LDTs. The FDA has claimed regulatory authority over all LDTs, but has stated that it exercised enforcement discretion with regard to most LDTs performed by high complexity CLIA-certified laboratories.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the 21st Century Cures Act, the FDA issued final guidance regarding its position on the regulation of clinical decision software, which may be used in connection with LDTs. The guidance attempts to address uncertainty regarding whether FDA approval of certain software is required.  It has been used by the FDA, in part, to assert authority over the annotation software aspects of pharmacogenetic testing services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legislation introduced in Congress would enable the FDA to regulate LDTs, in vitro diagnostics, software and other items used in the diagnosis of disease. The FDA and the U. S. Department of Health and Human Services also have expressed views regarding the regulation of LDTs. Either new law or a revised approach to regulation of LDTs could have a significant impact on the clinical laboratory testing industry, including regulating LDTs in new ways, while creating avenues of opportunity and competition regarding clinical laboratory testing.  New competitors may enter the industry, and competition may come in new forms. </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Environmental, Health and Safety</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are subject to laws and regulations related to the protection of the environment, the health and safety of employees and the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For example, the U.S. Occupational Safety and Health Administration has established extensive requirements relating specifically to workplace safety for healthcare employers in the U.S.  This includes requirements to develop and implement multi-faceted programs to protect workers from exposure to blood-borne pathogens, including preventing or minimizing any exposure through needle stick injuries. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of transportation, some biological materials and laboratory supplies are classified as hazardous materials and are subject to regulation by one or more of the following agencies: the U.S. Department of Transportation, the U.S. Public Health Service, the U.S. Postal Service and the International Air Transport Association. </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Physicians</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our pathologists are required to hold a valid license to practice medicine in the jurisdiction in which they practice.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Several jurisdictions in which our businesses are located prohibit business corporations from engaging in the practice of medicine. In certain jurisdictions, business corporations are prohibited from employing licensed healthcare professionals to provide services on behalf of the corporation; these laws vary.  In some jurisdictions, anatomic pathology services are delivered through physician-owned entities that employ the practicing pathologists.  The manner in which licensed physicians can be organized to perform medical services may be governed by the laws of the jurisdictions in which medical services are provided and by the medical boards or other entities authorized by these jurisdictions to oversee the practice of medicine. </span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Privacy and Security of Health and Personal Information</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are subject to laws and regulations regarding protecting the security and privacy of certain healthcare and personal information, including: (a) the federal Health Insurance Portability and Accountability Act and the regulations thereunder, which establish (i) a complex regulatory framework including requirements for safeguarding protected health information and (ii) comprehensive federal standards regarding the uses and disclosures of protected health information; (b) state laws, including the California Consumer Privacy Act and similar laws in other states ; and (c) laws outside the U.S., including the European Union's General Data Protection Regulation. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A healthcare provider may be subject to penalties for non-compliance and may be required to notify individuals or state, federal or county governments if the provider discovers certain breaches of personal information or protected health information.  </span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Drug Testing; Controlled Substances</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All U.S. laboratories that perform drug testing for certain public sector employees and employees of certain federally regulated businesses are required to be certified as meeting the detailed performance and quality standards of the Substance Abuse and Mental Health Services Administration. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To obtain access to controlled substances used to perform drugs-of-abuse testing in the United States, laboratories must be licensed by the Drug Enforcement Administration. </span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Compliance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We strive to conduct our business in compliance with all applicable laws and regulations.  We license and maintain appropriate accreditations for all of our laboratories and, where applicable, patient service centers, as required by federal and state agencies.  We have a long-standing and well-established compliance program.  The Quality and Compliance Committee of our Board of Directors oversees, and receives periodic management reports regarding, our compliance program.  Our program includes detailed policies and procedures and training programs intended to ensure the implementation and observance of all applicable laws and regulations (including regarding billing and reimbursement, and privacy of protected health information and personally identifiable information) and Company policies.  Further, we conduct in-depth reviews of procedures and facilities to assure regulatory compliance throughout our operations.  We conduct annual training of our employees on these compliance policies and procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As an integral part of our billing compliance program, we investigate reported or suspected failures to comply with federal and state healthcare reimbursement requirements.  Any Medicare or Medicaid overpayments resulting from non-compliance are refunded by us.  As a result of these efforts, we have periodically identified and reported overpayments, refunded the payers for overpayments and taken appropriate corrective action. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="ib4001cf8768244cca3f772bfc08f865b_37"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Securities and Exchange Commission (the &#8220;SEC&#8221;) maintains an internet site, www.sec.gov, that contains annual, quarterly and current reports, proxy and information statements and other information that issuers file electronically with the SEC.  We file reports, proxy statements and other information with the SEC; they are publicly available at the SEC's internet site.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our internet address is www.QuestDiagnostics.com.  The information on or accessible through our website is not part of and is not  incorporated by reference into this Report.  We make available free of charge, on or through our Investor Relations webpage (www.QuestDiagnostics.com/investor), our proxy statements, Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), as soon as reasonably practical after such material is filed with, or furnished to, the SEC.    </span></div><div><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:57.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.410%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">www.QuestDiagnostics.com/investor provides information about our corporate governance.</span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Information Available at Our Corporate Governance Webpage (Table 17)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors</span></div></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Governance Guidelines</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Composition of the committees of our Board of Directors</span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Code of Ethics</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior management</span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Incorporation</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charters for the committees of our Board of Directors</span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bylaws</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information about our corporate political contributions </span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Values </span></div></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statements of beneficial ownership of our equity securities filed by our directors, officers and others under Section 16 of the Exchange Act</span></div></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also maintain a Corporate Responsibility webpage that provides information about our corporate responsibility program, including our focus on environmental, social and governance issues and our annual Corporate Responsibility Report.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:57.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.410%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">www.QuestDiagnostics.com/our-company/corporate-responsibility provides information about our corporate responsibility program.</span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Information Available at Our Corporate Responsibility Webpage (Table 18)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Responsibility Reports</span></div></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest for Health Equity</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information about our corporate political contributions</span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics Foundation </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental, social and governance resources</span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sustainability</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governance, ethics and values</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Community giving </span></div></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_40"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION ABOUT OUR EXECUTIVE OFFICERS </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:32.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Officers (Table 19)</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;border-left:1pt solid #acacac;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name, Age, Title</span></td><td colspan="3" style="background-color:#dddddd;border-left:1pt solid #acacac;border-right:1pt solid #acacac;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Background</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Stephen H. Rusckowski (64) <br/>Chairman of the Board, Chief Executive Officer and President </span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Rusckowski joined the Company in May 2012 as Chief Executive Officer and President and became Chairman of the Board on January 1, 2017.  From October 2006 until he joined the Company, he was Chief Executive Officer of Philips Healthcare, the largest unit of Royal Philips Electronics, and a member of the Board of Management of Royal Philips Electronics and its Executive Committee.  Previously, he was CEO of the Imaging Systems business of Royal Phillips Electronics. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On February 3, 2022, the Company announced that, as part of its ongoing leadership succession planning, effective November 1, 2022, Mr. Rusckowski would step down as Chief Executive Officer and President, and become Executive Chairman and continue to serve on the Company's Board of Directors through March 2023. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Before joining Philips in 2001, Mr. Rusckowski held numerous management positions with the healthcare division of Hewlett-Packard/Agilent Technologies. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Rusckowski has been a director of the Company since May 2012.  He was a director of Xerox Corporation from February 2015 to 2018, and a director of Covidien plc from December 2013 to January 2015.  Mr. Rusckowski served as Chairman of the American Clinical Laboratory Association from 2014 to 2017.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:32.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">James E. Davis (59) <br/>Executive Vice President, General Diagnostics; Chief Executive Officer - Elect</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In January 2017, he became Executive Vice President, General Diagnostics; previously Mr. Davis was Senior Vice President and Group Executive - Regional Businesses.  In January 2015, he assumed responsibility for the general management of the Company's regional Diagnostic Information Services business.  Mr. Davis was responsible for our products business from February 2014 until 2016.  From February 2014 to January 2015, he was responsible for operations for the Company's Diagnostic Information Services business. &#160;Mr. Davis joined Quest Diagnostics in April 2013 as Senior Vice President, Diagnostics Solutions, with responsibility for the healthcare information technology, risk assessment, clinical trials, diagnostic products and employer solutions businesses.&#160;<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On February 3, 2022, the Company announced that Mr. Davis was appointed Chief Executive Officer - Elect, effective immediately, and that he would become Chief Executive Officer effective November 1, 2022.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior to joining Quest Diagnostics, from March 2012 to April 2013, Mr. Davis served as Lead Director, and then as Chief Executive Officer, of InSightec, Inc., a medical device company that designs and develops ultrasound ablation devices that are guided by magnetic resonance imaging systems.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously, Mr. Davis held a number of senior positions in General Electric&#8217;s healthcare business, including from 2007 to 2012 as Vice President and General Manager of GE Healthcare&#8217;s magnetic resonance imaging business.  Prior to joining GE Healthcare, Mr. Davis held leadership positions in GE&#8217;s aviation business and led the development of strategic and operational improvement initiatives for clients of McKinsey &amp; Company, Inc.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Catherine T. Doherty (59) <br/>Senior Vice President and Group Executive - Clinical Franchise Solutions and Marketing</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Since January 2013, Ms. Doherty has been responsible for overseeing the development of clinical franchise solutions in the areas of general health and wellness, cardiovascular, metabolic and endocrinology, infectious disease and immunology, and prescription drug monitoring and toxicology, as well as enterprise-wide marketing.  Ms. Doherty is also responsible for the employer solutions and risk assessment businesses, and since February 2020, our sports diagnostics franchise.  Additionally, in October 2018, QuestDirect</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, our consumer initiated testing platform was launched under her leadership.  She also was responsible for clinical franchise solutions in the areas of neurology and women's health from January 2013 to January 2017 and for the healthcare information technology business from February 2014 to January 2017.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior to January 2013, Ms. Doherty held a variety of positions of increasing responsibility since joining the Company in 1990, including Senior Vice President, Physician Services; Vice President, Hospital Services; Vice President, Office of the Chairman; Vice President, Finance and Administration for the Hospital business; Vice President, Communications and Investor Relations; and Chief Accounting Officer.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:32.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Carrie Eglinton Manner (47)<br/>Senior Vice President, Advanced Diagnostics</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ms. Eglinton Manner joined the Company in January 2017.  She is responsible for the Company's advanced testing activities, including overseeing the development of clinical franchise solutions in the areas of neurology, oncology, pathology and women's health, as well as the Company's global business and pharmaceutical/diagnostic development services.   Ms. Eglinton Manner has served as a director of Repligen Corporation since June 2020.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously, Ms. Eglinton Manner spent over 20 years in various leadership roles in healthcare businesses at General Electric. From 2015 to 2016, she served as President and CEO of the Detection and Guidance Solutions business, delivering advanced x-ray technologies spanning the continuum of healthcare.  From 2013 to 2015, Ms. Eglinton Manner served as President and CEO of OEC Surgical Mobile C-arm systems.  She was President and CEO of General Electric's diagnostic pathology laboratory services business from 2012 to 2013, and President of the Maternal Infant Care Business from 2009 to 2012.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mark J. Guinan (60) <br/>Executive Vice President and Chief Financial Officer<br/></span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Guinan joined the Company in July 2013.  From 2010 until joining Quest Diagnostics in 2013, he served as Chief Financial Officer for Hill-Rom Holdings Inc., a manufacturer and provider of medical technologies and related services for the healthcare industry.  Mr. Guinan has served as a director of Myovant Sciences, Ltd. since July 2018.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On February 3, 2022, the Company announced that Mr. Guinan would retire in 2022.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously, he had served in a number of finance and operations roles in a long career at Johnson &amp; Johnson including 2009 to 2010 as Vice President, Chief Procurement Officer, and 2005 to 2009 as Vice President, Group Finance Pharmaceuticals.  Before joining Johnson &amp; Johnson in 1997, he held a number of financial roles at Procter &amp; Gamble.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Michael E. Prevoznik (60) <br/>Senior Vice President and General Counsel</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Prevoznik joined the Company as Vice President and General Counsel in August 1999.  In 2003, he assumed responsibility for governmental affairs.  From 1999 until April 2009, Mr. Prevoznik also had responsibility for the Company's Compliance Department.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, from April 2011 to January 2017, he had management responsibility for the Company's diagnostic information services activities outside the U.S., and from April 2011 to January 2013, he had management responsibility for the Company's clinical trials business.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior to joining the Company, Mr. Prevoznik served in positions of increasing responsibility within the compliance organization at SmithKline Beecham, most recently as Vice President, Compliance, with responsibility for coordinating all SmithKline Beecham compliance activities worldwide.</span></td></tr></table></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1A. Risk Factors </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;You should carefully consider all of the information set forth in this Report, including the following risk factors, before deciding to invest in any of our securities.  The risks below are not the only ones that we face. Additional risks not presently known to us, or that we presently deem immaterial, may also negatively impact us.  Our business, consolidated financial condition, revenues, results of operations, profitability, reputation or cash flows, or the price of our common stock, could be materially impacted by any of these factors.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Report also includes forward-looking statements that involve risks or uncertainties.  Our results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks we face described below and elsewhere.  See &#8220;Cautionary Factors that May Affect Future Results&#8221; on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_58">42</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td></tr></table></div><div id="ib4001cf8768244cca3f772bfc08f865b_46"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR BUSINESS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The U.S. healthcare system is evolving and medical laboratory testing market fundamentals are changing, and our business could be adversely impacted if we fail to adapt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The U.S. healthcare system continues to evolve.  Significant change is taking place in the healthcare system, including as discussed above under the heading The Clinical Testing Industry, beginning on page 15.  For example, value-based reimbursement is increasing (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, UnitedHealthcare's Preferred Lab Network); CMS has set goals for value-based reimbursement to be achieved.  Patients are encouraged to take increased interest in and responsibility for, and often are bearing increased responsibility for payment for, their healthcare.  Healthcare industry participants are evolving and consolidating.  Healthcare services increasingly are being provided by non-traditional providers (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., physician assistants), in non-traditional venues (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., retail medical clinics, urgent care centers) and using new technologies (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., telemedicine, digital pathology).  Utilization of the healthcare system is being influenced by several factors and may result in a decline in the demand for diagnostic information services.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, we believe that clinical testing market fundamentals are changing.  We believe that PAMA-driven reimbursement pressure remains a catalyst for structural change in the market.  We also believe that health plans and consumers increasingly are focusing on driving better value in laboratory testing services.  We expect that the evolution of the healthcare industry will continue, and that industry change is likely to be extensive. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The clinical testing business is highly competitive, and if we fail to provide an appropriately priced level of service or otherwise fail to compete effectively it could have a material adverse effect on our revenues and profitability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The clinical testing business remains a fragmented and highly competitive industry.  We primarily compete with three types of clinical testing providers: other commercial clinical laboratories, IDN-affiliated laboratories and physician-office laboratories. We also compete with other providers, including anatomic pathology practices, large physician group practices and providers of consumer-initiated testing. IDNs generally maintain on-site laboratories to perform testing on their patients (inpatient or outpatient). In addition, many IDNs compete with commercial clinical laboratories for outreach (non-IDN patients) testing.  IDNs may seek to leverage their relationships with community clinicians and encourage the clinicians to send their outreach testing to the IDN's laboratory.  As a result of this affiliation between IDNs and community clinicians, we compete against IDN-affiliated laboratories primarily based on quality and scope of service as well as pricing. In addition, IDNs that own physician practices may encourage or require the practices to refer testing to the IDN's laboratory. In recent years, there has been a trend of IDNs acquiring physician practices, increasing the percentage of physician practices owned by IDNs.  Increased IDN ownership of physician practices may enhance clinician ties to IDN-affiliated laboratories and may strengthen their competitive position.  The formation of ACOs and DCEs and their approach to contracts with healthcare providers also may increase competition to provide diagnostic information services.  In addition, new players have recently started to provide clinical lab testing services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., employers; government agencies).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The diagnostic information services industry also is faced with changing technology and new product introductions. Competitors may compete using advanced technology, including technology that enables more convenient or cost-effective testing.  Digital pathology, still in an emerging state, is an example of this.  Competitors also may compete on the basis of new service offerings.  Competitors also may offer testing to be performed outside of a commercial clinical laboratory, such as (1) point-of-care testing that can be performed by physicians in their offices; (2) advanced testing that can be performed by IDNs in their own laboratories; and (3) home testing that can be carried out without requiring the services of outside providers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government payers, such as Medicare and Medicaid, have taken steps to reduce the utilization and reimbursement of healthcare services, including clinical testing services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We face efforts by government payers to reduce utilization of and reimbursement for diagnostic information services.   One example of this is increased use of prior authorization requirements.  We expect efforts to reduce reimbursements, to impose more stringent cost controls and to reduce utilization of clinical test services will continue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to PAMA, reimbursement rates for many clinical laboratory tests provided under Medicare were reduced from 2018 - 2020.  PAMA calls for further revision of the Medicare Clinical Laboratory Fee Schedule for years after 2020, based on future surveys of market rates; reimbursement rate reduction from 2023-25 is capped by PAMA at 15% annually.  PAMA's next data collection and reporting period have been delayed, most recently by federal legislation adopted in December 2021, which further delayed the reimbursement rate reductions and reporting requirements until January 1, 2023.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, CMS has adopted policies limiting or excluding coverage for clinical tests that we perform. We also provide physician services that are reimbursed by Medicare under a physician fee schedule, which is subject to adjustment on an annual basis.  Medicaid reimbursement varies by state and is subject to administrative and billing requirements and budget pressures.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, over the last several years, the federal government has expanded its contracts with private health insurance plans for Medicare beneficiaries, called &#8220;Medicare Advantage&#8221; programs, and has encouraged such beneficiaries to switch from the traditional programs to the private programs.  There has been growth of health insurance plans offering Medicare Advantage programs, and of beneficiary enrollment in these programs.  States have mandated that Medicaid beneficiaries enroll in private managed care arrangements.  In addition, state budget pressures have encouraged states to consider several courses of action that may impact our business, such as delaying payments, reducing reimbursement, restricting coverage eligibility, denying claims and service coverage restrictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursement for Medicare services also is subject to annual reduction under the Budget Control Act of 2011, the Statutory Pay-As-You-Go Act of 2010 and the Physician Fee Schedule.       </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the federal government has considered whether competitive bidding could be used to provide clinical testing services for Medicare beneficiaries at attractive rates while maintaining quality and access to care.  Congress periodically considers cost-saving initiatives.  These initiatives have included coinsurance for clinical testing services, co-payments for clinical testing and further laboratory physician fee schedule reductions.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other steps taken to reduce utilization and reimbursement include requirements to obtain diagnosis codes to obtain  payment, increased documentation requirements, limiting the allowable number of tests or ordering frequency, expanded prior authorization programs and otherwise increasing payment denials.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Steps to reduce utilization and reimbursement also discourage innovation and access to innovative solutions that we may offer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health plans and other third parties have taken steps to reduce the utilization and reimbursement of health services, including clinical testing services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We face efforts by non-governmental third-party payers, including health plans, to reduce utilization of and reimbursement for clinical testing services. Examples include increased use of prior authorization requirements and increased denial of coverage for services. There is increased market activity regarding alternative payment models, including bundled payment models. We expect continuing efforts by third-party payers, including in their rules, practices and policies, to reduce reimbursements, to impose more stringent cost controls and to reduce utilization of clinical testing services. ACOs, DCEs and IDNs also may undertake efforts to reduce utilization of, or reimbursement for, diagnostic information services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The healthcare industry has experienced a trend of consolidation among health insurance plans, resulting in fewer but larger insurance plans with significant bargaining power to negotiate fee arrangements with healthcare providers, including clinical testing providers.  The increased consolidation among health plans also has increased pricing transparency and their bargaining power and the potential adverse impact of ceasing to be a contracted provider with any such insurer.  Health plans, and independent physician associations, may demand that clinical testing providers accept discounted fee structures or assume all or a portion of the financial risk associated with providing testing services to their members through capitated payment arrangements. Some health plans also are reviewing test coding, evaluating coverage decisions and requiring preauthorization of certain testing. There are also an increasing number of patients enrolling in consumer driven products and high deductible plans that involve greater patient cost-sharing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other steps taken to reduce utilization and reimbursement include requirements to obtain diagnosis codes to obtain  payment, increased documentation requirements, limiting the allowable number of tests or ordering frequency, expanded prior authorization programs and otherwise increasing payment denials.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Steps to reduce utilization and reimbursement also discourage innovation and access to innovative solutions that we may offer.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to develop, or acquire licenses for, new tests, technology and services could negatively impact our testing volume and revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The diagnostic information services industry is faced with changing technology and new product introductions. Other companies or individuals, including our competitors, may obtain patents or other property rights that would prevent, limit or interfere with our ability to develop, perform or sell our solutions or operate our business or increase our costs. In addition, they could introduce new tests, technologies or services that may result in a decrease in the demand for our services or cause us to reduce the prices of our services. Our success in continuing to introduce new solutions, technology and services will depend, in part, on our ability to license new and improved technologies on favorable terms. We may be unable to develop or introduce new solutions or services. Other companies or individuals, including our competitors, may obtain patents or other property rights on tests or processes that we may be performing, that could prevent, limit or interfere with our ability to develop, perform or sell our tests or operate our business.  We also may be unable to continue to negotiate acceptable licensing arrangements, and arrangements that we do conclude may not yield commercially successful clinical tests. If we are unable to license these testing methods at competitive rates, our research and development costs may increase as a result. In addition, if we are unable to develop and introduce, or license, new solutions, technology and services to expand our advanced testing capabilities, our services may become outdated when compared with our competition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to establish, and perform to, appropriate quality standards, or to assure that the appropriate standard of quality is observed in the performance of our diagnostic information services, could adversely affect the results of our operations and adversely impact our reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The provision of diagnostic information services involves certain inherent risks. The services that we provide are intended to provide information in providing patient care. Therefore, users of our services may have a greater sensitivity to errors than the users of services or products that are intended for other purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Negligence in performing our services can lead to injury or other adverse events. We may be sued under physician liability or other liability law for acts or omissions by our pathologists, laboratory personnel and IDN employees who are under the supervision of our IDN-based pathologists. We are subject to the attendant risk of substantial damages awards and risk to our reputation.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_49"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO CHANGE IN PUBLIC POLICY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND THE REGULATORY AND LEGAL ENVIRONMENT</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to numerous legal and regulatory requirements governing our activities, and we may face substantial fines and penalties, and our business activities may be impacted, if we fail to comply.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our business is subject to or impacted by extensive and frequently changing laws and regulations in the United States (including at both the federal and state levels) and the other jurisdictions in which we engage in business. While we seek to conduct our business in compliance with all applicable laws, many of the laws and regulations applicable to us are vague or indefinite and have not been interpreted by the courts, including many of those relating to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">billing and reimbursement of clinical testing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certification or licensure of clinical laboratories;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anti-self-referral and anti-kickback laws and regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the laws and regulations administered by the FDA;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the corporate practice of medicine;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operational, personnel and quality requirements intended to ensure that clinical testing services are accurate, reliable and timely;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">physician fee splitting;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">relationships with physicians and IDNs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safety and health of laboratory employees; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These laws and regulations may be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that could require us to make changes in our operations, including our pricing and/or billing practices. We may not be able to maintain, renew or secure required permits, licenses or any other regulatory approvals needed to operate our business or commercialize our services. If we fail to comply with applicable laws and regulations, or if we fail to maintain, renew or obtain necessary permits, licenses and approvals, we could suffer civil and criminal penalties, fines, exclusion from participation in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">governmental healthcare programs and the loss of various licenses, certificates and authorizations necessary to operate our business, as well as incur additional liabilities from third-party claims. If any of the foregoing were to occur, our reputation could be damaged and important business relationships with third parties could be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We regularly receive requests for information, and occasionally subpoenas, from governmental authorities. We also are subject from time to time to qui tam claims brought by former employees or other &#8220;whistleblowers.&#8221; The federal and state governments continue aggressive enforcement efforts against perceived healthcare fraud.  Legislative provisions relating to healthcare fraud and abuse provide government enforcement personnel substantial funding, powers, penalties and remedies to pursue suspected cases of fraud and abuse.  In addition, the government has substantial leverage in negotiating settlements since the amount of potential damages far exceeds the rates at which we are reimbursed for our services, and the government has the remedy of excluding a non-compliant provider from participation in the Medicare and Medicaid programs. Regardless of merit or eventual outcome, these types of investigations and related litigation can result in:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management time and attention;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenditure of large amounts of cash on legal fees, costs and payment of damages;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases to our administrative, billing or other operating costs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limitations on our ability to continue some of our operations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enforcement actions, fines and penalties or the assertion of private litigation claims and damages;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases to the amount of reimbursement related to diagnostic information services performed;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse affects to important business relationships with third parties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased demand for our services; and/or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injury to our reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Changes in applicable laws and regulations may result in existing practices becoming more restricted, or subject our existing or proposed services to additional costs, delay, modification, withdrawal or reconsideration. Such changes also could require us to modify our business objectives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business could be adversely impacted by the FDA's approach to regulation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The FDA has regulatory responsibility over, among other areas, instruments, software, test kits, reagents and other devices used by clinical laboratories to perform diagnostic testing in the U.S.  A number of tests we develop internally are offered as LDTs. The FDA has claimed regulatory authority over all LDTs, but has stated that it exercised enforcement discretion with regard to most LDTs performed by high complexity CLIA-certified laboratories. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As the FDA moves to regulate more clinical laboratory testing, its approach to regulation is impacting industry practices and participants, new competitors may enter the industry, and competition may come in new forms.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Legislation introduced in Congress would enable the FDA to regulate LDTs, in vitro diagnostics, software and other items used in the diagnosis of disease. The FDA and the U. S. Department of Health and Human Services also have expressed views regarding the regulation of LDTs. Either new law or a revised approach to regulation of LDTs could have a significant impact on the clinical laboratory testing industry, including regulating LDTs in new ways, while creating avenues of opportunity and competition regarding clinical laboratory testing.  New competitors may enter the industry, and competition may come in new forms. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the 21st Century Cures Act, the FDA issued final guidance regarding its position on the regulation of clinical decision software, which may be used in connection with LDTs. The guidance attempts to clarify whether FDA approval of certain software is required.  It has been used by the FDA, in part, to assert authority over the annotation software aspects of pharmacogenetic testing services.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to accurately bill for our services, or to comply with applicable laws relating to government healthcare programs, could have a material adverse effect on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Billing for diagnostic information services is complex and subject to extensive and non-uniform rules and administrative requirements. Depending on the billing arrangement and applicable law, we bill various payers, such as patients, insurance companies, Medicare, Medicaid, clinicians, IDNs and employer groups.  The majority of billing and related operations for our Company are being provided by a third party under the Company's oversight.  Failure to accurately bill for our services could have a material adverse effect on our business.  In addition, failure to comply with applicable laws relating to billing government healthcare programs may result in various consequences, including: civil and criminal fines and penalties, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exclusion from participation in governmental healthcare programs and the loss of various licenses, certificates and authorizations necessary to operate our business, as well as incur additional liabilities from third-party claims, all of which could have a material adverse effect on our business.  Certain violations of these laws may also provide the basis for a civil remedy under the federal False Claims Act, including fines and damages of up to three times the amount claimed.  The qui tam provisions of the federal False Claims Act and similar provisions in certain state false claims acts allow private individuals to bring lawsuits against healthcare companies on behalf of government payers, private payers and/or patients alleging inappropriate billing practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Although we believe that we are in compliance, in all material respects, with applicable laws and regulations, there can be no assurance that a regulatory agency or tribunal would not reach a different conclusion.  The federal or state government may bring claims based on our current practices, which we believe are lawful.  The federal and state governments have substantial leverage in negotiating settlements since the amount of potential damages and fines far exceeds the rates at which we are reimbursed, and the government has the remedy of excluding a non-compliant provider from participation in the Medicare and Medicaid programs.  We believe that federal and state governments continue aggressive enforcement efforts against perceived healthcare fraud.  Legislative provisions relating to healthcare fraud and abuse provide government enforcement personnel with substantial funding, powers, penalties and remedies to pursue suspected cases of fraud and abuse. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to numerous political, legal, operational and other risks as a result of our international operations which could impact our business in many ways.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our international operations increase our exposure to risks inherent in doing business in non-U.S. markets, which may vary by market and include: intellectual property legal protections and remedies; weak legal systems which may, among other things, affect our ability to enforce contractual rights; trade regulations and procedures and actions affecting approval, production, pricing, reimbursement and marketing of services; and challenges based on differing languages and cultures.  International operations also require us to devote management resources to implement our controls and systems in new markets, and to comply with the U.S. Foreign Corrupt Practices Act and similar anti-corruption laws in non-U.S. jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be unable to obtain, maintain or enforce our intellectual property rights and may be subject to intellectual property litigation that could adversely impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We may be unable to obtain or maintain adequate patent or other proprietary rights for our solutions or services or to successfully enforce our proprietary rights. In addition, we may be subject to intellectual property litigation, and we may be found to infringe on the proprietary rights of others, which could force us to do one or more of the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cease developing, performing or selling solutions or services that incorporate the challenged intellectual property;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain and pay for licenses from the holder of the infringed intellectual property right;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">redesign or re-engineer our tests;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">change our business processes; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay substantial damages, court costs and attorneys' fees, including potentially increased damages for any infringement held to be willful.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adverse results in material litigation could have an adverse financial impact and an adverse impact on our client base and reputation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are involved in various legal proceedings arising in the ordinary course of business including, among other things, disputes as to intellectual property, professional liability and employee-related matters, as well as inquiries from governmental </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agencies and Medicare or Medicaid carriers. Some proceedings against us involve claims that are substantial in amount and could divert management's attention from operations. These proceedings also may result in substantial monetary damages.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Government rules and regulations concerning mandatory COVID-19 vaccination of U.S.-based employees of companies that work on or in support of federal government contracts, or other COVID-19 vaccine mandates, could have a material adverse impact on our business and consolidated results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In September 2021, President Biden issued an executive order requiring all employers with U.S. Government contracts to ensure that their U.S.-based employees, contractors and subcontractors, that work on or in support of U.S. government contracts, are fully vaccinated against COVID-19 as required by the executive order.  The executive order is being challenged in courts and is currently not in effect.  However, other federal, state and local government vaccine mandates are in effect; some of these mandates have application to the Company (directly or indirectly), others do not have application to the Company.  Further, additional vaccine and testing mandates have been and may in the future be announced by private parties (such as contract counterparties) and in other jurisdictions in which we operate; such mandates may conflict with each other.  Requirements to mandate COVID-19 vaccination of all or significant portions of our workforce could result in labor disruptions, employee attrition, difficulty in satisfying future labor needs and sanctions or penalties.         </span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_52"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">RISKS RELATED TO OUR INDEBTEDNESS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our outstanding debt may impair our financial and operating flexibility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December 31, 2021, we had approximately $4.0 billion of debt outstanding.  Other than credit facilities in the normal course of business, we do not have any off-balance sheet financing arrangements in place or available. Our debt agreements contain various restrictive covenants. These restrictions could limit our ability to use operating cash flow in other areas of our business because we must use a portion of these funds to make principal and interest payments on our debt. We have obtained ratings on our public debt from Standard and Poor's, Moody's Investor Services and Fitch Ratings. There can be no assurance that any rating so assigned will remain for any given period of time or that a rating will not be lowered or withdrawn entirely by a rating agency if in that rating agency's judgment future circumstances relating to the basis of the rating, such as adverse changes in our Company or our industry, so warrant. If such ratings are lowered, our borrowing costs could increase. Changes in our credit ratings, however, do not require repayment or acceleration of any of our debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;Borrowings under our credit facilities may be made at interest rates that are based on the London Interbank Offered Rate (&#8220;LIBOR&#8221;), which is a widely used benchmark for establishing interest rates globally.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of concerns regarding the accuracy of the calculation of LIBOR, the United Kingdom&#8217;s Financial Conduct Authority announced that it intends to no longer compel member banks to submit rates used to calculate LIBOR after December 31, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These reforms may cause LIBOR to cease to exist as a reference rate.  A committee established by the Federal Reserve Board announced a new index, based on overnight repurchase agreements collateralized by U.S. Treasury securities, as an alternative to LIBOR; other jurisdictions have proposed different alternatives. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At this time, it is not possible to predict the replacement rate for U.S. dollar LIBOR (which is the LIBOR rate that we most frequently rely on), and the consequences to us cannot be predicted. While we expect to be able to transition all LIBOR-based instruments and contracts to an alternative reference rate upon the cessation of LIBOR, there is no guarantee that we will be able to do so.  Changes in market interest rates may negatively influence our financing costs and the valuation of derivative instruments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;We or our subsidiaries may incur additional indebtedness in the future. Our ability to make principal and interest payments will depend on our ability to generate cash in the future. If we incur additional debt, a greater portion of our cash flows may be needed to satisfy our debt service obligations and if we do not generate sufficient cash to meet our debt service requirements, we may need to seek additional financing. In that case, it may be more difficult, or we may be unable, to obtain financing on terms that are acceptable to us. As a result, we would be more vulnerable to general adverse economic, industry and capital markets conditions as well as the other risks associated with indebtedness.</span></div><div id="ib4001cf8768244cca3f772bfc08f865b_55"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR OPERATIONS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The development of new technologies (including artificial intelligence technologies) may impact the healthcare industry, and the development of new, more cost-effective solutions that can be performed by our customers or by patients, and the continued internalization of testing by IDNs or clinicians, could negatively impact our testing volume and revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The diagnostic information services industry is faced with changing technology and new product introductions, including technology that enables more convenient or cost-effective testing.  For example, digital pathology is an emerging </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology that may change the practice of pathology.  Information technology that includes self-learning or "artificial intelligence" features is growing and may impact the healthcare industry.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Competitors also may offer testing to be performed outside of a commercial clinical laboratory, such as (1) point-of-care testing that can be performed by clinicians in their offices; (2) complex testing that can be performed by IDNs in their own laboratories; and (3) home testing that can be carried out without requiring the services of outside providers.  Advances in technology also may lead to the need for less frequent testing.  Further, diagnostic tests approved or cleared by the FDA for home use are automatically deemed to be &#8220;waived&#8221; tests under CLIA and may be performed by consumers in their homes; test kit manufacturers could seek to increase sales to patients of such test kits. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some traditional customers for anatomic pathology services, including specialty physicians that generate biopsies through surgical procedures, such as dermatologists, gastroenterologists, urologists and oncologists, are consolidating, have added in-office histology labs or have retained pathologists to read cases on site.  IDNs also are internalizing clinical laboratory testing, including some non-routine and advanced testing.  Internalization of testing may reduce demand for services previously referred to outside service providers, such as the Company. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hardware and software failures or delays in our information technology systems, including failures resulting from our systems conversions or otherwise, could disrupt our operations and cause the loss of confidential information, customers and business opportunities or otherwise adversely impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;IT systems are used extensively in virtually all aspects of our business, including clinical testing, test reporting, billing, customer service, logistics and management of medical data. Our success depends, in part, on the continued and uninterrupted performance of our IT systems.  A failure or delay in our IT systems could impede our ability to serve our customers and patients and protect their confidential data.  Despite redundancy and backup measures and precautions that we have implemented, our IT systems may be vulnerable to damage, disruptions and shutdown from a variety of sources, including telecommunications or network failures, system conversion or standardization initiatives, human acts and natural disasters.  These issues can also arise as a result of failures by third parties with whom we do business and over which we have limited control.  Any disruption or failure of our IT systems could have a material impact on our ability to serve our customers and patients, including negatively affecting our reputation in the marketplace.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business could be negatively affected if we are unable to continue to strengthen our efficiency.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;It is important that we continue to strengthen our efficiency to promote our competitive position and to enable us to mitigate the impact on our profitability of steps taken by government payers and health insurers to reduce the utilization and reimbursement of healthcare services, including diagnostic information services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business operations and reputation may be materially impaired if we do not comply with privacy laws or information security policies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our business, we collect, generate, process or maintain sensitive information, such as patient data and other personal information. If we do use or not adequately safeguard that information in compliance with applicable requirements under federal, state and international laws, or if it were disclosed to persons or entities that should not have access to it, our business could be materially impaired, our reputation could suffer and we could be subject to fines, penalties and litigation.  In the event of a data security breach, we may be subject to notification obligations, litigation and governmental investigation or sanctions, and may suffer reputational damage, which could have an adverse impact on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are subject to laws and regulations regarding protecting the security and privacy of certain healthcare and personal information, including: (a) the federal Health Insurance Portability and Accountability Act and the regulations thereunder, which establish (i) a complex regulatory framework including requirements for safeguarding protected health information and (ii) comprehensive federal standards regarding the uses and disclosures of protected health information; (b) state laws, including the California Consumer Privacy Act and similar laws in other states; and (c) laws outside the U.S., including the European Union's General Data Protection Regulation.  </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The IT systems that we rely on may be subject to unauthorized tampering, cyberattack or other security breach.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our IT systems have been and are subject to potential cyberattacks, tampering or other security breaches. These attacks, if successful, could result in shutdowns or significant disruptions of our IT systems and/or in unauthorized persons exfiltrating and misappropriating intellectual property and other confidential information, including patient and employee data that we collect, transmit and store on and through our IT systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;External actors may develop and deploy viruses, other malicious software programs, ransomware attacks, distributed denial of service attacks or other attempts to harm or obtain unauthorized access to our systems. External actors may also deploy programs targeting our employees which are designed to attack our IT systems or otherwise exploit security vulnerabilities through programs such as electronic spamming, phishing, smishing, spear phishing or similar tactics. As a result of the difficulty in detecting many of these attacks, intrusions and breaches, failures or losses may be repeated or compounded before they are discovered or rectified, which could further increase these costs and consequences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Although the Company has robust security measures implemented, which are monitored and routinely tested both by internal resources and external parties, cyber threats against us continue to evolve and may not be recognized until after an incident. In August 2021, ReproSource, our subsidiary, experienced a data security incident in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients (in connection with the incident, ReproSource discovered and contained ransomware). The Company&#8217;s other systems were not impacted or compromised by this incident. Although the attacks we have experienced have not materially disrupted, interrupted, damaged or shutdown the Company's IT systems, or materially disrupted the Company's performance of its business, the mitigation or remediation efforts that we have undertaken, and may undertake in the future, require the attention of management and expenditures of resources, which can be significant. There can be no assurance that the Company can anticipate all evolving future attacks, viruses or intrusions, implement adequate preventative measures, or remediate any security vulnerabilities. If our IT systems are successfully attacked, it could result in major disruption of our business, compromise confidential information, and result in litigation and potential liability for the Company, government investigation, significant damage to our reputation or otherwise adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, third parties to whom we outsource certain of our services or functions, or with whom we interface, store or process confidential patient and employee data or other confidential information, as well as those third parties&#8217; providers, are also subject to the risks outlined above. For example, in June 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;), informed the Company about a data security incident involving AMCA. AMCA, which provided debt collection services for a company that provides revenue management services to the Company, informed the Company in May 2019 that AMCA had learned that an unauthorized user had access to AMCA&#8217;s system during 2018 and 2019. AMCA&#8217;s affected system included financial, medical and other personal information. The Company&#8217;s systems or databases were not involved in this incident. A breach or attack affecting third parties with whom we engage could also harm our business, results of operations and reputation and subject us to liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have taken, and continue to take, precautionary measures to reduce the risk of, and detect and respond to, future cyber threats, and prevent or minimize vulnerabilities in our IT systems, including the loss or theft of intellectual property, patient and employee data or other confidential information that we obtain and store on our systems. We also have taken, and will continue to take, measures to assess the cybersecurity protections used by third parties to whom we outsource certain of our services or functions, or with whom we interface, store or process confidential patient and employee data or other confidential information. In addition, we collaborate with government agencies regarding potential cyber threats and have worked with firms that have cyber security expertise to evaluate our systems and the attacks we experience and strengthen our systems. There can be no assurances that our precautionary measures or measures used by our third party providers will prevent, contain or successfully defend against cyber or information security threats that could have a significant impact on our business, results of operations and reputation and subject us to liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to attract and retain qualified employees is critical to the success of our business and the failure to do so may materially adversely affect our performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The supply of qualified technical, managerial and other personnel, including phlebotomists and processors, is currently constrained; competition for qualified employees, even across different industries, is intense, including as individuals leave the job market.  We may lose, or fail to attract and retain, key management personnel, or qualified skilled technical, professional or other employees. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Business development activities are inherently risky and integrating our operations with businesses we acquire may be difficult.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We plan selectively to enhance our business from time to time through business development activities, such as acquisitions, licensing arrangements, investments and alliances. However, these plans are subject to the availability of appropriate opportunities and competition from other companies seeking similar opportunities. Moreover, the success of any such effort may be affected by a number of factors, including our ability to properly assess and value the potential business opportunity, and to integrate it into our business. The success of our strategic alliances depends not only on our contributions and capabilities, but also on the property, resources, efforts and skills contributed by our strategic partners. Further, disputes may arise with strategic partners, due to conflicting priorities or conflicts of interests.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Acquisitions are not all the same (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., asset acquisitions differ from acquisitions of equity interests); different acquisitions offer different risks.  Acquisitions may involve the integration of a separate company that has different systems, processes, policies and cultures. Integration of acquisitions involves a number of risks including the diversion of management's attention to the assimilation of the operations of assets or businesses we have acquired, difficulties in the integration of operations and systems and the realization of potential operating synergies, the assimilation and retention of the personnel of the acquired businesses, challenges in retaining the customers of the combined businesses, and potential adverse effects on operating results. The process of combining acquisitions may be disruptive to our businesses and may cause an interruption of, or a loss of momentum in, such businesses as a result of the following difficulties, among others:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of key customers or employees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in standardizing information and other systems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in consolidating facilities and infrastructure;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to maintain the quality or timeliness of services that our Company has historically provided;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management's attention from the day-to-day business of our Company as a result of the need to deal with the foregoing disruptions and difficulties; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the added costs of dealing with such disruptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If we are unable successfully to integrate strategic acquisitions in a timely manner, our business and our growth strategies could be negatively affected. Even if we are able to successfully complete the integration of the operations of other assets or businesses we may acquire in the future, we may not be able to realize all or any of the benefits that we expect to result from such integration, either in monetary terms or in a timely manner. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our operations may be adversely impacted by the effects of natural disasters such as hurricanes and earthquakes, public health emergencies and health pandemics, hostilities or acts of terrorism and other criminal activities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;We operate facilities across the United States, and consumers frequently visit our facilities in person.  The ability of our employees and consumers to access our facilities may be adversely impacted by the effects of extreme weather events and natural disasters, such as hurricanes, earthquakes, tropical storms, floods, fires, earthquakes or other extreme weather conditions, including major winter storms, droughts and heat waves, whether as a result of climate change or otherwise; public health emergencies and health pandemics; hostilities or acts of terrorism or other activities. Although we maintain a business continuity program to prepare for and respond to such events, because of their unpredictable nature, these events may limit or interrupt our ability to conduct operations.  Additionally, such events may interrupt our ability to transport specimens, to receive materials from our suppliers or otherwise to provide our services.  These events also may result in a decline in the number of patients who seek clinical testing services or in our employees' ability to perform their job duties.    </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The COVID-19 pandemic has significantly affected our consolidated results of operations, financial position and cash flows, and may continue to do so.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A pandemic caused by a novel strain of coronavirus (COVID-19) continues to severely impact the economy of the United States and other countries around the world. Federal, state and local governmental authorities in the United States have implemented numerous policies and initiatives to try and reduce the transmission of COVID-19, such as travel bans and restrictions, quarantines, shelter-in-place orders, business shutdowns, and vaccination and masking mandates. These policies and initiatives have resulted in, among other things, a significant reduction in physician office visits, the cancellation of elective medical procedures, customers closing or severely curtailing their operations (voluntarily or in response to government orders), increased unemployment, constrained labor supply and loss of healthcare insurance, and the adoption of work-from-home policies, all of which have had, and we believe will continue to have, an impact on our consolidated results of operations, financial position and cash flows. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Due to the COVID-19 pandemic, we have experienced significant volatility, including periods of material decline compared to prior year periods, in testing volume in our base business (which excludes COVID-19 molecular and antibody testing) and this volatility, including periods of material decline, could continue. Although we also have experienced heavy demand for COVID-19 molecular testing as a result of the COVID-19 pandemic, which has had a positive impact on our overall testing volume, the duration and level of the demand for, and reimbursement for, COVID-19 molecular testing is uncertain.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;We may also experience an adverse impact on cash collections and labor supply and supply chain disruptions, including shortages, delays and price increases in testing equipment and supplies, as a result of the impact of the COVID-19 pandemic.  A number of suppliers and manufacturers we rely upon have been experiencing and may continue to experience disruptions and delays, as a result of ongoing raw material and labor shortages, supply challenges, and business limitations or shutdowns resulting from the COVID-19 pandemic, which may prevent us from obtaining equipment and supplies in a timely manner or at a reasonable price. The COVID-19 pandemic has also caused significant disruptions in transport and logistics services as a result of facility closures, labor shortages or other challenges, which may affect our ability to transport specimens, receive supplies or materials from our suppliers or otherwise provide our services. These conditions may continue or deteriorate in the future.  Any of these events could have an adverse impact on our business, consolidated results of operation, financial position and cash flows. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe the COVID-19 pandemic&#8217;s adverse impact on our consolidated results of operations, financial position and cash flows will be primarily driven by: the severity and duration of the COVID-19 pandemic (including any variants); the COVID-19 pandemic&#8217;s impact on the U.S. healthcare system and the U.S. economy; the timing, scope and effectiveness of federal, state and local governmental responses; and effective and comprehensive COVID-19 vaccination across the U.S.  These primary drivers are beyond our knowledge and control and will change over time, and as a result, at this time we cannot reasonably estimate the adverse impact the COVID-19 pandemic will have on our businesses, consolidated results of operations, financial position and cash flows, and the adverse impact may be material. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our business also may be impacted by changes in the severity of the COVID-19 pandemic at different times in the various cities and regions where we operate and offer services, and by challenges faced in implementing nationwide COVID-19 vaccinations, including the degree to which the public is vaccinated and the effectiveness of vaccines at preventing infection or illness in connection with new or existing variants of COVID-19.  Even after the COVID-19 pandemic has moderated and business conditions have eased, we may continue to experience similar adverse effects to our businesses, consolidated results of operations, financial position and cash flows arising from long-term changes in behavior by consumers or other healthcare system participants and resulting from a recessionary economic environment that may persist. The impact that the COVID-19 pandemic will have on our businesses, consolidated results of operations, financial position and cash flows could exacerbate other risks identified in this Report.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_58"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some statements and disclosures in this document are forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;plan&#8221; or &#8220;continue.&#8221; These forward-looking statements are based on our current plans and expectations and are subject to a number of risks and uncertainties that could cause our plans and expectations, including actual results, to differ materially from the forward-looking statements. Investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this document. The following important factors could cause our actual financial results to differ materially from those projected, forecasted or estimated by us in forward-looking statements:</span></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Heightened competition from commercial clinical testing companies, IDNs, physicians and others.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Increased pricing pressure from customers, including payers and patients.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;A decline in economic conditions.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Impact of changes in payment mix, including increased patient financial responsibility and any shift from fee-for-service to discounted, capitated or bundled fee arrangements.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Adverse actions by government or other third-party payers, including healthcare reform that focuses on reducing healthcare costs but does not recognize the value and importance to healthcare of clinical testing or innovative solutions, unilateral reduction of fee schedules payable to us, unilateral recoupment of amounts allegedly owed and competitive bidding.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;The impact upon our testing volume and collected revenue or general or administrative expenses resulting from compliance with policies and requirements imposed by Medicare, Medicaid and other third-party payers. These include:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;the requirements of government and other payers to provide diagnosis codes and other information for many tests;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;inability to obtain from patients a valid advance consent form for tests that cannot be billed without prior receipt of the form; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;the impact of additional or expanded limited coverage policies and limits on the allowable number of test units or ordering frequency of same; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;the impact of increased prior authorization programs.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;Adverse results from pending or future government investigations, lawsuits or private actions. These include, in particular, monetary damages, loss or suspension of licenses, and/or suspension or exclusion from the Medicare and Medicaid programs and/or criminal penalties.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Failure to efficiently integrate acquired businesses and to manage the costs related to any such integration, or to retain key technical, professional or management personnel.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Denial, suspension or revocation of CLIA certification or other licenses for any of our clinical laboratories under the CLIA standards, revocation or suspension of the right to bill the Medicare and Medicaid programs or other adverse regulatory actions by federal, state and local agencies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;Changes in and complexity of federal, state or local laws or regulations, including changes that result in new or increased federal or state regulation of commercial clinical laboratories, tests developed by commercial clinical laboratories or other products or services that we offer or activities in which we are engaged, including regulation by the FDA.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;Inability to achieve expected benefits from our acquisitions of other businesses.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;Inability to achieve additional benefits from our business performance tools and efficiency initiatives.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;Adverse publicity and news coverage about the diagnostic information services industry or us.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;Failure of the Company to maintain, defend and secure its financial, accounting, technology, customer data and other operational systems from cyberattacks, IT system outages, telecommunications failures, malicious human acts and failure of the systems of third parties upon which the Company relies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;Development of technologies that substantially alter the practice of clinical testing, including technology changes that lead to the development of more convenient or cost-effective testing, or testing to be performed outside of a commercial clinical laboratory, such as (1) point-of-care testing that can be performed by physicians in their offices, (2) advanced testing that can be performed by IDNs in their own laboratories or (3) home testing that can be carried out without requiring the services of clinical laboratories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;Negative developments regarding intellectual property and other property rights that could prevent, limit or interfere with our ability to develop, perform or sell our tests or operate our business. These include:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;issuance of patents or other property rights to our competitors or others; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;inability to obtain or maintain adequate patent or other proprietary rights for our products and services or to successfully enforce our proprietary rights.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;Development of tests by our competitors or others which we may not be able to license, or usage (or theft) of our technology or similar technologies or our trade secrets or other intellectual property by competitors, any of which could negatively affect our competitive position.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;Regulatory delay or inability to commercialize newly developed or licensed tests or technologies or to obtain appropriate reimbursements for such tests.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;The complexity of billing and revenue recognition for clinical laboratory testing.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;Increases in interest rates and negative changes in our credit ratings from Standard &amp; Poor's, Moody's Investor Services or Fitch Ratings causing an unfavorable impact on our cost of or access to capital.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;Inability to hire or retain qualified employees, including key senior management personnel.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;Terrorist and other criminal activities, hurricanes, earthquakes or other natural disasters, and public health emergencies and health pandemics, which could affect our customers or suppliers, transportation or systems, or our facilities, and for which insurance may not adequately reimburse us.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(w)&#160;&#160;&#160;&#160;Difficulties and uncertainties in the discovery, development, regulatory environment and/or marketing of new services or solutions or new uses of existing tests.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;Failure to adapt to changes in the healthcare system (including the medical laboratory testing market) and healthcare delivery, including those stemming from PAMA, trends in utilization of the healthcare system and increased patient financial responsibility for services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(y) &#160;&#160;&#160;&#160;Results and consequences of governmental inquiries.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(z)   Difficulty in implementing, or lack of success with, our strategic plan.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(aa) The impact of healthcare data analysis on our industry and the ability of our Company to adapt to that impact.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bb) Failure to adequately operationalize appropriate controls around use of our data, including risk of non-compliance with privacy law requirements.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(cc) The COVID-19 pandemic.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1B. Unresolved Staff Comments</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are no unresolved SEC comments that require disclosure.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 2. Properties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our executive offices are located at 500 Plaza Drive, Secaucus, New Jersey.  We maintain clinical testing laboratories throughout the continental United States; in several instances a joint venture of which we are a partner maintains the laboratory.  We also maintain offices, data centers, call centers, distribution centers and patient service centers at locations throughout the United States.  In addition, we maintain offices, patient service centers and clinical laboratories in locations outside the United States, including in Finland, Puerto Rico and Mexico.  Our properties that are not owned are leased on terms and for durations that are reflective of commercial standards in the communities where these properties are located. We believe that, in general, our facilities are suitable and adequate for our current and anticipated future levels of operation and are adequately maintained.  We believe that if we were unable to renew a lease on any of our facilities, we could find alternative space at competitive market rates and relocate our operations to such new location without material disruption to our business.  Several of our principal facilities are highlighted below.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:77.639%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.428%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leased or Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3600 Northgate Blvd., Sacramento, California  95834  (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8401 Fallbrook Avenue, West Hills, California  91304 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33608 Ortega Hwy., San Juan Capistrano, California 92675 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4151C East Fowler Avenue, Tampa, Florida  33617 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1777 Montreal Circle, Tucker, Georgia 30084-6802  (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">506 E State Parkway, Schaumburg, Illinois 60173 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1355 Mittle Blvd., Wood Dale, Illinois 60191 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">200 Forest Street, Marlborough, Massachusetts  01752  (laboratories)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">800 Business Center Drive, Horsham, Pennsylvania 19044  (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4770 Regent Blvd., Irving, Texas  75063 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14225 Newbrook Drive, Chantilly, Virginia 22021  (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10101 Renner Blvd., Lenexa, Kansas  66219 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4380 Federal Drive, Greensboro, North Carolina  27410 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2501 South State Hwy 121, Lewisville, Texas 75067 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6700 Euclid Avenue, Cleveland, Ohio 44103 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">One Insights Drive, Clifton, NJ  07012 (laboratory)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr></table></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 3. Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 18 to the Consolidated Financial Statements (Part II, Item</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;8 of th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is Report) for information regarding legal proceedings in which we are involved.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 4. Mine Safety Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44 </span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our common stock is listed and traded on the New York Stock Exchange under the symbol &#8220;DGX.&#8221; As of February 1, 2022, we had approximately 2,500 record holders of our common stock; we believe that the number of beneficial holders of our common stock exceeds the number of record holders. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The table below sets forth the information with respect to purchases made by or on behalf of the Company of its common stock during the fourth quarter of 2021. </span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.704%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.704%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.704%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.706%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ISSUER PURCHASES OF EQUITY SECURITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price<br/>Paid per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased<br/>as Part of Publicly<br/>Announced Plans<br/>or Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Yet Be Purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Under the Plans</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">or Programs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2021 &#8211; October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2021 &#8211; November 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2021 &#8211; December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695,906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,556,498&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,556,498&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695,906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">In each of February 2021 and March 2021, our Board of Directors increased the size of our share repurchase program by $1 billion.  Since the share repurchase program's inception in May 2003, our Board of Directors has authorized $11&#160;billion of share repurchases of our common stock through December&#160;31, 2021.  The share repurchase authority has no set expiration or termination date.  In February 2022, our Board of Directors authorized the Company to repurchase an additional $1&#160;billion of our common stock, which is in addition to the $0.7 billion that was available as of December&#160;31, 2021 under our share repurchase program.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes: (1) shares delivered or attested to in satisfaction of the exercise price and/or tax withholding obligations by holders of stock options (granted under the Company's Amended and Restated Employee Long-Term Incentive Plan) who exercised options; and (2) shares withheld (under the terms of grants under the Amended and Restated Employee Long-Term Incentive Plan) to offset tax withholding obligations that occur upon the delivery of outstanding common shares underlying restricted share units and performance share units.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes the reclassification of $300 million from additional paid-in capital to treasury stock and the final delivery of 1,640,193 shares associated with the completion of the April 2021 accelerated share repurchase agreements ("ASRs"). See Note 16 to the audited consolidated financial statements for further information regarding the ASRs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Set forth below is a line graph comparing the cumulative total shareholder return on Quest Diagnostics' common stock since December&#160;31, 2016 based on the market price of the Company's common stock and assuming reinvestment of dividends, with the cumulative total shareholder return of companies on the Standard &amp; Poor's (S&amp;P) 500 Stock Index and the S&amp;P 500 Health Care (Sector) Index.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="dgx-20211231_g5.jpg" alt="dgx-20211231_g5.jpg" style="height:480px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.676%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Closing DGX Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholder Return</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Graph Values</span></td></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DGX</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500 Health Care (Sector)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DGX</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500 Health Care (Sector)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2017</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.49&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.16&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.83&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.08&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.16&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.83&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.08&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2018</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.84)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/30/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/29/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 6 [Reserved]</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:29.25pt;text-indent:-31.5pt"><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_133">57</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46 </span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 7A. Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Management's Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 8. Financial Statements and Supplementary Data</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Item 15(a)1 and Item 15(a)2.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;None.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 9A. Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conclusion Regarding Effectiveness of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended).  Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this annual report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Management on Internal Control Over Financial Reporting</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_148">75</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the fourth quarter of 2021, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 9B. Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#160;&#160;&#160;&#160;On February 24, 2022, the Company's Board of Directors increased the Company's share repurchase authorization by $1 billion. The increased authority is an addition to the $0.7 billion that was available as of December 31, 2021 under the Company's share repurchase program.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_2192"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47 </span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our Code of Ethics applies to all employees, executive officers and directors, including our Chief Executive Officer, Chief Financial Officer and Corporate Controller.  You can find our Code of Ethics on our corporate governance website,  www.QuestDiagnostics.com/investor.  We will post any amendments to the Code of Ethics, and any waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange, on our website.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information regarding the Company's executive officers is contained in Part I, Item 1 of this Report under &#8220;Information about our Executive Officers.&#8221;  Information regarding the directors and executive off</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">icers of the Company appearing in our Proxy Statement to be filed by April&#160;30, 2022 (&#8220;Proxy Statement&#8221;) under the captions &#8220;Proposal No. 1 - Election of Directors,&#8221; &#8220;Director Independence,&#8221; &#8220;Board Committees&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and "Delinquent Section 16(a) Reports" is incorporated by reference herein.</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 11. Executive Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information appearing in our Proxy Statement under the captions</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;2021 Director Compensation Table,&#8221; &#8220;Compensation Discussion and Analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;Information Regarding Executive Compensation&#8221; and &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation Committee Report&#8221; is incorporated by reference herein.  </span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_109"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders' Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information regarding security ownership of certain beneficial owners and management appearing in our Proxy Statement under the captions </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Stock Ownership Information&#8221; and "Equity Compensation Plan Information" is incorporated by reference herein. </span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information regarding certain relationships and related transactions appearing in our Proxy Statement under the captions</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Related Person Transactions&#8221; and &#8220;Director Independence&#8221; is incorporated by reference herein. </span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 14. Principal Accounting Fees and Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information regarding principal accountant fees and services appearing in our Proxy Statement under the caption </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Audit" (excluding the information under the subheading &#8220;Audit and Finance Committee Report&#8221;) is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incorporated by reference herein. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48 </span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_121"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 15. Exhibits, Financial Statement Schedules</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Documents filed as part of this Report.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Index to financial statements and supplementary data filed as part of this Report.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:85.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_151">Report of Independent Registered Public Accounting Fir</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_151">m </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_151">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_151">PCAOB ID </a></span><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xMjEvZnJhZzoxZDJiNmY3NGI3NzY0Mzg2YTY0NTYxMGQ3NDczOTE1Ny90YWJsZTo0NDM4OGI4MjJlMzU0YmUzYWY4OGRmMmNhODg0NTAyZC90YWJsZXJhbmdlOjQ0Mzg4YjgyMmUzNTRiZTNhZjg4ZGYyY2E4ODQ1MDJkXzItMC0xLTEtNDA2NDYvdGV4dHJlZ2lvbjpjYjk3N2M5MmI4YjQ0ZTkxOWI4YmM0MzIxMDVlMDM1M18yNzQ4Nzc5MDY5NTM1_a72c51a2-4719-4677-96dd-e29cf8ac50c5">238</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_151">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_151">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_157">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_157">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_160">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_160">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_163">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_163">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_166">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_166">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_169">Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_169">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_172">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_172">8</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Financial Statement Schedule.</span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:85.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_244">Schedule II - Valuation Accounts and Reserves</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_244">44</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Exhibits </span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207918000180/dgx09302018ex31.htm">Restated Certificate of Incorporation (filed as an Exhibit to the Company's current report on Form 10-Q for the quarter ended September 30, 2018 (Date of Report: October 24, 2018)  and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000144/dgx051319ex31.htm">Amended and Restated By-Laws of the Company (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: May 17, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex10-1.htm">Form of 6.95% Senior Note due 2037 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041309005747/c59372_ex1-1.htm">Form of 5.750% Senior Note due 2040 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787114000160/ss206544_ex0101.htm">Form of 4.250% Senior Note due 2024 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787115000168/ss419933_ex0101.htm">Form of 3.500% Senior Note due 2025 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787115000168/ss419933_ex0101.htm">Form of 4.700% Senior Note due 2045 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787116001220/ss1485098_ex0101.htm">Form of 3.450% Senior Note due 2026 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 23, 2016) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000202/ss128814_ex0101.htm">Form of 4.200% Senior Note due 2029 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: March 7, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000957/ss159854_ex0101.htm">Form of 2.950% Senior Note due 2030 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: December 9, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000458/ss173511_ex0101.htm">Form of 2.800% Senior Note due 2031 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 11, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787101500290/ex4-3_062801.txt">Indenture dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and the Trustee (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787101500290/ex4-4_062801.txt">First Supplemental Indenture, dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787101501115/ex4-1_112601.txt">Second Supplemental Indenture, dated as of November 26, 2001, among the Company, the Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 26, 2001) and incorporated herein by reference) (Commission File Number 001-12215)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787102000692/ex4-1_040902.txt">Third Supplemental Indenture, dated as of April 4, 2002, among the Company, the Additional Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: April 1, 2002) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011703001797/ex10-1.txt">Fourth Supplemental Indenture dated as of March 19, 2003, among Unilab Corporation (f/k/a Quest Diagnostics Newco Incorporated), the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2003 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011704001657/ex10-1.txt">Fifth Supplemental Indenture dated as of April 16, 2004, among Unilab Acquisition Corporation (d/b/a FNA Clinics of America), the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2004 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011705004157/ex4-7.htm">Sixth Supplemental Indenture dated as of October 31, 2005, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: October 31, 2005) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011705004480/ex4-1.htm">Seventh Supplemental Indenture dated as of November 21, 2005, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 21, 2005) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011706003285/ex4-1.htm">Eighth Supplemental Indenture dated as of July 31, 2006, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: July 31, 2006) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011706004130/ex4-1.htm">Ninth Supplemental Indenture dated as of September 30, 2006, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: September 30, 2006) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-11.htm">Tenth Supplemental Indenture dated as of June 22, 2007, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-14.htm">Eleventh Supplemental Indenture dated as of June 22, 2007, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-15.htm">Twelfth Supplemental Indenture dated as of June 25, 2007, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041309005838/c59427_ex4-14.htm">Thirteenth Supplemental Indenture dated as of November 17, 2009, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.24</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041311002247/c64911_ex4-15.htm">Fourteenth Supplemental Indenture dated as of March 24, 2011, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041312000949/c68209_ex4-24.htm">Fifteenth Supplemental Indenture dated as of November 30, 2011, among the Company, The Bank of New York Mellon Trust Company, N.A., as successor trustee to The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's 2011 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.26</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787114000160/ss206544_ex0417.htm">Sixteenth Supplemental Indenture dated as of March 17, 2014, between the Company, The Bank of New York Mellon Trust Company, N.A., (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787115000168/ss419933_ex0418.htm">Seventeenth Supplemental Indenture dated as of March 10, 2015, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787116001220/ss1485098_ex0419.htm">Eighteenth Supplemental Indenture dated as of May 26, 2016, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 23, 2016) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.29</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000202/ss128814_ex0402.htm">Nineteenth Supplemental Indenture dated as of March 12 2019, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: March 7, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000973/ss160605_ex0402.htm">Twentieth Supplemental Indenture dated as of December 16, 2019, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: December 16, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000458/ss173511_ex0402.htm">Twenty-First Supplemental Indenture dated as of May 13, 2020, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 11, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207920000017/dgx12312019ex431.htm">Description of Securities (filed as an Exhibit to the Company&#8217;s 2019 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000118/dgx03312019ex101.htm">Amended and Restated Employee Stock Purchase Plan, as amended, effective February 18, 2019 (filed as an Exhibit to the Company's quarterly report on form 10-Q for the quarter ended March 31, 2019 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000166/dgx063019ex101.htm">Amended and Restated Quest Diagnostics Incorporated Employee Long-Term Incentive Plan as amended May 14, 2019 (filed as an Exhibit to the Company's </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000166/dgx063019ex101.htm">quarterly report on Form 10-Q for the quarter ended June 30, 2019 and incorporated herein by reference) (Commission file number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207918000106/dgx033118ex101.htm">Form of Equity Award Agreement dated as of February 19, 2018 (filed as an Exhibit to the Company&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207918000106/dgx033118ex101.htm"> quarterly report on Form 10-Q for the quarter ended March 31, 2018 and incorporated herein by reference) (Commission file number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000070/dgx03312021ex101.htm">Form of Equity Award Agreement dated as of February ___, 2021 (filed as an Exhibit to the Company&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000070/dgx03312021ex101.htm">q</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000070/dgx03312021ex101.htm">uarterly report on Form 10-Q for the quarter ended March 31, 2021 and incorporated herein by reference) (Commission file number 001-12215)</a></span></div><div><span><br/></span></div><div><span><br/></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex102.htm">Quest Diagnostics Supplemental Deferred Compensation Plan (Post 2004) amended and restated as of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex102.htm">December</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex102.htm"> 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex102.htm">, 2020 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex102.htm">(filed as an Exhibit to the Company&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex102.htm">quarterly report on Form 10-Q for the quarter ending September 30, 2021 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000029/dgx12312020ex105.htm">Quest Diagnostics Supplemental Deferred Compensation Plan (Pre-2005) amended and restated December 1, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">(filed as an Exhibit to the Company&#8217;s 2020 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000118/dgx03312019ex102.htm">Quest Diagnostics Incorporated Senior Management Incentive Plan, as amended and restated February 18, 2019 (filed as an Exhibit to the Company's </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000118/dgx03312019ex102.htm">quarterly report on Form 10-Q for the quarter ended March 31, 2019 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000189/dgx111919ex101.htm">Amended and Restated Quest Diagnostics Incorporated Executive Officer Severance Plan as amended November 19, 2019 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 19, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex101.htm">The</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex101.htm">Quest Diagnostics Incorporated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex101.htm"> Profit Sharing Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex101.htm"> (Amendment and Restatement, effective as of August 15, 2021) (filed as an Exhibit to the Company&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex101.htm">quarterly report on Form 10-Q for the quarter ending September 30, 2021 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207920000017/dgx12312019ex1012.htm">Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan For Directors as amended effective February 18, 2020 (filed as an Exhibit to the Company&#8217;s 2019 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000029/dgx12312020ex1017.htm">Amended and Restated Quest Diagnostics Incorporated Long-Term Incentive Plan for Non-Employee Directors, as amended and restated as of November 18, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000029/dgx12312020ex1017.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000029/dgx12312020ex1017.htm">(filed as an Exhibit to the Company&#8217;s 2020 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041312000949/c68209_ex10-40.htm">Form of Non-Employee Director Equity Award Agreement (filed as an Exhibit to the Company's 2011 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207916000195/dgx12312015ex1015.htm">Form of Non-Employee Director Equity Award Agreement dated May 15, 2015 (filed as an Exhibit to the Company&#8217;s 2015 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041312000949/c68209_ex10-41.htm">Form of Non-Employee Director Elective Option Award Agreement (filed as an Exhibit to the Company's 2011 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787112000371/ss142217_ex1001.htm">Employment Agreement between Stephen H. Rusckowski and Quest Diagnostics Incorporated, dated April 3, 2012 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: April 9, 2012) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207915000099/ex101061115.htm">Amendment to Employment Agreement between Stephen H. Rusckowski and Quest Diagnostics Incorporated, dated June 11, 2015 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: June 11, 2015) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207914000013/dgx12312013ex1030.htm">Aircraft Timesharing Agreement dated as of December 17, 2013 between Quest Diagnostics Incorporated and Stephen H. Rusckowski (filed as an Exhibit to the Company&#8217;s 2013 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000166/dgx063019ex102.htm">Assignment and Amendment No. 1 to Aircraft Timesharing Agreement dated as of May 29, 2019 between Quest Diagnostics Incorporated and Stephen H. Rusckowski (filed as an Exhibit to the Company&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000166/dgx063019ex102.htm">quarterly report on Form 10-Q for the quarter ended June 30, 2019 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312021ex211.htm">Subsidiaries of Quest Diagnostics Incorporated</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312021ex22.htm">Subsidiary Guarantors of Securities</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312021ex231.htm">Consent of PricewaterhouseCoopers LLP</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_127">Power of Attorney (included on signature page)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312021ex311.htm">Rule 13a-14(a) Certification of Chief Executive Officer</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312021ex312.htm">Rule 13a-14(a) Certification of Chief Financial Officer</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312021ex321.htm">Section 1350 Certification of Chief Executive Officer</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312021ex322.htm">Section 1350 Certification of Chief Financial Officer</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000094787120000426/ss171981_ex9901.htm">Fourth Amended and Restated Receivables Sa</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000094787120000426/ss171981_ex9901.htm">le</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000094787120000426/ss171981_ex9901.htm"> Agreement, dated as of October 28, 2015, between Quest Diagnostics Incorporated and the subsidiaries</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000094787120000426/ss171981_ex9901.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000094787120000426/ss171981_ex9901.htm">party</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000094787120000426/ss171981_ex9901.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000094787120000426/ss171981_ex9901.htm">thereto from time to time</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000094787120000426/ss171981_ex9901.htm">, as Sellers, and Quest Diagnostics Receivables Inc., as Buyer (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9902.htm">Amendment No. 1 to Fourth Amended and Restated Receivables Sale</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9902.htm"> Agreement, dated October 25, 2019 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000094787120000426/ss171981_ex9903.htm">Sixth Amended and Restated Credit and Security Agreement, dated as of October 27, 2017 among Quest Diagnostics Receivables Inc., as Borrower, Quest Diagnostics Incorporated, as Initial Servicer, MUFG Bank, Ltd. (formerly known as The Bank of Tokyo Mitsubishi UFJ, Ltd.), as Administrative Agent, the Lenders party thereto, the financial institutions party thereto as agents for the conduit lenders (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9904.htm">Amendment No. 1 to Sixth Amended and Restated Credit and Security Agreement, dated as of October 26, 2018 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9905.htm">Amendment No. 2 to Sixth Amended and Restated Credit and Security Agreement, dated as of June 14, 2019 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9906.htm">Amendment No. 3 to Sixth Amended and Restated Credit and Security Agreement, dated as of October 25, 2019 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000029/dgx12312020ex997.htm">Amendment No. 4 to Sixth Amended and Restated Credit and Security Agreement, dated as of October 22, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000029/dgx12312020ex997.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000029/dgx12312020ex997.htm"> (filed a</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000029/dgx12312020ex997.htm">s an Exhibit to the Compan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000029/dgx12312020ex997.htm">y's 2020 annual report of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000029/dgx12312020ex997.htm">Form 10-K and incorporated herei</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000029/dgx12312020ex997.htm">n by reference) (Commission </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000029/dgx12312020ex997.htm">File Num</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207921000029/dgx12312020ex997.htm">ber 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex991.htm">Amendment No. 5 to Sixth Amended and Restated Credit and Security Agreement, dated as of August 13, 2021 (filed as an Exhibit to the Company&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001022079/000102207921000144/dgx09302021ex991.htm">quarterly report on Form 10-Q for the quarter ended September 30, 2021 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312021ex999.htm">Amendment No. 6 to Sixth Amended and Restated Credit and Security Agreement, dated as of October 21, 2021</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.10*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312021ex9910.htm">Amendment and Restatement Agreement, dated as of November 23, 2021, relating to the Second Amended and Restated Credit Agreement, dated as of March 22, 2018, among Quest Diagnostics Incorporated, as Borrower, the lenders party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, and other agents party thereto and which includes, as Exhibit A, the Third Restated Credit Agreement</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document - dgx-20211231.xsd</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document - dgx-20211231_cal.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document - dgx-20211231_def.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document - dgx-20211231_lab.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document - dgx-20211231_pre.xml</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from this annual report on Form 10-K, formatted in Inline XBRL.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or compensatory plan or arrangement required to be filed as an Exhibit to this Form 10-K pursuant to Item 15(b) of Form 10-K.</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits filed as part of this Report.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The exhibit index in (a) above is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">None.</span></div><div id="ib4001cf8768244cca3f772bfc08f865b_124"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 16. Form 10-K Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_127"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February&#160;28, 2022.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:53.459%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">QUEST DIAGNOSTICS INCORPORATED</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board, Chief Executive Officer and President </span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Each individual whose signature appears below constitutes and appoints Michael E. Prevoznik and William J. O'Shaughnessy, Jr., and each of them singly, his or her true and lawful attorneys-in-fact and agents with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K filed with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all the said attorneys-in-fact and agents or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on February&#160;28, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:357.75pt"><tr><td style="width:1.0pt"></td><td style="width:175.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:154.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Capacity</span></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Stephen H. Rusckowski</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board, Chief Executive Officer and President<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Mark J. Guinan</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Michael J. Deppe</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. Deppe</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Corporate Controller and Chief Accounting Officer<br/>(Principal Accounting Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Tracey C. Doi</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tracey C. Doi </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Vicky B. Gregg</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vicky B. Gregg</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Wright L. Lassiter, III</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wright L. Lassiter, III</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Timothy L. Main</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy L. Main</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Denise M. Morrison</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denise M. Morrison</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Gary M. Pfeiffer</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gary M. Pfeiffer</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Timothy M. Ring</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy M. Ring</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Helen I. Torley </span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Gail R. Wilensky</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gail R. Wilensky</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56 </span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostic Information Services</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics empowers people to take action to improve health outcomes.  We use our extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  Our diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  We provide services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  We offer the broadest access in the United States to diagnostic information services through our nationwide network of laboratories, patient service centers and phlebotomists in physician offices and our connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  We are the world's leading provider of diagnostic information services.  We provide interpretive consultation with one of the largest medical and scientific staffs in the industry.  Our DIS business makes up greater than 95% of our consolidated net revenues.  During 2021, we processed approximately 218 million test requisitions through our extensive laboratory network. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The clinical testing that we perform is an essential element in the delivery of healthcare services.  Clinicians use clinical testing for predisposition, screening, monitoring, diagnosis, prognosis and treatment choices of diseases and other medical conditions.  The United States clinical testing industry consists of two segments.  One segment includes hospital inpatient and outpatient testing.  The second segment includes testing of persons who are not hospital patients, including testing done in commercial clinical laboratories, physician-office laboratories and other locations, as well as hospital outreach (non-hospital patients) and consumer-initiated testing.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The clinical testing industry is subject to seasonal fluctuations in operating results and cash flows.  Typically, testing volume declines during vacation and major holiday periods, reducing net revenues and operating cash flows below annual averages.  Testing volume is also subject to declines due to severe weather or other events (such as public health emergencies and health pandemics), which can deter patients from having testing performed and which can vary in duration and severity from year to year.  Additionally, orders for clinical testing generated from clinician offices, hospitals, employers and consumers can be affected by factors such as changes in the United States economy and regulatory environment, which affect the number of unemployed and uninsured, and design changes in healthcare plans, which affect utilization as well as patient responsibility for healthcare costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We assess our revenue performance for the DIS business based upon, among other factors, volume (measured by test requisitions) and revenue per requisition.  Each requisition accompanies patient specimens, indicating the test(s) to be performed and the party to be billed for the test(s).  Revenue per requisition is impacted by various factors, including, among other items, the impact of fee schedule changes (i.e. unit price), test mix, payer mix, and the number of tests per requisition.  Management uses number of requisitions and revenue per requisition data to assist with assessing the growth and performance of the business, including understanding trends affecting number of requisitions, pricing and test mix. Therefore, we believe that information related to changes in these metrics from period to period are useful information for investors as it allows them to assess the performance of the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostic Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Diagnostic Solutions ("DS") businesses, which represent the balance of our consolidated net revenues, we offer a variety of solutions for life insurers and healthcare organizations and clinicians.  We are the leading provider of risk assessment services for the life insurance industry.  In addition, we offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 Highlights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share data)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10,788</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,437</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,726</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base business revenues (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8,018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,714</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,726</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,770</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,723</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10,494</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,139</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,405</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue per requisition change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$294</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$298</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$321</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to Quest Diagnostics</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,995</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,431</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$838</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share from continuing operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15.55</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.47</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.13</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,233</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,005</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,243</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Excludes COVID-19 testing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact that the COVID-19 pandemic had on our DIS revenues, including requisition volume and revenue per requisition are discussed further below under "Impact of COVID-19" and "Results of Operations".</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of the year-over-year changes for the year ended December 31, 2021 compared to the year ended December 31, 2020, see "Results of Operations" below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a novel strain of coronavirus (COVID-19) continues to impact the economy of the United States and other countries around the world, we are committed to being a part of the coordinated public and private sector response to this unprecedented challenge. We have made substantial investments to expand and maintain the amount of COVID-19 testing available to the country. We have been effectively managing challenges in the global supply chain; and, at this point, we have sufficient supplies to conduct our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2020 and 2021, our testing volume and revenues were materially impacted by the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Beginning in March 2020, we experienced a material decline in base testing volume (which excludes COVID-19 testing) due to the COVID-19 pandemic.  The decrease in base testing volume was driven by federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19, a significant reduction in physician office visits, the cancellation of elective medical procedures, customers closing or severely curtailing their operations (voluntarily or in response to government orders), increased unemployment and loss of healthcare insurance and the adoption of work-from-home policies, all of which have had, and may continue to have, an impact on our operating results, financial position and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During May and June 2020, we began to experience a recovery in base testing volume, which continued in 2021.  The recovery has been driven by people returning to the healthcare system as well as contributions from new Professional Laboratory Services arrangements.  For the first, second, third and fourth quarters of 2021, our base testing volume, excluding volume associated with recent acquisitions, was 2.8% below, 1.9% above, 3.8% above and 4.8% above our historical first, second, third and fourth quarter of 2019 levels, respectively.  Recent agreements associated with our Professional Laboratory Services offerings contributed 5.2%, 5.8%, 5.2% and 5.6% volume growth for the first, second, third and fourth quarters of 2021 compared to 2019, respectively.  Unless there is a change in the severity of the COVID-19 pandemic, we believe that there will be a continued return to healthcare with, in some cases, patients pursuing care delayed during the COVID-19 pandemic.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Beginning in the second quarter of 2020, we experienced growing demand for COVID-19 testing services and we expanded our capacity throughout 2020 in order to satisfy the demand, which has had a significant impact on our testing volumes. During 2021, demand for our COVID-19 testing has generally fluctuated in line with changes in the prevalence of the virus and related variants.  We expect demand to trend down in 2022 and beyond.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our revenue per requisition has been positively impacted by COVID-19 molecular testing. In April 2020 the Centers for Medicare and Medicaid Services ("CMS") announced that it would increase the reimbursement for certain COVID-19 molecular tests making use of high-throughput technologies developed by the private sector that allow for increased testing capacity, faster results, and more effective means of combating the spread of the virus to $100 per test, effective April 14, 2020. Beginning January 1, 2021, Medicare changed the base reimbursement rate for COVID-19 diagnostic tests run on high-throughput technologies to $75 per test with an additional payment of $25 per test if the laboratory (1) completes the test in two calendar days or less and (2) completes the majority of its COVID-19 tests that use high throughput technology in two calendar days or less for all of its patients in the previous month.  Certain healthcare insurers have now moved to a similar reimbursement model for COVID-19 molecular tests.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the COVID-19 pandemic&#8217;s impact on our consolidated results of operations, financial position and cash flows will be primarily driven by: the severity and duration of the COVID-19 pandemic (including any variants); healthcare insurer, government, and client payer reimbursement rates for COVID-19 molecular testing; the COVID-19 pandemic&#8217;s impact on the U.S. healthcare system and the U.S. economy; the timing, scope and effectiveness of federal, state and local governmental responses to the COVID-19 pandemic; and effective and comprehensive COVID-19 vaccination across the U.S. We may also be impacted by changes in the severity of the COVID-19 pandemic at different times in the various cities and regions where we operate and offer services, and by challenges faced in implementing nationwide COVID-19 vaccinations, including the degree to which the public is vaccinated and the effectiveness of vaccines at preventing infection or illness in connection with new or existing variants of COVID-19. Even as the COVID-19 pandemic moderates over time and the business and social distancing restrictions ease, we may continue to experience similar effects to our businesses, consolidated results of operations, financial position and cash flows arising from long-term changes in behavior by consumers or other healthcare system participants and resulting from a recessionary economic environment that may persist.  In the longer term, given the many challenges that hospitals will face, we may have more opportunities to partner with hospitals to help achieve their laboratory strategies, and the COVID-19 pandemic may also be a further catalyst for consolidation in the laboratory testing industry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Sequestration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursement for Medicare services is subject to annual reduction (sequestration) of 2% under the Budget Control Act of 2011.  Beginning in May 2020, there has been a suspension of sequestration, which has resulted in a small benefit to us in the form of higher reimbursement rates for diagnostic testing services performed on behalf of Medicare beneficiaries.  During December 2021, the suspension of Medicare sequestration was further extended through March 31, 2022 and it was reduced to 1% from April 1, 2022 to June 30, 2022, with the full annual 2% reduction in rates resuming thereafter.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Two Point Strategy </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our two point strategy and our operating principles are described in detail in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">". We continued to execute our strategy and leverage our operating principles during 2021 as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Acquisition of the Outreach Services Business of Mercy Health</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 1, 2021, we completed the acquisition of the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $225&#160;million.  The acquired business is included in our DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details, see Note 5 to the audited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition of Assets of Labtech Diagnostics, LLC ("Labtech")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On December 13, 2021, we completed the acquisition of assets of Labtech, an independent clinical diagnostics laboratory provider serving physicians and patients primarily in South Carolina, North Carolina, Florida and Georgia, in an all cash transaction for $85&#160;million, which consisted of cash consideration of $80&#160;million and contingent consideration initially estimated at $5&#160;million. The contingent consideration arrangement is dependent upon the achievement of certain testing volume benchmarks.  The acquired business is included in our DIS business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details, see Note 5 to the audited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Investments to Accelerate Growth</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition to our normal expenditures to operate the business, we have been making additional investments to accelerate growth, particularly in the advanced diagnostics and consumer-initiated testing areas which we believe represent long term growth opportunities for us.  During 2021, such investments totaled approximately $70 million and, during 2022, such investments are expected to approximate $160 million.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Sale of Ownership Interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"> Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"> Solutions") to IQVIA Holdings, Inc. ("IQVIA")</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, we sold our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, our clinical trials central laboratory services joint venture, to IQVIA, our joint venture partner, for $760&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, we accounted for our minority interest as an equity method investment.  As a result of the transaction, during the year ended December&#160;31, 2021, we recorded a $314&#160;million pre-tax gain in other income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the year ended December&#160;31, 2021, we also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, we will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details, see Note 6 to the audited consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accelerated Share Repurchase Agreements ("ASRs")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;In April 2021, we entered into ASRs with several financial institutions to repurchase our common stock as part of our share repurchase program.  Each of the ASRs was structured to permit us to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of our common stock during the repurchase period, less a fixed discount. During the year ended December&#160;31, 2021, we paid $1.5&#160;billion to the financial institutions and received 10.7&#160;million shares of our common stock under the ASRs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details regarding the ASRs and our repurchases of our common stock, see Note 16 to the audited consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Invigorate Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are engaged in a multi-year program called Invigorate, which is designed to reduce our cost structure and improve our performance.  We currently aim annually to achieve savings and productivity improvements of approximately 3% of our costs and in 2021 we exceeded that goal.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Invigorate has consisted of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain. These flagship programs include: organization excellence; information </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence. In addition to these programs, we have identified key themes to change how we operate including reducing denials and patient price concessions; further digitizing our business; standardization and automation; and optimization initiatives in our lab network and patient service center network. We believe that our efforts to standardize our information technology systems, equipment and data also foster our efforts to strengthen our foundation for growth and support the value creation initiatives of our clinical franchises by enhancing our operational flexibility, empowering and enhancing the customer experience, facilitating the delivery of actionable insights and bolstering our large data platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, we incurred $56&#160;million of pre-tax charges under our Invigorate program primarily consisting of systems conversion and integration costs, all of which result in cash expenditures. Additional restructuring charges may be incurred in future periods as we identify additional opportunities to achieve further productivity improvements and savings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outlook and Trends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The healthcare system in the United States is evolving; significant change is taking place in the system.   We expect that the evolution of the healthcare industry, including impacts of the COVID-19 pandemic, such as increased adoption of telemedicine, will continue, and that industry change is likely to be extensive.  There are a number of key trends that are having, and that we expect will continue to have, a significant impact on the diagnostic information services business in the United States and on our business.  We believe that several of the trends, including consolidation, price transparency and consumerization, are favorable to our business.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Healthcare market participants, including governments, are focusing on controlling costs, including potentially by reducing reimbursement for healthcare services, changing reimbursement for healthcare services (including but not limited to a shift from fee-for-service to capitation), changing medical coverage policies (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., healthcare benefits design), denying coverage for services, requiring preauthorization of laboratory testing, requiring co-pays, introducing laboratory spend management utilities and payment and patient care innovations such as ACOs, DCEs and patient-centered medical homes.  In recent years, there has been an ongoing trend of rising patient responsibility (including attributable to payer denials) which has resulted in an increase in our reserves for patient price concessions.  As health plans and government programs require greater levels of patient cost-sharing, our patient price concessions may continue to be negatively impacted and adversely impact our results of operations.  As previously mentioned, there could be a shift to capitation arrangements where we agree to a predetermined monthly reimbursement rate for each member enrolled in a restricted plan, generally regardless of the number or cost of services provided by us.  In both 2021 and 2020, we derived approximately 3% of our consolidated net revenues from capitated payment arrangements.  In both 2021 and 2020, we derived approximately 8% of our testing volume from capitated payment arrangements.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Medicare Clinical Laboratory Fee Schedule ("CLFS") and the Medicare Physician Fee Schedule established under Part B of the Medicare program have been subject to change, including each year.  Pursuant to the Protecting Access to Medicare Act ("PAMA"), CMS promulgated revised reimbursement schedules for 2018-2020 for clinical laboratory testing services provided under Medicare. Under the revised Medicare Clinical Laboratory Fee Schedule (in 2021 CLFS revenues comprised 7% of our consolidated net revenues), reimbursement rates for clinical laboratory testing were reduced from 2018 - 2020.   PAMA calls for further revision of the CLFS for years after 2020, based on future surveys of market rates; reimbursement reduction from 2023 - 2025 is capped by PAMA at 15% annually.  PAMA's next data collection and reporting period have been delayed, most recently by federal legislation adopted in 2021, which further delayed the reimbursement rate reductions and reporting requirements until 2023.  Overall, we expect total reimbursement rate pressure (i.e., unit price changes) for 2022 from all payers on a combined basis to be less than 1%.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, the trend of consolidating, converging and diversifying among our customers, payers and other healthcare industry participants has continued and may result in increased price transparency and bargaining power, and may encourage internalization of clinical testing.  We also believe that PAMA, among other factors, may be a further catalyst for consolidation as diagnostic information services providers realize lower Medicare reimbursement rates and large diagnostic information services providers may be able to increase their share of the overall diagnostic information services industry due to their large networks and lower cost structures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For a discussion of the impact of the COVID-19 pandemic on our business, see "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">above.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that inflation generally has not had a material adverse effect on our results of operations or financial condition.  Given the current environment, we expect wage inflation (excluding the impact of changes in performance-based compensation) of 3% to 4% during 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our key trends, which present both opportunities and risks, see "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business: The Clinical Testing Industry</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions and select accounting policies that affect our reported financial results and the disclosure of contingent assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our revenues are primarily comprised of a high volume of relatively low-dollar transactions, and about one-half of our total costs and expenses consist of employee compensation and benefits.  Due to the nature of our business, several of our accounting policies involve significant estimates and judgments: </span></div><div><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">revenues and accounts receivable associated with DIS; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reserves for general and professional liability claims; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reserves for other legal proceedings; and</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accounting for and recoverability of goodwill.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Revenues and accounts receivable associated with DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The process for estimating revenues and the ultimate collection of receivables associated with our DIS business involves significant assumptions and judgments.  We recognize as revenue the amount of consideration to which we expect to be entitled primarily upon completion of the testing process (when results are reported) or when services have been rendered.  We estimate the amount of consideration we expect to be entitled to receive from customer groups in exchange for providing services using the portfolio approach.  These estimates include the impact of contractual allowances (including payer denials), and patient price concessions, as discussed below.  The portfolios determined using the portfolio approach consist of the following customers:  </span></div><div><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Healthcare Insurers</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Government Payers</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Client Payers</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patients</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have a standardized approach to estimate the amount of consideration that we expect to be entitled to, including the impact of contractual allowances (including payer denials), and patient price concessions.  Historical collection and payer reimbursement experience (along with the period of time that the receivables have been outstanding) is an integral part of the estimation process related to revenues and receivables.  Adjustments to our estimated contractual allowances and implicit patient price concessions are recorded in the current period as changes in estimates. Further adjustments to the allowances, based on actual receipts, may be recorded upon settlement.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We regularly assess the state of our billing operations in order to identify issues which may impact the collectability of receivables or revenue estimates. We believe that the collectability of our receivables is directly linked to the quality of our billing processes, most notably those related to obtaining the correct information in order to bill effectively for the services we provide. As such, we strive to implement &#8220;best practices&#8221; and endeavor to increase the use of electronic ordering to reduce the number of requisitions that we receive from healthcare providers with missing or incorrect billing information. We believe that our collection and revenue estimation processes, along with our close monitoring of our billing operations, help to reduce the risk associated with material adjustments to reserve estimates.  However, changes to our estimate of the impact of contractual allowances (including payer denials) and patient price concessions could have a material impact on our results of operations and financial condition in the period that the estimates are adjusted.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table shows the approximate percentage of our total requisition volume and net revenues associated with our DIS business during 2021 applicable to each customer group: </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Volume</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenues</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients *</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97%</span></td></tr></table></div><div style="padding-left:9pt;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Patients revenue includes coinsurance and deductible responsibilities but volume associated with such revenue is reported under Healthcare insurers.</span></div><div style="padding-left:9pt;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table shows net accounts receivable as of December&#160;31, 2021 applicable to each customer group:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:83.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Accounts</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Receivable</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Healthcare insurers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from healthcare insurers are based on fee-for-service schedules and on capitated payment rates.  Under fee-for-service arrangements, healthcare insurers are billed at our list price.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration we expect to receive from such payers, which considers historical denial and collection experience and the terms of our contractual arrangements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Substantially all of the accounts receivable due from healthcare insurers represent amounts billed under fee-for-service arrangements.  Collection of our net revenues from healthcare insurers is normally a function of providing complete and correct billing information to the healthcare insurers within the various filing deadlines and generally occurs within 30 to 60 days of billing.  Provided we have billed healthcare insurers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, we determine if the amounts in question will likely go past the filing deadline, and if so, we will reserve accordingly for the billing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under capitated arrangements with healthcare insurers, we recognize revenue based on a predetermined monthly reimbursement rate for each member of an insurer's health plan regardless of the number or cost of services provided by us.  Under capitated payment arrangements, the healthcare insurers typically reimburse us in the same month services are performed, essentially giving rise to no outstanding accounts receivable at the end of a reporting period.  If any capitated payments are not received on a timely basis, we determine the cause and make a separate determination as to whether or not the collection of the amount from the healthcare insurer is at risk and, if so, would reserve accordingly.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Government payers</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from government payers are based on fee-for-service schedules set by governmental authorities, including traditional Medicare and Medicaid.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration we expect to receive from such payers, which considers historical denial and collection experience.  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Collection of our net revenues from government payers is normally a function of providing the complete and correct billing information within the various filing deadlines.  Collection generally occurs within 30 days of billing.  Provided we have billed government payers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, we determine if the amounts in question will likely go past the filing deadline, and, if so, we will reserve for the billing accordingly.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Client payers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Client payers include physicians, hospitals, ACOs, DCEs, IDNs, employers, other commercial laboratories and institutions for which services are performed on a wholesale basis, and are billed based on a negotiated fee schedule.  Credit risk and ability to pay are more of a consideration for these payers than healthcare insurers and government payers.  Collection of consideration we expect to receive generally occurs within 60 to 90 days of billing.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We principally estimate the allowance for credit losses for client payers based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period of time that the receivables have been outstanding. To the extent that any individual client payers are identified that have deteriorated in credit quality, we establish allowances based on the individual risk characteristics of such customers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Patients</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Uninsured patients are billed based on established patient fee schedules or fees negotiated with physicians on behalf of their patients.  Insured patients (includes coinsurance and deductible responsibilities) are billed based on fees negotiated with healthcare insurers.  Collection of billings from patients is subject to credit risk and ability of the patients to pay.  Net revenues consist of amounts billed net of discounts provided to uninsured patients in accordance with our policies and implicit price concessions.  Implicit price concessions represent differences between amounts billed and the estimated consideration we expect to receive from patients, which considers historical collection experience (along with the period of time that the receivables have been outstanding) and other factors including current market conditions.  Patient billings are generally fully reserved for when the related service reaches 210 days outstanding.  Balances are automatically written off when they are sent to collection agencies.  Allowances are further adjusted for estimated recoveries of amounts sent to collection agencies based on historical collection experience, which is regularly monitored.  Collection of consideration we expect to receive generally occurs within 30 to 60 days of billing.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Reserves for general and professional liability claims</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a general matter, providers of diagnostic information services may be subject to lawsuits alleging negligence or other similar claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on our client base and reputation.  We maintain various liability insurance coverages for claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  Our insurance coverage limits our maximum exposure on individual claims; however, we are essentially self-insured for a significant portion of these claims.  While the basis for claims reserves is actuarially determined losses based upon our historical and projected loss experience, the process of analyzing, assessing and establishing reserve estimates relative to these types of claims involves a high degree of judgment.  Although we believe that our present reserves and insurance coverage are sufficient to cover currently estimated exposures, it is possible that we may incur liabilities in excess of our recorded reserves or insurance coverage.  Changes in the facts and circumstances associated with claims could have a material impact on our results of operations (principally costs of services), cash flows and financial condition in the period that reserve estimates are adjusted or paid.  See Note 18 to the audited consolidated financial statements for a discussion of our reserves for general and professional liability claims. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Reserves for other legal proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our businesses are subject to or impacted by extensive and frequently changing laws and regulations, including inspections and audits by governmental agencies, in the United States (at both the federal and state levels) and the other jurisdictions in which we conduct business.  Although we believe that we are in compliance, in all material respects, with applicable laws and regulations, there can be no assurance that a regulatory agency would not reach a different conclusion.  Any noncompliance by us with applicable laws and regulations could have a material adverse effect on our results of operations.  In addition, these laws and regulations may be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that could require us to make changes in our operations, including our pricing and/or billing practices.  In addition, certain federal and state statutes, including the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of federal and state false claims acts, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers alleging inappropriate billing practices.  We are aware of certain pending lawsuits including class action lawsuits, and have received subpoenas related to billing practices.  See Note 18 to the audited consolidated financial statements for a discussion of the various legal proceedings that we are involved in. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The process of analyzing, assessing and establishing reserve estimates relative to legal proceedings involves a high degree of judgment.  Management has established reserves for legal proceedings in accordance with generally accepted accounting principles in the United States.  Changes in facts and circumstances related to such proceedings could lead to significant adjustments to reserve estimates for such matters and could have a material impact on our results of operations, cash flows and financial condition in the period that reserve estimates are adjusted or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Accounting for and recoverability of goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We do not amortize goodwill, but evaluate the recoverability and measure the potential impairment of our goodwill annually, or more frequently, in the case of other events that indicate a potential impairment.  We identified the following reporting units for goodwill impairment testing in 2021:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS business;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk assessment services business, which is part of our DS businesses</span></div><div style="padding-left:63pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The DIS reporting unit components have been aggregated into a single reporting unit because they have similar economic characteristics, including similarities in financial performance, nature of products or services, nature of production processes and types of customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On a quarterly basis, we perform a review of our business to determine if events or changes in circumstances have occurred which could have a material adverse effect on our fair value and our goodwill.  If such events or changes in circumstances were deemed to have occurred, we would perform an impairment test of goodwill and record any noted impairment loss.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative analysis may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying value, we assess relevant events and circumstances, such as: (a) macroeconomic conditions; (b) industry and market considerations; (c) cost factors; (d) overall financial performance; (e) other relevant entity-specific events; (f) events affecting a reporting unit; and (g) a sustained decrease in share price.  If, after assessing the totality of events or circumstances, we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then we are required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, our policy is to update the fair value calculation of our reporting units and perform the quantitative goodwill impairment test on a periodic basis.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  If the carrying value is greater than our estimate of fair value, an impairment loss will be recognized in the amount of the excess.   We calculate the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation.  The discounted cash flows analysis includes several unobservable inputs related to our own assumptions.  The assumptions and estimates used in the discounted cash flows model are based upon the best available information in the circumstances and include a forecast of expected future cash flows, long-term growth rates, discount rates that are commensurate with economic risks, assumed income tax rates and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates of capital expenditures and working capital.  The fair values of the reporting units could be different if, for example, forecasted revenue growth rates, economic conditions, government regulations or actions by payers to control utilization of or reimbursement for healthcare services, turn out to be different than our assumptions or estimates.  Changes in the assumed discount rates due to changes in interest rates could also affect the estimated fair values of the reporting units.  We use a discount rate that considers a weighted average cost of capital plus an appropriate risk premium based upon the reporting unit being valued.  Our analysis also considers publicly available information regarding our market capitalization, as well as (i) the financial projections and future prospects of our business, including its growth opportunities and likely operational improvements, and (ii) comparable sales prices, if available.  We believe our estimation methods are reasonable and reflect common valuation practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We perform our annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2021, we performed the qualitative assessment for our DIS and risk assessment services reporting units.  Based on the totality of the information available for each reporting unit, we concluded that it was more likely than not that the estimated fair values were greater than the carrying values of the reporting units, and as such, no further analysis was required.  As a sensitivity, in conjunction with the most recent quantitative test performed for the year ended December 31, 2020, if the estimated fair values of each of our reporting units decreased by 10%, we would have concluded that our goodwill was not impaired.  </span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For a comparison of results of operations for the year ended December 31, 2020 compared to December 31, 2019, along with the results of operations for the year ended December 31, 2019, see "Item 7 - Management's Discussion and Analysis of Financial Condition and Result of Operations" of our Annual Report on Form 10-K for the year ended December 31, 2020.  See "Available Information."</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our DIS business currently represents our one reportable business segment.  The DIS business for the years ended December&#160;31, 2021 and 2020 accounted for greater than 95% of our consolidated net revenues.  Our other operating segments consist of our DS businesses.  For further details regarding our business segment information, see Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19 to the audited consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table sets forth certain results of operations data for the periods presented:&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:57.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions, except per share data)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,788&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,804&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,407&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,466&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:57.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating income (expense), net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share attributable to Quest Diagnostics&#8217; common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM - Not Meaningful</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table sets forth certain results of operations data as a percentage of net revenues for the periods presented:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:78.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Operating Results</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the year ended December&#160;31, 2021 were affected by certain items that on a net basis increased diluted earnings per share by $1.31 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain recorded in other income, net of $314&#160;million, or $2.02 per diluted share, on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">a net pre-tax gain of $23&#160;million (a $39&#160;million gain recorded in other income, net, partially offset by $16 million of costs recorded in selling, general and administrative expenses), or $0.16 per diluted share, primarily representing changes in the carrying value of our strategic investments, and a gain recognized by an equity method investee to adjust certain of its investments to fair value, partially offset by costs associated with donations, contributions and other financial support through Quest for Health Equity (our initiative with the Quest Diagnostics Foundation to reduce health disparities in underserved communities), and a non-cash impairment charge to the carrying value of an equity method investment; and </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $19 million, or $0.14 per diluted share, recorded in income tax expense; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $105 million ($103 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes) or $0.62 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $61 million ($30 million in cost of services and $31 million in selling, general and administrative expenses), or $0.36 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $4 million in cost of services, or $0.03 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic, including incremental costs incurred to protect the health and safety of our employees and customers.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December 31, 2021, diluted earnings per share benefited from the impact of the ASRs on our weighted average shares outstanding as compared to the prior year.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the year ended December 31, 2020 were affected by certain items that on a net basis decreased diluted earnings per share by $0.71 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $114&#160;million ($103&#160;million in amortization of intangible assets and $11&#160;million in equity in earnings of equity method investees, net of taxes) or $0.63 per diluted share; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net pre-tax charges of $72&#160;million ($57&#160;million of charges in cost of services, $10&#160;million of charges in selling, general and administrative expenses and $9&#160;million of charges in other operating (income) expense, net, partially offset by a $4&#160;million gain in equity in earnings of equity method investees, net of taxes), or $0.39 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic, principally including expense associated with payments to eligible employees to help offset expenses they incurred as a result of COVID-19, incremental costs incurred primarily to protect the health and safety of our employees and customers, and certain asset impairment charges; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $58&#160;million ($27&#160;million in cost of services and $31&#160;million in selling, general and administrative expenses), or $0.32 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain of $70&#160;million, or $0.46 per diluted share, recognized in other income, net, based on the difference between the fair value and the carrying value of an equity interest; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $23&#160;million, or $0.17 per diluted share, recorded in income tax expense; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $2&#160;million (a $14&#160;million gain in equity in earnings of equity method investees, net of taxes, partially offset by a $10&#160;million loss in other income, net, and $2&#160;million of charges in selling, general and administrative expenses) primarily due to a gain recognized by an equity method investee to adjust certain of its investments to fair value, a loss on retirement of debt, and, to a lesser extent, costs associated with Quest for Health Equity.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenues </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the year ended December&#160;31, 2021 increased by 14.3% compared to the prior year. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the year ended December&#160;31, 2021 increased by 14.8% compared to the prior year.  For the year ended December&#160;31, 2021:  </span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Organic revenue and acquisitions contributed approximately 13.0% and 1.8%, respectively, to DIS revenue growth compared to the prior year.  Organic revenue growth was driven by growth in the base business and, to a lesser extent, demand for COVID-19 molecular testing.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues in the base business (including the impact of recent acquisitions) increased by 20.4% compared to the prior year, which was negatively impacted as a result of the COVID-19 pandemic.  Compared to historical levels in 2019, revenues in the base business, excluding revenue associated with recent acquisitions, increased by 0.4%.  Recent agreements associated with our Professional Laboratory Services offerings contributed 2.3% revenue growth compared to 2019.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume increased by 16.5% with organic volume and acquisitions contributing approximately 13.6% and 2.9%, respectively.  Organic volume growth was driven by growth in the base business.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing volume in the base business (including the impact of recent acquisitions) continued to recover and was up 19.7% compared to the prior year, which was negatively impacted as a result of the COVID-19 pandemic.  Compared to historical levels in 2019, testing volume in the base business, excluding volume associated with recent acquisitions, increased by 2.0%.  Recent agreements associated with our Professional Laboratory Services offerings contributed 5.5% volume growth compared to 2019.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition decreased by 1.6% compared to the prior year primarily due to growth in our Professional Laboratory Services engagements, which carry a lower revenue per requisition than the average for the remainder of the DIS business, and pricing pressure of approximately 1.1%, partially offset by favorable test mix.  </span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Cost of Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cost of services consists principally of costs for obtaining, transporting and testing specimens as well as facility costs used for the delivery of our services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cost of services increased by $775 million for the year ended December&#160;31, 2021 compared to the prior year.  The increase was primarily driven by higher variable expenses related to increased testing volumes, higher compensation and benefits costs (primarily related to wage increases), and, to a lesser extent, additional operating costs associated with our acquisitions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses ("SG&amp;A")</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A consists principally of the costs associated with our sales and marketing efforts, billing operations, credit loss expense and general management and administrative support, as well as administrative facility costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $177 million for the year ended December&#160;31, 2021, compared to the prior year, primarily driven by higher variable expenses to support our increase in testing volumes, investments in our strategic growth initiatives and higher compensation and benefit costs (including headcount and wage increases).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, amortization expense was flat compared to the prior year.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Operating (Income) Expense, Net</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other operating (income) expense, net includes miscellaneous income and expense items and other charges related to operating activities.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, other operating (income) expense, net primarily represents impairment charges due to the impact of the COVID-19 pandemic.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net decreased by $12 million for the year ended December&#160;31, 2021 compared to the prior year, primarily due to lower average outstanding indebtedness and, to a lesser extent, lower interest rates due to recent refinancing transactions, including the termination of our interest rate swap agreements in April 2020, which resulted in a deferred gain that is being amortized as a reduction of interest expense, net over the remaining term of the associated debt.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other income, net represents miscellaneous income and expense items related to non-operating activities, such as gains and losses associated with investments and other non-operating assets.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, other income, net included a $314&#160;million pre-tax gain on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, our clinical trials central laboratory services joint venture, to IQVIA, our joint venture partner (see Note 6 to the audited consolidated financial statements), $39&#160;million in gains associated with changes in the carrying value of our strategic investments, and $17&#160;million in gains associated with investments in our deferred compensation plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, other income, net included a $70&#160;million gain recognized as a result of the remeasurement of our previously held equity interest in Mid America Clinical Laboratories, LLC ("MACL") to fair value (see Note 5 to the audited consolidated financial statements) and $15&#160;million in gains associated with investments in our deferred compensation plans, partially offset by a $9&#160;million loss on the retirement of debt, principally due to premiums paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the years ended December&#160;31, 2021 and 2020 was $597 million and $460 million, respectively.  The increase in income tax expense compared to the prior year was primarily driven by an increase in income before income taxes and equity in earnings of equity method investees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective income tax rate for the years ended December&#160;31, 2021 and 2020 was 23.0% and 24.5%, respectively.  The effective income tax rate for the year ended December&#160;31, 2021 benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions.  The effective income tax rate for the year ended December&#160;31, 2020 benefited from a lower effective income tax rate, 11.8%, associated with a $70&#160;million gain recognized as a result of the remeasurement of our previously held equity interest in MACL to fair value.  In addition, the effective income tax rates benefited from $19 million and $23&#160;million of excess tax benefits associated with stock-based compensation arrangements for the years ended December 31, 2021 and 2020, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in Earnings of Equity Method Investees, Net of Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, there was a $3 million increase in equity in earnings of equity method investees, net of taxes, compared to the prior year primarily due to the demand for COVID-19 testing services and recovery in the base business of the investees, partially offset by lower equity earnings as a result of the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70 </span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We address our exposure to market risks, principally the risk of changes in interest rates, through a controlled program of risk management that includes the use of derivative financial instruments.  We do not hold or issue derivative financial instruments for speculative purposes.  We seek to mitigate the variability in cash outflows that result from changes in interest rates by maintaining a balanced mix of fixed-rate and variable-rate debt obligations.  In order to achieve this objective, we have historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements are recognized as an adjustment to interest expense, net.  We believe that our exposures to foreign exchange impacts and changes in commodity prices are not material to our consolidated results of operations, financial position or cash flows.  For further details regarding our significant accounting policies on interest rate risk and foreign currency, see Note 2 to the audited consolidated financial statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021 and 2020, the fair value of our debt was estimated at approximately $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xMzkvZnJhZzo3NDJmODE1ZjZhNjk0YjJhYTY2MjkzZGUzNDIxYzhkNy90ZXh0cmVnaW9uOjc0MmY4MTVmNmE2OTRiMmFhNjYyOTNkZTM0MjFjOGQ3XzEyNzg_c27f3a69-6c4c-49c4-a1b8-4fa09c4a1a21">4.4</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xMzkvZnJhZzo3NDJmODE1ZjZhNjk0YjJhYTY2MjkzZGUzNDIxYzhkNy90ZXh0cmVnaW9uOjc0MmY4MTVmNmE2OTRiMmFhNjYyOTNkZTM0MjFjOGQ3XzEyODU_88db4277-5ec6-4eff-8ab2-757e81339c2d">4.6</ix:nonFraction> billion, respectively, principally using quoted prices in active markets and yields for the same or similar types of borrowings, taking into account the underlying terms of the debt instruments.  As of December&#160;31, 2021 and 2020, the estimated fair value exceeded the carrying value of the debt by $403&#160;million and $597&#160;million, respectively.  A hypothetical 10% increase in interest rates (representing 23 basis points as of December&#160;31, 2021 and 17 basis points as of December&#160;31, 2020) would potentially reduce the estimated fair value of our debt by approximately $89&#160;million and $82&#160;million as of December&#160;31, 2021 and 2020, respectively.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Borrowings under our secured receivables credit facility and our senior unsecured revolving credit facility are subject to variable interest rates.  Interest on our secured receivables credit facility is based on either commercial paper rates for highly rated issuers, or London Interbank Offered Rate ("LIBOR"), plus a spread.  As of December&#160;31, 2021, interest on our senior unsecured revolving credit facility is based on certain published rates plus an applicable margin based on changes in our public debt ratings. As such, our borrowing cost under this credit arrangement is subject to fluctuations in interest rates and changes in our public debt ratings.  As of December&#160;31, 2021, the borrowing rates under these debt instruments were: for our secured receivables credit facility, commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.725% to 0.80%; and for our senior unsecured revolving credit facility, LIBOR plus <ix:nonFraction unitRef="number" contextRef="ib618186b3e3648a0a5c22c9e567fe03f_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xMzkvZnJhZzo3NDJmODE1ZjZhNjk0YjJhYTY2MjkzZGUzNDIxYzhkNy90ZXh0cmVnaW9uOjc0MmY4MTVmNmE2OTRiMmFhNjYyOTNkZTM0MjFjOGQ3Xzc2OTY1ODE0MDk3MzI_bf2840f9-6875-4fb7-8ed3-7a2350743c21">1.00</ix:nonFraction>%.  As of December&#160;31, 2021, there were no borrowings outstanding under either our $600&#160;million secured receivables credit facility or our $750&#160;million senior unsecured revolving credit facility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A hypothetical 10% change to the variable rate component of our variable rate indebtedness would not materially change our annual interest expense. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our outstanding debt and our financial instruments and hedging activities, see Notes 13 and 15, respectively, to the audited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Associated with Investment Portfolio</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in our consolidated balance sheet with changes in fair value recorded in current earnings in our consolidated statement of operations.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  During the year ended December&#160;31, 2021, certain of our equity investments became publicly-traded and, based on the readily determinable fair values of such investments, we recognized gains of $39&#160;million in other income, net in our consolidated statement of operations.  For further details, see Notes 2 and 7 to the audited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We regularly evaluate equity investments that do not have readily determinable fair values to determine if there are any indicators that the investments are impaired.  The carrying value of our equity investments that do not have readily determinable fair values was $4&#160;million as of December&#160;31, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We do not hedge our equity price risk.  As of December&#160;31, 2021, a 10% change in the fair values of our equity investments with readily determinable fair values would have impacted our consolidated income before income taxes and equity in earnings of equity method investees by $4&#160;million.  The impact of an adverse movement in equity prices on our holdings in privately held companies cannot be easily quantified, as our ability to realize returns on investments depends on, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">among other things, the enterprises&#8217; ability to raise additional capital or derive cash inflows from continuing operations or through liquidity events such as initial public offerings, mergers or private sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our audited consolidated financial statements for the year ended December&#160;31, 2021, we considered whether the carrying values of our investments were impaired and concluded that no such impairment existed.  </span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_142"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,540)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,267)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,273)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash and cash equivalents consist of cash and highly-liquid short-term investments.  Cash and cash equivalents as of December&#160;31, 2021 and 2020 totaled $872 million and $1,158 million, respectively.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, approximately 5% of our $872 million of consolidated cash and cash equivalents were held outside of the United States.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by operating activities for the year ended December&#160;31, 2021 was $2,233 million, and increased $228 million compared to the prior year primarily as a result of:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher operating income in 2021 as compared to 2020; and, </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of movements in our working capital accounts; partially offset by </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $349 million increase in income tax payments due to higher income in 2021 as compared to 2020, as well as timing of payments; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher performance-based compensation payments in 2021 compared to 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Days sales outstanding ("DSO"), a measure of billing and collection efficiency, was 48 days as of December&#160;31, 2021 and 46 days as of December&#160;31, 2020.  Recent changes in our DSO are partially due to fluctuations in our monthly revenue due to the impact of the COVID-19 pandemic.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by investing activities for the year ended December&#160;31, 2021 was $21 million, compared to net cash used in investing activities of $772 million for the year ended December&#160;31, 2020.  This $793 million change in cash provided by (used in) investing activities was primarily a result of $755 million of net cash proceeds received during 2021 from the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in financing activities for the year ended December&#160;31, 2021 was $2,540 million, compared to $1,267 million for the year ended December&#160;31, 2020.  This $1,273 million increase in cash used in financing activities was primarily a result of:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $1,874 million increase in repurchases of our common stock (see "Share Repurchases" for further details); and, to a lesser extent,</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $103 million change in bank overdrafts, which are generally settled in cash the following day;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $60 million decrease in proceeds from the exercise of stock options, which was a result of a decrease in the volume of stock options exercised compared to the prior year; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $41 million increase in distributions to noncontrolling interest partners; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$805 million of net debt repayments (repayments of debt less proceeds from borrowings) in 2020 compared to $2 million of net debt repayments in 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, there were no borrowings or repayments under our secured receivables credit facility or senior unsecured revolving credit facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During January 2020, we redeemed in full the outstanding indebtedness under our senior notes due January 2020 and senior notes due March 2020 using net proceeds from the issuance, in December 2019, of the $800&#160;million aggregate principal amount of 2.95% senior notes due June 2030, along with cash on hand.  During May 2020, we completed the issuance of the $550&#160;million aggregate principal amount of 2.80% senior notes due June 2031, the net proceeds from which were used during November 2020, along with cash on hand, to redeem in full the outstanding indebtedness under our senior notes due April 2021.  Additionally, during the year ended December&#160;31, 2020, we borrowed $100&#160;million under our secured receivables credit facility and $100&#160;million under our senior unsecured revolving credit facility, both of which were repaid prior to December&#160;31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For details regarding our debt and related transactions, see Note 13 to the audited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the four quarters of 2021, our Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, our Board of Directors declared a quarterly cash dividend of $0.56 per common share.  On February 3, 2022, we announced that our Board of Directors authorized a 6.5% increase in our quarterly cash dividend from $0.62 to $0.66 per share, or $2.64 per share annually, commencing with the dividend payable in April 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February and March 2021, our Board of Directors increased the size of our share repurchase program by $1&#160;billion.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of December&#160;31, 2021, $0.7 billion remained available under our share repurchase authorization.  In February 2022, our Board of Directors authorized us to repurchase an additional $1&#160;billion of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, we repurchased 16.0 million shares of our common stock for $2.2 billion, including 10.7&#160;million shares repurchased under ASRs.  See "2021 Highlights" above for further details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, we repurchased 2.7 million shares of our common stock for $325 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our share repurchases, see Note 16 to the audited consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="text-align:center;text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; A description of the terms of our indebtedness and related debt service requirements is contained in Note 13 to the audited consolidated financial statements.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A discussion of our lease obligations is contained in Note 14 to the audited consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A discussion of our noncancellable commitments to purchase products or services is contained in Note 18 to the audited consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investees</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our equity method investees primarily consist of our diagnostic information services joint venture and investments in funds that purchase strategic holdings in private companies in the healthcare industry. Such investees are accounted for under the equity method of accounting.  Our investment in equity method investees is less than 5% of our consolidated total assets.  Our proportionate share of income before income taxes associated with our equity method investees is less than 5% of our consolidated income from continuing operations before income taxes and equity in earnings of equity method investees.  We have no material unconditional obligations or guarantees to, or in support of, our equity method investees and their operations.  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our audited consolidated financial statements for the year ended December&#160;31, 2021, we considered whether the carrying values of our equity method investments were impaired and during the year ended December&#160;31, 2021 we recorded an $8&#160;million impairment charge for one of the investments. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We estimate that we will invest approximately $400 million during 2022 for capital expenditures, to support and grow our existing operations, principally related to investments in information technology; laboratory equipment and facilities, including laboratory automations and footprint optimizations; and investments in our advanced diagnostics and consumer growth strategies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, we had $1.3&#160;billion of borrowing capacity available under our existing credit facilities, including $530&#160;million available under our secured receivables credit facility and $750&#160;million available under our senior unsecured revolving credit facility.  There were no outstanding borrowings under these credit facilities as of December&#160;31, 2021.  In support of our risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of December&#160;31, 2021.  During the fourth quarter of 2021, we amended both our $600&#160;million secured receivables credit facility and our $750&#160;million senior unsecured revolving credit facility to extend the maturity dates for each underlying commitment, while maintaining the borrowing capacity.  The secured receivables credit facility includes a $250 million loan commitment which matures in October 2022, and a $250 million loan commitment and a $100 million letter of credit facility which mature in October 2023.  The senior unsecured revolving credit facility matures in November 2026. For further details regarding our credit facilities, see Note 13 to the audited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our secured receivables credit facility is subject to customary affirmative and negative covenants, and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility. Our senior unsecured revolving credit facility is also subject to certain financial covenants and limitations on indebtedness.  As of December&#160;31, 2021, we were in compliance with all such applicable financial covenants.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have assessed the impact of the cessation of LIBOR and have identified and evaluated financial instruments and other contracts that refer to LIBOR.  Our underlying exposure to LIBOR includes our existing credit facilities (see discussion above) under which we had no outstanding borrowings as of December 31, 2021.  We expect to be able to transition all LIBOR-based instruments and contracts to an alternative reference rate on or before the cessation of LIBOR and we do not believe that the cessation of LIBOR, or its replacement with an alternative reference rate or rates, will have a material impact on us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that our cash and cash equivalents and cash from operations, together with our borrowing capacity under our credit facilities, will provide sufficient financial flexibility to fund seasonal and other working capital requirements, capital expenditures, debt service requirements and other obligations, cash dividends on common shares, share repurchases and additional growth opportunities for the foreseeable future.  However, should it become necessary, we believe that our credit profile should provide us with access to additional financing in order to fund normal business operations, make interest payments, fund growth opportunities and satisfy upcoming debt maturities. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_145"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of New Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#160;&#160;&#160;&#160;The adoption of new accounting standards is discussed in Note 2 to the audited consolidated financial statements.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The impacts of recent accounting pronouncements not yet effective on our audited consolidated financial statements are discussed in Note 2 to the audited consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74 </span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_148"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF MANAGEMENT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The management of the Company, including its Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended.  Management assessed the effectiveness of the Company's internal control over financial reporting as of December&#160;31, 2021 based on criteria for effective internal control over financial reporting described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Internal Control - Integrated Framework (2013)&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission.  Based on this assessment, management has determined that the Company's internal control over financial reporting as of December&#160;31, 2021 is effective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.  Internal control over financial reporting includes policies and procedures that: (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorization of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;PricewaterhouseCoopers LLP, the independent registered public accounting firm that audited the financial statements included in this annual report, audited the Company's internal control over financial reporting as of December&#160;31, 2021 and issued their audit report on the Company's internal control over financial reporting included herein. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75 </span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_151"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Stockholders of Quest Diagnostics Incorporated</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of Quest Diagnostics Incorporated and its subsidiaries</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(the &#8220;Company&#8221;) as of December 31, 2021 and 2020,</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and the related consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">statements of operations, comprehensive income, stockholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2021, including the related notes and financial statement schedule of valuation accounts and reserves for each of the three years in the period ended December 31, 2021 listed in the index appearing under Item 15(a)(2)</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(collectively referred to as the &#8220;consolidated financial statements&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also have audited the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2013)</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Report of Management on Internal Control Over Financial Reporting. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audits of the  consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Diagnostic Information Services (DIS) Business Accounts Receivable - Contractual Allowances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 3 to the consolidated financial statements, management estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials) and patient price concessions. The portfolio approach includes the following groups of customers: healthcare insurers, government payers, client payers and patients (<ix:nonFraction unitRef="number" contextRef="i4a05287b4f02418c82cd5f2e6e79c6dc_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2MTc_d47a07ee-c7f9-49da-a91f-b2c95997e6b5">32</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i37a9f450d5fc42bd8a4cedc5a182bb1d_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2MjI_646ce812-164c-4ac2-9eb4-a4a80ea0b577"><ix:nonFraction unitRef="number" contextRef="i93a20c5e9811442496e0ddbc0d32b35f_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2MjI_9d9b707a-c902-43fe-8302-4a01065fbde0">6</ix:nonFraction></ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i30f9993ad61e49b8889d85cebdd9a0ca_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2Mjc_e1f842cf-169c-4fe5-9fbc-3757edb821dd">38</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="icb3cd0ebcab8404c8e2d53703218de07_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2MzI_69834b97-aabb-416b-a00f-133c527d00c4">21</ix:nonFraction>% of consolidated net accounts receivable as of December 31, 2021, respectively, as disclosed by management). The DIS business accounted for <ix:nonFraction unitRef="number" contextRef="i1d0d6530dd894b1c87f220eb4e22a87b_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2NDk_2d813632-dae2-4c19-986f-53e15273c5f7">97</ix:nonFraction>% of consolidated net accounts receivable ($<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2NTQ_285ddf19-2931-4f46-b858-858304e8ccc3">1,438</ix:nonFraction> million) as of December 31, 2021. Net revenues and accounts receivable recognized from healthcare insurers and government payers consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and, additionally for healthcare insurers, the terms of the Company&#8217;s contractual arrangements. As disclosed by management, the process for estimating revenues and the ultimate collection of receivables associated with the DIS business involves significant assumptions and judgments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal considerations for our determination that performing procedures relating to the valuation of DIS business accounts receivable - contractual allowances is a critical audit matter are the estimate of net collectible accounts receivable, specifically contractual allowances, involves significant judgment and estimation on the part of management; this in turn led to significant auditor judgment, subjectivity and effort in performing procedures to evaluate the audit evidence related to the contractual allowances. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the valuation of DIS business accounts receivable, which included controls over management&#8217;s methodology and data used to estimate contractual allowances. These procedures also included, among others, testing management's process for developing the estimate for contractual allowances, including (i) evaluating the appropriateness of the methodology, (ii) testing the completeness and accuracy of the historical contractual allowance and collection data from the Company&#8217;s billing system, which is an input to the methodology, and (iii) evaluating the reasonableness of management&#8217;s assumptions used to estimate contractual allowances by comparing actual cash collected to the prior year estimate (net accounts receivable). </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.602%"><tr><td style="width:1.0%"></td><td style="width:9.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.587%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90YWJsZTo3NDcxNzAzNDQ3NWU0NTAzOWZjY2UyZWMwYWU5Y2MyMS90YWJsZXJhbmdlOjc0NzE3MDM0NDc1ZTQ1MDM5ZmNjZTJlYzBhZTljYzIxXzAtMS0xLTEtMzc4ODE_1712200f-42e3-4d37-8b1d-4f88a98f70c8">PricewaterhouseCoopers LLP</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90YWJsZTo3NDcxNzAzNDQ3NWU0NTAzOWZjY2UyZWMwYWU5Y2MyMS90YWJsZXJhbmdlOjc0NzE3MDM0NDc1ZTQ1MDM5ZmNjZTJlYzBhZTljYzIxXzItMS0xLTEtMzc4ODQ_467eb1ba-7e9e-4873-ba1a-f6d02a7edaae">Florham Park, New Jersey</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1995.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_154"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DECEMBER&#160;31, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_157"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMtMS0xLTEtMjA5MjU_27517ed7-b0b0-4b2b-8881-91c4c049cc06">872</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMtMy0xLTEtMjA5MjU_5cfa3ab7-51b9-4e46-a6a0-8d10161faebe">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQtMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjo1MDVlNjA5NmJhODU0NTY4OWFmOWQ0NjE2M2I1ZWYxMF8xMDk5NTExNjI3OTAw_691ffbcd-31ca-45e9-ba7a-cd2bcf2af354">31</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQtMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjo1MDVlNjA5NmJhODU0NTY4OWFmOWQ0NjE2M2I1ZWYxMF8xMDk5NTExNjI3ODk2_7f6c0409-1e66-42f4-bc37-a0ffe87d7bf3">28</ix:nonFraction> as of December&#160;31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQtMS0xLTEtMjA5MjU_285ddf19-2931-4f46-b858-858304e8ccc3">1,438</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQtMy0xLTEtMjA5MjU_5d20b201-0bc2-4085-93d7-2769559959ee">1,520</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzUtMS0xLTEtMjA5MjU_64060797-391c-4c43-a460-74643d20052a">208</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzUtMy0xLTEtMjA5MjU_7208254b-e86c-4aab-8547-87c7cbd79287">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzYtMS0xLTEtMjA5MjU_2fa568e6-3e1e-4f72-9dab-b31c792bb286">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzYtMy0xLTEtMjA5MjU_9dfe6649-be9e-4903-a787-7faae68c9fe7">157</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzgtMS0xLTEtMjA5MjU_57e18538-ad47-4313-8689-a4d01f26fd76">2,741</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzgtMy0xLTEtMjA5MjU_aa77d55c-f0bd-4419-97d3-15db9ba04af7">3,058</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzktMS0xLTEtMjA5MjU_328387e7-9383-4cc6-89c1-d97c37363837">1,707</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzktMy0xLTEtMjA5MjU_9c163745-f455-44d7-a143-78881170ea07">1,627</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEwLTEtMS0xLTIwOTI1_7f5dba9b-a2e1-42a1-8994-78632d838697">597</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEwLTMtMS0xLTIwOTI1_7dc651ce-2a7b-4f9b-b497-77b4437d0008">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzExLTEtMS0xLTIwOTI1_fee12d31-0146-4f57-ad36-353122e804c3">7,095</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzExLTMtMS0xLTIwOTI1_b754603a-b1ab-48c3-a2f6-ce7e56d804a6">6,873</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEyLTEtMS0xLTIwOTI1_7072a44d-75f0-49ce-8e04-ca37816a4fc1">1,167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEyLTMtMS0xLTIwOTI1_a2251242-28db-4576-b44a-2ee591f8ae2f">1,167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments in equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEzLTEtMS0xLTIwOTI1_0e1823bb-83a1-4662-839c-2e2ba4b06b8b">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEzLTMtMS0xLTIwOTI1_fc77f7dc-95c3-4882-8f54-cd43aabcb62e">521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzE0LTEtMS0xLTIwOTI1_be43fa96-3689-4a88-b093-e1e3cf0b72ef">163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzE0LTMtMS0xLTIwOTI1_1e5687d0-0a0d-4500-ad28-f21ecf2b0738">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzE2LTEtMS0xLTIwOTI1_82ce2186-d2ba-4f48-aad1-eef611e49c61">13,611</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzE2LTMtMS0xLTIwOTI1_c0fede22-464b-43c6-9da8-7cf693283278">14,026</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIwLTEtMS0xLTIwOTI1_56e90e76-8b72-46e5-a951-12bdbddcf0f4">1,600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIwLTMtMS0xLTIwOTI1_cd70d019-f25c-4b38-b165-b53d2d441e9e">1,633</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIxLTEtMS0xLTIwOTI1_f95e4f2f-d6c4-4b82-8beb-0719828233ed">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIxLTMtMS0xLTIwOTI1_50bc436e-8113-49d0-815f-376c2472ab6b">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIyLTEtMS0xLTIwOTI1_d515ec79-9f4a-4ea5-83e9-a33e45140dcd">151</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIyLTMtMS0xLTIwOTI1_57e7b086-4a4a-4e1f-96c1-c63b7d24dbfb">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIzLTEtMS0xLTIwOTI1_a6d5e4e6-4748-4ef5-86a3-0c153ebdf1db">1,753</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIzLTMtMS0xLTIwOTI1_7327bfe5-5611-4615-9f1a-ba23a9c3e729">1,776</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI0LTEtMS0xLTIwOTI1_4e6f1ac0-8454-4a22-9939-0f22cd940430">4,010</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI0LTMtMS0xLTIwOTI1_aa6a8fbd-7e99-401a-b696-2a0d79cc6ec1">4,013</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI1LTEtMS0xLTIwOTI1_0dfe896d-44f1-46a9-b8a1-9a7e389474c0">494</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI1LTMtMS0xLTIwOTI1_0e8557c5-ba1e-452e-af65-757192537d21">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI2LTEtMS0xLTIwOTI1_dbba11cc-ad09-4ac7-ab3b-9cd69c73e5a6">792</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI2LTMtMS0xLTIwOTI1_03d13f81-2ffd-4966-973c-c27cb7cb773a">847</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI4LTEtMS0xLTIwOTI1_c5af2c01-da8f-43ff-89f0-0973fd6000bf"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI4LTMtMS0xLTIwOTI1_738bd417-6ed8-406e-a8ad-9ba5a5f02691"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI5LTEtMS0xLTIwOTI1_8d00f3ea-3ca8-463c-9b14-fc6b45837f49">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI5LTMtMS0xLTIwOTI1_b015b385-7cfc-4648-ac84-51a94c7db2d5">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfMjg_7f032837-50f6-4a6b-b90d-9b7e89e02135"><ix:nonFraction unitRef="usdPerShare" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfMjg_d04c5e03-2a34-49e7-915a-82bc63e39bbd">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfNDI_0b241fcf-31af-470e-b5c2-272bc1575185"><ix:nonFraction unitRef="shares" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfNDI_b76405a1-e587-4009-bf51-db76d271c5aa">600</ix:nonFraction></ix:nonFraction> shares authorized as of both December 31, 2021 and 2020; <ix:nonFraction unitRef="shares" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfMTA5OTUxMTYyNzk0NQ_f6fa5bfb-ea07-48f3-8cdb-cb6556088946">162</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfMTAy_1959520b-f189-4b04-b55b-24c50971bb5e">217</ix:nonFraction> shares issued as of December 31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTEtMS0xLTIwOTI1_8e776d28-7ecf-4c23-a9ac-d0927389dadf">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTMtMS0xLTIwOTI1_e7d1c35a-d21d-4ea4-95c4-115ebfa9cf7c">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMzLTEtMS0xLTIwOTI1_57b05998-97c7-4307-9366-e9ffac6cd2bf">2,260</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMzLTMtMS0xLTIwOTI1_e4dc71fa-56fd-4646-a905-411c71302c7e">2,841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM0LTEtMS0xLTIwOTI1_d167a083-135c-4422-b6e6-a51db83e8520">7,649</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM0LTMtMS0xLTIwOTI1_e19ce841-4e42-4acb-b694-eff5fb34a21f">9,303</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM1LTEtMS0xLTIwOTI1_15e71b96-5f5d-46c3-a0cd-040c38c56900">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM1LTMtMS0xLTIwOTI1_b1207023-3afd-466d-ae79-0bdd20ef9d76">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM2LTAtMS0xLTIwOTI1L3RleHRyZWdpb246MThlNTYxMDFhYWRiNGEyZWJhOTRhOTY0YTY1MTUyNGRfMTA5OTUxMTYyNzg4OQ_742d49cb-2fc2-421a-bb77-ef84ce0d58a6">43</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM2LTAtMS0xLTIwOTI1L3RleHRyZWdpb246MThlNTYxMDFhYWRiNGEyZWJhOTRhOTY0YTY1MTUyNGRfMTA5OTUxMTYyNzg4NQ_a4b5ecfd-350c-4b7e-937f-dd32e1a23072">84</ix:nonFraction> shares as of December 31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM2LTEtMS0xLTIwOTI1_10011f19-3a41-4d84-a03b-4bd2be1c6f3d">3,453</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM2LTMtMS0xLTIwOTI1_21798de7-ed26-4e69-ab2a-8687018acb1b">5,366</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Quest Diagnostics stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM3LTEtMS0xLTIwOTI1_4601f6e9-a726-4f71-b143-efa058550a7b">6,444</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM3LTMtMS0xLTIwOTI1_68b7b8d8-e8b7-42d6-aa50-e45f7710eb69">6,759</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM4LTEtMS0xLTIwOTI1_9d7db6ad-7adf-48bb-8c15-b59f25f5083b">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM4LTMtMS0xLTIwOTI1_51370587-e79b-4fb6-a3b5-38beed3b3786">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM5LTEtMS0xLTIwOTI1_f7291849-6c50-45da-9a6a-22e84faf36f7">6,483</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM5LTMtMS0xLTIwOTI1_bd133411-162b-49b4-b5b3-4d2478740072">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQwLTEtMS0xLTIwOTI1_3afa000c-1cb0-4193-b357-ae787d395e0d">13,611</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQwLTMtMS0xLTIwOTI1_b9bb3099-3097-4090-a765-2e1ca8ecf93b">14,026</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_160"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER&#160;31, 2021, 2020 AND 2019 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.003%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzItMS0xLTEtMjA5MjU_5b35bdd6-a97c-4bed-b52a-c126914a9336">10,788</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzItMy0xLTEtMjA5MjU_0d1e3c02-ccd7-41b6-b4dc-d96a5652724d">9,437</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzItNS0xLTEtMjA5MjU_89dea8f0-201a-4955-8aa5-2ae7af2e2548">7,726</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating expense (income):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzUtMS0xLTEtMjA5MjU_d8070039-5b51-413d-ab31-767f98468b23">6,579</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzUtMy0xLTEtMjA5MjU_b0ff2c81-c249-4b4f-b065-a95d9dcb0833">5,804</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzUtNS0xLTEtMjA5MjU_16eeb2eb-a97a-48ac-bfc7-e42658c04f57">5,037</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzYtMS0xLTEtMjA5MjU_a252c8cd-561e-4868-bca6-240c8814cfa3">1,727</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzYtMy0xLTEtMjA5MjU_34dc4d6c-6458-4bb9-938c-0ad45978fe63">1,550</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzYtNS0xLTEtMjA5MjU_60735763-6f02-48b3-a029-d4114f29aaaa">1,457</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzctMS0xLTEtMjA5MjU_faa64d11-9cd2-4c91-b856-da52713bf66a">103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzctMy0xLTEtMjA5MjU_29576cfd-4c07-43cb-af40-eb9ce15043b0">103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzctNS0xLTEtMjA5MjU_9d5d6b62-f4bd-4214-9bec-ce438fdf0000">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzgtMS0xLTEtMjA5MjU_7f057593-38ea-47b8-97cf-e68f09766c44">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzgtMy0xLTEtMjA5MjU_c7579909-e95b-4bf1-9fe1-442a8cf0b732">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzgtNS0xLTEtMjA5MjU_7520012c-1b3f-4919-813b-3f77a29ba8b0">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzktMS0xLTEtMjA5MjU_8da1e535-6fb5-4a5d-ab37-0e15f57ed0ec">8,407</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzktMy0xLTEtMjA5MjU_03f62493-1fc2-426d-83bb-d6ecf05e8570">7,466</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzktNS0xLTEtMjA5MjU_30ad7bfc-2140-4db0-92c5-1b02e2b94f61">6,495</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzExLTEtMS0xLTIwOTI1_497f27e5-5147-4403-a8e2-435db1d246a7">2,381</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzExLTMtMS0xLTIwOTI1_5ba33e90-17d8-4d45-83fa-3f16b6e87fc1">1,971</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzExLTUtMS0xLTIwOTI1_ef091698-553b-445d-a7cc-c5faae637535">1,231</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE0LTEtMS0xLTIwOTI1_7f659fd8-b251-485d-9d6c-14bbccf82d0b">151</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE0LTMtMS0xLTIwOTI1_23cf9e3e-937f-48e1-af46-e2bfb5851dba">163</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE0LTUtMS0xLTIwOTI1_1fab77bd-c637-4cd4-9d58-214c83209029">175</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE1LTEtMS0xLTIwOTI1_c54a1a02-6958-48f2-8a59-f40669f04b2a">369</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE1LTMtMS0xLTIwOTI1_29df900c-126b-4be3-96ff-7c52249cea07">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE1LTUtMS0xLTIwOTI1_f9213044-7e22-4814-8cb5-da01d3dbcf3d">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating income (expense), net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE2LTEtMS0xLTIwOTI1_9c3b09bd-3a7c-4ced-ad34-bce1442334ec">218</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE2LTMtMS0xLTIwOTI1_31bb6a8f-a79c-4aab-8772-5820fb650988">87</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE2LTUtMS0xLTIwOTI1_fec60e26-8d73-4368-a127-8d0a17f47965">155</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations before income taxes and equity in earnings of equity method investees</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE4LTEtMS0xLTIwOTI1_66958641-b546-49c9-a51d-ba1af5faf2a5">2,599</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE4LTMtMS0xLTIwOTI1_7574e637-c1aa-4884-ac2d-68d9ead65ba9">1,884</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE4LTUtMS0xLTIwOTI1_76a07075-9ad5-4ae6-95d2-fd1e5009eaf5">1,076</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE5LTEtMS0xLTIwOTI1_6b6adecc-b48f-48fe-90a8-ec9b01b991fa">597</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE5LTMtMS0xLTIwOTI1_8b0908a2-0366-4ba2-8c8d-5e9ee64c1512">460</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE5LTUtMS0xLTIwOTI1_e6d5014b-1ddb-4b7a-bb74-c0bffdc7e8aa">247</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIwLTEtMS0xLTIwOTI1_14f94a7d-78f2-4681-b861-fae8284b4c11">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIwLTMtMS0xLTIwOTI1_547dacc5-0b6c-4361-906d-b3b33075e3ca">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIwLTUtMS0xLTIwOTI1_930c1114-9ebc-4e94-a9a2-850a67a0b8c6">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIzLTEtMS0xLTIwOTI1_0ded4108-2726-4e60-a141-ce5e7c2d6238">2,080</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIzLTMtMS0xLTIwOTI1_dfabc4b0-b27f-48db-886b-630ed697a414">1,499</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIzLTUtMS0xLTIwOTI1_5b782a79-e946-40d4-b7ce-44965d573eb7">886</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI0LTEtMS0xLTIwOTI1_f2588ba8-744b-4936-9ad2-8f07390a700b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI0LTMtMS0xLTIwOTI1_250c12a9-d848-4672-bb22-2bbcc9a003c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI0LTUtMS0xLTIwOTI1_1416bd74-5b94-47ae-9d29-6a8f72ad2bd6">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI1LTEtMS0xLTIwOTI1_6674bd49-c4b0-410b-bfde-a25301e2859a">2,080</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI1LTMtMS0xLTIwOTI1_db78103c-0c95-4f69-9f94-bbb293e50b99">1,499</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI1LTUtMS0xLTIwOTI1_ab79e4e6-0a8a-4b79-be90-216b6f61c4f6">906</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI2LTEtMS0xLTIwOTI1_c5abae76-1eb3-472c-a7f9-267f3deb3c09">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI2LTMtMS0xLTIwOTI1_97d9a95c-2a8c-4d37-8925-05a8aac073f2">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI2LTUtMS0xLTIwOTI1_c3a1a0fb-280b-417c-b542-e9af5b0041ed">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI3LTEtMS0xLTIwOTI1_4c399235-ed45-41f8-b511-eeb8db66d178">1,995</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI3LTMtMS0xLTIwOTI1_6c31afe0-f480-490a-a017-441163c5608d">1,431</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI3LTUtMS0xLTIwOTI1_3554eb6e-b8e5-47b8-873f-a83b28f6ed22">858</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMwLTEtMS0xLTIwOTI1_4c79b348-7d6b-4267-b3c7-c4fb41306426">1,995</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMwLTMtMS0xLTIwOTI1_44066cc6-da0c-4b95-853f-9fb1939d81f8">1,431</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMwLTUtMS0xLTIwOTI1_8e61a124-ba2f-41db-ac0c-f530a6a98223">838</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMxLTEtMS0xLTIwOTI1_65d16c9d-aaa4-466a-a87a-8998cdc275dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMxLTMtMS0xLTIwOTI1_b773ada2-3fc6-4a12-aac7-3b3e140fe85f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMxLTUtMS0xLTIwOTI1_1ea047f3-2882-476b-93c0-4853d40ffd0d">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMyLTEtMS0xLTIwOTI1_da70d4f9-abf5-4267-88d5-be952522fcdb">1,995</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMyLTMtMS0xLTIwOTI1_2f667f06-19a1-4adb-8b72-8a800cf54fbc">1,431</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMyLTUtMS0xLTIwOTI1_38de0e6f-3ef7-4984-870d-b2775fe3c239">858</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM1LTEtMS0xLTIwOTI1_953ed003-e6d3-40ed-955e-043a10bd2a69">15.85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM1LTMtMS0xLTIwOTI1_1e03e1c2-ed95-45b0-ad44-d0451a37ce0e">10.62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM1LTUtMS0xLTIwOTI1_64651a85-ad9e-46d5-be60-2ab6b80be41c">6.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM2LTEtMS0xLTIwOTI1_cbbd7fa1-afa7-456b-b4ec-adbf4aa5cc1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM2LTMtMS0xLTIwOTI1_82de0d56-0a83-417a-b5ee-5fee0ba19a84">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM2LTUtMS0xLTIwOTI1_bfea90f3-55bd-43b8-acfd-88d209fa2251">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM3LTEtMS0xLTIwOTI1_a64d5008-dda3-4b76-860c-ffda7eb08ac8">15.85</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM3LTMtMS0xLTIwOTI1_c9aba9b3-0623-4bb9-9e23-2e6972871f1d">10.62</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM3LTUtMS0xLTIwOTI1_9d1cb49b-ffa7-4877-941e-ddfd09d324de">6.36</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQwLTEtMS0xLTIwOTI1_80e055a0-cd53-4a2b-8cb9-22f57aa7aaf6">15.55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQwLTMtMS0xLTIwOTI1_b33059a8-60a7-402c-b92f-1e93a8d77795">10.47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQwLTUtMS0xLTIwOTI1_28d05ca0-a8d5-4fa6-a2a5-22c16e096b0e">6.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQxLTEtMS0xLTIwOTI1_c53a973f-e19f-4efa-bab6-f241309fc6de">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQxLTMtMS0xLTIwOTI1_a8bc936e-feaa-465e-b2f8-d94930a77cdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQxLTUtMS0xLTIwOTI1_89b1df81-335f-47f0-8b93-05ef35f2f95e">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQyLTEtMS0xLTIwOTI1_878ace95-b408-460f-9c89-b7fb20e305fc">15.55</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQyLTMtMS0xLTIwOTI1_95907647-caf3-45fa-b544-ba9796956b57">10.47</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQyLTUtMS0xLTIwOTI1_c120066b-7d4b-4ae7-b8e9-0da9340a9bb8">6.28</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_163"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER&#160;31, 2021, 2020 AND 2019 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzItMS0xLTEtMjA5MjU_6674bd49-c4b0-410b-bfde-a25301e2859a">2,080</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzItMy0xLTEtMjA5MjU_f87b2a42-2061-4f13-a03c-5921b054ac75">1,499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzItNS0xLTEtMjA5MjU_d217ba5e-7cbf-4131-9d41-7b18481bf781">906</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzUtMS0xLTEtMjA5MjU_8ccaa948-4681-4af0-bea4-32076e788fc4">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzUtMy0xLTEtMjA5MjU_4bea3f84-33b5-4822-a6bd-232801d7d19f">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzUtNS0xLTEtMjA5MjU_55a8f51d-b8a6-4a18-87ac-6424820d15eb">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in available-for-sale debt securities, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzYtMS0xLTEtMjA5MjU_24ea983d-7b84-4f0e-8958-54eeba703899">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzYtMy0xLTEtMjA5MjU_4794c83d-c8bd-4799-aa63-b5858c5c15f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzYtNS0xLTEtMjA5MjU_77f70ddd-3f0d-4743-9597-402585d99acb">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred gain on cash flow hedges, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzctMS0xLTEtMjA5MjU_4ecb65b5-ad49-441f-aced-ec1ebba94f46">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzctMy0xLTEtMjA5MjU_06cce5cf-dfec-4635-9166-bdc49d3eee5b">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzctNS0xLTEtMjA5MjU_24d7845d-21bc-41bd-9361-3b9be7a0b63b">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzktMS0xLTEtMjA5MjU_e3795d59-5297-4d7d-8004-e65ad6a05e00">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzktMy0xLTEtMjA5MjU_c8e8524b-37d2-4138-9395-8d5eb6a990d4">18</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzktNS0xLTEtMjA5MjU_aa831106-9b44-4beb-92a1-66f209dc4530">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzExLTEtMS0xLTIwOTI1_0bd37ce5-3ed7-47a9-802f-e975f8137407">2,087</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzExLTMtMS0xLTIwOTI1_8423e76a-d951-49f3-8268-bca47615ea1b">1,517</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzExLTUtMS0xLTIwOTI1_6a3b4822-9277-4d98-b55b-00602ed2c759">926</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEyLTEtMS0xLTIwOTI1_89a4d36c-19ff-4fe5-bc9b-0c7e9b6c9b56">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEyLTMtMS0xLTIwOTI1_c5bb555c-0774-49e3-9ca6-8c6bf5f07d66">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEyLTUtMS0xLTIwOTI1_b830d5ce-4564-4e09-8965-292d078eee0d">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEzLTEtMS0xLTIwOTI1_aa4b824b-7715-47c6-85a2-7305769ced83">2,002</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEzLTMtMS0xLTIwOTI1_89f615bd-e380-4f1a-a88a-25894edca624">1,449</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEzLTUtMS0xLTIwOTI1_e7aa9565-a4a6-481e-a7e3-f4e68942ac69">878</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_166"></div><hr style="page-break-after:always"/><div style="min-height:67.32pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER&#160;31, 2021, 2020 AND 2019 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzItMS0xLTEtMjA5MjU_0e50e4d3-53b1-4fe5-847b-8fdbc8a889cb">2,080</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzItMy0xLTEtMjA5MjU_11e60c18-65f9-4310-aaca-bdcdbffd79c5">1,499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzItNS0xLTEtMjA5MjU_977f41d2-c7ba-4820-bd45-fba682f0411f">906</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQtMS0xLTEtMjA5MjU_8ac66da0-2bba-433b-a723-b9ea37f448e8">408</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQtMy0xLTEtMjA5MjU_bfe0290a-4b4f-423f-95cd-b966e5e5a88f">361</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQtNS0xLTEtMjA5MjU_44fee77d-fe62-4be8-b76b-fe097b8ba6b5">329</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUtMS0xLTEtMjA5MjU_06a1f676-f4b8-459f-b8d4-1a10385fe2a1">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUtMy0xLTEtMjA5MjU_7ac06791-56cc-4f54-9c00-796b2c6dc275">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUtNS0xLTEtMjA5MjU_8a044799-dbb6-4142-8f07-915d15757d02">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax (benefit) provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzYtMS0xLTEtMjA5MjU_1e3fbf3a-bf3d-453b-87f2-b6d844381d7b">57</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzYtMy0xLTEtMjA5MjU_dac73c5a-f3d0-48af-bf15-c1120f749642">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzYtNS0xLTEtMjA5MjU_83d96d12-f3d3-46ec-a37e-5034c0ad1a31">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzctMS0xLTEtMjA5MjU_bbeed6f0-e9e0-47bd-aae3-cd9ec0486682">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzctMy0xLTEtMjA5MjU_672a8dc6-86a6-4da8-b395-6199b31c0c56">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzctNS0xLTEtMjA5MjU_2173d1eb-da0f-4c32-a618-18e56a3cb32b">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposition of joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="dgx:GainLossOnDispositionOfJointVenture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzgtMS0xLTEtMjA5MjU_f3ba734d-5f38-455b-99f8-fb76d19b2660">314</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:GainLossOnDispositionOfJointVenture" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzgtMy0xLTEtMjA5MjU_f34936e9-ac6c-4ed4-be70-143227d0943f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:GainLossOnDispositionOfJointVenture" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzgtNS0xLTEtMjA5MjU_ba96bbf5-9858-41ea-ba95-19a9a6778719">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses (gains) on sale of property, plant and equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzEzLTEtMS0xLTIwOTI1_a60231d9-0a31-4dca-b4ae-89ed9a4506a4">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzEzLTMtMS0xLTIwOTI1_b5bcde4a-b58d-4b71-b097-fe5a3d5352f3">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzEzLTUtMS0xLTIwOTI1_d422117b-0af7-4dd4-aef3-52dde697567f">70</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE0LTEtMS0xLTIwOTI1_67f4ea97-5c2d-4ca7-86ab-407bd68fd670">63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE0LTMtMS0xLTIwOTI1_9bcc13e2-2b56-453a-9d1e-a0205ff7781b">81</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE0LTUtMS0xLTIwOTI1_7ff3391a-37de-4d11-ab86-cec0ebafd71e">39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE2LTEtMS0xLTIwOTI1_05a41b9d-5325-434b-8555-7f5532877888">81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE2LTMtMS0xLTIwOTI1_d271bfc8-9660-4896-b2e5-16f1990a64e6">455</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE2LTUtMS0xLTIwOTI1_637507f3-9ca1-404c-a3a4-567fa2b959da">63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE3LTEtMS0xLTIwOTI1_330ee71c-bcda-4cb8-bf4a-c3ed81d105f4">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE3LTMtMS0xLTIwOTI1_dd51723b-0d8b-43ba-85a3-dd374ae13216">452</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE3LTUtMS0xLTIwOTI1_67525285-215f-48e2-8e61-9d93c3f68414">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE5LTEtMS0xLTIwOTI1_567e2b25-d250-4dc6-806c-54891d449cd1">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE5LTMtMS0xLTIwOTI1_3b560535-b352-4683-978c-5faa38ecb741">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE5LTUtMS0xLTIwOTI1_1caf9319-563b-4e85-970b-3d7140c3fe1a">29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination of interest rate swap agreements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="dgx:TerminationOfInterestRateSwapAgreements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIwLTEtMS0xLTIwOTI1_4f046bb4-d350-4052-954b-ad72fc258256">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:TerminationOfInterestRateSwapAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIwLTMtMS0xLTIwOTI1_c3aeaf8c-953a-4ef2-a573-05afc90edc47">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:TerminationOfInterestRateSwapAgreements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIwLTUtMS0xLTIwOTI1_c8fd44f0-67b0-4c5a-a46d-3ce9ffbbc44b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIxLTEtMS0xLTIwOTI1_5267ea6d-8dcb-48f6-8adf-5b21fa30bb5b">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIxLTMtMS0xLTIwOTI1_d67b458f-4fd1-4672-9765-9ef07ba23fc1">37</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIxLTUtMS0xLTIwOTI1_f6c5435b-0c5b-4a62-8edb-462447982b4b">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIyLTEtMS0xLTIwOTI1_96c52340-6c90-4b8b-9eba-b3172cd427bf">2,233</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIyLTMtMS0xLTIwOTI1_bdf493c9-bd47-4656-9cc5-aa40d861249b">2,005</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIyLTUtMS0xLTIwOTI1_d073cf09-d4a3-4afe-9608-6b845231908c">1,243</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI1LTEtMS0xLTIwOTI1_4c916d76-7fc8-415b-932f-2a246060f6fa">331</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI1LTMtMS0xLTIwOTI1_13d76a5c-78f7-4972-b88d-9b97aec925a4">330</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI1LTUtMS0xLTIwOTI1_dfa57b8b-cb86-4bf7-88fd-b583cdead3e7">58</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from disposition of joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI2LTEtMS0xLTIwOTI1_c669d53f-f11e-4578-a53a-f79dbce40948">755</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI2LTMtMS0xLTIwOTI1_4dfbeaeb-2bcc-491b-9a40-12d6b3e22dca">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI2LTUtMS0xLTIwOTI1_df204f7d-99a7-4177-85e5-2ec4a776b1ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from disposition of property, plant, and equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI4LTEtMS0xLTIwOTI1_4313a850-1b97-4297-b109-39428cdaea7a">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI4LTMtMS0xLTIwOTI1_6874530e-e668-4425-a12d-aff178b97ad3">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI4LTUtMS0xLTIwOTI1_f78c8ecd-2dcb-4914-8b42-f9dccc56fa91">91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI5LTEtMS0xLTIwOTI1_2e7b3c59-b9d3-4940-8f5e-e989581dcc63">403</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI5LTMtMS0xLTIwOTI1_ca28a7b2-84f5-453d-b54a-a65d858cfce4">418</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI5LTUtMS0xLTIwOTI1_6c2d6312-7586-420c-ba3a-9b691b75c455">400</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase in investments and other assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMxLTEtMS0xLTIwOTI1_55c489a3-2477-4592-97ab-c5d1295a0cd7">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMxLTMtMS0xLTIwOTI1_7ca55139-6d01-44b4-9e63-67cbb5bc6f45">27</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMxLTUtMS0xLTIwOTI1_da5afc3d-a33b-46ab-b4f6-5999c8ed2984">44</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMyLTEtMS0xLTIwOTI1_1cf6e6d5-6033-4fde-a61e-7bd48f3b50c6">21</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMyLTMtMS0xLTIwOTI1_df430de0-1b3f-47d8-a3fd-430d5a35b93d">772</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMyLTUtMS0xLTIwOTI1_6c48973a-73e9-4acf-a259-9395b0f2e8d0">411</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM1LTEtMS0xLTIwOTI1_6fa79c9c-5dff-4ec1-8b75-9dea668052c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM1LTMtMS0xLTIwOTI1_9b127c63-bc77-4c21-a2eb-f8701921d2b8">749</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM1LTUtMS0xLTIwOTI1_0ba837d9-683a-4b16-906e-b78afc235fc6">2,281</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM2LTEtMS0xLTIwOTI1_62d89d33-51a6-4f41-a30f-a00f851449a1">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM2LTMtMS0xLTIwOTI1_e662faa0-5dac-497f-a5c2-e08d306d4d59">1,554</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM2LTUtMS0xLTIwOTI1_e8790db1-7990-4f5b-885f-bc649091e1e0">1,449</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM3LTEtMS0xLTIwOTI1_a7678973-a3bb-4d3b-b81e-21460f00fab9">2,199</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM3LTMtMS0xLTIwOTI1_d5568e43-7164-46f4-9a6b-401c824b2813">325</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM3LTUtMS0xLTIwOTI1_a9762389-4cad-4e71-80de-2519abfe9e1d">353</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM4LTEtMS0xLTIwOTI1_5e0edeff-3e54-455b-8866-784a717e12fa">129</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM4LTMtMS0xLTIwOTI1_37eb3c12-a5ee-4cf8-95eb-4ea6001888b0">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM4LTUtMS0xLTIwOTI1_8f860127-6f54-46d1-822f-38873ec056bc">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM5LTEtMS0xLTIwOTI1_2581b4ad-0fba-46ca-87ec-372845997095">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM5LTMtMS0xLTIwOTI1_d57f1a34-e251-473e-a7bf-463cf8c3bf1a">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM5LTUtMS0xLTIwOTI1_08dda805-d67b-403c-b5f4-1eeb0f2a9bf8">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQwLTEtMS0xLTIwOTI1_0b79e354-a335-404a-97d2-4460a034296f">309</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQwLTMtMS0xLTIwOTI1_e14b47b3-6929-41c4-852f-cc3294fc313d">297</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQwLTUtMS0xLTIwOTI1_ccbe9699-ec86-4c36-885d-8663ef3bafb5">286</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQxLTEtMS0xLTIwOTI1_eee4cc24-395f-4a62-ad62-bd6d112d59b7">99</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQxLTMtMS0xLTIwOTI1_ea774910-ca0a-4960-9298-b42164cc0187">58</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQxLTUtMS0xLTIwOTI1_398913c7-5087-4024-8e6e-0c2f15dcb063">54</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ1LTEtMS0xLTIwOTI1_28ca22b7-f73a-45fa-8055-67d756143dbd">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ1LTMtMS0xLTIwOTI1_fba268e7-9fce-4a4e-bc32-3009b03f86ed">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ1LTUtMS0xLTIwOTI1_e5204d5f-a37d-42ff-bf89-55caa107a680">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ2LTEtMS0xLTIwOTI1_829dfa44-a4ce-44a6-8e96-613ad4a38f57">2,540</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ2LTMtMS0xLTIwOTI1_05f0d608-54c0-4025-b15c-226f4b378577">1,267</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ2LTUtMS0xLTIwOTI1_fea48a33-73e2-42cf-85d3-cb7a0c852636">225</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ4LTEtMS0xLTIwOTI1_87f21e91-0516-4ef2-b586-9b0f36c92892">286</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ4LTMtMS0xLTIwOTI1_82bc7c57-7beb-466b-81f7-ab02a8571dec">34</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ4LTUtMS0xLTIwOTI1_84b14b10-e129-4e6f-bdb6-eaf0135b1b6d">1,057</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUwLTEtMS0xLTIwOTI1_e0c21a93-951b-4815-815f-3f2d524c4f6f">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUwLTMtMS0xLTIwOTI1_b98e25e3-6987-46f6-994e-fb413cdea8b2">1,192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i751cd9d2a9c24eeb80a337f22c577eed_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUwLTUtMS0xLTIwOTI1_1513394e-441e-4a53-943e-c7ff9dfb6557">135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, end of year</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUxLTEtMS0xLTIwOTI1_f435af79-ae39-4b88-98a6-87642783235d">872</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUxLTMtMS0xLTIwOTI1_6a9ee05f-6503-4cdf-a05e-f68db692fce5">1,158</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUxLTUtMS0xLTIwOTI1_d2d62b7e-b6c7-4f86-ae0d-5e7acd8e10ac">1,192</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_169"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER&#160;31, 2021, 2020 AND 2019 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.436%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Shares of<br/>Common<br/>Stock Out-<br/>standing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>&#160;Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Total Stock-holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2018</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b6f2cccffed48a8b1dceaea5ff25de2_I20181231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItMS0xLTEtMjA5MjU_8d7e5578-80e0-464b-8903-46bb5badb3c0">135</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b6f2cccffed48a8b1dceaea5ff25de2_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItMi0xLTEtMjA5MjU_8eaab544-c117-4db6-a722-9e1825626a8f">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda5f95daad049caab9cbe2bfb827136_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItMy0xLTEtMjA5MjU_73e60ed6-06a2-49a6-bc6e-2bed4b499d79">2,667</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5299549fc0c64e619315ae69e3a2d208_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItNC0xLTEtMjA5MjU_9c348a5f-c8e8-4dc4-a934-960175f1b649">7,602</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aab3fa36e3d4c9784c83bb58dbc0467_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItNS0xLTEtMjA5MjU_e81eda18-604a-48d4-bc72-eb11487f64ef">59</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f2e5616f9864fd5b5916bfd56220c6d_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItNi0xLTEtMjA5MjU_c82a50c0-3339-4e3c-9c07-fe965ff055bd">4,996</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1066f069691a446899ccc794445c6f7e_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItNy0xLTEtMjA5MjU_efed68e0-4610-4912-808c-10bed0c89dd8">51</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i751cd9d2a9c24eeb80a337f22c577eed_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItOC0xLTEtMjA5MjU_55bc5750-d482-475a-bc5e-d3bb342ad078">5,267</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i751cd9d2a9c24eeb80a337f22c577eed_I20181231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItMTEtMS0xLTIwOTI1_176551bf-5157-4b01-ae1b-406669298696">77</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b348bf53ef45a6b79322e9729d0498_D20190101-20191231" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMtNC0xLTEtMjA5MjU_3d5b88f7-5805-440a-aa30-c1c1de74283a">858</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c4749bcaac4d619fd98fd7d8f56cf3_D20190101-20191231" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMtNy0xLTEtMjA5MjU_02786fc7-97cf-4d72-a359-3f4f013b7306">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMtOC0xLTEtMjA5MjU_6874cd46-1c7d-4f4c-bd61-862b675fe05b">900</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMtMTEtMS0xLTIwOTI1_c64e7182-593d-4513-8a5b-6e8fc4858f7d">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267bcc57d1894a25886a84780745fe3f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQtNS0xLTEtMjA5MjU_682dfdab-0aeb-4b36-8e34-080c803552b9">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQtOC0xLTEtMjA5MjU_f0ebc4eb-3aae-46fc-aa40-593d08230015">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88b348bf53ef45a6b79322e9729d0498_D20190101-20191231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzUtNC0xLTEtMjA5MjU_7c9c79a8-7beb-4fe5-991a-0abca1c4d4de">286</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzUtOC0xLTEtMjA5MjU_e4d2427b-e292-4e8b-8ac4-997e89ffc98f">286</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1c4749bcaac4d619fd98fd7d8f56cf3_D20190101-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzYtNy0xLTEtMjA5MjU_0c70e1e7-f987-43ba-8d25-346d2b1470ff">47</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzYtOC0xLTEtMjA5MjU_6f9efbec-e7f2-48d8-bb16-f071d16dd4c1">47</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzYtMTEtMS0xLTIwOTI1_7b56637f-4749-47cf-9891-58901738cffc">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209ef77b3d74e11bcf8556dd3482d4a_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzctMy0xLTEtMjA5MjU_65374d4d-5eca-4d5f-bd6b-1403839a8b1f">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzctNi0xLTEtMjA5MjU_106ee7c3-9bb5-4faf-9bbc-f716e5423b27">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzctOC0xLTEtMjA5MjU_d4107280-bc87-4f3d-867e-7881ed7e502f">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209ef77b3d74e11bcf8556dd3482d4a_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzgtMy0xLTEtMjA5MjU_e7cb9261-7ef1-46a9-9160-2aa120cc389e">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzgtNi0xLTEtMjA5MjU_3e0026ba-11d1-4e2e-8439-cd79655ac921">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzgtOC0xLTEtMjA5MjU_4858b230-6a10-4740-9308-acb3c810f1d7">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3be5ad04ae5542ecb8f3b50fb4e30464_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzktMS0xLTEtMjA5MjU_44b44174-0878-4060-95d9-075b44592cda">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209ef77b3d74e11bcf8556dd3482d4a_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzktMy0xLTEtMjA5MjU_b4c0f2ab-23b1-4884-b1d9-918a0d58b35a">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzktNi0xLTEtMjA5MjU_3b3e6c68-f074-4e2e-91ca-7b95b3f4f8f9">112</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzktOC0xLTEtMjA5MjU_bda04db7-86b4-4f6b-8650-59528d0ae1d2">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie209ef77b3d74e11bcf8556dd3482d4a_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzEwLTMtMS0xLTIwOTI1_50fb771f-4373-4c5e-8bb8-3c0a52c710e8">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzEwLTgtMS0xLTIwOTI1_996c4f75-4f5d-4356-93bb-733ba53b02bc">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3be5ad04ae5542ecb8f3b50fb4e30464_D20190101-20191231" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzEyLTEtMS0xLTIwOTI1_37611c75-efd0-47c6-a3e8-0f2bcb1a1dd3">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzEyLTYtMS0xLTIwOTI1_376520cf-aa0a-405b-b125-2c05780f1d42">350</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzEyLTgtMS0xLTIwOTI1_447720a9-4e90-4c0c-9569-87dc9d648bcc">350</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf54f2e101be444fae80a5c5c2d3c804_I20191231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTEtMS0xLTIwOTI1_ae0c8c00-5225-42a6-aec2-9ac87e1e6a85">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf54f2e101be444fae80a5c5c2d3c804_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTItMS0xLTIwOTI1_10944c51-1f28-4f7a-b4a7-f3af7d060fe1">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae81071de369404b8afd4d5fc92817db_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTMtMS0xLTIwOTI1_d4e53cb2-b378-4302-a351-4bebbdae696b">2,722</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67c2565c4020431eab3d950ad045cb6d_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTQtMS0xLTIwOTI1_614b18bc-ea51-42bd-a3e7-3410fd66a785">8,174</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if98d4882c785427cb6359a1c4887bd59_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTUtMS0xLTIwOTI1_2a8c7c8a-a163-4dfd-ba53-bb22a6e6b396">39</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb7782dfdbdd41bcb0c2a7ce6d9fc4e9_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTYtMS0xLTIwOTI1_b8f951bd-d85e-4217-8d67-b42ee6070bd3">5,218</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7887c43e3ff4c0eaa862aa8feccb3a5_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTctMS0xLTIwOTI1_177870ef-efd1-4360-8aa8-ed205c2301b7">46</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTgtMS0xLTIwOTI1_b867f0e7-e57a-4848-b31d-d7162f0ca0a1">5,687</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTExLTEtMS0yMDkyNQ_7f55234d-eddc-4193-8879-8c31c403dbcc">76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7109a9f8e79b43adaac841ce00ee330f_D20200101-20201231" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE3LTQtMS0xLTIwOTI1_fe1b798d-65ed-44f0-a118-a12d73a2ca8f">1,431</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100aacd303a1475289f1b48d599c5544_D20200101-20201231" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE3LTctMS0xLTIwOTI1_8c0157b1-ff74-4ec3-9670-beb342daeb1c">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE3LTgtMS0xLTIwOTI1_e86e3849-e90a-4a0b-847b-a4743bfe1274">1,484</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE3LTExLTEtMS0yMDkyNQ_ee89386c-97a2-46f8-886c-a3c8873dae71">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i873b50b7201e479895a613c8644d45a8_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE4LTUtMS0xLTIwOTI1_49504acd-729d-48cc-ac40-d6c36833dac2">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE4LTgtMS0xLTIwOTI1_2e1abea0-1426-484a-b612-618c9a330b71">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7109a9f8e79b43adaac841ce00ee330f_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE5LTQtMS0xLTIwOTI1_218eb813-ae4c-4f15-81cf-e3e2a33ab2bf">302</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE5LTgtMS0xLTIwOTI1_e8c946fa-136b-4817-8b09-099a82f70474">302</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100aacd303a1475289f1b48d599c5544_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIwLTctMS0xLTIwOTI1_58b6d7a8-47e5-46b8-b88b-1a4b48ba0990">49</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIwLTgtMS0xLTIwOTI1_cd8f444b-569a-4e60-bf66-9cf617d85287">49</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIwLTExLTEtMS0yMDkyNQ_6c0a2f03-f73b-4e1e-921a-e09583092c85">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9a6dfcd580714f519c23752e3e04312e_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIxLTEtMS0xLTIwOTI1_d8a45ec2-cf55-463b-89f8-74407945b5e1">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aa4482609c643a18d09f0c105d38575_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIxLTMtMS0xLTIwOTI1_8af8bd2f-fe0b-4709-8d2c-754eaff75b2a">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIxLTYtMS0xLTIwOTI1_8519d8d2-3b77-48f0-a323-35bcc5cc4ebd">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIxLTgtMS0xLTIwOTI1_6b543cf6-0260-41aa-95d0-90e6f06e8bd7">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aa4482609c643a18d09f0c105d38575_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIyLTMtMS0xLTIwOTI1_d41a5e43-f2ad-4e6c-be4e-bdeadb226fa3">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIyLTgtMS0xLTIwOTI1_9de3bb2a-3467-4baf-861d-c43d43afe0d5">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9a6dfcd580714f519c23752e3e04312e_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIzLTEtMS0xLTIwOTI1_dc7c2251-75f8-4007-a4e8-663aeece5307">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aa4482609c643a18d09f0c105d38575_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIzLTMtMS0xLTIwOTI1_ce55c92f-aa82-4fb7-9f11-f5d5559eae57">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIzLTYtMS0xLTIwOTI1_c373c1a9-e12d-452e-961a-d359c6ec6f52">163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIzLTgtMS0xLTIwOTI1_3264f1ed-eed8-4266-969c-35496fbc1749">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aa4482609c643a18d09f0c105d38575_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzI0LTMtMS0xLTIwOTI1_d3279c98-221a-423d-90ad-60aa12b56958">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzI0LTgtMS0xLTIwOTI1_fbcff4fe-0ede-40bc-9d53-79d286516459">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9a6dfcd580714f519c23752e3e04312e_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzI2LTEtMS0xLTIwOTI1_e268019c-7fea-497b-95a4-2013d2039ea3">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzI2LTYtMS0xLTIwOTI1_16a06bf1-4a0b-46b1-a381-8d795fcf1740">325</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzI2LTgtMS0xLTIwOTI1_b2442f16-02f6-4f79-aff4-edc2a0eb221b">325</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b3040c4c16442589b2b35eb56972716_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTEtMS0xLTIwOTI1_d70e6156-b7be-4f45-af31-700b6aa8c081">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b3040c4c16442589b2b35eb56972716_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTItMS0xLTIwOTI1_5cee590b-2137-4fe4-ad76-83f109bdd614">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47828d248b649a69973dd77b69d8e47_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTMtMS0xLTIwOTI1_41462c4f-bd2d-4559-bfb7-8a153e30f48e">2,841</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed179caf3f3462791e29a68b26fdab2_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTQtMS0xLTIwOTI1_54b47db6-6af2-414c-9534-a4098b7b5bb5">9,303</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf17d00ced53485da1e88eb50e730ada_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTUtMS0xLTIwOTI1_cdfc6142-ba9b-4000-aa03-7395e0dd74d1">21</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84e35541023d468e8cb0c202d383eddc_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTYtMS0xLTIwOTI1_2a66ec54-3263-4764-a032-503394820750">5,366</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b11d3e18df649ec889a7fa850cc7e67_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTctMS0xLTIwOTI1_be65b9b3-4507-437e-929a-0062a660e261">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTgtMS0xLTIwOTI1_99284ce9-9a47-4b7c-9374-159eb5fdb573">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTExLTEtMS0yMDkyNQ_502d4c14-9f15-49da-9548-cc83984b33e7">82</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7215d41c21ea4fbdb2f7240f3cc276ee_D20210101-20211231" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMxLTQtMS0xLTIwOTI1_51d6454e-ea9f-4c5e-b2e0-5b12cfb183d0">1,995</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i184e53e381dc4d5bb40497f1d9fc9b8d_D20210101-20211231" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMxLTctMS0xLTIwOTI1_a4b2ed65-5d02-4362-9654-ebf877c25457">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMxLTgtMS0xLTIwOTI1_24dc2ea6-729c-42ef-9d43-c17d854d2be0">2,067</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMxLTExLTEtMS0yMDkyNQ_60453ed7-09c4-490d-b709-003dc1f539a3">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecc4fcf7570e403c98d584e438978f0c_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMyLTUtMS0xLTIwOTI1_39164077-2fee-4b14-8ba8-a1ac73b080be">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMyLTgtMS0xLTIwOTI1_d7b30aa1-1e1d-40b0-baee-0382b015c31a">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Dividends declared</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7215d41c21ea4fbdb2f7240f3cc276ee_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMzLTQtMS0xLTIwOTI1_6a440b44-ef09-43f3-8659-ac9644e37917">307</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMzLTgtMS0xLTIwOTI1_20b14989-4c9a-463e-b9a8-a2705ef17fec">307</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i184e53e381dc4d5bb40497f1d9fc9b8d_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM0LTctMS0xLTIwOTI1_3844bbf4-47c6-4f49-aee3-324978a9cb26">83</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM0LTgtMS0xLTIwOTI1_ff58a0e2-eaa2-4fdd-9b7d-ab8bba76ff32">83</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM0LTExLTEtMS0yMDkyNQ_302d6c34-6b9f-4e2d-8eac-98ec04c6fbe2">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM1LTMtMS0xLTIwOTI1_a6662fbb-5b9d-4542-b5a5-35045f4f1638">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM1LTYtMS0xLTIwOTI1_6907129f-2208-4562-9e49-01388ae19bf9">47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM1LTgtMS0xLTIwOTI1_3943ff84-66e0-44d2-afba-c049ef56eafa">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM2LTMtMS0xLTIwOTI1_cf8f8729-c10b-4db1-8613-20c9a8f7b0b5">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM2LTgtMS0xLTIwOTI1_dde37df3-2f6f-4bdc-b3ff-2174f72498d5">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Exercise of stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6174bff25adb42cdbd66e7fb9ff9c37d_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM3LTEtMS0xLTIwOTI1_7f464a1f-c09c-42ce-9c1c-1d40011c7d21">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM3LTMtMS0xLTIwOTI1_60c48f0c-d8d2-48ad-a56b-fc31c72c056b">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM3LTYtMS0xLTIwOTI1_e61361d9-9db1-4ca0-9305-4cdbea1982ab">109</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM3LTgtMS0xLTIwOTI1_1fd6fb2c-09a1-432e-9a3d-daecbfcba2d5">129</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM4LTMtMS0xLTIwOTI1_95b60c6d-f541-4fd4-b22a-1ecbdf0cd8f0">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM4LTYtMS0xLTIwOTI1_ee975a5b-a367-4fa2-bb61-3c69dda008d4">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM4LTgtMS0xLTIwOTI1_9782504f-dbb6-4f58-b267-644610f3803c">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6174bff25adb42cdbd66e7fb9ff9c37d_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM5LTEtMS0xLTIwOTI1_db2c971e-8ea9-4cb4-ab12-801bf63a6209">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM5LTYtMS0xLTIwOTI1_edabec67-d735-464f-a51e-58e31147d943">2,222</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM5LTgtMS0xLTIwOTI1_78a7104f-6eca-4465-aa2b-ba34892e2f53">2,222</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQxLTMtMS0xLTIwOTI1_8bb7063c-f9ab-4053-9fdb-4430afa8323a">649</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7215d41c21ea4fbdb2f7240f3cc276ee_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQxLTQtMS0xLTIwOTI1_a787bf79-e1d5-45df-a544-259ad89482c8">3,342</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQxLTYtMS0xLTIwOTI1_7c88cdbf-9ae0-413f-bbba-06f6ef2efae7">3,991</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQxLTgtMS0xLTIwOTI1_df2b49a2-203a-4e37-8808-0037349b153d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i38edfda579db45e2b38455c17b62991c_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTEtMS0xLTIwOTI1_1a93108f-e7ac-41bd-9152-6a44fe6386f4">119</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38edfda579db45e2b38455c17b62991c_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTItMS0xLTIwOTI1_304ee863-acb3-40a1-8f85-4f349bafb737">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6273937e3079404bac24531420de0b6c_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTMtMS0xLTIwOTI1_9e5d551a-7748-469b-a230-a008b0cda424">2,260</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id617ebe9e53c430eab235ef5b09c5eb1_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTQtMS0xLTIwOTI1_20707dc9-bd7e-4b38-9fc6-87d34f99be31">7,649</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie250c2a689ff4ef885295f77abd96941_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTUtMS0xLTIwOTI1_d0396055-c47d-4518-a17b-41c31c26b36c">14</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7d076d028664d249c58ef5ec036b46f_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTYtMS0xLTIwOTI1_b95b296a-c1a3-4431-9128-bb429a69b405">3,453</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a7255d9f5c4ffa878e62ba379a4038_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTctMS0xLTIwOTI1_c72b34e3-a107-4079-90af-ab680d94dabb">39</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTgtMS0xLTIwOTI1_ff4e5041-ea42-4c7a-bd1c-d26423cb5a56">6,483</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTExLTEtMS0yMDkyNQ_83cfed9c-e0e7-495f-b98b-848285267647">79</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_172"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_175"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzUvZnJhZzoxOTM5YzY2ZDY0MWI0MGQ5YjI5YjEwN2E2YmQ5MDIzYy90ZXh0cmVnaW9uOjE5MzljNjZkNjQxYjQwZDliMjliMTA3YTZiZDkwMjNjXzE2OTc_7e3fd8ee-c76e-4f3d-b4d1-e3450acc8889" continuedAt="i36712ca5f6b944238c09f1e414bac53c" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="i36712ca5f6b944238c09f1e414bac53c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</span></div></ix:continuation><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_178"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzUz_b7c48048-3ae0-442e-a30b-e89728c1de8a" continuedAt="ia595902ae2e34ddcb81160be0785742a" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="ia595902ae2e34ddcb81160be0785742a" continuedAt="ia6ec57a06bf64e69bb54575ed6122081"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjgw_a5567d13-0c1a-4ab4-bdc3-d2c022f75d5f" continuedAt="id754e51d21494f2fb0f8125d21efc11d" escape="true">The consolidated financial statements include the accounts of all entities controlled by the Company through its direct or indirect ownership of a majority voting interest.  Additionally, the consolidated financial statements include the accounts of variable interest entities (&#8220;VIEs&#8221;) in which the Company has a variable interest and for which the Company is the &#8220;primary beneficiary&#8221; as it has both: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.  All significant intercompany accounts and transactions are eliminated in consolidation.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id754e51d21494f2fb0f8125d21efc11d">&#160;&#160;&#160;&#160;Income attributable to the minority interest in the Company's majority owned and controlled consolidated subsidiaries is recorded as net income attributable to noncontrolling interests in the consolidated statements of operations and the noncontrolling interest is reflected as a separate component of consolidated stockholders' equity in the consolidated balance sheet.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzI5_76406a6a-2f79-4406-bad3-00b73aa64a37" escape="true">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  The accompanying consolidated statements of operations and related disclosures report the results of NID as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  See Note 20 for a further discussion of discontinued operations.</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjY4_8e67826d-fc1c-4504-b060-668d5f76e083" escape="true">Investments in entities which the Company does not control, but in which it has a substantial ownership interest (generally between <ix:nonFraction unitRef="number" contextRef="i0ef869edccf349a68f85c65c81e97770_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIwNjQ_f7a53746-645d-4360-9fc3-cd99ab4e751e">20</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ice911685201a460b8af3f58815059f82_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIwNzE_c24a5049-7ba5-4870-b93f-64e48313ef46">49</ix:nonFraction>%) and can exercise significant influence, are accounted for using the equity method of accounting.  These investments are classified as investments in equity method investees in the consolidated balance sheet.  The Company records its pro rata share of the earnings, adjusted for accretion of basis difference, of these investments in equity in earnings of equity method investees, net of taxes in the consolidated statements of operations.  The Company reviews its investments in equity method investees for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</ix:nonNumeric>  </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="ia6ec57a06bf64e69bb54575ed6122081" continuedAt="ia9f66e3881284472ad6e4fa4accc0c38"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzU3_bd0d12d8-3e21-41a8-981c-5398737fec7f" escape="true">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</ix:nonNumeric>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzU4_61a18e5e-7e6f-4eed-bd2f-d09a68f7e46f" escape="true">The Company recognizes as revenue the amount that reflects the consideration to which it expects to be entitled in exchange for goods sold or services rendered primarily upon completion of the testing process (when results are reported) or when services have been rendered (see Note 3).  Net revenues from Medicare and Medicaid programs were approximately <ix:nonFraction unitRef="number" contextRef="i641831615df34b538199d475b2c51f92_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzM1NjU_82d1f534-6eff-48c2-a9ac-b8a39bc0668e">10</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i89f3081e1b5445c6bfec2edf60f2f909_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzM1Njk_2bbb8339-a0c2-4570-a121-2052771e65a8">11</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ia5e542d0dfea43e2af9118d20432c274_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzM1NzY_e47b4e18-4d88-47d8-a388-ef4487258d4e">15</ix:nonFraction>% of the Company's consolidated net revenues for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes on Income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzgx_c8c64078-f6ad-4e41-bfdc-c03ce1172ae8" escape="true">The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year.  Current and deferred income taxes are measured based on the tax laws that are enacted as of the balance sheet date of the relevant reporting period.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.  Tax benefits from uncertain tax positions are recognized only if the tax position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position.</ix:nonNumeric> </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjY0_c5bf8709-5ea7-42b1-b051-0f1509e25e25" escape="true">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan (&#8220;ELTIP&#8221;) and its Amended and Restated Non-Employee Director Long-Term Incentive Plan (&#8220;DLTIP&#8221;), as well as the dilutive effect of accelerated share repurchase agreements ("ASRs"), if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="ia9f66e3881284472ad6e4fa4accc0c38" continuedAt="iba3f978f462d4d999e6e7468d504528f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjg1_af177c62-ef3a-48ba-abc0-b7832bd60e00" continuedAt="i04b8f36694844d3d9f5657d9744ee5c6" escape="true">The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards.  As such, the Company recognizes stock-based compensation cost</ix:nonNumeric></span><ix:continuation id="i04b8f36694844d3d9f5657d9744ee5c6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants.  The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.  The terms of the Company's performance share units allow the recipients of such awards to earn a variable number of shares based on the achievement of the performance goals, which are based on the financial performance of the Company and the total shareholder return of the Company relative to an index of peer companies ("relative TSR"), specified in the awards.  For performance share units with a goal based on the financial performance of the Company, stock-based compensation expense is recognized based on management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned.  The cumulative effect on current and prior periods of a change in the estimated number of performance share units expected to be earned for these awards is recognized as compensation cost in earnings in the period of the change.  For performance share units with a market-based relative TSR goal, stock-based compensation expense is recognized based on the estimated fair value of the award regardless of the actual number of shares earned.  For further details regarding stock-based compensation, see Note&#160;17.</span></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjU5_43fed4d0-f8f9-46b8-b8b9-e1fb4634baff" continuedAt="i8895cf5fb3304f0fbb1f068392d438a4" escape="true">The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i8895cf5fb3304f0fbb1f068392d438a4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy.  The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzQ3_43cf6c55-72ca-42b3-a603-62852c4ba143" escape="true">The Company predominately uses the U.S. dollar as its functional currency.  The functional currency of the Company's foreign operating subsidiaries generally is the applicable local currency.  Assets and liabilities denominated in non-U.S. dollars are translated into U.S. dollars at exchange rates as of the end of the reporting period.  Income and expense items are translated at the average monthly exchange rates during the year.  Resulting translation adjustments are recorded as a component of accumulated other comprehensive loss within stockholders' equity.  Gains and losses from foreign currency transactions, which are denominated in a currency other than the functional currency, are included within other operating (income) expense, net in the consolidated statements of operations.  Foreign currency transaction gains and losses have historically not been material.  The Company may be exposed to market risk for changes in foreign exchange rates primarily under certain intercompany receivables and payables.  From time to time, the Company uses foreign exchange forward contracts to mitigate the exposure of the eventual net cash inflows or outflows resulting from these intercompany transactions.  The Company's foreign exchange exposure is not material to the Company's consolidated financial condition.  The Company does not hedge its net investment in non-U.S. subsidiaries because it views those investments as long-term in nature.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjk2_e5adaabe-60d8-4a51-98e3-1b68c8b0c5fc" escape="true">Cash and cash equivalents include all highly-liquid investments with original maturities, at the time acquired by the Company, of three months or less.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="iba3f978f462d4d999e6e7468d504528f" continuedAt="ifad4647a30fb45f8bd0aa19f51d6c93d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzI1_2df7f6e9-95ac-40a8-a60b-c832c059ea16" escape="true">Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash, cash equivalents, short-term investments, accounts receivable and derivative financial instruments.  The Company's policy is to place its cash, cash equivalents and short-term investments in highly-rated financial instruments and institutions.  Concentration of credit risk with respect to accounts receivable is mitigated by the diversity of the Company's payers and their dispersion across many different geographic regions, and credit risk is concentrated among certain payers who are large buyers of the Company's services.  To reduce risk, the Company routinely assesses the financial strength of these payers and, consequently, believes that its accounts receivable credit risk exposure, with respect to these payers, is limited.  While the Company has receivables due from federal and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent on submitting appropriate documentation timely.  As of both December&#160;31, 2021 and 2020, receivables due from government payers under the Medicare and Medicaid programs represented approximately <ix:nonFraction unitRef="number" contextRef="i37a9f450d5fc42bd8a4cedc5a182bb1d_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzExOTQz_646ce812-164c-4ac2-9eb4-a4a80ea0b577"><ix:nonFraction unitRef="number" contextRef="i93a20c5e9811442496e0ddbc0d32b35f_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzExOTQz_9d9b707a-c902-43fe-8302-4a01065fbde0">6</ix:nonFraction></ix:nonFraction>% of the Company's consolidated net accounts receivable.  The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.  As of December&#160;31, 2021 and 2020, receivables due from patients represented approximately <ix:nonFraction unitRef="number" contextRef="icb3cd0ebcab8404c8e2d53703218de07_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NzIyMTM_69834b97-aabb-416b-a00f-133c527d00c4">21</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ie5d364f684594c5783514a961ba1cb23_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NzIyMTc_f62bb49c-80f7-4eb7-bcc4-789af4bb0969">11</ix:nonFraction>%, respectively, of the Company's consolidated net accounts receivable.  The Company applies assumptions and judgments including historical collection experience (including the period of time that the receivables have been outstanding) for assessing collectability and determining net revenues and accounts receivable from patients.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dgx:AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzQz_2bda7281-4438-46a2-8073-a7f625d3df45" continuedAt="ic692225cdae14448afd3ac11abb0c280" escape="true">Accounts receivable are reported net of allowances for credit losses.  </ix:nonNumeric></span></div><ix:continuation id="ic692225cdae14448afd3ac11abb0c280"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;When estimating its allowance for credit losses, the Company pools its trade receivables based on the following customer types: healthcare insurers, government payers, client payers and patients, which are described in Note 3.&#160; The Company principally estimates the allowance for credit losses by pool based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period of time that the receivables have been outstanding.&#160; To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the customers from their respective pools and establishes allowances based on the individual risk characteristics of such customers.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjYy_c87350cf-7aa2-48d8-845a-464bd10a6caa" escape="true">Inventories, which consist principally of finished goods testing supplies and reagents, are valued at the lower of cost (first in, first out method) or net realizable value.</ix:nonNumeric>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjc4_f157c25f-9df7-42b3-8c21-9fec372414e0" continuedAt="ibed4d1ca5db645e19ff3fb9bd639a445" escape="true">Property, plant and equipment is recorded at cost.  Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.  Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and expensed as incurred for preliminary project activities and post-implementation activities.  Capitalized costs include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with the internal-use software project, and interest costs incurred, when material, while developing internal-use software.  Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose.  Costs for maintenance and training are expensed as incurred.  The Company capitalizes interest on borrowings during the active construction period of major capital projects.  Capitalized interest is added to the cost of the underlying assets and is amortized over the expected useful lives of the assets.  Depreciation and amortization are provided on the straight-line method over expected useful asset lives as of December&#160;31, 2021 as follows: </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibed4d1ca5db645e19ff3fb9bd639a445"><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">buildings and improvements, ranging up to thirty-one and a half years; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory equipment and furniture and fixtures, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1MDYw_1d199ab7-3192-43a9-a2e6-2c9e9839ee94">five</span> to <ix:nonNumeric contextRef="ifb8e5cfafc1a42d58d6cad9058f4760e_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1MDY2_db87dfb5-c1e0-402a-b13a-556f2db29fb5">twelve years</ix:nonNumeric>; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">leasehold improvements, the lesser of the useful life of the improvement or the remaining life of the building or lease, as applicable; and </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">computer software developed or obtained for internal use, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1Mjcw_88e6f6e4-a789-4494-8767-bda409fe0bc3">five</span> to <ix:nonNumeric contextRef="i0b00f7e1bf43453099ed71ff43d6717f_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1Mjc2_a3e84db4-49f0-4fc2-8ddd-bb740870bae2">ten years</ix:nonNumeric>.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="ifad4647a30fb45f8bd0aa19f51d6c93d" continuedAt="i15dab445bd784f30909d6b11da37b23c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzQw_2f733cbc-0bec-441b-ac17-7f77e0632d76" continuedAt="i824b6a1b68c7443c86b2d0c2540c14ea" escape="true">Goodwill represents the excess of the fair value of the acquiree (including the fair value of non-controlling interests) over the recognized bases of the net identifiable assets acquired and includes the future economic benefits from other assets that could not be individually identified and separately recognized.  Goodwill is not amortized, but instead is periodically reviewed for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of goodwill exceeds its fair value.  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i824b6a1b68c7443c86b2d0c2540c14ea"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On a quarterly basis, the Company performs a review of its business to determine if events or changes in circumstances have occurred which could have a material adverse effect on the fair value of the Company and its goodwill.  If such events or changes in circumstances were deemed to have occurred, the Company would perform an impairment test of goodwill as of the end of the quarter and record any noted impairment loss.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The goodwill test is performed at least annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired.  The annual impairment test includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative test may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company is required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, the Company's policy is to update the fair value calculation of its reporting units and perform the quantitative goodwill impairment test on a periodic basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  The Company calculates the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  The Company assesses the valuation methodology based upon the relevance and availability of the data at the time that the valuation is performed.  The Company compares the estimate of fair value for the reporting unit to the carrying value of the reporting unit.  If the carrying value is greater than the estimate of fair value, an impairment loss will be recognized in the amount of the excess. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company performs its annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2021, the Company performed a qualitative impairment test and, based on the totality of information available for the reporting units, the Company concluded that it was more-likely-than-not that the estimated fair values of the reporting units were greater than the carrying values of the reporting units and, as such, no further analysis was required.  For the year ended December&#160;31, 2020, in accordance with its policy to perform the quantitative test on a periodic basis, the Company updated the fair value calculation of its reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzIx_4ecffd48-51bf-4b2a-a776-ac11d341ca41" continuedAt="i9339d2a3a9c149eba7cb4d8b8d3a51d7" escape="true">Intangible assets are recognized at fair value, as an asset apart from goodwill if the asset (i) arises from contractual or other legal rights, or (ii) is separable.  Intangible assets, principally representing the cost of customer-related intangibles, non-competition agreements and technology acquired, are capitalized and amortized on the straight-line method over their expected useful lives, which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE5MTMy_22152b9e-6ae5-4ec5-ae0f-101ca8483d0a">five</span> to <ix:nonNumeric contextRef="i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE5MTM4_da541fe1-7e9f-4433-bdf1-fe6561c59787">twenty years</ix:nonNumeric>.  Intangible assets with indefinite useful lives, consisting principally of acquired tradenames, are not amortized, but instead are periodically reviewed for impairment.  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9339d2a3a9c149eba7cb4d8b8d3a51d7" continuedAt="i19d0606e75b645239e5a02f1a9840897"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company reviews indefinite-lived intangible assets periodically for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of an indefinite-lived intangible asset is more than its estimated fair value.  The indefinite-lived intangible asset impairment test is performed at least annually, or more frequently in the case of other events that indicate a potential impairment.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Based upon the Company&#8217;s most recent annual impairment tests completed during the fourth quarters of the years ended December&#160;31, 2021 and 2020, the Company concluded that indefinite-lived intangible assets were not impaired.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="padding-right:4.5pt"><span><br/></span></div><ix:continuation id="i15dab445bd784f30909d6b11da37b23c" continuedAt="ic0bbe64800864beeb09bf595027a98ae"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i19d0606e75b645239e5a02f1a9840897">&#160;&#160;&#160;&#160;The Company reviews the recoverability of its long-lived assets (including amortizable intangible assets), other than goodwill and indefinite-lived intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.  Evaluation of possible impairment is based on the Company's ability to recover the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations.  If these cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.</ix:continuation></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzM1_8e51b19c-2327-4d70-94e1-a74f02086ba9" continuedAt="i5c2aa1f905ca4298a004fafd6908a640" escape="true">The Company's investments (except for those accounted for under the equity method of accounting) include:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5c2aa1f905ca4298a004fafd6908a640"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments with readily determinable fair values, including investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries (such investments, which previously did not have readily determinable fair values, became publicly-traded during the year ended December 31, 2021); as well as participant-directed investments of deferred employee compensation and related Company matching contributions held in trusts pursuant to the Company's supplemental deferred compensation plans (see Note 17).  These investments are measured at fair value with both realized and unrealized gains and losses recorded in current earnings within other income, net in the consolidated statements of operations.  For the years ended December&#160;31, 2021, 2020 and 2019, gains from all equity investments with readily determinable fair values totaled $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjA2NDI_5eb2bd92-ebfe-422a-a568-687f6b3a8ec3">56</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIxMzg4_334d11ed-f10e-4970-94c0-403b5b54db33">8</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIxMzk2_a79db7f3-8b3b-4c11-b6dc-555629c3fb6d">10</ix:nonFraction> million, respectively.  The carrying values of these investments was $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjA3MDU_16dbedea-ec01-43a1-b373-3b94945ba8cf">121</ix:nonFraction> million at December 31, 2021, of which $<ix:nonFraction unitRef="usd" contextRef="i972899ce7ba6442aaf147d47867cd482_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0Mzk2NjY_8a1dfacd-0f50-4d18-9485-e2c0cec73554">44</ix:nonFraction> million was included in prepaid expenses and other current assets and $<ix:nonFraction unitRef="usd" contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0Mzk2NzE_89b800bc-9267-4c2b-bfd6-a40fd29241c2"><ix:nonFraction unitRef="usd" contextRef="iba604be725684156a3eb0ffeedf8b741_I20211231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0Mzk2NzE_95262d48-dbba-41c8-a1a3-54958278022c">77</ix:nonFraction></ix:nonFraction> million was included in other assets in the consolidated balance sheet.  The carrying values of these investments was $<ix:nonFraction unitRef="usd" contextRef="i6abd46db2a6b4225801b044e7620dd70_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIxNDY3_213d6389-5c82-4b3c-94b7-fa5dfc45fc04">67</ix:nonFraction> million at December 31, 2020, which was included in other assets in the consolidated balance sheet.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments that do not have readily determinable fair values, which consist of investments in preferred and common shares of privately held companies.  These investments are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  The Company regularly evaluates these equity investments to determine if there are any indicators that the investment is impaired; <ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="INF" name="dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjI4NzQ_42c3bc9f-49b7-4c78-9f4d-1fbf2c392c95"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="INF" name="dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjI4NzQ_6f096a30-4208-4c3a-bbda-925431946772"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="INF" name="dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjI4NzQ_fc1e9aa1-2b6f-40d2-b5fd-4598e78598dc">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment charges were recognized related to these investments for the years ended December&#160;31, 2021, 2020 and 2019.  The carrying value of these investments was $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjE0Mzg_162581fd-dc34-4b4d-a8ab-5791abb40c4c">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIyMDY2_c64e42bf-67b1-4a9e-8fad-485f15247471">25</ix:nonFraction> million at December&#160;31, 2021 and 2020, respectively.  Such amounts were included in other assets in the consolidated balance sheet.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale debt securities of privately-held companies.  These investments are measured at fair value with unrealized gains and losses presented in other comprehensive income (loss).  The carrying amount of these investments was $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjA3MTY_1d16ff35-0335-4a76-bc0f-c17aaa618f06">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIyMzI1_6f75c0f3-8d7b-4acd-be2f-fcf109e9091d">12</ix:nonFraction> million at December&#160;31, 2021 and 2020, respectively.  Such amounts were included in other assets in the consolidated balance sheet.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjcz_a48e3d59-cbb8-472a-b601-f93d30f82fc4" continuedAt="ie46731cb74674155adfaefc1f259064e" escape="true">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit risk-related contingent features or requirements to post collateral.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="ic0bbe64800864beeb09bf595027a98ae" continuedAt="i28b9edf97f674df7bf386d46ea1d375a"><ix:continuation id="ie46731cb74674155adfaefc1f259064e" continuedAt="ia15404da851246efb35993a581e92dbb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate debt instruments and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia15404da851246efb35993a581e92dbb">&#160;&#160;&#160;&#160;The Company accounts for these derivatives as either an asset or liability measured at its fair value.  The fair value is based upon model-derived valuations in which all significant inputs are observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.  For a derivative instrument that has been formally designated as a fair value hedge, fair value gains or losses on the derivative instrument along with offsetting fair value gains or losses on the hedged item that are attributable to the risk being hedged are reported in other income, net in the consolidated statements of operations.  For derivatives that have been formally designated as a cash flow hedge, the change in the fair value of the derivatives is recorded in accumulated other comprehensive loss.  Upon maturity or early termination of an effective interest rate swap agreement designated as a cash flow hedge, unrealized gains or losses are deferred in stockholders' equity, as a component of accumulated other comprehensive loss, and are amortized as an adjustment to interest expense over the period during which the hedged forecasted transaction affects earnings, which is when the Company recognizes interest expense on the hedged cash flows.  At inception and quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item.  After the initial quantitative assessment, this analysis is initially performed on a qualitative basis and, if it is determined that the hedging relationship was and continues to be highly effective, no further analysis is required.  All components of each derivative financial instrument's gain or loss are included in the assessment of hedge effectiveness.  If it is determined that a derivative ceases to be a highly effective hedge, the Company discontinues hedge accounting and any deferred gains or losses related to a discontinued cash flow hedge shall continue to be reported in accumulated other comprehensive loss, unless it is probable that the forecasted transaction will not occur.  If it is probable that the forecasted transaction will not occur by the originally specified time period, the Company discontinues hedge accounting and any deferred gains or losses reported in accumulated other comprehensive loss are classified into earnings immediately.</ix:continuation>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:StockholdersEquityPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzcz_abd2b61d-4569-4da1-a43d-f499e74858e3" continuedAt="ic558aaeabbcc452c9e8f1a57421b2fcc" escape="true">Comprehensive income (loss) encompasses all changes in stockholders' equity (except those arising from transactions with stockholders) and includes:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic558aaeabbcc452c9e8f1a57421b2fcc"><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Notes 15 and 16); and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzI3NDg3NzkxMTU5MDU_8c663574-6be7-4d09-b40d-605ee26f0c06" escape="true">Advertising costs are expensed as incurred.  For the years ended December 31, 2021, 2020 and 2019, advertising costs were $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0NDA2OTI_0144c67b-33de-4977-99ae-021ab6ab2080">78</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0NDA3MDU_e9e5a3d0-21f3-4d89-8862-0317beb85c30">38</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0NDA3MTg_fcc67c12-13dd-46c8-aa88-24ff777e1b7d">18</ix:nonFraction>&#160;million, respectively.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzIy_3999ebc2-d02a-4427-9d20-565ed9404f2b" continuedAt="ia2b7499166464868b59576bae8bd1bac" escape="true">New Accounting Standards To Be Adopted</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="ia2b7499166464868b59576bae8bd1bac" continuedAt="ic307ee8c1028454481d46d252e62ddf8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of </span></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i28b9edf97f674df7bf386d46ea1d375a"><ix:continuation id="ic307ee8c1028454481d46d252e62ddf8">the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</ix:continuation></ix:continuation>&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="ib4001cf8768244cca3f772bfc08f865b_184"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzc5MDM_76444456-d301-4c8b-9cef-740f2a05a71b" continuedAt="i1dcb02a124fc4c6eab8b0174f6fb677e" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1dcb02a124fc4c6eab8b0174f6fb677e" continuedAt="id32aae773bef43be9e7a6b5d663495be"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for greater than <ix:nonFraction unitRef="number" contextRef="i3a090f7f88f3481086c45baf1ec6dabd_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzEwNg_1bba286c-e189-4c6c-8928-18cc793c40ef"><ix:nonFraction unitRef="number" contextRef="ice4e3139e0ba4820be8e5d8cf02f15fe_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzEwNg_b772228e-2d00-4882-bf30-053997a344d0"><ix:nonFraction unitRef="number" contextRef="idb62d67015ba418c9bcc8c4ca149ca60_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzEwNg_fa70d45a-a659-4270-9351-c52fcc12d971">95</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the Company&#8217;s consolidated net revenues for the years ended December&#160;31, 2021, 2020 and 2019 and are primarily comprised of a high volume of relatively low-dollar transactions.  The DIS business, which provides clinical testing services and other services, satisfies its performance obligation and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions, as discussed below. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.  Contracts with customers in the DIS business do not contain significant financing components based on the typical period of time between performance of services and collection of consideration.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The process for estimating revenues and the ultimate collection of accounts receivable involves significant judgment and estimation.  The Company follows a standard process, which considers historical denial and collection experience and other factors (including the period of time that the receivables have been outstanding), to estimate contractual allowances and implicit price concessions, recording adjustments in the current period as changes in estimates.  Further adjustments to the allowances, based on actual receipts, may be recorded upon settlement.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following are descriptions of the DIS business&#8217; portfolios:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Insurers </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from healthcare insurers are based on negotiated fee-for-service schedules and on capitated payment rates.  Under fee-for-service arrangements, healthcare insurers are billed at the Company's list price.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and the terms of the Company&#8217;s contractual arrangements. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Collection of the Company's net revenues from healthcare insurers is normally a function of providing complete and correct billing information to the healthcare insurers within the various filing deadlines and generally occurs within <ix:nonNumeric contextRef="ie799399ba4554af3b75c1e5d805f52c7_D20210101-20211231" name="dgx:RevenueCollectionofConsiderationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzI2MTE_e08454a6-829f-49a8-8f15-7f56e28e45d7">30</ix:nonNumeric> to <ix:nonNumeric contextRef="i88dd508f2a244b859dab8f3eb925f23a_D20210101-20211231" name="dgx:RevenueCollectionofConsiderationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzI2MTc_0959028c-64a2-4c98-9b62-b88506b4a1eb">60</ix:nonNumeric> days of billing.  Provided the Company has billed healthcare insurers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and if so, it will reserve accordingly for the billing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under capitated arrangements with healthcare insurers, the Company recognizes revenue based on a predetermined monthly reimbursement rate for each member of an insurer's health plan regardless of the number or cost of services provided by the Company.  Healthcare insurers typically reimburse the Company under capitated arrangements in the same month services are performed, essentially giving rise to no outstanding accounts receivable at the end of a reporting period.  If any capitated payments are not received on a timely basis, the Company determines the cause and makes a separate determination as to whether or not the collection of the amount from the healthcare insurer is at risk and, if so, would reserve accordingly.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Payers</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="id32aae773bef43be9e7a6b5d663495be" continuedAt="i8f4ca2b10c304a4aadd11072390fae40"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from government payers are based on fee-for-service schedules set by governmental authorities, including traditional Medicare and Medicaid.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and other factors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Collection of the Company's net revenues from government payers is normally a function of providing the complete and correct billing information within the various filing deadlines and generally occurs within <ix:nonNumeric contextRef="i3dd2fa8993ba4765a061aa8753907429_D20210101-20211231" name="dgx:RevenueCollectionofConsiderationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzQ0MTE_481c93c1-051c-409d-80bd-b1bd99a9115b">30</ix:nonNumeric> days of billing.  Provided the Company has billed government payers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and, if so, it will reserve for the billing accordingly.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Client Payers </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Client payers include physicians, hospitals, ACOs, DCEs, IDNs, employers, other commercial laboratories and institutions for which services are performed on a wholesale basis, and are billed based on negotiated fee schedules.  Credit risk and ability to pay are more of a consideration for these payers than healthcare insurers and government payers.  Collection of consideration the Company expects to receive generally occurs within <ix:nonNumeric contextRef="i886f4c78cd9c49dda5f59730477bd7a8_D20210101-20211231" name="dgx:RevenueCollectionofConsiderationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzUyNTY_da1f876d-2181-4f4a-bba3-581da53bc0f5">60</ix:nonNumeric> to <ix:nonNumeric contextRef="ic7db216ea09e4faf817a70826756f79f_D20210101-20211231" name="dgx:RevenueCollectionofConsiderationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzUyNjI_d901fb1a-10d9-4d11-a28c-a874620486c3">90</ix:nonNumeric> days of billing.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company principally estimates the allowance for credit losses for client payers based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period of time that the receivables have been outstanding. To the extent that any individual client payers are identified that have deteriorated in credit quality, the Company establishes allowances based on the individual risk characteristics of such customers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patients</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Uninsured patients are billed based on established patient fee schedules or fees negotiated with physicians on behalf of their patients.  Insured patients (includes coinsurance and deductible responsibilities) are billed based on fees negotiated with healthcare insurers.  Collection of billings from patients is subject to credit risk and ability of the patients to pay.  Net revenues consist of amounts billed net of discounts provided to uninsured patients in accordance with the Company&#8217;s policies and implicit price concessions.  Implicit price concessions represent differences between amounts billed and the estimated consideration the Company expects to receive from patients, which considers historical collection experience (including the period of time that the receivables have been outstanding) and other factors including current market conditions. Patient billings are generally fully reserved for when the related service reaches <ix:nonNumeric contextRef="i5b66d5c815234d649c202faa47b0836f_D20210101-20211231" name="dgx:PeriodofBillingFullyReserve" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzY3NDI_8f66d6b9-648f-46cb-85c3-97a218b4c2e9">210</ix:nonNumeric> days outstanding.  Balances are automatically written off when they are sent to collection agencies.  Allowances are further adjusted for estimated recoveries of amounts sent to collection agencies based on historical collection experience, which is regularly monitored.  Collection of consideration the Company expects to receive generally occurs within <ix:nonNumeric contextRef="iceca007bdcd64d67a3cfc72359b58092_D20210101-20211231" name="dgx:RevenueCollectionofConsiderationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzcxMDA_06077ad7-6489-4f4a-af79-2cd51b74d5ef">30</ix:nonNumeric> to <ix:nonNumeric contextRef="i24c4e46338874112b41b05ba07c69b13_D20210101-20211231" name="dgx:RevenueCollectionofConsiderationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzcxMDY_d3ee48f2-2d87-4581-b995-b5a1fbc757bb">60</ix:nonNumeric> days of billing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered.  Collection of consideration the Company expects to receive generally occurs within <ix:nonNumeric contextRef="i3e8e2db9ab7a4c3c8b0971c8eb34874d_D20210101-20211231" name="dgx:RevenueCollectionofConsiderationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzczNzU_31d68954-2b6b-46ff-9f16-8a3c8c27209a">30</ix:nonNumeric> to <ix:nonNumeric contextRef="i5bed9502f4964d15af65cfe68d0a3389_D20210101-20211231" name="dgx:RevenueCollectionofConsiderationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzczODE_a94ef9f6-6511-4e8f-a274-4a379e1f53f3">60</ix:nonNumeric> days of billing.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i8f4ca2b10c304a4aadd11072390fae40"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzc5MDA_f7cdb27b-f44d-4607-94aa-99b138e2e6c8" continuedAt="i66c56eb9295d431586dd5b6bfd280bb0" escape="true">The approximate percentage of net revenue by type of customer was as follows:</ix:nonNumeric></span></div><div style="text-align:center;text-indent:36pt"><ix:continuation id="i66c56eb9295d431586dd5b6bfd280bb0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:62.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.702%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7008d482a62245bb9875f7b05fec3156_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzMtMS0xLTEtMjA5MjU_953297e6-8dff-4007-99f9-1e5d50f50cb4">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bb294ef9720428da49024b4cc1c015e_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzMtMy0xLTEtMjA5MjU_bf98645a-022b-4210-8359-a819aefdcadd">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58580a51b19549c984bf823f6103da97_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzMtNS0xLTEtMjA5MjU_3207a7de-b714-4354-92e3-d8cbb4a5e8d2">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3c0596ed88949319f741c4098014adc_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzQtMS0xLTEtMjA5MjU_7701ef61-4998-4938-9fab-b6f96f71b5f1">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53e0c40604dc436dac0d5316b6aa3124_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzQtMy0xLTEtMjA5MjU_ded4e208-02db-4380-a6cd-04aecbc2710c">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17c7defe77e94feca925988ab94659bc_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzQtNS0xLTEtMjA5MjU_61b27f6f-d00f-4db4-87c8-db2c8d0ab493">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if59d0382710d43bd95feee9461a26bdc_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzUtMS0xLTEtMjA5MjU_a085d58e-3960-4302-a2cf-4154e6c95492">42</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c17eb1dddb643999d1956c1832f752a_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzUtMy0xLTEtMjA5MjU_cd737a86-0405-4ce4-b0bb-932ad0bd3168">37</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b5e5b177ae448c083554c9494be58aa_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzUtNS0xLTEtMjA5MjU_b1adc0e9-2a98-4026-b82f-a3e977b94531">36</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i641831615df34b538199d475b2c51f92_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzYtMS0xLTEtMjA5MjU_82d1f534-6eff-48c2-a9ac-b8a39bc0668e">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i89f3081e1b5445c6bfec2edf60f2f909_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzYtMy0xLTEtMjA5MjU_2bbb8339-a0c2-4570-a121-2052771e65a8">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5e542d0dfea43e2af9118d20432c274_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzYtNS0xLTEtMjA5MjU_e47b4e18-4d88-47d8-a388-ef4487258d4e">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a09d850f846426d9dfd70228809d98a_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzctMS0xLTEtMjA5MjU_a30191e3-1b0b-4019-998b-7cc38269d3a3">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i101444f4d55c4f7face8b6cbb4ad8c7c_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzctMy0xLTEtMjA5MjU_69e33470-03d2-4f6d-8b7a-02a350e7ba16">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67a12fbdd2794793bdbac9d69717453a_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzctNS0xLTEtMjA5MjU_aafff747-807d-474c-804d-b8490832c7e9">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b66d5c815234d649c202faa47b0836f_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzgtMS0xLTEtMjA5MjU_dfd7b8f8-90df-4e9b-98b5-40f0840ba010">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i842c67659a084bca972b57a09beab75c_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzgtMy0xLTEtMjA5MjU_937adcd0-edcc-48ba-b73c-b567c4dd4617">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia0bd2018f1ae4210af8adb65d7d4adec_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzgtNS0xLTEtMjA5MjU_e05a2c7a-012f-4caf-afd3-a013f3c3eff6">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6815212460d4587af042592f64aaf60_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzktMS0xLTEtMjA5MjU_cf94eddd-f8f7-4563-93b2-7823b656ff6a">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id22f162e49514311adf2fd36a699bba9_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzktMy0xLTEtMjA5MjU_9ca6eb9a-2e66-4c2e-b1cf-f3b8839305a9">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzktNS0xLTEtMjA5MjU_151dd063-4293-466a-bf61-4465c5cd1d1c">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d589ca3abf844d78f270902170a0189_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzEwLTEtMS0xLTIwOTI1_ad50f797-3270-4ed1-b33e-a0850a5ad751">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41ddf51214fb499e84fddd91bbb595d0_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzEwLTMtMS0xLTIwOTI1_1809cb6d-b699-4cc6-ba0e-5822809a5d40">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62d8cd061af34ddda090b2a1ed70a859_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzEwLTUtMS0xLTIwOTI1_5196c82d-7625-4d57-8154-af5a2b63d305">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzExLTEtMS0xLTIwOTI1_2900795e-1820-4964-aa35-6c524261e06c">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzExLTMtMS0xLTIwOTI1_db914fe8-99cd-4499-9b5a-c2354a6dff09">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzExLTUtMS0xLTIwOTI1_082bc0b6-f652-4f44-ab4b-a04cf155a65d">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, substantially all of the Company&#8217;s services were provided within the United States, see Note 19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dgx:AccountsReceivableDisaggregationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzc5MDI_2af55120-b91e-4a68-bf99-e1b515b83151" continuedAt="i982d8823a46f4a2db8a4aaa1146aeac1" escape="true">The approximate percentage of net accounts receivable by type of customer as of December&#160;31, 2021 and 2020 was as follows:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i982d8823a46f4a2db8a4aaa1146aeac1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:74.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a05287b4f02418c82cd5f2e6e79c6dc_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzItMS0xLTEtMjA5MjU_d47a07ee-c7f9-49da-a91f-b2c95997e6b5">32</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2add5ec575124eaa815d9e79f4d20f0e_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzItMy0xLTEtMjA5MjU_35667e76-c57b-4412-8253-cae0ed8865f4">34</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37a9f450d5fc42bd8a4cedc5a182bb1d_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzMtMS0xLTEtMjA5MjU_646ce812-164c-4ac2-9eb4-a4a80ea0b577"><ix:nonFraction unitRef="number" contextRef="i93a20c5e9811442496e0ddbc0d32b35f_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzMtMS0xLTEtMjA5MjU_9d9b707a-c902-43fe-8302-4a01065fbde0">6</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37a9f450d5fc42bd8a4cedc5a182bb1d_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzMtMy0xLTEtMjA5MjU_79109e28-05be-4e5f-bcd0-c9dd3cdee6e3">6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i30f9993ad61e49b8889d85cebdd9a0ca_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzQtMS0xLTEtMjA5MjU_e1f842cf-169c-4fe5-9fbc-3757edb821dd">38</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia36c52a54f80476e9f66b1b0b7134265_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzQtMy0xLTEtMjA5MjU_7dcea6e6-7142-4812-bc2e-187b2e12f0ee">46</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb3cd0ebcab8404c8e2d53703218de07_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzUtMS0xLTEtMjA5MjU_69834b97-aabb-416b-a00f-133c527d00c4">21</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5d364f684594c5783514a961ba1cb23_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzUtMy0xLTEtMjA5MjU_f62bb49c-80f7-4eb7-bcc4-789af4bb0969">11</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1d0d6530dd894b1c87f220eb4e22a87b_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzYtMS0xLTEtMjA5MjU_2d813632-dae2-4c19-986f-53e15273c5f7">97</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if86384a0f5614da3a89e030848de8448_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzYtMy0xLTEtMjA5MjU_018c3039-88e1-4447-a81f-212e33f01f19">97</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i47fc543fa62f457495efbed248f47831_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzctMS0xLTEtMjA5MjU_2d67464c-b188-4076-a830-4d9773f62676">3</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i618e3edc7d0e472db6505e306cf617c9_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzctMy0xLTEtMjA5MjU_586ac0ee-e208-4b1f-a5bb-706cd898558a">3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzgtMS0xLTEtMjA5MjU_5b04d555-98e2-4621-bb6d-621d107b013f">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzgtMy0xLTEtMjA5MjU_6519a9ff-d698-4230-9d87-33e8582c692c">100</ix:nonFraction>%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzc4OTc_6ef67cae-8683-4995-892c-08e2f8431199" continuedAt="id64115dc1e1d4e53b432581c46373069" escape="true">The following table summarizes the activity for the Company's allowance for credit losses during the years ended December&#160;31, 2021 and 2020, which principally relates to client payers:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="id64115dc1e1d4e53b432581c46373069"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for Credit Losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, January 1, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzItMS0xLTEtMjk3NTk_5ff0081f-6eac-4eba-80e9-6c7613764187">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzMtMS0xLTEtMjk3NTk_4d281567-d29b-4361-aca1-9f7be584ba1f">19</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of accounts receivable, net of recoveries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzQtMS0xLTEtMjk3NTk_46ac5010-574b-42c5-bffc-3e851d04e1dc">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzItMS0xLTEtMjA5MjU_edb0e477-84da-4658-b31f-00da7769c3e1">28</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzMtMS0xLTEtMjA5MjU_06a1f676-f4b8-459f-b8d4-1a10385fe2a1">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of accounts receivable, net of recoveries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzQtMS0xLTEtMjA5MjU_78703cc5-25bb-4322-a73d-73d585113670">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2021</span></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzUtMS0xLTEtMjA5MjU_86ab5ea1-2eb1-4a17-8025-711a1bfef0b2">31</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_187"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90ZXh0cmVnaW9uOmUyZTZhYWNiNzg0OTRkMThhYjllYzY4M2IyNWZjNGE1XzI5OA_cca66c28-7d64-4e74-86f1-6dace904cc96" continuedAt="i884d7cd036e045849c1f0469b12cd2fa" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i884d7cd036e045849c1f0469b12cd2fa"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90ZXh0cmVnaW9uOmUyZTZhYWNiNzg0OTRkMThhYjllYzY4M2IyNWZjNGE1XzI5Mw_120151ad-17d3-4679-9a3b-7c7ce2ff9d2e" continuedAt="i7b9c4c4778644d2c81052f4cfcdfb1ac" escape="true">The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i7b9c4c4778644d2c81052f4cfcdfb1ac"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzItMS0xLTEtMjA5MjU_4c79b348-7d6b-4267-b3c7-c4fb41306426">1,995</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzItMy0xLTEtMjA5MjU_44066cc6-da0c-4b95-853f-9fb1939d81f8">1,431</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzItNS0xLTEtMjA5MjU_8e61a124-ba2f-41db-ac0c-f530a6a98223">838</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzMtMS0xLTEtMjA5MjU_65d16c9d-aaa4-466a-a87a-8998cdc275dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzMtMy0xLTEtMjA5MjU_b773ada2-3fc6-4a12-aac7-3b3e140fe85f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzMtNS0xLTEtMjA5MjU_1ea047f3-2882-476b-93c0-4853d40ffd0d">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics' common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzQtMS0xLTEtMjA5MjU_da70d4f9-abf5-4267-88d5-be952522fcdb">1,995</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzQtMy0xLTEtMjA5MjU_2f667f06-19a1-4adb-8b72-8a800cf54fbc">1,431</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzQtNS0xLTEtMjA5MjU_38de0e6f-3ef7-4984-870d-b2775fe3c239">858</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzYtMS0xLTEtMjA5MjU_5b53be52-f27c-444a-90d6-9917f0c2e16e">1,995</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzYtMy0xLTEtMjA5MjU_e6126962-490a-433d-90c3-3362ec879754">1,431</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzYtNS0xLTEtMjA5MjU_5fdbf774-5c6d-4a99-ad99-bc6477f3441e">838</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzctMS0xLTEtMjA5MjU_a02551ea-6366-4022-b333-b17afea0ac9e">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzctMy0xLTEtMjA5MjU_8474e519-04bf-44ff-91d5-8362c4de595e">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzctNS0xLTEtMjA5MjU_c19bd3d9-31c3-454b-8291-5aa31c28d3f3">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzgtMS0xLTEtMjA5MjU_6d4ef409-3092-44d5-8afe-ce46717bc377">1,988</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzgtMy0xLTEtMjA5MjU_fdf640ce-4fda-466b-bafe-0fdbb85b5f46">1,425</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzgtNS0xLTEtMjA5MjU_b552cdba-ea2b-4454-84cc-b14ccf1a64aa">835</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEwLTEtMS0xLTIwOTI1_076abeb7-b8ea-4ac7-80e8-527901c23d08">125</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEwLTMtMS0xLTIwOTI1_6c9ac131-3f5c-40db-9bf6-ebc80e88e5b5">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEwLTUtMS0xLTIwOTI1_ffa53ebd-9f50-4666-9ff1-e126236841fe">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEyLTEtMS0xLTIwOTI1_901f4d28-545e-4601-8ae8-5772c9acc019">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEyLTMtMS0xLTIwOTI1_fb74402c-67a7-4461-870e-2aff07b8ba10">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEyLTUtMS0xLTIwOTI1_3efda3d6-6344-4920-8ab5-3fa094d68845">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEzLTEtMS0xLTIwOTI1_9b058f1d-48cb-470d-bf30-926a92351163">128</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEzLTMtMS0xLTIwOTI1_6dc48790-f27e-470a-b688-d21bd4a5a685">136</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEzLTUtMS0xLTIwOTI1_a7ac9a8b-7a86-4565-b4cd-fcb0710b45fa">136</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE2LTEtMS0xLTIwOTI1_953ed003-e6d3-40ed-955e-043a10bd2a69">15.85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE2LTMtMS0xLTIwOTI1_1e03e1c2-ed95-45b0-ad44-d0451a37ce0e">10.62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE2LTUtMS0xLTIwOTI1_64651a85-ad9e-46d5-be60-2ab6b80be41c">6.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE3LTEtMS0xLTIwOTI1_cbbd7fa1-afa7-456b-b4ec-adbf4aa5cc1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE3LTMtMS0xLTIwOTI1_82de0d56-0a83-417a-b5ee-5fee0ba19a84">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE3LTUtMS0xLTIwOTI1_bfea90f3-55bd-43b8-acfd-88d209fa2251">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE4LTEtMS0xLTIwOTI1_a64d5008-dda3-4b76-860c-ffda7eb08ac8">15.85</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE4LTMtMS0xLTIwOTI1_c9aba9b3-0623-4bb9-9e23-2e6972871f1d">10.62</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE4LTUtMS0xLTIwOTI1_9d1cb49b-ffa7-4877-941e-ddfd09d324de">6.36</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIxLTEtMS0xLTIwOTI1_80e055a0-cd53-4a2b-8cb9-22f57aa7aaf6">15.55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIxLTMtMS0xLTIwOTI1_b33059a8-60a7-402c-b92f-1e93a8d77795">10.47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIxLTUtMS0xLTIwOTI1_28d05ca0-a8d5-4fa6-a2a5-22c16e096b0e">6.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIyLTEtMS0xLTIwOTI1_c53a973f-e19f-4efa-bab6-f241309fc6de">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIyLTMtMS0xLTIwOTI1_a8bc936e-feaa-465e-b2f8-d94930a77cdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIyLTUtMS0xLTIwOTI1_89b1df81-335f-47f0-8b93-05ef35f2f95e">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIzLTEtMS0xLTIwOTI1_878ace95-b408-460f-9c89-b7fb20e305fc">15.55</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIzLTMtMS0xLTIwOTI1_95907647-caf3-45fa-b544-ba9796956b57">10.47</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIzLTUtMS0xLTIwOTI1_c120066b-7d4b-4ae7-b8e9-0da9340a9bb8">6.28</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into ASRs with several financial institutions to repurchase $<ix:nonFraction unitRef="usd" contextRef="i1dc63d78467b4990a09bb4edf33bc0d9_D20210401-20210430" decimals="-6" name="dgx:AcceleratedShareRepurchasesPayment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90ZXh0cmVnaW9uOmUyZTZhYWNiNzg0OTRkMThhYjllYzY4M2IyNWZjNGE1Xzc2OTY1ODEzOTUxODQ_6893c306-c02f-42f1-a141-faeaa6e1c1a2">1.5</ix:nonFraction>&#160;billion of the Company's common stock as part of the Company's share repurchase program. See Note 16 for further details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90ZXh0cmVnaW9uOmUyZTZhYWNiNzg0OTRkMThhYjllYzY4M2IyNWZjNGE1XzI4Nw_c567f37c-84bd-4f10-b1cf-703074816f4f" continuedAt="i8e9be79f7bd746abbbb0843eeb3030e6" escape="true">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i8e9be79f7bd746abbbb0843eeb3030e6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZTpiODFlMjRkZWQ0YWI0ZDBkODM2MzE0YWVmN2NiN2QyMS90YWJsZXJhbmdlOmI4MWUyNGRlZDRhYjRkMGQ4MzYzMTRhZWY3Y2I3ZDIxXzItMS0xLTEtMjA5MjU_48eeb61b-b45d-4649-aad8-38f5b97d4f28">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZTpiODFlMjRkZWQ0YWI0ZDBkODM2MzE0YWVmN2NiN2QyMS90YWJsZXJhbmdlOmI4MWUyNGRlZDRhYjRkMGQ4MzYzMTRhZWY3Y2I3ZDIxXzItMy0xLTEtMjA5MjU_45a4e44a-8608-4b51-ac88-91482b2ec72b">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZTpiODFlMjRkZWQ0YWI0ZDBkODM2MzE0YWVmN2NiN2QyMS90YWJsZXJhbmdlOmI4MWUyNGRlZDRhYjRkMGQ4MzYzMTRhZWY3Y2I3ZDIxXzItNS0xLTEtMjA5MjU_750d4b95-66ac-4243-8e19-4078ef890027">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="ib4001cf8768244cca3f772bfc08f865b_193"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwNjU1_57fe6800-5db8-42d7-9a03-5ed3a8ce6a26" continuedAt="i8000c90d9d834d8f9d0a2999b3c6d94f" escape="true">BUSINESS ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8000c90d9d834d8f9d0a2999b3c6d94f" continuedAt="i50aec17212d04cb68e99662d6fbe8b0d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2021 Acquisitions</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company completed acquisitions for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI3NDg3NzkwODc4MjA_42224ad9-daf0-4393-95c9-414f9147a6f5">336</ix:nonFraction>&#160;million, net of cash acquired, including the acquisitions discussed below.  The 2021 acquisitions resulted in goodwill of $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI3NDg3NzkwODc4MzI_5df41ea2-b500-42d3-8532-85d1ccdd99af">228</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI3NDg3NzkwODc4NDQ_6b833ed8-1954-434d-898a-43b48ec7b709">223</ix:nonFraction>&#160;million is deductible for tax purposes.  These acquisitions also resulted in $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI3NDg3NzkwODc4NTY_7162166d-eb8f-477e-a740-f017bdb9e7a5">104</ix:nonFraction>&#160;million of intangible assets, principally comprised of customer-related intangible assets.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the outreach laboratory services business of Mercy Health</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i50aec17212d04cb68e99662d6fbe8b0d" continuedAt="i8582094c97ad4892b19d4c928fffb01f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2021, the Company completed the acquisition of the outreach laboratory services business of Mercy Health ("Mercy Health"), which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $<ix:nonFraction unitRef="usd" contextRef="icbd86fbda26d4940870279bbf2723a39_D20210601-20210601" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwOTk1MTE2NDYwOTc_30a74be3-d624-4176-b8d0-66c39d90bf00">225</ix:nonFraction>&#160;million.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $<ix:nonFraction unitRef="usd" contextRef="i1aee2bd26ebb41528a08b0155d7985b1_I20210601" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwOTk1MTE2NDYxMTE_d584a68f-01ab-40ea-8c45-8317cc27a295">54</ix:nonFraction>&#160;million of customer-related intangible assets and $<ix:nonFraction unitRef="usd" contextRef="iaade8f13b4c24c27921a397d61fbbfce_I20210601" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwOTk1MTE2NDYxMjQ_0296b93e-02c3-4546-86d1-6fa7de986af8"><ix:nonFraction unitRef="usd" contextRef="iaade8f13b4c24c27921a397d61fbbfce_I20210601" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwOTk1MTE2NDYxMjQ_9021595a-9a51-4000-b043-07a5f324948a">171</ix:nonFraction></ix:nonFraction>&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of <ix:nonNumeric contextRef="i3ede7ec3a11842568aa070ef6416d46f_D20210601-20210601" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwOTk1MTE2NDYxMzc_e4889d75-b0bc-4375-93fc-8ab0c12ebb08">15</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of assets of Labtech Diagnostics, LLC ("Labtech")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2021, the Company completed the acquisition of assets of Labtech, an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South Carolina, North Carolina, Florida and Georgia, in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i15009b0e1117479090ce699335523d61_D20211213-20211213" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzM2MTU_fc4087bb-fbf7-41c2-857a-a98075b0c2eb">85</ix:nonFraction>&#160;million, which consisted of cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i15009b0e1117479090ce699335523d61_D20211213-20211213" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzM2MzE_47176286-e407-4ab8-8a88-40c5c9e6429f">80</ix:nonFraction>&#160;million and contingent consideration initially estimated at $<ix:nonFraction unitRef="usd" contextRef="i81a78a06e59d4de0972e28a1dee3dbe4_I20211213" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzM2NDc_1856c63a-0561-412e-aaf4-38b94046d4bb">5</ix:nonFraction>&#160;million. The contingent consideration arrangement is dependent upon the achievement of certain testing volume benchmarks.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $<ix:nonFraction unitRef="usd" contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ0MTc_092ceef0-989f-44de-a8a6-f06da65594c7">41</ix:nonFraction>&#160;million of intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ0MzA_c547b736-a44e-4ae6-b22e-070a003f6ea7">40</ix:nonFraction>&#160;million of goodwill (of which $<ix:nonFraction unitRef="usd" contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzcxNDY4MjU2MDg1MDQ_cf87e1f5-4ca1-4975-9c07-755aa12b2b03">35</ix:nonFraction>&#160;million is tax deductible), $<ix:nonFraction unitRef="usd" contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ4NDA_2bc786be-fb3e-4546-a4c2-640f8f93519f">11</ix:nonFraction>&#160;million of property, plant and equipment, $<ix:nonFraction unitRef="usd" contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ5Mjc_6f629ea3-e0a7-47a8-b994-6339da798471">9</ix:nonFraction>&#160;million of finance lease liabilities, $<ix:nonFraction unitRef="usd" contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ4NTU_8e4a1aaa-d16a-4bb2-b6a3-6c4b02fcd83f">6</ix:nonFraction>&#160;million of operating lease right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ4Njg_707d61ff-be34-4f44-94ca-d9674ff937b7">6</ix:nonFraction>&#160;million of operating lease liabilities, and $<ix:nonFraction unitRef="usd" contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ1MDM_12fe71ce-bcf5-40d7-b0f9-b38cbc5853d1">2</ix:nonFraction>&#160;million of inventories. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of <ix:nonNumeric contextRef="i31f1113940444a80a3c10cf968e6c6ce_D20211213-20211213" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI3NDg3NzkwOTY3OTE_f23557f2-0eba-4c7c-9c94-89acfab26fb9">15</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2020 Acquisitions</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company completed acquisitions for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEzNQ_3b65f4f0-ff0c-4b7b-a948-d0d93a3ce05b">330</ix:nonFraction>&#160;million, net of cash acquired, including the acquisitions discussed below.  The 2020 acquisitions resulted in goodwill of $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI1Mg_2bf79805-a571-433f-a383-1c7927bbcf5b">247</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI2NQ_a8b86446-2da9-45d6-8a11-8e9a51a58f70">210</ix:nonFraction>&#160;million is deductible for tax purposes.  These acquisitions also resulted in $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzMzNw_97bb25f0-7c95-46e1-9eb2-0369d7e7806b">146</ix:nonFraction>&#160;million of intangible assets, principally comprised of customer-related and technology intangible assets.  Net revenues attributable to the 2020 acquisitions were $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:BusinessAcquisitionPostacquisitionRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQ5NQ_6c6d9e24-773e-455b-acef-e3cbb8cd3ed9">127</ix:nonFraction>&#160;million for the year ended December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Blueprint Genetics Oy</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 21, 2020, the Company completed the acquisition of Blueprint Genetics Oy ("Blueprint Genetics"), in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="ie3246f22b780495da5706a912cfe9e8f_D20200121-20200121" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzcxNg_6b827098-1a5e-46ef-8550-ae85775539b9">108</ix:nonFraction>&#160;million, net of $<ix:nonFraction unitRef="usd" contextRef="ie3246f22b780495da5706a912cfe9e8f_D20200121-20200121" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzcyNw_78f218d1-1a52-41ec-9333-55273dbc3afd">3</ix:nonFraction>&#160;million cash acquired.  Blueprint Genetics is a leading specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing and proprietary bioinformatics.  Through the acquisition, the Company acquired all of Blueprint Genetics' operations.  Based on the purchase price allocation, the assets acquired and liabilities assumed primarily consist of $<ix:nonFraction unitRef="usd" contextRef="ib9011e0276964d49be24c92eb49f6aab_I20200121" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE0NTA_0d4912aa-c147-46ba-8144-6f756fa5a976"><ix:nonFraction unitRef="usd" contextRef="ib9011e0276964d49be24c92eb49f6aab_I20200121" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE0NTA_da0e6b4b-b0b9-43cc-b8ae-2c0ce31eb40e">66</ix:nonFraction></ix:nonFraction>&#160;million of tax-deductible goodwill, $<ix:nonFraction unitRef="usd" contextRef="ib9011e0276964d49be24c92eb49f6aab_I20200121" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE0ODE_62a18240-accf-4478-9faa-5d0b65564413">43</ix:nonFraction>&#160;million of intangible assets, and $<ix:nonFraction unitRef="usd" contextRef="ib9011e0276964d49be24c92eb49f6aab_I20200121" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE1MTA_db64bc2e-531a-4fde-bbd5-68dcb059b128">2</ix:nonFraction>&#160;million of property, plant and equipment and working capital.  The intangible assets primarily consist of technology and customer-related assets which are being amortized over a useful life of <ix:nonNumeric contextRef="iba6f3990b67144cba1d435606505c8f4_D20200121-20200121" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE2OTg_c4ca1f1b-4053-4da7-aa75-145e3dd6732c">10</ix:nonNumeric> years and <ix:nonNumeric contextRef="ic51e744f4f2e4bcaa5294155d679de88_D20200121-20200121" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE3MDQ_4aa0c388-225e-4de9-813c-1bca13a953ff">15</ix:nonNumeric> years, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Outreach Laboratory Services Business of Memorial Hermann Health System</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company completed the acquisition of select assets which constitute substantially all of the operations of Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System ("Memorial Hermann"), in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i60b68dc1052845acade8ae63bf8e6344_D20200406-20200406" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzIxMDg_4980cb4f-65a8-4f90-9a83-2cfaa5761625">120</ix:nonFraction>&#160;million.  Memorial Hermann is a not-for-profit health system in Southeast Texas.  Based on the purchase price allocation, the assets acquired primarily consist of $<ix:nonFraction unitRef="usd" contextRef="i4617473021984d69adc99b7ffdf6247a_I20200406" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzIzNzQ_10918aee-16d3-41d9-8ee4-8166f760cddf">27</ix:nonFraction>&#160;million of customer-related intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i8776f0149dc24a4fb8b364ad4db1ebb4_I20200406" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI0MTk_11f0113a-d660-4b5c-b515-f997fa595ba9"><ix:nonFraction unitRef="usd" contextRef="i8776f0149dc24a4fb8b364ad4db1ebb4_I20200406" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI0MTk_d7a99b44-e447-4e82-b468-aefd449c1f7e">93</ix:nonFraction></ix:nonFraction>&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of <ix:nonNumeric contextRef="i7e2e808f5d17421891028da702156879_D20200406-20200406" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI1MTU_e2f36e88-1508-430e-96c1-ec658c340898">15</ix:nonNumeric> years.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Remaining <ix:nonFraction unitRef="number" contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI1NTI_69e26cd5-45f4-48f9-bdb7-0fd3d60baf6e">56</ix:nonFraction>% Interest in Mid America Clinical Laboratories, LLC</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i8582094c97ad4892b19d4c928fffb01f" continuedAt="i81ef597107bb481da99367ae8b6d676d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On August 1, 2020, the Company completed the acquisition of the remaining <ix:nonFraction unitRef="number" contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI2ODI_cb1af06e-ef59-4cc3-981c-72c5030455c8">56</ix:nonFraction>% interest in Mid America Clinical Laboratories, LLC ("MACL") from its joint venture partners in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i4f962685f1e94c24ad92c8ab20b848a9_D20200801-20200801" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI4MDg_e122ea1f-4519-4b78-8c4c-04380c8f97e7">93</ix:nonFraction>&#160;million, net of $<ix:nonFraction unitRef="usd" contextRef="i4f962685f1e94c24ad92c8ab20b848a9_D20200801-20200801" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI4MTk_67894816-9615-4c4b-aefa-126460a0ee60">18</ix:nonFraction>&#160;million cash acquired.  MACL is the largest independent clinical laboratory provider in Indiana.  Prior to the acquisition, the Company accounted for its <ix:nonFraction unitRef="number" contextRef="i0e0666473465402491e5adb9a61aa8a9_I20200731" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI5Njg_f76040d0-6e20-4d50-9c9a-81e917fb6793">44</ix:nonFraction>% interest in MACL as an equity method investment, which was remeasured to its fair value of $<ix:nonFraction unitRef="usd" contextRef="id6481d3eb8e74ecb8e9190ad66be0074_D20200731-20200731" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzMwNjI_ad43ca3e-96ca-439d-a268-0f4c5faae7b3">87</ix:nonFraction>&#160;million on the acquisition date, resulting in a gain of $<ix:nonFraction unitRef="usd" contextRef="i45f309f68fd843a48e8af03cd2f2fd0f_D20200801-20200801" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzMxMTM_e4c7263f-dac0-4d27-9b34-a5f74daef749">70</ix:nonFraction>&#160;million that was recognized in other income, net in the consolidated statements of operations.  The fair value of the previously held equity interest was determined using a discounted cash flow analysis that took into account, among other items, MACL's expected future cash flows, long-term growth rate (<ix:nonFraction unitRef="number" contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801" decimals="3" name="dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzMzOTg_e6abb48f-b182-4944-83ea-e5a1d507e788">1.5</ix:nonFraction>%), and a discount rate commensurate with economic risk (<ix:nonFraction unitRef="number" contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801" decimals="3" name="dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM0NTY_3731b356-1c3e-4d28-8eb9-8a059828c0f9">7.5</ix:nonFraction>%).  Based on the purchase price allocation, the assets acquired and liabilities assumed consist of $<ix:nonFraction unitRef="usd" contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM2NjU_2c2a0032-a6d4-4eca-ad9b-d60305b5cdfe">84</ix:nonFraction>&#160;million of goodwill (of which $<ix:nonFraction unitRef="usd" contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM2OTA_0b784792-ff71-49ac-b17f-a609d753eb2f">47</ix:nonFraction>&#160;million is tax-deductible), $<ix:nonFraction unitRef="usd" contextRef="ib4508da7ee96473cacb0e8b34be9019b_I20200801" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM3MTM_6cc6475d-1271-4d32-a8af-c24f540d2d7b">74</ix:nonFraction>&#160;million of intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM3Mzg_cb01b410-2160-439d-aee1-bca52628adb3">11</ix:nonFraction>&#160;million of working capital and $<ix:nonFraction unitRef="usd" contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM3NjQ_f172bc45-f98d-4cd6-80a4-7c6089653fa6">11</ix:nonFraction>&#160;million of property, plant and equipment.  The intangible assets consist of customer-related assets which are being amortized over a useful life of <ix:nonNumeric contextRef="ie3555bc8ae0b4b1cbeefc4ba15b1ff96_D20200801-20200801" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM5MDc_78b678cf-2adf-4d79-ad44-85ef52700cbb">15</ix:nonNumeric> years.  As a result of the acquisition, MACL became a wholly owned subsidiary of the Company.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2019 Acquisitions</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2019, the Company completed acquisitions for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQxMDM_50132951-a726-497c-b64c-58e52dc6341d">63</ix:nonFraction> million, including the acquisition discussed below.  The 2019 acquisitions resulted in goodwill of $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQxOTc_4e6bbe9e-0b08-44d7-9655-d7b412b50786">43</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQyMTA_a2338e7f-179e-4e4d-9ae0-3e75e8b7e87d">36</ix:nonFraction> million is deductible for tax purposes.  These acquisitions also resulted in $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQyODI_8dfc8cbe-c851-44f6-a4a0-2bbfb3cd53bb">21</ix:nonFraction> million of intangible assets, principally comprised of customer-related intangible assets. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Clinical Laboratory Services Business of Boyce &amp; Bynum Pathology Laboratories, P.C.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On February 11, 2019, the Company completed the acquisition of certain assets of the clinical laboratory services business of Boyce &amp; Bynum Pathology Laboratories, P.C. in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="ic42d65a53e2e4f8caac33c19b3fe9550_D20190211-20190211" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQ2ODg_d8519b63-bc9b-4cfe-8d4b-22b8af3b3dc5">61</ix:nonFraction> million, which consisted of cash consideration of $<ix:nonFraction unitRef="usd" contextRef="ic42d65a53e2e4f8caac33c19b3fe9550_D20190211-20190211" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQ3MzM_6ce0654c-0b61-4e87-9d98-9c4c8d5cbea5">55</ix:nonFraction> million and contingent consideration initially estimated at $<ix:nonFraction unitRef="usd" contextRef="ibf8a6d03f13d4234a113977f48f0640c_I20190211" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQ3ODg_a9de2e6c-4b74-495f-a14c-931e5ee5595b">6</ix:nonFraction> million.  The contingent consideration arrangement was dependent upon the achievement of certain testing volume benchmarks.  During 2019, the liability was reduced to $<ix:nonFraction unitRef="usd" contextRef="i30539b4ef73742fd917103c75f8a131d_I20191231" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQ5NTA_49c12934-7ff2-41ea-af91-c32fd122203f">0</ix:nonFraction> as a result of updated testing volume forecasts for the earn-out period compared to the testing volume target included in the contingent consideration arrangement, resulting in a $<ix:nonFraction unitRef="usd" contextRef="i0443eda130d94868aa628f929fc4e6bd_D20190101-20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzUxMzI_96df517a-fa30-48d0-a924-cd90f188bc66">6</ix:nonFraction> million gain recorded in other operating (income) expense, net.  Based on the purchase price allocation, the assets acquired principally consist of $<ix:nonFraction unitRef="usd" contextRef="i423ce88d5a4046c7b9394f997e1e0db6_I20190211" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzUyNzU_6a7ce0af-f80a-4323-8b1a-c9ca0779d291">41</ix:nonFraction> million of goodwill (of which $<ix:nonFraction unitRef="usd" contextRef="i423ce88d5a4046c7b9394f997e1e0db6_I20190211" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzUzMDA_dece51e4-c427-4922-bc70-2ec30a7a3e9a">35</ix:nonFraction> million is tax deductible) and $<ix:nonFraction unitRef="usd" contextRef="i7356ad2d38bf4e7e85b6c706c139d415_I20190211" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzUzMjY_dc95db08-c097-4150-b9af-cfa517ac0f1a">20</ix:nonFraction> million of customer-related intangible assets.  The intangible assets are being amortized over a useful life of <ix:nonNumeric contextRef="i31f33c5e991148e899c59f925d85d5b1_D20190211-20190211" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzU0MzM_cbaa8f1b-9c26-4e8a-a57b-ef47c4bcdd13">15</ix:nonNumeric> years.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;General Information</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i81ef597107bb481da99367ae8b6d676d">&#160;&#160;&#160;&#160;The acquisitions described above were accounted for under the acquisition method of accounting.  As such, the assets acquired and liabilities assumed are recorded based on their estimated fair values as of the closing date.  Supplemental pro forma combined financial information has not been presented as the impact of the acquisitions is not material to the Company's consolidated financial statements.  The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entities with those of the Company and the value associated with an&#160;assembled workforce and other intangible assets that do not qualify for separate recognition.  All of the goodwill acquired in connection with these acquisitions has been allocated to the Company's DIS business.  For further details regarding business segment information, see Note 19.</ix:continuation> </span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_2015"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8yNzQ4Nzc5MDcxMDcw_906faf03-9a10-46ee-a776-a62ee477c1bf" continuedAt="i3f21c6c009c846d6a1ffa69bcaf94b8b" escape="true">DISPOSITION</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f21c6c009c846d6a1ffa69bcaf94b8b" continuedAt="i373b3e67bb204ec0943791313aea3d3c">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its <ix:nonFraction unitRef="number" contextRef="i9c1e96cb7a8540ba9373cdf8a930af85_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMTE2_2a21501e-4072-44f9-992b-0af37774b0dc">40</ix:nonFraction>% ownership interest in Q2 Solutions&#174; ("Q2 Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner, for $<ix:nonFraction unitRef="usd" contextRef="iff8c10fa9efa4acb8369a234686c91ff_D20210401-20210401" decimals="-6" name="dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMTIx_74a31cf5-0ed1-470f-a17e-daa4c01f4d35">760</ix:nonFraction>&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the year ended December&#160;31, 2021, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i8e96757089434161b4f6a911623f3a76_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMTcx_df83eec6-702e-4fef-857f-012576d8947a">314</ix:nonFraction>&#160;million pre-tax gain in other income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $<ix:nonFraction unitRef="usd" contextRef="i3b20ad37382b4dbd949a4bd8cd17fa6c_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMTg1_481e04ed-e51c-4b3c-ba5d-46c877738151">20</ix:nonFraction>&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the year ended December&#160;31, 2021, the Company also recorded $<ix:nonFraction unitRef="usd" contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMjQ4_6c4d9251-4331-4fb5-92d4-97b73735923f">55</ix:nonFraction>&#160;million of income tax expense related to the gain, consisting of $<ix:nonFraction unitRef="usd" contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMjYx_6c0b8832-3c0d-4c3f-962f-d282e099d20c">127</ix:nonFraction>&#160;million of current income tax expense, partially offset by $<ix:nonFraction unitRef="usd" contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMjc1_77d3da73-6712-4fa3-adaf-11637e7c049e">72</ix:nonFraction>&#160;million of deferred income tax benefit.</ix:continuation></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><ix:continuation id="i373b3e67bb204ec0943791313aea3d3c" continuedAt="i3f0ee7c158244db6808947b7a1c813a9"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></ix:continuation></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_196"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzU1NzY_5ada3e85-f4eb-4591-8c09-67e72062ea2e" continuedAt="i05c42511a53d41f2a3410593265f88a2" escape="true">FAIR VALUE MEASUREMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i05c42511a53d41f2a3410593265f88a2" continuedAt="id0f957aa2c37416c8ae6ba95dc2f9c01"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzU1ODY_7db7ef40-74cb-4d93-a3cf-fc7990f1a7e5" continuedAt="i1e8597bd7dd3472ca961950eb1952b7f" escape="true">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i1e8597bd7dd3472ca961950eb1952b7f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzUtMS0xLTEtMjA5MjU_b24c55f2-3b58-4696-a23e-68f61b6b690f">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzUtMy0xLTEtMjA5MjU_fe958796-a307-4c58-a3ef-b751cae8f269">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzUtNS0xLTEtMjA5MjU_9b0e2d5a-685a-4a2f-8609-666c5052aa2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzUtNy0xLTEtMjA5MjU_df933b15-9b1c-4f7d-86d7-383f5f656057">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzYtMS0xLTEtMjA5MjU_48cdfda7-a160-46e0-ba57-2eaa141f5291">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzYtMy0xLTEtMjA5MjU_6511f864-8676-4584-8604-70ab973721ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzYtNS0xLTEtMjA5MjU_25cf11f9-8e0e-43c7-9d70-ae1a4b9c403b">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzYtNy0xLTEtMjA5MjU_b32271cd-d977-40d0-ae6d-45c22fb55af9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtMS0xLTEtMzAyODg_520f7558-53da-4103-9368-bef7a8cede10">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtMy0xLTEtMzAyODg_33511dab-0611-4092-a448-53e36a722697">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtNS0xLTEtMzAyODg_073aee19-138b-4aec-bdcb-7639e9379a32">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtNy0xLTEtMzAyODg_235232c5-deeb-4a11-8045-f58cd3d0b3fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtMS0xLTEtMjA5MjU_72f63a2a-2cfe-4c07-a8b8-9059d46c1da9">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtMy0xLTEtMjA5MjU_ffd7b14d-776a-4346-b370-97c87893abbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtNS0xLTEtMjA5MjU_7d0f5cfb-28a9-4ede-92a6-436cf04ca39a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtNy0xLTEtMjA5MjU_4b2afbf3-aa3a-48d5-9d96-56ef2bcd3940">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzExLTEtMS0xLTIwOTI1_3d41c50f-05b6-42e2-b916-94313ddb4238">179</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzExLTMtMS0xLTIwOTI1_7ff624cd-105f-4690-a976-003d0b8d6235">121</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzExLTUtMS0xLTIwOTI1_016a00cb-885b-4237-a848-730e6c16dd47">57</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzExLTctMS0xLTIwOTI1_919e929a-50cf-4b7c-8ca0-701209ca9ce8">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE0LTEtMS0xLTIwOTI1_2382237b-f697-4773-8596-803211cba71c">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE0LTMtMS0xLTIwOTI1_077c50c0-8f1e-45b9-a61f-76d3eb1bad0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE0LTUtMS0xLTIwOTI1_54439aa4-d5d1-45f5-b3c8-2d8a190e0315">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE0LTctMS0xLTIwOTI1_0e960b97-9f57-425f-970e-220cec884c10">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE2LTEtMS0xLTIwOTI1_f9dfccdb-5785-44ec-bbb5-28e228fddc23">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE2LTMtMS0xLTIwOTI1_b3b85424-964f-4a68-b1c8-7b8877ee7d8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE2LTUtMS0xLTIwOTI1_f29f01ea-2ca3-449e-bcc9-3903a6f17328">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE2LTctMS0xLTIwOTI1_3c6bba74-26e0-4766-bb03-3021e22b0e40">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE5LTEtMS0xLTIwOTI1_4eef1597-b065-4674-b9c1-81d9b46e490f">148</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE5LTMtMS0xLTIwOTI1_adb3b40e-d702-4100-9db6-92017c54ffeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE5LTUtMS0xLTIwOTI1_6ef48e5b-7cfa-4f4c-9244-95f98ad5e90e">143</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE5LTctMS0xLTIwOTI1_b0a67201-7ded-4bf4-9345-b9919eff0009">5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzIxLTEtMS0xLTIwOTI1_50ba2c7f-a03f-42fc-a3e4-00f34e421f5a">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzIxLTMtMS0xLTIwOTI1_3e817dbe-0bbf-4ee6-b65a-53cfae5b8c0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzIxLTctMS0xLTIwOTI1_342346c1-c549-4715-a2f5-f63812536182">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI1LTEtMS0xLTIwOTI1_3f0a5f50-93ca-4b45-8224-1d55dfdf902d">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI1LTMtMS0xLTIwOTI1_a14498c6-372f-4fda-bc95-b0502a3a99c3">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38f5b3d3498744299e5a0aef9e2f770b_I20201231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI1LTUtMS0xLTIwOTI1_17be89ed-8e6d-4539-beca-b3123c187020">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI1LTctMS0xLTIwOTI1_cf66bef4-614f-4e5a-b8f7-6caf934a9c5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI2LTEtMS0xLTIwOTI1_c5801219-6fce-4c61-be89-a45a6f334b03">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI2LTMtMS0xLTIwOTI1_a22eff39-1c4c-42e0-a603-cd586f12f51d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38f5b3d3498744299e5a0aef9e2f770b_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI2LTUtMS0xLTIwOTI1_50b71854-4e1b-4622-b41f-591c6ae0f772">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI2LTctMS0xLTIwOTI1_cc20c7ce-af76-4344-a172-7c802b407cfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI5LTEtMS0xLTIwOTI1_b6404971-ba8e-4051-8152-df30e22ceaf6">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI5LTMtMS0xLTIwOTI1_1c7c072e-8107-4b5a-b256-3bfd7b0f652e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38f5b3d3498744299e5a0aef9e2f770b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI5LTUtMS0xLTIwOTI1_93253c76-a21c-40bf-a402-44a9d19d4f6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI5LTctMS0xLTIwOTI1_b1f364cc-be7c-4747-8c8c-3bf769aa9583">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzMxLTEtMS0xLTIwOTI1_e31da381-6a1c-4fcd-bdf2-607c978a00d8">129</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzMxLTMtMS0xLTIwOTI1_07eaf8ce-83a7-43ba-8a97-435bc27cecd7">67</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38f5b3d3498744299e5a0aef9e2f770b_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzMxLTUtMS0xLTIwOTI1_9c9fcecf-ff8d-47b5-a8c7-ee39c4176a8e">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzMxLTctMS0xLTIwOTI1_8faa0f0e-eef1-4dba-b2ff-3ed0e5366c3d">12</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzM0LTEtMS0xLTIwOTI1_e99dfd3e-4aba-4c13-8c17-06aead9a2abc">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzM0LTMtMS0xLTIwOTI1_b7e2f699-3beb-420c-9bb8-96a975ef387c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38f5b3d3498744299e5a0aef9e2f770b_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzM0LTUtMS0xLTIwOTI1_4dda59c1-7291-4317-921a-fd9dbf057f25">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzM0LTctMS0xLTIwOTI1_710c1707-9fb7-439e-894c-854d7d58cb43">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzQxLTEtMS0xLTIwOTI1_828d3f74-fb30-42cb-a684-506104e782ed">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzQxLTMtMS0xLTIwOTI1_75b2f679-7ad3-49cf-addc-8301584d7321">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzQxLTctMS0xLTIwOTI1_fa5043af-c294-4b2d-a8f8-a19d4877be25">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="id0f957aa2c37416c8ae6ba95dc2f9c01" continuedAt="i094b84bcf7154eb2928e5a020cb17ce1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries. Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  During the year ended December 31, 2021, certain of the Company's equity investments became publicly traded. Such equity investments are now classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the acquisition of Labtech (see Note 5), the Company has a contingent consideration obligation of up to $<ix:nonFraction unitRef="usd" contextRef="ie17bd574ae9c4ff8ae0d21265f27f20e_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzc2OTY1ODE0MDkyNzM_e2a9b03d-33fb-45cc-bad7-caf38d18249e">20</ix:nonFraction>&#160;million that is to be paid based on the achievement of certain testing volume benchmarks.  As of December&#160;31, 2021, the fair value of the contingent consideration liability totaled $<ix:nonFraction unitRef="usd" contextRef="i434a8ab4e7b34865bb3ce497565a2bf6_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzEwOTk1MTE2MzczODA_3cf2bec9-4d27-4678-9a52-80e0e502b2b1">5</ix:nonFraction> million, which was measured at fair value using an option-pricing method and classified within Level 3 of the fair value hierarchy as the fair value was determined based on significant inputs that are not observable.  Significant inputs include management&#8217;s estimate of volume and other market inputs, including comparable company revenue volatility (<ix:nonFraction unitRef="number" contextRef="i617406ef61a34f3aa8f1d1f3c8941262_I20211231" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzc2OTY1ODE0MDkzNjM_bd8241d4-caf4-4967-b073-a63fa47d9191">7.5</ix:nonFraction>%) and a discount rate (<ix:nonFraction unitRef="number" contextRef="i124355337c804541809469ff7ef7f47f_I20211231" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzc2OTY1ODE0MDkzNjk_6f28f162-c22c-4061-b6e8-0415867b4f1a">2.5</ix:nonFraction>%).</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzU1NzQ_e4927615-a683-4054-aa5a-fb7cee421a4c" continuedAt="id983845f009145aca0970c3bf60ce183" escape="true">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="id983845f009145aca0970c3bf60ce183"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.912%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a58a0ecc1d462f851c119a2540a972_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzItMS0xLTEtMjA5MjU_9b7ffb59-27a1-48b2-a7ce-05d1889fe76b">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc94c6adc50e45d1a843a6310b57c833_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzQtMS0xLTEtMjA5MjU_b30a1d52-8547-4e58-ac2d-a0d490a6473e">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value adjustments included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc94c6adc50e45d1a843a6310b57c833_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzUtMS0xLTEtMjA5MjU_e2c944ef-8f92-43b8-b2bc-07fd31bacd15">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67b969149f9b4fee96f681a629e8e1bf_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzktMS0xLTEtMjA5MjU_0cd1ec02-ba0d-4439-b17d-e0ae14da1f45">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i021bad29b33a4e059cf6ee59d7e0df44_D20210101-20211231" decimals="-6" name="dgx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzExLTEtMS0xLTMwMzU4_ff21e248-83d6-4c84-87b4-a281349373fe">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i434a8ab4e7b34865bb3ce497565a2bf6_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzEzLTEtMS0xLTIwOTI1_3cf2bec9-4d27-4678-9a52-80e0e502b2b1">5</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The $<ix:nonFraction unitRef="usd" contextRef="i9c47ea6a797a43599cb7fc4368a7daa1_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzQwMzg_205e62eb-ba93-4000-a378-887e31da4c39">1</ix:nonFraction> million net gain included in earnings associated with the changes in the fair value of contingent consideration for the year ended December&#160;31, 2020 is reported in other operating (income) expense, net.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i10c8c1d0f30246589418e5588a96ce94_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzQyNDg_6bfa891b-5a98-4e58-a53c-f02adbf1a1d9">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of December&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long-term growth rates, and a discount rate commensurate with economic risk.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i094b84bcf7154eb2928e5a020cb17ce1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, the Company recorded an $<ix:nonFraction unitRef="usd" contextRef="i41d87f6d82ea49589aa5d33a9546d817_D20210101-20211231" decimals="-6" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzc2OTY1ODE0MDgwNjQ_02d3d1ad-9dc9-4518-a2dd-5c7407d614c1">8</ix:nonFraction>&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of December&#160;31, 2021 and 2020, the fair value of the Company&#8217;s debt was estimated at $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzUyMDg_c27f3a69-6c4c-49c4-a1b8-4fa09c4a1a21">4.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzUyMTU_88db4277-5ec6-4eff-8ab2-757e81339c2d">4.6</ix:nonFraction> billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_199"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzYwNjg_cef5ba6e-92ab-46f9-96a9-97a2dcf21bf7" continuedAt="i5448396cde414a8e858c0a42ab367ff3" escape="true">TAXES ON INCOME</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5448396cde414a8e858c0a42ab367ff3" continuedAt="i2cabc252f40e464db5281eca3d57b708"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's pre-tax income from continuing operations before equity in earnings of equity method investees consisted of approximately <ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-8" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5Xzc2OTY1ODE0MDQwMzA_0ec1415e-36f3-46f7-9b1d-4268e02be323">2.5</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-8" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzE3NA_b5c99915-a88e-4600-b437-e23af161307d">1.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-8" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzE4MQ_7edb36db-dac6-46b3-a854-64142f5f60ba">1.1</ix:nonFraction> billion from U.S. operations and pre-tax income (loss) of $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIzNA_fa3ea408-2a2f-4f07-bc9e-ace7be45b3a1">148</ix:nonFraction> million, $(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIzOA_0a43fac2-6be4-4068-9951-522f1e9335e5">7</ix:nonFraction>) million and $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI0NQ_3e9112db-9d86-4048-a4f7-a16730d279e4">15</ix:nonFraction> million from foreign operations for the years ended December&#160;31, 2021, 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;Pre-tax income from continuing operations before equity in earnings of equity method investees for U.S. and foreign operations include pre-tax gains of $<ix:nonFraction unitRef="usd" contextRef="i20d31ae01df141748e29ec7263dbe9c1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzMyOTg1MzQ4OTI1NTU_e067190f-88a8-4399-a1d7-17be8bfb21f5">171</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8c9bfd94887a4b799eb75fdf00ff90c6_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzMyOTg1MzQ4OTI1Njk_f7cf79a9-8533-4839-af8a-f84b1005ccd2">143</ix:nonFraction>&#160;million, respectively, from the sale of the Company's <ix:nonFraction unitRef="number" contextRef="i9c1e96cb7a8540ba9373cdf8a930af85_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzMyOTg1MzQ4OTI1ODM_d51d9326-513b-4ece-9cb2-587f369c5e1a">40</ix:nonFraction>% ownership interest in Q2 Solutions.  During the year ended December&#160;31, 2021, the Company also recorded $<ix:nonFraction unitRef="usd" contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzEwOTk1MTE2Mjg2NDQw_6c4d9251-4331-4fb5-92d4-97b73735923f">55</ix:nonFraction>&#160;million of income tax expense related to the gain, consisting of $<ix:nonFraction unitRef="usd" contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzEwOTk1MTE2Mjg2NTAx_6c0b8832-3c0d-4c3f-962f-d282e099d20c">127</ix:nonFraction>&#160;million of current income tax expense, partially offset by $<ix:nonFraction unitRef="usd" contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzEwOTk1MTE2Mjg2NTU2_77d3da73-6712-4fa3-adaf-11637e7c049e">72</ix:nonFraction>&#160;million of deferred income tax benefit.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzYwNDg_4f1fba5e-de1d-4ad2-8b9a-292c36352f17" continuedAt="i85338ee650bf46fba39d191ad74adf17" escape="true">The components of income tax expense (benefit) for 2021, 2020 and 2019 were as follows: </ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i85338ee650bf46fba39d191ad74adf17"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzItMS0xLTEtMjA5MjU_47efca21-58ee-4007-aa0d-f37818e29e45">528</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzItMy0xLTEtMjA5MjU_a5fb9d22-d1bf-4982-9d3f-c1a46767a33e">300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzItNS0xLTEtMjA5MjU_d21594ed-bbec-4e83-8624-fb0adc79130b">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzMtMS0xLTEtMjA5MjU_c95b2930-3f9e-4121-9028-9d4e8187d8d1">123</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzMtMy0xLTEtMjA5MjU_fff584fc-4ecf-47e9-b3ee-21e4978724de">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzMtNS0xLTEtMjA5MjU_9b8d84e4-6c9a-412d-bcfa-a9fcc0453e4a">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzQtMS0xLTEtMjA5MjU_683877a7-4a9e-4c34-a5af-0a0919a1f092">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzQtMy0xLTEtMjA5MjU_08c303c0-06c9-48d1-9cac-d12df6924813">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzQtNS0xLTEtMjA5MjU_9a822124-8f1a-4bfc-b765-1559c2402583">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzYtMS0xLTEtMjA5MjU_755e5aca-d898-45dc-a45e-28721ef3fe9c">61</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzYtMy0xLTEtMjA5MjU_73d17487-c57a-4ff5-bec1-2ab4744d7f93">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzYtNS0xLTEtMjA5MjU_f35b3464-539f-49ec-a949-fcc910fc8364">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzctMS0xLTEtMjA5MjU_370507c3-89de-40c9-abb2-c6732ed7526d">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzctMy0xLTEtMjA5MjU_5988e830-0e0f-4961-a03a-4045ed4cbd0f">29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzctNS0xLTEtMjA5MjU_a761c228-bf89-423f-90a8-cf9bc1d9e539">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzgtMS0xLTEtMjA5MjU_93bedf58-22be-416f-9472-55044f52347a">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzgtMy0xLTEtMjA5MjU_86785b20-ecaf-4842-836a-39197a193db3">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzgtNS0xLTEtMjA5MjU_9c1d8a6a-4a69-474a-9432-388b26a97181">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzktMS0xLTEtMjA5MjU_90b7512f-bd92-4c45-b03a-a9712fe28357">597</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzktMy0xLTEtMjA5MjU_432850c3-dd7a-4c2a-ab8b-d71ee501c96e">460</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzktNS0xLTEtMjA5MjU_6a4b2b2b-5f81-4722-af13-51851a341368">247</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:42.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzYwNjA_93868015-e3e9-475e-b146-97b1ce029298" continuedAt="i8b17cad4a7f84cd2b74e8c6450ad9216" escape="true">A reconciliation of the federal statutory income tax rate to the Company's effective income tax rate for 2021, 2020 and 2019 was as follows: </ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i8b17cad4a7f84cd2b74e8c6450ad9216"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at statutory rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzItMS0xLTEtMjA5MjU_599d6fe4-abbf-4016-b0bb-a65ae9cfa478">21.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzItMy0xLTEtMjA5MjU_b8b665e2-862b-4aab-919f-472f63fff6d0">21.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzItNS0xLTEtMjA5MjU_ced5fdcd-a88a-4e81-b049-a2ca318d0e30">21.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzMtMS0xLTEtMjA5MjU_84035bf2-3011-4df6-adde-f0b587fdcd02">4.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzMtMy0xLTEtMjA5MjU_5abaabfe-d014-41e1-b569-c0493648d57e">4.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzMtNS0xLTEtMjA5MjU_10a8032a-d4b1-410f-a81d-03d6797b764b">4.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzgtMS0xLTEtMjA5MjU_37304853-5b66-455e-be56-2f37550a8d1d">0.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzgtMy0xLTEtMjA5MjU_63882977-d90a-47d7-90e8-c49d72573a6c">0.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzgtNS0xLTEtMjA5MjU_76fece90-1ba4-411f-a65f-82c373a3a7f6">1.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on stock-based compensation arrangements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzEwLTEtMS0xLTIwOTI1_4bc1594a-ab63-4de7-9418-9be390a76ce3">0.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzEwLTMtMS0xLTIwOTI1_62fa9d97-ce1b-4c12-baee-9a5d07f958aa">1.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzEwLTUtMS0xLTIwOTI1_ab209774-0a19-436e-adcb-95ad2fb5d6c7">1.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision true-ups </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzExLTEtMS0xLTIwOTI1_ccb26ded-a8e7-4eef-81bd-e09c1f846939">0.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzExLTMtMS0xLTIwOTI1_a52e4bae-84ca-435a-9620-90bb779d4379">0.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzExLTUtMS0xLTIwOTI1_18a7500e-07da-429c-9055-d1c10406a7cc">1.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of equity earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE0LTEtMS0xLTIwOTI1_b7d5b748-52f6-4b88-802c-0e67f6b3cd81">0.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE0LTMtMS0xLTIwOTI1_71e83e72-8d9e-4807-82cc-0f3b1e426ff3">0.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE0LTUtMS0xLTIwOTI1_c6a693e5-1fdf-4b51-baec-d37ffda535d6">1.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in reserves for uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" name="dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE1LTEtMS0xLTIwOTI1_a45c1c0d-b9c3-41cf-a8d1-cd487144b6f0">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" name="dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE1LTMtMS0xLTIwOTI1_8c3b1d00-c059-4129-acaa-3a9727d2d295">0.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" name="dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE1LTUtMS0xLTIwOTI1_e7550ca4-5c0e-439f-83f8-1cc7ef31a3c7">1.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowances associated with certain net operating losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE2LTEtMS0xLTIwOTI1_ad6b0857-b154-4f4c-8c14-27018726cbba">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE2LTMtMS0xLTIwOTI1_8541b9df-168f-4e7a-865d-4256a31d5ef4">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE2LTUtMS0xLTIwOTI1_c7b57f49-c371-40f6-9144-2be531cea428">1.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE3LTEtMS0xLTIwOTI1_d89ab5c2-e777-4d80-80aa-92f00f7fd008">0.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE3LTMtMS0xLTIwOTI1_70c0adb5-b448-45b7-a4c5-66854442b44e">0.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE3LTUtMS0xLTIwOTI1_9b427497-f4a6-42ff-adc0-0bdea9ea91fc">0.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE4LTEtMS0xLTIwOTI1_ad8cfbd8-679f-448c-8929-1b9885d48c58">23.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE4LTMtMS0xLTIwOTI1_7cee863f-ecf2-4c9c-87e3-38cb8b8596fc">24.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE4LTUtMS0xLTIwOTI1_c4d9c7b6-03fb-47ed-a5ae-008de2f339f2">23.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><ix:continuation id="i2cabc252f40e464db5281eca3d57b708" continuedAt="i644cb73115614d82b420d1ac25ccd4b1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December 31, 2019, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5Xzk4Nw_c4741c64-5e02-4025-84a1-bdc87965aed1">12</ix:nonFraction> million net income tax benefit due to the release of valuation allowances associated with certain net operating loss carryforwards.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzYwNTY_3fbddf1b-033a-415d-8f1a-4694f22bb0c3" continuedAt="i02505a1dd4974ade82e38312f0514cf4" escape="true">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) as of December&#160;31, 2021 and 2020 were as follows: </ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i02505a1dd4974ade82e38312f0514cf4"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current deferred tax assets (liabilities):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable reserves</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzItMS0xLTEtMjA5MjU_8bcb27be-0aec-4166-ab7b-13dfb1db496c">89</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzItMy0xLTEtMjA5MjU_c1d57e66-3281-4375-a9f1-55e9c0703ddb">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities not currently deductible</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzMtMS0xLTEtMjA5MjU_3df9ad5e-fdbc-49b0-8949-b34574bbf400">180</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzMtMy0xLTEtMjA5MjU_a19c4b90-8ada-431d-a5b9-47eea83c1c46">146</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzQtMS0xLTEtMjA5MjU_ee6343d4-a7d7-42fb-894c-138e956fc81a">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzQtMy0xLTEtMjA5MjU_d33f0fde-9b1d-4afc-8443-c9ee2cfa7556">47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis differences in investments, joint ventures and subsidiaries </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzYtMS0xLTEtMjA5MjU_89cd3ec0-d773-4461-bdc6-28886e0c0f84">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzYtMy0xLTEtMjA5MjU_661a5fad-2aba-4a38-9dad-120236ff8ec1">81</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards, net of valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzctMS0xLTEtMjA5MjU_19f724fb-651f-4b04-abee-3bfaee711fe7">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzctMy0xLTEtMjA5MjU_98e67cca-9129-4ed3-a65c-aa51e3edff7b">61</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzgtMS0xLTEtMjA5MjU_a3028895-36a8-48a0-8951-815555b0080c">150</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzgtMy0xLTEtMjA5MjU_25520c95-a3ac-49dd-aca5-f76706c7a82b">151</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzktMS0xLTEtMjA5MjU_b7602944-59e3-4be1-bf17-b9f53b52f633">162</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzktMy0xLTEtMjA5MjU_e09f274b-dc04-4f47-b62c-14b0e80ff3a2">161</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzEwLTEtMS0xLTIwOTI1_dcfacb50-52ab-47e1-9342-452894c87426">633</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzEwLTMtMS0xLTIwOTI1_fc212036-27d2-47ee-b042-7072ba788cac">604</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current deferred tax liabilities, net</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzExLTEtMS0xLTIwOTI1_e7626aef-bfbe-4f24-b450-b430ff5c1ada">290</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzExLTMtMS0xLTIwOTI1_7feefe2c-e4d2-45c8-854e-13cf30b6767b">350</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021 and 2020, non-current deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="ieaadd96b316f4fe3aa85d0828713bc7d_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIxNDA_676948f4-4a30-4c6c-bc87-259258e2a77c">290</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i83edf4f54cea471cb6078513f0ebb62d_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIxNDc_59b122f2-1462-459e-ad4b-4804d23fa3f5">350</ix:nonFraction> million, respectively, are included in other liabilities in the consolidated balance sheet. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, the Company had estimated net operating loss carryforwards for federal and state income tax purposes of $<ix:nonFraction unitRef="usd" contextRef="ie38bc8aadde34be2a92c9c3930883626_I20211231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIzNTE_2e3d1240-c8a9-45c7-93ea-4d49ad5a3770">31</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2b96d806bd364953ade441ac89234392_I20211231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIzNTg_bec21013-42be-466f-9ca6-3ab0002790a4">676</ix:nonFraction> million, respectively, which expire at various dates through 2041.  Estimated net operating loss carryforwards for foreign income tax purposes are $<ix:nonFraction unitRef="usd" contextRef="i5fe0a4d10c264c40b9e40c8f509f7adc_I20211231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI0OTg_c32c2041-6c75-4db5-88f5-4b654b6c6493">70</ix:nonFraction> million as of December&#160;31, 2021, some of which can be carried forward indefinitely while others expire at various dates through 2041.  As of December&#160;31, 2021 and 2020, deferred tax assets associated with net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI3MDA_a4bdf4e5-02e6-4179-be3f-9445152c1996">71</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI3MDc_e77bc776-c9d6-4c54-8526-bbfb31c7d274">94</ix:nonFraction> million, respectively, have each been reduced by valuation allowances of $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI3NzU_04047834-d0e9-4620-a0e4-5fa3b5bd928c">29</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI3ODI_f021292e-19a6-48c0-bb4e-22169be14110">33</ix:nonFraction> million, respectively.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income taxes payable, including those classified as long-term in other liabilities in the consolidated balance sheet as of December&#160;31, 2021 and 2020, were $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI5NDQ_b0a3a147-5ab4-4403-ab53-46a65408d368">106</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AccruedIncomeTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI5NTE_97070937-de05-43ce-8814-f75e34474325">135</ix:nonFraction> million, respectively.  Prepaid income taxes were $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI5OTY_838bf6ae-00ec-4f8b-a8b9-58f2631f3dae">36</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzMwMDM_879b48a3-3eb0-4807-9c39-ea94206c4409">2</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively, and were recorded in prepaid expenses and other current assets in the consolidated balance sheet. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzYwNTI_3a0aff88-05e2-41c3-aecb-e9cfcf1aa9e8" continuedAt="i3d7741e610e843799ace4a374a2df467" escape="true">The total amount of unrecognized tax benefits as of and for the years ended December&#160;31, 2021, 2020 and 2019 consisted of the following:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i3d7741e610e843799ace4a374a2df467"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzItMS0xLTEtMjA5MjU_4da343a9-fa26-4168-8e4b-587f7d9fdbe2">93</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzItMy0xLTEtMjA5MjU_c663d440-1ee4-4320-a5ff-87b2700ae140">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i751cd9d2a9c24eeb80a337f22c577eed_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzItNS0xLTEtMjA5MjU_3ec179af-42f3-4ef7-a746-bbcad7b06ca7">107</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzQtMS0xLTEtMjA5MjU_1d328875-7d4e-4abe-aaf5-c35c808108eb">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzQtMy0xLTEtMjA5MjU_0c909d3a-a944-480c-a450-c264206407a4">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzQtNS0xLTEtMjA5MjU_ec7e97bb-7a57-441c-9d44-84927fe0a33a">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzUtMS0xLTEtMjA5MjU_e787e835-4138-4b68-b5ab-2b2f7b5f1a04">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzUtMy0xLTEtMjA5MjU_95553cf8-d99a-4808-8e42-dd081b05c7bf">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzUtNS0xLTEtMjA5MjU_75143594-e52e-47a3-b381-93b8aa7318da">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in judgment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="dgx:ReductionsForChangesInJudgment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzctMS0xLTEtMjA5MjU_64e75432-e9fa-4280-81dc-33207938a73e">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:ReductionsForChangesInJudgment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzctMy0xLTEtMjA5MjU_baf2278e-3acf-4ba3-8ec3-49d632cbdec7">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:ReductionsForChangesInJudgment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzctNS0xLTEtMjA5MjU_922e2f66-2a8a-4b4c-8078-9eeadaf4bf9b">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expirations of statutes of limitations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzgtMS0xLTEtMjA5MjU_0097e02f-dc3e-49c1-9ea9-df8b9e7a40b1">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzgtMy0xLTEtMjA5MjU_b11b382f-cc57-41df-b0a5-41032bf357e8">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzgtNS0xLTEtMjA5MjU_278a89d8-6866-48b5-a867-a6a5f4087194">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzktMS0xLTEtMjA5MjU_b7487a84-fbc0-42b9-a6f6-634a10c71b73">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzktMy0xLTEtMjA5MjU_c0e27fba-0df3-4ed8-8735-fb6ebb858f29">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzktNS0xLTEtMjA5MjU_a8f3fdfc-916e-4869-9cc9-c85588112955">32</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzEwLTEtMS0xLTIwOTI1_4bf95934-fce8-4116-b0b4-5099f278322c">110</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzEwLTMtMS0xLTIwOTI1_c8ebd81e-6844-47c9-a3bb-8399a046f4c8">93</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzEwLTUtMS0xLTIwOTI1_d0f76695-9c78-48ba-9110-06b54b6e3c79">88</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The contingent liabilities for tax positions primarily relate to uncertainties associated with the realization of tax benefits derived from the allocation of income and expense among state jurisdictions, the characterization and timing of certain tax deductions associated with business combinations, certain tax credits and the deductibility of certain expenses and settlement payments.   </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i644cb73115614d82b420d1ac25ccd4b1" continuedAt="i1cbd3a909e89477cbcb05afbb9c6a6f8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total amount of unrecognized tax benefits as of December&#160;31, 2021, that, if recognized, would affect the effective income tax rate is $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzM3Nzc_3c404966-4f8e-4633-8423-6af6f6ea559c">90</ix:nonFraction> million.  Based upon the expiration of statutes of limitations, settlements and/or the conclusion of tax examinations, the Company believes it is reasonably possible that the total amount of unrecognized tax benefits may decrease by up to $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQwMTE_f137560c-e69c-479e-abbb-ce89402a7280">15</ix:nonFraction> million within the next twelve months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accruals for interest expense on contingent tax liabilities are classified in income tax expense in the consolidated statements of operations.  Accruals for penalties have historically been immaterial.  Interest (income) expense included in income tax expense in each of the years ended December&#160;31, 2021, 2020 and 2019 was approximately $(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQzNTc_1389cfc2-62b5-44ad-8b95-5c6f845f876a">2</ix:nonFraction>) million, $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQzNjE_21bd1e8d-4d4f-4eb4-ac3c-8b66ca574142">6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQzNjg_b1ec9da6-4f99-4fb2-899f-59ccb627bb54">5</ix:nonFraction> million, respectively.  As of December&#160;31, 2021 and 2020, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQ0MzQ_8a9daf59-2c87-4508-87c3-04ba563ea563">20</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQ0NDE_361c49f4-fc24-43a4-973a-15f98cc771bd">21</ix:nonFraction> million, respectively, accrued, net of the benefit of a federal and state deduction, for the payment of interest on uncertain tax positions.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The recognition and measurement of certain tax benefits includes estimates and judgment by management and inherently involves subjectivity.  Changes in estimates may create volatility in the Company's effective tax rate in future periods and may be due to settlements with various tax authorities (either favorable or unfavorable), the expiration of the statute of limitations on certain tax positions and obtaining new information about particular tax positions that may cause management to change its estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the regular course of business, various federal, state, local and foreign tax authorities conduct examinations of the Company's income tax filings and the Company generally remains subject to examination until the statute of limitations expires for the respective jurisdiction.  The Internal Revenue Service has either completed its examinations of the Company's consolidated federal income tax returns or the statute of limitations has expired up through and including the 2016 tax year.  At this time, the Company does not believe that there will be any material additional payments beyond its recorded contingent liability reserves that may be required as a result of these tax audits.  As of December&#160;31, 2021, a summary of the tax years that remain subject to examination, awaiting approval, are under appeal, or are otherwise unresolved for the Company's major jurisdictions are:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;United States - federal&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2017 - 2020 </span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1cbd3a909e89477cbcb05afbb9c6a6f8">&#160;&#160;&#160;&#160;United States - various states&#160;&#160;&#160;&#160;2002 - 2020</ix:continuation> </span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_202"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90ZXh0cmVnaW9uOmMxMzI2MWM0ZTFhZTQ4MzhhMDg0Y2U2MTZmNDA2ZjQ3XzQ0Mg_7ac06c39-26d8-4317-b0c9-9e90fd72b18e" continuedAt="ie1eb023d6fe74d3cb2877bf5a0eade96" escape="true">SUPPLEMENTAL CASH FLOW AND OTHER DATA </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie1eb023d6fe74d3cb2877bf5a0eade96"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90ZXh0cmVnaW9uOmMxMzI2MWM0ZTFhZTQ4MzhhMDg0Y2U2MTZmNDA2ZjQ3XzQ0Ng_d90fdff8-fb7e-4058-8ec0-fa3fc6d7c3b4" continuedAt="i428c03f7d57c42219dde5928739095cc" escape="true">Supplemental cash flow and other data for the years ended December&#160;31, 2021, 2020 and 2019 was as follows:</ix:nonNumeric></span></div><ix:continuation id="i428c03f7d57c42219dde5928739095cc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzItMS0xLTEtMjA5MjU_e1498cb6-6204-41bf-a1bf-14a7c0c245f9">305</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzItMy0xLTEtMjA5MjU_0a3e1d69-33ef-458a-9826-4a3ac6e00d75">258</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzItNS0xLTEtMjA5MjU_b2130837-e649-4d95-a8c6-c976b96a8442">233</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzMtMS0xLTEtMjA5MjU_4666f20e-7c60-4549-b86e-1dc5bcf8d8b3">103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzMtMy0xLTEtMjA5MjU_71679faa-c9be-46c7-adf3-bd25d0e65775">103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzMtNS0xLTEtMjA5MjU_8557f45c-6b6a-48ee-b0c4-4615051dee11">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzQtMS0xLTEtMjA5MjU_f2f4aed0-0d70-4700-9001-286841a3e5b6">408</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzQtMy0xLTEtMjA5MjU_c482e9c8-92b5-42dd-8732-d51e25d15385">361</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzQtNS0xLTEtMjA5MjU_f7378668-610f-4292-860f-a96b3d7e4943">329</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzYtMS0xLTEtMjA5MjU_55c57946-eefa-4423-801a-e64cd139d3db">152</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzYtMy0xLTEtMjA5MjU_18ec39f2-2ff8-4057-9482-8cddf4ac6cf2">166</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzYtNS0xLTEtMjA5MjU_cd6a1ab3-256d-4f15-a763-6803e172143f">180</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzctMS0xLTEtMjA5MjU_f61a4aa2-0de1-4c74-ae81-7289db3f6d3d">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzctMy0xLTEtMjA5MjU_797d3f80-5216-4a36-8693-5e5c6403c667">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzctNS0xLTEtMjA5MjU_31bf9a11-a4ad-4523-ab65-958dc15d71b5">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzgtMS0xLTEtMjA5MjU_fa9cecf4-a4eb-476b-8828-4590d53e63e6">151</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzgtMy0xLTEtMjA5MjU_27c04739-1233-44cf-a692-5e826058fd3d">163</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzgtNS0xLTEtMjA5MjU_36b994cb-e7e9-47b5-9f84-6cc9ae91ee52">175</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEwLTEtMS0xLTIwOTI1_28094966-8db8-4800-aa84-f208c721425f">159</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEwLTMtMS0xLTIwOTI1_8f1fe47d-4e6e-4648-a2ea-1960d1ac166b">201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEwLTUtMS0xLTIwOTI1_2a8f6448-c59b-43d3-a26e-cb0efcbdb042">192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzExLTEtMS0xLTIwOTI1_c58de435-ac07-4fb3-8e7d-99097a21c61c">709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzExLTMtMS0xLTIwOTI1_615cd4d1-fcfc-41bd-85a9-c15ffad88948">360</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzExLTUtMS0xLTIwOTI1_a36219df-fe3d-43d8-8eb8-24b161cb9492">202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEzLTEtMS0xLTIwOTI1_4c552fab-1c8d-4470-9460-06d5520763b9">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEzLTMtMS0xLTIwOTI1_72e88c3f-3a9d-4bdf-9ea7-d5257452f523">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEzLTUtMS0xLTIwOTI1_7389c1bd-75b1-47c1-a0d0-ea2bb9ee8b4f">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with purchases of treasury stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:TreasuryStockPurchasedbutNotyetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE0LTEtMS0xLTIwOTI1_c9a80683-95a2-4f7a-9677-1d75d0b1ea01">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="dgx:TreasuryStockPurchasedbutNotyetPaid" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE0LTMtMS0xLTIwOTI1_08a2c1a1-45a3-4f05-8ab9-92ee743fde46">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="dgx:TreasuryStockPurchasedbutNotyetPaid" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE0LTUtMS0xLTIwOTI1_e43e5ce4-2954-4c4e-b07f-34a2331e7987">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE1LTEtMS0xLTIwOTI1_e77b87cc-a537-4e31-839b-5bcdbf268b28">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE1LTMtMS0xLTIwOTI1_c208bc88-52d6-43c6-9506-a4336230aedc">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE1LTUtMS0xLTIwOTI1_b1ef5b26-fde9-476f-a3bc-ce4b0ed880d2">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends received from equity method investees</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE3LTEtMS0xLTM1NDI5_96109d34-ae68-487c-a438-87a451d9c144">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE3LTMtMS0xLTM1NDI5_66476b13-bdc5-4ae8-a685-2aa0e2f028f7">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE3LTUtMS0xLTM1NDI5_332b3fad-79a5-410a-90bd-4724fa424673">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE4LTEtMS0xLTIwOTI1_792853f3-ec84-4fb0-b0d9-6244ee244d3a">354</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE4LTMtMS0xLTIwOTI1_d652b282-dce9-4f5c-8a19-c900b8914c59">368</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE4LTUtMS0xLTIwOTI1_5842f3d9-a3bf-4caf-a44f-27795a8044f7">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE5LTEtMS0xLTIwOTI1_43d6dd43-f2ff-4884-a17b-64a4b66e618c">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE5LTMtMS0xLTIwOTI1_90156b9a-e13f-4bb7-8f92-208ee4c3dc65">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIwLTEtMS0xLTIwOTI1_e4db5f9a-a9a3-49ce-b26a-f4f28276c0fb">336</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIwLTMtMS0xLTIwOTI1_69d48c04-cbdb-4317-88e7-1fac773ae220">351</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIwLTUtMS0xLTIwOTI1_cfc103df-25df-4b7f-9194-0f34996a16ba">63</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIxLTEtMS0xLTIwOTI1_cf4aa290-37e6-4b0b-b41d-0df6cc9b7d16">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:Mergerconsiderationpaidpayablenet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIxLTMtMS0xLTIwOTI1_4d003093-cf3d-457c-bfa2-c7af0e11c220">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" sign="-" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIxLTUtMS0xLTIwOTI1_921716bb-83da-43c9-aa65-e5d7daa305f6">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIyLTEtMS0xLTIwOTI1_08c999db-8fea-4f58-9a80-a71f81c33eeb">331</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIyLTMtMS0xLTIwOTI1_4b170ce8-80fd-4cbb-b39f-80a399af94a0">351</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIyLTUtMS0xLTIwOTI1_aedb017e-56d8-4df2-86ec-a7c1f6709cdb">58</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIzLTMtMS0xLTIwOTI1_8a03994d-891f-46a1-8a62-e3c672b2ccd4">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzI0LTEtMS0xLTIwOTI1_77336c64-55ab-41e9-85c8-136d5dec2640">331</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzI0LTMtMS0xLTIwOTI1_1f73c962-ca64-4757-9208-17be04eac95a">330</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzI0LTUtMS0xLTIwOTI1_9bbfb226-3760-4d2f-a173-07480957ca8d">58</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzMtNC0xLTEtMjA5MjU_0c53c3b3-49dc-4e09-bd15-7b0bdb1e9dbc">185</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzMtNi0xLTEtMjA5MjU_698ac39e-d98d-44ff-887b-4d7ec9da41f7">185</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzMtOC0xLTEtMjM5MTE_a970e085-cf41-439f-bb34-4db461f71597">180</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzQtNC0xLTEtMjA5MjU_f0ded040-f7cd-4a89-9511-a33bc7479a57">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzQtNi0xLTEtMjA5MjU_2c8ce3dd-0c91-48a7-9ed7-8977d5237480">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzQtOC0xLTEtMjM5MTE_ab3685d4-01dd-45f7-8df3-4fd3279dde07">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzUtNC0xLTEtMjA5MjU_f47cdfc6-f9ac-45d3-8c72-288e1d188d3a">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzUtNi0xLTEtMjA5MjU_f9ebbcc5-2705-4be8-a3f7-0a29a586b9e5">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzUtOC0xLTEtMjM5MTE_eba27e70-dcbe-4f35-ada4-0b06b1e9fc52">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzYtNC0xLTEtMjA5MjU_30076094-e1f3-4141-bb2f-8897b34805e7">150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzYtNi0xLTEtMjA5MjU_dd2bd175-f667-49b6-9858-c6e1c4e9513f">219</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzYtOC0xLTEtMjM5MTE_5df7e5cf-96e0-4dd9-9d95-6e37305f1548">164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzctNC0xLTEtMjA5MjU_9acee96b-a743-4c55-a7aa-1185b4c016d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzctNi0xLTEtMjA5MjU_2d9f44a6-80c6-4207-94e8-539a962008fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzctOC0xLTEtMjA5MjU_ec145839-eccd-4b4c-9d8d-00b5a9f803cb">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_205"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90ZXh0cmVnaW9uOmMzZGFkNjgwZmU0ZDQ5NWViMTdiZGZlODhkNmFiNzM0XzIyOA_d033dbcd-e11c-4a7f-8fb3-fb17928b3d49" continuedAt="ie9271dd8beac4e768f3486c3623d65ea" escape="true">PROPERTY, PLANT AND EQUIPMENT</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie9271dd8beac4e768f3486c3623d65ea"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90ZXh0cmVnaW9uOmMzZGFkNjgwZmU0ZDQ5NWViMTdiZGZlODhkNmFiNzM0XzIzMQ_2fb7bef8-9a5d-4b45-ac6d-299467f55f80" continuedAt="i8ea6072b59c14e98ad8e53272d699c09" escape="true">Property, plant and equipment as of December&#160;31, 2021 and 2020 consisted of the following: </ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i8ea6072b59c14e98ad8e53272d699c09"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee54bfafa2142ab925140ee00165fea_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzItMS0xLTEtMjA5MjU_2bfc91fb-9cfa-464c-87a4-94111dcf245e">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95334650a7794ede9d0240487ccf5b99_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzItMy0xLTEtMjA5MjU_c73d508f-ad01-4a9a-a447-59b9bd65ba5a">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d5ebce76e5d403e9298f0728ff53d6e_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzMtMS0xLTEtMjA5MjU_c4a48f23-f6c0-4d0c-803a-c9c1001438b8">532</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c68c29716a45b6ae635ee994106a2f_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzMtMy0xLTEtMjA5MjU_3a790b21-e0c5-45b1-a6af-03914d85e3d3">526</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment and furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b876c41bbc04618b47e5868c157a986_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzQtMS0xLTEtMjA5MjU_27dca9b7-9dd7-468b-ada5-c57456863feb">2,009</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib69a77afcc7848b9bcdb721d263b8590_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzQtMy0xLTEtMjA5MjU_ebdf2d25-b426-443f-8105-4a62ee003927">1,974</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc448c5c6a4434ca848bbf1bcbbdbab_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzUtMS0xLTEtMjA5MjU_48e96a7d-db9a-4f45-99b8-55834a65b304">705</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0550e1e6602405196f7a86f02932b05_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzUtMy0xLTEtMjA5MjU_3a7b9dea-247d-4364-8e71-e5637baa8c89">666</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software developed or obtained for internal use</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850a9e2e7a37450487c5434158c02aec_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzYtMS0xLTEtMjA5MjU_2edd65d1-d1af-469d-a881-f979aafd6239">1,292</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3445b8f4bd484038bb1c8dba887da7aa_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzYtMy0xLTEtMjA5MjU_5cf6eefc-8276-4cb4-a69b-0aee4eed4dbe">1,209</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9051075426f64d9fb6d5c2874af92f58_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzctMS0xLTEtMjA5MjU_cb7d8f2e-8d3c-494d-9d96-26504fcfb9f1">214</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i703f397efc54465491f61111e9d00225_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzctMy0xLTEtMjA5MjU_e5efab70-69bb-4e05-909b-ae62949b9f92">202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzgtMS0xLTEtMjA5MjU_4fa2a11f-128e-4ad3-8603-7f5646bf430b">4,795</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzgtMy0xLTEtMjA5MjU_263dfdc4-38ff-4147-a0d2-18c69cb78c71">4,619</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzktMS0xLTEtMjA5MjU_2e12e776-b21c-47ca-94fa-3c5711153481">3,088</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzktMy0xLTEtMjA5MjU_6ccaae57-49db-4939-a676-fc31be738b09">2,992</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzEwLTEtMS0xLTIwOTI1_882312cd-2425-4b0c-b192-8793d44e9c29">1,707</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzEwLTMtMS0xLTIwOTI1_3a0e1407-7751-45bb-b2f6-295235715357">1,627</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December 31, 2019, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i75cf772afd4440dbabbaa7a8d8609ebd_D20190101-20191231" decimals="-6" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90ZXh0cmVnaW9uOmMzZGFkNjgwZmU0ZDQ5NWViMTdiZGZlODhkNmFiNzM0Xzc2OTY1ODEzOTQ5NTA_db751913-b17c-4b7c-a22c-52c0265b53b1">73</ix:nonFraction>&#160;million gain in other operating (income) expense, net on the sale and leaseback of a property.</span></div></ix:continuation><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_208"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90ZXh0cmVnaW9uOjJiM2I4MTI1ZWVlOTQ1OWViYjE4NmM0ZGIwOTZlZDBmXzEwNDg_27d6a42e-3c17-4161-8663-1a054a21fd50" continuedAt="icb97cb85f5084c529ccb1e77281597ae" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icb97cb85f5084c529ccb1e77281597ae" continuedAt="icfd2bbb7faad49ca92625dfb73009b91"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90ZXh0cmVnaW9uOjJiM2I4MTI1ZWVlOTQ1OWViYjE4NmM0ZGIwOTZlZDBmXzEwMjk_bdbc1e68-b0db-4dcb-999a-449ea3b20f7e" continuedAt="ia2ead1fcee7e4907b34f49b25104ec03" escape="true">The changes in goodwill for the years ended December&#160;31, 2021 and 2020 were as follows:</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ia2ead1fcee7e4907b34f49b25104ec03"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzItMS0xLTEtMjA5MjU_8d4dec95-af68-4535-be1e-b2e88a746a0d">6,873</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzItMy0xLTEtMjA5MjU_9e9b258d-cb51-4e01-830a-8cee5e5fc111">6,619</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzMtMS0xLTEtMjA5MjU_25417167-96cc-4c31-a7f9-d14361ea1661">228</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzMtMy0xLTEtMjA5MjU_a8595fd8-67e6-4097-b035-9c92c03f2670">247</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzQtMS0xLTEtMjA5MjU_e39b5ec6-b366-4e55-894f-3868e325973c">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzQtMy0xLTEtMjA5MjU_262dee17-2e07-4a10-96fd-a1d1abefae11">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzUtMS0xLTEtMjA5MjU_27d44ca8-cb65-4ac4-a985-3a0e4ed48eda">7,095</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzUtMy0xLTEtMjA5MjU_44211a6c-2b26-4716-8353-f5a7c2af0411">6,873</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of December&#160;31, 2021 and 2020 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, goodwill acquired during the period was principally associated with the acquisitions of the assets of Mercy Health and assets of Labtech (see Note 5). For the year ended December&#160;31, 2021, adjustments to goodwill related to foreign currency translation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, goodwill acquired during the period was principally associated with the acquisitions of Blueprint Genetics, assets of Memorial Hermann and MACL (see Note 5). For the year ended December&#160;31, 2020, adjustments to goodwill related to foreign currency translation. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90ZXh0cmVnaW9uOjJiM2I4MTI1ZWVlOTQ1OWViYjE4NmM0ZGIwOTZlZDBmXzEwNDM_631f3edb-4b69-4b16-b123-29f6007ec206" continuedAt="i63ef6fe871a249e58bc9038867f40485" escape="true">Intangible assets as of December&#160;31, 2021 and 2020 consisted of the following:</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="icfd2bbb7faad49ca92625dfb73009b91"><div style="margin-top:5pt"><ix:continuation id="i63ef6fe871a249e58bc9038867f40485"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.436%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie440f7efd91b4288b67e34da88f9d851_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtMS0xLTEtMjA5MjU_5c8933bc-cbf3-4a4a-a12e-14d3ef9a7e21">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b6430db74f74cdba668c4da15ce72f5_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtMy0xLTEtMjA5MjU_eae215af-c1b2-46cc-a178-e4b125632192">1,581</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b6430db74f74cdba668c4da15ce72f5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtNS0xLTEtMjA5MjU_33aa3626-b733-4614-ab83-8c6cb464ab58">726</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b6430db74f74cdba668c4da15ce72f5_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtNy0xLTEtMjA5MjU_ccdf86d9-15f1-442f-839e-c431fd53dea3">855</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19172532941b40db90a9673c0a833751_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtOS0xLTEtMjA5MjU_2285e4cc-3c22-4252-981d-1108c8ebde94">1,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19172532941b40db90a9673c0a833751_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtMTEtMS0xLTIwOTI1_1454cd6b-a20d-402a-8425-1f9b741ba68b">638</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19172532941b40db90a9673c0a833751_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtMTMtMS0xLTIwOTI1_a8d7fc35-29a8-4c17-bb51-16ae14f5e952">841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2ac379b1564746b29091a6803b4e237e_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtMS0xLTEtMjA5MjU_072d616b-fc3c-482d-bbf5-e1b3ed369a76">9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic96f44c6128f47809c839fe1a70df50d_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtMy0xLTEtMjA5MjU_fa7a3d20-20ea-4d9b-a414-9dd2895fa942">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic96f44c6128f47809c839fe1a70df50d_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtNS0xLTEtMjA5MjU_bdb2aadc-788e-48cb-8b38-5a6ae75bc4cc">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic96f44c6128f47809c839fe1a70df50d_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtNy0xLTEtMjA5MjU_bfbdd9cc-7b15-4619-9c19-f1a90e1e716c">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01eaebddea0d433ea24e6c5ef38bd564_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtOS0xLTEtMjA5MjU_0230708b-5e84-456b-bfb2-59289cb0505d">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01eaebddea0d433ea24e6c5ef38bd564_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtMTEtMS0xLTIwOTI1_042019b8-bb9f-4bff-8c3c-81ee0a191fa1">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01eaebddea0d433ea24e6c5ef38bd564_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtMTMtMS0xLTIwOTI1_7a48aaf7-3b3a-4503-be47-5baa2da042d1">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic8c4fd41a16d47c691063b053f0f15a1_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtMS0xLTEtMjA5MjU_666e2b5a-bef6-4598-8a24-d78c7c565adc">14</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id49dc7dd9f1c473ba5418fbddca06d3f_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtMy0xLTEtMjA5MjU_304d637a-64ab-4cf3-a945-c46b6b0bfa6c">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id49dc7dd9f1c473ba5418fbddca06d3f_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtNS0xLTEtMjA5MjU_61e423d0-bcc3-4949-aec1-e93ae6bc8017">74</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id49dc7dd9f1c473ba5418fbddca06d3f_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtNy0xLTEtMjA5MjU_aa49f4fb-d689-4fac-b19c-dfedd6407dc4">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf12734ab0ab46498369e1f89b24439b_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtOS0xLTEtMjA5MjU_1efacf86-7987-4816-b92c-8e866e32a69a">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf12734ab0ab46498369e1f89b24439b_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtMTEtMS0xLTIwOTI1_6b85644a-c444-4404-b173-60bfc039af26">65</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf12734ab0ab46498369e1f89b24439b_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtMTMtMS0xLTIwOTI1_6b9e4108-07c8-430b-8255-e6cefc62a660">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i662626ed24964bfba9dc3b27519b5804_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtMS0xLTEtMjA5MjU_94ed333a-3ad9-4330-88e2-a5e96beda494">5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7ac3e799d44879aad973d51eb36f14_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtMy0xLTEtMjA5MjU_960fdce5-bf58-401a-af4b-bf55a293fee2">109</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7ac3e799d44879aad973d51eb36f14_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtNS0xLTEtMjA5MjU_e5641315-3bd1-4ac2-9540-dd614aa0e2b4">101</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7ac3e799d44879aad973d51eb36f14_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtNy0xLTEtMjA5MjU_61563b45-2a66-4b43-9040-b400ed9f0486">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0367af741674c3fb7c7d805734fd8e1_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtOS0xLTEtMjA5MjU_caad149e-9599-4419-ab0e-7a5593350d5e">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0367af741674c3fb7c7d805734fd8e1_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtMTEtMS0xLTIwOTI1_bec99483-227a-4058-8a11-f51e5443aa56">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0367af741674c3fb7c7d805734fd8e1_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtMTMtMS0xLTIwOTI1_9bf437ca-06c9-4753-bb21-5c6a02af0344">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a08e02b7c23441cb6f556cdb634cb88_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctMS0xLTEtMjA5MjU_ce9ac79b-d462-4d6f-a3be-030e6ea3dd21">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97af82c328c645e99f19d0e2e6ce85e0_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctMy0xLTEtMjA5MjU_489c229b-6ae3-491a-8879-a1fc9cb6ee62">1,834</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97af82c328c645e99f19d0e2e6ce85e0_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctNS0xLTEtMjA5MjU_caed961d-446d-4cfd-aa80-cdcd2b1ac1de">903</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97af82c328c645e99f19d0e2e6ce85e0_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctNy0xLTEtMjA5MjU_42d732e8-88aa-4ef6-803b-a7d636979b99">931</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05d194442c87432d9686414335afe7cf_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctOS0xLTEtMjA5MjU_d58bb44e-a9b7-4408-9665-b807461c1b7f">1,731</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05d194442c87432d9686414335afe7cf_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctMTEtMS0xLTIwOTI1_271a0f3e-fb86-4563-8b69-0ea3df972bce">800</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05d194442c87432d9686414335afe7cf_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctMTMtMS0xLTIwOTI1_c078fa3e-08ef-4af2-b4fe-1e7a888c45f6">931</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1456547e481a4de1a93ec35f388b1295_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEwLTMtMS0xLTIwOTI1_a48179c6-04b3-4177-8903-473565535bdb">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1456547e481a4de1a93ec35f388b1295_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEwLTctMS0xLTIwOTI1_94359647-333c-4fed-a23d-524039386a10">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70b2a42da95c4ef2a98b0f15b9f4b9c7_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEwLTktMS0xLTIwOTI1_31d279ad-fcda-4ff1-a8e8-8d5c34fd6d1e">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70b2a42da95c4ef2a98b0f15b9f4b9c7_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEwLTEzLTEtMS0yMDkyNQ_c08b823e-b99f-49d5-8de7-ff54e85afd4a">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5164e43d9194c4eb7704645ad2ab56a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzExLTMtMS0xLTIwOTI1_222f1f2f-d281-4429-9c1f-10fb041df11b">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5164e43d9194c4eb7704645ad2ab56a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzExLTctMS0xLTIwOTI1_e6a17e7c-d333-4de3-b99d-4b4942d57b92">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb21621cd5b4062b5cb405b6542855f_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzExLTktMS0xLTIwOTI1_3f708403-245f-4ebc-ad3f-3a8ffccc91ab">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb21621cd5b4062b5cb405b6542855f_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzExLTEzLTEtMS0yMDkyNQ_d46d965a-49f3-4331-8dbe-dfcd3b1efc18">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTMtMS0xLTIwOTI1_e78a1e3a-1cd7-42a0-9b77-14471ce9eabb">2,070</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTUtMS0xLTIwOTI1_9e328a6f-bbf4-4b60-a10e-632476dca4d9">903</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTctMS0xLTIwOTI1_2bbea2bd-e926-4b0a-ac93-26c87fa60448">1,167</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTktMS0xLTIwOTI1_dc257220-30d3-41d7-837b-2c0f705ddc99">1,967</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTExLTEtMS0yMDkyNQ_644241fa-9a14-476f-a0e7-d0c0f0a5c8e9">800</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTEzLTEtMS0yMDkyNQ_6e01ef76-f86a-4a29-96fa-c167d9c43af7">1,167</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90ZXh0cmVnaW9uOjJiM2I4MTI1ZWVlOTQ1OWViYjE4NmM0ZGIwOTZlZDBmXzEwMjI_f2246eb4-53fa-4d9d-822b-b9514f567c37" continuedAt="ic72edb4873c7467b9183c4c7e7405d86" escape="true">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December&#160;31, 2021 is as follows:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="ic72edb4873c7467b9183c4c7e7405d86"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.959%"><tr><td style="width:1.0%"></td><td style="width:71.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzEtMS0xLTEtMjA5MjU_24905cf7-b60b-4fc9-a2cb-edc468cf215b">105</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzItMS0xLTEtMjA5MjU_1ddc47a2-1f7e-4df3-8d36-6ab589342b69">103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzMtMS0xLTEtMjA5MjU_48cb3bd0-4fb0-44bc-a84a-a48f1a789423">100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzQtMS0xLTEtMjA5MjU_d23ba4e9-5144-4a42-9ed1-9684ba2e59cf">98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzUtMS0xLTEtMjA5MjU_5c8e7f9d-ff4c-42d0-9522-4deab8559c34">93</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzYtMS0xLTEtMjA5MjU_8b613026-3a6d-48a2-85b8-da07ea112e44">432</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzctMS0xLTEtMjA5MjU_0ee75d2c-e2e1-41f4-8222-f57723814765">931</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_211"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90ZXh0cmVnaW9uOjExNThmOTJhYjg1NDQ4MTU4ZjlhNmJhOGNlZDJmZGMyXzEzOA_014a0830-24b8-409e-a741-43163c552bdb" continuedAt="i342f913d9b7d43ef908d351a7762573f" escape="true">ACCOUNTS PAYABLE AND ACCRUED EXPENSES </ix:nonNumeric></span></div><ix:continuation id="i342f913d9b7d43ef908d351a7762573f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90ZXh0cmVnaW9uOjExNThmOTJhYjg1NDQ4MTU4ZjlhNmJhOGNlZDJmZGMyXzE0Mw_1add2c2b-cd11-4479-8356-52a742202e10" continuedAt="id2b6c3e937bf455584ece7baf07a80c0" escape="true">Accounts payable and accrued expenses as of December&#160;31, 2021 and 2020 consisted of the following: </ix:nonNumeric></span></div><div style="text-align:center;text-indent:36pt"><ix:continuation id="id2b6c3e937bf455584ece7baf07a80c0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages and benefits (including incentive compensation)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzItMS0xLTEtMjA5MjU_b24b3594-6da5-411f-affc-8528df409fca">518</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzItMy0xLTEtMjA5MjU_46020abe-2e12-4965-a9a7-3ccf3ae98a32">502</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzMtMS0xLTEtMjA5MjU_39777870-3306-46f9-bf1f-c498315de6b9">460</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzMtMy0xLTEtMjA5MjU_f19a1f9a-8e40-4295-bdc4-fce916f00345">356</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzQtMS0xLTEtMjA5MjU_f5c9269e-e1a3-46f4-a674-1d4abff046b5">357</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzQtMy0xLTEtMjA5MjU_5446a75b-8927-4c5e-b149-ff3cf5204f18">446</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overdrafts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:BankOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzUtMS0xLTEtMjA5MjU_eac85bfa-0292-4eb9-944a-1356619a589a">116</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:BankOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzUtMy0xLTEtMjA5MjU_f15939ef-9a8a-40ec-81be-a4639ae7ef2c">153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzYtMS0xLTEtMjA5MjU_a766c1e3-eeee-4ffa-81ca-e3f4bd25c889">74</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzYtMy0xLTEtMjA5MjU_62e0b7b8-20ec-451d-ac0e-51064312e9a6">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AccruedInsuranceCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzctMS0xLTEtMjA5MjU_fe014513-0bce-4576-bb69-776a49b5b5d5">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AccruedInsuranceCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzctMy0xLTEtMjA5MjU_d90e1565-b9f7-4c89-9427-d3d8c0c2264b">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzgtMS0xLTEtMjA5MjU_b16c331d-7863-4956-9c18-c029313f872b">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzgtMy0xLTEtMjA5MjU_a20b8eec-c462-459d-9baa-9a63397d171b">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzktMS0xLTEtMjA5MjU_dc93e125-b3f8-460a-983d-8015b766df37">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzktMy0xLTEtMjA5MjU_47545c0e-f194-489d-bb40-2e4fb4c7052e">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:MergerConsiderationPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzEwLTEtMS0xLTIwOTI1_3d947ac5-513e-4bfd-bc92-4f69ecd17f29">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="dgx:MergerConsiderationPayableCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzEwLTMtMS0xLTIwOTI1_b604ffd5-b377-4376-a91f-8bae0b66653a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzExLTEtMS0xLTIwOTI1_f582b23b-cab3-4053-b31c-e4f40bd626ce">1,600</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzExLTMtMS0xLTIwOTI1_2a767f8c-003b-4289-bfb6-57903b595804">1,633</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_214"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzY5ODA_5271e66f-dfc5-4614-9afd-ef0ac11379d5" continuedAt="idea7afaba95b49cbbf20d36b794a6e7a" escape="true">DEBT</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="idea7afaba95b49cbbf20d36b794a6e7a" continuedAt="i0934e8cd93984a1bae4cd88c60c13103"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzY5NzI_b82e176e-134b-4432-9e26-86ab60b96922" continuedAt="ibeb6bc9b970c48f9a7c099895ff3d6a3" escape="true">Long-term debt (including finance lease obligations) as of December&#160;31, 2021 and 2020 consisted of the following: </ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ibeb6bc9b970c48f9a7c099895ff3d6a3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:77.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0594f257da04350b8a4a4b497e30e2e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzUtMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjo3MzI4YjBiNmI4ODU0MzRmOGI5YTQwMTk0NjA2OTU4Zl80_3ae33500-b561-4a5a-9f2c-6a515c12a7f0">4.25</ix:nonFraction>% Senior Notes due April 2024</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0594f257da04350b8a4a4b497e30e2e_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzUtMS0xLTEtMjA5MjU_72cded29-1baa-404d-b316-98fdfb735b9a">311</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c6fef0c959f4836b6be1689a5919adf_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzUtMy0xLTEtMjA5MjU_6a6e4568-39f5-4e1d-82f2-a693eef52c0b">316</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7fadb78c01474e89b32f31ed14c21f18_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzYtMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjo1YTM4OTNjNDBjMTg0YzRiOGIyY2JjNzUyYWY4NTk2OV80_73a1476c-985a-4578-a2c6-b1baf8e799f5">3.50</ix:nonFraction>% Senior Notes due March 2025</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fadb78c01474e89b32f31ed14c21f18_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzYtMS0xLTEtMjA5MjU_c93dc983-b41a-4f1a-8eb2-b4aea835dac9">616</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7492430de4dbfa02f30eb630168d1_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzYtMy0xLTEtMjA5MjU_0a2786de-8cbb-48ea-a69f-2ef332e35d6a">622</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5202c6f3e7cf486b94bb890d000fb968_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzctMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjowNDY1MTliMzA5OWI0YzY3YWUzMzQ1ZTI2NzdkMjgyNl80_96b6fb29-f88a-4e3a-9146-a0fc6bde942a">3.45</ix:nonFraction>% Senior Notes due June 2026</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5202c6f3e7cf486b94bb890d000fb968_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzctMS0xLTEtMjA5MjU_4f954833-e8ff-4e82-8c12-db6bfd1f7294">510</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82cb0de9768a4944bc7de354bb2821b1_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzctMy0xLTEtMjA5MjU_e468f8cc-ce7f-4674-8813-29e7b84567da">512</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5df62b2adde478ea217430cd360e7e5_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzgtMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjoyN2VhYjBhODk1ZDk0OWIxYjZmMzAwZDAzY2VlMTZlY180_3252c1f0-496b-41e7-a6fa-9d8dbdc69610">4.20</ix:nonFraction>% Senior Notes due June 2029</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5df62b2adde478ea217430cd360e7e5_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzgtMS0xLTEtMjA5MjU_c3fcf4f4-ef18-4f9e-980d-4e78476b0737">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida0ded49fab44741b80d31af3ba70aae_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzgtMy0xLTEtMjA5MjU_fc93b499-5d99-4b2a-9c72-7f2d3ac50b49">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i766f928a9c9346038b77495a2d20fb42_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzktMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjpkZTg3MTk3NWQyOWQ0OTkyOTQ3NmM0NzQ1M2ZhNDA4NF80_dafea6a8-c710-42f2-98f7-825f54123979">2.95</ix:nonFraction>% Senior Notes due June 2030</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766f928a9c9346038b77495a2d20fb42_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzktMS0xLTEtMjA5MjU_051a8acf-cc8a-4e60-b611-d0007eecec43">798</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc060a500fe64aac9a2a927778e50857_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzktMy0xLTEtMjA5MjU_1d8da4e9-769c-4cf7-ab6d-14913e8eb341">798</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i378672f20c0d4618a6b6e81143b6720a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEwLTAtMS0xLTIwOTI1L3RleHRyZWdpb246MmQ1NDAzYjg5YWYyNDIwNDgxZTdiYjQwYzlhNWY1YWFfNA_c50326da-e990-42ab-ac29-cfeb2a7b9f04">2.80</ix:nonFraction>% Senior Notes due June 2031</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378672f20c0d4618a6b6e81143b6720a_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEwLTEtMS0xLTIwOTI1_4eee246f-3394-4407-8c48-b6e2c16fbb91">549</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88cc643b6da843ffa1c10a9f855203c7_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEwLTMtMS0xLTIwOTI1_b302fd9f-68a6-4a22-8477-6e2c67cd9600">549</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4ce1f1f310449c2b6c89c7e62ade9b8_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzExLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ZjQ1ZjU1MGM0NGU4NDUxYWFlZmRiMDNjMDVkMWY4OGRfNA_0f1ca107-a969-476c-8872-490ae4b5880e">6.95</ix:nonFraction>% Senior Notes due July 2037</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ce1f1f310449c2b6c89c7e62ade9b8_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzExLTEtMS0xLTIwOTI1_bd51526f-2a6c-4ade-aa2b-ba55b3261273">175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df76549d2994abd97388a4720896161_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzExLTMtMS0xLTIwOTI1_e1906bb5-e1d4-4ff0-b72e-42b7b9387f24">175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b9881c9daf746ff96ea2d9b6927e946_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246Y2IwNmFmYTRkYzNiNDU0NGJiYzY3YzM0N2NhYjYzODBfNA_496e6c97-8eb4-4d3b-9f24-d6f6f9d3c5db">5.75</ix:nonFraction>% Senior Notes due January 2040</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9881c9daf746ff96ea2d9b6927e946_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEyLTEtMS0xLTIwOTI1_be7fe12c-864b-4142-993a-7161c170db75">245</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82a4a8a3b9d14622adefe38f6d57418f_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEyLTMtMS0xLTIwOTI1_37db42cf-688f-48b6-abca-450b9fa6824e">245</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09bbac6d7bf04160afe3a6e074127aba_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEzLTAtMS0xLTIwOTI1L3RleHRyZWdpb246MzU0ZDJkMjA4M2UxNDYxNzg4ZWRhOTY1ZjI0YmNkMjRfNA_c1a02949-d1b3-4dea-820d-47230febeedf">4.70</ix:nonFraction>% Senior Notes due March 2045</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09bbac6d7bf04160afe3a6e074127aba_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEzLTEtMS0xLTIwOTI1_dbcc8c94-f531-4601-b1bb-4befb36e3c73">300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic73df93e889f4d69ac6970fe52f080ce_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEzLTMtMS0xLTIwOTI1_e6893972-1371-49cb-ae9b-dac42aac13f4">300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a32e3b91ca84b89b38c8ba51a6735ec_I20211231" decimals="-6" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE0LTEtMS0xLTIwOTI1_a75e02ec-1f31-4e07-a343-3aa1d18a6f7b">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72472dddee4a401c94ec4e9a3d939bc5_I20201231" decimals="-6" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE0LTMtMS0xLTIwOTI1_c2518b8a-779f-4d82-a6a8-709201c21b8c">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE1LTEtMS0xLTIwOTI1_3bcbc82e-6f79-45c4-a37d-ef13fdc0112c">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE1LTMtMS0xLTIwOTI1_b1367545-612c-45a4-9a64-04e3b3acfe0b">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE2LTEtMS0xLTIwOTI1_28de68cc-dc60-4d72-af83-a5ccdc7d8e2e">4,012</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE2LTMtMS0xLTIwOTI1_8f6393ad-d9f6-4be8-a3d3-7f708749383f">4,015</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE3LTEtMS0xLTIwOTI1_f95e4f2f-d6c4-4b82-8beb-0719828233ed">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE3LTMtMS0xLTIwOTI1_4915bbf9-0b05-4ac1-a2a5-6b0fbe5cf9e4">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE4LTEtMS0xLTIwOTI1_6f95de1e-41c8-4d41-8c14-b9dc9d84af8f">4,010</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE4LTMtMS0xLTIwOTI1_695151f6-245b-4c1e-8e60-60eb55075d9d">4,013</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Secured Receivables Credit Facility </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During October 2021, the Company amended its $<ix:nonFraction unitRef="usd" contextRef="ife8fa0dbace2463781c162f0d572554e_I20211031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzIyMg_68dd077e-65c4-40da-bed3-978fb0e8f8c1">600</ix:nonFraction>&#160;million secured receivables credit facility (the &#8220;Secured Receivables Credit Facility&#8221;), previously amended in October 2020, to extend the maturity dates for each underlying commitment by <ix:nonNumeric contextRef="i9f138175e3a44f5ebf659b1a78903b5d_D20211001-20211031" name="dgx:DebtInstrumentExtensionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzQwNQ_59045671-dfcf-4c80-876f-c19977c292ca">one year</ix:nonNumeric>, while maintaining the borrowing capacity under the facility at $<ix:nonFraction unitRef="usd" contextRef="ife8fa0dbace2463781c162f0d572554e_I20211031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzQ3Mg_351f4d70-635f-4735-b0b2-57d480c2d6ba">600</ix:nonFraction>&#160;million.  Under the Secured Receivables Credit Facility, the Company can borrow against a $<ix:nonFraction unitRef="usd" contextRef="i8413e7af478b4f60b3be63a14fc02040_I20211031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzU1Nw_533ab308-8afb-4313-a248-de50b34be824">250</ix:nonFraction>&#160;million loan commitment maturing October 2022 and a $<ix:nonFraction unitRef="usd" contextRef="id7273399a8b249109c5141327f9e2f70_I20211031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzU5NA_dfa6eb99-0475-471c-82fd-efd80186e8dc">250</ix:nonFraction>&#160;million loan commitment maturing October 2023, and can issue up to $<ix:nonFraction unitRef="usd" contextRef="if0f0ea4be7af4410af0e10d2186e1e37_I20211031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzY0Ng_7a0728cf-be44-4948-b4e0-b602dbc7647f">100</ix:nonFraction>&#160;million of letters of credit (see Note 18) through October 2023.  Borrowings under the Secured Receivables Credit Facility are collateralized by certain domestic receivables.  As of December&#160;31, 2021, interest on the borrowings under the Secured Receivables Credit Facility was based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread of <ix:nonFraction unitRef="number" contextRef="if5bd74de8e5d42bd9ceb6ea699aa16ca_D20211231-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzk4NQ_d21543cf-a573-48ab-9710-04a062716b76">0.725</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i1730f3f4c2874eff9f3ca20705fbdfce_D20211231-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzk5MQ_d6e88ef4-5a7d-4430-9923-b090dc4e721d">0.80</ix:nonFraction>%.  The Secured Receivables Credit Facility is subject to customary affirmative and negative covenants and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility.  As of both December&#160;31, 2021 and 2020, there were <ix:nonFraction unitRef="usd" contextRef="i90044be8ca1a4466aea5fb0404e36a2d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzEyNzI_5dabe0ce-7867-4321-9557-a7971001de11"><ix:nonFraction unitRef="usd" contextRef="i8e4a6015d1ef460f9e8ae76bf0c3381f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzEyNzI_9f8295dc-734d-4e28-8d46-ba34b9fe398c">no</ix:nonFraction></ix:nonFraction> outstanding borrowings under the Secured Receivables Credit Facility. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Unsecured Revolving Credit Facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During November 2021, the Company amended and restated the agreement for its $<ix:nonFraction unitRef="usd" contextRef="ia3d6de33f3ed4d19a2ec16d2ece3dab0_I20211130" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzE0MjA_77e3683d-539b-47e2-8b9a-f3dae7c307d9">750</ix:nonFraction>&#160;million senior unsecured revolving credit facility (the &#8220;Credit Facility&#8221; or "Senior Unsecured Revolving Credit Facility") to extend the maturity date to November 2026 while maintaining the borrowing capacity under the facility at $<ix:nonFraction unitRef="usd" contextRef="ia3d6de33f3ed4d19a2ec16d2ece3dab0_I20211130" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzc2OTY1ODE0MTkwMzI_7294fc74-5e71-4cd1-abe0-f7f0e15c3f9d">750</ix:nonFraction>&#160;million.  Under the Credit Facility, the Company can issue letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="icaa60f894264418b86cad34928e740c7_I20211130" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzE2MzY_1cad676a-4ff3-453c-9fa6-42a81ef02b38">150</ix:nonFraction>&#160;million (see Note 18).  Issued letters of credit reduce the available borrowing capacity under the Credit Facility.  Interest on the Credit Facility is based on certain published rates plus an applicable margin based on changes in the Company's public debt ratings.  At the option of the Company, it may elect to lock into LIBOR-based interest rates for periods up to six months.  Interest on any outstanding amounts not covered under LIBOR-based interest rate contracts is based on an alternate base rate, which is calculated by reference to the prime rate, the federal funds rate or an adjusted LIBOR rate.  As of December&#160;31, 2021, the Company's borrowing rate for LIBOR-based loans under the Credit Facility was LIBOR plus <ix:nonFraction unitRef="number" contextRef="ib618186b3e3648a0a5c22c9e567fe03f_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzIzNzg_bf2840f9-6875-4fb7-8ed3-7a2350743c21">1.00</ix:nonFraction>%.  The Credit Facility contains various covenants, including the maintenance of a financial leverage ratio, which could impact the Company's ability to, among other things, incur additional indebtedness.  As of both December&#160;31, 2021 and 2020, there were <ix:nonFraction unitRef="usd" contextRef="iae8c124c79124e13a5f8a65b35a85a2d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzM0Mjc_5d166b84-de90-47c5-8370-3b3a54409300"><ix:nonFraction unitRef="usd" contextRef="i8f48d5ae19c347f5a146cb05e040a26f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzM0Mjc_f32ba37b-c798-4ed0-8e45-a8ff07324ce4">no</ix:nonFraction></ix:nonFraction> outstanding borrowings under the Senior Unsecured Revolving Credit Facility.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><ix:continuation id="i0934e8cd93984a1bae4cd88c60c13103"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes Offerings</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company completed a senior notes offering, consisting of $<ix:nonFraction unitRef="usd" contextRef="if8194949fa694c51b9a86b2aa1a10860_I20200531" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzI3NDg3NzkwODMyMzU_463891c9-1ff8-4ad9-9fb2-6ff2fcb79865">550</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="if8194949fa694c51b9a86b2aa1a10860_I20200531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzI3NDg3NzkwODMyNzg_a1cb6d9c-b139-4180-b380-4a18360fe73f">2.80</ix:nonFraction>% senior notes due June 2031 (the &#8220;2031 Senior Notes&#8221;), which were issued at an original issue discount of $<ix:nonFraction unitRef="usd" contextRef="if8194949fa694c51b9a86b2aa1a10860_I20200531" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzI3NDg3NzkwODMyNjA_48443fd9-724e-4eb4-8d3d-1cecb6563f4d">1</ix:nonFraction>&#160;million.  The Company incurred $<ix:nonFraction unitRef="usd" contextRef="if8194949fa694c51b9a86b2aa1a10860_I20200531" decimals="-6" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzQxMTE_313d24a8-b1a8-4e5a-8867-29661eb733e0">5</ix:nonFraction>&#160;million of debt issuance costs associated with the 2031 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During November 2020, the net proceeds from the 2031 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under the Company's senior notes due April 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During January 2020, the Company redeemed in full the outstanding indebtedness under the Company's senior notes due January 2020 and senior notes due March 2020, using the net proceeds from the issuance, in December 2019, of the senior notes due June 2030.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, the Company recorded a loss on retirement of debt, principally comprised of premiums paid, of $<ix:nonFraction unitRef="usd" contextRef="i754db448c4a141e587eb41b3530387d7_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzYwMzI_a4687e92-8de5-4132-8242-1aa6cf88150a">9</ix:nonFraction>&#160;million in other income, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All of the senior notes are unsecured obligations of the Company and rank equally with the Company's other senior unsecured obligations.  None of the Company's senior notes have a sinking fund requirement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may redeem its outstanding senior notes prior to scheduled maturity, as a whole or in part, at a redemption price equal to the present value of the remaining scheduled payments of principal and interest, except for certain notes for which the Company also has an option to redeem such instruments at par value on or after dates specified in the indentures governing the notes ("the par value redemption option"). &#160;For notes with the par value redemption option, if such notes are redeemed prior to the specified dates, the redemption price calculations exclude any interest that would have been due after such dates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturities of Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzY5Nzg_93f9bc4e-70fe-43b5-bd7c-e92454237533" continuedAt="i6556cf5dac6c415e8910fb2ede22198e" escape="true">As of December&#160;31, 2021, long-term debt matures as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i6556cf5dac6c415e8910fb2ede22198e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:297.00pt"><tr><td style="width:1.0pt"></td><td style="width:235.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzEtMS0xLTEtMjA5MjU_a1aae57e-d563-40ba-aff7-a0444f77852b">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzItMS0xLTEtMjA5MjU_533cb66b-fb2e-402c-89ab-12287301ee87">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzMtMS0xLTEtMjA5MjU_a8d5dc12-9eda-46f5-834d-c007b68fe4cf">303</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzQtMS0xLTEtMjA5MjU_246b4c4d-1e39-4bee-8fbe-b56c7f45faa5">603</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzUtMS0xLTEtMjA5MjU_736725b9-714c-4ac8-bd98-c9052e997545">503</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzYtMS0xLTEtMjA5MjU_ecb4e626-24b0-4a75-b0d3-908a37758f33">2,596</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total maturities of long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LongTermDebtMaturitiesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzctMS0xLTEtMjA5MjU_d19cc462-8bcf-4f64-937c-2968a9e9c969">4,009</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzgtMS0xLTEtMjA5MjU_45474569-e487-4794-bfba-6dfdf4065efe">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzktMS0xLTEtMjA5MjU_3bcbc82e-6f79-45c4-a37d-ef13fdc0112c">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value basis adjustments attributable to hedged debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" sign="-" name="dgx:DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzEwLTEtMS0xLTIwOTI1_f362d223-6a0f-428e-97ba-9ec0d37c8130">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzExLTEtMS0xLTIwOTI1_3bdbc927-b829-4c1c-be2c-bd7da82fd656">4,012</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzEyLTEtMS0xLTIwOTI1_0e976754-b5d4-4290-9db9-5f85325d58e0">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzEzLTEtMS0xLTIwOTI1_c4c0d88f-43c5-4f5c-bdb4-25437c39209d">4,010</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_217"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTQ_65124396-17a5-40e8-a6dc-e079c12ec392" continuedAt="ic173f303ee6a48178fef2182607afef1" escape="true"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTU_c5eb06e6-3884-4350-9af7-12e75e02e52f" continuedAt="i2dc77799353a408eb3d1f2ff46c2d05d" escape="true">LEASES</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="ic173f303ee6a48178fef2182607afef1" continuedAt="i9b74f484724d418893037e958326fbe6"><ix:continuation id="i2dc77799353a408eb3d1f2ff46c2d05d" continuedAt="i1adf15f1363b4629a562fdf9a5c14c95"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4ODg_8cbd7a52-7a01-4843-b2c2-f638a08ef8c3" escape="true">The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_50c95c33-a401-4066-8573-e62f6ca75cd3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_6f7e233a-96d4-4732-aa53-9f719523830d">right-of-use asset</span></span>, representing the underlying asset during the lease term, and a lease <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_1997e471-5c97-4a99-87d8-0ad010e8dfa3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_2b9b9016-510b-480e-96bb-962223d0e820">liability</span></span>, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_375a58c6-c5ec-4296-b7ed-b111e088fff7"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_b44b257f-98c9-4e44-912d-5c75a894370c">liability</span></span> is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.</ix:nonNumeric>  For the years ended December&#160;31, 2021, 2020, and 2019, lease expense associated with short-term leases was not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company primarily uses its collateralized incremental borrowing rate in determining the present value of lease payments as the Company's leases generally do not provide an implicit rate.  Such incremental borrowing rates, which take into account interest rates offered to companies that have similar credit ratings to the Company, are determined using a portfolio approach which groups the Company&#8217;s leases based on tenor.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has lease agreements with (i) right-of-use asset payments and (ii) non-lease components (i.e., payments related to maintenance fees, utilities, etc.) which have been combined and accounted for as a single lease component. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's leases have remaining terms of less than <ix:nonNumeric contextRef="i5e3f8aa3f21c4630b2c2d3a505ba4881_D20210101-20211231" name="dgx:LeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzE5NjE_618eebf7-bbda-4b20-91c3-3d9e2f600c0b">1</ix:nonNumeric> year to <ix:nonNumeric contextRef="i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231" name="dgx:LeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzE5Njc_8544fdc6-eb81-4a20-bf96-ce4b1b794d60">15</ix:nonNumeric> years, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231" name="dgx:LeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzIwMzI_63181fd7-3ab0-4387-bb80-5def1e5abd16">15</ix:nonNumeric> years. The Company's lease terms may include renewal options that are reasonably certain to be exercised and termination options that are reasonably certain not to be exercised. Certain leases also include options to purchase the leased property.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain of the Company's lease agreements include rental payments adjusted periodically for inflation or a market rate which are included in the lease liabilities.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dgx:ScheduleOfLeaseByAssetTypeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4ODk_d533d52d-8894-43a2-b53e-419746233673" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's assets and liabilities for its lease agreements as of December&#160;31, 2021 and 2020 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:21.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.672%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.573%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzItNC0xLTEtMjA5MjU_7f5dba9b-a2e1-42a1-8994-78632d838697">597</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzItNi0xLTEtMjA5MjU_7dc651ce-2a7b-4f9b-b497-77b4437d0008">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzMtNC0xLTEtMjA5MjU_e1d47e11-f4f7-4864-89bf-9d2cf14ad413">29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzMtNi0xLTEtMjA5MjU_e0e4b2c6-8ae9-4f09-84cf-f40176a47293">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LeaseRightofUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzQtNC0xLTEtMjA5MjU_a918e34a-7355-4d66-92c6-a41583bcff46">626</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="dgx:LeaseRightofUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzQtNi0xLTEtMjA5MjU_9a8e277e-27a8-434b-92b8-3f14ae5d2a32">626</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzgtNC0xLTEtMjA5MjU_d515ec79-9f4a-4ea5-83e9-a33e45140dcd">151</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzgtNi0xLTEtMjA5MjU_57e7b086-4a4a-4e1f-96c1-c63b7d24dbfb">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzktNC0xLTEtMjA5MjU_c5740090-212f-48c9-8a82-5f9487df5f76">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzktNi0xLTEtMjA5MjU_ad31ac78-55ee-47f6-8ab7-f3e873686d31">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzExLTQtMS0xLTIwOTI1_0dfe896d-44f1-46a9-b8a1-9a7e389474c0">494</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzExLTYtMS0xLTIwOTI1_0e8557c5-ba1e-452e-af65-757192537d21">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_0ffa204f-63da-4cb5-97eb-2b95e023c547"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_47976c32-56f0-4b24-a8fa-f838f8d5f156">Long-term debt</span></span></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTQtMS0xLTIwOTI1_796b3a4b-0b1b-4906-9c65-354cb5172c6a">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTYtMS0xLTIwOTI1_a8f12235-cbc9-4263-b4cd-4f1c02d99d04">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEzLTQtMS0xLTIwOTI1_4aa30422-9469-4e55-881a-038a0c20d9f6">679</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="dgx:LeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEzLTYtMS0xLTIwOTI1_f5b9fe93-8566-40dd-b8a5-31aa2dbac33b">667</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Finance lease assets as of December&#160;31, 2021 and 2020 were recorded net of accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI2Njc_27f8e6c2-4598-4ab1-9f23-4ded32c5f645">8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI2NzQ_5d71cecb-f833-4e48-aef6-cfb7b0e1e915">14</ix:nonFraction>&#160;million, respectively.</span></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i9b74f484724d418893037e958326fbe6"><ix:continuation id="i1adf15f1363b4629a562fdf9a5c14c95"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTA_ea8b5cf8-d064-4a91-83c9-86d94479642d" continuedAt="ic67908c0c23442dc94bd676086233e73" escape="true">Components of lease cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</ix:nonNumeric></span></div><ix:continuation id="ic67908c0c23442dc94bd676086233e73"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.75pt"><tr><td style="width:1.0pt"></td><td style="width:247.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="dgx:OperatingLeaseFixedAndVariableCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzItMi0xLTEtMjA5MjU_b4a664ae-9bd5-4e9d-bfde-9da009a36984">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:OperatingLeaseFixedAndVariableCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzItNC0xLTEtMjA5MjU_3295f5b1-37d1-426c-8d9c-8b779eb672f4">300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:OperatingLeaseFixedAndVariableCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzItNS0xLTEtMzAyMjE_ef4ebf63-e69b-4c74-8b05-92a3c889f884">294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzUtMi0xLTEtMjA5MjU_7f2090c3-3344-4ae2-91c3-d2ed6f9e962d">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzUtNC0xLTEtMjA5MjU_b9895e73-d280-49eb-80e0-602eccd61a0c">6</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzUtNS0xLTEtMzAyMjc_a812e998-5cd5-4c75-abc2-6b55b32065c8">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzYtMi0xLTEtMjA5MjU_0d42ab2a-eb8d-4d06-8e62-bac37ffa4348">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzYtNC0xLTEtMjA5MjU_6c2fd261-2a4f-457b-8baa-09b31e45cc1e">3</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzYtNS0xLTEtMzAyNTE_8e5de20b-7c48-434d-86fb-5748ab396a63">3</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzctMi0xLTEtMjA5MjU_b3578c74-73f6-46a8-ac18-02edcdfb5170">325</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzctNC0xLTEtMjA5MjU_8eb045f7-215a-4d80-a076-bfd041801f46">309</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzctNS0xLTEtMzA3MDg_563a0e45-be86-45bb-8347-69dd1ff423b7">304</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="dgx:ShorttermLeaseandVariableLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI5NzI_7c6bae93-0c02-4056-aa96-88196d1077cf">140</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:ShorttermLeaseandVariableLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4Xzc2OTY1ODEzOTg3MzI_7077beb3-7f64-41f4-8fb4-1a518397428f">120</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:ShorttermLeaseandVariableLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4Xzc2OTY1ODEzOTg3MTg_129b7133-3fe9-4f64-bf79-556341d1c25f">120</ix:nonFraction>&#160;million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTE_01e1f8df-3a99-4662-9af5-c13c72e31a58" continuedAt="i178063e6bc2347d093fe4f3d8b208ba8" escape="true"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTI_a36fe7f5-9325-4c3d-8e50-07628db4eeec" continuedAt="i29506985855b442986c78ddc6751f299" escape="true">The maturity of the Company's lease liabilities as of December&#160;31, 2021 is as follows:</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i178063e6bc2347d093fe4f3d8b208ba8"><ix:continuation id="i29506985855b442986c78ddc6751f299"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:365.25pt"><tr><td style="width:1.0pt"></td><td style="width:163.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzEtMi0xLTEtMjA5MjU_25e4e268-2e01-48e3-a285-b109f053752e">169</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzEtNC0xLTEtMjA5MjU_385acc19-602e-469b-911c-f3e20035c71c">4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzEtNi0xLTEtMjA5MjU_8048813d-0fe1-463e-9fd0-899d4b1d6876">173</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzItMi0xLTEtMjA5MjU_59ae882e-bafb-40b2-906e-0f55be110872">153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzItNC0xLTEtMjA5MjU_236d9bf8-fe99-46ac-8389-20455bf15f9f">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzItNi0xLTEtMjA5MjU_5fb79ed9-5b63-43c3-93fd-0b6998ba7aa3">157</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzMtMi0xLTEtMjA5MjU_d1befc27-b5e8-4c38-8dee-dc3bab8ef0ab">116</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzMtNC0xLTEtMjA5MjU_fc0b2942-719c-469f-a79f-b99593361f96">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzMtNi0xLTEtMjA5MjU_796b18c0-5704-4483-890f-7b4122da172a">121</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzQtMi0xLTEtMjA5MjU_906592db-6007-4ad6-8683-f484f310e55b">83</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzQtNC0xLTEtMjA5MjU_ef8f9f55-cc88-46d9-804b-e7f4333a52b1">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzQtNi0xLTEtMjA5MjU_4cb3cf99-8f79-465d-9e80-33f1a58569c0">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzUtMi0xLTEtMjA5MjU_c2a3c5a6-9951-4988-bbee-cca4303dbb7d">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzUtNC0xLTEtMjA5MjU_584fd2c3-114f-4f60-b857-95020360cf20">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzUtNi0xLTEtMjA5MjU_9d76abbf-67bc-41ea-b555-a9823fd56703">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzYtMi0xLTEtMjA5MjU_d72b6d71-531c-4ba6-b085-db21aaa2ef6a">139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzYtNC0xLTEtMjA5MjU_cf040a6b-e655-4e7a-a47e-6a1e2e387d67">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzYtNi0xLTEtMjA5MjU_d319c59d-0b07-4977-831c-8e27cbeec520">166</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzctMi0xLTEtMjA5MjU_f917b905-758f-4638-94a9-ad407f557f71">714</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzctNC0xLTEtMjA5MjU_cf9e2f63-3cb6-4636-845e-f1d492469471">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzctNi0xLTEtMjA5MjU_16be4322-3e61-4d3a-b090-35e4d63b3164">764</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzgtMi0xLTEtMjA5MjU_12a721cc-0290-4b58-aa49-b11177f60039">69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzgtNC0xLTEtMjA5MjU_925d2135-f2f5-4068-af0e-5a31bcff3c22">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzgtNi0xLTEtMjA5MjU_ff0bc29b-850a-48a3-a9ee-8de4fe1d9932">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzktMi0xLTEtMjA5MjU_f5df9e9b-956e-4219-8200-42a3f61309b4">645</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzktNC0xLTEtMjA5MjU_aa0cfc21-62c0-4963-92d1-0cf70086361a">34</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:OperatingandFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzktNi0xLTEtMjA5MjU_95796fd6-1f50-4f03-97b5-4f67f59bd432">679</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dgx:ScheduleofLeaseTermandDiscountRateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTM_6f05616b-a903-49a3-8d06-cf41827ffdf6" continuedAt="ie825f7ab8bb2418eb909a536ee34feac" escape="true">Lease term and discount rate as of December&#160;31, 2021 and 2020 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ie825f7ab8bb2418eb909a536ee34feac"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:363.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzItMS0xLTEtMjA5MjU_d9b20c18-b79b-44a9-a442-c94de53a7043">6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzItMy0xLTEtMjA5MjU_10d26d72-7e16-4271-8672-b6a849825c23">6</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzMtMS0xLTEtMjA5MjU_6ea8c742-4088-40c5-8373-a82ce7f722d7">11</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzMtMy0xLTEtMjA5MjU_1ce17e67-0671-4c01-92f5-fe6c6ce8cc39">13</ix:nonNumeric></span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzYtMS0xLTEtMjA5MjU_00a77682-a5c7-4d96-879b-e686f27521bf">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzYtMy0xLTEtMjA5MjU_477d1474-df96-473d-81a4-8286e7d72ea4">3.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzctMS0xLTEtMjA5MjU_9474ce18-4cae-4530-9bc4-0854bb2cf40d">6.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzctMy0xLTEtMjA5MjU_06134764-e588-45bb-90d2-811c18328432">8.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's discount rates for its operating leases were primarily determined using the Company's incremental borrowing rate.  The Company's weighted-average discount rate for its finance leases principally reflects the implicit interest rate on a lease obligation assumed in a business combination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 9 for cash flow information on cash paid for amounts included in the measurement of lease liabilities, leased assets obtained in exchange for new operating lease liabilities, and leased assets obtained in exchange for new finance lease liabilities for the years ended December&#160;31, 2021, 2020 and 2019.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_220"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90ZXh0cmVnaW9uOmRhNWViYjdjZDFlZDQxOTU4YjIwZDU2MTFmZTgwYTdhXzMxMjQ_5ec8142f-4fba-4dc6-96f1-7381d011482e" continuedAt="i41df5ffe3ab342fdaba16e3cd0f9cbc6" escape="true">FINANCIAL INSTRUMENTS </ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i41df5ffe3ab342fdaba16e3cd0f9cbc6" continuedAt="i75dff72e96a349a289515e43a5bc225e">&#160;&#160;&#160;&#160;</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i75dff72e96a349a289515e43a5bc225e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt. All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90ZXh0cmVnaW9uOmRhNWViYjdjZDFlZDQxOTU4YjIwZDU2MTFmZTgwYTdhXzI3NDg3NzkwNzY1NDM_57bd99bb-7bed-46a8-a9b3-85967c4de3d0" continuedAt="i94aeaea48f0a4808964f357a0abadd84" escape="true">As of December&#160;31, 2021 and 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i94aeaea48f0a4808964f357a0abadd84"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.380%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088cf7af90a4499da82634db3e749425_I20211231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZToxMWE3MGU0OTBiZGQ0ZjM0OGVkZjY4NTM1NTFiYmRlYy90YWJsZXJhbmdlOjExYTcwZTQ5MGJkZDRmMzQ4ZWRmNjg1MzU1MWJiZGVjXzItMy0xLTEtMjA5MjU_dc12d775-a961-496a-8385-412165a36098">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088cf7af90a4499da82634db3e749425_I20211231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZToxMWE3MGU0OTBiZGQ0ZjM0OGVkZjY4NTM1NTFiYmRlYy90YWJsZXJhbmdlOjExYTcwZTQ5MGJkZDRmMzQ4ZWRmNjg1MzU1MWJiZGVjXzItNS0xLTEtMjA5MjU_89bedb0f-29d3-4497-bd43-54fb39957662">38</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b611f9fb71a4871a95107ddf00e5972_I20201231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZToxMWE3MGU0OTBiZGQ0ZjM0OGVkZjY4NTM1NTFiYmRlYy90YWJsZXJhbmdlOjExYTcwZTQ5MGJkZDRmMzQ4ZWRmNjg1MzU1MWJiZGVjXzItNy0xLTEtMjA5MjU_81e2fe5d-f8c2-4613-8742-b015ab22fc09">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b611f9fb71a4871a95107ddf00e5972_I20201231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZToxMWE3MGU0OTBiZGQ0ZjM0OGVkZjY4NTM1NTFiYmRlYy90YWJsZXJhbmdlOjExYTcwZTQ5MGJkZDRmMzQ4ZWRmNjg1MzU1MWJiZGVjXzItOS0xLTEtMjA5MjU_02bee02d-c566-481f-a508-4a995295761c">51</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both December&#160;31, 2021 and 2020, the entire balance is associated with remaining unamortized hedging adjustments on discounted relationships. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the years ended December&#160;31, 2021, 2020 and 2019, respectively:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.246%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzMtMy0xLTEtMjA5MjU_c54a1a02-6958-48f2-8a59-f40669f04b2a">369</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzMtNS0xLTEtMjA5MjU_29df900c-126b-4be3-96ff-7c52249cea07">76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzMtNy0xLTEtMjA5MjU_f9213044-7e22-4814-8cb5-da01d3dbcf3d">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c302abd9aa427ba7d0156fe01460ec_D20210101-20211231" decimals="-6" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzYtMy0xLTEtMjA5MjU_792f3ae2-467e-4795-b9e2-5cf591abb949">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cc5031c24924569b75aea0f1da108a1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzYtNS0xLTEtMjA5MjU_cac9daa8-4bbb-4719-843b-1095dda82683">68</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i003a13fe51aa4e869629249e6bbb90d5_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzYtNy0xLTEtMjA5MjU_8c64acfe-8dc7-4bf5-a7b7-98a7e3dc3f0e">65</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8afa4ad788744a6a80595836c35781a_D20210101-20211231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzctMy0xLTEtMjA5MjU_4a264888-31c0-4932-9347-8add26efa4e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia36018d33c604038aa1aa14c366c4dd2_D20200101-20201231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzctNS0xLTEtMjA5MjU_9143b2fe-ae2d-43b8-9f9b-cc540cc970c5">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85aba486145433bbe90c96b488714b9_D20190101-20191231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzctNy0xLTEtMjA5MjU_6fd216e1-54a5-42a8-a091-c626781b6d37">65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div id="ib4001cf8768244cca3f772bfc08f865b_223"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzQ2OTI_231639b3-baa3-40e3-aad6-528e642729cd" continuedAt="ibc970b8804354d2c99d93e578d40a502" escape="true">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ix:nonNumeric></span></div><ix:continuation id="ibc970b8804354d2c99d93e578d40a502" continuedAt="i011e3807671448d3b17afb15916f30fd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Series Preferred Stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="ice911685201a460b8af3f58815059f82_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzE2OQ_c5a88470-0403-40df-a9a6-f8e2486f1f45">10</ix:nonFraction> million shares of Series Preferred Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIxNg_a9d23929-a1c9-4b80-8d38-825303960489">1.00</ix:nonFraction> per share.  The Company's Board of Directors has the authority to issue such shares without stockholder approval and to determine the designations, preferences, rights and restrictions of such shares.  <ix:nonFraction unitRef="shares" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzQyMQ_c86e5d72-9815-4a27-91d9-774f49592077">No</ix:nonFraction> shares are currently outstanding.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the Company's Restated Certificate of Incorporation the number of authorized shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzU5NQ_5310ed32-a0ea-4f1d-8419-a94196aced37">0.01</ix:nonFraction> per share, is <ix:nonFraction unitRef="shares" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzYxMg_537bfc02-ccd5-43a7-a2f8-7b1b4d575c81">600</ix:nonFraction> million shares.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i011e3807671448d3b17afb15916f30fd" continuedAt="i5102d60f6ff5412db1c07794c54dd4dc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Changes in Accumulated Other Comprehensive Loss by Component</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Comprehensive income (loss) includes:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 15); and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020, and 2019, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzQ2ODI_51e0b6da-838c-4239-a4d6-afcc6b32d9a9" continuedAt="if51c4116b323461cbfae1e2be9e5c79e" escape="true">The changes in accumulated other comprehensive loss by component for 2021, 2020 and 2019 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="if51c4116b323461cbfae1e2be9e5c79e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Changes in Available-for-Sale Debt Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Losses on Cash Flow Hedges, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f78e9964d4545d0b470900cf41790eb_I20181231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzItMS0xLTEtMjA5MjU_fb91fb0d-1726-4090-b2f4-4031f6641c9f">49</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaf3d2d6da574aad843e8c47db812bde_I20181231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzItMy0xLTEtMjA5MjU_00682929-4afb-4f77-8e72-50b7ab3f1147">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e6f13795fa643d4a934ef2779cf20c8_I20181231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzItNS0xLTEtMjA5MjU_a81d6862-491d-443d-9450-7e83c49ef911">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icedac86dbdd94e328db0b81523eb9490_I20181231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzItNy0xLTEtMjA5MjU_0420dbbd-c2f7-4ea3-9848-87679183e278">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aab3fa36e3d4c9784c83bb58dbc0467_I20181231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzItOS0xLTEtMjA5MjU_2674ddf1-e4e7-452c-bf14-4c513d4035c1">59</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i172b86f75b754578b0023e98bbdbb60a_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzMtMS0xLTEtMjA5MjU_7be3c214-098f-4540-92fa-4161d1acc126">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854a8c819539479993d7ec23a433969f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzMtMy0xLTEtMjA5MjU_1946acfc-16cb-454f-9fc2-b9b172263024">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee641cc51754d1cb00d4f664780d7e8_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzMtNS0xLTEtMjA5MjU_0df3f23f-e289-41d4-bffa-faa97fccbede">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be9b6bedf67403391fbe4666a7b7789_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzMtNy0xLTEtMjA5MjU_2cd7b7f1-861c-4944-b856-600b9568328e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267bcc57d1894a25886a84780745fe3f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzMtOS0xLTEtMjA5MjU_5c34eea1-dc7b-4a66-b362-ab96e8ada0a0">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i172b86f75b754578b0023e98bbdbb60a_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzQtMS0xLTEtMjA5MjU_a5c89ea0-3ab2-4d28-ae7e-974cb12a13cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854a8c819539479993d7ec23a433969f_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzQtMy0xLTEtMjA5MjU_d764d6db-d3da-4d5f-af7e-064b6f70bea3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee641cc51754d1cb00d4f664780d7e8_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzQtNS0xLTEtMjA5MjU_4543ae97-9da6-4d93-8c23-7fd1ef7ea953">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be9b6bedf67403391fbe4666a7b7789_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzQtNy0xLTEtMjA5MjU_b352da52-cc7e-4240-b5f8-8c93ee11b384">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267bcc57d1894a25886a84780745fe3f_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzQtOS0xLTEtMjA5MjU_446470dd-a320-46ad-94be-2d3fe447e346">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i172b86f75b754578b0023e98bbdbb60a_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzUtMS0xLTEtMjA5MjU_93c4e812-8967-4c4b-a6e0-ea77c8e94425">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854a8c819539479993d7ec23a433969f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzUtMy0xLTEtMjA5MjU_a41ad402-6f8d-4afc-97b5-487d4e4e6eb0">8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee641cc51754d1cb00d4f664780d7e8_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzUtNS0xLTEtMjA5MjU_ced18d3e-17ca-49e9-8351-9077bed7e05c">5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be9b6bedf67403391fbe4666a7b7789_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzUtNy0xLTEtMjA5MjU_03d198b6-1031-424e-8f42-f96b2970bad8">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267bcc57d1894a25886a84780745fe3f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzUtOS0xLTEtMjA5MjU_dda037a1-232c-40f0-8402-2241214d3c7e">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46c2e1b5de824befa49ed510987e9918_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzctMS0xLTEtMjA5MjU_c07b5100-f28f-4ea2-bef9-d9d788831e6d">42</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i586f4c60ec0941b798835a56c0a9126d_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzctMy0xLTEtMjA5MjU_816df2dc-63b8-4590-83bb-ce88fff67c44">8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d895060707c4feab2cdb2374be33e9e_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzctNS0xLTEtMjA5MjU_7417cdfc-3235-4fb8-b1a0-fc8eaea5fef5">4</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20f21fbe58224ed6b3cf27749d03f137_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzctNy0xLTEtMjA5MjU_6c124eec-14cf-4e78-b0e6-a8db2e73f30c">1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if98d4882c785427cb6359a1c4887bd59_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzctOS0xLTEtMjA5MjU_726c8c38-5729-487e-b3ec-c938aedebbab">39</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i823d173be3fb47b8a4246a64c03b0a01_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzgtMS0xLTEtMjA5MjU_0f33c485-3519-4ff8-a592-0096d9765a0f">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aa0eae48f174f9b9a05ca9da0eab655_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzgtMy0xLTEtMjA5MjU_631cb8e5-01c0-4213-9c2f-01172ff3a129">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcd6a47fcc964ce4a5dc370e77b30cbe_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzgtNS0xLTEtMjA5MjU_b862f14b-41c1-4b85-9bcf-8b9dff0ab0f9">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455a47bd993d476393c8224860c4376d_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzgtNy0xLTEtMjA5MjU_b786b2c2-d8ce-4bf3-aeef-af3030271fc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i873b50b7201e479895a613c8644d45a8_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzgtOS0xLTEtMjA5MjU_21934578-045c-4254-9cc5-4440c4a4da73">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i823d173be3fb47b8a4246a64c03b0a01_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzktMS0xLTEtMjA5MjU_08f77ea7-194d-46c9-a262-4d8c9010f241">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aa0eae48f174f9b9a05ca9da0eab655_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzktMy0xLTEtMjA5MjU_58783721-6555-4d54-b84c-a36d734cb7e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcd6a47fcc964ce4a5dc370e77b30cbe_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzktNS0xLTEtMjA5MjU_96271e66-8bf0-46c1-b31f-191a421f0a47">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455a47bd993d476393c8224860c4376d_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzktNy0xLTEtMjA5MjU_6e38eb13-b6a7-4f6a-833f-0c970ee27c7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i873b50b7201e479895a613c8644d45a8_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzktOS0xLTEtMjA5MjU_0f67c6d3-2b20-4a8f-ad0b-f93d9c21cbc1">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i823d173be3fb47b8a4246a64c03b0a01_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEwLTEtMS0xLTIwOTI1_52cd2899-ab50-4d68-97c4-d3d88580ecac">15</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aa0eae48f174f9b9a05ca9da0eab655_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEwLTMtMS0xLTIwOTI1_873dbb0d-9f33-4910-ba84-640920fbe94e">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcd6a47fcc964ce4a5dc370e77b30cbe_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEwLTUtMS0xLTIwOTI1_eb0bb8c2-4b82-44b8-9c1e-e265e7adf750">3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455a47bd993d476393c8224860c4376d_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEwLTctMS0xLTIwOTI1_3be230d0-eef5-4961-88be-98848045efb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i873b50b7201e479895a613c8644d45a8_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEwLTktMS0xLTIwOTI1_09501579-9352-49fa-bb7b-ae9c07817ba8">18</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2ea7757788d44a2a8005c4e5c5e5d8d_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEyLTEtMS0xLTIwOTI1_48925c80-dd45-42c4-93d2-704c904d8c6f">27</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a589942e02b472d8d4555b653f21c8e_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEyLTMtMS0xLTIwOTI1_c1a06607-b3b5-48bb-bdf2-90bc717f5815">8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e3a08874f20424ebeb0772967620d16_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEyLTUtMS0xLTIwOTI1_d4784d90-7f37-4758-ad9c-e88fab30af9a">1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia329d4330d184f4db61e55f388db1e37_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEyLTctMS0xLTIwOTI1_b43df60d-3b92-4a46-84ef-57d90301244a">1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf17d00ced53485da1e88eb50e730ada_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEyLTktMS0xLTIwOTI1_9dd59daa-655a-4b2e-a855-ef224e119041">21</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08a3f5f05e8446a81e70c779986707e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEzLTEtMS0xLTIwOTI1_a0f137ea-f0cb-4c01-b6a0-84d58ccda499">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b0ee439d5e042c0ad07cb7eea297ef4_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEzLTMtMS0xLTIwOTI1_95e99e78-6169-4cdd-9178-e92cdf31e390">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i131d1f6ef78b4ccda288b254ef8513eb_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEzLTUtMS0xLTIwOTI1_c23cee72-a2ab-4496-b23b-92bb6ec83335">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614f87384bc04f7eb3b659a197d00719_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEzLTctMS0xLTIwOTI1_dac49463-1f82-4250-914f-ae204a19c59d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecc4fcf7570e403c98d584e438978f0c_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEzLTktMS0xLTIwOTI1_3d352b29-88dd-456e-97e3-2c0ab713f4a0">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08a3f5f05e8446a81e70c779986707e_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE0LTEtMS0xLTIwOTI1_5d7bd131-ef99-4d2a-9383-884a8db16538">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b0ee439d5e042c0ad07cb7eea297ef4_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE0LTMtMS0xLTIwOTI1_1f07bb5a-8039-4843-b162-aa123dd28668">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i131d1f6ef78b4ccda288b254ef8513eb_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE0LTUtMS0xLTIwOTI1_ae57f3e0-475f-4f6f-a2ae-8538e7e05df6">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614f87384bc04f7eb3b659a197d00719_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE0LTctMS0xLTIwOTI1_ea2eb45d-66be-46c4-8237-e988ab53d9c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecc4fcf7570e403c98d584e438978f0c_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE0LTktMS0xLTIwOTI1_84edfb2a-11fb-4e18-9f0b-58c22ba4ca0a">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08a3f5f05e8446a81e70c779986707e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE1LTEtMS0xLTIwOTI1_f1947fd2-f044-4b6c-85a9-cd196216acb4">13</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b0ee439d5e042c0ad07cb7eea297ef4_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE1LTMtMS0xLTIwOTI1_daaf8985-c5ea-4007-b87f-111a2a40566b">7</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i131d1f6ef78b4ccda288b254ef8513eb_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE1LTUtMS0xLTIwOTI1_485df642-5eee-4fa3-bdfb-685f8c33bede">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614f87384bc04f7eb3b659a197d00719_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE1LTctMS0xLTIwOTI1_a2ecc307-122c-43ea-8ef9-cd634fcab4a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecc4fcf7570e403c98d584e438978f0c_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE1LTktMS0xLTIwOTI1_49053554-172d-472f-8791-cd103ae5349c">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8c928ba4d594c0d8a8bc43cc0eaff7a_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE3LTEtMS0xLTIwOTI1_ad4d7bef-785b-41b5-9435-3a9dc92476d4">14</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i172575bb71684d5b977ed5b5efb382cf_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE3LTMtMS0xLTIwOTI1_675ab81f-c0e1-431d-8140-a72edd0d9794">1</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be47c24890a4321b9eab67a24b8a937_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE3LTUtMS0xLTIwOTI1_b4e76efa-c194-4325-914c-a4774aadd48b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie014908da8a24f6e98f6bd987c799a93_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE3LTctMS0xLTIwOTI1_b3d69325-542c-4ea1-920d-a22c1eee8519">1</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie250c2a689ff4ef885295f77abd96941_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE3LTktMS0xLTIwOTI1_11cf0b9f-5762-48f1-85af-299f694e7885">14</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its <ix:nonFraction unitRef="number" contextRef="i9c1e96cb7a8540ba9373cdf8a930af85_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3Xzc2OTY1ODE0MDQzMjk_2a21501e-4072-44f9-992b-0af37774b0dc">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, its clinical trials central laboratory services joint venture, to IQVIA, its joint venture partner.  As a result of the transaction, during the year ended December&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="i3b20ad37382b4dbd949a4bd8cd17fa6c_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3Xzc2OTY1ODE0MDUwOTI_ea192b7b-25e1-48a8-bdc4-d93451955c51">20</ix:nonFraction>&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other income, net.  See Note 6 for further details. &#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Additionally, for the year ended December 31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i823d173be3fb47b8a4246a64c03b0a01_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3Xzc2OTY1ODE0MDU1MDM_d0079b5b-67c5-4b30-b7ec-e00391e11725">3</ix:nonFraction>&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other operating (income) expense, net as a result of the sale of foreign subsidiaries.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i5102d60f6ff5412db1c07794c54dd4dc" continuedAt="i916bce44641a4195a0f841b325a75868"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, the gross deferred losses on cash flow hedges were reclassified from accumulated other comprehensive loss to interest expense, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the four quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i037da802480a40f1aceb3032d77fd42d_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIxMzQ_72087200-0da4-4681-a1c2-01811c0e9c37"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc7daa98ed14443ba924d16779e53a1b_D20211001-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIxMzQ_74a92618-8b95-4a75-8a31-e744f9fec7e8"><ix:nonFraction unitRef="usdPerShare" contextRef="i46b7967df9714e9abdb47bd55a82bb99_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIxMzQ_c50723ef-4d61-43df-b67d-07a5de2d1e94"><ix:nonFraction unitRef="usdPerShare" contextRef="i256fbf2ceee847e3a69e9615a1382681_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIxMzQ_f3a1f697-14bc-4cc0-9c1b-d7640bd4c3c7">0.62</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4c85169bb26d4f7487f2139697536c87_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIyNjk_4f0d2788-23fc-4f2b-8290-36be7580a41a"><ix:nonFraction unitRef="usdPerShare" contextRef="i80051b14fe464495a4d017e6d935f7b4_D20200401-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIyNjk_84aac8de-53df-496d-9389-fc6f6b154c37"><ix:nonFraction unitRef="usdPerShare" contextRef="i75da353bc1d84ecf943ea64892e87557_D20201001-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIyNjk_d9cd9963-62ae-439a-9272-8e1a0a3f4fcd"><ix:nonFraction unitRef="usdPerShare" contextRef="i1a65b7fef56742dfa223a86fcbbc87ed_D20200101-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIyNjk_f4981d04-a9fc-40d5-820c-254e8b98d906">0.56</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share.  During each of the four quarters of 2019, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i920aa1cda167443c8b0444671613bbf4_D20190101-20190331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI0MTE_2952aef2-fc0f-4039-889b-7ad2a3845215"><ix:nonFraction unitRef="usdPerShare" contextRef="ieda553b13ff74c3c8adddf0770a90cb1_D20191001-20191231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI0MTE_707052ce-2caf-4196-86f8-b236fcd6f1da"><ix:nonFraction unitRef="usdPerShare" contextRef="iea6463b11ecf4c00a41fca1508914f0f_D20190401-20190630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI0MTE_b431d16d-bbd5-4ec2-a1bd-68b242638d34"><ix:nonFraction unitRef="usdPerShare" contextRef="i83a23412d4724363966c8ea6e44ab909_D20190701-20190930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI0MTE_cfea337a-6222-4407-bea9-22e419cb135b">0.53</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share.  On February&#160;3, 2022, the Company announced that its Board of Directors authorized a <ix:nonFraction unitRef="number" contextRef="i2bc256f3969842e6a0da1ee27ff4d814_I20220203" decimals="INF" name="dgx:IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA5NzQ_e2570722-b6aa-4088-95bd-86270431e7ee">6.5</ix:nonFraction>% increase in its quarterly cash dividend from $<ix:nonFraction unitRef="usdPerShare" contextRef="ifc7daa98ed14443ba924d16779e53a1b_D20211001-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA5ODI_d71935e1-e290-43d0-8c11-d8b7506cb5b5">0.62</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="iab2af8571ad549cc8ca5ad0958512f11_D20220203-20220203" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA5Nzg_5afdf40f-b95a-4d29-8306-d7a84c8065a2">0.66</ix:nonFraction> per share, or $<ix:nonFraction unitRef="usdPerShare" contextRef="i27c3f506bf6b40788ce7094bb62e2e2d_D20220101-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA5ODY_38dab282-b85b-4bef-bc8c-e945d4de2e34">2.64</ix:nonFraction> per share annually, commencing with the dividend payable in April 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February 2021 and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $<ix:nonFraction unitRef="usd" contextRef="i2bbace4627094c78b2e45eaf382e646d_D20210201-20210228" decimals="INF" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzE2NDkyNjc0NDc4MzQ_7dfde363-ab36-45f4-bf84-f9269a98596b"><ix:nonFraction unitRef="usd" contextRef="i23fa7d555abb409cb510e5e698113fc5_D20210301-20210331" decimals="INF" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzE2NDkyNjc0NDc4MzQ_e3bbc035-24c5-490e-8ea5-c34f56dfc926">1</ix:nonFraction></ix:nonFraction>&#160;billion.  As of December&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI4MzE_839f3060-e541-4e61-9b30-ef3b91a27afe">0.7</ix:nonFraction> billion remained available under the Company&#8217;s share repurchase authorization.  In February 2022, the Company's Board of Directors authorized the Company to repurchase an additional $<ix:nonFraction unitRef="usd" contextRef="i0f71fea2861045d2bc904b3d6d15ea55_D20220201-20220228" decimals="INF" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3Xzc2OTY1ODE0MDg0MjY_f4f12007-92d2-4f97-94ad-625cdaa62bf6">1</ix:nonFraction>&#160;billion of the Company's common stock.  The share repurchase authorization has no set expiration or termination date.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMDQ_e0a8bbd6-9bed-4d8d-bd91-2d9a29282f4e">16.0</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231" decimals="-8" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMTA_395839ad-b2b3-45b8-8458-add40a02fd8a">2.2</ix:nonFraction> billion, including shares repurchased under ASRs.  The repurchases during the year included an accrual of $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:TreasuryStockPurchasedbutNotyetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA2NDg_c9a80683-95a2-4f7a-9677-1d75d0b1ea01">23</ix:nonFraction> million recorded in accounts payable and accrued expenses in the consolidated balance sheet for share repurchases not settled until after December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase its common stock as part of a share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount, and was accounted for as two transactions: (1) a treasury stock repurchase and (2) a forward contract.  During the year ended December&#160;31, 2021, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i1dc63d78467b4990a09bb4edf33bc0d9_D20210401-20210430" decimals="-6" name="dgx:AcceleratedShareRepurchasesPayment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI3NDg3NzkwODIzNDc_4dcf407a-79f4-4a43-b7eb-e680a83a45a2">1.5</ix:nonFraction>&#160;billion to the financial institutions and received <ix:nonFraction unitRef="shares" contextRef="i1dafd9b95c6842e2b8662b418c9af1b3_D20210101-20211231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA2OTg_49d5c665-eb87-46c8-b81d-1979884cc5f9">10.7</ix:nonFraction>&#160;million shares of its common stock under the ASRs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMTY_5d842041-73db-42d4-a57d-e160f87f447c">2.7</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMjE_3fb18a5b-c61d-4231-976b-3d376cd0a53b">325</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMjY_4bfabcab-ef18-4f5a-8050-e2cd2bbddce5">3.5</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMzE_2ec05886-eaa5-45e7-bfaa-547a5ccb2591">350</ix:nonFraction> million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Shares Reissued from Treasury Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, the Company reissued <ix:nonFraction unitRef="shares" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzM2ODc_955fb5c8-c584-45ce-96e5-af9443bb13e9">2</ix:nonFraction> million shares, <ix:nonFraction unitRef="shares" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzM2OTg_64cfb8ca-6f2d-486f-ae9e-ed91644cf1d8">3</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzM3MTI_1dfe07e3-413c-4d64-a6e4-f6a29de182fa">2</ix:nonFraction> million shares, respectively, from treasury stock for shares issued under the Employee Stock Purchase Plan ("ESPP") and stock-based compensation program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Treasury Stock Retirement &#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, the Company retired <ix:nonFraction unitRef="shares" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2MzU2MTQ_78bc1234-b047-46f1-ba7b-9d687d0c66b0">55</ix:nonFraction>&#160;million shares of treasury stock.  In accordance with the Company's policy, the amount paid to repurchase the shares in excess of par value was allocated between retained earnings and additional paid-in capital based on a pro-rata allocation of additional paid-in capital at the time of the share retirement.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><ix:continuation id="i916bce44641a4195a0f841b325a75868" continuedAt="i7a5f592273cc4ab1a3f9bfc60d854272"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interest</span></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7a5f592273cc4ab1a3f9bfc60d854272">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i10c8c1d0f30246589418e5588a96ce94_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzM5MjA_f45b24bc-9ce3-4a79-9bb5-1a2b831533c8">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  The Company records changes in the fair value of the noncontrolling interest immediately as they occur.  As of December&#160;31, 2021 and 2020, the redeemable noncontrolling interest was $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDEwMDY_83cfed9c-e0e7-495f-b98b-848285267647">79</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDEwMTA_502d4c14-9f15-49da-9548-cc83984b33e7">82</ix:nonFraction> million, respectively, and was presented at its fair value.</ix:continuation> </span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_226"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwOTA1_c68413e3-006f-4b41-8467-3cdcda00b56d" continuedAt="i44da5dc9bce84b5cab7a332098b9c3f5" escape="true">STOCK OWNERSHIP AND COMPENSATION PLANS</ix:nonNumeric></span></div><ix:continuation id="i44da5dc9bce84b5cab7a332098b9c3f5" continuedAt="ida4fe81e7495482d8defcdaac569fde7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee and Non-employee Directors Stock Ownership Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;The ELTIP provides for three types of awards: (a) stock options, (b) stock appreciation rights and (c) stock awards.  The ELTIP provides for the grant to eligible employees of either non-qualified or incentive stock options, or both, to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Grants of stock appreciation rights allow eligible employees to receive a payment based on the appreciation of Company common stock in cash, shares of Company common stock or a combination thereof.  The stock appreciation rights are granted at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Stock options and stock appreciation rights granted under the ELTIP expire on the date designated by the Board of Directors but in no event more than <ix:nonNumeric contextRef="i069088e9e79e44e78b230470438a9c05_D20210101-20211231" name="dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwMDE_7cc5f5ee-4a60-4266-a156-e55b875b2dbe">ten years</ix:nonNumeric> from date of grant.  No stock appreciation rights have been granted under the ELTIP.  Under the ELTIP, awards are subject to forfeiture if employment terminates prior to the end of the vesting period prescribed by the Board of Directors.  For all award types, the vesting period is generally over <ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEzMDE_ee4b9c25-345c-4572-8590-eb193b4c9213">three years</ix:nonNumeric> from the date of grant.  For performance share units, the actual amount of shares earned is based on the achievement of the performance goals specified in the awards.  The performance goals for awards granted for 2019 were based on the financial performance of the Company.  The performance goals for awards granted in 2020 and 2021 were based on the financial performance of the Company, as well as relative TSR.  The maximum number of shares of Company common stock in respect of which awards may be granted under the ELTIP is approximately <ix:nonFraction unitRef="shares" contextRef="i34ff8916a5f444ccb368b1089fe044ab_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzE4NDY_6d8c6b0c-f3f9-4f06-be1b-60c7f8853d10">79</ix:nonFraction> million shares.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The DLTIP provides for the grant to non-employee directors of non-qualified stock options to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  The DLTIP also permits awards of restricted stock and restricted stock units to non-employee directors.  Stock options granted under the DLTIP expire on the date designated by the Board of Directors but in no event more than <ix:nonNumeric contextRef="i89212b0997f444118e64670ec656f232_D20210101-20211231" name="dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzIzMjg_d6f5f318-883f-43e8-94fb-c66f2f4e80d6">ten years</ix:nonNumeric> from date of grant.  For all award types, the vesting period is generally over <ix:nonNumeric contextRef="i89212b0997f444118e64670ec656f232_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzI0MTA_1f60e838-e314-4bf1-bfc1-fde0e0dd0e2b">three years</ix:nonNumeric> from the date of grant, regardless of whether the award recipient remains a director of the Company.  The maximum number of shares that may be issued under the DLTIP is <ix:nonFraction unitRef="shares" contextRef="i57198eacfa274bdda46d180bc4e3f05d_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzI1ODI_4b9ca539-cbf8-44ef-a991-c4dacb4f690c">2.4</ix:nonFraction> million shares.  For the years ended December&#160;31, 2021, 2020 and 2019, grants under the DLTIP totaled <ix:nonFraction unitRef="shares" contextRef="i89212b0997f444118e64670ec656f232_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzI2NjA_962c0e36-7897-499a-88d7-6a012d74acfc">12</ix:nonFraction> thousand shares, <ix:nonFraction unitRef="shares" contextRef="iad5bf5052c604fa2982645d51ef2f9bf_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzI2NzE_972d98dc-6734-4180-ae6c-8172a12f538a">14</ix:nonFraction> thousand shares and <ix:nonFraction unitRef="shares" contextRef="i3b1d357b32ce4113917ff628a45e0a1b_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzI2ODU_4e88e57e-714b-43b9-b2fa-3fa35953264a">14</ix:nonFraction> thousand shares, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  See Note 16 for further information regarding the Company's share repurchase program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of each stock option award granted was estimated on the date of grant using a Black-Scholes option-valuation model.  The expected volatility under the Black-Scholes option-valuation model was based on historical volatilities of the Company's common stock.  The dividend yield was based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the expected holding period of the related award.  The expected holding period was estimated using the historical stock option exercise behavior of employees. The Black-Scholes option-valuation model also incorporates the average market price of the Company's common stock at the date of grant.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><ix:continuation id="ida4fe81e7495482d8defcdaac569fde7" continuedAt="i94884f8571f64d5dbd89334a15b8f379"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwOTEw_4764423f-643a-45f8-92f4-09e8d443411f" continuedAt="i761912a22a144e5da40c46ed7e89d26c" escape="true">The weighted average assumptions used in valuing stock options granted in the periods presented were:  </ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i761912a22a144e5da40c46ed7e89d26c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:61.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.219%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzItMS0xLTEtMjA5MjU_d7872b90-b386-485f-8dc1-efb75c7d05d0">21.82</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzItMy0xLTEtMjA5MjU_d3864095-3494-43aa-9637-a61c5ac07d5f">17.25</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzItNS0xLTEtMjA5MjU_37947643-20c3-4f8d-aebc-c6cbf322eb7e">14.30</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzMtMS0xLTEtMjA5MjU_445ab187-e4a3-4306-bc8e-29c04359456d">25.6</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzMtMy0xLTEtMjA5MjU_71d4a51d-9237-4d9c-a13f-38a4a07cbf2f">20.3</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzMtNS0xLTEtMjA5MjU_bbde0767-b69d-404f-aa78-a1232d00c3e5">20.4</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzQtMS0xLTEtMjA5MjU_92dfe293-db50-4f0a-be5a-e4cfb0d7aa7a">2.0</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzQtMy0xLTEtMjA5MjU_1e41c48a-e87f-4a90-8ed3-4762e028aee8">2.0</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzQtNS0xLTEtMjA5MjU_00287948-2f4c-4de0-b9cd-5756a2ef45bd">2.4</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzUtMS0xLTEtMjA5MjU_8cf88af2-656c-4a7b-8e56-322615735fc6">0.6</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzUtMy0xLTEtMjA5MjU_ef927958-d5c3-4fa0-aba4-1e8c1f1cdfa6">1.5</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzUtNS0xLTEtMjA5MjU_edafee37-8532-41bb-88b1-3800038b61be">2.5</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected holding period, in years</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzYtMS0xLTEtMjA5MjU_3274e9e6-92ac-42de-b2ab-8bcde29ff846">4.8</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzYtMy0xLTEtMjA5MjU_31ff67b3-f3f5-47c7-bb96-6198528084fc">5.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzYtNS0xLTEtMjA5MjU_6961151b-0dcd-47be-8a81-9be4792d8a9b">5.2</ix:nonNumeric></span></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwODk2_b76a7ba4-4cc8-44b8-b23b-0e30f366a02b" continuedAt="ic04e89811828446c8b4de5eb45a0f12e" escape="true">The following summarizes the activity relative to stock option awards for 2021: </ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ic04e89811828446c8b4de5eb45a0f12e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:54.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i30b7bc67e7bb4a52a97e03ff7b345782_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzItMS0xLTEtMjA5MjU_05d6706e-ecc7-47c5-adca-ef0d1a0295e8">6.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i30b7bc67e7bb4a52a97e03ff7b345782_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzItMy0xLTEtMjA5MjU_b430372e-fb82-47cb-812e-9d2fa8ec9139">90.32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzMtMS0xLTEtMjA5MjU_01487205-e640-4426-9df2-7d8856e50327">0.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzMtMy0xLTEtMjA5MjU_8b799da6-3a1c-4732-aee4-d6f033dabd0d">122.18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzQtMS0xLTEtMjA5MjU_4b4ad2d4-d2ad-4aa8-b1aa-552fcf639070">1.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzQtMy0xLTEtMjA5MjU_cdc4f179-85ef-45d8-af6b-851e06c2195f">84.09</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited and canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzUtMS0xLTEtMjA5MjU_c3a6d78f-0041-4a9f-979a-6d6fd0629e78">0.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzUtMy0xLTEtMjA5MjU_01d11704-ef53-4acd-ab39-d3d1fa0ecc3d">107.50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, end of year</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzYtMS0xLTEtMjA5MjU_c9918b72-2c40-4390-90b2-94197737e69a">5.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzYtMy0xLTEtMjA5MjU_5bb3795f-18f0-4dd2-9355-c46cba7b1ca7">96.44</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzYtNS0xLTEtMjA5MjU_4b52f567-7796-4c26-bc38-d0a882d53e7f">6.5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzYtNy0xLTEtMjA5MjU_a3bd37ea-8d56-4006-86fc-42a6e1b676d9">433</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzgtMS0xLTEtMjA5MjU_8dc7597f-f981-4631-9c8d-ba7ad796f028">3.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzgtMy0xLTEtMjA5MjU_4fee40ee-e3aa-4c43-9c8e-0ad6f178fccd">89.17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzgtNS0xLTEtMjA5MjU_493ec4be-b199-40cb-89c1-4d91fd5e3702">5.5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzgtNy0xLTEtMjA5MjU_184eb798-700d-4b60-8f73-687f0c298e78">309</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzktMS0xLTEtMjA5MjU_17f4a8f1-a724-4ed2-baa5-aee92bedc04c">5.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzktMy0xLTEtMjA5MjU_c1746dc4-852e-4717-b196-b149e83a3070">96.22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzktNS0xLTEtMjA5MjU_8ede43ff-3dc8-4139-a7b2-dee84454f617">6.4</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzktNy0xLTEtMjA5MjU_8143ad9a-318e-4e1a-b7dd-79ae3bf59c28">430</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company's closing common stock price on the last trading day of 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December&#160;31, 2021.  This amount changes based on the fair market value of the Company's common stock.  Total intrinsic value of options exercised in 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzQ0Mzk_780ee14c-134b-4e2a-a9c0-e226ca92c7e4">83</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie07834d81a9d4a88aaf80835b2bb5156_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzQ0NDM_1e261d7e-1d01-42f4-9030-8563b39242e7">113</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0edf8a3dee0e4be4a7970782a11e919b_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzQ0NTA_1fd44ffa-fe98-489b-b136-8bcba1e79bcc">62</ix:nonFraction> million, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzQ0OTI_3d0ff69f-f75c-4db4-8f64-444e949280a3">7</ix:nonFraction> million of unrecognized stock-based compensation cost related to nonvested stock options which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzQ2NDU_d8b7e6ca-52ea-45d3-91ab-a09ca63aade9">1.6</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of restricted stock awards and restricted stock units is the average market price of the Company's common stock at the date of grant.  For performance share units with a goal based on the financial performance of the Company, the fair value is based on the average market price of the Company's common stock at the date of grant, adjusted for the present value of dividends expected to be paid on the Company's common stock during the vesting period.  For performance share units with a market-based relative TSR goal, the fair value is estimated on the date of grant using a Monte Carlo valuation model.  The expected volatility under the Monte Carlo valuation model is based on the historical volatility of the common stock of the Company and the common stock of the companies in the peer index.  The dividend yield is based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the performance period of the related award. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i94884f8571f64d5dbd89334a15b8f379" continuedAt="ie1000cd69b9d4535a767cf0d2cac9abc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dgx:ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwOTAx_f6a81011-03e0-433d-8104-09e8dc4c5964" continuedAt="i977351ccbfae455ebc3d96ac4a5a7894" escape="true">The weighted average assumptions used in valuing performance share units with a market-based relative TSR goal in the periods presented were:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:continuation id="i977351ccbfae455ebc3d96ac4a5a7894" continuedAt="iadf8cfe3847d4261892f19e62d1da40e">  </ix:continuation></span></div><div><span><br/></span></div><div><ix:continuation id="iadf8cfe3847d4261892f19e62d1da40e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ic601ee56a8d64d41a238221625b7f525_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzAtMS0xLTEtMjA5MjU_5757a59c-daa6-4440-85e4-01ef4121fdd9">150.15</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i71d3304ab3de4fac88d8ba9dc1cdc015_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzItMy0xLTEtNDA4OTQ_b1f45dad-f627-4d9a-ad65-715494d3241b">144.03</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic601ee56a8d64d41a238221625b7f525_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzEtMS0xLTEtMjA5MjU_e3a21929-d9fa-47e1-bd61-fa5a08235a37">30.2</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71d3304ab3de4fac88d8ba9dc1cdc015_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzMtMy0xLTEtNDA5MDE_5f9aef8e-0b3c-4c6b-8c74-af141e54afae">20.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic601ee56a8d64d41a238221625b7f525_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzItMS0xLTEtMjA5MjU_fd5007af-c0d3-4c82-a84b-1f8dc2ce3e95">2.0</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71d3304ab3de4fac88d8ba9dc1cdc015_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzQtMy0xLTEtNDA5MDg_fb0f0048-e0a8-43ef-a350-2c6428da8498">2.0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic601ee56a8d64d41a238221625b7f525_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzMtMS0xLTEtMjA5MjU_9fe772cd-14b1-4669-887f-6de2098e60a2">0.2</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71d3304ab3de4fac88d8ba9dc1cdc015_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzUtMy0xLTEtNDA5MTU_d95d7172-d87a-49f1-aa81-22fccc4e7669">1.4</ix:nonFraction>%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwOTE3_3d0d2f49-4d52-4789-aeab-3e5b4c8d9295" continuedAt="i9f61e53938b84d699f10cb5503a2362b" escape="true">The following summarizes the activity relative to stock awards, including restricted stock units and performance share units, for 2021, 2020 and 2019: </ix:nonNumeric></span></div><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center;text-indent:31.5pt"><ix:continuation id="i9f61e53938b84d699f10cb5503a2362b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic50d104c1f2e4df4a4f6e3d9ae3c0287_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtMS0xLTEtMjA5MjU_15d31335-dc72-45d1-a867-b9e3f05b5439">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic50d104c1f2e4df4a4f6e3d9ae3c0287_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtMy0xLTEtMjA5MjU_d5ff7db4-bf6d-46dc-abea-25214ac98817">100.12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaeeaf4706c6e49b7a86e967f2bd3443a_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtNS0xLTEtMjA5MjU_2ec54b9d-b274-4cf8-b034-0b345886aed6">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaeeaf4706c6e49b7a86e967f2bd3443a_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtNy0xLTEtMjA5MjU_bf97757c-4763-4936-8dae-dc38925d915e">93.30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58ae2069c994411b8ad5cf3e9fd7f728_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtOS0xLTEtMjA5MjU_3ab985e0-c984-4272-a58f-e5043a3f4bc6">1.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58ae2069c994411b8ad5cf3e9fd7f728_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtMTEtMS0xLTIwOTI1_1c8d13f5-6219-43d6-abc9-78f03405ba40">88.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtMS0xLTEtMjA5MjU_3a79e0d0-65f4-4808-a69c-858174bbcbc4">0.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtMy0xLTEtMjA5MjU_157a6333-6808-4997-9e20-bdaf76fdd881">122.78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtNS0xLTEtMjA5MjU_48876dca-a3b3-4107-b1bf-7852a291fccc">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtNy0xLTEtMjA5MjU_391a4739-4466-4864-9f11-976431c1ad43">112.43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtOS0xLTEtMjA5MjU_1ea28192-efb4-4d2c-b2cf-d06d58772b12">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtMTEtMS0xLTIwOTI1_d6db2025-3c7d-42fe-a392-f34309ab90c2">86.28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtMS0xLTEtMjA5MjU_a0c78e60-369f-48f1-a051-ae4d169348fc">0.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtMy0xLTEtMjA5MjU_29b55959-73e7-49ac-9cb5-a8db9f1f1e8e">103.41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtNS0xLTEtMjA5MjU_a4041c9c-31bf-4dfd-8993-48ed86e4cc33">0.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtNy0xLTEtMjA5MjU_83e9a2c0-de6e-4b27-b4e8-2c2108278a4b">96.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtOS0xLTEtMjA5MjU_2f5a3012-6ad2-425c-ad75-4231cb73f4c5">0.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtMTEtMS0xLTIwOTI1_9ebb5326-3ad8-4a51-8ed9-9a71d2cd916b">75.58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares forfeited and canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtMS0xLTEtMjA5MjU_91a7ac10-f1fa-4f31-a4f7-d4c1165736cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtMy0xLTEtMjA5MjU_1c6292ad-8130-4ad1-b096-8fe2fac277c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtNS0xLTEtMjA5MjU_7afe3109-ec72-4df6-af85-b05e156908d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtNy0xLTEtMjA5MjU_22626e30-1824-41ae-b3a3-e962590a6f0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtOS0xLTEtMjA5MjU_d5b84b39-4301-46c8-b432-78f31e9e9fc1">0.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtMTEtMS0xLTIwOTI1_8b2971e7-7b55-40ca-936b-eed9e5cbb80e">94.09</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of year</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i152aaa9d36b34e3496329cdd1df55d76_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtMS0xLTEtMjA5MjU_32b66fab-f16b-4828-807b-e6f22bb3e716">1.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i152aaa9d36b34e3496329cdd1df55d76_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtMy0xLTEtMjA5MjU_cc860f34-7af4-4eb8-87d5-7fa8d899f8d0">107.46</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic50d104c1f2e4df4a4f6e3d9ae3c0287_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtNS0xLTEtMjA5MjU_4cf1aef7-2e08-4426-b334-a48f378ee6f1">1.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic50d104c1f2e4df4a4f6e3d9ae3c0287_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtNy0xLTEtMjA5MjU_4c52f96c-75cf-4e3a-84c7-879d1fde8909">100.12</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaeeaf4706c6e49b7a86e967f2bd3443a_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtOS0xLTEtMjA5MjU_94f90088-8220-483e-9ff4-009b82c5ad80">1.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaeeaf4706c6e49b7a86e967f2bd3443a_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtMTEtMS0xLTIwOTI1_f37215df-9664-4a91-90c4-ad16a728f643">93.30</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i152aaa9d36b34e3496329cdd1df55d76_I20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzYxMjM_8d2ddb70-9ac7-47af-acf5-a8bface2d158">27</ix:nonFraction> million of unrecognized stock-based compensation cost related to nonvested stock awards, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzYyNzY_ce8ffc15-d29f-47d5-aa72-6e4c06fd5f56">1.5</ix:nonNumeric> years.  Total fair value of shares vested was $<ix:nonFraction unitRef="usd" contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzYzMjU_916466c4-542b-4e5d-ae39-1f2dd9a93e0d">59</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzYzMjk_6ce08163-bdf4-40da-a638-bffec5a172ce">37</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzYzMzY_254b1740-df6f-46fb-9de6-a9ac8a02f39b">40</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.  For performance share units with a goal based on financial performance of the Company, the amount of unrecognized stock-based compensation cost is subject to change based on changes, if any, to management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned at the end of the performance periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, stock-based compensation expense totaled $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzY4NTI_dbeb1835-9e75-42e2-87e1-32c76013f8fc">79</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzY4NTY_0aec1745-1672-4f05-94b3-6f1ed44ad7cb">97</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzY4NjM_c97104de-ced3-4992-a4ad-0323f890f92c">56</ix:nonFraction> million, respectively.  Income tax benefits recognized in the consolidated statements of operations related to stock-based compensation expense totaled $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcwMTA_0e5671d8-3d52-46a5-9f5e-c26773ccc4f7">32</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcwMTQ_53fc8062-4095-4f23-841d-db62d12a9463">39</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcwMjE_c1fc52e8-20cd-41fb-a3f4-f8be6faea593">27</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively, which includes excess tax benefits associated with stock-based compensation arrangements of $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcxNjU_75ddc601-f0bb-4a29-b76b-d02b0da061c1">19</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcxNjk_5b19f0e3-f719-45e2-ac22-9171616d9fcb">23</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcxNzY_d58605c2-c551-4271-818f-f81d60f8057c">13</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the Company's ESPP, substantially all employees can elect to have up to <ix:nonFraction unitRef="number" contextRef="i186f5b12f07149329dc5f3bd351174d2_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzczNDA_9507f56a-e890-4259-915b-98a4a8cc8dc8">10</ix:nonFraction>% of their annual wages withheld to purchase Quest Diagnostics common stock.  The purchase price of the stock is <ix:nonFraction unitRef="number" contextRef="ifaf57f30a4d148c7832fab56a16d3c67_D20210101-20211231" decimals="INF" name="dgx:MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzc0NTQ_bbaff4f3-3253-4078-b21a-df3b2c618f0d">95</ix:nonFraction>% of the market price of the Company's common stock on the last business day of each calendar month.  Under the ESPP, the maximum number of shares of Quest Diagnostics common stock which may be purchased by eligible employees is <ix:nonFraction unitRef="shares" contextRef="i186f5b12f07149329dc5f3bd351174d2_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzc2ODQ_f685f30b-35dc-4f50-be44-862e11c1689e">9</ix:nonFraction> million.  Approximately <ix:nonFraction unitRef="shares" contextRef="ifaf57f30a4d148c7832fab56a16d3c67_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzc3MDM_33d9ba27-2c10-49e1-a8c2-73dc4852a4b8">200</ix:nonFraction> thousand shares, <ix:nonFraction unitRef="shares" contextRef="i133ed156b2ae4c0cb1ccbd97cc19199f_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzc3MTQ_aff04e78-f340-48d7-bb92-3855fc863074">225</ix:nonFraction> thousand shares and <ix:nonFraction unitRef="shares" contextRef="if54829fa59064ad3adf7093c5e760b0e_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzc3Mjg_26b9bef8-b1bb-4b25-92da-0e23f02245e7">269</ix:nonFraction> thousand shares of common stock were purchased by eligible employees in 2021, 2020 and 2019, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="ie1000cd69b9d4535a767cf0d2cac9abc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company maintains qualified defined contribution plans covering substantially all of its employees.  The maximum Company matching contribution is <ix:nonFraction unitRef="number" contextRef="i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzgwMDc_ba964fc7-3e32-4ae3-b266-c92400ce2693">5</ix:nonFraction>% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions for certain qualified defined contribution plans; matching contributions were reinstated in the third quarter of 2020.  The Company's expense for contributions to its defined contribution plans aggregated $<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzgzMjE_bb1f0104-3263-4f09-b9f6-03ecc4c4b4b2">93</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzgzMjU_1ac104f1-ccf5-4347-be9c-97f34335e61e">64</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzgzMzI_484d1a23-b868-46c4-b292-1c1cffdaf2c3">84</ix:nonFraction> million for 2021, 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Deferred Compensation Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has a supplemental deferred compensation plan that is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to <ix:nonFraction unitRef="number" contextRef="i946d409692054dddb8d20bf8697e64db_D20210101-20211231" decimals="2" name="dgx:SupplementalDeferredCompensationPlanSalaryDeferral" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzg1OTc_3f5e1f62-e613-49db-b4d3-356ababd7449">50</ix:nonFraction>% of their salary in excess of their defined contribution plan limits and for certain eligible employees, up to <ix:nonFraction unitRef="number" contextRef="i946d409692054dddb8d20bf8697e64db_D20210101-20211231" decimals="2" name="dgx:SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzg3MTA_f4cf3ca2-6140-4497-affc-08e23d93bf97">95</ix:nonFraction>% of their variable incentive compensation.  The maximum Company matching contribution is <ix:nonFraction unitRef="number" contextRef="i33d716f8929d432d844c17e2ba676a0b_D20210101-20211231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzg4MDE_4061fe24-c10a-4c95-8391-14ec1e0a29c5">5</ix:nonFraction>% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions; matching contributions were reinstated in the third quarter of 2020.  The compensation deferred under this plan, together with Company matching amounts, are credited with earnings or losses measured by the mirrored rate of return on investments elected by plan participants.  Each plan participant is fully vested in all deferred compensation, Company match and earnings credited to their account.  The amounts accrued under the Company's deferred compensation plans were $<ix:nonFraction unitRef="usd" contextRef="i8fc7b757284449cebf65a284bd73bd8d_I20211231" decimals="-6" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzkzODM_2a9faefe-057b-4107-afaa-370f1f277317">77</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9e961edb5fcd410ea3ec16b2c6c74476_I20201231" decimals="-6" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzkzOTA_b4f4888d-2a6d-41ba-84b6-d7c1fb9addc6">67</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively.  Although the Company is currently contributing all participant deferrals and matching amounts to a trust, the funds in this trust, totaling $<ix:nonFraction unitRef="usd" contextRef="i8fc7b757284449cebf65a284bd73bd8d_I20211231" decimals="-6" name="dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzk1NjU_b5c79425-f119-4422-af6a-46430c0e4d2f">77</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9e961edb5fcd410ea3ec16b2c6c74476_I20201231" decimals="-6" name="dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzk1NzI_a59d3f13-231b-438e-8283-b4f227aa8979">67</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively, are general assets of the Company and are subject to any claims of the Company's creditors. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company also offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  The Company matches employee contributions equal to <ix:nonFraction unitRef="number" contextRef="i037161dc8162495a912293e3e9a40ec4_D20210101-20211231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzk4Nzc_625bc735-626a-4e43-9aa2-0a45ac3a9b9b">25</ix:nonFraction>%, up to a maximum of $<ix:nonFraction unitRef="usd" contextRef="i61c9407736c741d0ab822ef30250f2a8_D20210101-20211231" decimals="-3" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzk5MDA_8c901af8-5000-45ad-94e7-5620b66f5d48">5</ix:nonFraction> thousand per plan year.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  Each participant is fully vested in their deferred compensation and vests in Company matching contributions over a period of <ix:nonNumeric contextRef="i037161dc8162495a912293e3e9a40ec4_D20210101-20211231" name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwMjQy_44481283-2379-4883-946a-4d11fc55d8f6">four years</ix:nonNumeric> at <ix:nonFraction unitRef="number" contextRef="i037161dc8162495a912293e3e9a40ec4_D20210101-20211231" decimals="2" name="dgx:SdcpIiGradedVestingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwMjQ4_d5f89645-f41f-45a6-bd80-d37b13c91285">25</ix:nonFraction>% per year.  This plan was amended effective January 1, 2018 so that future deferrals under the plan may only be made by participants who made deferrals under the plan in 2017.  The amounts accrued under this plan were $<ix:nonFraction unitRef="usd" contextRef="i8095617a570e4c32b5ffb3c1434f3dc7_I20211231" decimals="-6" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwNDY4_fedbe7e1-c135-4eba-8ff5-a8753ede4777">66</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icb5c138d0e66484badc0c6cfaeb41e0a_I20201231" decimals="-6" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwNDc1_a5affdd4-f397-44f1-8607-72092d048f8b">59</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  The cash surrender value of such life insurance policies was $<ix:nonFraction unitRef="usd" contextRef="i8095617a570e4c32b5ffb3c1434f3dc7_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwNzI2_a030499f-1820-4354-85f3-f2c73b08fcf9">57</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icb5c138d0e66484badc0c6cfaeb41e0a_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwNzMz_f915f04b-0a47-4271-b54a-975a374dc296">50</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  For each of the years ended December&#160;31, 2021, 2020 and 2019, the Company's expense for matching contributions to these plans was not material.</span></div></ix:continuation><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_229"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwNzkw_98badd20-b21e-4ba1-932b-748b174aeb6e" continuedAt="ic9caa4f5c95b48c491c2d2840a5167a3" escape="true">COMMITMENTS AND CONTINGENCIES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic9caa4f5c95b48c491c2d2840a5167a3" continuedAt="i8a1ae1cafe8b40119ce9c27ec2836f0e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit and Contractual Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit under its Secured Receivables Credit Facility and Senior Unsecured Revolving Credit Facility (see Note 13).  In support of its risk management program, to ensure the Company&#8217;s performance or payment to third parties, $<ix:nonFraction unitRef="usd" contextRef="i041613d64bbb4a13a8721a2ee2352a92_I20211231" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzM0OQ_97c84d1d-5fbd-4987-9c8b-b1839615d368">70</ix:nonFraction> million in letters of credit under the Secured Receivables Credit Facility were outstanding as of December&#160;31, 2021.  The letters of credit primarily represent collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has certain noncancelable commitments, primarily under take-or-pay arrangements, to purchase products or services from various suppliers, mainly for consulting and other service agreements, and standing orders to purchase reagents and other laboratory supplies.  As of December&#160;31, 2021, the approximate total future purchase commitments are $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzkyNg_dc8d228e-7918-47d4-9273-7edcbdd656ae">252</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzkzOQ_b9c52d8e-ce17-4c75-90b9-912ea81dd0ad">53</ix:nonFraction> million are expected to be incurred in 2022, $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="dgx:UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzk3Nw_179be4ae-4c78-4d9f-b576-e16fa6dd2791">87</ix:nonFraction> million are expected to be incurred in 2023 through 2024 and the balance thereafter. </span></div></ix:continuation><div style="padding-right:13.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i8a1ae1cafe8b40119ce9c27ec2836f0e" continuedAt="ibf34b11c86ee42dcbb424fa300931857"><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Billing and Collection Agreement</span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In September 2016, the Company entered into a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzExMzc_708f737c-5f7e-406e-a9c5-dbbc99a6dcd3">ten</span>-year agreement with a third party to outsource its billing and  related operations for the majority of the Company&#8217;s revenues.  Services under the agreement commenced during the fourth quarter of 2016.  The agreement includes an annual fee, which is subject to adjustment based on certain changes in the Company's requisition volume and the achievement of various performance metrics.</span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases, including real estate leases that were entered into by certain predecessor companies of a subsidiary prior to the Company's acquisition of the subsidiary.  While over the course of many years, the title to certain properties and interest in the subject leases have been transferred to third parties and the subject leases have been amended several times by such third parties, the lessors have not formally released the subsidiary predecessor companies from their original obligations under the leases and therefore remain contingently liable in the event of default.  The remaining terms of the lease obligations and the Company's corresponding indemnifications range up to <ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="dgx:RemainingTermsofContingentLeaseObligationsMaximum" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzIzMjI_01ad971a-2f2d-46dd-88cd-6f9300d6325c">26</ix:nonNumeric> years.  The lease payments under certain leases are subject to market value adjustments and contingent rental payments and therefore, the total contingent obligations under the leases cannot be precisely determined but are likely to total several hundred million dollars.  A claim against the Company would be made only upon the current lessee's default and, in certain cases, after a series of claims and corresponding defaults by third parties that precede the Company in the order of liability.  The Company also has certain indemnification rights from other parties to recover losses in the event of default on the lease obligations.  The Company believes that the likelihood of its performance under these contingent obligations is remote and no liability has been recorded for any potential payments under the contingent lease obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, <ix:nonFraction unitRef="claim" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwOTk1MTE2NDAxNTk_eb43b23e-4495-43dd-af05-9054ef9f3652">two</ix:nonFraction> putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwOTk1MTE2NDAxNjA_93d5dbf6-c1eb-46d0-935d-df80f48c0159">two</ix:nonFraction> lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="ibf34b11c86ee42dcbb424fa300931857" continuedAt="i2779dc9a92b144ff85586262d3d812ee"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of the government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of December&#160;31, 2021, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzk1MTY_d955bc2d-34bd-4e4b-aba9-bbef71494644">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwOTk1MTE2NDg3OTM_63f8458e-b687-46c5-a14b-54a69d7bfeab">1</ix:nonFraction>&#160;million as of December&#160;31, 2021 and December&#160;31, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2779dc9a92b144ff85586262d3d812ee">&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $<ix:nonFraction unitRef="usd" contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231" decimals="-6" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwNjE2_a4ed279b-4f5b-48f2-b891-c9703a71239c">159</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231" decimals="-6" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwNjIz_cf625def-f4a1-40a9-81c8-e9fdf320813f">138</ix:nonFraction> million as of December&#160;31, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_232"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><br/>19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90ZXh0cmVnaW9uOjQ1OTQzYTMwNDA5ZjQ1MDhhYzNmYzlhOWY2MTc0OGNlXzI0NTc_ff842dfd-a9e7-4ce5-bf82-81e672ac11a1" continuedAt="i0a955a56f89f4b7eb200db0dd5e4e02a" escape="true">BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0a955a56f89f4b7eb200db0dd5e4e02a" continuedAt="i6a87078f3ad84c44a92fa78ac3955f17"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs, and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than <ix:nonFraction unitRef="number" contextRef="i3a090f7f88f3481086c45baf1ec6dabd_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90ZXh0cmVnaW9uOjQ1OTQzYTMwNDA5ZjQ1MDhhYzNmYzlhOWY2MTc0OGNlXzgwOA_1bba286c-e189-4c6c-8928-18cc793c40ef"><ix:nonFraction unitRef="number" contextRef="ice4e3139e0ba4820be8e5d8cf02f15fe_D20210101-20211231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90ZXh0cmVnaW9uOjQ1OTQzYTMwNDA5ZjQ1MDhhYzNmYzlhOWY2MTc0OGNlXzgwOA_b772228e-2d00-4882-bf30-053997a344d0"><ix:nonFraction unitRef="number" contextRef="idb62d67015ba418c9bcc8c4ca149ca60_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90ZXh0cmVnaW9uOjQ1OTQzYTMwNDA5ZjQ1MDhhYzNmYzlhOWY2MTc0OGNlXzgwOA_fa70d45a-a659-4270-9351-c52fcc12d971">95</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of net revenues in 2021, 2020 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90ZXh0cmVnaW9uOjQ1OTQzYTMwNDA5ZjQ1MDhhYzNmYzlhOWY2MTc0OGNlXzI0NDQ_b52ccd11-1928-40e5-8796-b1ff0febbc66" continuedAt="i5b49e0046dc5421a8159dac21f42b87b" escape="true">The following table is a summary of segment information for the years ended December&#160;31, 2021, 2020 and 2019. Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangibles assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2.</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i5b49e0046dc5421a8159dac21f42b87b" continuedAt="id5060e85b23a4894ab21056109e81ce3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6815212460d4587af042592f64aaf60_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzItMS0xLTEtMjA5MjU_1b91c3ba-e0b9-4f6a-a2e4-82b583e85d2e">10,494</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22f162e49514311adf2fd36a699bba9_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzItMy0xLTEtMjA5MjU_348b57f9-84ef-4116-bc32-3d490a5d79de">9,139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzItNS0xLTEtMjA5MjU_1625ca59-a739-45be-8d2d-c56aa0231ff7">7,405</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id980e16d89514f7aa100a29c06e97763_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzMtMS0xLTEtMjA5MjU_d33eb413-d6e7-4b27-87c0-8b1f59df1a47">294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744ee99a69fd4003b8a54a40eb3c8813_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzMtMy0xLTEtMjA5MjU_53ffc58b-7e6d-45f6-b992-5924a4ca7a57">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if013d02c91354f9286988eda03c628e0_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzMtNS0xLTEtMjA5MjU_5acbb4f9-4121-447f-929f-05f47593f287">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzQtMS0xLTEtMjA5MjU_b8eeed38-5f89-44be-8f2d-513a55631a98">10,788</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzQtMy0xLTEtMjA5MjU_9101bf7a-36ff-425f-9086-efb6c8146171">9,437</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzQtNS0xLTEtMjA5MjU_bfc8a698-2e29-439e-85cf-a012c7a8407f">7,726</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6815212460d4587af042592f64aaf60_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzctMS0xLTEtMjA5MjU_cafc99f7-dd3c-4163-ad83-227e27f4d2a4">2,646</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22f162e49514311adf2fd36a699bba9_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzctMy0xLTEtMjA5MjU_fc456cb0-41a1-4f6a-8737-c3c9d29f3e0a">2,201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzctNS0xLTEtMjA5MjU_a7054b1e-9748-4c36-959e-f93910ff93e2">1,298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id980e16d89514f7aa100a29c06e97763_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzgtMS0xLTEtMjA5MjU_067d3ae7-f29c-4696-96bd-47379cf82b88">29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744ee99a69fd4003b8a54a40eb3c8813_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzgtMy0xLTEtMjA5MjU_320402c1-7b45-4f74-ba3f-bf06c1ce9de0">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if013d02c91354f9286988eda03c628e0_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzgtNS0xLTEtMjA5MjU_c6217f67-9bcf-4a7a-a662-d0e16a59b3c2">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bb108bc797e4252abac7baa59a2e9d4_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzktMS0xLTEtMjA5MjU_57f00678-1bcf-4f6a-807e-e3f01a51b84c">294</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cd1adca053c4d6580c37c9b0bff2f37_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzktMy0xLTEtMjA5MjU_0cc25b1b-152f-48f8-b868-f50269bffaa7">269</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cec06921db4ba883aa7b2610ace433_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzktNS0xLTEtMjA5MjU_6bcd0f2e-a78a-4339-85c9-083164288be5">109</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEwLTEtMS0xLTIwOTI1_37a33017-9aeb-4a60-9793-adfa3deeb619">2,381</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEwLTMtMS0xLTIwOTI1_6e0d0f50-173c-4bb2-b769-d449bfe810ad">1,971</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEwLTUtMS0xLTIwOTI1_9faaebb3-5447-4d38-a770-37db10415628">1,231</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzExLTEtMS0xLTIwOTI1_9c3b09bd-3a7c-4ced-ad34-bce1442334ec">218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzExLTMtMS0xLTIwOTI1_31bb6a8f-a79c-4aab-8772-5820fb650988">87</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzExLTUtMS0xLTIwOTI1_fec60e26-8d73-4368-a127-8d0a17f47965">155</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations before income taxes and equity in earnings of equity method investees</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEyLTEtMS0xLTIwOTI1_66958641-b546-49c9-a51d-ba1af5faf2a5">2,599</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEyLTMtMS0xLTIwOTI1_7574e637-c1aa-4884-ac2d-68d9ead65ba9">1,884</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEyLTUtMS0xLTIwOTI1_76a07075-9ad5-4ae6-95d2-fd1e5009eaf5">1,076</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEzLTEtMS0xLTIwOTI1_6b6adecc-b48f-48fe-90a8-ec9b01b991fa">597</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEzLTMtMS0xLTIwOTI1_8b0908a2-0366-4ba2-8c8d-5e9ee64c1512">460</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEzLTUtMS0xLTIwOTI1_e6d5014b-1ddb-4b7a-bb74-c0bffdc7e8aa">247</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE0LTEtMS0xLTIwOTI1_14f94a7d-78f2-4681-b861-fae8284b4c11">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE0LTMtMS0xLTIwOTI1_547dacc5-0b6c-4361-906d-b3b33075e3ca">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE0LTUtMS0xLTIwOTI1_930c1114-9ebc-4e94-a9a2-850a67a0b8c6">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE1LTEtMS0xLTIwOTI1_0ded4108-2726-4e60-a141-ce5e7c2d6238">2,080</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE1LTMtMS0xLTIwOTI1_dfabc4b0-b27f-48db-886b-630ed697a414">1,499</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE1LTUtMS0xLTIwOTI1_5b782a79-e946-40d4-b7ce-44965d573eb7">886</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE2LTEtMS0xLTIwOTI1_f2588ba8-744b-4936-9ad2-8f07390a700b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE2LTMtMS0xLTIwOTI1_250c12a9-d848-4672-bb22-2bbcc9a003c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE2LTUtMS0xLTIwOTI1_1416bd74-5b94-47ae-9d29-6a8f72ad2bd6">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE3LTEtMS0xLTIwOTI1_6674bd49-c4b0-410b-bfde-a25301e2859a">2,080</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE3LTMtMS0xLTIwOTI1_db78103c-0c95-4f69-9f94-bbb293e50b99">1,499</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE3LTUtMS0xLTIwOTI1_ab79e4e6-0a8a-4b79-be90-216b6f61c4f6">906</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE4LTEtMS0xLTIwOTI1_c5abae76-1eb3-472c-a7f9-267f3deb3c09">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE4LTMtMS0xLTIwOTI1_97d9a95c-2a8c-4d37-8925-05a8aac073f2">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE4LTUtMS0xLTIwOTI1_c3a1a0fb-280b-417c-b542-e9af5b0041ed">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE5LTEtMS0xLTIwOTI1_4c399235-ed45-41f8-b511-eeb8db66d178">1,995</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE5LTMtMS0xLTIwOTI1_6c31afe0-f480-490a-a017-441163c5608d">1,431</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE5LTUtMS0xLTIwOTI1_3554eb6e-b8e5-47b8-873f-a83b28f6ed22">858</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="i6a87078f3ad84c44a92fa78ac3955f17"><ix:continuation id="id5060e85b23a4894ab21056109e81ce3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Depreciation and amortization expense for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6815212460d4587af042592f64aaf60_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzItMS0xLTEtMjA5MjU_8740769e-0bd0-4bde-8137-1aac9b710c75">294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22f162e49514311adf2fd36a699bba9_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzItMy0xLTEtMjA5MjU_79940b3a-ec10-48b1-85b5-b6047aa9e7c3">249</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzItNS0xLTEtMjA5MjU_639dcf4a-6a13-4786-9aed-253efc113f83">226</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id980e16d89514f7aa100a29c06e97763_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzMtMS0xLTEtMjA5MjU_61b5aa9e-95a0-41d4-ac4b-b05491849aff">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744ee99a69fd4003b8a54a40eb3c8813_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzMtMy0xLTEtMjA5MjU_068c80d6-4f9a-49af-bd71-9399e4abe927">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if013d02c91354f9286988eda03c628e0_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzMtNS0xLTEtMjA5MjU_36f234aa-cf8a-403a-b4eb-596b8e27c52b">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bb108bc797e4252abac7baa59a2e9d4_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzQtMS0xLTEtMjA5MjU_0906a2f0-facc-445f-9e2f-0d37beeff866">104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd1adca053c4d6580c37c9b0bff2f37_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzQtMy0xLTEtMjA5MjU_8a5f8a24-708f-4466-8051-d12f84616316">104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cec06921db4ba883aa7b2610ace433_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzQtNS0xLTEtMjA5MjU_d11234af-aed7-4343-868e-16083afc67fa">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzgtMS0xLTEtMjA5MjU_142d9af6-f176-4125-ba95-0fac0bc6acfb">408</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzgtMy0xLTEtMjA5MjU_d3d1e282-ce3d-4337-abf0-d68dc59108e1">361</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzgtNS0xLTEtMjA5MjU_c402d0bd-c337-4318-bb28-788a99832dea">329</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Capital expenditures for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6815212460d4587af042592f64aaf60_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzItMS0xLTEtMjA5MjU_888b7b66-83ed-4d51-95d1-67546bef79bf">379</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22f162e49514311adf2fd36a699bba9_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzItMy0xLTEtMjA5MjU_b1f0af80-0fca-4a38-b3fe-498a483b7070">394</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzItNS0xLTEtMjA5MjU_6d26921b-5c13-4d6e-9c7a-73368022f5e0">373</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id980e16d89514f7aa100a29c06e97763_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzMtMS0xLTEtMjA5MjU_dc3df5f0-2861-4f72-a8a1-fc1be6a7f9fd">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744ee99a69fd4003b8a54a40eb3c8813_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzMtMy0xLTEtMjA5MjU_ee821331-0f4d-455f-bf53-fce0b4f8c6ae">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if013d02c91354f9286988eda03c628e0_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzMtNS0xLTEtMjA5MjU_b9732339-d7a6-4147-90e1-d0fc4fd738ee">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bb108bc797e4252abac7baa59a2e9d4_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzQtMS0xLTEtMjA5MjU_cce9d6cd-665f-4552-a1ef-91bc1b41df1c">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd1adca053c4d6580c37c9b0bff2f37_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzQtMy0xLTEtMjA5MjU_1d38e490-7b90-4d54-a775-a03acfb1474b">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cec06921db4ba883aa7b2610ace433_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzQtNS0xLTEtMjA5MjU_377f254b-3470-4cb5-89fc-a74e06080bd5">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzgtMS0xLTEtMjA5MjU_36a19f8a-5469-4080-b60a-651ad62f410c">403</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzgtMy0xLTEtMjA5MjU_4cf70a37-b54b-412c-abd7-fd4cfb84254f">418</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzgtNS0xLTEtMjA5MjU_6c65e884-7bfa-417f-aa88-3588805d6401">400</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service for the years ended December&#160;31, 2021, 2020 and 2019 were as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3764f252b9f84910a98e8576a15f1852_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzItMS0xLTEtMjA5MjU_d78b400a-d4ff-4017-9aa4-447f2384a990">4,293</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98112ec95e1d4aab9f4cde79cf53b385_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzItMy0xLTEtMjA5MjU_7ae308b8-d158-4f9e-8bc8-7aba90d5e435">3,836</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc9427fc9d114228a3d3efa6bcb432e9_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzItNS0xLTEtMjA5MjU_f9baa7f3-71ed-4647-886c-c49697fa51db">4,206</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208fa7e6f0334944b10d285de0b70711_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzMtMS0xLTEtMjA5MjU_aee3f4e9-c9ea-4495-a773-212690d9d14d">2,770</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f08a738c5804d11b70644f0148c895c_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzMtMy0xLTEtMjA5MjU_136af7ec-46f7-40a9-a7c8-8cc81edffc18">2,723</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib527ecaf883c4b36bb71ff0a85b4d81a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzMtNS0xLTEtMjA5MjU_021f8a7a-5e26-4af9-b358-075f4a0436d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i338f15fece2f4712847fd4e04333fc1d_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzQtMS0xLTEtMjA5MjU_56b61550-ae53-4fcb-b76d-c98d03be3de4">2,878</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975831888a86459eb1bac2b48531332d_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzQtMy0xLTEtMjA5MjU_45e735f9-01c4-4b48-91b0-b27ce4a77615">2,098</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19a2acf57ffa4509ab771b661fcea999_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzQtNS0xLTEtMjA5MjU_e9a916c9-25db-4bd9-8004-7545d7f417ae">2,620</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c039428d6d84b189717417daf0d8fe3_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzUtMS0xLTEtMjA5MjU_28564203-8408-461d-84b2-ae5b0b09bb11">553</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a494abcac9c47fca32926023c31eae6_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzUtMy0xLTEtMjA5MjU_7c3123fe-82e2-4f01-aad9-2fc79a5558bf">482</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f07a6ecd11b4fb5b1eaf5f119c9eb51_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzUtNS0xLTEtMjA5MjU_9ae3d459-30be-435e-bef0-06ef3cbf0239">579</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4766ba2728754ca5b737ca40088cd12b_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzYtMS0xLTEtMjA5MjU_9e640221-1344-424e-a35f-d6549da9d7ef">294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5343cf8aa45f4acc956a10119ecd34d5_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzYtMy0xLTEtMjA5MjU_bf8237a6-5841-4da2-9813-33510f017655">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5096412349bf441a965c02745c0985c1_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzYtNS0xLTEtMjA5MjU_42667143-48db-429a-bb4f-4991f0f0d33e">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzctMS0xLTEtMjA5MjU_6caba892-353f-49d7-9b31-fe8e74d19e16">10,788</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzctMy0xLTEtMjA5MjU_438a0abc-79d9-4cbf-9589-6d71fe71f311">9,437</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzctNS0xLTEtMjA5MjU_ce19a8a7-24e7-4fcc-99db-326110898896">7,726</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_238"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:continuation id="i3f0ee7c158244db6808947b7a1c813a9" continuedAt="ib2018c1e9ad540f48b6b0a7cac16ebf5">DISCONTINUED OPERATIONS</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib2018c1e9ad540f48b6b0a7cac16ebf5">&#160;&#160;&#160;&#160;Discontinued operations, net of taxes, for the year ended December 31, 2019 includes discrete tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i3694f852a462494f91d7c0a3b1211df9_D20190101-20191231" decimals="-6" name="dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzgvZnJhZzpmYTQ4OTc4MmE2YjM0ZTNmOWE2NTVjM2ZkMzg0ZWNjZC90ZXh0cmVnaW9uOmZhNDg5NzgyYTZiMzRlM2Y5YTY1NWMzZmQzODRlY2NkXzE0Ng_d0815ab5-6340-4446-afc4-dfaf63172ea8">20</ix:nonFraction> million associated with the favorable resolution of certain tax contingencies related to NID.  In addition, net cash provided by operating activities in the consolidated statement of cash flows for the year ended December 31, 2019 included a $<ix:nonFraction unitRef="usd" contextRef="i3694f852a462494f91d7c0a3b1211df9_D20190101-20191231" decimals="-6" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzgvZnJhZzpmYTQ4OTc4MmE2YjM0ZTNmOWE2NTVjM2ZkMzg0ZWNjZC90ZXh0cmVnaW9uOmZhNDg5NzgyYTZiMzRlM2Y5YTY1NWMzZmQzODRlY2NkXzM4Mw_2e8ca490-11d9-43e5-b5b4-24d6e1d5cd8f">28</ix:nonFraction> million refund from the taxing authorities related to discontinued operations.</ix:continuation></span></div><div><span><br/></span></div><div id="ib4001cf8768244cca3f772bfc08f865b_2096"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDk2L2ZyYWc6ODM3Nzc0Y2FlNzA5NGExMDlhMTMxODE0M2FlNzRiZGIvdGV4dHJlZ2lvbjo4Mzc3NzRjYWU3MDk0YTEwOWExMzE4MTQzYWU3NGJkYl8yNzQ4Nzc5MDcyMjcx_8e19d342-6f63-4f88-ae65-f052563b412b" continuedAt="i2afca56af6a14ff1a5b3f835a255d217" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2afca56af6a14ff1a5b3f835a255d217"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition of Pack Health, LLC</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On February 1, 2022, the Company acquired Pack Health, LLC ("Pack Health"), a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i6e7331c77972481e85855c53b18546a4_D20220201-20220201" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDk2L2ZyYWc6ODM3Nzc0Y2FlNzA5NGExMDlhMTMxODE0M2FlNzRiZGIvdGV4dHJlZ2lvbjo4Mzc3NzRjYWU3MDk0YTEwOWExMzE4MTQzYWU3NGJkYl8yNzQ4Nzc5MDc0NzU4_6d865623-91e4-4eaa-bc6b-d87a3f2350db">105</ix:nonFraction>&#160;million with up to $<ix:nonFraction unitRef="usd" contextRef="i8a6f1832ce5e4035a5b9b14f52d94a3f_I20220201" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDk2L2ZyYWc6ODM3Nzc0Y2FlNzA5NGExMDlhMTMxODE0M2FlNzRiZGIvdGV4dHJlZ2lvbjo4Mzc3NzRjYWU3MDk0YTEwOWExMzE4MTQzYWU3NGJkYl8yNzQ4Nzc5MDc0Nzcy_3a05f946-2a57-4c2a-9415-4e6d0d9f195d">20</ix:nonFraction>&#160;million of contingent consideration if certain revenue benchmarks are achieved. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preliminary purchase price allocation for the acquisition, which will be accounted for as a business combination, is not provided as the appraisal necessary to assess the fair values of assets acquired and liabilities assumed is not yet complete, but a significant portion of the purchase price is expected to be allocated to intangible assets and goodwill.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><div id="ib4001cf8768244cca3f772bfc08f865b_244"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4001cf8768244cca3f772bfc08f865b_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:nonNumeric contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90ZXh0cmVnaW9uOmQ0MDdhM2Y4ZGQ2ZTRmMDc5YmZkZTVjZDA1YzhlYjBjXzIwMw_7c46584b-3ba0-4636-84cc-ab4ea68b2cd1" continuedAt="i0d44a557c7f440e4a73cab431d39a2e3" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II - VALUATION ACCOUNTS AND RESERVES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:51.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Provision for Credit Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deductions<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>End of Year</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfee6ac293a4d0693346eada0d23f20_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzItMS0xLTEtMjA5MjU_b645aa5b-a29b-4fa7-918a-702a1a675ace">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a07547d99340ac959c9e338dbbd36c_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzItMy0xLTEtMjA5MjU_18239910-2d36-43bc-a8e4-926d9d9f8508">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a07547d99340ac959c9e338dbbd36c_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzItNS0xLTEtMjA5MjU_8a806109-4a9b-49b8-a120-e534d4418984">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2934d884c7734d478ccf8f3700348ced_I20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzItNy0xLTEtMjA5MjU_ae4bc8b5-e9ec-4643-aa08-3d4fec3c2755">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66fc5387af244c48b34e4b6ff0662c58_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzUtMS0xLTEtMjA5MjU_8baf79b8-c8a4-424f-98ce-0425eaf7133c">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c6d71b26c14be794b19fdcba867621_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzUtMy0xLTEtMjA5MjU_d9e6359f-07a9-46c0-8fcf-232862d8140d">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c6d71b26c14be794b19fdcba867621_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzUtNS0xLTEtMjA5MjU_5508dee3-26fe-419a-aa76-d5e2b6f753ec">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfee6ac293a4d0693346eada0d23f20_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzUtNy0xLTEtMjA5MjU_950734e0-aca2-4205-ad84-b52fe6e4e3fd">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts and allowances</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33dd72fa523b4d1d80a0eabd16074f43_I20181231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzgtMS0xLTEtMjA5MjU_d579a410-2036-4966-8125-44e5f59ba66b">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6f1ed6fbd9646ca9077dc5312767b5f_D20190101-20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzgtMy0xLTEtMjA5MjU_9d42dbbb-9cc2-4e51-b087-9b7860c78b19">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6f1ed6fbd9646ca9077dc5312767b5f_D20190101-20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzgtNS0xLTEtMjA5MjU_ca6feb81-e67f-4156-a12c-1f25aabddf8a">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66fc5387af244c48b34e4b6ff0662c58_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzgtNy0xLTEtMjA5MjU_fd999ff2-8f61-406d-b997-19c717ca1f0c">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0d44a557c7f440e4a73cab431d39a2e3" continuedAt="i3a1909fc8ef44976950ff98f4c04b395">(a)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"><ix:continuation id="i3a1909fc8ef44976950ff98f4c04b395">Primarily represents the write-off of accounts receivable, net of recoveries.</ix:continuation> </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>dgx12312021ex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i53b27a5e94224388b3bc4214500167f5_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quest Diagnostics Incorporated (DE)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Incorporated on December 12, 1990 in Delaware&#59; EIN&#58; 16-1387862)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiaries, Joint Ventures and Affiliates</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of February 1, 2022</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.848%"><tr><td style="width:1.0%"></td><td style="width:3.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.849%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.149%"></td><td style="width:0.0%"></td><td style="width:0.1%"></td><td style="width:2.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.149%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:3.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.891%"></td><td style="width:0.1%"></td></tr><tr><td colspan="30" style="background-color:#00b0f0;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company</font></td><td colspan="3" style="background-color:#00b0f0;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registered Alternate name</font></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Quest Diagnostics Holdings Incorporated (DE)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Quest Diagnostics International Holdings Limited (UK)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="24" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics Holdings Ltd. (UK)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  ExamOne Canada, Inc. (New Brunswick)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics Brasil Holdings Ltd. (UK)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9%  Quest Diagnostics HTAS India Private Limited (India) (0.1% Quest Diagnostics International Holdings Limited (UK)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics of Puerto Rico, Inc. (PR)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics Ireland Limited (Ireland)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics (Shanghai) Co., Ltd. (China)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics Subsidiary Holdings Ltd. (UK)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics Clinical Laboratories, Inc. (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Toxicology Network</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Labtech Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solstas Lab Partners Group</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solstas Lab Partners</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smithkline Beecham Clinical      </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Laboratories</font></div></td></tr><tr><td colspan="9" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Lab</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, LLC (MO)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LabOne, LLC of Kansas</font></div></td></tr><tr><td colspan="24" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Exam</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> World Wide, Inc. (PA)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% ExamOne LLC (DE)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% ExamOne World Wide of NJ, Inc. (NJ)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51%  DGXWMT JV, LLC (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Check by Quest Diagnostics</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% PACK Health, LLC (AL)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Quest HealthConnect, LLC (CA)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%  Quest Diagnostics Health &#38; Wellness, LLC (DE)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="24" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Lab</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of Ohio, Inc. (DE)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LabOne</font></div></td></tr><tr><td colspan="9" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51% Diagnostic Laboratory of Oklahoma LLC (OK)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Mid America Clinical Laboratories, LLC (IN)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49% Sonora Quest Laboratories LLC (AZ)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics do Brasil Ltda. (Brazil)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics Incorporated (MD)</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%  Quest Diagnostics India Private Limited (India)</font></div><div><font><br></font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%  Quest Diagnostics International LLC (DE)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Quest Diagnostics Investments LLC  (DE)</font></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1                                                                                                                    </font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.848%"><tr><td style="width:1.0%"></td><td style="width:3.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.849%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.149%"></td><td style="width:0.0%"></td><td style="width:0.1%"></td><td style="width:2.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.149%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:3.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.891%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics LLC (IL)<br></font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics LLC</font></td></tr><tr style="height:14pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics LLC (MA)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics LLC</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quest Diagnostics of Connecticut LLC</font></div><div><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81.1% Quest Diagnostics Massachusetts LLC (MA)  </font></div><div><font><br></font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics LLC (CT)</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="33" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics Mexico, S de RL de CV (Mexico)</font></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics Nichols Institute (CA)</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics of Pennsylvania Inc. (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51% Quest Diagnostics Venture LLC (PA)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.5% Associated Clinical Laboratories of Pennsylvania, L.L.C. (PA)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1% Associated Clinical Laboratories, L.P. (PA)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52.97% Associated Clinical Laboratories, L.P. (PA)</font></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics Receivables Inc. (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics TB, LLC (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 % Quest Diagnostics Ventures LLC (DE)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Athena Diagnostics, Inc. (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  American Medical Laboratories, Incorporated (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%   Quest Diagnostics Nichols Institute, Inc. (VA)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nichols Institute<br>Quest Diagnostics<br>Quest Diagnostics Nichols Institute, <br>&#160;&#160;&#160;Institute, Inc. of Virginia</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%   Quest Diagnostics Incorporated (NV)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated of Nevada</font></div><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics</font></div></td></tr><tr style="height:12pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Blueprint Genetics Inc. (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Blueprint Genetics Oy (Finland)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Blueprint Genetics FZ-LLC (UAE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Cleveland HeartLab, Inc. (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleveland Heartlab Services, Inc.</font></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%   Isabella Street Urban Renewal, LLC (NJ)</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Med Fusion, LLC (TX)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">med fusion</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">med fusion clin-trials</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">med fusion clin-labs</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Nomad Massachusetts, Inc. (MA)</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                  </font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.848%"><tr><td style="width:1.0%"></td><td style="width:3.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.849%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.149%"></td><td style="width:0.0%"></td><td style="width:0.1%"></td><td style="width:2.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.149%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:3.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.891%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Reprosource Fertility Diagnostics, Inc. (MA)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Unilab Corporation (DE)</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics</font></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath, Inc. (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Cincinnati, Inc. (OH)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richfield Laboratory of Dermatopathology</font></div><div style="padding-left:8.1pt;text-indent:-8.1pt"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Cleveland, Inc. (OH)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath GI Institute</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Consolidated Labs, Inc. (FL)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Florida, LLC (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Central Florida </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Northeast Florida</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Southwest Florida</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bay Area Dermatopathology</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics Bay Area</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Institute for Immunofluorescence</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Institute for Podiatric Pathology</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Hospital Services Florida, LLC (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Kentucky, Inc. (KY)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Lubbock 5.01(A) Corporation (TX)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arlington Pathology Associates</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics Texas</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">North Arlington Pathology </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Associates</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pathology Associates of Texas</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath New York, LLC (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath East</font></div><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Gastrointestinal Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Northeast</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;NE-Braintree</font></div><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ackerman Academy of Dermatopathology</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics New York</font></div><div><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Texas Inc. (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Tucson, Inc. (AZ)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriPath Arizona</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Consolidated DermPath, Inc. (DE)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  DFW 5.01(a) Corporation (TX)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath North Texas</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Dallas</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath DFW 5.01(a) </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Corporation</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Diagnostic Pathology Services, Inc. (OK)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriPath Oklahoma</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Kailash B. Sharma, M.D., Inc. (GA)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="18" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Nuclear Medicine and Pathology Associates (GA)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Institute for Dermatopathology, Inc. (PA)</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Mid Atlantic</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dermatopathology </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Laboratory</font></div></td></tr></table></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                  </font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.848%"><tr><td style="width:1.0%"></td><td style="width:3.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.849%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.149%"></td><td style="width:0.0%"></td><td style="width:0.1%"></td><td style="width:2.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.149%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:3.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.891%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Ocmulgee Medical Pathology Association, Inc. (GA)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Georgia Gastrointestinal Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Specialty Laboratories, Inc. (CA)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Nichols </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Institute of Valencia, Inc.</font></div></td></tr><tr><td colspan="30" style="background-color:#00b0f0;border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Entities Consolidated for Accounting Purposes</font></td><td colspan="3" style="background-color:#00b0f0;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.6pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Indianapolis, PC (IN)&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Indianapolis, PSC</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado Pathology Consultants, P.C. (CO)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Colorado</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatopathology of Wisconsin, S.C. (WI)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriPath Great Lakes</font></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hoffman, M.D., Associated Pathologists, Chartered (NV)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associated Pathologists, </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Chartered</font></div></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kilpatrick Pathology, P.A. (NC)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PhenoPath Laboratories, PLLC (WA)</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                  </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>3
<FILENAME>dgx12312021ex22.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2c30779072ae4d9fa4f1dc269dd0a9a1_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit 22</font></div><div style="text-align:right;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Subsidiary Guarantors of Securities</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of February 1, 2022, the following subsidiaries of Quest Diagnostics Incorporated provided, subject to the terms of such senior notes, unconditional and irrevocable guarantees to the senior notes listed below that were issued by Quest Diagnostics Incorporated pursuant to an offering registered under the Securities Act of 1933, as amended&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:27.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Securities</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Issuer</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Subsidiary Guarantor</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">State of Organization</font></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.95% Senior Notes due 2037</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.75% Senior Notes due 2040</font></div></td><td colspan="3" rowspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">American Medical Laboratories, Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Consolidated Labs, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Hospital Services Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Kentucky, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kentucky</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath New York, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Texas, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Athena Diagnostics, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Diagnostic Pathology Services, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Oklahoma</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pennsylvania</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide of NJ, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New Jersey</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kailash B. Sharma, M.D., Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Missouri</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne of Ohio, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ocmulgee Medical Pathology Association, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Clinical Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Holdings Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Maryland</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nevada</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Infectious Disease, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Investments LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Connecticut</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Illinois</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Massachusetts</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Virginia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics of Pennsylvania Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Specialty Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unilab Corporation</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>dgx12312021ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i61de7322dd5143ff9516d17d8eca6645_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-232138) and Form S-8 (Nos. 333-184580, 333-182863, 333-143889, 333-136196, 333-60758, 333-60477, 333-157447, 333-162710, 333-162711, 333-207746, 333-214215, 333-221076 and 333-234328) of Quest Diagnostics Incorporated of our report dated February&#160;28, 2022 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.163%"><tr><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PricewaterhouseCoopers LLP</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PricewaterhouseCoopers LLP</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florham Park, New Jersey</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;28, 2022</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>dgx12312021ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6fa10c8930844cf7a9075289d98d6bcc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen H. Rusckowski, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.988%"><tr><td style="width:1.0%"></td><td style="width:11.943%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>dgx12312021ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id471fb0d1b684df7aa4b45062f20f87a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark J. Guinan, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:15.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>dgx12312021ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8ed10deeda374b6689f3fec378b9737b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Annual Report on Form 10-K for the period ended December&#160;31, 2021 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Office and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>dgx12312021ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8b1f769eb7384801be16330bfd9690ed_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Annual Report on Form 10-K for the period ended December&#160;31, 2021 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.9
<SEQUENCE>9
<FILENAME>dgx12312021ex999.htm
<DESCRIPTION>EX-99.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i195f02cb56674cf6aaf27f8dd6848503_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 99.9</font></div></div><div><font><br></font></div><div id="i195f02cb56674cf6aaf27f8dd6848503_38"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AMENDMENT NO. 6 TO SIXTH AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Amendment No. 6 to Sixth Amended and Restated Credit and Security Agreement (this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Amendment&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) is entered into as of October 21, 2021 (the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), by and among&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(1) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">QUEST DIAGNOSTICS RECEIVABLES INC., a Delaware corporation (together with its successors and permitted assigns, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">),</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(2) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">QUEST DIAGNOSTICS INCORPORATED, a Delaware corporation, as initial servicer (in such capacity, together with any successor servicer or sub-servicer, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Servicer&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">),</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(3) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PNC BANK, NATIONAL ASSOCIATION, in its individual capacity as a Lender (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;PNC&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;PNC Group&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and as issuer of the Letters of Credit,</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(4) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GOTHAM FUNDING CORPORATION, a Delaware corporation (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Gotham&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), and MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), in its capacity as a Liquidity Bank to Gotham (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;MUFG&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and, together with Gotham, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Gotham Group&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">),</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(5)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> ATLANTIC ASSET SECURITIZATION LLC, a Delaware limited liability company (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Atlantic&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), and CR&#201;DIT AGRICOLE CORPORATE AND INVESTMENT BANK, in its capacity as a Liquidity Bank to Atlantic (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;CACIB&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and, together with Atlantic, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Atlantic Group&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">),</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(6) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PNC BANK, NATIONAL ASSOCIATION, in its capacity as agent for the PNC Group (together with its successors in such capacity, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Co-Agent&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), CR&#201;DIT AGRICOLE CORPORATE AND INVESTMENT BANK, in its capacity as agent for the Atlantic Group (together with its successors in such capacity, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Co-Agent&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), and MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), in its capacity as agent for the Gotham Group (together with its successors in such capacity, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Co-Agent&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(7) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PNC BANK, NATIONAL ASSOCIATION, in its capacity as Letter of Credit issuer (together with its successors in such capacity, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;LC Issuer&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), and</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(8) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), as administrative agent for the Atlantic Group, the PNC Group, the Gotham Group and the Co-Agents (in such capacity, together with any successors thereto in such capacity, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Administrative Agent&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and together with each of the Co-Agents, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Agents&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RECITALS&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.87pt">The Borrower, the Servicer, the PNC Group, the Gotham Group, the Atlantic Group and the Agents are parties to that certain Sixth Amended and Restated Credit and Security Agreement, dated as of October 27, 2017 (as amended, restated or otherwise modified from time to time, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Credit and Security Agreement&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; capitalized terms used and not otherwise defined herein are used with the meanings attributed thereto in the Credit and Security Agreement).</font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.&#160;&#160;&#160;&#160;Each of the parties hereto desires to amend the Credit and Security Agreement as hereinafter set forth.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">NOW, THEREFORE,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in consideration of the premises, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.91pt;text-decoration:underline">Amendments to the Credit and Security Agreement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Effective as of the Effective Date&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Credit and Security Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effect of Benchmark Transition Event</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein or in any other Transaction Document, if a Benchmark Transition Event, an Early Opt-in Election or an Other Benchmark Rate Election, as applicable, and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then (x) if a Benchmark Replacement is determined in accordance with clause (a)(1) or (a)(2) of the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Replacement&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any other Transaction Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Agreement or any other Transaction Document and (y) if a Benchmark Replacement is determined in accordance with clause (a)(3) or clause (c) of the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Replacement&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any other Transaction Document in respect of any Benchmark setting at or after 5&#58;00 p.m. (New York City time) on the fifth (5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) Business Day after the date notice of such Benchmark Replacement is provided to the Co-Agents without any amendment to, or further action or consent of any other party to, this Agreement or any other Transaction Document so long as the Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacement from any of the Co-Agents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein or in any other Transaction Document, if a Term SOFR Transition Event and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then the applicable Benchmark Replacement will replace the then-current Benchmark for all purposes hereunder or under any other Transaction Document in respect of such Benchmark setting and subsequent Benchmark settings, without any amendment to, or further action or consent of any other party to, this Agreement or any other Transaction Document&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that this clause (ii) shall not be effective unless the Administrative Agent has delivered to the Borrower a Term SOFR Notice.  For the avoidance of doubt, the Administrative Agent shall not be required to deliver a Term SOFR Notice after a Term SOFR Transition Event and may do so in its sole discretion.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In connection with the implementation of a Benchmark Replacement, the Administrative Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Transaction Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Transaction Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Notices&#59; Standards for Decisions and Determinations</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent will promptly notify the Borrower of (i) any occurrence of a Benchmark Transition Event, a Term SOFR Transition Event, an Early Opt-in Election or an Other Benchmark Rate Election, as applicable, and its related Benchmark Replacement Date, (ii) the implementation of any Benchmark Replacement and any Benchmark Replacement Adjustment, (iii) the effectiveness of any Benchmark Replacement Conforming Changes and (iv) the removal or reinstatement of any tenor of a Benchmark pursuant to clause (d) below. Any determination, decision or election that may be made by the Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any related definition, with the consent of or in agreement with the Borrower.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Unavailability of Tenor of Benchmark</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary herein or in any other Transaction Document, at any time (including in connection with the implementation of a Benchmark Replacement), (i) if the then-current Benchmark is a term rate (including Term SOFR or USD LIBOR) and either (A) any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion or (B) the regulatory supervisor for the administrator of such Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is or will be no longer representative, then the Administrative Agent may modify the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Interest Period&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for any Benchmark settings at or after such time to remove such unavailable or non-representative tenor and (ii) if a tenor that was removed pursuant to clause (i) above either (A) is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (B) is not, or is no longer, subject to an announcement that it is or will no longer be representative for a Benchmark (including a Benchmark Replacement), then the Administrative Agent (in consultation with the Borrower) may modify the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Interest Period&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for all Benchmark settings at or after such time to reinstate such previously removed tenor.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Unavailability Period</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Upon the Borrower&#8217;s receipt of notice of the commencement of a Benchmark Unavailability Period, the Borrower may revoke any request for a borrowing of, conversion to or continuation of Eurodollar Loans or LMIR Loans to be made, converted or continued during any Benchmark Unavailability Period </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and, failing that, the Borrower will be deemed to have converted any such request into a request for a borrowing of or conversion to Alternate Base Rate Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Rates</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent does not warrant or accept responsibility for, and shall not have any liability with respect to (i) the administration of, submission of or any other matter related to the Benchmark, any component definition thereof or rates referred to in the definition thereof or any alternative, comparable or successor rate thereto (including any then-current Benchmark or any Benchmark Replacement), including whether the composition or characteristics of any such alternative, comparable or successor rate (including any Benchmark Replacement) will be similar to, or produce the same value or economic equivalence of, or have the same volume or liquidity as, the then-current Benchmark or (ii) the effect, implementation or composition of any Benchmark Replacement Conforming Changes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">London Interbank Offered Rate Benchmark Transition Event</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  On March 5, 2021, the ICE Benchmark Administration (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">IBA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), the administrator of the London interbank offered rate, and the Financial Conduct Authority (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">FCA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), the regulatory supervisor of the IBA, announced in public statements (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Announcements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;) that the final publication or representativeness date for (i) 1-week and 2-month London interbank offered rate tenor settings will be December 31, 2021 and (ii) overnight, 1-month, 3-month, 6-month and 12-month London interbank offered rate tenor settings will be June 30, 2023.  No successor administrator for the IBA was identified in such Announcements.  The parties hereto agree and acknowledge that the Announcements resulted in the occurrence of a Benchmark Transition Event with respect to the London interbank offered rate pursuant to the terms of this Agreement and that any obligation of the Administrative Agent to notify any parties of such Benchmark Transition Event pursuant to clause (c) of this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed satisfied.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Certain Defined Terms</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As used in this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Available Tenor&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, as of any date of determination and with respect to the then-current Benchmark, as applicable, (x) if the then-current Benchmark is a term rate, any tenor for such Benchmark or (y) otherwise, any payment period for interest calculated with reference to such Benchmark, as applicable, that is or may be used for determining the length of an Interest Period pursuant to this Agreement as of such date and not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Interest Period&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> pursuant to clause (d) of this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, initially, USD LIBOR&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if a Benchmark Transition Event, a Term SOFR Transition Event, an Early Opt-in Election or an Other Benchmark Rate Election, as applicable, and its related Benchmark Replacement Date have occurred with respect to USD LIBOR or the then-current Benchmark, then </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to clause (a) of this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>4</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Replacement&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, for any Available Tenor,</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) with respect to any Benchmark Transition Event or Early Opt-in Election, the first alternative set forth in the order below that can be determined by the Administrative Agent (in consultation with the Borrower) for the applicable Benchmark Replacement Date&#58;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">the sum of&#58; (A) Term SOFR and (B) the related Benchmark Replacement Adjustment&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the Borrower has provided a notification to the Administrative Agent in writing on or prior to such Benchmark Replacement Date that the Borrower has a hedge agreement in place with respect to any of the Loans as of the date of such notice (which such notification the Administrative Agent shall be entitled to rely upon and shall have no duty or obligation to ascertain the correctness or completeness of), then the Administrative Agent, in consultation with the Borrower, may decide not to determine the Benchmark Replacement pursuant to this clause (a)(1) for such Benchmark Transition Event or Early Opt-in Election, as applicable&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">the sum of&#58; (A) Daily Simple SOFR and (B) the related Benchmark Replacement Adjustment&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">the sum of&#58; (A) the alternate benchmark rate that has been selected by the Administrative Agent, in consultation with the Borrower, as the replacement for the then-current Benchmark for the applicable Corresponding Tenor giving due consideration to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (ii) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement for the then-current Benchmark for Dollar-denominated syndicated credit facilities at such time and (B) the related Benchmark Replacement Adjustment&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) with respect to any Term SOFR Transition Event, the sum of (i) Term SOFR and (ii) the related Benchmark Replacement Adjustment&#59; or</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) with respect to any Other Benchmark Rate Election, the sum of&#58; (i) the alternate benchmark rate that has been selected by the Administrative Agent and the Borrower as the replacement for the then-current Benchmark for the applicable Corresponding Tenor giving due consideration to any evolving or then-prevailing market convention for determining a benchmark rate as a replacement for the then-current Benchmark for Dollar-denominated syndicated credit facilities at such time and (ii) the related Benchmark Replacement Adjustment&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, (i) in the case of clause (a)(1), if the Administrative Agent, in consultation with the Borrower, decides that Term SOFR is not administratively feasible for the Administrative Agent, then Term SOFR will be deemed unable to be determined for purposes of this definition and (ii) in the case of clause (a)(1) or clause (b) of this definition, the applicable Unadjusted Benchmark Replacement is displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion. If the Benchmark Replacement as determined pursuant to clause (a)(1), (a)(2) or (a)(3), clause (b) or clause (c) of this definition would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor for the purposes of this Agreement and the other Transaction Documents&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>5</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Replacement Adjustment&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark Replacement, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent and the Borrower giving due consideration to (a) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body or (b)  any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for Dollar-denominated syndicated credit facilities.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Replacement Conforming Changes&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Business Day,&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Interest Period,&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, length of lookback periods, the applicability of breakage provisions and other technical, administrative or operational matters) that the Administrative Agent and the Borrower reasonably determine is reasonably necessary or appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent and the Borrower decide that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent and the Borrower reasonably determine that no market practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Administrative Agent and the Borrower reasonably determine is reasonably necessary in connection with the administration of this Agreement and the other Transaction Documents).</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Replacement Date&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means the earliest to occur of the following events with respect to the then-current Benchmark&#58;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">in the case of clause (1) or (2) of the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Transition Event,&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the later of (a) the date of the public statement or publication of information referenced therein and (b) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide all Available Tenors of such Benchmark (or such component thereof)&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">in the case of clause (3) of the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Transition Event,&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the date of the public statement or publication of information referenced therein&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">in the case of a Term SOFR Transition Event, the date that is thirty (30) days after the Administrative Agent has provided a Term SOFR Notice to the Borrower pursuant to clause (a)(ii) of this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; or</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">in the case of an Early Opt-in Election or an Other Benchmark Rate Election, the first (1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) Business Day after the date notice of such Early Opt-in Election or Other Benchmark Rate Election is provided to the Borrower.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>6</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;padding-right:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the avoidance of doubt, (i) if the event giving rise to the Benchmark Replacement Date occurs on the same day as, but earlier than, the Reference Time in respect of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination and (ii) the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Replacement Date&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> will be deemed to have occurred in the case of clause (1) or (2) with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Transition Event&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means the occurrence of one or more of the following events with respect to the then-current Benchmark&#58;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased to provide all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">provided </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Board of Governors of the Federal Reserve System, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), which states that the administrator of such Benchmark (or such component) has ceased to provide all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that all Available Tenors of such Benchmark (or such component thereof) are no longer representative.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the avoidance of doubt, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Benchmark Transition Event&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Benchmark Unavailability Period</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, the period (if any) (a) beginning at the time that a Benchmark Replacement Date has occurred if, at such time, no Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with Section 4.5 and (b) ending at the time that a Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with Section 4.5.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>7</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Corresponding Tenor&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with respect to any Available Tenor means, as applicable, either a tenor (including overnight) or an interest payment period having approximately the same length (disregarding business day adjustment) as such Available Tenor.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Daily Simple SOFR&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means, for any day, SOFR, with the conventions for this rate (which will include a lookback) being established by the Administrative Agent in accordance with the conventions for this rate selected or recommended by the Relevant Governmental Body for determining </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Daily Simple SOFR&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for bilateral business loans&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the Administrative Agent decides that any such convention is not administratively feasible for the Administrative Agent, then the Administrative Agent may establish another convention in its reasonable discretion.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Early Opt-in Election&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, if the then-current Benchmark is USD LIBOR, the occurrence of&#58;</font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">a notification by the Administrative Agent (or a request by the Borrower to the Administrative Agent to notify) each of the other parties hereto that at least ten (10 ) currently outstanding Dollar-denominated syndicated or bilateral credit facilities at such time contain (as a result of amendment or as originally executed) a SOFR-based rate (including SOFR, a term SOFR or any other rate based upon SOFR) as a benchmark rate, and</font></div><div style="padding-left:72pt;padding-right:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt">the joint election by the Administrative Agent and the Borrower to trigger a fallback from USD LIBOR and the provision by the Administrative Agent of written notice of such election to the Co-Agents.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Floor&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means zero percent (0%) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Other Benchmark Rate Election&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, if the then-current Benchmark is USD LIBOR, the occurrence of&#58;</font></div><div style="margin-bottom:8pt;padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.08pt">a notification by the Administrative Agent to (or the request by the Borrower to the Administrative Agent to notify) each of the other parties hereto that at least five currently outstanding Dollar-denominated syndicated credit facilities at such time contain (as a result of amendment or as originally executed), in lieu of a USD LIBOR-based rate, a term benchmark rate that is not a SOFR-based rate as a benchmark rate (and such syndicated credit facilities are identified in such notice and are publicly available for review), and</font></div><div style="margin-bottom:8pt;padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.57pt">the joint election by the Administrative Agent and the Borrower that they will no longer use USD LIBOR and the provision by the Administrative Agent of written notice of such election to the Co-Agents.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Reference Time&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with respect to any setting of the then-current Benchmark means (1) if such Benchmark is USD LIBOR, 11&#58;00 a.m. (London time) on the day that is two London banking days preceding the date of such setting, and (2) if such Benchmark is not USD LIBOR, the time determined by the Administrative Agent in its reasonable discretion in consultation with the Borrower.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Relevant Governmental Body&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;SOFR&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, with respect to any Business Day, a rate per annum equal to the secured overnight financing rate for such Business Day published by the SOFR Administrator on the SOFR Administrator&#8217;s Website on the immediately succeeding Business Day. </font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;SOFR Administrator&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate).</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;SOFR Administrator&#8217;s Website&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means the website of the Federal Reserve Bank of New York, currently at  </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;www.newyorkfed.org</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or any successor source for the secured overnight financing rate identified as such by the SOFR Administrator from time to time.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Term SOFR&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, for the applicable Corresponding Tenor as of the applicable Reference Time, the forward-looking term rate based on SOFR that has been selected or recommended by the Relevant Governmental Body.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Term SOFR Notice&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means a written notification by the Administrative Agent to the Borrower of the occurrence of a Term SOFR Transition Event.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Term SOFR Transition Event&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means the determination by the Administrative Agent and the Borrower that (a) Term SOFR has been recommended for use by the Relevant Governmental Body, (b) the administration of Term SOFR is administratively feasible for the Administrative Agent and (c) a Benchmark Transition Event, an Early Opt-in Election or an Other Benchmark Rate Election, as applicable, has previously occurred resulting in the replacement of the then-current Benchmark for all purposes hereunder and under any other Transaction Document in accordance with this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with a Benchmark Replacement the Unadjusted Benchmark Replacement component of which is not Term SOFR.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Unadjusted Benchmark Replacement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Benchmark Replacement excluding the Benchmark Replacement Adjustment.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;USD LIBOR&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means the London interbank offered rate for Dollars.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2.&#160;&#160;&#160;&#160;The definitions of the defined terms set forth below are hereby amended and restated in their entirety to read as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;A-Commitment Expiry Date&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means October 21, 2022.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Alternate Base Rate&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means for any day, the rate </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> equal to the higher as of such day of (i) the Prime Rate, or (ii) one-half of one percent (0.50%) above the Federal Funds Rate.  For purposes of determining the Alternate Base Rate for any day, changes in the Prime Rate or the Federal Funds Rate shall be effective on the date of each such change&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that if either (i) the Prime Rate or (ii) one-half of one percent (0.50%) above the Federal Funds Rate at any time shall be less than zero percent (0.00%) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, such rate for purposes of this definition shall be deemed to be zero percent (0.00%) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Biennial Commitment Expiry Date&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means October 20, 2023.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Scheduled Termination Date</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means October 20, 2023.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>9</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.91pt;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Amendment shall become effective as of the Effective Date provided that each of the following conditions precedent is satisfied&#58;  (a) The Administrative Agent shall have received counterparts of this Amendment (whether by electronic mail or otherwise) duly executed by each of the parties hereto&#59; (b) the Fee Letter dated of even date herewith shall have been duly executed by all parties thereto, and each of the Co-Agents shall have received payment in immediately available funds of their respective Amendment Structuring Fees (as defined in such Fee Letter)&#59; and (c) each of the representations and warranties set forth in Section 3 of this Amendment is true and correct as of the Effective Date. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.91pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower hereby represents and warrants to the Agents and the Lenders as of the Effective Date as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.08pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The representations and warranties contained in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article VI</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Credit and Security Agreement are true and correct as of the date hereof (unless stated to relate solely to an earlier date, in which case such representations or warranties were true and correct as of such earlier date).</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.57pt;text-decoration:underline">Enforceability</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The execution and delivery by each of the Borrower and the Servicer of this Amendment, and the performance of each of its obligations under this Amendment and the Credit and Security Agreement, as amended hereby, are within each of its organizational powers and have been duly authorized by all necessary action on each of its parts.  This Amendment and the Credit and Security Agreement, as amended hereby, are each of the Borrower&#8217;s and the Servicer&#8217;s valid and legally binding obligations, enforceable in accordance with its terms.</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.69pt;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Immediately after giving effect to this Amendment and the transactions contemplated hereby, no Event of Default or Unmatured Default exists or shall exist.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 4. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.91pt;text-decoration:underline">Legal Fees and Disbursements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower hereby acknowledges and agrees that this Amendment constitutes a Transaction Document and that the provisions of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 14.5(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Credit and Security Agreement apply hereto.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.91pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Amendment shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to any otherwise applicable conflicts of law principles (other than Sections 5-1401 and 5-1402 of the New York General Obligations Law which shall apply hereto).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.91pt;text-decoration:underline">Effect of Amendment&#59; Ratification</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as specifically amended hereby, the Credit and Security Agreement is hereby ratified and confirmed in all respects, and all of its provisions shall remain in full force and effect.  After this Amendment becomes effective, all references in the Credit and Security Agreement (or in any other Transaction Document) to &#8220;the Credit and Security Agreement&#8221;, &#8220;this Agreement&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221;, or words of similar effect, in each case referring to the Credit and Security Agreement, shall be deemed to be references to the Credit and Security Agreement as amended hereby.  This Amendment shall not be deemed to expressly or impliedly waive, amend, or supplement any provision of the Credit and Security Agreement other than as specifically set forth herein.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 7. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.91pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, and each counterpart shall be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.  To the fullest extent permitted by applicable law, delivery of an executed</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>10</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">counterpart of a signature page of this Amendment by telefacsimile or electronic image scan transmission (such as a &#8220;pdf&#8221; file) will be effective to the same extent as delivery of a manually executed original counterpart of this Amendment.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.91pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The various headings of this Amendment are inserted for convenience only and shall not affect the meaning or interpretation of this Amendment or the Credit and Security Agreement or any provision hereof or thereof.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.91pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Amendment shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 10. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.34pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any one or more of the provisions or terms of this Amendment shall for any reason whatsoever be held invalid or unenforceable, then such agreements, provisions or terms shall be deemed severable from the remaining agreements, provisions and terms of this Amendment and shall in no way affect the validity or enforceability of the provisions of this Amendment or the Credit and Security Agreement.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#60;Balance of page intentionally left blank&#62;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>11</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div id="i195f02cb56674cf6aaf27f8dd6848503_41"></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">IN WITNESS WHEREOF,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the parties have executed this Amendment as of the date first written above.</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">QUEST DIAGNOSTICS RECEIVABLES INC.<br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; &#160;&#160;&#160;&#160;&#47;s&#47; Sandip R. Patel<br>Name&#58;   Sandip R. Patel<br>Title&#58;     Vice President and Treasurer</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">QUEST DIAGNOSTICS INCORPORATED, as Servicer<br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; &#160;&#160;&#160;&#160;&#47;s&#47; Sandip R. Patel</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;   Sandip R. Patel<br>Title&#58;     Vice President and Treasurer</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>12</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:203.05pt;text-indent:-1.45pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ATLANTIC ASSET SECURITIZATION LLC, as a Conduit</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Konstantina Kourmpetis&#160;&#160;&#160;&#160;</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;  Konstantina Kourmpetis</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;   Managing Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">____Richard McBride__________________</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>Name&#58; Richard McBride <br>Title&#58;    Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CR&#201;DIT AGRICOLE CORPORATE AND INVESTMENT BANK, individually as a Liquidity Bank for Atlantic and as Atlantic Group Agent</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Konstantina Kourmpetis&#160;&#160;&#160;&#160;</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;  Konstantina Kourmpetis</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;   Managing Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">____Richard McBride__________________</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>Name&#58; Richard McBride <br>Title&#58;    Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;    </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PNC BANK, NATIONAL ASSOCIATION,</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">individually as a Lender, as PNC Group Agent and as LC Issuer</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; &#160;&#160;&#160;&#160;&#47;s&#47;Henry Chan&#160;&#160;&#160;&#160;<br>Name&#58;   Henry Chan<br>Title&#58;    Senior Vice President</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GOTHAM FUNDING CORPORATION, as a Conduit</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; &#160;&#160;&#160;&#160;&#47;s&#47; Kevin Corrigan&#160;&#160;&#160;&#160;<br>Name&#58;  Kevin Corrigan<br>Title&#58;    Vice President</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), INDIVIDUALLY AS A LIQUIDITY BANK FOR GOTHAM</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  __</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Eric Williams</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________                                   </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Eric Williams</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;    Managing Director         </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), AS GOTHAM AGENT</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  __</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Eric Williams</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________                                   </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Eric Williams</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;    Managing Director             </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), AS ADMINISTRATIVE AGENT</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  __</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Eric Williams</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________                                   </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Eric Williams</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;    Managing Director           </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Quest Amendment No. 6 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.10
<SEQUENCE>10
<FILENAME>dgx12312021ex9910.htm
<DESCRIPTION>EX-99.10
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i722171e1fc8d400187c14df1181aca29_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 99.10</font></div></div><div><font><br></font></div><div id="i722171e1fc8d400187c14df1181aca29_38"></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">__________________________________________________________________________</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIRD AMENDED AND RESTATED CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated as of November 23, 2021</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">among</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">QUEST DIAGNOSTICS INCORPORATED,</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;as Borrower,&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THE LENDERS IDENTIFIED HEREIN,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">JPMORGAN CHASE BANK, N.A.,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Administrative Agent,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MORGAN STANLEY SENIOR FUNDING, INC.,</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Syndication Agent</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">________________________________________________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">JPMORGAN CHASE BANK, N.A.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MORGAN STANLEY SENIOR FUNDING, INC.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MIZUHO BANK, LTD., and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WELLS FARGO SECURITIES, LLC,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Joint Lead Arrangers and Joint Bookrunners</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MIZUHO BANK, LTD. and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WELLS FARGO BANK, N.A.<br>as Documentation Agents</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">__________________________________________________________________________</font></div><div style="margin-top:0.2pt;padding-right:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;CS&#38;M Ref. No. 6702-376&#93;</font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i722171e1fc8d400187c14df1181aca29_41"></div><hr style="page-break-after:always"><div style="min-height:76.8pt;width:100%"><div style="padding-left:2.87pt;padding-right:2.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Page</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1 DEFINITIONS AND ACCOUNTING TERMS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Interpretive Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">38</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accounting Terms&#47;Calculation of Financial Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">39</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rounding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Rates&#59; Currency Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Alternative Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">41</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">References to Agreements and Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">42</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">42</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Rates&#59; LIBOR Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">42</a></font></div></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2 CREDIT FACILITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">43</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">43</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Subfacility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">45</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loans Subfacility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">53</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Continuations and Conversions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">54</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">55</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">55</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Facilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">57</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension of Revolving Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">59</a></font></div></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3 GENERAL PROVISIONS APPLICABLE TO LOANS AND LETTERS OF CREDIT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">61</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">61</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Place and Manner of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">61</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">62</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">63</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment in Full at Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">64</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Computations of Interest and Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">64</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Rata Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">65</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sharing of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">66</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Adequacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">67</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Rate of Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">67</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Illegality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">71</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Requirements of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">71</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">72</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">75</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Determination and Survival of Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">76</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notification by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">76</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.17</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mitigation&#59; Mandatory Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">76</a></font></div></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4 &#91;Reserved&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">77</a></font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.8pt;width:100%"><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Page</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5 CONDITIONS PRECEDENT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">77</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">77</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to All Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">78</a></font></div></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6 REPRESENTATIONS AND WARRANTIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">79</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Organization and Good Standing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">79</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Due Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">80</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Enforceable Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">80</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">80</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">80</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">81</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">81</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">81</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">81</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">82</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">82</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">82</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Licensing and Accreditation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Government Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.17</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.18</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">84</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">84</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.20</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.22</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">85</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7 AFFIRMATIVE COVENANTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Information Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">88</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Preservation of Existence and Franchises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">89</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">89</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Maintenance of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Audits&#47;Inspections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">91</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">91</a></font></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8 NEGATIVE COVENANTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">92</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness of Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">92</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">93</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sale and Leaseback Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">94</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ii</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.8pt;width:100%"><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Page</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">94</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fundamental Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">94</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transactions with Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">94</a></font></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9 EVENTS OF DEFAULT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">95</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">95</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acceleration&#59; Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">97</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Allocation of Payments After Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">98</a></font></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10 AGENCY PROVISIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">99</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appointment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">99</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delegation of Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">100</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exculpatory Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">100</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reliance on Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">100</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">101</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Reliance on Administrative Agent and Other Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">101</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">102</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent in Its Individual Capacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">103</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successor Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">103</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agent May&#160;File Proofs of Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">103</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Lender Representations, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">104</a></font></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11 MISCELLANEOUS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">107</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">107</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Right of Set-Off</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">110</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benefit of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">110</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Waiver&#59; Remedies Cumulative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">115</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Expenses&#59; Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">115</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments, Waivers and Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">117</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">119</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">119</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Survival of Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">119</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law&#59; Venue&#59; Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">119</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Jury Trial&#59; Waiver of Consequential Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">120</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">121</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">121</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">121</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Public Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">122</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Entirety</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">122</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.17</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Binding Effect&#59; Continuing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">122</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.18</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PATRIOT Act Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">123</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Advisory or Fiduciary Responsibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">123</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.20</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Judgment Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">124</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgment and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i722171e1fc8d400187c14df1181aca29_47" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">124</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">iii</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><div id="i722171e1fc8d400187c14df1181aca29_44"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SCHEDULES</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 1.1(a)&#160;&#160;&#160;&#160;Commitment Percentages&#47;Lending Offices</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Existing Letters of Credit</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 6.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Litigation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 8.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Indebtedness</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 8.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Liens</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 8.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Affiliate Transactions</font></div><div style="margin-bottom:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 11.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notices</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 2.1(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Notice of Borrowing</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 2.1(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Revolving Note</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 2.3(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Swing Line Loan Request</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 2.3(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Swing Line Loan Note</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 2.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Notice of Continuation&#47;Conversion</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 3.13(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Tax Certificate</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 7.1(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Officer&#8217;s Certificate</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 7.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Guarantee</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 11.3(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Assignment and Assumption</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><div id="i722171e1fc8d400187c14df1181aca29_47"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIRD AMENDED AND RESTATED CREDIT AGREEMENT, dated as of November&#160;23, 2021 (as amended, amended and restated, supplemented or otherwise modified from time to time, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by and among QUEST DIAGNOSTICS INCORPORATED, a Delaware corporation, as Borrower, the various financial institutions and other Persons from time to time parties hereto, as Lenders, JPMORGAN CHASE BANK, N.A., as Administrative Agent, MORGAN STANLEY SENIOR FUNDING, INC., as syndication agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Syndication Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and MIZUHO BANK, LTD. and WELLS FARGO BANK, N.A., as documentation agents (in such capacities, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, for purposes of providing financing for the working capital and general corporate needs of the Borrower and its Subsidiaries, including acquisitions, the Borrower requested a $750,000,000 revolving credit facility (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, on the Prior Closing Date, the Lenders agreed, on the terms and subject to the conditions hereinafter set forth, to provide the Revolving Credit Facility&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree that, subject to the satisfaction of the conditions set forth in Section 5.1, the Existing Credit Agreement shall be and hereby is amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt"><br><br>DEFINITIONS AND ACCOUNTING TERMS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As used herein, the following terms shall have the meanings herein specified unless the context otherwise requires&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Daily Simple SONIA Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Borrowing denominated in Sterling, an interest rate per annum equal to the Daily Simple SONIA Rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> if the Adjusted Daily Simple SONIA Rate as so determined would be less than the Floor, such rate shall be deemed to be equal to the Floor for the purposes of this Credit Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted EURIBO Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Euros for any Interest Period, an interest rate per annum equal to (a)&#160; the EURIBO Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> if the Adjusted EURIBO Rate as so determined would be less than the Floor, such rate shall be deemed to be equal to the Floor for the purposes of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted LIBO Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Interest Period, with respect to an Interest Period for a LIBOR Loan denominated in Dollars, an interest rate per annum (rounded upwards, if necessary, to the next 1&#47;100 of 1%) equal to (a)&#160;the LIBO Rate for such Interest Period multiplied by (b)&#160;the Statutory Reserve Rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> if the Adjusted LIBO Rate as so determined would be less than the Floor, such rate shall be deemed to be equal to the Floor for the purposes of this Credit Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means JPMorgan (or any successor thereto) or any successor administrative agent appointed pursuant to Section 10.9.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Questionnaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, any other Person directly or indirectly controlling (including but not limited to all directors and officers of such Person), controlled by or under direct or indirect common control with such Person.  A Person shall be deemed to control a corporation if such Person possesses, directly or indirectly, the power (a)&#160;to vote 10% or more of the securities having ordinary voting power for the election of directors of  such corporation or (b)&#160;to direct or cause direction of the management and policies of such corporation, whether through the ownership of voting securities, by contract or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agency Services Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any currency, the Administrative Agent&#8217;s address and, as appropriate, account as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> with respect to such currency, or such other address or account with respect to such currency as the Administrative Agent may from time to time designate by written notice to the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agent-Related Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Administrative Agent (including any successor administrative agent) and its Related Parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Administrative Agent, the Syndication Agent and the Documentation Agents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreed Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Dollars and each Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.20.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Euro, Sterling</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and each other currency (other than Dollars) that is approved in accordance with Section&#160;1.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment and Restatement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Amendment and Restatement Agreement, dated as of November 23, 2021, among the Borrower, the Lenders party thereto and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all laws, rules, and regulations of any jurisdiction applicable to the Borrower or its Subsidiaries from time to time concerning or relating to bribery, money laundering or corruption.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the appropriate applicable percentage corresponding to the Debt Rating of the Borrower in effect from time to time as described below&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pricing Level</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Debt Rating</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Applicable Percentage for Term Benchmark Revolving Loans and RFR Loans</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Applicable Percentage for Base Rate Revolving Loans</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Applicable Percentage for Letter of Credit Fees</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Applicable Percentage for Facility Fee on the Revolving Commitments</font></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A from S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A2 from Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.630%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.630%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.070%</font></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">II</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A- from S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A3 from Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.785%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.785%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.090%</font></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">III</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BBB+ from S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Baa1 from Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.900%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.900%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.100%</font></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IV</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BBB from S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Baa2 from Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.000%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.000%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.125%</font></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">V</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BBB- from S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Baa3 from Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.100%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.100%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.100%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.150%</font></td></tr><tr><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">VI</font></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8804; BB+ or unrated by S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8804; Ba1 or unrated by Moody&#8217;s</font></div></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.275%</font></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.225%</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Applicable Percentage for Revolving Loans that are Term Benchmark Loans, RFR Loans and Base Rate Loans, for Letter of Credit Fees and for Facility Fees shall, in each case, be determined and adjusted on the date (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Calculation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) one Business Day after the date on which the Borrower&#8217;s Debt Rating is upgraded or downgraded in a manner which requires a change in the then applicable pricing level set forth above.  If at any time there is a split in the Borrower&#8217;s Debt Ratings between S&#38;P and Moody&#8217;s, the Applicable Percentages shall be determined by the higher of the two Debt Ratings (i.e., the lower pricing)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if the two Debt Ratings are more than one level apart, the Applicable Percentage shall be based on the Debt Rating which is one level lower than the higher Debt Rating.  Each Applicable Percentage shall be effective from one Calculation Date until the next Calculation Date.  Any adjustment in the Applicable Percentage shall be applicable to all existing Revolving Loans that are Term Benchmark Loans, RFR Loans and Base Rate Loans and to all existing Letters of Credit as well as any new Revolving Loans, that are Term Benchmark Loans, RFR Loans or Base Rate Loans, made or any new Letters of Credit issued.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any borrowings and payments in any Alternative Currency, the local time in the place of settlement for such Alternative Currency as may be determined by the Administrative Agent (and notified to the Borrower in writing) to be necessary for timely settlement on the relevant date in accordance with normal banking procedures in the place of payment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Fund that is administered or managed by (i)&#160;a Lender, (ii)&#160;an Affiliate of a Lender or (iii)&#160;an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignee Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means two or more Eligible Assignees that are Affiliates of one another or two or more Approved Funds managed by the same investment advisor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Assignment and Assumption substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 11.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Attorney Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all reasonable and documented out-of-pocket fees and disbursements of any law firm or other external counsel.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Attributable Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to a Sale and Leaseback Transaction, an amount equal to the lesser of&#58; (a)&#160;the fair market value of the Property subject thereto (as determined in good faith by the Borrower&#8217;s board of directors) and (b)&#160;the present value of the total net amount of rent payments to be made under the lease during its remaining term, discounted at the rate of interest set forth or implicit in the terms of the lease, compounded semiannually.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Authorized Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the chief executive officer, president, chief financial officer, corporate controller, treasurer or assistant treasurer of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Available Tenor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination and with respect to the then-current Benchmark for any Agreed Currency, as applicable, any tenor for such Benchmark (or component thereof) or payment period for interest calculated with reference to such Benchmark (or component thereof), as applicable, that is or may be used for determining the length of an Interest Period for any term rate or otherwise, for determining any frequency of making payments of interest calculated pursuant to this Credit Agreement as of such date and not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of &#8220;Interest Period&#8221; pursuant to clause (g) of  Section 3.10.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, regulation, rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bankruptcy Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Bankruptcy Code in Title 11 of the United States Code, as amended, modified, succeeded or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bankruptcy Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, that such Person has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, conservator, trustee, administrator, custodian, assignee for the benefit of creditors or similar Person charged with the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">reorganization or liquidation of its business appointed for it, or, in the good faith determination of the Administrative Agent, has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in, any such proceeding or appointment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that a Bankruptcy Event shall not result solely by virtue of any ownership interest, or the acquisition of any ownership interest, in such Person by a Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such ownership interest does not result in or provide such Person with immunity from the jurisdiction of courts within the United States of America or from the enforcement of judgments or writs of attachment on its assets or permit such Person (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any agreements made by such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, a rate per annum equal to the greatest of (a)&#160;the Prime Rate in effect on such day, (b)&#160;the NYFRB Rate in effect on such day </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#189; of 1% per annum and (c) the Adjusted LIBO Rate on such day (or if such day is not a Business Day, the immediately preceding Business Day) for a deposit in Dollars with a maturity of one month </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 1% per annum.  For purposes of clause (c) above, the Adjusted LIBO Rate for any day shall be based on the Screen Rate at approximately 11&#58;00 a.m., London time, on such day for deposits in Dollars with a maturity of one month&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if such rate shall be less than zero, such rate shall be deemed to be zero for all purposes of this Credit Agreement.  Any change in the Base Rate due to a change in the Prime Rate, the NYFRB Rate or the Adjusted LIBO Rate shall be effective from and including the effective date of such change in the Prime Rate, the NYFRB Rate or the Adjusted LIBO Rate, as the case may be.  If the Base Rate is being used as an alternate rate of interest pursuant to Section 3.10 (for the avoidance of doubt, only until any amendment has become effective pursuant to Section 3.10(b)), then the Base Rate shall be the greater of clauses (a) and (b) above and shall be determined without reference to clause (c) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Loan bearing interest at a rate determined by reference to the Base Rate.  Base Rate Loans may be denominated only in Dollars.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, initially, with respect to any (i) RFR Loan, the applicable Relevant Rate or (ii) Term Benchmark Loan, the Relevant Rate for such Agreed Currency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if a Benchmark Transition Event, a Term SOFR Transition Event, an Early Opt-in Election or an Other Benchmark Rate Election, as applicable, and its related Benchmark Replacement Date have occurred with respect to the applicable Relevant Rate or the then-current Benchmark for such Agreed Currency, then &#8220;Benchmark&#8221; means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to clause (b) or clause (c) of Section&#160;3.10.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Available Tenor, the first alternative set forth in the order below that can be determined by the Administrative Agent (in consultation with the Borrower) for the applicable Benchmark Replacement Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, in the case of any Loan denominated in an Alternative Currency or in the case of an Other Benchmark Rate Election, &#8220;Benchmark Replacement&#8221; shall mean the alternative set forth in clause (3) below&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;in the case of any Loan denominated in Dollars, the sum of&#58; (a) Term SOFR and (b) the related Benchmark Replacement Adjustment&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;in the case of any Loan denominated in Dollars, the sum of&#58; (a) Daily Simple SOFR and (b) the related Benchmark Replacement Adjustment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;the sum of&#58; (a) the alternate benchmark rate that has been reasonably selected by the Administrative Agent and the Borrower as the replacement for the then-current Benchmark for the applicable Corresponding Tenor giving due consideration to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body, (ii) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement for the then-current Benchmark for syndicated credit facilities denominated in the applicable Agreed Currency at such time in the United States and (b) the related Benchmark Replacement Adjustment&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, in the case of clause (1), Term SOFR is displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that, in the case of clause (3), when such clause is used to determine the Benchmark Replacement in connection with the occurrence of an Other Benchmark Rate Election, the alternate benchmark rate selected by the Administrative Agent and the Borrower shall be the term benchmark rate that is used in lieu of a LIBOR-based rate in the relevant other Dollar-denominated syndicated credit facilities referenced in clause (a) of the &#8220;Other Benchmark Rate Election&#8221; definition&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, notwithstanding anything to the contrary in this Credit Agreement or in any other Credit Document, upon the occurrence of a Term SOFR Transition Event, and the delivery of a Term SOFR Notice, on the applicable Benchmark Replacement Date the &#8220;Benchmark Replacement&#8221; shall revert to and shall be deemed to be the sum of (a) Term SOFR and (b) the related Benchmark Replacement Adjustment, as set forth in clause (1) of this definition (subject to the first proviso above).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Benchmark Replacement as determined pursuant to clause (1), (2) or (3) above would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor for the purposes of this Credit Agreement and the other Credit Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark Replacement for any applicable Interest Period and Available Tenor for any setting of such Unadjusted Benchmark Replacement&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;for purposes of clauses (1) and (2) of the definition of &#8220;Benchmark Replacement,&#8221; the first alternative set forth in the order below that can be determined by the Administrative Agent (in consultation with the Borrower)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;the spread adjustment, or method for calculating or determining such spread adjustment (which may be a positive or negative value or zero), as of the Reference Time such Benchmark Replacement is first set for such Interest Period that has been selected or recommended by the Relevant Governmental Body for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for the applicable Corresponding Tenor&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;the spread adjustment (which may be a positive or negative value or zero) as of the Reference Time such Benchmark Replacement is first set for such Interest Period that would apply to the fallback rate for a derivative transaction referencing the ISDA Definitions to be effective upon an index cessation event with respect to such Benchmark for the applicable Corresponding Tenor&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;for purposes of clause (3) of the definition of &#8220;Benchmark Replacement,&#8221; the spread adjustment, or method for calculating or determining such spread adjustment (which may be a positive or negative value or zero), that has been selected by the Administrative Agent and the Borrower for the applicable Corresponding Tenor giving due consideration to (i) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body on the applicable Benchmark Replacement Date and&#47;or (ii) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for syndicated credit facilities denominated in the applicable Agreed Currency at such time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, in the case of clause (1) above, such adjustment is displayed on a screen or other information service that publishes such Benchmark Replacement Adjustment from time to time as selected by the Administrative Agent in its reasonable discretion (in consultation with the Borrower).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of &#8220;Base Rate,&#8221; the definition of &#8220;Business Day,&#8221; the definition of &#8220;Interest Period,&#8221; the definition of &#8220;RFR Business Day,&#8221; timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Administrative Agent, in consultation with the Borrower, decides may be appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Administrative Agent decides is reasonably necessary in connection with the administration of this Credit Agreement and the other Credit Documents).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark, the earliest to occur of the following events with respect to such then-current Benchmark&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;in the case of clause (1) or (2) of the definition of &#8220;Benchmark Transition Event,&#8221; the later of (a) the date of the public statement or publication of information referenced therein and (b) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide all Available Tenors of such Benchmark (or such component thereof)&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;in the case of clause (3) of the definition of &#8220;Benchmark Transition Event,&#8221; the first date on which such Benchmark (or the published component used in the calculation thereof) has been determined and announced by the regulatory supervisor for the administrator of such Benchmark (or such component thereof) to be no longer representative&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such non-representativeness will be determined by reference to the most recent statement or publication referenced in such clause (c) and even if any Available Tenor of such Benchmark (or such component thereof) continues to be provided on such date&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;in the case of a Term SOFR Transition Event, the date that is thirty (30) days after the date a Term SOFR Notice is provided to the Lenders and the Borrower pursuant to Section 3.10(c)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;in the case of an Early Opt-in Election or an Other Benchmark Rate Election, the sixth (6th) Business Day after the date notice of such Early Opt-in Election or Other Benchmark Rate Election, as applicable, is provided to the Lenders, so long as the Administrative Agent has not received, by 5&#58;00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Early Opt-in Election or Other Benchmark Rate Election, as applicable, is provided to the Lenders, written notice of objection to such Early Opt-in Election or Other Benchmark Rate Election, as applicable, from Lenders comprising the Required Lenders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the avoidance of doubt, (i) if the event giving rise to the Benchmark Replacement Date occurs on the same day as, but earlier than, the Reference Time in respect of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination and (ii) the &#8220;Benchmark Replacement Date&#8221; will be deemed to have occurred in the case of clause (1) or (2) with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark, the occurrence of one or more of the following events with respect to such then-current Benchmark&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1) a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2) a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Federal Reserve Board, the NYFRB, the central bank for the Agreed </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Currency applicable to such Benchmark, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), in each case, which states that the administrator of such Benchmark (or such component) has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3) a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that all Available Tenors of such Benchmark (or such component thereof) are no longer, or as of a specified future date will no longer be, representative.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the avoidance of doubt, a &#8220;Benchmark Transition Event&#8221; will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Unavailability Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark, the period (if any) (x) beginning at the time that a Benchmark Replacement Date pursuant to clauses (1) or (2) of that definition has occurred if, at such time, no Benchmark Replacement has replaced such then-current Benchmark for all purposes hereunder and under any Credit Document in accordance with Section 3.10 and (y) ending at the time that a Benchmark Replacement has replaced such then-current Benchmark for all purposes hereunder and under any Credit Document in accordance with Section 3.10.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a certification regarding beneficial ownership or control as required by the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means 31 C.F.R. &#167; 1010.230.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in and subject to Section 4975 of the Code or (c) any Person whose assets include (for purposes of ERISA Section 3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Quest Diagnostics Incorporated, a Delaware corporation, together with any successors and permitted assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;7.1(h).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;Revolving Borrowing or (b)&#160;a Swing Line Loan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Minimum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) in the case of a borrowing of Revolving Loans denominated in Dollars, $10,000,000, (b) in the case of a borrowing of Revolving Loans denominated in Euro, EUR10,000,000, (c) in the case of a borrowing of Revolving Loans denominated in Sterling, &#163;10,000,000 and (d) in the case of a borrowing of Revolving Loans denominated in any other Alternative Currency, the smallest amount of such Alternative Currency that is an integral multiple of 1,000,000 units of such currency and that has a Dollar Equivalent in excess of $10,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Multiple</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) in the case of a borrowing of Revolving Loans denominated in Dollars, $1,000,000, (b) in the case of a borrowing of Revolving Loans denominated in Euro, EUR1,000,000, (c) in the case of a borrowing of Revolving Loans denominated in Sterling, &#163;1,000,000 and (d) in the case of a borrowing of Revolving Loans denominated in any other Alternative Currency, 1,000,000 units of such currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, any day (other than a Saturday or a Sunday) on which banks are open for business in New York City&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, the term &#8220;Business Day&#8221; shall mean (a) in relation to Loans denominated in Sterling and in relation to the calculation or computation of LIBOR, any day (other than a Saturday or a Sunday) on which banks are open for business in London, (b) in relation to Loans denominated in Euros and in relation to the calculation or computation of EURIBOR, any day which is a TARGET Day and (c) in relation to RFR Loans and any interest rate settings, fundings, disbursements, settlements or payments of any such RFR Loan, or any other dealings in the applicable Agreed Currency of such RFR Loan, any such day that is only an RFR Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Calculation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;Applicable Percentage&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">CAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the College of American Pathologists.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as applied to any Person, any lease of any Property (whether real, personal or mixed) by that Person as lessee which, in accordance with GAAP, is or should be accounted for as a capital lease on the balance sheet of that Person and the amount of such obligation shall be the capitalized amount thereof determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;in the case of a corporation, all classes of capital stock of such corporation, (b)&#160;in the case of a partnership, partnership interests (whether general or limited), (c)&#160;in the case of a limited liability company, membership interests and (d)&#160;any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cash and Cash Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;cash and cash equivalents, in accordance with GAAP, and the following items to the extent that they are excluded from cash and cash equivalents in accordance with GAAP&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;direct obligations of, or obligations the principal of and interest on which are unconditionally guaranteed by, the United&#160;States of America (or by any agency thereof to the extent such obligations are backed by the full faith and credit of the United&#160;States of America), in each case maturing within one year from the date of acquisition thereof&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;investments in commercial paper maturing within 270 days from the date of acquisition thereof and having, at such date of acquisition, the highest credit rating obtainable from S&#38;P or from Moody&#8217;s&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;investments in certificates of deposit, banker&#8217;s acceptances and time deposits maturing within 180 days from the date of acquisition thereof issued or guaranteed by or placed with, and money market deposit accounts issued or offered by, any domestic office of any commercial bank organized under the laws of the United&#160;States of America or any State thereof which has a combined capital and surplus and undivided profits of not less than $500,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;fully collateralized repurchase agreements with a term of not more than 30 days for securities described in clause (b) above and entered into with a financial institution satisfying the criteria described in clause (d) above&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;money market funds that (i)&#160;comply with the criteria set forth in SEC Rule 2a-7 under the Investment Company Act of 1940, and (ii)&#160;are rated AAA by S&#38;P and Aaa by Moody&#8217;s.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Central Bank Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, the greater of (A) (i) for any Loan denominated in (a) Sterling, the Bank of England (or any successor thereto)&#8217;s &#8220;Bank Rate&#8221; as published by the Bank of England (or any successor thereto) from time to time, (b) Euro, one of the following three rates as may be selected by the Administrative Agent in its reasonable discretion&#58; (1) the fixed rate for the main refinancing operations of the European Central Bank (or any successor thereto), or, if that rate is not published, the minimum bid rate for the main refinancing operations of the European Central Bank (or any successor thereto), each as published by the European Central Bank (or any successor thereto) from time to time, (2) the rate for the marginal lending facility of the European Central Bank (or any successor thereto), as published by the European Central Bank (or any successor thereto) from time to time or (3) the rate for the deposit facility of the central banking system of the Participating Member States, as published by the European Central Bank (or any successor thereto) from time to time, and (c) any other Alternative Currency determined after the Restatement Effective Date, a central bank rate as determined by the Administrative Agent in its reasonable discretion </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the applicable Central Bank Rate Adjustment, and (B) 0.00%.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Central Bank Rate Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, for any Loan denominated in (a)&#160;Euros, a rate equal to the difference (which may be a positive or negative value or zero) of (i)&#160;the average of the EURIBO Rate for the five most recent Business Days preceding such day for which the applicable Screen Rate was available (excluding, from such averaging, the highest and the lowest EURIBO Rate applicable during such period of five Business Days) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the Central Bank Rate in respect of Euro in effect on the last Business Day in such period, (b) Sterling, a rate equal to the difference (which may be a positive or negative value or zero) of (i) the average of SONIA for the five most recent RFR Business Days preceding such day for which SONIA was available (excluding, from such averaging, the highest and the lowest SONIA applicable during such period of five RFR Business Days) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the Central Bank Rate in respect of Sterling in effect on the last RFR Business Day in such period, and (c) any other Alternative Currency determined after the Restatement Effective Date, a Central Bank Rate Adjustment as determined by the Administrative Agent in its reasonable discretion (in consultation with the Borrower). For purposes of this definition, (x) the term Central Bank Rate shall be determined disregarding clause&#160;(B) of the definition of such term and (y) the EURIBO Rate on any day shall be based on the applicable Screen Rate on such day at approximately the time referred to in the definition of such term for deposits in the applicable Agreed Currency for a maturity of one month. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the occurrence, after the date of this Credit Agreement, of any of the following&#58;  (a)&#160;the adoption or taking effect of any rule, regulation, treaty or other law, (b)&#160;any change in any rule, regulation, treaty or other law or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (c)&#160;the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) of any Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, for all purposes of this Credit Agreement and notwithstanding anything herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a &#8220;Change in Law&#8221;, regardless of the date enacted, adopted, promulgated or issued. Notwithstanding the foregoing, no Lender shall be entitled to seek compensation for costs imposed in accordance with the previous sentence if it shall not be the general policy of such Lender at such time to seek compensation from investment grade borrowers with the same or similar ratings under yield protection provisions in credit agreements with such borrowers that provide for such compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means either of the following events&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;any &#8220;person&#8221; or &#8220;group&#8221; (within the meaning of Section&#160;13(d) or 14(d) of the Exchange Act) has become, directly or indirectly, the &#8220;beneficial owner&#8221; (as defined in Rules&#160;13d3 and 13d5 under the Exchange Act), by way of merger, consolidation or otherwise, of 35% or more of the Voting Stock of the Borrower on a fullydiluted basis, after giving effect to the conversion and exercise of all outstanding warrants, options and other securities of the Borrower convertible into or exercisable for Voting Stock of the Borrower (whether or not such securities are then currently convertible or exercisable)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;during any period of twelve calendar months, individuals who at the beginning of such period constituted the board of directors of the Borrower together with any new members of such board of directors whose elections by such board or board of directors or whose nomination for election by the stockholders of the Borrower was approved by a vote of a majority of the members of such board of directors then still in office who either were directors at the beginning of such period or whose election or nomination for election was previously so approved cease for any reason to constitute a majority of the directors of the Borrower then in office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">CLIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Clinical Laboratory Improvement Amendment as set forth at 42 U.S.C. 263a and the regulations promulgated thereunder, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">CMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Centers for Medicare and Medicaid Services of HHS, any successor thereof and any predecessor thereof, including the HCFA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended, modified, succeeded or replaced from time to time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, without duplication, (a) the Revolving Commitment of each Lender, (b)&#160;the LOC Commitment of each Issuing Lender, (c)&#160;any Incremental Term Commitment of an Incremental Term Lender and (d)&#160;any Incremental Revolving Commitment of an Incremental Revolving Lender.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Corresponding Tenor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with respect to any Available Tenor means, as applicable, either a tenor (including overnight) or an interest payment period having approximately the same length (disregarding business day adjustment) as such Available Tenor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means this Credit Agreement, the Amendment and Restatement Agreement, the Notes, any Incremental Facility Agreement, the LOC Documents, any Notice of Borrowing, any Swing Line Loan Request, any guarantee agreement delivered pursuant to Section&#160;7.10 and any Issuing Lender Agreement, as such documents may be amended, modified, supplemented or restated from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;Required Lenders&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Daily Simple SONIA Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means, for any day (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Interest Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), an interest rate per annum equal to, for any Loan denominated in Sterling, SONIA for the day that is 4 RFR Business Days prior to (A) if such RFR Interest Day is an RFR Business Day, such RFR Interest Day or (B) if such RFR Interest Day is not an RFR Business Day, the RFR Business Day immediately preceding such RFR Interest Day. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Daily Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, SOFR, with the conventions for this rate (which may include a lookback) being established by the Administrative Agent in accordance with the conventions for this rate selected or recommended by the Relevant Governmental Body for determining &#8220;Daily Simple SOFR&#8221; for business loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if the Administrative Agent decides that any such convention is not administratively feasible for the Administrative Agent, then the Administrative Agent may establish another convention in its reasonable discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Debt Rating</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the longterm senior unsecured, noncredit enhanced debt rating of the Borrower from S&#38;P and Moody&#8217;s.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any event, act or condition which with notice or lapse of time, or both, would constitute an Event of Default.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Revolving Lender that (a)&#160;has failed, within two Business Days of the date required to be funded or paid, (i)&#160;to fund any portion of its Loans, (ii)&#160;to fund any portion of its participations in Letters of Credit or Swing Line Loans or (iii)&#160;to pay to any Financing Party any other amount required to be paid by it hereunder, unless, in the case of clause (i) above, such Lender notifies the Administrative Agent in writing that such failure is the result of such Lender&#8217;s good faith determination that a condition precedent to funding (specifically identified in such writing, including, if applicable, by reference to a specific Default) has not been satisfied, (b)&#160;has notified the Borrower or any Financing Party in writing, or has made a public statement, to the effect that it does not intend or expect to comply with any of its funding obligations under this Credit Agreement (unless such writing or public statement indicates that such position is based on such Lender&#8217;s good-faith determination that a condition precedent (specifically identified in such writing, including, if applicable, by reference to a specific Default) to funding a Loan cannot be satisfied) or generally under other agreements in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">which it commits to extend credit, (c)&#160;has failed, within three Business Days after request by a Financing Party made in good faith, to provide a certification in writing from an authorized officer of such Lender that it will comply with its obligations to fund prospective Loans and participations in then outstanding Letters of Credit and Swing Line Loans, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon such Financing Party&#8217;s receipt of such certification in form and substance reasonably satisfactory to it and the Administrative Agent, or (d)&#160;has become, or has a Revolving Lender Parent that has become, the subject of a Bankruptcy Event or a Bail-In Action.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any payment of dividends or any other distribution upon any shares of any class of Capital Stock of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dodd-Frank Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;Change in Law&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, (a)&#160;with respect to any amount denominated in Dollars, such amount, and (b)&#160;with respect to any amount denominated in any Alternative Currency, the equivalent amount thereof in Dollars as determined by the Administrative Agent at such time on the basis of the Exchange Rate (determined in respect of the most recent Revaluation Date) for the purchase of Dollars with such Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means dollars in lawful currency of the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Domestic Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each direct and indirect Subsidiary of the Borrower that is domiciled or organized under the laws of any State of the United States or the District of Columbia.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Early Opt-in Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, if the then current Benchmark with respect to Dollars is the LIBO Rate, the occurrence of&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;a notification by the Administrative Agent to (or the request by the Borrower to the Administrative Agent to notify) each of the other parties hereto that at least five currently outstanding Dollar denominated syndicated credit facilities at such time contain (as a result of amendment or as originally executed) a SOFR-based rate (including SOFR, a term SOFR or any other rate based upon SOFR) as a benchmark rate (and such syndicated credit facilities are identified in such notice and are publicly available for review), and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;the joint election by the Administrative Agent and the Borrower to trigger a fallback from the LIBO Rate and the provision, as applicable, by the Administrative Agent of written notice of such election to the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any period, with respect to the Borrower and its Subsidiaries on a consolidated basis, (a)&#160;Net Income for such period (excluding the effect of any extraordinary or other non-recurring gains and losses (including any gain or loss from the sale of Property)) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b)&#160;an amount which, in the determination of Net Income for such period, has been deducted for (i)&#160;Interest Expense for such period, (ii)&#160;total Federal, state, foreign or other income or franchise </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">taxes for such period, (iii)&#160;all depreciation and amortization for such period, (iv)&#160;other items of expense during such period that do not involve a cash payment at any time (other than the provision for bad debt in connection with uncollectible accounts receivable), (v)&#160;cash charges during such period for which the Borrower and its Subsidiaries are reimbursed by a third party during such period, (vi)&#160;special or restructuring items during any such period included in Net Income that do not involve a cash payment during such period (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">NonCash Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (vii) expenses charged pursuant to FASB ASC 718, as promulgated in accordance with GAAP, during such period </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (c)&#160;any actual cash payments during the applicable period related to NonCash Items expensed or reserved under clauses&#160;(v) and (vi) above </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (d)&#160;Tender Costs during such period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) any credit institution or investment firm established in any EEA Member Country that is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country that is a parent of an institution described in clause (a) above or (c) any financial institution established in an EEA Member Country that is a subsidiary of an institution described in clause (a) or (b) above and is subject to consolidated supervision with its parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Member Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any member state of the European Union, Iceland, Liechtenstein and Norway.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Signature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an electronic sound, symbol, or process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) a Lender, (b) an Affiliate of a Lender, (c)&#160;an Approved Fund and (d) any other Person approved by the Administrative Agent, each Issuing Lender, the Swing Line Lender and the Borrower (such approval not to be unreasonably withheld)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i) the Borrower&#8217;s approval shall not be required during the existence and continuation of an Event of Default, (ii)&#160;neither the Borrower nor an Affiliate of the Borrower shall qualify as an Eligible Assignee, (iii) no competitor of the Borrower identified in a letter dated the Restatement Effective Date of the Borrower to the Administrative Agent (as such letter may be amended, amended and restated, supplemented or otherwise modified by the Borrower from time to time to identify additional Persons engaged in the business in which the Borrower is engaged), which letter shall be made available to the Administrative Agent, shall qualify as an Eligible Assignee, and (iv) no consent of any Issuing Lender shall be required with respect to any Incremental Term Commitment or Incremental Term Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EMU Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the legislative measures of the European Council for the introduction of, changeover to or operation of a single or unified European currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any current or future legally enforceable requirement of any Governmental Authority pertaining to (a) the protection of the indoor or outdoor environment, (b) the conservation, management, or use of natural resources and wildlife, (c) the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">protection or use of surface water and groundwater, (d) the management, manufacture, possession, presence, use, generation, transportation, treatment, storage, disposal, release, threatened release, abatement, removal, remediation or handling of, or exposure to, any hazardous or toxic substance or material or (e) pollution (including any release to land surface water and groundwater) and includes, without limitation, the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended by the Superfund Amendments and Reauthorization Act of 1986, 42 USC 9601 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act of 1976 and Hazardous and Solid Waste Amendments of 1984, 42 USC 6901 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Federal Water Pollution Control Act, as amended by the Clean Water Act of 1977, 33 USC 1251 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Clean Air Act of 1966, as amended, 42 USC 7401 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Toxic Substances Control Act of 1976, 15 USC 2601 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Hazardous Materials Transportation Act, 49 USC App. 1801 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Occupational Safety and Health Act of 1970, as amended, 29 USC 651 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Oil Pollution Act of 1990, 33 USC 2701 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Emergency Planning and Community Right-to-Know Act of 1986, 42 USC 11001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> National Environmental Policy Act of 1969, 42 USC 4321 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Safe Drinking Water Act of 1974, as amended, 42 USC 300(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> any analogous implementing or successor law, and any amendment, rule, regulation, order, or directive issued thereunder. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any liability, obligation, loss, claim, action, order or cost, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines, penalties and indemnities), directly or indirectly resulting from or based upon (a)&#160;violation of any Environmental Law, (b)&#160;the generation, use, handling, transportation, storage, treatment or disposal of any Hazardous Materials, (c)&#160;exposure to any Hazardous Materials, (d)&#160;the release or threatened release of any Hazardous Materials or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended, and any successor statute thereto, as interpreted by the rules and regulations thereunder, all as the same may be in effect from time to time.  References to sections of ERISA shall be construed also to refer to any successor sections.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an entity, whether or not incorporated, which is treated as a single employer with the Borrower under Sections&#160;414(b) or (c) of the Code and solely for purposes of Section 302 of ERISA and Section 412 of the Code under Section 414 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any Single Employer or Multiple Employer Plan, the occurrence of a reportable event within the meaning of Section&#160;4043 of ERISA (unless the 30-day notice requirement with respect to such event was waived by the PBGC) or a substantial cessation of operations within the meaning of Section 4062(e) of ERISA&#59; (b) the withdrawal of the Borrower or any ERISA Affiliate from a Multiple Employer Plan during a plan year in which it was a substantial employer (as such term is defined in Section 4001(a)(2) of ERISA), or the termination of a Multiple Employer Plan&#59; (c) the distribution of a notice of intent to terminate or the actual termination of a Plan pursuant to Section 4041(a)(2) of ERISA&#59; (d) the institution of proceedings to terminate or the actual termination of any Plan by the PBGC under Section 4042 of ERISA&#59; (e) any event or condition which might constitute grounds under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Plan&#59; (f) the complete or partial withdrawal of the Borrower or any ERISA Affiliate from a Multiemployer Plan&#59; or (g) the conditions for imposition of a lien under Section&#160;303(k) of ERISA exist with respect to any Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EU Bail-In Legislation Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor Person), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBO Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Loan denominated in Euros for any Interest Period, the applicable Screen Rate as of the Specified Time on the Quotation Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan bearing interest at a rate determined by reference to the EURIBO Rate.  All Loans denominated in Euros shall be EURIBOR Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Euro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EUR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; mean the lawful currency of the Participating Member States introduced in accordance with the EMU Legislation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the events or circumstances specified in Section&#160;9.1.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, as amended, modified, succeeded or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means on any day, for purposes of determining the Dollar Equivalent of any other currency, the rate at which such other currency may be exchanged into Dollars at the time of determination on such day as set forth on the Bloomberg WCR Page for such currency.  In the event that such rate does not appear on any Bloomberg WCR Page, the Exchange Rate shall be determined by reference to such other publicly available service for displaying exchange rates as may be agreed upon by the Administrative Agent and the Borrower or, in the absence of such an agreement, such Exchange Rate shall instead be the arithmetic average of the spot rates of exchange of the Administrative Agent in the market where its foreign currency exchange operations in respect of such currency are then being conducted, at or about such time as the Administrative Agent shall elect after determining that such rates shall be the basis for determining the Exchange Rate, on such date for the purchase of Dollars for delivery two Business Days later&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if at the time of any such determination, for any reason, no such spot rate is being quoted, the Administrative Agent may use any reasonable method it deems appropriate to determine such rate, and such determination shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means this Credit Agreement, as in effect immediately prior to the occurrence of the Restatement Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the outstanding letters of credit originally issued or deemed issued under the Existing Credit Agreement that are identified on Schedule 2.2.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extending Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.8(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Confirmation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.8(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.8(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Lender, the making or extension of a Loan by such Lender (or a participation therein by a Lender) or the issuance or extension or increase in the face amount of, or participation in, a Letter of Credit by such Lender.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.8(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Facility Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 3.4(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FAS 842</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 1.3(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Sections&#160;1471 through 1474 of the Code (or any amended or successor version that is substantively comparable thereto) and any regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 1.10.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Funds Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, the rate calculated by the NYFRB based on such day&#8217;s federal funds transactions by depository institutions (as determined in such manner as shall set forth on the Federal Reserve Board of New York&#8217;s Website from time to time) and published on the next succeeding Business Day by the NYFRB as the effective federal funds rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if such rate shall be less than zero, such rate shall be deemed to be zero for all purposes of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Reserve Bank of New York&#8217;s Website</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the website of the NYFRB at http&#58;&#47;&#47;www.newyorkfed.org, or any successor source.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fee Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the JPMorgan Fee Letter, the Morgan Stanley Fee Letter, the Mizuho Fee Letter and the Wells Fargo Fee Letter, as such documents may be amended, modified, supplemented or restated from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financing Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Administrative Agent, each Issuing Lender, the Swing Line Lender and each other Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Floor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the benchmark rate floor, if any, provided in this Credit Agreement (as of the execution and delivery of this Credit Agreement, the modification, amendment or renewal of this Credit Agreement or otherwise) with respect to the Adjusted LIBO Rate, the Adjusted EURIBO Rate or the Adjusted Daily Simple SONIA Rate, as applicable. For the avoidance of doubt the initial Floor for each of the Adjusted LIBO Rate, the Adjusted EURIBO Rate and the Adjusted Daily Simple SONIA Rate shall be 0.00%.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Currency Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.1(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each direct and indirect Subsidiary of the Borrower that is not a Domestic Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its business.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Funded Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, without duplication, the sum of (a)&#160;all Indebtedness of the Borrower and its Subsidiaries for borrowed money, (b)&#160;all purchase money Indebtedness of the Borrower and its Subsidiaries, (c)&#160;the principal portion of all obligations of the Borrower and its Subsidiaries under Capital Leases, (d)&#160;all drawn but unreimbursed amounts under all letters of credit (other than letters of credit supporting trade payables in the ordinary course of business) issued for the account of the Borrower or any of its Subsidiaries, (e)&#160;all Funded Debt of another Person secured by a Lien on any Property of the Borrower and its Subsidiaries whether or not such Funded Debt has been assumed by a Borrower or any of its Subsidiaries, (f)&#160;all Funded Debt of any partnership or unincorporated joint venture to the extent the Borrower or one of its Subsidiaries is legally obligated with respect thereto and (g)&#160;the amount of principal attributable under any outstanding Synthetic Lease.  It is understood and agreed that Indebtedness incurred pursuant to Hedging Agreements is not Funded Debt.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means generally accepted accounting principles in the United States applied on a consistent basis and subject to Section 1.3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Government Acts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;2.2(j)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the government of the United States of America or any other nation or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government, including any applicable supra-national bodies (such as the European Union or the European Central Bank).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Granting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;11.3(g).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantee Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, without duplication, any obligations (other than endorsements in the ordinary course of business of negotiable instruments for deposit or collection) guaranteeing any Indebtedness of any other Person in any manner, whether direct or indirect, and including without limitation any obligation, whether or not contingent, (a) to purchase any such Indebtedness or other obligation or any Property constituting security therefor, (b)&#160;to advance or provide funds or other support for the payment or purchase of such Indebtedness or obligation or to maintain working capital, solvency or other balance sheet condition of such other Person (including, without limitation, maintenance agreements, comfort letters, take or pay arrangements, put agreements or similar agreements or arrangements) for the benefit of the holder of Indebtedness of such other Person, (c) to lease or purchase Property, securities or services primarily for the purpose of assuring the owner of such Indebtedness or (d) to otherwise assure or hold harmless the owner of such Indebtedness or obligation against loss in respect thereof.  The amount of any Guarantee Obligation hereunder shall (subject to any limitations set forth therein) be deemed to be an amount equal to the outstanding principal amount (or maximum principal amount, if larger) of the Indebtedness in respect of which such Guarantee Obligation is made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any substance, material or waste defined in or regulated under any Environmental Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">HCFA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Health Care Financing Administration and any successor thereto, including CMS.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Hedging Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, interest rate protection agreements, foreign currency exchange agreements, commodity purchase or option agreements or other interest or exchange rate or commodity price hedging agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">HHS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Department of Health and Human Services and any successor thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">HIPAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Health Insurance Portability and Accountability Act of 1996, Pub. L. 104-191, Aug. 21, 1996, 110 Stat. 1936 and regulations promulgated thereunder, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Incremental Revolving Commitment or an Incremental Term Commitment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Committed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;2.7(a). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Facility Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Incremental Facility Agreement, in form and substance reasonably satisfactory to the Administrative Agent, among the Borrower, the Administrative Agent and one or more Incremental Lenders, establishing Incremental Term Commitments of any Series or Incremental Revolving Commitments and effecting such other amendments hereto and to the other Credit Documents as are contemplated by Section&#160;2.7. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Incremental Revolving Lender or an Incremental Term Lender. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender, the commitment, if any, of such Lender, established pursuant to an Incremental Facility Agreement and Section&#160;2.7, to make Revolving Loans and to acquire participations in Letters of Credit and Swing Line Loans hereunder, expressed as an amount representing the maximum aggregate permitted amount of such Lender&#8217;s Revolving Exposure under such Incremental Facility Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Lender with an Incremental Revolving Commitment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender, the commitment, if any, of such Lender, established pursuant to an Incremental Facility Agreement and Section&#160;2.7, to make Incremental Term Loans of any Series hereunder, expressed as an amount representing the maximum principal amount of the Incremental Term Loans of such Series to be made by such Lender. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Lender with an Incremental Term Commitment or an outstanding Incremental Term Loan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan made by an Incremental Term Lender to the Borrower pursuant to Section&#160;2.7. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to Incremental Term Loans of any Series, the scheduled date on which such Incremental Term Loans shall become due and payable in full hereunder, as specified in the applicable Incremental Facility Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; of any Person means, without duplication, (a) all obligations of such Person for borrowed money, (b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, or upon which interest payments are customarily made, (c) all obligations of such Person under conditional sale or other title retention agreements relating to Property purchased by such Person to the extent of the value of such Property (other than customary reservations or retentions of title under agreements with suppliers entered into in the ordinary course of business), (d) all obligations, other than intercompany items, of such Person issued or assumed as the deferred purchase price of property or services purchased by such Person which would appear as liabilities on a balance sheet of such Person, (e) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on, or payable out of the proceeds of production from, property owned or acquired by such Person, whether or not the obligations secured thereby have been assumed, (f) all Guarantee Obligations of such Person, (g) the principal portion of all obligations of such Person under (i) Capital Leases and (ii) any synthetic lease, tax retention operating lease, off-balance sheet loan or similar offbalance sheet financing product of such Person where such transaction is considered borrowed money indebtedness for tax purposes but is classified as an operating lease in accordance with GAAP, (h) all obligations of such Person to repurchase any securities which repurchase obligation is related to the issuance thereof, including, without limitation, obligations commonly known as residual equity appreciation potential shares, (i) all net obligations of such Person in respect of Hedging Agreements, (j) the maximum amount of all performance and standby letters of credit issued or bankers&#8217; acceptance facilities created for the account of such Person and, without duplication, all drafts drawn thereunder (to the extent unreimbursed) and (k) the aggregate amount of uncollected accounts receivable of such Person subject at such time to a sale of receivables (or similar transaction) regardless of whether such transaction is effected without recourse to such Person or in a manner that would not be reflected on the balance sheet of such Person in accordance with GAAP.  The Indebtedness of any Person shall include the Indebtedness of any partnership or unincorporated joint venture in which such Person is legally obligated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnified Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.5(c)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.5(c)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;6.19.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to the Borrower and its Subsidiaries on a consolidated basis for any period, all interest expense, including, without duplication, the interest component under Capital Leases, as determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) as to Base Rate Loans and Swing Line Loans, the last day of each calendar quarter and the applicable Maturity Date and, in the case of Swing Line Loans, the date on which the principal of such Loans is due and payable as provided in Section 2.3, (b) as to RFR Loans, (x) the date that is on the numerically corresponding day in the calendar month that is one month after the borrowing of such Loan and each one-month anniversary thereafter (or, in each case, if there is no such numerically corresponding day in such month, then the last day of such month) and (y) the applicable Maturity Date and (c) as to Term Benchmark Loans, the last day of each Interest Period applicable to the Borrowing of which such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loan is a part and, in the case of a Term Benchmark Loan with an Interest Period of more than three months&#8217; duration, each day prior to the last day of such Interest Period that occurs at intervals of three months&#8217; duration after the first day of such Interest Period, and the applicable Maturity Date.  If an Interest Payment Date falls on a date which is not a Business Day, such Interest Payment Date shall be deemed to be the next succeeding Business Day, except that in the case of Term Benchmark Loans where the next succeeding Business Day falls in the next succeeding calendar month, then such Interest Payment Date shall be deemed to be the next preceding Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to any Term Benchmark Loan, the period commencing on the date of such Borrowing and ending on the numerically corresponding day in the calendar month that is one, three or six months thereafter (in each case, subject to the availability for the Benchmark applicable to the relevant Loan or Commitment for any Agreed Currency), as the Borrower may elect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that (i)&#160;if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless such next succeeding Business Day would fall in the next calendar month, in which case such Interest Period shall end on the next preceding Business Day, (ii)&#160;any Interest Period that commences on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the last calendar month of such Interest Period) shall end on the last Business Day of the last calendar month of such Interest Period and (iii) no tenor that has been removed from this definition pursuant to Section 3.10(g) shall be available for specification in such Notice of Borrowing or Notice of Continuation&#47;Conversion unless and until such tenor shall have been reinstated in accordance with Section 3.10(g). For purposes hereof, the date of a Borrowing initially shall be the date on which such Borrowing is made and, in the case of a Revolving Borrowing, thereafter shall be the effective date of the most recent conversion or continuation of such Borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ISDA Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the 2006 ISDA Definitions published by the International Swaps and Derivatives Association, Inc. or any successor thereto, as amended or supplemented from time to time, or any successor definitional booklet for interest rate derivatives published from time to time by the International Swaps and Derivatives Association, Inc. or such successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) JPMorgan, Morgan Stanley Bank, N.A., Mizuho Bank, Ltd., Wells Fargo Bank, N.A. and (b) each other Lender designated by the Borrower as an &#8220;Issuing Lender&#8221; hereunder that has agreed to such designation (and is reasonably acceptable to the Administrative Agent), each in its capacity as an issuer of one or more Letters of Credit hereunder, in each case, so long as such Person shall remain an Issuing Lender hereunder.  Any Issuing Lender may, in its discretion and, in the case of Letters of Credit issued for the benefit of a U.S. Person, subject to the Borrower&#8217;s prior written consent, arrange for one or more Letters of Credit to be issued by Affiliates of such Issuing Lender, in which case the term &#8220;Issuing Lender&#8221; shall include any such Affiliate with respect to Letters of Credit issued by such Affiliate (it being agreed that such Issuing Lender shall, or shall cause such Affiliate to, comply with the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> with respect to such Letters of Credit).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;2.2(l).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 3.4(b)(ii).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">JPMorgan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means JPMorgan Chase Bank, N.A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">JPMorgan Engagement Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain letter agreement dated as of November&#160;10, 2021, between the Borrower and JPMorgan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">JPMorgan Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain letter agreement dated as of November 23, 2021, between the Borrower and JPMorgan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Judgment Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.20.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, all international, foreign, federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directed duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority, in each case whether or not having the force of law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lead Arrangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means JPMorgan, Morgan Stanley, Mizuho Bank, Ltd. and Wells Fargo Securities, LLC.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the Persons identified as a &#8220;Lender&#8221; on the signature pages hereto, any Eligible Assignee which may become a Lender by way of assignment in accordance with the terms hereof and any Incremental Lender, in each case, together with their successors and permitted assigns.  Unless the context otherwise requires, the term &#8220;Lenders&#8221; includes the Swing Line Lender and the Issuing Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lender-Related Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.5(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Lender, the office or offices of such Lender described as such on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, or such other office or offices as a Lender may from time notify to the Borrower and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any letter of credit issued for the account of the Borrower by an Issuing Lender pursuant to Section&#160;2.2, as such letter of credit may be amended, modified, extended, renewed or replaced.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any drawing under a Letter of Credit denominated in an Alternative Currency, the rate specified by the applicable Issuing Lender as the rate at which it was (or would have been) able, at or about the time of such drawing, to exchange Dollars into such Alternative Currency for purposes of obtaining an amount of such Alternative Currency equal to the amount of such drawing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;3.4(b)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Increase Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 7.2.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Increase Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 7.2.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as of the last day of each fiscal quarter, the ratio of (a)(i)&#160;Funded Debt on such date </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the aggregate amount of any unrestricted Cash and Cash Equivalents held by the Borrower on a consolidated basis on such date to (b)&#160;EBITDA for the twelve month period ending on such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LIBO Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any LIBOR Loan for any Interest Period, the applicable Screen Rate as of the Specified Time on the Quotation Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 1.10.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LIBOR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan bearing interest at a rate determined by reference to the Adjusted LIBO Rate.  All LIBOR Loans shall be denominated in Dollars.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any mortgage, pledge, hypothecation, assignment, deposit arrangement, security interest, encumbrance, lien (statutory or otherwise), preference, priority or charge of any kind, including, without limitation, any agreement to give any of the foregoing, any conditional sale or other title retention agreement, and any lease in the nature thereof (other than operating leases).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Revolving Loans, the Swing Line Loans (or any portion thereof), any Incremental Term Loans and any Incremental Revolving Loans, individually or collectively, as appropriate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;11.3(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LOC Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the commitment of each Issuing Lender to issue Letters of Credit for the account of the Borrower in an aggregate face amount outstanding (together with the amounts of any unreimbursed drawings thereon) at any time of up to the applicable LOC Committed Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LOC Committed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) on the Restatement Effective Date, as to each Issuing Lender specified in clause (a) of the definition &#8220;Issuing Lender&#8221; individually, $37,500,000 (or such different amount as may be agreed among the Borrower and each such Issuing Lender), and (b) at any time, as to all Issuing Lenders collectively, $150,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LOC Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Letter of Credit, such Letter of Credit, any amendments thereto, any documents delivered in connection therewith, any application therefor, and any agreements, instruments, guarantees or other documents (whether general in application or applicable only to such Letter of Credit) governing or providing for (a) the rights and obligations of the parties concerned or at risk or (b) any collateral security for such obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LOC Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, the sum of (a) the sum of the Dollar Equivalents of the maximum amounts which are, or at any time thereafter may become, available to be drawn under Letters of Credit then outstanding, assuming compliance with all requirements for drawings referred to in such Letters of Credit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the sum of the Dollar Equivalents of the aggregate amounts of all drawings under Letters of Credit honored by any Issuing Lender but not theretofore reimbursed.  The LOC Obligation of any Revolving Lender at any time shall be its Revolving Loan Commitment Percentage of the total LOC Obligations at such time, adjusted to give effect to any reallocation under Section 2.6(c) of the LOC Obligations of any Defaulting Lender in effect at such time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Local Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;with respect to Loans denominated in Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or any Letter of Credit, New&#160;York City time and (b)&#160;with respect to Loans denominated in Sterling, Euros or an Alternative Currency, London time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;2.2(e)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any acquisition or a series of related acquisitions (other than solely among the Borrower and its Subsidiaries or Affiliates) of (a) Capital Stock in any Person if, after giving effect thereto, such Person will become a Subsidiary or (b) assets comprising all or substantially all the assets of (or all or substantially all the assets constituting a business unit, division, product line or line of business of) any Person&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the aggregate consideration therefor (including Indebtedness assumed in connection therewith, all obligations in respect of deferred purchase price (including obligations under any purchase price adjustment but excluding earnout or similar payments) and all other consideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) exceeds $100,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a material adverse effect on (a) the business, operations or financial condition of the Borrower and its Subsidiaries taken as a whole, (b) the ability of the Borrower to perform its obligations under this Credit Agreement or any of the other Credit Documents or (c) the validity or enforceability of this Credit Agreement, any of the other Credit Documents, or the rights and remedies of the Lenders hereunder or thereunder taken as a whole. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, without duplication (1) any obligation of the Borrower for money borrowed, (2) any obligation of the Borrower evidenced by bonds, debentures, notes or other similar instruments, (3) any reimbursement obligation of the Borrower in respect of letters of credit or other similar instruments which support financial obligations which would otherwise become Indebtedness and (4) any obligation of the Borrower under Capital Leases, in an aggregate principal amount, if and to the extent the aggregate amount of all obligations referred to in such clauses (1) through (4) is greater than $50,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that &#8220;Material Debt&#8221; shall not include any obligation of the Borrower to any Subsidiary or to any Person with respect to which the Borrower is a Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that &#8220;Material Debt&#8221; shall not include any Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Revolving Maturity Date or the Incremental Term Maturity Date with respect to Incremental Term Loans of any Series, as the context requires.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicaid</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the entitlement program under Title XIX of the Social Security Act that provides federal grants to states for medical assistance based on specific eligibility criteria.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicaid Provider Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an agreement entered into between a state agency or other such entity administering the Medicaid program and a health care provider or supplier under which the health care provider or supplier agrees to provide services for Medicaid patients in accordance with the terms of the agreement and Medicaid Regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicaid Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, (a) all federal statutes (whether set forth in Title XIX of the Social Security Act or elsewhere) affecting Medicaid and any statutes succeeding thereto, (b) all applicable provisions of all federal rules, regulations, manuals and orders and administrative, reimbursement and other guidelines having the force of law of all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Governmental Authorities promulgated pursuant to or in connection with the statutes described in clause (a) above, (c) all state statutes and plans for medical assistance enacted in connection with the statutes and provisions described in clauses (a) and (b) above and (d) all applicable provisions of all rules, regulations, manuals and orders and administrative, reimbursement and other guidelines having the force of law of all Governmental Authorities promulgated pursuant to or in connection with the statutes described in clause (c) above and all state administrative, reimbursement and other guidelines of all Governmental Authorities having the force of law promulgated pursuant to or in connection with the statutes described in clause (b) above, in each case, as may be amended, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medical Reimbursement Programs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Medicare, Medicaid and TRICARE programs and any other healthcare program operated by or financed in whole or in part by any foreign, domestic, federal, state or local government and any other non-government funded third party payor programs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicare</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that government-sponsored entitlement program under Title XVIII of the Social Security Act that provides for a health insurance system for eligible elderly and disabled individuals.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicare Provider Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an agreement entered into between CMS or other such entity administering the Medicare program on behalf of CMS, and a health care provider or supplier under which the health care provider or supplier agrees to provide services for Medicare patients in accordance with the terms of the agreement and Medicare Regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicare Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, all federal statutes (whether set forth in Title XVIII of the Social Security Act or elsewhere) affecting the health insurance program for the aged and disabled established by Title XVIII of the Social Security Act and any statutes succeeding thereto&#59; together with all applicable provisions of all rules, regulations, manuals and orders and administrative, reimbursement and other guidelines having the force of law of all Governmental Authorities (including, without limitation, the HHS, CMS, the OIG, or any Person succeeding to the functions of any of the foregoing) promulgated pursuant to or in connection with any of the foregoing having the force of law, as each may be amended, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mizuho Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain letter agreement dated as of November 23, 2021, between the Borrower and Mizuho Bank, Ltd.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">MNPI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means material information concerning the Borrower and its Subsidiaries and their securities that has not been disseminated in a manner making it available to investors generally, within the meaning of Regulation FD under the Securities Act and the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Moody&#8217;s Investors Service, Inc., or any successor or assignee of the business of such company in the business of rating securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Morgan Stanley</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Morgan Stanley Senior Funding, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Morgan Stanley Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain letter agreement dated as of November 23, 2021, between the Borrower and Morgan Stanley Bank, N.A.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Multiemployer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Plan which is a multiemployer plan as defined in Section 3(37) or 4001(a)(3) of ERISA to which the Borrower or any ERISA Affiliate is making or accruing an obligation to make contributions or has made or accrued an obligation to make contributions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Multiple Employer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Plan covered by Title IV of ERISA (other than a Multiemployer Plan) in which the Borrower or any ERISA Affiliate and at least one employer other than the Borrower or any ERISA Affiliate are contributing sponsors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any period, the net income after taxes for such period of the Borrower and its Subsidiaries on a consolidated basis, determined in accordance with GAAP and without duplication.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Net Worth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, the consolidated stockholder&#8217;s equity of the Borrower and its Subsidiaries calculated on a consolidated basis in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Cash Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;EBITDA&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Consenting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;11.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, any Lender that is not a Defaulting Lender at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Extending Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.8(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Revolving Notes, the Swing Line Loan Note and any promissory notes of the Borrower in favor of any Incremental Lender evidencing any Incremental Commitment, as such promissory notes may be amended, modified, supplemented, extended, renewed or replaced from time to time, individually or collectively, as appropriate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a request by the Borrower for a Loan, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Continuation&#47;Conversion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a request by the Borrower to continue an existing Term Benchmark Loan to a new Interest Period or to convert a Term Benchmark Loan denominated in Dollars to a Base Rate Loan or a Base Rate Loan to a Term Benchmark Loan denominated in Dollars, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">NYFRB</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Federal Reserve Bank of New York.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">NYFRB Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, the greater of (a) the Federal Funds Rate in effect on such day and (b) the Overnight Bank Funding Rate in effect on such day (or for any day that is not a Business Day, on the immediately preceding Business Day)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if none of such rates are published for any day that is a Business Day, the term &#8220;NYFRB Rate&#8221; shall mean the rate for a federal funds transaction quoted at 11&#58;00 a.m., New&#160;York&#160;City time, on such day received by the Administrative Agent from a federal funds broker of recognized standing selected by it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if any of the aforesaid rates shall be less than zero, the term &#8220;NYFRB Rate&#8221; shall be deemed to be zero for all purposes of this Credit Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">27</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, without duplication, (a) the due and punctual payment by the Borrower of (i) the principal of and interest (including interest accruing during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) on the Loans, when and as due, whether at maturity, by acceleration, upon one or more dates set for prepayment or otherwise, (ii) each payment required to be made by the Borrower under this Credit Agreement in respect of any Letter of Credit, when and as due, including payments in respect of reimbursement of disbursements, interest thereon and obligations to provide cash collateral, and (iii) all other monetary obligations of the Borrower under this Credit Agreement and each of the other Credit Documents (including obligations to pay fees and expense reimbursement and indemnification obligations), whether primary, secondary, direct, contingent, fixed or otherwise (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) and (b) the due and punctual performance of all other obligations of the Borrower under or pursuant to this Credit Agreement and each of the other Credit Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OIG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Office of Inspector General of HHS and any successor thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;Refinancing Indebtedness&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Benchmark Rate Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Loan denominated in Dollars, if the then-current Benchmark is the LIBO Rate, the occurrence of&#58; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a) a request by the Borrower to the Administrative Agent to notify each of the other parties hereto that, at the determination of the Borrower, Dollar-denominated syndicated credit facilities at such time contain (as a result of amendment or as originally executed), in lieu of a LIBOR-based rate, a term benchmark rate as a benchmark rate, and </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b) the Administrative Agent, in its sole discretion, and the Borrower jointly elect to trigger a fallback from the LIBO Rate and the provision, as applicable, by the Administrative Agent of written notice of such election to the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 3.13(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Overnight Bank Funding Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, the rate comprised of both overnight federal funds and overnight eurocurrency borrowings by U.S.-managed banking offices of depository institutions, as such composite rate shall be determined by the NYFRB as set forth on its public website from time to time, and published on the next succeeding Business Day by the NYFRB as an overnight bank funding rate (from and after such date as the NYFRB shall commence to publish such composite rate).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Overnight Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, (a) with respect to any amount denominated in Dollars, the greater of (i) the Federal Funds Rate and (ii) the Overnight Bank Funding Rate, and (b) with respect to any amount denominated in an Alternative Currency, the rate of interest per annum at which overnight deposits in the applicable Alternative Currency, in an amount approximately equal to the amount with respect to which such rate is being determined, would be offered for such day by a branch or Affiliate of JPMorgan in the applicable offshore interbank market for such currency to major banks in such interbank market.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.3(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Lenders with a Revolving Loan Commitment Percentage greater than zero.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participating Member State</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each state so described in any EMU Legislation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participation Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Extension of Credit by a Revolving Lender by way of a purchase of a participation in (a)&#160;Letters of Credit or LOC Obligations as provided in Section&#160;2.2, (b)&#160;Swing Line Loans as provided in Section 2.3 or (c)&#160;any Loans as provided in Section 3.8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), as amended and supplemented from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in Section 10.11(d)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in Section 10.11(d)(ii).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PBGC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV of ERISA and any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;Liens securing Obligations, if any, (b)&#160;Liens for taxes not yet due or Liens for taxes being contested in good faith by appropriate proceedings for which adequate reserves determined in accordance with GAAP have been established (and as to which the Property subject to any such Lien is not yet subject to foreclosure, sale, collection, levy or loss on account thereof), (c)&#160;Liens in respect of Property imposed by law arising in the ordinary course of business such as materialmen&#8217;s, mechanics&#8217;, warehousemen&#8217;s, carrier&#8217;s, landlords&#8217; and other nonconsensual statutory Liens which are not yet due and payable or which are being contested in good faith by appropriate proceedings for which adequate reserves determined in accordance with GAAP have been established (and as to which the Property subject to any such Lien is not yet subject to foreclosure, sale or loss on account thereof), (d)&#160;Liens (other than Liens imposed under ERISA) consisting of pledges or deposits made in the ordinary course of business to secure payment of worker&#8217;s compensation insurance, unemployment insurance, pensions or social security programs, (e)&#160;Liens arising from good faith deposits in connection with or to secure performance of tenders, bids, leases, government contracts, performance and return-of-money bonds and other similar obligations incurred in the ordinary course of business (other than obligations in respect of the payment of borrowed money), (f)&#160;Liens arising from good faith deposits in connection with or to secure performance of statutory obligations and surety and appeal bonds, (g)&#160;easements, rights-of-way, restrictions (including zoning restrictions), matters of plat, minor defects or irregularities in title and other similar charges or encumbrances not, in any material respect, impairing the use of the encumbered Property for its intended purposes, (h)&#160;judgment Liens in respect of judgments that would not constitute an Event of Default, (i)&#160;Liens arising by virtue of any statutory or common law provision relating to banker&#8217;s liens, rights of setoff or similar rights as to deposit accounts or other funds maintained with a creditor depository institution and (j) Liens with respect to lease filings for notice purposes only.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Receivables Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any transaction entered into pursuant to documentation in which (a) the Borrower or one or more Domestic Subsidiaries sells, conveys or otherwise transfers to Quest Receivables and (b) Quest Receivables sells, conveys or otherwise transfers to any other Person or grants a security interest to any Person in, any Receivables (whether now existing or hereafter acquired) of the Borrower or such Domestic Subsidiaries, and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any assets related thereto including all collateral securing such Receivables, all contracts and all Guarantee Obligations or other obligations in respect of such Receivables, all proceeds of such Receivables and all other assets that are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving Receivables&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the purchasers or lenders in such transaction shall have no recourse to the Borrower or any Subsidiary other than recourse of  types and in amounts customary in &#8220;true sale&#8221; receivables securitizations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any individual, partnership, joint venture, firm, corporation, limited liability company, association, trust or other enterprise (whether or not incorporated), or any Governmental Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any employee benefit plan (as defined in Section 3(3) of ERISA) covered by ERISA that is sponsored, maintained or contributed to by the Borrower or any ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning given thereto in Section 7.1(h).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the rate of interest per annum publicly announced from time to time by JPMorgan as its prime rate in effect at its principal office in New York City.  Each change in the Prime Rate shall be effective from and including the date such change is publicly announced as being effective.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prior Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means March 22, 2018.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any right, title or interest in or to any property or asset of any kind whatsoever, whether real, personal or mixed and whether tangible or intangible.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Public Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning given thereto in Section 7.1(h).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Quest Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Quest Diagnostics Receivables Incorporated, a Delaware corporation, a wholly-owned, bankruptcy-remote, special purpose Subsidiary of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Quotation Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to any applicable currency for any Interest Period, the day two Business Days prior to the first day of such Interest Period, in each case unless market practice differs for loans such as the applicable Loans priced by reference to rates quoted in the Relevant Interbank Market, in which case the Quotation Day for such currency shall be determined by the Administrative Agent (and notified to the Borrower in writing) in accordance with market practice for such loans priced by reference to rates quoted in the Relevant Interbank Market (and if quotations would normally be given by leading banks for such loans priced by reference to rates quoted in the Relevant Interbank Market on more than one day, the Quotation Day shall be the last of those days).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the indebtedness and payment obligations of any Person to the Borrower or any Domestic Subsidiary or acquired by the Borrower or any Domestic Subsidiary (including obligations constituting an account or general intangible or evidenced by a note, instrument, contract, security agreement, chattel paper or other evidence of indebtedness or security) arising from a sale of merchandise or the provision of services in the ordinary course of business by the Borrower or any Domestic Subsidiary or the Person from which such indebtedness and payment obligation were acquired by the Borrower or any Domestic Subsidiary, including (a) any right to payment for goods sold or for services rendered and (b) the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">right to payment of any interest, sales taxes, finance charges, returned check or late charges and other obligations of such Person with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reference Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; with respect to any setting of the then-current Benchmark means (1) if such Benchmark is the LIBO Rate, 11&#58;00 a.m. (London time) on the day that is two London banking days preceding the date of such setting, (2) if such Benchmark is the EURIBO Rate, 11&#58;00&#160;a.m. Brussels time two TARGET Days preceding the date of such setting, (3) if such Benchmark is SONIA, then four Business Days prior to such setting or (4) if such Benchmark is none of the LIBO Rate, the EURIBO Rate or SONIA, the time determined by the Administrative Agent in its reasonable discretion (and notified to the Borrower in writing).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, in respect of any Indebtedness (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), any Indebtedness that extends, renews or refinances such Original Indebtedness (or any Refinancing Indebtedness in respect thereof)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (a) the principal amount of such Refinancing Indebtedness shall not exceed the principal amount of such Original Indebtedness&#59; (b)&#160;the stated final maturity of such Refinancing Indebtedness shall not be earlier than that of such Original Indebtedness&#59; (c) such Refinancing Indebtedness shall not be required to be repaid, prepaid, redeemed, repurchased or defeased, whether on one or more fixed dates, upon the occurrence of one or more events or at the option of any holder thereof (except, in each case, upon the occurrence of an event of default or a change in control or as and to the extent such repayment, prepayment, redemption, repurchase or defeasance would have been required pursuant to the terms of such Original Indebtedness) prior to the earlier of (i) the maturity of such Original Indebtedness and (ii)&#160;the date 180 days after the latest Maturity Date, to each case as in effect on the date of such extension, renewal or refinancing&#59; (d) such Refinancing Indebtedness shall not constitute an obligation (including pursuant to a guarantee) of any Subsidiary that shall not have been (or, in the case of after-acquired Subsidiaries, shall not have been required to become) an obligor in respect of such Original Indebtedness&#59; (e) if such Original Indebtedness shall have been subordinated to the obligations under this Credit Agreement, such Refinancing Indebtedness shall also be subordinated to the obligations hereunder on terms not less favorable in any material respect to the Lenders&#59; and (f) such Refinancing Indebtedness shall not be secured by any Lien on any asset other than the assets that secured such Original Indebtedness (or would have been required to secure such Original Indebtedness pursuant to the terms thereof). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.3(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Regulation T, U or X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Regulation T, U or X, respectively, of the Board of Governors of the Federal Reserve System as from time to time in effect and any successor to all or a portion thereof. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Related Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any specified Person, such Person&#8217;s Affiliates and the directors, officers, employees, partners, members, agents and advisors of such Person and of such Person&#8217;s Affiliates.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relevant Governmental Body</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to a Benchmark Replacement in respect of Loans denominated in Dollars, the Federal Reserve Board and&#47;or the NYFRB, or a committee officially endorsed or convened by the Federal Reserve Board and&#47;or the NYFRB or, in each case, any successor thereto, (ii) with respect to a Benchmark Replacement in respect of Loans denominated in Sterling, the Bank of England, or a committee officially endorsed or convened by the Bank of England or, in each case, any successor thereto, (iii) with respect to a Benchmark Replacement in respect of Loans denominated in Euros, the European Central Bank, or a committee officially endorsed or convened by the European Central Bank or, in each case, any successor thereto, and (iv) with respect to a Benchmark Replacement in respect of Loans denominated in any other currency, (a) the central bank for the currency in which such Benchmark Replacement is denominated or any central bank or other supervisor which is responsible for supervising either (1) such Benchmark Replacement or (2) the administrator of such Benchmark Replacement or (b) any working group or committee officially endorsed or convened by (1) the central bank for the currency in which such Benchmark Replacement is denominated, (2) any central bank or other supervisor that is responsible for supervising either (A) such Benchmark Replacement or (B) the administrator of such Benchmark Replacement, (3) a group of those central banks or other supervisors or (4) the Financial Stability Board or any part thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relevant Interbank Market</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any currency other than Euros, the London interbank market, and (b) with respect to Euros, the European interbank market.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relevant Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to any Term Benchmark Loan denominated in Dollars, the LIBO Rate, (ii) with respect to any Term Benchmark Loan denominated in Euros, the EURIBO Rate or (iii) with respect to any Loan denominated in Sterling, the Daily Simple SONIA Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Required Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Lenders whose aggregate Credit Exposure (as hereinafter defined) constitutes more than 50% of the Credit Exposure of all Lenders at such time.  For purposes hereof, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; as applied to each Lender shall mean (a) at any time prior to the termination of the Commitments, the sum of the Revolving Loan Commitment Percentage of such Lender multiplied by the Revolving Committed Amount, and (b) at any time after the termination of the Commitments, the sum of (i) the principal balance of the outstanding Loans of such Lender </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) such Lender&#8217;s Participation Interests in the face amount of the outstanding Letters of Credit and outstanding Swing Line Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Requirement of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Person, the articles or certificate of incorporation and by-laws or other organizational or governing documents of such Person, and any law, treaty, rule or regulation or final, non-appealable determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or to which any of its material Property is subject.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restatement Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the date on which the conditions set forth in Section 5.1 shall have been satisfied (or waived in accordance with Section 11.6).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revaluation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;with respect to any Loan, each of the following&#58;  (i)&#160;each date of a borrowing of a Loan denominated in an Alternative Currency, and (ii) each date of a continuation of a Term Benchmark Loan denominated in an Alternative Currency pursuant to Section&#160;2.4, and (b)&#160;with respect to any Letter of Credit, each of the following&#58;  (i)&#160;each date of issuance, extension or renewal of a Letter of Credit denominated in an Alternative Currency and the last Business Day of each subsequent calendar quarter, (ii)&#160;each date of an amendment of any Letter of Credit denominated in an Alternative Currency having the effect of increasing the amount thereof, and (iii)&#160;each date of any payment by any Issuing Lender under any Letter of Credit denominated in an Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Revolving Loans of the same Type and Agreed Currency, made, converted or continued on the same date and, in the case of Term Benchmark Loans, as to which a single Interest Period is in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Lender, the commitment, if any, of such Lender to make Revolving Loans and to acquire Participation Interests in Letters of Credit and Swing Line Loans hereunder, expressed as an amount representing the maximum aggregate permitted amount of such Lender&#8217;s Revolving Exposure hereunder, as such commitment may be (a)&#160;reduced from time to time pursuant to Section&#160;2.1(d), (b) increased from time to time pursuant to Section&#160;2.7 and (c)&#160;reduced or increased from time to time pursuant to assignments by or to such Lender pursuant to Section&#160;11.3.  The initial amount of each Lender&#8217;s Revolving Commitment is set forth on Schedule 1.1(a), or in the Assignment and Assumption or the Incremental Facility Agreement pursuant to which such Lender shall have assumed its Revolving Commitment, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Committed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means $750,000,000 or such other amount to which the Revolving Committed Amount may be reduced pursuant to Section&#160;2.1(d) or increased pursuant to Section&#160;2.7.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the recitals.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender at any time, the sum of the Dollar Equivalents of such Lender&#8217;s outstanding Revolving Loans and such Lender&#8217;s LOC Obligations and Swing Line Exposure at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Lender with a Revolving Commitment or Revolving Exposure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Lender Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Revolving Lender, any Person in respect of which such Lender is a subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loan Commitment Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for each Lender, at any time, the percentage identified as its Revolving Loan Commitment Percentage on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 1.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as such percentage may be modified in connection with any assignment made in accordance with the provisions of Section 11.3 and with the establishment of any Incremental Revolving Commitments (or if the Revolving Commitments have been terminated or expired, such Lender&#8217;s Revolving Commitment most recently in effect, giving effect to any assignments)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that for purposes of Section&#160;2.6, if any Defaulting Lender exists at such time, the Revolving Loan Commitment Percentages shall be calculated disregarding such Defaulting Lender&#8217;s Revolving Commitment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the revolving loans made to the Borrower pursuant to Section&#160;2.1(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the fifth anniversary of the Restatement Effective Date, as such date may be extended pursuant to Section 2.8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any promissory notes of the Borrower in favor of any of the Lenders evidencing the Revolving Loans provided pursuant to Section 2.1, individually or collectively, as appropriate, as such promissory notes may be amended, modified, supplemented, extended, renewed or replaced from time to time and as evidenced in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 2.1(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Loan denominated in Sterling, any day except for (i)&#160;a Saturday, (ii) a Sunday or (iii)&#160;a day on which banks are closed for general business in London.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Interest Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in the definition of &#8220;Daily Simple SONIA Rate&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest at a rate based on the Adjusted Daily Simple SONIA Rate.  All Loans denominated in Sterling shall be RFR Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Standard &#38; Poor&#8217;s Financial Services LLC, a division of S&#38;P Global Inc., and its successors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sale and Leaseback Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any arrangement with any Person providing for the leasing by the Borrower or one of its Subsidiaries of any Property that has been or is to be sold or transferred by the Borrower or any of its Subsidiaries to such Person, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Same Day Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to disbursements and payments in Dollars, immediately available funds, and (b) with respect to disbursements and payments in an Alternative Currency, same day or other funds as may be determined by the Administrative Agent or each applicable Issuing Lender, as the case may be, to be customary in the place of disbursement or payment for the settlement of international banking transactions in the relevant Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctioned Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, a country, region or territory which is the target of any countrywide, region-wide or territory-wide Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctioned Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S. Department of State or by the United Nations Security Council, the European Union or Her Majesty&#8217;s Treasury of the United Kingdom, (b) any Person operating, organized or resident in a Sanctioned Country or (c) any Person owned by controlled by any such Person described in the foregoing clause (a) or (b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State, (b) the United Nations Security Council, (c) the European Union or (d) Her Majesty&#8217;s Treasury of the United Kingdom.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">34</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Screen Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) in respect of the LIBO Rate for any Interest Period or with respect to any determination of the Base Rate pursuant to clause (c) of the definition thereof, a rate per annum equal to the London interbank offered rate as administered by the ICE Benchmark Administration (or any other Person that takes over the administration of such rate) for deposits in Dollars for a period equal in length to such Interest Period as displayed on the applicable Bloomberg L.P. &#8220;BBAM&#8221; screen page that displays such rate (or, in the event such rate does not appear on a page of the Bloomberg&#160;L.P. screen, on the appropriate page of such other information service that publishes such rate as shall be selected by the Administrative Agent from time to time in its reasonable discretion) and (b) in respect of the EURIBO Rate for any Interest Period, the euro interbank offered rate administered by the European Money Markets Institute (or any other person which takes over the administration of that rate) for the relevant period displayed on the applicable Bloomberg L.P. &#8220;BBAM&#8221; screen page (or, in the event such rate does not appear on a page of the Bloomberg L.P. screen, on the appropriate page of such other information service that publishes such rate as shall be selected by the Administrative Agent from time to time in its reasonable discretion).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, as amended, modified, succeeded or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Series</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.7(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Single Employer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Plan which is covered by Title IV of ERISA, but which is not a Multiemployer Plan or a Multiple Employer Plan, that is maintained for employees of the Borrower or ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Social Security Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Social Security Act as set forth in Title 42 of the United States Code, as amended, and any successor statute thereto, as interpreted by the rules and regulations issued thereunder, in each case as in effect from time to time.  References to sections of the Social Security Act shall be construed also to refer to any successor sections.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Business Day, a rate per annum equal to the secured overnight financing rate for such Business Day published by the SOFR Administrator on the SOFR Administrator&#8217;s Website on the immediately succeeding Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the NYFRB (or a successor administrator of the secured overnight financing rate).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Administrator&#8217;s Website</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the NYFRB&#8217;s website, currently at http&#58;&#47;&#47;www.newyorkfed.org, or any successor source for the secured overnight financing rate identified as such by the SOFR Administrator from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Business Day, a rate per annum equal to the Sterling Overnight Index Average for such Business Day published by the SONIA Administrator on the SONIA Administrator&#8217;s Website on the immediately succeeding Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Bank of England (or any successor administrator of the Sterling Overnight Index Average).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA Administrator&#8217;s Website</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Bank of England&#8217;s website, currently at http&#58;&#47;&#47;www.bankofengland.co.uk, or any successor source for the Sterling Overnight Index Average identified as such by the SONIA Administrator from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SPC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.3(g).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to the LIBO Rate, 11&#58;00 a.m., London time, and (b)&#160;with respect to the EURIBO Rate, 11&#58;00 a.m., Frankfurt time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Statutory Reserve Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a fraction (expressed as a decimal), the numerator of which is the number one and the denominator of which is the number one </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the aggregate of the maximum reserve percentage (including any marginal, special, emergency or supplemental reserves), expressed as a decimal, established by the Federal Reserve Board to which the Administrative Agent is subject with respect to the Adjusted EURIBO Rate or Adjusted LIBOR Rate, as applicable, for eurocurrency funding (currently referred to as &#8220;Eurocurrency liabilities&#8221; in Regulation D) or any other reserve ratio or analogous requirement of any central banking or financial regulatory authority imposed in respect of the maintenance of the Commitments or the funding of Loans.  Such reserve percentage shall include those imposed pursuant to Regulation D.  Term Benchmark Loans shall be deemed to constitute eurocurrency funding and to be subject to such reserve requirements without benefit of or credit for proration, exemptions or offsets that may be available from time to time to any Lender under Regulation D or any comparable regulation.  The Statutory Reserve Rate shall be adjusted automatically on and as of the effective date of any change in any reserve percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sterling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#163;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; mean the lawful currency of the United Kingdom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Person at any time, (a) any corporation more than 50% of whose stock of any class or classes having by the terms thereof ordinary voting power to elect a majority of the directors of such corporation (irrespective of whether or not at the time, any class or classes of such corporation shall have or might have voting power by reason of the occurrence of any contingency) is at such time owned directly or indirectly by such Person and (b) any partnership, association, joint venture or other entity in which such Person directly or indirectly has more than a 50% equity interest at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, the aggregate principal amount of all Swing Line Loans outstanding at such time.  The Swing Line Exposure of any Revolving Lender at any time shall be its Revolving Loan Commitment Percentage of the total Swing Line Exposure at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means JPMorgan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the promissory note of the Borrower in favor of the Swing Line Lender evidencing the Swing Line Loans provided pursuant to Section&#160;2.3, as such promissory note may be amended, modified, supplemented, extended, renewed or replaced from time to time in and as evidenced by the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a request by the Borrower for a Swing Line Loan in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; have the meanings set forth in Section&#160;2.3(a).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">36</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Subfacility Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; have the meaning set forth in Section 2.3(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Syndication Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Synthetic Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any synthetic lease, tax retention operating lease, off-balance sheet loan or similar offbalance sheet financing product where such transaction is considered borrowed money indebtedness for tax purposes but is classified as an operating lease in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">TARGET Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any day on which the Trans-European Automated Real-time Gross Settlement Express Transfer (TARGET) payment system (or, if such payment system ceases to be operative, such other payment system (if any)&#160;determined by the Administrative Agent (and notified to the Borrower in writing) to be a suitable replacement) is open for the settlement of payments in Euros.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 3.13(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tender Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the costs incurred by the Borrower in connection with any tender for outstanding indebtedness of the Borrower and the termination of the interest rate swap contracts related thereto, in an aggregate amount not to exceed $100,000,000 during the term of this Credit Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Adjusted EURIBO Rate or the Adjusted LIBO Rate.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for the applicable Corresponding Tenor as of the applicable Reference Time, the forward-looking term rate based on SOFR that has been selected or recommended by the Relevant Governmental Body.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a notification by the Administrative Agent to the Lenders and the Borrower of the occurrence of a Term SOFR Transition Event.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the determination by the Administrative Agent that (a) Term SOFR has been recommended for use by the Relevant Governmental Body, (b) the administration of Term SOFR is administratively feasible for the Administrative Agent and (c) a Benchmark Transition Event or an Early Opt-in Election, as applicable (and, for the avoidance of doubt, not in the case of an Other Benchmark Rate Election), has previously occurred resulting in a Benchmark Replacement in accordance with  Section 3.10 that is not Term SOFR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Total Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all items that in accordance with GAAP would be classified as assets of the Borrower and its Subsidiaries on a consolidated basis.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">TRICARE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Department of Defense health care program for service families including, but not limited to, TRICARE Prime, TRICARE Extra and TRICARE Standard, and any successor to or predecessor thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Type</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, when used in reference to any Loan or Borrowing, refers to whether the rate of interest on such Loan, or on the Loans comprising such Borrowing, is determined by reference to the Adjusted LIBO Rate, the Adjusted EURIBO Rate, the Base Rate or the Adjusted Daily Simple SONIA Rate.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">UK Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">UK Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unadjusted Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means the Benchmark Replacement excluding the Benchmark Replacement Adjustment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the Unadjusted Benchmark Replacement as so determined would be less than zero, the Unadjusted Benchmark Replacement will be deemed to be zero for the purposes of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Upfront Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 5.1(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Voting Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all classes of the Capital Stock of such Person then outstanding and normally entitled to vote in the election of directors (or similar governing authority).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Wells Fargo Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain letter agreement dated as of November 23, 2021, between the Borrower and Wells Fargo Bank, N.A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Write-Down and Conversion Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Other Interpretive Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With reference to this Credit Agreement and each other Credit Document, unless otherwise specified herein or in such other Credit Document&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The meanings of defined terms are equally applicable to the singular and plural forms of the defined terms.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">(i)&#160;&#160;&#160;&#160;The words &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">herein</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">hereto</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">hereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">hereunder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and words of similar import when used in any Credit Document shall refer to such Credit Document as a whole and not to any particular provisions thereof.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">Article, Section, Exhibit and Schedule references are to the Credit Document in which such reference appears.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; is by way of example and not limitation.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; includes any and all instruments, documents, agreements, certificates, notices, reports, financial statements and other writings, however evidenced, whether in physical or electronic form.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In the computation of periods of time from a specified date to a later specified date, the word &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">from</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">from and including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;&#59; the words &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">until</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; each mean &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">to but excluding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;&#59; and the word &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">through</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">to and including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Section headings herein and in the other Credit Documents are included for convenience of reference only and shall not affect the interpretation of this Credit Agreement or any other Credit Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">References to &#8220;the date hereof&#8221; or &#8220;the date of this Credit Agreement&#8221;, or phrases of similar import, herein shall mean November 23, 2021. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Accounting Terms&#47;Calculation of Financial Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Except as otherwise expressly provided herein, all accounting terms used herein shall be interpreted, and all financial statements, certificates and reports as to financial matters required to be delivered to the Lenders hereunder shall be prepared, in accordance with GAAP applied on a consistent basis. Except as otherwise expressly provided herein, all accounting terms used herein shall be construed in accordance with GAAP as in effect from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if the Borrower, by notice to the Administrative Agent, shall request an amendment to any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or in the application thereof on the operation of such provision (or if the Administrative Agent or the Required Lenders, by notice to the Borrower, shall request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith.  Following the delivery of any such notice, the Borrower, the Administrative Agent and the Lenders agree to negotiate in good faith to amend this Credit Agreement in an appropriate manner to eliminate the effect of any such change.  Notwithstanding any other provision contained herein, all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made, without giving effect to (i) any election under Statement of Financial Accounting Standards 159, The Fair Value Option for Financial Assets and Financial Liabilities, or any successor thereto (including pursuant to the Accounting Standards Codification) to value any Indebtedness of the Borrower or any Subsidiary at &#8220;fair value&#8221;, as defined therein, and (ii) any change in accounting for leases pursuant to GAAP resulting from the adoption of Financial Accountings Standards Board Accounting Standards Update No. 2016-02, Leases (Topic 842) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FAS 842</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), to the extent such adoption would require (x) treating any lease (or similar arrangement conveying the right to use) as a capital lease where such lease (or similar arrangement) would not have been required to be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">so treated under GAAP as in effect on the date hereof or (y) recognizing liabilities on the balance sheet with respect to operating leases under FAS 842.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Notwithstanding anything herein to the contrary, for the purposes of calculating the financial covenant set forth in Section 7.2, (i) income statement items (positive or negative) attributable to any Person or Property acquired by the Borrower or one of its Subsidiaries and Indebtedness incurred in connection with such acquisition shall, without duplication, be treated as if such Person or Property had been acquired or such Indebtedness incurred as of the first day of the twelve month period ending as of the most recently completed fiscal quarter of the Borrower for which financial statements have been delivered pursuant to Section 7.1(a) or (b) (or, prior to the delivery of the first financial statements pursuant to Section 7.1(a) or (b), as of the first day of the twelve month period ending as of the date of the most recent balance sheet delivered to the Lenders prior to the Restatement Effective Date) and (ii) income statement items (positive or negative) attributable to Property disposed of by the Borrower or one of its Subsidiaries and Indebtedness retired in connection with such disposition shall, without duplication, be treated as if such disposition had occurred as of the first day of the twelve month period referred to in the preceding clause (i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Rounding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any financial ratio required to be maintained by the Borrower pursuant to this Credit Agreement shall be calculated by dividing the appropriate component by the other component, carrying the result to one place more than the number of places by which such ratio is expressed herein and rounding the result up or down to the nearest number (with a rounding-up if there is no nearest number).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Exchange Rates&#59; Currency Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent shall determine the Exchange Rates as of each Revaluation Date to be used for calculating Dollar Equivalent amounts of Loans and Letters of Credit denominated in Alternative Currencies.  Such Exchange Rates shall become effective as of such Revaluation Date and shall be the Exchange Rates employed in converting any amounts between the applicable currencies until the next Revaluation Date to occur in respect of the applicable Loan or Letter of Credit.  Except for purposes of financial statements delivered by the Borrower hereunder or calculating the financial covenant hereunder or except as otherwise provided herein, the applicable amount of any currency (other than Dollars) for purposes of the Credit Documents shall be such Dollar Equivalent amount at the applicable Exchange Rate on the date of such determination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Additional Alternative Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Borrower may from time to time request that Loans be made in a currency other than those specifically listed in the definition of &#8220;Alternative Currency&#8221;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (a)&#160;such requested currency is a lawful currency (other than Dollars) that is readily available and freely transferable and convertible into Dollars, (b) such currency may be used by any Lender to make Loans hereunder and&#47;or to permit the Borrower to borrow and repay the principal thereof and to pay the interest thereon without any central bank or other governmental authorization in the country of issue of such currency, unless such authorization has been obtained and is in full force and effect, and (c) prior to any such request, the Borrower, the Administrative Agent and the Revolving Lenders shall have amended this Credit Agreement to provide for an interest rate agreed to by the Borrower, the Administrative Agent and the Revolving Lenders and to include such other administrative requirements as may be necessary to implement such interest rate. In the case of any such request with respect to the making of Loans in any such currency, such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">request shall be subject to the approval of the Administrative Agent and each of the Revolving Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Any such request shall be made to the Administrative Agent not later than 20&#160;Business Days prior to the date of the desired making of Loans (or such other time or date as may be agreed by the Administrative Agent).  In the case of any such request, the Administrative Agent shall promptly notify each Revolving Lender thereof.  Each Revolving Lender shall notify the Administrative Agent, not later than 10 Business Days after receipt of such request whether it consents, in its sole discretion, to the making of Loans in such requested currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Any failure by a Revolving Lender to respond to such request within the time period specified in the preceding sentence shall be deemed to be a refusal by such Lender to permit Loans to be made in such requested currency.  If the Administrative Agent and all the Revolving Lenders consent to making Loans in such requested currency, the Administrative Agent shall so notify the Borrower and such currency shall thereupon be deemed to be an Alternative Currency hereunder for purposes of any borrowings of Loans. If the Administrative Agent shall fail to obtain consent to any request for an additional currency under this Section 1.6, the Administrative Agent shall promptly so notify the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Change of Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Each obligation of the Borrower to make a payment denominated in the national currency unit of any member state of the European Union that adopts the Euro as its lawful currency after the Restatement Effective Date shall be redenominated into Euro at the time of such adoption (in accordance with the EMU Legislation).  If, in relation to the currency of any such member state, the basis of accrual of interest expressed in this Credit Agreement in respect of that currency shall be inconsistent with any convention or practice in the London interbank market for the basis of accrual of interest in respect of the Euro, such expressed basis shall be replaced by such convention or practice with effect from the date on which such member state adopts the Euro as its lawful currency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if any borrowing in the currency of such member state is outstanding immediately prior to such date, such replacement shall take effect, with respect to such borrowing, at the end of the then current Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Each provision of this Credit Agreement shall be subject to such reasonable changes of construction as the Administrative Agent may from time to time specify to be appropriate to reflect the adoption of the Euro by any member state of the European Union and any relevant market conventions or practices relating to the Euro.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">41</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Each provision of this Credit Agreement also shall be subject to such reasonable changes of construction as the Administrative Agent may from time to time specify to be appropriate to reflect a change in currency of any other country and any relevant market conventions or practices relating to the change in currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">References to Agreements and Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Unless otherwise expressly provided herein, (a)&#160;references to organizational documents, agreements (including the Credit Documents) and other contractual instruments shall be deemed to include all subsequent amendments, restatements, extensions, supplements and other modifications thereto, but only to the extent that such amendments, restatements, extensions, supplements and other modifications are not prohibited by any Credit Document and (b)&#160;references to any law shall include all statutory and regulatory provisions (having the force of law) consolidating, amending, replacing, supplementing or interpreting such law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Letter of Credit Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Unless otherwise specified, all references herein to the amount of a Letter of Credit at any time shall be deemed to mean the maximum face amount of such Letter of Credit after giving effect to all increases thereof contemplated by such Letter of Credit or the LOC Documents related thereto, whether or not such maximum face amount is in effect at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Interest Rates&#59; LIBOR Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The interest rate on a Loan denominated in Dollars or an Alternative Currency may be derived from an interest rate benchmark that is, or may in the future become, the subject of regulatory reform.  Regulators have signaled the need to use alternative benchmark reference rates for some of these interest rate benchmarks and, as a result, such interest rate benchmarks may cease to comply with applicable laws and regulations, may be permanently discontinued, and&#47;or the basis on which they are calculated may change.  The London interbank offered rate (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is intended to represent the rate at which contributing banks may obtain short-term borrowings from each other in the London interbank market.  On March 5, 2021, the U.K. Financial Conduct Authority (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) publicly announced that&#58;  (a) immediately after December 31, 2021, publication of all seven euro LIBOR settings, the overnight, 1-week, 2-month and 12-month British Pound Sterling LIBOR settings, and the 1-week and 2-month U.S. Dollar LIBOR settings will permanently cease&#59; immediately after June 30, 2023, publication of the overnight and 12-month U.S. Dollar LIBOR settings will permanently cease&#59; immediately after December 31, 2021, the 1-month, 3-month and 6-month British Pound Sterling LIBOR settings will cease to be provided or, subject to consultation by the FCA, be provided on a changed methodology (or &#8220;synthetic&#8221;) basis and no longer be representative of the underlying market and economic reality they are intended to measure and that representativeness will not be restored&#59; and immediately after June 30, 2023, the 1-month, 3-month and 6-month U.S. Dollar LIBOR settings will cease to be provided or, subject to the FCA&#8217;s consideration of the case, be provided on a synthetic basis and no longer be representative of the underlying market and economic reality they are intended to measure and that representativeness will not be restored.  There is no assurance that dates announced by the FCA will not change or that the administrator of LIBOR and&#47;or regulators will not take further action that could impact the availability, composition, or characteristics of LIBOR or the currencies and&#47;or tenors for which LIBOR is published.  Each party to this Credit Agreement should consult its own advisors to stay informed of any such developments.  Public and private sector industry initiatives are currently underway to identify new or alternative reference rates to be used in place of LIBOR.  Upon the occurrence of a Benchmark Transition Event, a Term SOFR Transition Event, an Early Opt-In Election or an Other Benchmark Rate </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Election, Section 3.10(b) and Section&#160;3.10(c) provide a mechanism for determining an alternative rate of interest.  The Administrative Agent will promptly notify the Borrower, pursuant to Section 3.10(e), of any change to the reference rate upon which the interest rate on Term Benchmark Loans is based.  However, the Administrative Agent does not warrant or accept any responsibility for, and shall not have any liability with respect to, the administration, submission, performance or any other matter related to the Daily Simple SONIA Rate, LIBOR or other rates in the definition of &#8220;LIBO Rate&#8221; (or &#8220;EURIBO Rate&#8221;) or with respect to any alternative or successor rate thereto, or replacement rate thereof (including, without limitation, (i)&#160;any such alternative, successor or replacement rate implemented pursuant to Section 3.10(b) or&#160;Section 3.10(c), whether upon the occurrence of a Benchmark Transition Event, a Term SOFR Transition Event, an Early Opt-in Election or an Other Benchmark Rate Election, and (ii)&#160;the implementation of any Benchmark Replacement Conforming Changes pursuant to Section&#160;3.10(d)), including without limitation, whether the composition or characteristics of any such alternative, successor or replacement reference rate will be similar to, or produce the same value or economic equivalence of, the Daily Simple SONIA Rate, the LIBO Rate (or the EURIBO Rate) or have the same volume or liquidity as did the London interbank offered rate prior to its discontinuance or unavailability (excluding, in each case, in the event of bad faith, gross negligence or willful misconduct on the part of the Administrative Agent (as determined by a court of competent jurisdiction in a final, non-appealable judgment)).  The Administrative Agent and its affiliates and&#47;or other related entities may engage in transactions that affect the calculation of any Daily Simple SONIA Rate, any alternative, successor or alternative rate (including any Benchmark Replacement) and&#47;or any relevant adjustments thereto,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in each case, in a manner adverse to the Borrower. The Administrative Agent may select information sources or services in its reasonable discretion to ascertain Daily Simple SONIA Rate, LIBO Rate or EURIBO Rate, any component thereof, or rates referenced in the definition thereof, in each case pursuant to the terms of this Credit Agreement, and shall have no liability to the Borrower, any Lender or any other person or entity for damages of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity), for any error or calculation of any such rate (or component thereof) provided by any such information source or service.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt"><br><br>CREDIT FACILITIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Revolving Loan Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions set forth herein, including but not limited to Section 5.2, each Lender severally agrees to make Revolving Loans to the Borrower, in Dollars or in one or more Alternative Currencies, in an amount equal to its Revolving Loan Commitment Percentage, if any, of any borrowing of Revolving Loans, at </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any time and from time to time, during the period from and including the Restatement Effective Date to but not including the Revolving Maturity Date (or such earlier date if the Commitments have been terminated as provided herein)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, after giving effect to any borrowing of Revolving Loans, the sum of (i) the aggregate amount of the Dollar Equivalent of Revolving Loans outstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the aggregate amount of the Dollar Equivalent of LOC Obligations outstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (iii) the aggregate amount of Swing Line Loans outstanding shall not exceed the Revolving Committed Amount, and the aggregate amount of the Dollar Equivalent of Revolving Loans and LOC Obligations denominated in Alternative Currencies at any time shall not exceed $100,000,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Currency Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Subject to the terms of this Credit Agreement, the Borrower may borrow, repay and reborrow Revolving Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Method of Borrowing for Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By no later than (i) 11&#58;00 a.m., Local Time, on the date of the requested borrowing of Revolving Loans that will be made as Base Rate Loans, (ii)&#160;1&#58;00 p.m., Local Time, three Business Days prior to the date of the requested borrowing of Revolving Loans that will be made as Term Benchmark Loans denominated in Dollars, (iii)&#160;12&#58;00 p.m., New York City time, three Business Days prior to the date of the requested borrowing of Revolving Loans that will be made as Term Benchmark Loans denominated in Euros, or (iv) 11&#58;00 a.m., New York City time, four RFR Business Days prior to the date of the requested borrowing of Revolving Loans that will be made as RFR Loans denominated in Sterling, the Borrower shall provide written notice, submitted by fax, email or hand delivery, to the Administrative Agent in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 2.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (or, in the case of any borrowing of Revolving Loans denominated in Dollars, by telephonic notification, confirmed promptly by written notice, submitted by fax, email or hand delivery, to the Administrative Agent in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), each of such telephonic notice and such written Notice of Borrowing setting forth (A)&#160;the amount requested, (B)&#160;whether such Revolving Loans shall accrue interest at the Base Rate, the Adjusted Daily Simple SONIA Rate, the Adjusted LIBO Rate or the Adjusted EURIBO Rate, (C)&#160;with respect to Revolving Loans that will be Term Benchmark Loans, the Interest Period applicable thereto, (D)&#160;with respect to Revolving Loans that will be Term Benchmark Loans or RFR Loans, the applicable currency thereof, (E)&#160;certification that the Borrower has complied in all respects with Section&#160;5.2 and (F) in the case of a Revolving Loan borrowing requested to finance the reimbursement of a Letter of Credit as provided in Section 2.2(d), the identity of the Issuing Lender that has issued such Letter of Credit.  Each such notice must be received by the Administrative Agent not later than (i) three Business Days prior to the requested date of any borrowing of, conversion to or continuation of Term Benchmark Loans denominated in Dollars or of any conversion of Term Benchmark Loans denominated in Dollars to Base Rate Loans, (ii)&#160;three Business Days prior to the requested date of any borrowing or continuation of Term Benchmark Loans denominated in Euros, (iii) four RFR Business Days prior to the requested date of any borrowing of RFR Loans and (iv) on the requested date of any borrowing of Base Rate Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Funding of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon receipt of a Notice of Borrowing, the Administrative Agent shall promptly inform the Lenders as to the terms thereof.  Each Lender shall make its Revolving Loan Commitment Percentage of the requested borrowing of Revolving Loans available to the Administrative Agent in Same Day Funds at the Agency Services Address for the applicable currency not later than 1&#58;00 p.m., Local Time, in each case on the Business Day specified in the Notice of Borrowing.  The amount of the requested Revolving Loans will then be made available to the Borrower by the Administrative Agent as directed by the Borrower in writing, to the extent the amount of such Revolving Loans are made available to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Lender shall be responsible for the failure or delay by any other Lender in its obligation to make Revolving Loans hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the failure of any Lender to fulfill its obligations hereunder shall not relieve any other Lender of its obligations hereunder.  Unless the Administrative Agent shall have been notified by any Lender prior to the time of any such Revolving Loan that such Lender does not intend to make available to the Administrative Agent its portion of the Revolving Loans to be made on such date, the Administrative Agent may assume that such Lender has made such amount available to the Administrative Agent on the date of such Revolving Loans, and the Administrative Agent in reliance upon such assumption may (in its sole discretion but without any obligation to do so) make available to the Borrower a corresponding amount.  If such Lender&#8217;s portion of the Revolving Loans is not in fact made available to the Administrative Agent, the Administrative Agent shall be able to recover from such Lender an amount equal to such corresponding amount which the Administrative Agent has made available to the Borrower.  If such Lender does not pay such amount upon the Administrative Agent&#8217;s demand therefor, the Administrative Agent will promptly notify the Borrower, and the Borrower shall immediately pay such amount to the Administrative Agent.  The Administrative Agent shall also be entitled to recover from such Lender or the Borrower, as the case may be, interest on such amount in respect of each day from the date an amount equal to such corresponding amount was made available by the Administrative Agent to the Borrower to the date such corresponding amount is recovered by the Administrative Agent at a per annum rate equal to (i) from the Borrower, at the applicable rate for such Revolving Loan pursuant to the Notice of Borrowing or (ii) from such Lender, at the Overnight Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> any administrative, processing or similar fees customarily charged by the Administrative Agent in connection with the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Reductions of Revolving Committed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon at least three Business Days&#8217; prior written notice, the Borrower shall have the right to permanently reduce, without premium or penalty, all or part of the aggregate unused amount of the Revolving Committed Amount at any time or from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i)&#160;each partial reduction shall be in an aggregate amount at least equal to $10,000,000 and in integral multiples of $1,000,000 above such amount and (ii)&#160;no reduction shall be made which would reduce the Revolving Committed Amount to an amount less than the aggregate amount of the Dollar Equivalent of outstanding Revolving Loans </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the aggregate amount of the Dollar Equivalent of outstanding LOC Obligations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the aggregate amount of outstanding Swing Line Loans.  Any reduction in (or termination of) the Revolving Committed Amount pursuant to this Section 2.1(d) shall be permanent and may not be reinstated.  The Administrative Agent shall immediately notify the Lenders of any reduction in the Revolving Committed Amount pursuant to this Section 2.1(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Revolving Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Revolving Loans made by each Lender shall be evidenced by a duly executed promissory note of the Borrower to each Lender that requests a Revolving Note in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 2.1(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Letter of Credit Subfacility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Issuance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions hereof and of the LOC Documents, if any, and any other terms and conditions relating to the Borrower which the applicable Issuing</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">45</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Lender may reasonably require (so long as such terms and conditions do not impose any financial obligation on or require any Lien (not otherwise contemplated by this Credit Agreement) to be given by the Borrower or any of its Subsidiaries or conflict with any obligation of, or detract from any action which may be taken by, the Borrower under this Credit Agreement), each Issuing Lender agrees, in reliance upon the agreements of the other Lenders set forth in this Section&#160;2.2, from time to time upon request, to issue (from the Restatement Effective Date to thirty days prior to the Revolving Maturity Date and in a form reasonably acceptable to such Issuing Lender), in Dollars or, to the extent specified by the Borrower in the applicable request for issuance, in one or more Alternative Currencies, and Participants shall participate in, Letters of Credit for the account of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, after giving effect to the issuance (or drawdown or extension) of any Letter of Credit, (i) the aggregate amount of the Dollar Equivalent of LOC Obligations for such Issuing Lender shall not at any time exceed the LOC Committed Amount of such Issuing Lender, (ii)&#160;the aggregate amount of the Dollar Equivalent of LOC Obligations shall not at any time exceed the aggregate LOC Committed Amount for all Issuing Lenders, (iii)&#160;the sum of (A)&#160;the aggregate amount of the Dollar Equivalent of outstanding LOC Obligations, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (B)&#160;the aggregate amount of the Dollar Equivalent of Revolving Loans outstanding, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (C) the aggregate amount of Swing Line Loans outstanding shall not exceed the Revolving Committed Amount and (iv)&#160;the aggregate amount of the Dollar Equivalent of Revolving Loans and LOC Obligations denominated in Alternative Currencies at any time shall not exceed the Foreign Currency Sublimit.  Each Issuing Lender may require the issuance and expiry date of each Letter of Credit issued by it to be a Business Day.  Each Letter of Credit shall be&#160;a standby letter of credit issued to support the obligations (including pension or insurance obligations), contingent or otherwise, of the Borrower or any of its Subsidiaries.  No Letter of Credit shall have an original expiry date after the earlier of (x) one year from the date of issuance and (y) five Business Days prior to the Revolving Maturity Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that any Letter of Credit may contain customary automatic renewal provisions agreed upon by the Borrower and the relevant Issuing Lender pursuant to which the expiration date of such Letter of Credit shall automatically be extended for a period of up to 12 months (but not to a date later than the date set forth in clause (y) above), subject to a right on the part of such Issuing Lender to prevent any such renewal from occurring by giving notice to the beneficiary in advance of any such renewal.  Each Letter of Credit shall comply with the related LOC Documents.   The Borrower shall promptly examine a copy of each Letter of Credit and each amendment thereto that is delivered to it and, in the event of any claim of noncompliance with the Borrower&#8217;s instructions or other irregularity, the Borrower will immediately notify the relevant Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Notice and Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The request for the issuance of a Letter of Credit (or the amendment, renewal or extension of an outstanding Letter of Credit (other than an automatic renewal permitted pursuant to paragraph (a) of this Section)) shall be submitted to the Administrative Agent for distribution by the Administrative Agent to the relevant Issuing Lender as specified by  the Borrower by hand delivery, fax or email at least three Business Days prior to the requested date of issuance for the Administrative Agent to coordinate with the respective Issuing Lenders.  Each Issuing Lender will, at least quarterly and more frequently upon request, provide to the Administrative Agent for dissemination to the Lenders a report specifying the Letters of Credit which are then issued and outstanding.  Each Issuing Lender will further provide to the Administrative Agent, promptly upon request, copies of the Letters of Credit and the other LOC Documents.  For the avoidance of any doubt, the Borrower shall be entitled at all times to select which Issuing Lender will be used to issue a Letter of Credit.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">46</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Participant, upon issuance of a Letter of Credit, shall be deemed to have purchased without recourse a risk participation from the relevant Issuing Lender in such Letter of Credit and each LOC Document related thereto and the rights and obligations arising thereunder and any collateral relating thereto, in each case in an amount equal to its Revolving Loan Commitment Percentage of the obligations under such Letter of Credit, and shall absolutely, unconditionally and irrevocably assume, as primary obligor and not as surety, and be obligated to pay to such Issuing Lender therefor and discharge when due, its Revolving Loan Commitment Percentage of the obligations arising under such Letter of Credit.  Without limiting the scope and nature of each Participant&#8217;s participation in any Letter of Credit, to the extent that any Issuing Lender has not been reimbursed as required hereunder or under any such Letter of Credit or pursuant to a Mandatory Borrowing under Section&#160;2.2(e)(i), each such Participant shall fund its Participation Interest in such unreimbursed drawing in accordance with the terms of Section&#160;2.2(e)(ii).  Each Participant acknowledges and agrees that its obligation to acquire participations pursuant to this paragraph in respect of Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including any amendment, renewal or extension of any Letter of Credit (provided that such Letter of Credit shall expire no later than the date set forth in paragraph (a) of this Section), the occurrence and continuance of a Default, any reduction or termination of the Commitments or any force majeure or other event that under any rule of law or uniform practices to which any Letter of Credit is subject permits a drawing to be made under such Letter of Credit after the expiration thereof or of the Commitments, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever.  Each Participant further acknowledges and agrees that, in issuing, amending, renewing or extending any Letter of Credit, the relevant Issuing Lender shall be entitled to rely, and shall not incur any liability for relying, upon the representations and warranties of the Borrower deemed made pursuant to Section 5.2.  Any such reimbursement shall not relieve or otherwise impair the obligation of the Borrower to reimburse the relevant Issuing Lender under any Letter of Credit, together with interest as hereinafter provided.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Reimbursement by Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of any drawing under any Letter of Credit, the relevant Issuing Lender will promptly notify the Borrower.  Unless the Borrower shall notify such Issuing Lender of its intent to otherwise reimburse such Issuing Lender and shall reimburse such Issuing Lender in same day funds in the currency of such drawing within one hour of receipt of notice of such drawing from such Issuing Lender, (i) if such drawing relates to a Letter of Credit denominated in an Alternative Currency, automatically and with no further action, the obligation of the Borrower to reimburse such drawing shall be permanently converted into an obligation to reimburse the Dollar Equivalent of such drawing, calculated using the Letter of Credit Exchange Rate applicable to such drawing and (ii) the Borrower shall be deemed to have requested a Revolving Loan borrowing in Dollars at the Base Rate in the amount of such drawing or Dollar Equivalent thereof, as the case may be, the proceeds of which will be used to satisfy the Borrower&#8217;s reimbursement obligations.  Pending the satisfaction of the Borrower&#8217;s reimbursement obligations through the making of Revolving Loans pursuant to Section 2.2(e)(i), the unreimbursed amount of such drawing or the Dollar Equivalent thereof, as the case may be, will bear interest, payable from time to time on demand or, if no demand has been made, on the date on which the Borrower reimburses the applicable Letter of Credit in full, at the rate applicable to Base Rate Loans, for the accounts of the relevant Issuing Lender and the Participants, as their interests may appear.  The Borrower&#8217;s reimbursement obligations hereunder shall be absolute, unconditional and irrevocable under all circumstances irrespective of (but without waiver of) (i) any rights of set-off, counterclaim or defense to payment the applicable account party or the Borrower may claim or have against any Issuing Lender, the Administrative Agent, the Lenders, the beneficiary of the Letter of Credit drawn upon or any other Person, including without limitation, any defense based on any failure of the applicable account party or the Borrower to receive consideration, (ii) the legality, validity, regularity or unenforceability of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any Letter of Credit, this Credit Agreement or any other Credit Document, (iii) any draft or other document presented under a Letter of Credit proving to be forged, fraudulent or invalid in any respect or any statement therein being untrue or inaccurate in any respect, or (iv) any force majeure or other event that under any rule of law or uniform practices to which any Letter of Credit is subject permits a drawing to be made under such Letter of Credit after the stated expiration date thereof or of the Commitments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Reimbursement by Lenders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Reimbursement with Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  On any day on which the Borrower shall have requested, or been deemed to have requested, a Revolving Loan borrowing to reimburse a drawing under a Letter of Credit (as set forth in clause (d) above), the Administrative Agent shall give notice to the Lenders, and a Revolving Loan borrowing in the amount of the Borrower&#8217;s reimbursement obligation comprised solely of Base Rate Loans (each such borrowing, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall be made from all Revolving Lenders (without giving effect to any termination of the Commitments pursuant to Section&#160;9.2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> based on each Revolving Lender&#8217;s respective Revolving Loan Commitment Percentage and the proceeds thereof shall be paid directly to the relevant Issuing Lender for application to the respective LOC Obligations.  Each applicable Lender hereby irrevocably agrees to make such Revolving Loans upon any such request or deemed request on account of each such Mandatory Borrowing in the amount and in the manner specified in the preceding sentence and in accordance with the terms of Section&#160;2.2(e)(iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">notwithstanding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (A) the amount of Mandatory Borrowing may not comply with the minimum amount for borrowings of Revolving Loans otherwise required hereunder, (B) whether any conditions specified in Section 5.2 are then satisfied or waived, (C) whether a Default or Event of Default then exists, (D) failure of any such request or deemed request for Revolving Loans to be made by the time otherwise required hereunder, (E) the date of such Mandatory Borrowing, (F) any reduction in the Revolving Committed Amount or any termination of the Commitments, or (G) any set-off, counterclaim, recoupment, defense or other right which such Lender may have against any Issuing Lender, the Borrower or any other Person for any reason whatsoever.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt;text-decoration:underline">Reimbursement Through Funding of Participation Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event that any Mandatory Borrowing cannot for any reason be made on the date otherwise required above (including, without limitation, as a result of the commencement of a proceeding under the Bankruptcy Code with respect to the Borrower), the relevant Issuing Lender will promptly notify the Participants of the Dollar amount of any unreimbursed drawing (determined as provided above and adjusted for any payments received from the Borrower on or after the date of such drawing and prior to the funding of the Participation Interests therein) and each Participant shall fund its Participation Interest in such unreimbursed drawing by paying to the relevant Issuing Lender, in Dollars and in immediately available funds, the amount of such Participant&#8217;s Revolving Loan Commitment Percentage of such unreimbursed drawing.  Each Participant&#8217;s obligation to make such payment to such Issuing Lender, and the right of such Issuing Lender to receive the same, shall be absolute and unconditional, shall not be affected by any circumstance whatsoever and without regard to (A) the termination of this Credit Agreement or the Commitments hereunder, (B) the existence of a Default or Event of Default, (C) the acceleration of the obligations hereunder and (D) any set-off, counterclaim, recoupment, defense or other right which such Participant may have against such Issuing Lender, the Borrower or any other Person for any reason whatsoever.  Simultaneously with the making of each such payment by a Participant to any Issuing Lender, such Participant shall, automatically and without any further action on the part of the relevant Issuing Lender or such Participant, acquire a participation in an amount equal to such payment (excluding the portion of such payment constituting interest owing to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">48</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">such Issuing Lender) in the related unreimbursed LOC Obligation and in the interest thereon and in the related LOC Documents, and shall have a claim against the Borrower with respect thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Funding of Mandatory Borrowing or Participation Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Revolving Lender and each Participant shall upon any notice pursuant to Section&#160;2.2(e)(i) or Section&#160;2.2(e)(ii), respectively, make its Revolving Loan Commitment Percentage of the unreimbursed drawing or Dollar Equivalent thereof, as the case may be, available to the Administrative Agent, for the benefit of the relevant Issuing Lender, by 1&#58;00 p.m., Local Time, on the day of the notice if notice is given on or before 11&#58;00 a.m. or by 1&#58;00 p.m., Local Time, the next Business Day if notice is given after 11&#58;00 a.m., in Dollars in immediately available funds at the Agency Services Address.  The Administrative Agent shall remit the funds so received to such Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Modification and Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The issuance of any supplement, modification, amendment, renewal, or extensions to any Letter of Credit shall, for purposes hereof, be treated in all respects the same as the issuance of a new Letter of Credit hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Applicability of ISP98</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Unless otherwise expressly agreed by the relevant Issuing Lender and the Borrower when a Letter of Credit is issued, the rules of the &#8220;International Standby Practices 1998&#8221; published by the Institute of International Banking Law &#38; Practice (or such later version thereof as may be in effect at the time of issuance) shall apply to each Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Responsibility of Issuing Lenders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">It is expressly understood and agreed as between the Lenders that the obligations of each Issuing Lender hereunder to the Participants are only those expressly set forth in this Credit Agreement and that each Issuing Lender shall be entitled to assume that the conditions precedent set forth in Section 5.2 have been satisfied unless it shall have acquired actual knowledge that any such condition precedent has not been satisfied&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that nothing set forth in this Section&#160;2.2 shall be deemed to prejudice the right of any Participant to recover from any Issuing Lender any amounts made available by such Participant to such Issuing Lender pursuant to this Section&#160;2.2 in the event that it is determined by a court of competent jurisdiction by a final and non-appealable judgment that the payment with respect to a Letter of Credit constituted gross negligence or willful misconduct on the part of such Issuing Lender.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">49</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">No Issuing Lender shall be under any obligation to issue any Letter of Credit if (a)&#160;any order, judgment or decree of any Governmental Authority or arbitrator shall by its terms purport to enjoin or restrain such Issuing Lender from issuing such Letter of Credit, (b)&#160;any Requirement of Law applicable to such Issuing Lender or any request or directive (whether or not having the force of law) from any Governmental Authority with jurisdiction over such Issuing Lender shall prohibit, or request that such Issuing Lender refrain from, the issuance of letters of credit generally or such Letter of Credit in particular or shall impose upon such Issuing Lender with respect to such Letter of Credit any restriction, reserve or capital requirement (for which such Issuing Lender is not otherwise compensated hereunder) not in effect on the Restatement Effective Date, or shall impose upon any Issuing Lender any unreimbursed loss, cost or expense which was not applicable on the Restatement Effective Date and which such Issuing Lender in good faith deems material to it, or (c)&#160;the issuance of such Letter of Credit would violate one or more policies of such Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Conflict with LOC Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of any conflict between this Credit Agreement and any LOC Document, this Credit Agreement shall govern.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Indemnification of Issuing Lenders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">In addition to its other obligations under this Credit Agreement, the Borrower hereby agrees to protect, indemnify, pay and hold harmless each Issuing Lender from and against any and all claims, demands, liabilities, damages, losses, costs, charges and expenses (including Attorney Costs) that any Issuing Lender may incur or be subject to as a consequence, direct or indirect, of (A) the issuance of any Letter of Credit or (B) the failure of any Issuing Lender to honor a drawing under a Letter of Credit as a result of any act or omission, whether rightful or wrongful, of any present or future de jure or de facto Governmental Authority (all such acts or omissions, herein called &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Government Acts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">As between the Borrower and each Issuing Lender, the Borrower shall assume all risks of the acts, omissions or misuse of any Letter of Credit by the beneficiary thereof.  No Issuing Lender shall be responsible for (except in the case of (A), (B) and (C) below if such Issuing Lender has actual knowledge to the contrary)&#58;  (A)&#160;the form, validity, sufficiency, accuracy, genuineness or legal effect of any document submitted by any party in connection with the application for and issuance of any Letter of Credit, even if it should in fact prove to be in any or all respects invalid, insufficient, inaccurate, fraudulent or forged&#59; (B)&#160;the validity or sufficiency of any instrument transferring or assigning or purporting to transfer or assign any Letter of Credit or the rights or benefits thereunder or proceeds thereof, in whole or in part, that may prove to be invalid or ineffective for any reason&#59; (C)&#160;failure of the beneficiary of a Letter of Credit to comply fully with conditions required in order to draw upon a Letter of Credit&#59; (D)&#160;errors, omissions, interruptions or delays in transmission or delivery of any messages, by mail, cable, telegraph, telex or otherwise, whether or not they be in cipher&#59; (E)&#160;any loss or delay in the transmission or otherwise of any document required in order to make a drawing under a Letter of Credit or of the proceeds thereof and (F)&#160;any consequences arising from causes beyond the control of such Issuing Lender, including, without limitation, any Government Acts.  None of the above shall affect, impair, or prevent the vesting of any Issuing Lender&#8217;s rights or powers hereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">50</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">In furtherance and extension and not in limitation of the specific provisions hereinabove set forth, any action taken or omitted by any Issuing Lender, under or in connection with any Letter of Credit or the related certificates, if taken or omitted in good faith, shall not put such Issuing Lender under any resulting liability to the Borrower.  It is the intention of the parties that this Credit Agreement shall be construed and applied to protect and indemnify each Issuing Lender against any and all risks involved in the issuance of the Letters of Credit, all of which risks are hereby assumed by the Borrower, including, without limitation, any and all risks of the acts or omissions, whether rightful or wrongful, of any present or future Government Acts.  No Issuing Lender shall, in any way, be liable for any failure by any Issuing Lender or anyone else to pay any drawing under any Letter of Credit as a result of any Government Acts or any other cause beyond the control of such Issuing Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">None of the Administrative Agent, the Lenders or the Issuing Lenders, or any of their Related Parties, shall have any liability or responsibility by reason of or in connection with the issuance or transfer of any Letter of Credit or any payment or failure to make any payment thereunder (irrespective of any of the circumstances referred to in the preceding sentence), or any error, omission, interruption, loss or delay in transmission or delivery of any draft, notice or other communication under or relating to any Letter of Credit (including any document required to make a drawing thereunder), any error in interpretation of technical terms or any consequence arising from causes beyond the control of any Issuing Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the foregoing shall not be construed to excuse any Issuing Lender from liability to the Borrower to the extent of any direct damages (as opposed to special, indirect, consequential or punitive damages, claims in respect of which are hereby waived by the Borrower to the extent permitted by applicable law) suffered by the Borrower that are caused by such Issuing Lender&#8217;s failure to exercise care when determining whether drafts and other documents presented under a Letter of Credit comply with the terms thereof.&#160; The parties hereto expressly agree that, in the absence of gross negligence or willful misconduct on the part of any Issuing Lender (as finally determined by a court of competent jurisdiction), such Issuing Lender shall be deemed to have exercised care in each such determination.&#160; In furtherance of the foregoing and without limiting the generality thereof, the parties agree that, with respect to documents presented which appear on their face to be in substantial compliance with the terms of a Letter of Credit, the relevant Issuing Lender may, in its sole discretion, either accept and make payment upon such documents without responsibility for further investigation, regardless of any notice or information to the contrary, or refuse to accept and make payment upon such documents if such documents are not in strict compliance with the terms of such Letter of Credit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Nothing in this subsection (j) is intended to limit the reimbursement obligation of the Borrower contained in this Section&#160;2.2.  The obligations of the Borrower under this subsection (j) shall survive the termination of this Credit Agreement.  No act or omission of any current or prior beneficiary of a Letter of Credit shall in any way affect or impair the rights of any Issuing Lender to enforce any right, power or benefit under this Credit Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">Notwithstanding anything to the contrary contained in this subsection&#160;(j), the Borrower shall have no obligation to indemnify any Issuing Lender in respect of any liability incurred by such Issuing Lender arising out of the gross negligence, willful misconduct or bad faith of such Issuing Lender, as determined by a court of competent jurisdiction by a final and non-appealable judgment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Designation of other Persons as Account Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary set forth in this Credit Agreement, including without limitation Section&#160;2.2(a) hereof, a Letter of Credit issued hereunder may contain a statement to the effect that such Letter of Credit is issued for the account of a Subsidiary of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that notwithstanding such statement, the Borrower shall be the actual account party for all purposes of this Credit Agreement for such Letter of Credit and such statement shall not affect the Borrower&#8217;s reimbursement obligations hereunder with respect to such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Designation of Additional Issuing Lenders.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  From time to time, the Borrower may by notice to the Administrative Agent and the Lenders designate as additional Issuing Lenders one or more Lenders that agree to serve in such capacity as provided below.  The acceptance by a Lender of any appointment as an Issuing Lender hereunder shall be evidenced by an agreement (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which shall be in a form satisfactory to the Borrower and the Administrative Agent, shall set forth the LOC Commitment of such Lender and shall be executed by such Lender, the Borrower and the Administrative Agent and, from and after the effective date of such agreement, (i)&#160;such Lender shall have all the rights and obligations of an Issuing Lender under this Credit Agreement and the other Credit Documents and (ii) references herein and in the other Credit Documents to the term &#8220;Issuing Lender&#8221; shall be deemed to include such Lender in its capacity as an Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt;text-decoration:underline">Termination of an Issuing Lender.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  An Issuing Lender may be terminated as Issuing Lender by written agreement among the Borrower, the Administrative Agent and such Issuing Lender.  The Administrative Agent shall notify the Lenders of any such termination of an Issuing Lender.  At the time any such termination shall become effective, the Borrower shall pay all unpaid fees accrued for the account of the terminated Issuing Lender pursuant to Section 3.4(b).  After the termination of an Issuing Lender hereunder, the terminated Issuing Lender shall remain a party hereto and shall continue to have all the rights and obligations of an Issuing Lender under this Credit Agreement and the other Credit Documents with respect to Letters of Credit issued by it prior to such termination, but shall not be required to amend, renew (other than automatic renewal pursuant to the terms of such Letter of Credit) or extend any such Letter of Credit or to issue additional Letters of Credit.  The termination of any Issuing Lender shall not affect the LOC Commitment of any other Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Existing Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As of the Restatement Effective Date, without further action on the part of any Person, each Existing Letter of Credit shall be automatically deemed to be a Letter of Credit issued hereunder for all purposes of this Credit Agreement, and the original issuing lender of each such Letter of Credit shall be the Issuing Lender thereof for all purposes hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Swing Line Loans Subfacility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrative Agent, the Swing Line Lender and the Lenders agree that in order to facilitate the administration of this Credit Agreement and the other Credit Documents, the Swing Line Lender may (but shall have absolutely no obligation to) make loans (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to the Borrower, in Dollars, at any time and from time to time, during the period from and including the Restatement Effective Date to but not including the Revolving Maturity Date (or such earlier date on which the Commitments have been terminated as provided herein) on the terms and subject to the conditions set forth herein and in the other Credit Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, after giving effect to the issuance of any such Swing Line Loan, (i)&#160;the aggregate principal amount of the Swing Line Loans outstanding at any one time shall not exceed $50,000,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Subfacility Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) at any time and (ii)&#160;the sum of (A) the aggregate amount of Swing Line Loans outstanding, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (B) the aggregate amount of the Dollar Equivalent of Revolving Loans outstanding, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (C) the aggregate amount of the Dollar Equivalent of LOC Obligations outstanding shall not exceed the Revolving Committed Amount.  Subject to the terms of this Credit Agreement, the Borrower may borrow, repay and reborrow Swing Line Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Method of Borrowing and Funding Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By no later than 1&#58;00&#160;p.m., Local Time, on the date of the requested borrowing of Swing Line Loans, the Borrower shall provide telephone notice to the Swing Line Lender, followed promptly by a written Swing Line Loan Request in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (which may be submitted by fax), setting forth (i)&#160;the amount of the requested Swing Line Loan and (ii)&#160;the date of the requested Swing Line Loan and complying in all respects with Section&#160;5.2.  If the Swing Line Lender elects to make such Swing Line Loans, the Swing Line Lender shall initiate the transfer of funds representing the Swing Line Loan advance to the Borrower by 3&#58;00 p.m., Local Time, on the Business Day of the requested borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Repayment and Participations of Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower agrees to repay each Swing Line Loan immediately upon the existence of a Default or Event of Default or otherwise on the earlier of the Revolving Maturity Date and the first date after such Swing Line Loan is made that is the 15th or last day of a calendar month and is at least three Business Days after such Swing Line Loan is made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that on each date that a borrowing of Revolving Loans denominated in Dollars is made, the Borrower shall repay all Swing Line Loans that were outstanding on the date such borrowing was requested.  Each repayment of a Swing Line Loan may be accomplished by requesting Revolving Loans which request is not subject to the conditions set forth in Section&#160;5.2.  In the event that the Borrower shall fail to timely repay any Swing Line Loan, and in any event upon (i)&#160;a request by the Swing Line Lender, (ii)&#160;the occurrence of an Event of Default described in Section&#160;9.1(f) or (iii)&#160;the acceleration of any Loan or termination of any Commitment pursuant to Section&#160;9.2, each Revolving Lender shall promptly irrevocably and unconditionally purchase from the Swing Line Lender, without recourse or warranty, an undivided interest and participation in such Swing Line Loan in an amount equal to such other Lender&#8217;s Revolving Loan Commitment Percentage thereof, by directly purchasing a participation in such Swing Line Loan in such amount (regardless of whether the conditions precedent thereto set forth in Section&#160;5.2 are then satisfied, whether or not the Borrower has submitted a Notice of Borrowing and whether or not the Commitments are then in effect, any Event of Default exists or all the Loans have been accelerated) and paying the proceeds thereof to the Swing Line Lender at the Agency Services Address, or at such other address as the Swing Line Lender may designate, in Dollars and in immediately available funds.  If such Participant does not pay such amount forthwith upon the Swing Line Lender&#8217;s demand therefor, and until such time as such Participant makes the required payment, the Swing Line Lender shall be deemed to continue to have outstanding Swing Line Loans in the amount of such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">unpaid participation obligation for all purposes of the Credit Documents other than those provisions requiring the other Participants to purchase a participation therein.  Further, such Participant shall be deemed to have assigned any and all payments made of principal and interest on its Loans, and any other amounts due to it hereunder to the Swing Line Lender to fund Swing Line Loans in the amount of the participation in Swing Line Loans that such Participant failed to purchase pursuant to this Section&#160;2.3(c) until such amount has been purchased (as a result of such assignment or otherwise).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Swing Line Loan Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Swing Line Loans made by the Swing Line Lender shall, if requested by the Swing Line Lender, be evidenced by a duly executed promissory note of the Borrower to the Swing Line Lender in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Continuations and Conversions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subject to the terms below, the Borrower shall have the option, on any Business Day, to continue existing Term Benchmark Loans for a subsequent Interest Period, to convert Base Rate Loans into Term Benchmark Loans denominated in Dollars or to convert Term Benchmark Loans denominated in Dollars into Base Rate Loans.  By no later than 11&#58;00 a.m., Local Time, (a)&#160;on the date of the requested conversion of a Term Benchmark Loan denominated in Dollars to a Base Rate Loan or (b)&#160;three Business Days prior to the date of the requested continuation of a Term Benchmark Loan denominated in Dollars or conversion of a Base Rate Loan to a Term Benchmark Loan denominated in Dollars or (c) three Business Days prior to the date of the requested continuation of a Term Benchmark Loan denominated in Euros, the Borrower shall provide a written Notice of Continuation&#47;Conversion, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, submitted by hand delivery, fax or email, to the Administrative Agent (or, in the case of a continuation or conversion of Loans denominated in Dollars to Loans denominated in Dollars, telephonic notice, confirmed promptly by hand delivery, fax or email to the Administrative Agent of a written Notice of Continuation&#47;Conversion, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) setting forth (i)&#160;whether the Borrower wishes to continue or convert such Loans and (ii)&#160;if the request is to continue a Term Benchmark Loan or convert a Base Rate Loan to a Term Benchmark Loan, the Interest Period applicable thereto.  Notwithstanding anything herein to the contrary, (A)&#160;except as provided in Section 3.11, Term Benchmark Loans may only be continued or converted into Base Rate Loans on the last day of the Interest Period applicable thereto, (B)&#160;Term Benchmark Loans may not be continued nor may Base Rate Loans be converted into Term Benchmark Loans during the existence and continuation of an Event of Default, (C)&#160;any request to continue a Term Benchmark Loan that fails to comply with the terms hereof or any failure to request a continuation of a Term Benchmark Loan at the end of an Interest Period shall constitute a conversion to a Base Rate Loan on the last day of the applicable Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in the case of a failure to timely request a continuation of Term Benchmark Loans denominated in an Alternative Currency or if any such request fails to comply with the terms hereof, such Loans shall be continued as Term Benchmark Loans in their original currency with an Interest Period of one month, and (D)&#160;any failure to state the Interest Period with respect to the continuation of a Term Benchmark Loan or the conversion of a Base Rate Loan to a Term Benchmark Loan shall constitute a request for a one month Interest Period.  No Revolving Loans may be converted into or continued as Revolving Loans denominated in a different currency, but instead must be prepaid in the original currency of such Revolving Loans and reborrowed in the other currency. It is understood and agreed that Swing Line Loans may not be continued or converted.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Minimum Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each request for a borrowing, conversion or continuation shall be subject to the requirements that (a)&#160;each Term Benchmark Loan and RFR Loan shall be in an aggregate amount that is an integral multiple of the Borrowing Multiple and not less than the Borrowing Minimum, (b)&#160;each Base Rate Loan shall be in a minimum amount of the lesser of $5,000,000 (and in integral multiples of $1,000,000 in excess thereof) or the remaining available Revolving Committed Amount, (c)&#160;each Swing Line Loan shall be in a minimum amount of the lesser of $1,000,000 (and in integral multiples of $100,000 in excess thereof) or the remaining available Swing Line Subfacility Amount and (d)&#160;no more than 10 Term Benchmark Loans and RFR Loans shall be outstanding hereunder at any one time.  For the purposes of this Section&#160;2.5, all Term Benchmark Loans denominated in the same currency with the same Interest Periods that begin and end on the same date shall be considered as one Term Benchmark Loan, but Term Benchmark Loans with different Interest Periods, even if they begin on the same date, shall be considered as separate Term Benchmark Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Defaulting Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any provision of this Credit Agreement to the contrary, if any Revolving Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Revolving Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Facility Fees shall cease to accrue on the Revolving Commitment of such Defaulting Lender pursuant to Section 3.4(a)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Revolving Commitment and Revolving Exposure of such Defaulting Lender shall not be included in determining whether the Required Lenders or any other requisite Lenders have taken or may take any action hereunder or under any other Credit Document (including any consent to any amendment, waiver or other modification pursuant to Section 11.6)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that any amendment, waiver or other modification requiring the consent of all Lenders or all Lenders affected thereby shall, except as otherwise provided in Section 11.6, require the consent of such Defaulting Lender in accordance with the terms hereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">if any Swing Line Exposure or LOC Obligation exists at the time such Revolving Lender becomes a Defaulting Lender then&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">the Swing Line Exposure and LOC Obligations of such Defaulting Lender shall be reallocated among the Non-Defaulting Lenders in accordance with their respective Revolving Loan Commitment Percentages but only to the extent that the sum of all Non-Defaulting Lenders&#8217; Revolving Exposures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> such Defaulting Lender&#8217;s Swing Line Exposure and LOC Obligations does not exceed the sum of all Non-Defaulting Lenders&#8217; Revolving Commitments&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">if the reallocation described in clause (i) above cannot, or can only partially, be effected, the Borrower shall, within one Business Day following notice by the Administrative Agent (A) first, prepay the portion of such Defaulting Lender&#8217;s Swing Line Exposure that has not been reallocated and (B)&#160;second, cash collateralize for the benefit of the Issuing Lenders the portion of such Defaulting Lender&#8217;s LOC Obligations that has not been reallocated for so long as such LOC Obligations are outstanding by depositing cash in such amount in an account with the Administrative Agent, in the name of the Administrative Agent and for the benefit of the Lenders&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">if the Borrower cash collateralizes any portion of such Defaulting Lender&#8217;s LOC Obligations pursuant to clause (ii) above, the Borrower shall not be required to pay Letter of Credit Fees to such Defaulting Lender pursuant to Section&#160;3.4(b) with respect to such portion of such Defaulting Lender&#8217;s LOC Obligations for so long as such Defaulting Lender&#8217;s LOC Obligations are cash collateralized&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">if any portion of the LOC Obligations of such Defaulting Lender is reallocated pursuant to clause (i) above, then the fees payable to the Lenders pursuant to Sections 3.4(a) and 3.4(b) shall be adjusted to give effect to such reallocation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">if such Defaulting Lender&#8217;s LOC Obligations or Swing Line Exposure or any portion thereof are not repaid or reallocated or cash collateralized pursuant to clause (i) or (ii) above, then, without prejudice to any rights or remedies of any Issuing Lender or any other Lender hereunder, all Facility Fees that otherwise would have been payable to such Defaulting Lender (solely with respect to the portion of such Defaulting Lender&#8217;s Commitment utilized by such LOC Obligations and Swing Line Exposure) and Letter of Credit Fees payable under Section 3.4(b) with respect to such Defaulting Lender&#8217;s LOC Obligations shall be payable to the relevant Issuing Lender and the Swing Line Lender, as its interests may appear, until and to the extent that such LOC Obligation and Swing Line Exposure is reallocated and&#47;or cash collateralized or repaid.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event that (x) any event described in Section 9.1(f) with respect to a Revolving Lender Parent shall have occurred following the Restatement Effective Date and for so long as such Event of Default under Section 9.1(f) shall continue or (y) any Issuing Lender has a good faith belief that any Revolving Lender has defaulted in fulfilling its obligations under one or more other agreements in which such Lender commits to extend credit, no Issuing Lender shall be required to issue, amend, renew or extend any Letter of Credit unless such Issuing Lender shall have entered into arrangements with the Borrower or such Revolving Lender satisfactory to such Issuing Lender to defease any risk to it in respect of such Lender hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event that the Administrative Agent, the Borrower, the Swing Line Lender and the Issuing Lenders agree that a Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then (i)&#160;the Swing Line Exposure and LOC Obligation of the Revolving Lenders shall be readjusted to reflect the inclusion of such Lender&#8217;s Revolving Commitment, (ii)&#160;on such date such Lender shall purchase at par such of the Revolving Loans of the other Revolving Lenders (other than Swing Line Loans) as the Administrative Agent shall determine may be necessary in order for such Revolving Lender to hold such Loans in accordance with its Revolving Loan Commitment Percentage and (iii)&#160;any and all cash collateral provided by the Borrower in respect of such Defaulting Lender&#8217;s Swing Line Exposure or LOC </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Obligations in accordance with Section&#160;2.6(c)(ii) above shall be immediately released to the Borrower and the Administrative Agent and the Lenders shall promptly execute such documents as may be necessary to give effect to such release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Incremental Facilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Borrower may on one or more occasions, by written notice to the Administrative Agent and with the consent of the Administrative Agent and the Incremental Lenders, request (i)&#160;during the period from and including the Restatement Effective Date to but not including the Revolving Maturity Date (or any earlier date on which the Commitments have been terminated as provided herein), the establishment of Incremental Revolving Commitments and&#47;or (ii) the establishment of Incremental Term Commitments, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the aggregate principal amount of all the Incremental Commitments established hereunder shall not exceed $500,000,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Committed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Each such notice shall specify (A) the date on which the Borrower proposes that the Incremental Revolving Commitments or the Incremental Term Commitments, as applicable, shall be effective, which shall be a date not less than 10 Business Days (or such shorter period as may be agreed to by the Administrative Agent) after the date on which such notice is delivered to the Administrative Agent and (B) the amount of the Incremental Revolving Commitments or Incremental Term Commitments, as applicable, being requested (it being agreed that (x) any Lender approached to provide any Incremental Revolving Commitment or Incremental Term Commitment may elect or decline, in its sole discretion, to provide such Incremental Revolving Commitment or Incremental Term Commitment and (y) any Person that the Borrower proposes to become an Incremental Lender, if such Person is not then a Lender, must be an Eligible Assignee).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The terms and conditions of any Incremental Revolving Commitment and loans and other extensions of credit to be made thereunder shall be identical to those of the Revolving Commitments and Loans and other extensions of credit made hereunder, and shall be treated as a single class with such Revolving Commitments and Loans.  The terms and conditions of any Incremental Term Commitments and the Incremental Term Loans to be made thereunder shall be as set forth in the applicable Incremental Facility Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i)&#160;no Incremental Term Maturity Date shall be earlier than, and no Incremental Term Loans shall require any repayment or prepayment of any principal amount thereof (other than amortization payments not in excess of 1% per annum of the initial principal amount of such Incremental Term Loans) prior to, the Revolving Maturity Date, (ii)&#160;Incremental Term Loans shall not have the benefit of any guarantees or collateral that do not equally benefit the Revolving Commitments and Loans and (iii)&#160;Incremental Term Loans shall not have the benefit of any representation or warranty, covenant or event of default other than those set forth herein.  Any Incremental Term Commitments established pursuant to an Incremental Facility Agreement that have identical terms and conditions, and any Incremental Term Loans made thereunder, shall be designated as a separate series (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Series</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of Incremental Term Commitments and Incremental Term Loans for all purposes of this Credit Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Incremental Commitments shall be effected pursuant to one or more Incremental Facility Agreements executed and delivered by the Borrower, each Incremental Lender providing such Incremental Commitments and the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no Incremental Commitments shall become effective unless (i) no Default or Event of Default shall have occurred and be continuing on the date of effectiveness thereof, both immediately prior to and immediately after giving effect to such Incremental Commitments and the making of Loans and issuance of Letters of Credit thereunder on such date, (ii) on the date of effectiveness thereof, the representations and warranties of the Borrower set forth in the Credit Documents shall be true and correct (A) in the case of the representations and warranties qualified as to materiality, in all respects and (B) otherwise, in all material respects, in each case on and as of such date, except in the case of any such representation and warranty that expressly relates to a prior date, in which case such representation and warranty shall be so true and correct on and as of such prior date, (iii) after giving effect to such Incremental Commitments and the making of Loans and other extensions of credit thereunder on the date of effectiveness thereof, the Borrower shall be in pro forma compliance with the financial covenant set forth in Section 7.2, (iv) the Borrower shall make any payments required to be made pursuant to Section 3.14 in connection with such Incremental Commitments and the related transactions under this Section and (v) the Borrower shall have delivered to the Administrative Agent such legal opinions, board resolutions, secretary&#8217;s certificates, officer&#8217;s certificates and other documents as shall reasonably be requested by the Administrative Agent in connection with any such transaction.  Each Incremental Facility Agreement may, without the consent of any Lender, effect such amendments to this Credit Agreement and the other Credit Documents as may be necessary or appropriate, in the opinion of the Administrative Agent, to give effect to the provisions of this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Upon the effectiveness of an Incremental Commitment of any Incremental Lender, (i) such Incremental Lender shall be deemed to be a &#8220;Lender&#8221; (and a Lender in respect of Commitments and Loans of the applicable class) hereunder, and henceforth shall be entitled to all the rights of, and benefits accruing to, Lenders (or Lenders in respect of Commitments and Loans of the applicable class) hereunder and shall be bound by all agreements, acknowledgements and other obligations of Lenders (or Lenders in respect of Commitments and Loans of the applicable class) hereunder and under the other Credit Documents, and (ii) in the case of any Incremental Revolving Commitment, (A) in the case of an Incremental Lender that does not already have a Revolving Commitment, such Incremental Revolving Commitment shall constitute the Revolving Commitment of such Incremental Lender and (B) in the case of an Incremental Lender that already has a Revolving Commitment, the Revolving Commitment of such Incremental Lender shall be increased by the amount of such Incremental Revolving Commitment, in each case, subject to further increase or reduction from time to time as set forth in the definition of the term &#8220;Revolving Commitment&#8221;.  For the avoidance of doubt, upon the effectiveness of any Incremental Revolving Commitment, the Revolving Exposure of the Incremental Revolving Lender holding such Incremental Revolving Commitment, and the Revolving Loan Commitment Percentages of all the Revolving Lenders, shall automatically be adjusted to give effect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">On the date of effectiveness of any Incremental Revolving Commitments, each Revolving Lender shall assign to each Incremental Revolving Lender holding such Incremental Revolving Commitment, and each such Incremental Revolving Lender shall purchase from each Revolving Lender, at the principal amount thereof (together with accrued interest), such interests in the Revolving Loans and participations in Letters of Credit and Swing Line Loans outstanding on such date as shall be necessary in order that, after giving effect to all such assignments and purchases, such Revolving Loans and participations in Letters of Credit and Swing Line Loans will be held by all the Revolving Lenders (including such Incremental Revolving Lenders) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">58</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ratably in accordance with their Revolving Loan Commitment Percentages after giving effect to the effectiveness of such Incremental Revolving Commitment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Subject to the terms and conditions set forth herein and in the applicable Incremental Facility Agreement, each Incremental Term Lender holding an Incremental Term Commitment of any Series shall make a loan to the Borrower in an amount equal to such Incremental Term Commitment on the date specified in such Incremental Facility Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Administrative Agent shall notify the Lenders promptly upon receipt by the Administrative Agent of any notice from the Borrower referred to in this Section and of the effectiveness of any Incremental Commitments, in each case advising the Lenders of the details thereof and, in the case of effectiveness of any Incremental Revolving Commitments, of the Revolving Loan Commitment Percentages of the Revolving Lenders after giving effect thereto and of the assignments required to be made pursuant to Section&#160;2.7(e).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Extension of Revolving Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Not earlier than 12 months after the Restatement Effective Date, nor later than 30&#160;days prior to the Revolving Maturity Date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Borrower may not exercise such right more than twice), the Borrower may, upon notice to the Administrative Agent (which shall promptly notify the Lenders), request a one-year extension of the Revolving Maturity Date then in effect (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the Revolving Maturity Date may not be extended more than once in any 12-month period.  Within 10 Business Days after the delivery of such Extension Request, each Lender shall notify the Administrative Agent and the Borrower whether or not it consents to such Extension Request (which consent may be given or withheld in such Lender&#8217;s sole and absolute discretion) (each Lender agreeing to a requested extension being called an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extending Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and each Lender declining to agree to a requested extension being called a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Extending Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Any Lender with a then effective Commitment may consent to an Extension Request irrespective of whether such Lender previously had not been an Extending Lender with respect to a previous Extension Request.  Any Lender not responding within the above specified time period shall be deemed not to have consented to such Extension Request.  The Administrative Agent shall promptly notify the Borrower and the Lenders of the Lenders&#8217; responses.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Revolving Maturity Date shall be extended only if the Required Lenders (calculated excluding any Defaulting Lender and prior to giving effect to any replacements of Lenders permitted herein) have consented to the Extension Request.  For each such Extension Request, if so approved, (i) the Revolving Maturity Date, as to Extending Lenders (irrespective of whether such Lender previously had been a Non-Extending Lender), shall be extended to the same date in the following year after giving effect to any prior extensions (such existing Revolving Maturity Date being the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (ii) the Revolving Maturity Date, as to any Non-Extending Lender, shall remain the Revolving Maturity Date in effect for such Non-Extending Lender prior to the Extension Effective Date.  With respect to any previously Non-Extending Lender who is an Extending Lender with respect to a current Extension Request, by giving its consent, such Extending Lender shall be approving an extension of more than one year.  Non-Extending Lenders shall remain Lenders until the Revolving Maturity Date applicable to such Lenders, at which time their Commitments shall terminate and the Borrower shall repay all Loans owing to such Lenders, together with any accrued interest thereon and any accrued fees and other amounts payable to or for the account of such Non-Extending Lenders hereunder, and shall make such other prepayments of the Loans as shall be required in order that, after giving effect to the termination of the Commitments of, and all payments to, Non-Extending Lenders pursuant to this Section, (i)&#160;no Lender&#8217;s Credit Exposure shall exceed such Lender&#8217;s Commitment and (ii)&#160;the Credit Exposures shall not exceed the total Commitments.  The Administrative Agent and the Borrower shall promptly confirm to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Lenders such extension of the Revolving Maturity Date, specifying the date of such confirmation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Confirmation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Extension Effective Date, and the extended Revolving Maturity Date with respect to the Extending Lenders.  As condition precedents to such extension, the Borrower shall deliver to the Administrative Agent (i) such evidence of authorization, reaffirmations and legal opinions as the Administrative Agent may reasonably request and (ii) a certificate of the Borrower dated as of the Extension Confirmation Date signed by an Authorized Officer of the Borrower certifying that before and after giving effect to such extension, the representations and warranties contained in Section 6 made by it are true and correct (A) in the case of the representations and warranties qualified as to materiality, in all respects and (B) otherwise, in all material respects, in each case on and as of the Extension Confirmation Date, except in the case of any such representation and warranty that expressly relates to a prior date, in which case such representation and warranty shall be so true and correct on and as of such earlier date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding anything to the contrary in this Section 2.8,&#160;the Revolving Maturity Date may not be extended with respect to any Issuing Lender without the prior written consent of such Issuing Lender (it being understood and agreed that, in the event any Issuing Lender shall not have consented to any such extension, (i) such Issuing Lender shall continue to have all the rights and obligations of an Issuing Lender hereunder through the applicable existing Revolving Maturity Date and thereafter shall have no obligation to issue, amend, extend or renew any Letter of Credit (but shall continue to be entitled to the benefits hereunder as to Letters of Credit issued prior to such time) and (ii) the Borrower shall cause the LOC Obligations attributable to Letters of Credit issued by such Issuing Lender to be zero no later than the day on which such LOC Obligations would have been required to have been reduced to zero in accordance with the terms hereof without giving effect to the effectiveness of the extension of the applicable existing Revolving Maturity Date pursuant to this Section 2.8 (and, in any event, no later than such existing Revolving Maturity Date) together with any accrued interest thereon, on the existing Revolving Maturity Date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In connection with any extension of the Revolving Maturity Date under this Section&#160;2.8, the Administrative Agent and the Borrower may, without the consent of any Lender or Issuing Lender, effect such amendments to this Credit Agreement and the other Credit Documents as may be necessary or appropriate, in the opinion of the Administrative Agent and the Borrower, to give effect to the provisions of this Section 2.8.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">60</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt"><br><br>GENERAL PROVISIONS APPLICABLE<br>TO LOANS AND LETTERS OF CREDIT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to Section 3.1(b), (i) each Base Rate Loan shall accrue interest at the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage, (ii) each Term Benchmark Loan denominated in Dollars shall accrue interest at the Adjusted LIBO Rate for the Interest Period in effect for such Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage, (iii) each Term Benchmark Loan denominated in Euros shall accrue interest at the Adjusted EURIBO Rate for the Interest Period in effect for such Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage, (iv) each RFR Loan shall accrue interest at the Adjusted Daily Simple SONIA Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage and (v) each Swing Line Loan shall accrue interest at the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Default Rate of Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the occurrence, and during the continuation, of an Event of Default pursuant to Section&#160;9.1(a), the principal of and, to the extent permitted by law, interest on the Loans and any other amounts owing hereunder or under the other Credit Documents (including without limitation fees and expenses) but not paid when due shall bear interest, payable on demand, at a per annum rate equal to (i) in the case of overdue principal of any Loan, 2% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the rate which would otherwise be applicable, or (ii) in the case of any other amount, the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2% per annum.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Interest Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as set forth in clause (b) above, interest on Loans shall be due and payable in arrears on each Interest Payment Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Place and Manner of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All payments to be made by the Borrower shall be made without condition or deduction for any counterclaim, defense, recoupment or setoff.  Except as otherwise expressly provided herein and except with respect to principal of and interest on Loans and drawings under Letters of Credit denominated in an Alternative Currency, all payments by the Borrower hereunder shall be made to the Administrative Agent, for the account of the respective Lenders or the relevant Issuing Lender, as applicable, to which such payment is owed, at the applicable Agency Services Address in Dollars and in Same Day Funds not later than 2&#58;00 p.m. on the date specified herein.  Except as otherwise expressly provided herein, all payments by the Borrower hereunder with respect to principal and interest on Loans or in respect of drawings under Letters of Credit denominated in an Alternative Currency shall be made to the Administrative Agent for the account of the respective Lenders (or for the account of the relevant Issuing Lender, as applicable) to which such payment is owed, at the applicable Agency Services Address in such Alternative Currency and in Same Day Funds not later than the Applicable Time specified by the Administrative Agent to the Borrower in writing on the dates specified herein. Without limiting the generality of the foregoing, the Administrative Agent may require that any payments due under this Credit Agreement be made in the United States.  If, for any reason, the Borrower is prohibited by any Law from making any required payment hereunder in an Alternative Currency, the Borrower shall make such payment in Dollars in the Dollar Equivalent of the Alternative Currency payment amount.  The Administrative Agent will promptly distribute to each Lender its pro rata share of such payment (based upon the applicable Commitments of the Lenders) in like funds as received by wire transfer to such Lender&#8217;s Lending Office.  All payments received by the Administrative Agent (i) after 2&#58;00 p.m. New York City time, in the case of payments in Dollars, or (ii) after the Applicable Time specified by the Administrative Agent in writing to the Borrower in the case of payments in an Alternative Currency, shall in each case be deemed received on the next succeeding Business Day and any applicable interest or fee shall continue to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">accrue.  If any payment to be made by the Borrower shall come due on a day other than a Business Day, payment shall be made on the next following Business Day, and such extension of time shall be reflected in computing interest or fees, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Voluntary Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall have the right to prepay Loans in whole or in part from time to time without premium or penalty&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Borrower shall notify the Administrative Agent (and, in the case of prepayment of Swing Line Loans, the Swing Line Lender) by telephone (confirmed by telecopy or electronic mail) of any prepayment hereunder (i)&#160;(A)&#160;in the case of prepayment of Term Benchmark Loans denominated in Dollars, not later than 3&#58;00 p.m., New&#160;York City time, three Business Days before the date of prepayment, (B)&#160;in the case of prepayment of Term Benchmark Loans denominated in Euros, not later than 3&#58;00 p.m., New&#160;York City time, three Business Days before the date of prepayment, (C)&#160;in the case of prepayment of RFR Loans, not later than four RFR Business Days before the date of prepayment and (D)&#160;in the case of prepayment of Base Rate Loans, not later than 11&#58;00&#160;a.m., New&#160;York City time, on the date of prepayment, and (ii)&#160;each such partial prepayment of Term Benchmark Loans, Base Rate Loans or Swing Line Loans shall be in an amount that would be permitted in the case of a borrowing of such Loans in the currency thereof as provided in Section&#160;2.5.  Amounts prepaid pursuant to this Section&#160;3.3(a) shall be applied as the Borrower may elect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, if the Borrower fails to specify, such prepayment will be applied in the manner set forth in Section&#160;3.3(c) below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Mandatory Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If at any time (i)&#160;the sum of the aggregate amount of the Dollar Equivalent of outstanding Revolving Loans </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the aggregate amount of the Dollar Equivalent of outstanding LOC Obligations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the aggregate amount of outstanding Swing Line Loans exceeds the Revolving Committed Amount, (ii)&#160;the aggregate amount of the Dollar Equivalent of outstanding LOC Obligations exceeds the LOC Committed Amount or (iii)&#160;the aggregate amount of the Dollar Equivalent of Revolving Loans and LOC Obligations in Alternative Currencies exceeds the Foreign Currency Sublimit, the Borrower shall immediately make a principal payment to the Administrative Agent (or with respect to LOC Obligations an amount to be held as cash collateral) in a manner and in an amount (and in the applicable currency) necessary to be in compliance with Sections&#160;2.1, 2.2 and 2.3, as applicable and as directed by the Administrative Agent (any such prepayment with respect to clause&#160;(i) above to be applied as set forth in Section&#160;3.3(c) below).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Application of Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All amounts paid pursuant to Section&#160;3.3(b)(i) and, solely if the Borrower has not otherwise elected an application of such amounts as contemplated in Section 3.3(a), all amounts paid pursuant to Section 3.3(a) shall be applied </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to Swing Line Loans, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to Revolving Loans (first to Base Rate Loans and then to Term Benchmark Loans in direct order of Interest Period maturities) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to a cash collateral account in respect of LOC Obligations.  All prepayments under this Section&#160;3.3 shall be subject to Section&#160;3.14.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Facility Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In consideration of the commitments under the Revolving Credit Facility being made available by the Lenders hereunder, the Borrower agrees to pay to the Administrative Agent a per annum fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Facility Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in Dollars for the pro rata benefit of each Revolving Lender (based upon such Lender&#8217;s pro rata committed portion of the Revolving Committed Amount), which Facility Fee shall be calculated by multiplying, at any time of determination, the Applicable Percentage then in effect for the Facility Fee, by the daily average amount of the Revolving Committed Amount (whether or not drawn or available to be drawn) during the fiscal quarter or other relevant period for which such Facility Fee is being calculated.  The Facility Fee shall accrue from the Restatement Effective Date and shall be due and payable in arrears on the last day of each fiscal quarter of the Borrower for such fiscal quarter, or period ended thereon, and on the Revolving Maturity Date, with the first such payment to be made on the last day of the first full fiscal quarter following the Restatement Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Letter of Credit Fees.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Letter of Credit Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In consideration of the issuance of Letters of Credit hereunder, the Borrower agrees to pay to the Administrative Agent, for the pro rata benefit of each Revolving Lender (based on each Lender&#8217;s Revolving Loan Commitment Percentage), a per annum fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in Dollars for each Letter of Credit equal to the Applicable Percentage for Letter of Credit Fees on the average daily maximum amount available to be drawn under each such Letter of Credit (whether or not such maximum amount is then in effect under such Letter of Credit) from the date of issuance to the date of expiration.  The Letter of Credit Fees will be payable in arrears on the third Business Day following the last day of March, June, September and December of each fiscal year of the Borrower for such fiscal quarter, or period ended thereon, and on the Revolving Maturity Date, with the first such payment to be made on the third Business Day following the last day of the first full fiscal quarter following the Restatement Effective Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt;text-decoration:underline">Issuing Lender Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to the Letter of Credit Fees payable pursuant to subsection (i) above, the Borrower shall pay to each Issuing Lender for its own account, without sharing by the other Lenders, (A)&#160;the customary, incidental and&#47;or out of pocket charges from time to time of such Issuing Lender for its services in connection with the issuance, amendment, payment, transfer, administration, cancellation and conversion of, and drawings under, Letters of Credit and (B) with respect to each Letter of Credit, a letter of credit fronting fee in Dollars at a rate per annum agreed to between the Borrower and such Issuing Lender of the face amount of each Letter of Credit, payable quarterly on the third Business Day following the last day of March, June, September and December of each fiscal year of the Borrower for such fiscal quarter, and on the Revolving Maturity Date (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Administrative Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower agrees to pay to the Administrative Agent, for its own account, an annual fee in Dollars as agreed to between the Borrower and the Administrative Agent as set forth in the JPMorgan Engagement Letter.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Payment in Full at Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">On the Revolving Maturity Date, the entire outstanding principal balance of all Revolving Loans, all Swing Line Loans and all LOC Obligations, together with accrued but unpaid interest and all other sums owing with respect thereto, shall be due and payable in full, unless accelerated sooner pursuant to Section 9.2.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Computations of Interest and Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">All computations of interest and fees hereunder shall be made on the basis of the actual number of days elapsed over a year of 360 days&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that in the case of (i) Base Rate Loans and Swing Line Loans that are based upon the Prime Rate, interest shall be computed on the basis of the actual number of days elapsed over a year of 365 or 366 days, as the case may be, (ii) Loans denominated in Sterling, interest shall be computed on the basis of a year of 365 days and (iii) Loans denominated in Alternative Currencies, other than Sterling, as to which market practice differs from the foregoing, interest shall be computed in accordance with such market practice.  Interest shall accrue from and include the date of borrowing (or continuation or conversion) but exclude the date of payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">It is the intent of the Lenders and the Borrower to conform to and contract in strict compliance with applicable usury law from time to time in effect.  All agreements between the Lenders and the Borrower are hereby limited by the provisions of this paragraph, which shall override and control all such agreements, whether now existing or hereafter arising and whether written or oral.  In no way, nor in any event or contingency (including but not limited to prepayment or acceleration of the maturity of any obligation), shall the interest taken, reserved, contracted for, charged, or received under this Credit Agreement, under the Notes or otherwise, exceed the maximum nonusurious amount permissible under applicable law.  If, from any possible construction of any of the Credit Documents or any other document, interest would otherwise be payable in excess of the maximum nonusurious amount, any such construction shall be subject to the provisions of this paragraph and such documents shall be automatically reduced to the maximum nonusurious amount permitted under applicable law, without the necessity of execution of any amendment or new document.  If any Lender shall ever receive anything of value which is characterized as interest on the Loans under applicable law and which would, apart from this provision, be in excess of the maximum nonusurious amount, an amount equal to the amount which would have been excessive interest shall, without penalty, be applied to the reduction of the principal amount owing on the Loans and not to the payment of interest, or refunded to the Borrower or the other payor thereof if and to the extent such amount which would have been excessive exceeds such unpaid principal amount of the Loans.  The right to demand payment of the Loans or any other Indebtedness evidenced by any of the Credit Documents does not include the right to accelerate the payment of any interest which has not otherwise accrued on the date of such demand, and the Lenders do not intend to charge or receive any unearned interest in the event of such demand.  All interest paid or agreed to be paid to the Lenders with respect to the Loans shall, to the extent permitted by applicable law, be amortized, prorated, allocated, and spread throughout the full stated term (including any renewal or extension) of the Loans so that the amount of interest on account of such Indebtedness does not exceed the maximum nonusurious amount permitted by applicable law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Pro Rata Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the extent otherwise provided herein&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as otherwise provided herein, each Revolving Loan borrowing (including, without limitation, each Mandatory Borrowing), each payment or prepayment of principal of any Revolving Loan, each payment of fees (other than the Issuing Lender Fees retained by each Issuing Lender for its own account and fees under the JPMorgan Engagement Letter and JPMorgan Fee Letter retained by the Administrative Agent for its own account), each reduction of the Revolving Committed Amount and each conversion or continuation of any Revolving Loan shall (except as otherwise provided in Section 3.11) be allocated pro rata among the relevant Lenders in accordance with the respective Revolving Loan Commitment Percentages of such Lenders, as applicable (or, if the Commitments of such Lenders have expired or been terminated, in accordance with the respective principal amounts of the outstanding Revolving Loans and Participation Interests of such Lenders)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if any Lender shall have failed to pay its applicable pro rata share of any Revolving Loan, then any amount to which such Lender would otherwise be entitled pursuant to this subsection (a) shall instead be payable to the Administrative Agent until the share of such Loan not funded by such Lender has been repaid&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in the event any amount paid to any Lender pursuant to this subsection (a) is recovered from or must otherwise be returned by the Administrative Agent, each Lender shall, upon the request of the Administrative Agent, repay to the Administrative Agent the amount so paid to such Lender, with interest for the period commencing on the date such payment is returned by the Administrative Agent until the date the Administrative Agent receives such repayment at a rate per annum equal to (i) if the applicable Loan is denominated in Dollars, during the period to but excluding the date two Business Days after such request, the Federal Funds Rate, and thereafter, the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2% per annum and (ii) if the applicable Loan is denominated in an Alternative Currency, during the period to but excluding the date two Business Days after such request, at the customary rate for the applicable currency set by the Administrative Agent for the correction of errors among banks, and thereafter, the Adjusted LIBO Rate or the EURIBO Rate, as applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2% per annum.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as otherwise provided herein, each payment of unreimbursed drawings in respect of LOC Obligations shall be allocated to each Participant pro rata in accordance with its Revolving Loan Commitment Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if any Participant shall have failed to pay its applicable pro rata share of any drawing under any Letter of Credit, then any amount to which such Participant would otherwise be entitled pursuant to this subsection (b) shall instead be payable to the relevant Issuing Lender until the share of such unreimbursed drawing not funded by such Lender has been repaid&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in the event any amount paid to any Participant pursuant to this subsection (b) is recovered from or must otherwise be returned by any Issuing Lender, each Participant shall, upon the request of such Issuing Lender, repay to the Administrative Agent for the account of such Issuing Lender the amount so paid to such Participant, with interest for the period commencing on the date such payment is returned by such Issuing Lender until the date such Issuing Lender receives such repayment at a rate per annum equal to (i) if the applicable drawing under a Letter of Credit is denominated in Dollars, during the period to but excluding the date two Business Days after such request, the Federal Funds Rate, and thereafter, the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2% per annum and (ii)&#160;if the applicable drawing under a Letter of Credit is denominated in an Alternative Currency, during the period to but excluding the date two </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Business Days after such request, at the customary rate for the applicable currency set by the Administrative Agent for the correction of errors among banks, and thereafter, the Adjusted LIBO Rate or the EURIBO Rate, as applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2% per annum.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Swing Line Lender shall receive, for its own account, all payments or prepayments of principal and interest with respect to the Swing Line Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, upon the funding of the Participants&#8217; participation interests with respect to a Swing Line Loan pursuant to Section&#160;2.3(c), such Participants shall be entitled to receive their pro rata share of any payment or prepayment of principal and interest with respect to such Swing Line Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Sharing of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Lenders agree among themselves that, except to the extent otherwise provided herein, in the event that any Lender shall obtain payment in respect of any Loan, unreimbursed drawing with respect to any LOC Obligations or any other obligation owing to such Lender under this Credit Agreement through the exercise of a right of setoff, banker&#8217;s lien or counterclaim, or pursuant to a secured claim under Section 506 of the Bankruptcy Code or other security or interest arising from, or in lieu of, such secured claim, received by such Lender under any applicable bankruptcy, insolvency or other similar law or otherwise, or by any other means, in excess of its pro rata share of such payment as provided for in this Credit Agreement, such Lender shall promptly pay in cash or purchase from the other Lenders a participation in such Loans, LOC Obligations, and other obligations in such amounts, and make such other adjustments from time to time, as shall be equitable to the end that all Lenders share such payment in accordance with their respective ratable shares as provided for in this Credit Agreement.  The Lenders further agree among themselves that if payment to a Lender obtained by such Lender through the exercise of a right of setoff, banker&#8217;s lien, counterclaim or other event as aforesaid shall be rescinded or must otherwise be restored, each Lender which shall have shared the benefit of such payment shall, by payment in cash or a repurchase of a participation theretofore sold, return its share of that benefit (together with its share of any accrued interest payable with respect thereto) to each Lender whose payment shall have been rescinded or otherwise restored.  The Borrower agrees that any Lender so purchasing such a participation may, to the fullest extent permitted by law, exercise all rights of payment, including setoff, banker&#8217;s lien or counterclaim, with respect to such participation as fully as if such Lender were a holder of such Loan, LOC Obligation or other obligation in the amount of such participation.  Except as otherwise expressly provided in this Credit Agreement, if any Lender or the Administrative Agent shall fail to remit to any other Lender an amount payable by such Lender or the Administrative Agent to such other Lender pursuant to this Credit Agreement on the date when such amount is due, such payments shall be made together with interest thereon for each date from the date such amount is due until the date such amount is paid to the Administrative Agent or such other Lender at a rate per annum equal to the Federal Funds Rate.  If under any applicable bankruptcy, insolvency or other similar law, any Lender receives a secured claim in lieu of a setoff to which this Section 3.8 applies, such Lender shall, to the extent practicable, exercise its rights in respect of such secured claim in a manner consistent with the rights of the Lenders under this Section 3.8 to share in the benefits of any recovery on such secured claim.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">66</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Capital Adequacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If, after the date thereof, any Lender determines that a Change in Law has or would have the effect of reducing the rate of return on the capital or assets of such Lender or any corporation controlling such Lender as a consequence of such Lender&#8217;s obligations hereunder (taking into consideration its policies with respect to capital adequacy and liquidity and such Lender&#8217;s desired return on capital), then from time to time upon demand of such Lender (with a copy of such demand to the Administrative Agent), the Borrower shall pay to such Lender such additional amounts as will compensate such Lender for such reduction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Alternate Rate of Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Subject</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to clauses (b), (c), (d), (e), (g) and (h) of this Section&#160;3.10, if&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">the Administrative Agent determines (which determination shall be conclusive absent manifest error) (A) prior to the commencement of any Interest Period for a Term Benchmark Loan, that adequate and reasonable means do not exist for ascertaining the Adjusted LIBO Rate, the LIBO Rate or the Adjusted EURIBO Rate or the EURIBO Rate (including because the applicable Screen Rate is not available or published on a current basis), for the applicable Agreed Currency and such Interest Period or (B) at any time, that adequate and reasonable means do not exist for ascertaining the Daily Simple SONIA Rate or SONIA for the applicable Agreed Currency&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">the Administrative Agent is advised by the Required Lenders that (A) prior to the commencement of any Interest Period for a Term Benchmark Borrowing, the Adjusted LIBO Rate, the LIBO Rate or the Adjusted EURIBO Rate or the EURIBO Rate for the applicable Agreed Currency and such Interest Period will not adequately and fairly reflect the cost to such Lenders (or Lender) of making or maintaining their Loans (or its Loan) included in such Borrowing for the applicable Agreed Currency and such Interest Period or (B) at any time, the applicable Daily Simple SONIA Rate or SONIA for the applicable Agreed Currency will not adequately and fairly reflect the cost to such Lenders (or Lender) of making or maintaining their Loans (or its Loan) included in such Borrowing for the applicable Agreed Currency&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">then the Administrative Agent shall give notice thereof to the Borrower and the Lenders by telephone, telecopy or electronic mail as promptly as practicable thereafter and, until the Administrative Agent notifies the Borrower and the Lenders that the circumstances giving rise to such notice no longer exist, (A)&#160;any Notice of Continuation&#47;Conversion that requests the conversion of any Revolving Borrowing to, or continuation of any Revolving Borrowing as, a Term Benchmark Borrowing shall be ineffective, (B)&#160;if any Notice of Borrowing requests a Term Benchmark Borrowing in Dollars, such Borrowing shall be made as a Base Rate Borrowing and (C) if any Notice of Borrowing requests a Term Benchmark Loan or an RFR Loan for the relevant rate above in an Alternative Currency, then such request shall be ineffective&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that&#160;if only one Type of Borrowings is affected, then all other Types of Borrowings shall be permitted.  Furthermore, if any Term Benchmark Loan or RFR Loan in any Agreed Currency is outstanding on the date of the Borrower&#8217;s receipt of the notice from the Administrative Agent referred to in this Section 3.10 with respect to a Relevant Rate applicable to such Term Benchmark Loan or RFR Loan, then until the Administrative Agent notifies the Borrower and the Lenders that the circumstances giving rise to such notice no longer exist, (i) if such Term Benchmark Loan is denominated in Dollars, then on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day), </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">such Loan shall be converted by the Administrative Agent to, and shall constitute, a Base Rate Loan denominated in Dollars on such day, (ii) if such Term Benchmark Loan is denominated in any Agreed Currency other than Dollars, then such Loan shall, on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day) bear interest at the Central Bank Rate for the applicable Agreed Currency </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate for the applicable Agreed Currency cannot be determined, any outstanding affected Term Benchmark Loans denominated in any Agreed Currency other than Dollars shall, at the Borrower&#8217;s election prior to such day&#58; (A) be prepaid by the Borrower on such day or (B) solely for the purpose of calculating the interest rate applicable to such Term Benchmark Loan, such Term Benchmark Loan denominated in any Agreed Currency other than Dollars shall be deemed to be a Term Benchmark Loan denominated in Dollars and shall accrue interest at the same interest rate applicable to Term Benchmark Loans denominated in Dollars at such time or (iii) if such RFR Loan is denominated in any Agreed Currency other than Dollars, then such Loan shall bear interest at the Central Bank Rate for the applicable Agreed Currency </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate for the applicable Agreed Currency cannot be determined, any outstanding affected RFR Loans denominated in any Agreed Currency other than Dollars, at the Borrower&#8217;s election, shall either (A) be converted into Base Rate Loans denominated in Dollars (in an amount equal to the Dollar Equivalent of such Alternative Currency) immediately or (B) be prepaid in full immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Notwithstanding anything to the contrary herein or in any other Credit Document, if a Benchmark Transition Event or an Early Opt-in Election or an Other Benchmark Rate Election, as applicable, and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then (x) if a Benchmark Replacement is determined in accordance with clause (1) or (2) of the definition of &#8220;Benchmark Replacement&#8221; with respect to Dollars for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Credit Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Credit Agreement or any other Credit Document and (y) if a Benchmark Replacement is determined in accordance with clause (3) of the definition of &#8220;Benchmark Replacement&#8221; with respect to any Agreed Currency for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Credit Document in respect of any Benchmark setting at or after 5&#58;00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Credit Agreement or any other Credit Document so long as the Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacement from Lenders comprising the Required Lenders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding anything to the contrary herein or in any other Credit Document and subject to the proviso below in this paragraph, with respect to a Loan denominated in Dollars, if a Term SOFR Transition Event and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then the applicable Benchmark Replacement will replace the then-current Benchmark for all purposes hereunder or under any Credit Document in respect of such Benchmark setting and subsequent Benchmark settings, without any amendment to, or further action or consent of any other party to, this Credit Agreement or any other Credit Document&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, this clause (c) shall not be effective unless the Administrative Agent has delivered to the Lenders and the Borrower a Term SOFR Notice.  For the avoidance of doubt, the Administrative Agent shall not be required to deliver a Term SOFR Notice after the occurrence of a Term SOFR Transition Event and may do so in its sole discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In connection with the implementation of a Benchmark Replacement, the Administrative Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Credit Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Credit Agreement or any other Credit Document (other than the Administrative Agent and the Borrower).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent will promptly notify the Borrower and the Lenders of (i)&#160;any occurrence of a Term SOFR Transition Event, a Benchmark Transition Event, an Early Opt-in Election or an Other Benchmark Rate Election, as applicable, and its related Benchmark Replacement Date, (ii) the implementation of any Benchmark Replacement, (iii)&#160;the effectiveness of any Benchmark Replacement Conforming Changes, (iv) the removal or reinstatement of any tenor of a Benchmark pursuant to clause (g) below and (v) the commencement or conclusion of any Benchmark Unavailability Period.  Any reasonable determination, decision or election that may be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders) pursuant to this Section&#160;3.10, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party to this Credit Agreement or any other Credit Document, except, in each case, as expressly required pursuant to this Section&#160;3.10.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">To the extent administratively and operationally feasible, the Administrative Agent shall use commercially reasonable efforts to cooperate with the Borrower&#8217;s requests to ensure that any Benchmark Replacement and any Benchmark Replacement Changes meet the standards set forth in Proposed Treasury Regulation Section 1.1001-6 (or any successor or final version of such regulation or other official guidance issued by the U.S. Internal Revenue Service) so as not to be treated as a &#8220;modification&#8221; (and therefore an exchange) of this Agreement for purposes of Treasury Regulation Section 1.1001-3, it being understood that for these purposes, the substantially equivalent fair market value requirement of Proposed Treasury Regulation Section&#160;1.1001-6(b)(2) shall be deemed satisfied, and it being further understood that the Administrative Agent shall not be required to take any action under this provision that would cause it any commercially unreasonable burden, as determined in good faith by the Administrative Agent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Notwithstanding anything to the contrary herein or in any other Credit Document, at any time (including in connection with the implementation of a Benchmark Replacement), (i) if the then-current Benchmark is a term rate (including Term SOFR, LIBO Rate or EURIBO Rate) and either (A) any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion or (B) the regulatory supervisor for the administrator of such Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is or will be no longer representative, then the Administrative Agent may modify the definition of &#8220;Interest Period&#8221; for any Benchmark settings at or after such time to remove such unavailable or non-representative tenor and (ii) if a tenor that was removed pursuant to clause (i) above either (A)&#160;is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (B) is not, or is no longer, subject to an announcement that it is or will no longer be representative for a Benchmark (including a Benchmark Replacement), then the Administrative Agent may modify the definition of &#8220;Interest Period&#8221; for all Benchmark settings at or after such time to reinstate such previously removed tenor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Upon the Borrower&#8217;s receipt of notice of the commencement of a Benchmark Unavailability Period, the Borrower may revoke any request for a Term Benchmark Loan or RFR Loan or any request for the conversion to or continuation of Term Benchmark Loans to be made, converted or continued during any Benchmark Unavailability Period and, failing that, either (x)&#160;the Borrower will be deemed to have converted any request for a Term Benchmark Borrowing denominated in Dollars into a request for a Borrowing of or conversion to Base Rate Loans or (y)&#160;any Term Benchmark Loan or RFR Loan denominated in an Alternative Currency shall be ineffective.  During any Benchmark Unavailability Period or at any time that a tenor for the then-current Benchmark is not an Available Tenor, the component of the Base Rate based upon the then-current Benchmark or such tenor for such Benchmark, as applicable, will not be used in any determination of the Base Rate.  Furthermore, if any Term Benchmark Loan or RFR Loan in any Agreed Currency is outstanding on the date of the Borrower&#8217;s receipt of notice of the commencement of a Benchmark Unavailability Period with respect to a Relevant Rate applicable to such Term Benchmark Loan or RFR Loan, then until such time as a Benchmark Replacement for such Agreed Currency is implemented pursuant to this Section&#160;3.10, (i) if such Term Benchmark Loan is denominated in Dollars, then on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day), such Loan shall be converted by the Administrative Agent to, and shall constitute, a Base Rate Loan denominated in Dollars on such day, (ii) if such Term Benchmark Loan is denominated in any Agreed Currency other than Dollars, then such Loan shall, on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day) bear interest at the Central Bank Rate for the applicable Agreed Currency </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate for the applicable Agreed Currency cannot be determined, any outstanding affected Term Benchmark Loans denominated in any Agreed Currency other than Dollars shall, at the Borrower&#8217;s election prior to such day&#58; (A) be prepaid by the Borrower on such day or (B) solely for the purpose of calculating the interest rate applicable to such Term Benchmark Loan, such Term Benchmark Loan denominated in any Agreed Currency other than Dollars shall be deemed to be a Term Benchmark Loan denominated in Dollars and shall accrue interest at the same interest rate applicable to Term Benchmark Loans denominated in Dollars at such time or (iii) if such RFR Loan is denominated in any Agreed Currency other than Dollars, then such Loan shall bear interest at the Central Bank Rate for the applicable Agreed Currency </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate for the applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">70</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Agreed Currency cannot be determined, any outstanding affected RFR Loans denominated in any Agreed Currency, at the Borrower&#8217;s election, shall either (A) be converted into Base Rate Loans denominated in Dollars (in an amount equal to the Dollar Equivalent of such Alternative Currency) immediately or (B) be prepaid in full immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Illegality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If any Lender determines that any Requirement of Law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for any Lender or its applicable Lending Office to make, maintain or fund LIBOR Loans or EURIBOR Loans, or materially restricts the authority of such Lender to purchase or sell, or to take deposits of, the applicable currency in the applicable offshore market for such currency, or to determine or charge interest rates based upon the LIBO Rate or EURIBO Rate, as applicable, then, on notice thereof by such Lender to the Borrower through the Administrative Agent, any obligation of such Lender to make or continue LIBOR Loans or EURIBOR Loans or to convert Base Rate Loans to LIBOR Loans, as applicable, shall be suspended until such Lender notifies the Administrative Agent and the Borrower that the circumstances giving rise to such determination no longer exist.  Upon receipt of such notice, the Borrower shall, upon demand from such Lender (with a copy to the Administrative Agent), prepay or, if applicable, convert all Term Benchmark Loans of such Lender to Base Rate Loans in the Dollar Equivalent of such Term Benchmark Loans, either on the last day of the Interest Period thereof, if such Lender may lawfully continue to maintain such Term Benchmark Loans to such day, or immediately, if such Lender may not lawfully continue to maintain such Term Benchmark Loans.  Upon any such prepayment or conversion, the Borrower shall also pay interest on the amount so prepaid or converted, together with any amounts due with respect thereto pursuant to Section 3.14.  Each Lender agrees to designate a different Lending Office if such designation will avoid the need for such notice and will not, in the good faith judgment of such Lender, otherwise be materially disadvantageous to such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Requirements of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If any Lender determines that as a result of any Change in Law, or such Lender&#8217;s compliance therewith, there shall be any increase in the cost to such Lender of agreeing to make or making, funding or maintaining Loans or (as the case may be) issuing, participating in or maintaining any Letters of Credit (or of maintaining its obligation to participate in or to issue any Letter of Credit), or a reduction in the amount received or receivable by such Lender in connection with any of the foregoing (excluding for purposes of this Section&#160;3.12 any such increased costs or reduction in amount resulting from (i)&#160;taxes other than capital taxes imposed on such Lender&#8217;s loans, loan principal, letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto and (ii) reserve requirements utilized in the determination of the LIBO Rate or EURIBO Rate, as applicable), then from time to time, within 10 days of demand of such Lender (with a copy of such demand to the Administrative Agent), the Borrower shall pay to such Lender such additional amounts as will compensate such Lender for such increased cost or reduction in yield.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">71</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Any and all payments by or on behalf of the Borrower to or for the account of the Administrative Agent or any Lender under any Credit Document shall be made free and clear of and without deduction for any and all present or future income, stamp or other taxes, duties, levies, imposts, deductions, assessments, fees or other charges imposed by any Governmental Authority, withholdings or similar charges, and all liabilities with respect thereto, but excluding, in the case of the Administrative Agent and each Lender, (x)&#160;any branch profit taxes or taxes imposed on or measured by its net income, (y)&#160;franchise taxes imposed on it (in lieu of net income taxes), in each case by the jurisdiction (or any political subdivision thereof) under the laws of which the Administrative Agent or such Lender, as the case may be, is organized or maintains its Lending Office, and (z) any taxes imposed by FATCA (all such non-excluded present or future income, stamp or other taxes, duties, levies, imposts, deductions, assessments, fees or other charges imposed by any Governmental Authority, withholdings or similar charges, and liabilities being hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  If the Borrower shall be required by any Requirement of Law to deduct any Taxes or Other Taxes from or in respect of any sum payable under any Credit Document to the Administrative Agent or any Lender, (i) the sum payable shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this Section 3.13(a)), the Administrative Agent or such Lender, as the case may be, receives an amount equal to the sum it would have received had no such deductions been made, (ii) the Borrower shall make such deductions, (iii)&#160;the Borrower shall pay the full amount deducted to the relevant taxation authority or other Governmental Authority in accordance with applicable Requirements of Law and (iv) within 30&#160;days after the date of such payment, the Borrower shall furnish to the Administrative Agent (which shall forward the same to such Lender) the original or a certified copy of a receipt evidencing payment thereof, to the extent such receipt is issued therefor, or other written proof of payment thereof that is reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In addition, the Borrower agrees to pay any and all present or future stamp, court or documentary taxes and any other excise or property taxes or charges or similar levies which arise from any payment made under any Credit Document or from the execution, delivery, performance, enforcement or registration of, or otherwise with respect to, any Credit Document (hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#91;Reserved&#93;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Borrower agrees to indemnify the Administrative Agent and each Lender for (i) the full amount of Taxes and Other Taxes (including any Taxes or Other Taxes imposed or asserted by any jurisdiction on amounts payable under this Section 3.13(d)) paid by the Administrative Agent and such Lender and (ii)&#160;any liability (including penalties, interest and reasonable expenses) arising therefrom or with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In the case of any payment hereunder or under any other Credit Document by or on behalf of the Borrower through an account or branch outside the United States, or on behalf of the Borrower by a payor that is not a United States person, if the Borrower determines that no taxes are payable in respect thereof, the Borrower shall furnish, or shall cause such payor to furnish, to the Administrative Agent, an opinion of counsel reasonably acceptable to the Administrative Agent stating that such payment is exempt from Taxes.  For purposes of this subsection&#160;(e), the terms &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">United States</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">United States person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meanings specified in Section&#160;7701 of the Code.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">72</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Each Lender that is not a &#8220;United States person&#8221; within the meaning of Section&#160;7701(a)(30) of the Code shall deliver to the Borrower and the Administrative Agent, on or prior to the date on which such Lender becomes a Lender under this Credit Agreement, (i) two duly signed completed copies of either IRS Form W-8BEN or any successor thereto, including IRS Form W-8BEN-E (relating to such Lender and entitling it to an exemption from, or reduction of, withholding tax on all payments to be made to such Lender by the Borrower pursuant to this Credit Agreement), IRS Form W-8ECI or any successor thereto (relating to all payments to be made to such Lender by the Borrower pursuant to this Credit Agreement), or IRS Form W-8IMY or any successor thereto (relating to all payments to be made to such Lender by the Borrower pursuant to this Credit Agreement) as appropriate, or such other evidence satisfactory to the Borrower and the Administrative Agent that such Lender is entitled to an exemption from, or reduction of, United States withholding tax and (ii) in the case of a foreign Lender claiming exemption from United States withholding tax under Section 871(h) or 881(c) of the Code with respect to payments of &#8220;portfolio interest&#8221;, a &#8220;Certificate of Non-Bank Status for Foreign Entities&#8221; substantially in the form of Exhibit 3.13(f) together with the applicable IRS Form W-8, or any subsequent versions thereof or successors thereto, properly completed and duly executed by such foreign Lender claiming complete exemption from, or a reduced rate of, United States withholding tax on payments under this Credit Agreement and the other Credit Documents.  Each Lender that is a &#8220;United States person&#8221; within the meaning of Section&#160;7701(a)(30) of the Code shall deliver to the Borrower and the Administrative Agent, on or prior to the date on which such Lender becomes a Lender under this Credit Agreement two duly signed completed copies of IRS Form&#160;W9 or any successor thereto or such other evidence satisfactory to the Borrower and the Administrative Agent that such Lender is entitled to an exemption from, or reduction of, United States withholding tax.  If a payment made to a Lender under any Credit Document would be subject to United States withholding tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section&#160;1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower and Administrative Agent, at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent, such documentation prescribed by applicable law (including as prescribed by Section&#160;1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower or the Administrative Agent to comply with its obligations under FATCA, to determine whether such Lender has or has not complied with such Lender&#8217;s obligations under FATCA and, as necessary, to determine the amount to deduct and withhold from such payment.  Solely for purposes of this Section&#160;3.13(f), &#8220;FATCA&#8221; shall include any amendments made to FATCA after the Restatement Effective Date.  Thereafter and from time to time, each such Lender shall (i)&#160;promptly submit to the Administrative Agent such additional duly completed and signed copies of one of such forms (or such successor forms as shall be adopted from time to time by the relevant United States taxing authorities), as appropriate, as may reasonably be requested by the Borrower or the Administrative Agent and then be available under then current United States laws and regulations to avoid, or such evidence as is satisfactory to the Borrower and the Administrative Agent of any available exemption from or reduction of, United States withholding taxes in respect of all payments to be made to such Lender by the Borrower pursuant to this Credit Agreement, (ii)&#160;promptly notify the Administrative Agent of any change in circumstances which would modify or render invalid any claimed exemption or reduction (or it is determined the earlier claimed exemption was incorrectly claimed for any reason), (iii) promptly update any previously delivered form or certification that has expired or become obsolete or inaccurate in any respect (or promptly notify the Borrower and Administrative Agent of its legal inability to do so) and (iv)&#160;take such steps as shall not be materially disadvantageous to it, in the reasonable judgment of such Lender, and as may be reasonably necessary (including the re-designation of its Lending Office) to avoid any Requirement of Law that the Borrower make any deduction or withholding for taxes from amounts payable to such Lender.  If payments to any Lender, at the time such Lender (i) acquires the applicable interest in a Loan or Commitment </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(other than pursuant to an assignment request by the Borrower under Section 3.17) or (ii) changes its Lending Office, are subject to United States withholding tax at a rate in excess of zero pursuant to a law in effect at that time, withholding tax at such rate shall be considered excluded from Taxes for purposes of any indemnity or gross up unless and until a lesser rate applies, whereupon  withholding tax at such rate only shall be considered excluded from Taxes for periods thereafter&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, if at the date (i) of any assignment pursuant to which such Lender becomes a party to this Credit Agreement or (ii) such Lender changes its Lending Office, such Lender&#8217;s assignor (or such Lender immediately before it changed its Lending Office) was entitled to payments under subsection (a) of this Section 3.13 in respect of United States withholding tax at such date, then, to such extent, the term Taxes shall include (in addition to withholding taxes that may be imposed in the future or other amounts otherwise includable in Taxes) United States withholding tax, if any, applicable with respect to such Lender on such date.  If such Lender fails to deliver the above forms or other evidence, then the Borrower or the Administrative Agent may withhold from any interest payment to such Lender an amount equal to the applicable withholding tax imposed by the Code, without reduction.  If any Governmental Authority asserts that the Borrower or the Administrative Agent did not properly withhold any tax or other amount from payments made in respect of such Lender, such Lender shall indemnify the Borrower or the Administrative Agent therefor, including all penalties and interest, any taxes imposed by any jurisdiction on the amounts payable to the Borrower or the Administrative Agent under this Section&#160;3.13(f), and costs and expenses (including Attorney Costs) of the Borrower or the Administrative Agent.  For any period with respect to which a Lender has failed to provide the Administrative Agent with the above forms or other evidence (other than if such failure is due to a change in the applicable law, or in the interpretation or application thereof, occurring after the date on which such form or other evidence originally was required to be provided or if such form or other evidence otherwise is not required), such Lender shall not be entitled to indemnification under subsection&#160;(d) of this Section&#160;3.13 nor shall the Borrower be required to make additional payments under subsection (a) of this Section 3.13 with respect to Taxes imposed by the United States by reason of such failure&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that should a Lender become subject to Taxes because of its failure to deliver such form or other evidence required hereunder, the Borrower shall take such steps as such Lender shall reasonably request to assist such Lender in recovering such Taxes.  The obligation of the Lenders under this Section 3.13(f) shall survive the payment of all Obligations and the resignation or replacement of the Administrative Agent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">74</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In the event that an additional payment is made under Section&#160;3.13(a) for the account of any Lender and such Lender, in its reasonable judgment, determines that it has finally and irrevocably received or been granted a credit against or release or remission for, or repayment of, any tax paid or payable by it in respect of or calculated with reference to the deduction or withholding giving rise to such payment, such Lender shall, to the extent that it determines that it can do so without prejudice to the retention of the amount of such credit, relief, remission or repayment, pay to the Borrower such amount as such Lender shall, in its reasonable judgment, have determined to be attributable to such deduction or withholding and which will leave such Lender (after such payment) in no worse position than it would have been in if the Borrower had not been required to make such deduction or withholding.  Nothing herein contained shall interfere with the right of a Lender to arrange its tax affairs in whatever manner it thinks fit nor oblige any Lender to claim any tax credit or to disclose any information relating to its tax affairs or any computations in respect thereof or require any Lender to do anything that would prejudice its ability to benefit from any other credits, reliefs, remissions or repayments to which it may be entitled.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">For purposes of determining withholding tax imposed under FATCA, from and after the Restatement Effective Date, the Borrower and the Administrative Agent shall treat (and the Lenders hereby authorize the Administrative Agent to treat) this Credit Agreement as not qualifying as a &#8220;grandfathered obligation&#8221; within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Solely for purposes of this Section 3.13, the term &#8220;Credit Document&#8221; includes the Fee Letters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon the written demand of any Lender, the Borrower shall promptly compensate such Lender for and hold such Lender harmless from any loss, cost or expense incurred by it as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">any continuation, conversion, payment or prepayment of any Term Benchmark Loan or RFR Loan, on a day other than the last day of the Interest Period for such Term Benchmark Loan or on the Interest Payment Date of such RFR Loan, as applicable (whether voluntary, mandatory, automatic, by reason of acceleration, or otherwise)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">any failure by the Borrower (for a reason other than the failure of such Lender to make a Term Benchmark Loan or RFR Loan) to prepay, borrow, continue or convert any Term Benchmark Loan or RFR Loan on the date or in the amount previously requested by the Borrower&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">any assignment required pursuant to Section&#160;2.7(e), Section&#160;3.17 or Section&#160;11.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The amount each such Lender shall be compensated pursuant to this Section&#160;3.14 shall include, without limitation, (i)&#160;any loss incurred by such Lender in connection with the re-employment of funds paid, prepaid or repaid, or not borrowed or paid, as the case may be, and (ii)&#160;any reasonable and documented out-of-pocket expenses (including Attorney Costs) incurred and reasonably attributable thereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">75</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to Term Benchmark Loans, for purposes of calculating amounts payable by the Borrower to the Lenders under this Section&#160;3.14, each Lender may deem itself to have funded each Term Benchmark Loan made by it at the LIBO Rate or EURIBO Rate, as applicable, for such Term Benchmark Loan by a matching deposit or other borrowing in the applicable offshore interbank markets for such currency for a comparable amount and for a comparable period, whether or not such Term Benchmark Loan was in fact so funded.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Determination and Survival of Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All determinations by the Administrative Agent or a Lender of amounts owing under Sections&#160;3.9 through 3.14, inclusive, shall, absent manifest error, be conclusive and binding on the parties hereto.  In determining such amount, the Administrative Agent or such Lender may use any reasonable averaging and attribution methods.  Section&#160;3.9 through 3.14, inclusive, shall survive the termination of this Credit Agreement and the payment of all Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Notification by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Lender shall notify the Borrower of any event that will entitle such Lender to compensation under Section 3.9, 3.12, 3.13 or 3.14 as promptly as practicable, but in any event within 90 days after such Lender obtains actual knowledge thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if any Lender fails to give such notice within 90 days after it obtains actual knowledge of such an event, such Lender shall, with respect to compensation payable pursuant to Section 3.9, 3.12, 3.13 or 3.14 in respect of any costs resulting from such event, only be entitled to payment under Section 3.9, 3.12, 3.13 or 3.14 for costs incurred from and after the date 90 days prior to the date that such Lender gives such notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the event giving rise to such Lender&#8217;s right to compensation under Section&#160;3.9, 3.12, 3.13 or 3.14 is retroactive in effect, then the 90-day period referred to above shall be extended to include the period of retroactive effect thereof.  If requested by the Borrower, each Lender will furnish to the Borrower within 10 Business Days of the time the Lender requests compensation under Section 3.9, 3.12, 3.13 or 3.14, a certificate setting forth the basis, amount and reasonable detail of computation of each request by such Lender for compensation under Section 3.9, 3.12, 3.13 or 3.14, which certificate shall, except for demonstrable error, be final, conclusive and binding for all purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Mitigation&#59; Mandatory Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Lender shall use reasonable efforts to avoid or mitigate any increased cost or suspension of the availability of an interest rate under Sections 3.9 through and including 3.14 above to the greatest extent practicable (including transferring the Loans to another Lending Office or Affiliate of a Lender) unless, in the reasonable opinion of such Lender, such efforts would be likely to have an adverse effect upon it.  In the event (a) a Lender makes a request to the Borrower for additional payments in accordance with Section 3.9, 3.12, 3.13 or 3.14, or delivers a notice under Section 3.10 or 3.11 or (b) any Lender shall be a Defaulting Lender, then, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no Default or Event of Default has occurred and is continuing at such time, the Borrower may, (a) in the case of a Lender that makes a request to the Borrower for additional payments in accordance with Section 3.9, 3.12, 3.13 or 3.14, or delivers a notice under Section 3.10 or 3.11, at its own expense (such expense to include, without limitation, any transfer fee payable to the Administrative Agent under Section 11.3(b)), and (b) in the case of a Defaulting Lender, at the replacement Lender&#8217;s expense (such expense to include, without limitation, any transfer fee payable to the Administrative Agent under Section 11.3(b)), and, in each case, in its sole discretion, require such Lender or Defaulting Lender, as the case may be, to transfer and assign in whole (but not in part), without recourse (in accordance with and subject to the terms and conditions of Section 11.3(b)), all of its interests, rights and obligations under this Credit Agreement to an Eligible Assignee which shall assume such assigned obligations (which assignee may be another Lender, if a Lender accepts such assignment)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (a) such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">76</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">assignment shall not conflict with any law, rule or regulation or order of any court or other Governmental Authority and (b) the Borrower or such assignee shall have paid to the assigning Lender in immediately available funds the principal of and interest accrued to the date of such payment on the portion of the Loans hereunder held by such assigning Lender and all other amounts owed to such assigning Lender hereunder, including amounts owed pursuant to Sections&#160;3.9, 3.12, 3.13 or 3.14 hereof.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt"><br><br>&#91;RESERVED&#93;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt"><br><br>CONDITIONS PRECEDENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The effectiveness of this Credit Agreement shall be subject to the satisfaction of the following conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall have received duly executed counterparts of the Amendment and Restatement Agreement that, when taken together, bear the signatures of the Borrower, each Lender and the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Administrative Agent shall have received a written opinion of Shearman &#38; Sterling LLP and a written opinion of the Deputy General Counsel of the Borrower, each (A) dated the Restatement Effective Date, (B) addressed to the Administrative Agent on behalf of the Lenders and (C) in form and substance consistent with the opinions delivered by Shearman &#38; Sterling LLP and the Deputy General Counsel of the Borrower, respectively, on the Prior Closing Date, but giving effect to the amendment and restatement of the Existing Credit Agreement in the form hereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall have received such customary documents and certificates as the Administrative Agent or its counsel may reasonably request relating to the organization, existence and good standing of the Borrower and the authorization of the transactions contemplated hereby by the Borrower, all in form and substance reasonably satisfactory to the Administrative Agent, consistent with those delivered on the Prior Closing Date and giving effect to the Amendment and Restatement Agreement. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">77</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Administrative Agent shall have received payment from the Borrower, for the account of each Lender that executes and delivers a counterpart signature page to the Amendment and Restatement Agreement, of an upfront fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Upfront Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in an amount equal to (i) 0.06% of the amount of the Revolving Commitment of such Lender that does not exceed its Revolving Commitment under the Existing Credit Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) 0.10%  of the amount by which the Revolving Commitment of such Lender exceeds its Revolving Commitment (if any) under the Existing Credit Agreement.  The Upfront Fee shall be payable in immediately available funds and, once paid, shall not be refundable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall have received, in immediately available funds, payment of all interest and fees accrued to the Restatement Effective Date under the Existing Credit Agreement, as well as costs, fees, out-of-pocket expenses, compensation and other amounts then due and payable in connection with the Existing Credit Agreement, the Amendment and Restatement Agreement or the transactions contemplated thereby, including, to the extent invoiced, all amounts payable under Section 6 of the Amendment and Restatement Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">(i) The Lenders shall have received all documentation and other information required by bank regulatory authorities under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the PATRIOT Act to the extent requested at least five days prior to the Restatement Effective Date and (ii) to the extent the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, any Lender that has requested, in a written notice to the Borrower, a Beneficial Ownership Certification in relation to the Borrower shall have received such Beneficial Ownership Certification (provided that, upon the execution and delivery by such Lender of its signature page to this Credit Agreement, the condition set forth in this clause (ii) shall be deemed to be satisfied).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The representations set forth in paragraphs (b) and (c) of Section 3 of the Amendment and Restatement Agreement and in Section 6 of this Credit Agreement shall be true and correct on and as of the Restatement Effective Date and the Administrative Agent shall have received a certificate of an Authorized Officer of the Borrower, dated the Restatement Effective Date, to such effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent shall notify the Borrower and the Lenders of the Restatement Effective Date and such notice shall be conclusive and binding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Conditions to All Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the conditions precedent stated in Section 5.1, the Lenders shall not be obligated to make Loans nor shall any Issuing Lender be required to issue, extend or increase the amount of a Letter of Credit, in each case on or after the Restatement Effective Date unless as of the date thereof&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">78</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall have delivered (i)&#160;in the case of any Loan, to the Administrative Agent, an appropriate Notice of Borrowing, duly executed and completed, by the time specified in Section 2.1, and (ii)&#160;in the case of any Letter of Credit, to the Administrative Agent for distribution by the Administrative Agent to the relevant Issuing Lender as specified by the Borrower, an appropriate request for issuance of a Letter of Credit in accordance with the provisions of Section&#160;2.2 and (iii) in the case of any Swing Line Loan, to the Swing Line Lender, a Swing Line Loan Request, duly executed and completed, by the time specified in Section 2.3.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The representations and warranties made by the Borrower in this Credit Agreement or any Credit Document (other than, in the case of any Extension of Credit made after the Restatement Effective Date, the representations and warranties set forth in Sections 6.7 and 6.10) are true and correct (i) in the case of any representation and warranty that is qualified by materiality, in all respects and (ii)&#160;otherwise, in all material respects, at and as of the date of such Extension of Credit except to the extent they expressly and exclusively relate to an earlier date in which case such representations and warranties shall be true and correct (x) in the case of any representation and warranty that is qualified by materiality, in all respects and (y)&#160;otherwise, in all material respects, as of such earlier date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No Default or Event of Default shall exist and be continuing either prior to or after giving effect to such Extension of Credit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Availability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Immediately after giving effect to the making of a Loan (and the application of the proceeds thereof) or to the issuance of a Letter of Credit, as the case may be, (i)&#160;the sum of the Dollar Equivalent of outstanding Revolving Loans </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Dollar Equivalent of outstanding LOC Obligations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> outstanding Swing Line Loans shall not exceed the Revolving Committed Amount and (ii)&#160;the sum of the Dollar Equivalent of outstanding LOC Obligations shall not exceed the LOC Committed Amount.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The delivery of each Notice of Borrowing, each request for a Letter of Credit and each Swing Line Loan Request shall constitute a representation and warranty by the Borrower of the correctness of the matters specified in subsections (b), (c) and (d) above.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt"><br><br>REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower hereby represents to the Administrative Agent and each Lender that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Organization and Good Standing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower and each Domestic Subsidiary (a)&#160;is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, unless, solely with respect to each Domestic Subsidiary, the failure to be so duly organized, validly existing and in good standing would not have or would not reasonably be expected to have a Material Adverse Effect, (b) is duly qualified and in good standing as a foreign organization and authorized to do business in every other jurisdiction where its ownership or operation of property or the conduct of its business would require it to be qualified, in good standing and authorized, unless the failure to be so qualified, in good standing or authorized would not have or would not reasonably be expected to have a Material Adverse Effect and (c) has the power and authority to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">79</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">own and operate its properties and to carry on its business as now conducted and as currently proposed to be conducted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Due Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower (a) has the power and authority to execute, deliver and perform this Credit Agreement and the other Credit Documents to which it is a party and to incur the obligations herein and therein provided for and (b) has duly taken all necessary action to authorize, and is duly authorized, to execute, deliver and perform this Credit Agreement and the other Credit Documents to which it is a party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Enforceable Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower has duly executed this Credit Agreement and each other Credit Document to which the Borrower is a party and this Credit Agreement and such other Credit Documents constitute legal, valid and binding obligations of the Borrower enforceable against the Borrower in accordance with their respective terms, except as may be limited by bankruptcy or insolvency laws or similar laws affecting creditors&#8217; rights generally or by general equitable principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">No Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Neither the execution and delivery of this Credit Agreement and the other Credit Documents to which it is a party, nor the consummation of the transactions contemplated herein and therein, nor the performance of or compliance with the terms and provisions hereof and thereof by the Borrower will (a) violate, contravene or conflict with any provision of the Borrower&#8217;s organizational documents, (b)&#160;violate, contravene or conflict with any Requirement of Law (including, without limitation, Regulations T, U or X), order, writ, judgment, injunction, decree, license or permit applicable to the Borrower which violation would have or would reasonably be expected to have a Material Adverse Effect, (c) violate, contravene or conflict with contractual provisions of, or cause an event of default under, any indenture, loan agreement, mortgage, deed of trust, or other material contract, agreement or instrument to which the Borrower or any Domestic Subsidiary is a party or by which it or its properties may be bound which violation would have or would reasonably be expected to have a Material Adverse Effect, or (d) result in or require the creation of any Lien upon or with respect to the Properties of the Borrower or any Domestic Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except for consents, approvals and authorizations which have been obtained or the absence of which would not have or would not reasonably be expected to have a Material Adverse Effect, no consent, approval, authorization or order of, or filing, registration or qualification with, any Governmental Authority, equity owner or third party in respect of the Borrower is required in connection with the execution, delivery or performance of this Credit Agreement or any of the other Credit Documents, or the consummation of any transaction contemplated herein or therein by the Borrower.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">80</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Financial Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower has heretofore furnished to the Lenders its consolidated balance sheet and income statement, together with related consolidated statements of operations, cash flows and changes in stockholders&#8217; equity as of and for the fiscal year ended December 31, 2020, audited by and accompanied by the opinion of PricewaterhouseCoopers LLP, independent registered public accountants.  Such financial statements, and the financial statements that shall at any time have been delivered to the Administrative Agent and the Lenders pursuant to Sections 7.1(a) and (b)&#58;  (a) have been prepared in accordance with GAAP and (b)&#160;present fairly the consolidated financial condition, results of operations and cash flows of the Borrower and its Subsidiaries as of such date and for such periods.  Since December 31, 2020, there has been no sale, transfer or other disposition by the Borrower or any of its Subsidiaries of any material part of the business or property of the Borrower and its Subsidiaries, taken as a whole, or purchase or other acquisition by any such Person of any business or property (including any Capital Stock of any other Person) material in relation to the consolidated financial condition of the Borrower and its Subsidiaries, taken as a whole, in each case, which is not (i) reflected in the most recent financial statements delivered to the Lenders prior to the date hereof or pursuant to Section 7.1(a) or (b) or in the notes thereto or (ii) otherwise permitted by the terms of this Credit Agreement and communicated to the Administrative Agent and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Since December 31, 2020, there has been no event or condition that has resulted or could reasonably be expected to result in a material adverse change in or affecting the business, operations or financial condition of the Borrower and its Subsidiaries, taken as a whole, other than as disclosed to the Lenders or in the Borrower&#8217;s filings with the Securities and Exchange Commission prior to the Restatement Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Neither this Credit Agreement, nor any other Credit Document, nor any financial statements delivered to the Administrative Agent or the Lenders nor any other document, certificate or statement furnished to the Administrative Agent or the Lenders by or on behalf of the Borrower in connection with the transactions contemplated hereby, taken as a whole, contains any untrue statement of a material fact or omits to state a material fact necessary in order to make the statements contained therein or herein not materially misleading.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">As of the Restatement Effective Date, to the best knowledge of the Borrower, the information included in the Beneficial Ownership Certification provided on or prior to the Restatement Effective Date to any Lender in connection with this Credit Agreement (if any) is true and correct in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Default or Event of Default has occurred and is continuing or would result from the consummation of the transactions contemplated by this Credit Agreement and the other Credit Documents.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">81</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or as disclosed in the Borrower&#8217;s filings with the Securities and Exchange Commission prior to the Restatement Effective Date, no litigation, investigation, claim, criminal prosecution, civil investigative demand, imposition of criminal or civil fines and penalties, or any other proceeding of or before any arbitrator or Governmental Authority is pending or, to the knowledge of the Borrower, threatened by or against the Borrower or any of its Subsidiaries or against any of its or their respective Properties (a) with respect to the Credit Documents or any Extension of Credit or any of the transactions contemplated hereby or (b) which would reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower and each of its Subsidiaries has filed, or caused to be filed, all material tax returns (federal, state, local and foreign) required to be filed and has paid (a) all amounts of taxes shown thereon to be due (including interest and penalties) and (b) all other material taxes, fees, assessments and other governmental charges (including mortgage recording taxes, documentary stamp taxes and intangibles taxes) owing by it, except for such taxes (i) that are not yet delinquent or (ii) that are being contested in good faith and by proper proceedings, and against which adequate reserves are being maintained in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the extent the same would not reasonably be expected to have a Material Adverse Effect&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Borrower and each of its Subsidiaries is in compliance with all Requirements of Law (including, without limitation, Environmental Laws, ERISA, HIPAA, Medicaid Regulations and Medicare Regulations) and all material orders, writs, injunctions and decrees applicable to it, or to its Properties.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">(i) Neither the Borrower nor any of its Subsidiaries nor any individual employed by the Borrower or any of its Subsidiaries has been, or may reasonably be expected to be, excluded or suspended from participation in any Medical Reimbursement Program for their corporate or individual actions or failures to act and (ii) there is no member of management continuing to be employed by the Borrower or any of its Subsidiaries who has been, or may reasonably be expected to have, individual criminal culpability for healthcare matters under investigation by any Governmental Authority unless such member of management has been, within a reasonable period of time after discovery of such actual or potential culpability, either suspended or removed from positions of responsibility related to those activities under challenge by the Governmental Authority.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Current billing policies, arrangements, protocols and instructions comply with all material requirements of Medical Reimbursement Programs and are administered by properly trained personnel.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">82</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Current medical director compensation arrangements and other arrangements with referring physicians comply with state and federal self-referral and anti-kickback laws, including without limitation 42 U.S.C. Section 1320a-7b(b)(1) - (b)(2) and 42 U.S.C. Section 1395nn.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Licensing and Accreditation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the extent the same would not be reasonably expected to have a Material Adverse Effect, the Borrower and each of its Domestic Subsidiaries has, to the extent applicable, (a)&#160;obtained and maintains in good standing all required licenses, permits, authorizations and approvals of each Governmental Authority necessary to the conduct of its business, (b) to the extent prudent and customary in the industry in which it is engaged, has obtained and maintains accreditation from all generally recognized accrediting agencies (including, but not limited to, CAP), (c) has obtained and maintains CLIA certification, (d) has entered into and maintains in good standing its Medicare Provider Agreements and its Medicaid Provider Agreements and (e)&#160;has ensured that all such required licenses, certifications and accreditations are in full force and effect and have not been revoked or suspended or otherwise limited.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The properties of the Borrower and each of its Subsidiaries are insured with financially sound and reputable insurance companies that are not Affiliates of the Borrower (except to the extent that self-insurance is maintained in reasonable amounts), in such amounts, with such deductibles and covering such risks, as is reasonable and prudent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The proceeds of the Loans have been and will be used solely for the purposes specified in Section&#160;7.8.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Government Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Margin stock&#8221; within the meaning of Regulation U does not constitute more than 25% of the value of the consolidated assets of the Borrower and its Subsidiaries.  None of the transactions contemplated by the Credit Documents (including, without limitation, the direct or indirect use of the proceeds of the Loans) will violate or result in a violation of Regulations T, U or X.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Borrower is not subject to regulation under the Investment Company Act of 1940, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as would not reasonably be expected to result in a Material Adverse Effect&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">(i) No ERISA Event has occurred, and, to the best knowledge of the Borrower and each ERISA Affiliate, no event or condition has occurred or exists as a result of which any ERISA Event could reasonably be expected to occur, with respect to</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">83</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> any Plan, (ii) no Plan (other than a Multiemployer Plan) has failed to meet the &#8220;minimum funding standard&#8221; (as such term is defined in Section 302 of ERISA and Section 412 of the Code) applicable to such Plan, in each instance, whether or not waived, and no application for a funding waiver or an extension of any amortization period pursuant to Section 412 of the Code has been made with respect to any Plan, (iii) each Plan has been maintained, operated, and funded in compliance with its own terms and in material compliance with the provisions of ERISA, the Code, and any other applicable federal or state laws and (iv) no Lien in favor of the PBGC or a Plan has arisen or is reasonably likely to arise on account of any Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Neither the Borrower nor any ERISA Affiliate has incurred, or, to the best of each such party&#8217;s knowledge, is reasonably expected to incur, any liability under Title IV of ERISA with respect to any Single Employer Plan, other than for the payment of premiums arising in the ordinary course of business, or any withdrawal liability under ERISA to any Multiemployer Plan or Multiple Employer Plan.  Neither the Borrower nor any ERISA Affiliate has received any notification that any Multiemployer Plan is insolvent (within the meaning of Section 4245 of ERISA), or has been terminated (within the meaning of Title IV of ERISA), and no Multiemployer Plan is, to the best of each such Person&#8217;s knowledge, reasonably expected to be insolvent or terminated.  Neither the Borrower nor any ERISA Affiliate has engaged in a transaction that could be subject to Sections 4069 or 4212(c) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Environmental Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except with respect to matters that would not reasonably be expected to result in a Material Adverse Effect, neither the Borrower nor any of its Subsidiaries (i)&#160;has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, (ii)&#160;has become subject to any Environmental Liability, (iii)&#160;has received notice of any claim with respect to any Environmental Liability or (iv)&#160;knows of any basis for any Environmental Liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower and each of its Subsidiaries owns, or has the legal right to use, all material patents, trademarks, copyrights and other intellectual property rights (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) necessary for each of them to conduct its business as currently conducted other than as would not be reasonably expected to have a Material Adverse Effect.  To the knowledge of the Borrower and its Subsidiaries, (i) no claim has been asserted and is pending before any Governmental Authority by any Person against the Borrower or any of its Subsidiaries challenging the use, validity or effectiveness of any Intellectual Property owned by the Borrower or any of its Subsidiaries and (ii) the use of any Intellectual Property by the Borrower and its Subsidiaries does not infringe on the rights of any Person, in the case of each of (i) and (ii) except for claims and infringements that, in the aggregate, would not have or reasonably be expected to have a Material Adverse Effect.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As of the Restatement Effective Date and unless the Borrower shall have complied with its obligations under Section 7.10, there are no Domestic Subsidiaries of the Borrower that, individually or together with their Subsidiaries, guarantee Material Debt of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower has implemented and maintains in effect policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, and the Borrower, its Subsidiaries and their respective officers and employees and to the knowledge of the Borrower its directors and agents, are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects.  None of (a) the Borrower, any Subsidiary or, to the knowledge of the Borrower, any of their respective directors, officers or employees, or (b) to the knowledge of the Borrower, any agent of the Borrower or any Subsidiary that will act in any capacity in connection with or benefit from the credit facility established hereby, is a Sanctioned Person.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Loan or Letter of Credit, use of the proceeds of any Loan or any Letter of Credit or other transaction contemplated by this Credit Agreement will result in a violation by any party hereto of Anti-Corruption Laws or applicable Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower is not is an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt"><br><br>AFFIRMATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower hereby covenants and agrees that so long as this Credit Agreement is in effect and until the Loans and LOC Obligations, together with interest and fees and other obligations then due and payable hereunder, have been paid in full (other than contingent obligations for which no claim has been made) and the Commitments and Letters of Credit hereunder shall have terminated or expired (or, in the case of Letters of Credit, the LOC Obligations have been cash collateralized), as applicable&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Information Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will furnish, or cause to be furnished, to the Administrative Agent for the benefit of each of the Lenders&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Annual Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as available, and in any event within 95 days after the close of each fiscal year of the Borrower, a consolidated balance sheet and income statement of the Borrower and its Subsidiaries, as of the end of such fiscal year, together with related consolidated statements of operations, cash flows and changes in stockholders&#8217; equity for such fiscal year, setting forth in comparative form consolidated figures for the preceding fiscal year, all such consolidated financial information described above to be audited by independent certified public accountants of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">85</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">recognized national standing and whose opinion shall be to the effect that such financial statements fairly present in all material respects the consolidated financial position, results of operations and cash flows of the Borrower and its Subsidiaries as at the end of, and for, such fiscal year in accordance with GAAP and shall not be limited as to the scope of the audit or qualified in any manner.  Notwithstanding the above, it is understood and agreed that filing of the Borrower&#8217;s applicable Form 10-K shall satisfy the requirements of this Section 7.1(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as available, and in any event within 50 days after the close of each of the first three fiscal quarters of the Borrower, a consolidated balance sheet and income statement of the Borrower and its Subsidiaries, as of the end of such fiscal quarter, together with related consolidated statements of operations, cash flows and changes in stockholders&#8217; equity for such fiscal quarter setting forth in each case in comparative form the corresponding consolidated statements of operations and cash flows for the corresponding period of the preceding fiscal year, and accompanied by a certificate of an Authorized Officer of the Borrower to the effect that such quarterly financial statements fairly present in all material respects the consolidated financial condition of the Borrower and its Subsidiaries and in accordance with GAAP, subject to changes resulting from audit and normal year-end audit adjustments.  Notwithstanding the above, it is understood and agreed that filing of the Borrower&#8217;s applicable Form 10-Q shall satisfy the requirements of this Section 7.1(b).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Officer&#8217;s Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  At the time of delivery of the financial statements provided for in Sections 7.1(a) and 7.1(b) above, a certificate of an Authorized Officer of the Borrower substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 7.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, (i) demonstrating compliance with the financial covenant contained in Section 7.2 by calculation thereof as of the end of each such fiscal period, and (ii) stating that no Default or Event of Default exists, or if any Default or Event of Default does exist, specifying the nature and extent thereof and what action the Borrower proposes to take with respect thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Promptly upon transmission or receipt thereof, copies of all financial statements, proxy statements, notices and reports which the Borrower or any of its Subsidiaries shall send to shareholders of the Borrower generally and, upon request of the Administrative Agent, copies of any filings and registrations with, and reports to or from, any Governmental Authority which has regulatory authority with respect to the Borrower and its Subsidiaries.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the Borrower obtaining knowledge thereof, the Borrower will give written notice to the Administrative Agent promptly (and in any event within five Business Days) of (i)&#160;the occurrence of any Default or Event of Default, specifying the nature and existence thereof and what action the Borrower proposes to take with respect thereto, (ii)&#160;the occurrence of any of the following with respect to the Borrower or any of its Subsidiaries (A) the pendency or commencement of any litigation, arbitration or governmental proceeding against the Borrower or any of its Subsidiaries which has had or would reasonably be expected to have a Material Adverse Effect or (B)&#160;material noncompliance with, or the institution of any proceedings against the Borrower or any of its Subsidiaries with respect to, or the receipt of written notice by such Person of potential liability or responsibility for violation, or alleged violation of, any Requirement of Law (including, without limitation, Environmental Laws) the violation of which has had or would reasonably be expected to have a Material Adverse Effect, (iii)&#160;any change to any Debt Rating of the Borrower, (iv)&#160;any change in the information provided in the Beneficial Ownership Certification delivered to any Lender (if any) that would result in a change to the list of beneficial owners identified in such certification and (v)&#160;any proceeding against the Borrower or any of its Subsidiaries to suspend, revoke or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">terminate any Medicaid Provider Agreement or Medicare Provider Agreement, or to exclude the Borrower or any of its Subsidiaries from any Medical Reimbursement Program, which is reasonably expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the Borrower or any ERISA Affiliate obtaining knowledge thereof, such Person shall give written notice to the Administrative Agent promptly (and in any event within 10 Business Days) of the occurrence of any of the following events which has had or would be reasonably expected to have a Material Adverse Effect&#58; (i) any ERISA Event, (ii) with respect to any Multiemployer Plan, the receipt of notice as prescribed in ERISA or otherwise of any withdrawal liability assessed against the Borrower or any ERISA Affiliate (within the meaning of Title IV of ERISA), (iii) the failure to make full payment on or before the due date (including extensions) thereof of all amounts which the Borrower or any ERISA Affiliate is required to contribute to each Plan pursuant to its terms and as required to meet the &#8220;minimum funding standard&#8221; (as such term is defined in Section 302 of ERISA and Section 412 of the Code) applicable to such Plan or (iv) any change in the funding status of any Plan that would reasonably be expected to have a Material Adverse Effect&#59; in each case together with a description of any such event or condition or a copy of any such notice and a statement by an Authorized Officer of the Borrower briefly setting forth the details regarding such event, condition, or notice, and the action, if any, which has been or is being taken or is proposed to be taken by such Person with respect thereto.  Promptly upon request, the Borrower shall furnish the Administrative Agent with such additional information concerning any Plan as may be reasonably requested, including, but not limited to, copies of each annual report&#47;return (Form 5500 series), as well as all schedules and attachments thereto required to be filed with the Department of Labor pursuant to ERISA and the Code, respectively, for each &#8220;plan year&#8221; (within the meaning of Section 3(39) of ERISA).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  With reasonable promptness upon any such request, (x)&#160;such other information regarding the business, properties or financial condition of the Borrower and its Subsidiaries as the Administrative Agent may reasonably request and (y)&#160;information and documentation reasonably requested by the Administrative Agent or any Lender for purposes of compliance with applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the Patriot Act and the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Public&#47;Private Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower hereby acknowledges that (i)&#160;the Administrative Agent will make available to the Lenders materials and&#47;or information provided by or on behalf of the Borrower hereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) by posting the Borrower Materials on  IntraLinks or another similar electronic system (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (ii)&#160;certain of the Lenders may be &#8220;public-side&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Lenders (i.e., Lenders that do not wish to receive MNPI) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Public Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The Borrower hereby agrees that (A)&#160;all Borrower Materials that are to be made available to the Public Lenders shall be clearly and conspicuously marked &#8220;PUBLIC&#8221; which, at a minimum, shall mean that the word &#8220;PUBLIC&#8221; shall appear prominently on the first page thereof, (B)&#160;by marking Borrower Materials &#8220;PUBLIC&#8221;, the Borrower shall be deemed to have authorized the Administrative Agent and the Lenders to treat such Borrower Materials as either publicly available information or not material information (although it may be sensitive and proprietary) with respect to the Borrower or its securities for purposes of United States federal and state securities laws, (C)&#160;all Borrower Materials marked &#8220;PUBLIC&#8221; are permitted to be made available through a portion of the Platform designated as &#8220;Public&#8221; and (D)&#160;the Administrative Agent shall be entitled to treat any Borrower Materials that are not marked &#8220;PUBLIC&#8221; as being suitable only for posting on a portion of the Platform not marked &#8220;Public&#8221;.  Notwithstanding the foregoing, the Borrower shall be under no obligation to mark any Borrower Materials &#8220;PUBLIC&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Documents required to be delivered pursuant to Section&#160;7.1(a) or (b) (to the extent any such documents are included in materials otherwise filed with the Securities and Exchange Commission) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date (i)&#160;on which the Borrower posts such documents, or provides a link thereto on the Borrower&#8217;s website on the Internet at the website address listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or (ii)&#160;on which such documents are posted on the Borrower&#8217;s behalf on an Internet or intranet website, if any, to which each Lender and the Administrative Agent have access (whether a commercial, third-party website or whether sponsored by the Administrative Agent)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that&#58; (A)&#160;the Borrower shall deliver paper copies of such documents to the Administrative Agent or any Lender that requests the Borrower to deliver such paper copies until a written request to cease delivering paper copies is given by the Administrative Agent or such Lender and (B)&#160;the Borrower shall notify (which may be facsimile or electronic mail) the Administrative Agent and each Lender of the posting of any such documents and provide to the Administrative Agent by electronic mail electronic versions (i.e., soft copies) of such documents.  Except for such compliance certificates, the Administrative Agent shall have no obligation to request the delivery or to maintain copies of the documents referred to above, and in any event shall have no responsibility to monitor compliance by the Borrower with any such request for delivery, and each Lender shall be solely responsible for requesting delivery to it or maintaining its copies of such documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Financial Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Leverage Ratio, as of the last day of each fiscal quarter of the Borrower, shall be less than or equal to 4.00 to 1.00&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, following the consummation of a Material Acquisition that, on a pro forma basis, would result in an increase in the Leverage Ratio, if the Borrower shall so elect by a notice delivered to the Administrative Agent within 30 days following such completion (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Increase Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), such maximum Leverage Ratio shall be increased to 4.50 to 1.00 at the end of and for the fiscal quarter during which such Material Acquisition shall have been consummated and at the end of and for each of the following three consecutive fiscal quarters, it being understood and agreed that the Borrower shall have the right, in its sole and absolute discretion, to decide (by written notice to the Administrative Agent) that such increased Leverage Ratio shall be in effect for a shorter period of time (the period during which any such increase in the Leverage Ratio shall actually be in effect (taking into account such Borrower&#8217;s election to shorten the period during which the increased Leverage Ratio shall be in effect) being called a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Increase Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Notwithstanding the foregoing, after the Borrower elects to make a Leverage Increase Election the Borrower may not make a subsequent Leverage Increase Election until two fiscal quarters </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">88</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">have elapsed since the end of the prior Leverage Increase Period.  The Borrower may terminate any Leverage Increase Period by a notice delivered to the Administrative Agent whereupon, on the last day of the fiscal quarter during which such notice was given and on the last day of each fiscal quarter thereafter until another Leverage Increase Period has commenced as provided in this Section, the maximum Leverage Ratio shall be 4.00 to 1.00.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Preservation of Existence and Franchises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will, and will cause its Subsidiaries to, maintain and preserve its existence and any rights, franchises, Intellectual Property and authority that are used or useful in the conduct of business except as permitted by Section 8.4, in each case to the extent and in the manner customary for companies in similar businesses, except where the failure to do so would not reasonably be expected to cause a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the extent the failure to do so would not reasonably be expected to have a Material Adverse Effect, the Borrower will, and will cause each of its Subsidiaries to, (a) comply with all Requirements of Law, and all applicable restrictions imposed by all Governmental Authorities, applicable to it and its Property (including, without limitation, Environmental Laws and ERISA), (b) conform with and duly observe in all material respects all laws, rules and regulations and all other valid requirements of any regulatory authority with respect to the conduct of its business, including without limitation, HIPAA, Medicare Regulations, Medicaid Regulations, and all laws, rules and regulations of Governmental Authorities, pertaining to the business of the Borrower and the Domestic Subsidiaries, (c) obtain and maintain all licenses, permits, certifications and approvals of all applicable Governmental Authorities as are required for the conduct of its business as currently conducted and herein contemplated, including without limitation professional licenses, CLIA certifications, Medicare Provider Agreements and Medicaid Provider Agreements, (d) ensure that (i) billing policies, arrangements, protocols and instructions will comply with reimbursement requirements under Medicare, Medicaid and other Medical Reimbursement Programs and will be administered by properly trained personnel, (ii) medical director compensation arrangements and other arrangements with referring physicians will comply with applicable state and federal self-referral and anti-kickback laws, including without limitation 42 U.S.C. Section 1320a-7b(b)(1) - (b)(2) 42 U.S.C. and 42 U.S.C. Section 1395nn and (iii)&#160;no event or related events occur that result in the exclusion of the Borrower or any of its Subsidiaries from participation in any Medical Reimbursement Program and (e)&#160;make commercially reasonable efforts to implement policies that are consistent with HIPAA on or before the date that the Borrower and the Domestic Subsidiaries are required to comply therewith.  The Borrower will maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">89</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Payment of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will, and will cause its Subsidiaries to, pay, settle or discharge all material taxes, assessments and governmental charges or levies imposed upon it, or upon its income or profits, or upon any of its properties, before they shall become delinquent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Borrower and its Subsidiaries shall not be required to pay any such tax, assessment, charge or levy which is being contested in good faith by appropriate proceedings and as to which adequate reserves have been established in accordance with GAAP, unless the failure to make any such payment (i) would give rise to an immediate right to foreclose or collect on a Lien securing such amounts or (ii) would reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will, and will cause each of its Subsidiaries to, at all times maintain in full force and effect insurance (including worker&#8217;s compensation, liability, casualty and business interruption insurance) with reputable national companies that are not Affiliates of the Borrower (except to the extent that self-insurance is maintained in reasonable amounts), in such amounts, covering such risks and liabilities as is reasonable and prudent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Maintenance of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will, and will cause its Subsidiaries to, maintain and preserve its properties and equipment that are used or useful in the conduct of business in good repair, working order and condition, normal wear and tear excepted, and will make, or cause to be made, in such properties and equipment from time to time all repairs, renewals, replacements, extensions, additions, betterments and improvements thereto as may be needed or proper, in each case to the extent and in the manner customary for companies in similar businesses, except where the failure to do so would not reasonably be expected to cause a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Borrower will use the proceeds of the Loans and the issuance of the Letters of Credit solely for working capital and other general corporate purposes of the Borrower and its Subsidiaries, including acquisitions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Borrower will not request any Loan or Letter of Credit, and the Borrower shall not use, and shall procure that its Subsidiaries and its or their respective directors, officers, employees and agents shall not use, the proceeds of any Loan or Letter of Credit (A) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, (B) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country, or (C) in any manner that would result in the violation of  any Sanctions applicable to any party hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Audits&#47;Inspections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon reasonable notice and during normal business hours, but not more than once per calendar year, the Borrower will, and will cause each of its Subsidiaries to, permit representatives appointed by the Administrative Agent or any Lender, including, without limitation, independent accountants, agents, attorneys and appraisers, to visit and inspect the Borrower&#8217;s or any Subsidiary&#8217;s Property, including its books and records, its accounts receivable and inventory, its facilities and its other business assets, and to make photocopies or photographs </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">90</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">thereof and to write down and record any information such representative obtains and shall permit the Administrative Agent, any Lender or its representatives to investigate and verify the accuracy of information provided to the Administrative Agent or the Lenders and to discuss all such matters with the officers, employees and representatives of the Borrower and&#47;or its Subsidiaries&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, during the existence of a Default or Event of Default, the Administrative Agent and the Lenders may request as many inspections as reasonable under the circumstances.  Any expenses incurred in connection with this Section&#160;7.9 shall be for the account of the Lenders unless an Event of Default exists, in which case such reasonable and documented out-of-pocket expenses shall be for the account of the Borrower.  Any representatives appointed by the Administrative Agent shall sign a confidentiality agreement reasonably acceptable to the Borrower prior to any visit, investigation, inspection or verification permitted by this Section&#160;7.9.  Notwithstanding the foregoing, neither the Borrower nor any of its Subsidiaries shall be required to (i) disclose documents where such disclosure could result in the loss of attorney-client privilege or a violation of applicable Laws or (ii) violate any confidentiality agreement with a Person other than the Borrower or a Subsidiary binding on it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Subsidiary Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If at any time any Domestic Subsidiary of the Borrower shall guarantee or otherwise become liable for any Material Debt of the Borrower, the Borrower shall so notify the Administrative Agent and promptly thereafter (but in any event within 10 days) shall cause such Domestic Subsidiary to (i) enter into a guarantee agreement, substantially in the form attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 7.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto and (ii)&#160;deliver such other documentation as the Administrative Agent may reasonably request in connection with the foregoing, including, without limitation, certified resolutions and other organizational and authorizing documents of such Subsidiary and favorable opinions of counsel to such Subsidiary (which shall cover, among other things, the legality, validity, binding effect and enforceability of the guarantee agreement referred to above), all in form, content and scope reasonably satisfactory to the Administrative Agent.  The Borrower further agrees to countersign any such guarantee agreement in the space provided therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Compliance Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will, and will cause each of its Domestic Subsidiaries that operates a clinical laboratory to, maintain, and be operated in accordance with, a compliance program which is reasonably designed to provide effective internal controls that promote adherence to applicable federal and state law and the program requirements of federal and state health plans, and which includes the implementation of internal audits and monitoring on a regular basis to monitor compliance with the requirements of the compliance program and applicable law, regulations and company policies.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">91</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt"><br><br>NEGATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower hereby covenants and agrees that so long as this Credit Agreement is in effect and until the Loans and LOC Obligations, together with interest, fees and other obligations then due and payable hereunder, have been paid in full (other than contingent obligations for which no claim has been made) and the Commitments and Letters of Credit hereunder shall have terminated or expired (or, in the case of Letters of Credit, the LOC Obligations have been cash collateralized)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Indebtedness of Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not permit any of its Subsidiaries to create, incur, assume or permit to exist any Indebtedness, other than&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Guarantee Obligations under guarantee agreements entered into pursuant to Section 7.10&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Indebtedness existing on the Restatement Effective Date as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Indebtedness in respect of current accounts payable and accrued expenses incurred in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Indebtedness owing by a Subsidiary of the Borrower to the Borrower or another Subsidiary of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no such Indebtedness shall be assigned or pledged to a Person other than the Borrower or a Subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">purchase money Indebtedness (including Capital Leases) to finance the purchase of any Property&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i) the total of all such Indebtedness shall not exceed an aggregate principal amount of $175,000,000 at any one time outstanding, (ii)&#160;such Indebtedness when incurred shall not exceed the purchase price of the asset(s) financed and (iii) no such Indebtedness shall be refinanced for a principal amount in excess of the principal balance outstanding thereon at the time of such refinancing&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Indebtedness arising from Permitted Receivables Financings in an amount not to exceed $1,000,000,000 in the aggregate at any one time outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Indebtedness evidenced by Hedging Agreements entered into in the ordinary course of business and not for speculative purposes&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">any guarantees of Indebtedness of the Borrower by its Domestic Subsidiaries&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that in the case of any guarantee by a Domestic Subsidiary of Material Debt of the Borrower, such Domestic Subsidiary becomes a guarantor of the Obligations as required by Section 7.10&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">92</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Indebtedness of any Person that becomes a Subsidiary after the Restatement Effective Date, and Indebtedness secured by any Property acquired by a Subsidiary after the Restatement Effective Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such Indebtedness exists at the time such Person becomes a Subsidiary or such Property is acquired, is not created in contemplation thereof or in connection therewith and is not assumed or guaranteed by any Subsidiary of the Borrower (unless such assumption or guarantee is permitted by another clause of this Section 8.1)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Indebtedness incurred after the Restatement Effective Date by Foreign Subsidiaries in an amount not to exceed $400,000,000 (or, the Dollar Equivalent thereof and measured for purposes of this clause (j), solely on the date of incurrence thereof) in the aggregate at any time outstanding&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Refinancing Indebtedness in respect of Indebtedness permitted under clauses (b) and (i) above&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">other secured or unsecured Indebtedness&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that at the time any such Indebtedness is incurred and after giving effect thereto, the aggregate amount of such Indebtedness and all outstanding Indebtedness theretofore incurred under this clause (l) does not exceed 15% of Net Worth at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not, nor will it permit its Subsidiaries to, create, incur, assume or permit to exist any Lien with respect to any of its Property of any kind (whether real or personal, tangible or intangible), whether now owned or after acquired, other than&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Permitted Liens&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Liens existing on the Restatement Effective Date and identified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Liens in connection with Indebtedness of the type permitted by Section 8.1(e) incurred by any Subsidiary on the assets financed with such Indebtedness or by Section 8.1(k) (but only in the case of Indebtedness permitted by Section 8.1(k) to the extent the refinanced Indebtedness was secured by Liens on the applicable asset)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Liens upon Property acquired (or the Property of a Subsidiary that is acquired) after the Restatement Effective Date by the Borrower or its Subsidiaries, which Liens existed on such Property before the time of such acquisition and were not created in anticipation thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; that (A)&#160;no such Lien shall extend to or cover any Property other than the Property so acquired and improvements thereon and proceeds thereof, and (B)&#160;the Indebtedness secured by any such Lien is permitted under Section 8.1(i)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Liens in connection with Permitted Receivables Financings&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">93</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Liens on Property of non-wholly owned Subsidiaries of the Borrower incurred to finance working capital&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Liens on Property of Foreign Subsidiaries securing Indebtedness of the type permitted by Section 8.1(j) incurred by Foreign Subsidiaries&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">other Liens securing Indebtedness or other obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that at the time any such Lien is incurred and after giving effect thereto, the aggregate amount of Indebtedness and other obligations secured thereby under this clause (h) does not exceed 15% of Net Worth at such time&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">renewals and extensions of the foregoing so long as such Liens (i) do not cover any additional Property, (ii) do not secure additional Indebtedness and (iii)&#160;are not otherwise prohibited by this Credit Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Sale and Leaseback Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not, and will not permit any of its Subsidiaries to, enter into any Sale and Leaseback Transactions unless, after giving effect thereto, all Attributable Debt in respect of such Sale and Leaseback Transactions (measured, in the case of each such Sale and Leaseback Transaction at the time it is entered into by the Borrower or its Subsidiary) does not exceed 15% of Net Worth. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Nature of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not, nor will it permit its Subsidiaries to, alter the character of its business from that conducted as of the Restatement Effective Date or engage in any substantial manner in any business other than (a) the business conducted by the Borrower and its Subsidiaries as of the Restatement Effective Date and (b) other healthcare-related businesses and businesses reasonably related thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that any business incidental, reasonably related or ancillary to the business conducted by the Borrower and the Subsidiaries, taken as a whole, on the Restatement Effective Date or reasonable extensions thereof shall be permitted hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Fundamental Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not enter into any transaction of merger or consolidation, or liquidate, wind up or dissolve itself, or suffer any such liquidation, winding-up or dissolution, or convey, sell, lease, transfer or otherwise voluntarily dispose of, in one transaction or a series of transactions, all or substantially all of its business or assets, whether now owned or hereafter acquired&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the Borrower may merge with a Subsidiary of the Borrower or any other Person if (a) the Borrower is the surviving Person and (b) at the time thereof and immediately after giving effect thereto no Default or Event of Default shall have occurred and be continuing or would result from such merger or consolidation. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Transactions with Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not, nor will it permit its Subsidiaries to, enter into any transaction or series of transactions, whether or not in the ordinary course of business, with any officer, director, shareholder or Affiliate other than on terms and conditions substantially as favorable as would be obtainable in a comparable arm&#8217;s-length transaction with a Person other than an officer, director, shareholder, Subsidiary or Affiliate, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">except</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, notwithstanding the foregoing, each of the following shall be permitted&#58;  (a)&#160;transactions between or among the Borrower and its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">94</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subsidiaries and transactions between or among Subsidiaries, (b)&#160;advances to employees in the ordinary course of business, (c)&#160;Dividends, (d)&#160;fees, compensation and other benefits paid to, and customary indemnity and reimbursement provided on behalf of, officers, directors and employees of the Borrower or any of its Subsidiaries in the ordinary course of business, (e)&#160;any employment agreements entered into by the Borrower or any of its Subsidiaries in the ordinary course of business, (f)&#160;any Permitted Receivables Financing and (g)&#160;transactions and agreements in existence on the Restatement Effective Date and listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and, in each case, any amendment thereto.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt"><br><br>EVENTS OF DEFAULT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">An Event of Default shall exist upon the occurrence, and during the continuation, of any of the following specified events (each an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall default in the payment (i) when due of any principal of any of the Loans or any reimbursement obligation arising from drawings under Letters of Credit or (ii)&#160;within three Business Days of when due of any interest on the Loans or any fees or other amounts owing hereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any representation, warranty or statement made or deemed to be made by the Borrower herein, in any of the other Credit Documents, or in any statement or certificate delivered or required to be delivered pursuant hereto or thereto shall prove untrue in any material respect on the date as of which it was made or deemed to have been made.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">default in the due performance or observance of any term, covenant or agreement contained in Sections 7.2, Section 7.3 or Section 7.10 or Section&#160;8&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">default in the due performance or observance by it of any term, covenant or agreement contained in Section 7.1 (excepting Section 7.1(e) for which the unremedied period shall only be five Business Days) and such default shall continue unremedied for a period of ten Business Days&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">default in the due performance or observance by it of any term, covenant or agreement (other than those referred to in subsections (a), (b), (c)(i) or (c)(ii) of this Section 9.1) contained in this Credit Agreement and such default shall continue unremedied for a period of at least 30 days after the earlier of an Authorized Officer of the Borrower becoming aware of such default or notice thereof given by the Administrative Agent.<br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">95</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Other Credit Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  (i) The Borrower shall default in the due performance or observance of any term, covenant or agreement in any of the other Credit Documents and such default shall continue unremedied for a period of at least 30 days after the earlier of an Authorized Officer of the Borrower becoming aware of such default or notice thereof given by the Administrative Agent, (ii) any Credit Document shall fail to be in full force and effect or the Borrower, or any future guarantor party thereto, shall so assert or (iii) any Credit Document shall fail to give the Administrative Agent and&#47;or the Lenders the rights, powers and privileges purported to be created by such Credit Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#91;Reserved&#93;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Bankruptcy, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The occurrence of any of the following with respect to the Borrower or any Domestic Subsidiary&#58; (i) a court or governmental agency having jurisdiction in the premises shall enter a decree or order for relief in respect of the Borrower or such Domestic Subsidiary in an involuntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or appoint a receiver, liquidator, assignee, custodian, trustee, sequestrator, administrator or similar official of the Borrower or such Domestic Subsidiary or for any substantial part of its Property or ordering the winding up or liquidation of, or an administrator in respect of, its affairs, (ii)&#160;an involuntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect is commenced against the Borrower or any Domestic Subsidiary and such petition remains unstayed and in effect for a period of 60 consecutive days, (iii) the Borrower or any Domestic Subsidiary shall commence a voluntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or consent to the entry of an order for relief in an involuntary case under any such law, or consent to the appointment or taking possession by a receiver, liquidator, assignee, custodian, trustee, sequestrator, administrator or similar official of such Person or any substantial part of its Property or make any general assignment for the benefit of creditors or (iv) the Borrower or any Domestic Subsidiary shall fail generally, or shall admit in writing its inability, to pay its debts as they become due or any action shall be taken by such Person in furtherance of any of the aforesaid purposes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Defaults under Other Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  With respect to any Indebtedness in excess of $200,000,000 (other than Indebtedness outstanding under this Credit Agreement) of the Borrower or any of its Subsidiaries (A) such Person shall (x) default in any payment (beyond the applicable grace period with respect thereto, if any) with respect to any such Indebtedness or (y) default (after giving effect to any applicable grace period) in the observance or performance of any covenant or agreement relating to such Indebtedness or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event or condition shall occur or condition exist, the effect of which default or other event or condition is to cause, or permit, the holder or holders of such Indebtedness (or trustee or agent on behalf of such holders, if any) to require any such Indebtedness to become due prior to its stated maturity, (B) any such Indebtedness shall be declared due and payable, or required to be prepaid other than by a regularly scheduled required prepayment prior to the stated maturity thereof or (C) any such Indebtedness shall mature and remain unpaid.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">96</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Judgments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  One or more judgments, orders, or decrees shall be entered against any one or more of the Borrower and its Subsidiaries involving a liability of $200,000,000 or more, in the aggregate, (to the extent not paid, covered by insurance provided by a carrier who has acknowledged coverage or covered by an indemnification from Corning Incorporated or SmithKline Beecham PLC) and such judgments, orders or decrees (i)&#160;are the subject of any enforcement proceeding commenced by any creditor or (ii)&#160;shall continue unsatisfied, undischarged and unstayed for a period ending on the first to occur of (A) the last day on which such judgment, order or decree becomes final and non-appealable or (B) 60 days.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The occurrence of any of the following events or conditions which individually or in the aggregate has had or would reasonably be expected to have a Material Adverse Effect&#58; (i) any Plan (other than a Multiemployer Plan) shall fail to meet the &#8220;minimum funding standard&#8221; (as such term is defined in Section 302 of ERISA and Section 412 of the Code) applicable to each Plan, in each instance, whether or not waived, or any Lien shall arise on the assets of the Borrower or any ERISA Affiliate in favor of the PBGC or a Plan, other than a Multiemployer Plan, (ii) an ERISA Event shall occur or (iii) the Borrower or any ERISA Affiliate fails to pay when due, after the expiration of any applicable grace period, any installment payment with respect to its withdrawal liability under Section 4201 of ERISA under a Multiemployer Plan in an aggregate amount in excess of $200,000,000.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Ownership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  There shall occur a Change of Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Acceleration&#59; Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon the occurrence and during the continuation of an Event of Default, the Administrative Agent may or shall, upon the request and direction of the Required Lenders, take the following actions without prejudice to the rights of the Administrative Agent or any Lender to enforce its claims against the Borrower, except as otherwise specifically provided for herein&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Termination of Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Declare the Commitments terminated whereupon the Commitments shall be immediately terminated.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Acceleration of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Declare the unpaid principal of and any accrued interest in respect of all Loans, any reimbursement obligations arising from drawings under Letters of Credit and any and all other Indebtedness or obligations of any and every kind owing by the Borrower to any of the Lenders under the Credit Documents to be due whereupon the same shall be immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Cash Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Direct the Borrower to pay (and the Borrower agrees that upon receipt of such notice, or upon the occurrence of an Event of Default under Section 9.1(f), it will immediately pay) to the Administrative Agent additional cash, to be held by the Administrative Agent, for the benefit of the Lenders, in a cash collateral account as additional security for the LOC Obligations in respect of subsequent drawings under all then outstanding Letters of Credit in an amount equal to the maximum aggregate amount which may be drawn under all Letters of Credits then outstanding.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">97</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Enforcement of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent permitted by law, enforce any and all rights and interests created and existing under the Credit Documents, including, without limitation, all rights of set-off.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if an Event of Default specified in Section 9.1(f) shall occur, then the Commitments shall automatically terminate and all Loans, all reimbursement obligations under Letters of Credit, all accrued interest in respect thereof, all accrued and unpaid fees and other indebtedness or obligations owing to the Lenders hereunder shall immediately become due and payable without the giving of any notice or other action by the Administrative Agent or the Lenders, which notice or other action is expressly waived by the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the fact that enforcement powers reside primarily with the Administrative Agent, each Lender has, to the extent permitted by law, a separate right of payment and shall be considered a separate &#8220;creditor&#8221; holding a separate &#8220;claim&#8221; within the meaning of Section 101(5) of the Bankruptcy Code or any other insolvency statute.  Notwithstanding the foregoing, no Lender shall have any right individually to enforce any guarantee agreement delivered pursuant to Section 7.10, it being understood and agreed that all powers, rights and remedies thereunder may be exercised solely by the Administrative Agent on behalf of the Lenders and the relevant Issuing Lender in accordance with the terms thereof.  Upon the execution of any guarantee pursuant to Section 7.10, each Lender will be deemed, by its acceptance of the benefits of such guarantee, to have agreed to the foregoing provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Allocation of Payments After Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any other provisions of this Credit Agreement, after the exercise of any remedies by the Administrative Agent or the Lenders pursuant to Section&#160;9.2 (or after any Event of Default that causes the Commitments to terminate and&#47;or all of the Obligations to be due hereunder), all amounts collected or received by the Administrative Agent or any Lender on account of amounts outstanding under any of the Credit Documents shall be paid over or delivered as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FIRST, to the payment of all reasonable and documented out-of-pocket costs and expenses (including without limitation reasonable and documented out-of-pocket Attorney Costs) of the Administrative Agent in connection with enforcing the rights of the Lenders under the Credit Documents, pro rata as set forth below&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECOND, to payment of any fees owed to the Administrative Agent, any Issuing Lender, the Swing Line Lender or any Lender, pro rata as set forth below&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIRD, to the payment of all accrued interest payable to the Lenders hereunder, pro rata as set forth below&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FOURTH, to the payment of the outstanding principal amount of the Loans and unreimbursed drawings under Letters of Credit, and to the payment or cash collateralization of the outstanding LOC Obligations, pro rata as set forth below&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FIFTH, to all other obligations which shall have become due and payable under the Credit Documents and not repaid pursuant to clauses &#8220;FIRST&#8221; through &#8220;FOURTH&#8221; above&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SIXTH, to the payment of the surplus, if any, to whoever may be lawfully entitled to receive such surplus.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In carrying out the foregoing, (a) amounts received shall be applied in the numerical order provided until exhausted prior to application to the next succeeding category&#59; (b) each of the Lenders shall receive an amount equal to its pro rata share (based on the proportion that the then-outstanding Loans, and LOC Obligations held by such Lender bears to the aggregate then-outstanding Loans and LOC Obligations of amounts available to be applied&#59; and (c)&#160;to the extent that any amounts available for distribution pursuant to clause &#8220;FOURTH&#8221; above are attributable to the issued but undrawn amount of outstanding Letters of Credit, such amounts shall be held by the Administrative Agent in a cash collateral account and applied (i)&#160;first, to reimburse the Issuing Lenders from time to time for any drawings under such Letters of Credit and (ii)&#160;then, following the expiration of all Letters of Credit, to all other obligations of the types described in clauses &#8220;FOURTH&#8221; and &#8220;FIFTH&#8221; above in the manner provided in this Section 9.3.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.36pt"><br><br>AGENCY PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Appointment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Each Lender hereby irrevocably appoints, designates and authorizes the Administrative Agent to take such action on its behalf under the provisions of this Credit Agreement and each other Credit Document and to exercise such powers and perform such duties as are expressly delegated to it by the terms of this Credit Agreement or any other Credit Document, together with such powers as are reasonably incidental thereto.  Notwithstanding any provision to the contrary contained elsewhere herein or in any other Credit Document, the Administrative Agent shall not have any duties or responsibilities, except those expressly set forth herein which duties shall be administrative in nature, nor shall the Administrative Agent have or be deemed to have any fiduciary or trustee relationship with any Lender or participant, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Credit Agreement or any other Credit Document or otherwise exist against the Administrative Agent.  Without limiting the generality of the foregoing sentence, the use of the term &#8220;agent&#8221; herein and in the other Credit Documents with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable law.  Instead, such term is used merely as a matter of market custom, and is intended to create or reflect only an administrative relationship between independent contracting parties.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">99</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Each Issuing Lender shall have all of the benefits and immunities (i)&#160;provided to the Administrative Agent in this Section 10 with respect to any acts taken by or omissions of any Issuing Lender in connection with Letters of Credit issued by it or proposed to be issued by it and the application and agreements for letters of credit pertaining to the Letters of Credit as fully as if the term &#8220;Administrative Agent&#8221; as used in this Section 10 included such Issuing Lender with respect to such acts or omissions and (ii)&#160;as additionally provided herein with respect to any Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Anything herein to the contrary notwithstanding, none of the Joint Bookrunners, Syndication Agent, Documentation Agents or Lead Arrangers listed on the cover page hereof shall have any powers, duties or obligations whatsoever under this Credit Agreement or the other Credit Documents, except in its capacity, as applicable, as Administrative Agent, a Lender or an Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Delegation of Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent may execute any of its duties under this Credit Agreement or any other Credit Document by or through Affiliates, agents, employees or attorneys-in-fact and shall be entitled to advice of counsel and other consultants or experts concerning all matters pertaining to such duties.  The Administrative Agent shall not be responsible for the negligence or misconduct of any agent or attorney-in-fact that it selects with reasonable care.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Exculpatory Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Agent-Related Person shall (a) be liable for any action taken or omitted to be taken by any of them under or in connection with this Credit Agreement or any other Credit Document or the transactions contemplated hereby (except for its own gross negligence or willful misconduct in connection with its duties expressly set forth herein) or (b) be responsible in any manner to any Lender or participant for any recital, statement, representation or warranty made by the Borrower or any officer thereof, contained herein or in any other Credit Document, or in any certificate, report, statement or other document referred to or provided for in, or received by the Administrative Agent under or in connection with, this Credit Agreement or any other Credit Document, or the validity, effectiveness, genuineness, enforceability or sufficiency of this Credit Agreement or any other Credit Document, or for any failure of the Borrower or any other party to any Credit Document to perform its obligations hereunder or thereunder.  No Agent-Related Person shall be under any obligation to any Lender or participant to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or conditions of, this Credit Agreement or any other Credit Document, or to inspect the properties, books or records of the Borrower or any of its Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Reliance on Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall be entitled to rely, and shall be fully protected in relying, upon any writing, communication, signature, resolution, representation, notice, consent, certificate, affidavit, letter, telegram, facsimile, telex or telephone message, statement or other document or conversation believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons, and upon advice and statements of legal counsel (including counsel to the Borrower), independent accountants and other experts selected by the Administrative Agent.  The Administrative Agent may deem and treat each Lender as the owner of its interests hereunder for all purposes unless a written notice of assignment, negotiation or transfer thereof shall have been delivered to the Administrative Agent in accordance with Section 11.3(b).  The Administrative Agent shall be fully justified in failing or refusing to take any action </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">under any Credit Document unless it shall first receive such advice or concurrence of the Required Lenders as it deems appropriate and, if it so requests, it shall first be indemnified to its satisfaction by the Lenders against any and all liability and expense which may be incurred by it by reason of taking or continuing to take any such action.  The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Credit Agreement or any other Credit Document in accordance with a request or consent of the Required Lenders or all the Lenders, if required hereunder, and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders and participants, and their respective successors and assigns.  Where this Credit Agreement expressly permits or prohibits an action unless the Required Lenders otherwise determine, the Administrative Agent shall, and in all other instances, the Administrative Agent may, but shall not be required to, initiate any solicitation for the consent or a vote of the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">For purposes of determining compliance with the conditions specified in Section 5.1, each Lender that has signed this Credit Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter either sent by the Administrative Agent to such Lender for consent, approval, acceptance or satisfaction, or required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Notice of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or Event of Default, except with respect to defaults in the payment of principal, interest and fees required to be paid to the Administrative Agent for the account of the Lenders, unless the Administrative Agent shall have received written notice from a Lender or the Borrower referring to this Credit Agreement, describing such Default or Event of Default and stating that such notice is a &#8220;notice of default.&#8221;  The Administrative Agent will notify the Lenders of its receipt of any such notice.  The Administrative Agent shall take such action with respect to such Default or Event of Default as may be reasonably directed by the Required Lenders in accordance with Section 9.2&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that unless and until the Administrative Agent has received any such direction, the Administrative Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable or in the best interest of the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Non-Reliance on Administrative Agent and Other Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Lender and Issuing Lender acknowledges that no Agent-Related Person has made any representation or warranty to it, and that no act by the Administrative Agent hereinafter taken, including any consent to and acceptance of any assignment or review of the affairs of the Borrower or any of its Affiliates, shall be deemed to constitute any representation or warranty by any Agent-Related Person to any Lender as to any matter, including whether Agent-Related Persons have disclosed material information in their possession.  Each Lender and Issuing Lender represents to the Administrative Agent that it has, independently and without reliance upon any Agent-Related Person, any Issuing Lender or any other Lender and based on such documents and information as it has deemed appropriate, made its own appraisal of and investigation into the business, prospects, operations, Property, financial and other condition and creditworthiness of the Borrower and its Affiliates, and all applicable bank or other regulatory laws relating to the transactions contemplated hereby, and made its own decision to enter into this Credit Agreement and to extend credit to the Borrower hereunder.  Each Lender and Issuing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">101</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Lender also represents that it will, independently and without reliance upon any Agent-Related Person, any Issuing Lender or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Credit Agreement and the other Credit Documents, and to make such investigations as it deems necessary to inform itself as to the business, prospects, operations, Property, financial and other condition and creditworthiness of the Borrower.  Except for notices, reports and other documents expressly required to be furnished to the Lenders by the Administrative Agent herein, the Administrative Agent shall not have any duty or responsibility to provide any Lender or Issuing Lender with any credit or other information concerning the business, prospects, operations, Property, financial and other condition or creditworthiness of the Borrower or any of its Affiliates which may come into the possession of any Agent-Related Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">To the extent that the Borrower for any reason fails to indefeasibly pay any amount required under Section 11.5 to be paid by it to the Administrative Agent (or any sub-agent thereof), the relevant Issuing Lender or any Agent-Related Person of any of the foregoing, each Lender severally, not jointly, agrees to pay to the Administrative Agent (or any such sub-agent), each relevant Issuing Lender or such Agent-Related Person, as the case may be, such Lender&#8217;s  Revolving Loan Commitment Percentage (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent (or any such sub-agent) or such Issuing Lender in its capacity as such, or against any Agent-Related Person of any of the foregoing acting for the Administrative Agent (or any such sub-agent) or such Issuing Lender in connection with such capacity.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Each Lender shall severally indemnify the Administrative Agent for (i) any Taxes attributable to such Lender and paid by the Administrative Agent (but only to the extent the Borrower has not already indemnified the Administrative Agent for such Taxes and without limiting the obligation of the Borrower to do so), (ii) any taxes attributable to such Lender that are excluded from the definition of Taxes in Section 3.13(a) or 3.13(f) and that are paid by the Administrative Agent, (iii) any taxes attributable to such Lender&#8217;s failure to comply with the provisions of Section 11.3(d) relating to the maintenance of a Participant Register and (iv) any liability arising from or with respect to any taxes described in clauses&#160;(i), (ii) or (iii) above (including any taxes imposed or asserted by any jurisdiction on amounts payable under this Section 10.7(b), penalties, interest and reasonable expenses).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">102</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Administrative Agent in Its Individual Capacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">JPMorgan and its Affiliates may make loans to, issue letters of credit for the account of, accept deposits from, acquire Capital Stock of and generally engage in any kind of banking, trust, financial advisory, underwriting or other business with the Borrower and its Affiliates as though JPMorgan were not the Administrative Agent or an Issuing Lender hereunder and without notice to or consent of the Lenders.  The Lenders and Issuing Lenders acknowledge that, pursuant to such activities, JPMorgan or its Affiliates may receive information regarding the Borrower or its Affiliates (including information that may be subject to confidentiality obligations in favor of the Borrower or such Affiliate) and that the Administrative Agent shall be under no obligation to provide such information to them.  With respect to its Loans, JPMorgan shall have the same rights and powers under this Credit Agreement as any other Lender and may exercise such rights and powers as though it were not the Administrative Agent or an Issuing Lender, and the terms &#8220;Lender&#8221; and &#8220;Lenders&#8221; include JPMorgan in its individual capacity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Successor Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent may resign as Administrative Agent upon 30 days&#8217; notice to the Lenders.  If the Administrative Agent resigns under this Credit Agreement, the Required Lenders shall appoint from among the Lenders a successor administrative agent for the Lenders (such appointment, absent the existence of an Event of Default, to be subject to the consent of the Borrower, which consent of the Borrower shall not be unreasonably withheld or delayed).  If no successor administrative agent is appointed prior to the effective date of the resignation of the Administrative Agent, the Administrative Agent may appoint, after consulting with the Lenders and the Borrower, a successor administrative agent from among the Lenders.  Upon the acceptance of its appointment as successor administrative agent hereunder, such successor administrative agent shall succeed to all the rights, powers and duties of the retiring Administrative Agent and the term &#8220;Administrative Agent&#8221; shall mean such successor administrative agent and the retiring Administrative Agent&#8217;s appointment, powers and duties as Administrative Agent shall be terminated.  After any retiring Administrative Agent&#8217;s resignation hereunder as Administrative Agent, the provisions of this Section 10 and Sections 11.5 and 11.9 shall continue to inure to its benefit as to any actions taken or omitted to be taken by it while it was Administrative Agent under this Credit Agreement.  If no successor administrative agent has accepted appointment as Administrative Agent by the date which is 30 days following a retiring Administrative Agent&#8217;s notice of resignation, the retiring Administrative Agent&#8217;s resignation shall nevertheless thereupon become effective and the Lenders shall perform all of the duties of the Administrative Agent hereunder until such time, if any, as the Required Lenders appoint a successor agent as provided for above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Agent May&#160;File Proofs of Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In case of the pendency of any receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding relative to the Borrower or any of its Subsidiaries, the Administrative Agent (irrespective of whether the principal of any Loan shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on the Borrower) shall be entitled and empowered, by intervention in such proceeding or otherwise&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">103</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders and the Administrative Agent (including any claim for the reasonable and documented out-of-pocket compensation, expenses, disbursements and advances of the Lenders and the Administrative Agent and their respective agents and counsel and all other amounts due the Lenders and the Administrative Agent) allowed in such judicial proceeding&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Lender to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders, to pay to the Administrative Agent any amount due for the reasonable and documented out-of-pocket compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the Administrative Agent under the Credit Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of any Lender any plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender or to authorize the Administrative Agent to vote in respect of the claim of any Lender in any such proceeding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Certain Lender Representations, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Each Lender represents and warrants, as of the date such Person became a Lender party hereto, to, and covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of the Administrative Agent and the institutions named as Joint Lead Arrangers, Joint Bookrunners, Syndication Agent and Documentation Agents listed on the cover page hereof and their respective Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Borrower or any of its Subsidiaries, that at least one of the following is and will be true&#58;   </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">such Lender is not using &#8220;plan assets&#8221; (within the meaning of 29 CFR &#167; 2510.3-101, as modified by Section 3(42) of ERISA) of one or more Benefit Plans in connection with the Commitments,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Commitments and this Credit Agreement, (C) the entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement, or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In addition, unless clause (i) of the immediately preceding paragraph is true with respect to such Lender or such Lender has not provided another representation, warranty and covenant as provided in clause (iv) of the immediately preceding paragraph, such Lender further represents and warrants, as of the date such Person became a Lender party hereto, to, and covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and the institutions named as Bookrunners, Syndication Agent, Documentation Agents or Lead Arrangers on the cover page hereof and their respective Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Borrower or any of its Subsidiaries, that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">none of the Administrative Agent or any of the institutions named as Joint Lead Arrangers, Joint Bookrunners, Syndication Agent and Documentation Agents on the cover page hereof or their respective Affiliates is a fiduciary with respect to the assets of such Lender (including in connection with the reservation or exercise of any rights by any Person under this Credit Agreement or any documents related to hereto or thereto),</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">the Person making the investment decision on behalf of such Lender with respect to the entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement is independent (within the meaning of 29 CFR &#167; 2510.3-21) and is a bank, an insurance carrier, an investment adviser, a broker-dealer or other person that holds, or has under management or control, total assets of at least $50,000,000, in each case as described in 29 CFR &#167; 2510.3-21(c)(1)(i)(A)-(E),</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">the Person making the investment decision on behalf of such Lender with respect to the entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement is capable of evaluating investment risks independently, both in general and with regard to particular transactions and investment strategies,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">105</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">the Person making the investment decision on behalf of such Lender with respect to the entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement is a fiduciary under ERISA or the Code, or both, with respect to the Commitments and this Credit Agreement and is responsible for exercising independent judgment in evaluating the transactions hereunder, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">no fee or other compensation is being paid directly to the Administrative Agent or any of the institutions named as Joint Lead Arrangers, Joint Bookrunners, Syndication Agent and Documentation Agents on the cover page of this Credit Agreement or their respective Affiliates for investment advice (as opposed to other services) in connection with the Commitments or this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent and the institutions named as Joint Lead Arrangers, Joint Bookrunners, Syndication Agent and Documentation Agents on the cover page of this Credit Agreement hereby inform the Lenders that each such Person is not undertaking to provide impartial investment advice, or to give advice in a fiduciary capacity, in connection with the transactions contemplated hereby, and that such Person has a financial interest in the transactions contemplated hereby in that such Person or an Affiliate thereof (i) may receive interest or other payments with respect to the Commitments and this Credit Agreement, (ii) may recognize a gain if it extended the Commitments for an amount less than the amount being paid for an interest in the Commitments by such Lender or (iii) may receive fees or other payments in connection with the transactions contemplated hereby or otherwise, including structuring fees, commitment fees, arrangement fees, facility fees, upfront fees, underwriting fees, ticking fees, agency fees, administrative agent or collateral agent fees, utilization fees, minimum usage fees, letter of credit fees, fronting fees, deal-away or alternate transaction fees, amendment fees, processing fees, term out premiums, banker&#8217;s acceptance fees, breakage or other early termination fees or fees similar to the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">(i) Each Lender hereby agrees that (x) if the Administrative Agent notifies&#160;such Lender that the Administrative Agent has determined&#160;in its sole discretion that any funds received by such Lender from the Administrative Agent or any of its Affiliates (whether as a payment, prepayment or repayment of principal, interest, fees or otherwise&#59; individually and collectively, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) were erroneously transmitted to such Lender (whether or not known to such Lender), and demands the return of such Payment (or a portion thereof), such Lender shall promptly, but in no event later than one Business Day thereafter, return to the Administrative Agent the amount of any such Payment (or portion thereof) as to which such a demand was made in same day funds, together with interest thereon in respect of each day from and including the date such Payment (or portion thereof) was received by such Lender to the date such amount is repaid to the Administrative Agent at the greater of the NYFRB Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect, and (y) to the extent permitted by applicable law, such Lender shall not assert, and hereby waives, as to the Administrative Agent, any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by the Administrative Agent for the return of any Payments received, including without limitation any defense based on &#8220;discharge for value&#8221; or any similar doctrine.  A notice of the Administrative Agent to any Lender under this Section 10.11(d) shall be conclusive, absent manifest error.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">106</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">Each Lender hereby further agrees that if it&#160;receives a Payment from the Administrative Agent or any of its Affiliates (x) that is in a different amount than, or on a different date from, that specified in a notice of payment sent by the Administrative Agent (or any of its Affiliates) with respect to such Payment (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or (y) that was not preceded or accompanied by a Payment Notice, it shall be on notice, in each such case, that an error has been made with respect to such Payment.&#160; Each Lender agrees that, in each such case, or if it otherwise becomes aware a Payment (or portion thereof) may have been sent in error, such Lender shall promptly notify the Administrative Agent of such occurrence and, upon demand from the Administrative Agent, it shall promptly, but in no event later than one Business Day thereafter, return to the Administrative Agent the amount of any such Payment (or portion thereof) as to which such a demand was made in same day funds, together with interest thereon in respect of each day from and including the date such Payment (or portion thereof) was received by such Lender to the date such amount is repaid to the Administrative Agent at the greater of the NYFRB Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">The Borrower hereby agrees that (x) in the event an erroneous Payment (or portion thereof) are not recovered from any Lender that has received such Payment (or portion thereof) for any reason, the Administrative Agent shall be subrogated to all the rights of such Lender with respect to such amount and (y) an erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed by the Borrower, except, in each case, to the extent such erroneous Payment is, and solely with respect to the amount of such erroneous Payment that is, comprised of funds received by the Administrative Agent or any of its Affiliates from the Borrower.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">Each party&#8217;s obligations under this Section 10.11(d) shall survive the resignation or replacement of the Administrative Agent or any transfer of rights or obligations by, or the replacement of, a Lender, the termination of the Commitments or the repayment, satisfaction or discharge of all Obligations under any Credit Document.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.36pt"><br><br>MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Notices, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Unless otherwise expressly provided herein, all notices and other communications provided for hereunder shall be in writing (including by facsimile transmission).  All such written notices shall be mailed by certified or registered mail, faxed or delivered to the applicable address, facsimile number or (subject to subsection&#160;(c) below) electronic mail address, and all notices and other communications expressly permitted hereunder to be given by telephone shall be made to the applicable telephone number, as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">if to the Borrower, to the address, facsimile number, electronic mail address or telephone number specified for the Borrower on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or to such other address, facsimile number, electronic mail address or telephone number as shall be designated by such party in a notice to the other parties&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">107</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">if to the Administrative Agent or to the Swing Line Lender, to JPMorgan Chase Bank, N.A., 10&#160;South Dearborn, Floor L2, Suite IL1-0480, Chicago, IL 60603-2300, Attention of Selena Shofner (Email&#58; selena.shofner&#64;chase.com) with copy(s) to JPMorgan Chase Bank, N.A., Middle Market Servicing, 10&#160;South Dearborn, Floor L2, Suite&#160;IL10480, Chicago, IL 60603-2300, Attention of Commercial Banking Group (Facsimile No. (844) 490-5663) (Email&#58; jpm.agency.cri&#64;jpmorgan.com&#59; jpm.agency.servicing.1&#64;jpmorgan.com)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">if to JPMorgan, in its capacity as an Issuing Lender, to JPMorgan Chase Bank, N.A., 10&#160;South Dearborn, Floor L2, Suite&#160;IL10480, Chicago, IL 60603-2300, Attention of LC Agency Team (Telephone No. (800) 364-1969) (Facsimile No. (856) 294-5267) (Email&#58; chicago.lc.agency.activity.team&#64;jpmchase.com)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">if to Morgan Stanley Bank, N.A., in its capacity as an Issuing Lender, to Morgan Stanley Bank, N.A., 1000 Lancaster Street, Baltimore, MD 21202, United States, Attention of Morgan Stanley Loan Servicing (Facsimile No. (718) 233-2140) (Email&#58; msloanservicing&#64;morganstanley.com)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">if to Mizuho Bank, Ltd., in its capacity as an Issuing Lender, to Mizuho Bank, Ltd., 1800 Plaza Ten, Harborside Financial Ctr., Jersey City, NJ 07311, United States, Attention of Shirly Wu (Facsimile No. (201) 626-9941) (Email&#58;&#160;LAU_USCorp2&#64;mizuhocbus.com)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">if to Wells Fargo Bank, N.A., in its capacity as an Issuing Lender, to Wells Fargo Bank, N.A., 401 N. Research Pkwy., Winston-Salem, NC 27101, United States, Attention of SBLC New (Email&#58; SLBC-New&#64;wellsfargo.com)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15.36pt">if to any other Lender, to the address, facsimile number, electronic mail address or telephone number specified in its Administrative Questionnaire provided by the Administrative Agent or to such other address, facsimile number, electronic mail address or telephone number as shall be designated by such party in a notice to the Borrower and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notices sent by hand or overnight courier service, or mailed by certified or registered mail, shall be deemed to have been given when received&#59; notices sent by facsimile shall be deemed to have been given when sent (except that, if not given during normal business hours for the recipient, such notices shall be deemed to have been given at the opening of business on the next Business Day for the recipient).  Notices delivered through electronic communications to the extent provided in subsection (b) below, shall be effective as provided in such subsection (b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notices and other communications to the Lenders hereunder may be delivered or furnished by electronic communication (including email and Internet or intranet websites) pursuant to procedures approved by the Administrative Agent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the foregoing shall not apply to notices to any Lender pursuant to Section 2 if such Lender has notified the Administrative Agent that it is incapable of receiving notices under such</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">108</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Section 2 by electronic communication.  The Administrative Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that approval of such procedures may be limited to particular notices or communications.  Unless the Administrative Agent otherwise prescribes, (i) notices and other communications sent to an e-mail address shall be deemed received upon the sender&#8217;s receipt of an acknowledgement from the intended recipient (such as by the &#8220;return receipt requested&#8221; function, as available, return e-mail or other written acknowledgement), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next Business Day for the recipient, and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing clause&#160;(i) of notification that such notice or communication is available and identifying the website address therefor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">The Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  THE PLATFORM IS PROVIDED &#8220;AS IS&#8221; AND &#8220;AS AVAILABLE.&#8221; THE AGENT-RELATED PERSONS DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY ANY AGENT-RELATED PERSON IN CONNECTION WITH THE BORROWER MATERIALS OR THE PLATFORM. In no event shall the Agent-Related Persons have any liability to the Borrower, any Lender or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of the Borrower&#8217;s or the Administrative Agent&#8217;s transmission of Borrower Materials through the Internet, except to the extent that such losses, claims, damages, liabilities or expenses are determined by a court of competent jurisdiction by a final and non-appealable judgment to have resulted from the gross negligence, bad faith or willful misconduct of such Agent-Related Person&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in no event shall any Agent-Related Person have any liability to the Borrower, any Lender or any other Person for indirect, special, incidental, consequential or punitive damages (as opposed to direct or actual damages).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Effectiveness of Facsimile or Electronically Transmitted Documents and Signatures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Credit Documents may be transmitted and&#47;or signed by facsimile or other electronic means (e.g. &#8220;.pdf&#8221; or &#8220;.tif&#8221;).  The effectiveness of any such documents and signatures shall, subject to applicable law, have the same force and effect as manuallysigned originals and shall be binding on the Borrower, the Administrative Agent and the Lenders.  The Administrative Agent may also require that any such documents and signatures be confirmed by a manuallysigned original thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the failure to request or deliver the same shall not limit the effectiveness of any document or signature transmitted by facsimile or other electronic means (e.g. &#8220;.pdf&#8221; or &#8220;.tif&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Reliance by Administrative Agent and Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrative Agent and the Lenders shall be entitled to rely and act upon any notices (including telephonic notices) purportedly given by or on behalf of the Borrower even if (i)&#160;such notices were not made in a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">109</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">manner specified herein, were incomplete or were not preceded or followed by any other form of notice specified herein, or (ii)&#160;the terms thereof, as understood by the recipient, varied from any confirmation thereof.  The Borrower shall indemnify each AgentRelated Person and each Lender from all losses, costs, expenses and liabilities resulting from the reliance by such Person on each notice purportedly given by or on behalf of the Borrower.  All telephonic notices to and other communications with the Administrative Agent may be recorded by the Administrative Agent, and each of the parties hereto hereby consents to such recording.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Change of Address, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each of the Borrower, the Administrative Agent, each Issuing Lender and the Swing Line Lender may change its address, telecopier or telephone number for notices and other communications hereunder by written notice to the other parties hereto.  Each other Lender may change its address, telecopier or telephone number for notices and other communications hereunder by notice to the Borrower, the Administrative Agent, each Issuing Lender and the Swing Line Lender.  In addition, each Lender agrees to notify the Administrative Agent from time to time to ensure that the Administrative Agent has on record (i) an effective address, contact name, telephone number, telecopier number and electronic mail address to which notices and other communications may be sent and (ii) accurate wire instructions for such Lender.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Right of Set-Off</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to any rights now or hereafter granted under applicable law or otherwise, and not by way of limitation of any such rights, upon the occurrence of an Event of Default and the commencement of remedies described in Section 9.2, each Lender is authorized at any time and from time to time, without presentment, demand, protest or other notice of any kind (all of which rights being hereby expressly waived), to set-off and to appropriate and apply any and all deposits (general or special) and any other indebtedness at any time held or owing by such Lender (including, without limitation, branches, agencies or Affiliates of such Lender wherever located) to or for the credit or the account of the Borrower against obligations and liabilities of the Borrower to the Lenders hereunder, under the Notes, the other Credit Documents or otherwise, irrespective of whether the Administrative Agent or the Lenders shall have made any demand hereunder and although such obligations, liabilities or claims, or any of them, may be contingent or unmatured, and any such set-off shall be deemed to have been made immediately upon the occurrence of an Event of Default even though such charge is made or entered on the books of such Lender subsequent thereto.  The Borrower hereby agrees that any Person purchasing a participation in the Loans and Commitments hereunder pursuant to Section 11.3(d) or 3.8 may exercise all rights of set-off with respect to its participation interest as fully as if such Person were a Lender hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Benefit of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The provisions of this Credit Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby, except that the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of each Lender and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i)&#160;to an Eligible Assignee in accordance with the provisions of subsection&#160;(b) of this Section, (ii)&#160;by way of participation in accordance with the provisions of subsection&#160;(d) of this Section, (iii)&#160;by way of pledge or assignment of a security interest subject to the restrictions of subsection&#160;(f) of this Section or (iv) to an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SPC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> in accordance with the provisions of subsection (g) of this Section (and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">110</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any other attempted assignment or transfer by any party hereto shall be null and void).  Nothing in this Credit Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, Loan Participants to the extent provided in subsection&#160;(d) of this Section and, to the extent expressly contemplated hereby, the Indemnitees) any legal or equitable right, remedy or claim under or by reason of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Assignments by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any Lender may at any time assign to one or more assignees all or a portion of its rights and obligations under this Credit Agreement (including all or a portion of its Commitment and the Loans (including participations in LOC Obligations and in Swing Line Loans) at the time owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that any such assignment shall be subject to the following conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Minimum Amounts.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">in the case of an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitment and the Loans at the time owing to it or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">in any case not described in subsection (b)(i)(A) of this Section, the aggregate amount of the Commitment (which for this purpose includes Loans outstanding thereunder) or, if the applicable Commitment is not then in effect, the principal outstanding balance of the Loans of the assigning Lender subject to each such assignment, shall not be less than $5,000,000 unless the Administrative Agent and, so long as no Event of Default has occurred and is continuing, the Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that concurrent assignments to members of an Assignee Group and concurrent assignments from members of an Assignee Group to a single Eligible Assignee (or to an Eligible Assignee and members of its Assignee Group) will be treated as a single assignment for purposes of determining whether such minimum amount has been met.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt;text-decoration:underline">Proportionate Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations under this Credit Agreement with respect to the Loans or the Commitment assigned, except that this clause (ii) shall not apply to the Swing Line Lender&#8217;s rights and obligations in respect of Swing Line Loans&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Required Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No consent shall be required for any assignment except to the extent required by subsection (b)(i)(B) of this Section and as set forth below&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">the consent of the Borrower (such consent not to be unreasonably withheld or delayed) shall be required unless (1) an Event of Default has occurred and is continuing at the time of such assignment or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">111</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;such assignment is to a Lender, an Affiliate of a Lender or an Approved Fund, and such consent shall be deemed given if no objection is received by the assigning Lender and the Administrative Agent from the Borrower within five Business Days after notice of such proposed assignment has been delivered to the Borrower&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">the consent of the Administrative Agent (such consent not to be unreasonably withheld or delayed) shall be required for any assignment in respect of the Revolving Credit Facility unless such assignment is to a Lender or an Affiliate of a Lender&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">the consent of each Issuing Lender (such consent not to be unreasonably withheld or delayed) shall be required for any assignment that increases the obligation of the assignee to participate in exposure under one or more Letters of Credit (whether or not then outstanding)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">the consent of the Swing Line Lender (such consent not to be unreasonably withheld or delayed) shall be required for any assignment in respect of the Revolving Credit Facility.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee in the amount of $3,500&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Administrative Agent may, in its sole discretion, elect to waive such processing and recordation fee in the case of any assignment.  The assignee, if it is not a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">No Assignment to Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No such assignment shall be made to the Borrower or any of the Borrower&#8217;s Affiliates or Subsidiaries.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt;text-decoration:underline">No Assignment to Natural Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No such assignment shall be made to a natural person.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subject to acceptance and recording thereof by the Administrative Agent pursuant to subsection (c) of this Section, from and after the effective date specified in each Assignment and Assumption, the assignee thereunder shall be a party to this Credit Agreement and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Credit Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Credit Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Credit Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 3.9, 3.12, 3.13, 3.14 and 11.5 with respect to facts and circumstances occurring prior to the effective date of such assignment).  Upon request, the Borrower (at its expense) shall execute and deliver a Note to the assignee Lender.  Any assignment or transfer by a Lender of rights or obligations under this Credit Agreement that does not comply with this subsection shall be treated for purposes of this Credit Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with subsection (d) of this Section.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">112</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrative Agent, acting solely for this purpose as an agent of the Borrower, shall maintain at the Agency Service Address a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) of the Loans owing to, each Lender pursuant to the terms hereof from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The entries in the Register shall be conclusive (absent manifest error), and the Borrower, the Administrative Agent and the Lenders may treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Credit Agreement, notwithstanding notice to the contrary.  The Register shall be available for inspection by the Borrower, at any reasonable time and from time to time upon reasonable prior notice. In addition, the Register shall be available for inspection by any Lender as to entries pertaining to it at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any Lender may at any time, without the consent of, or notice to, the Borrower, any Issuing Lender, the Swing Line Lender or the Administrative Agent, sell participations to any Person (other than a natural person or the Borrower or any of the Borrower&#8217;s Affiliates or Subsidiaries or any competitor of the Borrower identified in a letter dated the Restatement Effective Date of the Borrower to the Administrative Agent (as such letter may be amended, amended and restated, supplemented or otherwise modified by the Borrower from time to time to identify additional Persons engaged in the business in which the Borrower is engaged), which letter shall be made available to the Lenders) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), in all or a portion of such Lender&#8217;s rights and&#47;or obligations under this Credit Agreement (including all or a portion of its Commitment and&#47;or the Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i)&#160;such Lender&#8217;s obligations under this Credit Agreement shall remain unchanged, (ii)&#160;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (iii)&#160;the Borrower, the Administrative Agent and the other Lenders shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Credit Agreement.  Each Lender that sells a participation pursuant to this Section 11.3(d) shall, acting as a non-fiduciary agent of the Borrower solely for the purpose of maintaining a register in order to satisfy the requirements of Section 5f.103-1(c) of the United States Treasury Regulations, maintain a register on which it records the name and address of each Loan Participant to which it has sold a participation and the principal amounts (and stated interest) of each such Loan Participant&#8217;s interest in the Loans or other rights and obligations of such Lender under this Credit Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no Lender shall have any obligation to disclose all or any portion of the Participant Register to any Person (including the identity of any Loan Participant or any information relating to a Loan Participant&#8217;s interest in any Commitments, Loans, Letters of Credit or its other obligations under any this Credit Agreement) except to the extent that such disclosure is necessary to establish that such Commitment, Loan, Letter of Credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations.  The entries in the Participant Register shall be conclusive absent manifest error.  Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Credit Agreement and to approve any amendment, modification or waiver of any provision of this Credit Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such agreement or instrument may provide that such Lender will not, without the consent of the Loan Participant, agree to any amendment, waiver or other modification that would change the amount, interest rate or maturity of the Loans or any other matter that requires unanimous consent of all of the Lenders.  Subject to subsection&#160;(e) of this Section, the Borrower agrees that each Loan Participant shall be entitled to the benefits of Sections&#160;3.9, 3.12, 3.13 and 3.14 to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to subsection&#160;(b) of this Section.  To the extent permitted by law, each Loan Participant also shall be entitled to the benefits of Section&#160;11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as though it were a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">113</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Lender, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> such Loan Participant agrees to be subject to Section&#160;3.8 as though it were a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Loan Participant&#8217;s Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A Loan Participant shall not be entitled to receive any greater payment under Section&#160;3.9, 3.12 or 3.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">than the applicable Lender would have been entitled to receive with respect to the participation sold to such Loan Participant, unless the sale of the participation to such Loan Participant is made with the Borrower&#8217;s prior written consent.  A Loan Participant that would be a foreign Lender if it were a Lender shall not be entitled to the benefits of Section&#160;3.13 unless the Borrower is notified of the participation sold to such Loan Participant, the participating Lender provides the Borrower with an IRS Form W-8IMY and such Loan Participant agrees, for the benefit of the Borrower, to comply with Section&#160;3.13 as though it were a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Unrestricted Assignments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Credit Agreement (including under its Note(s), if any) to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank, and this Section shall not apply to any such pledge or assignment of a security interest&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Special Purpose Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary contained herein, so long as any action in accordance with this Section 11.3(g) does not cause increased costs or expenses for the Borrower, any Lender (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Granting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) may grant to a special purpose funding vehicle (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SPC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) the option to fund all or any part of any Loan that such Granting Lender would otherwise be obligated to fund pursuant to this Credit Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i)&#160;nothing herein shall constitute a commitment by any SPC to fund any Loan, (ii)&#160;if an SPC elects not to exercise such option or otherwise fails to fund all or any part of such Loan, the Granting Lender shall be obligated to fund such Loan pursuant to the terms hereof, (iii)&#160;no SPC shall have any voting rights pursuant to Section&#160;11.6 and (iv)&#160;with respect to notices, payments and other matters hereunder, the Borrower, the Administrative Agent and the Lenders shall not be obligated to deal with an SPC, but may limit their communications and other dealings relevant to such SPC to the applicable Granting Lender.  The funding of a Loan by an SPC hereunder shall utilize the Commitment of the Granting Lender to the same extent that, and as if, such Loan were funded by such Granting Lender.  Each party hereto hereby agrees that no SPC shall be liable for any indemnity or payment under this Credit Agreement for which a Lender would otherwise be liable for so long as, and to the extent, the Granting Lender provides such indemnity or makes such payment.  Notwithstanding anything to the contrary contained in this Credit Agreement, any SPC may disclose any non-public information relating to its funding of Loans to any rating agency, commercial paper dealer or provider of any surety or guarantee to such SPC so long as such disclosure is clearly designated as being made on a confidential basis.  This Section&#160;11.3(g) may not be amended without the prior written consent of each Granting Lender, all or any part of whose Loan is being funded by an SPC at the time of such amendment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">114</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Electronic Execution of Assignments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; and words of like import in any Assignment and Assumption shall be deemed to include Electronic Signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">No Waiver&#59; Remedies Cumulative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No failure or delay on the part of the Administrative Agent or any Lender in exercising any right, power or privilege hereunder or under any other Credit Document and no course of dealing between the Borrower and the Administrative Agent or any Lender shall operate as a waiver thereof&#59; nor shall any single or partial exercise of any right, power or privilege hereunder or under any other Credit Document preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder or thereunder.  The rights and remedies provided herein are cumulative and not exclusive of any rights or remedies which the Administrative Agent or any Lender would otherwise have.  No notice to or demand on the Borrower in any case shall entitle the Borrower to any other or further notice or demand in similar or other circumstances or constitute a waiver of the rights of the Administrative Agent or the Lenders to any other or further action in any circumstances without notice or demand.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Payment of Expenses&#59; Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Borrower shall pay on demand&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">any and all Attorney Costs and reasonable and documented out-of-pocket costs and expenses incurred by the Administrative Agent, the Lead Arrangers and their respective Affiliates in connection with the drafting, negotiation and administration of the Credit Documents and any amendments thereto and the closing of the transactions contemplated thereby&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">all reasonable and documented out-of-pocket costs and expenses (including fees and disbursements of inhouse and other attorneys, appraisers and consultants) incurred by the Agents or the Lenders in any workout, restructuring or similar arrangements or, after an Event of Default, in connection with the protection, preservation, exercise or enforcement of any of the terms of the Credit Documents or in connection with any foreclosure, collection or bankruptcy proceedings&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, however, that Attorney Costs shall in each case be limited to the Attorney Costs of one counsel, but excluding the allocated cost of internal counsel and, if necessary, of a single local counsel in each appropriate jurisdiction (which may include a single special counsel acting in multiple jurisdictions). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">115</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The foregoing costs and expenses shall include all reasonable and documented out-of-pocket expenses incurred by the Administrative Agent and the reasonable and documented out-of-pocket cost of independent public accountants and other outside experts retained by the Administrative Agent or any Lender.  If requested by the Borrower, the Administrative Agent or a Lender, as applicable, will furnish to the Borrower, within 10 Business Days of such request, a certificate setting forth the basis in reasonable detail with respect to any amounts requested under this Section&#160;11.5(a).  All amounts due under this Section&#160;11.5(a) shall be payable within 20&#160;Business Days after demand therefor.  The agreements in this Section&#160;shall survive the termination of the Commitments and repayment of all Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Limitation of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent permitted by applicable law, (i) the Borrower shall not assert, and the Borrower hereby waives, any claim against the Administrative Agent, any Lead Arranger, any Syndication Agent, any Documentation Agent, any Issuing Lender and any Lender, and any Related Party of any of the foregoing Persons (each such Person being called a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lender-Related Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) for any Liabilities (as defined below) arising from the use by others of any information or other materials obtained through IntraLinks or other similar information transmission systems in connection with the Credit Agreement (except to the extent they are found by a final, non-appealable judgment of a court of competent jurisdiction to arise from the gross negligence, bad faith or willful misconduct of such Lender-Related Person or its Related Parties), and (ii) no party hereto shall assert, and each such party hereby waives, any Liabilities against (x)&#160;any Lender-Related Person or (y) the Borrower and any Related Party of the Borrower (each such Person being called a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company-Related Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Credit Agreement, any other Credit Document or any agreement or instrument contemplated hereby or thereby, any transactions contemplated hereby or thereby, any Loan or Letter of Credit or the use of the proceeds thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, nothing in this Section 11.5(b) shall relieve the Borrower of any obligation it may have to indemnify an Indemnitee, as provided in Section 11.5(c), against any special, indirect, consequential or punitive damages asserted against such Indemnitee by a third party.  As used in this Section 11.5(b), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any losses, claims (including intraparty claims), demands, damages or liabilities of any kind.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">The Borrower shall indemnify and hold harmless each Agent, each Lead Arranger, each Lender and their respective Related Parties of the foregoing (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) from and against any and all liabilities, obligations, losses, damages, penalties, claims (including intraparty claims), demands, actions, judgments, suits, costs, reasonable and documented out-of-pocket expenses and disbursements (including Attorney Costs, limited to the reasonable and documented out-of-pocket fees and expenses of one counsel representing all Indemnitees, taken as a whole, but excluding the allocated cost of internal counsel, and, if necessary, of a single local counsel in each appropriate jurisdiction (which may include a single special counsel acting in multiple jurisdictions) for all such Indemnitees, taken as whole (and, in the case of an actual or perceived conflict of interest where any Indemnitee affected by such conflict notifies the Borrower of the existence of such conflict and thereafter retains its own counsel, those of another firm of counsel for each such affected Indemnitee and all other Indemnitees similarly situated))) of any kind or nature whatsoever which may at any time be imposed on, incurred by or asserted against any such Indemnitee in any way relating to or arising out of or in connection with (A)&#160;the execution, delivery, enforcement, performance or administration of any Credit Document or any other agreement, letter or instrument delivered in connection with the transactions contemplated thereby or the consummation </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">116</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the transactions contemplated thereby, (B)&#160;any Commitment or Loan or the use or proposed use of the proceeds therefrom, (C)&#160;any actual or alleged presence or release of Hazardous Materials on or from any property currently or formerly owned or operated by the Borrower or any of its Subsidiaries or any Environmental Liability related in any way to the Borrower or any of its Subsidiaries or (D)&#160;any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory (including any investigation of, preparation for, or defense of any pending or threatened claim, investigation, litigation or proceeding) and regardless of whether commenced by the Borrower, any Indemnitee or any third party and whether any Indemnitee is a party thereto (all the foregoing, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnified Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such indemnity shall not, as to any Indemnitee, be available (x) to the extent that such liabilities, obligations, losses, damages, penalties, claims, demands, actions, judgments, suits, costs, expenses or disbursements are determined by a final and non-appealable judgment of a court of competent jurisdiction to have resulted from the gross negligence, bad faith or willful misconduct of such Indemnitee or its Related Parties, (y) to any claim brought by the Borrower against any Indemnitee for a material breach of such Indemnitee&#8217;s (or its Related Parties&#8217;) obligations under this Credit Agreement or the other Credit Documents (to the extent such material breach is determined by a court of competent jurisdiction in a final and non-appealable judgment) or (z) to any liabilities, obligations, losses, damages, penalties, claims, demands, actions, judgments, suits, costs, expenses or disbursements arising from actions, suits or proceedings (including any investigations or inquiries) by any Indemnitee against another Indemnitee (other than actions, suits, proceedings (including any investigations or inquiries) involving (a) alleged conduct or omission by the Borrower or its Affiliates or (b) against the Administrative Agent, any other Agent or any other arranger or bookrunner in its capacity as such).  All amounts due under this Section&#160;11.5(c) shall be payable within 10 Business Days after demand therefor.  The agreements in this Section&#160;shall survive the resignation of the Administrative Agent, the replacement of any Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all the Obligations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">To the extent that the undertaking to indemnify set forth in Section&#160;11.5(c)(i) may be unenforceable as violative of any applicable law or public policy, the Borrower shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities that is permissible under applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Amendments, Waivers and Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subject to Section 3.10(b) and (c), neither this Credit Agreement nor any other Credit Document nor any of the terms hereof or thereof may be amended, changed, waived, discharged or terminated unless such amendment, change, waiver, discharge or termination is in writing and signed by the Required Lenders and the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no such amendment, change, waiver, discharge or termination shall without the consent of each Lender affected thereby&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">117</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">extend the Maturity Date of any Loan (except as permitted under Section 2.8) or extend or postpone the time for any payment or prepayment of principal of any Loan or unreimbursed drawing of any Letter of Credit&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">reduce the rate or amount or extend the time of payment of interest (other than as a result of waiving the applicability of any post-default increase in interest rates) thereon or fees hereunder&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">reduce or waive the principal amount of any Loan or unreimbursed drawing of any Letter of Credit&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">increase or extend the Commitment of a Lender (it being understood and agreed that a waiver of any Default or Event of Default or a waiver of any mandatory reduction in the Commitments shall not constitute a change in the terms of any Commitment of any Lender)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">release the Borrower from its obligations or consent to the assignment or transfer by the Borrower of any of its rights and obligations under (or in respect of) the Credit Documents, or release any Domestic Subsidiary from its obligations under any guarantee agreement delivered pursuant to Section 7.10&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">amend, modify or waive any provision of this Section 11.6 or Section 3.7 (or any other provision providing for the pro rata nature of payments or disbursements to Lenders), 3.8 or 9.1(a)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">reduce any percentage specified in the definition of Required Lenders&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">amend or otherwise modify the definition of Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the above, (i) no provisions of Section 10 may be amended or modified without the consent of the Administrative Agent, (ii) no provisions of Section&#160;2.2 may be amended or modified without the consent of any Issuing Lender and (iii) no provisions of Section 2.3 may be amended or modified without the consent of the Swing Line Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the fact that the consent of all the Lenders is required in certain circumstances as set forth above, (x) each Lender is entitled to vote as such Lender sees fit on any reorganization plan that affects the Loans or the Letters of Credit, and each Lender acknowledges that the provisions of Section 1126(c) of the Bankruptcy Code supersede the unanimous consent provisions set forth herein and (y) the Required Lenders may consent to allow the Borrower to use cash collateral in the context of a bankruptcy or insolvency proceeding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If, in connection with any proposed amendment, waiver or consent requiring the consent of a greater percentage of the Lenders than the Required Lenders and the consent of the Required Lenders is obtained, but the consent of one or more other Lenders is not obtained (any such Lender which declares in writing that it will not provide such consent or whose consent is not obtained within the applicable period prescribed for such amendment, waiver or consent being referred to herein as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Consenting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then, so long as the Administrative Agent is not a Non-Consenting Lender, the Borrower may, within 45 days of such Lender becoming a Non-Consenting Lender, give notice in writing to the Administrative Agent and such Non-Consenting Lender of the Borrower&#8217;s intention to cause such Non-Consenting Lender to sell all of such Non-Consenting Lenders&#8217; interests in its Commitments for an amount equal to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">118</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">principal balances thereof and all accrued interest and fees with respect thereto through the date of sale pursuant to one or more Assignment and Assumptions, such sale being without premium or discount.  In the event of any such notice, such Non-Consenting Lender shall be required to sell and assign such interests (including all of its related rights and obligations) as provided in this Section.  Any such sale of a Non-Consenting Lender&#8217;s Commitments must be to an Eligible Assignee and, unless otherwise agreed to by the Administrative Agent, the Borrower shall be solely responsible for sourcing such Eligible Assignee, at no cost or expense to the Administrative Agent or any Lender.  Any such assignment to an Eligible Assignee pursuant to this Section shall be in accordance with clause (b)(iv) of Section 11.3.  At any time during or after the period during which a proposed amendment, waiver or consent was pending, upon the request of the Borrower, the Administrative Agent shall promptly provide (but in any event within one Business Day) the Borrower with the names, contact information, Commitment percentages, principal balances and any other information reasonably requested for each Lender that, at the time of such request, was either a Non-Consenting Lender or had not yet decided whether or not to approve or consent to such amendment, waiver or consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Credit Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be an original, but all of which shall constitute one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The headings of the sections and subsections hereof are provided for convenience only and shall not in any way affect the meaning or construction of any provision of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Survival of Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All indemnities set forth herein (including those set forth in Sections 3.9, 3.12, 3.13, 3.14 and 11.5), shall survive the execution and delivery of this Credit Agreement, the making of the Loans, the issuance of the Letters of Credit and the repayment of the Loans, LOC Obligations and other obligations and the termination of the Commitments hereunder.  All representations and warranties made hereunder and in any other Credit Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and thereof. Such representations and warranties have been or will be relied upon by the Administrative Agent and each Lender, regardless of any investigation made by the Administrative Agent or any Lender or on their behalf and notwithstanding that the Administrative Agent or any Lender may have had notice or knowledge of any Default at the time of any Extension of Credit, and shall continue in full force and effect as long as any Loan or any other Obligations hereunder shall remain unpaid or unsatisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Governing Law&#59; Venue&#59; Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">THIS CREDIT AGREEMENT AND THE OTHER CREDIT DOCUMENTS AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER AND </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">119</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THEREUNDER SHALL BE GOVERNED BY AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.  Except as provided below in this paragraph, (i) each party hereto irrevocably and unconditionally submits, for itself and its property, to the jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any suit, action, proceeding, claim or counterclaim arising out of or relating to this Credit Agreement or any other Credit Document, or for recognition or enforcement of any judgment relating to this Credit Agreement or any other Credit Document, and (ii) each party hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such suit, action, proceeding, claim or counterclaim shall be brought only in such New&#160;York State or, to the extent permitted by law, in such Federal court, or in the courts (or, to the extent permitted by law, Federal courts) of the State of New Jersey.  The Borrower irrevocably consents to the service of process in any suit, action, proceeding, claim or counterclaim with respect to this Credit Agreement or any other Credit Document by the mailing of copies thereof by registered or certified mail, postage prepaid, to it at the address for notices pursuant to Section 11.1, such service to become effective 10 days after such mailing.  Nothing herein shall affect the right of a Lender to serve process in any other manner permitted by law or to commence legal proceedings or otherwise proceed against the Borrower in any other jurisdiction.  The Borrower agrees that a final judgment in any suit, action, proceeding, claim or counterclaim in any court referred to above shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that nothing in this Section&#160;11.10(a) is intended to impair the Borrower&#8217;s right under applicable law to appeal or seek a stay of any judgment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Borrower hereby irrevocably waives any objection which it may now or hereafter have to the laying of venue of any of the aforesaid suits, actions, proceedings, claims or counterclaims arising out of or in connection with this Credit Agreement or any other Credit Document in the courts referred to in subsection&#160;(a) hereof and hereby further irrevocably waives and agrees not to plead or claim in any such court that any such suit, action, proceeding, claim or counterclaim brought in any such court has been brought in an inconvenient forum.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Waiver of Jury Trial&#59; Waiver of Consequential Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EACH OF THE PARTIES TO THIS CREDIT AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY SUIT, ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS CREDIT AGREEMENT, ANY OF THE OTHER CREDIT DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.  EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS CREDIT AGREEMENT AND THE OTHER CREDIT DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.  Each of the parties hereto agrees not to assert any claim against any other party hereto, any of its Affiliates, or any of their respective directors, officers, employees, attorneys or agents, on any theory of liability, for special, indirect, consequential or punitive damages arising out of or otherwise relating to any of the transactions contemplated herein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that nothing contained in this sentence shall limit the Borrower&#8217;s indemnity obligations under Section 11.5(c).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">120</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If any provision of any of the Credit Documents is determined to be illegal, invalid or unenforceable, such provision shall be fully severable and the remaining provisions shall remain in full force and effect and shall be construed without giving effect to the illegal, invalid or unenforceable provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower agrees, upon the reasonable request of the Administrative Agent, to promptly take such actions, as reasonably requested, as is necessary to carry out the intent of this Credit Agreement and the other Credit Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each of the Administrative Agent, the Issuing Lenders and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its Affiliates and to its and its Affiliates&#8217; respective partners, directors, officers, employees, agents, advisors and representatives, excluding equity security departments and their members (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b)&#160;to the extent requested by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as the National Association of Insurance Commissioners), (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d) to any other party hereto, (e) in connection with the exercise of any remedies hereunder or under any other Credit Document or any action or proceeding relating to this Credit Agreement or any other Credit Document or the enforcement of rights hereunder or thereunder, (f) subject to either (x) an agreement containing provisions substantially the same as those of this Section or (y) the standard confidentiality undertaking on an IntraLinks or similar website, to (i) any assignee of or Loan Participant in, or any prospective assignee of or Loan Participant in, any of its rights or obligations under this Credit Agreement, (ii) to any insurance broker or provider of credit insurance or (iii) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (g) with the prior written consent of the Borrower or (h) to the extent such Information (x) becomes publicly available other than as a result of a breach of this Section or (y) becomes available to the Administrative Agent, any Lender or any of their respective Affiliates on a non-confidential basis from a source other than the Borrower, which source is not known by the applicable Agent, Issuing Lender or Lender to have breached any confidentiality obligation by its disclosure of the Information. In addition, the Administrative Agent and the Lenders may disclose the existence of this Credit Agreement and information about this Credit Agreement to market data collectors, credit ratings agencies, similar service providers to the lending industry and service providers to the Administrative Agent and the Lenders in connection with the administration and management of this Credit Agreement, the other Credit Documents and the Loans. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">121</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Section, &#8220;Information&#8221; means all information received from the Borrower or any of its Subsidiaries relating to the Borrower or any Subsidiary or any of their respective businesses, other than any such information that is available to the Administrative Agent or any Lender on a non-confidential basis prior to disclosure by the Borrower or any Subsidiary, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, in the case of information received from the Borrower or any Subsidiary after the Restatement Effective Date, such information is clearly identified in writing at the time of delivery as confidential. Any Person required to maintain the confidentiality of Information as provided in this Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Non-Public Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Lender acknowledges that all information, including requests for waivers and amendments, furnished by the Borrower or the Administrative Agent pursuant to or in connection with, or in the course of administering, this Credit Agreement will be syndicate-level information, which may contain MNPI.  Each Lender represents to and agrees with the Borrower and the Administrative Agent that (i) it has developed compliance procedures regarding the use of MNPI and that it will handle MNPI in accordance with such procedures and applicable law, including Federal, state and foreign securities laws, (ii) it has identified in its Administrative Questionnaire a credit contact who may receive information that may contain MNPI in accordance with its compliance procedures and applicable law, including Federal, state and foreign securities laws and (iii) it will cause at least one individual at or on behalf of such Public Lender to at all times have selected the &#8220;Private Side Information&#8221; or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender&#8217;s compliance procedures and applicable law, including United States Federal and state securities Laws, to make reference to Borrower Materials that are not made available through the &#8220;Public Side Information&#8221; portion of the Platform and that may contain MNPI. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Entirety</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Credit Agreement together with the other Credit Documents, the JPMorgan Engagement Letter and the Fee Letters represent the entire agreement of the parties hereto and thereto, and supersede all prior agreements and understandings, oral or written, if any, including any commitment letters, engagement letters or correspondence relating to the Credit Documents or the transactions contemplated herein and therein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that provisions of commitment letters or engagement letters to which the Borrower and the Agents and their Affiliates are party will survive the execution and delivery of this Credit Agreement to the extent expressly provided therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Binding Effect&#59; Continuing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">This Credit Agreement shall become effective when it shall have been executed and delivered by the Borrower and the Administrative Agent, and the Administrative Agent shall have received copies hereof (faxed or otherwise) which, when taken together, bear the signatures of each Lender, and thereafter this Credit Agreement shall be binding upon and inure to the benefit of the Borrower, the Administrative Agent and each Lender and their respective successors and assigns.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">122</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">This Credit Agreement shall be a continuing agreement and shall remain in full force and effect until all Loans, LOC Obligations, interest, fees and other Obligations have been paid in full (other than contingent obligations for which no claim has been made) and all Commitments and Letters of Credit have been terminated (or, in the case of Letters of Credit, the LOC Obligations have been cash collateralized).  Upon termination, the Borrower shall have no further obligations (other than the indemnification provisions that survive) under the Credit Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that should any payment, in whole or in part, of the Obligations be rescinded or otherwise required to be restored or returned by the Administrative Agent or any Lender, whether as a result of any proceedings in bankruptcy or reorganization or otherwise, then the Credit Documents shall automatically be reinstated and all amounts required to be restored or returned and all reasonable and documented out-of-pocket costs and expenses incurred by the Administrative Agent or any Lender in connection therewith shall be deemed included as part of the Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">PATRIOT Act Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Lender that is subject to the PATRIOT Act and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that pursuant to the requirements of the PATRIOT Act, it is required to obtain, verify and record information that identifies the Borrower or any future guarantor, which information includes the name and address of the Borrower or any future guarantor and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrower or any future guarantor in accordance with the PATRIOT Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">No Advisory or Fiduciary Responsibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In connection with all aspects of each transaction contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Credit Document), the Borrower acknowledges and agrees, and acknowledges its Affiliates&#8217; understanding, that&#58; (i) (A) the arranging and other services regarding this Credit Agreement provided by the Agents, the Lenders, the Issuing Lenders and the Lead Arrangers are arm&#8217;s-length commercial transactions between the Borrower and its Affiliates, on the one hand, and the Agents, the Lenders, the Issuing Lenders and the Lead Arrangers, on the other hand, (B) the Borrower has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, and (C) the Borrower is capable of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other Credit Documents&#59; (ii) (A) each of the Agents, the Lenders, the Issuing Lenders and the Lead Arrangers is and has been acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for the Borrower or any of its Affiliates, or any other Person and (B) none of the Agents, the Lenders, the Issuing Lenders or Lead Arrangers has any obligation to the Borrower or any of its Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein and in the other Credit Documents&#59; and (iii) the Agents, the Lenders, the Issuing Lenders and the Lead Arrangers and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Borrower and its Affiliates, and none of the Agents, the Lenders, the Issuing Lenders or the Lead Arrangers has any obligation to disclose any of such interests to the Borrower or any of its Affiliates.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">123</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Judgment Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If, for the purposes of obtaining judgment in any court, it is necessary to convert a sum due hereunder or any other Credit Document in one currency into another currency, the rate of exchange used shall be that at which in accordance with normal banking procedures the Administrative Agent could purchase the first currency with such other currency on the Business Day preceding that on which final judgment is given.  The obligation of the Borrower in respect of any such sum due from it to any Agent or the Lenders hereunder or under the other Credit Documents shall, notwithstanding any judgment in a currency (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Judgment Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) other than that in which such sum is denominated in accordance with the applicable provisions of this Credit Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), be discharged only to the extent that on the Business Day following receipt by the Administrative Agent of any sum adjudged to be so due in the Judgment Currency, the Administrative Agent may in accordance with normal banking procedures purchase the Agreement Currency with the Judgment Currency.  If the amount of the Agreement Currency so purchased is less than the sum originally due to the Administrative Agent from the Borrower in the Agreement Currency, the Borrower agrees, as a separate obligation and notwithstanding any such judgment, to indemnify the Administrative Agent or the Person to whom such obligation was owing against such loss.  If the amount of the Agreement Currency so purchased is greater than the sum originally due to the Administrative Agent in such currency, the Administrative Agent agrees to promptly return the amount of any excess to such Borrower (or to any other Person who may be entitled thereto under applicable law).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Acknowledgment and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary in any Credit Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Affected Financial Institution arising under any Credit Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an Affected Financial Institution&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the effects of any Bail-in Action on any such liability, including, if applicable, (i) a reduction in full or in part or cancellation of any such liability, (ii) a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Credit Agreement or any other Credit Document or (iii) the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">124</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of the applicable Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">125</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div><div id="i722171e1fc8d400187c14df1181aca29_50"></div><hr style="page-break-after:always"><div style="min-height:73.96pt;width:100%"><div style="margin-bottom:24pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5731659&#93;&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>dgx-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c829db2e-c850-44b9-90d1-7027e34dc7fe,g:892aaabe-58ca-45ff-95da-140e039c9f49-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dgx="http://questdiagnostics.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://questdiagnostics.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://questdiagnostics.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://questdiagnostics.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1001003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS_1" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1">
        <link:definition>1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1006008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>2404401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION">
        <link:definition>2105103 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONTables" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables">
        <link:definition>2306301 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONDetails" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails">
        <link:definition>2407402 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE">
        <link:definition>2108104 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSLOSSPERSHARETables" roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables">
        <link:definition>2309302 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSLOSSPERSHAREDetails" roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails">
        <link:definition>2410403 - Disclosure - EARNINGS (LOSS) PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS">
        <link:definition>2111105 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDetails" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails">
        <link:definition>2412404 - Disclosure - BUSINESS ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISPOSITION" roleURI="http://questdiagnostics.com/role/DISPOSITION">
        <link:definition>2113106 - Disclosure - DISPOSITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISPOSITIONDetails" roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails">
        <link:definition>2414405 - Disclosure - DISPOSITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2115107 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2316303 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
        <link:definition>2417406 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails">
        <link:definition>2418407 - Disclosure - FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>2419408 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails">
        <link:definition>2420409 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOME" roleURI="http://questdiagnostics.com/role/TAXESONINCOME">
        <link:definition>2121108 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOMETables" roleURI="http://questdiagnostics.com/role/TAXESONINCOMETables">
        <link:definition>2322304 - Disclosure - TAXES ON INCOME (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOMEDetails" roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails">
        <link:definition>2423410 - Disclosure - TAXES ON INCOME (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWANDOTHERDATA" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA">
        <link:definition>2124109 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWANDOTHERDATATables" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables">
        <link:definition>2325305 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWANDOTHERDATADetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails">
        <link:definition>2426411 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENT" roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT">
        <link:definition>2127110 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables">
        <link:definition>2328306 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTDetails" roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails">
        <link:definition>2429412 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2130111 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2331307 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails">
        <link:definition>2432413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSES" roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES">
        <link:definition>2133112 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables">
        <link:definition>2334308 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails">
        <link:definition>2435414 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://questdiagnostics.com/role/DEBT">
        <link:definition>2136113 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://questdiagnostics.com/role/DEBTTables">
        <link:definition>2337309 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTLongTermDebtDetails" roleURI="http://questdiagnostics.com/role/DEBTLongTermDebtDetails">
        <link:definition>2438415 - Disclosure - DEBT (Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSecuredReceivablesCreditFacilityNarrativeDetails" roleURI="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails">
        <link:definition>2439416 - Disclosure - DEBT (Secured Receivables Credit Facility) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" roleURI="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails">
        <link:definition>2440417 - Disclosure - DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSeniorNotesOfferingDetails" roleURI="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails">
        <link:definition>2441418 - Disclosure - DEBT (Senior Notes Offering) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTMaturitiesofLongTermDebtDetails" roleURI="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails">
        <link:definition>2442419 - Disclosure - DEBT (Maturities of Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://questdiagnostics.com/role/LEASES">
        <link:definition>2143114 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://questdiagnostics.com/role/LEASESTables">
        <link:definition>2344310 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://questdiagnostics.com/role/LEASESNarrativeDetails">
        <link:definition>2445420 - Disclosure - LEASES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLiabilitiesDetails" roleURI="http://questdiagnostics.com/role/LEASESLiabilitiesDetails">
        <link:definition>2446421 - Disclosure - LEASES (Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESCostsDetails" roleURI="http://questdiagnostics.com/role/LEASESCostsDetails">
        <link:definition>2447422 - Disclosure - LEASES (Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESMaturityDetails" roleURI="http://questdiagnostics.com/role/LEASESMaturityDetails">
        <link:definition>2448423 - Disclosure - LEASES (Maturity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTermandRateDetails" roleURI="http://questdiagnostics.com/role/LEASESTermandRateDetails">
        <link:definition>2449424 - Disclosure - LEASES (Term and Rate) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2150115 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2351311 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails">
        <link:definition>2452425 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSBalanceSheetsDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails">
        <link:definition>2453426 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSIncomeStatementDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails">
        <link:definition>2454427 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST">
        <link:definition>2155116 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables">
        <link:definition>2356312 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails">
        <link:definition>2457428 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails">
        <link:definition>2458429 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANS" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS">
        <link:definition>2159117 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSTables" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables">
        <link:definition>2360313 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails">
        <link:definition>2461430 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails">
        <link:definition>2462431 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails">
        <link:definition>2463432 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails">
        <link:definition>2464433 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails">
        <link:definition>2465434 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails">
        <link:definition>2466435 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2167118 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2468436 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATION" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION">
        <link:definition>2169119 - Disclosure - BUSINESS SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>2370314 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONDetails" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails">
        <link:definition>2471437 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISCONTINUEDOPERATIONS" roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS">
        <link:definition>2172120 - Disclosure - DISCONTINUED OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISCONTINUEDOPERATIONSDetails" roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails">
        <link:definition>2473438 - Disclosure - DISCONTINUED OPERATIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTS">
        <link:definition>2174121 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>2475439 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationAccountsandReserves" roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves">
        <link:definition>2176122 - Disclosure - Schedule II - Valuation Accounts and Reserves</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationAccountsandReservesDetails" roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails">
        <link:definition>2477440 - Disclosure - Schedule II - Valuation Accounts and Reserves (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" abstract="false" name="InvestmentwithoutReadilyDeterminableFairValueImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" abstract="false" name="ScheduleOfLeaseByAssetTypeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_LongTermDebtMaturitiesGross" abstract="false" name="LongTermDebtMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_MemorialHermannMember" abstract="true" name="MemorialHermannMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_StockRepurchaseProgramAdditionalAmountAuthorized" abstract="false" name="StockRepurchaseProgramAdditionalAmountAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PercentageofNetAccountsReceivable" abstract="false" name="PercentageofNetAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" abstract="true" name="MidAmericaClinicalLaboratoriesLLCMACLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_SixPointNineFivePercentSeniorNotesDue2037Member" abstract="true" name="SixPointNineFivePercentSeniorNotesDue2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" abstract="false" name="EquityMethodInvestmentOwnershipPercentDisposedOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_GenebasedandesoterictestingservicesMember" abstract="true" name="GenebasedandesoterictestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ClientPayersMember" abstract="true" name="ClientPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_TerminationOfInterestRateSwapAgreements" abstract="false" name="TerminationOfInterestRateSwapAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LabtechDiagnosticsLLCMember" abstract="true" name="LabtechDiagnosticsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LoanCommitmentMaturingOctober2022Member" abstract="true" name="LoanCommitmentMaturingOctober2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" abstract="false" name="NetOperatingLossCarryfowardsNetOfValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_MergerConsiderationPayableCurrent" abstract="false" name="MergerConsiderationPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ScheduleOfShareholdersEquityTable" abstract="true" name="ScheduleOfShareholdersEquityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_Mergerconsiderationpaidpayablenet" abstract="false" name="Mergerconsiderationpaidpayablenet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_GainLossOnDispositionOfJointVenture" abstract="false" name="GainLossOnDispositionOfJointVenture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" abstract="true" name="ThreePointFourFivePercentSeniorNotesdueJune2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" abstract="false" name="DiscontinuedOperationGainonSettlingUncertainTaxBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FourpointtwofivepercentSeniorNotesDue2024Member" abstract="true" name="FourpointtwofivepercentSeniorNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FairValueOfNetAssetsAcquired" abstract="false" name="FairValueOfNetAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" abstract="false" name="AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AgreementtoOutsourceBillingandCollectionFunction" abstract="false" name="AgreementtoOutsourceBillingandCollectionFunction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_MercyHealthMember" abstract="true" name="MercyHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LeaseRightofUseAsset" abstract="false" name="LeaseRightofUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LoanCommitmentMaturingOctober2023Member" abstract="true" name="LoanCommitmentMaturingOctober2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_CapitatedMember" abstract="true" name="CapitatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ReductionsForChangesInJudgment" abstract="false" name="ReductionsForChangesInJudgment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_DebtInstrumentExtensionPeriod" abstract="false" name="DebtInstrumentExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_LeaseRemainingLeaseTerm" abstract="false" name="LeaseRemainingLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" abstract="true" name="CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" abstract="false" name="BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_EmployeeLongTermIncentivePlanEltipMember" abstract="true" name="EmployeeLongTermIncentivePlanEltipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FinanceLeaseObligationsandOtherMember" abstract="true" name="FinanceLeaseObligationsandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_Sharebasedcompensationexcesstaxbenefitamount" abstract="false" name="Sharebasedcompensationexcesstaxbenefitamount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" abstract="true" name="FivePointSevenFivePercentSeniorNotesDue2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" abstract="false" name="IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_RoutineclinicaltestingservicesMember" abstract="true" name="RoutineclinicaltestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_OperatingLeaseFixedAndVariableCost" abstract="false" name="OperatingLeaseFixedAndVariableCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" abstract="false" name="ScheduleofLeaseTermandDiscountRateTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_COVID19TestingServicesMember" abstract="true" name="COVID19TestingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AnatomicpathologytestingservicesMember" abstract="true" name="AnatomicpathologytestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_GovernmentPayersMember" abstract="true" name="GovernmentPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" abstract="false" name="UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_OtherEquityComponentsMember" abstract="true" name="OtherEquityComponentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_StockAwardsMember" abstract="true" name="StockAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AllotherservicesMember" abstract="true" name="AllotherservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_OperatingandFinanceLeaseLiability" abstract="false" name="OperatingandFinanceLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_RevenueCollectionofConsiderationPeriod" abstract="false" name="RevenueCollectionofConsiderationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_SupplementalDeferredCompensationPlanSalaryDeferral" abstract="false" name="SupplementalDeferredCompensationPlanSalaryDeferral" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" abstract="false" name="DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_TreasuryStockPurchasedbutNotyetPaid" abstract="false" name="TreasuryStockPurchasedbutNotyetPaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" abstract="true" name="ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_UMassJointVentureMember" abstract="true" name="UMassJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AcceleratedShareRepurchasesPayment" abstract="false" name="AcceleratedShareRepurchasesPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" abstract="true" name="PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" abstract="false" name="IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" abstract="true" name="MeasurementInputComparableCompanyRevenueVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_RemainingTermsofContingentLeaseObligationsMaximum" abstract="false" name="RemainingTermsofContingentLeaseObligationsMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_SupplementalDeferredCompensationPlanMember" abstract="true" name="SupplementalDeferredCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" abstract="false" name="ProceedsFromSaleOfEquityMethodInvestmentsGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PercentageofNetRevenues" abstract="false" name="PercentageofNetRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_RestatedDirectorLongTermIncentivePlanDltipMember" abstract="true" name="RestatedDirectorLongTermIncentivePlanDltipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" abstract="false" name="LaboratoryEquipmentAndFurnitureAndFixturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LaboratoryEquipmentFurnitureAndFixturesMember" abstract="true" name="LaboratoryEquipmentFurnitureAndFixturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LeaseRenewalTerm" abstract="false" name="LeaseRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_HealthcareInsurersMember" abstract="true" name="HealthcareInsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ScheduleOfShareholdersEquityLineItems" abstract="true" name="ScheduleOfShareholdersEquityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" abstract="false" name="DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" abstract="true" name="TwoPointEightZeroPercentSeniorNotesDueJune2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" abstract="false" name="BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_ForeignCurrencyTranslationMember" abstract="true" name="ForeignCurrencyTranslationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" abstract="false" name="FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_SdcpIiMember" abstract="true" name="SdcpIiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AcceleratedShareRepurchaseAgreementsMember" abstract="true" name="AcceleratedShareRepurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_SeniorunsecuredrevolvingcreditfacilityMember" abstract="true" name="SeniorunsecuredrevolvingcreditfacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PeriodofBillingFullyReserve" abstract="false" name="PeriodofBillingFullyReserve" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_BusinessAcquisitionPostacquisitionRevenue" abstract="false" name="BusinessAcquisitionPostacquisitionRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AccountsReceivableDisaggregationTableTextBlock" abstract="false" name="AccountsReceivableDisaggregationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_ShorttermLeaseandVariableLeaseCost" abstract="false" name="ShorttermLeaseandVariableLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" abstract="true" name="FourPointTwoZeroPercentSeniorNotesdueJune2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" abstract="true" name="FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DSBusinessesMember" abstract="true" name="DSBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FeeforserviceMember" abstract="true" name="FeeforserviceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" abstract="false" name="SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" abstract="false" name="EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" abstract="true" name="TwoPointNineFivePercentSeniorNotesdueJune2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" abstract="false" name="ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_PatientMember" abstract="true" name="PatientMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_NidMember" abstract="true" name="NidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_BlueprintGeneticsOyMember" abstract="true" name="BlueprintGeneticsOyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" abstract="true" name="FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_PackHealthLLCMember" abstract="true" name="PackHealthLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" abstract="true" name="BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" abstract="false" name="FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_Q2SolutionsMember" abstract="true" name="Q2SolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" abstract="false" name="MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_OtherIncomeExpenseMember" abstract="true" name="OtherIncomeExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_TotalAmortizingIntangibleAssetsMember" abstract="true" name="TotalAmortizingIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DiagnosticInformationServicesBusinessMember" abstract="true" name="DiagnosticInformationServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_SdcpIiGradedVestingPercentage" abstract="false" name="SdcpIiGradedVestingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>dgx-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c829db2e-c850-44b9-90d1-7027e34dc7fe,g:892aaabe-58ca-45ff-95da-140e039c9f49-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_dbdc9c2f-0482-4cc0-ac3a-732ac7108084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ba0eab65-754c-4ef3-9662-e51875cf8394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dbdc9c2f-0482-4cc0-ac3a-732ac7108084" xlink:to="loc_us-gaap_LiabilitiesCurrent_ba0eab65-754c-4ef3-9662-e51875cf8394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_30cf48d2-3ec3-4712-a3bd-d332083ba38f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dbdc9c2f-0482-4cc0-ac3a-732ac7108084" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_30cf48d2-3ec3-4712-a3bd-d332083ba38f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_df155fbc-2b3d-460f-97ed-7559d38c7eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dbdc9c2f-0482-4cc0-ac3a-732ac7108084" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_df155fbc-2b3d-460f-97ed-7559d38c7eee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e9e09828-2104-47fb-ad49-2b6b386f78cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dbdc9c2f-0482-4cc0-ac3a-732ac7108084" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e9e09828-2104-47fb-ad49-2b6b386f78cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_06cba6e4-28e2-4e9e-a349-49730fa5a7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dbdc9c2f-0482-4cc0-ac3a-732ac7108084" xlink:to="loc_us-gaap_CommitmentsAndContingencies_06cba6e4-28e2-4e9e-a349-49730fa5a7c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_2189fda3-3ccf-4964-b942-0e4f338b92b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dbdc9c2f-0482-4cc0-ac3a-732ac7108084" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_2189fda3-3ccf-4964-b942-0e4f338b92b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b10490b2-cb66-476b-804f-b14053c74f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dbdc9c2f-0482-4cc0-ac3a-732ac7108084" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b10490b2-cb66-476b-804f-b14053c74f22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_511a01a2-0fdf-48e5-8904-9b46f4da9eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5f04e7fc-a9b4-402b-8188-bf0371bd24a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_511a01a2-0fdf-48e5-8904-9b46f4da9eff" xlink:to="loc_us-gaap_AssetsCurrent_5f04e7fc-a9b4-402b-8188-bf0371bd24a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5df1003c-5da7-4494-9f3a-02bc28d6e675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_511a01a2-0fdf-48e5-8904-9b46f4da9eff" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5df1003c-5da7-4494-9f3a-02bc28d6e675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_79e19f79-d01c-4a35-ac7f-4bccf9c5604d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_511a01a2-0fdf-48e5-8904-9b46f4da9eff" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_79e19f79-d01c-4a35-ac7f-4bccf9c5604d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c1a5bb87-479e-4162-a899-d6d631726759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_511a01a2-0fdf-48e5-8904-9b46f4da9eff" xlink:to="loc_us-gaap_Goodwill_c1a5bb87-479e-4162-a899-d6d631726759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fbee7b2b-92ac-471b-a379-86a57b82ae0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_511a01a2-0fdf-48e5-8904-9b46f4da9eff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fbee7b2b-92ac-471b-a379-86a57b82ae0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_f0760b25-70bd-4f1c-8a8a-5e856cb7d56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_511a01a2-0fdf-48e5-8904-9b46f4da9eff" xlink:to="loc_us-gaap_EquityMethodInvestments_f0760b25-70bd-4f1c-8a8a-5e856cb7d56f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9c120be0-6e45-44f5-8a9b-75ab4c04715c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_511a01a2-0fdf-48e5-8904-9b46f4da9eff" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9c120be0-6e45-44f5-8a9b-75ab4c04715c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0294ac7c-978d-41e0-a668-ee7aeabc9b33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_8fdb9088-970b-4d82-a5f3-493bc44d401d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0294ac7c-978d-41e0-a668-ee7aeabc9b33" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_8fdb9088-970b-4d82-a5f3-493bc44d401d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7f09ff25-e400-4562-a54a-c7c6fc227e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0294ac7c-978d-41e0-a668-ee7aeabc9b33" xlink:to="loc_us-gaap_LongTermDebtCurrent_7f09ff25-e400-4562-a54a-c7c6fc227e3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_302dc929-9d48-4130-b564-b12ff7600536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0294ac7c-978d-41e0-a668-ee7aeabc9b33" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_302dc929-9d48-4130-b564-b12ff7600536" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_af95741f-8eec-4fc7-8a40-6cd6c5b5afbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_79d61659-58b9-45d5-b4fa-5a45280b6056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af95741f-8eec-4fc7-8a40-6cd6c5b5afbb" xlink:to="loc_us-gaap_CommonStockValue_79d61659-58b9-45d5-b4fa-5a45280b6056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a0850c3b-24a4-4ef9-99ba-088c1cd7029d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af95741f-8eec-4fc7-8a40-6cd6c5b5afbb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a0850c3b-24a4-4ef9-99ba-088c1cd7029d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_370e5c07-58d3-4ae7-aeb8-2d0c3c7ae9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af95741f-8eec-4fc7-8a40-6cd6c5b5afbb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_370e5c07-58d3-4ae7-aeb8-2d0c3c7ae9ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f07fae4a-eaaa-4cf9-9b68-05c218b80c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af95741f-8eec-4fc7-8a40-6cd6c5b5afbb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f07fae4a-eaaa-4cf9-9b68-05c218b80c74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_dc373f7c-ef34-4f14-a23c-f567b62186e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af95741f-8eec-4fc7-8a40-6cd6c5b5afbb" xlink:to="loc_us-gaap_TreasuryStockValue_dc373f7c-ef34-4f14-a23c-f567b62186e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2999bdca-9922-41ac-abab-6cf182687e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_97834d48-e26f-49e6-aa63-38b8788beaef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2999bdca-9922-41ac-abab-6cf182687e05" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_97834d48-e26f-49e6-aa63-38b8788beaef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d86613ec-c0a9-4e95-9c6d-b8d5592c4d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2999bdca-9922-41ac-abab-6cf182687e05" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d86613ec-c0a9-4e95-9c6d-b8d5592c4d26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ec62bde0-eb88-45f5-9c54-a9b006f5beb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2999bdca-9922-41ac-abab-6cf182687e05" xlink:to="loc_us-gaap_InventoryNet_ec62bde0-eb88-45f5-9c54-a9b006f5beb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c0f17506-395b-41f2-8d3c-cce257af4f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2999bdca-9922-41ac-abab-6cf182687e05" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c0f17506-395b-41f2-8d3c-cce257af4f01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf035d50-92df-458d-943d-9b12bdc62b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e5aed379-3990-4f95-a99d-4406e2cf26b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf035d50-92df-458d-943d-9b12bdc62b55" xlink:to="loc_us-gaap_StockholdersEquity_e5aed379-3990-4f95-a99d-4406e2cf26b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_cdd6cedb-449b-419e-8989-e12c9f96ad4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf035d50-92df-458d-943d-9b12bdc62b55" xlink:to="loc_us-gaap_MinorityInterest_cdd6cedb-449b-419e-8989-e12c9f96ad4b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ba6aaa66-f414-4107-9b48-d22df3ba64c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_fb580e8d-5812-460e-843c-d10404ba9b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ba6aaa66-f414-4107-9b48-d22df3ba64c0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_fb580e8d-5812-460e-843c-d10404ba9b9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_71196a94-adfd-4098-9e6a-29e6cd119f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ba6aaa66-f414-4107-9b48-d22df3ba64c0" xlink:to="loc_us-gaap_OperatingIncomeLoss_71196a94-adfd-4098-9e6a-29e6cd119f38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ae64e630-5136-470d-8c38-846689eaccfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_cf2ee7b5-749e-4d9d-ad13-c97d1919a80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_ae64e630-5136-470d-8c38-846689eaccfa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_cf2ee7b5-749e-4d9d-ad13-c97d1919a80a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_5cf95011-5502-45d8-bcea-798dc05d7f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_ae64e630-5136-470d-8c38-846689eaccfa" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_5cf95011-5502-45d8-bcea-798dc05d7f3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_fde7f1b0-a123-4ca3-80f4-d8d87e9c30cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_50fa4b59-f41c-438e-bd9a-93ab0371f0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_fde7f1b0-a123-4ca3-80f4-d8d87e9c30cb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_50fa4b59-f41c-438e-bd9a-93ab0371f0e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1c14384d-cc64-456c-900b-940f23d3ff4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_fde7f1b0-a123-4ca3-80f4-d8d87e9c30cb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1c14384d-cc64-456c-900b-940f23d3ff4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e47dd76a-397e-41a0-ad24-b5d9c45c46ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_fde7f1b0-a123-4ca3-80f4-d8d87e9c30cb" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e47dd76a-397e-41a0-ad24-b5d9c45c46ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9d2c63ba-eab9-4b12-a401-c23612d9e05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e6632d99-3bc2-40ce-baf5-1f4901a4dbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9d2c63ba-eab9-4b12-a401-c23612d9e05d" xlink:to="loc_us-gaap_CostsAndExpenses_e6632d99-3bc2-40ce-baf5-1f4901a4dbf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4d3789ff-c3a8-4697-8bab-90d97f7faed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9d2c63ba-eab9-4b12-a401-c23612d9e05d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4d3789ff-c3a8-4697-8bab-90d97f7faed3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_68ef8423-ada8-4e25-84ae-f9812c74bb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_7583dc55-fc47-4c8b-8067-d132883b904f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_68ef8423-ada8-4e25-84ae-f9812c74bb3c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_7583dc55-fc47-4c8b-8067-d132883b904f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2bed828d-00ed-40be-9b24-d6656dd2e2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_68ef8423-ada8-4e25-84ae-f9812c74bb3c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2bed828d-00ed-40be-9b24-d6656dd2e2f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a28cac7d-b68f-4d72-b4e5-e41055a6b262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_6692de77-75ac-4970-9ffd-bdf92ec3997a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_a28cac7d-b68f-4d72-b4e5-e41055a6b262" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_6692de77-75ac-4970-9ffd-bdf92ec3997a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_b0ec104a-656e-4f0d-aeff-c2048763f26e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_a28cac7d-b68f-4d72-b4e5-e41055a6b262" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_b0ec104a-656e-4f0d-aeff-c2048763f26e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ebf9101f-100b-4f17-8de7-aa992deb3b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_cb5ef932-12a6-43c1-8c22-f0f061f062c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ebf9101f-100b-4f17-8de7-aa992deb3b1c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_cb5ef932-12a6-43c1-8c22-f0f061f062c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_2f4a71cc-e103-44eb-9e7c-ab96e93168d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ebf9101f-100b-4f17-8de7-aa992deb3b1c" xlink:to="loc_us-gaap_CostOfRevenue_2f4a71cc-e103-44eb-9e7c-ab96e93168d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_05a48e1b-f1d9-47c3-9f88-b574723cf27d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ebf9101f-100b-4f17-8de7-aa992deb3b1c" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_05a48e1b-f1d9-47c3-9f88-b574723cf27d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ffd0fe27-dd6b-4024-822f-c700cded1794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ebf9101f-100b-4f17-8de7-aa992deb3b1c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ffd0fe27-dd6b-4024-822f-c700cded1794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_492b0ac9-1774-46fa-8c05-17ecf88f93ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_8c03767d-235e-47bb-8b66-7f6e1f67a81d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_492b0ac9-1774-46fa-8c05-17ecf88f93ae" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_8c03767d-235e-47bb-8b66-7f6e1f67a81d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_dd00bc0c-7c18-45c0-a505-ee26af44a9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_492b0ac9-1774-46fa-8c05-17ecf88f93ae" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_dd00bc0c-7c18-45c0-a505-ee26af44a9dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_beaeeb25-0851-4639-8141-9b9494e177d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_c6bfb988-0e04-483a-b00a-2d894e83f34d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_beaeeb25-0851-4639-8141-9b9494e177d6" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_c6bfb988-0e04-483a-b00a-2d894e83f34d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3a9bb23c-ee65-4807-a21d-548651ea0387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_beaeeb25-0851-4639-8141-9b9494e177d6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3a9bb23c-ee65-4807-a21d-548651ea0387" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS_1"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_14a4ae8c-499b-4c7b-a3d0-eaf5eec4f6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dc852faf-af2e-4a25-9885-050bbc6e5dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_14a4ae8c-499b-4c7b-a3d0-eaf5eec4f6c6" xlink:to="loc_us-gaap_ProfitLoss_dc852faf-af2e-4a25-9885-050bbc6e5dd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d2cf0aed-2784-4a64-a28c-9f429be467e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_14a4ae8c-499b-4c7b-a3d0-eaf5eec4f6c6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d2cf0aed-2784-4a64-a28c-9f429be467e2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_46aa4b50-0119-4edf-a9aa-21ce81747132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8cd264ab-e753-4f73-8439-f6a4d161d94f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_46aa4b50-0119-4edf-a9aa-21ce81747132" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8cd264ab-e753-4f73-8439-f6a4d161d94f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_06235b5f-3102-4c46-ac83-cb7a0d27cbad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_46aa4b50-0119-4edf-a9aa-21ce81747132" xlink:to="loc_us-gaap_ProfitLoss_06235b5f-3102-4c46-ac83-cb7a0d27cbad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ebba0240-3bde-42f0-a81b-d037f52d0f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5678a9ca-a141-47fc-9bb8-85ad69a3bb12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ebba0240-3bde-42f0-a81b-d037f52d0f8e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5678a9ca-a141-47fc-9bb8-85ad69a3bb12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a3e89d3b-6cd4-4a64-a8ae-a6da678bd255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ebba0240-3bde-42f0-a81b-d037f52d0f8e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a3e89d3b-6cd4-4a64-a8ae-a6da678bd255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_13e4f7a8-70d9-4bb3-8247-bf3629ec9c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ed5b38bb-237c-48e6-a1c3-303182479a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_13e4f7a8-70d9-4bb3-8247-bf3629ec9c2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ed5b38bb-237c-48e6-a1c3-303182479a32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b337e527-b36d-4ff3-b5c8-9c41a1ce3a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_13e4f7a8-70d9-4bb3-8247-bf3629ec9c2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b337e527-b36d-4ff3-b5c8-9c41a1ce3a55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_9128c3c9-2740-4721-9a46-20b368aae527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_13e4f7a8-70d9-4bb3-8247-bf3629ec9c2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_9128c3c9-2740-4721-9a46-20b368aae527" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03bc55f9-c4af-47d7-9ef2-2a5db4b4cf09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_2a62f79d-8fc2-4879-a2e6-bf713f03ddfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03bc55f9-c4af-47d7-9ef2-2a5db4b4cf09" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_2a62f79d-8fc2-4879-a2e6-bf713f03ddfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b3e50d01-0d07-4424-b8fd-7645505fdd52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03bc55f9-c4af-47d7-9ef2-2a5db4b4cf09" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b3e50d01-0d07-4424-b8fd-7645505fdd52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_20d768eb-1ee5-4016-af6d-e09a7a130453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03bc55f9-c4af-47d7-9ef2-2a5db4b4cf09" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_20d768eb-1ee5-4016-af6d-e09a7a130453" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_cc65c6b4-a850-4d04-97f1-e114bd318a28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03bc55f9-c4af-47d7-9ef2-2a5db4b4cf09" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_cc65c6b4-a850-4d04-97f1-e114bd318a28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_b9ac28be-c4ba-469f-9d51-c5ea63b63048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03bc55f9-c4af-47d7-9ef2-2a5db4b4cf09" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_b9ac28be-c4ba-469f-9d51-c5ea63b63048" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_ea66cd81-973d-497d-ae07-9ab7a668b203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03bc55f9-c4af-47d7-9ef2-2a5db4b4cf09" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_ea66cd81-973d-497d-ae07-9ab7a668b203" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bdaecc6a-c3f8-4e4f-b71f-78d4a1ccd326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03bc55f9-c4af-47d7-9ef2-2a5db4b4cf09" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bdaecc6a-c3f8-4e4f-b71f-78d4a1ccd326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_95835647-7d69-4f91-a171-6cceffb144c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_03bc55f9-c4af-47d7-9ef2-2a5db4b4cf09" xlink:to="loc_us-gaap_RepaymentsOfDebt_95835647-7d69-4f91-a171-6cceffb144c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a13652f4-e2e8-4059-96e4-5d7f55c3225a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_12a3b862-9846-4a9f-8b27-c2564c8206ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a13652f4-e2e8-4059-96e4-5d7f55c3225a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_12a3b862-9846-4a9f-8b27-c2564c8206ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1169b172-52de-4c20-b4d4-bdfe8926ae86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a13652f4-e2e8-4059-96e4-5d7f55c3225a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1169b172-52de-4c20-b4d4-bdfe8926ae86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_dca693d4-983e-46eb-b94f-311b4c609267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a13652f4-e2e8-4059-96e4-5d7f55c3225a" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_dca693d4-983e-46eb-b94f-311b4c609267" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5babeb8e-2b8c-4cc3-8baf-5e0a26b53c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a13652f4-e2e8-4059-96e4-5d7f55c3225a" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5babeb8e-2b8c-4cc3-8baf-5e0a26b53c6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a32bbc1b-f347-47ac-b7bc-dd0b881b88b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a13652f4-e2e8-4059-96e4-5d7f55c3225a" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a32bbc1b-f347-47ac-b7bc-dd0b881b88b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6b11c91c-5f87-4d63-8026-29c4ad768a40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7561d470-fe3e-4b87-b664-33fe9f3b960f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6b11c91c-5f87-4d63-8026-29c4ad768a40" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7561d470-fe3e-4b87-b664-33fe9f3b960f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6eaa16dd-5e22-4214-bf77-a383638653a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6b11c91c-5f87-4d63-8026-29c4ad768a40" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6eaa16dd-5e22-4214-bf77-a383638653a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_23d83218-ec11-4319-8627-bd9cc39a99cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6b11c91c-5f87-4d63-8026-29c4ad768a40" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_23d83218-ec11-4319-8627-bd9cc39a99cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_504b8dca-3770-4630-92c6-077e8ee127e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_ProfitLoss_504b8dca-3770-4630-92c6-077e8ee127e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a0954194-231e-40d6-ba49-9f8c888e9448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a0954194-231e-40d6-ba49-9f8c888e9448" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_80370b11-7365-4733-9066-0fa98be663d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_80370b11-7365-4733-9066-0fa98be663d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d64f634b-5bd5-46a0-a751-e892f26c1856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d64f634b-5bd5-46a0-a751-e892f26c1856" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e73950b4-6e4d-4ff6-8ac9-d0611fa42f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_ShareBasedCompensation_e73950b4-6e4d-4ff6-8ac9-d0611fa42f37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossOnDispositionOfJointVenture_be16ac5f-f37b-4631-9cb1-b22cd9259a23" xlink:href="dgx-20211231.xsd#dgx_GainLossOnDispositionOfJointVenture"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_dgx_GainLossOnDispositionOfJointVenture_be16ac5f-f37b-4631-9cb1-b22cd9259a23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_0df9cc25-734a-4db9-b84a-7b6142c8d0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_0df9cc25-734a-4db9-b84a-7b6142c8d0ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d85907d2-fdfa-480d-8641-894586077356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d85907d2-fdfa-480d-8641-894586077356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f7f51fee-d511-4baf-9dff-6e934f204023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f7f51fee-d511-4baf-9dff-6e934f204023" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements_052d40c1-ec3f-4003-bfe6-52e818e6fb4f" xlink:href="dgx-20211231.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_dgx_TerminationOfInterestRateSwapAgreements_052d40c1-ec3f-4003-bfe6-52e818e6fb4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ebf190e0-e669-4d0d-af8b-c6b1e0475578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ebf190e0-e669-4d0d-af8b-c6b1e0475578" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7ee136a8-ca02-4a36-9c6b-779285ee9f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7ee136a8-ca02-4a36-9c6b-779285ee9f2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e6d23cd0-6f99-4e6d-a27e-59a171ab805f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0189e03d-eca3-448d-9446-141292a3cb11" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e6d23cd0-6f99-4e6d-a27e-59a171ab805f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#EARNINGSLOSSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_cb60239b-d6fd-4dc3-bf73-3f41870719fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_88eb9b87-9c9e-4a86-97da-72c557f9c1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_cb60239b-d6fd-4dc3-bf73-3f41870719fb" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_88eb9b87-9c9e-4a86-97da-72c557f9c1ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_0d561d01-841e-4ef7-a0b7-0c05cbea92c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_cb60239b-d6fd-4dc3-bf73-3f41870719fb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_0d561d01-841e-4ef7-a0b7-0c05cbea92c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2bff5e8a-050b-425a-935f-095ade1d6904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_309e53b9-a980-45f7-948c-e2883263024f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2bff5e8a-050b-425a-935f-095ade1d6904" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_309e53b9-a980-45f7-948c-e2883263024f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_40b2c8af-c553-4b01-809f-8220c6c8faa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2bff5e8a-050b-425a-935f-095ade1d6904" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_40b2c8af-c553-4b01-809f-8220c6c8faa1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ac1ae0c9-a15a-4bb8-9e16-a2e50f3e76e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_1c5333db-9a4d-41a5-b69d-ca57220b65a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_ac1ae0c9-a15a-4bb8-9e16-a2e50f3e76e0" xlink:to="loc_us-gaap_TradingSecurities_1c5333db-9a4d-41a5-b69d-ca57220b65a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_a8a23321-1686-4e0b-a7f3-c0349d60c46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_ac1ae0c9-a15a-4bb8-9e16-a2e50f3e76e0" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_a8a23321-1686-4e0b-a7f3-c0349d60c46b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_e26371a8-eb21-42fe-b91e-250aaf9825c8" xlink:href="dgx-20211231.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_ac1ae0c9-a15a-4bb8-9e16-a2e50f3e76e0" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_e26371a8-eb21-42fe-b91e-250aaf9825c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a255e51-f540-4ae4-a662-259e42b7fb90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_ac1ae0c9-a15a-4bb8-9e16-a2e50f3e76e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a255e51-f540-4ae4-a662-259e42b7fb90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_340fcf21-8c39-4add-946b-4a77dfc41635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_75fbdbbb-3047-4c27-b2fc-8c4fcf0f1189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_340fcf21-8c39-4add-946b-4a77dfc41635" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_75fbdbbb-3047-4c27-b2fc-8c4fcf0f1189" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ae4312f7-b20e-4a66-9b0d-3be46cf42ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_340fcf21-8c39-4add-946b-4a77dfc41635" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ae4312f7-b20e-4a66-9b0d-3be46cf42ede" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#TAXESONINCOMEDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5aa1bdff-6273-4290-ae49-0f9c5d254ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_8921623c-6ec2-4510-9c0a-f14afab2df68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5aa1bdff-6273-4290-ae49-0f9c5d254ec3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_8921623c-6ec2-4510-9c0a-f14afab2df68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_e37f7d7c-3d4c-480e-bdee-43f573be75b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5aa1bdff-6273-4290-ae49-0f9c5d254ec3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_e37f7d7c-3d4c-480e-bdee-43f573be75b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_2d1149cc-da9d-49c4-a0c6-50187b6321b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5aa1bdff-6273-4290-ae49-0f9c5d254ec3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_2d1149cc-da9d-49c4-a0c6-50187b6321b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_50f7f97b-28ec-4ffe-a80c-4098745b833b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5aa1bdff-6273-4290-ae49-0f9c5d254ec3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_50f7f97b-28ec-4ffe-a80c-4098745b833b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_6d37f74a-b8c0-4fde-8f56-794f16cde978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5aa1bdff-6273-4290-ae49-0f9c5d254ec3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_6d37f74a-b8c0-4fde-8f56-794f16cde978" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_79b405a9-4d7a-4de1-ada7-ff5df682bef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5aa1bdff-6273-4290-ae49-0f9c5d254ec3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_79b405a9-4d7a-4de1-ada7-ff5df682bef1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_4dfcc096-5e6a-4ae9-9dbb-0074dc912656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5aa1bdff-6273-4290-ae49-0f9c5d254ec3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_4dfcc096-5e6a-4ae9-9dbb-0074dc912656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_1389de2c-aca5-4bb0-834b-19523c56aed4" xlink:href="dgx-20211231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5aa1bdff-6273-4290-ae49-0f9c5d254ec3" xlink:to="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_1389de2c-aca5-4bb0-834b-19523c56aed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_a71cb10b-2743-4fdc-8a26-d616e0a8bf08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5aa1bdff-6273-4290-ae49-0f9c5d254ec3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_a71cb10b-2743-4fdc-8a26-d616e0a8bf08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_09b76e89-ea70-4062-83b9-0b617f6650ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f691fbe9-3d2d-4cd8-90da-77064864eb82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_09b76e89-ea70-4062-83b9-0b617f6650ed" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f691fbe9-3d2d-4cd8-90da-77064864eb82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4e49ccf4-47d5-4e7c-8fa2-9defcd7751be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_09b76e89-ea70-4062-83b9-0b617f6650ed" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4e49ccf4-47d5-4e7c-8fa2-9defcd7751be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_02876dc2-fea8-42b7-84b3-3ba01dfe4546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_09b76e89-ea70-4062-83b9-0b617f6650ed" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_02876dc2-fea8-42b7-84b3-3ba01dfe4546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_323a4672-a248-43f6-b142-fb744b49e51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_09b76e89-ea70-4062-83b9-0b617f6650ed" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_323a4672-a248-43f6-b142-fb744b49e51e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a111cb62-93af-49ad-94e0-44755d6d38fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_09b76e89-ea70-4062-83b9-0b617f6650ed" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a111cb62-93af-49ad-94e0-44755d6d38fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_5e05ea2e-8190-408e-a4c9-0741510e9808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_09b76e89-ea70-4062-83b9-0b617f6650ed" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_5e05ea2e-8190-408e-a4c9-0741510e9808" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATADetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b98acc63-4bf3-4512-9843-9c6f73709cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0142a61a-e892-4fdc-8515-3fbc80b64e13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b98acc63-4bf3-4512-9843-9c6f73709cbb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0142a61a-e892-4fdc-8515-3fbc80b64e13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_f54be603-5a53-4f50-914d-8f30997b70b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b98acc63-4bf3-4512-9843-9c6f73709cbb" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_f54be603-5a53-4f50-914d-8f30997b70b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_49b7a499-a922-4d0a-9eb0-b3784205a9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_71365322-ef60-46dc-811e-6bdbd88d8254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_49b7a499-a922-4d0a-9eb0-b3784205a9d9" xlink:to="loc_us-gaap_Depreciation_71365322-ef60-46dc-811e-6bdbd88d8254" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d13ff92b-447a-4b21-95c6-ce8af5ed479a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_49b7a499-a922-4d0a-9eb0-b3784205a9d9" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d13ff92b-447a-4b21-95c6-ce8af5ed479a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_74549241-22e2-4660-b5fd-31efe7f623c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_52d97ca3-bcee-4fb6-a9f8-2ce3bbd05abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_74549241-22e2-4660-b5fd-31efe7f623c2" xlink:to="loc_us-gaap_InterestExpense_52d97ca3-bcee-4fb6-a9f8-2ce3bbd05abf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_8dcbb0c1-1ce7-4958-9c83-1e0c446a75e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_74549241-22e2-4660-b5fd-31efe7f623c2" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_8dcbb0c1-1ce7-4958-9c83-1e0c446a75e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_2f90c9e9-cc9e-46e5-a463-32b27e810068" xlink:href="dgx-20211231.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_ce9a3c2d-db16-44cf-bb80-fb3b56536dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_2f90c9e9-cc9e-46e5-a463-32b27e810068" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_ce9a3c2d-db16-44cf-bb80-fb3b56536dbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_029c4ebd-046c-4a52-b374-90ec473da98a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_2f90c9e9-cc9e-46e5-a463-32b27e810068" xlink:to="loc_us-gaap_LiabilitiesAssumed1_029c4ebd-046c-4a52-b374-90ec473da98a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_473167c5-150b-43e1-9782-36545080c2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8d88b99c-d27a-4a30-93a6-dc43551fd390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_473167c5-150b-43e1-9782-36545080c2d1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8d88b99c-d27a-4a30-93a6-dc43551fd390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2286cdc6-a5a7-4876-a306-28b017936064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_473167c5-150b-43e1-9782-36545080c2d1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2286cdc6-a5a7-4876-a306-28b017936064" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_cdc0f1fd-8d6f-46f0-a6f2-6acf41ba1f29" xlink:href="dgx-20211231.xsd#dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_11f36a67-673d-4dd2-83ea-f6f099be098d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_cdc0f1fd-8d6f-46f0-a6f2-6acf41ba1f29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_11f36a67-673d-4dd2-83ea-f6f099be098d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_86a4abe5-3a33-42f3-a745-59bf975f8de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_cdc0f1fd-8d6f-46f0-a6f2-6acf41ba1f29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_86a4abe5-3a33-42f3-a745-59bf975f8de1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f9c1a0c6-dae1-43cd-9ede-be86194e4eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_cdc0f1fd-8d6f-46f0-a6f2-6acf41ba1f29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f9c1a0c6-dae1-43cd-9ede-be86194e4eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_231e9697-c715-4c35-991f-8c9a4035fde2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_cdc0f1fd-8d6f-46f0-a6f2-6acf41ba1f29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_231e9697-c715-4c35-991f-8c9a4035fde2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_acfb9d18-d0b8-4de9-95fa-b017d3f905f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_cdc0f1fd-8d6f-46f0-a6f2-6acf41ba1f29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_acfb9d18-d0b8-4de9-95fa-b017d3f905f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_cfa9ef3d-e446-4666-ae4b-01288bd25eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_cdc0f1fd-8d6f-46f0-a6f2-6acf41ba1f29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_cfa9ef3d-e446-4666-ae4b-01288bd25eb3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2b2a6ccb-749d-495f-9c4f-94ddfcad4a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_eaa31dac-3629-4887-9e9e-bb8789b278c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2b2a6ccb-749d-495f-9c4f-94ddfcad4a93" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_eaa31dac-3629-4887-9e9e-bb8789b278c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_70c0438d-62cb-4fdd-b7ee-c5108637fbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2b2a6ccb-749d-495f-9c4f-94ddfcad4a93" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_70c0438d-62cb-4fdd-b7ee-c5108637fbeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_5b50dffb-88c1-454a-bdf6-0cd5e49a2a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2b2a6ccb-749d-495f-9c4f-94ddfcad4a93" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_5b50dffb-88c1-454a-bdf6-0cd5e49a2a30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_e02f81ad-adf7-46c4-a59a-c5a74240388a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2b2a6ccb-749d-495f-9c4f-94ddfcad4a93" xlink:to="loc_us-gaap_InterestPayableCurrent_e02f81ad-adf7-46c4-a59a-c5a74240388a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cc7729c1-46ff-4c1d-80f8-c1a4b7c4703c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2b2a6ccb-749d-495f-9c4f-94ddfcad4a93" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_cc7729c1-46ff-4c1d-80f8-c1a4b7c4703c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_69f401c6-668f-4268-8375-c4b35dc11cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2b2a6ccb-749d-495f-9c4f-94ddfcad4a93" xlink:to="loc_us-gaap_DividendsPayableCurrent_69f401c6-668f-4268-8375-c4b35dc11cda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_9b563dcc-9af2-4306-bfd9-4b72396aafad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2b2a6ccb-749d-495f-9c4f-94ddfcad4a93" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_9b563dcc-9af2-4306-bfd9-4b72396aafad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankOverdrafts_3b7762a5-76db-4e9a-aa6b-2a845af2e7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BankOverdrafts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2b2a6ccb-749d-495f-9c4f-94ddfcad4a93" xlink:to="loc_us-gaap_BankOverdrafts_3b7762a5-76db-4e9a-aa6b-2a845af2e7c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MergerConsiderationPayableCurrent_398f16b1-45fc-477f-940d-01a48c49bd39" xlink:href="dgx-20211231.xsd#dgx_MergerConsiderationPayableCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2b2a6ccb-749d-495f-9c4f-94ddfcad4a93" xlink:to="loc_dgx_MergerConsiderationPayableCurrent_398f16b1-45fc-477f-940d-01a48c49bd39" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_26681962-57ef-4604-8ae7-9c8a65d906ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_09e511a1-c508-4b82-8629-fd256c7e6411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_26681962-57ef-4604-8ae7-9c8a65d906ca" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_09e511a1-c508-4b82-8629-fd256c7e6411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b1b39af1-cc4b-4947-b88b-678bc0e01899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_26681962-57ef-4604-8ae7-9c8a65d906ca" xlink:to="loc_us-gaap_LongTermDebtCurrent_b1b39af1-cc4b-4947-b88b-678bc0e01899" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTMaturitiesofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cf137d66-6851-43d7-b2ac-d7c9a9bacbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LongTermDebtMaturitiesGross_0499933f-ad12-4487-936a-a58a135bfa39" xlink:href="dgx-20211231.xsd#dgx_LongTermDebtMaturitiesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cf137d66-6851-43d7-b2ac-d7c9a9bacbdb" xlink:to="loc_dgx_LongTermDebtMaturitiesGross_0499933f-ad12-4487-936a-a58a135bfa39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_14fdd24f-8f43-4f82-8a4c-efe9b7df41eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cf137d66-6851-43d7-b2ac-d7c9a9bacbdb" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_14fdd24f-8f43-4f82-8a4c-efe9b7df41eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_9548a970-a5cb-4b65-b760-05a82e223022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cf137d66-6851-43d7-b2ac-d7c9a9bacbdb" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_9548a970-a5cb-4b65-b760-05a82e223022" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_7b2c6edb-2429-439d-a9cc-3c616c660f54" xlink:href="dgx-20211231.xsd#dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cf137d66-6851-43d7-b2ac-d7c9a9bacbdb" xlink:to="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_7b2c6edb-2429-439d-a9cc-3c616c660f54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LongTermDebtMaturitiesGross_294e5f90-9608-4491-8785-29a53d6920c0" xlink:href="dgx-20211231.xsd#dgx_LongTermDebtMaturitiesGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_46e469ce-c570-41bb-b9f2-ef7d92b29162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_294e5f90-9608-4491-8785-29a53d6920c0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_46e469ce-c570-41bb-b9f2-ef7d92b29162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_91276831-6f7b-4826-9635-776158e5db68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_294e5f90-9608-4491-8785-29a53d6920c0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_91276831-6f7b-4826-9635-776158e5db68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_32c87cd7-9b6a-4457-ac0b-ca1a73114a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_294e5f90-9608-4491-8785-29a53d6920c0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_32c87cd7-9b6a-4457-ac0b-ca1a73114a6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_05e12e15-0d98-47a9-ad3f-df592b72672f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_294e5f90-9608-4491-8785-29a53d6920c0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_05e12e15-0d98-47a9-ad3f-df592b72672f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0e32c8e8-c8e0-41ca-b498-a5ce51340fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_294e5f90-9608-4491-8785-29a53d6920c0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0e32c8e8-c8e0-41ca-b498-a5ce51340fa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_234c46c9-e6bf-4130-9c3d-b246100e006a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_294e5f90-9608-4491-8785-29a53d6920c0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_234c46c9-e6bf-4130-9c3d-b246100e006a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESLiabilitiesDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASESLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/LEASESLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRightofUseAsset_316d022d-0af6-4bf2-b6ce-b698d28e81b7" xlink:href="dgx-20211231.xsd#dgx_LeaseRightofUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_694f070b-0226-4c36-a51c-c3bc78fbf61e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseRightofUseAsset_316d022d-0af6-4bf2-b6ce-b698d28e81b7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_694f070b-0226-4c36-a51c-c3bc78fbf61e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_f348112a-74b8-42ea-92ae-5398b6dfc9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseRightofUseAsset_316d022d-0af6-4bf2-b6ce-b698d28e81b7" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_f348112a-74b8-42ea-92ae-5398b6dfc9a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseLiability_8848e898-d717-486b-b75c-9dfdd0532fd3" xlink:href="dgx-20211231.xsd#dgx_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1bce2836-a1b9-4769-8cb0-149e621d91ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseLiability_8848e898-d717-486b-b75c-9dfdd0532fd3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1bce2836-a1b9-4769-8cb0-149e621d91ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_81cbfcc1-90b0-4e29-a475-a6035cb567b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseLiability_8848e898-d717-486b-b75c-9dfdd0532fd3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_81cbfcc1-90b0-4e29-a475-a6035cb567b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d74b2dff-e499-4490-9b4e-8f5d92b4d8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseLiability_8848e898-d717-486b-b75c-9dfdd0532fd3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d74b2dff-e499-4490-9b4e-8f5d92b4d8c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6d467406-eac0-489a-829d-9c42401b5789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseLiability_8848e898-d717-486b-b75c-9dfdd0532fd3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6d467406-eac0-489a-829d-9c42401b5789" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESCostsDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASESCostsDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/LEASESCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_da4a766f-a774-47c6-9beb-e269b6c64799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2636f2f7-e9e8-4285-bc16-871895b20590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_da4a766f-a774-47c6-9beb-e269b6c64799" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2636f2f7-e9e8-4285-bc16-871895b20590" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingLeaseFixedAndVariableCost_58828342-05a2-41da-b9da-1ed0d21efa7b" xlink:href="dgx-20211231.xsd#dgx_OperatingLeaseFixedAndVariableCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_da4a766f-a774-47c6-9beb-e269b6c64799" xlink:to="loc_dgx_OperatingLeaseFixedAndVariableCost_58828342-05a2-41da-b9da-1ed0d21efa7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_cf33bc08-0ecd-4796-984f-fbd273c9bab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_da4a766f-a774-47c6-9beb-e269b6c64799" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_cf33bc08-0ecd-4796-984f-fbd273c9bab1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESMaturityDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASESMaturityDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/LEASESMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_bd0a6c20-a37b-4b62-9d4f-98aeb8eed9de" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a71343cc-22eb-450e-a9e9-b44bb5bfe0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_bd0a6c20-a37b-4b62-9d4f-98aeb8eed9de" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a71343cc-22eb-450e-a9e9-b44bb5bfe0e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_4bc625ad-b31a-4880-a44c-26b15efb3335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_bd0a6c20-a37b-4b62-9d4f-98aeb8eed9de" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_4bc625ad-b31a-4880-a44c-26b15efb3335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_22327d4d-08ec-4ae8-9731-b15722b91aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d2db22cc-8671-46cf-ab7c-6c27e77be3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_22327d4d-08ec-4ae8-9731-b15722b91aa3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d2db22cc-8671-46cf-ab7c-6c27e77be3a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fd1a6ce6-ab18-499c-87ce-1567fa60d517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_22327d4d-08ec-4ae8-9731-b15722b91aa3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fd1a6ce6-ab18-499c-87ce-1567fa60d517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9eb3df53-05eb-41e5-81da-7d1ba934ed25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_22327d4d-08ec-4ae8-9731-b15722b91aa3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9eb3df53-05eb-41e5-81da-7d1ba934ed25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_80aed7a4-cbd3-4961-8a09-3a26fceb5aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_22327d4d-08ec-4ae8-9731-b15722b91aa3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_80aed7a4-cbd3-4961-8a09-3a26fceb5aab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_125ea299-4a50-4f83-99ef-46ffa9438546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_22327d4d-08ec-4ae8-9731-b15722b91aa3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_125ea299-4a50-4f83-99ef-46ffa9438546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6d38644e-e88c-4b7b-952f-fa1cb863d42f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_22327d4d-08ec-4ae8-9731-b15722b91aa3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6d38644e-e88c-4b7b-952f-fa1cb863d42f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a225aa90-f466-4c53-a6c8-e508fe5214a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_6b99a3be-eaad-4847-8721-cc6240e1062e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a225aa90-f466-4c53-a6c8-e508fe5214a4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_6b99a3be-eaad-4847-8721-cc6240e1062e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ad3f374c-d5c4-4f84-a0d6-1ee2fcb16122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a225aa90-f466-4c53-a6c8-e508fe5214a4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ad3f374c-d5c4-4f84-a0d6-1ee2fcb16122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4c323e7e-688f-4a93-b1df-edb2698738e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a225aa90-f466-4c53-a6c8-e508fe5214a4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4c323e7e-688f-4a93-b1df-edb2698738e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d9bc5e98-9854-45b4-9535-3a3e9b0b15ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a225aa90-f466-4c53-a6c8-e508fe5214a4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d9bc5e98-9854-45b4-9535-3a3e9b0b15ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_cb74999f-21a8-4816-972c-7a3a43410f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a225aa90-f466-4c53-a6c8-e508fe5214a4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_cb74999f-21a8-4816-972c-7a3a43410f24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b2d2a2d7-2bba-4ea0-8575-e3984d38bf1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a225aa90-f466-4c53-a6c8-e508fe5214a4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b2d2a2d7-2bba-4ea0-8575-e3984d38bf1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingandFinanceLeaseLiability_0f4b225b-aaaa-4fa8-a961-8875bde358cf" xlink:href="dgx-20211231.xsd#dgx_OperatingandFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_322547e7-b5f4-47bb-a85d-736fb3cceb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_OperatingandFinanceLeaseLiability_0f4b225b-aaaa-4fa8-a961-8875bde358cf" xlink:to="loc_us-gaap_OperatingLeaseLiability_322547e7-b5f4-47bb-a85d-736fb3cceb1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4d6c25c7-a54a-4f3e-897b-b2728d897bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_OperatingandFinanceLeaseLiability_0f4b225b-aaaa-4fa8-a961-8875bde358cf" xlink:to="loc_us-gaap_FinanceLeaseLiability_4d6c25c7-a54a-4f3e-897b-b2728d897bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_6dfbf23d-d9b6-4177-984a-55cacb8bb3eb" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c94830b9-0f7f-4201-91c8-d06d59137cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_6dfbf23d-d9b6-4177-984a-55cacb8bb3eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c94830b9-0f7f-4201-91c8-d06d59137cb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_244e2aca-5e42-44c5-bf93-e451ad4ed76b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_6dfbf23d-d9b6-4177-984a-55cacb8bb3eb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_244e2aca-5e42-44c5-bf93-e451ad4ed76b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_be605091-025e-4be1-a293-047738cdf5ae" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c359a26f-63f8-4361-9db6-783256f05600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_be605091-025e-4be1-a293-047738cdf5ae" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c359a26f-63f8-4361-9db6-783256f05600" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_751f3a22-5575-4a37-acf8-609f05db1f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_be605091-025e-4be1-a293-047738cdf5ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_751f3a22-5575-4a37-acf8-609f05db1f8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_84a3167d-8a02-4b19-8a1b-3095d6bc305c" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6ac71f0a-10ae-4c99-807c-a06821b2240a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_84a3167d-8a02-4b19-8a1b-3095d6bc305c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6ac71f0a-10ae-4c99-807c-a06821b2240a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_74eeb818-7dab-4a52-8ee9-26f548fffa14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_84a3167d-8a02-4b19-8a1b-3095d6bc305c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_74eeb818-7dab-4a52-8ee9-26f548fffa14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_996cb046-43c8-4754-916c-68f859890f76" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_158ffbbb-6f3a-4e9a-a95c-38e78158264c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_996cb046-43c8-4754-916c-68f859890f76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_158ffbbb-6f3a-4e9a-a95c-38e78158264c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f74f27b4-0434-448e-be9b-5478154357df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_996cb046-43c8-4754-916c-68f859890f76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f74f27b4-0434-448e-be9b-5478154357df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_ce330c7d-435b-4920-8349-08a704c5daa6" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7f768683-f82c-4b14-8887-72a17d3b9325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_ce330c7d-435b-4920-8349-08a704c5daa6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7f768683-f82c-4b14-8887-72a17d3b9325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_131bc94f-d550-4aa5-a350-134eb5d90de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_ce330c7d-435b-4920-8349-08a704c5daa6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_131bc94f-d550-4aa5-a350-134eb5d90de3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_64f1e2b6-2aae-42d8-9bd4-f23031b6c981" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_bb0b3aed-bfc1-4599-bf95-6b2c9ebe18e3" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_64f1e2b6-2aae-42d8-9bd4-f23031b6c981" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_bb0b3aed-bfc1-4599-bf95-6b2c9ebe18e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_a404a1b1-4a7c-49f2-ab9a-2ad8ef007226" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_64f1e2b6-2aae-42d8-9bd4-f23031b6c981" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_a404a1b1-4a7c-49f2-ab9a-2ad8ef007226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_e9645ef2-e44b-4468-828f-97d43ea784e6" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_64f1e2b6-2aae-42d8-9bd4-f23031b6c981" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_e9645ef2-e44b-4468-828f-97d43ea784e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_a8ef4cdc-a7a5-4b93-8e60-d9c1d4f46e27" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_64f1e2b6-2aae-42d8-9bd4-f23031b6c981" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_a8ef4cdc-a7a5-4b93-8e60-d9c1d4f46e27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_4f7d764d-9600-4280-8e9c-341e7c58584c" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_64f1e2b6-2aae-42d8-9bd4-f23031b6c981" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_4f7d764d-9600-4280-8e9c-341e7c58584c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_ca989863-1acb-46b5-8d1f-f232a8267f75" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_64f1e2b6-2aae-42d8-9bd4-f23031b6c981" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_ca989863-1acb-46b5-8d1f-f232a8267f75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_405f8a1a-923b-4b22-b0f4-c18e27e8d7de" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5679de41-08eb-431c-bc3d-444355947357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_405f8a1a-923b-4b22-b0f4-c18e27e8d7de" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5679de41-08eb-431c-bc3d-444355947357" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a929ffb4-db21-4be6-8bb7-16bf04a33f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_405f8a1a-923b-4b22-b0f4-c18e27e8d7de" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a929ffb4-db21-4be6-8bb7-16bf04a33f84" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>dgx-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c829db2e-c850-44b9-90d1-7027e34dc7fe,g:892aaabe-58ca-45ff-95da-140e039c9f49-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="ia86d3667cd5646b7a77fbb12b3465d7f_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ade8ad86-81ce-473f-b4ee-ac35fea77ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ade8ad86-81ce-473f-b4ee-ac35fea77ba8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f62f3ee-b874-4dc2-b259-bab4ab2310d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f62f3ee-b874-4dc2-b259-bab4ab2310d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fe912562-73a8-4521-bc93-12580806aa50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_fe912562-73a8-4521-bc93-12580806aa50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_736c617c-c7b0-429b-91e8-4b1f70b83228" xlink:href="dgx-20211231.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_736c617c-c7b0-429b-91e8-4b1f70b83228" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7f5b2be5-e432-4cc9-ab22-0fa6e08170c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7f5b2be5-e432-4cc9-ab22-0fa6e08170c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_b697b32b-ce0e-4297-898f-2c098b584154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_DividendsCommonStockCash_b697b32b-ce0e-4297-898f-2c098b584154" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_dc46b02d-d0b3-4418-b21d-8d07339e6241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_dc46b02d-d0b3-4418-b21d-8d07339e6241" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_03fc7a18-a036-403a-88a8-ef063f4542d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_03fc7a18-a036-403a-88a8-ef063f4542d9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1858577d-7bc1-46b8-9da9-cbe239da7e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1858577d-7bc1-46b8-9da9-cbe239da7e76" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_063df5d9-e18c-4c63-b379-2efdafa8ddc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_063df5d9-e18c-4c63-b379-2efdafa8ddc6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_250fdbaa-ea64-44d0-89d5-ed5b626ad4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_250fdbaa-ea64-44d0-89d5-ed5b626ad4c3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_40c6cc26-fb89-4469-bb76-78fea471e72a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_40c6cc26-fb89-4469-bb76-78fea471e72a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2b3a599e-0313-4a8f-af07-787c824789df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2b3a599e-0313-4a8f-af07-787c824789df" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f2cdd8e0-73f4-4469-ac80-e8c1f1bc7464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f2cdd8e0-73f4-4469-ac80-e8c1f1bc7464" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_5efad68e-1729-489b-a5ef-5f59aeab9c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_5efad68e-1729-489b-a5ef-5f59aeab9c1c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_fccc0141-987b-4c01-bf6e-aea1e4cd556c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_fccc0141-987b-4c01-bf6e-aea1e4cd556c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bea99c6f-3e9a-4f0d-962d-2e6a854c7c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8f4cb118-36bf-4644-a7b1-2a31956c96da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ade8ad86-81ce-473f-b4ee-ac35fea77ba8" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d9a35dea-a34b-43af-bbea-582bfb0d5e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d9a35dea-a34b-43af-bbea-582bfb0d5e1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_681de719-7ff4-46bb-a056-cbc833ad46c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_681de719-7ff4-46bb-a056-cbc833ad46c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_7eb447ef-645f-4b9b-8947-5c99e1569c6c" xlink:href="dgx-20211231.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_7eb447ef-645f-4b9b-8947-5c99e1569c6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0f865f76-d583-4c3a-b2b1-231b60d8ecba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b2cb39e2-7f3f-4a42-9f34-694f0c0690af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ade8ad86-81ce-473f-b4ee-ac35fea77ba8" xlink:to="loc_us-gaap_StatementTable_b2cb39e2-7f3f-4a42-9f34-694f0c0690af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6ac0feeb-b790-41cd-93f8-333a0cdb5442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b2cb39e2-7f3f-4a42-9f34-694f0c0690af" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6ac0feeb-b790-41cd-93f8-333a0cdb5442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6ac0feeb-b790-41cd-93f8-333a0cdb5442_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6ac0feeb-b790-41cd-93f8-333a0cdb5442" xlink:to="loc_us-gaap_EquityComponentDomain_6ac0feeb-b790-41cd-93f8-333a0cdb5442_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6ac0feeb-b790-41cd-93f8-333a0cdb5442" xlink:to="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f6800142-88a1-4ad6-9197-ad642a35aa97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_CommonStockMember_f6800142-88a1-4ad6-9197-ad642a35aa97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2fa18eba-5f0c-4dfd-a696-aaf280de163c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2fa18eba-5f0c-4dfd-a696-aaf280de163c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cce53742-02de-40f2-9136-4670629f1d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_RetainedEarningsMember_cce53742-02de-40f2-9136-4670629f1d85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1486a400-bc09-4785-a7ff-a5585469ff8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1486a400-bc09-4785-a7ff-a5585469ff8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_053f76af-552c-4ae1-8ad6-6ce77fdec607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_TreasuryStockMember_053f76af-552c-4ae1-8ad6-6ce77fdec607" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_47156361-dddd-4000-a754-ed31edd5c360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_NoncontrollingInterestMember_47156361-dddd-4000-a754-ed31edd5c360" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended" id="i7ed1f55502f34b988b3f8e2ac4a5f964_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:href="dgx-20211231.xsd#dgx_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0ee9fa1c-2eee-4637-b8ed-2ef774cf9026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0ee9fa1c-2eee-4637-b8ed-2ef774cf9026" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_d950275c-b82e-4281-a6d3-49bd2e50b28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_d950275c-b82e-4281-a6d3-49bd2e50b28c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_682ac276-c906-4d67-a509-5f8880ad2f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquityMethodInvestments_682ac276-c906-4d67-a509-5f8880ad2f6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_fa05b701-3ca3-4d38-a4d2-9a0e6aded9fa" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_dgx_PercentageofNetRevenues_fa05b701-3ca3-4d38-a4d2-9a0e6aded9fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e1e5fe23-4bc8-48d9-beca-eeb6d3ab394b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e1e5fe23-4bc8-48d9-beca-eeb6d3ab394b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_c97713f4-2c65-456e-bce6-392a65b86db4" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_c97713f4-2c65-456e-bce6-392a65b86db4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_aeca6703-ba08-4cc4-95ab-c40a42e74bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_aeca6703-ba08-4cc4-95ab-c40a42e74bf8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9ebfbb2e-2af2-4dc5-9b88-26b3539960cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9ebfbb2e-2af2-4dc5-9b88-26b3539960cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b4e6adb9-4145-41ba-8c59-2f353e7430b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_OperatingIncomeLoss_b4e6adb9-4145-41ba-8c59-2f353e7430b5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c06c9935-1e3e-44f3-b668-5fb44353a7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_ProfitLoss_c06c9935-1e3e-44f3-b668-5fb44353a7a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_c8737bec-2439-41b8-8074-9452cc44883c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_c8737bec-2439-41b8-8074-9452cc44883c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_24d8b126-8f25-4925-a4c2-88930957d874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_24d8b126-8f25-4925-a4c2-88930957d874" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_4bd30131-a886-4536-b9ca-4d0e636d248d" xlink:href="dgx-20211231.xsd#dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_4bd30131-a886-4536-b9ca-4d0e636d248d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_af48feb7-58a2-4fa1-86a5-0abbd29f83b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_af48feb7-58a2-4fa1-86a5-0abbd29f83b6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_99b77878-835e-4aa1-a6d6-bd040a655168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_99b77878-835e-4aa1-a6d6-bd040a655168" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a1d667af-9160-4ce0-b354-dfab8a2b4da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a1d667af-9160-4ce0-b354-dfab8a2b4da8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d8ecf3d9-281c-4ed2-b88f-bc41127ed8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_OperatingLeaseLiability_d8ecf3d9-281c-4ed2-b88f-bc41127ed8df" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_77ff5b94-72d4-4f32-b19f-84be90b2f1e0" xlink:href="dgx-20211231.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_77ff5b94-72d4-4f32-b19f-84be90b2f1e0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_d4a55f51-e965-49aa-8ee3-260fb9266b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_TradingSecurities_d4a55f51-e965-49aa-8ee3-260fb9266b68" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:href="dgx-20211231.xsd#dgx_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_594f9800-596f-48dd-9ee1-13cb91ed6bd3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_srt_RangeAxis_594f9800-596f-48dd-9ee1-13cb91ed6bd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_594f9800-596f-48dd-9ee1-13cb91ed6bd3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_594f9800-596f-48dd-9ee1-13cb91ed6bd3" xlink:to="loc_srt_RangeMember_594f9800-596f-48dd-9ee1-13cb91ed6bd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6919d98-80a0-42b3-8e5b-686ccf07e2d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_594f9800-596f-48dd-9ee1-13cb91ed6bd3" xlink:to="loc_srt_RangeMember_b6919d98-80a0-42b3-8e5b-686ccf07e2d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ed53903f-8991-47d0-a76d-0ac833578cc0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b6919d98-80a0-42b3-8e5b-686ccf07e2d8" xlink:to="loc_srt_MinimumMember_ed53903f-8991-47d0-a76d-0ac833578cc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cdb86eac-cdf3-45e9-b784-730d94f62c79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b6919d98-80a0-42b3-8e5b-686ccf07e2d8" xlink:to="loc_srt_MaximumMember_cdb86eac-cdf3-45e9-b784-730d94f62c79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ff645a21-dd77-4226-8a38-dcff6a8f5399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ff645a21-dd77-4226-8a38-dcff6a8f5399" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ff645a21-dd77-4226-8a38-dcff6a8f5399_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ff645a21-dd77-4226-8a38-dcff6a8f5399" xlink:to="loc_us-gaap_SegmentDomain_ff645a21-dd77-4226-8a38-dcff6a8f5399_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_46d0024b-f519-49fd-974f-80d94e8f014b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ff645a21-dd77-4226-8a38-dcff6a8f5399" xlink:to="loc_us-gaap_SegmentDomain_46d0024b-f519-49fd-974f-80d94e8f014b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_0ef58775-b3eb-41c4-bbf4-5dd8c68b9d4f" xlink:href="dgx-20211231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_46d0024b-f519-49fd-974f-80d94e8f014b" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_0ef58775-b3eb-41c4-bbf4-5dd8c68b9d4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_ed9d23e2-9528-4d11-9233-e2e9188fc074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_SubsegmentsAxis_ed9d23e2-9528-4d11-9233-e2e9188fc074" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_ed9d23e2-9528-4d11-9233-e2e9188fc074_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_ed9d23e2-9528-4d11-9233-e2e9188fc074" xlink:to="loc_us-gaap_SubsegmentsDomain_ed9d23e2-9528-4d11-9233-e2e9188fc074_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_18b221c8-67ad-4a03-a040-6b319e499dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_ed9d23e2-9528-4d11-9233-e2e9188fc074" xlink:to="loc_us-gaap_SubsegmentsDomain_18b221c8-67ad-4a03-a040-6b319e499dac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_82b00da7-4327-49ac-a648-952dab37f9f9" xlink:href="dgx-20211231.xsd#dgx_GovernmentPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_18b221c8-67ad-4a03-a040-6b319e499dac" xlink:to="loc_dgx_GovernmentPayersMember_82b00da7-4327-49ac-a648-952dab37f9f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientMember_ee8f5c13-e2f2-4373-9189-0f28cc974427" xlink:href="dgx-20211231.xsd#dgx_PatientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_18b221c8-67ad-4a03-a040-6b319e499dac" xlink:to="loc_dgx_PatientMember_ee8f5c13-e2f2-4373-9189-0f28cc974427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_130b91b9-484f-4466-946f-516f2757a716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_130b91b9-484f-4466-946f-516f2757a716" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_130b91b9-484f-4466-946f-516f2757a716_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_130b91b9-484f-4466-946f-516f2757a716" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_130b91b9-484f-4466-946f-516f2757a716_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a07064be-82e0-4013-a3f1-3f273db89d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_130b91b9-484f-4466-946f-516f2757a716" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a07064be-82e0-4013-a3f1-3f273db89d35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_a52ee9c9-1fa1-451d-bbfa-bb6e72e03ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a07064be-82e0-4013-a3f1-3f273db89d35" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_a52ee9c9-1fa1-451d-bbfa-bb6e72e03ee2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_23e090b2-49e9-4bc7-8289-51feed9594bc" xlink:href="dgx-20211231.xsd#dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a07064be-82e0-4013-a3f1-3f273db89d35" xlink:to="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_23e090b2-49e9-4bc7-8289-51feed9594bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_831275b4-339a-490b-89cd-0f2a231e140e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a07064be-82e0-4013-a3f1-3f273db89d35" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_831275b4-339a-490b-89cd-0f2a231e140e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_021f8910-f22b-4190-8b6d-1901fa84741d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_021f8910-f22b-4190-8b6d-1901fa84741d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_021f8910-f22b-4190-8b6d-1901fa84741d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_021f8910-f22b-4190-8b6d-1901fa84741d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_021f8910-f22b-4190-8b6d-1901fa84741d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8946f7c0-8ef0-4fdd-a7ea-8b588de4d2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_021f8910-f22b-4190-8b6d-1901fa84741d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8946f7c0-8ef0-4fdd-a7ea-8b588de4d2db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b3a4116f-752b-4c34-b836-9b937d5b64c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8946f7c0-8ef0-4fdd-a7ea-8b588de4d2db" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b3a4116f-752b-4c34-b836-9b937d5b64c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ccb97e13-bb85-4894-8bf2-9829f1420676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ccb97e13-bb85-4894-8bf2-9829f1420676" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ccb97e13-bb85-4894-8bf2-9829f1420676_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ccb97e13-bb85-4894-8bf2-9829f1420676" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ccb97e13-bb85-4894-8bf2-9829f1420676_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6e3a6f2c-5e7b-477a-9428-700e4c67c401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ccb97e13-bb85-4894-8bf2-9829f1420676" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6e3a6f2c-5e7b-477a-9428-700e4c67c401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_8a010c13-470c-491b-960a-8e9270188b29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e3a6f2c-5e7b-477a-9428-700e4c67c401" xlink:to="loc_us-gaap_OtherAssetsMember_8a010c13-470c-491b-960a-8e9270188b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_cc720198-846e-4e0b-8581-c8b28b48a8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e3a6f2c-5e7b-477a-9428-700e4c67c401" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_cc720198-846e-4e0b-8581-c8b28b48a8cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_56d0d122-6f7b-4737-92c0-e8ff12ad4c15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_srt_StatementScenarioAxis_56d0d122-6f7b-4737-92c0-e8ff12ad4c15" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_56d0d122-6f7b-4737-92c0-e8ff12ad4c15_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_56d0d122-6f7b-4737-92c0-e8ff12ad4c15" xlink:to="loc_srt_ScenarioUnspecifiedDomain_56d0d122-6f7b-4737-92c0-e8ff12ad4c15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b47d7830-68e1-473b-8a69-8ce6adb16edf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_56d0d122-6f7b-4737-92c0-e8ff12ad4c15" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b47d7830-68e1-473b-8a69-8ce6adb16edf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_64ba851b-dce8-4fff-a682-ccf6d62c7fdb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_b47d7830-68e1-473b-8a69-8ce6adb16edf" xlink:to="loc_srt_ScenarioForecastMember_64ba851b-dce8-4fff-a682-ccf6d62c7fdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_16f3153e-c45c-4c89-81b5-6a7e6b62999a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_16f3153e-c45c-4c89-81b5-6a7e6b62999a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_16f3153e-c45c-4c89-81b5-6a7e6b62999a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_16f3153e-c45c-4c89-81b5-6a7e6b62999a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_16f3153e-c45c-4c89-81b5-6a7e6b62999a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_90c2551b-77ea-444f-8e2f-30a6016cf75e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_16f3153e-c45c-4c89-81b5-6a7e6b62999a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_90c2551b-77ea-444f-8e2f-30a6016cf75e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7ff5e088-faed-4352-bcd2-b76450c19494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_90c2551b-77ea-444f-8e2f-30a6016cf75e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7ff5e088-faed-4352-bcd2-b76450c19494" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#REVENUERECOGNITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended" id="i9510176c5b454a33892535dd52b31b00_REVENUERECOGNITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_734a84c9-1ac0-415b-9409-8945d085036a" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_dgx_PercentageofNetRevenues_734a84c9-1ac0-415b-9409-8945d085036a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RevenueCollectionofConsiderationPeriod_0b07d941-e3dd-49ce-82d0-a0860683a6ca" xlink:href="dgx-20211231.xsd#dgx_RevenueCollectionofConsiderationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_dgx_RevenueCollectionofConsiderationPeriod_0b07d941-e3dd-49ce-82d0-a0860683a6ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PeriodofBillingFullyReserve_95abeb5e-d6b7-4bd3-bf52-be327846b920" xlink:href="dgx-20211231.xsd#dgx_PeriodofBillingFullyReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_dgx_PeriodofBillingFullyReserve_95abeb5e-d6b7-4bd3-bf52-be327846b920" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_19ed6977-4af9-4175-b59c-ca75c2150d52" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_19ed6977-4af9-4175-b59c-ca75c2150d52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_81c79e1b-9bdd-4cb7-8a79-f8f37e793928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_81c79e1b-9bdd-4cb7-8a79-f8f37e793928" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_89c0bff3-e537-4c6e-926f-e79d760325a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_81c79e1b-9bdd-4cb7-8a79-f8f37e793928" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_89c0bff3-e537-4c6e-926f-e79d760325a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_7f4d2292-54e4-4868-884e-5d6ec5a5a817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_81c79e1b-9bdd-4cb7-8a79-f8f37e793928" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_7f4d2292-54e4-4868-884e-5d6ec5a5a817" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ecf764f4-bbdc-4406-b439-ee31530fa001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_96195678-5e26-490e-83ac-09c1ab503fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_96195678-5e26-490e-83ac-09c1ab503fe1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5209b67d-77b7-4732-8641-f05e9e9691c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5209b67d-77b7-4732-8641-f05e9e9691c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5209b67d-77b7-4732-8641-f05e9e9691c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5209b67d-77b7-4732-8641-f05e9e9691c8" xlink:to="loc_us-gaap_SegmentDomain_5209b67d-77b7-4732-8641-f05e9e9691c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b927b843-ae4e-4143-8fae-7fda5025ce32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5209b67d-77b7-4732-8641-f05e9e9691c8" xlink:to="loc_us-gaap_SegmentDomain_b927b843-ae4e-4143-8fae-7fda5025ce32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_a8d68200-b02c-4948-84d8-512dbbcfdcbd" xlink:href="dgx-20211231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b927b843-ae4e-4143-8fae-7fda5025ce32" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_a8d68200-b02c-4948-84d8-512dbbcfdcbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_a637337e-b252-458a-8011-c5d020ccb721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b927b843-ae4e-4143-8fae-7fda5025ce32" xlink:to="loc_us-gaap_AllOtherSegmentsMember_a637337e-b252-458a-8011-c5d020ccb721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_43bce977-bed2-4785-9ccb-eefd5afa3f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:to="loc_us-gaap_SubsegmentsAxis_43bce977-bed2-4785-9ccb-eefd5afa3f7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_43bce977-bed2-4785-9ccb-eefd5afa3f7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_43bce977-bed2-4785-9ccb-eefd5afa3f7d" xlink:to="loc_us-gaap_SubsegmentsDomain_43bce977-bed2-4785-9ccb-eefd5afa3f7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_43bce977-bed2-4785-9ccb-eefd5afa3f7d" xlink:to="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_f0064f72-1b62-4b87-adde-4d2ffbb360b9" xlink:href="dgx-20211231.xsd#dgx_HealthcareInsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:to="loc_dgx_HealthcareInsurersMember_f0064f72-1b62-4b87-adde-4d2ffbb360b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_d4963d21-545e-46fd-8824-6ba8d0babbea" xlink:href="dgx-20211231.xsd#dgx_GovernmentPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:to="loc_dgx_GovernmentPayersMember_d4963d21-545e-46fd-8824-6ba8d0babbea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_b5c1aae6-63f2-4ef9-877f-4810da2cef02" xlink:href="dgx-20211231.xsd#dgx_ClientPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:to="loc_dgx_ClientPayersMember_b5c1aae6-63f2-4ef9-877f-4810da2cef02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientMember_fd06fd54-84c0-42da-9bf7-9866fa77cfaf" xlink:href="dgx-20211231.xsd#dgx_PatientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:to="loc_dgx_PatientMember_fd06fd54-84c0-42da-9bf7-9866fa77cfaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_6b2561e5-8bbd-4ae8-b03f-6cba583e4f5d" xlink:href="dgx-20211231.xsd#dgx_DSBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:to="loc_dgx_DSBusinessesMember_6b2561e5-8bbd-4ae8-b03f-6cba583e4f5d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_36fb0974-9317-44e1-b719-ba638758e758" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:to="loc_srt_ProductOrServiceAxis_36fb0974-9317-44e1-b719-ba638758e758" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_36fb0974-9317-44e1-b719-ba638758e758_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_36fb0974-9317-44e1-b719-ba638758e758" xlink:to="loc_srt_ProductsAndServicesDomain_36fb0974-9317-44e1-b719-ba638758e758_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_acecdbb7-1ad7-472e-883e-1ccc26423133" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_36fb0974-9317-44e1-b719-ba638758e758" xlink:to="loc_srt_ProductsAndServicesDomain_acecdbb7-1ad7-472e-883e-1ccc26423133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_6279d803-fdf2-40cc-9fc1-435eb6968281" xlink:href="dgx-20211231.xsd#dgx_FeeforserviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_acecdbb7-1ad7-472e-883e-1ccc26423133" xlink:to="loc_dgx_FeeforserviceMember_6279d803-fdf2-40cc-9fc1-435eb6968281" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_82ec73d8-d4a0-4be8-a72b-74845639fe69" xlink:href="dgx-20211231.xsd#dgx_CapitatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_acecdbb7-1ad7-472e-883e-1ccc26423133" xlink:to="loc_dgx_CapitatedMember_82ec73d8-d4a0-4be8-a72b-74845639fe69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6731e98a-60a4-47fd-b3e7-45a3f3aa9cb2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:to="loc_srt_RangeAxis_6731e98a-60a4-47fd-b3e7-45a3f3aa9cb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6731e98a-60a4-47fd-b3e7-45a3f3aa9cb2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6731e98a-60a4-47fd-b3e7-45a3f3aa9cb2" xlink:to="loc_srt_RangeMember_6731e98a-60a4-47fd-b3e7-45a3f3aa9cb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_97fe6520-34f5-460e-9d1f-296db961da9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6731e98a-60a4-47fd-b3e7-45a3f3aa9cb2" xlink:to="loc_srt_RangeMember_97fe6520-34f5-460e-9d1f-296db961da9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_17afdb97-ccf4-4708-bc6a-83229766af26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_97fe6520-34f5-460e-9d1f-296db961da9d" xlink:to="loc_srt_MinimumMember_17afdb97-ccf4-4708-bc6a-83229766af26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d1546f17-276f-4855-9f9a-d842da92547d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_97fe6520-34f5-460e-9d1f-296db961da9d" xlink:to="loc_srt_MaximumMember_d1546f17-276f-4855-9f9a-d842da92547d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#EARNINGSLOSSPERSHAREDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="extended" id="i07020c850ad24d8dbbfa47bcf48cf738_EARNINGSLOSSPERSHAREDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_e7b209fa-3a23-4f6b-a4a3-f3d2f541650e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesPayment_9893d0a0-eaae-4c1e-95b7-21f1e6074bf0" xlink:href="dgx-20211231.xsd#dgx_AcceleratedShareRepurchasesPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_e7b209fa-3a23-4f6b-a4a3-f3d2f541650e" xlink:to="loc_dgx_AcceleratedShareRepurchasesPayment_9893d0a0-eaae-4c1e-95b7-21f1e6074bf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_8b354125-a504-4856-b86b-721d22a51d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_e7b209fa-3a23-4f6b-a4a3-f3d2f541650e" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_8b354125-a504-4856-b86b-721d22a51d1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16aa5174-e6d9-42ba-b7fc-a12254394bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_8b354125-a504-4856-b86b-721d22a51d1f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16aa5174-e6d9-42ba-b7fc-a12254394bf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_16aa5174-e6d9-42ba-b7fc-a12254394bf4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16aa5174-e6d9-42ba-b7fc-a12254394bf4" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_16aa5174-e6d9-42ba-b7fc-a12254394bf4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_68861d04-d4f2-43b7-b5f5-728a63949753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16aa5174-e6d9-42ba-b7fc-a12254394bf4" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_68861d04-d4f2-43b7-b5f5-728a63949753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b0472727-ca49-4091-b10f-5fddec0a162e" xlink:href="dgx-20211231.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_68861d04-d4f2-43b7-b5f5-728a63949753" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b0472727-ca49-4091-b10f-5fddec0a162e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended" id="ia298adc077e3485f99cc5fc4fd6b6535_BUSINESSACQUISITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_369b10da-bc19-4cdd-8836-666e0090cd28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_369b10da-bc19-4cdd-8836-666e0090cd28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c995fd7b-f3ff-42fe-bbdd-3e1aafc0e824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c995fd7b-f3ff-42fe-bbdd-3e1aafc0e824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b6ae3bdf-3563-438c-a6b0-10d7226a3dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b6ae3bdf-3563-438c-a6b0-10d7226a3dfb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b33f147e-9001-4588-9f6b-63563b791a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b33f147e-9001-4588-9f6b-63563b791a37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3d300144-9cf6-4b0e-acbf-7868eb27a58f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3d300144-9cf6-4b0e-acbf-7868eb27a58f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_03ff5611-2c22-400b-bed8-f6a5d2f7a0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_03ff5611-2c22-400b-bed8-f6a5d2f7a0cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities_82040513-a733-4056-ac22-ad29d3bf84a9" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities_82040513-a733-4056-ac22-ad29d3bf84a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_41124e5f-4701-4a84-aebf-4a8d5a5a3a30" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_41124e5f-4701-4a84-aebf-4a8d5a5a3a30" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_2e9a0c21-6077-4bd0-9ab4-c7a5cec3d060" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_2e9a0c21-6077-4bd0-9ab4-c7a5cec3d060" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_a6267eec-e129-4376-92ee-c9315a94dcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_a6267eec-e129-4376-92ee-c9315a94dcb0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_fe292547-6996-4a1d-9987-a74ff79e0047" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_fe292547-6996-4a1d-9987-a74ff79e0047" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessAcquisitionPostacquisitionRevenue_78f7d941-fefa-4c5a-b3ba-ba92953867c8" xlink:href="dgx-20211231.xsd#dgx_BusinessAcquisitionPostacquisitionRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessAcquisitionPostacquisitionRevenue_78f7d941-fefa-4c5a-b3ba-ba92953867c8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2ce54cd8-cf63-4fea-b6fd-b28d8eb7fb47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2ce54cd8-cf63-4fea-b6fd-b28d8eb7fb47" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3109798b-8590-43bb-a45d-8ab25d5be6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_Goodwill_3109798b-8590-43bb-a45d-8ab25d5be6ab" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_11d6496c-1a3a-41ec-9f53-79a16e50e33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_11d6496c-1a3a-41ec-9f53-79a16e50e33d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_3917bbed-425f-4ab5-a2a2-d32738060ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_3917bbed-425f-4ab5-a2a2-d32738060ec0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_0dd3d0f0-0de0-4902-ad64-3a888873b2a8" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_0dd3d0f0-0de0-4902-ad64-3a888873b2a8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_330cfe34-a379-4fb9-8ad4-44a67659e495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_330cfe34-a379-4fb9-8ad4-44a67659e495" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_f5493b88-a38b-45e4-accd-b741defa424f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_f5493b88-a38b-45e4-accd-b741defa424f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_ce48d816-235e-48c1-8abc-ae64dce5c4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_ce48d816-235e-48c1-8abc-ae64dce5c4ba" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_4bd2f2af-2807-4edb-bae4-147ebd48633d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_4bd2f2af-2807-4edb-bae4-147ebd48633d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_8dcd09df-bc58-432f-93cf-2838566f2199" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_8dcd09df-bc58-432f-93cf-2838566f2199" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_4a96090e-013d-4d54-9431-4ddba28d70d0" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_4a96090e-013d-4d54-9431-4ddba28d70d0" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_e77872e2-bf6b-4e7c-a983-d3835d3202d4" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_e77872e2-bf6b-4e7c-a983-d3835d3202d4" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cfb3f38f-4146-4519-ac00-3232aeecd4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cfb3f38f-4146-4519-ac00-3232aeecd4ad" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_be0dbcad-097e-425e-accc-11bb5b0d25d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_be0dbcad-097e-425e-accc-11bb5b0d25d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be0dbcad-097e-425e-accc-11bb5b0d25d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be0dbcad-097e-425e-accc-11bb5b0d25d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be0dbcad-097e-425e-accc-11bb5b0d25d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be0dbcad-097e-425e-accc-11bb5b0d25d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MercyHealthMember_0cde1f28-8e3c-4582-9e30-795e98d9b244" xlink:href="dgx-20211231.xsd#dgx_MercyHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_MercyHealthMember_0cde1f28-8e3c-4582-9e30-795e98d9b244" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember_3bb14522-35ff-469d-a9f8-995f484ba592" xlink:href="dgx-20211231.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_LabtechDiagnosticsLLCMember_3bb14522-35ff-469d-a9f8-995f484ba592" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BlueprintGeneticsOyMember_3a180ca6-9590-49aa-abcf-e8eb929a9acd" xlink:href="dgx-20211231.xsd#dgx_BlueprintGeneticsOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_BlueprintGeneticsOyMember_3a180ca6-9590-49aa-abcf-e8eb929a9acd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MemorialHermannMember_8ffc2cbd-610d-44e8-97a3-9320c6ba4a4a" xlink:href="dgx-20211231.xsd#dgx_MemorialHermannMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_MemorialHermannMember_8ffc2cbd-610d-44e8-97a3-9320c6ba4a4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_9836d206-d150-4a37-ad04-c47d668937a7" xlink:href="dgx-20211231.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_9836d206-d150-4a37-ad04-c47d668937a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_b525453f-e169-4945-99c5-a1c620f25315" xlink:href="dgx-20211231.xsd#dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_b525453f-e169-4945-99c5-a1c620f25315" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_021afbb6-815a-4247-8b02-a9374d07b447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_021afbb6-815a-4247-8b02-a9374d07b447" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_021afbb6-815a-4247-8b02-a9374d07b447_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_021afbb6-815a-4247-8b02-a9374d07b447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_021afbb6-815a-4247-8b02-a9374d07b447_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fb84490-81ce-4820-b2ba-a2d47fb688ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_021afbb6-815a-4247-8b02-a9374d07b447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fb84490-81ce-4820-b2ba-a2d47fb688ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6c3b2475-a758-4759-932c-b8b5141bc4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fb84490-81ce-4820-b2ba-a2d47fb688ed" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6c3b2475-a758-4759-932c-b8b5141bc4e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c44f609c-b85f-4d4e-9932-9817bc40c831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fb84490-81ce-4820-b2ba-a2d47fb688ed" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c44f609c-b85f-4d4e-9932-9817bc40c831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_474e1a64-881f-4383-b716-50b1a1867d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_474e1a64-881f-4383-b716-50b1a1867d9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_474e1a64-881f-4383-b716-50b1a1867d9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_474e1a64-881f-4383-b716-50b1a1867d9b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_474e1a64-881f-4383-b716-50b1a1867d9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_06fb4165-50dd-426c-bfdb-6e7dde42e39b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_474e1a64-881f-4383-b716-50b1a1867d9b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_06fb4165-50dd-426c-bfdb-6e7dde42e39b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember_d88ac931-00d7-472f-8628-45a58a13a6e6" xlink:href="dgx-20211231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_06fb4165-50dd-426c-bfdb-6e7dde42e39b" xlink:to="loc_dgx_OtherIncomeExpenseMember_d88ac931-00d7-472f-8628-45a58a13a6e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_81d0e5d1-89ce-47ca-890d-8ac95b9cf7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_06fb4165-50dd-426c-bfdb-6e7dde42e39b" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_81d0e5d1-89ce-47ca-890d-8ac95b9cf7b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_087438c3-a2b0-4668-a3b7-bd8c19ec0ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_087438c3-a2b0-4668-a3b7-bd8c19ec0ed6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_087438c3-a2b0-4668-a3b7-bd8c19ec0ed6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_087438c3-a2b0-4668-a3b7-bd8c19ec0ed6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_087438c3-a2b0-4668-a3b7-bd8c19ec0ed6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fa1d870-1446-4f88-8d42-5be43c7504e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_087438c3-a2b0-4668-a3b7-bd8c19ec0ed6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fa1d870-1446-4f88-8d42-5be43c7504e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_de5fe47d-4fa3-4b89-b9ab-06ac3d8a57c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fa1d870-1446-4f88-8d42-5be43c7504e5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_de5fe47d-4fa3-4b89-b9ab-06ac3d8a57c8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DISPOSITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="extended" id="iefa03ce5d8444c39a06e78421aa7015b_DISPOSITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_1d0f38ce-3dd0-4767-8b07-f95a0d27f5c1" xlink:href="dgx-20211231.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_1d0f38ce-3dd0-4767-8b07-f95a0d27f5c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_8e49ef55-1bd4-4b31-82be-bd0037983156" xlink:href="dgx-20211231.xsd#dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_8e49ef55-1bd4-4b31-82be-bd0037983156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_992ff8d9-3806-4432-8e31-121987fa788f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_992ff8d9-3806-4432-8e31-121987fa788f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_53079913-9f8a-4ff5-b209-6041c951c14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_53079913-9f8a-4ff5-b209-6041c951c14a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8dcb9fa6-d879-4c3e-90bb-68365f758d57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8dcb9fa6-d879-4c3e-90bb-68365f758d57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cc1f062f-b4cb-49c9-924b-7e2950a640ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cc1f062f-b4cb-49c9-924b-7e2950a640ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_55fa27f1-edb5-441b-b8c0-3650dce1e152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_55fa27f1-edb5-441b-b8c0-3650dce1e152" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1b126547-ac8d-409d-a767-3b6c3dfc7c62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1b126547-ac8d-409d-a767-3b6c3dfc7c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1b126547-ac8d-409d-a767-3b6c3dfc7c62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1b126547-ac8d-409d-a767-3b6c3dfc7c62" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1b126547-ac8d-409d-a767-3b6c3dfc7c62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eb38c9d1-4255-46c8-b828-8353112d551c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1b126547-ac8d-409d-a767-3b6c3dfc7c62" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eb38c9d1-4255-46c8-b828-8353112d551c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_478bc59a-525e-4833-b339-7f1bfa155294" xlink:href="dgx-20211231.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eb38c9d1-4255-46c8-b828-8353112d551c" xlink:to="loc_dgx_Q2SolutionsMember_478bc59a-525e-4833-b339-7f1bfa155294" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e021a286-d437-46f7-9613-846e46546ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e021a286-d437-46f7-9613-846e46546ba8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e021a286-d437-46f7-9613-846e46546ba8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e021a286-d437-46f7-9613-846e46546ba8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e021a286-d437-46f7-9613-846e46546ba8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5569136c-698c-4e4b-a7ff-604d75408093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e021a286-d437-46f7-9613-846e46546ba8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5569136c-698c-4e4b-a7ff-604d75408093" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_415d0240-a0e7-423e-9704-bc47f0224070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_5569136c-698c-4e4b-a7ff-604d75408093" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_415d0240-a0e7-423e-9704-bc47f0224070" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0347ac57-1a2e-4650-b5de-3fd803984e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0347ac57-1a2e-4650-b5de-3fd803984e7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0347ac57-1a2e-4650-b5de-3fd803984e7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0347ac57-1a2e-4650-b5de-3fd803984e7b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0347ac57-1a2e-4650-b5de-3fd803984e7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_75385e02-a4ea-4984-80d2-1efcdab1ea81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0347ac57-1a2e-4650-b5de-3fd803984e7b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_75385e02-a4ea-4984-80d2-1efcdab1ea81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_59fce770-4f7e-4074-89ae-25e0ac93af4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_75385e02-a4ea-4984-80d2-1efcdab1ea81" xlink:to="loc_us-gaap_OtherIncomeMember_59fce770-4f7e-4074-89ae-25e0ac93af4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_33282099-61e7-44f5-aeea-9a057263e353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_33282099-61e7-44f5-aeea-9a057263e353" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_33282099-61e7-44f5-aeea-9a057263e353_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_33282099-61e7-44f5-aeea-9a057263e353" xlink:to="loc_us-gaap_EquityComponentDomain_33282099-61e7-44f5-aeea-9a057263e353_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_252029d6-44bb-480f-866d-c10822288028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_33282099-61e7-44f5-aeea-9a057263e353" xlink:to="loc_us-gaap_EquityComponentDomain_252029d6-44bb-480f-866d-c10822288028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_155ddef5-3034-415b-87b4-8158842efdbe" xlink:href="dgx-20211231.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_252029d6-44bb-480f-866d-c10822288028" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_155ddef5-3034-415b-87b4-8158842efdbe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="i759a8ad1954c4c919f360f41f1a62c6a_FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_e76c939c-9c40-4c5b-b4ce-9cfeded65ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_TradingSecurities_e76c939c-9c40-4c5b-b4ce-9cfeded65ad5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_c11d550a-2286-4a79-8789-90bdf0a456cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_c11d550a-2286-4a79-8789-90bdf0a456cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_7eb3910f-6b24-41c0-b05a-68456c2269ca" xlink:href="dgx-20211231.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_7eb3910f-6b24-41c0-b05a-68456c2269ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a67bbff-0c44-4422-8098-1156873d7681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a67bbff-0c44-4422-8098-1156873d7681" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9634f0f8-1182-40ff-965e-1cecb3d42ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_9634f0f8-1182-40ff-965e-1cecb3d42ef5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_4c146884-aa25-4500-93c6-34e32fe407b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_4c146884-aa25-4500-93c6-34e32fe407b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_560870d8-2457-450c-8541-00af17442721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_560870d8-2457-450c-8541-00af17442721" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_06f84493-f0c8-40e1-aab5-d998359f0856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_06f84493-f0c8-40e1-aab5-d998359f0856" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_5eb85429-c09d-44ee-9ec5-109bd13a1111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_5eb85429-c09d-44ee-9ec5-109bd13a1111" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5a149688-1da0-47b4-a548-49e07fc9fa09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5a149688-1da0-47b4-a548-49e07fc9fa09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_53561d0d-179a-4e37-9db7-ddf318d9c6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5a149688-1da0-47b4-a548-49e07fc9fa09" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_53561d0d-179a-4e37-9db7-ddf318d9c6fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_53561d0d-179a-4e37-9db7-ddf318d9c6fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_53561d0d-179a-4e37-9db7-ddf318d9c6fa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_53561d0d-179a-4e37-9db7-ddf318d9c6fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f9f2db44-bc87-4af2-95c3-15708eaeb7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_53561d0d-179a-4e37-9db7-ddf318d9c6fa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f9f2db44-bc87-4af2-95c3-15708eaeb7a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d6cade5a-bdbf-430e-a909-d3f7ca86884c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f9f2db44-bc87-4af2-95c3-15708eaeb7a6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d6cade5a-bdbf-430e-a909-d3f7ca86884c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6ba07b38-3199-4103-b326-08312e558828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5a149688-1da0-47b4-a548-49e07fc9fa09" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6ba07b38-3199-4103-b326-08312e558828" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ba07b38-3199-4103-b326-08312e558828_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6ba07b38-3199-4103-b326-08312e558828" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ba07b38-3199-4103-b326-08312e558828_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1064a523-4283-4de6-a54b-69b6a5d2a32f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6ba07b38-3199-4103-b326-08312e558828" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1064a523-4283-4de6-a54b-69b6a5d2a32f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_87a75ddf-cc64-4616-aace-a736ff9af10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1064a523-4283-4de6-a54b-69b6a5d2a32f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_87a75ddf-cc64-4616-aace-a736ff9af10d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b42ddff7-d9e9-4720-a1f7-5fdabfb3127c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1064a523-4283-4de6-a54b-69b6a5d2a32f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b42ddff7-d9e9-4720-a1f7-5fdabfb3127c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5e763f55-1b8b-45e2-8239-46135524305b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1064a523-4283-4de6-a54b-69b6a5d2a32f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5e763f55-1b8b-45e2-8239-46135524305b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="extended" id="i96ca3d4b75b0408dafac86ea9ee16f67_FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_451f86be-2de6-414f-9c0a-c35720eb3e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_48402991-ba38-4c45-b576-1f112198b16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_451f86be-2de6-414f-9c0a-c35720eb3e22" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_48402991-ba38-4c45-b576-1f112198b16f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_bff7f4cb-372e-4acd-9004-dcff7a46c7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_451f86be-2de6-414f-9c0a-c35720eb3e22" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_bff7f4cb-372e-4acd-9004-dcff7a46c7a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683d964a-f0fa-42b0-ac24-78752d0d18b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_451f86be-2de6-414f-9c0a-c35720eb3e22" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683d964a-f0fa-42b0-ac24-78752d0d18b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f052cc67-3db3-4328-b660-5de5b4d3aa5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683d964a-f0fa-42b0-ac24-78752d0d18b3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f052cc67-3db3-4328-b660-5de5b4d3aa5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f052cc67-3db3-4328-b660-5de5b4d3aa5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f052cc67-3db3-4328-b660-5de5b4d3aa5a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f052cc67-3db3-4328-b660-5de5b4d3aa5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8fc0ae16-489e-4013-8a10-abb1c6c9c455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f052cc67-3db3-4328-b660-5de5b4d3aa5a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8fc0ae16-489e-4013-8a10-abb1c6c9c455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember_1ec2fdf8-c988-4b71-8f07-e4065e0a6505" xlink:href="dgx-20211231.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8fc0ae16-489e-4013-8a10-abb1c6c9c455" xlink:to="loc_dgx_LabtechDiagnosticsLLCMember_1ec2fdf8-c988-4b71-8f07-e4065e0a6505" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_88c3419d-a5e1-46db-9a5d-c53900a6a493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683d964a-f0fa-42b0-ac24-78752d0d18b3" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_88c3419d-a5e1-46db-9a5d-c53900a6a493" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_88c3419d-a5e1-46db-9a5d-c53900a6a493_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_88c3419d-a5e1-46db-9a5d-c53900a6a493" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_88c3419d-a5e1-46db-9a5d-c53900a6a493_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_db2ee35f-3219-4085-aa9a-8a1b33e92528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_88c3419d-a5e1-46db-9a5d-c53900a6a493" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_db2ee35f-3219-4085-aa9a-8a1b33e92528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_61a3d4f1-4f78-44b1-a02e-1e0a12ff713c" xlink:href="dgx-20211231.xsd#dgx_MeasurementInputComparableCompanyRevenueVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_db2ee35f-3219-4085-aa9a-8a1b33e92528" xlink:to="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_61a3d4f1-4f78-44b1-a02e-1e0a12ff713c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_955d5b54-eda3-40e0-8c3c-cb143bd7465d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_db2ee35f-3219-4085-aa9a-8a1b33e92528" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_955d5b54-eda3-40e0-8c3c-cb143bd7465d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="ibefaa1e196f74261a74dc4435a855fee_FAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0a6bf795-0a33-43a5-95f2-aa5ea0abda14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0a6bf795-0a33-43a5-95f2-aa5ea0abda14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c3b2c6bc-3176-4855-bfc2-54c62b036905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c3b2c6bc-3176-4855-bfc2-54c62b036905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d28f8ac5-545f-4b1b-8b74-2a542d26a09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d28f8ac5-545f-4b1b-8b74-2a542d26a09a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_05da39a2-9ab8-4a3d-adaf-706a2159a926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_05da39a2-9ab8-4a3d-adaf-706a2159a926" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_ebfada33-4d30-4735-b896-bcc3a176a757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_ebfada33-4d30-4735-b896-bcc3a176a757" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_08c1410a-6c89-45bf-8e04-4466f5e24db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_DebtInstrumentFairValue_08c1410a-6c89-45bf-8e04-4466f5e24db9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85ef6c12-6f60-4f25-ba60-15734007cb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85ef6c12-6f60-4f25-ba60-15734007cb13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_85ef6c12-6f60-4f25-ba60-15734007cb13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85ef6c12-6f60-4f25-ba60-15734007cb13" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_85ef6c12-6f60-4f25-ba60-15734007cb13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_852cf14e-573d-4ec2-a5fa-1a92604e1ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85ef6c12-6f60-4f25-ba60-15734007cb13" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_852cf14e-573d-4ec2-a5fa-1a92604e1ae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_bfcbeeb4-0d17-4c02-a7f9-dae2e6ac4087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_852cf14e-573d-4ec2-a5fa-1a92604e1ae4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_bfcbeeb4-0d17-4c02-a7f9-dae2e6ac4087" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1f068548-3758-420e-93bc-3d48ba8ec588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1f068548-3758-420e-93bc-3d48ba8ec588" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1f068548-3758-420e-93bc-3d48ba8ec588_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1f068548-3758-420e-93bc-3d48ba8ec588" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1f068548-3758-420e-93bc-3d48ba8ec588_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_37d93410-8b8d-4a5c-a9f9-786cbd21886c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1f068548-3758-420e-93bc-3d48ba8ec588" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_37d93410-8b8d-4a5c-a9f9-786cbd21886c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_06946d19-acc4-49ac-a19d-6e6c1f5480ff" xlink:href="dgx-20211231.xsd#dgx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_37d93410-8b8d-4a5c-a9f9-786cbd21886c" xlink:to="loc_dgx_ContingentConsiderationMember_06946d19-acc4-49ac-a19d-6e6c1f5480ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d351cf2b-2624-4354-a774-f7aa5c201cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d351cf2b-2624-4354-a774-f7aa5c201cc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d351cf2b-2624-4354-a774-f7aa5c201cc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d351cf2b-2624-4354-a774-f7aa5c201cc0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d351cf2b-2624-4354-a774-f7aa5c201cc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7cd7ccc5-42c3-49d9-858c-968a13cab7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d351cf2b-2624-4354-a774-f7aa5c201cc0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7cd7ccc5-42c3-49d9-858c-968a13cab7bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_7952709d-7d4e-4764-89d2-d8af35822598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7cd7ccc5-42c3-49d9-858c-968a13cab7bd" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_7952709d-7d4e-4764-89d2-d8af35822598" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_08b3655c-bcfd-4ccc-ae48-43d892d7be8c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:to="loc_srt_OwnershipAxis_08b3655c-bcfd-4ccc-ae48-43d892d7be8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_08b3655c-bcfd-4ccc-ae48-43d892d7be8c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_08b3655c-bcfd-4ccc-ae48-43d892d7be8c" xlink:to="loc_srt_OwnershipDomain_08b3655c-bcfd-4ccc-ae48-43d892d7be8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a9d24eef-4cbc-4e40-b7ff-f4e077872d1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_08b3655c-bcfd-4ccc-ae48-43d892d7be8c" xlink:to="loc_srt_OwnershipDomain_a9d24eef-4cbc-4e40-b7ff-f4e077872d1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_e5b9d9b5-0eff-4034-b959-0022a686f263" xlink:href="dgx-20211231.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_a9d24eef-4cbc-4e40-b7ff-f4e077872d1d" xlink:to="loc_dgx_UMassJointVentureMember_e5b9d9b5-0eff-4034-b959-0022a686f263" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" xlink:type="extended" id="id3982999390c41cc848ce4612da061d7_FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d123baa8-c96b-479c-98c7-7bd415645f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d123baa8-c96b-479c-98c7-7bd415645f3a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_99a27f09-c59b-4473-a187-03e50162610e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_99a27f09-c59b-4473-a187-03e50162610e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_dfa41553-619a-4674-8c7f-5b936f1c315a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_dfa41553-619a-4674-8c7f-5b936f1c315a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_28dc566e-f003-407d-b514-e33753a918e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_28dc566e-f003-407d-b514-e33753a918e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_2c62353c-5ab7-4bb0-935d-80777f85d06c" xlink:href="dgx-20211231.xsd#dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:to="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_2c62353c-5ab7-4bb0-935d-80777f85d06c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6e6f2e72-2de7-4bb6-9083-3989777822d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4f6d69de-9932-4822-a6b3-a0835200e4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d123baa8-c96b-479c-98c7-7bd415645f3a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4f6d69de-9932-4822-a6b3-a0835200e4d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e8eed05-288b-439c-8858-02eb31a87bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4f6d69de-9932-4822-a6b3-a0835200e4d5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e8eed05-288b-439c-8858-02eb31a87bca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e8eed05-288b-439c-8858-02eb31a87bca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e8eed05-288b-439c-8858-02eb31a87bca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e8eed05-288b-439c-8858-02eb31a87bca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_788a6892-590a-4263-9dba-79308a5cdc97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e8eed05-288b-439c-8858-02eb31a87bca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_788a6892-590a-4263-9dba-79308a5cdc97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_529058f3-bfa1-40c7-96c7-a8799e0c76db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_788a6892-590a-4263-9dba-79308a5cdc97" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_529058f3-bfa1-40c7-96c7-a8799e0c76db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_92648ee4-66c8-4b50-9312-c10f163b4c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4f6d69de-9932-4822-a6b3-a0835200e4d5" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_92648ee4-66c8-4b50-9312-c10f163b4c92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_92648ee4-66c8-4b50-9312-c10f163b4c92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_92648ee4-66c8-4b50-9312-c10f163b4c92" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_92648ee4-66c8-4b50-9312-c10f163b4c92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e08ca49a-53ff-4ecf-88de-fe54b73909f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_92648ee4-66c8-4b50-9312-c10f163b4c92" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e08ca49a-53ff-4ecf-88de-fe54b73909f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_f1d24ea7-a003-4c9e-b799-49e97768cbcb" xlink:href="dgx-20211231.xsd#dgx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e08ca49a-53ff-4ecf-88de-fe54b73909f3" xlink:to="loc_dgx_ContingentConsiderationMember_f1d24ea7-a003-4c9e-b799-49e97768cbcb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#TAXESONINCOMEDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended" id="i738bff0263ba44778d185ab25ea5cbea_TAXESONINCOMEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_5ff68fd5-9ea3-44b1-9d5e-d7a2ab3e7eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_5ff68fd5-9ea3-44b1-9d5e-d7a2ab3e7eb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_68ebdb52-b34e-4a4b-8414-84b0864a76ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_68ebdb52-b34e-4a4b-8414-84b0864a76ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_602289e2-75ba-489f-aedf-702d1de8590d" xlink:href="dgx-20211231.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_602289e2-75ba-489f-aedf-702d1de8590d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_210d5721-2574-4860-8473-9db5d1e2e6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_210d5721-2574-4860-8473-9db5d1e2e6e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_270c5347-6244-4301-8677-f176eb93f8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_270c5347-6244-4301-8677-f176eb93f8d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e4ee02f3-5b78-4ac1-8322-666b0ce9f70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e4ee02f3-5b78-4ac1-8322-666b0ce9f70b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e5c281db-65b2-4cca-a3ff-a3072896cce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e5c281db-65b2-4cca-a3ff-a3072896cce5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_506bf003-4345-4318-af73-ccef1d3d8554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_506bf003-4345-4318-af73-ccef1d3d8554" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b4a3a226-708a-4198-a09c-f069d61070db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b4a3a226-708a-4198-a09c-f069d61070db" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ea5f997a-0ce8-4ec7-8218-16657611c6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ea5f997a-0ce8-4ec7-8218-16657611c6ce" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7742ea30-3469-48ac-8ced-fde8b52f3d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7742ea30-3469-48ac-8ced-fde8b52f3d4c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1e416b5f-2f4b-4a31-9df4-25f967916022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1e416b5f-2f4b-4a31-9df4-25f967916022" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b437a1b0-ea3c-4257-997d-d65dfa6b88bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b437a1b0-ea3c-4257-997d-d65dfa6b88bd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_b2f23da2-9763-43ff-87e6-8623f7de2cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_b2f23da2-9763-43ff-87e6-8623f7de2cea" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_2c958c55-05ba-4dd2-9fa6-e0fb07bcb43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_2c958c55-05ba-4dd2-9fa6-e0fb07bcb43a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_0115b10b-1a4d-4a5b-aeb2-113faa1f16fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_0115b10b-1a4d-4a5b-aeb2-113faa1f16fe" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_c1e29d83-2dcd-4812-8f67-890bf16ee170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_c1e29d83-2dcd-4812-8f67-890bf16ee170" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_c05190b2-3a5e-4055-a1cd-e75a04208a90" xlink:href="dgx-20211231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_c05190b2-3a5e-4055-a1cd-e75a04208a90" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c8239b6e-8145-44ff-8154-099d1babaf96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c8239b6e-8145-44ff-8154-099d1babaf96" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_cf0b9704-b84e-43ad-b0db-dfcace56dc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_cf0b9704-b84e-43ad-b0db-dfcace56dc3a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2c012f7b-5435-4852-afa3-641603be1851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2c012f7b-5435-4852-afa3-641603be1851" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_79e7d54e-ff3c-4648-8152-afe7a5a5cae5" xlink:href="dgx-20211231.xsd#dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_79e7d54e-ff3c-4648-8152-afe7a5a5cae5" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c11b7c29-4260-4621-938f-742022a6444b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c11b7c29-4260-4621-938f-742022a6444b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c28cdc77-298b-4d3d-bada-558b50d6815c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c28cdc77-298b-4d3d-bada-558b50d6815c" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_8b49fee7-af22-42b0-90a4-2707d8964f31" xlink:href="dgx-20211231.xsd#dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_8b49fee7-af22-42b0-90a4-2707d8964f31" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_31046bf7-db67-4cc3-bd12-91dff7729fc6" xlink:href="dgx-20211231.xsd#dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_31046bf7-db67-4cc3-bd12-91dff7729fc6" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8a08cb24-54ea-48ad-9237-518df387d02f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8a08cb24-54ea-48ad-9237-518df387d02f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_4ca17c66-be5c-4d4b-ba80-07349ff72c88" xlink:href="dgx-20211231.xsd#dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_4ca17c66-be5c-4d4b-ba80-07349ff72c88" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0354eaf3-4bba-4cc5-939a-0f38c90c3df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0354eaf3-4bba-4cc5-939a-0f38c90c3df2" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_d68cb894-43fa-4c4f-81da-0035640fdd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxLiabilities_d68cb894-43fa-4c4f-81da-0035640fdd2f" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_35e5475e-cac4-4fc0-9b54-5abae2a188ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_35e5475e-cac4-4fc0-9b54-5abae2a188ff" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1b9a3c9c-5cb4-450c-b396-fa5ca92ba6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1b9a3c9c-5cb4-450c-b396-fa5ca92ba6a4" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d3e43272-3933-4398-ac28-3c95cd307392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d3e43272-3933-4398-ac28-3c95cd307392" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_731dd94c-160c-4e3b-9afd-e0a41217dc67" xlink:href="dgx-20211231.xsd#dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_731dd94c-160c-4e3b-9afd-e0a41217dc67" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_5073cc72-b13c-4deb-bf44-696842ac0e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_AccruedIncomeTaxes_5073cc72-b13c-4deb-bf44-696842ac0e26" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_8d5df26a-dbc5-4cf6-bdd8-8bf5de6f8110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_PrepaidTaxes_8d5df26a-dbc5-4cf6-bdd8-8bf5de6f8110" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_12f4717e-3a65-4dc1-90c3-ca6b352d0326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_12f4717e-3a65-4dc1-90c3-ca6b352d0326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5d687df7-155b-4df2-92c2-afa70273e03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5d687df7-155b-4df2-92c2-afa70273e03c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_cdb8c74f-2ae5-4c42-a9c3-402846a8eb80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_cdb8c74f-2ae5-4c42-a9c3-402846a8eb80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReductionsForChangesInJudgment_fbf308a9-9624-4eae-8c32-07a4f346df16" xlink:href="dgx-20211231.xsd#dgx_ReductionsForChangesInJudgment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_dgx_ReductionsForChangesInJudgment_fbf308a9-9624-4eae-8c32-07a4f346df16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_33fce594-8aaf-43e1-9a52-0c817a20d20a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_33fce594-8aaf-43e1-9a52-0c817a20d20a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a78551e3-32dc-4074-b597-2dc6a3f9862e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a78551e3-32dc-4074-b597-2dc6a3f9862e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d42e20e9-09b7-4cf0-a681-9bbb84b993a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8ea66f55-1151-45d1-9e41-c60f4cad5ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8ea66f55-1151-45d1-9e41-c60f4cad5ddc" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_e26688e4-66f0-4627-a512-228d83ac4a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_e26688e4-66f0-4627-a512-228d83ac4a5e" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_9ff97c80-ea95-426e-b9a3-222a6a11f04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_9ff97c80-ea95-426e-b9a3-222a6a11f04c" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_23af0eb8-40e4-4b71-baad-e1e68c55f564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_23af0eb8-40e4-4b71-baad-e1e68c55f564" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0ca7534-a88c-4392-b1f0-5b0edf99a79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0ca7534-a88c-4392-b1f0-5b0edf99a79e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c0ca7534-a88c-4392-b1f0-5b0edf99a79e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0ca7534-a88c-4392-b1f0-5b0edf99a79e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c0ca7534-a88c-4392-b1f0-5b0edf99a79e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_06486e90-b32a-4e6b-bbd3-7518fc3e3d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0ca7534-a88c-4392-b1f0-5b0edf99a79e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_06486e90-b32a-4e6b-bbd3-7518fc3e3d1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_d4448542-0034-4915-9ec7-e84c254a2000" xlink:href="dgx-20211231.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_06486e90-b32a-4e6b-bbd3-7518fc3e3d1f" xlink:to="loc_dgx_Q2SolutionsMember_d4448542-0034-4915-9ec7-e84c254a2000" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9256f269-6f4a-45b4-8379-8e3a5281b6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9256f269-6f4a-45b4-8379-8e3a5281b6ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9256f269-6f4a-45b4-8379-8e3a5281b6ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9256f269-6f4a-45b4-8379-8e3a5281b6ca" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9256f269-6f4a-45b4-8379-8e3a5281b6ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_04e2a6e2-4bf0-4ba2-95a4-7852da097785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9256f269-6f4a-45b4-8379-8e3a5281b6ca" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_04e2a6e2-4bf0-4ba2-95a4-7852da097785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_5871bf2a-7565-4f97-9c69-9c59f07b3e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_04e2a6e2-4bf0-4ba2-95a4-7852da097785" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_5871bf2a-7565-4f97-9c69-9c59f07b3e80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_aa615485-5ca2-4ac1-b34b-133110943b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_aa615485-5ca2-4ac1-b34b-133110943b08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_aa615485-5ca2-4ac1-b34b-133110943b08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_aa615485-5ca2-4ac1-b34b-133110943b08" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_aa615485-5ca2-4ac1-b34b-133110943b08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_72ad82f2-b9f9-45da-a270-385b31fbb680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_aa615485-5ca2-4ac1-b34b-133110943b08" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_72ad82f2-b9f9-45da-a270-385b31fbb680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_54b64173-381c-4fe9-b0df-a8a9439c021b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_72ad82f2-b9f9-45da-a270-385b31fbb680" xlink:to="loc_us-gaap_DomesticCountryMember_54b64173-381c-4fe9-b0df-a8a9439c021b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_606c9574-f104-4134-82cc-df0ac7e9a3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_72ad82f2-b9f9-45da-a270-385b31fbb680" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_606c9574-f104-4134-82cc-df0ac7e9a3f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_672e8460-9bf9-4669-8359-c2141d7418c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_72ad82f2-b9f9-45da-a270-385b31fbb680" xlink:to="loc_us-gaap_ForeignCountryMember_672e8460-9bf9-4669-8359-c2141d7418c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6a08be27-4acd-4957-89bc-d6c2b3ce345a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6a08be27-4acd-4957-89bc-d6c2b3ce345a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6a08be27-4acd-4957-89bc-d6c2b3ce345a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6a08be27-4acd-4957-89bc-d6c2b3ce345a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6a08be27-4acd-4957-89bc-d6c2b3ce345a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4c7f792c-3a1f-4a99-a02e-1ac1c7d926ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6a08be27-4acd-4957-89bc-d6c2b3ce345a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4c7f792c-3a1f-4a99-a02e-1ac1c7d926ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_7001c361-d0d3-45a7-908f-1e9afc8f1edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4c7f792c-3a1f-4a99-a02e-1ac1c7d926ac" xlink:to="loc_us-gaap_OtherLiabilitiesMember_7001c361-d0d3-45a7-908f-1e9afc8f1edd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended" id="i1db68a546a324d42bad04745ac8cf427_PROPERTYPLANTANDEQUIPMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_52606509-b43d-4c6b-afd2-5f84de0f3f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_52606509-b43d-4c6b-afd2-5f84de0f3f1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6fac135c-6dc7-4102-956e-81c1490515a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6fac135c-6dc7-4102-956e-81c1490515a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_63882d16-f5ff-42d3-9ae0-81017af5b59b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_63882d16-f5ff-42d3-9ae0-81017af5b59b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_b9960e40-ae80-4754-9e9f-1ee62c8a125e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_b9960e40-ae80-4754-9e9f-1ee62c8a125e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_079bd9aa-47c7-447b-ab78-4faf0ca10725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_079bd9aa-47c7-447b-ab78-4faf0ca10725" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd0907be-1867-43eb-b07e-b47529e3dd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_079bd9aa-47c7-447b-ab78-4faf0ca10725" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd0907be-1867-43eb-b07e-b47529e3dd3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd0907be-1867-43eb-b07e-b47529e3dd3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd0907be-1867-43eb-b07e-b47529e3dd3e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd0907be-1867-43eb-b07e-b47529e3dd3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd0907be-1867-43eb-b07e-b47529e3dd3e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_17f8add4-f7a0-44d1-87da-6603f227d6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_us-gaap_LandMember_17f8add4-f7a0-44d1-87da-6603f227d6f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_0f5d1412-a980-4ea1-bbe3-0980c3282424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_0f5d1412-a980-4ea1-bbe3-0980c3282424" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_e4625978-36cf-4b99-b725-ae2d25972072" xlink:href="dgx-20211231.xsd#dgx_LaboratoryEquipmentFurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_e4625978-36cf-4b99-b725-ae2d25972072" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_cd84c115-b9e4-48c3-b822-59e2b984bb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_cd84c115-b9e4-48c3-b822-59e2b984bb9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_da92a999-8b9a-4f5f-90aa-d35cb3220dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_da92a999-8b9a-4f5f-90aa-d35cb3220dff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_2bffefe9-f816-4f14-b5ff-f5870c391d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_us-gaap_ConstructionInProgressMember_2bffefe9-f816-4f14-b5ff-f5870c391d9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_de140624-d68e-42ee-862e-218d8d4b0c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_079bd9aa-47c7-447b-ab78-4faf0ca10725" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_de140624-d68e-42ee-862e-218d8d4b0c30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_de140624-d68e-42ee-862e-218d8d4b0c30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_de140624-d68e-42ee-862e-218d8d4b0c30" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_de140624-d68e-42ee-862e-218d8d4b0c30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dd868738-dc81-46ea-adc7-c330d41a2a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_de140624-d68e-42ee-862e-218d8d4b0c30" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dd868738-dc81-46ea-adc7-c330d41a2a71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_41e8be42-b0ea-4c4d-9a13-5012e4d041e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dd868738-dc81-46ea-adc7-c330d41a2a71" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_41e8be42-b0ea-4c4d-9a13-5012e4d041e9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended" id="i9b760db2ac174bc7b5ba1ccf63a8dc6e_GOODWILLANDINTANGIBLEASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:href="dgx-20211231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_63fd9817-83fd-43b4-8f5d-844993ef7207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_63fd9817-83fd-43b4-8f5d-844993ef7207" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e0a7a006-aa3c-467b-bcfe-e034f0eb1f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e0a7a006-aa3c-467b-bcfe-e034f0eb1f66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4b427ee4-6897-4cd7-9e35-8b76223f438d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4b427ee4-6897-4cd7-9e35-8b76223f438d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_16cab87d-ae03-47b6-968c-c05f8fc3e716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_16cab87d-ae03-47b6-968c-c05f8fc3e716" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c8e2b14e-bde8-44b6-9f9a-da4091bc796d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c8e2b14e-bde8-44b6-9f9a-da4091bc796d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f802552e-120a-48dc-8d4d-ab3bdb231fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f802552e-120a-48dc-8d4d-ab3bdb231fac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a3db6fdf-87af-453b-a0f0-9c92fb9f85bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a3db6fdf-87af-453b-a0f0-9c92fb9f85bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_88ec96a2-527c-42c9-a2bd-a0075700f054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_88ec96a2-527c-42c9-a2bd-a0075700f054" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9bafd2f5-b8b1-4c53-b7b6-447e3e76581c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9bafd2f5-b8b1-4c53-b7b6-447e3e76581c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_cebe86c3-5d61-45ba-add9-7d7471164fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_cebe86c3-5d61-45ba-add9-7d7471164fd4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_c8aab883-c6f0-41b7-a391-c48989ccc647" xlink:href="dgx-20211231.xsd#dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_c8aab883-c6f0-41b7-a391-c48989ccc647" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_48008e15-07f1-4972-8f35-29e977c65f82" xlink:href="dgx-20211231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_48008e15-07f1-4972-8f35-29e977c65f82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2f608d98-40c1-4233-a211-36c82ff17010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_48008e15-07f1-4972-8f35-29e977c65f82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2f608d98-40c1-4233-a211-36c82ff17010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f608d98-40c1-4233-a211-36c82ff17010_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2f608d98-40c1-4233-a211-36c82ff17010" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f608d98-40c1-4233-a211-36c82ff17010_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2f608d98-40c1-4233-a211-36c82ff17010" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1dd222b7-fcb5-42fc-9287-a33d1fff9669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1dd222b7-fcb5-42fc-9287-a33d1fff9669" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_5b4254f4-0539-4a3f-97e7-8d4bf63b9f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_5b4254f4-0539-4a3f-97e7-8d4bf63b9f26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_db2d2ad8-ea8a-448a-a8e2-2204f5ea71c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_db2d2ad8-ea8a-448a-a8e2-2204f5ea71c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_9f37f0ab-2f73-4702-a572-7a4a2a216601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_9f37f0ab-2f73-4702-a572-7a4a2a216601" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_42043c1c-a9b7-4795-b013-cf8d32cbc753" xlink:href="dgx-20211231.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_42043c1c-a9b7-4795-b013-cf8d32cbc753" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b01d158e-cc3d-4e3a-91db-6ce637a309c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_48008e15-07f1-4972-8f35-29e977c65f82" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b01d158e-cc3d-4e3a-91db-6ce637a309c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b01d158e-cc3d-4e3a-91db-6ce637a309c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b01d158e-cc3d-4e3a-91db-6ce637a309c1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b01d158e-cc3d-4e3a-91db-6ce637a309c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_de43103e-660a-4373-bce1-fae5946dc490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b01d158e-cc3d-4e3a-91db-6ce637a309c1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_de43103e-660a-4373-bce1-fae5946dc490" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_40b76f21-bbaa-461f-9a4a-f6599c42c101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_de43103e-660a-4373-bce1-fae5946dc490" xlink:to="loc_us-gaap_TradeNamesMember_40b76f21-bbaa-461f-9a4a-f6599c42c101" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_7cff7096-1bb6-4be3-ab5d-8b0e8150e71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_de43103e-660a-4373-bce1-fae5946dc490" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_7cff7096-1bb6-4be3-ab5d-8b0e8150e71b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="extended" id="i08b44a9cfbb549cd8263508696ed5b21_DEBTLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_24727325-859c-44c9-a3b9-7acd01cc816b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_LongTermDebt_24727325-859c-44c9-a3b9-7acd01cc816b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_a4c432eb-7cd7-4a21-8a8c-320b4fa554ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_OtherLongTermDebt_a4c432eb-7cd7-4a21-8a8c-320b4fa554ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_7172ad84-7fc8-4729-b539-93f0a20787c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_7172ad84-7fc8-4729-b539-93f0a20787c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_349a7196-0fd5-453a-aa03-535696ee5a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_LongTermDebtCurrent_349a7196-0fd5-453a-aa03-535696ee5a9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_67b58eef-bbb9-4a8d-9419-f958732dcf4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_67b58eef-bbb9-4a8d-9419-f958732dcf4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_141a4706-12ff-4b9c-9db8-eb6e971f17fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_141a4706-12ff-4b9c-9db8-eb6e971f17fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_27119342-777b-41f3-aa5e-406618ccab70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_DebtInstrumentTable_27119342-777b-41f3-aa5e-406618ccab70" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3d862979-b2d9-4413-89f6-8498ec138682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_27119342-777b-41f3-aa5e-406618ccab70" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3d862979-b2d9-4413-89f6-8498ec138682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3d862979-b2d9-4413-89f6-8498ec138682_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d862979-b2d9-4413-89f6-8498ec138682" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3d862979-b2d9-4413-89f6-8498ec138682_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_151dd4a8-4dc3-44f7-b7b5-cfb7608e82d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d862979-b2d9-4413-89f6-8498ec138682" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_151dd4a8-4dc3-44f7-b7b5-cfb7608e82d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_b58236ec-fbe7-49ce-8d4e-e537e7d5e84e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_151dd4a8-4dc3-44f7-b7b5-cfb7608e82d7" xlink:to="loc_us-gaap_SeniorNotesMember_b58236ec-fbe7-49ce-8d4e-e537e7d5e84e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9c2634ef-b2a0-4fb8-9e0f-2469abef9a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_27119342-777b-41f3-aa5e-406618ccab70" xlink:to="loc_us-gaap_DebtInstrumentAxis_9c2634ef-b2a0-4fb8-9e0f-2469abef9a71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9c2634ef-b2a0-4fb8-9e0f-2469abef9a71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9c2634ef-b2a0-4fb8-9e0f-2469abef9a71" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9c2634ef-b2a0-4fb8-9e0f-2469abef9a71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9c2634ef-b2a0-4fb8-9e0f-2469abef9a71" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_b5f9bdbf-11fd-4f9c-beef-11ab13f1501c" xlink:href="dgx-20211231.xsd#dgx_FourpointtwofivepercentSeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_b5f9bdbf-11fd-4f9c-beef-11ab13f1501c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_7510a085-d0fe-4330-9488-191941b1e2e9" xlink:href="dgx-20211231.xsd#dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_7510a085-d0fe-4330-9488-191941b1e2e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_78c0d82d-3aa6-4758-8125-6bb1f655cde4" xlink:href="dgx-20211231.xsd#dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_78c0d82d-3aa6-4758-8125-6bb1f655cde4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_114614a1-6c2e-4d9d-819c-b099102743da" xlink:href="dgx-20211231.xsd#dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_114614a1-6c2e-4d9d-819c-b099102743da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_c1a62fe5-7d22-4406-8e3a-2d08a42c90dc" xlink:href="dgx-20211231.xsd#dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_c1a62fe5-7d22-4406-8e3a-2d08a42c90dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_97dfe7d7-6c8f-4c98-b311-6891810c1ea6" xlink:href="dgx-20211231.xsd#dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_97dfe7d7-6c8f-4c98-b311-6891810c1ea6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_ebc3a4da-d41e-4afa-9c24-85fe4bbbd895" xlink:href="dgx-20211231.xsd#dgx_SixPointNineFivePercentSeniorNotesDue2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_ebc3a4da-d41e-4afa-9c24-85fe4bbbd895" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_84e9c242-2ce9-4fab-b677-201cde81202e" xlink:href="dgx-20211231.xsd#dgx_FivePointSevenFivePercentSeniorNotesDue2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_84e9c242-2ce9-4fab-b677-201cde81202e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_3cb91350-78b6-4693-a46c-0f6ef74182ae" xlink:href="dgx-20211231.xsd#dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_3cb91350-78b6-4693-a46c-0f6ef74182ae" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FinanceLeaseObligationsandOtherMember_4fdc1f0f-3264-4fc0-acd4-29ba7ddd8330" xlink:href="dgx-20211231.xsd#dgx_FinanceLeaseObligationsandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_FinanceLeaseObligationsandOtherMember_4fdc1f0f-3264-4fc0-acd4-29ba7ddd8330" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTSecuredReceivablesCreditFacilityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails" xlink:type="extended" id="ie1aa5fc6bf21458c90a4848bec9d9309_DEBTSecuredReceivablesCreditFacilityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ed47a918-be8a-4e45-93a4-d38ace9e1969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ed47a918-be8a-4e45-93a4-d38ace9e1969" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentExtensionPeriod_a1ffc255-d96f-483c-b0a0-434d2aff502d" xlink:href="dgx-20211231.xsd#dgx_DebtInstrumentExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:to="loc_dgx_DebtInstrumentExtensionPeriod_a1ffc255-d96f-483c-b0a0-434d2aff502d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_faf60372-41a7-4f7b-9584-75a48cc8d5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_faf60372-41a7-4f7b-9584-75a48cc8d5c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ea90dd98-1635-4952-a662-de4dd61e1992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ea90dd98-1635-4952-a662-de4dd61e1992" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:to="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2c138ae4-931d-4725-8aa7-9d7ec98c5234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2c138ae4-931d-4725-8aa7-9d7ec98c5234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2c138ae4-931d-4725-8aa7-9d7ec98c5234_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2c138ae4-931d-4725-8aa7-9d7ec98c5234" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2c138ae4-931d-4725-8aa7-9d7ec98c5234_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b4dd6d2e-96e9-4338-b325-9e6bb724f192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2c138ae4-931d-4725-8aa7-9d7ec98c5234" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b4dd6d2e-96e9-4338-b325-9e6bb724f192" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f009b290-09bc-4470-9708-079e7bbdfc70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b4dd6d2e-96e9-4338-b325-9e6bb724f192" xlink:to="loc_us-gaap_SecuredDebtMember_f009b290-09bc-4470-9708-079e7bbdfc70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d584cc78-3d3f-41c9-b951-4e0bb5feb8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_us-gaap_DebtInstrumentAxis_d584cc78-3d3f-41c9-b951-4e0bb5feb8d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d584cc78-3d3f-41c9-b951-4e0bb5feb8d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d584cc78-3d3f-41c9-b951-4e0bb5feb8d4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d584cc78-3d3f-41c9-b951-4e0bb5feb8d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c54d2b58-3806-44d6-97de-1a63d2dc87ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d584cc78-3d3f-41c9-b951-4e0bb5feb8d4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c54d2b58-3806-44d6-97de-1a63d2dc87ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2022Member_d3c82078-9563-4674-8158-fea7e674af60" xlink:href="dgx-20211231.xsd#dgx_LoanCommitmentMaturingOctober2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c54d2b58-3806-44d6-97de-1a63d2dc87ae" xlink:to="loc_dgx_LoanCommitmentMaturingOctober2022Member_d3c82078-9563-4674-8158-fea7e674af60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2023Member_fddf71bf-076d-4db4-9441-bdaa32753454" xlink:href="dgx-20211231.xsd#dgx_LoanCommitmentMaturingOctober2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c54d2b58-3806-44d6-97de-1a63d2dc87ae" xlink:to="loc_dgx_LoanCommitmentMaturingOctober2023Member_fddf71bf-076d-4db4-9441-bdaa32753454" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_008045f1-c96a-45d8-931a-1ddb912ecb60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_us-gaap_CreditFacilityAxis_008045f1-c96a-45d8-931a-1ddb912ecb60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_008045f1-c96a-45d8-931a-1ddb912ecb60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_008045f1-c96a-45d8-931a-1ddb912ecb60" xlink:to="loc_us-gaap_CreditFacilityDomain_008045f1-c96a-45d8-931a-1ddb912ecb60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5d568bc7-fbbb-4e29-964a-445c36059d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_008045f1-c96a-45d8-931a-1ddb912ecb60" xlink:to="loc_us-gaap_CreditFacilityDomain_5d568bc7-fbbb-4e29-964a-445c36059d78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_82663c2b-3b88-45d0-b12f-374dd404d5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5d568bc7-fbbb-4e29-964a-445c36059d78" xlink:to="loc_us-gaap_LetterOfCreditMember_82663c2b-3b88-45d0-b12f-374dd404d5bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_491ac912-79cd-4253-ba47-29d3f25a9e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5d568bc7-fbbb-4e29-964a-445c36059d78" xlink:to="loc_us-gaap_LineOfCreditMember_491ac912-79cd-4253-ba47-29d3f25a9e4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e88eafc6-514a-497b-9abb-9d98b32724aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_us-gaap_VariableRateAxis_e88eafc6-514a-497b-9abb-9d98b32724aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e88eafc6-514a-497b-9abb-9d98b32724aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_e88eafc6-514a-497b-9abb-9d98b32724aa" xlink:to="loc_us-gaap_VariableRateDomain_e88eafc6-514a-497b-9abb-9d98b32724aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c2c4e408-cdbf-481f-92b4-76f3915cd486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_e88eafc6-514a-497b-9abb-9d98b32724aa" xlink:to="loc_us-gaap_VariableRateDomain_c2c4e408-cdbf-481f-92b4-76f3915cd486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_c89b75c0-1f80-4ec3-9101-5f1662ed2ba7" xlink:href="dgx-20211231.xsd#dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c2c4e408-cdbf-481f-92b4-76f3915cd486" xlink:to="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_c89b75c0-1f80-4ec3-9101-5f1662ed2ba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_69dc5447-3695-48b7-a0f2-381876350bf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_srt_RangeAxis_69dc5447-3695-48b7-a0f2-381876350bf5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_69dc5447-3695-48b7-a0f2-381876350bf5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_69dc5447-3695-48b7-a0f2-381876350bf5" xlink:to="loc_srt_RangeMember_69dc5447-3695-48b7-a0f2-381876350bf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9fb995cf-edcb-417d-93c9-43822353253f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_69dc5447-3695-48b7-a0f2-381876350bf5" xlink:to="loc_srt_RangeMember_9fb995cf-edcb-417d-93c9-43822353253f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_264a286e-7354-45c3-8559-db3f282b3c3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9fb995cf-edcb-417d-93c9-43822353253f" xlink:to="loc_srt_MinimumMember_264a286e-7354-45c3-8559-db3f282b3c3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7c26a90b-872d-474b-80fa-2de2e5aa9441" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9fb995cf-edcb-417d-93c9-43822353253f" xlink:to="loc_srt_MaximumMember_7c26a90b-872d-474b-80fa-2de2e5aa9441" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" xlink:type="extended" id="i74fdd3209b1a4374a1c7069152a00a6c_DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9026a336-c66a-4ac0-bf8c-613fc2963f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ab485b35-01e0-48cd-9ef3-ce19fd615ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9026a336-c66a-4ac0-bf8c-613fc2963f05" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ab485b35-01e0-48cd-9ef3-ce19fd615ebb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_901792bf-622a-47af-9d77-5baa4e27e400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9026a336-c66a-4ac0-bf8c-613fc2963f05" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_901792bf-622a-47af-9d77-5baa4e27e400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_974ccc8e-f03d-4655-8780-7a93d0482f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9026a336-c66a-4ac0-bf8c-613fc2963f05" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_974ccc8e-f03d-4655-8780-7a93d0482f25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9026a336-c66a-4ac0-bf8c-613fc2963f05" xlink:to="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3ee6b1e0-fb8e-43e0-9d7c-3d51805e1300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3ee6b1e0-fb8e-43e0-9d7c-3d51805e1300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3ee6b1e0-fb8e-43e0-9d7c-3d51805e1300_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3ee6b1e0-fb8e-43e0-9d7c-3d51805e1300" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3ee6b1e0-fb8e-43e0-9d7c-3d51805e1300_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86481b41-36fa-4ecc-8edf-91b01be844cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3ee6b1e0-fb8e-43e0-9d7c-3d51805e1300" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86481b41-36fa-4ecc-8edf-91b01be844cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_d7dc79eb-cc38-492c-b85d-0723f3daa9f2" xlink:href="dgx-20211231.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86481b41-36fa-4ecc-8edf-91b01be844cf" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_d7dc79eb-cc38-492c-b85d-0723f3daa9f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_ac5c5b66-ff33-4b6a-a641-29684732c8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86481b41-36fa-4ecc-8edf-91b01be844cf" xlink:to="loc_us-gaap_SecuredDebtMember_ac5c5b66-ff33-4b6a-a641-29684732c8c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_390d6c66-21bc-49da-a7ee-32034b084b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:to="loc_us-gaap_CreditFacilityAxis_390d6c66-21bc-49da-a7ee-32034b084b11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_390d6c66-21bc-49da-a7ee-32034b084b11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_390d6c66-21bc-49da-a7ee-32034b084b11" xlink:to="loc_us-gaap_CreditFacilityDomain_390d6c66-21bc-49da-a7ee-32034b084b11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_867e2ecd-85e7-4af6-b151-218a2e65d222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_390d6c66-21bc-49da-a7ee-32034b084b11" xlink:to="loc_us-gaap_CreditFacilityDomain_867e2ecd-85e7-4af6-b151-218a2e65d222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_c328bfb0-7a2e-47b0-a16e-e7c6df69c918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_867e2ecd-85e7-4af6-b151-218a2e65d222" xlink:to="loc_us-gaap_LetterOfCreditMember_c328bfb0-7a2e-47b0-a16e-e7c6df69c918" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_5020c204-3eed-498e-bd8b-e18d89583ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:to="loc_us-gaap_VariableRateAxis_5020c204-3eed-498e-bd8b-e18d89583ddf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5020c204-3eed-498e-bd8b-e18d89583ddf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_5020c204-3eed-498e-bd8b-e18d89583ddf" xlink:to="loc_us-gaap_VariableRateDomain_5020c204-3eed-498e-bd8b-e18d89583ddf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3497e5a7-a6aa-4791-a339-78aaa15c2d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_5020c204-3eed-498e-bd8b-e18d89583ddf" xlink:to="loc_us-gaap_VariableRateDomain_3497e5a7-a6aa-4791-a339-78aaa15c2d7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d6b1cc30-6bae-4bf1-b558-44e393e651a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3497e5a7-a6aa-4791-a339-78aaa15c2d7c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d6b1cc30-6bae-4bf1-b558-44e393e651a9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTSeniorNotesOfferingDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails" xlink:type="extended" id="iae9cec4d841045368d6d6bc23e5f0a85_DEBTSeniorNotesOfferingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1ea7602c-b1ab-478d-9db0-831be271ba4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1ea7602c-b1ab-478d-9db0-831be271ba4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bf4a61d0-8b53-4a5f-822b-eeb320ebfe02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bf4a61d0-8b53-4a5f-822b-eeb320ebfe02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6e5548f5-ab85-48c5-8f75-f31aa00e8433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6e5548f5-ab85-48c5-8f75-f31aa00e8433" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_29e96483-baf8-46a3-af58-eaef4200c197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_29e96483-baf8-46a3-af58-eaef4200c197" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3a4bbd95-2daa-4a8d-bb32-fb76de85fb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3a4bbd95-2daa-4a8d-bb32-fb76de85fb4c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_71718d4c-f134-48e3-95a8-1b3a3f8093d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_71718d4c-f134-48e3-95a8-1b3a3f8093d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_71718d4c-f134-48e3-95a8-1b3a3f8093d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_71718d4c-f134-48e3-95a8-1b3a3f8093d2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_71718d4c-f134-48e3-95a8-1b3a3f8093d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b56cf606-5bd9-4b8f-99fd-0dfb8aefabd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_71718d4c-f134-48e3-95a8-1b3a3f8093d2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b56cf606-5bd9-4b8f-99fd-0dfb8aefabd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1b52f40e-d06f-44b0-973f-9b78ddc9bde6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b56cf606-5bd9-4b8f-99fd-0dfb8aefabd0" xlink:to="loc_us-gaap_SeniorNotesMember_1b52f40e-d06f-44b0-973f-9b78ddc9bde6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bb67daa3-ebb2-46e8-a939-4628f4df7f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:to="loc_us-gaap_DebtInstrumentAxis_bb67daa3-ebb2-46e8-a939-4628f4df7f9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bb67daa3-ebb2-46e8-a939-4628f4df7f9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_bb67daa3-ebb2-46e8-a939-4628f4df7f9d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bb67daa3-ebb2-46e8-a939-4628f4df7f9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e440a4a7-5142-4ab2-808d-19d65433dce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_bb67daa3-ebb2-46e8-a939-4628f4df7f9d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e440a4a7-5142-4ab2-808d-19d65433dce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_ba018054-1cb2-46a3-9cd2-14d39d657191" xlink:href="dgx-20211231.xsd#dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e440a4a7-5142-4ab2-808d-19d65433dce3" xlink:to="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_ba018054-1cb2-46a3-9cd2-14d39d657191" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_49a175e6-119a-43ff-a7ec-abb9f34550d5" xlink:href="dgx-20211231.xsd#dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e440a4a7-5142-4ab2-808d-19d65433dce3" xlink:to="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_49a175e6-119a-43ff-a7ec-abb9f34550d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_415ba6b4-3125-4f30-9daf-af3ded0a232c" xlink:href="dgx-20211231.xsd#dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e440a4a7-5142-4ab2-808d-19d65433dce3" xlink:to="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_415ba6b4-3125-4f30-9daf-af3ded0a232c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a717bac4-a2b6-4802-a9b1-379be06f6f75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a717bac4-a2b6-4802-a9b1-379be06f6f75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a717bac4-a2b6-4802-a9b1-379be06f6f75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a717bac4-a2b6-4802-a9b1-379be06f6f75" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a717bac4-a2b6-4802-a9b1-379be06f6f75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a75a161b-b315-42b9-9f2e-9b0753217959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a717bac4-a2b6-4802-a9b1-379be06f6f75" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a75a161b-b315-42b9-9f2e-9b0753217959" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember_a5eadf68-3c17-409a-b4b2-2909bbd2e7ee" xlink:href="dgx-20211231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a75a161b-b315-42b9-9f2e-9b0753217959" xlink:to="loc_dgx_OtherIncomeExpenseMember_a5eadf68-3c17-409a-b4b2-2909bbd2e7ee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/LEASESNarrativeDetails" xlink:type="extended" id="i1accd70538df42898662ddf64b5f6365_LEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_c3fa5ea3-ec10-4aaa-b66e-9875c92cb3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRemainingLeaseTerm_28fa65d0-5ab9-4433-832d-f1c615720e54" xlink:href="dgx-20211231.xsd#dgx_LeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c3fa5ea3-ec10-4aaa-b66e-9875c92cb3e4" xlink:to="loc_dgx_LeaseRemainingLeaseTerm_28fa65d0-5ab9-4433-832d-f1c615720e54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRenewalTerm_aa7fbf7c-13c3-4c44-966c-8cc831772100" xlink:href="dgx-20211231.xsd#dgx_LeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c3fa5ea3-ec10-4aaa-b66e-9875c92cb3e4" xlink:to="loc_dgx_LeaseRenewalTerm_aa7fbf7c-13c3-4c44-966c-8cc831772100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_79c3e98e-deff-4876-9124-552d0f9fad37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c3fa5ea3-ec10-4aaa-b66e-9875c92cb3e4" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_79c3e98e-deff-4876-9124-552d0f9fad37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f4344951-dfaa-4d33-b23d-90638a14e307" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79c3e98e-deff-4876-9124-552d0f9fad37" xlink:to="loc_srt_RangeAxis_f4344951-dfaa-4d33-b23d-90638a14e307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f4344951-dfaa-4d33-b23d-90638a14e307_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f4344951-dfaa-4d33-b23d-90638a14e307" xlink:to="loc_srt_RangeMember_f4344951-dfaa-4d33-b23d-90638a14e307_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d534aa4d-9528-49e4-9a5c-a2b4219f91b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f4344951-dfaa-4d33-b23d-90638a14e307" xlink:to="loc_srt_RangeMember_d534aa4d-9528-49e4-9a5c-a2b4219f91b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b167dfe5-3496-41db-8db3-67df8819086c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d534aa4d-9528-49e4-9a5c-a2b4219f91b2" xlink:to="loc_srt_MinimumMember_b167dfe5-3496-41db-8db3-67df8819086c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_093c1ca7-c9e7-4bea-9133-54f5a735304e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d534aa4d-9528-49e4-9a5c-a2b4219f91b2" xlink:to="loc_srt_MaximumMember_093c1ca7-c9e7-4bea-9133-54f5a735304e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended" id="ic592a0da74c045c9ac1878e2025e1bdc_FINANCIALINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_286e5e8e-ee50-4a9e-9b82-07417f55411c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_890ea659-73eb-4804-8434-23df0a6a9825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_286e5e8e-ee50-4a9e-9b82-07417f55411c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_890ea659-73eb-4804-8434-23df0a6a9825" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_286e5e8e-ee50-4a9e-9b82-07417f55411c" xlink:to="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aac33c04-65e1-482a-8a00-672b0be1f58a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aac33c04-65e1-482a-8a00-672b0be1f58a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_aac33c04-65e1-482a-8a00-672b0be1f58a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aac33c04-65e1-482a-8a00-672b0be1f58a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_aac33c04-65e1-482a-8a00-672b0be1f58a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_072f8720-05bf-4544-8c07-43a16111696b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aac33c04-65e1-482a-8a00-672b0be1f58a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_072f8720-05bf-4544-8c07-43a16111696b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_7283aff6-f15a-4016-87a3-302d08da412f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_072f8720-05bf-4544-8c07-43a16111696b" xlink:to="loc_us-gaap_FairValueHedgingMember_7283aff6-f15a-4016-87a3-302d08da412f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_481ee091-0b62-4b6d-a8c6-6318b0af965a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_srt_StatementScenarioAxis_481ee091-0b62-4b6d-a8c6-6318b0af965a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_481ee091-0b62-4b6d-a8c6-6318b0af965a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_481ee091-0b62-4b6d-a8c6-6318b0af965a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_481ee091-0b62-4b6d-a8c6-6318b0af965a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1ba76dd1-25bb-42bb-a794-5a11f5c8e622" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_481ee091-0b62-4b6d-a8c6-6318b0af965a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1ba76dd1-25bb-42bb-a794-5a11f5c8e622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_3709f33e-60b2-479f-9304-f7185f2e7415" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1ba76dd1-25bb-42bb-a794-5a11f5c8e622" xlink:to="loc_srt_ScenarioForecastMember_3709f33e-60b2-479f-9304-f7185f2e7415" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_dafe1697-8253-4604-84cd-9a95838e94c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_us-gaap_VariableRateAxis_dafe1697-8253-4604-84cd-9a95838e94c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_dafe1697-8253-4604-84cd-9a95838e94c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_dafe1697-8253-4604-84cd-9a95838e94c8" xlink:to="loc_us-gaap_VariableRateDomain_dafe1697-8253-4604-84cd-9a95838e94c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0cbbaa7e-d26b-497f-bccb-2568d9055ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_dafe1697-8253-4604-84cd-9a95838e94c8" xlink:to="loc_us-gaap_VariableRateDomain_0cbbaa7e-d26b-497f-bccb-2568d9055ede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a2233d11-73cb-4505-9cbe-cb2bf4b1d97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_0cbbaa7e-d26b-497f-bccb-2568d9055ede" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a2233d11-73cb-4505-9cbe-cb2bf4b1d97c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dda149f1-8f83-49f8-80b9-f8f1fe7de3df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_srt_RangeAxis_dda149f1-8f83-49f8-80b9-f8f1fe7de3df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dda149f1-8f83-49f8-80b9-f8f1fe7de3df_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dda149f1-8f83-49f8-80b9-f8f1fe7de3df" xlink:to="loc_srt_RangeMember_dda149f1-8f83-49f8-80b9-f8f1fe7de3df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_93f1fcb6-955e-4874-ba0e-82cbd500243e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dda149f1-8f83-49f8-80b9-f8f1fe7de3df" xlink:to="loc_srt_RangeMember_93f1fcb6-955e-4874-ba0e-82cbd500243e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_20bb17d2-01a8-4a3c-887b-c8928f88f958" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_93f1fcb6-955e-4874-ba0e-82cbd500243e" xlink:to="loc_srt_MinimumMember_20bb17d2-01a8-4a3c-887b-c8928f88f958" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8eb2d66e-7ab5-4983-8357-70dbff6f7557" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_93f1fcb6-955e-4874-ba0e-82cbd500243e" xlink:to="loc_srt_MaximumMember_8eb2d66e-7ab5-4983-8357-70dbff6f7557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fb82bf0c-df2d-4f27-9bdb-3f6e0453a56a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fb82bf0c-df2d-4f27-9bdb-3f6e0453a56a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fb82bf0c-df2d-4f27-9bdb-3f6e0453a56a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb82bf0c-df2d-4f27-9bdb-3f6e0453a56a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fb82bf0c-df2d-4f27-9bdb-3f6e0453a56a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6d34adf6-3f04-46a4-b2c0-a3500724281c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb82bf0c-df2d-4f27-9bdb-3f6e0453a56a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6d34adf6-3f04-46a4-b2c0-a3500724281c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_a800de5f-c213-441e-ad94-ebb471204049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6d34adf6-3f04-46a4-b2c0-a3500724281c" xlink:to="loc_us-gaap_LongTermDebtMember_a800de5f-c213-441e-ad94-ebb471204049" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended" id="ia2f1342c623b4200854f9580e9cdfadf_FINANCIALINSTRUMENTSBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_16ab5d7b-0fb7-4f37-ba8a-eb71f3ab6291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_c4da601a-eb44-45a4-a240-08f921880986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_16ab5d7b-0fb7-4f37-ba8a-eb71f3ab6291" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_c4da601a-eb44-45a4-a240-08f921880986" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_5aea648c-ae78-4268-ab6e-8cab3a64c8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_16ab5d7b-0fb7-4f37-ba8a-eb71f3ab6291" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_5aea648c-ae78-4268-ab6e-8cab3a64c8e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_9aea838b-3c72-43e6-b5c5-9c15128a81fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_16ab5d7b-0fb7-4f37-ba8a-eb71f3ab6291" xlink:to="loc_us-gaap_DerivativeTable_9aea838b-3c72-43e6-b5c5-9c15128a81fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4666fb02-0897-42d9-bef0-626f3a6f1f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9aea838b-3c72-43e6-b5c5-9c15128a81fe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4666fb02-0897-42d9-bef0-626f3a6f1f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4666fb02-0897-42d9-bef0-626f3a6f1f7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4666fb02-0897-42d9-bef0-626f3a6f1f7c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4666fb02-0897-42d9-bef0-626f3a6f1f7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_36ac96b6-a870-487a-83e1-74da6539ee14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4666fb02-0897-42d9-bef0-626f3a6f1f7c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_36ac96b6-a870-487a-83e1-74da6539ee14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_ec939345-0908-4be4-b767-a453ff74a608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_36ac96b6-a870-487a-83e1-74da6539ee14" xlink:to="loc_us-gaap_LongTermDebtMember_ec939345-0908-4be4-b767-a453ff74a608" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ead88e9-af16-4e9c-89b3-b3d93488dde7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9aea838b-3c72-43e6-b5c5-9c15128a81fe" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ead88e9-af16-4e9c-89b3-b3d93488dde7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3ead88e9-af16-4e9c-89b3-b3d93488dde7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ead88e9-af16-4e9c-89b3-b3d93488dde7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3ead88e9-af16-4e9c-89b3-b3d93488dde7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0831f2ac-2576-4606-bc9e-9cf44fa282ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ead88e9-af16-4e9c-89b3-b3d93488dde7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0831f2ac-2576-4606-bc9e-9cf44fa282ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_290b16ad-e57d-4fda-b310-90f1cf145d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0831f2ac-2576-4606-bc9e-9cf44fa282ee" xlink:to="loc_us-gaap_FairValueHedgingMember_290b16ad-e57d-4fda-b310-90f1cf145d37" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended" id="i335c917825c449bcbf8a4e1344913a56_FINANCIALINSTRUMENTSIncomeStatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1d8d7f29-016d-4792-8929-43a1224dcfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a756ea9d-f8b9-46fc-adc8-d42fbb9db9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1d8d7f29-016d-4792-8929-43a1224dcfc9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a756ea9d-f8b9-46fc-adc8-d42fbb9db9e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_dfb3471d-5d32-4879-9102-0762102bdccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1d8d7f29-016d-4792-8929-43a1224dcfc9" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_dfb3471d-5d32-4879-9102-0762102bdccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_7e194c22-c572-4c19-83bd-36b3f41b7825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1d8d7f29-016d-4792-8929-43a1224dcfc9" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_7e194c22-c572-4c19-83bd-36b3f41b7825" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_6c6ed25b-bede-46aa-b0b0-3dafe04b12a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_1d8d7f29-016d-4792-8929-43a1224dcfc9" xlink:to="loc_us-gaap_DerivativeTable_6c6ed25b-bede-46aa-b0b0-3dafe04b12a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e47a377b-62c4-42fa-99ae-d6d6362ed616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6c6ed25b-bede-46aa-b0b0-3dafe04b12a8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e47a377b-62c4-42fa-99ae-d6d6362ed616" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e47a377b-62c4-42fa-99ae-d6d6362ed616_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e47a377b-62c4-42fa-99ae-d6d6362ed616" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e47a377b-62c4-42fa-99ae-d6d6362ed616_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a4e035a2-9d7b-4ef7-b13d-cc6eddd0bbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e47a377b-62c4-42fa-99ae-d6d6362ed616" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a4e035a2-9d7b-4ef7-b13d-cc6eddd0bbe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1c071479-38fd-46ed-9178-9155efd70e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a4e035a2-9d7b-4ef7-b13d-cc6eddd0bbe2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1c071479-38fd-46ed-9178-9155efd70e69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_976e0e0c-08ca-4db1-b590-963b5cbf876e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6c6ed25b-bede-46aa-b0b0-3dafe04b12a8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_976e0e0c-08ca-4db1-b590-963b5cbf876e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_976e0e0c-08ca-4db1-b590-963b5cbf876e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_976e0e0c-08ca-4db1-b590-963b5cbf876e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_976e0e0c-08ca-4db1-b590-963b5cbf876e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c6e0b4d0-bb57-42df-a681-6d5b375da49b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_976e0e0c-08ca-4db1-b590-963b5cbf876e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c6e0b4d0-bb57-42df-a681-6d5b375da49b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_fc4479d8-8fd9-408c-bf27-8cb0d269f3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c6e0b4d0-bb57-42df-a681-6d5b375da49b" xlink:to="loc_us-gaap_FairValueHedgingMember_fc4479d8-8fd9-408c-bf27-8cb0d269f3f5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="extended" id="idf420a1c4c5345c6a41fc5231dbdd835_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareholdersEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9f2044f5-ae01-4fa3-9124-8f96d34e7fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9f2044f5-ae01-4fa3-9124-8f96d34e7fac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f0b59bed-2c02-49f7-b3eb-007441fb0be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f0b59bed-2c02-49f7-b3eb-007441fb0be1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_2ac607a4-0504-4d35-a43d-b5509b10d330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_2ac607a4-0504-4d35-a43d-b5509b10d330" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_48d787cb-a7ac-4751-8e43-8477aec38612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_48d787cb-a7ac-4751-8e43-8477aec38612" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4cc2187a-4878-4e6e-97f9-e95bf52b347e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4cc2187a-4878-4e6e-97f9-e95bf52b347e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_91e970b2-8780-4461-a664-270d479f15b4" xlink:href="dgx-20211231.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_91e970b2-8780-4461-a664-270d479f15b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2ad2c608-1b6b-4c1c-b90d-7c1c365440bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2ad2c608-1b6b-4c1c-b90d-7c1c365440bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_9801c619-0444-41c2-b566-32c47eaa6f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_9801c619-0444-41c2-b566-32c47eaa6f0a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_04caf955-1fe3-46ac-b04a-5241b0d25207" xlink:href="dgx-20211231.xsd#dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_04caf955-1fe3-46ac-b04a-5241b0d25207" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_dc20b854-257f-4aff-866c-cc54c03d9649" xlink:href="dgx-20211231.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_dc20b854-257f-4aff-866c-cc54c03d9649" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_2acb30dc-eb7c-4f7d-aa94-a6af5da203d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_2acb30dc-eb7c-4f7d-aa94-a6af5da203d6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_361e7c2c-d061-41be-a872-9d26888c1a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_361e7c2c-d061-41be-a872-9d26888c1a7a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0d53b9a2-c959-4820-9ebe-04d6eb5af875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0d53b9a2-c959-4820-9ebe-04d6eb5af875" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesPayment_c793a6af-58a3-4934-ad1f-a6f05b0c9b31" xlink:href="dgx-20211231.xsd#dgx_AcceleratedShareRepurchasesPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_dgx_AcceleratedShareRepurchasesPayment_c793a6af-58a3-4934-ad1f-a6f05b0c9b31" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_bd6ccb70-5292-4a06-9901-213f3518870f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_bd6ccb70-5292-4a06-9901-213f3518870f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_8495ce1a-95f2-42f5-b95d-89f3c26a6c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_8495ce1a-95f2-42f5-b95d-89f3c26a6c1f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b2e271f3-77b1-4176-9129-6d327e8333db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b2e271f3-77b1-4176-9129-6d327e8333db" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f9e2f00f-eb04-453e-9a92-2f2b0720711d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f9e2f00f-eb04-453e-9a92-2f2b0720711d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareholdersEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b4df36c3-b16f-4a49-9746-969b830b6493" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_srt_RangeAxis_b4df36c3-b16f-4a49-9746-969b830b6493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b4df36c3-b16f-4a49-9746-969b830b6493_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b4df36c3-b16f-4a49-9746-969b830b6493" xlink:to="loc_srt_RangeMember_b4df36c3-b16f-4a49-9746-969b830b6493_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_28f5920b-8137-46fa-a1f6-de3da65ebcbb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b4df36c3-b16f-4a49-9746-969b830b6493" xlink:to="loc_srt_RangeMember_28f5920b-8137-46fa-a1f6-de3da65ebcbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c7ac19d4-3c2f-4680-b547-e348787ef754" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_28f5920b-8137-46fa-a1f6-de3da65ebcbb" xlink:to="loc_srt_MaximumMember_c7ac19d4-3c2f-4680-b547-e348787ef754" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_85977d98-9ac2-4c4e-9670-9dc59d856c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_85977d98-9ac2-4c4e-9670-9dc59d856c3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_85977d98-9ac2-4c4e-9670-9dc59d856c3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_85977d98-9ac2-4c4e-9670-9dc59d856c3e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_85977d98-9ac2-4c4e-9670-9dc59d856c3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7bfcfefd-bbd1-42dd-a3ab-a6775cd2e46a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_85977d98-9ac2-4c4e-9670-9dc59d856c3e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7bfcfefd-bbd1-42dd-a3ab-a6775cd2e46a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_33b57680-7436-4581-a33b-5c7d6474fe40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7bfcfefd-bbd1-42dd-a3ab-a6775cd2e46a" xlink:to="loc_us-gaap_SubsequentEventMember_33b57680-7436-4581-a33b-5c7d6474fe40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_41856b10-0c47-41de-8005-818844f42d7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_srt_StatementScenarioAxis_41856b10-0c47-41de-8005-818844f42d7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_41856b10-0c47-41de-8005-818844f42d7b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_41856b10-0c47-41de-8005-818844f42d7b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_41856b10-0c47-41de-8005-818844f42d7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a710f740-cba9-4256-9919-cf98a0cd603c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_41856b10-0c47-41de-8005-818844f42d7b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a710f740-cba9-4256-9919-cf98a0cd603c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_487ab7f8-7f49-4a28-95ee-75fbd327babb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a710f740-cba9-4256-9919-cf98a0cd603c" xlink:to="loc_srt_ScenarioForecastMember_487ab7f8-7f49-4a28-95ee-75fbd327babb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c0ee9beb-cf82-42f9-b1d8-ee75f1a4b770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c0ee9beb-cf82-42f9-b1d8-ee75f1a4b770" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c0ee9beb-cf82-42f9-b1d8-ee75f1a4b770_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0ee9beb-cf82-42f9-b1d8-ee75f1a4b770" xlink:to="loc_us-gaap_EquityComponentDomain_c0ee9beb-cf82-42f9-b1d8-ee75f1a4b770_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8640b52b-1de8-4c9d-b415-d339addc592a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0ee9beb-cf82-42f9-b1d8-ee75f1a4b770" xlink:to="loc_us-gaap_EquityComponentDomain_8640b52b-1de8-4c9d-b415-d339addc592a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_dfcd5bf0-b09f-453b-b42f-fa5d71038a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8640b52b-1de8-4c9d-b415-d339addc592a" xlink:to="loc_us-gaap_TreasuryStockMember_dfcd5bf0-b09f-453b-b42f-fa5d71038a74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_85eaf271-cd63-4596-a421-b7507111587e" xlink:href="dgx-20211231.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8640b52b-1de8-4c9d-b415-d339addc592a" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_85eaf271-cd63-4596-a421-b7507111587e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_125adf80-0e24-496c-8ac1-fb143fb2936d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8640b52b-1de8-4c9d-b415-d339addc592a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_125adf80-0e24-496c-8ac1-fb143fb2936d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_63d33621-1e67-48c9-8fb9-26bf5a4fa3c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_srt_OwnershipAxis_63d33621-1e67-48c9-8fb9-26bf5a4fa3c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_63d33621-1e67-48c9-8fb9-26bf5a4fa3c2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_63d33621-1e67-48c9-8fb9-26bf5a4fa3c2" xlink:to="loc_srt_OwnershipDomain_63d33621-1e67-48c9-8fb9-26bf5a4fa3c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b878b728-043e-4093-9d73-3c8034b33b39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_63d33621-1e67-48c9-8fb9-26bf5a4fa3c2" xlink:to="loc_srt_OwnershipDomain_b878b728-043e-4093-9d73-3c8034b33b39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_39776024-5b5c-4486-90a9-b1b26e7644e7" xlink:href="dgx-20211231.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b878b728-043e-4093-9d73-3c8034b33b39" xlink:to="loc_dgx_UMassJointVentureMember_39776024-5b5c-4486-90a9-b1b26e7644e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3c363919-7e40-4eb3-8a63-f83475a4303e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3c363919-7e40-4eb3-8a63-f83475a4303e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3c363919-7e40-4eb3-8a63-f83475a4303e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3c363919-7e40-4eb3-8a63-f83475a4303e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3c363919-7e40-4eb3-8a63-f83475a4303e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d0f44cab-b99e-4a88-830d-52050b7e650f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3c363919-7e40-4eb3-8a63-f83475a4303e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d0f44cab-b99e-4a88-830d-52050b7e650f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_3dfa0e36-9c41-4b62-9e98-8e4ea0a34a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d0f44cab-b99e-4a88-830d-52050b7e650f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_3dfa0e36-9c41-4b62-9e98-8e4ea0a34a4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0fb4136c-387b-419f-953e-988ab35174c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0fb4136c-387b-419f-953e-988ab35174c6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0fb4136c-387b-419f-953e-988ab35174c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0fb4136c-387b-419f-953e-988ab35174c6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0fb4136c-387b-419f-953e-988ab35174c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8feb8672-b5e0-4f35-aae1-072875bc18fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0fb4136c-387b-419f-953e-988ab35174c6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8feb8672-b5e0-4f35-aae1-072875bc18fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_e91c622e-31c9-4012-b7dc-129e12828b08" xlink:href="dgx-20211231.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8feb8672-b5e0-4f35-aae1-072875bc18fa" xlink:to="loc_dgx_Q2SolutionsMember_e91c622e-31c9-4012-b7dc-129e12828b08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7e23be97-9a6d-4c20-8b05-067b7845e51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7e23be97-9a6d-4c20-8b05-067b7845e51a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_7e23be97-9a6d-4c20-8b05-067b7845e51a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7e23be97-9a6d-4c20-8b05-067b7845e51a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_7e23be97-9a6d-4c20-8b05-067b7845e51a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bce4d855-438b-4c70-8ac3-6da33aaf3c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7e23be97-9a6d-4c20-8b05-067b7845e51a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bce4d855-438b-4c70-8ac3-6da33aaf3c8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_a7e52b3c-af9a-4a46-ae60-f5fa604f9b41" xlink:href="dgx-20211231.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bce4d855-438b-4c70-8ac3-6da33aaf3c8d" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_a7e52b3c-af9a-4a46-ae60-f5fa604f9b41" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended" id="ifc969ad1fabb4531bb9db9c438490534_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareholdersEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fd970387-c8cb-427d-b7c3-383e1d9a8790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fd970387-c8cb-427d-b7c3-383e1d9a8790" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d74613d3-58d7-4e0c-9437-8976b32f82f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d74613d3-58d7-4e0c-9437-8976b32f82f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d3ca4c02-9172-4bcb-b2f3-ee4c644b572f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d3ca4c02-9172-4bcb-b2f3-ee4c644b572f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93363386-f635-42c1-a7b9-58f60d4568fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93363386-f635-42c1-a7b9-58f60d4568fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a7a4bdb2-56c4-4555-a6ab-9e059f1c7624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityTable_6dac2ade-0284-4367-a2b4-646379c0c798" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareholdersEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:to="loc_dgx_ScheduleOfShareholdersEquityTable_6dac2ade-0284-4367-a2b4-646379c0c798" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_44a58149-60e9-4c67-b2b6-b141e82ae273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_6dac2ade-0284-4367-a2b4-646379c0c798" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_44a58149-60e9-4c67-b2b6-b141e82ae273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_44a58149-60e9-4c67-b2b6-b141e82ae273_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_44a58149-60e9-4c67-b2b6-b141e82ae273" xlink:to="loc_us-gaap_EquityComponentDomain_44a58149-60e9-4c67-b2b6-b141e82ae273_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_44a58149-60e9-4c67-b2b6-b141e82ae273" xlink:to="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_53d3a666-aeb3-4a0b-a162-76800d174523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_53d3a666-aeb3-4a0b-a162-76800d174523" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_f7dd622f-058d-47f0-af2f-443b0246c886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_f7dd622f-058d-47f0-af2f-443b0246c886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_95e9e515-1270-43ab-a653-bd4a296ffe37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_95e9e515-1270-43ab-a653-bd4a296ffe37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherEquityComponentsMember_dca79fca-741b-4985-bb5d-70a90abfabbb" xlink:href="dgx-20211231.xsd#dgx_OtherEquityComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:to="loc_dgx_OtherEquityComponentsMember_dca79fca-741b-4985-bb5d-70a90abfabbb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774f8126-b41a-4013-a61a-f8f7845ee86a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774f8126-b41a-4013-a61a-f8f7845ee86a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" xlink:type="extended" id="i30d83c2bd715465182dfcc9ba0df7781_STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_615f5ea9-c7e6-4ce2-99d8-872d4e6975d7" xlink:href="dgx-20211231.xsd#dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:to="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_615f5ea9-c7e6-4ce2-99d8-872d4e6975d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ef46a585-7a3f-48df-96bc-26302a507f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ef46a585-7a3f-48df-96bc-26302a507f84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b5637a88-9bd0-4dad-9b34-06fde3873350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b5637a88-9bd0-4dad-9b34-06fde3873350" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0c796e36-3e8a-4b48-a873-37779436f253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0c796e36-3e8a-4b48-a873-37779436f253" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4db831f6-a629-40e4-854e-96270a68b47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4db831f6-a629-40e4-854e-96270a68b47d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2f8f03d0-29ef-439e-8987-673e1865d3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4db831f6-a629-40e4-854e-96270a68b47d" xlink:to="loc_us-gaap_AwardTypeAxis_2f8f03d0-29ef-439e-8987-673e1865d3ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f8f03d0-29ef-439e-8987-673e1865d3ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2f8f03d0-29ef-439e-8987-673e1865d3ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f8f03d0-29ef-439e-8987-673e1865d3ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8eab7a8f-4503-456a-adb8-7331d71ef6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2f8f03d0-29ef-439e-8987-673e1865d3ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8eab7a8f-4503-456a-adb8-7331d71ef6a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EmployeeLongTermIncentivePlanEltipMember_11b834a2-c622-4732-896c-8f953168353e" xlink:href="dgx-20211231.xsd#dgx_EmployeeLongTermIncentivePlanEltipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8eab7a8f-4503-456a-adb8-7331d71ef6a2" xlink:to="loc_dgx_EmployeeLongTermIncentivePlanEltipMember_11b834a2-c622-4732-896c-8f953168353e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_6367817a-cd64-41e3-8b32-a61aed898b6b" xlink:href="dgx-20211231.xsd#dgx_RestatedDirectorLongTermIncentivePlanDltipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8eab7a8f-4503-456a-adb8-7331d71ef6a2" xlink:to="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_6367817a-cd64-41e3-8b32-a61aed898b6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_48d33d8f-d60c-43e6-a9e6-d24045e3faaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8eab7a8f-4503-456a-adb8-7331d71ef6a2" xlink:to="loc_us-gaap_StockOptionMember_48d33d8f-d60c-43e6-a9e6-d24045e3faaf" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" xlink:type="extended" id="ida59e5802aef4004b5f8e69e305dd480_STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_14040ea3-6116-4927-ab4a-350ce334a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_14040ea3-6116-4927-ab4a-350ce334a93f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0a29a9f8-3273-42fe-887a-5e532ad1de3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0a29a9f8-3273-42fe-887a-5e532ad1de3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c757227b-c225-48a5-b609-76a48af71d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c757227b-c225-48a5-b609-76a48af71d73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_93cce174-2f0a-49e0-9d99-8b92af5822f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_93cce174-2f0a-49e0-9d99-8b92af5822f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_18d96f63-aa09-4ef7-b111-261be9fa02e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_18d96f63-aa09-4ef7-b111-261be9fa02e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ef578774-12f7-452f-a14a-3c0f5da339ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ef578774-12f7-452f-a14a-3c0f5da339ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31eb2c16-117a-45f4-9816-b1052e1914cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31eb2c16-117a-45f4-9816-b1052e1914cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_90c30b7b-b725-460d-9458-81e5dd1b3023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31eb2c16-117a-45f4-9816-b1052e1914cf" xlink:to="loc_us-gaap_AwardTypeAxis_90c30b7b-b725-460d-9458-81e5dd1b3023" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90c30b7b-b725-460d-9458-81e5dd1b3023_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_90c30b7b-b725-460d-9458-81e5dd1b3023" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90c30b7b-b725-460d-9458-81e5dd1b3023_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1e9e090-368b-49a5-93f7-92b79d849b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_90c30b7b-b725-460d-9458-81e5dd1b3023" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1e9e090-368b-49a5-93f7-92b79d849b0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_a366df3d-6c4c-4150-90f5-a02f466b1a86" xlink:href="dgx-20211231.xsd#dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1e9e090-368b-49a5-93f7-92b79d849b0a" xlink:to="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_a366df3d-6c4c-4150-90f5-a02f466b1a86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_26a09246-89f8-4869-8711-d09dc92f5cd6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31eb2c16-117a-45f4-9816-b1052e1914cf" xlink:to="loc_srt_RangeAxis_26a09246-89f8-4869-8711-d09dc92f5cd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_26a09246-89f8-4869-8711-d09dc92f5cd6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_26a09246-89f8-4869-8711-d09dc92f5cd6" xlink:to="loc_srt_RangeMember_26a09246-89f8-4869-8711-d09dc92f5cd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_77e07ba2-e9a1-4756-b47e-8c49e736d8a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_26a09246-89f8-4869-8711-d09dc92f5cd6" xlink:to="loc_srt_RangeMember_77e07ba2-e9a1-4756-b47e-8c49e736d8a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2bcc2162-7a40-4d71-94b9-5d93ed92c602" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_77e07ba2-e9a1-4756-b47e-8c49e736d8a9" xlink:to="loc_srt_MinimumMember_2bcc2162-7a40-4d71-94b9-5d93ed92c602" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ef782ed-3f4b-4a5e-bf7c-59c7c015cfb0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_77e07ba2-e9a1-4756-b47e-8c49e736d8a9" xlink:to="loc_srt_MaximumMember_2ef782ed-3f4b-4a5e-bf7c-59c7c015cfb0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" xlink:type="extended" id="i792769edb0594089bb3fdffa53b3aa36_STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_24cc80fe-5a55-48c9-8a1a-353d6e9cd53c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_24cc80fe-5a55-48c9-8a1a-353d6e9cd53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_335f631a-8a01-4464-9507-5f5bb74c7ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_335f631a-8a01-4464-9507-5f5bb74c7ed8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_efb90556-32cc-4fbe-adb7-cc17d5ce58f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_efb90556-32cc-4fbe-adb7-cc17d5ce58f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2820cc53-08bf-4024-bb5e-edff6a2419c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2820cc53-08bf-4024-bb5e-edff6a2419c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1f16bb3c-5c78-40cb-b156-3b666fa3b8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f474c71d-f03e-4924-823b-cd426ebc43a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f474c71d-f03e-4924-823b-cd426ebc43a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_15888210-4d29-4523-af66-41123a814b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_15888210-4d29-4523-af66-41123a814b40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b075ceb4-74eb-4ce1-bb61-eb089f3d3c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b075ceb4-74eb-4ce1-bb61-eb089f3d3c7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_9137ad49-22fc-48de-88cb-119031412340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_9137ad49-22fc-48de-88cb-119031412340" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_64d45a45-e915-4f4c-8471-e76b67b5f59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c3d5f8c4-4686-4484-ba18-20aecf9494d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c3d5f8c4-4686-4484-ba18-20aecf9494d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f7c6047b-ba9f-4aba-adaa-acc5f29e4d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f7c6047b-ba9f-4aba-adaa-acc5f29e4d1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4bb27ba7-3408-4c37-8bc3-2763ebd33dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4bb27ba7-3408-4c37-8bc3-2763ebd33dd1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f6c45c87-4e93-486b-b4d1-71dbdc33ae0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f6c45c87-4e93-486b-b4d1-71dbdc33ae0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4771f822-2d63-4dc0-807b-3b0093e1bef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4771f822-2d63-4dc0-807b-3b0093e1bef5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_474efd21-2450-4209-a88d-df0faf705e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_474efd21-2450-4209-a88d-df0faf705e7f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1be6b274-dd99-4183-ab77-e5a1cb7c3427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1be6b274-dd99-4183-ab77-e5a1cb7c3427" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_498a450b-35a6-4477-a19e-826d073e84a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_498a450b-35a6-4477-a19e-826d073e84a1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_e537425e-5ebb-4323-9c4c-8d5e9cf0a8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_e537425e-5ebb-4323-9c4c-8d5e9cf0a8e7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_301360a1-f0ae-4db8-a161-1995e1e4c73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_301360a1-f0ae-4db8-a161-1995e1e4c73a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c177dcd5-e18f-4752-8a38-f1218041834f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c177dcd5-e18f-4752-8a38-f1218041834f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_3c43681c-76e0-43fe-8c67-b55dba119b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_3c43681c-76e0-43fe-8c67-b55dba119b22" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_717ca999-8137-42e0-9b3f-5b26ae181b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_717ca999-8137-42e0-9b3f-5b26ae181b9f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c35aa21c-06ec-412c-81af-1622514e7756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c35aa21c-06ec-412c-81af-1622514e7756" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7ddc0f5b-ffd7-42dc-bcd6-56c506de950b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c35aa21c-06ec-412c-81af-1622514e7756" xlink:to="loc_us-gaap_AwardTypeAxis_7ddc0f5b-ffd7-42dc-bcd6-56c506de950b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ddc0f5b-ffd7-42dc-bcd6-56c506de950b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7ddc0f5b-ffd7-42dc-bcd6-56c506de950b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ddc0f5b-ffd7-42dc-bcd6-56c506de950b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46862aa2-851e-4b1e-aec0-a70c0d234a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7ddc0f5b-ffd7-42dc-bcd6-56c506de950b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46862aa2-851e-4b1e-aec0-a70c0d234a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_ad95b574-5c1e-4697-8b9f-ad9e77b79276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46862aa2-851e-4b1e-aec0-a70c0d234a01" xlink:to="loc_us-gaap_StockOptionMember_ad95b574-5c1e-4697-8b9f-ad9e77b79276" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" xlink:type="extended" id="i3a0939b358fd4cd5b8d6c391f2c0b799_STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75309128-10fe-4e4b-ad4e-ec666e68451c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75309128-10fe-4e4b-ad4e-ec666e68451c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_02b75e76-f842-4374-976e-87fe29e5a03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_02b75e76-f842-4374-976e-87fe29e5a03b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d3ecb356-6da4-4195-9349-c0e5553fd437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d3ecb356-6da4-4195-9349-c0e5553fd437" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a082d3c1-0546-40ac-870f-102c6f7cb9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a082d3c1-0546-40ac-870f-102c6f7cb9e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6dbbe537-3ffd-4f16-a657-c4e68477cbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b0d0b8bb-7c62-4388-ac7e-c6aa9243077c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b0d0b8bb-7c62-4388-ac7e-c6aa9243077c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3d12eb1d-81b4-4c97-8bb5-15aab41a28fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3d12eb1d-81b4-4c97-8bb5-15aab41a28fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_09e836e7-0083-46ef-96ab-d46d73828195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_09e836e7-0083-46ef-96ab-d46d73828195" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_486fe248-615c-4349-88fe-dc4e6718485c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_486fe248-615c-4349-88fe-dc4e6718485c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_67c7dd06-b0b1-42cb-b7f6-d3c829c31e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bf42ee4e-ae8a-4e03-aefc-f87a894df58b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bf42ee4e-ae8a-4e03-aefc-f87a894df58b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ada000d8-fc9b-4b2f-83d3-e871c1f9dd88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ada000d8-fc9b-4b2f-83d3-e871c1f9dd88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3ffd069c-e95d-4c6a-b64e-afc632806c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3ffd069c-e95d-4c6a-b64e-afc632806c3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6cd751ed-2a6f-49cd-93e2-1fc74af85a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_ShareBasedCompensation_6cd751ed-2a6f-49cd-93e2-1fc74af85a17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a8fff7fc-4a3b-4e95-bb9f-955be6b8d52d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a8fff7fc-4a3b-4e95-bb9f-955be6b8d52d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_90c1a7eb-d44d-4710-a0d7-45ca1ebbcc40" xlink:href="dgx-20211231.xsd#dgx_Sharebasedcompensationexcesstaxbenefitamount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_90c1a7eb-d44d-4710-a0d7-45ca1ebbcc40" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f17d1c10-32d5-4e02-927b-a53499fda14b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f17d1c10-32d5-4e02-927b-a53499fda14b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e17cd2a4-b41b-4340-9ed6-07107b8e6182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f17d1c10-32d5-4e02-927b-a53499fda14b" xlink:to="loc_us-gaap_AwardTypeAxis_e17cd2a4-b41b-4340-9ed6-07107b8e6182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e17cd2a4-b41b-4340-9ed6-07107b8e6182_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e17cd2a4-b41b-4340-9ed6-07107b8e6182" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e17cd2a4-b41b-4340-9ed6-07107b8e6182_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da5b4e35-60f0-4790-a952-454bfcaedff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e17cd2a4-b41b-4340-9ed6-07107b8e6182" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da5b4e35-60f0-4790-a952-454bfcaedff9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockAwardsMember_56bf1b01-7b77-416f-b0fc-32b50dd38e25" xlink:href="dgx-20211231.xsd#dgx_StockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da5b4e35-60f0-4790-a952-454bfcaedff9" xlink:to="loc_dgx_StockAwardsMember_56bf1b01-7b77-416f-b0fc-32b50dd38e25" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" xlink:type="extended" id="ib3b2dc2278ca44f5af7f196a5a6d3b44_STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_198e50e5-716c-40af-b1f8-b6c3b2bf447e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_198e50e5-716c-40af-b1f8-b6c3b2bf447e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_26ca64b2-ad70-4415-b0cc-97449d34ce9d" xlink:href="dgx-20211231.xsd#dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_26ca64b2-ad70-4415-b0cc-97449d34ce9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b98e7420-d24a-45bb-86f4-1e0f78ff9138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b98e7420-d24a-45bb-86f4-1e0f78ff9138" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_08cd49cd-529b-4595-ac41-f23ecead4c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_08cd49cd-529b-4595-ac41-f23ecead4c8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_8ed6c89c-c64e-4a7a-a03c-6b4ade2f3f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_8ed6c89c-c64e-4a7a-a03c-6b4ade2f3f14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_67eade26-9d9a-4fe9-b8db-2add75d14686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_67eade26-9d9a-4fe9-b8db-2add75d14686" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e7573eb-9e7b-44cd-85d0-91e5d51f94a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e7573eb-9e7b-44cd-85d0-91e5d51f94a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fec454b1-dd52-4a61-9e91-b10e1dec1805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e7573eb-9e7b-44cd-85d0-91e5d51f94a2" xlink:to="loc_us-gaap_AwardTypeAxis_fec454b1-dd52-4a61-9e91-b10e1dec1805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fec454b1-dd52-4a61-9e91-b10e1dec1805_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_fec454b1-dd52-4a61-9e91-b10e1dec1805" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fec454b1-dd52-4a61-9e91-b10e1dec1805_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_667b18f0-ba71-47d3-9ef0-41b5a3d1023e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_fec454b1-dd52-4a61-9e91-b10e1dec1805" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_667b18f0-ba71-47d3-9ef0-41b5a3d1023e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_9150767b-b324-4fcc-a5e1-a8c6b4e24412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_667b18f0-ba71-47d3-9ef0-41b5a3d1023e" xlink:to="loc_us-gaap_EmployeeStockMember_9150767b-b324-4fcc-a5e1-a8c6b4e24412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e20b48ed-fd65-4a12-b306-2185dd25db71" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e7573eb-9e7b-44cd-85d0-91e5d51f94a2" xlink:to="loc_srt_RangeAxis_e20b48ed-fd65-4a12-b306-2185dd25db71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e20b48ed-fd65-4a12-b306-2185dd25db71_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e20b48ed-fd65-4a12-b306-2185dd25db71" xlink:to="loc_srt_RangeMember_e20b48ed-fd65-4a12-b306-2185dd25db71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_305e3c43-bcee-4872-83ec-b91a7850607d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e20b48ed-fd65-4a12-b306-2185dd25db71" xlink:to="loc_srt_RangeMember_305e3c43-bcee-4872-83ec-b91a7850607d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0b24c40f-2508-4af6-a12b-878dde775024" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_305e3c43-bcee-4872-83ec-b91a7850607d" xlink:to="loc_srt_MaximumMember_0b24c40f-2508-4af6-a12b-878dde775024" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" xlink:type="extended" id="i963ed9adcd3a4794a6b86dc180f3ebe7_STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_3aed691a-1cd3-41c4-a53f-0f01d5bf33e5" xlink:href="dgx-20211231.xsd#dgx_SupplementalDeferredCompensationPlanSalaryDeferral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_3aed691a-1cd3-41c4-a53f-0f01d5bf33e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_115b3fd7-83d2-4228-9252-53515a2ab2db" xlink:href="dgx-20211231.xsd#dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_115b3fd7-83d2-4228-9252-53515a2ab2db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_24a8f8dc-acc6-4340-a8de-525f6b57a3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_24a8f8dc-acc6-4340-a8de-525f6b57a3f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_daaa320d-cd90-4a03-9472-4e812858344a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_daaa320d-cd90-4a03-9472-4e812858344a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_965a072c-2373-4311-92ce-981d59db6d19" xlink:href="dgx-20211231.xsd#dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_965a072c-2373-4311-92ce-981d59db6d19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_42ea194f-360d-4e3a-b646-2be1de3317c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_42ea194f-360d-4e3a-b646-2be1de3317c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_2adc9a98-0b4e-40bc-aa1c-d0b0c07b8334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_2adc9a98-0b4e-40bc-aa1c-d0b0c07b8334" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiGradedVestingPercentage_7f5872ee-c297-4eb6-be1b-58d57bb222ce" xlink:href="dgx-20211231.xsd#dgx_SdcpIiGradedVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_dgx_SdcpIiGradedVestingPercentage_7f5872ee-c297-4eb6-be1b-58d57bb222ce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_c0b6607f-706d-4b73-9932-6b6aeb06e2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_c0b6607f-706d-4b73-9932-6b6aeb06e2b4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_f8a25533-856d-4295-aed4-2821bc1d7167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_f8a25533-856d-4295-aed4-2821bc1d7167" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_3458665a-04c4-43e9-b8ac-32d5bb6d4e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_f8a25533-856d-4295-aed4-2821bc1d7167" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_3458665a-04c4-43e9-b8ac-32d5bb6d4e50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_3458665a-04c4-43e9-b8ac-32d5bb6d4e50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_3458665a-04c4-43e9-b8ac-32d5bb6d4e50" xlink:to="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_3458665a-04c4-43e9-b8ac-32d5bb6d4e50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_cf4a0568-943c-4b7d-bae4-3d96baa4c7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_3458665a-04c4-43e9-b8ac-32d5bb6d4e50" xlink:to="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_cf4a0568-943c-4b7d-bae4-3d96baa4c7c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanMember_2d9dbe5b-eaa6-48ab-8e53-471e739f8bc4" xlink:href="dgx-20211231.xsd#dgx_SupplementalDeferredCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_cf4a0568-943c-4b7d-bae4-3d96baa4c7c8" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanMember_2d9dbe5b-eaa6-48ab-8e53-471e739f8bc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiMember_90aee030-4408-4872-9071-f0345b91fb88" xlink:href="dgx-20211231.xsd#dgx_SdcpIiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_cf4a0568-943c-4b7d-bae4-3d96baa4c7c8" xlink:to="loc_dgx_SdcpIiMember_90aee030-4408-4872-9071-f0345b91fb88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ee7c9a2b-57df-4864-938a-2b0f06dbddb0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_f8a25533-856d-4295-aed4-2821bc1d7167" xlink:to="loc_srt_RangeAxis_ee7c9a2b-57df-4864-938a-2b0f06dbddb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ee7c9a2b-57df-4864-938a-2b0f06dbddb0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ee7c9a2b-57df-4864-938a-2b0f06dbddb0" xlink:to="loc_srt_RangeMember_ee7c9a2b-57df-4864-938a-2b0f06dbddb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_deb0af5f-eb94-4c57-beb1-ca5020308253" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ee7c9a2b-57df-4864-938a-2b0f06dbddb0" xlink:to="loc_srt_RangeMember_deb0af5f-eb94-4c57-beb1-ca5020308253" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_921ac258-5d68-439f-b0ba-465259304727" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_deb0af5f-eb94-4c57-beb1-ca5020308253" xlink:to="loc_srt_MaximumMember_921ac258-5d68-439f-b0ba-465259304727" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="if34455c2a8714216b06f30ccf18699cb_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e2e35128-1b23-48e7-ad1c-ccff1b923da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e2e35128-1b23-48e7-ad1c-ccff1b923da5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_7355842a-aa75-4b46-abbe-f1d1f31db2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_7355842a-aa75-4b46-abbe-f1d1f31db2e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_7a3a023b-3be9-453f-a853-437d480540da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_7a3a023b-3be9-453f-a853-437d480540da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_5613b66b-fb73-49ca-bb76-926eda7bef1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_5613b66b-fb73-49ca-bb76-926eda7bef1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_b27fb773-f0b0-4570-9a1a-1d2b8868f64a" xlink:href="dgx-20211231.xsd#dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_b27fb773-f0b0-4570-9a1a-1d2b8868f64a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction_c3708ff2-4aef-4eb9-add4-230acb31c192" xlink:href="dgx-20211231.xsd#dgx_AgreementtoOutsourceBillingandCollectionFunction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction_c3708ff2-4aef-4eb9-add4-230acb31c192" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum_dee17ee7-32a6-4e93-85eb-be0ce719d751" xlink:href="dgx-20211231.xsd#dgx_RemainingTermsofContingentLeaseObligationsMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum_dee17ee7-32a6-4e93-85eb-be0ce719d751" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_54dc82c6-1699-43c7-9919-05449b39446d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_54dc82c6-1699-43c7-9919-05449b39446d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_11f2c2dc-7337-441b-ab90-78b59f05e499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_LitigationReserve_11f2c2dc-7337-441b-ab90-78b59f05e499" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_ba3b9faa-6d44-4ce8-a9f7-e5a7f65218a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_ba3b9faa-6d44-4ce8-a9f7-e5a7f65218a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ec1cef21-6f8e-44ec-825b-9d520dabafea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ec1cef21-6f8e-44ec-825b-9d520dabafea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ec1cef21-6f8e-44ec-825b-9d520dabafea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ec1cef21-6f8e-44ec-825b-9d520dabafea" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ec1cef21-6f8e-44ec-825b-9d520dabafea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4d7e8f69-d1e2-440f-800f-5113bf58bc77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ec1cef21-6f8e-44ec-825b-9d520dabafea" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4d7e8f69-d1e2-440f-800f-5113bf58bc77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_6136d4e7-eeef-43df-8a24-56367490261d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4d7e8f69-d1e2-440f-800f-5113bf58bc77" xlink:to="loc_us-gaap_SecuredDebtMember_6136d4e7-eeef-43df-8a24-56367490261d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_92d6a8cd-26e8-4027-9b88-5b46a5112b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:to="loc_us-gaap_CreditFacilityAxis_92d6a8cd-26e8-4027-9b88-5b46a5112b2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_92d6a8cd-26e8-4027-9b88-5b46a5112b2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_92d6a8cd-26e8-4027-9b88-5b46a5112b2b" xlink:to="loc_us-gaap_CreditFacilityDomain_92d6a8cd-26e8-4027-9b88-5b46a5112b2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_65265c49-9d4b-48ef-9dae-1e781fb81342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_92d6a8cd-26e8-4027-9b88-5b46a5112b2b" xlink:to="loc_us-gaap_CreditFacilityDomain_65265c49-9d4b-48ef-9dae-1e781fb81342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_95a2c2de-7152-467b-88e0-15362f47f249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_65265c49-9d4b-48ef-9dae-1e781fb81342" xlink:to="loc_us-gaap_LetterOfCreditMember_95a2c2de-7152-467b-88e0-15362f47f249" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0468f44d-6964-403a-8392-e986abd29077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:to="loc_us-gaap_DebtInstrumentAxis_0468f44d-6964-403a-8392-e986abd29077" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0468f44d-6964-403a-8392-e986abd29077_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0468f44d-6964-403a-8392-e986abd29077" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0468f44d-6964-403a-8392-e986abd29077_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_10f4ffce-eb02-48a3-b073-c60e23339850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0468f44d-6964-403a-8392-e986abd29077" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_10f4ffce-eb02-48a3-b073-c60e23339850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_5d825581-2ba0-4d95-bebc-63f9fb909d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_10f4ffce-eb02-48a3-b073-c60e23339850" xlink:to="loc_us-gaap_LetterOfCreditMember_5d825581-2ba0-4d95-bebc-63f9fb909d0c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended" id="id8b87c6169014187bacc733b6c3e8cf1_BUSINESSSEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_ac128f84-78f1-494d-bb44-58fbc919dac3" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_dgx_PercentageofNetRevenues_ac128f84-78f1-494d-bb44-58fbc919dac3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2746c6ba-b9b3-4cc3-9f09-a3102b9c466b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2746c6ba-b9b3-4cc3-9f09-a3102b9c466b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e6dd8107-0345-403f-b96d-d8d6e96b6e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_OperatingIncomeLoss_e6dd8107-0345-403f-b96d-d8d6e96b6e9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_dd3f9e44-57aa-46d6-a598-1e3113c94078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_dd3f9e44-57aa-46d6-a598-1e3113c94078" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1855a266-36de-417e-819d-35395aa4b460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1855a266-36de-417e-819d-35395aa4b460" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e9a37484-514c-4628-a887-38a6ac7afe63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e9a37484-514c-4628-a887-38a6ac7afe63" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_39c0c7ac-dcb6-4573-b12e-167af569c306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_39c0c7ac-dcb6-4573-b12e-167af569c306" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_73b43119-fdf1-4bee-8ee4-5d20bfa073d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_73b43119-fdf1-4bee-8ee4-5d20bfa073d4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_afed0fcd-c6e8-41da-9b62-4c11cee76a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_afed0fcd-c6e8-41da-9b62-4c11cee76a83" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_aac53484-0f71-4eea-85db-47a5237aec2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_ProfitLoss_aac53484-0f71-4eea-85db-47a5237aec2b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4b53e3e-3efd-4d05-9a26-738a4fae9b79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4b53e3e-3efd-4d05-9a26-738a4fae9b79" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_76318134-bd8c-4e1c-ad7f-e0d75ee49246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_NetIncomeLoss_76318134-bd8c-4e1c-ad7f-e0d75ee49246" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_684066a1-01c5-409a-a580-14e0e1a68f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_684066a1-01c5-409a-a580-14e0e1a68f4d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5091e68d-1b4e-4ae1-8566-c09594349b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5091e68d-1b4e-4ae1-8566-c09594349b3e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3956b43c-7dfa-410d-a583-2f968e5a9187" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:to="loc_srt_RangeAxis_3956b43c-7dfa-410d-a583-2f968e5a9187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3956b43c-7dfa-410d-a583-2f968e5a9187_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3956b43c-7dfa-410d-a583-2f968e5a9187" xlink:to="loc_srt_RangeMember_3956b43c-7dfa-410d-a583-2f968e5a9187_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59a4279c-e4ed-4505-b994-a9b5f65856b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3956b43c-7dfa-410d-a583-2f968e5a9187" xlink:to="loc_srt_RangeMember_59a4279c-e4ed-4505-b994-a9b5f65856b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_220f9546-96f9-4334-84e8-982d2709ebba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_59a4279c-e4ed-4505-b994-a9b5f65856b5" xlink:to="loc_srt_MinimumMember_220f9546-96f9-4334-84e8-982d2709ebba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9cd502b3-cc2c-4c54-8f75-12b5dbf5fc51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9cd502b3-cc2c-4c54-8f75-12b5dbf5fc51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9cd502b3-cc2c-4c54-8f75-12b5dbf5fc51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9cd502b3-cc2c-4c54-8f75-12b5dbf5fc51" xlink:to="loc_us-gaap_SegmentDomain_9cd502b3-cc2c-4c54-8f75-12b5dbf5fc51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_49c4ce51-bef9-4cd5-9062-77e5b5805661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9cd502b3-cc2c-4c54-8f75-12b5dbf5fc51" xlink:to="loc_us-gaap_SegmentDomain_49c4ce51-bef9-4cd5-9062-77e5b5805661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_8ffbdb86-f109-4500-b9a1-fbbad4768c00" xlink:href="dgx-20211231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_49c4ce51-bef9-4cd5-9062-77e5b5805661" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_8ffbdb86-f109-4500-b9a1-fbbad4768c00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_23144612-a852-4690-90ec-27ed39b9724e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_49c4ce51-bef9-4cd5-9062-77e5b5805661" xlink:to="loc_us-gaap_AllOtherSegmentsMember_23144612-a852-4690-90ec-27ed39b9724e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_e7d73b2d-963f-470e-81c8-48819c73d642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_49c4ce51-bef9-4cd5-9062-77e5b5805661" xlink:to="loc_us-gaap_CorporateMember_e7d73b2d-963f-470e-81c8-48819c73d642" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5c88b02b-f8be-414a-83d0-d8e5e3b625cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:to="loc_srt_ProductOrServiceAxis_5c88b02b-f8be-414a-83d0-d8e5e3b625cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5c88b02b-f8be-414a-83d0-d8e5e3b625cd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5c88b02b-f8be-414a-83d0-d8e5e3b625cd" xlink:to="loc_srt_ProductsAndServicesDomain_5c88b02b-f8be-414a-83d0-d8e5e3b625cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5c88b02b-f8be-414a-83d0-d8e5e3b625cd" xlink:to="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_9cdac503-0474-46da-888c-a0c45f316690" xlink:href="dgx-20211231.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_9cdac503-0474-46da-888c-a0c45f316690" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_f9472e8c-79bf-4e4b-b573-2110e1379466" xlink:href="dgx-20211231.xsd#dgx_COVID19TestingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:to="loc_dgx_COVID19TestingServicesMember_f9472e8c-79bf-4e4b-b573-2110e1379466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_1cc94a6a-0754-4402-a7c4-0a82b4e7bdc4" xlink:href="dgx-20211231.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_1cc94a6a-0754-4402-a7c4-0a82b4e7bdc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_74059254-b997-4d1e-a966-eab370af0962" xlink:href="dgx-20211231.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_74059254-b997-4d1e-a966-eab370af0962" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_952d1ead-ceb5-49d3-9fab-eacf1f662640" xlink:href="dgx-20211231.xsd#dgx_AllotherservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:to="loc_dgx_AllotherservicesMember_952d1ead-ceb5-49d3-9fab-eacf1f662640" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DISCONTINUEDOPERATIONSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="extended" id="i595c6cd85ae641ebacf2960a2b1b95b0_DISCONTINUEDOPERATIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d9e00a62-9458-4c6c-b2fa-7c0d9c377fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_73b60d31-53f7-4025-94a2-39db07d85f87" xlink:href="dgx-20211231.xsd#dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d9e00a62-9458-4c6c-b2fa-7c0d9c377fa5" xlink:to="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_73b60d31-53f7-4025-94a2-39db07d85f87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_c440b40f-f8bb-415f-9cc9-772395e81968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d9e00a62-9458-4c6c-b2fa-7c0d9c377fa5" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_c440b40f-f8bb-415f-9cc9-772395e81968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_16e67455-b9c0-48e6-a883-75f454d56c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d9e00a62-9458-4c6c-b2fa-7c0d9c377fa5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_16e67455-b9c0-48e6-a883-75f454d56c44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a118ba52-7498-4bf5-a949-642f6245d0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_16e67455-b9c0-48e6-a883-75f454d56c44" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a118ba52-7498-4bf5-a949-642f6245d0ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a118ba52-7498-4bf5-a949-642f6245d0ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a118ba52-7498-4bf5-a949-642f6245d0ae" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a118ba52-7498-4bf5-a949-642f6245d0ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_04456ade-b080-46f6-abe7-f953aa5ff11a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a118ba52-7498-4bf5-a949-642f6245d0ae" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_04456ade-b080-46f6-abe7-f953aa5ff11a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NidMember_a1e337d0-0838-4b8d-89b6-eb898741a293" xlink:href="dgx-20211231.xsd#dgx_NidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_04456ade-b080-46f6-abe7-f953aa5ff11a" xlink:to="loc_dgx_NidMember_a1e337d0-0838-4b8d-89b6-eb898741a293" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended" id="i14347a13d1e84226a48170b9ff669c90_SUBSEQUENTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_37453094-ad3f-4420-ac40-083d3537f52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_553eb3fd-7f17-42bd-93a8-cce924ecc145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_37453094-ad3f-4420-ac40-083d3537f52c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_553eb3fd-7f17-42bd-93a8-cce924ecc145" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_83817851-827e-4419-b563-df1eb9987dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_37453094-ad3f-4420-ac40-083d3537f52c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_83817851-827e-4419-b563-df1eb9987dc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a2911163-4817-40ca-a9d5-6649c879696f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_37453094-ad3f-4420-ac40-083d3537f52c" xlink:to="loc_us-gaap_SubsequentEventTable_a2911163-4817-40ca-a9d5-6649c879696f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fdee4749-28ee-452b-9c9b-7c6b04e233c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a2911163-4817-40ca-a9d5-6649c879696f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fdee4749-28ee-452b-9c9b-7c6b04e233c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fdee4749-28ee-452b-9c9b-7c6b04e233c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fdee4749-28ee-452b-9c9b-7c6b04e233c1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fdee4749-28ee-452b-9c9b-7c6b04e233c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ded9a45c-74a3-44d8-95d0-a49904e144a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fdee4749-28ee-452b-9c9b-7c6b04e233c1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ded9a45c-74a3-44d8-95d0-a49904e144a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5932f556-bb57-4844-8951-58950497459a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ded9a45c-74a3-44d8-95d0-a49904e144a0" xlink:to="loc_us-gaap_SubsequentEventMember_5932f556-bb57-4844-8951-58950497459a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bdd65294-4495-4524-a49d-45ef1553d35a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a2911163-4817-40ca-a9d5-6649c879696f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bdd65294-4495-4524-a49d-45ef1553d35a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdd65294-4495-4524-a49d-45ef1553d35a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bdd65294-4495-4524-a49d-45ef1553d35a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdd65294-4495-4524-a49d-45ef1553d35a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62e83c44-aaa9-4ce7-8268-1741257f8d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bdd65294-4495-4524-a49d-45ef1553d35a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62e83c44-aaa9-4ce7-8268-1741257f8d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCMember_ccf4e386-632d-4dcf-bc37-9fac31a16144" xlink:href="dgx-20211231.xsd#dgx_PackHealthLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62e83c44-aaa9-4ce7-8268-1741257f8d48" xlink:to="loc_dgx_PackHealthLLCMember_ccf4e386-632d-4dcf-bc37-9fac31a16144" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#ScheduleIIValuationAccountsandReservesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails" xlink:type="extended" id="i4a30eb4be0fc40d2b7039dd919889f0f_ScheduleIIValuationAccountsandReservesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_240da7cc-cc55-4324-8b9c-89b54485faac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_240da7cc-cc55-4324-8b9c-89b54485faac" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_4727fec2-732c-441d-bbd7-cf007df84184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_4727fec2-732c-441d-bbd7-cf007df84184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1c20005c-da4c-428e-b93f-b70b451aca71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1c20005c-da4c-428e-b93f-b70b451aca71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_68f6b9cb-d99f-414b-a0df-c6b7e9303701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_68f6b9cb-d99f-414b-a0df-c6b7e9303701" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_a9fadb92-cc60-4055-8eec-e95743568320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7dfa3d9e-9d92-43ea-87fa-9fb19c9208cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_240da7cc-cc55-4324-8b9c-89b54485faac" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7dfa3d9e-9d92-43ea-87fa-9fb19c9208cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_46507946-4157-491e-9932-39e9906e4698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7dfa3d9e-9d92-43ea-87fa-9fb19c9208cb" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_46507946-4157-491e-9932-39e9906e4698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_46507946-4157-491e-9932-39e9906e4698_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_46507946-4157-491e-9932-39e9906e4698" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_46507946-4157-491e-9932-39e9906e4698_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_f8d1fbe5-bb74-4e9d-a018-49f75ca6a742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_46507946-4157-491e-9932-39e9906e4698" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_f8d1fbe5-bb74-4e9d-a018-49f75ca6a742" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_1cf173a0-647e-4cbe-8f31-3701320a6c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_f8d1fbe5-bb74-4e9d-a018-49f75ca6a742" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_1cf173a0-647e-4cbe-8f31-3701320a6c54" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>dgx-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c829db2e-c850-44b9-90d1-7027e34dc7fe,g:892aaabe-58ca-45ff-95da-140e039c9f49-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_cfa701ad-68c1-41b8-8754-bf0f44ed1065_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Changes in Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_6e50d423-92aa-47a0-b6d2-f2b26f018619_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bf01b191-095f-451d-a233-7896a813d34b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_0893b698-f48b-49c0-9339-ac4520116ac1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current state and local income tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_25dbbf46-a99d-4986-b54f-8d95b8d40dda_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_b42f99d6-883a-40b5-bb8c-fce6af98d280_totalLabel_en-US" xlink:label="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_label_en-US" xlink:label="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, Estimated amortization expense, total</link:label>
    <link:label id="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_documentation_en-US" xlink:label="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, estimated amortization expense, total.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:href="dgx-20211231.xsd#dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:to="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_8d8819f7-0201-40a8-ac04-5c908d47fdf3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_0db6540c-bd70-42c4-889f-fcf64a6be09c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Subject To Amortization</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dbb5f9ff-cd3c-4db5-9df4-b59a33d99ed8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to provision true-ups</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_3dd69d4e-e588-4920-897f-37d65a061e7d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_510d76d3-47db-474a-b665-e1a12aa3fc62_terseLabel_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric (including advanced diagnostics) testing services</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_label_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_documentation_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:href="dgx-20211231.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:to="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_170544e6-69b3-4cfb-a5cc-aca16e24bf6d_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_24a6ccc8-622f-4ccd-8f1c-d6f086d765ec_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d94adc4c-4e69-48bb-8c48-d115e3b1e5c0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares forfeited and cancelled weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6f6edf4c-ceb0-4925-91bc-a233d72554fa_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term, Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_10e0097d-23ca-40b3-b8f2-0c235464943e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LeaseRenewalTerm_aa649ae2-6d5c-41f7-a7fe-b7f7c92890aa_terseLabel_en-US" xlink:label="lab_dgx_LeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_dgx_LeaseRenewalTerm_label_en-US" xlink:label="lab_dgx_LeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Renewal Term</link:label>
    <link:label id="lab_dgx_LeaseRenewalTerm_documentation_en-US" xlink:label="lab_dgx_LeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRenewalTerm" xlink:href="dgx-20211231.xsd#dgx_LeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LeaseRenewalTerm" xlink:to="lab_dgx_LeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_918bc34b-7e02-4d0e-8b92-32e80a50d28b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_d8629088-2a1d-447c-b7b3-7cce39d16960_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_e8e6f85a-bf22-44e5-93ca-349c28b26012_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_e70c03f7-9ec4-4839-ae0f-6571f0fd1af0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e22ec86f-4e9f-40da-8dde-bf529483f642_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_72e7eee2-29dd-4b02-8f95-9337de1fcafc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_312935b6-681b-470c-bb84-6e76fca0b407_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_165b8b83-0949-4bfb-ab16-0f4d1c97b87e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (gains)/losses included in earnings - realized/unrealized</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9d1953a7-25e0-499e-8db3-db1b8f1aa649_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (gains)/losses included in earnings - realized/unrealized</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_01aa09f8-8227-4b53-a3ee-63275c19d0c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6ddd06c8-2049-4e77-991c-ecac70e02c26_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtfull accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_0b8b6be0-f915-4ed9-9a56-f2604dbf7c8d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_3f76b201-6fcf-4cae-a12b-6fa1ffd4043a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_cc64f32b-1e88-44a7-83e4-b9c02479234b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_8a3c3f3e-6504-450a-9e29-3b2237c07243_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c3746bc1-3fb6-4e00-b4e1-8f7e23dd9501_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_d92ceed0-8c62-46f8-8846-26747921e5ea_terseLabel_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Other</link:label>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unclassified Indefinite-lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_85db2098-f0ca-4065-93ec-63b6d44b4a2c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_972847aa-9473-4620-9cb3-06e1ef72851b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate, Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f94a9e7e-bafa-4eec-b871-5e21db32f8d0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units not included due to their antidilutive effect</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_8464a7cc-6263-4880-acf1-ef2952031894_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II vesting period</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_e3312f7c-00c7-4bfb-bbc9-d58f7975e6b8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_f22ecfea-022f-42cd-a66e-d768c8b57119_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_15c1e16e-1043-4b84-9067-78351daec468_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of Hedged Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_9e4ca119-cb80-410d-8a90-da445d0f6a1a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_c6e46426-06a2-4e4e-bd3e-cfeac9dcefb9_terseLabel_en-US" xlink:label="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual life of stock options and other awards under the shared-based compensation plans</link:label>
    <link:label id="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_label_en-US" xlink:label="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual life of stock options and other awards under the Shared-based compensation plans</link:label>
    <link:label id="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_documentation_en-US" xlink:label="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual life of stock options and other awards under the Shared-based compensation plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:href="dgx-20211231.xsd#dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:to="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b482b37c-b785-4df7-9afc-bbb9dc2592af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aa9f7913-151a-437d-9a6e-ea7ea627ea4b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future amortization expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e327bd66-c988-4247-96c2-d833316750cc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_a1272ab2-c881-41c0-b4e7-bb5545163c16_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_79cc362d-1fc2-4c25-a798-faba279f4a62_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of year shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_3e9374e8-cf55-4425-8401-10ca6f7f63e6_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant change in unrecognized tax benefits is reasonably possible, estimated range of change, upper bound</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1c2f52a9-7ac0-42b3-855a-886cd7669338_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_69a9c763-32f1-423c-95ba-9b8d9c44205c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CapitatedMember_55138d88-4715-4c20-8a66-f6bee716b424_terseLabel_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated</link:label>
    <link:label id="lab_dgx_CapitatedMember_label_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:label id="lab_dgx_CapitatedMember_documentation_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember" xlink:href="dgx-20211231.xsd#dgx_CapitatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CapitatedMember" xlink:to="lab_dgx_CapitatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c325deaa-be60-4c1d-8a4e-8bee130e556f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_bbe8cafe-c67e-4645-85bc-d47ddf9649b5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_1218034d-9c16-4182-8fe4-6f07abd393a5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_9dda8253-9d01-44d1-b282-39a2bea4e97f_terseLabel_en-US" xlink:label="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.45% Senior Notes due June 2026</link:label>
    <link:label id="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_label_en-US" xlink:label="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Four Five Percent Senior Notes due June 2026 [Member]</link:label>
    <link:label id="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_documentation_en-US" xlink:label="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Four Five Percent Senior Notes due June 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:href="dgx-20211231.xsd#dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:to="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_6e54152a-44bc-44f7-bbcd-89ebbf87923b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends received from equity method investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_96868aea-5c69-4121-9939-3b2896a5ca94_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_5e16c4f5-ad1b-44f9-9ea9-dca081b39766_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9c985adc-e81f-4d31-855f-d5f7066306e9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_f5537e68-4960-4c27-b24f-fde89ed43c2e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_850acc4e-cdce-4f9f-8050-67b0a829c580_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_342929fb-642e-40a3-9a52-c9bf5b5e7aef_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_28dd7577-9275-4452-8987-36c94cb6f446_terseLabel_en-US" xlink:label="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_documentation_en-US" xlink:label="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:href="dgx-20211231.xsd#dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:to="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_0997957f-990d-4598-be74-86adf4f5a28a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_67276563-86be-4417-bc83-dfb721ff377f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_b0a73cce-bb42-438e-ae8d-4b5f5ac65cb0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2ac2d752-5c2f-41eb-8f85-d92325cbec08_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanMember_182aa2cf-fc53-4bbd-a603-f926350f9b81_terseLabel_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Deferred Compensation Plan</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanMember_label_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Deferred Compensation Plan [Member]</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanMember_documentation_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Deferred Compensation Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanMember" xlink:href="dgx-20211231.xsd#dgx_SupplementalDeferredCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalDeferredCompensationPlanMember" xlink:to="lab_dgx_SupplementalDeferredCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_7e0b8a29-5b4d-43d4-8580-0b251849f6d7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGNITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_2ec99044-f95d-492b-9c60-3da3da4455ee_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired from acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_0c2ea24a-f0d6-4da2-ab06-7a7c89d08057_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2ab62373-34ae-4cb7-ac90-974ef12e5acd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, beginning of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1a66aa7b-6b48-4b33-86f9-9dcc10ec01dc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, end of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cf9b94bd-2f55-43bf-9802-35b093b7a1cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bdd3f60e-d13d-48fd-893b-715f50d6c625_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_525450e7-6838-45d8-82e1-d260375c6d13_terseLabel_en-US" xlink:label="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comparable Company Revenue Volatility</link:label>
    <link:label id="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_label_en-US" xlink:label="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Comparable Company Revenue Volatility [Member]</link:label>
    <link:label id="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_documentation_en-US" xlink:label="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Comparable Company Revenue Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:href="dgx-20211231.xsd#dgx_MeasurementInputComparableCompanyRevenueVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:to="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c74700c5-af31-423b-a8b4-06777d597849_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_a2274cd9-36fa-4efb-b7ee-7220268cfbf0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_db139552-87fa-404c-932b-01e7bb088fda_terseLabel_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of ownership interest sold</link:label>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_label_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percent Disposed Of</link:label>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_documentation_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percent Disposed Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:href="dgx-20211231.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:to="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_4ba536f9-ed22-444d-88e1-2dc0b5b07282_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_2493c113-87d6-45bb-9c93-6fedf2a3114e_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCHEDULE II - VALUATION ACCOUNTS AND RESERVES</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_c4476bae-89ad-4b9b-8e70-165d002401ec_terseLabel_en-US" xlink:label="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable reserves</link:label>
    <link:label id="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_label_en-US" xlink:label="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Receivables</link:label>
    <link:label id="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_documentation_en-US" xlink:label="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:href="dgx-20211231.xsd#dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:to="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_a7548d04-f3ce-4265-85c6-4046007d8d44_terseLabel_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration payable</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_label_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_documentation_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:href="dgx-20211231.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:to="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_8e6cd5f7-2809-4961-b6ff-c0cec33ff15f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_3f7a499c-2ac6-4809-bdc2-614d32fd904c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_46bf1a06-19c5-4077-8e57-c9cdf4aaabe7_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_19f136cf-8821-442d-9ac7-fa6cf4691069_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation, 2022</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_3c331fcd-390d-49a8-8353-660494d65b4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax liability - depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_dd9a91f0-2dd8-43d8-b611-9c4c54521fe3_terseLabel_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_label_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_documentation_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:href="dgx-20211231.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:to="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_eac3affa-c631-46a9-a2ea-1b598bd308a2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_c8746bf8-7434-429a-9d64-06b61d0d7f6a_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_cd4d31bb-9b1f-48b0-a68b-7c357c4edfed_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_57b76cfb-35fe-4063-94b1-6e4a60e3380c_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_b8b5ed4f-9600-4f03-9d70-f368c2ef950d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7df5972a-0be1-456e-b050-6ffee04537a2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_26efca42-69f0-41a8-aa5f-a2c9c88b81e7_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net accounts receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_label_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_documentation_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetAccountsReceivable" xlink:to="lab_dgx_PercentageofNetAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_bb1fe996-281a-4569-b9d4-a0465c1fb862_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_5bda1a7e-1f20-47a3-b8ee-b38a5eb9286f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6076cd51-eedf-432b-9a5f-20e3d3f1a272_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_eacf340f-d322-4d4d-90db-7c300cdc2b00_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_2f7cecc6-e5a2-4671-9413-f26c4e4c9429_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_3b34c49e-7f2c-4cc5-8152-6e0011bc5322_terseLabel_en-US" xlink:label="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment and Furniture and Fixtures</link:label>
    <link:label id="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_label_en-US" xlink:label="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment And Furniture And Fixtures [Member]</link:label>
    <link:label id="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_documentation_en-US" xlink:label="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment and furniture and fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:href="dgx-20211231.xsd#dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:to="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_97a70bc8-811f-4eab-856e-a366664e315b_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_b8ab2185-2228-4016-b7ef-2aae8259e10d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete Agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61be3428-d706-4923-93f3-40bf77b3be3c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_028984d1-20e2-453b-b7a4-337a569f22af_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_df099856-b1c7-4d10-b1c4-6f0d16b0ca13_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_67629cbb-44d5-4acd-bbb1-1576d3c3351c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1e9525db-5ca6-4fdc-8079-b81142e840a2_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_bd549758-f744-48b6-a9eb-7a65fd934257_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_1a5b0410-9d18-4f19-9e18-8bde32896b86_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading equity securities gain or (loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_f7cc423e-8c1d-44f4-9e50-d87ec4888d0f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d5ed878e-23a2-4fca-95a2-20ab075e6106_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_638842c7-4311-40a8-9564-d31ba6e0417a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_69bedf3a-6ed0-4941-8bf8-4f2e6e9d6c4f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c066aaf5-d7ac-4091-b827-a241f5f3264c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, value</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock_42a7ee93-60f1-447b-8a56-0b713917467e_terseLabel_en-US" xlink:label="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</link:label>
    <link:label id="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses Policy [Policy Text Block]</link:label>
    <link:label id="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:href="dgx-20211231.xsd#dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:to="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b417307b-ba4a-4237-80d4-fa3f4716c85e_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_55f72433-f896-4abb-884f-a4a154968984_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration arrangements</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_008dbf82-ce29-4952-9cac-de8d1b9d2457_terseLabel_en-US" xlink:label="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.80% Senior Notes due June 2031</link:label>
    <link:label id="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_label_en-US" xlink:label="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Eight Zero Percent Senior Notes due June 2031 [Member]</link:label>
    <link:label id="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_documentation_en-US" xlink:label="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Eight Zero Percent Senior Notes due June 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:href="dgx-20211231.xsd#dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:to="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_81375054-f4de-4120-ba8a-481746d06fce_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0d699610-9ff5-4b1a-9f3c-a62465dc51d6_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DSBusinessesMember_a5d5a445-0d33-4ee0-8a98-94ec05e0607e_terseLabel_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_label_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_documentation_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember" xlink:href="dgx-20211231.xsd#dgx_DSBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DSBusinessesMember" xlink:to="lab_dgx_DSBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_fb4bfa6b-e26c-4e26-87dd-f085eb368dc3_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_e043d2d7-7159-45cc-8825-28cc61afe73b_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_c26bb6d3-e674-4790-90da-15de62763d17_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_4d556d70-bc67-4aba-949b-32a85c50bd95_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PeriodofBillingFullyReserve_aef5c626-6c6e-4b8c-8445-1694c140933f_terseLabel_en-US" xlink:label="lab_dgx_PeriodofBillingFullyReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of billing fully reserve</link:label>
    <link:label id="lab_dgx_PeriodofBillingFullyReserve_label_en-US" xlink:label="lab_dgx_PeriodofBillingFullyReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of Billing Fully Reserve</link:label>
    <link:label id="lab_dgx_PeriodofBillingFullyReserve_documentation_en-US" xlink:label="lab_dgx_PeriodofBillingFullyReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of Billing Fully Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PeriodofBillingFullyReserve" xlink:href="dgx-20211231.xsd#dgx_PeriodofBillingFullyReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PeriodofBillingFullyReserve" xlink:to="lab_dgx_PeriodofBillingFullyReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e34f02fd-f1ce-4cc2-8dc8-d479fcd3f403_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_12e46b3d-035e-45d3-aa03-6827c4b5899d_terseLabel_en-US" xlink:label="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Director Long-Term Incentive Plan (DLTIP)</link:label>
    <link:label id="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_label_en-US" xlink:label="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Director Long Term Incentive Plan Dltip [Member]</link:label>
    <link:label id="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_documentation_en-US" xlink:label="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Director Long-Term Incentive Plan (DLTIP) (Member)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:href="dgx-20211231.xsd#dgx_RestatedDirectorLongTermIncentivePlanDltipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:to="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_f3b800a2-f4a7-44f9-9b23-cdef4a52bbf5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2022Member_cf058b97-7c3b-4ba6-b82a-41041465285a_terseLabel_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2022</link:label>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2022Member_label_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2022 [Member]</link:label>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2022Member_documentation_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2022Member" xlink:href="dgx-20211231.xsd#dgx_LoanCommitmentMaturingOctober2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LoanCommitmentMaturingOctober2022Member" xlink:to="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TreasuryStockPurchasedbutNotyetPaid_f1cd8b36-5228-46c6-959d-db524f5dc669_terseLabel_en-US" xlink:label="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with purchases of treasury stock</link:label>
    <link:label id="lab_dgx_TreasuryStockPurchasedbutNotyetPaid_label_en-US" xlink:label="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchased but Not yet Paid</link:label>
    <link:label id="lab_dgx_TreasuryStockPurchasedbutNotyetPaid_documentation_en-US" xlink:label="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchased but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:href="dgx-20211231.xsd#dgx_TreasuryStockPurchasedbutNotyetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:to="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d7061deb-e310-4cf7-a71e-c56b715f5f55_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of year weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_02723c98-3b01-400c-b8bd-ef45c0444af6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_379bfc8e-e5c1-4041-9183-cdd363c0bb5f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, end of year weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_a426cc61-5b34-4174-80b3-0c45a37740a3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current federal tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_13fe7c3a-0e09-4845-9911-663155d6aa97_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_caef54d0-9ca6-4591-add6-23b79148e89b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_89ebf9f2-0061-4a1a-b27a-6878de39bc7d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_82f995a0-4ea7-4671-a8ab-fb2aae14c474_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits on stock-based compensation arrangements</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_801299a5-51c7-45ed-811b-e761b26687b7_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_6c069a36-5659-4961-9e40-eb65c24de03e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_2b66ba09-85c7-4df2-b974-5313f84680ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_fbb1d22d-f1a2-4749-9500-c32b902fd980_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share; 600 shares authorized as of both December 31, 2021 and 2020; 162 and 217 shares issued as of December 31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b807c1e7-14c1-471a-b4ba-27180fe14380_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate, Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_55e66ae8-1156-45ee-ac8d-7858e0700121_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation cost weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_06031db4-803b-4453-9e27-0f19c7f10fe7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, beginning of year weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_66727758-fd78-4c45-8dec-7ab2fab03cc0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, end of year weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_52975efc-91a7-4099-ba99-dacf95feb6d4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ClientPayersMember_22812d11-34d1-4736-8a8e-45201e2092e6_terseLabel_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client payers</link:label>
    <link:label id="lab_dgx_ClientPayersMember_label_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:label id="lab_dgx_ClientPayersMember_documentation_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember" xlink:href="dgx-20211231.xsd#dgx_ClientPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ClientPayersMember" xlink:to="lab_dgx_ClientPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_f00c3e8f-bc06-4c01-835e-8578eabae780_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_15aa8c48-b3ce-466d-90a8-c53fcf0bbc55_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of leased assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_061eaf05-64e1-4508-90cb-b7f61b54ea37_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_8cb80d3b-e8c1-4dd5-a22e-370aca8546cb_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_545d517e-3393-4f6f-a2ec-e79c0f58e840_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used in Valuing The Company's Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_9f86be64-a2fa-40de-8aa1-94fee32f7c1a_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4487ef20-f63e-46d6-8b2c-362647088a90_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred foreign income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_36482cd7-078d-4f9e-874a-ca6d520acc9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_dad0bb5d-aae0-478a-8ad9-31ddd746cacc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities not currently deductible</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_070bdc57-fd1f-4bce-9a5f-5ce0f3abc107_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_fb936b46-7739-429e-bd8c-9f0b75988165_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_4d4498e3-1d8b-4872-b57f-660368ffdafb_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_ae8941ef-f8f2-4a4b-a7f4-9da5cf9a3d80_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles1</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_b9832db9-dfaa-4240-8467-1fb12afb79a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_b41f8ac9-e8f0-4b6c-8431-48c5a70e30b7_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_116915fa-e12d-43c9-a31d-638db472abdb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_c94b06cb-e05b-477d-a0bb-bacea722713d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, remeasurement gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_e1905995-1d5b-46f1-928c-e026e625bf9b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1e69752f-3438-4771-a078-7f2ccef472b4_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ContingentConsiderationMember_9ea387fa-fca2-4db7-a714-085d64673a7d_terseLabel_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_dgx_ContingentConsiderationMember_label_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_dgx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember" xlink:href="dgx-20211231.xsd#dgx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ContingentConsiderationMember" xlink:to="lab_dgx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_273f7d13-4ec5-4f2e-bd50-6e149738b599_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_29c33860-3a3d-4723-ae87-80f29ef4281e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b3d5baa-cbbb-4495-a6b8-5d34a916099a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f15bf100-11e6-4a0f-b8f6-17f1ebea0686_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_53dc1462-7542-4d9c-bf01-7a2a929b023a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_bb7a4f35-5baa-4b8c-9f4c-34621cb89833_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_aaa8c46d-b0aa-4c86-b8e9-c31fd1b01f20_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_421a2de5-8c4b-43a3-add9-b9ff918e888d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_c80f0265-2e26-4209-8bc9-f0bc498bfd95_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_4ddca9fe-f569-40f2-84a9-31640248143c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_5c3aa2e2-9baf-4e01-b30c-7df467ebd58b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term,Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LeaseRemainingLeaseTerm_df1a55c5-e15e-4cd6-96c9-2f8939b65e8c_terseLabel_en-US" xlink:label="lab_dgx_LeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_dgx_LeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_dgx_LeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Remaining Lease Term</link:label>
    <link:label id="lab_dgx_LeaseRemainingLeaseTerm_documentation_en-US" xlink:label="lab_dgx_LeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRemainingLeaseTerm" xlink:href="dgx-20211231.xsd#dgx_LeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LeaseRemainingLeaseTerm" xlink:to="lab_dgx_LeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_61bf8f6e-bc6e-4999-afc2-464f2fba7336_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3e3f9b14-71c7-4bd1-83a2-6abd30a59cb5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4defa634-10e7-4de8-ada7-10c39ad9dff2_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BlueprintGeneticsOyMember_098f5045-91a1-42dc-a51c-1d233d615101_terseLabel_en-US" xlink:label="lab_dgx_BlueprintGeneticsOyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blueprint Genetics Oy</link:label>
    <link:label id="lab_dgx_BlueprintGeneticsOyMember_label_en-US" xlink:label="lab_dgx_BlueprintGeneticsOyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blueprint Genetics Oy [Member]</link:label>
    <link:label id="lab_dgx_BlueprintGeneticsOyMember_documentation_en-US" xlink:label="lab_dgx_BlueprintGeneticsOyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blueprint Genetics Oy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BlueprintGeneticsOyMember" xlink:href="dgx-20211231.xsd#dgx_BlueprintGeneticsOyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BlueprintGeneticsOyMember" xlink:to="lab_dgx_BlueprintGeneticsOyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_f5d7e600-e5b9-4e1a-b17d-af963a264390_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_c34bd062-7699-40e5-8c53-e03a061f237e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1a5958bf-8287-4105-932a-773acce8e23c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_dcb7592f-3280-4e90-baf3-1cec366b662d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_3a30d287-6de0-470c-bd86-511f16ac5409_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_420314d1-124d-48eb-a6f5-ebbc5fb48b92_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_0b5e737c-644b-4678-9691-a767d9f98d22_totalLabel_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_label_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_documentation_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired" xlink:href="dgx-20211231.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired" xlink:to="lab_dgx_FairValueOfNetAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_8588f007-0bd1-4373-9340-f42322886e01_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_f0636b2c-ed06-48ff-8af7-063e7e47e114_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_6ac6ef72-7c3f-4b42-ac9a-90f10a70461c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_4589e55c-e268-4754-ab88-28113110e526_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_aa5ded2a-bb73-4002-9bf7-32e9256fe97b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of equity earnings</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ac938024-8025-48e0-8e8b-39d08a70b802_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in investments and other assets, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_0d97068d-b932-441c-984d-ff7b87312a83_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_36f23852-6b8c-4336-8bc6-068f4989facf_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_650ee5bf-1061-445a-b298-6ec3c796503a_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_de1d8eac-8914-4095-b12e-639e8b096580_terseLabel_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of interest rate swap agreements</link:label>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_label_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Of Interest Rate Swap Agreements</link:label>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_documentation_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Of Interest Rate Swap Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements" xlink:href="dgx-20211231.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TerminationOfInterestRateSwapAgreements" xlink:to="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_95803747-2a58-4cbc-81be-85d9590a0ec5_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0012df1-aed4-46f0-bc74-efbfb95167f5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6e0b7029-6c4f-483b-8cf8-92791a97e191_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_fc02aa1a-602a-4de1-9989-a92cf56f222e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Quest Diagnostics stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_54c8e7d4-d7a1-459f-b6e5-ce2f3ae141c5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_84950d1e-221e-4c9d-9fda-7b5d646f0e42_terseLabel_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL)</link:label>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_label_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL) [Member]</link:label>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_documentation_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:href="dgx-20211231.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:to="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_fb17e794-56af-46a9-b55d-bd44e814305f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_80182bc8-f1c8-4992-a8bf-4356e236939e_terseLabel_en-US" xlink:label="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment, Furniture and Fixtures</link:label>
    <link:label id="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_label_en-US" xlink:label="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment, Furniture and Fixtures [Member]</link:label>
    <link:label id="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_documentation_en-US" xlink:label="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment, Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:href="dgx-20211231.xsd#dgx_LaboratoryEquipmentFurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:to="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ad5c7bb6-8941-4420-b6b8-73fa23ea34c4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of year aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_a3bdce1c-195e-4b5d-a6a6-33e3ecd9e2f6_terseLabel_en-US" xlink:label="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.95% Senior Notes due July 2037</link:label>
    <link:label id="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_label_en-US" xlink:label="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Point Nine Five Percent Senior Notes Due2037 [Member]</link:label>
    <link:label id="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_documentation_en-US" xlink:label="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Point Nine Five Percent Senior Notes Due 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:href="dgx-20211231.xsd#dgx_SixPointNineFivePercentSeniorNotesDue2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:to="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_84c2dc5d-b9d8-4f6d-a964-608311f0495e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1623bc6f-1716-46bb-8bf0-1d2a1a011b54_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ReductionsForChangesInJudgment_4795e8e9-0790-4426-aa31-b781693b89d6_negatedTerseLabel_en-US" xlink:label="lab_dgx_ReductionsForChangesInJudgment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for changes in judgment</link:label>
    <link:label id="lab_dgx_ReductionsForChangesInJudgment_label_en-US" xlink:label="lab_dgx_ReductionsForChangesInJudgment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for changes in judgment</link:label>
    <link:label id="lab_dgx_ReductionsForChangesInJudgment_documentation_en-US" xlink:label="lab_dgx_ReductionsForChangesInJudgment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The gross amount of decreases in unrecognized tax benefits resulting from changes in judgment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReductionsForChangesInJudgment" xlink:href="dgx-20211231.xsd#dgx_ReductionsForChangesInJudgment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ReductionsForChangesInJudgment" xlink:to="lab_dgx_ReductionsForChangesInJudgment" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_8210e696-7b61-4cfe-8c7e-3026103c22c8_terseLabel_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_label_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_documentation_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember" xlink:href="dgx-20211231.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AnatomicpathologytestingservicesMember" xlink:to="lab_dgx_AnatomicpathologytestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_9104eba6-cf63-414d-8314-b22af9b717a8_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Excluding Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_401671b3-ae94-47eb-9fb0-2ceeebeecc7d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_0eafed3d-7375-4905-8941-5946e2d7fa91_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_0a17f33e-b2bd-49b9-97c1-591d1048f644_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quest Diagnostics stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_d6bc6226-545b-4e67-bde7-e97b386adf93_negatedTerseLabel_en-US" xlink:label="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit due to release of valuation allowances associated with net operating loss carryforwards</link:label>
    <link:label id="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_label_en-US" xlink:label="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards</link:label>
    <link:label id="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_documentation_en-US" xlink:label="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:href="dgx-20211231.xsd#dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:to="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_74cbb72b-1d45-478e-be3c-d39abf3558b9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_8ca9f510-a007-42fe-b980-3e9ca5f5de86_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_e8a70960-9465-4089-8565-ce491007863a_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_c6f9813d-ccd3-442f-9c26-eed9f15c471d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Amounts Attributable to Parent, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_cd1da35b-9274-4935-b3e4-c469685ca2df_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_aceb2580-c4b6-4a8e-af47-4b9587316467_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable, current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_33950dd0-471c-4c0e-a5f8-7802045835d2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit related to stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_0b16e75c-202d-4547-b313-c7a3c7bd370b_terseLabel_en-US" xlink:label="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.20% Senior Notes due June 2029</link:label>
    <link:label id="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_label_en-US" xlink:label="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Two Zero Percent Senior Notes due June 2029 [Member]</link:label>
    <link:label id="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_documentation_en-US" xlink:label="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Two Zero Percent Senior Notes due June 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:href="dgx-20211231.xsd#dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:to="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_b78c7c98-c1a7-4874-8bcf-1db7c9fef3f9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_17cc844c-9dc5-4ac1-bd12-677cd6d7c574_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_aad9a4ad-3093-4d94-b432-57f9ff0a3990_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_0454766b-77a9-42ab-9d06-7ab3c5cfb79b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity method investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_8a0deb22-2975-40d6-9bd3-d49a004d06fb_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments carrying value</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_16739198-5c1e-42cd-8d4c-33c04fc360c1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5f7f97bc-ff9f-4c66-bb98-150005cf9857_terseLabel_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant accounting policies Line Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="dgx-20211231.xsd#dgx_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_8238e72e-7fea-4b2d-affd-fb77cb9a7ddb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_8820205c-b940-4eb1-81e9-7d1245bfa787_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_1a90797d-84fe-4da2-a4b6-804ea4e8f1ea_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deductions and other</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_2b1a6c5b-fe40-465f-ac0a-399594a96c21_terseLabel_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_label_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_documentation_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:href="dgx-20211231.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:to="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6592a8cf-2ae0-4bd7-834c-1640fa23f048_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_71650225-13b5-46e9-9205-8d43293c8fe9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_33bd86bf-df16-425f-851b-cc682766ecc4_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_c5e2f3dd-2569-42de-becd-d6e80c701d54_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $31 and $28 as of December&#160;31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5b53ba98-648a-4e5f-a178-45691cb48538_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_64186fab-66eb-48b7-b07b-a25bd27e4410_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ShorttermLeaseandVariableLeaseCost_6c656192-4082-4353-ac66-6538222bf3aa_terseLabel_en-US" xlink:label="lab_dgx_ShorttermLeaseandVariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term leases and variable lease costs</link:label>
    <link:label id="lab_dgx_ShorttermLeaseandVariableLeaseCost_label_en-US" xlink:label="lab_dgx_ShorttermLeaseandVariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease and Variable Lease, Cost</link:label>
    <link:label id="lab_dgx_ShorttermLeaseandVariableLeaseCost_documentation_en-US" xlink:label="lab_dgx_ShorttermLeaseandVariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease and Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ShorttermLeaseandVariableLeaseCost" xlink:href="dgx-20211231.xsd#dgx_ShorttermLeaseandVariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ShorttermLeaseandVariableLeaseCost" xlink:to="lab_dgx_ShorttermLeaseandVariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_d72242cd-72b7-404e-b1f0-671d0df7011b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4ae8fdd2-1478-4aa3-919e-13b3eec41e3f_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e92fe1fb-1560-4852-94b1-b27a7e3bce30_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares forfeited and cancelled</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_cfef7a55-0118-4f32-b7c2-a8ddab0c65d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_60f2f595-810a-485c-b560-747bdd13ec7f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_18515e82-5b87-42cb-84d5-8ce60e8b971c_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PatientMember_06f7022d-0b1a-4ca4-a0d2-2b97a4c8bcbb_terseLabel_en-US" xlink:label="lab_dgx_PatientMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients</link:label>
    <link:label id="lab_dgx_PatientMember_label_en-US" xlink:label="lab_dgx_PatientMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient [Member]</link:label>
    <link:label id="lab_dgx_PatientMember_documentation_en-US" xlink:label="lab_dgx_PatientMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientMember" xlink:href="dgx-20211231.xsd#dgx_PatientMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PatientMember" xlink:to="lab_dgx_PatientMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_7635f98a-1b72-478c-9271-62f7dd0e0ea5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_bd547425-be6a-4dbf-89ff-68276f717ffe_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_ec543fec-e9ab-4a11-80af-1ac5f60685ba_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_2831a738-9fb7-4f0b-bdb8-b299e0af9f39_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_01a0f9a3-58a5-4efe-9135-04ad39a2d185_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_82f039d1-15e5-4c96-a9dd-dc47cac5a912_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e6f9df38-b425-4cd8-8557-d6d8bd915793_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at grant date (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_579a7144-7d4b-482a-82c2-7022339135af_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_b9cffb15-2e82-4130-b836-7a9f7ed0f1b6_terseLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale recognized</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_label_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:to="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OtherIncomeExpenseMember_29490027-4e5e-4de0-adf4-3d9982b0600a_terseLabel_en-US" xlink:label="lab_dgx_OtherIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:label id="lab_dgx_OtherIncomeExpenseMember_label_en-US" xlink:label="lab_dgx_OtherIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense) [Member]</link:label>
    <link:label id="lab_dgx_OtherIncomeExpenseMember_documentation_en-US" xlink:label="lab_dgx_OtherIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember" xlink:href="dgx-20211231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OtherIncomeExpenseMember" xlink:to="lab_dgx_OtherIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_5b5161d0-3501-4eb8-8c87-849e2283e0b5_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, long-term growth rate used to determine fair value</link:label>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_label_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Long-term Growth Rate used to determine fair value</link:label>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Long-term Growth Rate used to determine fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:to="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_883bae31-c091-4092-ac68-cf9b801a2f24_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9cb28a1e-6d4e-4790-9a41-508186deb4f0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_dc5f6986-e589-4dc0-8786-7afa275560c0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_89db012a-5c27-4e5e-a96a-3a684b7cd6db_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowances associated with certain net operating losses</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_1b74a910-864c-43e0-9e34-0aabc598feb4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2113e563-9721-4095-b04e-5d30871318e7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_91abbd7f-a38b-4b90-b003-39b728ef272d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross excluding goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_58571165-3938-4960-9dd8-89e2f80ea7da_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_4661d88b-15a9-4d9b-b089-6bfe3bd81e50_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_eb4a2090-f9c8-46fb-a300-60a7c38915b1_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_770c9b6b-9089-42e6-9b7e-833e85bf9be8_terseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Earnings allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_6bf436be-1158-47cd-9f1b-48c942d99278_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c409abdb-6d13-4acf-abb4-3a3819d0cfc8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a88fd812-8591-437d-abb5-574737ab2f67_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_5839ef56-f71e-42a8-b182-cb3e4f4b14bf_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_a8d8e12e-8e69-40a2-b3f6-5ab5a7845e8d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FinanceLeaseObligationsandOtherMember_f9314f6c-e679-4487-8b67-7b0c3b31670c_verboseLabel_en-US" xlink:label="lab_dgx_FinanceLeaseObligationsandOtherMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dgx_FinanceLeaseObligationsandOtherMember_label_en-US" xlink:label="lab_dgx_FinanceLeaseObligationsandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations and Other [Member]</link:label>
    <link:label id="lab_dgx_FinanceLeaseObligationsandOtherMember_documentation_en-US" xlink:label="lab_dgx_FinanceLeaseObligationsandOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FinanceLeaseObligationsandOtherMember" xlink:href="dgx-20211231.xsd#dgx_FinanceLeaseObligationsandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FinanceLeaseObligationsandOtherMember" xlink:to="lab_dgx_FinanceLeaseObligationsandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_e3ef23d7-5ff7-4b08-a1e6-89ad26dd5be7_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_dc6b4b63-ed19-407f-8f0d-f86002386006_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_be0895c7-9bf7-497d-9985-3a0e8069edc7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebt_a2a3e339-161c-4c4c-b8bb-85b443a87bb1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt" xlink:to="lab_us-gaap_OtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cfc1ab09-47df-445d-a80c-ac5e499b3cac_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EmployeeLongTermIncentivePlanEltipMember_e197d8ef-e934-46cb-8656-6592bce58072_terseLabel_en-US" xlink:label="lab_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Long Term Incentive Plan ELTIP</link:label>
    <link:label id="lab_dgx_EmployeeLongTermIncentivePlanEltipMember_label_en-US" xlink:label="lab_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Long Term Incentive Plan Eltip [Member]</link:label>
    <link:label id="lab_dgx_EmployeeLongTermIncentivePlanEltipMember_documentation_en-US" xlink:label="lab_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Long-Term Incentive Plan (ELTIP) (Member)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:href="dgx-20211231.xsd#dgx_EmployeeLongTermIncentivePlanEltipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:to="lab_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_aa9bd1fe-f21a-4f4a-9d80-a5bd03e4c48e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_1c9ed4b0-7205-4b3d-8bd2-bd294899e4d8_terseLabel_en-US" xlink:label="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from disposition of joint venture</link:label>
    <link:label id="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_label_en-US" xlink:label="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments, Gross</link:label>
    <link:label id="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_documentation_en-US" xlink:label="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:href="dgx-20211231.xsd#dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:to="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_7a0654fb-c51f-4227-b5c5-b31cd6620fc9_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_47cdb106-4b3a-47e9-8114-970014e5e30c_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_20f194ad-cee9-4567-884e-d4db6e25fa79_terseLabel_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_label_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_documentation_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:href="dgx-20211231.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:to="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1303606e-a687-458e-b851-561cda8b1f1c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_fa0df2b9-e058-4152-8498-11d9a67bf4e3_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4f598ac0-23e1-49f2-9b3f-71941ab3f7c8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_fe5b539a-4e7e-4267-834f-c75500b7deaa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_15664622-d551-4c19-861b-9306308aa4e3_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d410efb8-32d3-425d-942e-32fd0d24cdd9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_1d70d565-0074-4d4b-afec-53512da4de1d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_bd4a0a23-dc26-4d25-9786-cc81b7a0085a_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other operating segments</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_5f324a32-93c8-4139-b1fc-f598237b4fd6_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_66a084e4-5510-4c5b-b611-10878fd84f05_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_edc02c80-e320-4808-84fb-ca87ef5965ce_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2acf1a97-f3e4-495f-818e-8e65bf51abaa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_63830604-70af-4f20-b43a-4e76babd6780_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_1894d6d7-bcf7-47fa-aaa3-198254d1e4d3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reissuance of shares for employee benefit plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_62933139-161e-4432-9fcb-7b1f76f77dd5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_08faf731-4386-4d60-ac5e-c5bbca0d6f68_terseLabel_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP variable incentive compensation deferral</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_label_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Deferred Compensation Plan Variable Incentive Compensation Deferral</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_documentation_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferral percentage of the variable incentive compensation under the Supplemental Deferred Compensation Plan. The plan is an unfunded, non-qualified plan that provides for certain management and highly compensated eligible employees to defer up to this percentage of their variable incentive compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:href="dgx-20211231.xsd#dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:to="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2023Member_1fb5e630-d2ba-497d-8bf5-14cc684b2623_terseLabel_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2023</link:label>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2023Member_label_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2023 [Member]</link:label>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2023Member_documentation_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2023Member" xlink:href="dgx-20211231.xsd#dgx_LoanCommitmentMaturingOctober2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LoanCommitmentMaturingOctober2023Member" xlink:to="lab_dgx_LoanCommitmentMaturingOctober2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_b6ede5c4-b533-4207-a128-bc80d1071dc7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_64aff41f-a599-4a6d-a42f-c28dfa925d4d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_edd32375-e607-499a-af85-c54dac0e836c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate income (expenses), Net</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_b50c6763-6e23-4607-af70-a8669cf8b2cc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b9b2f7e8-2ed1-46e3-b25b-8f32875674f5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_1a5884eb-7131-4922-a25d-fb45c5b60c3e_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 43 and 84 shares as of December 31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7f321d5a-2efa-4b09-a93a-fe46fe284b01_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_df9c7ea9-3756-4293-922d-7a5b28c2f18f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of equity method investees, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_94607478-6af6-4b8d-97a4-4716aa7512c3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of equity earnings from investments in affiliates</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_586a59b6-43f0-4259-8b64-060f4bbca182_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_771edb33-cc73-48b2-a0c8-6e1f69bddd58_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankOverdrafts_874da730-3931-46bd-a324-8ea3d17c3ab4_terseLabel_en-US" xlink:label="lab_us-gaap_BankOverdrafts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdrafts</link:label>
    <link:label id="lab_us-gaap_BankOverdrafts_label_en-US" xlink:label="lab_us-gaap_BankOverdrafts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Overdrafts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankOverdrafts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BankOverdrafts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankOverdrafts" xlink:to="lab_us-gaap_BankOverdrafts" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_31420175-3fb2-43f5-a93a-5b27e25f4478_negatedTerseLabel_en-US" xlink:label="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis differences in investments, joint ventures and subsidiaries</link:label>
    <link:label id="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_label_en-US" xlink:label="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Investments, Investments in Subsidiaries and Equity method investments</link:label>
    <link:label id="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_documentation_en-US" xlink:label="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Investments, Investments in Subsidiaries and Equity method investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:href="dgx-20211231.xsd#dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:to="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_b1e6e58d-c45c-4c00-8fbf-f95108ddba53_negatedTerseLabel_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dgx-20211231.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0b957487-5a25-4208-b2bd-ebfe8846f895_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_cfcdfb7c-bc34-44d5-9625-b36b5ff0320d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Country</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_1833d771-7192-4ede-9107-d7914034eadb_terseLabel_en-US" xlink:label="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75% Senior Notes due January 2040</link:label>
    <link:label id="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_label_en-US" xlink:label="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Point Seven Five Percent Senior Notes Due2040 [Member]</link:label>
    <link:label id="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_documentation_en-US" xlink:label="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Point Seven Five Percent Senior Notes Due 2040 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:href="dgx-20211231.xsd#dgx_FivePointSevenFivePercentSeniorNotesDue2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:to="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_aa09ec7f-62ab-49ec-9af1-8bd694f0acd4_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_5656ee8b-c7d1-4e81-9d1f-d66e0f7fdd70_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares retired (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_bbb0f457-f60c-4039-9aeb-7072ff6c3bd3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LongTermDebtMaturitiesGross_ed65094e-757e-42b9-be9e-c7d4ef30833e_totalLabel_en-US" xlink:label="lab_dgx_LongTermDebtMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total maturities of long-term debt</link:label>
    <link:label id="lab_dgx_LongTermDebtMaturitiesGross_label_en-US" xlink:label="lab_dgx_LongTermDebtMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities Gross</link:label>
    <link:label id="lab_dgx_LongTermDebtMaturitiesGross_documentation_en-US" xlink:label="lab_dgx_LongTermDebtMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date. May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer, and before deducting unamortized discount or premiums, if any.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LongTermDebtMaturitiesGross" xlink:href="dgx-20211231.xsd#dgx_LongTermDebtMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LongTermDebtMaturitiesGross" xlink:to="lab_dgx_LongTermDebtMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_64eaa272-511e-40c0-9be5-efac8a1bdff6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_daedc6b5-51fc-49c7-b29b-b29455c20f06_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b42bce50-4719-469e-9304-8eb2194433c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in available-for-sale debt securities, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e710c10c-f9fa-4fc7-91fe-f0f7be33c655_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_104bbb76-e653-4801-803a-cd7d8eab0b6c_terseLabel_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP salary deferral</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_label_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Deferred Compensation Plan Salary Deferral</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_documentation_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of salary deferral under the Supplemental Deferred Compensation Plan. This plans is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to this percentage of their annual salary in excess of their defined contribution plan limits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:href="dgx-20211231.xsd#dgx_SupplementalDeferredCompensationPlanSalaryDeferral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:to="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_600de924-a7d8-4cfe-8816-dc8159624e6e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_87f98b5a-dd07-456c-800e-1eeb8d944db0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred state and local income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_d86a1264-9e11-4af9-9b5f-8e704c2d877e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_783f9a01-7d4f-4e7d-86cb-73053e68fbdd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock_f2a9c2c1-34e0-4e81-9091-88bc621d0c91_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Lease By Asset Type</link:label>
    <link:label id="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Lease By Asset Type [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Lease By Asset Type [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfLeaseByAssetTypeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:to="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_0fdeeb50-6c17-4d79-92e3-4e159e215309_terseLabel_en-US" xlink:label="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds in a trust pertaining to all participant deferrals and company matching amounts related to the SDCP</link:label>
    <link:label id="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_label_en-US" xlink:label="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds in a trust pertaining to all participant deferrals and company matching amounts related to the SDCP</link:label>
    <link:label id="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_documentation_en-US" xlink:label="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds in a trust pertaining to all participant deferrals and company matching amounts related to the Supplemental Deferred Compensation Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:href="dgx-20211231.xsd#dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:to="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_fe801200-4b2a-467f-9561-b33c3c6392f0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_97669b8a-7933-408b-9b1a-dacb968ca4b2_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_33ad1628-5eb1-403b-a0a4-74c202fb3e88_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_484da31b-9502-47a2-bc0b-9448ce1000e5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_35987639-8996-48b7-acb4-08f576fcc2d2_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_d009c926-8531-4b96-8eee-407ba7f03e14_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_415abe5b-a7d9-450a-bc6f-651734e84e5e_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_73e613c8-0c4f-4734-ac0c-f6e507f8c6f2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NidMember_3571b2d3-21b7-4dc9-b01d-aee649a16ca6_terseLabel_en-US" xlink:label="lab_dgx_NidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NID</link:label>
    <link:label id="lab_dgx_NidMember_label_en-US" xlink:label="lab_dgx_NidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NID [Member]</link:label>
    <link:label id="lab_dgx_NidMember_documentation_en-US" xlink:label="lab_dgx_NidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NID [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NidMember" xlink:href="dgx-20211231.xsd#dgx_NidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NidMember" xlink:to="lab_dgx_NidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_51930103-6162-4a84-b3bd-235c47635a38_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a6448f0d-817f-47d5-b385-b24472d958ed_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning of year weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b908a462-0be0-4fa2-9e66-dc7897e1d28a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, end of year weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_b9b41983-5e42-41c3-a365-1085ee58bc09_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_88852f9b-cf6e-41ad-93bd-ee2ba3997e77_terseLabel_en-US" xlink:label="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, additions and issuances</link:label>
    <link:label id="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_label_en-US" xlink:label="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances</link:label>
    <link:label id="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_documentation_en-US" xlink:label="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:href="dgx-20211231.xsd#dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:to="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_0c1ca699-0e58-43bd-bd33-0e5f31c7ef05_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_8c3ed773-5ebc-4036-a117-e8c9c5464620_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b920d189-1cd3-49c7-bb76-98bae0ee1676_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_8eef1a36-0f53-4700-a682-90818111f5e1_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6d411183-3d13-4b8c-8e6d-509188f10275_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_e8ab632a-2278-4e71-9d2a-3adbfdecd1c9_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_fe3bbab9-da17-44dd-82ea-f4e1b8ecece6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses (gains) on sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_d9924324-752b-4a2c-a35a-25ecff16b929_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_a52d887c-9661-4a21-b962-0f03fb2f87ae_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_1f5d41f2-59f9-4dcf-a14c-faea57ed4f3e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes on Income</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_897293a7-aff9-47de-a97b-f502fe377696_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_f9fa3618-165b-4650-a613-7aaa0e710a0b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_882855bb-a96a-4fa3-b1da-5c54bc4d7a1a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_eb8b9665-be27-4da1-8b81-abeb43f12f27_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_b5988559-760f-4b4c-b593-11317cced9e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_b054d89e-e67f-46b5-99c7-7bf19f40955a_terseLabel_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_label_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation [Member]</link:label>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_documentation_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember" xlink:href="dgx-20211231.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ForeignCurrencyTranslationMember" xlink:to="lab_dgx_ForeignCurrencyTranslationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b513859-de6e-4902-868f-0cd375346d3f_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_23c9603b-f975-4b97-98a2-ea2f02adbd86_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations - domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_0b647d50-2f9c-47b0-a3d6-f0b8bd3c1c6f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TAXES ON INCOME</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_08d36e2c-3a98-41eb-bfd3-f79c8c33ff62_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_895b020c-b58a-4b40-8ad4-16b1154ac2ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Transactions Under The Company's Stock Option Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c61983e8-5644-4939-9d95-f880a48aa837_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate in excess of LIBOR</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_fda6fb7b-fddf-49f7-bb5a-b441645da4a0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate in excess of LIBOR</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_405bda30-ab4f-4fcd-a83d-6db6cecbf3ce_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_febc4ae9-cadc-4bf2-9b78-5535e33fc9ce_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7c6c128-e5b8-445b-94d6-2ee4c214ea21_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9714f5fd-a81e-497a-a233-26d721fffffc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_5ef49bd2-1d25-439e-adab-e95428239663_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxes" xlink:to="lab_us-gaap_AccruedIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e6b46529-50c0-43b7-9d7e-273ee4f7e1d6_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6ed45d18-15f9-4d5b-b87a-6ffec4c01de6_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_f1a5b39d-6d9f-468f-be7a-4857aa2f5144_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7034b254-678f-4bb8-b7e8-7fd6394d6bec_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected holding period, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e60faa8e-591a-4fc2-b10a-df3246c13efb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_bf089db1-c34c-44e6-a2e7-c9acf814d705_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_2e1e4b61-d181-4693-a9e2-7eed1a80a2a7_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged items (Long-term debt)</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_dd6f5861-5300-4d0e-acef-dc2d1dc2413b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_fd5bed2e-54a5-4803-9f7c-b5f123bb81ca_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GainLossOnDispositionOfJointVenture_9ac72e38-79c5-4922-83c2-2ee338899ce9_negatedTerseLabel_en-US" xlink:label="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposition of joint venture</link:label>
    <link:label id="lab_dgx_GainLossOnDispositionOfJointVenture_label_en-US" xlink:label="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Joint Venture</link:label>
    <link:label id="lab_dgx_GainLossOnDispositionOfJointVenture_documentation_en-US" xlink:label="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossOnDispositionOfJointVenture" xlink:href="dgx-20211231.xsd#dgx_GainLossOnDispositionOfJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GainLossOnDispositionOfJointVenture" xlink:to="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5f521d9b-0f02-4b99-a8bc-805bdd43f0cc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended company match percentage of employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b45063f7-35c3-4195-87e0-988d450602cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, end of year aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e1496a2d-0234-45bd-830c-531975c6a6bd_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_99ff9471-eb66-47cd-9b8f-2da65c761f63_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_89bba3c7-40db-4cb6-9ed4-d92055f78d5a_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fd8132bd-0bea-4a31-9fb2-2d6bb255b75c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d908ba12-229c-4ed5-9fda-d261e9f8ded4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LeaseLiability_0f9f79af-0839-415b-93a6-5cf27fe5d209_totalLabel_en-US" xlink:label="lab_dgx_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_dgx_LeaseLiability_label_en-US" xlink:label="lab_dgx_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_dgx_LeaseLiability_documentation_en-US" xlink:label="lab_dgx_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseLiability" xlink:href="dgx-20211231.xsd#dgx_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LeaseLiability" xlink:to="lab_dgx_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_a2a55f27-b99f-4b47-af67-f714d7c231cf_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New claims filed (in lawsuits)</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_a2465d1c-0e27-4785-b0ca-b995347f4026_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_StockAwardsMember_fec04406-53e5-40a4-8987-b522de0f05a8_terseLabel_en-US" xlink:label="lab_dgx_StockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards</link:label>
    <link:label id="lab_dgx_StockAwardsMember_label_en-US" xlink:label="lab_dgx_StockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards [Member]</link:label>
    <link:label id="lab_dgx_StockAwardsMember_documentation_en-US" xlink:label="lab_dgx_StockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement - Equity Instruments Other than Options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockAwardsMember" xlink:href="dgx-20211231.xsd#dgx_StockAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_StockAwardsMember" xlink:to="lab_dgx_StockAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_6ab6488b-3373-4979-946c-0105fd127fb9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_42760dbb-b8a7-4933-a3cf-2871389bbd4d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_d5235da4-f5d6-49d1-b1f7-860d9d72880f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_04b84dee-f6ea-4afa-8e75-a1b25b443638_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_3450cba8-e8c0-4c34-a989-8cb4550f3eb7_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_Goodwill_5b46a862-7a06-4e34-94af-e10940423161_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, balance at end of year</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_2d77eb36-72e0-4458-a0e8-290c8144f8d5_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_a5536cf1-7b2c-4702-badb-52dbf0a97744_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Goodwill, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_985a37fd-1948-45dd-83c0-e23a076253e1_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_31806eb7-0485-4755-b9ba-8223bfa5405e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_457e6aef-096a-41bd-954b-2c02bb5a211d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_65061b98-b6ab-4536-a117-36a6f61a780a_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_bd3d9942-ff5b-482e-8ebb-ec5cfd560128_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, end of year weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_7a0da8e2-fc18-4d9d-b9d7-2c06316c6876_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Bonus and Profit Sharing Plan, Type of Deferred Compensation [Axis]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_f8a02758-eb45-4fec-9d3c-2289b4e1ab3b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision at statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_47b57080-ea2f-4a6e-9e58-f40d2298de03_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_935dfe5d-88f9-4349-ad46-c0abdeb57e4b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_07a78237-9e21-4de2-951b-b850a17cc611_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2e0e0435-4667-46fa-a0bf-609cc1b8dd10_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_0cfe56a9-844c-441a-a127-70b7cf88214c_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_c3b0e89b-30df-4fd4-b3f8-105e297e613a_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of investment, before tax</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_ce329aea-867a-4eb0-ad52-98168bdaca07_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_30dc6aa3-c3e2-498f-a507-83ed341d2b48_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_029a9a94-1969-493b-9710-8ad13b00334d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued wages and benefits (including incentive compensation)</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5b246768-3ca8-4e05-83a0-4717e6e5e1af_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cae6b1de-c6d2-4ce3-a9a8-985acf2048fb_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization, intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9789aa62-2931-45ed-80d7-38c67c08c28a_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_8947077a-f9ef-44c7-bb47-8e17dddf3cc5_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of life insurance policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_a9c84229-ee64-4278-8988-b811d4f3012c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DebtInstrumentExtensionPeriod_8f00fe3b-0834-4893-aded-4ab127b0eae0_terseLabel_en-US" xlink:label="lab_dgx_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension period</link:label>
    <link:label id="lab_dgx_DebtInstrumentExtensionPeriod_label_en-US" xlink:label="lab_dgx_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Extension Period</link:label>
    <link:label id="lab_dgx_DebtInstrumentExtensionPeriod_documentation_en-US" xlink:label="lab_dgx_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentExtensionPeriod" xlink:href="dgx-20211231.xsd#dgx_DebtInstrumentExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DebtInstrumentExtensionPeriod" xlink:to="lab_dgx_DebtInstrumentExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OperatingLeaseFixedAndVariableCost_57c40101-3c21-44ed-a996-af7737ae1dad_terseLabel_en-US" xlink:label="lab_dgx_OperatingLeaseFixedAndVariableCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_dgx_OperatingLeaseFixedAndVariableCost_label_en-US" xlink:label="lab_dgx_OperatingLeaseFixedAndVariableCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Fixed and Variable Cost</link:label>
    <link:label id="lab_dgx_OperatingLeaseFixedAndVariableCost_documentation_en-US" xlink:label="lab_dgx_OperatingLeaseFixedAndVariableCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Fixed and Variable Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingLeaseFixedAndVariableCost" xlink:href="dgx-20211231.xsd#dgx_OperatingLeaseFixedAndVariableCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OperatingLeaseFixedAndVariableCost" xlink:to="lab_dgx_OperatingLeaseFixedAndVariableCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2b6d4adc-f5c4-4991-9d54-f955a7c834bc_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_b59cf6a3-7d30-424e-b303-92f0c91edab2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposition of property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_a043e547-9b63-40ff-a6b4-1324a2c4fa61_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_47777f7e-f76e-4801-b783-de7d733e2162_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityLineItems_f94db911-c799-41df-a0cb-99624cfc51a0_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityLineItems_label_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shareholders' Equity [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityLineItems_documentation_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Shareholders' Equity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityLineItems" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareholdersEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems" xlink:to="lab_dgx_ScheduleOfShareholdersEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_0ffa685b-b1d4-47a2-851f-3f271711633a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_f979ddc0-ce11-44ca-b0c9-afd6edeb315d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d1c0ed9e-d45f-435e-8291-a280fc6b4e95_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_fa23cefa-1d88-47ef-af77-9bd8a9d9cb6d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposition of joint venture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2c17a0f2-216a-4783-99f8-ec6c9b74a4ef_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_662e7175-5459-421c-8b41-79dfb501397c_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_6b6b2f49-a623-4b13-a90e-776cc8675f09_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_72468994-5442-4f30-9e11-57d95e43f25b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ff1c7bac-001a-43ce-8a68-331eeb1b5d91_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited and cancelled</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_9f446a92-ebe0-42ac-8d03-f05e915f2dbc_netLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISPOSITION</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_3258dc28-6548-4810-99da-80e3aaf2b7b3_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISCONTINUED OPERATIONS</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_11417815-5276-4aa6-86fb-461fa73ff708_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2e6fabf2-f354-4466-abdf-12c015ef7d82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_UMassJointVentureMember_2e14fb13-c89d-4935-b993-cae719c3e236_terseLabel_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_label_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_documentation_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember" xlink:href="dgx-20211231.xsd#dgx_UMassJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_UMassJointVentureMember" xlink:to="lab_dgx_UMassJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_127c9c1b-3f1f-49a5-ba3e-24162aa2d137_terseLabel_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:href="dgx-20211231.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:to="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_11494fc7-7f40-4cee-83a2-f99310fc44f1_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum_5f5c8485-c41b-4040-b406-259e6ac94203_terseLabel_en-US" xlink:label="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining terms of lease obligations, maximum</link:label>
    <link:label id="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum_label_en-US" xlink:label="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Terms of Contingent Lease Obligations, Maximum</link:label>
    <link:label id="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum_documentation_en-US" xlink:label="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Terms of Contingent Lease Obligations, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:href="dgx-20211231.xsd#dgx_RemainingTermsofContingentLeaseObligationsMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:to="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_b770d9a1-6eb5-4fd1-9338-cf6347a4d156_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_bf7ac17e-ed7b-4451-a709-a5bd5de8b04e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Accounting Basis Adjustment</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessAcquisitionPostacquisitionRevenue_96f72f0d-1d35-4984-8a6c-936653d7162b_terseLabel_en-US" xlink:label="lab_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_dgx_BusinessAcquisitionPostacquisitionRevenue_label_en-US" xlink:label="lab_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Post-acquisition Revenue</link:label>
    <link:label id="lab_dgx_BusinessAcquisitionPostacquisitionRevenue_documentation_en-US" xlink:label="lab_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Post-acquisition Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:href="dgx-20211231.xsd#dgx_BusinessAcquisitionPostacquisitionRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:to="lab_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_fb09f72b-b608-47c8-a084-4ff2dc9235c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_ccbb737d-c64b-4d9c-8f1f-0e8369d8c7c6_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_ad3b9b17-3c88-4ef7-85ad-605c7af1b279_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_72b4b103-e922-4520-8f8f-81ccb1cbfeba_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than temporary impairment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_6a2f6a4a-2d46-4372-9e23-507019d0dce5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87b89c9f-6cde-4745-9ff2-59454dd27594_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at grant date (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9d335b02-4509-4438-bc45-5a68c0c6ed41_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_08c89b41-4f2b-4187-bba9-369b61c77e5a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentsAbstract" xlink:to="lab_us-gaap_DebtInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_f788c1ad-6733-4973-97eb-270218f40e69_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d434d1ab-fa27-41b8-ba2b-a4f023a7949e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_3b05af0c-35b3-4b02-b569-99c8f71ba96d_terseLabel_en-US" xlink:label="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance and Operating Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:label id="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_documentation_en-US" xlink:label="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance and Operating Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="dgx-20211231.xsd#dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PackHealthLLCMember_baf4c3e7-e16a-43d0-8f14-ab97aa8b2a45_terseLabel_en-US" xlink:label="lab_dgx_PackHealthLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC</link:label>
    <link:label id="lab_dgx_PackHealthLLCMember_label_en-US" xlink:label="lab_dgx_PackHealthLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC [Member]</link:label>
    <link:label id="lab_dgx_PackHealthLLCMember_documentation_en-US" xlink:label="lab_dgx_PackHealthLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCMember" xlink:href="dgx-20211231.xsd#dgx_PackHealthLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PackHealthLLCMember" xlink:to="lab_dgx_PackHealthLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_a402aa39-c1f0-4ffa-b58b-31459f9bedc5_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_3a0d674f-74a8-4c57-9aac-d7f57af8feac_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetRevenues_eb3a4396-90b2-4fee-a58c-94f1b350f8b0_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_88cb36a1-529d-4f8e-b9ba-4b209d1b215b_verboseLabel_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net revenues from the DIS business</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_label_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_documentation_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetRevenues" xlink:to="lab_dgx_PercentageofNetRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_a3971ca8-5eef-4bfb-897a-2a9c6e75d941_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_f233dfec-8d4d-46b6-80a2-a0d72cfb7eda_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0a858d44-fa07-4ce6-a3aa-e99f073c2a9b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_b476fab8-9421-467c-a63b-74ba72e0ca0c_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1d45bffb-4ba8-497b-b67f-0298003cc503_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, end of year weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_db85de8d-efee-4cd8-a1a7-b77d1cb84ca2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d71b4b99-32fb-49f1-b18d-7c11686fa664_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_41816af6-efb0-470b-8448-4b823fdd4079_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_69d2f5b6-67a8-44ca-954d-102c5f883f11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e40cde1b-2d4e-4325-be8b-54089fa5366e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_55937301-f37d-4adc-8956-60b7db446e60_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9502cd71-5bb5-4889-ae45-4c27eec75338_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c173ea52-1052-4b36-af52-67ffef59c9f0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, end of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_ff2995ef-d645-44e8-b106-8fd53b90f85d_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Tradenames</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_48fd4e82-ce18-4023-a93a-fe39595677b0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_2b832e82-996c-4b9a-bf2a-7174ae1f8ed4_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3c794044-2624-4d37-ac1b-5c93cf008e0c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_832dfc19-dd52-4b0c-a389-834221973ad7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax Benefits, interest on income taxes expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7767e954-618e-4b5b-a268-13063484680a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_b005b305-7813-4bb4-b804-9ba314652120_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_f152051b-9033-44a0-9bdc-39452e3e5100_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Receivables Credit Facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_6d5c2ffc-c15f-4b22-bd82-d1caf8bbb624_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_a9e939c2-5b6d-4855-87a3-d62124b25f46_terseLabel_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_label_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_documentation_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:href="dgx-20211231.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:to="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_26e7f87f-7616-4aee-ac81-012ac8ea9127_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c490cb59-4e88-4e63-8170-de53ac27e76d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SdcpIiMember_e5a2c092-fd0c-4225-8590-ae7c0e6db791_terseLabel_en-US" xlink:label="lab_dgx_SdcpIiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II [Member]</link:label>
    <link:label id="lab_dgx_SdcpIiMember_label_en-US" xlink:label="lab_dgx_SdcpIiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sdcp Ii [Member]</link:label>
    <link:label id="lab_dgx_SdcpIiMember_documentation_en-US" xlink:label="lab_dgx_SdcpIiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiMember" xlink:href="dgx-20211231.xsd#dgx_SdcpIiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SdcpIiMember" xlink:to="lab_dgx_SdcpIiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_83379fca-4cde-496c-bc6c-37ed372ac0c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_86f66ec6-91c6-4905-9ffd-f6265bbdeae4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of maximum annual wages witheld for the ESPP</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_b445d294-088d-4bac-b418-c54cd6e415c1_terseLabel_en-US" xlink:label="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_label_en-US" xlink:label="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities, Noncurrent</link:label>
    <link:label id="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:href="dgx-20211231.xsd#dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:to="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_597e2468-15dc-4e9f-804e-77f5b163af92_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e6ac3aa8-a259-4873-96f2-a8914855cddd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_50e2fbc6-d6ca-44ab-8569-59701c2ee8c7_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_56dfaf93-e1ed-4465-9d95-294146413395_negatedTerseLabel_en-US" xlink:label="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value basis adjustments attributable to hedged debt</link:label>
    <link:label id="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_label_en-US" xlink:label="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, fair value basis adjustment attributable to hedged debt</link:label>
    <link:label id="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_documentation_en-US" xlink:label="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, fair value basis adjustment attributable to hedged debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:href="dgx-20211231.xsd#dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:to="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_707d7036-2f68-4d8a-a4a4-c34cecce2892_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_201f4230-05f6-4639-abfb-6fb60ed8139d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a5f85c7f-69f4-425d-a8cc-ceb4418fbd70_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_0f2ceeaf-604c-49e9-b32b-41c289536d00_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment and working capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment and Working Capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment and Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_c52457a1-b311-44bb-ae2f-59cf32f061f1_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_d275d242-7079-4762-b8e2-916d4b885ef8_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_d496aa06-7d42-4c29-a883-fb8cc31bd628_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0956e192-2c79-42fb-82e1-d7cfe1d2eb5c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_62bf1024-773e-42f6-a1ab-e8c465ec13da_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's expense for contributions to its defined contribution plans</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ccc079c2-622e-4aa1-9826-87e9fa2c4cba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4ab9a84a-c8a2-48c1-a914-2c7dfd3a53db_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_8a660798-2a98-4b16-9598-a76e61c07e13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Transactions Under Stock Awards Other than Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1753b5d2-9fca-4bb1-8a06-49610d18b0f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ad8fcf79-703c-4b84-bd45-f950c99ecb74_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_df49ab17-f061-4366-a50f-a3ee1b9f9a13_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_4f111786-50f9-472a-ade7-8ff13fc987e3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_9daf2292-81fc-4880-b13a-fbb75f7c4604_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_acbda967-795b-4e08-a76d-7e232b10e8c7_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_566fcb21-b2f9-49a0-b18f-c6838bd72b36_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation trading securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_3241cdcb-4e4a-4edf-8722-b4a3e9fe6bca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_de73ebba-f0c8-428b-855d-f09494fd72aa_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Q2SolutionsMember_a0162b06-3ac6-4b1c-98a0-9c0575a9ab51_terseLabel_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions</link:label>
    <link:label id="lab_dgx_Q2SolutionsMember_label_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions [Member]</link:label>
    <link:label id="lab_dgx_Q2SolutionsMember_documentation_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember" xlink:href="dgx-20211231.xsd#dgx_Q2SolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Q2SolutionsMember" xlink:to="lab_dgx_Q2SolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_b2a89105-407e-4ff5-908d-41e47e3b6868_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_288b40f8-b13e-41e3-8243-0560bd30e327_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_e0596689-c8b7-4aee-8145-404b132cf898_terseLabel_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_label_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</link:label>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_documentation_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:href="dgx-20211231.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:to="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_45fee18e-11b5-4cd8-bfdc-3211b6d6bd18_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued insurance</link:label>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Insurance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedInsuranceCurrent" xlink:to="lab_us-gaap_AccruedInsuranceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_4dc32d06-4cbf-47f1-92c7-60411763b6c5_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_829b2466-f66f-4630-a3a5-6e0ca8a095bb_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7895421f-a917-4532-9e5a-6e479bf86e56_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AllotherservicesMember_d46297db-4a5b-46a3-a0c4-ef89b0462256_terseLabel_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_label_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_documentation_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember" xlink:href="dgx-20211231.xsd#dgx_AllotherservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AllotherservicesMember" xlink:to="lab_dgx_AllotherservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2397dabe-4e8a-4c15-b370-eefea1b230c0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_b52b25ac-4520-40c5-9ce5-704af36e485d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5dc8edaf-1084-43e3-a3e9-5e144a246dfe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred gain on cash flow hedges, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_0114c6b2-8c28-4545-af05-38061741bd49_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3e2f2510-4583-4b7f-b47f-f49c277b1f0d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_12fefa3b-8b08-4bee-be4f-649533def281_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_defe3025-ebce-4cef-973f-52c0bf22c26f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_b41428de-530b-4f32-bf84-58ccf89cb5e8_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_f60e1d72-2455-4b5a-ab14-ea095ee0dd51_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_d96e20e7-3eb8-44fa-a475-071dc241c2ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0a030c25-25f9-4ed3-96af-b3f9457317c2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_81027063-4039-4330-aaf3-657f748b3b61_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_64402e97-41ac-42f2-8cfa-75b4392a21d9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock value acquired cost method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MergerConsiderationPayableCurrent_855531a4-d2fe-4919-8662-ab514ac3a913_terseLabel_en-US" xlink:label="lab_dgx_MergerConsiderationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration payable</link:label>
    <link:label id="lab_dgx_MergerConsiderationPayableCurrent_label_en-US" xlink:label="lab_dgx_MergerConsiderationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Consideration Payable, Current</link:label>
    <link:label id="lab_dgx_MergerConsiderationPayableCurrent_documentation_en-US" xlink:label="lab_dgx_MergerConsiderationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Consideration Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MergerConsiderationPayableCurrent" xlink:href="dgx-20211231.xsd#dgx_MergerConsiderationPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MergerConsiderationPayableCurrent" xlink:to="lab_dgx_MergerConsiderationPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_779bf6f1-23a8-4120-be9f-bea72d2ca0fd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_9ab73669-75e0-46d5-9559-33e7c5eeb40f_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_cb9c2ff0-9eaa-408d-91e3-35d9dea75443_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4284922b-e72d-44fd-8a89-1704b1311624_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_3f201b76-f879-4809-a649-74a4b28cffaf_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4728fd5d-15cf-454c-a5e2-a3829e40ca90_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations before income taxes and equity in earnings of equity method investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_c979de03-e373-4c86-946e-ae33ec0a595c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_b7e14e7d-0f7a-4d9e-af1a-8d502cb1f86f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited and cancelled weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_d6efef5c-a232-498e-a548-54c16be858c4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_68eb8daa-13d3-429d-ad36-9d82ddd2f401_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_c3814517-5298-4cff-a075-a320627ab520_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_ab1890e5-0205-47a7-9e66-5f6be977ab62_terseLabel_en-US" xlink:label="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.70% Senior Notes due March 2045</link:label>
    <link:label id="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_label_en-US" xlink:label="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Zero Percent Senior Notes due March 2045 [Member]</link:label>
    <link:label id="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_documentation_en-US" xlink:label="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Zero Percent Senior Notes due March 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:href="dgx-20211231.xsd#dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:to="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_0a5f3dff-2044-47a0-b761-0caff92f5a53_terseLabel_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIS business</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_label_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_documentation_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:href="dgx-20211231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:to="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9973e906-a948-41f0-a798-44abdaaa6100_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a5d0df71-870f-4ccc-b59b-060fb62d0089_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_7630f49d-789f-430f-b64d-006f03832ca1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_cf76676d-75eb-4dcd-bfcb-616a47c541a8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_d77eb0e7-8843-4290-81c5-2b50beab9d4d_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW AND OTHER DATA</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2c718d5c-a308-4ec3-b269-5f6c0362917c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c30d3fca-382c-440c-ae09-4bb54e3e7a8a_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_6773eccd-c4fe-4437-b835-d1c9f6083949_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_5b286959-8307-4d3e-a788-3b192479f67e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_005f3c62-8a53-4552-be3a-8530cfe0c0ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_07fdf976-1c06-47a7-88e5-a86d8b214fa6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_1f71cca9-86bb-4bd5-ae1b-d45992ecb131_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="dgx-20211231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ca729333-2a24-46d0-b620-ed08b179a06b_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK OWNERSHIP AND COMPENSATION PLANS</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_40f99362-7033-4044-9daf-ddd5315159bd_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_9117f411-0aa7-41b3-9e60-b31888c8dfd6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_ca207c33-585b-4489-acc8-ff7841613be9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LeaseRightofUseAsset_998de589-a52c-4238-ae1d-7d0ad1561e1b_totalLabel_en-US" xlink:label="lab_dgx_LeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease assets</link:label>
    <link:label id="lab_dgx_LeaseRightofUseAsset_label_en-US" xlink:label="lab_dgx_LeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_dgx_LeaseRightofUseAsset_documentation_en-US" xlink:label="lab_dgx_LeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRightofUseAsset" xlink:href="dgx-20211231.xsd#dgx_LeaseRightofUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LeaseRightofUseAsset" xlink:to="lab_dgx_LeaseRightofUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_78b0f97b-3015-4e71-ae0d-718de600f540_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_903cfd51-19fc-4383-8a56-a6d14885a5df_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:href="dgx-20211231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_b10a51e1-ac09-43ae-90a4-296f7036351b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses and other operating expense (income):</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_4b4bb7bd-6dff-4a28-8435-82fb9098b1ef_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_969d7aa5-3ef0-4a33-9ee7-7c00ab109e47_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-operating income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_4dbf64b1-caf3-4995-a126-34830c48290e_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_29adaa0d-e926-4625-beb1-e1124d2420e2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired during the year</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5d76b24e-627b-464b-8fa7-df9a386fc96a_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_f5881e15-fdff-4d59-8bf0-a2ca85bb194a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_8ae21ce4-6613-4d35-b576-706b1f087fee_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7c08cf9c-5f8e-4d42-b944-3c0c525c70f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_30a16dd6-1db3-4b8c-b0ef-90c019c8604d_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated net loss from designated or qualifying cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d87eb181-c07c-49c2-a65a-0e4f557b02a2_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_626633fc-0531-4f07-b02a-f80b0ae42d18_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1cdc1997-9013-4af0-8556-23a2bbc59c2f_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6c4c6f20-fe4b-4a62-9d61-9fdcfa62af84_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_b2c3cf07-7bd6-4588-b089-4a5cea6e4402_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_42ddd00c-328a-4f5f-9cd2-a38ac3ebddc4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_6aa9b975-3afe-44b4-b1a4-00345d227f39_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_01482f30-54c2-47c1-a876-0cc64a00a70b_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_bf1e4ce6-bdfc-469c-aabc-42e60889fec9_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses, net</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d8453286-de53-4a36-b986-e3545e5decaf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_da0a2489-0c30-498c-96af-5bdde4f86a1c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_53a48ef1-c63f-4bd2-8709-aeae33299872_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_e790d905-3732-4c63-a7dc-98c8db3fe50a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7f6b55b3-6843-4a23-bba1-8459d2dfa69a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_1260e483-34e0-4aa4-ba7b-9d2e48ce5534_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund from taxing authorities related to settlement of the uncertain tax benefits</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_e61f3439-f76a-4e7c-ba29-bb589f19972b_terseLabel_en-US" xlink:label="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units with market-based relative TSR goal</link:label>
    <link:label id="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_label_en-US" xlink:label="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units with market-based relative TSR goal [Member]</link:label>
    <link:label id="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_documentation_en-US" xlink:label="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units with market-based relative TSR goal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:href="dgx-20211231.xsd#dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:to="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RevenueCollectionofConsiderationPeriod_c05fcc4f-add5-42af-ba83-54858a1755b2_terseLabel_en-US" xlink:label="lab_dgx_RevenueCollectionofConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collection of consideration</link:label>
    <link:label id="lab_dgx_RevenueCollectionofConsiderationPeriod_label_en-US" xlink:label="lab_dgx_RevenueCollectionofConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Collection of Consideration Period</link:label>
    <link:label id="lab_dgx_RevenueCollectionofConsiderationPeriod_documentation_en-US" xlink:label="lab_dgx_RevenueCollectionofConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Collection of Consideration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RevenueCollectionofConsiderationPeriod" xlink:href="dgx-20211231.xsd#dgx_RevenueCollectionofConsiderationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RevenueCollectionofConsiderationPeriod" xlink:to="lab_dgx_RevenueCollectionofConsiderationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_23e43c08-cd13-4048-b5b7-3c1bc8b3f839_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_da41fcda-69b4-4539-832c-caab0aa96c1c_terseLabel_en-US" xlink:label="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.50% Senior Notes due March 2025</link:label>
    <link:label id="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_label_en-US" xlink:label="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Five Zero Percent Senior Notes due March 2025 [Member]</link:label>
    <link:label id="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_documentation_en-US" xlink:label="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Five Zero Percent Senior Notes due March 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:href="dgx-20211231.xsd#dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:to="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesTable_366c07e3-5a53-4820-8893-a2071fdbb081_terseLabel_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant accounting policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:href="dgx-20211231.xsd#dgx_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_f6fac47e-81b7-48ea-84ab-bbd56f261b56_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_41d322fc-bf15-4374-a49e-412e934547cc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_76edec6f-6b1c-4a4c-b322-ad72e9ba8062_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ca95e164-98e7-4711-b4be-6fed5da6d1f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations - foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_71674abb-ed22-4072-80da-34d7601df0b6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_34a6318a-9116-4570-884c-f75fcd8aef02_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3f54a989-015a-4a5f-9420-b15adc3c0114_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock_ff69a7c0-b2ff-40b7-bac5-3d819950dea2_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Term and Discount Rate</link:label>
    <link:label id="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Term and Discount Rate [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Term and Discount Rate [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:href="dgx-20211231.xsd#dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:to="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f7b39dbb-75f2-4a21-94d9-ae7a7534a450_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_04cb0962-de5b-48ff-b914-bf3b6091c287_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e5c0f6b3-f430-404a-a7dd-72ae94bdb112_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_6a871721-855f-4264-9175-3cdcee20abbb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_0784212f-9ac3-4f89-a602-317dc92054b8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_78e586cf-b774-48fa-b928-0abe8a1ef72e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_9ab5d090-3e53-4947-8ded-a22a166211c8_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_e5b5b183-c14b-4743-a68a-113554559f43_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_658e8ab4-fad3-4a09-8c9f-e038cc6592e9_verboseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_04190b36-904d-479a-8977-a4134a522bb6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at Cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_6280df27-2307-4b2f-bc1c-8f342a19fccb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_751df552-ddb7-4ef7-8d16-daa7d9171ffc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_60b366f3-d207-4e8b-86d7-adde5edf6baf_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1091cb03-1a85-4012-b210-398ea0250a57_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OtherEquityComponentsMember_e60b9ef6-61a6-4524-bd0e-3884332133eb_terseLabel_en-US" xlink:label="lab_dgx_OtherEquityComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dgx_OtherEquityComponentsMember_label_en-US" xlink:label="lab_dgx_OtherEquityComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Equity Components [Member]</link:label>
    <link:label id="lab_dgx_OtherEquityComponentsMember_documentation_en-US" xlink:label="lab_dgx_OtherEquityComponentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Equity Components [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherEquityComponentsMember" xlink:href="dgx-20211231.xsd#dgx_OtherEquityComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OtherEquityComponentsMember" xlink:to="lab_dgx_OtherEquityComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_6a53ffb3-2717-468b-8b4b-ceab6472930d_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_03864bc1-16bd-485b-911c-545d35ecf025_terseLabel_en-US" xlink:label="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryfowards, net of valuation allowance</link:label>
    <link:label id="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_label_en-US" xlink:label="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryfowards, net of valuation allowance</link:label>
    <link:label id="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_documentation_en-US" xlink:label="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:href="dgx-20211231.xsd#dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:to="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OperatingandFinanceLeaseLiability_b8c36c20-1121-4da6-aad8-a844c9e28d2d_totalLabel_en-US" xlink:label="lab_dgx_OperatingandFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_dgx_OperatingandFinanceLeaseLiability_label_en-US" xlink:label="lab_dgx_OperatingandFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and Finance Lease, Liability</link:label>
    <link:label id="lab_dgx_OperatingandFinanceLeaseLiability_documentation_en-US" xlink:label="lab_dgx_OperatingandFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lessee's discounted obligation for lease payments from operating and finance leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingandFinanceLeaseLiability" xlink:href="dgx-20211231.xsd#dgx_OperatingandFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OperatingandFinanceLeaseLiability" xlink:to="lab_dgx_OperatingandFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_COVID19TestingServicesMember_a88ff652-80fc-41b4-973a-3290239bbc5b_terseLabel_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 testing services</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_label_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services [Member]</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_documentation_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember" xlink:href="dgx-20211231.xsd#dgx_COVID19TestingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_COVID19TestingServicesMember" xlink:to="lab_dgx_COVID19TestingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_94ac14ff-750f-49e8-96bf-2ec5acf51669_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0f90d295-c1f5-49c7-a62b-009f4b3bc005_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, granted weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a2852e1f-654f-486e-8614-54ae5f9d5dca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, end of year aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_94a60dc4-a01a-42bc-bcc6-fcd09cbc9c77_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d1fe4709-b004-4c60-8b6d-d6be6539f3d1_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_fce525c2-0047-4d51-b20d-846d1dc4c9f7_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_4285b3f2-d2c8-4380-ae8f-7285faf8570b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_a5aafb47-a76a-4045-8702-5a93cf0ed01a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_d730c249-ad16-4cbb-87b7-c4c6c844889c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityTable_3a9ffd1d-a70b-4ae9-bd8c-381d5d302420_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shareholders' Equity [Table]</link:label>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityTable_label_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shareholders' Equity [Table]</link:label>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityTable_documentation_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shareholders' Equity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityTable" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareholdersEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable" xlink:to="lab_dgx_ScheduleOfShareholdersEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_33ada4e0-b815-4a80-a3dc-09580bb2b86e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_df0e83cd-b727-4e51-aa65-308281d8fa9c_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_bef86ef4-083f-4142-a574-f8e5577aebf1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP accrual</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Recorded Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_3ec3ae54-c06f-4665-82f5-0686079858ae_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_9cffd23b-a921-46a9-b58c-1211d98340fe_verboseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software Developed or Obtained for Internal Use</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_c85fa6ae-1ded-466f-804f-d9013f13035f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_c6c77f2f-02b9-4466-bf19-c7893ec47a7f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_c3e585a1-baa1-4213-b184-270e69d81ead_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount_bf397350-c4d8-4050-ae44-a9ba57f7f3da_terseLabel_en-US" xlink:label="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, excess tax benefit, amount</link:label>
    <link:label id="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount_label_en-US" xlink:label="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, excess tax benefit, amount</link:label>
    <link:label id="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount_documentation_en-US" xlink:label="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, excess tax benefit, amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:href="dgx-20211231.xsd#dgx_Sharebasedcompensationexcesstaxbenefitamount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:to="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e43afb5e-93df-4f96-8394-a5fe31b6659e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_2c293c3d-8737-4aca-a329-c3dcd5f20270_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:to="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SdcpIiGradedVestingPercentage_c4ed44b3-99ac-47f7-bac2-769ced7676e7_terseLabel_en-US" xlink:label="lab_dgx_SdcpIiGradedVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II graded vesting percentage</link:label>
    <link:label id="lab_dgx_SdcpIiGradedVestingPercentage_label_en-US" xlink:label="lab_dgx_SdcpIiGradedVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II graded vesting percentage</link:label>
    <link:label id="lab_dgx_SdcpIiGradedVestingPercentage_documentation_en-US" xlink:label="lab_dgx_SdcpIiGradedVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II graded vesting percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiGradedVestingPercentage" xlink:href="dgx-20211231.xsd#dgx_SdcpIiGradedVestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SdcpIiGradedVestingPercentage" xlink:to="lab_dgx_SdcpIiGradedVestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3c61c9da-7da2-4c03-b5c2-f6c329245343_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_634c51bb-f1dc-4e5b-94ef-a6102cbecd99_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_2423fd09-5ff8-4cd8-9e6a-d8e74a25222e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_ced4045c-c91b-4897-9672-8a6e4d924da7_terseLabel_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing and other services</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_label_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services [Member]</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_documentation_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember" xlink:href="dgx-20211231.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RoutineclinicaltestingservicesMember" xlink:to="lab_dgx_RoutineclinicaltestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_d406d22d-1c2b-4875-b616-2ef64732b8da_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_08b09918-f7b9-4b2d-96e5-c5691f3d870d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased by eligible employees under ESPP</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_0976d12f-de37-41ce-99cf-26b976ee1506_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_432aada5-262d-417a-a311-669a30f55a68_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_05607e76-ac34-4a4a-a0cc-ebcd42664616_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_e2cd7ca9-c33a-4eed-8139-a436b2410958_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Liability Balances Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_5a674334-67c6-4baf-be1f-9117dfdf6669_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_390d2246-beb8-4fc1-a283-7c4603e68cd4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_160195de-f262-4c04-b2e0-78a2f57b90fd_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1eb6faec-1388-4639-98e8-57eac9022145_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e0ccb50e-7b29-464f-bcdd-dc20e2e111f2_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2960b218-3ead-4050-9609-e035d885b003_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d6e50be5-ffd0-447f-9692-ecd7870e83fc_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_444ebb1b-2558-4c12-8990-a1645f47d6db_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_853c8025-d745-4753-9e79-2ae4e4c9556f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_82fb503d-5e0a-4de1-bed3-ea74e920dfb8_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_500f0cad-3bd6-42d3-9873-f610310e4b07_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
    <link:label id="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_label_en-US" xlink:label="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_6e3ceb85-ce4b-4d49-94e0-40746a16c367_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_746f20a6-755b-4f1e-83a8-9eac02e55e75_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Losses on Cash Flow Hedges, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_ba23c3d8-f103-46d7-849f-2cfd9dfdbb8f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b16db7e6-84f7-4cf0-8f33-bb101bc36b74_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_13487876-8ac5-495a-8b98-75d7cd6651ae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defered federal income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1a678462-4495-4653-b054-bafbc5f00429_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_734ae75b-bb71-4191-a094-187489d02630_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6c671f7c-7394-4f11-8443-53567950c9bd_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_d6656589-78df-4237-9378-8b55ba7e5d01_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_9ad93a88-c52a-4f48-bcdb-10d5869e45ee_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without readily determinable fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_c9956b22-3168-4bcf-b842-6ace60a4bf5b_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_bc3c68b5-7e85-4e7a-99ca-292585176a06_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_eda1c247-686f-4193-9c4f-2c67b0d596d9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans, sharers</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e7cdd3f6-4a55-43c7-94e7-500e9f04427e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_ee3225f1-3698-4cc6-972d-502b2eb68dfc_terseLabel_en-US" xlink:label="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on settling uncertain tax benefits</link:label>
    <link:label id="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_label_en-US" xlink:label="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain on Settling Uncertain Tax Benefits</link:label>
    <link:label id="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_documentation_en-US" xlink:label="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain on Settling Uncertain Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:href="dgx-20211231.xsd#dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:to="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MercyHealthMember_c3539865-ccc6-41d1-ab76-d6e20d3f81e4_terseLabel_en-US" xlink:label="lab_dgx_MercyHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mercy Health</link:label>
    <link:label id="lab_dgx_MercyHealthMember_label_en-US" xlink:label="lab_dgx_MercyHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mercy Health [Member]</link:label>
    <link:label id="lab_dgx_MercyHealthMember_documentation_en-US" xlink:label="lab_dgx_MercyHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mercy Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MercyHealthMember" xlink:href="dgx-20211231.xsd#dgx_MercyHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MercyHealthMember" xlink:to="lab_dgx_MercyHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_5275eeca-a4d3-4b55-942c-a330ac9f4bc4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_fa891a84-8f59-4d90-91ca-e5660328a895_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2615d28b-79ac-4303-acca-8405d4c4c672_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities_417d4441-24df-4959-b842-e3b6fbe73038_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finance Lease Liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finance Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_53301982-aa82-439e-b0a0-1b1a5e809749_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_7f7798a7-a810-4242-b08d-33356e4015d7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_7fdc5c29-b280-4250-ab24-1426ff207720_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Country</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_451b4c59-accd-4091-91a2-6716e3a2108e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_32be41d0-01a3-4d27-a611-829439a6a319_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Contingent Consideration Payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ba6ea4e7-6fa8-4f3e-b202-a84c638f7a0a_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration arrangements, range of outcomes, value, high</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0b378673-0454-42ed-8b86-82c5679fe1d4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5e684ea9-553c-4d85-9d60-a8d38c36f45c_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GovernmentPayersMember_aff8c88b-cb74-4b6a-94a7-a04e36778a8c_terseLabel_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government payers</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_label_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_documentation_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember" xlink:href="dgx-20211231.xsd#dgx_GovernmentPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GovernmentPayersMember" xlink:to="lab_dgx_GovernmentPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_acbc8674-57ce-49e9-bb78-991919d5370d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_9036a6c2-c41d-459b-9f45-a2d5a233107e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation arrangement with individual, employer contribution</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_46c7bb80-96ae-4675-a4d8-d698a4a0c455_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_68361a6e-0b8c-48ad-89a2-b40fd2ff50ec_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, interest on income taxes accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_9be615e3-7074-4e52-b91b-cc661080e2fa_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction_2e768fc7-43b8-447b-9f71-db03f6d26333_terseLabel_en-US" xlink:label="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement to outsource billing and collection function</link:label>
    <link:label id="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction_label_en-US" xlink:label="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement to Outsource Billing and Collection Function</link:label>
    <link:label id="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction_documentation_en-US" xlink:label="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement to Outsource Billing and Collection Function</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:href="dgx-20211231.xsd#dgx_AgreementtoOutsourceBillingandCollectionFunction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:to="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_c47474ea-e684-47f1-84cf-d6cc22a3ef84_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_30d4ac57-b102-4b6b-b66a-3755f88cb61b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ab0ac6e9-a6bc-4963-b88a-c2e13be07204_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_43d7717e-cae1-482d-ac44-6cce83e9fc4c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_ad550517-c0bb-4c08-9533-2a6fbf57cefe_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_ba071439-740b-4ba8-8b14-db79a4dc4767_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, discount rate used to determine fair value</link:label>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_label_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Dicount Rate used to determine fair value</link:label>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Dicount Rate used to determine fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:to="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_523e79e6-3d65-4cbc-81e2-a2550fbb484c_terseLabel_en-US" xlink:label="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in quarterly dividends as percent</link:label>
    <link:label id="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_label_en-US" xlink:label="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Common Stock, Dividends, Declared as Percent</link:label>
    <link:label id="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_documentation_en-US" xlink:label="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Common Stock, Dividends, Declared as Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:href="dgx-20211231.xsd#dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:to="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_c92c41dd-85a7-46d7-a0b4-601a358de5e1_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_87262151-0390-4969-97a6-9566eb9e0cb0_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_aba06b5b-7cd4-46ac-b71d-755e976f82fb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_8615ebd7-8431-47f3-8e02-7b167dc2c068_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_6d51bdbe-a9f9-4a69-a676-a45154bd6ef0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_83e5a65e-d8c2-459e-9b5d-bd121d8330f4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c9a4d420-3142-4289-ab44-354fb01f7d71_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c8446dfc-d9cc-4212-af33-7dc36347a615_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_912db2f1-bdd2-41cd-85f2-9e9dbf808c50_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_02a6d21e-ec10-4ccf-85f1-853c991d2626_terseLabel_en-US" xlink:label="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation, 2023 through 2024</link:label>
    <link:label id="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_label_en-US" xlink:label="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due within Two and Three Years</link:label>
    <link:label id="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_documentation_en-US" xlink:label="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due within Two and Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:href="dgx-20211231.xsd#dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:to="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_HealthcareInsurersMember_938f92f9-9d1b-4e34-a3a2-7e4ba55da810_terseLabel_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare insurers:</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_label_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_documentation_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember" xlink:href="dgx-20211231.xsd#dgx_HealthcareInsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_HealthcareInsurersMember" xlink:to="lab_dgx_HealthcareInsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_a991aff1-22e3-4dbb-8000-64f05593b8dc_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_194e5037-fe19-4fc4-ba7e-30cd3c5829b7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_36d98056-feac-40a0-9243-a7639f4d13d6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9a771d5-d352-49a1-a831-c7cfb78f9fe2_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5667ab0e-914b-4d23-b3b8-0662abc8df86_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b9622dd4-a913-4e2a-8f44-5d9cdb3d5d8b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_5ed9c66c-f827-4c50-a3fa-37df955733c2_terseLabel_en-US" xlink:label="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum)</link:label>
    <link:label id="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_label_en-US" xlink:label="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) [Member]</link:label>
    <link:label id="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_documentation_en-US" xlink:label="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:href="dgx-20211231.xsd#dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:to="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_71b94310-0a29-4e2b-b816-ffa6b6294bf1_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance reserves</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_2646f671-d07a-495c-b850-a144880c7220_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_91c3015b-1111-4f32-8ba0-af2310b6329f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_563ad9a4-2d8d-4869-a913-5f897764b482_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_cf85b762-22dc-4a3e-a60e-8f484b829a36_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b8441279-252f-4cb0-8278-3ffbe4c0029f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d7d4aa2d-ac17-4571-b6c5-edecc3a39ec7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_51d64340-6da3-45ec-b79d-80a7bac98767_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Federal Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_ea77c1b2-a775-4297-8a58-b496a8bbc0e6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_0bac49b5-12cf-4d02-a38f-c959387a4c85_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_7920b3fb-fed0-4942-a146-cef3a5b6de81_totalLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e77df6e4-47a8-4f6e-82e8-c23571d82108_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_238fd96c-21d2-44b2-a7c3-bccf7c9e16ae_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6ce0a310-d8cf-47c5-93d1-c553f1048871_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_089de6ac-623b-4e95-8bb5-d97aafbf91c6_terseLabel_en-US" xlink:label="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_label_en-US" xlink:label="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment without Readily Determinable Fair Value, Impairment</link:label>
    <link:label id="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_documentation_en-US" xlink:label="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment without Readily Determinable Fair Value, Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:href="dgx-20211231.xsd#dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:to="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ce5b04ee-53bc-4df6-abec-21df0d60fd1d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares, outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_964ff570-0e71-4add-9f34-aa7ffbf3638f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3ce9b2a0-3e4e-423a-9e6a-d6944fa1441c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_721f3760-bbfa-451a-a7f1-3ffb37ef3cfc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_e46cdce6-99ed-4706-b2f5-e5a881e2c323_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7453e653-8696-4bd5-b61b-694afec4a6e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_1297214f-cde7-43ab-aeb3-ea22d1ddff0e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_b9b5675b-0daf-4747-9031-2b70f7158137_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8b7e38c3-b515-490d-a048-290697bb6e4b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_85ba6307-5e3c-4702-9b81-3bfa85c17704_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d062a5ba-0bc5-4098-a302-c4a4d02594e6_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_2d6ac95a-b6a8-4da5-baa7-f1a25fdf8132_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer - related</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_02fbbd62-9354-4e2a-9239-5c36ba15be26_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MemorialHermannMember_3a109c95-e46d-4384-8145-f082a9990c52_terseLabel_en-US" xlink:label="lab_dgx_MemorialHermannMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Memorial Hermann</link:label>
    <link:label id="lab_dgx_MemorialHermannMember_label_en-US" xlink:label="lab_dgx_MemorialHermannMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Memorial Hermann [Member]</link:label>
    <link:label id="lab_dgx_MemorialHermannMember_documentation_en-US" xlink:label="lab_dgx_MemorialHermannMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Memorial Hermann [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MemorialHermannMember" xlink:href="dgx-20211231.xsd#dgx_MemorialHermannMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MemorialHermannMember" xlink:to="lab_dgx_MemorialHermannMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_ea8df110-96df-4098-805e-a5b59693131e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_65a32720-3c5a-463e-9e41-8cc5c4e1125f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ee274d47-bd21-4d00-b0c4-5daf74ad7c41_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_9d0bd7b4-ee99-4826-a44a-542bc3ce27e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_7df69ba2-19fc-4d23-985c-fbadcde08cc3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b7191d8a-cd91-4e82-bf87-4a9ae6f2ab60_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d11ed785-4006-4a18-917c-ea37af650106_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_efcb75d9-b701-4b97-8802-b608425ab0e7_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_79394359-ffb3-419d-8c03-f9ca37d94540_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock_e713999f-5d3c-4cdb-becd-987a1cedb73f_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used in Valuing The Company's Performance Share Units</link:label>
    <link:label id="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Performance Share Units, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Performance Share Units, Valuation Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:to="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FeeforserviceMember_86b6c634-2014-4d6f-9ec6-3527e7dceaa2_terseLabel_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_label_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_documentation_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember" xlink:href="dgx-20211231.xsd#dgx_FeeforserviceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FeeforserviceMember" xlink:to="lab_dgx_FeeforserviceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_3f68af03-0254-4226-816d-bd3b4da0dd69_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, end of year shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_02bd16dd-ede4-4504-8947-7291675657c6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_ff5c637f-405a-4618-8c98-e1071b1325c7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of year weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_cac9fa87-47da-409f-85dc-660bb6df123c_terseLabel_en-US" xlink:label="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% Senior Notes due April 2024</link:label>
    <link:label id="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_label_en-US" xlink:label="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four point two five percent Senior Notes Due 2024 [Member]</link:label>
    <link:label id="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_documentation_en-US" xlink:label="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four point two five percent Senior Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:href="dgx-20211231.xsd#dgx_FourpointtwofivepercentSeniorNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:to="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_39d08953-88fe-4e74-af55-b735e3b8aa2a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_99dd9e70-de2f-44f2-b88c-c3f992cd9087_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_2eabc42f-1d99-40e5-b940-6d4deb71e96e_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_cc8b860a-8559-4b94-a544-16b021468ae0_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_4df97d87-0665-479a-b941-4476a891aed5_terseLabel_en-US" xlink:label="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Senior Notes due June 2030</link:label>
    <link:label id="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_label_en-US" xlink:label="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Nine Five Percent Senior Notes due June 2030 [Member]</link:label>
    <link:label id="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_documentation_en-US" xlink:label="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Nine Five Percent Senior Notes due June 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:href="dgx-20211231.xsd#dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:to="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_d88ab6c4-ad5c-48f5-a7c9-400ef1be9913_terseLabel_en-US" xlink:label="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market price of company stock issued at a discount under the ESPP</link:label>
    <link:label id="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_label_en-US" xlink:label="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market price of Company stock issued at a discount under the ESPP</link:label>
    <link:label id="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_documentation_en-US" xlink:label="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Element represents the discounted market value of the Company stock on offering date or purchase date that participants pay for shares. Typically, the participant's per share cost is the lower of the prices on the two dates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:href="dgx-20211231.xsd#dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:to="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_239ba4e1-8a40-4aaa-91d3-f94d4d9d1799_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_092632a3-e224-4716-8219-b0e9917babe4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bcf52b16-99f2-40a9-abe3-2e580356b3ac_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_e2bb4b67-e603-431f-ab0c-0ae2d2b86c17_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_35027198-66bb-479b-a739-a5feb834f5b9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3908e83b-fd04-49a7-8837-e85ede26eedd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LabtechDiagnosticsLLCMember_c77e2d97-d119-410c-9755-1ce54526fdbe_terseLabel_en-US" xlink:label="lab_dgx_LabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labtech Diagnostics, LLC</link:label>
    <link:label id="lab_dgx_LabtechDiagnosticsLLCMember_label_en-US" xlink:label="lab_dgx_LabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labtech Diagnostics, LLC [Member]</link:label>
    <link:label id="lab_dgx_LabtechDiagnosticsLLCMember_documentation_en-US" xlink:label="lab_dgx_LabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labtech Diagnostics, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember" xlink:href="dgx-20211231.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LabtechDiagnosticsLLCMember" xlink:to="lab_dgx_LabtechDiagnosticsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_cf34ca57-1b9c-489c-a24a-a9f92db564d0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c135b802-0fca-4d55-8c05-44e78eaee994_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b5c7eb3f-cb30-4608-917f-64bc3e85745d_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b2958da5-2b22-4845-ba19-0d052ae94bc4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a598452e-b434-4819-896a-ee13aa4813fa_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2bb2170c-00b8-40ee-8d36-d0c3350bef39_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current period other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_c28fdec5-e8a4-40ba-ae2b-294a37c18c89_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_af01673c-ccad-4ea4-be30-511abf03a659_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_be9b7f31-d8d7-494b-8b6c-350d36fb76a4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_7d92b336-89bf-4df6-a791-f4e9286b91c8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_65e1631e-703b-4a2b-abbf-1dd4d58b14a7_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2810da11-e509-4288-a4c4-4641a19a6ef7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs of accounts receivable, net of recoveries</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_83152dab-13de-4fbe-90b7-af86db8653cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for expirations of statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_defc777a-e194-4bf6-b22f-8f43e42a2812_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3ae58a14-80e1-4151-8f48-0d8abe27a683_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_e94e7926-031b-44bb-94fa-24140b0af433_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_8697963a-5baa-4eea-a25c-3e7c1bfcbc0c_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_ee554f96-2ee3-40cf-ab56-1e3f65ea66e1_terseLabel_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreements</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_label_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreements [Member]</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_documentation_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:href="dgx-20211231.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:to="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9216155-40ed-4148-8ab2-10e0c7ad96a0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_02dbf4a6-71e5-4abb-a22f-f5b7a6c0291a_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_0fe3f739-f720-4107-bfa7-583af639ecce_verboseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_26354266-c412-4372-a4fe-2ddc014d6988_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_52ebbcb4-b7b5-4368-ab5f-c0f18eabb3ae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_41fba6c9-5abf-4f06-9081-645982a30c8c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_48a9f980-f8e8-4191-a21c-ee4ddd75bdb2_netLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for business acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AuditInformationAbstract_a17812b2-6caa-4362-8587-120a6d86c1a5_terseLabel_en-US" xlink:label="lab_dgx_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_dgx_AuditInformationAbstract_label_en-US" xlink:label="lab_dgx_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_dgx_AuditInformationAbstract_documentation_en-US" xlink:label="lab_dgx_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AuditInformationAbstract" xlink:href="dgx-20211231.xsd#dgx_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AuditInformationAbstract" xlink:to="lab_dgx_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d9d0986f-d3b5-4740-b519-0cf5cf20efa6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_4a321a8d-d811-4010-9be8-7e61c25a4859_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_458945b5-9cca-42ed-b759-483673a04c92_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_241348d3-5c69-40d5-8df5-5ce43fc79f8f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesPayment_242d6c2f-1e2b-4fb4-a17e-dee4f59403c1_terseLabel_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, payment</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesPayment_label_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Payment</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesPayment_documentation_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesPayment" xlink:href="dgx-20211231.xsd#dgx_AcceleratedShareRepurchasesPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AcceleratedShareRepurchasesPayment" xlink:to="lab_dgx_AcceleratedShareRepurchasesPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2341a07a-f546-47a5-a14f-01e440b91c60_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_d2f6efc2-cbe1-4922-ba99-e0fb4a3f775d_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising cost</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1d88a50e-716b-4f12-8ea2-5464065576d6_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_7f6ae5ca-6c88-42d9-9b45-32b8d57fecb0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_1c401da0-1121-4641-a71a-92b05beb2aff_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_15107da4-4b61-48e4-ae28-fd1a950c177d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_80a5d4b7-e5b4-4144-82ad-6030311ce7a5_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_ae76337f-defa-4faa-94a7-3870e07373d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_f6d04e8f-ef0c-4aa6-82c3-5f890ba36d70_terseLabel_en-US" xlink:label="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in reserves for uncertain tax positions</link:label>
    <link:label id="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_label_en-US" xlink:label="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change for uncertain tax position</link:label>
    <link:label id="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_documentation_en-US" xlink:label="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change for uncertain tax position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:href="dgx-20211231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:to="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_da6e0b49-ed9a-4357-a6e4-3aa76274742e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_d36cda09-44c5-47f5-ba74-1081b33988d3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current foreign income tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_a8052946-c1aa-4632-b9f1-a3fd725da7fd_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_f0a61f0c-7b8f-4a35-aa44-85d60d8c75ef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_0e32d030-974b-485d-85c7-1c6cb251d7bb_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_9355de57-f3ff-4a2d-954f-d4ddcd506f49_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_524380db-0ebd-4655-8577-f3e5ea5bf5cf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4422923c-e03b-4e40-9b78-c0927a487ae2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>dgx-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c829db2e-c850-44b9-90d1-7027e34dc7fe,g:892aaabe-58ca-45ff-95da-140e039c9f49-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20211231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f7fe9839-81b0-4890-9a29-33a22b7e75b9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_DocumentType_f7fe9839-81b0-4890-9a29-33a22b7e75b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_260349d3-cedd-4ad1-a35b-c214df00d3e5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_DocumentAnnualReport_260349d3-cedd-4ad1-a35b-c214df00d3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8dd8217c-62d2-443c-a045-a9f9e431b0ca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_DocumentPeriodEndDate_8dd8217c-62d2-443c-a045-a9f9e431b0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_8acb2a80-f336-4fd9-a868-3b189852227b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_CurrentFiscalYearEndDate_8acb2a80-f336-4fd9-a868-3b189852227b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f46b44ca-767c-4998-8657-51336caecc9e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_DocumentTransitionReport_f46b44ca-767c-4998-8657-51336caecc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e7638207-e1c9-4bea-bb92-93c8b8b88b12" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityFileNumber_e7638207-e1c9-4bea-bb92-93c8b8b88b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fc3be8d7-2210-4239-b918-eec9bc9fcc33" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityRegistrantName_fc3be8d7-2210-4239-b918-eec9bc9fcc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b880f38d-bba5-4d3d-a640-b4887ea6aca1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b880f38d-bba5-4d3d-a640-b4887ea6aca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9ded3c2d-18be-4518-9f60-14dfdff664c7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityTaxIdentificationNumber_9ded3c2d-18be-4518-9f60-14dfdff664c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e8995b92-efa8-4d8f-a677-e8f4ef3e8414" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityAddressAddressLine1_e8995b92-efa8-4d8f-a677-e8f4ef3e8414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_755a5e57-f3a0-4263-ace0-41208b3a3826" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityAddressCityOrTown_755a5e57-f3a0-4263-ace0-41208b3a3826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b55d834e-06fa-4a55-adb8-7dca831ca74e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityAddressStateOrProvince_b55d834e-06fa-4a55-adb8-7dca831ca74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_07ad0bb8-2b32-441d-817f-8137bced3dbd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityAddressPostalZipCode_07ad0bb8-2b32-441d-817f-8137bced3dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9a67f0a6-0b60-4057-ba16-0089f18da96e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_CityAreaCode_9a67f0a6-0b60-4057-ba16-0089f18da96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e3f9d0e3-b81c-44bb-a9ca-a737f8ec6424" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_LocalPhoneNumber_e3f9d0e3-b81c-44bb-a9ca-a737f8ec6424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c8e62376-83dd-4b2d-abfa-940c77b15b35" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_Security12bTitle_c8e62376-83dd-4b2d-abfa-940c77b15b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d4cb1127-e5d3-419e-a520-8bfd91cd2479" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_TradingSymbol_d4cb1127-e5d3-419e-a520-8bfd91cd2479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_925c5c04-5e57-4a55-9541-c57f77fd0664" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_SecurityExchangeName_925c5c04-5e57-4a55-9541-c57f77fd0664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_453501d4-2d86-44db-a1fd-4cba235e882d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_453501d4-2d86-44db-a1fd-4cba235e882d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_485a96a0-40d3-4b87-ad51-acaab6fd3fda" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityVoluntaryFilers_485a96a0-40d3-4b87-ad51-acaab6fd3fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ab8ce1a1-5df1-4f68-8467-2daaaff498dc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityCurrentReportingStatus_ab8ce1a1-5df1-4f68-8467-2daaaff498dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a07cbb78-4dbb-4c69-ae85-a8485c398415" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityInteractiveDataCurrent_a07cbb78-4dbb-4c69-ae85-a8485c398415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_89b33ff4-9a65-40eb-8532-694c1eb4cff9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityFilerCategory_89b33ff4-9a65-40eb-8532-694c1eb4cff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_617c76c2-b488-4195-b62c-29fd0487a58a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntitySmallBusiness_617c76c2-b488-4195-b62c-29fd0487a58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_39b6303f-e96b-49dd-bf0e-c2779e339d42" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityEmergingGrowthCompany_39b6303f-e96b-49dd-bf0e-c2779e339d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_897d4db2-a6d4-4e5e-9aa4-e70709f2e521" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityShellCompany_897d4db2-a6d4-4e5e-9aa4-e70709f2e521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_e8bfb834-1166-4b2a-99bf-8407ac227697" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityPublicFloat_e8bfb834-1166-4b2a-99bf-8407ac227697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c517a572-3a61-4e79-bdfc-79b5a240538c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c517a572-3a61-4e79-bdfc-79b5a240538c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_12b41ba7-fdf0-4865-b394-cc320f9d8f38" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_12b41ba7-fdf0-4865-b394-cc320f9d8f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_112908a9-39ec-44ed-a63c-5d4829341bcd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_EntityCentralIndexKey_112908a9-39ec-44ed-a63c-5d4829341bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_65a03641-391b-45a3-84da-7c00258abedd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_DocumentFiscalYearFocus_65a03641-391b-45a3-84da-7c00258abedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_18ab4f70-9fbe-490d-9e0e-dfd04355f83a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_DocumentFiscalPeriodFocus_18ab4f70-9fbe-490d-9e0e-dfd04355f83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_cae0e246-bc89-48f9-961f-5bc2f3da97a1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_AmendmentFlag_cae0e246-bc89-48f9-961f-5bc2f3da97a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_96ef4e35-8f72-420f-a2f2-da75cbb9291b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3e687503-4e8d-4bc0-a356-5515943f6772" xlink:to="loc_dei_IcfrAuditorAttestationFlag_96ef4e35-8f72-420f-a2f2-da75cbb9291b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/AuditInformation" xlink:type="simple" xlink:href="dgx-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AuditInformationAbstract_5f43333c-962d-4f0c-8888-a71c68496040" xlink:href="dgx-20211231.xsd#dgx_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_02bcc87d-6a72-4929-b5e8-b9dda384b530" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_AuditInformationAbstract_5f43333c-962d-4f0c-8888-a71c68496040" xlink:to="loc_dei_AuditorName_02bcc87d-6a72-4929-b5e8-b9dda384b530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_14f07b82-4760-4be0-86cb-44a3fe23f8c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_AuditInformationAbstract_5f43333c-962d-4f0c-8888-a71c68496040" xlink:to="loc_dei_AuditorLocation_14f07b82-4760-4be0-86cb-44a3fe23f8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_9f754af6-7142-4c69-b511-4ca5f9c6de91" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_AuditInformationAbstract_5f43333c-962d-4f0c-8888-a71c68496040" xlink:to="loc_dei_AuditorFirmId_9f754af6-7142-4c69-b511-4ca5f9c6de91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c768ecac-665d-4568-b849-f4a75a98ee7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c768ecac-665d-4568-b849-f4a75a98ee7b" xlink:to="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9989c8d7-d91c-4425-9f6c-1489f13a9595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9989c8d7-d91c-4425-9f6c-1489f13a9595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_837730c7-d35e-4ea9-8194-87753e94c36a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_837730c7-d35e-4ea9-8194-87753e94c36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_dfc5a1dc-22d6-4bd0-8f4a-34dbf526f727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_InventoryNet_dfc5a1dc-22d6-4bd0-8f4a-34dbf526f727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c67527c9-ec6b-4224-924b-9d1cbbae8b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c67527c9-ec6b-4224-924b-9d1cbbae8b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cc0983f4-3b14-41b8-a053-b27cb54a07e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_AssetsCurrent_cc0983f4-3b14-41b8-a053-b27cb54a07e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3093f21e-05aa-4271-82b8-bf4b6135fbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3093f21e-05aa-4271-82b8-bf4b6135fbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_20a363b9-d8a0-4da8-90ec-bea09a693a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_20a363b9-d8a0-4da8-90ec-bea09a693a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_43715411-5020-4571-8f12-cf4eb7848faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_Goodwill_43715411-5020-4571-8f12-cf4eb7848faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b1343574-9e69-44a9-82fa-66096cd3998b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b1343574-9e69-44a9-82fa-66096cd3998b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_0ab7c762-7164-4e57-a828-f52ed66b89c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_EquityMethodInvestments_0ab7c762-7164-4e57-a828-f52ed66b89c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9ca12ca8-d74d-450c-99b2-bd1da60b4b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9ca12ca8-d74d-450c-99b2-bd1da60b4b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f18418a1-40c3-426b-88ab-a205bbfb4b33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a028dba-8eb7-40dd-bec8-734b12d8a135" xlink:to="loc_us-gaap_Assets_f18418a1-40c3-426b-88ab-a205bbfb4b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c768ecac-665d-4568-b849-f4a75a98ee7b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2c624195-5e05-41f8-8f78-f69e241a151d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2c624195-5e05-41f8-8f78-f69e241a151d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b8c8f878-d231-4fcf-a4b7-b6e14feddb37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_LongTermDebtCurrent_b8c8f878-d231-4fcf-a4b7-b6e14feddb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_95c13ac7-d1f2-47da-8fee-d644faab9055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_95c13ac7-d1f2-47da-8fee-d644faab9055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_41d0446c-d662-4654-b2c7-0098a2d021ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_LiabilitiesCurrent_41d0446c-d662-4654-b2c7-0098a2d021ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_91e885cd-ebe0-40bf-990a-1ad38c5ddd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_91e885cd-ebe0-40bf-990a-1ad38c5ddd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_71020b37-c1ea-4ab7-9baa-241b1901b642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_71020b37-c1ea-4ab7-9baa-241b1901b642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3af9661a-322d-4859-a6c9-d2f87e5a712b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3af9661a-322d-4859-a6c9-d2f87e5a712b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f68732db-ea8f-47cd-b6a7-4e22df52e266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f68732db-ea8f-47cd-b6a7-4e22df52e266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6978c539-9a57-47d3-9385-aaa978e22f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6978c539-9a57-47d3-9385-aaa978e22f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_28d07531-d850-4888-9bb2-83deadf8e302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_28d07531-d850-4888-9bb2-83deadf8e302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_39383cc4-e9a1-49d9-b63b-c18cff308ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_28d07531-d850-4888-9bb2-83deadf8e302" xlink:to="loc_us-gaap_StockholdersEquityAbstract_39383cc4-e9a1-49d9-b63b-c18cff308ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_746230b4-d8a6-4478-853e-24d016cfb329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39383cc4-e9a1-49d9-b63b-c18cff308ed1" xlink:to="loc_us-gaap_CommonStockValue_746230b4-d8a6-4478-853e-24d016cfb329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b60a5b20-bde7-448d-bc63-4091717d5d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39383cc4-e9a1-49d9-b63b-c18cff308ed1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b60a5b20-bde7-448d-bc63-4091717d5d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cdfb7cd9-5e76-4a1d-a37c-1f1eaf424d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39383cc4-e9a1-49d9-b63b-c18cff308ed1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cdfb7cd9-5e76-4a1d-a37c-1f1eaf424d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_80bf8aab-067f-4826-acc9-d69144c75e79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39383cc4-e9a1-49d9-b63b-c18cff308ed1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_80bf8aab-067f-4826-acc9-d69144c75e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_42560cc3-2556-4453-9eec-52ab4af42e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39383cc4-e9a1-49d9-b63b-c18cff308ed1" xlink:to="loc_us-gaap_TreasuryStockValue_42560cc3-2556-4453-9eec-52ab4af42e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_498f451b-66eb-442e-bd15-5a54d22f94c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39383cc4-e9a1-49d9-b63b-c18cff308ed1" xlink:to="loc_us-gaap_StockholdersEquity_498f451b-66eb-442e-bd15-5a54d22f94c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_312f8a46-908a-4384-95da-3b40c3509808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_28d07531-d850-4888-9bb2-83deadf8e302" xlink:to="loc_us-gaap_MinorityInterest_312f8a46-908a-4384-95da-3b40c3509808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7249550b-9da8-4eb8-8045-88aad749c854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_28d07531-d850-4888-9bb2-83deadf8e302" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7249550b-9da8-4eb8-8045-88aad749c854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_79b1f07e-fc01-45d6-9cf3-75ad8f560796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_79b1f07e-fc01-45d6-9cf3-75ad8f560796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_42cb329c-9257-49ab-aa8d-c4e8eb8c6cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a3b6e9b-90a9-4141-b1d7-a9ad05820873" xlink:to="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_42cb329c-9257-49ab-aa8d-c4e8eb8c6cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_d52ee0d8-7f10-45c8-adad-92fce92a24b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_42cb329c-9257-49ab-aa8d-c4e8eb8c6cad" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_d52ee0d8-7f10-45c8-adad-92fce92a24b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d21114f5-83a9-4ce7-9f27-fce559a84a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_d52ee0d8-7f10-45c8-adad-92fce92a24b0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d21114f5-83a9-4ce7-9f27-fce559a84a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d1c6c6a4-ee16-4092-99c7-a7f61985e830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f58c7fb8-3987-4fa2-b8fd-6371f05a7602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1c6c6a4-ee16-4092-99c7-a7f61985e830" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f58c7fb8-3987-4fa2-b8fd-6371f05a7602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_47ece8fd-4759-4811-b38a-37282bcde6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1c6c6a4-ee16-4092-99c7-a7f61985e830" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_47ece8fd-4759-4811-b38a-37282bcde6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7e608a50-38ea-4724-80c8-8334cf40b8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1c6c6a4-ee16-4092-99c7-a7f61985e830" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7e608a50-38ea-4724-80c8-8334cf40b8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b89391fb-9887-475e-a835-efe06e0ce986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1c6c6a4-ee16-4092-99c7-a7f61985e830" xlink:to="loc_us-gaap_CommonStockSharesIssued_b89391fb-9887-475e-a835-efe06e0ce986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_91def0b5-d3aa-43cb-9703-b70cd9a189a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1c6c6a4-ee16-4092-99c7-a7f61985e830" xlink:to="loc_us-gaap_TreasuryStockShares_91def0b5-d3aa-43cb-9703-b70cd9a189a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_99164a4c-862b-43a0-a6bd-ecef7dc7681b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_99164a4c-862b-43a0-a6bd-ecef7dc7681b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_38c605f6-fd66-4309-8274-b7a53d4d5708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_CostOfRevenueAbstract_38c605f6-fd66-4309-8274-b7a53d4d5708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_941a6ad4-75e1-4568-86fe-2ae9ad9c1b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_38c605f6-fd66-4309-8274-b7a53d4d5708" xlink:to="loc_us-gaap_CostOfRevenue_941a6ad4-75e1-4568-86fe-2ae9ad9c1b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8ce7abfc-2773-47a1-9337-d256a252bf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_38c605f6-fd66-4309-8274-b7a53d4d5708" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8ce7abfc-2773-47a1-9337-d256a252bf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_559207dd-24ca-4868-a91c-d0769338fb85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_38c605f6-fd66-4309-8274-b7a53d4d5708" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_559207dd-24ca-4868-a91c-d0769338fb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_d481353d-cbbb-449f-8564-a5083e4b3fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_38c605f6-fd66-4309-8274-b7a53d4d5708" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_d481353d-cbbb-449f-8564-a5083e4b3fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ef7ec90d-b588-4f40-ac4f-24f9c8229117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_CostsAndExpenses_ef7ec90d-b588-4f40-ac4f-24f9c8229117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5bb4b529-8b0c-472d-b766-48b115143374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_OperatingIncomeLoss_5bb4b529-8b0c-472d-b766-48b115143374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5a1014f7-13be-4aa3-aa6d-481749e31732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5a1014f7-13be-4aa3-aa6d-481749e31732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_d1ae6593-c0e6-43e8-922f-54dae2172d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5a1014f7-13be-4aa3-aa6d-481749e31732" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_d1ae6593-c0e6-43e8-922f-54dae2172d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e77374c2-926d-45a2-bfb2-4044e5165627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5a1014f7-13be-4aa3-aa6d-481749e31732" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e77374c2-926d-45a2-bfb2-4044e5165627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_677ffe7a-edbe-42c0-9143-e4257ec5d698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5a1014f7-13be-4aa3-aa6d-481749e31732" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_677ffe7a-edbe-42c0-9143-e4257ec5d698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4bdd9e5b-5e22-47a8-97d4-6025acc2de8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4bdd9e5b-5e22-47a8-97d4-6025acc2de8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6e822572-034e-4a4a-969c-a8536dca7e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6e822572-034e-4a4a-969c-a8536dca7e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5649fb7c-d490-46fa-9a03-64409fb8d13f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5649fb7c-d490-46fa-9a03-64409fb8d13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_8de1f196-8998-4e84-a5f2-97ab9af3d183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_8de1f196-8998-4e84-a5f2-97ab9af3d183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_db23fece-852f-4add-b7b3-e6ccd0aaedba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_db23fece-852f-4add-b7b3-e6ccd0aaedba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_766b13eb-7c1b-4d45-9152-a2352774b442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_ProfitLoss_766b13eb-7c1b-4d45-9152-a2352774b442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2232f1cb-7c85-4ce1-b882-aa8d26a6d31a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2232f1cb-7c85-4ce1-b882-aa8d26a6d31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4ffd9e23-110a-4fef-b723-c00b128f7817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_NetIncomeLoss_4ffd9e23-110a-4fef-b723-c00b128f7817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6f3b5b8e-1b9d-4f8c-b2c8-a92301e4ada9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6f3b5b8e-1b9d-4f8c-b2c8-a92301e4ada9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_d2d5a3f0-b82c-4753-96a1-fc9a765e8fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6f3b5b8e-1b9d-4f8c-b2c8-a92301e4ada9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_d2d5a3f0-b82c-4753-96a1-fc9a765e8fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_09ac424b-45da-43d0-ad1f-7e80fbab52f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6f3b5b8e-1b9d-4f8c-b2c8-a92301e4ada9" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_09ac424b-45da-43d0-ad1f-7e80fbab52f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c947572b-37a5-4226-99f7-25761edf1d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6f3b5b8e-1b9d-4f8c-b2c8-a92301e4ada9" xlink:to="loc_us-gaap_NetIncomeLoss_c947572b-37a5-4226-99f7-25761edf1d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_a80e2b14-7283-477c-986c-80ba4f0286a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_a80e2b14-7283-477c-986c-80ba4f0286a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_7a7a6d43-a8c3-412d-913c-4e401c811fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_a80e2b14-7283-477c-986c-80ba4f0286a2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_7a7a6d43-a8c3-412d-913c-4e401c811fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_3fb66b61-e2be-4c45-beee-574b8ed836c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_a80e2b14-7283-477c-986c-80ba4f0286a2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_3fb66b61-e2be-4c45-beee-574b8ed836c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_22bf2ab6-e39b-498b-9353-a3f1aa2e285f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_a80e2b14-7283-477c-986c-80ba4f0286a2" xlink:to="loc_us-gaap_EarningsPerShareBasic_22bf2ab6-e39b-498b-9353-a3f1aa2e285f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_0c7a87fb-2bef-4d0c-9e2f-04d65ee459fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ac983fcc-b91e-4ec2-b7e1-8c8f103280c1" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_0c7a87fb-2bef-4d0c-9e2f-04d65ee459fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_cf192f21-8c69-45c3-9edd-db70c2a142d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_0c7a87fb-2bef-4d0c-9e2f-04d65ee459fc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_cf192f21-8c69-45c3-9edd-db70c2a142d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_6b4c2167-63c9-42f6-8768-473c174cfb47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_0c7a87fb-2bef-4d0c-9e2f-04d65ee459fc" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_6b4c2167-63c9-42f6-8768-473c174cfb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8b9329ab-f904-4e9a-9b67-bacebe35f758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_0c7a87fb-2bef-4d0c-9e2f-04d65ee459fc" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8b9329ab-f904-4e9a-9b67-bacebe35f758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS_1"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a45874bc-372d-4f6b-92af-b064ebffa30e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_39daa678-4c6a-49a6-8b0d-16821c626d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a45874bc-372d-4f6b-92af-b064ebffa30e" xlink:to="loc_us-gaap_ProfitLoss_39daa678-4c6a-49a6-8b0d-16821c626d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a58363d5-2756-4f9c-a3e5-73b880b1c5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a45874bc-372d-4f6b-92af-b064ebffa30e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a58363d5-2756-4f9c-a3e5-73b880b1c5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_000490a5-c168-49f7-9573-9eeba911cb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a58363d5-2756-4f9c-a3e5-73b880b1c5b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_000490a5-c168-49f7-9573-9eeba911cb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_32ab06d2-802e-4e78-a718-303a51ada20a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a58363d5-2756-4f9c-a3e5-73b880b1c5b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_32ab06d2-802e-4e78-a718-303a51ada20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_416892d5-8f8a-4915-860e-28361f4638a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a58363d5-2756-4f9c-a3e5-73b880b1c5b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_416892d5-8f8a-4915-860e-28361f4638a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a4ebe3c5-0537-4908-a158-fca39a5ef975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a58363d5-2756-4f9c-a3e5-73b880b1c5b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a4ebe3c5-0537-4908-a158-fca39a5ef975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a6028b88-0095-494a-b29d-e4aea3a08f80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a45874bc-372d-4f6b-92af-b064ebffa30e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a6028b88-0095-494a-b29d-e4aea3a08f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4aef4fe8-9080-4023-831f-fa6054e71a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a45874bc-372d-4f6b-92af-b064ebffa30e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4aef4fe8-9080-4023-831f-fa6054e71a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2786022a-70e8-471c-be53-f53093e16ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a45874bc-372d-4f6b-92af-b064ebffa30e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_2786022a-70e8-471c-be53-f53093e16ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_cdfa8c78-efbd-40dc-97a6-3f891937fc38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_845b1063-8358-41dc-a0e7-c40a4d3caa42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cdfa8c78-efbd-40dc-97a6-3f891937fc38" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_845b1063-8358-41dc-a0e7-c40a4d3caa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_608fe53e-194d-44b5-9045-90b93148c976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_845b1063-8358-41dc-a0e7-c40a4d3caa42" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_608fe53e-194d-44b5-9045-90b93148c976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_713cdff2-24a0-405d-9539-8cde3c09ba9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_608fe53e-194d-44b5-9045-90b93148c976" xlink:to="loc_us-gaap_ProfitLoss_713cdff2-24a0-405d-9539-8cde3c09ba9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4632e77a-f3df-4056-8388-25c5988764cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_608fe53e-194d-44b5-9045-90b93148c976" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4632e77a-f3df-4056-8388-25c5988764cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5938aeed-80e0-4cb4-a1bd-c878d2582fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4632e77a-f3df-4056-8388-25c5988764cf" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5938aeed-80e0-4cb4-a1bd-c878d2582fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_35d750f4-7b8a-42fb-8689-132690829dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4632e77a-f3df-4056-8388-25c5988764cf" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_35d750f4-7b8a-42fb-8689-132690829dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_94168e03-b99f-48d6-a2c6-b90f6f333a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4632e77a-f3df-4056-8388-25c5988764cf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_94168e03-b99f-48d6-a2c6-b90f6f333a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6f33bf90-1f28-4737-8014-f82f17b247a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4632e77a-f3df-4056-8388-25c5988764cf" xlink:to="loc_us-gaap_ShareBasedCompensation_6f33bf90-1f28-4737-8014-f82f17b247a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossOnDispositionOfJointVenture_72cf6565-5dbc-45e0-a161-c9f724f48b13" xlink:href="dgx-20211231.xsd#dgx_GainLossOnDispositionOfJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4632e77a-f3df-4056-8388-25c5988764cf" xlink:to="loc_dgx_GainLossOnDispositionOfJointVenture_72cf6565-5dbc-45e0-a161-c9f724f48b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_45d859d8-74b7-486f-bbc6-a3abd69ef02c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4632e77a-f3df-4056-8388-25c5988764cf" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_45d859d8-74b7-486f-bbc6-a3abd69ef02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_f185c965-4556-44c3-8b83-c247df6c49e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4632e77a-f3df-4056-8388-25c5988764cf" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_f185c965-4556-44c3-8b83-c247df6c49e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a075b843-f583-4aa1-bbbe-0297c2a5468b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4632e77a-f3df-4056-8388-25c5988764cf" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a075b843-f583-4aa1-bbbe-0297c2a5468b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0169a401-f029-42ef-a4da-fa3e66cabad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a075b843-f583-4aa1-bbbe-0297c2a5468b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0169a401-f029-42ef-a4da-fa3e66cabad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_23f35296-9493-4b17-9919-6af7fb2fe42e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a075b843-f583-4aa1-bbbe-0297c2a5468b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_23f35296-9493-4b17-9919-6af7fb2fe42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_03cc30be-77a6-460b-a388-fd2a5d0da3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a075b843-f583-4aa1-bbbe-0297c2a5468b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_03cc30be-77a6-460b-a388-fd2a5d0da3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements_1f50687b-d35c-48a9-a69d-0a8867ccbd92" xlink:href="dgx-20211231.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a075b843-f583-4aa1-bbbe-0297c2a5468b" xlink:to="loc_dgx_TerminationOfInterestRateSwapAgreements_1f50687b-d35c-48a9-a69d-0a8867ccbd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1ddaa7f0-991f-47dd-a2a8-e0d5d81fa532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a075b843-f583-4aa1-bbbe-0297c2a5468b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1ddaa7f0-991f-47dd-a2a8-e0d5d81fa532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97d66c84-ffe4-4e29-8d72-456742e64c67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_608fe53e-194d-44b5-9045-90b93148c976" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97d66c84-ffe4-4e29-8d72-456742e64c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49fcaa8d-5ea5-41fb-9b4f-0b6693f82874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_845b1063-8358-41dc-a0e7-c40a4d3caa42" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49fcaa8d-5ea5-41fb-9b4f-0b6693f82874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9bccbd7e-7d5c-4607-bd8b-12b84a449f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49fcaa8d-5ea5-41fb-9b4f-0b6693f82874" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9bccbd7e-7d5c-4607-bd8b-12b84a449f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_23c35b86-3c87-454f-95c4-5ee09353c683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49fcaa8d-5ea5-41fb-9b4f-0b6693f82874" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_23c35b86-3c87-454f-95c4-5ee09353c683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d2a15db4-9f9c-437e-b657-6720f457e11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49fcaa8d-5ea5-41fb-9b4f-0b6693f82874" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d2a15db4-9f9c-437e-b657-6720f457e11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_64574182-e13c-42b1-9180-7b2ad08e6077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49fcaa8d-5ea5-41fb-9b4f-0b6693f82874" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_64574182-e13c-42b1-9180-7b2ad08e6077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_41c51539-e21e-42f6-abe5-823e8ac57b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49fcaa8d-5ea5-41fb-9b4f-0b6693f82874" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_41c51539-e21e-42f6-abe5-823e8ac57b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17116802-ade4-4d30-94e8-92621be17e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49fcaa8d-5ea5-41fb-9b4f-0b6693f82874" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17116802-ade4-4d30-94e8-92621be17e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_845b1063-8358-41dc-a0e7-c40a4d3caa42" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_4daeffbe-856e-4043-9a3d-a0b7ac53b913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_4daeffbe-856e-4043-9a3d-a0b7ac53b913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_ecfb6539-e022-4360-b849-0aa7d02604df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:to="loc_us-gaap_RepaymentsOfDebt_ecfb6539-e022-4360-b849-0aa7d02604df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_87d37c65-8a9d-408a-a512-1b1a65af2671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_87d37c65-8a9d-408a-a512-1b1a65af2671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d70eed95-ddc1-4cee-8537-42cbd0f928a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d70eed95-ddc1-4cee-8537-42cbd0f928a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6236b0e9-f05c-4a9d-a2ce-62a5b0661376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6236b0e9-f05c-4a9d-a2ce-62a5b0661376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_424db79d-7f24-4b4b-852a-56e3608da200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_424db79d-7f24-4b4b-852a-56e3608da200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_5ff61bf7-3b7a-48a8-b392-d8c0f6781617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_5ff61bf7-3b7a-48a8-b392-d8c0f6781617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6ad73f93-c12c-4903-aaea-7122f30b85b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6ad73f93-c12c-4903-aaea-7122f30b85b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f7015357-b22c-45b1-840b-ccb02839b93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eba27c17-7a64-4c9d-9ff1-815bccc08c3a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f7015357-b22c-45b1-840b-ccb02839b93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_a8bfff26-2bbb-42d9-9315-b896a092eb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_845b1063-8358-41dc-a0e7-c40a4d3caa42" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_a8bfff26-2bbb-42d9-9315-b896a092eb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6bf2c203-f764-4107-9802-c367d00133d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_845b1063-8358-41dc-a0e7-c40a4d3caa42" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6bf2c203-f764-4107-9802-c367d00133d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_24a5cbea-5c9d-4be1-a15e-08ef628fa748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_845b1063-8358-41dc-a0e7-c40a4d3caa42" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_24a5cbea-5c9d-4be1-a15e-08ef628fa748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d68ccf04-febd-4380-8a0c-d4a947887bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b2cb39e2-7f3f-4a42-9f34-694f0c0690af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d68ccf04-febd-4380-8a0c-d4a947887bbd" xlink:to="loc_us-gaap_StatementTable_b2cb39e2-7f3f-4a42-9f34-694f0c0690af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6ac0feeb-b790-41cd-93f8-333a0cdb5442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b2cb39e2-7f3f-4a42-9f34-694f0c0690af" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6ac0feeb-b790-41cd-93f8-333a0cdb5442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6ac0feeb-b790-41cd-93f8-333a0cdb5442" xlink:to="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f6800142-88a1-4ad6-9197-ad642a35aa97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_CommonStockMember_f6800142-88a1-4ad6-9197-ad642a35aa97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2fa18eba-5f0c-4dfd-a696-aaf280de163c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2fa18eba-5f0c-4dfd-a696-aaf280de163c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cce53742-02de-40f2-9136-4670629f1d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_RetainedEarningsMember_cce53742-02de-40f2-9136-4670629f1d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1486a400-bc09-4785-a7ff-a5585469ff8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1486a400-bc09-4785-a7ff-a5585469ff8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_053f76af-552c-4ae1-8ad6-6ce77fdec607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_TreasuryStockMember_053f76af-552c-4ae1-8ad6-6ce77fdec607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_47156361-dddd-4000-a754-ed31edd5c360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_396de8b2-6173-4d6d-ab05-9c899efee6f0" xlink:to="loc_us-gaap_NoncontrollingInterestMember_47156361-dddd-4000-a754-ed31edd5c360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ade8ad86-81ce-473f-b4ee-ac35fea77ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b2cb39e2-7f3f-4a42-9f34-694f0c0690af" xlink:to="loc_us-gaap_StatementLineItems_ade8ad86-81ce-473f-b4ee-ac35fea77ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ade8ad86-81ce-473f-b4ee-ac35fea77ba8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f62f3ee-b874-4dc2-b259-bab4ab2310d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f62f3ee-b874-4dc2-b259-bab4ab2310d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fe912562-73a8-4521-bc93-12580806aa50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_fe912562-73a8-4521-bc93-12580806aa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_736c617c-c7b0-429b-91e8-4b1f70b83228" xlink:href="dgx-20211231.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_736c617c-c7b0-429b-91e8-4b1f70b83228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7f5b2be5-e432-4cc9-ab22-0fa6e08170c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7f5b2be5-e432-4cc9-ab22-0fa6e08170c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_b697b32b-ce0e-4297-898f-2c098b584154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_DividendsCommonStockCash_b697b32b-ce0e-4297-898f-2c098b584154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_dc46b02d-d0b3-4418-b21d-8d07339e6241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_dc46b02d-d0b3-4418-b21d-8d07339e6241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_03fc7a18-a036-403a-88a8-ef063f4542d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_03fc7a18-a036-403a-88a8-ef063f4542d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1858577d-7bc1-46b8-9da9-cbe239da7e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1858577d-7bc1-46b8-9da9-cbe239da7e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_063df5d9-e18c-4c63-b379-2efdafa8ddc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_063df5d9-e18c-4c63-b379-2efdafa8ddc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_250fdbaa-ea64-44d0-89d5-ed5b626ad4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_250fdbaa-ea64-44d0-89d5-ed5b626ad4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_40c6cc26-fb89-4469-bb76-78fea471e72a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_40c6cc26-fb89-4469-bb76-78fea471e72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2b3a599e-0313-4a8f-af07-787c824789df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2b3a599e-0313-4a8f-af07-787c824789df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f2cdd8e0-73f4-4469-ac80-e8c1f1bc7464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f2cdd8e0-73f4-4469-ac80-e8c1f1bc7464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_5efad68e-1729-489b-a5ef-5f59aeab9c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_5efad68e-1729-489b-a5ef-5f59aeab9c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_fccc0141-987b-4c01-bf6e-aea1e4cd556c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_fccc0141-987b-4c01-bf6e-aea1e4cd556c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bea99c6f-3e9a-4f0d-962d-2e6a854c7c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bea99c6f-3e9a-4f0d-962d-2e6a854c7c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8f4cb118-36bf-4644-a7b1-2a31956c96da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4414ddbd-d8ea-45f8-ac2f-5d849fa7a19d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8f4cb118-36bf-4644-a7b1-2a31956c96da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ade8ad86-81ce-473f-b4ee-ac35fea77ba8" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d9a35dea-a34b-43af-bbea-582bfb0d5e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d9a35dea-a34b-43af-bbea-582bfb0d5e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_681de719-7ff4-46bb-a056-cbc833ad46c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_681de719-7ff4-46bb-a056-cbc833ad46c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_7eb447ef-645f-4b9b-8947-5c99e1569c6c" xlink:href="dgx-20211231.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_7eb447ef-645f-4b9b-8947-5c99e1569c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0f865f76-d583-4c3a-b2b1-231b60d8ecba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_517a2efc-e72d-4571-bf80-923b7daf8836" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0f865f76-d583-4c3a-b2b1-231b60d8ecba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20211231.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e83ac302-95a3-45fd-9bf6-431f19042d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_5066e4ad-d724-47ba-8cf2-f70b3771013a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e83ac302-95a3-45fd-9bf6-431f19042d88" xlink:to="loc_us-gaap_NatureOfOperations_5066e4ad-d724-47ba-8cf2-f70b3771013a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_435c6f7e-9938-4cfb-a56a-03877a9c198b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_ab66c591-938a-482a-866c-6c6e93498de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_435c6f7e-9938-4cfb-a56a-03877a9c198b" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_ab66c591-938a-482a-866c-6c6e93498de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7531bffb-7330-45c6-a707-06d451d9bbba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7531bffb-7330-45c6-a707-06d451d9bbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_63251de5-4d90-43ca-bd30-79307be1875c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_63251de5-4d90-43ca-bd30-79307be1875c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_a4dd8a1f-f1af-405d-8e8c-3e843eb64293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_a4dd8a1f-f1af-405d-8e8c-3e843eb64293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_e3e0edbc-2df6-45c0-878b-8df4e1c590ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_UseOfEstimates_e3e0edbc-2df6-45c0-878b-8df4e1c590ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_be4c8621-205e-4e67-a1ca-744f8e80efa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_be4c8621-205e-4e67-a1ca-744f8e80efa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_e5281603-47e0-4c67-a45f-5c0b8c1cc7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_e5281603-47e0-4c67-a45f-5c0b8c1cc7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_8ebb08fe-72ff-4e93-bc88-bd781336599e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_8ebb08fe-72ff-4e93-bc88-bd781336599e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_addf6c89-9fd4-4866-8818-325c23238b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_addf6c89-9fd4-4866-8818-325c23238b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_b42a3bac-7322-4097-81b4-714dd374d567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_b42a3bac-7322-4097-81b4-714dd374d567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_24cf9aa1-d9f7-4426-b504-7a927af20497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_24cf9aa1-d9f7-4426-b504-7a927af20497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_ea80f96d-1363-4c75-bf27-2a1b700c5894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_ea80f96d-1363-4c75-bf27-2a1b700c5894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_094192b6-bde4-4a9f-ba4b-5404bd57305d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_094192b6-bde4-4a9f-ba4b-5404bd57305d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock_a727cda4-9c23-4edd-90b5-405d59488938" xlink:href="dgx-20211231.xsd#dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock_a727cda4-9c23-4edd-90b5-405d59488938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_d438a06a-4706-4dbb-ae79-2cf685c0fd35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_d438a06a-4706-4dbb-ae79-2cf685c0fd35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_fd32d26b-e698-4854-be2c-fe084e5727ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_fd32d26b-e698-4854-be2c-fe084e5727ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_4d98036e-2584-4a9b-a7d9-f65e51ad74cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_4d98036e-2584-4a9b-a7d9-f65e51ad74cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_90d02f27-2f8c-4cb4-902d-a6ae8c187e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_90d02f27-2f8c-4cb4-902d-a6ae8c187e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_13c4251a-16b0-42c9-af59-a5ccb76f7f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_13c4251a-16b0-42c9-af59-a5ccb76f7f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_b04b7bcd-d183-4400-b5ce-bc9feb636e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_b04b7bcd-d183-4400-b5ce-bc9feb636e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_6319af43-e53f-4077-a842-64dc50b0ce65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_6319af43-e53f-4077-a842-64dc50b0ce65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_38b1ca62-d63f-42a8-88ad-8c2da67a0f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_38b1ca62-d63f-42a8-88ad-8c2da67a0f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_56532a47-5efa-4d97-a75e-afe253440a35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_56532a47-5efa-4d97-a75e-afe253440a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_f3f3bcb9-c710-40bf-acad-366f7d2e8f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e43a5522-7ef8-4fd7-a9d0-f10c9624ad7d" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_f3f3bcb9-c710-40bf-acad-366f7d2e8f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f4141fb6-1167-422c-99f6-4874fc172476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_93821702-436e-43a9-b383-0b1d41bb045c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f4141fb6-1167-422c-99f6-4874fc172476" xlink:to="loc_us-gaap_AdvertisingExpense_93821702-436e-43a9-b383-0b1d41bb045c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:href="dgx-20211231.xsd#dgx_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f4141fb6-1167-422c-99f6-4874fc172476" xlink:to="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_594f9800-596f-48dd-9ee1-13cb91ed6bd3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_srt_RangeAxis_594f9800-596f-48dd-9ee1-13cb91ed6bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6919d98-80a0-42b3-8e5b-686ccf07e2d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_594f9800-596f-48dd-9ee1-13cb91ed6bd3" xlink:to="loc_srt_RangeMember_b6919d98-80a0-42b3-8e5b-686ccf07e2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ed53903f-8991-47d0-a76d-0ac833578cc0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b6919d98-80a0-42b3-8e5b-686ccf07e2d8" xlink:to="loc_srt_MinimumMember_ed53903f-8991-47d0-a76d-0ac833578cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cdb86eac-cdf3-45e9-b784-730d94f62c79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b6919d98-80a0-42b3-8e5b-686ccf07e2d8" xlink:to="loc_srt_MaximumMember_cdb86eac-cdf3-45e9-b784-730d94f62c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ff645a21-dd77-4226-8a38-dcff6a8f5399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ff645a21-dd77-4226-8a38-dcff6a8f5399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_46d0024b-f519-49fd-974f-80d94e8f014b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ff645a21-dd77-4226-8a38-dcff6a8f5399" xlink:to="loc_us-gaap_SegmentDomain_46d0024b-f519-49fd-974f-80d94e8f014b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_0ef58775-b3eb-41c4-bbf4-5dd8c68b9d4f" xlink:href="dgx-20211231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_46d0024b-f519-49fd-974f-80d94e8f014b" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_0ef58775-b3eb-41c4-bbf4-5dd8c68b9d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_ed9d23e2-9528-4d11-9233-e2e9188fc074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_SubsegmentsAxis_ed9d23e2-9528-4d11-9233-e2e9188fc074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_18b221c8-67ad-4a03-a040-6b319e499dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_ed9d23e2-9528-4d11-9233-e2e9188fc074" xlink:to="loc_us-gaap_SubsegmentsDomain_18b221c8-67ad-4a03-a040-6b319e499dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_82b00da7-4327-49ac-a648-952dab37f9f9" xlink:href="dgx-20211231.xsd#dgx_GovernmentPayersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_18b221c8-67ad-4a03-a040-6b319e499dac" xlink:to="loc_dgx_GovernmentPayersMember_82b00da7-4327-49ac-a648-952dab37f9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientMember_ee8f5c13-e2f2-4373-9189-0f28cc974427" xlink:href="dgx-20211231.xsd#dgx_PatientMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_18b221c8-67ad-4a03-a040-6b319e499dac" xlink:to="loc_dgx_PatientMember_ee8f5c13-e2f2-4373-9189-0f28cc974427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_130b91b9-484f-4466-946f-516f2757a716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_130b91b9-484f-4466-946f-516f2757a716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a07064be-82e0-4013-a3f1-3f273db89d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_130b91b9-484f-4466-946f-516f2757a716" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a07064be-82e0-4013-a3f1-3f273db89d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_a52ee9c9-1fa1-451d-bbfa-bb6e72e03ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a07064be-82e0-4013-a3f1-3f273db89d35" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_a52ee9c9-1fa1-451d-bbfa-bb6e72e03ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_23e090b2-49e9-4bc7-8289-51feed9594bc" xlink:href="dgx-20211231.xsd#dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a07064be-82e0-4013-a3f1-3f273db89d35" xlink:to="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_23e090b2-49e9-4bc7-8289-51feed9594bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_831275b4-339a-490b-89cd-0f2a231e140e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a07064be-82e0-4013-a3f1-3f273db89d35" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_831275b4-339a-490b-89cd-0f2a231e140e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_021f8910-f22b-4190-8b6d-1901fa84741d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_021f8910-f22b-4190-8b6d-1901fa84741d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8946f7c0-8ef0-4fdd-a7ea-8b588de4d2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_021f8910-f22b-4190-8b6d-1901fa84741d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8946f7c0-8ef0-4fdd-a7ea-8b588de4d2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b3a4116f-752b-4c34-b836-9b937d5b64c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8946f7c0-8ef0-4fdd-a7ea-8b588de4d2db" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b3a4116f-752b-4c34-b836-9b937d5b64c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ccb97e13-bb85-4894-8bf2-9829f1420676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ccb97e13-bb85-4894-8bf2-9829f1420676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6e3a6f2c-5e7b-477a-9428-700e4c67c401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ccb97e13-bb85-4894-8bf2-9829f1420676" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6e3a6f2c-5e7b-477a-9428-700e4c67c401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_8a010c13-470c-491b-960a-8e9270188b29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e3a6f2c-5e7b-477a-9428-700e4c67c401" xlink:to="loc_us-gaap_OtherAssetsMember_8a010c13-470c-491b-960a-8e9270188b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_cc720198-846e-4e0b-8581-c8b28b48a8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e3a6f2c-5e7b-477a-9428-700e4c67c401" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_cc720198-846e-4e0b-8581-c8b28b48a8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_56d0d122-6f7b-4737-92c0-e8ff12ad4c15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_srt_StatementScenarioAxis_56d0d122-6f7b-4737-92c0-e8ff12ad4c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b47d7830-68e1-473b-8a69-8ce6adb16edf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_56d0d122-6f7b-4737-92c0-e8ff12ad4c15" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b47d7830-68e1-473b-8a69-8ce6adb16edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_64ba851b-dce8-4fff-a682-ccf6d62c7fdb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_b47d7830-68e1-473b-8a69-8ce6adb16edf" xlink:to="loc_srt_ScenarioForecastMember_64ba851b-dce8-4fff-a682-ccf6d62c7fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_16f3153e-c45c-4c89-81b5-6a7e6b62999a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_16f3153e-c45c-4c89-81b5-6a7e6b62999a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_90c2551b-77ea-444f-8e2f-30a6016cf75e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_16f3153e-c45c-4c89-81b5-6a7e6b62999a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_90c2551b-77ea-444f-8e2f-30a6016cf75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7ff5e088-faed-4352-bcd2-b76450c19494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_90c2551b-77ea-444f-8e2f-30a6016cf75e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7ff5e088-faed-4352-bcd2-b76450c19494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:href="dgx-20211231.xsd#dgx_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_63afd42c-6cd3-41ea-9923-20701d5f98dc" xlink:to="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0ee9fa1c-2eee-4637-b8ed-2ef774cf9026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0ee9fa1c-2eee-4637-b8ed-2ef774cf9026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_d950275c-b82e-4281-a6d3-49bd2e50b28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_d950275c-b82e-4281-a6d3-49bd2e50b28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_682ac276-c906-4d67-a509-5f8880ad2f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquityMethodInvestments_682ac276-c906-4d67-a509-5f8880ad2f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_fa05b701-3ca3-4d38-a4d2-9a0e6aded9fa" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_dgx_PercentageofNetRevenues_fa05b701-3ca3-4d38-a4d2-9a0e6aded9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e1e5fe23-4bc8-48d9-beca-eeb6d3ab394b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e1e5fe23-4bc8-48d9-beca-eeb6d3ab394b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_c97713f4-2c65-456e-bce6-392a65b86db4" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_c97713f4-2c65-456e-bce6-392a65b86db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_aeca6703-ba08-4cc4-95ab-c40a42e74bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_aeca6703-ba08-4cc4-95ab-c40a42e74bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9ebfbb2e-2af2-4dc5-9b88-26b3539960cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9ebfbb2e-2af2-4dc5-9b88-26b3539960cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b4e6adb9-4145-41ba-8c59-2f353e7430b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_OperatingIncomeLoss_b4e6adb9-4145-41ba-8c59-2f353e7430b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c06c9935-1e3e-44f3-b668-5fb44353a7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_ProfitLoss_c06c9935-1e3e-44f3-b668-5fb44353a7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_c8737bec-2439-41b8-8074-9452cc44883c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_c8737bec-2439-41b8-8074-9452cc44883c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_24d8b126-8f25-4925-a4c2-88930957d874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_24d8b126-8f25-4925-a4c2-88930957d874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_4bd30131-a886-4536-b9ca-4d0e636d248d" xlink:href="dgx-20211231.xsd#dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_4bd30131-a886-4536-b9ca-4d0e636d248d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_af48feb7-58a2-4fa1-86a5-0abbd29f83b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_af48feb7-58a2-4fa1-86a5-0abbd29f83b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_99b77878-835e-4aa1-a6d6-bd040a655168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_99b77878-835e-4aa1-a6d6-bd040a655168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a1d667af-9160-4ce0-b354-dfab8a2b4da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a1d667af-9160-4ce0-b354-dfab8a2b4da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d8ecf3d9-281c-4ed2-b88f-bc41127ed8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_OperatingLeaseLiability_d8ecf3d9-281c-4ed2-b88f-bc41127ed8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_77ff5b94-72d4-4f32-b19f-84be90b2f1e0" xlink:href="dgx-20211231.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_77ff5b94-72d4-4f32-b19f-84be90b2f1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_d4a55f51-e965-49aa-8ee3-260fb9266b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_5064a4df-7abb-4526-b1f3-391dc3643f21" xlink:to="loc_us-gaap_TradingSecurities_d4a55f51-e965-49aa-8ee3-260fb9266b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="dgx-20211231.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e19fa4e-6302-4e5f-8544-fabca36d3404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_599b4cb7-eeb1-429a-922d-9f78806363f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e19fa4e-6302-4e5f-8544-fabca36d3404" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_599b4cb7-eeb1-429a-922d-9f78806363f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#REVENUERECOGNITIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2e4b0cf3-6611-4008-973f-e10b8e15e2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_72ce75aa-d157-41b2-9e4a-000e82d8a8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2e4b0cf3-6611-4008-973f-e10b8e15e2c2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_72ce75aa-d157-41b2-9e4a-000e82d8a8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_8c8fd0bb-3cde-4640-b092-d08cf926f75f" xlink:href="dgx-20211231.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2e4b0cf3-6611-4008-973f-e10b8e15e2c2" xlink:to="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_8c8fd0bb-3cde-4640-b092-d08cf926f75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_8678b198-ef22-4485-887c-1ed314d98229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2e4b0cf3-6611-4008-973f-e10b8e15e2c2" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_8678b198-ef22-4485-887c-1ed314d98229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#REVENUERECOGNITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7f5cff22-e1fb-4eec-b392-60d52011bf33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7f5cff22-e1fb-4eec-b392-60d52011bf33" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5209b67d-77b7-4732-8641-f05e9e9691c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5209b67d-77b7-4732-8641-f05e9e9691c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b927b843-ae4e-4143-8fae-7fda5025ce32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5209b67d-77b7-4732-8641-f05e9e9691c8" xlink:to="loc_us-gaap_SegmentDomain_b927b843-ae4e-4143-8fae-7fda5025ce32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_a8d68200-b02c-4948-84d8-512dbbcfdcbd" xlink:href="dgx-20211231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b927b843-ae4e-4143-8fae-7fda5025ce32" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_a8d68200-b02c-4948-84d8-512dbbcfdcbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_a637337e-b252-458a-8011-c5d020ccb721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b927b843-ae4e-4143-8fae-7fda5025ce32" xlink:to="loc_us-gaap_AllOtherSegmentsMember_a637337e-b252-458a-8011-c5d020ccb721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_43bce977-bed2-4785-9ccb-eefd5afa3f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:to="loc_us-gaap_SubsegmentsAxis_43bce977-bed2-4785-9ccb-eefd5afa3f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_43bce977-bed2-4785-9ccb-eefd5afa3f7d" xlink:to="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_f0064f72-1b62-4b87-adde-4d2ffbb360b9" xlink:href="dgx-20211231.xsd#dgx_HealthcareInsurersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:to="loc_dgx_HealthcareInsurersMember_f0064f72-1b62-4b87-adde-4d2ffbb360b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_d4963d21-545e-46fd-8824-6ba8d0babbea" xlink:href="dgx-20211231.xsd#dgx_GovernmentPayersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:to="loc_dgx_GovernmentPayersMember_d4963d21-545e-46fd-8824-6ba8d0babbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_b5c1aae6-63f2-4ef9-877f-4810da2cef02" xlink:href="dgx-20211231.xsd#dgx_ClientPayersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:to="loc_dgx_ClientPayersMember_b5c1aae6-63f2-4ef9-877f-4810da2cef02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientMember_fd06fd54-84c0-42da-9bf7-9866fa77cfaf" xlink:href="dgx-20211231.xsd#dgx_PatientMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:to="loc_dgx_PatientMember_fd06fd54-84c0-42da-9bf7-9866fa77cfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_6b2561e5-8bbd-4ae8-b03f-6cba583e4f5d" xlink:href="dgx-20211231.xsd#dgx_DSBusinessesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_0c7c50ff-0c0f-4a6f-9388-1fb347bc1a1b" xlink:to="loc_dgx_DSBusinessesMember_6b2561e5-8bbd-4ae8-b03f-6cba583e4f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_36fb0974-9317-44e1-b719-ba638758e758" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:to="loc_srt_ProductOrServiceAxis_36fb0974-9317-44e1-b719-ba638758e758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_acecdbb7-1ad7-472e-883e-1ccc26423133" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_36fb0974-9317-44e1-b719-ba638758e758" xlink:to="loc_srt_ProductsAndServicesDomain_acecdbb7-1ad7-472e-883e-1ccc26423133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_6279d803-fdf2-40cc-9fc1-435eb6968281" xlink:href="dgx-20211231.xsd#dgx_FeeforserviceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_acecdbb7-1ad7-472e-883e-1ccc26423133" xlink:to="loc_dgx_FeeforserviceMember_6279d803-fdf2-40cc-9fc1-435eb6968281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_82ec73d8-d4a0-4be8-a72b-74845639fe69" xlink:href="dgx-20211231.xsd#dgx_CapitatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_acecdbb7-1ad7-472e-883e-1ccc26423133" xlink:to="loc_dgx_CapitatedMember_82ec73d8-d4a0-4be8-a72b-74845639fe69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6731e98a-60a4-47fd-b3e7-45a3f3aa9cb2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:to="loc_srt_RangeAxis_6731e98a-60a4-47fd-b3e7-45a3f3aa9cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_97fe6520-34f5-460e-9d1f-296db961da9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6731e98a-60a4-47fd-b3e7-45a3f3aa9cb2" xlink:to="loc_srt_RangeMember_97fe6520-34f5-460e-9d1f-296db961da9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_17afdb97-ccf4-4708-bc6a-83229766af26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_97fe6520-34f5-460e-9d1f-296db961da9d" xlink:to="loc_srt_MinimumMember_17afdb97-ccf4-4708-bc6a-83229766af26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d1546f17-276f-4855-9f9a-d842da92547d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_97fe6520-34f5-460e-9d1f-296db961da9d" xlink:to="loc_srt_MaximumMember_d1546f17-276f-4855-9f9a-d842da92547d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90a20d64-b036-4f54-96c6-51f14cc04462" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_734a84c9-1ac0-415b-9409-8945d085036a" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_dgx_PercentageofNetRevenues_734a84c9-1ac0-415b-9409-8945d085036a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RevenueCollectionofConsiderationPeriod_0b07d941-e3dd-49ce-82d0-a0860683a6ca" xlink:href="dgx-20211231.xsd#dgx_RevenueCollectionofConsiderationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_dgx_RevenueCollectionofConsiderationPeriod_0b07d941-e3dd-49ce-82d0-a0860683a6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PeriodofBillingFullyReserve_95abeb5e-d6b7-4bd3-bf52-be327846b920" xlink:href="dgx-20211231.xsd#dgx_PeriodofBillingFullyReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_dgx_PeriodofBillingFullyReserve_95abeb5e-d6b7-4bd3-bf52-be327846b920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_19ed6977-4af9-4175-b59c-ca75c2150d52" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_19ed6977-4af9-4175-b59c-ca75c2150d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_81c79e1b-9bdd-4cb7-8a79-f8f37e793928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_81c79e1b-9bdd-4cb7-8a79-f8f37e793928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_89c0bff3-e537-4c6e-926f-e79d760325a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_81c79e1b-9bdd-4cb7-8a79-f8f37e793928" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_89c0bff3-e537-4c6e-926f-e79d760325a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_7f4d2292-54e4-4868-884e-5d6ec5a5a817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_81c79e1b-9bdd-4cb7-8a79-f8f37e793928" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_7f4d2292-54e4-4868-884e-5d6ec5a5a817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ecf764f4-bbdc-4406-b439-ee31530fa001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_81c79e1b-9bdd-4cb7-8a79-f8f37e793928" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ecf764f4-bbdc-4406-b439-ee31530fa001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_96195678-5e26-490e-83ac-09c1ab503fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_353bc4f8-4a4b-4957-b5f2-cbc6c2cfa4cb" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_96195678-5e26-490e-83ac-09c1ab503fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20211231.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e4d9d32d-b360-4365-9809-091d26ff9af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_ad22761b-0c5e-409e-b99c-46b89f2c156f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e4d9d32d-b360-4365-9809-091d26ff9af3" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_ad22761b-0c5e-409e-b99c-46b89f2c156f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables" xlink:type="simple" xlink:href="dgx-20211231.xsd#EARNINGSLOSSPERSHARETables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_692c3757-28f7-42e0-88f9-e50780573530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2a4a3e89-ef9d-41a7-95e4-61052b6a88ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_692c3757-28f7-42e0-88f9-e50780573530" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2a4a3e89-ef9d-41a7-95e4-61052b6a88ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ac39c4db-642a-4ba7-ad96-4ad30a99a7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_692c3757-28f7-42e0-88f9-e50780573530" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ac39c4db-642a-4ba7-ad96-4ad30a99a7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#EARNINGSLOSSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_1b34d30c-ad5f-4ce5-be8c-68233fa460dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_1b34d30c-ad5f-4ce5-be8c-68233fa460dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_501c4558-ff91-474b-94d6-acfaa11e2667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_501c4558-ff91-474b-94d6-acfaa11e2667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1e734d64-7037-478c-8709-7d0ec6a36af0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_NetIncomeLoss_1e734d64-7037-478c-8709-7d0ec6a36af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_fcb7a1dc-cca9-4c68-9a8f-783a85b64771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_fcb7a1dc-cca9-4c68-9a8f-783a85b64771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_b6b0baaa-b62c-4b3c-81ac-02e0974019ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_b6b0baaa-b62c-4b3c-81ac-02e0974019ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c9f4f267-b0f1-4ab8-9ad5-fa393609a52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c9f4f267-b0f1-4ab8-9ad5-fa393609a52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4a39ff41-e0b2-4eca-8cdd-7cd1c364e420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4a39ff41-e0b2-4eca-8cdd-7cd1c364e420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d71e646f-05ae-4e8a-81da-32082b77449c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d71e646f-05ae-4e8a-81da-32082b77449c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_fa4bfd53-0fbc-48fd-a089-c5ba9480b62a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_fa4bfd53-0fbc-48fd-a089-c5ba9480b62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_9aab3197-89c1-4f6d-8237-2219a5e63c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_9aab3197-89c1-4f6d-8237-2219a5e63c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_48e716dc-6164-44f8-98aa-2e76fab11170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_EarningsPerShareBasic_48e716dc-6164-44f8-98aa-2e76fab11170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_9640a85d-0156-416a-84f6-1d954acce507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_9640a85d-0156-416a-84f6-1d954acce507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_aaff4fef-4758-41a9-ac6e-74970b7b4356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_aaff4fef-4758-41a9-ac6e-74970b7b4356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ac62d8ad-7498-47ae-906b-533200ca7800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ac62d8ad-7498-47ae-906b-533200ca7800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b0792f26-514c-47aa-a37b-161989d0ee96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b0792f26-514c-47aa-a37b-161989d0ee96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_8b354125-a504-4856-b86b-721d22a51d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e960dac2-b389-4ca1-b887-5dd12acbcad5" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_8b354125-a504-4856-b86b-721d22a51d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16aa5174-e6d9-42ba-b7fc-a12254394bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_8b354125-a504-4856-b86b-721d22a51d1f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16aa5174-e6d9-42ba-b7fc-a12254394bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_68861d04-d4f2-43b7-b5f5-728a63949753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16aa5174-e6d9-42ba-b7fc-a12254394bf4" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_68861d04-d4f2-43b7-b5f5-728a63949753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b0472727-ca49-4091-b10f-5fddec0a162e" xlink:href="dgx-20211231.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_68861d04-d4f2-43b7-b5f5-728a63949753" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b0472727-ca49-4091-b10f-5fddec0a162e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_e7b209fa-3a23-4f6b-a4a3-f3d2f541650e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_8b354125-a504-4856-b86b-721d22a51d1f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_e7b209fa-3a23-4f6b-a4a3-f3d2f541650e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesPayment_9893d0a0-eaae-4c1e-95b7-21f1e6074bf0" xlink:href="dgx-20211231.xsd#dgx_AcceleratedShareRepurchasesPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_e7b209fa-3a23-4f6b-a4a3-f3d2f541650e" xlink:to="loc_dgx_AcceleratedShareRepurchasesPayment_9893d0a0-eaae-4c1e-95b7-21f1e6074bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20211231.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e00a97bd-5b41-405f-8134-2a3850010372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_582ed3da-d3be-4764-bf5c-9ee1bbf1b636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e00a97bd-5b41-405f-8134-2a3850010372" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_582ed3da-d3be-4764-bf5c-9ee1bbf1b636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_651c614f-59ad-4c0e-b590-f7a913814bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_651c614f-59ad-4c0e-b590-f7a913814bd6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_be0dbcad-097e-425e-accc-11bb5b0d25d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_be0dbcad-097e-425e-accc-11bb5b0d25d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be0dbcad-097e-425e-accc-11bb5b0d25d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MercyHealthMember_0cde1f28-8e3c-4582-9e30-795e98d9b244" xlink:href="dgx-20211231.xsd#dgx_MercyHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_MercyHealthMember_0cde1f28-8e3c-4582-9e30-795e98d9b244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember_3bb14522-35ff-469d-a9f8-995f484ba592" xlink:href="dgx-20211231.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_LabtechDiagnosticsLLCMember_3bb14522-35ff-469d-a9f8-995f484ba592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BlueprintGeneticsOyMember_3a180ca6-9590-49aa-abcf-e8eb929a9acd" xlink:href="dgx-20211231.xsd#dgx_BlueprintGeneticsOyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_BlueprintGeneticsOyMember_3a180ca6-9590-49aa-abcf-e8eb929a9acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MemorialHermannMember_8ffc2cbd-610d-44e8-97a3-9320c6ba4a4a" xlink:href="dgx-20211231.xsd#dgx_MemorialHermannMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_MemorialHermannMember_8ffc2cbd-610d-44e8-97a3-9320c6ba4a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_9836d206-d150-4a37-ad04-c47d668937a7" xlink:href="dgx-20211231.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_9836d206-d150-4a37-ad04-c47d668937a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_b525453f-e169-4945-99c5-a1c620f25315" xlink:href="dgx-20211231.xsd#dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc686246-828b-4f10-bb2c-2b6752088080" xlink:to="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_b525453f-e169-4945-99c5-a1c620f25315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_021afbb6-815a-4247-8b02-a9374d07b447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_021afbb6-815a-4247-8b02-a9374d07b447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fb84490-81ce-4820-b2ba-a2d47fb688ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_021afbb6-815a-4247-8b02-a9374d07b447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fb84490-81ce-4820-b2ba-a2d47fb688ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6c3b2475-a758-4759-932c-b8b5141bc4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fb84490-81ce-4820-b2ba-a2d47fb688ed" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6c3b2475-a758-4759-932c-b8b5141bc4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c44f609c-b85f-4d4e-9932-9817bc40c831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fb84490-81ce-4820-b2ba-a2d47fb688ed" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c44f609c-b85f-4d4e-9932-9817bc40c831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_474e1a64-881f-4383-b716-50b1a1867d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_474e1a64-881f-4383-b716-50b1a1867d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_06fb4165-50dd-426c-bfdb-6e7dde42e39b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_474e1a64-881f-4383-b716-50b1a1867d9b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_06fb4165-50dd-426c-bfdb-6e7dde42e39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember_d88ac931-00d7-472f-8628-45a58a13a6e6" xlink:href="dgx-20211231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_06fb4165-50dd-426c-bfdb-6e7dde42e39b" xlink:to="loc_dgx_OtherIncomeExpenseMember_d88ac931-00d7-472f-8628-45a58a13a6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_81d0e5d1-89ce-47ca-890d-8ac95b9cf7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_06fb4165-50dd-426c-bfdb-6e7dde42e39b" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_81d0e5d1-89ce-47ca-890d-8ac95b9cf7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_087438c3-a2b0-4668-a3b7-bd8c19ec0ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_087438c3-a2b0-4668-a3b7-bd8c19ec0ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fa1d870-1446-4f88-8d42-5be43c7504e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_087438c3-a2b0-4668-a3b7-bd8c19ec0ed6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fa1d870-1446-4f88-8d42-5be43c7504e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_de5fe47d-4fa3-4b89-b9ab-06ac3d8a57c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fa1d870-1446-4f88-8d42-5be43c7504e5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_de5fe47d-4fa3-4b89-b9ab-06ac3d8a57c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8e6a214-d283-400f-a1c9-41f7f7e54097" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_369b10da-bc19-4cdd-8836-666e0090cd28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_369b10da-bc19-4cdd-8836-666e0090cd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c995fd7b-f3ff-42fe-bbdd-3e1aafc0e824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c995fd7b-f3ff-42fe-bbdd-3e1aafc0e824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b6ae3bdf-3563-438c-a6b0-10d7226a3dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b6ae3bdf-3563-438c-a6b0-10d7226a3dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b33f147e-9001-4588-9f6b-63563b791a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b33f147e-9001-4588-9f6b-63563b791a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3d300144-9cf6-4b0e-acbf-7868eb27a58f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3d300144-9cf6-4b0e-acbf-7868eb27a58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_03ff5611-2c22-400b-bed8-f6a5d2f7a0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_03ff5611-2c22-400b-bed8-f6a5d2f7a0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities_82040513-a733-4056-ac22-ad29d3bf84a9" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities_82040513-a733-4056-ac22-ad29d3bf84a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_41124e5f-4701-4a84-aebf-4a8d5a5a3a30" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_41124e5f-4701-4a84-aebf-4a8d5a5a3a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_2e9a0c21-6077-4bd0-9ab4-c7a5cec3d060" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_2e9a0c21-6077-4bd0-9ab4-c7a5cec3d060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_a6267eec-e129-4376-92ee-c9315a94dcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_a6267eec-e129-4376-92ee-c9315a94dcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_fe292547-6996-4a1d-9987-a74ff79e0047" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_fe292547-6996-4a1d-9987-a74ff79e0047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessAcquisitionPostacquisitionRevenue_78f7d941-fefa-4c5a-b3ba-ba92953867c8" xlink:href="dgx-20211231.xsd#dgx_BusinessAcquisitionPostacquisitionRevenue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessAcquisitionPostacquisitionRevenue_78f7d941-fefa-4c5a-b3ba-ba92953867c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2ce54cd8-cf63-4fea-b6fd-b28d8eb7fb47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2ce54cd8-cf63-4fea-b6fd-b28d8eb7fb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3109798b-8590-43bb-a45d-8ab25d5be6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_Goodwill_3109798b-8590-43bb-a45d-8ab25d5be6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_11d6496c-1a3a-41ec-9f53-79a16e50e33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_11d6496c-1a3a-41ec-9f53-79a16e50e33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_3917bbed-425f-4ab5-a2a2-d32738060ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_3917bbed-425f-4ab5-a2a2-d32738060ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_0dd3d0f0-0de0-4902-ad64-3a888873b2a8" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_0dd3d0f0-0de0-4902-ad64-3a888873b2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_330cfe34-a379-4fb9-8ad4-44a67659e495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_330cfe34-a379-4fb9-8ad4-44a67659e495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_f5493b88-a38b-45e4-accd-b741defa424f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_f5493b88-a38b-45e4-accd-b741defa424f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_ce48d816-235e-48c1-8abc-ae64dce5c4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_ce48d816-235e-48c1-8abc-ae64dce5c4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_4bd2f2af-2807-4edb-bae4-147ebd48633d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_4bd2f2af-2807-4edb-bae4-147ebd48633d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_8dcd09df-bc58-432f-93cf-2838566f2199" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_8dcd09df-bc58-432f-93cf-2838566f2199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_4a96090e-013d-4d54-9431-4ddba28d70d0" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_4a96090e-013d-4d54-9431-4ddba28d70d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_e77872e2-bf6b-4e7c-a983-d3835d3202d4" xlink:href="dgx-20211231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_e77872e2-bf6b-4e7c-a983-d3835d3202d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cfb3f38f-4146-4519-ac00-3232aeecd4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_468a93b5-83cf-4047-bb2b-2c1cdbe1c533" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cfb3f38f-4146-4519-ac00-3232aeecd4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITION" xlink:type="simple" xlink:href="dgx-20211231.xsd#DISPOSITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISPOSITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ea4a5b0c-cc6c-4cce-8ac8-d0a286be0f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_0e8f25cb-f5b3-4405-9b0b-2c4918f90690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ea4a5b0c-cc6c-4cce-8ac8-d0a286be0f87" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_0e8f25cb-f5b3-4405-9b0b-2c4918f90690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DISPOSITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_eb19e990-88ad-4870-93d9-e7fcc23c88d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_eb19e990-88ad-4870-93d9-e7fcc23c88d3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1b126547-ac8d-409d-a767-3b6c3dfc7c62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1b126547-ac8d-409d-a767-3b6c3dfc7c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eb38c9d1-4255-46c8-b828-8353112d551c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1b126547-ac8d-409d-a767-3b6c3dfc7c62" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eb38c9d1-4255-46c8-b828-8353112d551c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_478bc59a-525e-4833-b339-7f1bfa155294" xlink:href="dgx-20211231.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eb38c9d1-4255-46c8-b828-8353112d551c" xlink:to="loc_dgx_Q2SolutionsMember_478bc59a-525e-4833-b339-7f1bfa155294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e021a286-d437-46f7-9613-846e46546ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e021a286-d437-46f7-9613-846e46546ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5569136c-698c-4e4b-a7ff-604d75408093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e021a286-d437-46f7-9613-846e46546ba8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5569136c-698c-4e4b-a7ff-604d75408093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_415d0240-a0e7-423e-9704-bc47f0224070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_5569136c-698c-4e4b-a7ff-604d75408093" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_415d0240-a0e7-423e-9704-bc47f0224070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0347ac57-1a2e-4650-b5de-3fd803984e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0347ac57-1a2e-4650-b5de-3fd803984e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_75385e02-a4ea-4984-80d2-1efcdab1ea81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0347ac57-1a2e-4650-b5de-3fd803984e7b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_75385e02-a4ea-4984-80d2-1efcdab1ea81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_59fce770-4f7e-4074-89ae-25e0ac93af4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_75385e02-a4ea-4984-80d2-1efcdab1ea81" xlink:to="loc_us-gaap_OtherIncomeMember_59fce770-4f7e-4074-89ae-25e0ac93af4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_33282099-61e7-44f5-aeea-9a057263e353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_33282099-61e7-44f5-aeea-9a057263e353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_252029d6-44bb-480f-866d-c10822288028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_33282099-61e7-44f5-aeea-9a057263e353" xlink:to="loc_us-gaap_EquityComponentDomain_252029d6-44bb-480f-866d-c10822288028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_155ddef5-3034-415b-87b4-8158842efdbe" xlink:href="dgx-20211231.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_252029d6-44bb-480f-866d-c10822288028" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_155ddef5-3034-415b-87b4-8158842efdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8997f413-9ae2-483f-b777-f03fe26ca663" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_1d0f38ce-3dd0-4767-8b07-f95a0d27f5c1" xlink:href="dgx-20211231.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_1d0f38ce-3dd0-4767-8b07-f95a0d27f5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_8e49ef55-1bd4-4b31-82be-bd0037983156" xlink:href="dgx-20211231.xsd#dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_8e49ef55-1bd4-4b31-82be-bd0037983156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_992ff8d9-3806-4432-8e31-121987fa788f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_992ff8d9-3806-4432-8e31-121987fa788f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_53079913-9f8a-4ff5-b209-6041c951c14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_53079913-9f8a-4ff5-b209-6041c951c14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8dcb9fa6-d879-4c3e-90bb-68365f758d57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8dcb9fa6-d879-4c3e-90bb-68365f758d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cc1f062f-b4cb-49c9-924b-7e2950a640ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cc1f062f-b4cb-49c9-924b-7e2950a640ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_55fa27f1-edb5-441b-b8c0-3650dce1e152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9b478be6-ea2a-41f4-adf4-b3b0c062f21e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_55fa27f1-edb5-441b-b8c0-3650dce1e152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3b3360fd-b6b1-481f-836e-b93c913eeec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_41d13415-0bd6-4818-ba57-d8a90decab97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3b3360fd-b6b1-481f-836e-b93c913eeec3" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_41d13415-0bd6-4818-ba57-d8a90decab97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f466ab45-8842-489d-8c00-3fb9f131d5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_bba9d0db-9b2a-4a85-94b5-11ee5eba05bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f466ab45-8842-489d-8c00-3fb9f131d5b9" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_bba9d0db-9b2a-4a85-94b5-11ee5eba05bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_92a8b918-ae61-4137-a80c-fd539c3195f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f466ab45-8842-489d-8c00-3fb9f131d5b9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_92a8b918-ae61-4137-a80c-fd539c3195f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ea67000b-527f-434f-a15f-c9853723f400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5a149688-1da0-47b4-a548-49e07fc9fa09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ea67000b-527f-434f-a15f-c9853723f400" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5a149688-1da0-47b4-a548-49e07fc9fa09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_53561d0d-179a-4e37-9db7-ddf318d9c6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5a149688-1da0-47b4-a548-49e07fc9fa09" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_53561d0d-179a-4e37-9db7-ddf318d9c6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f9f2db44-bc87-4af2-95c3-15708eaeb7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_53561d0d-179a-4e37-9db7-ddf318d9c6fa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f9f2db44-bc87-4af2-95c3-15708eaeb7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d6cade5a-bdbf-430e-a909-d3f7ca86884c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f9f2db44-bc87-4af2-95c3-15708eaeb7a6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d6cade5a-bdbf-430e-a909-d3f7ca86884c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6ba07b38-3199-4103-b326-08312e558828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5a149688-1da0-47b4-a548-49e07fc9fa09" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6ba07b38-3199-4103-b326-08312e558828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1064a523-4283-4de6-a54b-69b6a5d2a32f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6ba07b38-3199-4103-b326-08312e558828" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1064a523-4283-4de6-a54b-69b6a5d2a32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_87a75ddf-cc64-4616-aace-a736ff9af10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1064a523-4283-4de6-a54b-69b6a5d2a32f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_87a75ddf-cc64-4616-aace-a736ff9af10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b42ddff7-d9e9-4720-a1f7-5fdabfb3127c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1064a523-4283-4de6-a54b-69b6a5d2a32f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b42ddff7-d9e9-4720-a1f7-5fdabfb3127c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5e763f55-1b8b-45e2-8239-46135524305b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1064a523-4283-4de6-a54b-69b6a5d2a32f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5e763f55-1b8b-45e2-8239-46135524305b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5a149688-1da0-47b4-a548-49e07fc9fa09" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_e76c939c-9c40-4c5b-b4ce-9cfeded65ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_TradingSecurities_e76c939c-9c40-4c5b-b4ce-9cfeded65ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_c11d550a-2286-4a79-8789-90bdf0a456cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_c11d550a-2286-4a79-8789-90bdf0a456cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_7eb3910f-6b24-41c0-b05a-68456c2269ca" xlink:href="dgx-20211231.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_7eb3910f-6b24-41c0-b05a-68456c2269ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a67bbff-0c44-4422-8098-1156873d7681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a67bbff-0c44-4422-8098-1156873d7681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9634f0f8-1182-40ff-965e-1cecb3d42ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_9634f0f8-1182-40ff-965e-1cecb3d42ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_4c146884-aa25-4500-93c6-34e32fe407b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_4c146884-aa25-4500-93c6-34e32fe407b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_560870d8-2457-450c-8541-00af17442721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_560870d8-2457-450c-8541-00af17442721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_06f84493-f0c8-40e1-aab5-d998359f0856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_06f84493-f0c8-40e1-aab5-d998359f0856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_5eb85429-c09d-44ee-9ec5-109bd13a1111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec46dd94-6c71-4857-b549-12a0677ecffd" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_5eb85429-c09d-44ee-9ec5-109bd13a1111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_04d19683-cc20-4bf3-ba29-88845aa20b70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683d964a-f0fa-42b0-ac24-78752d0d18b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04d19683-cc20-4bf3-ba29-88845aa20b70" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683d964a-f0fa-42b0-ac24-78752d0d18b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f052cc67-3db3-4328-b660-5de5b4d3aa5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683d964a-f0fa-42b0-ac24-78752d0d18b3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f052cc67-3db3-4328-b660-5de5b4d3aa5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8fc0ae16-489e-4013-8a10-abb1c6c9c455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f052cc67-3db3-4328-b660-5de5b4d3aa5a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8fc0ae16-489e-4013-8a10-abb1c6c9c455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember_1ec2fdf8-c988-4b71-8f07-e4065e0a6505" xlink:href="dgx-20211231.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8fc0ae16-489e-4013-8a10-abb1c6c9c455" xlink:to="loc_dgx_LabtechDiagnosticsLLCMember_1ec2fdf8-c988-4b71-8f07-e4065e0a6505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_88c3419d-a5e1-46db-9a5d-c53900a6a493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683d964a-f0fa-42b0-ac24-78752d0d18b3" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_88c3419d-a5e1-46db-9a5d-c53900a6a493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_db2ee35f-3219-4085-aa9a-8a1b33e92528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_88c3419d-a5e1-46db-9a5d-c53900a6a493" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_db2ee35f-3219-4085-aa9a-8a1b33e92528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_61a3d4f1-4f78-44b1-a02e-1e0a12ff713c" xlink:href="dgx-20211231.xsd#dgx_MeasurementInputComparableCompanyRevenueVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_db2ee35f-3219-4085-aa9a-8a1b33e92528" xlink:to="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_61a3d4f1-4f78-44b1-a02e-1e0a12ff713c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_955d5b54-eda3-40e0-8c3c-cb143bd7465d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_db2ee35f-3219-4085-aa9a-8a1b33e92528" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_955d5b54-eda3-40e0-8c3c-cb143bd7465d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_451f86be-2de6-414f-9c0a-c35720eb3e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683d964a-f0fa-42b0-ac24-78752d0d18b3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_451f86be-2de6-414f-9c0a-c35720eb3e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_48402991-ba38-4c45-b576-1f112198b16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_451f86be-2de6-414f-9c0a-c35720eb3e22" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_48402991-ba38-4c45-b576-1f112198b16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_bff7f4cb-372e-4acd-9004-dcff7a46c7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_451f86be-2de6-414f-9c0a-c35720eb3e22" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_bff7f4cb-372e-4acd-9004-dcff7a46c7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b7ec0c1e-20b2-46cf-b883-d48c0fd8c877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b7ec0c1e-20b2-46cf-b883-d48c0fd8c877" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85ef6c12-6f60-4f25-ba60-15734007cb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85ef6c12-6f60-4f25-ba60-15734007cb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_852cf14e-573d-4ec2-a5fa-1a92604e1ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85ef6c12-6f60-4f25-ba60-15734007cb13" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_852cf14e-573d-4ec2-a5fa-1a92604e1ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_bfcbeeb4-0d17-4c02-a7f9-dae2e6ac4087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_852cf14e-573d-4ec2-a5fa-1a92604e1ae4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_bfcbeeb4-0d17-4c02-a7f9-dae2e6ac4087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1f068548-3758-420e-93bc-3d48ba8ec588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1f068548-3758-420e-93bc-3d48ba8ec588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_37d93410-8b8d-4a5c-a9f9-786cbd21886c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1f068548-3758-420e-93bc-3d48ba8ec588" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_37d93410-8b8d-4a5c-a9f9-786cbd21886c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_06946d19-acc4-49ac-a19d-6e6c1f5480ff" xlink:href="dgx-20211231.xsd#dgx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_37d93410-8b8d-4a5c-a9f9-786cbd21886c" xlink:to="loc_dgx_ContingentConsiderationMember_06946d19-acc4-49ac-a19d-6e6c1f5480ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d351cf2b-2624-4354-a774-f7aa5c201cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d351cf2b-2624-4354-a774-f7aa5c201cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7cd7ccc5-42c3-49d9-858c-968a13cab7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d351cf2b-2624-4354-a774-f7aa5c201cc0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7cd7ccc5-42c3-49d9-858c-968a13cab7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_7952709d-7d4e-4764-89d2-d8af35822598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7cd7ccc5-42c3-49d9-858c-968a13cab7bd" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_7952709d-7d4e-4764-89d2-d8af35822598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_08b3655c-bcfd-4ccc-ae48-43d892d7be8c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:to="loc_srt_OwnershipAxis_08b3655c-bcfd-4ccc-ae48-43d892d7be8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a9d24eef-4cbc-4e40-b7ff-f4e077872d1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_08b3655c-bcfd-4ccc-ae48-43d892d7be8c" xlink:to="loc_srt_OwnershipDomain_a9d24eef-4cbc-4e40-b7ff-f4e077872d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_e5b9d9b5-0eff-4034-b959-0022a686f263" xlink:href="dgx-20211231.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_a9d24eef-4cbc-4e40-b7ff-f4e077872d1d" xlink:to="loc_dgx_UMassJointVentureMember_e5b9d9b5-0eff-4034-b959-0022a686f263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9d76bc72-7f73-444e-985f-fb28ae92129e" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0a6bf795-0a33-43a5-95f2-aa5ea0abda14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0a6bf795-0a33-43a5-95f2-aa5ea0abda14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c3b2c6bc-3176-4855-bfc2-54c62b036905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c3b2c6bc-3176-4855-bfc2-54c62b036905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d28f8ac5-545f-4b1b-8b74-2a542d26a09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d28f8ac5-545f-4b1b-8b74-2a542d26a09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_05da39a2-9ab8-4a3d-adaf-706a2159a926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_05da39a2-9ab8-4a3d-adaf-706a2159a926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_ebfada33-4d30-4735-b896-bcc3a176a757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_ebfada33-4d30-4735-b896-bcc3a176a757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_08c1410a-6c89-45bf-8e04-4466f5e24db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a94172b8-68c8-4880-89d0-a57212b2c446" xlink:to="loc_us-gaap_DebtInstrumentFairValue_08c1410a-6c89-45bf-8e04-4466f5e24db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_074e4853-319e-40f6-864f-73a174abeb16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4f6d69de-9932-4822-a6b3-a0835200e4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_074e4853-319e-40f6-864f-73a174abeb16" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4f6d69de-9932-4822-a6b3-a0835200e4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e8eed05-288b-439c-8858-02eb31a87bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4f6d69de-9932-4822-a6b3-a0835200e4d5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e8eed05-288b-439c-8858-02eb31a87bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_788a6892-590a-4263-9dba-79308a5cdc97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5e8eed05-288b-439c-8858-02eb31a87bca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_788a6892-590a-4263-9dba-79308a5cdc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_529058f3-bfa1-40c7-96c7-a8799e0c76db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_788a6892-590a-4263-9dba-79308a5cdc97" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_529058f3-bfa1-40c7-96c7-a8799e0c76db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_92648ee4-66c8-4b50-9312-c10f163b4c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4f6d69de-9932-4822-a6b3-a0835200e4d5" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_92648ee4-66c8-4b50-9312-c10f163b4c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e08ca49a-53ff-4ecf-88de-fe54b73909f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_92648ee4-66c8-4b50-9312-c10f163b4c92" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e08ca49a-53ff-4ecf-88de-fe54b73909f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_f1d24ea7-a003-4c9e-b799-49e97768cbcb" xlink:href="dgx-20211231.xsd#dgx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e08ca49a-53ff-4ecf-88de-fe54b73909f3" xlink:to="loc_dgx_ContingentConsiderationMember_f1d24ea7-a003-4c9e-b799-49e97768cbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d123baa8-c96b-479c-98c7-7bd415645f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4f6d69de-9932-4822-a6b3-a0835200e4d5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d123baa8-c96b-479c-98c7-7bd415645f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d123baa8-c96b-479c-98c7-7bd415645f3a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_99a27f09-c59b-4473-a187-03e50162610e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_99a27f09-c59b-4473-a187-03e50162610e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_dfa41553-619a-4674-8c7f-5b936f1c315a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_dfa41553-619a-4674-8c7f-5b936f1c315a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_28dc566e-f003-407d-b514-e33753a918e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_28dc566e-f003-407d-b514-e33753a918e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_2c62353c-5ab7-4bb0-935d-80777f85d06c" xlink:href="dgx-20211231.xsd#dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:to="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_2c62353c-5ab7-4bb0-935d-80777f85d06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6e6f2e72-2de7-4bb6-9083-3989777822d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76366b57-efa9-42f4-8603-ed567b944258" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6e6f2e72-2de7-4bb6-9083-3989777822d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="simple" xlink:href="dgx-20211231.xsd#TAXESONINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c3179f7e-c87d-4e70-877c-d5eee051c38e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_d9523fd7-c794-42fd-91da-e17e5c7dffb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c3179f7e-c87d-4e70-877c-d5eee051c38e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_d9523fd7-c794-42fd-91da-e17e5c7dffb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMETables" xlink:type="simple" xlink:href="dgx-20211231.xsd#TAXESONINCOMETables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_aef123e3-c260-43fe-a7d5-9e7081f3952a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_2b908c3f-f49c-4e7a-b839-ea2977b0f09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aef123e3-c260-43fe-a7d5-9e7081f3952a" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_2b908c3f-f49c-4e7a-b839-ea2977b0f09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_c09c71e1-6e37-4bda-973e-858e69621857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aef123e3-c260-43fe-a7d5-9e7081f3952a" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_c09c71e1-6e37-4bda-973e-858e69621857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d0104746-67dc-4131-93c3-a369fc97c2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aef123e3-c260-43fe-a7d5-9e7081f3952a" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d0104746-67dc-4131-93c3-a369fc97c2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_f6ec86a4-609e-4daf-93ba-738edbbdedb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aef123e3-c260-43fe-a7d5-9e7081f3952a" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_f6ec86a4-609e-4daf-93ba-738edbbdedb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#TAXESONINCOMEDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9eded925-e47a-443b-ae92-fcf4cab3771b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9eded925-e47a-443b-ae92-fcf4cab3771b" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0ca7534-a88c-4392-b1f0-5b0edf99a79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0ca7534-a88c-4392-b1f0-5b0edf99a79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_06486e90-b32a-4e6b-bbd3-7518fc3e3d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0ca7534-a88c-4392-b1f0-5b0edf99a79e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_06486e90-b32a-4e6b-bbd3-7518fc3e3d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_d4448542-0034-4915-9ec7-e84c254a2000" xlink:href="dgx-20211231.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_06486e90-b32a-4e6b-bbd3-7518fc3e3d1f" xlink:to="loc_dgx_Q2SolutionsMember_d4448542-0034-4915-9ec7-e84c254a2000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9256f269-6f4a-45b4-8379-8e3a5281b6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9256f269-6f4a-45b4-8379-8e3a5281b6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_04e2a6e2-4bf0-4ba2-95a4-7852da097785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9256f269-6f4a-45b4-8379-8e3a5281b6ca" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_04e2a6e2-4bf0-4ba2-95a4-7852da097785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_5871bf2a-7565-4f97-9c69-9c59f07b3e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_04e2a6e2-4bf0-4ba2-95a4-7852da097785" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_5871bf2a-7565-4f97-9c69-9c59f07b3e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_aa615485-5ca2-4ac1-b34b-133110943b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_aa615485-5ca2-4ac1-b34b-133110943b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_72ad82f2-b9f9-45da-a270-385b31fbb680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_aa615485-5ca2-4ac1-b34b-133110943b08" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_72ad82f2-b9f9-45da-a270-385b31fbb680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_54b64173-381c-4fe9-b0df-a8a9439c021b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_72ad82f2-b9f9-45da-a270-385b31fbb680" xlink:to="loc_us-gaap_DomesticCountryMember_54b64173-381c-4fe9-b0df-a8a9439c021b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_606c9574-f104-4134-82cc-df0ac7e9a3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_72ad82f2-b9f9-45da-a270-385b31fbb680" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_606c9574-f104-4134-82cc-df0ac7e9a3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_672e8460-9bf9-4669-8359-c2141d7418c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_72ad82f2-b9f9-45da-a270-385b31fbb680" xlink:to="loc_us-gaap_ForeignCountryMember_672e8460-9bf9-4669-8359-c2141d7418c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6a08be27-4acd-4957-89bc-d6c2b3ce345a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6a08be27-4acd-4957-89bc-d6c2b3ce345a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4c7f792c-3a1f-4a99-a02e-1ac1c7d926ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6a08be27-4acd-4957-89bc-d6c2b3ce345a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4c7f792c-3a1f-4a99-a02e-1ac1c7d926ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_7001c361-d0d3-45a7-908f-1e9afc8f1edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4c7f792c-3a1f-4a99-a02e-1ac1c7d926ac" xlink:to="loc_us-gaap_OtherLiabilitiesMember_7001c361-d0d3-45a7-908f-1e9afc8f1edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_70e438a6-2bf8-492a-8c0f-029ffe5eb4b2" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_5ff68fd5-9ea3-44b1-9d5e-d7a2ab3e7eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_5ff68fd5-9ea3-44b1-9d5e-d7a2ab3e7eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_68ebdb52-b34e-4a4b-8414-84b0864a76ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_68ebdb52-b34e-4a4b-8414-84b0864a76ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_602289e2-75ba-489f-aedf-702d1de8590d" xlink:href="dgx-20211231.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_602289e2-75ba-489f-aedf-702d1de8590d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_210d5721-2574-4860-8473-9db5d1e2e6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_210d5721-2574-4860-8473-9db5d1e2e6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_270c5347-6244-4301-8677-f176eb93f8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_270c5347-6244-4301-8677-f176eb93f8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e4ee02f3-5b78-4ac1-8322-666b0ce9f70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e4ee02f3-5b78-4ac1-8322-666b0ce9f70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e5c281db-65b2-4cca-a3ff-a3072896cce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e5c281db-65b2-4cca-a3ff-a3072896cce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_506bf003-4345-4318-af73-ccef1d3d8554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_506bf003-4345-4318-af73-ccef1d3d8554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b4a3a226-708a-4198-a09c-f069d61070db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b4a3a226-708a-4198-a09c-f069d61070db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ea5f997a-0ce8-4ec7-8218-16657611c6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ea5f997a-0ce8-4ec7-8218-16657611c6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7742ea30-3469-48ac-8ced-fde8b52f3d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7742ea30-3469-48ac-8ced-fde8b52f3d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1e416b5f-2f4b-4a31-9df4-25f967916022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1e416b5f-2f4b-4a31-9df4-25f967916022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b437a1b0-ea3c-4257-997d-d65dfa6b88bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b437a1b0-ea3c-4257-997d-d65dfa6b88bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_b2f23da2-9763-43ff-87e6-8623f7de2cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_b2f23da2-9763-43ff-87e6-8623f7de2cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_2c958c55-05ba-4dd2-9fa6-e0fb07bcb43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_2c958c55-05ba-4dd2-9fa6-e0fb07bcb43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_0115b10b-1a4d-4a5b-aeb2-113faa1f16fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_0115b10b-1a4d-4a5b-aeb2-113faa1f16fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_c1e29d83-2dcd-4812-8f67-890bf16ee170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_c1e29d83-2dcd-4812-8f67-890bf16ee170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_c05190b2-3a5e-4055-a1cd-e75a04208a90" xlink:href="dgx-20211231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_c05190b2-3a5e-4055-a1cd-e75a04208a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c8239b6e-8145-44ff-8154-099d1babaf96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c8239b6e-8145-44ff-8154-099d1babaf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_cf0b9704-b84e-43ad-b0db-dfcace56dc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_cf0b9704-b84e-43ad-b0db-dfcace56dc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2c012f7b-5435-4852-afa3-641603be1851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2c012f7b-5435-4852-afa3-641603be1851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_79e7d54e-ff3c-4648-8152-afe7a5a5cae5" xlink:href="dgx-20211231.xsd#dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_79e7d54e-ff3c-4648-8152-afe7a5a5cae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c11b7c29-4260-4621-938f-742022a6444b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c11b7c29-4260-4621-938f-742022a6444b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c28cdc77-298b-4d3d-bada-558b50d6815c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c28cdc77-298b-4d3d-bada-558b50d6815c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_8b49fee7-af22-42b0-90a4-2707d8964f31" xlink:href="dgx-20211231.xsd#dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_8b49fee7-af22-42b0-90a4-2707d8964f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_31046bf7-db67-4cc3-bd12-91dff7729fc6" xlink:href="dgx-20211231.xsd#dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_31046bf7-db67-4cc3-bd12-91dff7729fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8a08cb24-54ea-48ad-9237-518df387d02f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8a08cb24-54ea-48ad-9237-518df387d02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_4ca17c66-be5c-4d4b-ba80-07349ff72c88" xlink:href="dgx-20211231.xsd#dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_4ca17c66-be5c-4d4b-ba80-07349ff72c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0354eaf3-4bba-4cc5-939a-0f38c90c3df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0354eaf3-4bba-4cc5-939a-0f38c90c3df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_d68cb894-43fa-4c4f-81da-0035640fdd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxLiabilities_d68cb894-43fa-4c4f-81da-0035640fdd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_35e5475e-cac4-4fc0-9b54-5abae2a188ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_35e5475e-cac4-4fc0-9b54-5abae2a188ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1b9a3c9c-5cb4-450c-b396-fa5ca92ba6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1b9a3c9c-5cb4-450c-b396-fa5ca92ba6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d3e43272-3933-4398-ac28-3c95cd307392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d3e43272-3933-4398-ac28-3c95cd307392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_731dd94c-160c-4e3b-9afd-e0a41217dc67" xlink:href="dgx-20211231.xsd#dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_731dd94c-160c-4e3b-9afd-e0a41217dc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_5073cc72-b13c-4deb-bf44-696842ac0e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_AccruedIncomeTaxes_5073cc72-b13c-4deb-bf44-696842ac0e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_8d5df26a-dbc5-4cf6-bdd8-8bf5de6f8110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_PrepaidTaxes_8d5df26a-dbc5-4cf6-bdd8-8bf5de6f8110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_12f4717e-3a65-4dc1-90c3-ca6b352d0326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_12f4717e-3a65-4dc1-90c3-ca6b352d0326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5d687df7-155b-4df2-92c2-afa70273e03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5d687df7-155b-4df2-92c2-afa70273e03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_cdb8c74f-2ae5-4c42-a9c3-402846a8eb80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_cdb8c74f-2ae5-4c42-a9c3-402846a8eb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReductionsForChangesInJudgment_fbf308a9-9624-4eae-8c32-07a4f346df16" xlink:href="dgx-20211231.xsd#dgx_ReductionsForChangesInJudgment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_dgx_ReductionsForChangesInJudgment_fbf308a9-9624-4eae-8c32-07a4f346df16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_33fce594-8aaf-43e1-9a52-0c817a20d20a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_33fce594-8aaf-43e1-9a52-0c817a20d20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a78551e3-32dc-4074-b597-2dc6a3f9862e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a78551e3-32dc-4074-b597-2dc6a3f9862e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d42e20e9-09b7-4cf0-a681-9bbb84b993a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7a32d3f6-cde7-4690-84f3-4b419960e5b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d42e20e9-09b7-4cf0-a681-9bbb84b993a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8ea66f55-1151-45d1-9e41-c60f4cad5ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8ea66f55-1151-45d1-9e41-c60f4cad5ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_e26688e4-66f0-4627-a512-228d83ac4a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_e26688e4-66f0-4627-a512-228d83ac4a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_9ff97c80-ea95-426e-b9a3-222a6a11f04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_9ff97c80-ea95-426e-b9a3-222a6a11f04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_23af0eb8-40e4-4b71-baad-e1e68c55f564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_915b7f51-8b11-47ac-a9a4-afc97e82d92c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_23af0eb8-40e4-4b71-baad-e1e68c55f564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATA"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_de5f5304-4c98-4ef5-8c23-4c1e2f514d32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_8409996a-dd71-4771-81b1-4de0ece68f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_de5f5304-4c98-4ef5-8c23-4c1e2f514d32" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_8409996a-dd71-4771-81b1-4de0ece68f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATATables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_3e69283a-d47f-4ba6-be1d-9a5dafec9276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_ad13ef90-196f-422d-8cfa-32f9252360cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3e69283a-d47f-4ba6-be1d-9a5dafec9276" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_ad13ef90-196f-422d-8cfa-32f9252360cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATADetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_41a2d822-bb7e-46dd-ad7c-ae6b0d982d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_Depreciation_41a2d822-bb7e-46dd-ad7c-ae6b0d982d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b419c8c7-bf24-4dd4-908d-28b39ba64777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b419c8c7-bf24-4dd4-908d-28b39ba64777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c618b87d-a068-4772-bf32-4fc9edce7c97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c618b87d-a068-4772-bf32-4fc9edce7c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a99ed688-039a-4fef-b8ef-a47c5705a775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_InterestExpense_a99ed688-039a-4fef-b8ef-a47c5705a775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_50a6ee78-98e2-44ac-8e82-aaca72c268ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_50a6ee78-98e2-44ac-8e82-aaca72c268ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_5aa21f9e-7ccb-449f-9c4f-2dfda215ff6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_5aa21f9e-7ccb-449f-9c4f-2dfda215ff6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_d9823119-3ecf-4b2d-b2b0-e592dda203da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_InterestPaidNet_d9823119-3ecf-4b2d-b2b0-e592dda203da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_c1d220bb-f9fe-47ea-9e62-d34254897273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_IncomeTaxesPaid_c1d220bb-f9fe-47ea-9e62-d34254897273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_7242afc1-1f09-4372-a1ee-039d87fd0c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_7242afc1-1f09-4372-a1ee-039d87fd0c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TreasuryStockPurchasedbutNotyetPaid_cca8093e-d1cb-4d86-b42a-eb26d5ad2600" xlink:href="dgx-20211231.xsd#dgx_TreasuryStockPurchasedbutNotyetPaid"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_dgx_TreasuryStockPurchasedbutNotyetPaid_cca8093e-d1cb-4d86-b42a-eb26d5ad2600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_ff74255c-0133-4ab0-984b-6cdf95afeebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_ff74255c-0133-4ab0-984b-6cdf95afeebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_9864c8fe-6280-43f4-8d4b-d666d6bf41a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_9864c8fe-6280-43f4-8d4b-d666d6bf41a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_00d16eed-d034-4759-a7dd-f3d3c0903309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_00d16eed-d034-4759-a7dd-f3d3c0903309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_3bf98084-ab9c-4776-99e8-7d3d3bc16913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_LiabilitiesAssumed1_3bf98084-ab9c-4776-99e8-7d3d3bc16913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_8e7c4b4a-1ec6-4b20-8858-4eb27b22f22a" xlink:href="dgx-20211231.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_dgx_FairValueOfNetAssetsAcquired_8e7c4b4a-1ec6-4b20-8858-4eb27b22f22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet_dd0eba76-8bf0-4fb3-b24f-755a1768a495" xlink:href="dgx-20211231.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_dgx_Mergerconsiderationpaidpayablenet_dd0eba76-8bf0-4fb3-b24f-755a1768a495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_b239449d-26ee-4b66-bec7-d6ba8e028c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_b239449d-26ee-4b66-bec7-d6ba8e028c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_eb9f4ff5-849b-4f35-9f37-1193855cbc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_eb9f4ff5-849b-4f35-9f37-1193855cbc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2acfe4eb-fa20-4b9d-a99d-fbd61ef1bc48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2acfe4eb-fa20-4b9d-a99d-fbd61ef1bc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_9b24e40d-0ce7-4629-a67e-5ce1e3d815ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fcd34fde-514d-43d8-a5ab-d6276eb9a20f" xlink:to="loc_us-gaap_LeaseCostAbstract_9b24e40d-0ce7-4629-a67e-5ce1e3d815ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_6a1236c7-7bf1-479e-bc99-4fe7accaf229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_9b24e40d-0ce7-4629-a67e-5ce1e3d815ae" xlink:to="loc_us-gaap_OperatingLeasePayments_6a1236c7-7bf1-479e-bc99-4fe7accaf229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_1a9df5dc-ec7d-4465-8552-61061ef13a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_9b24e40d-0ce7-4629-a67e-5ce1e3d815ae" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_1a9df5dc-ec7d-4465-8552-61061ef13a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_d838cfa3-734d-43fd-9997-5569b1e42c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_9b24e40d-0ce7-4629-a67e-5ce1e3d815ae" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_d838cfa3-734d-43fd-9997-5569b1e42c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_32b770cd-5e7e-4556-a9f3-2850117d2bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_9b24e40d-0ce7-4629-a67e-5ce1e3d815ae" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_32b770cd-5e7e-4556-a9f3-2850117d2bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_afc09e91-85f8-449c-a184-22dcb28c1259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_9b24e40d-0ce7-4629-a67e-5ce1e3d815ae" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_afc09e91-85f8-449c-a184-22dcb28c1259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="dgx-20211231.xsd#PROPERTYPLANTANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9cd6eeb1-7362-460e-a895-bf164dd72ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_de0cd543-1f56-4e74-8b0e-59f4e51f6a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9cd6eeb1-7362-460e-a895-bf164dd72ce2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_de0cd543-1f56-4e74-8b0e-59f4e51f6a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3616d2f5-98f1-434a-bbf8-32528ae44899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1aa4a57d-c1c0-4061-9524-50cdfc518d81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3616d2f5-98f1-434a-bbf8-32528ae44899" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1aa4a57d-c1c0-4061-9524-50cdfc518d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ad0ecbfe-63c9-479a-ab1f-dfe4d591f87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_079bd9aa-47c7-447b-ab78-4faf0ca10725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ad0ecbfe-63c9-479a-ab1f-dfe4d591f87e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_079bd9aa-47c7-447b-ab78-4faf0ca10725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd0907be-1867-43eb-b07e-b47529e3dd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_079bd9aa-47c7-447b-ab78-4faf0ca10725" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd0907be-1867-43eb-b07e-b47529e3dd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd0907be-1867-43eb-b07e-b47529e3dd3e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_17f8add4-f7a0-44d1-87da-6603f227d6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_us-gaap_LandMember_17f8add4-f7a0-44d1-87da-6603f227d6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_0f5d1412-a980-4ea1-bbe3-0980c3282424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_0f5d1412-a980-4ea1-bbe3-0980c3282424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_e4625978-36cf-4b99-b725-ae2d25972072" xlink:href="dgx-20211231.xsd#dgx_LaboratoryEquipmentFurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_e4625978-36cf-4b99-b725-ae2d25972072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_cd84c115-b9e4-48c3-b822-59e2b984bb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_cd84c115-b9e4-48c3-b822-59e2b984bb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_da92a999-8b9a-4f5f-90aa-d35cb3220dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_da92a999-8b9a-4f5f-90aa-d35cb3220dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_2bffefe9-f816-4f14-b5ff-f5870c391d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70f23fda-16f6-4c1f-bb61-de95b98eae8c" xlink:to="loc_us-gaap_ConstructionInProgressMember_2bffefe9-f816-4f14-b5ff-f5870c391d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_de140624-d68e-42ee-862e-218d8d4b0c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_079bd9aa-47c7-447b-ab78-4faf0ca10725" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_de140624-d68e-42ee-862e-218d8d4b0c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dd868738-dc81-46ea-adc7-c330d41a2a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_de140624-d68e-42ee-862e-218d8d4b0c30" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dd868738-dc81-46ea-adc7-c330d41a2a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_41e8be42-b0ea-4c4d-9a13-5012e4d041e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dd868738-dc81-46ea-adc7-c330d41a2a71" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_41e8be42-b0ea-4c4d-9a13-5012e4d041e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_079bd9aa-47c7-447b-ab78-4faf0ca10725" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_52606509-b43d-4c6b-afd2-5f84de0f3f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_52606509-b43d-4c6b-afd2-5f84de0f3f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6fac135c-6dc7-4102-956e-81c1490515a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6fac135c-6dc7-4102-956e-81c1490515a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_63882d16-f5ff-42d3-9ae0-81017af5b59b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_63882d16-f5ff-42d3-9ae0-81017af5b59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_b9960e40-ae80-4754-9e9f-1ee62c8a125e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e174028a-db59-463b-ae00-e3824d6660c0" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_b9960e40-ae80-4754-9e9f-1ee62c8a125e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20211231.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fde43ecc-261a-4879-ae7e-5598cfcaa480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4392d0fa-7dc1-49e7-a01a-42da9ca4d1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fde43ecc-261a-4879-ae7e-5598cfcaa480" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4392d0fa-7dc1-49e7-a01a-42da9ca4d1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0064dcc8-0541-4d69-a3ed-22fb820c0bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_067c5149-e32e-4ac2-b20a-813e4694047a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0064dcc8-0541-4d69-a3ed-22fb820c0bc6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_067c5149-e32e-4ac2-b20a-813e4694047a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_dd4809aa-b5ab-4e24-a1d4-bf22dab6080a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0064dcc8-0541-4d69-a3ed-22fb820c0bc6" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_dd4809aa-b5ab-4e24-a1d4-bf22dab6080a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_f2708250-e6d4-41c1-a6b2-2a7489d9f40f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0064dcc8-0541-4d69-a3ed-22fb820c0bc6" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_f2708250-e6d4-41c1-a6b2-2a7489d9f40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5603ff5-5b5c-4577-bc5b-6cb1acd77bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_2905a0fe-13e0-49fd-b602-c289ff25d309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5603ff5-5b5c-4577-bc5b-6cb1acd77bde" xlink:to="loc_us-gaap_GoodwillRollForward_2905a0fe-13e0-49fd-b602-c289ff25d309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_88d39cb3-ebbf-423c-a4d8-ad485d4e75c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2905a0fe-13e0-49fd-b602-c289ff25d309" xlink:to="loc_us-gaap_Goodwill_88d39cb3-ebbf-423c-a4d8-ad485d4e75c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b9a3eff5-352a-4c61-a6d5-8e5b9cd8bc35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2905a0fe-13e0-49fd-b602-c289ff25d309" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b9a3eff5-352a-4c61-a6d5-8e5b9cd8bc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_73566cdb-bfda-47b7-84c5-825979a1e2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2905a0fe-13e0-49fd-b602-c289ff25d309" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_73566cdb-bfda-47b7-84c5-825979a1e2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fbaaebc2-7ee3-4cf7-b9c9-9bb94071417a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2905a0fe-13e0-49fd-b602-c289ff25d309" xlink:to="loc_us-gaap_Goodwill_fbaaebc2-7ee3-4cf7-b9c9-9bb94071417a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_48008e15-07f1-4972-8f35-29e977c65f82" xlink:href="dgx-20211231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5603ff5-5b5c-4577-bc5b-6cb1acd77bde" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_48008e15-07f1-4972-8f35-29e977c65f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2f608d98-40c1-4233-a211-36c82ff17010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_48008e15-07f1-4972-8f35-29e977c65f82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2f608d98-40c1-4233-a211-36c82ff17010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2f608d98-40c1-4233-a211-36c82ff17010" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1dd222b7-fcb5-42fc-9287-a33d1fff9669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1dd222b7-fcb5-42fc-9287-a33d1fff9669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_5b4254f4-0539-4a3f-97e7-8d4bf63b9f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_5b4254f4-0539-4a3f-97e7-8d4bf63b9f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_db2d2ad8-ea8a-448a-a8e2-2204f5ea71c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_db2d2ad8-ea8a-448a-a8e2-2204f5ea71c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_9f37f0ab-2f73-4702-a572-7a4a2a216601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_9f37f0ab-2f73-4702-a572-7a4a2a216601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_42043c1c-a9b7-4795-b013-cf8d32cbc753" xlink:href="dgx-20211231.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fced0c3a-41c2-4b1a-b479-e7f990ec5f70" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_42043c1c-a9b7-4795-b013-cf8d32cbc753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b01d158e-cc3d-4e3a-91db-6ce637a309c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_48008e15-07f1-4972-8f35-29e977c65f82" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b01d158e-cc3d-4e3a-91db-6ce637a309c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_de43103e-660a-4373-bce1-fae5946dc490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b01d158e-cc3d-4e3a-91db-6ce637a309c1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_de43103e-660a-4373-bce1-fae5946dc490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_40b76f21-bbaa-461f-9a4a-f6599c42c101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_de43103e-660a-4373-bce1-fae5946dc490" xlink:to="loc_us-gaap_TradeNamesMember_40b76f21-bbaa-461f-9a4a-f6599c42c101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_7cff7096-1bb6-4be3-ab5d-8b0e8150e71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_de43103e-660a-4373-bce1-fae5946dc490" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_7cff7096-1bb6-4be3-ab5d-8b0e8150e71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:href="dgx-20211231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_48008e15-07f1-4972-8f35-29e977c65f82" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_63fd9817-83fd-43b4-8f5d-844993ef7207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_63fd9817-83fd-43b4-8f5d-844993ef7207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e0a7a006-aa3c-467b-bcfe-e034f0eb1f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e0a7a006-aa3c-467b-bcfe-e034f0eb1f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4b427ee4-6897-4cd7-9e35-8b76223f438d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4b427ee4-6897-4cd7-9e35-8b76223f438d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_16cab87d-ae03-47b6-968c-c05f8fc3e716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_16cab87d-ae03-47b6-968c-c05f8fc3e716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_9d483c9f-8c7e-4b51-99e5-9662a83d1827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c8e2b14e-bde8-44b6-9f9a-da4091bc796d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c8e2b14e-bde8-44b6-9f9a-da4091bc796d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f802552e-120a-48dc-8d4d-ab3bdb231fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f802552e-120a-48dc-8d4d-ab3bdb231fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a3db6fdf-87af-453b-a0f0-9c92fb9f85bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a3db6fdf-87af-453b-a0f0-9c92fb9f85bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_88ec96a2-527c-42c9-a2bd-a0075700f054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_88ec96a2-527c-42c9-a2bd-a0075700f054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9bafd2f5-b8b1-4c53-b7b6-447e3e76581c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9bafd2f5-b8b1-4c53-b7b6-447e3e76581c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_cebe86c3-5d61-45ba-add9-7d7471164fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_cebe86c3-5d61-45ba-add9-7d7471164fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_c8aab883-c6f0-41b7-a391-c48989ccc647" xlink:href="dgx-20211231.xsd#dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_313a2cbc-7d93-458d-8003-d015393f5eb5" xlink:to="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_c8aab883-c6f0-41b7-a391-c48989ccc647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="simple" xlink:href="dgx-20211231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_ae2e5215-a87f-451a-8c19-d698cb6fbbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_89c4de66-827d-44c7-90ce-e3062ad2d9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_ae2e5215-a87f-451a-8c19-d698cb6fbbdc" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_89c4de66-827d-44c7-90ce-e3062ad2d9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_31a9551e-31a9-4b75-9c36-46eb447a2a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_dc152141-4ce0-4aec-9734-128eff7778b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_31a9551e-31a9-4b75-9c36-46eb447a2a63" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_dc152141-4ce0-4aec-9734-128eff7778b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0827783d-af0e-4270-8d56-9d30e6a4cd76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0827783d-af0e-4270-8d56-9d30e6a4cd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cbd994ef-364b-49b0-903f-bff0c0761484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_cbd994ef-364b-49b0-903f-bff0c0761484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_1e39f9f4-b16b-4f3c-8558-aafabb8d05ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_1e39f9f4-b16b-4f3c-8558-aafabb8d05ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankOverdrafts_7fefdcd5-8a83-4d8c-ae35-ca11714d3c02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BankOverdrafts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:to="loc_us-gaap_BankOverdrafts_7fefdcd5-8a83-4d8c-ae35-ca11714d3c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_a37ee3ef-fe41-4134-b2ce-2affe5956d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:to="loc_us-gaap_DividendsPayableCurrent_a37ee3ef-fe41-4134-b2ce-2affe5956d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_3ecf83c0-8594-4219-bddd-020656189610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_3ecf83c0-8594-4219-bddd-020656189610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_c477b358-f8d0-48f0-ab13-60991fb878cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:to="loc_us-gaap_InterestPayableCurrent_c477b358-f8d0-48f0-ab13-60991fb878cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_dc4cf9b3-39c9-4315-9e44-b151f91cda90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_dc4cf9b3-39c9-4315-9e44-b151f91cda90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MergerConsiderationPayableCurrent_b1b9d0ef-cf7f-4fa3-a4b6-8c6946fa4aa1" xlink:href="dgx-20211231.xsd#dgx_MergerConsiderationPayableCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:to="loc_dgx_MergerConsiderationPayableCurrent_b1b9d0ef-cf7f-4fa3-a4b6-8c6946fa4aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_4f97d816-3486-4f0b-8ffb-7116c24c7921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_6ec86d9a-02d0-42a8-9e37-dc039b04bc75" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_4f97d816-3486-4f0b-8ffb-7116c24c7921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBT" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_4c2cfe19-eb63-4b12-9b34-2333696ff598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_8492f0e1-6ed4-4d60-b6bb-e48dee0e66bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_4c2cfe19-eb63-4b12-9b34-2333696ff598" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_8492f0e1-6ed4-4d60-b6bb-e48dee0e66bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_99ead900-4e62-46e9-8dd6-bc143d784a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_6ede5884-356a-47f3-a430-ec367d17a68a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_99ead900-4e62-46e9-8dd6-bc143d784a5b" xlink:to="loc_us-gaap_LongTermDebtTextBlock_6ede5884-356a-47f3-a430-ec367d17a68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_0168c1d2-1f54-4a89-a6a1-0042fd9b0309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_99ead900-4e62-46e9-8dd6-bc143d784a5b" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_0168c1d2-1f54-4a89-a6a1-0042fd9b0309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_aa27ea55-1e9e-4f5d-9ba5-6f1da878ecba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_27119342-777b-41f3-aa5e-406618ccab70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_aa27ea55-1e9e-4f5d-9ba5-6f1da878ecba" xlink:to="loc_us-gaap_DebtInstrumentTable_27119342-777b-41f3-aa5e-406618ccab70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3d862979-b2d9-4413-89f6-8498ec138682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_27119342-777b-41f3-aa5e-406618ccab70" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3d862979-b2d9-4413-89f6-8498ec138682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_151dd4a8-4dc3-44f7-b7b5-cfb7608e82d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d862979-b2d9-4413-89f6-8498ec138682" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_151dd4a8-4dc3-44f7-b7b5-cfb7608e82d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_b58236ec-fbe7-49ce-8d4e-e537e7d5e84e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_151dd4a8-4dc3-44f7-b7b5-cfb7608e82d7" xlink:to="loc_us-gaap_SeniorNotesMember_b58236ec-fbe7-49ce-8d4e-e537e7d5e84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9c2634ef-b2a0-4fb8-9e0f-2469abef9a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_27119342-777b-41f3-aa5e-406618ccab70" xlink:to="loc_us-gaap_DebtInstrumentAxis_9c2634ef-b2a0-4fb8-9e0f-2469abef9a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9c2634ef-b2a0-4fb8-9e0f-2469abef9a71" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_b5f9bdbf-11fd-4f9c-beef-11ab13f1501c" xlink:href="dgx-20211231.xsd#dgx_FourpointtwofivepercentSeniorNotesDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_b5f9bdbf-11fd-4f9c-beef-11ab13f1501c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_7510a085-d0fe-4330-9488-191941b1e2e9" xlink:href="dgx-20211231.xsd#dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_7510a085-d0fe-4330-9488-191941b1e2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_78c0d82d-3aa6-4758-8125-6bb1f655cde4" xlink:href="dgx-20211231.xsd#dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_78c0d82d-3aa6-4758-8125-6bb1f655cde4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_114614a1-6c2e-4d9d-819c-b099102743da" xlink:href="dgx-20211231.xsd#dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_114614a1-6c2e-4d9d-819c-b099102743da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_c1a62fe5-7d22-4406-8e3a-2d08a42c90dc" xlink:href="dgx-20211231.xsd#dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_c1a62fe5-7d22-4406-8e3a-2d08a42c90dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_97dfe7d7-6c8f-4c98-b311-6891810c1ea6" xlink:href="dgx-20211231.xsd#dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_97dfe7d7-6c8f-4c98-b311-6891810c1ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_ebc3a4da-d41e-4afa-9c24-85fe4bbbd895" xlink:href="dgx-20211231.xsd#dgx_SixPointNineFivePercentSeniorNotesDue2037Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_ebc3a4da-d41e-4afa-9c24-85fe4bbbd895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_84e9c242-2ce9-4fab-b677-201cde81202e" xlink:href="dgx-20211231.xsd#dgx_FivePointSevenFivePercentSeniorNotesDue2040Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_84e9c242-2ce9-4fab-b677-201cde81202e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_3cb91350-78b6-4693-a46c-0f6ef74182ae" xlink:href="dgx-20211231.xsd#dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_3cb91350-78b6-4693-a46c-0f6ef74182ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FinanceLeaseObligationsandOtherMember_4fdc1f0f-3264-4fc0-acd4-29ba7ddd8330" xlink:href="dgx-20211231.xsd#dgx_FinanceLeaseObligationsandOtherMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d8ac5c5-f408-4e18-8a6f-a0fe4aed801d" xlink:to="loc_dgx_FinanceLeaseObligationsandOtherMember_4fdc1f0f-3264-4fc0-acd4-29ba7ddd8330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_27119342-777b-41f3-aa5e-406618ccab70" xlink:to="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_24727325-859c-44c9-a3b9-7acd01cc816b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_LongTermDebt_24727325-859c-44c9-a3b9-7acd01cc816b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_a4c432eb-7cd7-4a21-8a8c-320b4fa554ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_OtherLongTermDebt_a4c432eb-7cd7-4a21-8a8c-320b4fa554ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_7172ad84-7fc8-4729-b539-93f0a20787c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_7172ad84-7fc8-4729-b539-93f0a20787c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_349a7196-0fd5-453a-aa03-535696ee5a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_LongTermDebtCurrent_349a7196-0fd5-453a-aa03-535696ee5a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_67b58eef-bbb9-4a8d-9419-f958732dcf4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_67b58eef-bbb9-4a8d-9419-f958732dcf4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_141a4706-12ff-4b9c-9db8-eb6e971f17fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36a5de58-b453-4adc-9760-6610913f72fe" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_141a4706-12ff-4b9c-9db8-eb6e971f17fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTSecuredReceivablesCreditFacilityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_6c3e1a0d-9a11-4b05-b02c-a49ece3450a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_6c3e1a0d-9a11-4b05-b02c-a49ece3450a4" xlink:to="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2c138ae4-931d-4725-8aa7-9d7ec98c5234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2c138ae4-931d-4725-8aa7-9d7ec98c5234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b4dd6d2e-96e9-4338-b325-9e6bb724f192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2c138ae4-931d-4725-8aa7-9d7ec98c5234" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b4dd6d2e-96e9-4338-b325-9e6bb724f192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f009b290-09bc-4470-9708-079e7bbdfc70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b4dd6d2e-96e9-4338-b325-9e6bb724f192" xlink:to="loc_us-gaap_SecuredDebtMember_f009b290-09bc-4470-9708-079e7bbdfc70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d584cc78-3d3f-41c9-b951-4e0bb5feb8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_us-gaap_DebtInstrumentAxis_d584cc78-3d3f-41c9-b951-4e0bb5feb8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c54d2b58-3806-44d6-97de-1a63d2dc87ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d584cc78-3d3f-41c9-b951-4e0bb5feb8d4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c54d2b58-3806-44d6-97de-1a63d2dc87ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2022Member_d3c82078-9563-4674-8158-fea7e674af60" xlink:href="dgx-20211231.xsd#dgx_LoanCommitmentMaturingOctober2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c54d2b58-3806-44d6-97de-1a63d2dc87ae" xlink:to="loc_dgx_LoanCommitmentMaturingOctober2022Member_d3c82078-9563-4674-8158-fea7e674af60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2023Member_fddf71bf-076d-4db4-9441-bdaa32753454" xlink:href="dgx-20211231.xsd#dgx_LoanCommitmentMaturingOctober2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c54d2b58-3806-44d6-97de-1a63d2dc87ae" xlink:to="loc_dgx_LoanCommitmentMaturingOctober2023Member_fddf71bf-076d-4db4-9441-bdaa32753454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_008045f1-c96a-45d8-931a-1ddb912ecb60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_us-gaap_CreditFacilityAxis_008045f1-c96a-45d8-931a-1ddb912ecb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5d568bc7-fbbb-4e29-964a-445c36059d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_008045f1-c96a-45d8-931a-1ddb912ecb60" xlink:to="loc_us-gaap_CreditFacilityDomain_5d568bc7-fbbb-4e29-964a-445c36059d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_82663c2b-3b88-45d0-b12f-374dd404d5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5d568bc7-fbbb-4e29-964a-445c36059d78" xlink:to="loc_us-gaap_LetterOfCreditMember_82663c2b-3b88-45d0-b12f-374dd404d5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_491ac912-79cd-4253-ba47-29d3f25a9e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5d568bc7-fbbb-4e29-964a-445c36059d78" xlink:to="loc_us-gaap_LineOfCreditMember_491ac912-79cd-4253-ba47-29d3f25a9e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e88eafc6-514a-497b-9abb-9d98b32724aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_us-gaap_VariableRateAxis_e88eafc6-514a-497b-9abb-9d98b32724aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c2c4e408-cdbf-481f-92b4-76f3915cd486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_e88eafc6-514a-497b-9abb-9d98b32724aa" xlink:to="loc_us-gaap_VariableRateDomain_c2c4e408-cdbf-481f-92b4-76f3915cd486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_c89b75c0-1f80-4ec3-9101-5f1662ed2ba7" xlink:href="dgx-20211231.xsd#dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c2c4e408-cdbf-481f-92b4-76f3915cd486" xlink:to="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_c89b75c0-1f80-4ec3-9101-5f1662ed2ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_69dc5447-3695-48b7-a0f2-381876350bf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_srt_RangeAxis_69dc5447-3695-48b7-a0f2-381876350bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9fb995cf-edcb-417d-93c9-43822353253f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_69dc5447-3695-48b7-a0f2-381876350bf5" xlink:to="loc_srt_RangeMember_9fb995cf-edcb-417d-93c9-43822353253f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_264a286e-7354-45c3-8559-db3f282b3c3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9fb995cf-edcb-417d-93c9-43822353253f" xlink:to="loc_srt_MinimumMember_264a286e-7354-45c3-8559-db3f282b3c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7c26a90b-872d-474b-80fa-2de2e5aa9441" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9fb995cf-edcb-417d-93c9-43822353253f" xlink:to="loc_srt_MaximumMember_7c26a90b-872d-474b-80fa-2de2e5aa9441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1c052c33-d813-4ac7-9d6f-62057d95bd55" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ed47a918-be8a-4e45-93a4-d38ace9e1969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ed47a918-be8a-4e45-93a4-d38ace9e1969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentExtensionPeriod_a1ffc255-d96f-483c-b0a0-434d2aff502d" xlink:href="dgx-20211231.xsd#dgx_DebtInstrumentExtensionPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:to="loc_dgx_DebtInstrumentExtensionPeriod_a1ffc255-d96f-483c-b0a0-434d2aff502d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_faf60372-41a7-4f7b-9584-75a48cc8d5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_faf60372-41a7-4f7b-9584-75a48cc8d5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ea90dd98-1635-4952-a662-de4dd61e1992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f126dfbd-d066-4ea4-bc47-b80fa646f93e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ea90dd98-1635-4952-a662-de4dd61e1992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_acde6dff-7306-4952-b89e-3dfa9a6a73f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_acde6dff-7306-4952-b89e-3dfa9a6a73f9" xlink:to="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3ee6b1e0-fb8e-43e0-9d7c-3d51805e1300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3ee6b1e0-fb8e-43e0-9d7c-3d51805e1300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86481b41-36fa-4ecc-8edf-91b01be844cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3ee6b1e0-fb8e-43e0-9d7c-3d51805e1300" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86481b41-36fa-4ecc-8edf-91b01be844cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_d7dc79eb-cc38-492c-b85d-0723f3daa9f2" xlink:href="dgx-20211231.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86481b41-36fa-4ecc-8edf-91b01be844cf" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_d7dc79eb-cc38-492c-b85d-0723f3daa9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_ac5c5b66-ff33-4b6a-a641-29684732c8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86481b41-36fa-4ecc-8edf-91b01be844cf" xlink:to="loc_us-gaap_SecuredDebtMember_ac5c5b66-ff33-4b6a-a641-29684732c8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_390d6c66-21bc-49da-a7ee-32034b084b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:to="loc_us-gaap_CreditFacilityAxis_390d6c66-21bc-49da-a7ee-32034b084b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_867e2ecd-85e7-4af6-b151-218a2e65d222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_390d6c66-21bc-49da-a7ee-32034b084b11" xlink:to="loc_us-gaap_CreditFacilityDomain_867e2ecd-85e7-4af6-b151-218a2e65d222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_c328bfb0-7a2e-47b0-a16e-e7c6df69c918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_867e2ecd-85e7-4af6-b151-218a2e65d222" xlink:to="loc_us-gaap_LetterOfCreditMember_c328bfb0-7a2e-47b0-a16e-e7c6df69c918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_5020c204-3eed-498e-bd8b-e18d89583ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:to="loc_us-gaap_VariableRateAxis_5020c204-3eed-498e-bd8b-e18d89583ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3497e5a7-a6aa-4791-a339-78aaa15c2d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_5020c204-3eed-498e-bd8b-e18d89583ddf" xlink:to="loc_us-gaap_VariableRateDomain_3497e5a7-a6aa-4791-a339-78aaa15c2d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d6b1cc30-6bae-4bf1-b558-44e393e651a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3497e5a7-a6aa-4791-a339-78aaa15c2d7c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d6b1cc30-6bae-4bf1-b558-44e393e651a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9026a336-c66a-4ac0-bf8c-613fc2963f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b6594914-cf47-4da3-b03e-4e57dd458277" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9026a336-c66a-4ac0-bf8c-613fc2963f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ab485b35-01e0-48cd-9ef3-ce19fd615ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9026a336-c66a-4ac0-bf8c-613fc2963f05" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ab485b35-01e0-48cd-9ef3-ce19fd615ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_901792bf-622a-47af-9d77-5baa4e27e400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9026a336-c66a-4ac0-bf8c-613fc2963f05" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_901792bf-622a-47af-9d77-5baa4e27e400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_974ccc8e-f03d-4655-8780-7a93d0482f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9026a336-c66a-4ac0-bf8c-613fc2963f05" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_974ccc8e-f03d-4655-8780-7a93d0482f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTSeniorNotesOfferingDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_1451d104-c1a9-463f-823e-e13d112345e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_1451d104-c1a9-463f-823e-e13d112345e2" xlink:to="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_71718d4c-f134-48e3-95a8-1b3a3f8093d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_71718d4c-f134-48e3-95a8-1b3a3f8093d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b56cf606-5bd9-4b8f-99fd-0dfb8aefabd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_71718d4c-f134-48e3-95a8-1b3a3f8093d2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b56cf606-5bd9-4b8f-99fd-0dfb8aefabd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1b52f40e-d06f-44b0-973f-9b78ddc9bde6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b56cf606-5bd9-4b8f-99fd-0dfb8aefabd0" xlink:to="loc_us-gaap_SeniorNotesMember_1b52f40e-d06f-44b0-973f-9b78ddc9bde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bb67daa3-ebb2-46e8-a939-4628f4df7f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:to="loc_us-gaap_DebtInstrumentAxis_bb67daa3-ebb2-46e8-a939-4628f4df7f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e440a4a7-5142-4ab2-808d-19d65433dce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_bb67daa3-ebb2-46e8-a939-4628f4df7f9d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e440a4a7-5142-4ab2-808d-19d65433dce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_ba018054-1cb2-46a3-9cd2-14d39d657191" xlink:href="dgx-20211231.xsd#dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e440a4a7-5142-4ab2-808d-19d65433dce3" xlink:to="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_ba018054-1cb2-46a3-9cd2-14d39d657191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_49a175e6-119a-43ff-a7ec-abb9f34550d5" xlink:href="dgx-20211231.xsd#dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e440a4a7-5142-4ab2-808d-19d65433dce3" xlink:to="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_49a175e6-119a-43ff-a7ec-abb9f34550d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_415ba6b4-3125-4f30-9daf-af3ded0a232c" xlink:href="dgx-20211231.xsd#dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e440a4a7-5142-4ab2-808d-19d65433dce3" xlink:to="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_415ba6b4-3125-4f30-9daf-af3ded0a232c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a717bac4-a2b6-4802-a9b1-379be06f6f75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a717bac4-a2b6-4802-a9b1-379be06f6f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a75a161b-b315-42b9-9f2e-9b0753217959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a717bac4-a2b6-4802-a9b1-379be06f6f75" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a75a161b-b315-42b9-9f2e-9b0753217959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember_a5eadf68-3c17-409a-b4b2-2909bbd2e7ee" xlink:href="dgx-20211231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a75a161b-b315-42b9-9f2e-9b0753217959" xlink:to="loc_dgx_OtherIncomeExpenseMember_a5eadf68-3c17-409a-b4b2-2909bbd2e7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8b800674-0f55-468c-a564-cc287ac4f563" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1ea7602c-b1ab-478d-9db0-831be271ba4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1ea7602c-b1ab-478d-9db0-831be271ba4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bf4a61d0-8b53-4a5f-822b-eeb320ebfe02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bf4a61d0-8b53-4a5f-822b-eeb320ebfe02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6e5548f5-ab85-48c5-8f75-f31aa00e8433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6e5548f5-ab85-48c5-8f75-f31aa00e8433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_29e96483-baf8-46a3-af58-eaef4200c197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_29e96483-baf8-46a3-af58-eaef4200c197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3a4bbd95-2daa-4a8d-bb32-fb76de85fb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ced9be1-2ab5-44f6-8b24-b6493e1b9b20" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3a4bbd95-2daa-4a8d-bb32-fb76de85fb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DEBTMaturitiesofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_98058581-aaf4-4135-a982-3a38baee9d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_98058581-aaf4-4135-a982-3a38baee9d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1e8d9248-d8e5-4103-a993-a170e70d3f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1e8d9248-d8e5-4103-a993-a170e70d3f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_92f3a292-da79-40ea-97df-e5c40197fba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_92f3a292-da79-40ea-97df-e5c40197fba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5d9f0102-9b96-4892-81a0-0975179916ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5d9f0102-9b96-4892-81a0-0975179916ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_2ee162fe-72d8-4690-992d-b6aca8ba7a49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_2ee162fe-72d8-4690-992d-b6aca8ba7a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_957477ed-b762-4c65-bbc0-ae0021aeca33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_957477ed-b762-4c65-bbc0-ae0021aeca33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LongTermDebtMaturitiesGross_66ccd3a6-efea-43d1-8432-5990ab2e78aa" xlink:href="dgx-20211231.xsd#dgx_LongTermDebtMaturitiesGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_dgx_LongTermDebtMaturitiesGross_66ccd3a6-efea-43d1-8432-5990ab2e78aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b66d7f8d-8adb-4ce9-bd6c-4598133436e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b66d7f8d-8adb-4ce9-bd6c-4598133436e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_a8ff0d70-f53e-4b6f-9ed1-33329d6bca19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_a8ff0d70-f53e-4b6f-9ed1-33329d6bca19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_acfd9f4e-2d8c-4e5a-a54f-4c42c3ffb68d" xlink:href="dgx-20211231.xsd#dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_acfd9f4e-2d8c-4e5a-a54f-4c42c3ffb68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_61e4a829-75c0-4d92-89f8-5a83b6ba8b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_LongTermDebt_61e4a829-75c0-4d92-89f8-5a83b6ba8b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7db00db3-0707-451c-873f-41416016c48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_LongTermDebtCurrent_7db00db3-0707-451c-873f-41416016c48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7faf4b5e-df45-48d0-a860-2fa78bbc6516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_27c2be39-275c-4574-a83f-4fe33e62d4df" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7faf4b5e-df45-48d0-a860-2fa78bbc6516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASES" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6ca9d512-1073-4e07-a1a7-7c45e5dc250a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_590e1b10-b0fc-4966-8108-47f8d5103333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6ca9d512-1073-4e07-a1a7-7c45e5dc250a" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_590e1b10-b0fc-4966-8108-47f8d5103333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_60b349e2-1ed9-451a-b868-4bd8d28f7e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6ca9d512-1073-4e07-a1a7-7c45e5dc250a" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_60b349e2-1ed9-451a-b868-4bd8d28f7e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3c5817a8-17b9-4478-b05e-dc9a8d6851d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock_f6f16d06-534c-4158-870a-36caf88728f9" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfLeaseByAssetTypeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c5817a8-17b9-4478-b05e-dc9a8d6851d7" xlink:to="loc_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock_f6f16d06-534c-4158-870a-36caf88728f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_1500f9d9-317f-40cb-ae16-fb71c2790054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c5817a8-17b9-4478-b05e-dc9a8d6851d7" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_1500f9d9-317f-40cb-ae16-fb71c2790054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_10c51ccf-28ef-4f6e-9cbc-771f7d04eb91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c5817a8-17b9-4478-b05e-dc9a8d6851d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_10c51ccf-28ef-4f6e-9cbc-771f7d04eb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_1c9ece32-68ed-4f7a-8231-62f5e5cf8453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c5817a8-17b9-4478-b05e-dc9a8d6851d7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_1c9ece32-68ed-4f7a-8231-62f5e5cf8453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock_f064b5c4-7c66-4c90-a25f-e43f1333890b" xlink:href="dgx-20211231.xsd#dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c5817a8-17b9-4478-b05e-dc9a8d6851d7" xlink:to="loc_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock_f064b5c4-7c66-4c90-a25f-e43f1333890b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e7a66da1-d201-41a2-a141-e588f5c0c2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_79c3e98e-deff-4876-9124-552d0f9fad37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7a66da1-d201-41a2-a141-e588f5c0c2bf" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_79c3e98e-deff-4876-9124-552d0f9fad37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f4344951-dfaa-4d33-b23d-90638a14e307" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79c3e98e-deff-4876-9124-552d0f9fad37" xlink:to="loc_srt_RangeAxis_f4344951-dfaa-4d33-b23d-90638a14e307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d534aa4d-9528-49e4-9a5c-a2b4219f91b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f4344951-dfaa-4d33-b23d-90638a14e307" xlink:to="loc_srt_RangeMember_d534aa4d-9528-49e4-9a5c-a2b4219f91b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b167dfe5-3496-41db-8db3-67df8819086c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d534aa4d-9528-49e4-9a5c-a2b4219f91b2" xlink:to="loc_srt_MinimumMember_b167dfe5-3496-41db-8db3-67df8819086c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_093c1ca7-c9e7-4bea-9133-54f5a735304e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d534aa4d-9528-49e4-9a5c-a2b4219f91b2" xlink:to="loc_srt_MaximumMember_093c1ca7-c9e7-4bea-9133-54f5a735304e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_c3fa5ea3-ec10-4aaa-b66e-9875c92cb3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79c3e98e-deff-4876-9124-552d0f9fad37" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_c3fa5ea3-ec10-4aaa-b66e-9875c92cb3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRemainingLeaseTerm_28fa65d0-5ab9-4433-832d-f1c615720e54" xlink:href="dgx-20211231.xsd#dgx_LeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c3fa5ea3-ec10-4aaa-b66e-9875c92cb3e4" xlink:to="loc_dgx_LeaseRemainingLeaseTerm_28fa65d0-5ab9-4433-832d-f1c615720e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRenewalTerm_aa7fbf7c-13c3-4c44-966c-8cc831772100" xlink:href="dgx-20211231.xsd#dgx_LeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c3fa5ea3-ec10-4aaa-b66e-9875c92cb3e4" xlink:to="loc_dgx_LeaseRenewalTerm_aa7fbf7c-13c3-4c44-966c-8cc831772100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESLiabilitiesDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASESLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_64a40630-87f3-407a-8a3d-e55dded65fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_64a40630-87f3-407a-8a3d-e55dded65fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_2f432d1d-3683-43e0-8194-a4f5f90af20c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_2f432d1d-3683-43e0-8194-a4f5f90af20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_9e559f0e-711e-4848-bcb8-0ab9fa1862b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_9e559f0e-711e-4848-bcb8-0ab9fa1862b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRightofUseAsset_ae61893a-112c-4f46-bcfe-27b7cac62b12" xlink:href="dgx-20211231.xsd#dgx_LeaseRightofUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_dgx_LeaseRightofUseAsset_ae61893a-112c-4f46-bcfe-27b7cac62b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a3e49599-5015-443a-af24-1c639aae3fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a3e49599-5015-443a-af24-1c639aae3fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_af76bf9c-befc-4642-8a90-1b98fda85867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_af76bf9c-befc-4642-8a90-1b98fda85867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_005374a2-ef46-4413-991c-943b5e4a7aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_005374a2-ef46-4413-991c-943b5e4a7aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_852c866b-bfad-4462-8bff-e31e5ad18568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_852c866b-bfad-4462-8bff-e31e5ad18568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d2547a85-ba83-4d9d-968f-d03edacec329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d2547a85-ba83-4d9d-968f-d03edacec329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_1f8195e4-aa40-4db9-ae0c-c28de1484324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_1f8195e4-aa40-4db9-ae0c-c28de1484324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseLiability_577d51de-88ec-41c3-870a-a44b5fa96aec" xlink:href="dgx-20211231.xsd#dgx_LeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_dgx_LeaseLiability_577d51de-88ec-41c3-870a-a44b5fa96aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_ee7d6395-4f4d-491b-82e2-7ff2523d1c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4b725f2c-5d72-4b83-a1ac-2443ac7517a2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_ee7d6395-4f4d-491b-82e2-7ff2523d1c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESCostsDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASESCostsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7c91db63-4c5e-4499-9191-11ce13f0c7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingLeaseFixedAndVariableCost_9c64ee28-a0b6-4a6b-b75e-f866f2bb63ed" xlink:href="dgx-20211231.xsd#dgx_OperatingLeaseFixedAndVariableCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7c91db63-4c5e-4499-9191-11ce13f0c7c2" xlink:to="loc_dgx_OperatingLeaseFixedAndVariableCost_9c64ee28-a0b6-4a6b-b75e-f866f2bb63ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_ca36fe82-3740-41eb-9d9b-b83239a42fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7c91db63-4c5e-4499-9191-11ce13f0c7c2" xlink:to="loc_us-gaap_LeaseCostAbstract_ca36fe82-3740-41eb-9d9b-b83239a42fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4ffff745-d59e-47e4-a466-28518658a831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_ca36fe82-3740-41eb-9d9b-b83239a42fa0" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4ffff745-d59e-47e4-a466-28518658a831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_92ab31d0-4790-41e5-b89f-1d5f8feebe5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_ca36fe82-3740-41eb-9d9b-b83239a42fa0" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_92ab31d0-4790-41e5-b89f-1d5f8feebe5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_bd4d6029-7933-4afd-867f-e5d31cd30e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7c91db63-4c5e-4499-9191-11ce13f0c7c2" xlink:to="loc_us-gaap_LeaseCost_bd4d6029-7933-4afd-867f-e5d31cd30e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ShorttermLeaseandVariableLeaseCost_966e794a-ea3a-40d9-ae56-39c351b4141c" xlink:href="dgx-20211231.xsd#dgx_ShorttermLeaseandVariableLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7c91db63-4c5e-4499-9191-11ce13f0c7c2" xlink:to="loc_dgx_ShorttermLeaseandVariableLeaseCost_966e794a-ea3a-40d9-ae56-39c351b4141c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESMaturityDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASESMaturityDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5dde5c61-055b-4f93-af16-43d1a49c6e57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5dde5c61-055b-4f93-af16-43d1a49c6e57" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_724876e3-2706-4d20-9a1e-e410ccb6aba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_724876e3-2706-4d20-9a1e-e410ccb6aba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_03e16bdd-0af9-4ce0-806d-97d5d62d30ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_03e16bdd-0af9-4ce0-806d-97d5d62d30ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_388a497e-b410-4d8e-bf9b-7ecc327c57db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_388a497e-b410-4d8e-bf9b-7ecc327c57db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_493531ec-0f7c-4476-a834-465759e38c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_493531ec-0f7c-4476-a834-465759e38c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0b7034b8-5118-4dc3-b49e-5c37e1ca79fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0b7034b8-5118-4dc3-b49e-5c37e1ca79fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_17dab4f1-ae67-46cc-837a-8930d0c536c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_17dab4f1-ae67-46cc-837a-8930d0c536c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_830ecbb1-059a-43b8-bdf2-cdc27c6a8103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_830ecbb1-059a-43b8-bdf2-cdc27c6a8103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5bd0024f-d512-4fc0-a473-8f6fcc6a55c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5bd0024f-d512-4fc0-a473-8f6fcc6a55c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_99b3a309-a485-497f-9899-61f5c4181687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b9afd48-5dac-40a1-a424-71dfd0f870be" xlink:to="loc_us-gaap_OperatingLeaseLiability_99b3a309-a485-497f-9899-61f5c4181687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5dde5c61-055b-4f93-af16-43d1a49c6e57" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c5ad523b-6a74-4c82-a792-09cedfa0351f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c5ad523b-6a74-4c82-a792-09cedfa0351f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_f1c90b5e-364f-4d69-a7ea-939de002d5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_f1c90b5e-364f-4d69-a7ea-939de002d5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c61c38e2-d200-48d3-b881-978e920765e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c61c38e2-d200-48d3-b881-978e920765e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_76d1450f-a914-4256-ad90-4856721fa7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_76d1450f-a914-4256-ad90-4856721fa7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f7f6625d-f119-4280-a857-fe0f6830fa83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f7f6625d-f119-4280-a857-fe0f6830fa83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_d7a7c7af-6e29-4308-92d3-cd4cbd8b08b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_d7a7c7af-6e29-4308-92d3-cd4cbd8b08b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c13a1e37-4428-48d7-ae99-42aa5f78e396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c13a1e37-4428-48d7-ae99-42aa5f78e396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_11b1d884-e90f-425b-840d-a178cd3fc8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_11b1d884-e90f-425b-840d-a178cd3fc8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_86a915f4-7d3a-47a1-8023-09084d60fd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_86a915f4-7d3a-47a1-8023-09084d60fd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_796364ba-2b26-4f5a-a89b-d7c43239c722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_84230e82-03c3-4fe2-98b6-c34f4f144324" xlink:to="loc_us-gaap_FinanceLeaseLiability_796364ba-2b26-4f5a-a89b-d7c43239c722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:href="dgx-20211231.xsd#dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5dde5c61-055b-4f93-af16-43d1a49c6e57" xlink:to="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_4bbc09b4-2fad-4095-96ca-d12867d8512c" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_4bbc09b4-2fad-4095-96ca-d12867d8512c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_b470ab99-c314-4fb6-addb-0a79fe65fdbe" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_b470ab99-c314-4fb6-addb-0a79fe65fdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_7ef5c562-7178-47a8-8113-6797eae6e6b2" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_7ef5c562-7178-47a8-8113-6797eae6e6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_808d7470-abc6-4b66-a74b-b81731f338d4" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_808d7470-abc6-4b66-a74b-b81731f338d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_9c3b3491-37f6-4f7c-9ac9-2c66d4cd6eac" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_9c3b3491-37f6-4f7c-9ac9-2c66d4cd6eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_736d0534-7a40-4485-97df-20cfbd648a23" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_736d0534-7a40-4485-97df-20cfbd648a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_e99c77b3-e18b-45c6-be2f-7f6548e89043" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_e99c77b3-e18b-45c6-be2f-7f6548e89043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_2b3b442f-c791-43a3-80c0-c8229288cc69" xlink:href="dgx-20211231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_2b3b442f-c791-43a3-80c0-c8229288cc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingandFinanceLeaseLiability_1e9c0ecd-6c29-48a4-8399-14ad7b937d55" xlink:href="dgx-20211231.xsd#dgx_OperatingandFinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_ff40658f-8151-413b-b0e8-37e091664d90" xlink:to="loc_dgx_OperatingandFinanceLeaseLiability_1e9c0ecd-6c29-48a4-8399-14ad7b937d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESTermandRateDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#LEASESTermandRateDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESTermandRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bbbaf584-d177-438e-adfd-3d5489715aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_25992f10-c009-4494-9a3c-f06c22d8f642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbbaf584-d177-438e-adfd-3d5489715aa1" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_25992f10-c009-4494-9a3c-f06c22d8f642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_cd8c51b7-5ca9-4112-9ca2-c61d4fe406cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbbaf584-d177-438e-adfd-3d5489715aa1" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_cd8c51b7-5ca9-4112-9ca2-c61d4fe406cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e1caf325-0065-4fe5-babb-98f38d63d8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbbaf584-d177-438e-adfd-3d5489715aa1" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e1caf325-0065-4fe5-babb-98f38d63d8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_46b3ceea-3a0e-483a-832e-9a1bad351726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbbaf584-d177-438e-adfd-3d5489715aa1" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_46b3ceea-3a0e-483a-832e-9a1bad351726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20211231.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d56f5caa-7cb9-45d2-bf3c-5d626cfdf58c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b8c89458-2953-4d2a-806d-8521b64b942a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d56f5caa-7cb9-45d2-bf3c-5d626cfdf58c" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b8c89458-2953-4d2a-806d-8521b64b942a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c98ebadb-655e-429d-84bb-8b05bd9e02ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1c3522ca-8dfb-40ee-a521-3597ff51c293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c98ebadb-655e-429d-84bb-8b05bd9e02ef" xlink:to="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1c3522ca-8dfb-40ee-a521-3597ff51c293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f29e6f22-32c3-432d-8ec4-9e922849bf3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f29e6f22-32c3-432d-8ec4-9e922849bf3b" xlink:to="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aac33c04-65e1-482a-8a00-672b0be1f58a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aac33c04-65e1-482a-8a00-672b0be1f58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_072f8720-05bf-4544-8c07-43a16111696b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aac33c04-65e1-482a-8a00-672b0be1f58a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_072f8720-05bf-4544-8c07-43a16111696b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_7283aff6-f15a-4016-87a3-302d08da412f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_072f8720-05bf-4544-8c07-43a16111696b" xlink:to="loc_us-gaap_FairValueHedgingMember_7283aff6-f15a-4016-87a3-302d08da412f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_481ee091-0b62-4b6d-a8c6-6318b0af965a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_srt_StatementScenarioAxis_481ee091-0b62-4b6d-a8c6-6318b0af965a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1ba76dd1-25bb-42bb-a794-5a11f5c8e622" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_481ee091-0b62-4b6d-a8c6-6318b0af965a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1ba76dd1-25bb-42bb-a794-5a11f5c8e622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_3709f33e-60b2-479f-9304-f7185f2e7415" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1ba76dd1-25bb-42bb-a794-5a11f5c8e622" xlink:to="loc_srt_ScenarioForecastMember_3709f33e-60b2-479f-9304-f7185f2e7415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_dafe1697-8253-4604-84cd-9a95838e94c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_us-gaap_VariableRateAxis_dafe1697-8253-4604-84cd-9a95838e94c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0cbbaa7e-d26b-497f-bccb-2568d9055ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_dafe1697-8253-4604-84cd-9a95838e94c8" xlink:to="loc_us-gaap_VariableRateDomain_0cbbaa7e-d26b-497f-bccb-2568d9055ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a2233d11-73cb-4505-9cbe-cb2bf4b1d97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_0cbbaa7e-d26b-497f-bccb-2568d9055ede" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a2233d11-73cb-4505-9cbe-cb2bf4b1d97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dda149f1-8f83-49f8-80b9-f8f1fe7de3df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_srt_RangeAxis_dda149f1-8f83-49f8-80b9-f8f1fe7de3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_93f1fcb6-955e-4874-ba0e-82cbd500243e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dda149f1-8f83-49f8-80b9-f8f1fe7de3df" xlink:to="loc_srt_RangeMember_93f1fcb6-955e-4874-ba0e-82cbd500243e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_20bb17d2-01a8-4a3c-887b-c8928f88f958" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_93f1fcb6-955e-4874-ba0e-82cbd500243e" xlink:to="loc_srt_MinimumMember_20bb17d2-01a8-4a3c-887b-c8928f88f958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8eb2d66e-7ab5-4983-8357-70dbff6f7557" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_93f1fcb6-955e-4874-ba0e-82cbd500243e" xlink:to="loc_srt_MaximumMember_8eb2d66e-7ab5-4983-8357-70dbff6f7557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fb82bf0c-df2d-4f27-9bdb-3f6e0453a56a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fb82bf0c-df2d-4f27-9bdb-3f6e0453a56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6d34adf6-3f04-46a4-b2c0-a3500724281c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb82bf0c-df2d-4f27-9bdb-3f6e0453a56a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6d34adf6-3f04-46a4-b2c0-a3500724281c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_a800de5f-c213-441e-ad94-ebb471204049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6d34adf6-3f04-46a4-b2c0-a3500724281c" xlink:to="loc_us-gaap_LongTermDebtMember_a800de5f-c213-441e-ad94-ebb471204049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_286e5e8e-ee50-4a9e-9b82-07417f55411c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_edbf24d1-f986-47fd-9259-fc41a90a0166" xlink:to="loc_us-gaap_DerivativeLineItems_286e5e8e-ee50-4a9e-9b82-07417f55411c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_890ea659-73eb-4804-8434-23df0a6a9825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_286e5e8e-ee50-4a9e-9b82-07417f55411c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_890ea659-73eb-4804-8434-23df0a6a9825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_87b693ca-157e-4fff-8f50-b6778c2a0495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_9aea838b-3c72-43e6-b5c5-9c15128a81fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_87b693ca-157e-4fff-8f50-b6778c2a0495" xlink:to="loc_us-gaap_DerivativeTable_9aea838b-3c72-43e6-b5c5-9c15128a81fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4666fb02-0897-42d9-bef0-626f3a6f1f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9aea838b-3c72-43e6-b5c5-9c15128a81fe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4666fb02-0897-42d9-bef0-626f3a6f1f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_36ac96b6-a870-487a-83e1-74da6539ee14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4666fb02-0897-42d9-bef0-626f3a6f1f7c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_36ac96b6-a870-487a-83e1-74da6539ee14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_ec939345-0908-4be4-b767-a453ff74a608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_36ac96b6-a870-487a-83e1-74da6539ee14" xlink:to="loc_us-gaap_LongTermDebtMember_ec939345-0908-4be4-b767-a453ff74a608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ead88e9-af16-4e9c-89b3-b3d93488dde7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9aea838b-3c72-43e6-b5c5-9c15128a81fe" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ead88e9-af16-4e9c-89b3-b3d93488dde7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0831f2ac-2576-4606-bc9e-9cf44fa282ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3ead88e9-af16-4e9c-89b3-b3d93488dde7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0831f2ac-2576-4606-bc9e-9cf44fa282ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_290b16ad-e57d-4fda-b310-90f1cf145d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0831f2ac-2576-4606-bc9e-9cf44fa282ee" xlink:to="loc_us-gaap_FairValueHedgingMember_290b16ad-e57d-4fda-b310-90f1cf145d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_16ab5d7b-0fb7-4f37-ba8a-eb71f3ab6291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9aea838b-3c72-43e6-b5c5-9c15128a81fe" xlink:to="loc_us-gaap_DerivativeLineItems_16ab5d7b-0fb7-4f37-ba8a-eb71f3ab6291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_c4da601a-eb44-45a4-a240-08f921880986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_16ab5d7b-0fb7-4f37-ba8a-eb71f3ab6291" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_c4da601a-eb44-45a4-a240-08f921880986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_5aea648c-ae78-4268-ab6e-8cab3a64c8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_16ab5d7b-0fb7-4f37-ba8a-eb71f3ab6291" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_5aea648c-ae78-4268-ab6e-8cab3a64c8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_090b9962-3301-46f1-86de-8f9ebd5c2e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_6c6ed25b-bede-46aa-b0b0-3dafe04b12a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_090b9962-3301-46f1-86de-8f9ebd5c2e83" xlink:to="loc_us-gaap_DerivativeTable_6c6ed25b-bede-46aa-b0b0-3dafe04b12a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e47a377b-62c4-42fa-99ae-d6d6362ed616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6c6ed25b-bede-46aa-b0b0-3dafe04b12a8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e47a377b-62c4-42fa-99ae-d6d6362ed616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a4e035a2-9d7b-4ef7-b13d-cc6eddd0bbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e47a377b-62c4-42fa-99ae-d6d6362ed616" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a4e035a2-9d7b-4ef7-b13d-cc6eddd0bbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1c071479-38fd-46ed-9178-9155efd70e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a4e035a2-9d7b-4ef7-b13d-cc6eddd0bbe2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1c071479-38fd-46ed-9178-9155efd70e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_976e0e0c-08ca-4db1-b590-963b5cbf876e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6c6ed25b-bede-46aa-b0b0-3dafe04b12a8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_976e0e0c-08ca-4db1-b590-963b5cbf876e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c6e0b4d0-bb57-42df-a681-6d5b375da49b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_976e0e0c-08ca-4db1-b590-963b5cbf876e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c6e0b4d0-bb57-42df-a681-6d5b375da49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_fc4479d8-8fd9-408c-bf27-8cb0d269f3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c6e0b4d0-bb57-42df-a681-6d5b375da49b" xlink:to="loc_us-gaap_FairValueHedgingMember_fc4479d8-8fd9-408c-bf27-8cb0d269f3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1d8d7f29-016d-4792-8929-43a1224dcfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6c6ed25b-bede-46aa-b0b0-3dafe04b12a8" xlink:to="loc_us-gaap_DerivativeLineItems_1d8d7f29-016d-4792-8929-43a1224dcfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a756ea9d-f8b9-46fc-adc8-d42fbb9db9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1d8d7f29-016d-4792-8929-43a1224dcfc9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a756ea9d-f8b9-46fc-adc8-d42fbb9db9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_dfb3471d-5d32-4879-9102-0762102bdccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1d8d7f29-016d-4792-8929-43a1224dcfc9" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_dfb3471d-5d32-4879-9102-0762102bdccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_7e194c22-c572-4c19-83bd-36b3f41b7825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1d8d7f29-016d-4792-8929-43a1224dcfc9" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_7e194c22-c572-4c19-83bd-36b3f41b7825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0544f3fe-5c4b-415a-9ad6-62806a77fc23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e798dee1-5929-467e-ba1a-9317d8fb8c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0544f3fe-5c4b-415a-9ad6-62806a77fc23" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e798dee1-5929-467e-ba1a-9317d8fb8c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_75d7b29a-68eb-487a-ad04-0ba783ede5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_95da1e40-d5c1-43d9-a7c1-172b8a2515e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_75d7b29a-68eb-487a-ad04-0ba783ede5ac" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_95da1e40-d5c1-43d9-a7c1-172b8a2515e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_749ccbb1-7031-4e7b-87b2-af0c380c0ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareholdersEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_749ccbb1-7031-4e7b-87b2-af0c380c0ef5" xlink:to="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b4df36c3-b16f-4a49-9746-969b830b6493" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_srt_RangeAxis_b4df36c3-b16f-4a49-9746-969b830b6493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_28f5920b-8137-46fa-a1f6-de3da65ebcbb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b4df36c3-b16f-4a49-9746-969b830b6493" xlink:to="loc_srt_RangeMember_28f5920b-8137-46fa-a1f6-de3da65ebcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c7ac19d4-3c2f-4680-b547-e348787ef754" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_28f5920b-8137-46fa-a1f6-de3da65ebcbb" xlink:to="loc_srt_MaximumMember_c7ac19d4-3c2f-4680-b547-e348787ef754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_85977d98-9ac2-4c4e-9670-9dc59d856c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_85977d98-9ac2-4c4e-9670-9dc59d856c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7bfcfefd-bbd1-42dd-a3ab-a6775cd2e46a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_85977d98-9ac2-4c4e-9670-9dc59d856c3e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7bfcfefd-bbd1-42dd-a3ab-a6775cd2e46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_33b57680-7436-4581-a33b-5c7d6474fe40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7bfcfefd-bbd1-42dd-a3ab-a6775cd2e46a" xlink:to="loc_us-gaap_SubsequentEventMember_33b57680-7436-4581-a33b-5c7d6474fe40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_41856b10-0c47-41de-8005-818844f42d7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_srt_StatementScenarioAxis_41856b10-0c47-41de-8005-818844f42d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a710f740-cba9-4256-9919-cf98a0cd603c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_41856b10-0c47-41de-8005-818844f42d7b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a710f740-cba9-4256-9919-cf98a0cd603c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_487ab7f8-7f49-4a28-95ee-75fbd327babb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a710f740-cba9-4256-9919-cf98a0cd603c" xlink:to="loc_srt_ScenarioForecastMember_487ab7f8-7f49-4a28-95ee-75fbd327babb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c0ee9beb-cf82-42f9-b1d8-ee75f1a4b770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c0ee9beb-cf82-42f9-b1d8-ee75f1a4b770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8640b52b-1de8-4c9d-b415-d339addc592a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0ee9beb-cf82-42f9-b1d8-ee75f1a4b770" xlink:to="loc_us-gaap_EquityComponentDomain_8640b52b-1de8-4c9d-b415-d339addc592a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_dfcd5bf0-b09f-453b-b42f-fa5d71038a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8640b52b-1de8-4c9d-b415-d339addc592a" xlink:to="loc_us-gaap_TreasuryStockMember_dfcd5bf0-b09f-453b-b42f-fa5d71038a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_85eaf271-cd63-4596-a421-b7507111587e" xlink:href="dgx-20211231.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8640b52b-1de8-4c9d-b415-d339addc592a" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_85eaf271-cd63-4596-a421-b7507111587e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_125adf80-0e24-496c-8ac1-fb143fb2936d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8640b52b-1de8-4c9d-b415-d339addc592a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_125adf80-0e24-496c-8ac1-fb143fb2936d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_63d33621-1e67-48c9-8fb9-26bf5a4fa3c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_srt_OwnershipAxis_63d33621-1e67-48c9-8fb9-26bf5a4fa3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b878b728-043e-4093-9d73-3c8034b33b39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_63d33621-1e67-48c9-8fb9-26bf5a4fa3c2" xlink:to="loc_srt_OwnershipDomain_b878b728-043e-4093-9d73-3c8034b33b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_39776024-5b5c-4486-90a9-b1b26e7644e7" xlink:href="dgx-20211231.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b878b728-043e-4093-9d73-3c8034b33b39" xlink:to="loc_dgx_UMassJointVentureMember_39776024-5b5c-4486-90a9-b1b26e7644e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3c363919-7e40-4eb3-8a63-f83475a4303e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3c363919-7e40-4eb3-8a63-f83475a4303e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d0f44cab-b99e-4a88-830d-52050b7e650f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3c363919-7e40-4eb3-8a63-f83475a4303e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d0f44cab-b99e-4a88-830d-52050b7e650f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_3dfa0e36-9c41-4b62-9e98-8e4ea0a34a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d0f44cab-b99e-4a88-830d-52050b7e650f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_3dfa0e36-9c41-4b62-9e98-8e4ea0a34a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0fb4136c-387b-419f-953e-988ab35174c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0fb4136c-387b-419f-953e-988ab35174c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8feb8672-b5e0-4f35-aae1-072875bc18fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0fb4136c-387b-419f-953e-988ab35174c6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8feb8672-b5e0-4f35-aae1-072875bc18fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_e91c622e-31c9-4012-b7dc-129e12828b08" xlink:href="dgx-20211231.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8feb8672-b5e0-4f35-aae1-072875bc18fa" xlink:to="loc_dgx_Q2SolutionsMember_e91c622e-31c9-4012-b7dc-129e12828b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7e23be97-9a6d-4c20-8b05-067b7845e51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7e23be97-9a6d-4c20-8b05-067b7845e51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bce4d855-438b-4c70-8ac3-6da33aaf3c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7e23be97-9a6d-4c20-8b05-067b7845e51a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bce4d855-438b-4c70-8ac3-6da33aaf3c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_a7e52b3c-af9a-4a46-ae60-f5fa604f9b41" xlink:href="dgx-20211231.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bce4d855-438b-4c70-8ac3-6da33aaf3c8d" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_a7e52b3c-af9a-4a46-ae60-f5fa604f9b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareholdersEquityLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_04bcbf58-982f-4829-9458-9766a64a98d2" xlink:to="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9f2044f5-ae01-4fa3-9124-8f96d34e7fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9f2044f5-ae01-4fa3-9124-8f96d34e7fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f0b59bed-2c02-49f7-b3eb-007441fb0be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f0b59bed-2c02-49f7-b3eb-007441fb0be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_2ac607a4-0504-4d35-a43d-b5509b10d330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_2ac607a4-0504-4d35-a43d-b5509b10d330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_48d787cb-a7ac-4751-8e43-8477aec38612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_48d787cb-a7ac-4751-8e43-8477aec38612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4cc2187a-4878-4e6e-97f9-e95bf52b347e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4cc2187a-4878-4e6e-97f9-e95bf52b347e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_91e970b2-8780-4461-a664-270d479f15b4" xlink:href="dgx-20211231.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_91e970b2-8780-4461-a664-270d479f15b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2ad2c608-1b6b-4c1c-b90d-7c1c365440bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2ad2c608-1b6b-4c1c-b90d-7c1c365440bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_9801c619-0444-41c2-b566-32c47eaa6f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_9801c619-0444-41c2-b566-32c47eaa6f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_04caf955-1fe3-46ac-b04a-5241b0d25207" xlink:href="dgx-20211231.xsd#dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_04caf955-1fe3-46ac-b04a-5241b0d25207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_dc20b854-257f-4aff-866c-cc54c03d9649" xlink:href="dgx-20211231.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_dc20b854-257f-4aff-866c-cc54c03d9649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_2acb30dc-eb7c-4f7d-aa94-a6af5da203d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_2acb30dc-eb7c-4f7d-aa94-a6af5da203d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_361e7c2c-d061-41be-a872-9d26888c1a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_361e7c2c-d061-41be-a872-9d26888c1a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0d53b9a2-c959-4820-9ebe-04d6eb5af875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0d53b9a2-c959-4820-9ebe-04d6eb5af875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesPayment_c793a6af-58a3-4934-ad1f-a6f05b0c9b31" xlink:href="dgx-20211231.xsd#dgx_AcceleratedShareRepurchasesPayment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_dgx_AcceleratedShareRepurchasesPayment_c793a6af-58a3-4934-ad1f-a6f05b0c9b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_bd6ccb70-5292-4a06-9901-213f3518870f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_bd6ccb70-5292-4a06-9901-213f3518870f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_8495ce1a-95f2-42f5-b95d-89f3c26a6c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_8495ce1a-95f2-42f5-b95d-89f3c26a6c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b2e271f3-77b1-4176-9129-6d327e8333db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b2e271f3-77b1-4176-9129-6d327e8333db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f9e2f00f-eb04-453e-9a92-2f2b0720711d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_2d7c947c-d82d-463a-97d3-31ab898e2ee9" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f9e2f00f-eb04-453e-9a92-2f2b0720711d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_92d263c3-fee3-4607-9064-bfb9abf13bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityTable_6dac2ade-0284-4367-a2b4-646379c0c798" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareholdersEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_92d263c3-fee3-4607-9064-bfb9abf13bdb" xlink:to="loc_dgx_ScheduleOfShareholdersEquityTable_6dac2ade-0284-4367-a2b4-646379c0c798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_44a58149-60e9-4c67-b2b6-b141e82ae273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_6dac2ade-0284-4367-a2b4-646379c0c798" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_44a58149-60e9-4c67-b2b6-b141e82ae273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_44a58149-60e9-4c67-b2b6-b141e82ae273" xlink:to="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_53d3a666-aeb3-4a0b-a162-76800d174523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_53d3a666-aeb3-4a0b-a162-76800d174523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_f7dd622f-058d-47f0-af2f-443b0246c886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_f7dd622f-058d-47f0-af2f-443b0246c886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_95e9e515-1270-43ab-a653-bd4a296ffe37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_95e9e515-1270-43ab-a653-bd4a296ffe37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherEquityComponentsMember_dca79fca-741b-4985-bb5d-70a90abfabbb" xlink:href="dgx-20211231.xsd#dgx_OtherEquityComponentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:to="loc_dgx_OtherEquityComponentsMember_dca79fca-741b-4985-bb5d-70a90abfabbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774f8126-b41a-4013-a61a-f8f7845ee86a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_93de0bc7-72dc-4d06-bf53-3837b9c26760" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774f8126-b41a-4013-a61a-f8f7845ee86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareholdersEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_6dac2ade-0284-4367-a2b4-646379c0c798" xlink:to="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fd970387-c8cb-427d-b7c3-383e1d9a8790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fd970387-c8cb-427d-b7c3-383e1d9a8790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d74613d3-58d7-4e0c-9437-8976b32f82f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d74613d3-58d7-4e0c-9437-8976b32f82f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d3ca4c02-9172-4bcb-b2f3-ee4c644b572f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d3ca4c02-9172-4bcb-b2f3-ee4c644b572f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93363386-f635-42c1-a7b9-58f60d4568fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93363386-f635-42c1-a7b9-58f60d4568fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a7a4bdb2-56c4-4555-a6ab-9e059f1c7624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_c7b7a678-3a82-47d3-9fee-6a4a08ad1b81" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a7a4bdb2-56c4-4555-a6ab-9e059f1c7624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_01d739ca-547e-4825-a228-21679971dcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_df61aa4c-a462-498c-9af2-e41c641cc279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_01d739ca-547e-4825-a228-21679971dcd6" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_df61aa4c-a462-498c-9af2-e41c641cc279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895c9e1b-4f65-4d82-94bb-7851a24915fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_93d52f50-2af5-4013-8d45-ecde11aec121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895c9e1b-4f65-4d82-94bb-7851a24915fd" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_93d52f50-2af5-4013-8d45-ecde11aec121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e27b43e1-c273-4971-be24-4ee9d1633885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895c9e1b-4f65-4d82-94bb-7851a24915fd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e27b43e1-c273-4971-be24-4ee9d1633885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock_ed4f1b8a-ed4d-4b5a-97be-b62f3e9f6c83" xlink:href="dgx-20211231.xsd#dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895c9e1b-4f65-4d82-94bb-7851a24915fd" xlink:to="loc_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock_ed4f1b8a-ed4d-4b5a-97be-b62f3e9f6c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_cb5b2fff-90f3-464b-a07a-a779a6848211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895c9e1b-4f65-4d82-94bb-7851a24915fd" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_cb5b2fff-90f3-464b-a07a-a779a6848211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_302510a9-feac-4204-86f2-7507696d3795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4db831f6-a629-40e4-854e-96270a68b47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_302510a9-feac-4204-86f2-7507696d3795" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4db831f6-a629-40e4-854e-96270a68b47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2f8f03d0-29ef-439e-8987-673e1865d3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4db831f6-a629-40e4-854e-96270a68b47d" xlink:to="loc_us-gaap_AwardTypeAxis_2f8f03d0-29ef-439e-8987-673e1865d3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8eab7a8f-4503-456a-adb8-7331d71ef6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2f8f03d0-29ef-439e-8987-673e1865d3ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8eab7a8f-4503-456a-adb8-7331d71ef6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EmployeeLongTermIncentivePlanEltipMember_11b834a2-c622-4732-896c-8f953168353e" xlink:href="dgx-20211231.xsd#dgx_EmployeeLongTermIncentivePlanEltipMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8eab7a8f-4503-456a-adb8-7331d71ef6a2" xlink:to="loc_dgx_EmployeeLongTermIncentivePlanEltipMember_11b834a2-c622-4732-896c-8f953168353e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_6367817a-cd64-41e3-8b32-a61aed898b6b" xlink:href="dgx-20211231.xsd#dgx_RestatedDirectorLongTermIncentivePlanDltipMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8eab7a8f-4503-456a-adb8-7331d71ef6a2" xlink:to="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_6367817a-cd64-41e3-8b32-a61aed898b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_48d33d8f-d60c-43e6-a9e6-d24045e3faaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8eab7a8f-4503-456a-adb8-7331d71ef6a2" xlink:to="loc_us-gaap_StockOptionMember_48d33d8f-d60c-43e6-a9e6-d24045e3faaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4db831f6-a629-40e4-854e-96270a68b47d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_615f5ea9-c7e6-4ce2-99d8-872d4e6975d7" xlink:href="dgx-20211231.xsd#dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:to="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_615f5ea9-c7e6-4ce2-99d8-872d4e6975d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ef46a585-7a3f-48df-96bc-26302a507f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ef46a585-7a3f-48df-96bc-26302a507f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b5637a88-9bd0-4dad-9b34-06fde3873350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b5637a88-9bd0-4dad-9b34-06fde3873350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0c796e36-3e8a-4b48-a873-37779436f253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd0b1677-d227-4385-9ee0-54c6d359e82a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0c796e36-3e8a-4b48-a873-37779436f253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79b6bea6-5785-45e7-81e5-859e4b596cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31eb2c16-117a-45f4-9816-b1052e1914cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79b6bea6-5785-45e7-81e5-859e4b596cbc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31eb2c16-117a-45f4-9816-b1052e1914cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_90c30b7b-b725-460d-9458-81e5dd1b3023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31eb2c16-117a-45f4-9816-b1052e1914cf" xlink:to="loc_us-gaap_AwardTypeAxis_90c30b7b-b725-460d-9458-81e5dd1b3023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1e9e090-368b-49a5-93f7-92b79d849b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_90c30b7b-b725-460d-9458-81e5dd1b3023" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1e9e090-368b-49a5-93f7-92b79d849b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_a366df3d-6c4c-4150-90f5-a02f466b1a86" xlink:href="dgx-20211231.xsd#dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1e9e090-368b-49a5-93f7-92b79d849b0a" xlink:to="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_a366df3d-6c4c-4150-90f5-a02f466b1a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_26a09246-89f8-4869-8711-d09dc92f5cd6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31eb2c16-117a-45f4-9816-b1052e1914cf" xlink:to="loc_srt_RangeAxis_26a09246-89f8-4869-8711-d09dc92f5cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_77e07ba2-e9a1-4756-b47e-8c49e736d8a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_26a09246-89f8-4869-8711-d09dc92f5cd6" xlink:to="loc_srt_RangeMember_77e07ba2-e9a1-4756-b47e-8c49e736d8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2bcc2162-7a40-4d71-94b9-5d93ed92c602" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_77e07ba2-e9a1-4756-b47e-8c49e736d8a9" xlink:to="loc_srt_MinimumMember_2bcc2162-7a40-4d71-94b9-5d93ed92c602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ef782ed-3f4b-4a5e-bf7c-59c7c015cfb0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_77e07ba2-e9a1-4756-b47e-8c49e736d8a9" xlink:to="loc_srt_MaximumMember_2ef782ed-3f4b-4a5e-bf7c-59c7c015cfb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31eb2c16-117a-45f4-9816-b1052e1914cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_14040ea3-6116-4927-ab4a-350ce334a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_14040ea3-6116-4927-ab4a-350ce334a93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0a29a9f8-3273-42fe-887a-5e532ad1de3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0a29a9f8-3273-42fe-887a-5e532ad1de3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c757227b-c225-48a5-b609-76a48af71d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c757227b-c225-48a5-b609-76a48af71d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_93cce174-2f0a-49e0-9d99-8b92af5822f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_93cce174-2f0a-49e0-9d99-8b92af5822f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_18d96f63-aa09-4ef7-b111-261be9fa02e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_18d96f63-aa09-4ef7-b111-261be9fa02e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ef578774-12f7-452f-a14a-3c0f5da339ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e89747e-e028-45af-a8f0-adad22fbb607" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ef578774-12f7-452f-a14a-3c0f5da339ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e89abe34-ee42-4ead-966e-2dc44708fd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c35aa21c-06ec-412c-81af-1622514e7756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e89abe34-ee42-4ead-966e-2dc44708fd0e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c35aa21c-06ec-412c-81af-1622514e7756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7ddc0f5b-ffd7-42dc-bcd6-56c506de950b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c35aa21c-06ec-412c-81af-1622514e7756" xlink:to="loc_us-gaap_AwardTypeAxis_7ddc0f5b-ffd7-42dc-bcd6-56c506de950b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46862aa2-851e-4b1e-aec0-a70c0d234a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7ddc0f5b-ffd7-42dc-bcd6-56c506de950b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46862aa2-851e-4b1e-aec0-a70c0d234a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_ad95b574-5c1e-4697-8b9f-ad9e77b79276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46862aa2-851e-4b1e-aec0-a70c0d234a01" xlink:to="loc_us-gaap_StockOptionMember_ad95b574-5c1e-4697-8b9f-ad9e77b79276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c35aa21c-06ec-412c-81af-1622514e7756" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_24cc80fe-5a55-48c9-8a1a-353d6e9cd53c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_24cc80fe-5a55-48c9-8a1a-353d6e9cd53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_335f631a-8a01-4464-9507-5f5bb74c7ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_335f631a-8a01-4464-9507-5f5bb74c7ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_efb90556-32cc-4fbe-adb7-cc17d5ce58f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_efb90556-32cc-4fbe-adb7-cc17d5ce58f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2820cc53-08bf-4024-bb5e-edff6a2419c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2820cc53-08bf-4024-bb5e-edff6a2419c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1f16bb3c-5c78-40cb-b156-3b666fa3b8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74ec1bf7-f019-4695-aba7-05acdfc42df6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1f16bb3c-5c78-40cb-b156-3b666fa3b8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f474c71d-f03e-4924-823b-cd426ebc43a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f474c71d-f03e-4924-823b-cd426ebc43a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_15888210-4d29-4523-af66-41123a814b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_15888210-4d29-4523-af66-41123a814b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b075ceb4-74eb-4ce1-bb61-eb089f3d3c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b075ceb4-74eb-4ce1-bb61-eb089f3d3c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_9137ad49-22fc-48de-88cb-119031412340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_9137ad49-22fc-48de-88cb-119031412340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_64d45a45-e915-4f4c-8471-e76b67b5f59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_416d09fd-a0fa-4dd1-af76-2ba7178292ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_64d45a45-e915-4f4c-8471-e76b67b5f59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c3d5f8c4-4686-4484-ba18-20aecf9494d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c3d5f8c4-4686-4484-ba18-20aecf9494d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f7c6047b-ba9f-4aba-adaa-acc5f29e4d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f7c6047b-ba9f-4aba-adaa-acc5f29e4d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4bb27ba7-3408-4c37-8bc3-2763ebd33dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4bb27ba7-3408-4c37-8bc3-2763ebd33dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f6c45c87-4e93-486b-b4d1-71dbdc33ae0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f6c45c87-4e93-486b-b4d1-71dbdc33ae0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4771f822-2d63-4dc0-807b-3b0093e1bef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4771f822-2d63-4dc0-807b-3b0093e1bef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_474efd21-2450-4209-a88d-df0faf705e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_474efd21-2450-4209-a88d-df0faf705e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1be6b274-dd99-4183-ab77-e5a1cb7c3427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1be6b274-dd99-4183-ab77-e5a1cb7c3427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_498a450b-35a6-4477-a19e-826d073e84a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_498a450b-35a6-4477-a19e-826d073e84a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_e537425e-5ebb-4323-9c4c-8d5e9cf0a8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_e537425e-5ebb-4323-9c4c-8d5e9cf0a8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_301360a1-f0ae-4db8-a161-1995e1e4c73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_301360a1-f0ae-4db8-a161-1995e1e4c73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c177dcd5-e18f-4752-8a38-f1218041834f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c177dcd5-e18f-4752-8a38-f1218041834f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_3c43681c-76e0-43fe-8c67-b55dba119b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_3c43681c-76e0-43fe-8c67-b55dba119b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_717ca999-8137-42e0-9b3f-5b26ae181b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f0fe11f-cc52-477f-809a-f57201ee60f5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_717ca999-8137-42e0-9b3f-5b26ae181b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_852d6a3f-f742-4364-a537-e96ad5f99e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f17d1c10-32d5-4e02-927b-a53499fda14b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_852d6a3f-f742-4364-a537-e96ad5f99e70" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f17d1c10-32d5-4e02-927b-a53499fda14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e17cd2a4-b41b-4340-9ed6-07107b8e6182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f17d1c10-32d5-4e02-927b-a53499fda14b" xlink:to="loc_us-gaap_AwardTypeAxis_e17cd2a4-b41b-4340-9ed6-07107b8e6182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da5b4e35-60f0-4790-a952-454bfcaedff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e17cd2a4-b41b-4340-9ed6-07107b8e6182" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da5b4e35-60f0-4790-a952-454bfcaedff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockAwardsMember_56bf1b01-7b77-416f-b0fc-32b50dd38e25" xlink:href="dgx-20211231.xsd#dgx_StockAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da5b4e35-60f0-4790-a952-454bfcaedff9" xlink:to="loc_dgx_StockAwardsMember_56bf1b01-7b77-416f-b0fc-32b50dd38e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f17d1c10-32d5-4e02-927b-a53499fda14b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75309128-10fe-4e4b-ad4e-ec666e68451c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75309128-10fe-4e4b-ad4e-ec666e68451c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_02b75e76-f842-4374-976e-87fe29e5a03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_02b75e76-f842-4374-976e-87fe29e5a03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d3ecb356-6da4-4195-9349-c0e5553fd437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d3ecb356-6da4-4195-9349-c0e5553fd437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a082d3c1-0546-40ac-870f-102c6f7cb9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a082d3c1-0546-40ac-870f-102c6f7cb9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6dbbe537-3ffd-4f16-a657-c4e68477cbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b557e26d-e43c-45c5-a34a-ae5895e7c9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6dbbe537-3ffd-4f16-a657-c4e68477cbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b0d0b8bb-7c62-4388-ac7e-c6aa9243077c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b0d0b8bb-7c62-4388-ac7e-c6aa9243077c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3d12eb1d-81b4-4c97-8bb5-15aab41a28fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3d12eb1d-81b4-4c97-8bb5-15aab41a28fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_09e836e7-0083-46ef-96ab-d46d73828195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_09e836e7-0083-46ef-96ab-d46d73828195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_486fe248-615c-4349-88fe-dc4e6718485c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_486fe248-615c-4349-88fe-dc4e6718485c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_67c7dd06-b0b1-42cb-b7f6-d3c829c31e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e27c1603-d1e7-410f-a7c2-7f383999210e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_67c7dd06-b0b1-42cb-b7f6-d3c829c31e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bf42ee4e-ae8a-4e03-aefc-f87a894df58b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bf42ee4e-ae8a-4e03-aefc-f87a894df58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ada000d8-fc9b-4b2f-83d3-e871c1f9dd88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ada000d8-fc9b-4b2f-83d3-e871c1f9dd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3ffd069c-e95d-4c6a-b64e-afc632806c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3ffd069c-e95d-4c6a-b64e-afc632806c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6cd751ed-2a6f-49cd-93e2-1fc74af85a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_ShareBasedCompensation_6cd751ed-2a6f-49cd-93e2-1fc74af85a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a8fff7fc-4a3b-4e95-bb9f-955be6b8d52d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a8fff7fc-4a3b-4e95-bb9f-955be6b8d52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_90c1a7eb-d44d-4710-a0d7-45ca1ebbcc40" xlink:href="dgx-20211231.xsd#dgx_Sharebasedcompensationexcesstaxbenefitamount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d8db7f2-57a5-46e8-88d9-a3516da99f2e" xlink:to="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_90c1a7eb-d44d-4710-a0d7-45ca1ebbcc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52ce3149-309d-4985-b30a-d4ef89a34fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e7573eb-9e7b-44cd-85d0-91e5d51f94a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52ce3149-309d-4985-b30a-d4ef89a34fc4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e7573eb-9e7b-44cd-85d0-91e5d51f94a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fec454b1-dd52-4a61-9e91-b10e1dec1805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e7573eb-9e7b-44cd-85d0-91e5d51f94a2" xlink:to="loc_us-gaap_AwardTypeAxis_fec454b1-dd52-4a61-9e91-b10e1dec1805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_667b18f0-ba71-47d3-9ef0-41b5a3d1023e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_fec454b1-dd52-4a61-9e91-b10e1dec1805" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_667b18f0-ba71-47d3-9ef0-41b5a3d1023e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_9150767b-b324-4fcc-a5e1-a8c6b4e24412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_667b18f0-ba71-47d3-9ef0-41b5a3d1023e" xlink:to="loc_us-gaap_EmployeeStockMember_9150767b-b324-4fcc-a5e1-a8c6b4e24412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e20b48ed-fd65-4a12-b306-2185dd25db71" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e7573eb-9e7b-44cd-85d0-91e5d51f94a2" xlink:to="loc_srt_RangeAxis_e20b48ed-fd65-4a12-b306-2185dd25db71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_305e3c43-bcee-4872-83ec-b91a7850607d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e20b48ed-fd65-4a12-b306-2185dd25db71" xlink:to="loc_srt_RangeMember_305e3c43-bcee-4872-83ec-b91a7850607d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0b24c40f-2508-4af6-a12b-878dde775024" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_305e3c43-bcee-4872-83ec-b91a7850607d" xlink:to="loc_srt_MaximumMember_0b24c40f-2508-4af6-a12b-878dde775024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e7573eb-9e7b-44cd-85d0-91e5d51f94a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_198e50e5-716c-40af-b1f8-b6c3b2bf447e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_198e50e5-716c-40af-b1f8-b6c3b2bf447e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_26ca64b2-ad70-4415-b0cc-97449d34ce9d" xlink:href="dgx-20211231.xsd#dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_26ca64b2-ad70-4415-b0cc-97449d34ce9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b98e7420-d24a-45bb-86f4-1e0f78ff9138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b98e7420-d24a-45bb-86f4-1e0f78ff9138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_08cd49cd-529b-4595-ac41-f23ecead4c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_08cd49cd-529b-4595-ac41-f23ecead4c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_8ed6c89c-c64e-4a7a-a03c-6b4ade2f3f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_8ed6c89c-c64e-4a7a-a03c-6b4ade2f3f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_67eade26-9d9a-4fe9-b8db-2add75d14686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dea80d36-758b-4a48-8c25-1c7653db180f" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_67eade26-9d9a-4fe9-b8db-2add75d14686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_93d88e7c-9361-4745-a7b9-1186c7df9780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_f8a25533-856d-4295-aed4-2821bc1d7167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_93d88e7c-9361-4745-a7b9-1186c7df9780" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_f8a25533-856d-4295-aed4-2821bc1d7167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_3458665a-04c4-43e9-b8ac-32d5bb6d4e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_f8a25533-856d-4295-aed4-2821bc1d7167" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_3458665a-04c4-43e9-b8ac-32d5bb6d4e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_cf4a0568-943c-4b7d-bae4-3d96baa4c7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_3458665a-04c4-43e9-b8ac-32d5bb6d4e50" xlink:to="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_cf4a0568-943c-4b7d-bae4-3d96baa4c7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanMember_2d9dbe5b-eaa6-48ab-8e53-471e739f8bc4" xlink:href="dgx-20211231.xsd#dgx_SupplementalDeferredCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_cf4a0568-943c-4b7d-bae4-3d96baa4c7c8" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanMember_2d9dbe5b-eaa6-48ab-8e53-471e739f8bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiMember_90aee030-4408-4872-9071-f0345b91fb88" xlink:href="dgx-20211231.xsd#dgx_SdcpIiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_cf4a0568-943c-4b7d-bae4-3d96baa4c7c8" xlink:to="loc_dgx_SdcpIiMember_90aee030-4408-4872-9071-f0345b91fb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ee7c9a2b-57df-4864-938a-2b0f06dbddb0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_f8a25533-856d-4295-aed4-2821bc1d7167" xlink:to="loc_srt_RangeAxis_ee7c9a2b-57df-4864-938a-2b0f06dbddb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_deb0af5f-eb94-4c57-beb1-ca5020308253" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ee7c9a2b-57df-4864-938a-2b0f06dbddb0" xlink:to="loc_srt_RangeMember_deb0af5f-eb94-4c57-beb1-ca5020308253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_921ac258-5d68-439f-b0ba-465259304727" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_deb0af5f-eb94-4c57-beb1-ca5020308253" xlink:to="loc_srt_MaximumMember_921ac258-5d68-439f-b0ba-465259304727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_f8a25533-856d-4295-aed4-2821bc1d7167" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_3aed691a-1cd3-41c4-a53f-0f01d5bf33e5" xlink:href="dgx-20211231.xsd#dgx_SupplementalDeferredCompensationPlanSalaryDeferral"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_3aed691a-1cd3-41c4-a53f-0f01d5bf33e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_115b3fd7-83d2-4228-9252-53515a2ab2db" xlink:href="dgx-20211231.xsd#dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_115b3fd7-83d2-4228-9252-53515a2ab2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_24a8f8dc-acc6-4340-a8de-525f6b57a3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_24a8f8dc-acc6-4340-a8de-525f6b57a3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_daaa320d-cd90-4a03-9472-4e812858344a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_daaa320d-cd90-4a03-9472-4e812858344a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_965a072c-2373-4311-92ce-981d59db6d19" xlink:href="dgx-20211231.xsd#dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_965a072c-2373-4311-92ce-981d59db6d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_42ea194f-360d-4e3a-b646-2be1de3317c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_42ea194f-360d-4e3a-b646-2be1de3317c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_2adc9a98-0b4e-40bc-aa1c-d0b0c07b8334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_2adc9a98-0b4e-40bc-aa1c-d0b0c07b8334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiGradedVestingPercentage_7f5872ee-c297-4eb6-be1b-58d57bb222ce" xlink:href="dgx-20211231.xsd#dgx_SdcpIiGradedVestingPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_dgx_SdcpIiGradedVestingPercentage_7f5872ee-c297-4eb6-be1b-58d57bb222ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_c0b6607f-706d-4b73-9932-6b6aeb06e2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_ae6641f7-d256-480b-9833-3a8e8fe8edde" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_c0b6607f-706d-4b73-9932-6b6aeb06e2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20211231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d18d8c9d-3eb8-415a-a4e1-1aa8342b53c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_512dc260-9bbe-45a2-bd27-5dca965464bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d18d8c9d-3eb8-415a-a4e1-1aa8342b53c0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_512dc260-9bbe-45a2-bd27-5dca965464bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_08f23919-ddd1-4836-8d21-112fae2604ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_08f23919-ddd1-4836-8d21-112fae2604ae" xlink:to="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ec1cef21-6f8e-44ec-825b-9d520dabafea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ec1cef21-6f8e-44ec-825b-9d520dabafea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4d7e8f69-d1e2-440f-800f-5113bf58bc77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ec1cef21-6f8e-44ec-825b-9d520dabafea" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4d7e8f69-d1e2-440f-800f-5113bf58bc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_6136d4e7-eeef-43df-8a24-56367490261d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4d7e8f69-d1e2-440f-800f-5113bf58bc77" xlink:to="loc_us-gaap_SecuredDebtMember_6136d4e7-eeef-43df-8a24-56367490261d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_92d6a8cd-26e8-4027-9b88-5b46a5112b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:to="loc_us-gaap_CreditFacilityAxis_92d6a8cd-26e8-4027-9b88-5b46a5112b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_65265c49-9d4b-48ef-9dae-1e781fb81342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_92d6a8cd-26e8-4027-9b88-5b46a5112b2b" xlink:to="loc_us-gaap_CreditFacilityDomain_65265c49-9d4b-48ef-9dae-1e781fb81342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_95a2c2de-7152-467b-88e0-15362f47f249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_65265c49-9d4b-48ef-9dae-1e781fb81342" xlink:to="loc_us-gaap_LetterOfCreditMember_95a2c2de-7152-467b-88e0-15362f47f249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0468f44d-6964-403a-8392-e986abd29077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:to="loc_us-gaap_DebtInstrumentAxis_0468f44d-6964-403a-8392-e986abd29077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_10f4ffce-eb02-48a3-b073-c60e23339850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0468f44d-6964-403a-8392-e986abd29077" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_10f4ffce-eb02-48a3-b073-c60e23339850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_5d825581-2ba0-4d95-bebc-63f9fb909d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_10f4ffce-eb02-48a3-b073-c60e23339850" xlink:to="loc_us-gaap_LetterOfCreditMember_5d825581-2ba0-4d95-bebc-63f9fb909d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed5afd27-74df-45c6-a5a8-09eec8379335" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e2e35128-1b23-48e7-ad1c-ccff1b923da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e2e35128-1b23-48e7-ad1c-ccff1b923da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_7355842a-aa75-4b46-abbe-f1d1f31db2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_7355842a-aa75-4b46-abbe-f1d1f31db2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_7a3a023b-3be9-453f-a853-437d480540da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_7a3a023b-3be9-453f-a853-437d480540da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_5613b66b-fb73-49ca-bb76-926eda7bef1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_5613b66b-fb73-49ca-bb76-926eda7bef1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_b27fb773-f0b0-4570-9a1a-1d2b8868f64a" xlink:href="dgx-20211231.xsd#dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_b27fb773-f0b0-4570-9a1a-1d2b8868f64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction_c3708ff2-4aef-4eb9-add4-230acb31c192" xlink:href="dgx-20211231.xsd#dgx_AgreementtoOutsourceBillingandCollectionFunction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction_c3708ff2-4aef-4eb9-add4-230acb31c192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum_dee17ee7-32a6-4e93-85eb-be0ce719d751" xlink:href="dgx-20211231.xsd#dgx_RemainingTermsofContingentLeaseObligationsMaximum"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum_dee17ee7-32a6-4e93-85eb-be0ce719d751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_54dc82c6-1699-43c7-9919-05449b39446d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_54dc82c6-1699-43c7-9919-05449b39446d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_11f2c2dc-7337-441b-ab90-78b59f05e499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_LitigationReserve_11f2c2dc-7337-441b-ab90-78b59f05e499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_ba3b9faa-6d44-4ce8-a9f7-e5a7f65218a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7cd7d7f-3ae7-4d0f-a710-7b10686fdfe1" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_ba3b9faa-6d44-4ce8-a9f7-e5a7f65218a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20211231.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_49ecc240-8cba-426e-a74e-bbbf3db1b49a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_54b3042c-5257-49cd-b853-c30cfc160d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_49ecc240-8cba-426e-a74e-bbbf3db1b49a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_54b3042c-5257-49cd-b853-c30cfc160d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20211231.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d8090901-a9f7-4f24-9152-4823372e6fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6235641d-188d-4638-83b1-9f808c40ae6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d8090901-a9f7-4f24-9152-4823372e6fc5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6235641d-188d-4638-83b1-9f808c40ae6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b53d7ca4-9d41-4b04-b409-d4b8e0d42520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b53d7ca4-9d41-4b04-b409-d4b8e0d42520" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3956b43c-7dfa-410d-a583-2f968e5a9187" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:to="loc_srt_RangeAxis_3956b43c-7dfa-410d-a583-2f968e5a9187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59a4279c-e4ed-4505-b994-a9b5f65856b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3956b43c-7dfa-410d-a583-2f968e5a9187" xlink:to="loc_srt_RangeMember_59a4279c-e4ed-4505-b994-a9b5f65856b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_220f9546-96f9-4334-84e8-982d2709ebba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_59a4279c-e4ed-4505-b994-a9b5f65856b5" xlink:to="loc_srt_MinimumMember_220f9546-96f9-4334-84e8-982d2709ebba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9cd502b3-cc2c-4c54-8f75-12b5dbf5fc51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9cd502b3-cc2c-4c54-8f75-12b5dbf5fc51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_49c4ce51-bef9-4cd5-9062-77e5b5805661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9cd502b3-cc2c-4c54-8f75-12b5dbf5fc51" xlink:to="loc_us-gaap_SegmentDomain_49c4ce51-bef9-4cd5-9062-77e5b5805661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_8ffbdb86-f109-4500-b9a1-fbbad4768c00" xlink:href="dgx-20211231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_49c4ce51-bef9-4cd5-9062-77e5b5805661" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_8ffbdb86-f109-4500-b9a1-fbbad4768c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_23144612-a852-4690-90ec-27ed39b9724e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_49c4ce51-bef9-4cd5-9062-77e5b5805661" xlink:to="loc_us-gaap_AllOtherSegmentsMember_23144612-a852-4690-90ec-27ed39b9724e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_e7d73b2d-963f-470e-81c8-48819c73d642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_49c4ce51-bef9-4cd5-9062-77e5b5805661" xlink:to="loc_us-gaap_CorporateMember_e7d73b2d-963f-470e-81c8-48819c73d642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5c88b02b-f8be-414a-83d0-d8e5e3b625cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:to="loc_srt_ProductOrServiceAxis_5c88b02b-f8be-414a-83d0-d8e5e3b625cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5c88b02b-f8be-414a-83d0-d8e5e3b625cd" xlink:to="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_9cdac503-0474-46da-888c-a0c45f316690" xlink:href="dgx-20211231.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_9cdac503-0474-46da-888c-a0c45f316690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_f9472e8c-79bf-4e4b-b573-2110e1379466" xlink:href="dgx-20211231.xsd#dgx_COVID19TestingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:to="loc_dgx_COVID19TestingServicesMember_f9472e8c-79bf-4e4b-b573-2110e1379466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_1cc94a6a-0754-4402-a7c4-0a82b4e7bdc4" xlink:href="dgx-20211231.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_1cc94a6a-0754-4402-a7c4-0a82b4e7bdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_74059254-b997-4d1e-a966-eab370af0962" xlink:href="dgx-20211231.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_74059254-b997-4d1e-a966-eab370af0962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_952d1ead-ceb5-49d3-9fab-eacf1f662640" xlink:href="dgx-20211231.xsd#dgx_AllotherservicesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61a65258-99c8-4a32-94bd-55928441d1a5" xlink:to="loc_dgx_AllotherservicesMember_952d1ead-ceb5-49d3-9fab-eacf1f662640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_122e626a-229a-4b2e-806b-4b82b797780c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_ac128f84-78f1-494d-bb44-58fbc919dac3" xlink:href="dgx-20211231.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_dgx_PercentageofNetRevenues_ac128f84-78f1-494d-bb44-58fbc919dac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2746c6ba-b9b3-4cc3-9f09-a3102b9c466b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2746c6ba-b9b3-4cc3-9f09-a3102b9c466b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e6dd8107-0345-403f-b96d-d8d6e96b6e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_OperatingIncomeLoss_e6dd8107-0345-403f-b96d-d8d6e96b6e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_dd3f9e44-57aa-46d6-a598-1e3113c94078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_dd3f9e44-57aa-46d6-a598-1e3113c94078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1855a266-36de-417e-819d-35395aa4b460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1855a266-36de-417e-819d-35395aa4b460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e9a37484-514c-4628-a887-38a6ac7afe63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e9a37484-514c-4628-a887-38a6ac7afe63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_39c0c7ac-dcb6-4573-b12e-167af569c306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_39c0c7ac-dcb6-4573-b12e-167af569c306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_73b43119-fdf1-4bee-8ee4-5d20bfa073d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_73b43119-fdf1-4bee-8ee4-5d20bfa073d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_afed0fcd-c6e8-41da-9b62-4c11cee76a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_afed0fcd-c6e8-41da-9b62-4c11cee76a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_aac53484-0f71-4eea-85db-47a5237aec2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_ProfitLoss_aac53484-0f71-4eea-85db-47a5237aec2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4b53e3e-3efd-4d05-9a26-738a4fae9b79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4b53e3e-3efd-4d05-9a26-738a4fae9b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_76318134-bd8c-4e1c-ad7f-e0d75ee49246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_NetIncomeLoss_76318134-bd8c-4e1c-ad7f-e0d75ee49246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_684066a1-01c5-409a-a580-14e0e1a68f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_684066a1-01c5-409a-a580-14e0e1a68f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5091e68d-1b4e-4ae1-8566-c09594349b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3a1fef36-017b-44c6-87a8-063a70386cb2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5091e68d-1b4e-4ae1-8566-c09594349b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS" xlink:type="simple" xlink:href="dgx-20211231.xsd#DISCONTINUEDOPERATIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_41af9280-e8bc-41d3-8fe5-e1cccc319af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_aba5e130-c31e-4c23-813f-abcc2d0ec0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_41af9280-e8bc-41d3-8fe5-e1cccc319af3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_aba5e130-c31e-4c23-813f-abcc2d0ec0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#DISCONTINUEDOPERATIONSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3a804626-3b3f-437a-a2e7-c75b6b90e351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_16e67455-b9c0-48e6-a883-75f454d56c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3a804626-3b3f-437a-a2e7-c75b6b90e351" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_16e67455-b9c0-48e6-a883-75f454d56c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a118ba52-7498-4bf5-a949-642f6245d0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_16e67455-b9c0-48e6-a883-75f454d56c44" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a118ba52-7498-4bf5-a949-642f6245d0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_04456ade-b080-46f6-abe7-f953aa5ff11a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a118ba52-7498-4bf5-a949-642f6245d0ae" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_04456ade-b080-46f6-abe7-f953aa5ff11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NidMember_a1e337d0-0838-4b8d-89b6-eb898741a293" xlink:href="dgx-20211231.xsd#dgx_NidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_04456ade-b080-46f6-abe7-f953aa5ff11a" xlink:to="loc_dgx_NidMember_a1e337d0-0838-4b8d-89b6-eb898741a293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d9e00a62-9458-4c6c-b2fa-7c0d9c377fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_16e67455-b9c0-48e6-a883-75f454d56c44" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d9e00a62-9458-4c6c-b2fa-7c0d9c377fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_73b60d31-53f7-4025-94a2-39db07d85f87" xlink:href="dgx-20211231.xsd#dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d9e00a62-9458-4c6c-b2fa-7c0d9c377fa5" xlink:to="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_73b60d31-53f7-4025-94a2-39db07d85f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_c440b40f-f8bb-415f-9cc9-772395e81968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d9e00a62-9458-4c6c-b2fa-7c0d9c377fa5" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_c440b40f-f8bb-415f-9cc9-772395e81968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_2b092af2-4e14-478a-b898-99c85f10bb98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_81cbd4f4-f3d0-4049-a33c-14f924e1aa15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_2b092af2-4e14-478a-b898-99c85f10bb98" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_81cbd4f4-f3d0-4049-a33c-14f924e1aa15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_27b08224-6f5c-4767-961f-a995f93bf2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a2911163-4817-40ca-a9d5-6649c879696f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_27b08224-6f5c-4767-961f-a995f93bf2c4" xlink:to="loc_us-gaap_SubsequentEventTable_a2911163-4817-40ca-a9d5-6649c879696f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fdee4749-28ee-452b-9c9b-7c6b04e233c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a2911163-4817-40ca-a9d5-6649c879696f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fdee4749-28ee-452b-9c9b-7c6b04e233c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ded9a45c-74a3-44d8-95d0-a49904e144a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fdee4749-28ee-452b-9c9b-7c6b04e233c1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ded9a45c-74a3-44d8-95d0-a49904e144a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5932f556-bb57-4844-8951-58950497459a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ded9a45c-74a3-44d8-95d0-a49904e144a0" xlink:to="loc_us-gaap_SubsequentEventMember_5932f556-bb57-4844-8951-58950497459a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bdd65294-4495-4524-a49d-45ef1553d35a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a2911163-4817-40ca-a9d5-6649c879696f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bdd65294-4495-4524-a49d-45ef1553d35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62e83c44-aaa9-4ce7-8268-1741257f8d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bdd65294-4495-4524-a49d-45ef1553d35a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62e83c44-aaa9-4ce7-8268-1741257f8d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCMember_ccf4e386-632d-4dcf-bc37-9fac31a16144" xlink:href="dgx-20211231.xsd#dgx_PackHealthLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62e83c44-aaa9-4ce7-8268-1741257f8d48" xlink:to="loc_dgx_PackHealthLLCMember_ccf4e386-632d-4dcf-bc37-9fac31a16144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_37453094-ad3f-4420-ac40-083d3537f52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a2911163-4817-40ca-a9d5-6649c879696f" xlink:to="loc_us-gaap_SubsequentEventLineItems_37453094-ad3f-4420-ac40-083d3537f52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_553eb3fd-7f17-42bd-93a8-cce924ecc145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_37453094-ad3f-4420-ac40-083d3537f52c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_553eb3fd-7f17-42bd-93a8-cce924ecc145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_83817851-827e-4419-b563-df1eb9987dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_37453094-ad3f-4420-ac40-083d3537f52c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_83817851-827e-4419-b563-df1eb9987dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves" xlink:type="simple" xlink:href="dgx-20211231.xsd#ScheduleIIValuationAccountsandReserves"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_164f9d5e-4963-4c6b-952b-7f9a7b675847" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_8a28a0c2-09be-4072-b85b-9c17f23287c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_164f9d5e-4963-4c6b-952b-7f9a7b675847" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_8a28a0c2-09be-4072-b85b-9c17f23287c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails" xlink:type="simple" xlink:href="dgx-20211231.xsd#ScheduleIIValuationAccountsandReservesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_d23828fc-6b4a-42a5-ae30-d87b5a948a79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7dfa3d9e-9d92-43ea-87fa-9fb19c9208cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_d23828fc-6b4a-42a5-ae30-d87b5a948a79" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7dfa3d9e-9d92-43ea-87fa-9fb19c9208cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_46507946-4157-491e-9932-39e9906e4698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7dfa3d9e-9d92-43ea-87fa-9fb19c9208cb" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_46507946-4157-491e-9932-39e9906e4698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_f8d1fbe5-bb74-4e9d-a018-49f75ca6a742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_46507946-4157-491e-9932-39e9906e4698" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_f8d1fbe5-bb74-4e9d-a018-49f75ca6a742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_1cf173a0-647e-4cbe-8f31-3701320a6c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_f8d1fbe5-bb74-4e9d-a018-49f75ca6a742" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_1cf173a0-647e-4cbe-8f31-3701320a6c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_240da7cc-cc55-4324-8b9c-89b54485faac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_7dfa3d9e-9d92-43ea-87fa-9fb19c9208cb" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_240da7cc-cc55-4324-8b9c-89b54485faac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_240da7cc-cc55-4324-8b9c-89b54485faac" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_4727fec2-732c-441d-bbd7-cf007df84184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_4727fec2-732c-441d-bbd7-cf007df84184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1c20005c-da4c-428e-b93f-b70b451aca71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1c20005c-da4c-428e-b93f-b70b451aca71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_68f6b9cb-d99f-414b-a0df-c6b7e9303701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_68f6b9cb-d99f-414b-a0df-c6b7e9303701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_a9fadb92-cc60-4055-8eec-e95743568320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5ddf9dfe-2b2f-4084-bfdb-c028ea54344c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_a9fadb92-cc60-4055-8eec-e95743568320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>dgx-20211231_g1.jpg
<TEXT>
begin 644 dgx-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YI8VAO;',L
M(%!A=')I8VEA($<   60 P "    %   $*R0!  "    %   $,"2D0 "
M S$S  "2D@ "     S$S  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MZ'KUCX@T];O3Y-R]'1OO(?0BM*@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "HKFYAL[62XNI%BBC4L[L< "I2<#)X%>,^/_&+:W>MI^GR?\2^
M!N2I_P!<P[_0=OS], %7QIXTG\271@MBT6G1GY(\\R'^\W]!VKE:** "BBB@
M J>SLKG4+A8+*WDN)6Z)&I)^OTKL/"WPWO-7V76K[[.S/(3&))![#^$>Y_+O
M7JNE:-8:+:BWTVV2!.Y Y8^I/4F@#S31OA1?7(636;E;1#R8HOG?Z$]!^M=M
MIO@'P[IH!6P6XD Y>Y/F9_ \?D*Z.B@!D<4<,:I$BHBC 51@"GT44 %%%%
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MA44 ?30(901R#R**YGX?ZO\ VMX1MM[9EMOW$G_ >G_CN*Z:@ HHHH ****
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M\U48C 9HP.1G -<?I_P]\9W\WAI?$\TLTBZ)J-G>WKW*2R6QG!$2,V09&52
M6 (R#R1@F6Z\*>+-;^$-A\-[O0'LW4PVEWJYNH6M1!#(&$L8#F5F81IA6C7E
M^< 9H [6P^)NA:AXRUKPS&EW'?Z/&TDAEC4).% +",[N2-RY! ZUO>'==MO$
MWANPUJP26.VOH5FB28 .%/3(!(S]":\HU;X:Z_-+XFUC2[18=9M]9-]HC-,F
M+F%H$CEB)W?*LB@J=V#P.G6O1/AUI-[H7PWT'2]5A\B]M+)(IHMZML8#D94D
M'\#0!TM%%% !1110 4444 <O\0=&&K^$[AD7,]I^_C/?C[P_+/'KBO#:^F2
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MC1D"1!$J%]ZD\J5W##9'RG$;>.M)M(Y&U2=8B=0DL($MXYIWED1=VW:(P=^
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MDZ9!H^E06-HNV*%=H]SW/U)YKF_A_P"$O[!TW[7>QXU"Y7Y@?^6:]E^O<_\
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M>FW=K Q>*"XM(Y$C8]2JD8!.3R*T+:V@L[6*ULX8X+>%!'%%$@5(U P%4#@
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M.*5E1[BX3<$D7.&V1H2,YP6]\USWPW\;W#^)/L^H>*%U63Q/I4NI);+?B?\
MLVY5WD-NJY)C B=?EXYC/'' ![O17A-]X@UL?L=+K,>K7XU;R(F-\MR_G_\
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M'Y3;=O&TC(P<%3D'TK5HH YC2_AWX:T?3)-,L[.Y;3I8&MVL;G4+BXM]C')
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M'^=>CUY6"001P1TKU"WE$]K%*.CH&_,4 24444 %%%% !1110 4444 %%%%
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M-OI4DV+VYADGBBVGYDC*!SG&!@R)P3GGCH:D-[:B_6Q-S"+MHC,MN9!YAC!
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MHTK8_0?XUR=% &C>:]J%]D23E$/\$?RC_$_C6=110 4444 %%*JEF"J"S$X
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IHHH T$C2)0L:A5'0 8Q3J** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>dgx-20211231_g2.jpg
<TEXT>
begin 644 dgx-20211231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YI8VAO;',L
M(%!A=')I8VEA($<   60 P "    %   $*R0!  "    %   $,"2D0 "
M S$P  "2D@ "     S$P  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH ]%\$7'G>'_ "B>8967'L>?ZFNBKCOA^^8;Y/1D/YY_PKL: "BBB@ HHHH
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M-OY;2=E:2,@$H21R,]_K5:N^N?LNIZ_JFG36%OE+?S!<;?WA;"\Y_$?E7 T
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M)%X/1E]#7*W%N]K<-%(/F4_G[U/IMZ;*Z#$_NVX<>WK0!U=% ((!!R#T(HH
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M:>=;$AEXDC;JAJ_6=H6E+I&E1VXP9#\TK>K'K_A^%:- !1110 4444 %%%%
M&;K-E]HMO.0?O(AGZBN:KMZY34[3[)?,JC"-\R?3TH UM#O/.MS Y^>+I[K_
M /6K5KD;"Y^R7L<O\.<-]*ZX'/2@ HHHH **** "BBB@ HHHH **** "BBL#
MQA=7MIHVZR.U&;;,X^\H/3'UZ9H H>)O%?D;['2WS+TDF7^'V'O[]JX<DDY/
M)-)10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5;T[4K
MG2[Q;BT?:PX(/1AZ&JE% 'JNBZW;ZU:^9"=LJ_ZR(GE3_4>]:5>1:==75IJ$
M4E@Q$^X*H'\6>V.^:];B+F%#, )-HW!>@/?% #J*** .$\;Z/Y%RNHP+\DQV
MR@=F['\?\]:Y.NI\7>(?MDS:?9O_ */&?WC _P"L8=OH*Y:@ HHHH **** "
MBBB@ HHHH **** "BBB@ KK/!&C^?<MJ,Z_)"=L0/=NY_#_/2N3KJ?"/B'['
M,NGWC_Z/(?W;$_ZMCV^AH [ZBBB@ HHHH **** "BBB@ K,UVW\VQ\T#YHCG
M\#UK3ILB"6)HV^ZP*G\: .*KJM)N/M&G1DG+)\A_#_ZV*Y>1#'(R-U4D&MCP
M]-B2:$]P&'X<?U% &[1110 4444 %%%% !1110 4444 %1W$$=U;203KNCD4
MJP]C4E% 'DFJ:?)I>I2VLO.P_*W]Y>QJG7HWBW0WU2S2>U3==0\!1U=3V_#K
M^=8%EX&U"?!NY([9>XSO;\AQ^M ',4^*&2>0)#&\CGHJ*23^%>AV?@K2[;!G
M$ETW_31L#\A_6MR"V@M8]EM#'$OHB@?RH \VC\*:Q);O-]E*!1D*S ,WT%8Y
M!5B&!!!P0>U>S5SOB'PK%JNZYM"L-WW_ +LGU]#[T >=45/=V=Q87#07<312
M+V/?W'K4% !1110 4444 %%%% !1110 5;T[3+K5;H06<>YL98G@*/4FKFC>
M'+S6&#*OE6^?FF8<?@.]>B:9IEMI5H(+1,#JS'JY]2: /-KWP_JEADSV<FT?
MQH-R_F*S:]GJC>:-IVH9^UVD;L?XP,-^8YH \FHKNKSP%;OEK&Z>(_W9!N'Y
M\'^=8K^#-6CNHXBB-&S &5&R%'J1UH O>"-'\V=M2G7Y(SMB![MW/X?YZ5W-
M0VEK%96<5M ,1Q+M'^-34 %8'BW6CIFG>1 V+BX!52/X5[G^@_\ K5OD@ DG
M '4FO*-<U)M5U>:Y)^3.V,>BCI_C^- &?1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 >D>$M:.IZ=Y$[9N+<!6)_B7L?Z'_Z];]>4:'J3:5J\-R#
M\F=L@]5/7_'\*]7!! (.0>A% !1110 4444 %%%% !1110!RVL1>5JDN.C88
M?C_]>DTB3R]4A]&)4_B*M>(4Q=1/ZIC\C_\ 7K-MG\NZB?\ NN#^M '94444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!5O\ 3K34H/*O85D7
ML3P5^A[5R&J>!9HR9-*E\Y?^>4A 8?0]#^E=S10!Y!=6%U8OMN[>2$]MZX!^
MA[U7KV5XTE0I(JNIZJPR#7DVKVOV+6+JW PJ2D*/;.1^F* *=%%% !1178^
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M^>-1_$P'ZU=UN3?J; ?P*%_K_6H=,C\S4X!Z-N_+F@#K**** "BBB@ HHHH
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M0 4444 %%%% !1110 5Q_B/Q=Y3/9:4WSC*R3C^'V7W]Z["O/O&>C_8M0%[
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M(R#6)?\ A'2K[++";:0_Q0G _+I6Y10!5TVPBTS3XK6#[L8Y8CECW)JU110
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MP5#;3ZVR7,*R$1%H]PSA@1V^E>BUY?X7G^S^);1L\,Q0_B"/YFO4* "BBB@
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M](JJBA44*HZ # %+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>dgx-20211231_g3.jpg
<TEXT>
begin 644 dgx-20211231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" #Z NP# 2(  A$! Q$!_\0
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ME:083=)A2.4$:(%!+.210!VWV'QO_P!##X?_ /!#/_\ )E'V'QO_ -##X?\
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M5F76GTV-[..TC@ME$ORDO(&$>5&"[EP%(PC,1D ];HKQ&P\7:K=3:;K<>O\
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M!OC"OO8LI\W"[3M-,T'7;O4OLGA[0O&MO.\WAP3V<T0MGF6X63&6(4JP&"F
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MZAC$89'<*<)(49> %8.0W!YSB@#KI-0LX;%;R:[@CM7V;9VE 1MY 7#9QR2
M/7(JCK^@+KZV(?4+NR^Q7:7:FU$?SLG0-O1N/I@^]>2>,_%L.L:/&NHZU$OV
M<Z5=V=E'!'(=1#RQF2=,*78J=Z_NB,;3D'<!5Z;QSXF75_$3SZ_H^F"S6]0:
M;=2!IK98P3!-Y'DJP#*$;>\S(WFC !(6@#V.JLVIV%O'=R3WUM$EDNZZ9YE
MMQMW9<D_*-O/...:\4U'Q?=:IH^H6=SXX1S;#0]0>YM#;1^6LUR%G&-K8C0&
M-SN)P2NXE6*FWXL\5PZCI.O65YXVM$BL?$.EQV\MN]LA,+/ YW;@P8J1*Y/
MS$W 0,E 'KVFZSIFLPF;1]1M+^( $O:SK*HSTY4FI[JZM[&TENKV>.WMX4+R
MS2N$2-0,EBQX  [FO(=0\87VD1ZUIV@ZWI;0V^KV\4EY&8;=;.&:$R/-(RQR
M(K/-\K2-&5W2'A>V9XX\2W>H_#R]TSQ+K]@F_P /27,$MNJ20ZS,))%(5I(Q
MN*K'$^8@GS2!A\H H ]PGN[:U@$UU<10Q,R())'"J6=@JC)[EF  [D@=ZFKC
M/&/B9]"\*:%J5MJ<&F17&IZ?%,U[&$:2"251(@#D;&V%F)()"JW /S+S'ACQ
MY>77BS3H-0\7Z?J"7NJ:A8_9+=(8T"1%C$PY9RQ^4#YL%67@GYF /5;JZM[&
MTENKV>.WMX4+RS2N$2-0,EBQX  [FBYNK>SA$MW/'!&75 \KA1N9@JKD]RQ
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M ,+'\=_]#;=_^ =G_P#&:/\ A8_CO_H;;O\ \ [/_P",USE% '1_\+'\=_\
M0VW?_@'9_P#QFC_A8_CO_H;;O_P#L_\ XS7.44 ='_PL?QW_ -#;=_\ @'9_
M_&:/^%C^._\ H;;O_P  [/\ ^,USE% '1_\ "Q_'?_0VW?\ X!V?_P 9H_X6
M/X[_ .AMN_\ P#L__C-<Y10!T?\ PL?QW_T-MW_X!V?_ ,9H_P"%C^._^AMN
M_P#P#L__ (S7.44 ='_PL?QW_P!#;=_^ =G_ /&:/^%C^._^AMN__ .S_P#C
M-<Y10!T?_"Q_'?\ T-MW_P" =G_\9H_X6/X[_P"AMN__  #L_P#XS7.44 ='
M_P +'\=_]#;=_P#@'9__ !FC_A8_CO\ Z&V[_P# .S_^,USE% '1_P#"Q_'?
M_0VW?_@'9_\ QFC_ (6/X[_Z&V[_ / .S_\ C-<Y10!T?_"Q_'?_ $-MW_X!
MV?\ \9H_X6/X[_Z&V[_\ [/_ .,USE% '1_\+'\=_P#0VW?_ (!V?_QFC_A8
M_CO_ *&V[_\  .S_ /C-<Y10!T?_  L?QW_T-MW_ . =G_\ &:/^%C^._P#H
M;;O_ , [/_XS7.44 ='_ ,+'\=_]#;=_^ =G_P#&:/\ A8_CO_H;;O\ \ [/
M_P",USE% '=Z)KGQ7\10SRZ-KU_=1V_^L86MDH!ZX&Z(9/L,FHH/$GQ0N-+D
MU&+Q%>&VC#L2;:Q5B$QO*H8MS!<C) ('>H_ 5O.MR^I1ZWIFGO9!_LD>H7HB
M#2NH5FV\G 7DG')"CGG'1:'K>E:=HMA)+?V\ZZ5;:C;S*TBB29I) 8]J$Y8,
M#U&0.<F@#(NM9^+%CHUOJUWKM]#8W!41S-:V./FZ$CRLJ#ZG Z>M4M:\5?$C
M26CMM4\4W47VJW$T;0Q6+!XVR RO'$>N#@@Y[U;OK2YMO ,D#^)-*N9;R=+B
MYMUOEEF9\JJIUQ@#+,V>P'09-3QZ(WC\/M!=6=P+?2(+67[/=1RE)4W;E(5C
MZCGH?6@!4O/B39:3I.HKXAN$L&06UE<$6!C4$ 88F/"GY,9?!&&&1S4-_P".
M?B%IE_+9WGBRX6>%MLBI;V,@!]-RQ$9]>>#QUK5T?78-$L=-TO76M[S0]0LS
M%>017"3&!O.=Q)M0DJP#H>Q_%<"Y:S^&OLNO7$T6GWUW)JTPD%S=1QYMB&VO
M&S*Q(!)/[KYR0.O (!S+?$+Q^D:2-XJO51\[&-C: -CK@^3S70I<_%V3R!%X
MBDD:XC,L"(VF,TJ 9)0!,L/I6;XTOK6\\,>&ET][#RH[0":*W\L/%+DD@@?.
M!R3SP3SR>:["WU#2(++P];RZC86NHP:>8(-3BO(I?L,^.CIN*E6&1N(XZ9!(
M( //C\1O'BL0WBR\!!P0;*TX_P#(-)_PL?QW_P!#;=_^ =G_ /&:Z2U31-.\
M%R),NDWVJB2X%W++>0LRMC,<B$J[2#@<(<9)#=\5]3U'PY=OH4S1:?%;ZBEN
MNIPVUM&C6_ENWF'Y1N3>6!XP2J]QB@##_P"%C^._^AMN_P#P#L__ (S3)?B%
MXYFA>*3Q;>;'4JVVTM%.#QU$.1]17=B;P[_PD6H9L_#R0Q65R(2]Q;2).V\&
M$@*JJIY88!WX W?PDMN8_#0U;5X[5] $ESI4,ELS& Q)<+D-@\JIZ$J,9ZX-
M '#1?$+QO!"D4/BNZ2.-0J*ME9@*!P!_J:?_ ,+'\=_]#;=_^ =G_P#&:[J5
M?"=OX@\036T.C73&2V:S@-S;QP-%A1(%9E95.0VX !L=,$Y/-Z]_9'_"$(+/
M^R(9E= BVY2:64$LP._"RHP'#!P5/RXVG(H BTSQ1\3=7C>2Q\3731HVQI)(
M+&)=V"V-SQ $[5)QV )Z5:U#6?BIIEB;R\\3NL/E+,"G]FR%HV8*'"K&25RP
M&0,<UEZWM_X5OX8^S_<\V[\_;T\W>N-WOLQU[5?\9)#/'X6CCO-.F$%A#:3[
M;Q)%CD!Y#[&)"^K#CT- %72O&7Q'UK4HK#3?%-U+<RYV(;:Q3=@9ZM$!T%2Z
M?XI^)NJZPVEV/B:YDO5+ Q&"Q0DK]X M$ 2,'IZ&NSN)O#&GZWX?O[:ZT6*2
MUO95N9;%HD!C,;8;8A)VY'&2Q&<9R<55L+[18O&NA7<ESI5O=Q-?27D\$T*1
M^4V]8=S*=K/R.,EL'+4 <+_PL?QW_P!#;=_^ =G_ /&:T;;Q5\2[S1[K5+;Q
M1<26EICSV$-ANCR< E/*W8)[X]?2K.N#08/ 5K!I\&FR7'V:/S9UNHO/CN1)
MB0;0I=P03R6V;0".VZOX46-? OB>*6[LHI;V*%;>*:\BC>0HY+?*S C@]^O;
M- #_ /A(OBC_ &9'J#>)+I+:380[P6"E5=BJNRF+*H2" Q 7WJC>>._B'I]Y
M+:7OB>^@GB;:\;V5H"I_[\UTEQKVF+X/GG%S;R&?0+73D@$B^;YZ,P;*?> '
MWMQ&#Q@YKFO'15KC0R2#<'1;8W!_B+X.-WOMV]?:@"'_ (6/X[_Z&V[_ / .
MS_\ C-'_  L?QW_T-MW_ . =G_\ &:YRB@#H_P#A8_CO_H;;O_P#L_\ XS1_
MPL?QW_T-MW_X!V?_ ,9KG** .C_X6/X[_P"AMN__  #L_P#XS1_PL?QW_P!#
M;=_^ =G_ /&:YRB@#H_^%C^._P#H;;O_ , [/_XS1_PL?QW_ -#;=_\ @'9_
M_&:YRB@#H_\ A8_CO_H;;O\ \ [/_P",T?\ "Q_'?_0VW?\ X!V?_P 9KG**
M .C_ .%C^._^AMN__ .S_P#C-'_"Q_'?_0VW?_@'9_\ QFN<HH Z/_A8_CO_
M *&V[_\  .S_ /C-'_"Q_'?_ $-MW_X!V?\ \9KG** .C_X6/X[_ .AMN_\
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M?_0VW?\ X!V?_P 9KG** .C_ .%C^._^AMN__ .S_P#C->[_  X_Y)9X4_[
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MAB\0?]]VO_QBO5** /*_^%!:'_T,7B#_ +[M?_C%'_"@M#_Z&+Q!_P!]VO\
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MO5** /*_^%!:'_T,7B#_ +[M?_C%'_"@M#_Z&+Q!_P!]VO\ \8KU2B@#RO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=)7-_#C_ ))9X4_[ MG_ .B$H +'_DJ>N_\ 8%TW_P!'WU=)7-V/_)4]=_[
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M8E;?A+_D/K_US:@#O**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!PIR2.#S5:'X=0VWQ#C\26][Y<$2KLM!%RI6$Q!0^?N;3G;C[W.: .THHHH
M\WU/XKSZ5?:_'<: LD&@WEM:W+PWNZ23S\;&C0QC<1N&5R/;-=O)X@TB'4FT
M^74K5+U$,C6[2@.% W9QUZ<_3FO/]0^$%S?^)]8\0KK<-KJEW>07EC<PVAW6
M;Q*$VG+_ +Q&7[RG'-::_#-Y?$HU2]U56C;41JLL44!5C<BW\DA6+'$>.=I!
M/;.* -J[^(/A6TTBZU(ZY9S6]K:B[D\B4.QB)PK #J">![U#!\0M%?4KR*ZO
M+.UL[:*V=;N6\C =IMVU"N<J?E&,]<\=*XVU^"-Q%HM]ID_B"*2&XT/^QXV2
MR*M&!.TJR']X<\O@CC..HJ_K'PIU#5[_ %.Y?7+6,ZA_9Y=?L3':;1MPQ^\Z
M,?R]Z .W_P"$JT#[!!>_VS8_9;B0Q13>>NUV!P0#GJ",'TJQJFM:9HD"3:Q?
MV]C%(VQ'N) @8XS@9]@37G<?P=D(LFO-4MKMK>ZOI989;5_)FCNF#,A42 Y5
MAP<X(X(KJ?$O@Y]:U71=1M+J"*72UFB,%S;^=!<12H$=63</0$'/J,'- %&/
MXD1/KMUIDEC'&]OK*:6':\1?,5HO,\U0P&< CY!D\\5H7?Q \/+H>HZAI6JZ
M?J3V-HUR88KR-=P' RQ.%!;Y=QX!ZUSTOPNOF\0MJ4>LVJJ==BUA8OL3<>7#
MY0CR).F.<X_"LJS^"E_:Z;=VA\0VS"XT>ZTK<+%A@3S^<7_UG)'(Q0!Z/;^)
M](EGAM9=1M(;Z2W%P;4W"EU4KNSUY '.?3GI63J_Q!TVRM],N-*:#5H+[58M
M,D>"X'[AY!D$X!SC@XXX-9NG?#F[TV;4VBU2TE74(5.9[ 2-;SBW\DO&68C:
M0 =I!XR,X-9&G_!Z_L8$0^(+>5AK%IJK,;)AEH(]A7_6<!L9]N@&,4 =[>>*
M](L?$]KH%S=JFH74#W"1GLBX!)/;KQ]#0/%OAXVL=P-9LC#+(8D<3KAF !(_
M(@_B/6L?Q/X"'B/Q)_:9U VT<FCW.DSQK'EBDQ!W*V>"".X.<UDP?"R2#0[*
MUAO[2VU"UD1_[3MK:1)MRHJ;P?-/)5=I4Y4C QQ0!L2_$?17O/LNFS17<J:O
M'I4RM.L6UV +,N[[^W.-HY)!Q6I:>,?#=_YWV+7=/G\B)II=ERIV1J<,QYX
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MB@ HHHH **** "N;^''_ "2SPI_V!;/_ -$)725S?PX_Y)9X4_[ MG_Z(2@
ML?\ DJ>N_P#8%TW_ -'WU=)7-V/_ "5/7?\ L"Z;_P"C[ZNDH PO&NNW'ACP
M7J>MV<$5Q)I\#3F*5BH<*,D9'0URS_$^YTU9(M<L+6&>;0VUBQECF8Q2*JC=
M')\NY""1R 1CGC%==XMT ^*?"E_H?VK[(E]"89)1'O*H>#@9'..]<Q<_"R+4
M+&Y34M7DGNGT<Z-;S+ %2VMR &(3)R[8Y8GTP!W -^U\::)+=6=A<:A;QZA<
MPK)Y()*@F/S-N_&,[<M@X..<55_X6;X0-O<7']L+Y%LL;RR^1+L59&VHV[;C
M:QZ'H:Q)?A6?[>L-9EUF2\ETU$$%M);+L8+ 863[PPK Y(SUZDUR/A+X:^)]
M1T75-%\26UEI-K<Q6JI=VZ.TRB"0.D6UG*[!S]W '/7/ !ZDWCWPRNEKJ!U6
M,V[S26XQ&Y?S(P3(NP#=\H4D\< 9/%+=^.?#UG#>2M?^<EG;?:9FMXGD54V;
MQ\R@KDJ0P&<X.:YI/A*B6[%-:D%X;V]NUN/LXPHNH]DJ;,\\8(.>"._(JU_P
MJK34 AM[R6WM1I3Z5MB0+)+"T7ECS'Z2;>6&5R">N.* +&G_ !(TR\O&>9X[
M/3UTB+4GDN"Z2IO<J 4*C(Z8()R3@"M#5_&5G:>!KSQ+I*-J4%NI.V-6!!#[
M'W#&X;3DL,9 4\5S5U\'X;^-DN]<G/\ Q*;?34:.!59#!)YD<@YZAAR.X_.N
MT;2KR71?LDFJ/'=&19&N[>%8\D.&(V<C!Q@@YR": ,31?B%I5]H9U2ZO[![1
MYE@MY[&1IA<.5W%1&%WAASE2,@#/2JLWQ.TVT\4W5M>36Z:)%I,.IIJ<;LX8
M22^6 0 >,XY]Z:?A=:+.;^WO%M=5.H?VAY\%L$A$GE&+'DYQ@HQR<Y+'.>U9
MLWP4TU]/N+"'5+B.TET6/254QAF4)+YHDW9Y.[J,8P: .BOOB/X>M)K:&.>:
MZEN-3.E^7#;R,R3@98$;<\#GW[5'IWQ&T>337N]7O+6T!N[F"(1L\F4A?:7;
MY05 &-Q(PN>36?;_  M6*X6YDUF22Y77CK@D%NH'F,A1DQGH0>/3WJH/@W;?
M8IH#K,V^X^VQ32"!?F@NV#RH!G@@KPW;N#0!U0\=>&SKO]C?VI&+_P Y;?R2
MCC]XR%U7=C'*@D<\XXJ]I?B'2]:M);K3;KSK>(9:4QLBD<_,"P 9>#R,BN-;
MX31#Q,FJP:Q)&D>HVM\EO]G!P8(3"B;MW3:QR?6M_P /^"X-"M=6MQ<F2'4V
M+/#%'Y44>5VL40$A6;.6Q@$]A0!S^O?$V\TSP;9^)[+2[233[NX185N;SRI)
M8G<(A4;2-[9+8) "]3G(%S_A8XC^(-[X?N+#9:VP<>>')D)6*.3=LQ]QO,V*
M<\L,=ZK:9X#U&X\)VOA[5]1>+3[:R.F7-H(DDBNXP?EF0GE'*X'.<'/' -=A
M+HEO+=6LA $-LFU8@OWB!A26ZG:,X'J<]0* ,BZ\:V]IX<;6&:UN(;2=8]22
MUN!(;12V.<=2N06'H#CMGJ000"#D'H17F<WPN_LSPGJNAZ1<373:V(;.2>;:
MJVMM'GDC^)@I89[DCH,FO2HHUAA2)/NHH49]!0!PGQC)'@/Y>/\ 2XLG\Z\.
MBU*]MSF"]N(C_L3,/ZU]2:CIEEJ]K]FU.VCN8-P;RY!D9'0U5@\,:%;?ZC1K
M!#ZBV3/YXH ^>+7Q=XFC.+76M1;'\(F9_P!#FMVQ\9?$)L?9GOKGTS9;_P#V
M6O>8[6WA&(H(T _NH!4M 'DECXH^*+XSH7G?]=K7R_\ V85T5EK?Q#DQ]I\,
M6 ]<W?E_U:NYHH R;&[UZ4#[=I5I!Z[;PMC_ ,<K54L5^8 'T!S39F9()&C
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MT(02_=&3E>O6NPTGQS!/XWET2\CNTN;AML0*J(H2(_,$9YW;RAW$XQGY<\4
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MVI'4(K1/MAC$0N'R[J@_A!.2!ZXZ]Z2]T'2M1U"*^OK""XN88GA221,D1O\
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M* "N;^''_)+/"G_8%L__ $0E=)7-_#C_ ))9X4_[ MG_ .B$H +'_DJ>N_\
M8%TW_P!'WU=)7-V/_)4]=_[ NF_^C[ZNDH **** "J5EHVF:;*\FG:=:VCR#
M#-!"J%N_.!5VB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F2
MP13A1/$D@1@Z[U!VL.A'N/6GT4 %%%% $<\$5S"T-S$DL3?>1U#*?J#4E%%
M!7.^(/"Z:ENN;+;%=?Q#HLGU]_>NBHH \BGMY;69H;B-HY%ZJPP:CKU74-*L
M]4BV7D0?'W6'#+]#7(ZCX)NH"7T^07"?W&^5A_0T <Q14]S9W-HVVZ@DB/\
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MJ?D:V** ,?\ L:;_ )ZI^1H_L:;_ )ZI^1K8HH Q_P"QIO\ GJGY&C^QIO\
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MF_\ A/-(_P"?/Q!_X3FH?_&*/^$\TC_GS\0?^$YJ'_QBNDHH YO_ (3S2/\
MGS\0?^$YJ'_QBC_A/-(_Y\_$'_A.:A_\8KI** .;_P"$\TC_ )\_$'_A.:A_
M\8H_X3S2/^?/Q!_X3FH?_&*Z2B@#F_\ A/-(_P"?/Q!_X3FH?_&*/^$\TC_G
MS\0?^$YJ'_QBNDHH YO_ (3S2/\ GS\0?^$YJ'_QBC_A/-(_Y\_$'_A.:A_\
M8KI** .;_P"$\TC_ )\_$'_A.:A_\8H_X3S2/^?/Q!_X3FH?_&*Z2B@#F_\
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.._P >,G_7U<?^CGH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>dgx-20211231_g4.jpg
<TEXT>
begin 644 dgx-20211231_g4.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YI8VAO;',L
M(%!A=')I8VEA($<   60 P "    %   $*R0!  "    %   $,"2D0 "
M S@X  "2D@ "     S@X  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M=)7-:KXZT[1/&>D^&]2MKN&;5]RVMV50P,P&=A.[<&/0#;R30 O_  GFD?\
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M9UE5!!YL@0.<\GKT YQU'6@"'_A/-(_Y\_$'_A.:A_\ &*/^$\TC_GS\0?\
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M4A??']%8#))QR: //)[Z\\#1_$9],O)II8]5TZ!;N_N"S0I+% NYY6#'Y5?
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M,;*6#9Y!.#Z55;X<^%I?"T/AV?36N-+@</!#/=32- 0,#RY&<NF!T"D8[=:
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M'8N0#M7 X''%2>)/!^B^+EM%UZ"XG6RE\Z 17LT&R3C#_NW7+#'!.2.<8R:
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M\@*P_P"O:/\ ]!% &O\ VSKG_0R^(/\ P<W7_P <H_MG7/\ H9?$'_@YNO\
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M&7Q!_P"#FZ_^.4?VSKG_ $,OB#_P<W7_ ,<JI10!;_MG7/\ H9?$'_@YNO\
MXY1_;.N?]#+X@_\ !S=?_'*N>&_#TWB?5DTVSN[:WN9 3$MQO DP"2 55L8
M)YQ5*^L7T_5KC3[B2,26\[02.N2N5;:3TSCCTS0 O]LZY_T,OB#_ ,'-U_\
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M9US_ *&7Q!_X.;K_ ..4?VSKG_0R^(/_  <W7_QRJE% %O\ MG7/^AE\0?\
M@YNO_CE']LZY_P!#+X@_\'-U_P#'*N^(_#5YX7O8+;4);>1YX%G4P2;@%)(
M.0.>/I[U.GA&ZE\&S^)8+RSEL[=UCEC4R"1')4;<% #]]3P<>] &7_;.N?\
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M?^#FZ_\ CE5** +?]LZY_P!#+X@_\'-U_P#'*/[9US_H9?$'_@YNO_CE5**
M+?\ ;.N?]#+X@_\ !S=?_'*/[9US_H9?$'_@YNO_ (Y6OX>\%ZCXCLFN[::U
MMH!.MLCW+E?,E(R$7:#SR.N!R.:H6OA_4+G7)-*,:P7$#,+AIFPD"I]]W;LH
MQR?RSD4 5_[9US_H9?$'_@YNO_CE']LZY_T,OB#_ ,'-U_\ '*K2*$E95=9
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M44 6_P"V=<_Z&7Q!_P"#FZ_^.4?VSKG_ $,OB#_P<W7_ ,<JI10!;_MG7/\
MH9?$'_@YNO\ XY1_;.N?]#+X@_\ !S=?_'*J44 6_P"V=<_Z&7Q!_P"#FZ_^
M.4?VSKG_ $,OB#_P<W7_ ,<JI10!;_MG7/\ H9?$'_@YNO\ XY1_;.N?]#+X
M@_\ !S=?_'*J44 6_P"V=<_Z&7Q!_P"#FZ_^.4?VSKG_ $,OB#_P<W7_ ,<J
MI10!;_MG7/\ H9?$'_@YNO\ XY1_;.N?]#+X@_\ !S=?_'*J44 6_P"V=<_Z
M&7Q!_P"#FZ_^.4?VSKG_ $,OB#_P<W7_ ,<JI10!;_MG7/\ H9?$'_@YNO\
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M+N!9R@5LG#'G:>G89J]8:)X8N=8\1ZYHULEY:VFF_:K2VF@80^8RR9(1U&X
MIQP0-QQT&//K;Q;K-G>7ES:W,437T?EW,:VL0BF7_:CV[#WYQGD^IJ.S\3ZQ
MI^K2:E97GD7,B>6Y2) A3  79C;M  P,8&!B@#T76;HW/PL\(7#P6X+ZBFZ-
M8%\L\R _)C;@]<8QST XK6N/"6AW/Q:> Z=:+!:Z4MS'9QQ!$DDWD9*C (]1
MWXKRNX\::_=0VL,VH?Z/:L&BMUAC6(8((S&%"L 0, @@=J?<>./$5SK,&K2Z
MCB^MU*).D,:-M_NMM4;A['(H U]&OM.\1^+-#@N?"RR2P(R745B$C^UL 2K&
M/Y$7!Y/(!'7@8K9\;:196'P_TS5(;>Q.H1:I) T\%LB*ZAI?E=514<CRU!^4
M@X.,@Y/%IXRUV+5X]3AO1#=1ER&A@C127^^Q15"LQXR2"3A?08?>>-=>U&S-
MI?7<5Q;^<)Q%):0E0XZ$#;Q]!P02#U.0#U"^\):)>?&*PLVT^VAM(M*%T;:&
M)8TE<2,!N4  ]0??;@\<5CR7IOO@GXD<VMM:[-4";+:%8EP'AQE5 &0#C..@
M&><D\->>-?$%_J]GJES?YOK+B">.&.-E']TE5&X=>#D<GU.2\\:^(;[3Y+&;
M462UE=GDBMXDA#EL[L[ ,@Y.0>">3S0!8^'7_)0]'_Z[_P#LIKU:.TLI?'WB
M6\T1P/%%M&HBANWW0NIC3YE4;2/[IRQQD'OBO$M(UJ]T*\%WICQ1SC[LCP1R
M%/==ZG!]Q5Z3QGKTFN1ZQ]L1-0CR!<1VT2,V1CYMJC?P,?-F@#J?!>CQ:G9^
M*];UL0/J=HCM_IL.Y8)&#EI'CVG.".FT\@\5JZ5>^$V^(-I:6MCIUUINKVRY
M:6PVK'<Y9?W?F*/E8KC XW'MS7")XY\11ZO-J<=^J7<\?E3.EO$!*O\ M*%V
ML>>I!..,UF3ZM>7&HQWSRA9XBIB,<:QK'M^[M50%4#K@"@#M9='BB\56'A"_
M2TW2ZB[W,ZVL22>47^2,.HR-RC=VP)%&,#%7_&UOX>L;?5K6WCL8M4TVYBEL
MX;:Q;Y(L1J5F)CVN"3N^8MR0,\XKSJ\U6^O]6?4[JYD>]DD$AG!VMN'0C&,8
MP,8Z8J_J7B_6M896U*YBG961BQM8@7V_=#D+\X&3PV1[4 >QR:)HLWQ(&B'0
M],6SDT4W#A+-%8N9=N0<?+@9Y&#SSG QP_AVVM)?@UK5_+8V4EY9W($$[VL;
M.HS&<%BN3RQZYX..G%87_"R/%/VX7O\ :$7VH1^2)_L4&_9G.W=LSC/.*S]/
M\5ZQI<=W%8W,<<-Y())H3;QM&6!R"$*E5_X"!T'H* /3M=\*:+>_%30=.-E;
M6UI+9--+#!&(A,R[SCY<>@_ &LC6(_"[7UIYEM;W-Y9:PT5W;:;8O&I@+.0A
M'EJK,NW'J0&Y/6N,O_&FOZGJ%I?7E_NN[,Y@G2&-'7VRJ@D>QR.3ZFFW?C#7
M+W4(KZ>\47,4GFK)%!'&2^,;FVJ-QQP"<X[4 =+\0M*MXM(L=4TA-.GTV[N)
M&BO+.%86 /*Q.@ &5 (R,'@[@#UJ>!;""YT?6[E].$EQ!&IBOKB));>V R6W
MHP.2< ?*K-SQCJ>>U/Q%J>KVL-M?7"M;PLSI#%"D2!FZMM0 $GU//)]:?I'B
MC6-"M+BUTN\\F"Y(,L;1I(K$=#A@<'W'H/04 >B^(]-\-:#\6H#>:8B::VG^
M=*D-OOCB?++YAC (VC XQC/.*Y+XA:*^D7^GLJV+V\]KF*[L%"1W7S$F38.%
M.&7@97&,<<#.N/&NOW=[%=W%\LEQ%"8!(;>++1G&4;Y?F''0YZGU.:&JZWJ&
MM/"VHSB06\8BA1(UC2-1V55 4?@* .M\'>-K'2]#ATG5+:[D^SZ@EY;-:(K%
MV'\# D8Y'49Z].*Z#3+6VUSQC=Z3J"B.XO-]]K,<4A/"D&.T#C& N07(Y)&,
M\5Y78WT^FWT5Y9LJ3PMNC9D5]I]<,",CJ#V/(YI]EJE[IVJ1ZE97,D5Y&_F+
M,#EMW?.>N<G(/7)S0!T?C70K#3M+\/ZGIT(MO[5L_-EMU=F5' 7)7<2V#NZ$
MGI5SPWIUG:?#'7?$?V>"YU&&=+:'[3$LJ1*6CRP1@02=YY(/3COGE-4UF_UJ
M6*349_-\F,11(J*B1H.BJJ@*H^@I=+US4-&6X73YPD=R@2>*2)98Y0#D;D<%
M3CL<<9/J: /5QI5CHGQ8\-SZ5!!;_P!IVS// L:E4.TG<@(^3.,?+CH1T)KS
MKQ[.\_CS5]XC'EW3H-D:ID!CUP!D^YY/K4">+]<37SK7VT/J&S8LTD,;[!Z*
MK*0OX =3ZFJ.JZM>:UJ#WNHO')</]]TA2/=[D* "??K0!Z5XZ$=Q\&O#4NF?
M/:1&(2;!G:WED$MCH=VX'W->?:$EQ=7,>F^9)'I]_=P073JHP,M\O)'!^\1]
M#2:5XEU;1;:>VT^\*6UP");>1%EB?.,Y1P5SP!G&<5!?ZS?:G'''=2J(8LE(
M(8DAC4GJ0B +D]SC)H ]:?P_HM_XG\2>&WTVSMK+3K")K>:.%5EC?8&WF3&Y
MOO<[B<X^M4])M[ > ?!UT^DZ9+<WVJQV<\TEE&6:/S74@\<DJH&3D]^O-<!<
M^,]?O+&6TN-0+1S1+#*XB022HO16D WL.3U)SD^M/M_'&O6NGV=C#<P"VLF#
MVT;64#>4XZ,,IG=DD[NN23F@#LWT_P .:7\2_$5E>6\-G;NB):7,ML)K>SED
M53ED8%0,GC.  ".!4\/A.WT_6?%-]J6FV/FZ7IB365O&N^W<F)AYNP]>8R=K
M9P6/7AJX*;QEKES?7%Y/=0R37**D^ZTA*S!<[=Z[=K8SW'8>@Q&/%NN?VX^K
M_P!H.;V2,Q.Y12K1XQL*8VE?;&,\]: /1;;2;!;SP'KL,,%M>WLJK<)!&(UE
MPOWPBX /K@#K6A)96=_XD^( OK*UN3;6Z20O+;HSQL8#R&(R/NCO7EA\7:VV
MJ6FH&\7S[)-EL/(C\N$8Q\L>W:/P%6E^(/B19[J9;V 27@"W+?88,S # #?)
MSP<<T =K8:?9>'M!\$SV=C:3W&J7\37-Q/"LC_,1@*Q&4QD8VD<KWR<OU'3[
M?4/C/X@6XTR2^*6B&)P(S';N88P)'$GRD 9ZY_W3V\^T[QCKNE6<5I97H6"&
M8S0H\$<GE.>I3<IV]3TQU/J:?!XW\1V^J7&H)JLSW-RACE:4+(K(3G;M8%0
M2<  8R0.IH [W6M/L-,\1^ +ZTL[%9[\Q+<O#;A(I"3%\XC( !^=B"5!''0@
M8M2Z7:^)?CK?66K0PRVUC")TC$2+YK;(N'8#<XR<X8GICID5YIJ'B_7-4CM$
MOKWS/L4GF6SB%%>)O9@H('3C..!Z"G3^,]?N=:AU:34"+Z$Y26.)$Y( )(4
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M:XU!!<27%F'CAA$@#(D:HP4D9&0!][J.M><)JU]'HTFDI<LMC+,)WA&,,X&
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MH *YOX<?\DL\*?\ 8%L__1"5TE<W\./^26>%/^P+9_\ HA* .DHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N;OO^2I
MZ%_V!=2_]'V-=)7-WW_)4]"_[ NI?^C[&@#I**** "N;^''_ "2SPI_V!;/_
M -$)725S?PX_Y)9X4_[ MG_Z(2@#I**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHI"0.I H 6BF^;&.KK^=)YT7_/1
M/^^A0 ^BFAU/1E/XTZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KF[[_DJ>A?\ 8%U+_P!'V-=)7-WW_)4]"_[ NI?^C[&@#I**** "N;^'
M'_)+/"G_ &!;/_T0E=)7-_#C_DEGA3_L"V?_ *(2@#I**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HIDT\5O&9)G5$49)8XKE=4\?V%KE+
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M$UK*T4BG(93B@#W2BN+\/>/([DK;:OB*3HLP^ZWU]*[,$,H*G(/0B@!:***
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M$)725S?PX_Y)9X4_[ MG_P"B$H Z2BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M**Y;Q9XK328FM;-@]VPP?^F?_P!>@"QXD\5V^B1F*+$UVPX0'A?K7F%_J%SJ
M=TUQ>2%W;WX'TJ&662>5I9G+NQRS$\FF4 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5T_AKQA/I#K;WI,UGTY^\GTKF**
M /=+6ZAO;9)[:19(W&0P-2UY#X<\27&@W0&3):L?GBST]Q7JUE>P:A:)<VKA
MXW&010!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!" W4
M _6HVMH'^_#&WU0&I:* ,>]\)Z#J&?MFE6\F>OR8_E6++\)?!,DAD70H8I3_
M ,M(W<$?K7944 <0?AA91?\ (-UO6-.]/LTZC'YJ:;_P@_B"T_X\?'&K3'TO
M61__ $%17<T4 <+*/''A^RNKZ]U72[ZTMX2^PV[B0D>^<5SW_"U-;_Y];+_O
MEO\ &O0?&/\ R)NJ?]>[5X2.E ':_P#"T];_ .?6R_[Y;_&C_A:>M_\ /K9?
M]\M_C7%44 =K_P +3UO_ )];+_OEO\:/^%IZW_SZV7_?+?XUQ5% ':_\+3UO
M_GULO^^6_P :/^%IZW_SZV7_ 'RW^-<510!VO_"T];_Y];+_ +Y;_&C_ (6G
MK?\ SZV7_?+?XUQ5% ':_P#"T];_ .?6R_[Y;_&C_A:>M_\ /K9?]\M_C7%4
M4 =K_P +3UO_ )];+_OEO\:/^%IZW_SZV7_?+?XUQ5% ':_\+3UO_GULO^^6
M_P :EM?B?K4][!"]M9A9)50D*V<$@>M<+5C3O^0K9_\ 7>/_ -"% 'T11110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5S=]_R5/0O^P+J7_H^QKI*YN^_Y*GH7_8%U+_T?
M8T =)1110 5S?PX_Y)9X4_[ MG_Z(2NDKF_AQ_R2SPI_V!;/_P!$)0!TE%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MURQ->/:]K,NMZF]Q(2(QQ&G]T5TWQ US?(-*MVX7#3$']*X:@ HHHH ****
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M_P A6S_Z[Q_^A"@#Z(HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M._Y"MG_UWC_]"% 'T11110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN* /:J*13N4'U&:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO66%U!(K]>[.-K?I7::3\8=#O2J:@DM@W\3R#*?IS0!V]]IEGJ4>V]MTEP,
MLO(^AKFK[X=V$P)L9I+=O]KYA70V&N:9J<>^POH9E_V6_H:OT >67W@/5K7+
M0!+A!W4_-^5<_<6=S:'%W;RPG./WBXKW.HY;>&=2)HD<'KN4&@#PJBO5[[P1
MH]X"4A-O(>KQG^AKG+[X<748+6%TD@'\,@PQ_*@#BZ*T;W0=4T\G[59R*H_B
M R#^59QX.&!!]",4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110!U_PYG\O6KB+_GK&/TYKTJO)/!4OE>++7T8,#^5>MT
M%%%% !12,P1"SG"J,D^@KBY/C#X BE:.3Q19JZG!'S=?RYH [6BL[0_$&E>)
M=-74-"O8[VT8E1+'G!(.#UK1Z=: "B@'(R.15/4M7L-'@6;5+N*UC=PBM(<;
MF)P * +E%4M6UBPT+39-0U>Y2UM8OOROG"_E3=%US3?$6EQZEHEY'>V<N=DT
M1X.#@_J* +]%8FH>,_#VE:_!HFH:K!!J=P 8K5B=[ G Z"MN@ HJKJ.I6>DV
M+WFI7,=M;1XW2R' &3@5$=;TT7%G ;M/,ODWVR\_O5XY'YB@"_1110 4444
M8OC'_D3=4_Z]VKPD=*]V\8_\B;JG_7NU>$CI0 4444 %%%% !1110 4444 %
M%%% !1110 5/8EAJ5J47<PF0JN<9.X<9J"K&G?\ (5L_^N\?_H0H ]8M_B1I
M,.H3V'B-7T"YA8@M?G9"_ILE.%;\*T[?QQX4N[A+>U\2Z1--(<)''?1LS'T
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M_MKV06;#(VO(N\ ,",GY3VKW:,%8U!P"  <'- #J*** "BBB@ HHHH ****
M"BBB@ HHHH *YN^_Y*GH7_8%U+_T?8UTE<W??\E3T+_L"ZE_Z/L: .DHHHH
M*YOX<?\ )+/"G_8%L_\ T0E=)7-_#C_DEGA3_L"V?_HA* .DHHHH **** /
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M<JW%QI\L4]UEOF2".,H7_P"^BHQ[UT7B.[\6VTT0\+:3IM]&1^\:\O&A*GV
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MI6GWD9%W;0MD<L5 /YT >)T5VNNZ%X8M58PWYMY1SY:'>3^!-<9*$65A$Q9
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M[N32XG78<8_=DX# *!NZU /A)JJ^$X=!3QG,+>&\^U*YTZ,G&=VWK_>YS^%
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M860$^S'-=Y0 4444 %%%% &+XQ_Y$W5/^O=J\)'2O=O&/_(FZI_U[M7A(Z4
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M0O\ L"ZE_P"C[&NDKF[[_DJ>A?\ 8%U+_P!'V- '24444 %<W\./^26>%/\
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M2IZ%_P!@74O_ $?8UTE<W??\E3T+_L"ZE_Z/L: .DHHHH *YOX<?\DL\*?\
M8%L__1"5TE<W\./^26>%/^P+9_\ HA* .DHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"IJMDFH
MZ5<6LGW9$(_K7BDL3P3/%(,.C%6'O7NU>7^/-)-CK7VN-<0W7.?]KO0!RU%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5V/P]TS[1J4M](N4@&U?]XUQX4LP51EB
M< >IKV'PQI?]E:%!"P D8;W/N>: ->BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#%\8_\B;JG_7NU>$CI7NWC'_D3=4_Z]VKPD=*
M"BBB@ HHHH **** "BBB@ HHHH **** "K&G?\A6S_Z[Q_\ H0JO5C3O^0K9
M_P#7>/\ ]"% 'T11110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5S=]_P E3T+_ + NI?\
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MMG=:I=Z=!*6NK,(9TV,-N\97DC!R/0F@"Y1110 4444 %%%% !1110 4444
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MKJS1DM-TE[-:&.UN)B.0TI.(0#TSG=GVK4D\6:W%X]TG2I8+4:=<Z8;IYXY
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M[<<>M:D/PJU./4I;]_&^H/<36']G2'[% H,()(4 +@<D\BDC^$EY'8Z':?\
M"9ZB8]$E\RV_T:'L1M!X[8H ]*HI$!5%#-N(&"V,9]Z6@ HHHH **** "BBB
M@ HHHH *YN^_Y*GH7_8%U+_T?8UTE<W??\E3T+_L"ZE_Z/L: .DHHHH *YOX
M<?\ )+/"G_8%L_\ T0E=)7-_#C_DEGA3_L"V?_HA* .DHHHH **** "BBB@
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M]_R5/0O^P+J7_H^QKI*YN^_Y*GH7_8%U+_T?8T =)1110 5S?PX_Y)9X4_[
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M*E\:_P#0)3_P)C_QKZ6HH ^:?^%2^-?^@2G_ ($Q_P"-'_"I?&O_ $"4_P#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5S=]_P E3T+_ + NI?\ H^QKI*YN^_Y*GH7_ &!=2_\
M1]C0!TE%%% !7-_#C_DEGA3_ + MG_Z(2NDKF_AQ_P DL\*?]@6S_P#1"4 =
M)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %<W??\E3T+_L"ZE_Z/L:Z2N;OO^2IZ%_V!=2_]'V- '24444 %<W\./\
MDEGA3_L"V?\ Z(2NDKF_AQ_R2SPI_P!@6S_]$)0!TE%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?_H8?#__ ((9_P#Y,KI** .;^P^-_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\
M@AG_ /DRNDHH YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z&'P__P""&?\ ^3*Z
M2B@#F_L/C?\ Z&'P_P#^"&?_ .3*/L/C?_H8?#__ ((9_P#Y,KI** .;^P^-
M_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\ @AG_ /DRNDHH YO[#XW_ .AA\/\
M_@AG_P#DRC[#XW_Z&'P__P""&?\ ^3*Z2B@#F_L/C?\ Z&'P_P#^"&?_ .3*
M/L/C?_H8?#__ ((9_P#Y,KI** .;^P^-_P#H8?#_ /X(9_\ Y,H^P^-_^AA\
M/_\ @AG_ /DRNDHH YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z&'P__P""&?\
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M_P#^"&?_ .3*/L/C?_H8?#__ ((9_P#Y,KI** .;^P^-_P#H8?#_ /X(9_\
MY,H^P^-_^AA\/_\ @AG_ /DRNDHH YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z
M&'P__P""&?\ ^3*Z2B@#F_L/C?\ Z&'P_P#^"&?_ .3*/L/C?_H8?#__ ((9
M_P#Y,KI** .;^P^-_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\ @AG_ /DRNDHH
M YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z&'P__P""&?\ ^3*Z2B@#F_L/C?\
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M?_H8?#__ ((9_P#Y,KI** .;^P^-_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\
M@AG_ /DRNDHH YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z&'P__P""&?\ ^3*Z
M2B@#F_L/C?\ Z&'P_P#^"&?_ .3*/L/C?_H8?#__ ((9_P#Y,KI** .;^P^-
M_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\ @AG_ /DRNDHH YO[#XW_ .AA\/\
M_@AG_P#DRC[#XW_Z&'P__P""&?\ ^3*Z2B@#F_L/C?\ Z&'P_P#^"&?_ .3*
M/L/C?_H8?#__ ((9_P#Y,KI** .;^P^-_P#H8?#_ /X(9_\ Y,H^P^-_^AA\
M/_\ @AG_ /DRNDHH YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z&'P__P""&?\
M^3*Z2B@#F_L/C?\ Z&'P_P#^"&?_ .3*/L/C?_H8?#__ ((9_P#Y,KI** .;
M^P^-_P#H8?#_ /X(9_\ Y,HT_0=<_P"$JMM9U[5]/N_LME/:10V6FO;?ZUX7
5+,S3R9QY    ZFNDHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>dgx-20211231_g5.jpg
<TEXT>
begin 644 dgx-20211231_g5.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
M'_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_X
MA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;
M_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*
MF?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_
M $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)
M=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_
M ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*
MAKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y
M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_
MF_\ 1T5?QA5_9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX
M_P#3Y/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_F_\ 1T5?QA5_9[_P7X_Y0V?M
M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE,_:[
M_P"WC_T^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ()M_&/3_AUXL5KCP[X]\30KH\^LV2,@DN[+3[B+,T>'C<+)-"^V6,LJ;P*
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M!U&.VFBT^Z@LR]@KW(2*-H7BN1&I8J8TA!<,Q"@'UE17YV_\$H_^#C#]G_\
MX*T?M%:Q^S?\(_V?/&?AK5-'\%77B-[WQ#=VC02Q07-K;F$>2[,'+7:$$C&%
M/M7-V?\ P<R?"#3_ /@HCIG_  32^(O['OC[P[X\OOB'9>$+JXFU?3KBSM;J
MZGCBCF+Q2DO%B5'RHR5/0'B@#]-J*^2O^"LW_!5O1/\ @DK\+]$^.'Q,_9T\
M3>,/"&KZQ'I$VK^&M4LT:QOI(YI8HI(9W5RK)!(1(N5!&TX)7/S3IG_!T/\
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MGW^SU>?&_P <> ]/FN_'^I)XJM]$T'1&BD6)K4W\L<QFN?-81^6D14-N!?\
M=R[.S_X)C_\ !6?X!_\ !3?0/%6E>"O#NL>#?B!\/M5;3?B%\-_$_E_;]&N%
MD>/<&C)2>$R12()%P0T9#JA*Y /J>OS@_;Y_X.3_ (!_\$U/C;_PHC]JS]BW
MXVZ1JEQ9"^TB_LK/1+FRU6T+L@GMYDU+#+N5@5;:ZD895R,_H_7Y\?\ !R+_
M ,$OU_X*0?L :GJ/P_\ #HN_B;\+UG\0^!C#%NGO8U0?;=-7N?/A0%5'6:"
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MZ+U6@#[:\"?\'-/_  3SN/VAF_99_:3\(_%'X#>-(KR.SN;'XQ^$HM/@@GD
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M92\:ZYI7C#3I+SPKXET#5+'R;Y85A^T(T4LBRPO&TZ*0ZX(8$$Y('DG[2?\
MP=1?#?X1?L^>#_VG_A#^P+\4_'/@7Q%;6*ZOXTN$_LK0]+U&X@$KZ6E\T,J7
M=U"?,BDV 1"6)D$C,K!0#]7**\6_X)^?MV_!3_@I!^RQX=_:P^ SWL>C:YYL
M-SIFJ1JEWIEY"Y2>UF52R[U89!!(965@<,*]IH **** "BBB@ HHHH ****
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M[3'P(U7P#XN\ ?LS^*]#U"PU#6=,OXKWRM&O-MS!+I]W<*8V4KQ)Y;A@PVD
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M)-X:DU;1?'GAB[.ES27]E<+<S1+J@D:!5MY-WE!Y.5VH_2OW7^*'BSQ/X%\
M:GXL\&?"[5_&NJV5OOL?"V@WEE;W>H.6"A(Y+ZXM[=,9W$R2J-JG&YL*0#^8
MC_@T*_Y3-:S_ -DSU_\ ]*[.NN_X. _V%O\ @H!_P3)_X*6^(/\ @K/^RSKG
MB"U\*^*/$(UNR\=^',R/X<OYD5+BROTP0L,C[@OF*8)8Y1$V6W*?4/\ @@'_
M ,$B?^"M7_!-_P#X*0VW[2/[1O[!NK+X5U;PYJ.BZE=Z)\0/"]S+IYNI(9%N
M#%_:@9XU:(!@F7VDE58C:?T+TGQ[_P %$OV:?VJ?VA=!^*O[ ?B7XS_LX^-?
M&C7GA5_"NHZ3=ZM:"?2[-;R$Z9?W4(N]/FE\P8# I(LY*.L@P ><?\&\_P#P
M67^%?_!5;QSXDN/B]\+=-\-?M':%X%L[/Q'JVCEUM/%.@6UTYCN(HRQ\IX;B
M\8/&V=IN@R,58QQ?F!_P:_>./%GQX_X+]:I\:OBE<2W'B36M#\5ZYJDUR29/
MMMRP,I.>0<S./8<5^B__  ;^?\$9OBE^RS^VY\9/^"B'Q3^!S_"30/%S:GI?
MPF^$][J4%U?:1I%WJ"76^Z\AW2$I'!!#'%O9L&7< %0OQ]W_ ,$@_P!I[_@E
M/_P6S3_@IA^Q_P# /4OBK\&?%-YJLOBGP9X/O;2/7/#PU&)_M$<%O=2PI<Q)
M<,LL0C;.P&)@FT2L ?$?_!W+XQU_X6_\%JO"OQ,^'VIR:=KVB?#;P[JFGZA;
M'$D%[!?WKPR@C^)3'&1_NBON'_@]%O[O5?\ @F_\'-4U"R-M/<_%>WEGMSUB
M=M'OB4_ DC\*H>/?^"/_ .T__P %C/\ @LY#^WW^U?\  #5OA/\  OPHNE0Z
M1X9\:W=HVN^)8; >8MO):VLTPMHI;AI#(9'!$3;4W,2R>P_\'1W[$?[=7_!1
MCX(_#W]G7]C/]E/5/&!T/Q9_PD6L^)'\5Z'IUE"!:W%LMJJWM_#.\O[W>2(O
M+"[<.S%E4 \:_9@TZPA_X,H]8DALHD:X^'?BR:=DC ,D@\37X#MC[S (HR><
M*!V%<_\ \&.\\S?"']H:U:0F-/$GAYE7/ )M[X$_^.C\J]6^#O[''_!1_P !
M?\&TNL?\$Q=6_8*\2-\6#8ZIX?L=/C\<>&#9W%O?ZM=:A]O^T_VKL6**.;RF
M0_O3+MVH4+2(W_@UG_X)\?\ !0C_ ()GW'Q6^&G[97[(NJ^&-/\ '4^E7VC>
M)[;QAH&H6D+VD=VLD,\=IJ$DZL_GQ["D3J</N*8!(!^PU?RV?\%/_'/BSXQ_
M\'9OASPWX_GEDL]&^.OP_P##^DV4YREMIZSZ8P10>BN\TLQ[%IV/>OZDZ_'O
M_@NU_P $/OVA_C#^VMX"_P""L7_!/WPE8>)/'WA/6=&O_&/@&YU.*QFUJ32Y
MXI+6[MYIBL9D\J%()$9E)2*(IN;<I /-?^#X*"T;X!? *Y=%\]/&&M+&QZA#
M:VQ8?3*I^0KZ%_9B^(_C3XJ_\&C6L>+?']U-/J2?LH>,].$UPQ+O;65CJ=E;
M$D\G]Q;Q<]Z\?_X*^?L>_M[_ /!P)\6/@O\ ";P%^Q_XS^"7P]\#-?7GC?QI
M\7'T^!X[F\^S*\=K:6MW-)=>5';N$8;5D>7#&)5WG[L_;+_9I\7_  =_X)'^
M)/\ @G]^Q)^S;K_CF6_^#>H> /"VGZ;K6DV8LQ-IKV27=Y-J-W;*03(9':,2
M.S;CM&[- 'Y7?\&-?_(T_M+?]@_PE_Z'J]?T'5^)W_!K_P#\$Y?^"DW_  2W
M^+'Q.T?]KC]B;7-+T7XDV>C16?B32_&WAN^@TV2RDO"QN8HM3,VQEN\@Q1R-
MF,C;SFOVQH _FG_X/9?@YXOT7]N7X5?'RXLYCH'B+X5C0K.Y*DH+RPU&[GFC
MST'[O4(&Q[D^M?K/_P &SOQ,T/XF_P#!%/X+3:1=1M-H5CJ6C:E IY@GMM2N
ME"MZ%HS%)])!7M7_  4Y_P"";'P'_P""IO[+NH_LU?'%9K)OM"W_ (8\36$2
MM=Z%J2*RQW,0;AUVLR/&2 Z.PRK;77\M_P#@G!^RO_P7&_X-]?'GB;X2:'^R
ME;_M'_ SQ-JOV]CX!\46]O>6-YM6/[9!;W166.1XDC66%HVC8Q)MF&TLX!^Y
M]9WB_GPGJ@'_ $#I_P#T6U?&J?MZ_P#!3/\ :$TW_A$_V8/^"4?BCP!JEZ@C
M;QK^T!XDT_3M*T4L/]<UE8SSWE\1SB*-8\D#<Z5]'?LI? 3Q?\ _@A;?#KXJ
M_&W6OB5XEN[JZU#Q5XQUZ)(I-2O;J1I)O+@C^2VMEW>7# N1%$B)D[<D _G&
M_P"#+;_E*MXS_P"R#ZM_Z=]&K/\ VG?^5PK3/^SF/"/\]-KV#_@G+_P2[_X+
M(?\ !%#_ (*F>(O%_P #/V%8OC)X;U30M1\-Z5X@/C*UTK3;O2[BY@GAO)+E
M][6TD;6L)DA>(L<2*F=R.6^.?^",'_!;^Q_X+9Z3_P %$?'7[+EC\1M/TWXO
M:%XNUS5_!?B_0-.M[Z&WDM9I[>QMK_48I@D2QO;Q&X"/((5=]I<F@#[9_P"#
MR3_E$?IO_98-&_\ 234*Y+_@WLTS3HO^#9SX@/%80HUYIOCU[MDB ,[?994W
M.1]X[%5<GLH'0"O7/^#E7]EC]MC_ (*%_L.>%/V:/V0_V2==\3:U>^+]/\1Z
MS=7?BG0-/M]'B@MKI&M)3<Z@C27&^=/]2)(L*Y\T_*&XO_@E#^RW_P %#/V-
MO^")/Q)_8F^+O[!?B?\ X6&UMX@@\+:=IWC;PQ-;:S_:D#I$PG_M4+ (9&)E
M\S:=FTQ^:Q** ?"O_!DA86,W[9_QCU&6RB:X@^&-ND,[1@O&K:C%N56Z@':N
M0.NT>@KSCXIR/8_\'A=JUHWEEOVE]&!V\9#FV#?GN.?K7US_ ,&T'_!+O_@J
M#_P2[_:S\9>+_P!JK]A_6;+PSXT\&#2H]:T?QUX:O/L%S'<QSH9HDU/S#&RJ
MZ[HU=@VSY=I9E\S\=_\ !)W_ (+!>)O^"[D?_!4.R_X)T:ZO@F'XUV'B@:._
MQ(\)#4GTRWGA!&S^U_+$[0Q%@GF;0Q"[\?-0![]_P>W?\F1_!_\ [*I+_P"F
MVXJ#X1_\J4EW_P!DRUO_ -2:ZKZ>_P"#C_\ X)K?'3_@J-_P3WT?PS^SQX>4
M^/?!OBBV\2Z?X6U2]@AEOXS:3P7%B)?,,"S@3JX)D\LF J'^8-7Q%\!/V5O^
M"\OQ._X(::U_P2L@_89TGP!8^'M)OX8O$GB7Q59_VMXNAFU)[Y=*M+*1TBLW
M\R4J]Y/,(_)3$:F0[@ ;_P#P8]_\D)^/_P#V-NA_^DMU7QU^T3_RN%:?_P!G
M,>%_YV%?HI_P:[?L$?\ !0C_ ()DZ+\6?AE^V)^QUK.@6WC"YL-4T+7;#QAX
M>O[=I+6&X22UD2WU%I4D?S(_+;88R=V]XP 6^6OBW_P2=_X+ >-?^"[D7_!4
M/1?^"=.O#P3;?&G2?%"://\ $CPDNI2:;9S6^X;!JYC$[10%@GF;0S!2^/FH
M ^V?^#ES]AS_ ()A?&3P9X,_:O\ ^"AO[47B?X:'P?%/I6DP>%A#<WGB2*1Q
M,UE;VDB.6G# D2KA$$A,ORA2OYJ_\'-OQR^/W[1G[,W[,/Q6\<?L]+\-/AS>
MP:TGPKT/Q#K3WOB>\TY;;2PM]J@ \JV,T7D,D"M+(/F:1\L%'UM_P=#?\$CO
M^"CW_!1SXP_"?]H#]E+X3WGB;1M.\##2-4\!W'B#3[:\\/ZA)<R7$D[B6Y%N
M_F++#"[0RR &S!R4VM7%_P#!7?\ X)-_\%\/^"A_[&'P@\8?''P]\-?$7C?X
M>R3V3?"_X=".TN+:UG@@5[^XO+NZ\BYNF:VC62"W*1(,&,/N8( ?>/['\LDW
M_!LIH+RN6(_9,OE!)[#19P!^0%?F5_P9!_\ )SGQT_[$/3/_ $M>OU>_X)?_
M ++/[7%E_P $AM._8J_;;\":%X#U9/AS<>#;/3M$U8:E<V]D]I);"ZNI(V\@
M3,),^3$SJH0$R$N4C_-C_@BG_P $OO\ @MS_ ,$DOVP?B+X3\.?LA^$]>TGQ
MMH*Z'!\3M4\>6L6BZ6([@/#JH@C9KN[0 N39^5#*Y*@O$,M0!F?\'Q__ "/W
M[-__ &!_%'_HW2Z_6']B;X#^ ?VH?^"&WP:_9T^*6G_:?#WC7]E[PSH^JQ@
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MRUXNOA>7W@/XA^,-':_6$QK>QP^(;]8KE5))598]D@&> X%?*'_!LO\ L?\
M_!13_@F%\.?&_P"S[^UO^P=XGTVU\8>,K35=-\5:-XV\+WUI9*8$MYOM4::K
MYZJ@1) 8HY68;P%W!0_Z]4 ?R]_\'IO_ "E4\$_]D%TG_P!/&M5^_?[?O[%O
MAS_@H1_P3F\8?LF:^D"7'BCP;&- O;@<6.JPHD]E<9ZA5N(XRV,$H77HQK\@
MO^#C?_@DE_P59_X*>_\ !06V^-G[,_[#&KS>$_#7@2T\+6FJZOX^\,VK:H]O
M>WUPUU%$VJ>8D+?:P%$H23"Y9$)Q7[J_L_\ B3QQXK^#?A[5_B3\)-7\#:Z=
M,BCU/PQK=]87-Q9S(H5@9;"XN('4D$J5D)*D;@IRH /YM/\ @V;_ ."I\?\
MP3*\>?'+]DW]I:VO+2PET/4=>T7PY/E;C_A*M*B=)=+B3_GXNXX_* Y)DM(D
M RU?N)\/OAK\2_V"_P#@DEXY\3:C<QS?%6W^'GBCQ]XUU.W )N_%UW;76IWC
M@\[E2Z?RH_2*&,= *^.OB%_P;_3^*/\ @Y#T7]N>W\&Q'X/7%B/B!KC801#Q
M;;N(DM-N=Q:2Y\G42Q!5MLZ\<9_7#Q)X=T3Q?X>O_"?B738KS3=4LI;34+.8
M92>"1"DD;#N&5B#]: /YJ?\ @T+\7_M:CXE_'K2/V6K+X8:CKVI:5H-[K$GQ
M.U;4896@CFOU+6YLX96?,DZ^87QSY6,Y-?H9_P $Q?\ @B)^W!^QM_P5J^(O
M_!1SXM?&;X;2:+\4I/$4_B7PEX.N=1=HY-3OA?K'']HMT5DCG5,%B&VCW(KX
M(\/?\$>O^"U/_!#/_@HO<?M#_P#!.+X,O\6/!3RW-GILUI=0RIJNBSNKG3M2
MMO-CFCE39$WFH-GF0I(K'E!^TG[",O\ P4D^._B.']H__@H%X'T;X306>E26
M?A3X,^$_$#7Q$DQ0RZCJURC&.>4*@2"W3Y(5DE9]TI3R@#ZJHHK/\5ZSJ7AW
MPW>ZYI'A+4->NK6W:2#1M)DMTN;QATCC:YEAA#'L9)$7U84 ?R1_\'#/[.FC
M?\$V/^"SFM>(/V8-;G\/G4)M.^(7AM;!1&V@ZA/.\K+"1P%6Z@>6,  (KJ@&
M$R?Z9/\ @E'\(_#/PD_X)^?#!M%FN;S4O%_A:T\7^+]<U"027>M:YJT*7]_?
M7$F 7DDGG?D_=0(@X0"OQ;_X+U_\$C?^"OO_  5%_;_O?VD_@;_P3RUS2_"]
MMX5T_0],7Q'\1O"<5W<BW\UWF:.+5I%C!>9@HWD[5!.TDJ/VF_X)M:Y\?]'_
M &6_AU\$_P!H/]DKQ;\.=>\&?#K2M(U:ZU?7M!O["YN[2VAMG6W?3M1N)6#[
M#(IDBC&W@D-@$ ^)_P#@\@^)GC'P'_P24TWPQX8O)H;/QE\7-(T?Q!Y3$"6S
M2TO[Y8VQU!GLK=O3Y!7D/_!(CX2?\% /VR/^#>;2?V5_@5;_  (L_ ?B[PKX
MJ\,/J?B+6-776+*2YU*_6:66*"V>'S \IE0!B"AC)P20/TF_X*X?\$\= _X*
M@_L+>+?V4=0UR#2-7OO)U'PEK=S&7CT_5K9M\$CA03Y; O#(0"PCF<J"0*_'
MS_@DK\+O^#DC_@CCXG\1_LK^"O\ @G?!\1O!?B#63>0V^I>*;2'3+.]*K&;Z
MVU!)]L4<D:1^9'(NX^6GRQON# 'W'_P30_X(?^-OV3?^"5WQC_X)R_MW?'+0
MM8\'>/-3OM0_MCP;J<\']BV<UG;I,XENX46(I):B;E6C^\6!#,#\>?L@ZI\%
M?V?_ -AO]JK]B3_@CBVN?&;PO:^#?$&J_&+X]?$:Z^P>'=,0Z//"++2;:W3S
M+^Z>&&0*W[N,MB1I7B"+7Z)_M<_L0_MX_M,?\$DOC)\"/%GQETV\^.7Q6TT7
MES!I-]-;Z!I962V)T'3_ #23%:M;6[6S328,TMQ--)M#[4_.G_@CE_P2D_X+
MZ?!']E_XQ_L2>*/"/P[^$7PX^)UAJ"ZMK'C00ZQK/VJ>P-DZ6":?=M&BRHL<
M;R7(98U!DB5VRK '(_\ !CW+(/CE^T! '.QO">A,RYX)%S=X/ZG\Z\+_ .#O
M+3KC5_\ @LU8:5:3>5+=?#;0(HY <;6:>Z4'\":^R/\ @V;_ ."7'_!6G_@F
M[^UCX[/QV_9DT'PUX)\3:;;66N^)]9\6VMS(1:RR2(MA!92R-.TOF8WR^4B*
M2V69?*?@/^"]/_!(S_@K7_P4,_X*<W7[3O[.W[!^J3^$=%TC3-)TJ\U?X@^&
M+674OL;R.UPL1U,M'&[2'8'"OM +(A)4 '[>Z1^PQ^R%IWA[X<^']0_9P\%:
MJ?A-8VUK\/+[5_#%K<W.@B!$6-[662,M ^8U?<A!WJ&^\ :]8K!^&/BWQ)XZ
M\"Z?XJ\7_"W6O!>I7<1:[\,^(;JQGN[%@Q7;))87-Q;MD#<#'*W##.TY4;U
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M;JOBZRAM_&=AI&S^U/M'VJSN6NG#6[1F[FVRA)4(5&Y8M&/J+_@X)_X)Q_\
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M\764%OXRL=),?]IBX^U65RUU(&MVC-U-MF5)4*JC<L6C'Z8?\%'?V&OVGO\
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M_P""_'_*&S]H3_LG\W_HZ*OXPJ /W^_X--O^4IG[7?\ V\?^GR>OW^K\ ?\
M@TV_Y2F?M=_]O'_I\GK]_J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#P#_ (*DZ7\6
MO%__  3_ /BS\)_@9\$];\>^*O'G@'6?"^C:-H=Y8VYAGO\ 3[BW2YFDO;B"
M-8(V<%]K,_("HW./RW_X-??^">O_  48_P""87QR^(]M^UI^Q)XHTG1OB)I>
MDVECX@T[Q%H5W!I\MM/,6:X2/4#*(RMP6W1HY'ED;>17[CT4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R
M!_P7X_Y0V?M"?]D_F_\ 1T5?QA5_9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]
M_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_F_\ 1T5?
MQA5_9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX_P#3Y/7[
M_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% 'YV?%']O/]H?\
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MC\)$^(GPG;Q1=&YN_"174X]/N-)\W S$S2F15 "[8P0 [2EJ?_!IQ87NB_\
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MH_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\
MOT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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MH_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\
MOT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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M^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ% %/\ X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\
M^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\ \^,/_?H4?V=I
M_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']
MG:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\
MWZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^JN?V=I_
M_/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G
M:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY
M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
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M_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\
MH-0?]]5<_L[3_P#GQA_[]"LGQ%:VL6JZ2D5M&H>[(<*@ 8;>A]: +7_"8^&/
M^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\
M"8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"
MG_PF/AC_ *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0
MH I_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\
MOT* *?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\
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M )%B]_ZX&KFG?\@^#_KBO\A5/QC_ ,BQ>_\ 7 U<T[_D'P?]<5_D* )J***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q
M[+_D=[W_ *\HOYFMBL>R_P"1WO?^O*+^9K8H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\2_P#(7T?_ *_3_P"@FMBL
M?Q+_ ,A?1_\ K]/_ *": -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?\CO>_\ 7E%_,UL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH **** "BBB@ HHHH **** ,>R_Y'>]_Z\HOYFMBL>R_Y'>]_P"O*+^9K8H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M9OC'_D6+W_K@:N:=_P @^#_KBO\ (53\8_\ (L7O_7 U<T[_ )!\'_7%?Y"@
M":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M -!-;%8_B7_D+Z/_ -?I_P#030!L4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!F^,?^18O?^N!JYIW_(/@_P"N*_R%
M4_&/_(L7O_7 U<T[_D'P?]<5_D* )J*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH Q[+_D=[W_KRB_F:V*Q[+_D=[W_K
MRB_F:V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *Q_$O_(7T?_K]/_H)K8K'\2_\A?1_^OT_^@F@#8HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ I&944N[  #))/ %8OQ$^(_@7X2
M^#[WQ_\ $CQ1::/H^GQ;[N^O9-JJ.P'=F)X"J"S$@ $G%?E;^W7_ ,%2_B'^
MTW=W'PC^!D5_H?@V>3[._E B_P!<R=H$FW)CC;H(5Y;/SDYVK]OP7P#GG&V,
MY,+'EHQ?OU9?#'_Y*5MHKYM+4^%XW\0,BX'P?/BI<]:2]RE'XI>?]V-]Y/Y)
MO0]Z_;W_ ."O6B> ?MOPC_96U&VU/6QNAU'Q<H66UL#T*VPY6>0?WSF->V\Y
MV_,O[&__  3T^-O[<7BF3XJ?$C6-1TSPK=7C3:GXIU(M)=ZK)N^=;?S,F1B<
M@RME%.?O$%*]M_8(_P""/LU[]B^+W[7&E-'#\LVF^!W)#OW5[TC[H[^0.>F\
MCYD/Z-:?I]AI-A#I>E6,-M:VT2Q6]M;Q!(XD48554<*    . !7Z;F_&O#?A
MU@)Y-P@E.N]*N)=GK_=>TFNEO<CT4FVS\PRC@CB7Q(S"&=<8-PPZUI897CI_
M>6\4^M_?EU<4DCF/@K\#?A=^SUX$MOAS\)?"EOI6F6_S,L8S)<28 ,LKGYI)
M#@98GL ,  #K:X3]I']ISX!?L@_"34_CK^TK\5-)\'^%=)3-WJNKW&T,Y!*Q
M1(,O-*V"%BC5G<\*I-?S<?\ !8O_ (.G?VA/VV;G4?V<OV#8M9^'/PUNW:SN
MM:A<Q^(?$R,=NTM&2;*!\X\F(F1P</)AS$/P'$XG$8RO*O7FYSD[N3;;;?5M
MZMG]!8;#8?!X>-"A!0A%644DDDMDDM$C[ _X.G/^"Y7P2T;]GK7_ /@FU^RG
M\4;?7_&OB>[6Q^)>IZ#,);71-,C;=/8-.IVM<S.JQ21H6V1"9)-K,JG\5/\
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M $=%7\85?V>_\%^/^4-G[0G_ &3^;_T=%7\85 '[_?\ !IM_RE,_:[_[>/\
MT^3U^_U?@#_P:;?\I3/VN_\ MX_]/D]?O]0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% '@O_!.K_DA^K_]CWK'_H^O>J\%_P""=7_)#]7_ .Q[
MUC_T?7O5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %8_B7_D+Z/\ ]?I_]!-;%8_B7_D+Z/\ ]?I_]!- &Q1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &;XQ_Y%
MB]_ZX&KFG?\ (/@_ZXK_ "%4_&/_ "+%[_UP-7-._P"0?!_UQ7^0H FHHHH
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M@S1U]J_LE?L<?LU_L,_!VQ^!'[+7PGTSPGX<LL,T%C&3->38 :XN9FS)<3,
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M\2_\A?1_^OT_^@F@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/5^2LE^K\%\!Y#P/@?8X*-ZDOCJ2^.;_ $CVBM%UN[M_HU_P5*_X+0_L9_\
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M[M@*!R22>@K\_OV]_P#@L!8>'/MOPB_9+U2&\OQNAU+QJ@#PVYZ%+0'B1_\
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ML_M4_$R'3?/1QH/AJP"SZMKDJCF*TMMP+\D!I&*Q)N&]U!%? G_!97_@ZF^
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MA8U'\SV ')) &2:BI4IT:<JE2244FVV[));MOHEU8FU%7>Q^8W[1_P :-?\
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MX8LI1]INST#-U\F+/61AC@A0Q&VORQ\=_$K]K7_@I]\<;?0[33[C5)]['2]
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M&D[.%-;I-+W7;I!>ZMWS-W7VC^U5^UY^S%^P;\%+KXU_M,?%#2?!OA;3(Q%
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M .AM\=_^%E<_XU[I10!\U_\ !.?P+H\?P)U.%;J]Q%XTU2)2;MLD)(%&?4X
MR>YYKWS_ (0?2/\ GYO?_ MJ\=_X)U?\D/U?_L>]8_\ 1]>]4 8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
M@6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO
M_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5
ML44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1
M_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &
M/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U'_"#
MZ1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
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M^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;
M%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U
M'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;5L52\1>(M#\):'=>)?$NJ0V5A90F6ZNKA]J1H.I)_IU)X%14J4Z5-
MSFTHI7;>B26[;Z)";45=F/XCTKP9X1T*Z\3>)M>GLK"RA,MU=7%\RI&@ZD_T
M'4D@#FO@3]I#]H7Q!^T5XSC\%_#ZTU$:"+M8M*TS>TDU_*3A9'49RQ)^5/X0
M>YR:O_M3_M3>+OVG_%\/@;P-9WB>'H[P1Z5I<*$S:A,3A99%')8D_*G\.?4D
MU]*_L;?L;Z;\#=,C\<^.;>&Z\6W4/LZ:8C#F-#T,A'#./]U>,EOYJS[/LY\8
M\ZEP_D$G3RZFU[>O_/KLNZ?V8_:?O2M%'R6)Q.(S[$/"X5VI+XI=_P"NBZ[O
M0K_LE_L2:-\(=%B\8>/P9_%5U%EO)E^33D8<Q(1U?'#./]T<9+>V?\(/I'_/
MS>_^!;5L45^^\.\.Y3PME-/+LNI\E.'WR?64GUD^K^2LDD?387"T<'05*DK)
M?U=^9C_\(/I'_/S>_P#@6U0:#I\.F>++RSMWD95LXR#(Y8\DGJ:WZQ[+_D=[
MW_KRB_F:]LZ#8HHHH **** "BBB@#Y _X+\?\H;/VA/^R?S?^CHJ_C"K^SW_
M (+\?\H;/VA/^R?S?^CHJ_C"H _?[_@TV_Y2F?M=_P#;Q_Z?)Z_?ZOP!_P"#
M3;_E*9^UW_V\?^GR>OW^H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#P7_ ()U?\D/U?\ ['O6/_1]>]5X+_P3J_Y(?J__ &/>L?\ H^O>J "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_
M$O\ R%]'_P"OT_\ H)K8K'\2_P#(7T?_ *_3_P"@F@#8HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-\8_\BQ>_P#7
M U<T[_D'P?\ 7%?Y"J?C'_D6+W_K@:N:=_R#X/\ KBO\A0!-1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/9?\CO>_
M]>47\S6Q6/9?\CO>_P#7E%_,UL4 %%%% !1110 4444 %%%% !1110 4444
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M_P Y\8LZEP]P_)T\OIO]_7Z379=T_LQ^V_>=HH^2Q.)Q&?8AX7"NU)?%+O\
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M****]TZ0HHHH *Q[+_D=[W_KRB_F:V*Q[+_D=[W_ *\HOYF@#8HHHH ****
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M#<+ LC-*R-)('=8CA=GS?%FI_P#!CS_9UW9VO_#SW?\ :YC'N_X4KC9QG/\
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MDOQ\WYA1117O'2%%%% !1110 4444 %8]E_R.][_ ->47\S6Q6/9?\CO>_\
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MN*_R% $U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 8]E_R.][_ ->47\S6Q6/9?\CO>_\ 7E%_,UL4 %%%% !1110
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MD442-YVK3;L*[*.=F<;(^I.&(S@+[K^Q9^Q;;?"6U@^)WQ.L(YO$\T>ZRLW
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M64GUD_N6B2221]'@\'0P-!4J2LE^+[L****^@.H**** "BBB@ HHHH ****
M"BBB@ HHHH *Q[+_ )'>]_Z\HOYFMBL>R_Y'>]_Z\HOYF@#8HHHH **** "B
MBB@#Y _X+\?\H;/VA/\ LG\W_HZ*OXPJ_L]_X+\?\H;/VA/^R?S?^CHJ_C"H
M _?[_@TV_P"4IG[7?_;Q_P"GR>OW^K\ ?^#3;_E*9^UW_P!O'_I\GK]_J "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \%_X)U?\D/U?_L>]8_]
M'U[U7@O_  3J_P"2'ZO_ -CWK'_H^O>J "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *Q_$O_(7T?\ Z_3_ .@FMBL?Q+_R
M%]'_ .OT_P#H)H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH S?&/_(L7O_7 U<T[_D'P?]<5_D*I^,?^18O?^N!J
MYIW_ "#X/^N*_P A0!-1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !117AW[8W_  4G_89_8#T ZY^UG^TIX;\)2M#YMKHD]V;C5+M>QAL8
M ]Q*,\;E0J,C)% 'N-4?$_BCPSX)\/W?BSQEXBL-(TK3X#-?ZGJ=VEO;VT8Z
MO)(Y"HH]20*_ []NO_@]4<_;/!O_  3L_9NP/FCB\<?$T\^F^'3K:3_@2O+/
MZ;HNHK\X@G_!<G_@OMX_S_Q<GXMVR7O4XL/#&D2?^0=/M6 /M(P'\1% '[P_
MMU_\'8'_  3%_9,^V>%_@SXAOOC9XJM]R)9>!G5-*20=!)J<H\ID/]^W6XZ]
M*_#/_@JK_P '$'[<7_!5/PE-\&/'%MH/@GX:-J45Y_PA7A>W9C=O$2T)O+N4
MF2X*,=P51%$65&,>Y%(_0K]A3_@RK ^Q^,_^"BG[2.?NR2^!_AD/Q"3:C<Q_
M\!9(H/7;+T-?G;J7_!&>VO-1GN[+]H-+2&69FAM8_"+,L*$Y" M>EB ,#)))
MQR2:^IX;X+XDXN55Y30]I[+EYO>A&W-S6^.4;_"]CY7B;C7AK@^5%9O7]E[7
MFY?=G*_+RW^",K?$MSX2K]L/^"+7_!(C_@C;\8OA!>?M%?MI^--=UNVTRQTV
MYM[;5O%PT_3=1:X%P7B2TLXTNS)$T!5D6XDSG!48Y^-?^'+W_5R7_EG?_=E?
M=W_!(W_@DU^T%XKT#6_A%X!^*.FZYHNCWT-U<:IJUG]A321<B3]V$669Y@YA
MD8!5 5@VXC>#7Z-D7A3CL!#$2XKP_P!7PW*G[?VM-NDU*/V8U&I>T5X*\96D
MXM(_-<^\6<!F$\/'A+$?6,3S->P]E42JIQE]J5-./LW:H[3C>*DFS[9C_P""
MA/[%_P"QEX>G^'/_  3(_8R\)>%X3'Y4OB ^'XK!;C'1V2(">Z/0[YY%;CE3
M7C-YKO[>_P#P48\3FR1_$OC"-)Q_HMLHM]*L6[;@-EO$<?Q,0Q ZFOO/]GC_
M ((R?LU_"KR-;^+%S=>/-6CPQ2_7[/IZ-[6Z,2_<?O'93_=%?6V@^'M \*Z1
M!X?\+Z'9Z;86J;+:QL+9(885]%1 %4>P%>B_$#P^X)7L^%<![:LO^7]6_P!Z
MO[_JE[-'G1\/?$/CA^TXKS!T:+_Y<4;?<[>YZ-^U?F?GI^SQ_P $+E'D:]^T
MY\2<]&;P]X6/X[9+F1?P*HGT?O7W#\&/V</@;^SUH_\ 8OP<^&>EZ&C(%FN+
M:#=<3@?\]9WS))_P)C7;45^7<2<=\5<5R?\ :&)DX?R+W8+_ +=6CMWE=^9^
MJ<-< \)\)Q7]G8:*G_/+WIO_ +>>JOVC9>04445\@?8A1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %8_B7_ )"^C_\ 7Z?_ $$UL5C^)?\ D+Z/
M_P!?I_\ 030!L4444 %%%0ZCJ-AI%A-JNJWL5M;6T32W%Q/($2-%&69F/
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M0 4444 %%%% !1110 4444 %8]E_R.][_P!>47\S6Q6/9?\ ([WO_7E%_,T
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M^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U
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M?\_-[_X%M69KGA73K74=-ACGN2)[DJY:X8D#;V]* .KHK'_X0?2/^?F]_P#
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\
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MZ1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\
MP@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_
M #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\
M_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_
M (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-
M[_X%M1_P@^D?\_-[_P"!;4 ;%8_B7_D+Z/\ ]?I_]!-'_"#Z1_S\WO\ X%M6
M9KGA73K74=-ACGN2)[DJY:X8D#;V]* .KHK'_P"$'TC_ )^;W_P+:H;_ ,+>
M&]+L9M3U/5;BWMK>)I)YY[\JD:*,EF).  !DDTI2C&+;=D@V-C4-0L=*L9M4
MU2\BM[:WB:6XN)Y J1HHRS,3P  ,DFO@C]L;]L75?CGJS?#/X:2SQ^&(K@(6
MB5A+JTH/RL1U\O.-J=2<,1G 6C^UK^U&_P 6M;D^'?PKN+X>&XYA&TAE<R:K
M(#P=O41YQM3&2<$\X"^U_L<_L-6O@>PM_B;\7+1SK\RB33M-W8_LU3T9_68_
M^.?[W3^;>)^)LY\5LYEPQPQ/EPD?]XQ'1KK&+ZQ>J23O4?:FFW\GC,77SJN\
M'@W:FOBE_EY?GZ%G]BG]BJ#X906WQ6^*NG+)XCE0/IVG2J"NF*1PS#O,1_WQ
MTZYQ]+UC_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M7[CPOPOE'"&40R[+H<L(
M[O[4I=92?5O[DK))))'T6#P=# T%2I+1?>WW9L45C_\ "#Z1_P _-[_X%M1_
MP@^D?\_-[_X%M7T1U&Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45
MC_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@
M^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P
M@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_
MS\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1
M_P _-[_X%M1_P@^D?\_-[_X%M0!L5CV7_([WO_7E%_,T?\(/I'_/S>_^!;5!
MH.GPZ9XLO+.W>1E6SC(,CECR2>IH WZ*** "BBB@ HHHH ^0/^"_'_*&S]H3
M_LG\W_HZ*OXPJ_L]_P""_'_*&S]H3_LG\W_HZ*OXPJ /W^_X--O^4IG[7?\
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MU\->$M.^S6;7<HDN+J5G:6:YG< !YI97DE=@ "SG 48 ]*HHH **** /!?\
M@G5_R0_5_P#L>]8_]'U[U7@O_!.K_DA^K_\ 8]ZQ_P"CZ]ZH **** "BBB@
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MK\O?&?[1?_!<7_@O/X]F\#V>I?$;XH6IN5\SPMX5LS9>'--).4,Z1>79PXX
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M444 %%%% !1110 4444 %8_B7_D+Z/\ ]?I_]!-;%8_B7_D+Z/\ ]?I_]!-
M&Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "AL_:$_[)_-_P"CHJ_C"H _?[_@TV_Y2F?M=_\ ;Q_Z?)Z_?ZOP!_X--O\
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M\$\TM-7^ G[-^F77B>T (\<^+0-4U@R#_EHD\P*VS'C(MTB4^E '\X7[,_\
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MGT^WR7/ZYH _JZHK^/UO^"P__!P[^U<Q7P9^TA\9]>-R?E'P[\+?9-V?[O\
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M\(9\1+GP_;_\)IX;74+6Z2SU)5V3^7+:RRQ-$[J9$VNV$=0V&# >@4 %%%%
M!117S=^U=_P5"_9R_9C%SX<M-5'BWQ3#E?[!T.X4K!(.UQ/RD//!4;G']SO7
MJY/DF;9_C%A<NHRJU'TBMO-O:*\VTO,\K.<\RCA_!O%YC7C2IKK)[^26\GY)
M-^1]'7-S;65M)>7EPD4,2%Y997"JB@9+$G@ #O7QY^U=_P %B_@=\&?M/A/X
M)0Q>.?$,>4-S;S;=+M7Z9:8<SXZ[8OE/(\Q37P_\9OVO_P!LK_@H)XP3X=:3
M#J$]G>2?Z'X)\)V\@@*@_>FP2TN."7E.U>2 @KZ._91_X(BD_9O&/[6OB#'1
MU\(:'<_^.W%ROY%8OJ).U?M>%\.>$>"*$<;QEBE*I:\</3=V_6UI/MIRQ3WF
MT?A^*\2>+^.<1+!<%X5QIWM+$5%9+TO>,>^O--K:"9\QZSXL_;?_ ."E_P 1
MAIB)JWB=X9=\>FV*?9]*TE6X#$9$4(QQO<EVQC<QK[0_91_X(L?#'X>_9O%_
M[2VK1^+=73#KH5F633+=NN')P]R0?78G4%&'-?97P_\ AQX"^%/A>W\%_#;P
MAI^B:5:C]S8Z;;+$@/=CC[S''+'))Y)-;5>#Q)XP9KC<-_9^14U@L*M$H64V
MO.2MRW[0L^\F?0<,^#F4X'%?VCGU1X[%O5NI=P3\HN[E;O.Z[1B5M'T;1_#N
ME6^A^'])MK&RM8A':V=G L44*#HJ(H 4#T Q5FBBOQZ4I3DY2=VS]DC&,(J,
M59(****0PHHHH **** "BBB@ HHHH **** ,>R_Y'>]_Z\HOYFMBL>R_Y'>]
M_P"O*+^9K8H ***I:[XC\/>%[%M4\3:]9:=;+]ZXOKI(8Q]6<@5%2I3I0<YM
M)+=O1(3:BKLNT5XUXZ_;W_9H\$%X8_&LFM7"=8-#M6FS])#MC/\ WW7C7CK_
M (*HZK+OM_AK\+8(?^>=WK=V9"?K%%MQ_P!]FOS_ #KQ6X R*ZKXZ$I+[-.]
M1W[>Y=)^K1YF(SK+,-\51-]EK^1]E5D>+/'W@;P):?;O&OC#3-)BQD/J-]'#
MN^FXC/T%?GKK7[5W[77QIOFT;1/%>LNTGW=.\+61B8 ]LP+YA'U8U;\*?L)?
MM2_$FZ_M76_#HTP3G+WOB/4-KL?5D&^7/U6OS^?CCC<YFZ?#.3UL2]N:2M%>
M;4%/3UE$\M\15,0[82A*?F]OPO\ FCZ@\=?\%%/V</".^#1M6U#Q!.O&S2;$
MA,^[R[ 1[KNKQGQU_P %2O'NH[[?X=_#K3=,0Y"W&ISO=28]0J^6JGV.X5TW
M@7_@E?H4&RX^)/Q1NKD]7M=%M%B ]O-DW$C_ ( *]E\"_L8_LV> -DNF_#&R
MO9TY^TZP6NV)]=LI**?]U14_4O'WBC^/6I9?3?2-G*WE;VDK_P#;\?T#V?$V
M,^*4:2\M_P!7^*/BB\^-?[8G[05R^GZ7XB\4:JCMM>T\/VSQ1 >C"W51C_>_
M&M_P3_P3J_:/\8R+=^(;+3]!BD.YY-5OP\I!ZG9%O.?9BM?H)9V5GIULEEI]
MI%!#&,1Q0QA54>@ X%2UT87P$R[&5EB.(,QKXRIYRY5^+G+[I(J'#5*I+FQ5
M64WZ_P##O\3Y:\"_\$M_AWIFRX^(7Q!U/59!RT&G0I:19]"3O8CW!4_2O9?
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M]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '@O_!.K_DA^K_\
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MC-99ABG2P]ZD<,N2BWK*7)4TBY-1BE93?O7N[[G]CO[)G_!7W_AJ/]H'P_\
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M[/\ A4O[*WPW\+>5CRO^$<\#:?8[,>GDPKBO2**   * J@  < 4444 %%%%
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M.<;SNFD7/;Y>*[O[.J0_CRC3_P 3U_\  8IR7S27F<']I4JG^[QE4\XKW?\
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M^?QKD]9_X(M?ML:7G[#I_A?4L9Q]BU\+G_O\B5^OE%>S0\=^/:/QRIS]:?\
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M -I74K7T^V>&8Y\?]\SQT?4O +%_\Q.(H_*3_P#<<P^N_2"P?_,-AZWSBO\
MW) ^D]&_X*6?L+Z]C[#^T9HT>>GVVWN+;_T=$N*ZS1OVP_V3O$&!I/[2W@25
MCTB/BNT5_P#OEI ?TKX4UC_@@E\1(,_\(_\ M%:+=>GVS0IH/_09)*Y/6?\
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M3O\ )+9+LDDET1^_91DN4Y#@UA,OHQI4UTBK?-O=ONVVWU84445YAZ84444
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M%^$8S64X6-)SW=Y2D_+FDY2MY7MY&^$R_!X&_L(*-_F_O>H4445]0=@4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_B7_D+Z/\
M]?I_]!-;%8_B7_D+Z/\ ]?I_]!- &Q1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !6/9?\ ([WO_7E%_,UL5CV7_([W
MO_7E%_,T ;%%%% !1110 4444 ?('_!?C_E#9^T)_P!D_F_]'15_&%7]GO\
MP7X_Y0V?M"?]D_F_]'15_&%0!^_W_!IM_P I3/VN_P#MX_\ 3Y/7[_5^ /\
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M/MDH_P"FER^Z:3_@3FO7Z?/@:7PQ<W_>]U?=%M_/G7IWGDQ]7XI*"_N^\_\
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MY/7[_4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X+_P $ZO\
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MP?X(4P&:"QUG6$%]=(.\%HFZXN/I'&QK\MOVP_\ @]'_ &/_ (;F[\.?L8_
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MN-9A5_P4MD_E7%:_^W5^RWX?W))\4(KJ0=(["PN)L_1E3;^M?+F@_P#!,_\
M:)U7:VJ7?A_2U/WA=:B[L/PBC<'\Z[;0?^"4^IR;7\4?&6"+^]%8:.TF?HSR
M+C_OFC_7?QLS3_<,BC23_P"?K>G_ (%.E^7R#^T>(:W\+#)>O_!:.WU[_@I_
M\"]/W1Z'X7\1Z@XZ-]FAAC/XM)N_\=KBM?\ ^"K%\^Z/PO\ !F&/^[+?ZR7S
M]42(8_[ZKL] _P""7_P.L-LFO>+/$>H..JK<0PQG\!&6_P#'J[;0/V$?V6M
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MJ%LEY874<\,@RDL+AE8>H(X-?$'C+_@EO\3M,WR^!OB!H^K(O(COHI+20^P
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MK1):)+LD>ZDHJR"BBBK&%%%% !1110 4444 8]E_R.][_P!>47\S6Q6/9?\
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M ,E0?V!BZO\ &Q4GY:_Y_H?F_8_L3_M<>-K@7NI> ;L%NMSJ^K0JP^H>3?\
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MOY(*^Y;BW@NH6MKJ!)(W&'CD4%6'H0>M<!XS_91_9U\>;V\0?"32!(_WI["
MVDA/J6@*$GZYKPO^(5^(>0ZY!G\[+:%:[BO_ $Y'_P D1S?V-FF&_P!VQ+])
M;?JOP/,?!O\ P4X^!^MA(?%V@:WH<I^^Y@6YA7_@49WG_OBO6/!O[2WP#\?[
M$\+?%C19I'^Y;SW8@F;Z1R[7_2O'?&7_  2]^$.K[YO!?C36M&D;[L=QLNX5
M^BD(_P";FO)_&7_!,7XVZ+OF\(^(]$UN)?NQ^<]M,W_ 7!0?]]T?ZQ>._#O^
M_9=3QD%]JG;F?HHN_P#Y2#ZUQ)A?XE)5%W6_X?Y'WBK*ZAT8%2,@@\$4M?FL
M_P /?VS?@"QDL-&\9:-#$<N^E32RVP_WC S1D?6M[PA_P45_:6\)N+?6]3TW
M6TC.UH]6TU5< =1NA,9S[G-;8?Q^RG"U51SS+Z^$GV<>9+[^27W094.)J$)<
MN(I2@_2_^3_ _0NBODKP;_P52\.S[(?B!\*;VV(X>XT>^2<'W$<@3'TW&O6/
M!O[<_P"S)XSV11_$:/3)FZP:S;O;;?J[#R__ !ZOT'*?$_@'.K+#9A33?2;]
MF_2U11N_2YZE#.,LQ'P55\]/SL>NT52T+Q-X<\4V8U'PSX@L=1MSTGL+M)D/
M_ D)%7:^ZIU*=:"G3::>S6J?S/134E=!1115C"BBB@ HHHH S?&/_(L7O_7
MU<T[_D'P?]<5_D*I^,?^18O?^N!JYIW_ "#X/^N*_P A0!-1110 445@^/\
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M.4HO_MVW4^?Q_#^%S'B#!YI6U>&C545_>J<BYOE&,E_V]?H?Q]U_29_P:\_
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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M '_@TV_Y2F?M=_\ ;Q_Z?)Z_?Z@ HHHH **** "BBB@ HHHH **** "BBB@
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MBB@ HHHH **** ,>R_Y'>]_Z\HOYFMBL>R_Y'>]_Z\HOYFMB@ HHHH ****
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M?]<5_D*I^,?^18O?^N!JYIW_ "#X/^N*_P A0!-1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/9?\ ([WO_7E%_,UL
M5CV7_([WO_7E%_,UL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5C^)?^0OH__7Z?_036Q6/XE_Y"^C_]?I_]!- &Q111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,WQC_P BQ>_]<#5S3O\
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M 4444 %%%% !6/9?\CO>_P#7E%_,UL5CV7_([WO_ %Y1?S- &Q1110 4444
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M^)?^0OH__7Z?_030!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!F^,?\ D6+W_K@:N:=_R#X/^N*_R%4_&/\ R+%[
M_P!<#5S3O^0?!_UQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#'LO^1WO?\ KRB_F:V*Q[+_ )'>]_Z\HOYF
MMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "L?Q+_ ,A?1_\ K]/_ *":V*Q_$O\ R%]'_P"OT_\ H)H V**** "BBB@
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M 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!CV7_([WO\ UY1?S-;%8]E_R.][_P!>47\S6Q0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/XE_Y"^C_P#7Z?\
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M10 5C^)?^0OH_P#U^G_T$UL5C^)?^0OH_P#U^G_T$T ;%%%% !1110 4444
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M_:?A&ZFU"\LWMX;V&)_/B:WEC=&>,1')Y&,>HH Y/]@GP]_P6=L?B)JNI_\
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M_P .ZO@?_P!#=X[_ /"OGH_X=U? _P#Z&[QW_P"%?/0![U17@O\ P[J^!_\
MT-WCO_PKYZ/^'=7P/_Z&[QW_ .%?/0![U17@O_#NKX'_ /0W>.__  KYZ/\
MAW5\#_\ H;O'?_A7ST >]45X+_P[J^!__0W>._\ PKYZ/^'=7P/_ .AN\=_^
M%?/0![U17@O_  [J^!__ $-WCO\ \*^>C_AW5\#_ /H;O'?_ (5\] 'O5%>"
M_P##NKX'_P#0W>.__"OGH_X=U? __H;O'?\ X5\] 'O5%>"_\.ZO@?\ ]#=X
M[_\ "OGH_P"'=7P/_P"AN\=_^%?/0![U17@O_#NKX'_]#=X[_P#"OGH_X=U?
M _\ Z&[QW_X5\] 'O5%>"_\ #NKX'_\ 0W>._P#PKYZ/^'=7P/\ ^AN\=_\
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M^%?/0![U17@O_#NKX'_]#=X[_P#"OGH_X=U? _\ Z&[QW_X5\] 'O5%>"_\
M#NKX'_\ 0W>._P#PKYZ/^'=7P/\ ^AN\=_\ A7ST >]45X+_ ,.ZO@?_ -#=
MX[_\*^>C_AW5\#_^AN\=_P#A7ST >]45X+_P[J^!_P#T-WCO_P *^>C_ (=U
M? __ *&[QW_X5\] 'O5%>"_\.ZO@?_T-WCO_ ,*^>C_AW5\#_P#H;O'?_A7S
MT >]45X+_P .ZO@?_P!#=X[_ /"OGH_X=U? _P#Z&[QW_P"%?/0![U17@O\
MP[J^!_\ T-WCO_PKYZ/^'=7P/_Z&[QW_ .%?/0![U17@O_#NKX'_ /0W>.__
M  KYZ/\ AW5\#_\ H;O'?_A7ST >]45X+_P[J^!__0W>._\ PKYZ/^'=7P/_
M .AN\=_^%?/0![U17@O_  [J^!__ $-WCO\ \*^>C_AW5\#_ /H;O'?_ (5\
M] 'O5%>"_P##NKX'_P#0W>.__"OGH_X=U? __H;O'?\ X5\] 'L5E_R.][_U
MY1?S-;%?&7A/]CCX9ZK^USXM^%%UXJ\7C2]*\*V%[:LGB:83&65V#;GZLO'
M[5ZG_P .ZO@?_P!#=X[_ /"OGH ]ZHKP7_AW5\#_ /H;O'?_ (5\]'_#NKX'
M_P#0W>.__"OGH ]ZHKP7_AW5\#_^AN\=_P#A7ST?\.ZO@?\ ]#=X[_\ "OGH
M ]ZHKP7_ (=U? __ *&[QW_X5\]'_#NKX'_]#=X[_P#"OGH ]ZHKP7_AW5\#
M_P#H;O'?_A7ST?\ #NKX'_\ 0W>._P#PKYZ />J*\%_X=U? _P#Z&[QW_P"%
M?/1_P[J^!_\ T-WCO_PKYZ />J*\%_X=U? __H;O'?\ X5\]'_#NKX'_ /0W
M>.__  KYZ />J*\%_P"'=7P/_P"AN\=_^%?/1_P[J^!__0W>._\ PKYZ />J
M*\%_X=U? _\ Z&[QW_X5\]'_  [J^!__ $-WCO\ \*^>@#WJBO!?^'=7P/\
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M*^>@#WJBO!?^'=7P/_Z&[QW_ .%?/1_P[J^!_P#T-WCO_P *^>@#WJBO!?\
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M"7Q)^,/BKQO)X4_:JUS0])U?QAK+WMVEA;001P1;VP%54 &U%5!SA5'%5O\
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M#CP%\(? FD_"_P"%WA#3] \.Z#8QV6C:-I5LL-O9P(,+&B*,  ?GU/)K:HH
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M1;72=$L(R2MM:6T*PPQ#/.%1%'X5MT44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5G^+/#.E^-/"VI>#M;DO4LM6L)K.[?3M2GLKA8I4*,8K
MBW=)H'PQVR1NKH<,K*0"-"B@#X-E_P"#9;_@B5-$\$W['%ZZ2[O-1OBOXJ(?
M<26R/[4YSDY]<U]2>%OV,OV7?!O[*UO^Q%H?P9TD_"JV\/MHD?@R^\R[MFL6
MR6C=IV>21BS%C([%RYW[MW->G44 >2?![]B/X _!7Q_#\5M TS7M:\3V6B'1
MM)\0>-/%VH:[=Z7II*L;2UDOYY3;QL40R%,/*40R,^Q<._:^_8?_ &:_V\OA
MH_P;_:H\&ZKXC\*S2QR76@6OC+5=+M;MHY%EC,Z6%U )]LB(ZB3<%901@BO6
M:* ,/P-\._#/P\\$VOP]T$ZE<Z79VY@B77M<N]4G:/&-LEQ>RRS2C''SNW''
M2O'M$_X)G?LD>'?!TGPHT?PGKL/@"2^:[/PS'C+4CX;#-+YS0C3S/Y(M3(2Q
ML\?926/[GFO?:* $CC2)%BB0*J@!548 'H*6BB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "OE_\ :Y_X(U?\$Z/V[?BPOQO_ &K?@=JWBSQ+
M%IT=A;7K_$?Q!9Q6ULG(BAM[2_BAA4G+,$1=S$LV6))^H** /F[]B[_@D7_P
M3R_X)Z_$#6?BI^R)^STOA7Q%X@TD:9JVK3^*M6U.::T$B2^2#?W4_EJ7C1CL
MVD[%SG:,;_Q,_P""<W[)_P 6?%OB?Q9XH\%ZM /'1A/Q T;1/%NHZ=IGBLQ(
M(T.HV=M.D%V3&%C<NA,T:B*7S(P$'N5% &>?"N@Q^%?^$)TZQ_L_3%T_[%!;
M:1*]G]F@">6J0M 4:#:N IC*E,#:1@5Y+^S)_P $]OV5?V._&/BOQ[^SWX0\
M0Z/J?CG6IM8\7RW_ ,1-=U2/5M1F),MY-#?7LT;3L2<R[=Q]>!7M5% 'E_Q<
M_9"^#/[0'B&/5?CI::MXLTN"ZAN;;P=K&MSMH(EBV%&ETY&6WO,.@D N5F"O
M\RA2!CTZ...&-888U1$4!548  Z "G44 %%%% !1110 4444 %%%% !1110
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M7Y^VS_T-?C'_ , '_P#C=>>_$KQ/\2/%WB4ZQ\4[_4;G5# B>9JD;+)Y8SM
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MB!X[_:!L_!OQ"\4ZIXJO+NX\4:9?PN)XKM))##M&TF.**..*+<!&B*B*O?\
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M?L@W46I:--\3-4FEO;>#5/LYMUN'G,EE'+'%"LHM&@W+&5&T.X-/X,Z3<?\
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M"Z,<VGZ=IULLB"6_<B.X,\C>5;I']V63Y5^)?^";WQD;PE^QK\<?^"0?Q/\
M#.I>'/VS]&N1X"T+6-/\07\&M>(XV5DT74X=1607*V&F1#[0R1LL$=E KJA$
M[(0#]JOCC%\16^%FM77PI\9VF@Z]:Z?-<:?J%_I(OH!(D3,JR0[T+(6"YPRG
M .".M?FC^Q#^WS_P6._:R_X)4S_\%-_!GQ#^">K:I9V^LWK?"K4?AAJ%NE];
M:;/,DL46I1:OE)Y$@9HRT!3>RHW&7K[X^!O[->E_LI?LHGX/V?Q%\6^+[S3_
M  U(NK^*?&OB:\U2_P!6NQ;;9;EY+J:0Q[V!;RD(C3.%4 5^8?\ P06^!'[:
M/[1?_! ;0?@K\#_VC_!'@'0/%]QXETJZURZ\ W6HZQIEM-J-U%<F!AJ,4#RL
MK/L=HU\O=T9E#T ?H[_P2^_;^\%?\%-OV+/"7[7G@OPK<:!_;JSVVKZ!<SB9
MM-O[>5H9X1(%42IN7<CX!9'0E5;*A_\ P45_:F\5?LS_  4L--^#^N^#K3XG
M?$'7X?#'PR7Q]J1M=(74Y4>5[F\=?G%O;VT,\[A 6<QI$H+RJ#M?L!?L0?"+
M_@G5^RAX5_9(^"<E[<:+X9MY3)J6ILK76HW4TK33W,I4 ;GD=B% PJ[5'"BJ
M?[;'_!-_]B[_ (**>'=,\,?MB_!*V\8VVAK<?V(\VJ7=K+I[3A!*\+VTL;*S
M>7'DY_@';B@#A_V!O#O_  64T_QYK.H_\%*_B-\ -2\,G1U7PY8_!VQU7[2]
MZ95)EN);Z.-5B6,, J!BS2 DJ$PW$? W]KW]K7_@HJWQA^*_[&'C[PKX5\%?
M#;QC?^$OAU'KGALZC_PG&K6$:-<W5W+Y\9M].DF=8(A!MEPLDK/]V(>;_P#!
M,CX.?'G_ ()R?M\_$W_@E-I7Q=UWQI\'I/A-;_$'X-7GBBZ^T7GA1'OVT^72
M6EP,Q^;ET4 (%B#*H9Y<L_X-.K-M*_X(_P"B:#J$#PZMIWQ!\1VVO03#][%>
M+>G<DF>=X4IG/- '?ZA_P7)^$B?\$@;3_@J#I7P_N)M5U%4T2Q^&[W@%PWBQ
MKDV7]DF3;D*MPK.9"H8VZ^8$R0M:OQD_:T_:I_X)Y^*/@QXN_;,^(WA?Q?X+
M^*_C.S\%^,[C0?#)TU?!FO7T3O93VKF:0SZ:98I()/M!,J QRB3[T1_''PUH
M_B2Z_P""1/@#X@7L<A\%W/\ P5'35M^#Y*Z2T)@64]O*$ZS+Z;F'>OTS_P"#
MKFWU35O^"9F@>%/#*LVNZY\;O#%AX=2/_6/?/).T83'.[Y6QCF@#],:_/CX8
M_MB?MV>)O^"XWC'_ ()K:]\7O![^ O"?PG@\<Q:K!X$*:K=+)<64'V)G^UF)
M?FN78RB/.U  H)W#]!Z_,GX+_P#*V5\7O^S1[+_TZ:50!^FU%?D]^SW^QY\*
M_CO_ ,%Q?VU?@1\7/$'C77O EKX5\"SS>$M1\>ZG+!>FYTYYFCGF:<W,ENLL
MDSK;&7R 9>8SY<7E^9?L^_MD?$O_ ()I_P#!'S]NRX^$^N7U[!^S[^TKXF\#
M_!V/6+E[TZ#8SW^GV-E&#,6WI;R7C3A7R&;<#D-B@#[C_P""]W[3'[4_[&?_
M  3,\>_M2_LF?$O1_#7B#PC_ &>TL^I^&$U*66.ZU*TLOW!FD\F%T^TM)F2&
M8-M"[5SNKZ[\)WUUJ?A;3-2OI=\UQI\,LS[0-S,@).!P.3VK\A?^"XG[ /[-
M'P\_X-^?$GQ@T7PM%>_$'1_#OA?4-2^)\DK/K?B:YN=4TZ.ZEU&])\Z^CF-P
M\OE2LT:NL3(J^5&%]\_:1^*GC[XT_P#!3GX:?\$^(OASX2\8^$[#]FZ7X@7W
M@CQQXMN-)TKQ!?2:G'IT7VD16%Z+];:**9UM)(_*+7!F;+01X /T.HKX)_8D
M_P""8GQ=^!7QY^,_AGXJV'PZT_\ 9U^*NEV]SH'[/_A_Q'?:M:>&=3B$"7$U
MD;BRM%MX)6,DI2!$$4A@" >6K#X[_9K^$.@?!_\ ;O\ $'_!!#X]_$6RU;X3
M:G\2F\>>!?&]]=SOK.OFUMK>[_X0Z2^ &RZA66"6:02"5K3?$%5;Y @!^W5%
M5=%T71_#>C6GAWP[I5M8:?86R6]C8V<"Q0V\**%2-$4 (JJ  H    %6J "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^0/^"_'_*&S]H3_
M +)_-_Z.BK^,*O[/?^"_'_*&S]H3_LG\W_HZ*OXPJ /W^_X--O\ E*9^UW_V
M\?\ I\GK]_J_ '_@TV_Y2F?M=_\ ;Q_Z?)Z_?Z@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "O&_VMOV2=(_:1TBVU/3-1
MCTWQ'IL1CLKV5"8IHB<^3+CG;DDAADJ2>#DBO9**\G/,CROB/*ZF7YA34Z4U
MJMO---:IIZIHPQ.&HXNBZ557BS\Z_P#AW?\ M1_VO_9O_"(V'D[\?VA_;,'D
MX]<;O,Q_P#/M7UA^R3^R3I'[-VD7.IZGJ,>I>(]2B$=[>Q(1%#$#GR8L\[<@
M$L<%B!P, 5[)17P7"?@[P;P?FG]H86,ZE57Y74DI<E]'RI1BKVTN[M=&>;@L
MBP& K>U@FY=+N]O31!1117ZF>R%%%% !7PKXL_8=_:<_X)O6_P 1OC+_ ,$A
M=,\/:]IGB_5I/$.N?LZ^,RT&FR:HZ@3W6B7L<B?V?+*$3=;3"2!]H"- %45]
MU44 ?FI_P2LU_P -?\%+OCRG[;G[;]_<6O[0OPC6]T6P^ VJZ"^DP_"U9WVO
M>0V=Q))<7<UW$(\ZC(VP@>6D<9BP/:OVH?\ @G'\??&7_!0+P]_P41_8\_:F
MTCX=>+D^'3>!/&FG^)? _P#;EEJNC?;3>1R1QK=6[1W"2]]V&"(,@!UD^G_&
M/PA^$_Q$U:PU_P ?_#'P]KE_I9)TN^U?18+F:S)ZF)Y$+1GW4BNBH ^*OV6_
M^"1.J?!/X]_M%_$GXN?M+WWQ#\*?M%Q6]OXM\':QX>@C>[BCT^2SD>XND(_U
MHN+C,4$<$:*8U4!4"UYE^S+_ ,$5/VW_ -EVT?\ 9@\#_P#!7#Q0?V:5NY3:
M^ &\$V9\00:=*Y:32X=99C):QL&*F:%4906,20LV\?I%10!\\:M^S5^U5X#_
M &AO$GQ9_9W^.G@NU\'^)?#FEZ8_PS\5^";B:VTZ>RCDB6]M[JVO(BI:-TC>
M Q%66",!T(R?$_''_!"_P%K/_!+&7_@G+X#^-D_A[4SXQ'C&#QU;^'(VAAU[
M^TOM[2)IPE"QVH8F%+<2YCC"9=V4E_O.B@#DO@AX0^*/@CX=66B_&CXLKXV\
M3\R:OX@@T./3+>:4_P ,%JCOY$2@ *K22-U+.Q-?+/[?G_!,']H?]LW]KCX+
M?M5^#?VP/"?@N3X$:Q?ZGX,T*^^$=QJRW-Q=BW67[9*NM6QE0+;1A1&L1&YN
M3D8^TZ* /D']H_\ X)S?M+_MT>$Q\&_VSOVYX)/AK=RHWB3P5\&_AV_A8^(H
MT8,+:\O;O4]2N/L[,/FC@:'>O!/0UVO[77[ NG?&_P#X)\ZU_P $]/V=O%6A
M?"OPSJWA5?#5O,OA)]4BTW2]@0Q00+=VV)-H $CNW))*L3FOHFB@#X0^./\
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M).<FOI30= T+PKH=GX9\+Z+::;INGVR6]AI]A;+#!;0HH5(XXT 5$50 %
M  H ^3_VX?\ @G7^T/\ MI^*O@3XRO?VK?"'AR]^"GQ$L?&NVW^$]S<Q:UJ=
MJS;4*MK2FWMV1BI0-(^26$G0 ^)/_!-SXD>&_P!NI_\ @HY^Q]\:]#\)>/\
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MC>"/!,^DKXAUZTB>.SU#4&GO+@*D1D>86D*JAFVLSLBB*H-!_P""=_QQT/\
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MIOPM\%_"[7M*U?3[K5/ SZ]>7ES8223([LM_:(IEGD>:8[&WNS8V XK[EHH
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MKY?_  K+SOM@^P;//S_;^<[,?;^?._Y\Z_</_AK#]EG_ *.5^'__ (65C_\
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M4)2/=_#N8 9[9K\H/^",'B_]CW_@J=\!=0U7]I;XS>++[]JB+5]4?XD6L_Q
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M_I;W-_ ]QX.\+Z6\DGV.^=&*PW4UQ)/>3IG"I):IEO)#OX=_P4S\&:7\0_\
M@XU_8?\ !NKZOJ]C!>>"_'&^[T'6[G3KN(KI%ZZF.XMG25/F49 ;#+E6#*S*
M0"'2_BO\<O\ @GS_ ,'"'PV_X)^?"OXY>-/&_P '_C9\/+K6;[P1X[\5W>OW
M/@^Z@BU%Q/9W=[)+<QVY-@O[N25E(FEX)6,K^J%]>VFFV4VHW\ZQ06\3232N
M>$11DD^P KQ/X!_\$ZOV4OV=/C7X@_:8\&>"M2U7XE>*+46FM?$#QEXFOM;U
M:6U&W;;1SWLTAMX0$0>7"$4A%!!VC'MT\\%K ]S<S)''&A:221@%50,DDGH
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MC^&/$=]X:U.'P_K&H!BOV6UUI[8:;<2EE90D=PQ+*5 )!%?FK\!OC3_P4?\
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M#_@ZB\'7NOZ#9WDUA^Q1<W-E)<0*YAF/B2YA+KGHWE32IG^[(P[U[%_P6O\
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MO\(/@IX@B\;6FI^+_%7B.W@>"T\1_$/QOJ.OWEG$XPZ6S7TTBV@< !_(6/S
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M6EI D-K;01A4BC4!515'     '0"IZ** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /D#_@OQ_P H;/VA/^R?S?\
MHZ*OXPJ_L]_X+\?\H;/VA/\ LG\W_HZ*OXPJ /W^_P"#3;_E*9^UW_V\?^GR
M>OW^K\ ?^#3;_E*9^UW_ -O'_I\GK]_J "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /D#_@OQ_P H;/VA/^R?S?\ HZ*OXPJ_L]_X+\?\H;/VA/\
MLG\W_HZ*OXPJ /W^_P"#3;_E*9^UW_V\?^GR>OW^K\ ?^#3;_E*9^UW_ -O'
M_I\GK]_J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]&/?$#_PHK'_  H_XC>?V6?^C'OB!_X45C_A0!^WU%?B#_Q&\_LL_P#1CWQ
M_P#"BL?\*/\ B-Y_99_Z,>^('_A16/\ A0!^WU%?B#_Q&\_LL_\ 1CWQ _\
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M%8_X4 ?M]17X@_\ $;S^RS_T8]\0/_"BL?\ "C_B-Y_99_Z,>^('_A16/^%
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M_P#1CWQ _P#"BL?\*/\ B-Y_99_Z,>^('_A16/\ A0!^WU%?B#_Q&\_LL_\
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MWQ _\**Q_P */^(WG]EG_HQ[X@?^%%8_X4 ?M]17X@_\1O/[+/\ T8]\0/\
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H?LG^%OV2/&FAZAXZ\-OIMIJVH:Y:20VKLZ-O=4&XCY>@]:_"V@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060248846744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Quest Diagnostics Inc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1387862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 Plaza Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Secaucus,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-2700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DGX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,454,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant's Proxy Statement to be filed by April&#160;30, 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001022079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060253762744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Florham Park, New Jersey<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060248922840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 872<span></span>
</td>
<td class="nump">$ 1,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $31 and $28 as of December&#160;31, 2021 and 2020, respectively</a></td>
<td class="nump">1,438<span></span>
</td>
<td class="nump">1,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,741<span></span>
</td>
<td class="nump">3,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,707<span></span>
</td>
<td class="nump">1,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">597<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,095<span></span>
</td>
<td class="nump">6,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity method investees</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">13,611<span></span>
</td>
<td class="nump">14,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of long-term operating lease liabilities</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,753<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">4,010<span></span>
</td>
<td class="nump">4,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">494<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">792<span></span>
</td>
<td class="nump">847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Quest Diagnostics stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share; 600 shares authorized as of both December 31, 2021 and 2020; 162 and 217 shares issued as of December 31, 2021 and 2020, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,260<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">7,649<span></span>
</td>
<td class="nump">9,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 43 and 84 shares as of December 31, 2021 and 2020, respectively</a></td>
<td class="num">(3,453)<span></span>
</td>
<td class="num">(5,366)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Quest Diagnostics stockholders' equity</a></td>
<td class="nump">6,444<span></span>
</td>
<td class="nump">6,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">6,483<span></span>
</td>
<td class="nump">6,809<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 13,611<span></span>
</td>
<td class="nump">$ 14,026<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060248878920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060246956744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 10,788<span></span>
</td>
<td class="nump">$ 9,437<span></span>
</td>
<td class="nump">$ 7,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Operating costs and expenses and other operating expense (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of services</a></td>
<td class="nump">6,579<span></span>
</td>
<td class="nump">5,804<span></span>
</td>
<td class="nump">5,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">1,727<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
<td class="nump">1,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating (income) expense, net</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses, net</a></td>
<td class="nump">8,407<span></span>
</td>
<td class="nump">7,466<span></span>
</td>
<td class="nump">6,495<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">2,381<span></span>
</td>
<td class="nump">1,971<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total non-operating income (expense), net</a></td>
<td class="nump">218<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from continuing operations before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">2,599<span></span>
</td>
<td class="nump">1,884<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(597)<span></span>
</td>
<td class="num">(460)<span></span>
</td>
<td class="num">(247)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">2,080<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income from discontinued operations, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,080<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract', window );"><strong>Amounts attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from continuing operations</a></td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from discontinued operations, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 1,995<span></span>
</td>
<td class="nump">$ 1,431<span></span>
</td>
<td class="nump">$ 858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from continuing operations (in dollars per share)</a></td>
<td class="nump">$ 15.85<span></span>
</td>
<td class="nump">$ 10.62<span></span>
</td>
<td class="nump">$ 6.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Income from discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (in dollars per share)</a></td>
<td class="nump">15.85<span></span>
</td>
<td class="nump">10.62<span></span>
</td>
<td class="nump">6.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from continuing operations (in dollars per share)</a></td>
<td class="nump">15.55<span></span>
</td>
<td class="nump">10.47<span></span>
</td>
<td class="nump">6.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Income from discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (in dollars per share)</a></td>
<td class="nump">$ 15.55<span></span>
</td>
<td class="nump">$ 10.47<span></span>
</td>
<td class="nump">$ 6.28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060246899384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 2,080<span></span>
</td>
<td class="nump">$ 1,499<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in available-for-sale debt securities, net of taxes</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net deferred gain on cash flow hedges, net of taxes</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">2,087<span></span>
</td>
<td class="nump">1,517<span></span>
</td>
<td class="nump">926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 2,002<span></span>
</td>
<td class="nump">$ 1,449<span></span>
</td>
<td class="nump">$ 878<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243676712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 2,080<span></span>
</td>
<td class="nump">$ 1,499<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision</a></td>
<td class="num">(57)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_GainLossOnDispositionOfJointVenture', window );">Gain on disposition of joint venture</a></td>
<td class="num">(314)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Losses (gains) on sale of property, plant and equipment</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">81<span></span>
</td>
<td class="num">(455)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TerminationOfInterestRateSwapAgreements', window );">Termination of interest rate swap agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities, net</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">2,233<span></span>
</td>
<td class="nump">2,005<span></span>
</td>
<td class="nump">1,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(331)<span></span>
</td>
<td class="num">(330)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from disposition of joint venture</a></td>
<td class="nump">755<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposition of property, plant, and equipment</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(403)<span></span>
</td>
<td class="num">(418)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Increase in investments and other assets, net</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">21<span></span>
</td>
<td class="num">(772)<span></span>
</td>
<td class="num">(411)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">749<span></span>
</td>
<td class="nump">2,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1,554)<span></span>
</td>
<td class="num">(1,449)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(2,199)<span></span>
</td>
<td class="num">(325)<span></span>
</td>
<td class="num">(353)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(309)<span></span>
</td>
<td class="num">(297)<span></span>
</td>
<td class="num">(286)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="num">(38)<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(2,540)<span></span>
</td>
<td class="num">(1,267)<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net change in cash and cash equivalents and restricted cash</a></td>
<td class="num">(286)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning of year</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, end of year</a></td>
<td class="nump">$ 872<span></span>
</td>
<td class="nump">$ 1,158<span></span>
</td>
<td class="nump">$ 1,192<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_GainLossOnDispositionOfJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Disposition of Joint Venture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_GainLossOnDispositionOfJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TerminationOfInterestRateSwapAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Termination Of Interest Rate Swap Agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TerminationOfInterestRateSwapAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060242891304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock, at Cost</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2018</a></td>
<td class="nump">$ 5,267<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,667<span></span>
</td>
<td class="nump">$ 7,602<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
<td class="num">$ (4,996)<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options, value</a></td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2019</a></td>
<td class="nump">5,687<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,722<span></span>
</td>
<td class="nump">8,174<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">$ (5,218)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, value at Dec. 31, 2018</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, value at Dec. 31, 2019</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">1,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under benefit plans, sharers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options, value</a></td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="num">(325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2020</a></td>
<td class="nump">6,809<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
<td class="nump">9,303<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">$ (5,366)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">2,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(83)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options, value</a></td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="num">(2,222)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,222)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(649)<span></span>
</td>
<td class="num">(3,342)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2021</a></td>
<td class="nump">6,483<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,260<span></span>
</td>
<td class="nump">$ 7,649<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (3,453)<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251494344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251533816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The consolidated financial statements include the accounts of all entities controlled by the Company through its direct or indirect ownership of a majority voting interest.  Additionally, the consolidated financial statements include the accounts of variable interest entities (&#8220;VIEs&#8221;) in which the Company has a variable interest and for which the Company is the &#8220;primary beneficiary&#8221; as it has both: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.  All significant intercompany accounts and transactions are eliminated in consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income attributable to the minority interest in the Company's majority owned and controlled consolidated subsidiaries is recorded as net income attributable to noncontrolling interests in the consolidated statements of operations and the noncontrolling interest is reflected as a separate component of consolidated stockholders' equity in the consolidated balance sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  The accompanying consolidated statements of operations and related disclosures report the results of NID as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  See Note 20 for a further discussion of discontinued operations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Investments in entities which the Company does not control, but in which it has a substantial ownership interest (generally between 20% and 49%) and can exercise significant influence, are accounted for using the equity method of accounting.  These investments are classified as investments in equity method investees in the consolidated balance sheet.  The Company records its pro rata share of the earnings, adjusted for accretion of basis difference, of these investments in equity in earnings of equity method investees, net of taxes in the consolidated statements of operations.  The Company reviews its investments in equity method investees for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes as revenue the amount that reflects the consideration to which it expects to be entitled in exchange for goods sold or services rendered primarily upon completion of the testing process (when results are reported) or when services have been rendered (see Note 3).  Net revenues from Medicare and Medicaid programs were approximately 10%, 11% and 15% of the Company's consolidated net revenues for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes on Income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year.  Current and deferred income taxes are measured based on the tax laws that are enacted as of the balance sheet date of the relevant reporting period.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.  Tax benefits from uncertain tax positions are recognized only if the tax position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan (&#8220;ELTIP&#8221;) and its Amended and Restated Non-Employee Director Long-Term Incentive Plan (&#8220;DLTIP&#8221;), as well as the dilutive effect of accelerated share repurchase agreements ("ASRs"), if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards.  As such, the Company recognizes stock-based compensation cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants.  The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.  The terms of the Company's performance share units allow the recipients of such awards to earn a variable number of shares based on the achievement of the performance goals, which are based on the financial performance of the Company and the total shareholder return of the Company relative to an index of peer companies ("relative TSR"), specified in the awards.  For performance share units with a goal based on the financial performance of the Company, stock-based compensation expense is recognized based on management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned.  The cumulative effect on current and prior periods of a change in the estimated number of performance share units expected to be earned for these awards is recognized as compensation cost in earnings in the period of the change.  For performance share units with a market-based relative TSR goal, stock-based compensation expense is recognized based on the estimated fair value of the award regardless of the actual number of shares earned.  For further details regarding stock-based compensation, see Note&#160;17.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy.  The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company predominately uses the U.S. dollar as its functional currency.  The functional currency of the Company's foreign operating subsidiaries generally is the applicable local currency.  Assets and liabilities denominated in non-U.S. dollars are translated into U.S. dollars at exchange rates as of the end of the reporting period.  Income and expense items are translated at the average monthly exchange rates during the year.  Resulting translation adjustments are recorded as a component of accumulated other comprehensive loss within stockholders' equity.  Gains and losses from foreign currency transactions, which are denominated in a currency other than the functional currency, are included within other operating (income) expense, net in the consolidated statements of operations.  Foreign currency transaction gains and losses have historically not been material.  The Company may be exposed to market risk for changes in foreign exchange rates primarily under certain intercompany receivables and payables.  From time to time, the Company uses foreign exchange forward contracts to mitigate the exposure of the eventual net cash inflows or outflows resulting from these intercompany transactions.  The Company's foreign exchange exposure is not material to the Company's consolidated financial condition.  The Company does not hedge its net investment in non-U.S. subsidiaries because it views those investments as long-term in nature.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash and cash equivalents include all highly-liquid investments with original maturities, at the time acquired by the Company, of three months or less.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash, cash equivalents, short-term investments, accounts receivable and derivative financial instruments.  The Company's policy is to place its cash, cash equivalents and short-term investments in highly-rated financial instruments and institutions.  Concentration of credit risk with respect to accounts receivable is mitigated by the diversity of the Company's payers and their dispersion across many different geographic regions, and credit risk is concentrated among certain payers who are large buyers of the Company's services.  To reduce risk, the Company routinely assesses the financial strength of these payers and, consequently, believes that its accounts receivable credit risk exposure, with respect to these payers, is limited.  While the Company has receivables due from federal and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent on submitting appropriate documentation timely.  As of both December&#160;31, 2021 and 2020, receivables due from government payers under the Medicare and Medicaid programs represented approximately 6% of the Company's consolidated net accounts receivable.  The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.  As of December&#160;31, 2021 and 2020, receivables due from patients represented approximately 21% and 11%, respectively, of the Company's consolidated net accounts receivable.  The Company applies assumptions and judgments including historical collection experience (including the period of time that the receivables have been outstanding) for assessing collectability and determining net revenues and accounts receivable from patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accounts receivable are reported net of allowances for credit losses.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;When estimating its allowance for credit losses, the Company pools its trade receivables based on the following customer types: healthcare insurers, government payers, client payers and patients, which are described in Note 3.&#160; The Company principally estimates the allowance for credit losses by pool based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period of time that the receivables have been outstanding.&#160; To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the customers from their respective pools and establishes allowances based on the individual risk characteristics of such customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inventories, which consist principally of finished goods testing supplies and reagents, are valued at the lower of cost (first in, first out method) or net realizable value.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Property, plant and equipment is recorded at cost.  Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.  Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and expensed as incurred for preliminary project activities and post-implementation activities.  Capitalized costs include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with the internal-use software project, and interest costs incurred, when material, while developing internal-use software.  Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose.  Costs for maintenance and training are expensed as incurred.  The Company capitalizes interest on borrowings during the active construction period of major capital projects.  Capitalized interest is added to the cost of the underlying assets and is amortized over the expected useful lives of the assets.  Depreciation and amortization are provided on the straight-line method over expected useful asset lives as of December&#160;31, 2021 as follows: </span></div><div><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">buildings and improvements, ranging up to thirty-one and a half years; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory equipment and furniture and fixtures, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1MDYw_1d199ab7-3192-43a9-a2e6-2c9e9839ee94">five</span> to twelve years; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">leasehold improvements, the lesser of the useful life of the improvement or the remaining life of the building or lease, as applicable; and </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">computer software developed or obtained for internal use, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1Mjcw_88e6f6e4-a789-4494-8767-bda409fe0bc3">five</span> to ten years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Goodwill represents the excess of the fair value of the acquiree (including the fair value of non-controlling interests) over the recognized bases of the net identifiable assets acquired and includes the future economic benefits from other assets that could not be individually identified and separately recognized.  Goodwill is not amortized, but instead is periodically reviewed for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of goodwill exceeds its fair value.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On a quarterly basis, the Company performs a review of its business to determine if events or changes in circumstances have occurred which could have a material adverse effect on the fair value of the Company and its goodwill.  If such events or changes in circumstances were deemed to have occurred, the Company would perform an impairment test of goodwill as of the end of the quarter and record any noted impairment loss.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The goodwill test is performed at least annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired.  The annual impairment test includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative test may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company is required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, the Company's policy is to update the fair value calculation of its reporting units and perform the quantitative goodwill impairment test on a periodic basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  The Company calculates the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  The Company assesses the valuation methodology based upon the relevance and availability of the data at the time that the valuation is performed.  The Company compares the estimate of fair value for the reporting unit to the carrying value of the reporting unit.  If the carrying value is greater than the estimate of fair value, an impairment loss will be recognized in the amount of the excess. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company performs its annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2021, the Company performed a qualitative impairment test and, based on the totality of information available for the reporting units, the Company concluded that it was more-likely-than-not that the estimated fair values of the reporting units were greater than the carrying values of the reporting units and, as such, no further analysis was required.  For the year ended December&#160;31, 2020, in accordance with its policy to perform the quantitative test on a periodic basis, the Company updated the fair value calculation of its reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets are recognized at fair value, as an asset apart from goodwill if the asset (i) arises from contractual or other legal rights, or (ii) is separable.  Intangible assets, principally representing the cost of customer-related intangibles, non-competition agreements and technology acquired, are capitalized and amortized on the straight-line method over their expected useful lives, which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE5MTMy_22152b9e-6ae5-4ec5-ae0f-101ca8483d0a">five</span> to twenty years.  Intangible assets with indefinite useful lives, consisting principally of acquired tradenames, are not amortized, but instead are periodically reviewed for impairment.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company reviews indefinite-lived intangible assets periodically for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of an indefinite-lived intangible asset is more than its estimated fair value.  The indefinite-lived intangible asset impairment test is performed at least annually, or more frequently in the case of other events that indicate a potential impairment.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Based upon the Company&#8217;s most recent annual impairment tests completed during the fourth quarters of the years ended December&#160;31, 2021 and 2020, the Company concluded that indefinite-lived intangible assets were not impaired.</span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company reviews the recoverability of its long-lived assets (including amortizable intangible assets), other than goodwill and indefinite-lived intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.  Evaluation of possible impairment is based on the Company's ability to recover the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations.  If these cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's investments (except for those accounted for under the equity method of accounting) include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments with readily determinable fair values, including investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries (such investments, which previously did not have readily determinable fair values, became publicly-traded during the year ended December 31, 2021); as well as participant-directed investments of deferred employee compensation and related Company matching contributions held in trusts pursuant to the Company's supplemental deferred compensation plans (see Note 17).  These investments are measured at fair value with both realized and unrealized gains and losses recorded in current earnings within other income, net in the consolidated statements of operations.  For the years ended December&#160;31, 2021, 2020 and 2019, gains from all equity investments with readily determinable fair values totaled $56 million, $8 million, and $10 million, respectively.  The carrying values of these investments was $121 million at December 31, 2021, of which $44 million was included in prepaid expenses and other current assets and $77 million was included in other assets in the consolidated balance sheet.  The carrying values of these investments was $67 million at December 31, 2020, which was included in other assets in the consolidated balance sheet.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments that do not have readily determinable fair values, which consist of investments in preferred and common shares of privately held companies.  These investments are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  The Company regularly evaluates these equity investments to determine if there are any indicators that the investment is impaired; no impairment charges were recognized related to these investments for the years ended December&#160;31, 2021, 2020 and 2019.  The carrying value of these investments was $4 million and $25 million at December&#160;31, 2021 and 2020, respectively.  Such amounts were included in other assets in the consolidated balance sheet.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale debt securities of privately-held companies.  These investments are measured at fair value with unrealized gains and losses presented in other comprehensive income (loss).  The carrying amount of these investments was $1 million and $12 million at December&#160;31, 2021 and 2020, respectively.  Such amounts were included in other assets in the consolidated balance sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit risk-related contingent features or requirements to post collateral.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate debt instruments and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company accounts for these derivatives as either an asset or liability measured at its fair value.  The fair value is based upon model-derived valuations in which all significant inputs are observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.  For a derivative instrument that has been formally designated as a fair value hedge, fair value gains or losses on the derivative instrument along with offsetting fair value gains or losses on the hedged item that are attributable to the risk being hedged are reported in other income, net in the consolidated statements of operations.  For derivatives that have been formally designated as a cash flow hedge, the change in the fair value of the derivatives is recorded in accumulated other comprehensive loss.  Upon maturity or early termination of an effective interest rate swap agreement designated as a cash flow hedge, unrealized gains or losses are deferred in stockholders' equity, as a component of accumulated other comprehensive loss, and are amortized as an adjustment to interest expense over the period during which the hedged forecasted transaction affects earnings, which is when the Company recognizes interest expense on the hedged cash flows.  At inception and quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item.  After the initial quantitative assessment, this analysis is initially performed on a qualitative basis and, if it is determined that the hedging relationship was and continues to be highly effective, no further analysis is required.  All components of each derivative financial instrument's gain or loss are included in the assessment of hedge effectiveness.  If it is determined that a derivative ceases to be a highly effective hedge, the Company discontinues hedge accounting and any deferred gains or losses related to a discontinued cash flow hedge shall continue to be reported in accumulated other comprehensive loss, unless it is probable that the forecasted transaction will not occur.  If it is probable that the forecasted transaction will not occur by the originally specified time period, the Company discontinues hedge accounting and any deferred gains or losses reported in accumulated other comprehensive loss are classified into earnings immediately.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Comprehensive income (loss) encompasses all changes in stockholders' equity (except those arising from transactions with stockholders) and includes:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Notes 15 and 16); and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Advertising costs are expensed as incurred.  For the years ended December 31, 2021, 2020 and 2019, advertising costs were $78&#160;million, $38&#160;million and $18&#160;million, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards To Be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of </span></div>the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251572616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for greater than 95% of the Company&#8217;s consolidated net revenues for the years ended December&#160;31, 2021, 2020 and 2019 and are primarily comprised of a high volume of relatively low-dollar transactions.  The DIS business, which provides clinical testing services and other services, satisfies its performance obligation and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions, as discussed below. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.  Contracts with customers in the DIS business do not contain significant financing components based on the typical period of time between performance of services and collection of consideration.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The process for estimating revenues and the ultimate collection of accounts receivable involves significant judgment and estimation.  The Company follows a standard process, which considers historical denial and collection experience and other factors (including the period of time that the receivables have been outstanding), to estimate contractual allowances and implicit price concessions, recording adjustments in the current period as changes in estimates.  Further adjustments to the allowances, based on actual receipts, may be recorded upon settlement.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following are descriptions of the DIS business&#8217; portfolios:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Insurers </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from healthcare insurers are based on negotiated fee-for-service schedules and on capitated payment rates.  Under fee-for-service arrangements, healthcare insurers are billed at the Company's list price.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and the terms of the Company&#8217;s contractual arrangements. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Collection of the Company's net revenues from healthcare insurers is normally a function of providing complete and correct billing information to the healthcare insurers within the various filing deadlines and generally occurs within 30 to 60 days of billing.  Provided the Company has billed healthcare insurers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and if so, it will reserve accordingly for the billing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under capitated arrangements with healthcare insurers, the Company recognizes revenue based on a predetermined monthly reimbursement rate for each member of an insurer's health plan regardless of the number or cost of services provided by the Company.  Healthcare insurers typically reimburse the Company under capitated arrangements in the same month services are performed, essentially giving rise to no outstanding accounts receivable at the end of a reporting period.  If any capitated payments are not received on a timely basis, the Company determines the cause and makes a separate determination as to whether or not the collection of the amount from the healthcare insurer is at risk and, if so, would reserve accordingly.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Payers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from government payers are based on fee-for-service schedules set by governmental authorities, including traditional Medicare and Medicaid.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and other factors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Collection of the Company's net revenues from government payers is normally a function of providing the complete and correct billing information within the various filing deadlines and generally occurs within 30 days of billing.  Provided the Company has billed government payers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and, if so, it will reserve for the billing accordingly.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Client Payers </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Client payers include physicians, hospitals, ACOs, DCEs, IDNs, employers, other commercial laboratories and institutions for which services are performed on a wholesale basis, and are billed based on negotiated fee schedules.  Credit risk and ability to pay are more of a consideration for these payers than healthcare insurers and government payers.  Collection of consideration the Company expects to receive generally occurs within 60 to 90 days of billing.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company principally estimates the allowance for credit losses for client payers based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period of time that the receivables have been outstanding. To the extent that any individual client payers are identified that have deteriorated in credit quality, the Company establishes allowances based on the individual risk characteristics of such customers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patients</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Uninsured patients are billed based on established patient fee schedules or fees negotiated with physicians on behalf of their patients.  Insured patients (includes coinsurance and deductible responsibilities) are billed based on fees negotiated with healthcare insurers.  Collection of billings from patients is subject to credit risk and ability of the patients to pay.  Net revenues consist of amounts billed net of discounts provided to uninsured patients in accordance with the Company&#8217;s policies and implicit price concessions.  Implicit price concessions represent differences between amounts billed and the estimated consideration the Company expects to receive from patients, which considers historical collection experience (including the period of time that the receivables have been outstanding) and other factors including current market conditions. Patient billings are generally fully reserved for when the related service reaches 210 days outstanding.  Balances are automatically written off when they are sent to collection agencies.  Allowances are further adjusted for estimated recoveries of amounts sent to collection agencies based on historical collection experience, which is regularly monitored.  Collection of consideration the Company expects to receive generally occurs within 30 to 60 days of billing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered.  Collection of consideration the Company expects to receive generally occurs within 30 to 60 days of billing.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.702%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, substantially all of the Company&#8217;s services were provided within the United States, see Note 19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer as of December&#160;31, 2021 and 2020 was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:74.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the activity for the Company's allowance for credit losses during the years ended December&#160;31, 2021 and 2020, which principally relates to client payers:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for Credit Losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, January 1, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of accounts receivable, net of recoveries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of accounts receivable, net of recoveries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2021</span></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251698152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics' common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.85&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.55&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into ASRs with several financial institutions to repurchase $1.5&#160;billion of the Company's common stock as part of the Company's share repurchase program. See Note 16 for further details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251474072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS ACQUISITIONS</a></td>
<td class="text">BUSINESS ACQUISITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2021 Acquisitions</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company completed acquisitions for an aggregate purchase price of $336&#160;million, net of cash acquired, including the acquisitions discussed below.  The 2021 acquisitions resulted in goodwill of $228&#160;million, of which $223&#160;million is deductible for tax purposes.  These acquisitions also resulted in $104&#160;million of intangible assets, principally comprised of customer-related intangible assets.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the outreach laboratory services business of Mercy Health</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2021, the Company completed the acquisition of the outreach laboratory services business of Mercy Health ("Mercy Health"), which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $225&#160;million.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $54&#160;million of customer-related intangible assets and $171&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of 15 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of assets of Labtech Diagnostics, LLC ("Labtech")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2021, the Company completed the acquisition of assets of Labtech, an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South Carolina, North Carolina, Florida and Georgia, in an all cash transaction for $85&#160;million, which consisted of cash consideration of $80&#160;million and contingent consideration initially estimated at $5&#160;million. The contingent consideration arrangement is dependent upon the achievement of certain testing volume benchmarks.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $41&#160;million of intangible assets, $40&#160;million of goodwill (of which $35&#160;million is tax deductible), $11&#160;million of property, plant and equipment, $9&#160;million of finance lease liabilities, $6&#160;million of operating lease right-of-use assets, $6&#160;million of operating lease liabilities, and $2&#160;million of inventories. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of 15 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2020 Acquisitions</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company completed acquisitions for an aggregate purchase price of $330&#160;million, net of cash acquired, including the acquisitions discussed below.  The 2020 acquisitions resulted in goodwill of $247&#160;million, of which $210&#160;million is deductible for tax purposes.  These acquisitions also resulted in $146&#160;million of intangible assets, principally comprised of customer-related and technology intangible assets.  Net revenues attributable to the 2020 acquisitions were $127&#160;million for the year ended December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Blueprint Genetics Oy</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 21, 2020, the Company completed the acquisition of Blueprint Genetics Oy ("Blueprint Genetics"), in an all cash transaction for $108&#160;million, net of $3&#160;million cash acquired.  Blueprint Genetics is a leading specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing and proprietary bioinformatics.  Through the acquisition, the Company acquired all of Blueprint Genetics' operations.  Based on the purchase price allocation, the assets acquired and liabilities assumed primarily consist of $66&#160;million of tax-deductible goodwill, $43&#160;million of intangible assets, and $2&#160;million of property, plant and equipment and working capital.  The intangible assets primarily consist of technology and customer-related assets which are being amortized over a useful life of 10 years and 15 years, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Outreach Laboratory Services Business of Memorial Hermann Health System</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company completed the acquisition of select assets which constitute substantially all of the operations of Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System ("Memorial Hermann"), in an all cash transaction for $120&#160;million.  Memorial Hermann is a not-for-profit health system in Southeast Texas.  Based on the purchase price allocation, the assets acquired primarily consist of $27&#160;million of customer-related intangible assets and $93&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of 15 years.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Remaining 56% Interest in Mid America Clinical Laboratories, LLC</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On August 1, 2020, the Company completed the acquisition of the remaining 56% interest in Mid America Clinical Laboratories, LLC ("MACL") from its joint venture partners in an all cash transaction for $93&#160;million, net of $18&#160;million cash acquired.  MACL is the largest independent clinical laboratory provider in Indiana.  Prior to the acquisition, the Company accounted for its 44% interest in MACL as an equity method investment, which was remeasured to its fair value of $87&#160;million on the acquisition date, resulting in a gain of $70&#160;million that was recognized in other income, net in the consolidated statements of operations.  The fair value of the previously held equity interest was determined using a discounted cash flow analysis that took into account, among other items, MACL's expected future cash flows, long-term growth rate (1.5%), and a discount rate commensurate with economic risk (7.5%).  Based on the purchase price allocation, the assets acquired and liabilities assumed consist of $84&#160;million of goodwill (of which $47&#160;million is tax-deductible), $74&#160;million of intangible assets, $11&#160;million of working capital and $11&#160;million of property, plant and equipment.  The intangible assets consist of customer-related assets which are being amortized over a useful life of 15 years.  As a result of the acquisition, MACL became a wholly owned subsidiary of the Company.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2019 Acquisitions</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2019, the Company completed acquisitions for an aggregate purchase price of $63 million, including the acquisition discussed below.  The 2019 acquisitions resulted in goodwill of $43 million, of which $36 million is deductible for tax purposes.  These acquisitions also resulted in $21 million of intangible assets, principally comprised of customer-related intangible assets. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Clinical Laboratory Services Business of Boyce &amp; Bynum Pathology Laboratories, P.C.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On February 11, 2019, the Company completed the acquisition of certain assets of the clinical laboratory services business of Boyce &amp; Bynum Pathology Laboratories, P.C. in an all cash transaction for $61 million, which consisted of cash consideration of $55 million and contingent consideration initially estimated at $6 million.  The contingent consideration arrangement was dependent upon the achievement of certain testing volume benchmarks.  During 2019, the liability was reduced to $0 as a result of updated testing volume forecasts for the earn-out period compared to the testing volume target included in the contingent consideration arrangement, resulting in a $6 million gain recorded in other operating (income) expense, net.  Based on the purchase price allocation, the assets acquired principally consist of $41 million of goodwill (of which $35 million is tax deductible) and $20 million of customer-related intangible assets.  The intangible assets are being amortized over a useful life of 15 years.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;General Information</span></div>&#160;&#160;&#160;&#160;The acquisitions described above were accounted for under the acquisition method of accounting.  As such, the assets acquired and liabilities assumed are recorded based on their estimated fair values as of the closing date.  Supplemental pro forma combined financial information has not been presented as the impact of the acquisitions is not material to the Company's consolidated financial statements.  The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entities with those of the Company and the value associated with an&#160;assembled workforce and other intangible assets that do not qualify for separate recognition.  All of the goodwill acquired in connection with these acquisitions has been allocated to the Company's DIS business.  For further details regarding business segment information, see Note 19.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251584376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISPOSITION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DISPOSITION</a></td>
<td class="text">DISPOSITION&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q2 Solutions&#174; ("Q2 Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner, for $760&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the year ended December&#160;31, 2021, the Company recorded a $314&#160;million pre-tax gain in other income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the year ended December&#160;31, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span>DISCONTINUED OPERATIONS&#160;&#160;&#160;&#160;Discontinued operations, net of taxes, for the year ended December 31, 2019 includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.  In addition, net cash provided by operating activities in the consolidated statement of cash flows for the year ended December 31, 2019 included a $28 million refund from the taxing authorities related to discontinued operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251537416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries. Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  During the year ended December 31, 2021, certain of the Company's equity investments became publicly traded. Such equity investments are now classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the acquisition of Labtech (see Note 5), the Company has a contingent consideration obligation of up to $20&#160;million that is to be paid based on the achievement of certain testing volume benchmarks.  As of December&#160;31, 2021, the fair value of the contingent consideration liability totaled $5 million, which was measured at fair value using an option-pricing method and classified within Level 3 of the fair value hierarchy as the fair value was determined based on significant inputs that are not observable.  Significant inputs include management&#8217;s estimate of volume and other market inputs, including comparable company revenue volatility (7.5%) and a discount rate (2.5%).</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.912%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value adjustments included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The $1 million net gain included in earnings associated with the changes in the fair value of contingent consideration for the year ended December&#160;31, 2020 is reported in other operating (income) expense, net.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of December&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long-term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, the Company recorded an $8&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of December&#160;31, 2021 and 2020, the fair value of the Company&#8217;s debt was estimated at $4.4 billion and $4.6 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251568424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text">TAXES ON INCOME<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's pre-tax income from continuing operations before equity in earnings of equity method investees consisted of approximately 2.5 billion, $1.9 billion and $1.1 billion from U.S. operations and pre-tax income (loss) of $148 million, $(7) million and $15 million from foreign operations for the years ended December&#160;31, 2021, 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;Pre-tax income from continuing operations before equity in earnings of equity method investees for U.S. and foreign operations include pre-tax gains of $171&#160;million and $143&#160;million, respectively, from the sale of the Company's 40% ownership interest in Q2 Solutions.  During the year ended December&#160;31, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The components of income tax expense (benefit) for 2021, 2020 and 2019 were as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:42.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A reconciliation of the federal statutory income tax rate to the Company's effective income tax rate for 2021, 2020 and 2019 was as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at statutory rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on stock-based compensation arrangements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision true-ups </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of equity earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in reserves for uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowances associated with certain net operating losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December 31, 2019, the Company recognized a $12 million net income tax benefit due to the release of valuation allowances associated with certain net operating loss carryforwards.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) as of December&#160;31, 2021 and 2020 were as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current deferred tax assets (liabilities):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable reserves</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities not currently deductible</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis differences in investments, joint ventures and subsidiaries </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards, net of valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(604)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current deferred tax liabilities, net</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021 and 2020, non-current deferred tax liabilities of $290 million and $350 million, respectively, are included in other liabilities in the consolidated balance sheet. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, the Company had estimated net operating loss carryforwards for federal and state income tax purposes of $31 million and $676 million, respectively, which expire at various dates through 2041.  Estimated net operating loss carryforwards for foreign income tax purposes are $70 million as of December&#160;31, 2021, some of which can be carried forward indefinitely while others expire at various dates through 2041.  As of December&#160;31, 2021 and 2020, deferred tax assets associated with net operating loss carryforwards of $71 million and $94 million, respectively, have each been reduced by valuation allowances of $29 million and $33 million, respectively.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income taxes payable, including those classified as long-term in other liabilities in the consolidated balance sheet as of December&#160;31, 2021 and 2020, were $106 million and $135 million, respectively.  Prepaid income taxes were $36 million and $2 million as of December&#160;31, 2021 and 2020, respectively, and were recorded in prepaid expenses and other current assets in the consolidated balance sheet. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total amount of unrecognized tax benefits as of and for the years ended December&#160;31, 2021, 2020 and 2019 consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in judgment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expirations of statutes of limitations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The contingent liabilities for tax positions primarily relate to uncertainties associated with the realization of tax benefits derived from the allocation of income and expense among state jurisdictions, the characterization and timing of certain tax deductions associated with business combinations, certain tax credits and the deductibility of certain expenses and settlement payments.   </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total amount of unrecognized tax benefits as of December&#160;31, 2021, that, if recognized, would affect the effective income tax rate is $90 million.  Based upon the expiration of statutes of limitations, settlements and/or the conclusion of tax examinations, the Company believes it is reasonably possible that the total amount of unrecognized tax benefits may decrease by up to $15 million within the next twelve months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accruals for interest expense on contingent tax liabilities are classified in income tax expense in the consolidated statements of operations.  Accruals for penalties have historically been immaterial.  Interest (income) expense included in income tax expense in each of the years ended December&#160;31, 2021, 2020 and 2019 was approximately $(2) million, $6 million and $5 million, respectively.  As of December&#160;31, 2021 and 2020, the Company had approximately $20 million and $21 million, respectively, accrued, net of the benefit of a federal and state deduction, for the payment of interest on uncertain tax positions.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The recognition and measurement of certain tax benefits includes estimates and judgment by management and inherently involves subjectivity.  Changes in estimates may create volatility in the Company's effective tax rate in future periods and may be due to settlements with various tax authorities (either favorable or unfavorable), the expiration of the statute of limitations on certain tax positions and obtaining new information about particular tax positions that may cause management to change its estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the regular course of business, various federal, state, local and foreign tax authorities conduct examinations of the Company's income tax filings and the Company generally remains subject to examination until the statute of limitations expires for the respective jurisdiction.  The Internal Revenue Service has either completed its examinations of the Company's consolidated federal income tax returns or the statute of limitations has expired up through and including the 2016 tax year.  At this time, the Company does not believe that there will be any material additional payments beyond its recorded contingent liability reserves that may be required as a result of these tax audits.  As of December&#160;31, 2021, a summary of the tax years that remain subject to examination, awaiting approval, are under appeal, or are otherwise unresolved for the Company's major jurisdictions are:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;United States - federal&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2017 - 2020 </span></div>&#160;&#160;&#160;&#160;United States - various states&#160;&#160;&#160;&#160;2002 - 2020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251593816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW AND OTHER DATA<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW AND OTHER DATA</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW AND OTHER DATA <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the years ended December&#160;31, 2021, 2020 and 2019 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with purchases of treasury stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends received from equity method investees</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251567304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY, PLANT AND EQUIPMENT</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Property, plant and equipment as of December&#160;31, 2021 and 2020 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment and furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software developed or obtained for internal use</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,795&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,619&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,088)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,992)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December 31, 2019, the Company recognized a $73&#160;million gain in other operating (income) expense, net on the sale and leaseback of a property.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251483496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in goodwill for the years ended December&#160;31, 2021 and 2020 were as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of December&#160;31, 2021 and 2020 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, goodwill acquired during the period was principally associated with the acquisitions of the assets of Mercy Health and assets of Labtech (see Note 5). For the year ended December&#160;31, 2021, adjustments to goodwill related to foreign currency translation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, goodwill acquired during the period was principally associated with the acquisitions of Blueprint Genetics, assets of Memorial Hermann and MACL (see Note 5). For the year ended December&#160;31, 2020, adjustments to goodwill related to foreign currency translation. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets as of December&#160;31, 2021 and 2020 consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.436%"/><td style="width:0.1%"/></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December&#160;31, 2021 is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.959%"><tr><td style="width:1.0%"/><td style="width:71.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251973896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</a></td>
<td class="text">ACCOUNTS PAYABLE AND ACCRUED EXPENSES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accounts payable and accrued expenses as of December&#160;31, 2021 and 2020 consisted of the following: </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages and benefits (including incentive compensation)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overdrafts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251606552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Long-term debt (including finance lease obligations) as of December&#160;31, 2021 and 2020 consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:77.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25% Senior Notes due April 2024</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50% Senior Notes due March 2025</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.45% Senior Notes due June 2026</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20% Senior Notes due June 2029</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% Senior Notes due June 2030</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80% Senior Notes due June 2031</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95% Senior Notes due July 2037</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75% Senior Notes due January 2040</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% Senior Notes due March 2045</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,010&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Secured Receivables Credit Facility </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During October 2021, the Company amended its $600&#160;million secured receivables credit facility (the &#8220;Secured Receivables Credit Facility&#8221;), previously amended in October 2020, to extend the maturity dates for each underlying commitment by one year, while maintaining the borrowing capacity under the facility at $600&#160;million.  Under the Secured Receivables Credit Facility, the Company can borrow against a $250&#160;million loan commitment maturing October 2022 and a $250&#160;million loan commitment maturing October 2023, and can issue up to $100&#160;million of letters of credit (see Note 18) through October 2023.  Borrowings under the Secured Receivables Credit Facility are collateralized by certain domestic receivables.  As of December&#160;31, 2021, interest on the borrowings under the Secured Receivables Credit Facility was based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.725% to 0.80%.  The Secured Receivables Credit Facility is subject to customary affirmative and negative covenants and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility.  As of both December&#160;31, 2021 and 2020, there were no outstanding borrowings under the Secured Receivables Credit Facility. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Unsecured Revolving Credit Facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During November 2021, the Company amended and restated the agreement for its $750&#160;million senior unsecured revolving credit facility (the &#8220;Credit Facility&#8221; or "Senior Unsecured Revolving Credit Facility") to extend the maturity date to November 2026 while maintaining the borrowing capacity under the facility at $750&#160;million.  Under the Credit Facility, the Company can issue letters of credit totaling $150&#160;million (see Note 18).  Issued letters of credit reduce the available borrowing capacity under the Credit Facility.  Interest on the Credit Facility is based on certain published rates plus an applicable margin based on changes in the Company's public debt ratings.  At the option of the Company, it may elect to lock into LIBOR-based interest rates for periods up to six months.  Interest on any outstanding amounts not covered under LIBOR-based interest rate contracts is based on an alternate base rate, which is calculated by reference to the prime rate, the federal funds rate or an adjusted LIBOR rate.  As of December&#160;31, 2021, the Company's borrowing rate for LIBOR-based loans under the Credit Facility was LIBOR plus 1.00%.  The Credit Facility contains various covenants, including the maintenance of a financial leverage ratio, which could impact the Company's ability to, among other things, incur additional indebtedness.  As of both December&#160;31, 2021 and 2020, there were no outstanding borrowings under the Senior Unsecured Revolving Credit Facility.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes Offerings</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company completed a senior notes offering, consisting of $550&#160;million aggregate principal amount of 2.80% senior notes due June 2031 (the &#8220;2031 Senior Notes&#8221;), which were issued at an original issue discount of $1&#160;million.  The Company incurred $5&#160;million of debt issuance costs associated with the 2031 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During November 2020, the net proceeds from the 2031 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under the Company's senior notes due April 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During January 2020, the Company redeemed in full the outstanding indebtedness under the Company's senior notes due January 2020 and senior notes due March 2020, using the net proceeds from the issuance, in December 2019, of the senior notes due June 2030.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, the Company recorded a loss on retirement of debt, principally comprised of premiums paid, of $9&#160;million in other income, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All of the senior notes are unsecured obligations of the Company and rank equally with the Company's other senior unsecured obligations.  None of the Company's senior notes have a sinking fund requirement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may redeem its outstanding senior notes prior to scheduled maturity, as a whole or in part, at a redemption price equal to the present value of the remaining scheduled payments of principal and interest, except for certain notes for which the Company also has an option to redeem such instruments at par value on or after dates specified in the indentures governing the notes ("the par value redemption option"). &#160;For notes with the par value redemption option, if such notes are redeemed prior to the specified dates, the redemption price calculations exclude any interest that would have been due after such dates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturities of Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, long-term debt matures as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:297.00pt"><tr><td style="width:1.0pt"/><td style="width:235.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total maturities of long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,009&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value basis adjustments attributable to hedged debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,010&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060255080904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_50c95c33-a401-4066-8573-e62f6ca75cd3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_6f7e233a-96d4-4732-aa53-9f719523830d">right-of-use asset</span></span>, representing the underlying asset during the lease term, and a lease <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_1997e471-5c97-4a99-87d8-0ad010e8dfa3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_2b9b9016-510b-480e-96bb-962223d0e820">liability</span></span>, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_375a58c6-c5ec-4296-b7ed-b111e088fff7"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_b44b257f-98c9-4e44-912d-5c75a894370c">liability</span></span> is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.  For the years ended December&#160;31, 2021, 2020, and 2019, lease expense associated with short-term leases was not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company primarily uses its collateralized incremental borrowing rate in determining the present value of lease payments as the Company's leases generally do not provide an implicit rate.  Such incremental borrowing rates, which take into account interest rates offered to companies that have similar credit ratings to the Company, are determined using a portfolio approach which groups the Company&#8217;s leases based on tenor.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has lease agreements with (i) right-of-use asset payments and (ii) non-lease components (i.e., payments related to maintenance fees, utilities, etc.) which have been combined and accounted for as a single lease component. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's leases have remaining terms of less than 1 year to 15 years, some of which include options to extend the leases for up to 15 years. The Company's lease terms may include renewal options that are reasonably certain to be exercised and termination options that are reasonably certain not to be exercised. Certain leases also include options to purchase the leased property.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain of the Company's lease agreements include rental payments adjusted periodically for inflation or a market rate which are included in the lease liabilities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's assets and liabilities for its lease agreements as of December&#160;31, 2021 and 2020 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:21.634%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.571%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.573%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_0ffa204f-63da-4cb5-97eb-2b95e023c547"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_47976c32-56f0-4b24-a8fa-f838f8d5f156">Long-term debt</span></span></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Finance lease assets as of December&#160;31, 2021 and 2020 were recorded net of accumulated amortization of $8&#160;million and $14&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Components of lease cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.75pt"><tr><td style="width:1.0pt"/><td style="width:247.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $140 million, $120&#160;million and $120&#160;million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The maturity of the Company's lease liabilities as of December&#160;31, 2021 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:365.25pt"><tr><td style="width:1.0pt"/><td style="width:163.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Lease term and discount rate as of December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:363.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's discount rates for its operating leases were primarily determined using the Company's incremental borrowing rate.  The Company's weighted-average discount rate for its finance leases principally reflects the implicit interest rate on a lease obligation assumed in a business combination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 9 for cash flow information on cash paid for amounts included in the measurement of lease liabilities, leased assets obtained in exchange for new operating lease liabilities, and leased assets obtained in exchange for new finance lease liabilities for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_50c95c33-a401-4066-8573-e62f6ca75cd3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_6f7e233a-96d4-4732-aa53-9f719523830d">right-of-use asset</span></span>, representing the underlying asset during the lease term, and a lease <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_1997e471-5c97-4a99-87d8-0ad010e8dfa3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_2b9b9016-510b-480e-96bb-962223d0e820">liability</span></span>, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_375a58c6-c5ec-4296-b7ed-b111e088fff7"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_b44b257f-98c9-4e44-912d-5c75a894370c">liability</span></span> is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.  For the years ended December&#160;31, 2021, 2020, and 2019, lease expense associated with short-term leases was not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company primarily uses its collateralized incremental borrowing rate in determining the present value of lease payments as the Company's leases generally do not provide an implicit rate.  Such incremental borrowing rates, which take into account interest rates offered to companies that have similar credit ratings to the Company, are determined using a portfolio approach which groups the Company&#8217;s leases based on tenor.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has lease agreements with (i) right-of-use asset payments and (ii) non-lease components (i.e., payments related to maintenance fees, utilities, etc.) which have been combined and accounted for as a single lease component. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's leases have remaining terms of less than 1 year to 15 years, some of which include options to extend the leases for up to 15 years. The Company's lease terms may include renewal options that are reasonably certain to be exercised and termination options that are reasonably certain not to be exercised. Certain leases also include options to purchase the leased property.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain of the Company's lease agreements include rental payments adjusted periodically for inflation or a market rate which are included in the lease liabilities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's assets and liabilities for its lease agreements as of December&#160;31, 2021 and 2020 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:21.634%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.571%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.573%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_0ffa204f-63da-4cb5-97eb-2b95e023c547"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_47976c32-56f0-4b24-a8fa-f838f8d5f156">Long-term debt</span></span></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Finance lease assets as of December&#160;31, 2021 and 2020 were recorded net of accumulated amortization of $8&#160;million and $14&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Components of lease cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.75pt"><tr><td style="width:1.0pt"/><td style="width:247.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $140 million, $120&#160;million and $120&#160;million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The maturity of the Company's lease liabilities as of December&#160;31, 2021 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:365.25pt"><tr><td style="width:1.0pt"/><td style="width:163.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Lease term and discount rate as of December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:363.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's discount rates for its operating leases were primarily determined using the Company's incremental borrowing rate.  The Company's weighted-average discount rate for its finance leases principally reflects the implicit interest rate on a lease obligation assumed in a business combination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 9 for cash flow information on cash paid for amounts included in the measurement of lease liabilities, leased assets obtained in exchange for new operating lease liabilities, and leased assets obtained in exchange for new finance lease liabilities for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251956344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS &#160;&#160;&#160;&#160;<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt. All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021 and 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both December&#160;31, 2021 and 2020, the entire balance is associated with remaining unamortized hedging adjustments on discounted relationships. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the years ended December&#160;31, 2021, 2020 and 2019, respectively:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251984472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Series Preferred Stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics is authorized to issue up to 10 million shares of Series Preferred Stock, par value $1.00 per share.  The Company's Board of Directors has the authority to issue such shares without stockholder approval and to determine the designations, preferences, rights and restrictions of such shares.  No shares are currently outstanding.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the Company's Restated Certificate of Incorporation the number of authorized shares of common stock, par value $0.01 per share, is 600 million shares.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Changes in Accumulated Other Comprehensive Loss by Component</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Comprehensive income (loss) includes:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 15); and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020, and 2019, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in accumulated other comprehensive loss by component for 2021, 2020 and 2019 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Changes in Available-for-Sale Debt Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Losses on Cash Flow Hedges, net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, its clinical trials central laboratory services joint venture, to IQVIA, its joint venture partner.  As a result of the transaction, during the year ended December&#160;31, 2021, $20&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other income, net.  See Note 6 for further details. &#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Additionally, for the year ended December 31, 2020, $3&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other operating (income) expense, net as a result of the sale of foreign subsidiaries.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, the gross deferred losses on cash flow hedges were reclassified from accumulated other comprehensive loss to interest expense, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the four quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.56 per common share.  During each of the four quarters of 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.53 per common share.  On February&#160;3, 2022, the Company announced that its Board of Directors authorized a 6.5% increase in its quarterly cash dividend from $0.62 to $0.66 per share, or $2.64 per share annually, commencing with the dividend payable in April 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February 2021 and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion.  As of December&#160;31, 2021, $0.7 billion remained available under the Company&#8217;s share repurchase authorization.  In February 2022, the Company's Board of Directors authorized the Company to repurchase an additional $1&#160;billion of the Company's common stock.  The share repurchase authorization has no set expiration or termination date.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, the Company repurchased 16.0 million shares of its common stock for $2.2 billion, including shares repurchased under ASRs.  The repurchases during the year included an accrual of $23 million recorded in accounts payable and accrued expenses in the consolidated balance sheet for share repurchases not settled until after December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase its common stock as part of a share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount, and was accounted for as two transactions: (1) a treasury stock repurchase and (2) a forward contract.  During the year ended December&#160;31, 2021, the Company paid $1.5&#160;billion to the financial institutions and received 10.7&#160;million shares of its common stock under the ASRs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, the Company repurchased 2.7 million shares of its common stock for $325 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, the Company repurchased 3.5 million shares of its common stock for $350 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Shares Reissued from Treasury Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, the Company reissued 2 million shares, 3 million shares and 2 million shares, respectively, from treasury stock for shares issued under the Employee Stock Purchase Plan ("ESPP") and stock-based compensation program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Treasury Stock Retirement &#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, the Company retired 55&#160;million shares of treasury stock.  In accordance with the Company's policy, the amount paid to repurchase the shares in excess of par value was allocated between retained earnings and additional paid-in capital based on a pro-rata allocation of additional paid-in capital at the time of the share retirement.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interest</span>&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  The Company records changes in the fair value of the noncontrolling interest immediately as they occur.  As of December&#160;31, 2021 and 2020, the redeemable noncontrolling interest was $79 million and $82 million, respectively, and was presented at its fair value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251551944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK OWNERSHIP AND COMPENSATION PLANS</a></td>
<td class="text">STOCK OWNERSHIP AND COMPENSATION PLANS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee and Non-employee Directors Stock Ownership Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;The ELTIP provides for three types of awards: (a) stock options, (b) stock appreciation rights and (c) stock awards.  The ELTIP provides for the grant to eligible employees of either non-qualified or incentive stock options, or both, to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Grants of stock appreciation rights allow eligible employees to receive a payment based on the appreciation of Company common stock in cash, shares of Company common stock or a combination thereof.  The stock appreciation rights are granted at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Stock options and stock appreciation rights granted under the ELTIP expire on the date designated by the Board of Directors but in no event more than ten years from date of grant.  No stock appreciation rights have been granted under the ELTIP.  Under the ELTIP, awards are subject to forfeiture if employment terminates prior to the end of the vesting period prescribed by the Board of Directors.  For all award types, the vesting period is generally over three years from the date of grant.  For performance share units, the actual amount of shares earned is based on the achievement of the performance goals specified in the awards.  The performance goals for awards granted for 2019 were based on the financial performance of the Company.  The performance goals for awards granted in 2020 and 2021 were based on the financial performance of the Company, as well as relative TSR.  The maximum number of shares of Company common stock in respect of which awards may be granted under the ELTIP is approximately 79 million shares.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The DLTIP provides for the grant to non-employee directors of non-qualified stock options to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  The DLTIP also permits awards of restricted stock and restricted stock units to non-employee directors.  Stock options granted under the DLTIP expire on the date designated by the Board of Directors but in no event more than ten years from date of grant.  For all award types, the vesting period is generally over three years from the date of grant, regardless of whether the award recipient remains a director of the Company.  The maximum number of shares that may be issued under the DLTIP is 2.4 million shares.  For the years ended December&#160;31, 2021, 2020 and 2019, grants under the DLTIP totaled 12 thousand shares, 14 thousand shares and 14 thousand shares, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  See Note 16 for further information regarding the Company's share repurchase program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of each stock option award granted was estimated on the date of grant using a Black-Scholes option-valuation model.  The expected volatility under the Black-Scholes option-valuation model was based on historical volatilities of the Company's common stock.  The dividend yield was based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the expected holding period of the related award.  The expected holding period was estimated using the historical stock option exercise behavior of employees. The Black-Scholes option-valuation model also incorporates the average market price of the Company's common stock at the date of grant.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The weighted average assumptions used in valuing stock options granted in the periods presented were:  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.219%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.82</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected holding period, in years</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following summarizes the activity relative to stock option awards for 2021: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited and canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, end of year</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.44&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company's closing common stock price on the last trading day of 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December&#160;31, 2021.  This amount changes based on the fair market value of the Company's common stock.  Total intrinsic value of options exercised in 2021, 2020 and 2019 was $83 million, $113 million and $62 million, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, there was $7 million of unrecognized stock-based compensation cost related to nonvested stock options which is expected to be recognized over a weighted average period of 1.6 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of restricted stock awards and restricted stock units is the average market price of the Company's common stock at the date of grant.  For performance share units with a goal based on the financial performance of the Company, the fair value is based on the average market price of the Company's common stock at the date of grant, adjusted for the present value of dividends expected to be paid on the Company's common stock during the vesting period.  For performance share units with a market-based relative TSR goal, the fair value is estimated on the date of grant using a Monte Carlo valuation model.  The expected volatility under the Monte Carlo valuation model is based on the historical volatility of the common stock of the Company and the common stock of the companies in the peer index.  The dividend yield is based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the performance period of the related award. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The weighted average assumptions used in valuing performance share units with a market-based relative TSR goal in the periods presented were:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.353%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.382%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$150.15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$144.03</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following summarizes the activity relative to stock awards, including restricted stock units and performance share units, for 2021, 2020 and 2019: </span></div><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center;text-indent:31.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.478%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares forfeited and canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of year</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.46&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.12&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.30&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, there was $27 million of unrecognized stock-based compensation cost related to nonvested stock awards, which is expected to be recognized over a weighted average period of 1.5 years.  Total fair value of shares vested was $59 million, $37 million and $40 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.  For performance share units with a goal based on financial performance of the Company, the amount of unrecognized stock-based compensation cost is subject to change based on changes, if any, to management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned at the end of the performance periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, stock-based compensation expense totaled $79 million, $97 million and $56 million, respectively.  Income tax benefits recognized in the consolidated statements of operations related to stock-based compensation expense totaled $32 million, $39 million and $27 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively, which includes excess tax benefits associated with stock-based compensation arrangements of $19 million, $23 million and $13 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the Company's ESPP, substantially all employees can elect to have up to 10% of their annual wages withheld to purchase Quest Diagnostics common stock.  The purchase price of the stock is 95% of the market price of the Company's common stock on the last business day of each calendar month.  Under the ESPP, the maximum number of shares of Quest Diagnostics common stock which may be purchased by eligible employees is 9 million.  Approximately 200 thousand shares, 225 thousand shares and 269 thousand shares of common stock were purchased by eligible employees in 2021, 2020 and 2019, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company maintains qualified defined contribution plans covering substantially all of its employees.  The maximum Company matching contribution is 5% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions for certain qualified defined contribution plans; matching contributions were reinstated in the third quarter of 2020.  The Company's expense for contributions to its defined contribution plans aggregated $93 million, $64 million and $84 million for 2021, 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Deferred Compensation Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has a supplemental deferred compensation plan that is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to 50% of their salary in excess of their defined contribution plan limits and for certain eligible employees, up to 95% of their variable incentive compensation.  The maximum Company matching contribution is 5% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions; matching contributions were reinstated in the third quarter of 2020.  The compensation deferred under this plan, together with Company matching amounts, are credited with earnings or losses measured by the mirrored rate of return on investments elected by plan participants.  Each plan participant is fully vested in all deferred compensation, Company match and earnings credited to their account.  The amounts accrued under the Company's deferred compensation plans were $77 million and $67 million as of December&#160;31, 2021 and 2020, respectively.  Although the Company is currently contributing all participant deferrals and matching amounts to a trust, the funds in this trust, totaling $77 million and $67 million as of December&#160;31, 2021 and 2020, respectively, are general assets of the Company and are subject to any claims of the Company's creditors. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company also offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  The Company matches employee contributions equal to 25%, up to a maximum of $5 thousand per plan year.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  Each participant is fully vested in their deferred compensation and vests in Company matching contributions over a period of four years at 25% per year.  This plan was amended effective January 1, 2018 so that future deferrals under the plan may only be made by participants who made deferrals under the plan in 2017.  The amounts accrued under this plan were $66 million and $59 million as of December&#160;31, 2021 and 2020, respectively.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  The cash surrender value of such life insurance policies was $57 million and $50 million as of December&#160;31, 2021 and 2020, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  For each of the years ended December&#160;31, 2021, 2020 and 2019, the Company's expense for matching contributions to these plans was not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251501672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit and Contractual Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit under its Secured Receivables Credit Facility and Senior Unsecured Revolving Credit Facility (see Note 13).  In support of its risk management program, to ensure the Company&#8217;s performance or payment to third parties, $70 million in letters of credit under the Secured Receivables Credit Facility were outstanding as of December&#160;31, 2021.  The letters of credit primarily represent collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has certain noncancelable commitments, primarily under take-or-pay arrangements, to purchase products or services from various suppliers, mainly for consulting and other service agreements, and standing orders to purchase reagents and other laboratory supplies.  As of December&#160;31, 2021, the approximate total future purchase commitments are $252 million, of which $53 million are expected to be incurred in 2022, $87 million are expected to be incurred in 2023 through 2024 and the balance thereafter. </span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Billing and Collection Agreement</span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In September 2016, the Company entered into a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzExMzc_708f737c-5f7e-406e-a9c5-dbbc99a6dcd3">ten</span>-year agreement with a third party to outsource its billing and  related operations for the majority of the Company&#8217;s revenues.  Services under the agreement commenced during the fourth quarter of 2016.  The agreement includes an annual fee, which is subject to adjustment based on certain changes in the Company's requisition volume and the achievement of various performance metrics.</span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases, including real estate leases that were entered into by certain predecessor companies of a subsidiary prior to the Company's acquisition of the subsidiary.  While over the course of many years, the title to certain properties and interest in the subject leases have been transferred to third parties and the subject leases have been amended several times by such third parties, the lessors have not formally released the subsidiary predecessor companies from their original obligations under the leases and therefore remain contingently liable in the event of default.  The remaining terms of the lease obligations and the Company's corresponding indemnifications range up to 26 years.  The lease payments under certain leases are subject to market value adjustments and contingent rental payments and therefore, the total contingent obligations under the leases cannot be precisely determined but are likely to total several hundred million dollars.  A claim against the Company would be made only upon the current lessee's default and, in certain cases, after a series of claims and corresponding defaults by third parties that precede the Company in the order of liability.  The Company also has certain indemnification rights from other parties to recover losses in the event of default on the lease obligations.  The Company believes that the likelihood of its performance under these contingent obligations is remote and no liability has been recorded for any potential payments under the contingent lease obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of the government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of December&#160;31, 2021, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $4 million and $1&#160;million as of December&#160;31, 2021 and December&#160;31, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $159 million and $138 million as of December&#160;31, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251568984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENT INFORMATION</a></td>
<td class="text">BUSINESS SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs, and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2021, 2020 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2021, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table is a summary of segment information for the years ended December&#160;31, 2021, 2020 and 2019. Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangibles assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,788&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,646&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations before income taxes and equity in earnings of equity method investees</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,080&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,080&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Depreciation and amortization expense for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Capital expenditures for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service for the years ended December&#160;31, 2021, 2020 and 2019 were as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,293&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,788&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251715576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DISCONTINUED OPERATIONS</a></td>
<td class="text">DISPOSITION&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q2 Solutions&#174; ("Q2 Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner, for $760&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the year ended December&#160;31, 2021, the Company recorded a $314&#160;million pre-tax gain in other income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the year ended December&#160;31, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span>DISCONTINUED OPERATIONS&#160;&#160;&#160;&#160;Discontinued operations, net of taxes, for the year ended December 31, 2019 includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.  In addition, net cash provided by operating activities in the consolidated statement of cash flows for the year ended December 31, 2019 included a $28 million refund from the taxing authorities related to discontinued operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251478504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition of Pack Health, LLC</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On February 1, 2022, the Company acquired Pack Health, LLC ("Pack Health"), a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $105&#160;million with up to $20&#160;million of contingent consideration if certain revenue benchmarks are achieved. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preliminary purchase price allocation for the acquisition, which will be accounted for as a business combination, is not provided as the appraisal necessary to assess the fair values of assets acquired and liabilities assumed is not yet complete, but a significant portion of the purchase price is expected to be allocated to intangible assets and goodwill.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251555992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation Accounts and Reserves<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II - VALUATION ACCOUNTS AND RESERVES</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II - VALUATION ACCOUNTS AND RESERVES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:51.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Provision for Credit Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deductions<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>End of Year</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts and allowances</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a)Primarily represents the write-off of accounts receivable, net of recoveries.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243625592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Principles of Consolidation and Basis of Presentation</a></td>
<td class="text">The consolidated financial statements include the accounts of all entities controlled by the Company through its direct or indirect ownership of a majority voting interest.  Additionally, the consolidated financial statements include the accounts of variable interest entities (&#8220;VIEs&#8221;) in which the Company has a variable interest and for which the Company is the &#8220;primary beneficiary&#8221; as it has both: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.  All significant intercompany accounts and transactions are eliminated in consolidation.&#160;&#160;&#160;&#160;Income attributable to the minority interest in the Company's majority owned and controlled consolidated subsidiaries is recorded as net income attributable to noncontrolling interests in the consolidated statements of operations and the noncontrolling interest is reflected as a separate component of consolidated stockholders' equity in the consolidated balance sheet.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  The accompanying consolidated statements of operations and related disclosures report the results of NID as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  See Note 20 for a further discussion of discontinued operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text">Investments in entities which the Company does not control, but in which it has a substantial ownership interest (generally between 20% and 49%) and can exercise significant influence, are accounted for using the equity method of accounting.  These investments are classified as investments in equity method investees in the consolidated balance sheet.  The Company records its pro rata share of the earnings, adjusted for accretion of basis difference, of these investments in equity in earnings of equity method investees, net of taxes in the consolidated statements of operations.  The Company reviews its investments in equity method investees for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">The Company recognizes as revenue the amount that reflects the consideration to which it expects to be entitled in exchange for goods sold or services rendered primarily upon completion of the testing process (when results are reported) or when services have been rendered (see Note 3).  Net revenues from Medicare and Medicaid programs were approximately 10%, 11% and 15% of the Company's consolidated net revenues for the years ended December&#160;31, 2021, 2020 and 2019, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Taxes on Income</a></td>
<td class="text">The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year.  Current and deferred income taxes are measured based on the tax laws that are enacted as of the balance sheet date of the relevant reporting period.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.  Tax benefits from uncertain tax positions are recognized only if the tax position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan (&#8220;ELTIP&#8221;) and its Amended and Restated Non-Employee Director Long-Term Incentive Plan (&#8220;DLTIP&#8221;), as well as the dilutive effect of accelerated share repurchase agreements ("ASRs"), if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards.  As such, the Company recognizes stock-based compensation cost<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants.  The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.  The terms of the Company's performance share units allow the recipients of such awards to earn a variable number of shares based on the achievement of the performance goals, which are based on the financial performance of the Company and the total shareholder return of the Company relative to an index of peer companies ("relative TSR"), specified in the awards.  For performance share units with a goal based on the financial performance of the Company, stock-based compensation expense is recognized based on management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned.  The cumulative effect on current and prior periods of a change in the estimated number of performance share units expected to be earned for these awards is recognized as compensation cost in earnings in the period of the change.  For performance share units with a market-based relative TSR goal, stock-based compensation expense is recognized based on the estimated fair value of the award regardless of the actual number of shares earned.  For further details regarding stock-based compensation, see Note&#160;17.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market.<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy.  The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text">The Company predominately uses the U.S. dollar as its functional currency.  The functional currency of the Company's foreign operating subsidiaries generally is the applicable local currency.  Assets and liabilities denominated in non-U.S. dollars are translated into U.S. dollars at exchange rates as of the end of the reporting period.  Income and expense items are translated at the average monthly exchange rates during the year.  Resulting translation adjustments are recorded as a component of accumulated other comprehensive loss within stockholders' equity.  Gains and losses from foreign currency transactions, which are denominated in a currency other than the functional currency, are included within other operating (income) expense, net in the consolidated statements of operations.  Foreign currency transaction gains and losses have historically not been material.  The Company may be exposed to market risk for changes in foreign exchange rates primarily under certain intercompany receivables and payables.  From time to time, the Company uses foreign exchange forward contracts to mitigate the exposure of the eventual net cash inflows or outflows resulting from these intercompany transactions.  The Company's foreign exchange exposure is not material to the Company's consolidated financial condition.  The Company does not hedge its net investment in non-U.S. subsidiaries because it views those investments as long-term in nature.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and cash equivalents include all highly-liquid investments with original maturities, at the time acquired by the Company, of three months or less.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration of Credit Risk</a></td>
<td class="text">Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash, cash equivalents, short-term investments, accounts receivable and derivative financial instruments.  The Company's policy is to place its cash, cash equivalents and short-term investments in highly-rated financial instruments and institutions.  Concentration of credit risk with respect to accounts receivable is mitigated by the diversity of the Company's payers and their dispersion across many different geographic regions, and credit risk is concentrated among certain payers who are large buyers of the Company's services.  To reduce risk, the Company routinely assesses the financial strength of these payers and, consequently, believes that its accounts receivable credit risk exposure, with respect to these payers, is limited.  While the Company has receivables due from federal and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent on submitting appropriate documentation timely.  As of both December&#160;31, 2021 and 2020, receivables due from government payers under the Medicare and Medicaid programs represented approximately 6% of the Company's consolidated net accounts receivable.  The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.  As of December&#160;31, 2021 and 2020, receivables due from patients represented approximately 21% and 11%, respectively, of the Company's consolidated net accounts receivable.  The Company applies assumptions and judgments including historical collection experience (including the period of time that the receivables have been outstanding) for assessing collectability and determining net revenues and accounts receivable from patients.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text">Accounts receivable are reported net of allowances for credit losses.  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;When estimating its allowance for credit losses, the Company pools its trade receivables based on the following customer types: healthcare insurers, government payers, client payers and patients, which are described in Note 3.&#160; The Company principally estimates the allowance for credit losses by pool based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period of time that the receivables have been outstanding.&#160; To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the customers from their respective pools and establishes allowances based on the individual risk characteristics of such customers.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories, which consist principally of finished goods testing supplies and reagents, are valued at the lower of cost (first in, first out method) or net realizable value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment is recorded at cost.  Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.  Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and expensed as incurred for preliminary project activities and post-implementation activities.  Capitalized costs include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with the internal-use software project, and interest costs incurred, when material, while developing internal-use software.  Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose.  Costs for maintenance and training are expensed as incurred.  The Company capitalizes interest on borrowings during the active construction period of major capital projects.  Capitalized interest is added to the cost of the underlying assets and is amortized over the expected useful lives of the assets.  Depreciation and amortization are provided on the straight-line method over expected useful asset lives as of December&#160;31, 2021 as follows: <div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">buildings and improvements, ranging up to thirty-one and a half years; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory equipment and furniture and fixtures, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1MDYw_1d199ab7-3192-43a9-a2e6-2c9e9839ee94">five</span> to twelve years; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">leasehold improvements, the lesser of the useful life of the improvement or the remaining life of the building or lease, as applicable; and </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">computer software developed or obtained for internal use, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1Mjcw_88e6f6e4-a789-4494-8767-bda409fe0bc3">five</span> to ten years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">Goodwill represents the excess of the fair value of the acquiree (including the fair value of non-controlling interests) over the recognized bases of the net identifiable assets acquired and includes the future economic benefits from other assets that could not be individually identified and separately recognized.  Goodwill is not amortized, but instead is periodically reviewed for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of goodwill exceeds its fair value.  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On a quarterly basis, the Company performs a review of its business to determine if events or changes in circumstances have occurred which could have a material adverse effect on the fair value of the Company and its goodwill.  If such events or changes in circumstances were deemed to have occurred, the Company would perform an impairment test of goodwill as of the end of the quarter and record any noted impairment loss.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The goodwill test is performed at least annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired.  The annual impairment test includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative test may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company is required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, the Company's policy is to update the fair value calculation of its reporting units and perform the quantitative goodwill impairment test on a periodic basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  The Company calculates the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  The Company assesses the valuation methodology based upon the relevance and availability of the data at the time that the valuation is performed.  The Company compares the estimate of fair value for the reporting unit to the carrying value of the reporting unit.  If the carrying value is greater than the estimate of fair value, an impairment loss will be recognized in the amount of the excess. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company performs its annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2021, the Company performed a qualitative impairment test and, based on the totality of information available for the reporting units, the Company concluded that it was more-likely-than-not that the estimated fair values of the reporting units were greater than the carrying values of the reporting units and, as such, no further analysis was required.  For the year ended December&#160;31, 2020, in accordance with its policy to perform the quantitative test on a periodic basis, the Company updated the fair value calculation of its reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text">Intangible assets are recognized at fair value, as an asset apart from goodwill if the asset (i) arises from contractual or other legal rights, or (ii) is separable.  Intangible assets, principally representing the cost of customer-related intangibles, non-competition agreements and technology acquired, are capitalized and amortized on the straight-line method over their expected useful lives, which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE5MTMy_22152b9e-6ae5-4ec5-ae0f-101ca8483d0a">five</span> to twenty years.  Intangible assets with indefinite useful lives, consisting principally of acquired tradenames, are not amortized, but instead are periodically reviewed for impairment.  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company reviews indefinite-lived intangible assets periodically for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of an indefinite-lived intangible asset is more than its estimated fair value.  The indefinite-lived intangible asset impairment test is performed at least annually, or more frequently in the case of other events that indicate a potential impairment.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Based upon the Company&#8217;s most recent annual impairment tests completed during the fourth quarters of the years ended December&#160;31, 2021 and 2020, the Company concluded that indefinite-lived intangible assets were not impaired.</span></div>&#160;&#160;&#160;&#160;The Company reviews the recoverability of its long-lived assets (including amortizable intangible assets), other than goodwill and indefinite-lived intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.  Evaluation of possible impairment is based on the Company's ability to recover the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations.  If these cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text">The Company's investments (except for those accounted for under the equity method of accounting) include:<div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments with readily determinable fair values, including investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries (such investments, which previously did not have readily determinable fair values, became publicly-traded during the year ended December 31, 2021); as well as participant-directed investments of deferred employee compensation and related Company matching contributions held in trusts pursuant to the Company's supplemental deferred compensation plans (see Note 17).  These investments are measured at fair value with both realized and unrealized gains and losses recorded in current earnings within other income, net in the consolidated statements of operations.  For the years ended December&#160;31, 2021, 2020 and 2019, gains from all equity investments with readily determinable fair values totaled $56 million, $8 million, and $10 million, respectively.  The carrying values of these investments was $121 million at December 31, 2021, of which $44 million was included in prepaid expenses and other current assets and $77 million was included in other assets in the consolidated balance sheet.  The carrying values of these investments was $67 million at December 31, 2020, which was included in other assets in the consolidated balance sheet.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments that do not have readily determinable fair values, which consist of investments in preferred and common shares of privately held companies.  These investments are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  The Company regularly evaluates these equity investments to determine if there are any indicators that the investment is impaired; no impairment charges were recognized related to these investments for the years ended December&#160;31, 2021, 2020 and 2019.  The carrying value of these investments was $4 million and $25 million at December&#160;31, 2021 and 2020, respectively.  Such amounts were included in other assets in the consolidated balance sheet.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale debt securities of privately-held companies.  These investments are measured at fair value with unrealized gains and losses presented in other comprehensive income (loss).  The carrying amount of these investments was $1 million and $12 million at December&#160;31, 2021 and 2020, respectively.  Such amounts were included in other assets in the consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit risk-related contingent features or requirements to post collateral.<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate debt instruments and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div>&#160;&#160;&#160;&#160;The Company accounts for these derivatives as either an asset or liability measured at its fair value.  The fair value is based upon model-derived valuations in which all significant inputs are observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.  For a derivative instrument that has been formally designated as a fair value hedge, fair value gains or losses on the derivative instrument along with offsetting fair value gains or losses on the hedged item that are attributable to the risk being hedged are reported in other income, net in the consolidated statements of operations.  For derivatives that have been formally designated as a cash flow hedge, the change in the fair value of the derivatives is recorded in accumulated other comprehensive loss.  Upon maturity or early termination of an effective interest rate swap agreement designated as a cash flow hedge, unrealized gains or losses are deferred in stockholders' equity, as a component of accumulated other comprehensive loss, and are amortized as an adjustment to interest expense over the period during which the hedged forecasted transaction affects earnings, which is when the Company recognizes interest expense on the hedged cash flows.  At inception and quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item.  After the initial quantitative assessment, this analysis is initially performed on a qualitative basis and, if it is determined that the hedging relationship was and continues to be highly effective, no further analysis is required.  All components of each derivative financial instrument's gain or loss are included in the assessment of hedge effectiveness.  If it is determined that a derivative ceases to be a highly effective hedge, the Company discontinues hedge accounting and any deferred gains or losses related to a discontinued cash flow hedge shall continue to be reported in accumulated other comprehensive loss, unless it is probable that the forecasted transaction will not occur.  If it is probable that the forecasted transaction will not occur by the originally specified time period, the Company discontinues hedge accounting and any deferred gains or losses reported in accumulated other comprehensive loss are classified into earnings immediately.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text">Comprehensive income (loss) encompasses all changes in stockholders' equity (except those arising from transactions with stockholders) and includes:<div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Notes 15 and 16); and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising costs are expensed as incurred.  For the years ended December 31, 2021, 2020 and 2019, advertising costs were $78&#160;million, $38&#160;million and $18&#160;million, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text">New Accounting Standards To Be Adopted<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of </span>the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_50c95c33-a401-4066-8573-e62f6ca75cd3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_6f7e233a-96d4-4732-aa53-9f719523830d">right-of-use asset</span></span>, representing the underlying asset during the lease term, and a lease <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_1997e471-5c97-4a99-87d8-0ad010e8dfa3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_2b9b9016-510b-480e-96bb-962223d0e820">liability</span></span>, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_375a58c6-c5ec-4296-b7ed-b111e088fff7"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_b44b257f-98c9-4e44-912d-5c75a894370c">liability</span></span> is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable and Allowance for Credit Losses Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21459-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060253273160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The approximate percentage of net revenue by type of customer was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.702%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AccountsReceivableDisaggregationTableTextBlock', window );">Accounts Receivable Disaggregation</a></td>
<td class="text">The approximate percentage of net accounts receivable by type of customer as of December&#160;31, 2021 and 2020 was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:74.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="text">The following table summarizes the activity for the Company's allowance for credit losses during the years ended December&#160;31, 2021 and 2020, which principally relates to client payers:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for Credit Losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, January 1, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of accounts receivable, net of recoveries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of accounts receivable, net of recoveries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2021</span></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AccountsReceivableDisaggregationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable Disaggregation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AccountsReceivableDisaggregationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060254667928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS (LOSS) PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text">The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics' common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.85&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.55&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060254667928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Beginning and Ending Liability Balances Unobservable Inputs</a></td>
<td class="text">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.912%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value adjustments included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060247583672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components of Income Tax Expense</a></td>
<td class="text">The components of income tax expense (benefit) for 2021, 2020 and 2019 were as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of the Federal Statutory Rate</a></td>
<td class="text">A reconciliation of the federal statutory income tax rate to the Company's effective income tax rate for 2021, 2020 and 2019 was as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at statutory rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on stock-based compensation arrangements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision true-ups </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of equity earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in reserves for uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowances associated with certain net operating losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) as of December&#160;31, 2021 and 2020 were as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current deferred tax assets (liabilities):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable reserves</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities not currently deductible</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis differences in investments, joint ventures and subsidiaries </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards, net of valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(604)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current deferred tax liabilities, net</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of Unrecognized Benefits</a></td>
<td class="text">The total amount of unrecognized tax benefits as of and for the years ended December&#160;31, 2021, 2020 and 2019 consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in judgment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expirations of statutes of limitations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251484056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow and Other Data</a></td>
<td class="text">Supplemental cash flow and other data for the years ended December&#160;31, 2021, 2020 and 2019 was as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with purchases of treasury stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends received from equity method investees</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251513768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment as of December&#160;31, 2021 and 2020 consisted of the following: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment and furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software developed or obtained for internal use</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,795&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,619&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,088)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,992)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060255072552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Goodwill, Net</a></td>
<td class="text">The changes in goodwill for the years ended December&#160;31, 2021 and 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets Excluding Goodwill</a></td>
<td class="text">Intangible assets as of December&#160;31, 2021 and 2020 consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.436%"/><td style="width:0.1%"/></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense Intangible Assets</a></td>
<td class="text">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December&#160;31, 2021 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.959%"><tr><td style="width:1.0%"/><td style="width:71.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251630760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text">Accounts payable and accrued expenses as of December&#160;31, 2021 and 2020 consisted of the following: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages and benefits (including incentive compensation)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overdrafts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251637800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term Debt</a></td>
<td class="text">Long-term debt (including finance lease obligations) as of December&#160;31, 2021 and 2020 consisted of the following: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:77.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25% Senior Notes due April 2024</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50% Senior Notes due March 2025</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.45% Senior Notes due June 2026</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20% Senior Notes due June 2029</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% Senior Notes due June 2030</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80% Senior Notes due June 2031</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95% Senior Notes due July 2037</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75% Senior Notes due January 2040</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% Senior Notes due March 2045</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,010&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text">As of December&#160;31, 2021, long-term debt matures as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:297.00pt"><tr><td style="width:1.0pt"/><td style="width:235.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total maturities of long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,009&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value basis adjustments attributable to hedged debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,010&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060254789592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock', window );">Schedule Of Lease By Asset Type</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's assets and liabilities for its lease agreements as of December&#160;31, 2021 and 2020 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:21.634%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.571%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.573%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_0ffa204f-63da-4cb5-97eb-2b95e023c547"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_47976c32-56f0-4b24-a8fa-f838f8d5f156">Long-term debt</span></span></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Finance lease assets as of December&#160;31, 2021 and 2020 were recorded net of accumulated amortization of $8&#160;million and $14&#160;million, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text">Components of lease cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.75pt"><tr><td style="width:1.0pt"/><td style="width:247.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $140 million, $120&#160;million and $120&#160;million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating Lease, Liability, Maturity</a></td>
<td class="text">The maturity of the Company's lease liabilities as of December&#160;31, 2021 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:365.25pt"><tr><td style="width:1.0pt"/><td style="width:163.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease, Liability, Maturity</a></td>
<td class="text">The maturity of the Company's lease liabilities as of December&#160;31, 2021 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:365.25pt"><tr><td style="width:1.0pt"/><td style="width:163.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock', window );">Schedule of Lease Term and Discount Rate</a></td>
<td class="text">Lease term and discount rate as of December&#160;31, 2021 and 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:363.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Lease By Asset Type [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfLeaseByAssetTypeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Lease Term and Discount Rate [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251609912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location</a></td>
<td class="text">As of December&#160;31, 2021 and 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both December&#160;31, 2021 and 2020, the entire balance is associated with remaining unamortized hedging adjustments on discounted relationships. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the years ended December&#160;31, 2021, 2020 and 2019, respectively:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251713208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">The changes in accumulated other comprehensive loss by component for 2021, 2020 and 2019 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Changes in Available-for-Sale Debt Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Losses on Cash Flow Hedges, net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060253314840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used in Valuing The Company's Stock Options</a></td>
<td class="text">The weighted average assumptions used in valuing stock options granted in the periods presented were:  <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.219%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.82</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected holding period, in years</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Transactions Under The Company's Stock Option Plans</a></td>
<td class="text">The following summarizes the activity relative to stock option awards for 2021: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited and canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, end of year</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.44&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used in Valuing The Company's Performance Share Units</a></td>
<td class="text">The weighted average assumptions used in valuing performance share units with a market-based relative TSR goal in the periods presented were:  <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.353%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.382%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$150.15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$144.03</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Transactions Under Stock Awards Other than Options</a></td>
<td class="text">The following summarizes the activity relative to stock awards, including restricted stock units and performance share units, for 2021, 2020 and 2019: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.478%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares forfeited and canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of year</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.46&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.12&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.30&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Share-based Payment Award, Performance Share Units, Valuation Assumptions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251703080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text">The following table is a summary of segment information for the years ended December&#160;31, 2021, 2020 and 2019. Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangibles assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,788&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,646&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations before income taxes and equity in earnings of equity method investees</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,080&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,080&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Depreciation and amortization expense for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Capital expenditures for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service for the years ended December&#160;31, 2021, 2020 and 2019 were as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,293&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,788&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060242325048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising cost</a></td>
<td class="nump">$ 78,000,000<span></span>
</td>
<td class="nump">$ 38,000,000<span></span>
</td>
<td class="nump">$ 18,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments carrying value</a></td>
<td class="nump">$ 141,000,000<span></span>
</td>
<td class="nump">$ 521,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of equity earnings from investments in affiliates</a></td>
<td class="nump">$ 78,000,000<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">$ 57,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">$ 2,381,000,000<span></span>
</td>
<td class="nump">$ 1,971,000,000<span></span>
</td>
<td class="nump">1,231,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,080,000,000<span></span>
</td>
<td class="nump">1,499,000,000<span></span>
</td>
<td class="nump">906,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Trading equity securities gain or (loss)</a></td>
<td class="nump">56,000,000<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Trading securities</a></td>
<td class="nump">121,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity Securities without readily determinable fair value</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">597,000,000<span></span>
</td>
<td class="nump">604,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="nump">645,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">44,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">77,000,000<span></span>
</td>
<td class="nump">67,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Trading securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Recurring Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">77,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets | Recurring Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">$ 44,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">$ 2,646,000,000<span></span>
</td>
<td class="nump">$ 2,201,000,000<span></span>
</td>
<td class="nump">$ 1,298,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Government payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Patients</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Laboratory Equipment and Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building and Building Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">31 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Laboratory Equipment and Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment without Readily Determinable Fair Value, Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies Line Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_PatientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_PatientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243289080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs of accounts receivable, net of recoveries</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember', window );">Healthcare insurers: | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember', window );">Healthcare insurers: | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember', window );">Government payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember', window );">Client payers | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember', window );">Client payers | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_PatientMember', window );">Patients | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_PatientMember', window );">Patients | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember', window );">DS | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember', window );">DS | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare insurers:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare insurers: | Fee-for-service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare insurers: | Capitated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Government payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Client payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Patients</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PeriodofBillingFullyReserve', window );">Period of billing fully reserve</a></td>
<td class="text">210 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments | DS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PeriodofBillingFullyReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of Billing Fully Reserve</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PeriodofBillingFullyReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_RevenueCollectionofConsiderationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, Collection of Consideration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_RevenueCollectionofConsiderationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_ClientPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_PatientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_PatientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_FeeforserviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_FeeforserviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_CapitatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_CapitatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060247524696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS (LOSS) PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,995<span></span>
</td>
<td class="nump">$ 1,431<span></span>
</td>
<td class="nump">$ 838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from discontinued operations, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic', window );">Less: Earnings allocated to participating securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,988<span></span>
</td>
<td class="nump">$ 1,425<span></span>
</td>
<td class="nump">$ 835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from continuing operations (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.85<span></span>
</td>
<td class="nump">$ 10.62<span></span>
</td>
<td class="nump">$ 6.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Income from discontinued operations (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.85<span></span>
</td>
<td class="nump">10.62<span></span>
</td>
<td class="nump">6.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from continuing operations (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.55<span></span>
</td>
<td class="nump">10.47<span></span>
</td>
<td class="nump">6.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Income from discontinued operations (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.55<span></span>
</td>
<td class="nump">$ 10.47<span></span>
</td>
<td class="nump">$ 6.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options and performance share units not included due to their antidilutive effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember', window );">Accelerated Share Repurchase Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AcceleratedShareRepurchasesPayment', window );">Accelerated share repurchases, payment</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AcceleratedShareRepurchasesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AcceleratedShareRepurchasesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2740-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060238827384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 13, 2021</div></th>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th"><div>Aug. 01, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Apr. 06, 2020</div></th>
<th class="th"><div>Jan. 21, 2020</div></th>
<th class="th"><div>Feb. 11, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336,000,000<span></span>
</td>
<td class="nump">$ 330,000,000<span></span>
</td>
<td class="nump">$ 63,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,000,000<span></span>
</td>
<td class="nump">351,000,000<span></span>
</td>
<td class="nump">58,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,000,000<span></span>
</td>
<td class="nump">247,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,000,000<span></span>
</td>
<td class="nump">210,000,000<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,000,000<span></span>
</td>
<td class="nump">146,000,000<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessAcquisitionPostacquisitionRevenue', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,095,000,000<span></span>
</td>
<td class="nump">6,873,000,000<span></span>
</td>
<td class="nump">6,619,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer - related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember', window );">Mercy Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember', window );">Mercy Health | Customer - related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember', window );">Labtech Diagnostics, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="nump">$ 85,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="nump">80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities', window );">Finance lease liabilities</a></td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="nump">41,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember', window );">Labtech Diagnostics, LLC | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember', window );">Labtech Diagnostics, LLC | Customer - related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BlueprintGeneticsOyMember', window );">Blueprint Genetics Oy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital', window );">Property, plant, and equipment and working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BlueprintGeneticsOyMember', window );">Blueprint Genetics Oy | Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BlueprintGeneticsOyMember', window );">Blueprint Genetics Oy | Customer - related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MemorialHermannMember', window );">Memorial Hermann</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MemorialHermannMember', window );">Memorial Hermann | Customer - related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember', window );">Mid America Clinical Laboratories, LLC (MACL)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Equity interest in acquiree, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Equity interest in acquiree, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue', window );">Equity interest in acquiree, long-term growth rate used to determine fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue', window );">Equity interest in acquiree, discount rate used to determine fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember', window );">Mid America Clinical Laboratories, LLC (MACL) | Other Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Equity interest in acquiree, remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember', window );">Mid America Clinical Laboratories, LLC (MACL) | Customer - related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember', window );">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember', window );">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember', window );">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) | Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember', window );">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) | Customer - related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessAcquisitionPostacquisitionRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Post-acquisition Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessAcquisitionPostacquisitionRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finance Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment and Working Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Step Acquisition, Equity Interest in Acquiree, Dicount Rate used to determine fair value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Step Acquisition, Equity Interest in Acquiree, Long-term Growth Rate used to determine fair value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_BlueprintGeneticsOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_BlueprintGeneticsOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MemorialHermannMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MemorialHermannMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243228792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISPOSITION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">$ 460<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross', window );">Gross proceeds from disposition of joint venture</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Taxes payable, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale | Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale | Other Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on sale of investment, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Sale of Equity Method Investments, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060242897624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251843784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Business Acquisition) (Details) - Labtech Diagnostics, LLC<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Maximum Contingent Consideration Payment</a></td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember', window );">Comparable Company Revenue Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.025<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=dgx_MeasurementInputComparableCompanyRevenueVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=dgx_MeasurementInputComparableCompanyRevenueVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060242242440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Trading equity securities gain or (loss)</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt</a></td>
<td class="nump">4,400<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Other than temporary impairment</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Total (gains)/losses included in earnings - realized/unrealized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Contingent Consideration | Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Total (gains)/losses included in earnings - realized/unrealized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=124268079&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243240840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details) - Level 3 - Contingent Consideration - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Total (gains)/losses included in earnings - realized/unrealized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances', window );">Purchases, additions and issuances</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending Balance</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060242762216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (loss) from continuing operations - domestic</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Income (loss) from continuing operations - foreign</a></td>
<td class="nump">148<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expense (benefit)</a></td>
<td class="num">(57)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current federal tax expense (benefit)</a></td>
<td class="nump">528<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current state and local income tax expense</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current foreign income tax expense</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Defered federal income tax expense (benefit)</a></td>
<td class="num">(61)<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred state and local income tax expense (benefit)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred foreign income tax expense (benefit)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="num">$ (597)<span></span>
</td>
<td class="num">$ (460)<span></span>
</td>
<td class="num">$ (247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax provision at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes, net of federal benefit</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Impact of noncontrolling interests</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther', window );">Excess tax benefits on stock-based compensation arrangements</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Return to provision true-ups</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary', window );">Impact of equity earnings</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition', window );">Changes in reserves for uncertain tax positions</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowances associated with certain net operating losses</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">24.50%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables', window );">Accounts receivable reserves</a></td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Liabilities not currently deductible</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments', window );">Basis differences in investments, joint ventures and subsidiaries</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance', window );">Net operating loss carryfowards, net of valuation allowance</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating lease right-of-use assets</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Non-current deferred tax liability - depreciation and amortization</a></td>
<td class="num">(633)<span></span>
</td>
<td class="num">(604)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total non-current deferred tax liabilities</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards', window );">Income tax benefit due to release of valuation allowances associated with net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxes', window );">Income taxes payable</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, beginning balance</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for tax positions of current year</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ReductionsForChangesInJudgment', window );">Reductions for changes in judgment</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions for expirations of statutes of limitations</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Reductions for settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, ending balance</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Significant change in unrecognized tax benefits is reasonably possible, estimated range of change, upper bound</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense', window );">Unrecognized tax Benefits, interest on income taxes expense</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued', window );">Unrecognized tax benefits, interest on income taxes accrued</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total non-current deferred tax liabilities</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Domestic Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (loss) from continuing operations - domestic</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Income (loss) from continuing operations - foreign</a></td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expense (benefit)</a></td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="num">$ (55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liability, Investments, Investments in Subsidiaries and Equity method investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change for uncertain tax position</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ReductionsForChangesInJudgment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross amount of decreases in unrecognized tax benefits resulting from changes in judgment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ReductionsForChangesInJudgment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due.  This amount is the total of current and noncurrent accrued income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense accrued for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251819624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 305<span></span>
</td>
<td class="nump">$ 258<span></span>
</td>
<td class="nump">$ 233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(152)<span></span>
</td>
<td class="num">(166)<span></span>
</td>
<td class="num">(180)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest income</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">709<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable associated with capital expenditures</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TreasuryStockPurchasedbutNotyetPaid', window );">Accounts payable associated with purchases of treasury stock</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividend payable</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Dividends received from equity method investees</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Fair value of liabilities assumed</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FairValueOfNetAssetsAcquired', window );">Fair value of net assets acquired</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Mergerconsiderationpaidpayablenet', window );">Merger consideration payable</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="nump">331<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">331<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Leased assets obtained in exchange for new finance lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of net assets acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Mergerconsiderationpaidpayablenet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger consideration paid (payable), net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Mergerconsiderationpaidpayablenet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TreasuryStockPurchasedbutNotyetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Purchased but Not yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TreasuryStockPurchasedbutNotyetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243226280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,795<span></span>
</td>
<td class="nump">$ 4,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,088)<span></span>
</td>
<td class="num">(2,992)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,707<span></span>
</td>
<td class="nump">1,627<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gain on sale recognized</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dgx_LaboratoryEquipmentFurnitureAndFixturesMember', window );">Laboratory Equipment, Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,009<span></span>
</td>
<td class="nump">1,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">705<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Computer Software Developed or Obtained for Internal Use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,292<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214<span></span>
</td>
<td class="nump">$ 202<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123417830&amp;loc=SL77919786-209982<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dgx_LaboratoryEquipmentFurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=dgx_LaboratoryEquipmentFurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243363016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, balance at beginning of year</a></td>
<td class="nump">$ 6,873<span></span>
</td>
<td class="nump">$ 6,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the year</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Adjustments to goodwill</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, balance at end of year</a></td>
<td class="nump">7,095<span></span>
</td>
<td class="nump">6,873<span></span>
</td>
<td class="nump">$ 6,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">2,070<span></span>
</td>
<td class="nump">1,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(903)<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future amortization expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal', window );">Total</a></td>
<td class="nump">931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Intangible Assets Not Subject to Amortization - Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember', window );">Intangible Assets Not Subject to Amortization - Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">$ 1,581<span></span>
</td>
<td class="nump">1,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(726)<span></span>
</td>
<td class="num">(638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 855<span></span>
</td>
<td class="nump">841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets, Subject To Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">$ 109<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember', window );">Total Amortizing Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">$ 1,834<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(903)<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 931<span></span>
</td>
<td class="nump">$ 931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived intangible assets, estimated amortization expense, total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060254789592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued wages and benefits (including incentive compensation)</a></td>
<td class="nump">$ 518<span></span>
</td>
<td class="nump">$ 502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade accounts payable</a></td>
<td class="nump">357<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BankOverdrafts', window );">Overdrafts</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Accrued insurance</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_MergerConsiderationPayableCurrent', window );">Merger consideration payable</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 1,633<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_MergerConsiderationPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Consideration Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_MergerConsiderationPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BankOverdrafts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BankOverdrafts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243412040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Long-Term Debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 4,012<span></span>
</td>
<td class="nump">$ 4,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Debt issuance costs</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net of current portion</a></td>
<td class="nump">4,010<span></span>
</td>
<td class="nump">4,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dgx_FinanceLeaseObligationsandOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% Senior Notes due April 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 311<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.50% Senior Notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 616<span></span>
</td>
<td class="nump">622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.45% Senior Notes due June 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 510<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">3.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.20% Senior Notes due June 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 499<span></span>
</td>
<td class="nump">499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.95% Senior Notes due June 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 798<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.80% Senior Notes due June 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 549<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.95% Senior Notes due July 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">6.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.75% Senior Notes due January 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.70% Senior Notes due March 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FinanceLeaseObligationsandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FinanceLeaseObligationsandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FourpointtwofivepercentSeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FourpointtwofivepercentSeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_SixPointNineFivePercentSeniorNotesDue2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_SixPointNineFivePercentSeniorNotesDue2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FivePointSevenFivePercentSeniorNotesDue2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FivePointSevenFivePercentSeniorNotesDue2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060242314632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Secured Receivables Credit Facility) (Narrative) (Details) - Secured Receivables Credit Facility - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DebtInstrumentExtensionPeriod', window );">Extension period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate in excess of LIBOR</a></td>
<td class="nump">0.725%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate in excess of LIBOR</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Loan commitment maturing October 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Loan commitment maturing October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DebtInstrumentExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, Extension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DebtInstrumentExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_LoanCommitmentMaturingOctober2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_LoanCommitmentMaturingOctober2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_LoanCommitmentMaturingOctober2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_LoanCommitmentMaturingOctober2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060246923544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior unsecured revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior unsecured revolving credit facility | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate in excess of LIBOR</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior unsecured revolving credit facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243447464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Senior Notes Offering) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember', window );">Other Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Losses on extinguishment of debt</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.80% Senior Notes due June 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.95% Senior Notes due June 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.20% Senior Notes due June 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060242314904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Maturities of Long-Term Debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LongTermDebtMaturitiesGross', window );">Total maturities of long-term debt</a></td>
<td class="nump">4,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Debt issuance costs</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt', window );">Fair value basis adjustments attributable to hedged debt</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">4,012<span></span>
</td>
<td class="nump">4,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net of current portion</a></td>
<td class="nump">$ 4,010<span></span>
</td>
<td class="nump">$ 4,013<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, fair value basis adjustment attributable to hedged debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LongTermDebtMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date. May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer, and before deducting unamortized discount or premiums, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LongTermDebtMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060253585400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060242312856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">$ 604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Operating lease assets<span></span>
</td>
<td class="text">Operating lease assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease assets</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LeaseRightofUseAsset', window );">Total lease assets</a></td>
<td class="nump">626<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accounts payable and accrued expenses<span></span>
</td>
<td class="text">Accounts payable and accrued expenses<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current finance lease liabilities</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent operating lease liabilities</a></td>
<td class="nump">$ 494<span></span>
</td>
<td class="nump">$ 499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term Debt and Lease Obligation<span></span>
</td>
<td class="text">Long-term Debt and Lease Obligation<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Noncurrent finance lease liabilities</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Right-of-use asset, accumulated amortization</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LeaseRightofUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LeaseRightofUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060254067128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_OperatingLeaseFixedAndVariableCost', window );">Operating lease cost</a></td>
<td class="nump">$ 321<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of leased assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net lease cost</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ShorttermLeaseandVariableLeaseCost', window );">Short-term leases and variable lease costs</a></td>
<td class="nump">$ 140<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_OperatingLeaseFixedAndVariableCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Fixed and Variable Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_OperatingLeaseFixedAndVariableCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ShorttermLeaseandVariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-term Lease and Variable Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ShorttermLeaseandVariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060238770568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Maturity) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other liabilities<span></span>
</td>
<td class="text">Other liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive', window );">Thereafter</a></td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_OperatingandFinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance and Operating Lease Liabilities, Payments, Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due after Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_OperatingandFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating and finance leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_OperatingandFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060242765784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Term and Rate) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term, Operating leases</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term,Finance leases</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate, Operating leases</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate, Finance leases</a></td>
<td class="nump">6.90%<span></span>
</td>
<td class="nump">8.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060251952392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated net loss from designated or qualifying cash flow hedges</a></td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060253239528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Balance Sheets) (Details) - Long-term Debt - Fair Value Hedging - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedge', window );">Carrying Amount of Hedged Long-Term Debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Hedge Accounting Basis Adjustment</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability hedged in fair value hedging relationship.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060254251624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Income Statement) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 369<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Hedged items (Long-term debt)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense) | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivatives designated as hedging instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060240841128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="12">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 03, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized', window );">Additional amount authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock value acquired cost method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,222,000,000<span></span>
</td>
<td class="nump">$ 325,000,000<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Reissuance of shares for employee benefit plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Shares retired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="nump">$ 82,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember', window );">Accelerated Share Repurchase Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AcceleratedShareRepurchasesPayment', window );">Accelerated share repurchases, payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposed of by Sale | Q2 Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock value acquired cost method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,222,000,000<span></span>
</td>
<td class="nump">$ 325,000,000<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost | Accelerated Share Repurchase Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember', window );">Foreign Currency Translation | Disposed of by Sale | Q2 Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent', window );">Increase in quarterly dividends as percent</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized', window );">Additional amount authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AcceleratedShareRepurchasesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AcceleratedShareRepurchasesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Common Stock, Dividends, Declared as Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfShareholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Shareholders' Equity [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfShareholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Additional Amount Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_StockRepurchaseProgramAdditionalAmountAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060242636424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">$ (21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Net Changes in Available-for-Sale Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Net Deferred Losses on Cash Flow Hedges, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=dgx_OtherEquityComponentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(14)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfShareholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Shareholders' Equity [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfShareholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=dgx_OtherEquityComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=dgx_OtherEquityComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243684792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dgx_EmployeeLongTermIncentivePlanEltipMember', window );">Employee Long Term Incentive Plan ELTIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans', window );">Contractual life of stock options and other awards under the shared-based compensation plans</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares available for award</a></td>
<td class="nump">79,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dgx_RestatedDirectorLongTermIncentivePlanDltipMember', window );">Restated Director Long-Term Incentive Plan (DLTIP)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans', window );">Contractual life of stock options and other awards under the shared-based compensation plans</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares available for award</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual life of stock options and other awards under the Shared-based compensation plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dgx_EmployeeLongTermIncentivePlanEltipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dgx_EmployeeLongTermIncentivePlanEltipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dgx_RestatedDirectorLongTermIncentivePlanDltipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dgx_RestatedDirectorLongTermIncentivePlanDltipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060240794648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value at grant date (in dollars per share)</a></td>
<td class="nump">$ 21.82<span></span>
</td>
<td class="nump">$ 17.25<span></span>
</td>
<td class="nump">$ 14.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">25.60%<span></span>
</td>
<td class="nump">20.30%<span></span>
</td>
<td class="nump">20.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected holding period, in years</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember', window );">Performance share units with market-based relative TSR goal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value at grant date (in dollars per share)</a></td>
<td class="nump">$ 150.15<span></span>
</td>
<td class="nump">$ 144.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">30.20%<span></span>
</td>
<td class="nump">20.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060238773640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details) - Equity Option - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning of year</a></td>
<td class="nump">6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="num">(1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options forfeited and cancelled</a></td>
<td class="num">(200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, end of year</a></td>
<td class="nump">5,700<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, beginning of year weighted average exercise price</a></td>
<td class="nump">$ 90.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, granted weighted average exercise price</a></td>
<td class="nump">122.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised weighted average exercise price</a></td>
<td class="nump">84.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options forfeited and cancelled weighted average exercise price</a></td>
<td class="nump">107.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, end of year weighted average exercise price</a></td>
<td class="nump">$ 96.44<span></span>
</td>
<td class="nump">$ 90.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding, end of year weighted average remaining contractual term</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, end of year aggregate intrinsic value</a></td>
<td class="nump">$ 433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, end of year shares</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, end of year weighted average exercise price</a></td>
<td class="nump">$ 89.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, end of year weighted average remaining contractual term</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, end of year aggregate intrinsic value</a></td>
<td class="nump">$ 309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest, end of year shares</a></td>
<td class="nump">5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest, end of year weighted average exercise price</a></td>
<td class="nump">$ 96.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest, end of year weighted average remaining contractual term</a></td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest, end of year aggregate intrinsic value</a></td>
<td class="nump">$ 430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation not yet recognized, stock options</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized stock-based compensation cost weighted average period</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243162600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit related to stock-based compensation expense</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Sharebasedcompensationexcesstaxbenefitamount', window );">Share-based compensation, excess tax benefit, amount</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dgx_StockAwardsMember', window );">Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares outstanding, beginning of year</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares forfeited and cancelled</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares outstanding, end of year</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Shares outstanding, beginning of year weighted average grant date fair value</a></td>
<td class="nump">$ 100.12<span></span>
</td>
<td class="nump">$ 93.30<span></span>
</td>
<td class="nump">$ 88.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Shares granted weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">122.78<span></span>
</td>
<td class="nump">112.43<span></span>
</td>
<td class="nump">86.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Shares vested weighted average grant date fair value</a></td>
<td class="nump">103.41<span></span>
</td>
<td class="nump">96.36<span></span>
</td>
<td class="nump">75.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Shares forfeited and cancelled weighted average grant date fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">94.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Shares outstanding, end of year weighted average grant date fair value</a></td>
<td class="nump">$ 107.46<span></span>
</td>
<td class="nump">$ 100.12<span></span>
</td>
<td class="nump">$ 93.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock-based compensation cost</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized stock-based compensation cost weighted average period</a></td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Sharebasedcompensationexcesstaxbenefitamount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation, excess tax benefit, amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Sharebasedcompensationexcesstaxbenefitamount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dgx_StockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dgx_StockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060254082168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Company's expense for contributions to its defined contribution plans</a></td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Amended company match percentage of employee contributions</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Percentage of maximum annual wages witheld for the ESPP</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp', window );">Market price of company stock issued at a discount under the ESPP</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares available for award</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares purchased by eligible employees under ESPP</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">269<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Element represents the discounted market value of the Company stock on offering date or purchase date that participants pay for shares. Typically, the participant's per share cost is the lower of the prices on the two dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060249041016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Amended company match percentage of employee contributions</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SupplementalDeferredCompensationPlanMember', window );">Supplemental Deferred Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalDeferredCompensationPlanSalaryDeferral', window );">SDCP salary deferral</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral', window );">SDCP variable incentive compensation deferral</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability', window );">SDCP accrual</a></td>
<td class="nump">$ 77,000<span></span>
</td>
<td class="nump">$ 67,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP', window );">Funds in a trust pertaining to all participant deferrals and company matching amounts related to the SDCP</a></td>
<td class="nump">$ 77,000<span></span>
</td>
<td class="nump">67,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SupplementalDeferredCompensationPlanMember', window );">Supplemental Deferred Compensation Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Amended company match percentage of employee contributions</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SdcpIiMember', window );">SDCP II [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Amended company match percentage of employee contributions</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability', window );">SDCP accrual</a></td>
<td class="nump">$ 66,000<span></span>
</td>
<td class="nump">59,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">SDCP II vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SdcpIiGradedVestingPercentage', window );">SDCP II graded vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">$ 57,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SdcpIiMember', window );">SDCP II [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer', window );">Deferred compensation arrangement with individual, employer contribution</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Funds in a trust pertaining to all participant deferrals and company matching amounts related to the Supplemental Deferred Compensation Plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SdcpIiGradedVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>SDCP II graded vesting percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SdcpIiGradedVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SupplementalDeferredCompensationPlanSalaryDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of salary deferral under the Supplemental Deferred Compensation Plan. This plans is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to this percentage of their annual salary in excess of their defined contribution plan limits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SupplementalDeferredCompensationPlanSalaryDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferral percentage of the variable incentive compensation under the Supplemental Deferred Compensation Plan. The plan is an unfunded, non-qualified plan that provides for certain management and highly compensated eligible employees to defer up to this percentage of their variable incentive compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the liability as of the balance sheet date to an individual under a deferred compensation arrangement. This amount may be the result of periodic accruals made over the period of active employment, or reflect termination benefits resulting contractual terms or a death benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20015-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6409961&amp;loc=d3e20487-108367<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SupplementalDeferredCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SupplementalDeferredCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SdcpIiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SdcpIiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243363448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount', window );">Purchase obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary', window );">Purchase obligation, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears', window );">Purchase obligation, 2023 through 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AgreementtoOutsourceBillingandCollectionFunction', window );">Agreement to outsource billing and collection function</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RemainingTermsofContingentLeaseObligationsMaximum', window );">Remaining terms of lease obligations, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">26 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">New claims filed (in lawsuits) | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted', window );">Self-insurance reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,000,000<span></span>
</td>
<td class="nump">$ 138,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AgreementtoOutsourceBillingandCollectionFunction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement to Outsource Billing and Collection Function</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AgreementtoOutsourceBillingandCollectionFunction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_RemainingTermsofContingentLeaseObligationsMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining Terms of Contingent Lease Obligations, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_RemainingTermsofContingentLeaseObligationsMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecorded Unconditional Purchase Obligation, Due within Two and Three Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyAccrualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060243551960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues from the DIS business</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 10,788<span></span>
</td>
<td class="nump">$ 9,437<span></span>
</td>
<td class="nump">$ 7,726<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">2,381<span></span>
</td>
<td class="nump">1,971<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating expenses, net</a></td>
<td class="nump">218<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from continuing operations before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">2,599<span></span>
</td>
<td class="nump">1,884<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(597)<span></span>
</td>
<td class="num">(460)<span></span>
</td>
<td class="num">(247)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">2,080<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,080<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: net income attributable to noncontrolling interests</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total capital expenditures</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">418<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember', window );">Routine clinical testing and other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">4,293<span></span>
</td>
<td class="nump">3,836<span></span>
</td>
<td class="nump">4,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember', window );">COVID-19 testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">2,770<span></span>
</td>
<td class="nump">2,723<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember', window );">Gene-based and esoteric (including advanced diagnostics) testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">2,878<span></span>
</td>
<td class="nump">2,098<span></span>
</td>
<td class="nump">2,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember', window );">Anatomic pathology testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember', window );">All other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 294<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues from the DIS business</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 10,494<span></span>
</td>
<td class="nump">$ 9,139<span></span>
</td>
<td class="nump">$ 7,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">2,646<span></span>
</td>
<td class="nump">2,201<span></span>
</td>
<td class="nump">1,298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total capital expenditures</a></td>
<td class="nump">379<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total capital expenditures</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">General corporate income (expenses), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="num">(294)<span></span>
</td>
<td class="num">(269)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total capital expenditures</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues from the DIS business</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AllotherservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060254653352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Details) - NID<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits', window );">Gain on settling uncertain tax benefits</a></td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Refund from taxing authorities related to settlement of the uncertain tax benefits</a></td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Gain on Settling Uncertain Tax Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_NidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_NidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060253997432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 331<span></span>
</td>
<td class="nump">$ 351<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Pack Health, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration arrangements, range of outcomes, value, high</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140060255170920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation Accounts and Reserves (Details) - SEC Schedule, 12-09, Allowance, Credit Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Provision for doubtfull accounts</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Net deductions and other</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>dgx-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:dgx="http://questdiagnostics.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dgx-20211231.xsd" xlink:type="simple"/>
    <context id="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i93ead1399e2e4ac494b71ed2bb631561_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4d0e2c71efc94e228f2767bcedc33dd0_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib618186b3e3648a0a5c22c9e567fe03f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a05287b4f02418c82cd5f2e6e79c6dc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i37a9f450d5fc42bd8a4cedc5a182bb1d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i93a20c5e9811442496e0ddbc0d32b35f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30f9993ad61e49b8889d85cebdd9a0ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icb3cd0ebcab8404c8e2d53703218de07_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1d0d6530dd894b1c87f220eb4e22a87b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0cadea5752cf4f50bc45f8f371d2168d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i751cd9d2a9c24eeb80a337f22c577eed_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4b6f2cccffed48a8b1dceaea5ff25de2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="idda5f95daad049caab9cbe2bfb827136_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5299549fc0c64e619315ae69e3a2d208_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6aab3fa36e3d4c9784c83bb58dbc0467_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1f2e5616f9864fd5b5916bfd56220c6d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1066f069691a446899ccc794445c6f7e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i88b348bf53ef45a6b79322e9729d0498_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic1c4749bcaac4d619fd98fd7d8f56cf3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i267bcc57d1894a25886a84780745fe3f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie209ef77b3d74e11bcf8556dd3482d4a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3be5ad04ae5542ecb8f3b50fb4e30464_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idf54f2e101be444fae80a5c5c2d3c804_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iae81071de369404b8afd4d5fc92817db_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i67c2565c4020431eab3d950ad045cb6d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if98d4882c785427cb6359a1c4887bd59_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb7782dfdbdd41bcb0c2a7ce6d9fc4e9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7887c43e3ff4c0eaa862aa8feccb3a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7109a9f8e79b43adaac841ce00ee330f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i100aacd303a1475289f1b48d599c5544_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i873b50b7201e479895a613c8644d45a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9a6dfcd580714f519c23752e3e04312e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0aa4482609c643a18d09f0c105d38575_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3b3040c4c16442589b2b35eb56972716_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib47828d248b649a69973dd77b69d8e47_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ed179caf3f3462791e29a68b26fdab2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf17d00ced53485da1e88eb50e730ada_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84e35541023d468e8cb0c202d383eddc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b11d3e18df649ec889a7fa850cc7e67_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7215d41c21ea4fbdb2f7240f3cc276ee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i184e53e381dc4d5bb40497f1d9fc9b8d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iecc4fcf7570e403c98d584e438978f0c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6174bff25adb42cdbd66e7fb9ff9c37d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i38edfda579db45e2b38455c17b62991c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6273937e3079404bac24531420de0b6c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id617ebe9e53c430eab235ef5b09c5eb1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie250c2a689ff4ef885295f77abd96941_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7d076d028664d249c58ef5ec036b46f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23a7255d9f5c4ffa878e62ba379a4038_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0ef869edccf349a68f85c65c81e97770_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice911685201a460b8af3f58815059f82_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i641831615df34b538199d475b2c51f92_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i89f3081e1b5445c6bfec2edf60f2f909_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia5e542d0dfea43e2af9118d20432c274_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie5d364f684594c5783514a961ba1cb23_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2807cd7680bc4bb4925dda96c4f03f1e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentAndFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifb8e5cfafc1a42d58d6cad9058f4760e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentAndFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i31a2f97bd63f4c42b34883f22a329ad2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0b00f7e1bf43453099ed71ff43d6717f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5e3f8aa3f21c4630b2c2d3a505ba4881_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i972899ce7ba6442aaf147d47867cd482_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id22911e2cc294cebbfc441d94dfaf441_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba604be725684156a3eb0ffeedf8b741_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6abd46db2a6b4225801b044e7620dd70_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba7313c4a10443ea84ad938944fb4263_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a090f7f88f3481086c45baf1ec6dabd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice4e3139e0ba4820be8e5d8cf02f15fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idb62d67015ba418c9bcc8c4ca149ca60_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie799399ba4554af3b75c1e5d805f52c7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i88dd508f2a244b859dab8f3eb925f23a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3dd2fa8993ba4765a061aa8753907429_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i886f4c78cd9c49dda5f59730477bd7a8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic7db216ea09e4faf817a70826756f79f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b66d5c815234d649c202faa47b0836f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iceca007bdcd64d67a3cfc72359b58092_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i24c4e46338874112b41b05ba07c69b13_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3e8e2db9ab7a4c3c8b0971c8eb34874d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5bed9502f4964d15af65cfe68d0a3389_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7008d482a62245bb9875f7b05fec3156_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0bb294ef9720428da49024b4cc1c015e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58580a51b19549c984bf823f6103da97_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib3c0596ed88949319f741c4098014adc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i53e0c40604dc436dac0d5316b6aa3124_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i17c7defe77e94feca925988ab94659bc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if59d0382710d43bd95feee9461a26bdc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0c17eb1dddb643999d1956c1832f752a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7b5e5b177ae448c083554c9494be58aa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3a09d850f846426d9dfd70228809d98a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i101444f4d55c4f7face8b6cbb4ad8c7c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i67a12fbdd2794793bdbac9d69717453a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i842c67659a084bca972b57a09beab75c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia0bd2018f1ae4210af8adb65d7d4adec_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id6815212460d4587af042592f64aaf60_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id22f162e49514311adf2fd36a699bba9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4d589ca3abf844d78f270902170a0189_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i41ddf51214fb499e84fddd91bbb595d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i62d8cd061af34ddda090b2a1ed70a859_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2add5ec575124eaa815d9e79f4d20f0e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia36c52a54f80476e9f66b1b0b7134265_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if86384a0f5614da3a89e030848de8448_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i47fc543fa62f457495efbed248f47831_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i618e3edc7d0e472db6505e306cf617c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1dc63d78467b4990a09bb4edf33bc0d9_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="icbd86fbda26d4940870279bbf2723a39_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="i1aee2bd26ebb41528a08b0155d7985b1_I20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="iaade8f13b4c24c27921a397d61fbbfce_I20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="i3ede7ec3a11842568aa070ef6416d46f_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="i15009b0e1117479090ce699335523d61_D20211213-20211213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-13</endDate>
        </period>
    </context>
    <context id="i81a78a06e59d4de0972e28a1dee3dbe4_I20211213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-13</instant>
        </period>
    </context>
    <context id="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-13</instant>
        </period>
    </context>
    <context id="i31f1113940444a80a3c10cf968e6c6ce_D20211213-20211213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-13</endDate>
        </period>
    </context>
    <context id="ie3246f22b780495da5706a912cfe9e8f_D20200121-20200121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-21</startDate>
            <endDate>2020-01-21</endDate>
        </period>
    </context>
    <context id="ib9011e0276964d49be24c92eb49f6aab_I20200121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-21</instant>
        </period>
    </context>
    <context id="iba6f3990b67144cba1d435606505c8f4_D20200121-20200121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-21</startDate>
            <endDate>2020-01-21</endDate>
        </period>
    </context>
    <context id="ic51e744f4f2e4bcaa5294155d679de88_D20200121-20200121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-21</startDate>
            <endDate>2020-01-21</endDate>
        </period>
    </context>
    <context id="i60b68dc1052845acade8ae63bf8e6344_D20200406-20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-06</startDate>
            <endDate>2020-04-06</endDate>
        </period>
    </context>
    <context id="i4617473021984d69adc99b7ffdf6247a_I20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-06</instant>
        </period>
    </context>
    <context id="i8776f0149dc24a4fb8b364ad4db1ebb4_I20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-06</instant>
        </period>
    </context>
    <context id="i7e2e808f5d17421891028da702156879_D20200406-20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-06</startDate>
            <endDate>2020-04-06</endDate>
        </period>
    </context>
    <context id="i91ecb9e9aa0543a9b24df0457649804e_I20200801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-01</instant>
        </period>
    </context>
    <context id="i4f962685f1e94c24ad92c8ab20b848a9_D20200801-20200801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-01</endDate>
        </period>
    </context>
    <context id="i0e0666473465402491e5adb9a61aa8a9_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="id6481d3eb8e74ecb8e9190ad66be0074_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i45f309f68fd843a48e8af03cd2f2fd0f_D20200801-20200801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dgx:OtherIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-01</endDate>
        </period>
    </context>
    <context id="ib4508da7ee96473cacb0e8b34be9019b_I20200801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-01</instant>
        </period>
    </context>
    <context id="ie3555bc8ae0b4b1cbeefc4ba15b1ff96_D20200801-20200801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-01</endDate>
        </period>
    </context>
    <context id="ic42d65a53e2e4f8caac33c19b3fe9550_D20190211-20190211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-11</startDate>
            <endDate>2019-02-11</endDate>
        </period>
    </context>
    <context id="ibf8a6d03f13d4234a113977f48f0640c_I20190211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-11</instant>
        </period>
    </context>
    <context id="i30539b4ef73742fd917103c75f8a131d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0443eda130d94868aa628f929fc4e6bd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i423ce88d5a4046c7b9394f997e1e0db6_I20190211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-11</instant>
        </period>
    </context>
    <context id="i7356ad2d38bf4e7e85b6c706c139d415_I20190211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-11</instant>
        </period>
    </context>
    <context id="i31f33c5e991148e899c59f925d85d5b1_D20190211-20190211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-11</startDate>
            <endDate>2019-02-11</endDate>
        </period>
    </context>
    <context id="i9c1e96cb7a8540ba9373cdf8a930af85_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="iff8c10fa9efa4acb8369a234686c91ff_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i8e96757089434161b4f6a911623f3a76_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3b20ad37382b4dbd949a4bd8cd17fa6c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0766501a28ea42ae98034d9409e0ed9d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib83ba03755a844f2aacb5ab477db26dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ad83b4de96747abb8cb8781622ee947_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i81f60e6780e640a694005a30b6a5abe5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i38f5b3d3498744299e5a0aef9e2f770b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i073fd4818f044aef89256b4a52dcbf2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie17bd574ae9c4ff8ae0d21265f27f20e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i434a8ab4e7b34865bb3ce497565a2bf6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i617406ef61a34f3aa8f1d1f3c8941262_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dgx:MeasurementInputComparableCompanyRevenueVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i124355337c804541809469ff7ef7f47f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66a58a0ecc1d462f851c119a2540a972_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibc94c6adc50e45d1a843a6310b57c833_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i67b969149f9b4fee96f681a629e8e1bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i021bad29b33a4e059cf6ee59d7e0df44_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9c47ea6a797a43599cb7fc4368a7daa1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i10c8c1d0f30246589418e5588a96ce94_I20150701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="i41d87f6d82ea49589aa5d33a9546d817_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i20d31ae01df141748e29ec7263dbe9c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8c9bfd94887a4b799eb75fdf00ff90c6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieaadd96b316f4fe3aa85d0828713bc7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83edf4f54cea471cb6078513f0ebb62d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie38bc8aadde34be2a92c9c3930883626_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b96d806bd364953ade441ac89234392_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5fe0a4d10c264c40b9e40c8f509f7adc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ee54bfafa2142ab925140ee00165fea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i95334650a7794ede9d0240487ccf5b99_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d5ebce76e5d403e9298f0728ff53d6e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82c68c29716a45b6ae635ee994106a2f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9b876c41bbc04618b47e5868c157a986_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib69a77afcc7848b9bcdb721d263b8590_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2dc448c5c6a4434ca848bbf1bcbbdbab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0550e1e6602405196f7a86f02932b05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i850a9e2e7a37450487c5434158c02aec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3445b8f4bd484038bb1c8dba887da7aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9051075426f64d9fb6d5c2874af92f58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i703f397efc54465491f61111e9d00225_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75cf772afd4440dbabbaa7a8d8609ebd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie440f7efd91b4288b67e34da88f9d851_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9b6430db74f74cdba668c4da15ce72f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i19172532941b40db90a9673c0a833751_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ac379b1564746b29091a6803b4e237e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic96f44c6128f47809c839fe1a70df50d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i01eaebddea0d433ea24e6c5ef38bd564_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8c4fd41a16d47c691063b053f0f15a1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id49dc7dd9f1c473ba5418fbddca06d3f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf12734ab0ab46498369e1f89b24439b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i662626ed24964bfba9dc3b27519b5804_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a7ac3e799d44879aad973d51eb36f14_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if0367af741674c3fb7c7d805734fd8e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a08e02b7c23441cb6f556cdb634cb88_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i97af82c328c645e99f19d0e2e6ce85e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i05d194442c87432d9686414335afe7cf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1456547e481a4de1a93ec35f388b1295_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i70b2a42da95c4ef2a98b0f15b9f4b9c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id5164e43d9194c4eb7704645ad2ab56a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ideb21621cd5b4062b5cb405b6542855f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id0594f257da04350b8a4a4b497e30e2e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourpointtwofivepercentSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c6fef0c959f4836b6be1689a5919adf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourpointtwofivepercentSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7fadb78c01474e89b32f31ed14c21f18_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8b7492430de4dbfa02f30eb630168d1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5202c6f3e7cf486b94bb890d000fb968_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFourFivePercentSeniorNotesdueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82cb0de9768a4944bc7de354bb2821b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFourFivePercentSeniorNotesdueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie5df62b2adde478ea217430cd360e7e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointTwoZeroPercentSeniorNotesdueJune2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida0ded49fab44741b80d31af3ba70aae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointTwoZeroPercentSeniorNotesdueJune2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i766f928a9c9346038b77495a2d20fb42_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointNineFivePercentSeniorNotesdueJune2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc060a500fe64aac9a2a927778e50857_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointNineFivePercentSeniorNotesdueJune2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i378672f20c0d4618a6b6e81143b6720a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i88cc643b6da843ffa1c10a9f855203c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4ce1f1f310449c2b6c89c7e62ade9b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:SixPointNineFivePercentSeniorNotesDue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5df76549d2994abd97388a4720896161_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:SixPointNineFivePercentSeniorNotesDue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b9881c9daf746ff96ea2d9b6927e946_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FivePointSevenFivePercentSeniorNotesDue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82a4a8a3b9d14622adefe38f6d57418f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FivePointSevenFivePercentSeniorNotesDue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i09bbac6d7bf04160afe3a6e074127aba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdueMarch2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic73df93e889f4d69ac6970fe52f080ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdueMarch2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9a32e3b91ca84b89b38c8ba51a6735ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FinanceLeaseObligationsandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i72472dddee4a401c94ec4e9a3d939bc5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FinanceLeaseObligationsandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife8fa0dbace2463781c162f0d572554e_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i9f138175e3a44f5ebf659b1a78903b5d_D20211001-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i8413e7af478b4f60b3be63a14fc02040_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoanCommitmentMaturingOctober2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="id7273399a8b249109c5141327f9e2f70_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoanCommitmentMaturingOctober2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="if0f0ea4be7af4410af0e10d2186e1e37_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="if5bd74de8e5d42bd9ceb6ea699aa16ca_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1730f3f4c2874eff9f3ca20705fbdfce_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i90044be8ca1a4466aea5fb0404e36a2d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e4a6015d1ef460f9e8ae76bf0c3381f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3d6de33f3ed4d19a2ec16d2ece3dab0_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="icaa60f894264418b86cad34928e740c7_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="iae8c124c79124e13a5f8a65b35a85a2d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f48d5ae19c347f5a146cb05e040a26f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8194949fa694c51b9a86b2aa1a10860_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i754db448c4a141e587eb41b3530387d7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dgx:OtherIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i088cf7af90a4499da82634db3e749425_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8b611f9fb71a4871a95107ddf00e5972_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11c302abd9aa427ba7d0156fe01460ec_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3cc5031c24924569b75aea0f1da108a1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i003a13fe51aa4e869629249e6bbb90d5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic8afa4ad788744a6a80595836c35781a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia36018d33c604038aa1aa14c366c4dd2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia85aba486145433bbe90c96b488714b9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4f78e9964d4545d0b470900cf41790eb_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibaf3d2d6da574aad843e8c47db812bde_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2e6f13795fa643d4a934ef2779cf20c8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="icedac86dbdd94e328db0b81523eb9490_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i172b86f75b754578b0023e98bbdbb60a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i854a8c819539479993d7ec23a433969f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6ee641cc51754d1cb00d4f664780d7e8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9be9b6bedf67403391fbe4666a7b7789_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i46c2e1b5de824befa49ed510987e9918_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i586f4c60ec0941b798835a56c0a9126d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d895060707c4feab2cdb2374be33e9e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i20f21fbe58224ed6b3cf27749d03f137_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i823d173be3fb47b8a4246a64c03b0a01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3aa0eae48f174f9b9a05ca9da0eab655_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifcd6a47fcc964ce4a5dc370e77b30cbe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i455a47bd993d476393c8224860c4376d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia2ea7757788d44a2a8005c4e5c5e5d8d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a589942e02b472d8d4555b653f21c8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2e3a08874f20424ebeb0772967620d16_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia329d4330d184f4db61e55f388db1e37_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib08a3f5f05e8446a81e70c779986707e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b0ee439d5e042c0ad07cb7eea297ef4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i131d1f6ef78b4ccda288b254ef8513eb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i614f87384bc04f7eb3b659a197d00719_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if8c928ba4d594c0d8a8bc43cc0eaff7a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i172575bb71684d5b977ed5b5efb382cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6be47c24890a4321b9eab67a24b8a937_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie014908da8a24f6e98f6bd987c799a93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i037da802480a40f1aceb3032d77fd42d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifc7daa98ed14443ba924d16779e53a1b_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i46b7967df9714e9abdb47bd55a82bb99_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i256fbf2ceee847e3a69e9615a1382681_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4c85169bb26d4f7487f2139697536c87_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i80051b14fe464495a4d017e6d935f7b4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i75da353bc1d84ecf943ea64892e87557_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1a65b7fef56742dfa223a86fcbbc87ed_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i920aa1cda167443c8b0444671613bbf4_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ieda553b13ff74c3c8adddf0770a90cb1_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iea6463b11ecf4c00a41fca1508914f0f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i83a23412d4724363966c8ea6e44ab909_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2bc256f3969842e6a0da1ee27ff4d814_I20220203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-03</instant>
        </period>
    </context>
    <context id="iab2af8571ad549cc8ca5ad0958512f11_D20220203-20220203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-03</startDate>
            <endDate>2022-02-03</endDate>
        </period>
    </context>
    <context id="i27c3f506bf6b40788ce7094bb62e2e2d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2bbace4627094c78b2e45eaf382e646d_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i23fa7d555abb409cb510e5e698113fc5_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0f71fea2861045d2bc904b3d6d15ea55_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="i1dafd9b95c6842e2b8662b418c9af1b3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i069088e9e79e44e78b230470438a9c05_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:EmployeeLongTermIncentivePlanEltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i34ff8916a5f444ccb368b1089fe044ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:EmployeeLongTermIncentivePlanEltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89212b0997f444118e64670ec656f232_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57198eacfa274bdda46d180bc4e3f05d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad5bf5052c604fa2982645d51ef2f9bf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3b1d357b32ce4113917ff628a45e0a1b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i30b7bc67e7bb4a52a97e03ff7b345782_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie07834d81a9d4a88aaf80835b2bb5156_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0edf8a3dee0e4be4a7970782a11e919b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic601ee56a8d64d41a238221625b7f525_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i71d3304ab3de4fac88d8ba9dc1cdc015_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic50d104c1f2e4df4a4f6e3d9ae3c0287_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaeeaf4706c6e49b7a86e967f2bd3443a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i58ae2069c994411b8ad5cf3e9fd7f728_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i152aaa9d36b34e3496329cdd1df55d76_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i186f5b12f07149329dc5f3bd351174d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifaf57f30a4d148c7832fab56a16d3c67_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i133ed156b2ae4c0cb1ccbd97cc19199f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if54829fa59064ad3adf7093c5e760b0e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i946d409692054dddb8d20bf8697e64db_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i33d716f8929d432d844c17e2ba676a0b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8fc7b757284449cebf65a284bd73bd8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e961edb5fcd410ea3ec16b2c6c74476_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i037161dc8162495a912293e3e9a40ec4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i61c9407736c741d0ab822ef30250f2a8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8095617a570e4c32b5ffb3c1434f3dc7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icb5c138d0e66484badc0c6cfaeb41e0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i041613d64bbb4a13a8721a2ee2352a92_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a2973ec261740218274bc1cb13b32b6_D20160901-20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2016-09-01</startDate>
            <endDate>2016-09-30</endDate>
        </period>
    </context>
    <context id="id980e16d89514f7aa100a29c06e97763_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i744ee99a69fd4003b8a54a40eb3c8813_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if013d02c91354f9286988eda03c628e0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6bb108bc797e4252abac7baa59a2e9d4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6cd1adca053c4d6580c37c9b0bff2f37_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73cec06921db4ba883aa7b2610ace433_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3764f252b9f84910a98e8576a15f1852_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i98112ec95e1d4aab9f4cde79cf53b385_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icc9427fc9d114228a3d3efa6bcb432e9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i208fa7e6f0334944b10d285de0b70711_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8f08a738c5804d11b70644f0148c895c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib527ecaf883c4b36bb71ff0a85b4d81a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i338f15fece2f4712847fd4e04333fc1d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i975831888a86459eb1bac2b48531332d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i19a2acf57ffa4509ab771b661fcea999_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1c039428d6d84b189717417daf0d8fe3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a494abcac9c47fca32926023c31eae6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f07a6ecd11b4fb5b1eaf5f119c9eb51_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4766ba2728754ca5b737ca40088cd12b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5343cf8aa45f4acc956a10119ecd34d5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5096412349bf441a965c02745c0985c1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3694f852a462494f91d7c0a3b1211df9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:NidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6e7331c77972481e85855c53b18546a4_D20220201-20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="i8a6f1832ce5e4035a5b9b14f52d94a3f_I20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-01</instant>
        </period>
    </context>
    <context id="icbfee6ac293a4d0693346eada0d23f20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i38a07547d99340ac959c9e338dbbd36c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2934d884c7734d478ccf8f3700348ced_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66fc5387af244c48b34e4b6ff0662c58_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib4c6d71b26c14be794b19fdcba867621_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i33dd72fa523b4d1d80a0eabd16074f43_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if6f1ed6fbd9646ca9077dc5312767b5f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="claim">
        <measure>dgx:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl80L2ZyYWc6MDM0MmEzYzIwYTdkNDZiYjhjNWI4MGU0ZmIyNjE2OTMvdGFibGU6M2ZhYTlhNzMxNzVlNDdmYTkwODY1OWRlZTBhNGFiZTQvdGFibGVyYW5nZTozZmFhOWE3MzE3NWU0N2ZhOTA4NjU5ZGVlMGE0YWJlNF8yLTEtMS0xLTIwOTI1_3881cce3-b3e0-4df8-a0f1-ef487d2bc10f">0001022079</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl80L2ZyYWc6MDM0MmEzYzIwYTdkNDZiYjhjNWI4MGU0ZmIyNjE2OTMvdGFibGU6M2ZhYTlhNzMxNzVlNDdmYTkwODY1OWRlZTBhNGFiZTQvdGFibGVyYW5nZTozZmFhOWE3MzE3NWU0N2ZhOTA4NjU5ZGVlMGE0YWJlNF80LTEtMS0xLTIwOTI1_7dc9861d-dfe8-4565-9fd3-e68de7c56b57">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl80L2ZyYWc6MDM0MmEzYzIwYTdkNDZiYjhjNWI4MGU0ZmIyNjE2OTMvdGFibGU6M2ZhYTlhNzMxNzVlNDdmYTkwODY1OWRlZTBhNGFiZTQvdGFibGVyYW5nZTozZmFhOWE3MzE3NWU0N2ZhOTA4NjU5ZGVlMGE0YWJlNF81LTEtMS0xLTIwOTI1_b25c1880-da3a-41c9-b5c6-2be5192925f5">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl80L2ZyYWc6MDM0MmEzYzIwYTdkNDZiYjhjNWI4MGU0ZmIyNjE2OTMvdGFibGU6M2ZhYTlhNzMxNzVlNDdmYTkwODY1OWRlZTBhNGFiZTQvdGFibGVyYW5nZTozZmFhOWE3MzE3NWU0N2ZhOTA4NjU5ZGVlMGE0YWJlNF82LTEtMS0xLTIwOTI1_b9d8da9f-f7db-4947-863a-95738f749636">false</dei:AmendmentFlag>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2807cd7680bc4bb4925dda96c4f03f1e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1MDYw_1d199ab7-3192-43a9-a2e6-2c9e9839ee94">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i31a2f97bd63f4c42b34883f22a329ad2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1Mjcw_88e6f6e4-a789-4494-8767-bda409fe0bc3">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5e3f8aa3f21c4630b2c2d3a505ba4881_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE5MTMy_22152b9e-6ae5-4ec5-ae0f-101ca8483d0a">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iba7313c4a10443ea84ad938944fb4263_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODEvZnJhZzo2OWM0NWUzNGM5OTE0YmIyOGMwZDExOWQzYjllZjg0Zi90YWJsZTphZWRiNTBjODNlZWE0ODJhYjU5MmVhNWEwZTkzZDAzNy90YWJsZXJhbmdlOmFlZGI1MGM4M2VlYTQ4MmFiNTkyZWE1YTBlOTNkMDM3XzEtMS0xLTEtMjA5MjU_ad17d72e-12ff-4028-a9b3-6cb270168a3d">P31Y6M</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_50c95c33-a401-4066-8573-e62f6ca75cd3">http://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAsset</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_6f7e233a-96d4-4732-aa53-9f719523830d">http://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAsset</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_1997e471-5c97-4a99-87d8-0ad010e8dfa3">http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_2b9b9016-510b-480e-96bb-962223d0e820">http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_375a58c6-c5ec-4296-b7ed-b111e088fff7">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_b44b257f-98c9-4e44-912d-5c75a894370c">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_0ffa204f-63da-4cb5-97eb-2b95e023c547">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_47976c32-56f0-4b24-a8fa-f838f8d5f156">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dgx:AgreementtoOutsourceBillingandCollectionFunction
      contextRef="i9a2973ec261740218274bc1cb13b32b6_D20160901-20160930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzExMzc_708f737c-5f7e-406e-a9c5-dbbc99a6dcd3">P10Y</dgx:AgreementtoOutsourceBillingandCollectionFunction>
    <dei:DocumentType
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM5_221131c2-498a-416c-9a89-8846878f29ab">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTMz_afc0af55-20be-4816-a97a-d0d88b7c9003">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8yMTM_4cec85ae-179e-488e-9454-4fdeff021d55">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8yMTM_6594aa33-2814-4f15-ad14-2269aed98556">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM0_9f43e3ad-5402-444a-9c9f-bbbc811b3705">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM1_973e38ff-51dc-49f6-bfe4-d4a8b8fcfff6">001-12215</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM2_3aa4867d-7a27-443e-8e5e-3621f53a1b56">Quest Diagnostics Inc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8wLTAtMS0xLTIwOTI1_a4613d5c-b362-4b78-a7bd-45c008763fb3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8wLTUtMS0xLTIwOTI1_0438ce41-21dd-41b1-ad3b-baf9524bbdd5">16-1387862</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8yLTAtMS0xLTIwOTI1_c86cb1ca-6bbe-4c96-bb8b-bd6b2e9d2cc1">500 Plaza Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8zLTAtMS0xLTIwOTI1_550d5f5d-3d62-4417-a506-88f760777a98">Secaucus,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8zLTEtMS0xLTIwOTI1_d6b9d029-2343-43d8-93e9-bc105222fc0b">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF8zLTItMS0xLTIwOTI1_48797348-d80c-4fe5-bea4-d1876e89d23e">07094</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF80LTAtMS0xLTIwOTI1_93fcf354-264c-4bcb-a7c8-df0fb2fea603">(973)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NDA0MWE5ZWFiZmM5NDRiM2E0MTk3MjUwOWYxNjFlYjAvdGFibGVyYW5nZTo0MDQxYTllYWJmYzk0NGIzYTQxOTcyNTA5ZjE2MWViMF80LTEtMS0xLTIwOTI1_d65a1af5-fe3a-4709-838a-06d21a8b5937">520-2700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NTExYTE5NjM5NjlmNGIxNWFmYjAzYjE3MDhjMzRkNjAvdGFibGVyYW5nZTo1MTFhMTk2Mzk2OWY0YjE1YWZiMDNiMTcwOGMzNGQ2MF8yLTAtMS0xLTIwOTI1_a889e080-9fb1-446e-8ac0-d89441899e6d">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NTExYTE5NjM5NjlmNGIxNWFmYjAzYjE3MDhjMzRkNjAvdGFibGVyYW5nZTo1MTFhMTk2Mzk2OWY0YjE1YWZiMDNiMTcwOGMzNGQ2MF8yLTEtMS0xLTIwOTI1_69c7724a-5bf5-43fb-8326-ff0c8b50c21c">DGX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6NTExYTE5NjM5NjlmNGIxNWFmYjAzYjE3MDhjMzRkNjAvdGFibGVyYW5nZTo1MTFhMTk2Mzk2OWY0YjE1YWZiMDNiMTcwOGMzNGQ2MF8yLTItMS0xLTIwOTI1_a2fbaf3b-2afe-4f05-9bfe-2eecb3d9548e">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTQw_e39059ee-60c4-4e46-b165-259a6eef7ede">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTQx_97c4a37d-26c0-4d08-ab57-dad3c3c74e78">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTQy_55a947d4-eddc-4d99-b49f-01117bfcb506">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM3_5d51d477-ea84-41b2-a1d1-d8891cc30f95">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6ZWRiNmIzZGNlZmQxNGRkYzk1M2MwOWUzNTgxOWUxNmUvdGFibGVyYW5nZTplZGI2YjNkY2VmZDE0ZGRjOTUzYzA5ZTM1ODE5ZTE2ZV8wLTAtMS0xLTIwOTI1_02ff7340-2af8-424d-87a9-c999d2163c1f">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6ZWRiNmIzZGNlZmQxNGRkYzk1M2MwOWUzNTgxOWUxNmUvdGFibGVyYW5nZTplZGI2YjNkY2VmZDE0ZGRjOTUzYzA5ZTM1ODE5ZTE2ZV8xLTMtMS0xLTIwOTI1_939f9b22-0468-4cb4-9aa7-dac4be8c864c">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6ZWRiNmIzZGNlZmQxNGRkYzk1M2MwOWUzNTgxOWUxNmUvdGFibGVyYW5nZTplZGI2YjNkY2VmZDE0ZGRjOTUzYzA5ZTM1ODE5ZTE2ZV8yLTMtMS0xLTIwOTI1_4b34e5c1-b0be-41ab-b56c-90bf32fda4a7">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTMy_2ff3a872-ad04-46af-93ec-12ff19614d3a">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8zMTM4_0171e31e-608e-4d17-afb3-3d3c01214dbd">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i93ead1399e2e4ac494b71ed2bb631561_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8yNzU1_c4a7645e-d708-443f-927c-d08ff37ff3ff"
      unitRef="usd">16100000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i4d0e2c71efc94e228f2767bcedc33dd0_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGV4dHJlZ2lvbjo0ZmZjZTc5NzVkZWY0ZjA5YWFlNTZmZDY4NWNhNzUwZF8yODk3_dff6546a-fc0b-4ca7-8c00-c2c837479e36"
      unitRef="shares">119454781</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xL2ZyYWc6NGZmY2U3OTc1ZGVmNGYwOWFhZTU2ZmQ2ODVjYTc1MGQvdGFibGU6YzdmNWY1ZjI0MGZiNDg4Nzg1Yzc2YmQ3YTZiMGI0NTQvdGFibGVyYW5nZTpjN2Y1ZjVmMjQwZmI0ODg3ODVjNzZiZDdhNmIwYjQ1NF8yLTAtMS0xLTIwOTI1_607fc369-c11c-4fd5-97d3-943ae8b64d4e">Portions of the registrant's Proxy Statement to be filed by April&#160;30, 2022</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xMjEvZnJhZzoxZDJiNmY3NGI3NzY0Mzg2YTY0NTYxMGQ3NDczOTE1Ny90YWJsZTo0NDM4OGI4MjJlMzU0YmUzYWY4OGRmMmNhODg0NTAyZC90YWJsZXJhbmdlOjQ0Mzg4YjgyMmUzNTRiZTNhZjg4ZGYyY2E4ODQ1MDJkXzItMC0xLTEtNDA2NDYvdGV4dHJlZ2lvbjpjYjk3N2M5MmI4YjQ0ZTkxOWI4YmM0MzIxMDVlMDM1M18yNzQ4Nzc5MDY5NTM1_a72c51a2-4719-4677-96dd-e29cf8ac50c5">238</dei:AuditorFirmId>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xMzkvZnJhZzo3NDJmODE1ZjZhNjk0YjJhYTY2MjkzZGUzNDIxYzhkNy90ZXh0cmVnaW9uOjc0MmY4MTVmNmE2OTRiMmFhNjYyOTNkZTM0MjFjOGQ3XzEyNzg_c27f3a69-6c4c-49c4-a1b8-4fa09c4a1a21"
      unitRef="usd">4400000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xMzkvZnJhZzo3NDJmODE1ZjZhNjk0YjJhYTY2MjkzZGUzNDIxYzhkNy90ZXh0cmVnaW9uOjc0MmY4MTVmNmE2OTRiMmFhNjYyOTNkZTM0MjFjOGQ3XzEyODU_88db4277-5ec6-4eff-8ab2-757e81339c2d"
      unitRef="usd">4600000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib618186b3e3648a0a5c22c9e567fe03f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xMzkvZnJhZzo3NDJmODE1ZjZhNjk0YjJhYTY2MjkzZGUzNDIxYzhkNy90ZXh0cmVnaW9uOjc0MmY4MTVmNmE2OTRiMmFhNjYyOTNkZTM0MjFjOGQ3Xzc2OTY1ODE0MDk3MzI_bf2840f9-6875-4fb7-8ed3-7a2350743c21"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i4a05287b4f02418c82cd5f2e6e79c6dc_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2MTc_d47a07ee-c7f9-49da-a91f-b2c95997e6b5"
      unitRef="number">0.32</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i37a9f450d5fc42bd8a4cedc5a182bb1d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2MjI_646ce812-164c-4ac2-9eb4-a4a80ea0b577"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i93a20c5e9811442496e0ddbc0d32b35f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2MjI_9d9b707a-c902-43fe-8302-4a01065fbde0"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i30f9993ad61e49b8889d85cebdd9a0ca_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2Mjc_e1f842cf-169c-4fe5-9fbc-3757edb821dd"
      unitRef="number">0.38</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="icb3cd0ebcab8404c8e2d53703218de07_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2MzI_69834b97-aabb-416b-a00f-133c527d00c4"
      unitRef="number">0.21</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i1d0d6530dd894b1c87f220eb4e22a87b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2NDk_2d813632-dae2-4c19-986f-53e15273c5f7"
      unitRef="number">0.97</dgx:PercentageofNetAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90ZXh0cmVnaW9uOjM1NzgwYzA1MDYzYjQ3YmE4YjQwNjUyYzdlZDcwNzYzXzEwOTk1MTE2Mzc2NTQ_285ddf19-2931-4f46-b858-858304e8ccc3"
      unitRef="usd">1438000000</us-gaap:AccountsReceivableNetCurrent>
    <dei:AuditorName
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90YWJsZTo3NDcxNzAzNDQ3NWU0NTAzOWZjY2UyZWMwYWU5Y2MyMS90YWJsZXJhbmdlOjc0NzE3MDM0NDc1ZTQ1MDM5ZmNjZTJlYzBhZTljYzIxXzAtMS0xLTEtMzc4ODE_1712200f-42e3-4d37-8b1d-4f88a98f70c8">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTEvZnJhZzozNTc4MGMwNTA2M2I0N2JhOGI0MDY1MmM3ZWQ3MDc2My90YWJsZTo3NDcxNzAzNDQ3NWU0NTAzOWZjY2UyZWMwYWU5Y2MyMS90YWJsZXJhbmdlOjc0NzE3MDM0NDc1ZTQ1MDM5ZmNjZTJlYzBhZTljYzIxXzItMS0xLTEtMzc4ODQ_467eb1ba-7e9e-4873-ba1a-f6d02a7edaae">Florham Park, New Jersey</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMtMS0xLTEtMjA5MjU_27517ed7-b0b0-4b2b-8881-91c4c049cc06"
      unitRef="usd">872000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMtMy0xLTEtMjA5MjU_5cfa3ab7-51b9-4e46-a6a0-8d10161faebe"
      unitRef="usd">1158000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQtMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjo1MDVlNjA5NmJhODU0NTY4OWFmOWQ0NjE2M2I1ZWYxMF8xMDk5NTExNjI3OTAw_691ffbcd-31ca-45e9-ba7a-cd2bcf2af354"
      unitRef="usd">31000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQtMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjo1MDVlNjA5NmJhODU0NTY4OWFmOWQ0NjE2M2I1ZWYxMF8xMDk5NTExNjI3ODk2_7f6c0409-1e66-42f4-bc37-a0ffe87d7bf3"
      unitRef="usd">28000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQtMS0xLTEtMjA5MjU_285ddf19-2931-4f46-b858-858304e8ccc3"
      unitRef="usd">1438000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQtMy0xLTEtMjA5MjU_5d20b201-0bc2-4085-93d7-2769559959ee"
      unitRef="usd">1520000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzUtMS0xLTEtMjA5MjU_64060797-391c-4c43-a460-74643d20052a"
      unitRef="usd">208000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzUtMy0xLTEtMjA5MjU_7208254b-e86c-4aab-8547-87c7cbd79287"
      unitRef="usd">223000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzYtMS0xLTEtMjA5MjU_2fa568e6-3e1e-4f72-9dab-b31c792bb286"
      unitRef="usd">223000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzYtMy0xLTEtMjA5MjU_9dfe6649-be9e-4903-a787-7faae68c9fe7"
      unitRef="usd">157000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzgtMS0xLTEtMjA5MjU_57e18538-ad47-4313-8689-a4d01f26fd76"
      unitRef="usd">2741000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzgtMy0xLTEtMjA5MjU_aa77d55c-f0bd-4419-97d3-15db9ba04af7"
      unitRef="usd">3058000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzktMS0xLTEtMjA5MjU_328387e7-9383-4cc6-89c1-d97c37363837"
      unitRef="usd">1707000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzktMy0xLTEtMjA5MjU_9c163745-f455-44d7-a143-78881170ea07"
      unitRef="usd">1627000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEwLTEtMS0xLTIwOTI1_7f5dba9b-a2e1-42a1-8994-78632d838697"
      unitRef="usd">597000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEwLTMtMS0xLTIwOTI1_7dc651ce-2a7b-4f9b-b497-77b4437d0008"
      unitRef="usd">604000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzExLTEtMS0xLTIwOTI1_fee12d31-0146-4f57-ad36-353122e804c3"
      unitRef="usd">7095000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzExLTMtMS0xLTIwOTI1_b754603a-b1ab-48c3-a2f6-ce7e56d804a6"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEyLTEtMS0xLTIwOTI1_7072a44d-75f0-49ce-8e04-ca37816a4fc1"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEyLTMtMS0xLTIwOTI1_a2251242-28db-4576-b44a-2ee591f8ae2f"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEzLTEtMS0xLTIwOTI1_0e1823bb-83a1-4662-839c-2e2ba4b06b8b"
      unitRef="usd">141000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzEzLTMtMS0xLTIwOTI1_fc77f7dc-95c3-4882-8f54-cd43aabcb62e"
      unitRef="usd">521000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzE0LTEtMS0xLTIwOTI1_be43fa96-3689-4a88-b093-e1e3cf0b72ef"
      unitRef="usd">163000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzE0LTMtMS0xLTIwOTI1_1e5687d0-0a0d-4500-ad28-f21ecf2b0738"
      unitRef="usd">176000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzE2LTEtMS0xLTIwOTI1_82ce2186-d2ba-4f48-aad1-eef611e49c61"
      unitRef="usd">13611000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzE2LTMtMS0xLTIwOTI1_c0fede22-464b-43c6-9da8-7cf693283278"
      unitRef="usd">14026000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIwLTEtMS0xLTIwOTI1_56e90e76-8b72-46e5-a951-12bdbddcf0f4"
      unitRef="usd">1600000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIwLTMtMS0xLTIwOTI1_cd70d019-f25c-4b38-b165-b53d2d441e9e"
      unitRef="usd">1633000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIxLTEtMS0xLTIwOTI1_f95e4f2f-d6c4-4b82-8beb-0719828233ed"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIxLTMtMS0xLTIwOTI1_50bc436e-8113-49d0-815f-376c2472ab6b"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIyLTEtMS0xLTIwOTI1_d515ec79-9f4a-4ea5-83e9-a33e45140dcd"
      unitRef="usd">151000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIyLTMtMS0xLTIwOTI1_57e7b086-4a4a-4e1f-96c1-c63b7d24dbfb"
      unitRef="usd">141000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIzLTEtMS0xLTIwOTI1_a6d5e4e6-4748-4ef5-86a3-0c153ebdf1db"
      unitRef="usd">1753000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzIzLTMtMS0xLTIwOTI1_7327bfe5-5611-4615-9f1a-ba23a9c3e729"
      unitRef="usd">1776000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI0LTEtMS0xLTIwOTI1_4e6f1ac0-8454-4a22-9939-0f22cd940430"
      unitRef="usd">4010000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI0LTMtMS0xLTIwOTI1_aa6a8fbd-7e99-401a-b696-2a0d79cc6ec1"
      unitRef="usd">4013000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI1LTEtMS0xLTIwOTI1_0dfe896d-44f1-46a9-b8a1-9a7e389474c0"
      unitRef="usd">494000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI1LTMtMS0xLTIwOTI1_0e8557c5-ba1e-452e-af65-757192537d21"
      unitRef="usd">499000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI2LTEtMS0xLTIwOTI1_dbba11cc-ad09-4ac7-ab3b-9cd69c73e5a6"
      unitRef="usd">792000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI2LTMtMS0xLTIwOTI1_03d13f81-2ffd-4966-973c-c27cb7cb773a"
      unitRef="usd">847000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI4LTEtMS0xLTIwOTI1_c5af2c01-da8f-43ff-89f0-0973fd6000bf"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI4LTMtMS0xLTIwOTI1_738bd417-6ed8-406e-a8ad-9ba5a5f02691"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI5LTEtMS0xLTIwOTI1_8d00f3ea-3ca8-463c-9b14-fc6b45837f49"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzI5LTMtMS0xLTIwOTI1_b015b385-7cfc-4648-ac84-51a94c7db2d5"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfMjg_7f032837-50f6-4a6b-b90d-9b7e89e02135"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfMjg_d04c5e03-2a34-49e7-915a-82bc63e39bbd"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfNDI_0b241fcf-31af-470e-b5c2-272bc1575185"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfNDI_b76405a1-e587-4009-bf51-db76d271c5aa"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfMTA5OTUxMTYyNzk0NQ_f6fa5bfb-ea07-48f3-8cdb-cb6556088946"
      unitRef="shares">162000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ODI4NWY1NTgzOTlmNGRjM2EyN2RjOGQzMmQzZjFjNDRfMTAy_1959520b-f189-4b04-b55b-24c50971bb5e"
      unitRef="shares">217000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTEtMS0xLTIwOTI1_8e776d28-7ecf-4c23-a9ac-d0927389dadf"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMyLTMtMS0xLTIwOTI1_e7d1c35a-d21d-4ea4-95c4-115ebfa9cf7c"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMzLTEtMS0xLTIwOTI1_57b05998-97c7-4307-9366-e9ffac6cd2bf"
      unitRef="usd">2260000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzMzLTMtMS0xLTIwOTI1_e4dc71fa-56fd-4646-a905-411c71302c7e"
      unitRef="usd">2841000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM0LTEtMS0xLTIwOTI1_d167a083-135c-4422-b6e6-a51db83e8520"
      unitRef="usd">7649000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM0LTMtMS0xLTIwOTI1_e19ce841-4e42-4acb-b694-eff5fb34a21f"
      unitRef="usd">9303000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM1LTEtMS0xLTIwOTI1_15e71b96-5f5d-46c3-a0cd-040c38c56900"
      unitRef="usd">-14000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM1LTMtMS0xLTIwOTI1_b1207023-3afd-466d-ae79-0bdd20ef9d76"
      unitRef="usd">-21000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM2LTAtMS0xLTIwOTI1L3RleHRyZWdpb246MThlNTYxMDFhYWRiNGEyZWJhOTRhOTY0YTY1MTUyNGRfMTA5OTUxMTYyNzg4OQ_742d49cb-2fc2-421a-bb77-ef84ce0d58a6"
      unitRef="shares">43000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM2LTAtMS0xLTIwOTI1L3RleHRyZWdpb246MThlNTYxMDFhYWRiNGEyZWJhOTRhOTY0YTY1MTUyNGRfMTA5OTUxMTYyNzg4NQ_a4b5ecfd-350c-4b7e-937f-dd32e1a23072"
      unitRef="shares">84000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM2LTEtMS0xLTIwOTI1_10011f19-3a41-4d84-a03b-4bd2be1c6f3d"
      unitRef="usd">3453000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM2LTMtMS0xLTIwOTI1_21798de7-ed26-4e69-ab2a-8687018acb1b"
      unitRef="usd">5366000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM3LTEtMS0xLTIwOTI1_4601f6e9-a726-4f71-b143-efa058550a7b"
      unitRef="usd">6444000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM3LTMtMS0xLTIwOTI1_68b7b8d8-e8b7-42d6-aa50-e45f7710eb69"
      unitRef="usd">6759000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM4LTEtMS0xLTIwOTI1_9d7db6ad-7adf-48bb-8c15-b59f25f5083b"
      unitRef="usd">39000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM4LTMtMS0xLTIwOTI1_51370587-e79b-4fb6-a3b5-38beed3b3786"
      unitRef="usd">50000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM5LTEtMS0xLTIwOTI1_f7291849-6c50-45da-9a6a-22e84faf36f7"
      unitRef="usd">6483000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzM5LTMtMS0xLTIwOTI1_bd133411-162b-49b4-b5b3-4d2478740072"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQwLTEtMS0xLTIwOTI1_3afa000c-1cb0-4193-b357-ae787d395e0d"
      unitRef="usd">13611000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNTcvZnJhZzphNDgxNGY5ODkzZDU0MTQyOWFjM2JmMjA0YWE4MjUwYi90YWJsZTo1YTBjNGYyNGVmZmI0NmIxOWUyM2NmNWVkN2QxYjZhZS90YWJsZXJhbmdlOjVhMGM0ZjI0ZWZmYjQ2YjE5ZTIzY2Y1ZWQ3ZDFiNmFlXzQwLTMtMS0xLTIwOTI1_b9bb3099-3097-4090-a765-2e1ca8ecf93b"
      unitRef="usd">14026000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzItMS0xLTEtMjA5MjU_5b35bdd6-a97c-4bed-b52a-c126914a9336"
      unitRef="usd">10788000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzItMy0xLTEtMjA5MjU_0d1e3c02-ccd7-41b6-b4dc-d96a5652724d"
      unitRef="usd">9437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzItNS0xLTEtMjA5MjU_89dea8f0-201a-4955-8aa5-2ae7af2e2548"
      unitRef="usd">7726000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzUtMS0xLTEtMjA5MjU_d8070039-5b51-413d-ab31-767f98468b23"
      unitRef="usd">6579000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzUtMy0xLTEtMjA5MjU_b0ff2c81-c249-4b4f-b065-a95d9dcb0833"
      unitRef="usd">5804000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzUtNS0xLTEtMjA5MjU_16eeb2eb-a97a-48ac-bfc7-e42658c04f57"
      unitRef="usd">5037000000</us-gaap:CostOfRevenue>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzYtMS0xLTEtMjA5MjU_a252c8cd-561e-4868-bca6-240c8814cfa3"
      unitRef="usd">1727000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzYtMy0xLTEtMjA5MjU_34dc4d6c-6458-4bb9-938c-0ad45978fe63"
      unitRef="usd">1550000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzYtNS0xLTEtMjA5MjU_60735763-6f02-48b3-a029-d4114f29aaaa"
      unitRef="usd">1457000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzctMS0xLTEtMjA5MjU_faa64d11-9cd2-4c91-b856-da52713bf66a"
      unitRef="usd">103000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzctMy0xLTEtMjA5MjU_29576cfd-4c07-43cb-af40-eb9ce15043b0"
      unitRef="usd">103000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzctNS0xLTEtMjA5MjU_9d5d6b62-f4bd-4214-9bec-ce438fdf0000"
      unitRef="usd">96000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzgtMS0xLTEtMjA5MjU_7f057593-38ea-47b8-97cf-e68f09766c44"
      unitRef="usd">2000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzgtMy0xLTEtMjA5MjU_c7579909-e95b-4bf1-9fe1-442a8cf0b732"
      unitRef="usd">-9000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzgtNS0xLTEtMjA5MjU_7520012c-1b3f-4919-813b-3f77a29ba8b0"
      unitRef="usd">95000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostsAndExpenses
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzktMS0xLTEtMjA5MjU_8da1e535-6fb5-4a5d-ab37-0e15f57ed0ec"
      unitRef="usd">8407000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzktMy0xLTEtMjA5MjU_03f62493-1fc2-426d-83bb-d6ecf05e8570"
      unitRef="usd">7466000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzktNS0xLTEtMjA5MjU_30ad7bfc-2140-4db0-92c5-1b02e2b94f61"
      unitRef="usd">6495000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzExLTEtMS0xLTIwOTI1_497f27e5-5147-4403-a8e2-435db1d246a7"
      unitRef="usd">2381000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzExLTMtMS0xLTIwOTI1_5ba33e90-17d8-4d45-83fa-3f16b6e87fc1"
      unitRef="usd">1971000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzExLTUtMS0xLTIwOTI1_ef091698-553b-445d-a7cc-c5faae637535"
      unitRef="usd">1231000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE0LTEtMS0xLTIwOTI1_7f659fd8-b251-485d-9d6c-14bbccf82d0b"
      unitRef="usd">-151000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE0LTMtMS0xLTIwOTI1_23cf9e3e-937f-48e1-af46-e2bfb5851dba"
      unitRef="usd">-163000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE0LTUtMS0xLTIwOTI1_1fab77bd-c637-4cd4-9d58-214c83209029"
      unitRef="usd">-175000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE1LTEtMS0xLTIwOTI1_c54a1a02-6958-48f2-8a59-f40669f04b2a"
      unitRef="usd">369000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE1LTMtMS0xLTIwOTI1_29df900c-126b-4be3-96ff-7c52249cea07"
      unitRef="usd">76000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE1LTUtMS0xLTIwOTI1_f9213044-7e22-4814-8cb5-da01d3dbcf3d"
      unitRef="usd">20000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE2LTEtMS0xLTIwOTI1_9c3b09bd-3a7c-4ced-ad34-bce1442334ec"
      unitRef="usd">218000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE2LTMtMS0xLTIwOTI1_31bb6a8f-a79c-4aab-8772-5820fb650988"
      unitRef="usd">-87000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE2LTUtMS0xLTIwOTI1_fec60e26-8d73-4368-a127-8d0a17f47965"
      unitRef="usd">-155000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE4LTEtMS0xLTIwOTI1_66958641-b546-49c9-a51d-ba1af5faf2a5"
      unitRef="usd">2599000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE4LTMtMS0xLTIwOTI1_7574e637-c1aa-4884-ac2d-68d9ead65ba9"
      unitRef="usd">1884000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE4LTUtMS0xLTIwOTI1_76a07075-9ad5-4ae6-95d2-fd1e5009eaf5"
      unitRef="usd">1076000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE5LTEtMS0xLTIwOTI1_6b6adecc-b48f-48fe-90a8-ec9b01b991fa"
      unitRef="usd">597000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE5LTMtMS0xLTIwOTI1_8b0908a2-0366-4ba2-8c8d-5e9ee64c1512"
      unitRef="usd">460000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzE5LTUtMS0xLTIwOTI1_e6d5014b-1ddb-4b7a-bb74-c0bffdc7e8aa"
      unitRef="usd">247000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIwLTEtMS0xLTIwOTI1_14f94a7d-78f2-4681-b861-fae8284b4c11"
      unitRef="usd">78000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIwLTMtMS0xLTIwOTI1_547dacc5-0b6c-4361-906d-b3b33075e3ca"
      unitRef="usd">75000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIwLTUtMS0xLTIwOTI1_930c1114-9ebc-4e94-a9a2-850a67a0b8c6"
      unitRef="usd">57000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIzLTEtMS0xLTIwOTI1_0ded4108-2726-4e60-a141-ce5e7c2d6238"
      unitRef="usd">2080000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIzLTMtMS0xLTIwOTI1_dfabc4b0-b27f-48db-886b-630ed697a414"
      unitRef="usd">1499000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzIzLTUtMS0xLTIwOTI1_5b782a79-e946-40d4-b7ce-44965d573eb7"
      unitRef="usd">886000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI0LTEtMS0xLTIwOTI1_f2588ba8-744b-4936-9ad2-8f07390a700b"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI0LTMtMS0xLTIwOTI1_250c12a9-d848-4672-bb22-2bbcc9a003c4"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI0LTUtMS0xLTIwOTI1_1416bd74-5b94-47ae-9d29-6a8f72ad2bd6"
      unitRef="usd">20000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI1LTEtMS0xLTIwOTI1_6674bd49-c4b0-410b-bfde-a25301e2859a"
      unitRef="usd">2080000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI1LTMtMS0xLTIwOTI1_db78103c-0c95-4f69-9f94-bbb293e50b99"
      unitRef="usd">1499000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI1LTUtMS0xLTIwOTI1_ab79e4e6-0a8a-4b79-be90-216b6f61c4f6"
      unitRef="usd">906000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI2LTEtMS0xLTIwOTI1_c5abae76-1eb3-472c-a7f9-267f3deb3c09"
      unitRef="usd">85000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI2LTMtMS0xLTIwOTI1_97d9a95c-2a8c-4d37-8925-05a8aac073f2"
      unitRef="usd">68000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI2LTUtMS0xLTIwOTI1_c3a1a0fb-280b-417c-b542-e9af5b0041ed"
      unitRef="usd">48000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI3LTEtMS0xLTIwOTI1_4c399235-ed45-41f8-b511-eeb8db66d178"
      unitRef="usd">1995000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI3LTMtMS0xLTIwOTI1_6c31afe0-f480-490a-a017-441163c5608d"
      unitRef="usd">1431000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzI3LTUtMS0xLTIwOTI1_3554eb6e-b8e5-47b8-873f-a83b28f6ed22"
      unitRef="usd">858000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMwLTEtMS0xLTIwOTI1_4c79b348-7d6b-4267-b3c7-c4fb41306426"
      unitRef="usd">1995000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMwLTMtMS0xLTIwOTI1_44066cc6-da0c-4b95-853f-9fb1939d81f8"
      unitRef="usd">1431000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMwLTUtMS0xLTIwOTI1_8e61a124-ba2f-41db-ac0c-f530a6a98223"
      unitRef="usd">838000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMxLTEtMS0xLTIwOTI1_65d16c9d-aaa4-466a-a87a-8998cdc275dd"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMxLTMtMS0xLTIwOTI1_b773ada2-3fc6-4a12-aac7-3b3e140fe85f"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMxLTUtMS0xLTIwOTI1_1ea047f3-2882-476b-93c0-4853d40ffd0d"
      unitRef="usd">20000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMyLTEtMS0xLTIwOTI1_da70d4f9-abf5-4267-88d5-be952522fcdb"
      unitRef="usd">1995000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMyLTMtMS0xLTIwOTI1_2f667f06-19a1-4adb-8b72-8a800cf54fbc"
      unitRef="usd">1431000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzMyLTUtMS0xLTIwOTI1_38de0e6f-3ef7-4984-870d-b2775fe3c239"
      unitRef="usd">858000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM1LTEtMS0xLTIwOTI1_953ed003-e6d3-40ed-955e-043a10bd2a69"
      unitRef="usdPerShare">15.85</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM1LTMtMS0xLTIwOTI1_1e03e1c2-ed95-45b0-ad44-d0451a37ce0e"
      unitRef="usdPerShare">10.62</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM1LTUtMS0xLTIwOTI1_64651a85-ad9e-46d5-be60-2ab6b80be41c"
      unitRef="usdPerShare">6.21</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM2LTEtMS0xLTIwOTI1_cbbd7fa1-afa7-456b-b4ec-adbf4aa5cc1f"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM2LTMtMS0xLTIwOTI1_82de0d56-0a83-417a-b5ee-5fee0ba19a84"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM2LTUtMS0xLTIwOTI1_bfea90f3-55bd-43b8-acfd-88d209fa2251"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM3LTEtMS0xLTIwOTI1_a64d5008-dda3-4b76-860c-ffda7eb08ac8"
      unitRef="usdPerShare">15.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM3LTMtMS0xLTIwOTI1_c9aba9b3-0623-4bb9-9e23-2e6972871f1d"
      unitRef="usdPerShare">10.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzM3LTUtMS0xLTIwOTI1_9d1cb49b-ffa7-4877-941e-ddfd09d324de"
      unitRef="usdPerShare">6.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQwLTEtMS0xLTIwOTI1_80e055a0-cd53-4a2b-8cb9-22f57aa7aaf6"
      unitRef="usdPerShare">15.55</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQwLTMtMS0xLTIwOTI1_b33059a8-60a7-402c-b92f-1e93a8d77795"
      unitRef="usdPerShare">10.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQwLTUtMS0xLTIwOTI1_28d05ca0-a8d5-4fa6-a2a5-22c16e096b0e"
      unitRef="usdPerShare">6.13</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQxLTEtMS0xLTIwOTI1_c53a973f-e19f-4efa-bab6-f241309fc6de"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQxLTMtMS0xLTIwOTI1_a8bc936e-feaa-465e-b2f8-d94930a77cdd"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQxLTUtMS0xLTIwOTI1_89b1df81-335f-47f0-8b93-05ef35f2f95e"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQyLTEtMS0xLTIwOTI1_878ace95-b408-460f-9c89-b7fb20e305fc"
      unitRef="usdPerShare">15.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQyLTMtMS0xLTIwOTI1_95907647-caf3-45fa-b544-ba9796956b57"
      unitRef="usdPerShare">10.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjAvZnJhZzo4N2JjYjA5YjNiYTM0YWYwODFlY2JhNzg3YjZiMzUyZS90YWJsZTpjY2E3MmFlMGZjNjI0NWNkYTdlNDdkNDM0NzUyNDMyOS90YWJsZXJhbmdlOmNjYTcyYWUwZmM2MjQ1Y2RhN2U0N2Q0MzQ3NTI0MzI5XzQyLTUtMS0xLTIwOTI1_c120066b-7d4b-4ae7-b8e9-0da9340a9bb8"
      unitRef="usdPerShare">6.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzItMS0xLTEtMjA5MjU_6674bd49-c4b0-410b-bfde-a25301e2859a"
      unitRef="usd">2080000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzItMy0xLTEtMjA5MjU_f87b2a42-2061-4f13-a03c-5921b054ac75"
      unitRef="usd">1499000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzItNS0xLTEtMjA5MjU_d217ba5e-7cbf-4131-9d41-7b18481bf781"
      unitRef="usd">906000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzUtMS0xLTEtMjA5MjU_8ccaa948-4681-4af0-bea4-32076e788fc4"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzUtMy0xLTEtMjA5MjU_4bea3f84-33b5-4822-a6bd-232801d7d19f"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzUtNS0xLTEtMjA5MjU_55a8f51d-b8a6-4a18-87ac-6424820d15eb"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzYtMS0xLTEtMjA5MjU_24ea983d-7b84-4f0e-8958-54eeba703899"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzYtMy0xLTEtMjA5MjU_4794c83d-c8bd-4799-aa63-b5858c5c15f1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzYtNS0xLTEtMjA5MjU_77f70ddd-3f0d-4743-9597-402585d99acb"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzctMS0xLTEtMjA5MjU_4ecb65b5-ad49-441f-aced-ec1ebba94f46"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzctMy0xLTEtMjA5MjU_06cce5cf-dfec-4635-9166-bdc49d3eee5b"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzctNS0xLTEtMjA5MjU_24d7845d-21bc-41bd-9361-3b9be7a0b63b"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzktMS0xLTEtMjA5MjU_e3795d59-5297-4d7d-8004-e65ad6a05e00"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzktMy0xLTEtMjA5MjU_c8e8524b-37d2-4138-9395-8d5eb6a990d4"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzktNS0xLTEtMjA5MjU_aa831106-9b44-4beb-92a1-66f209dc4530"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzExLTEtMS0xLTIwOTI1_0bd37ce5-3ed7-47a9-802f-e975f8137407"
      unitRef="usd">2087000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzExLTMtMS0xLTIwOTI1_8423e76a-d951-49f3-8268-bca47615ea1b"
      unitRef="usd">1517000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzExLTUtMS0xLTIwOTI1_6a3b4822-9277-4d98-b55b-00602ed2c759"
      unitRef="usd">926000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEyLTEtMS0xLTIwOTI1_89a4d36c-19ff-4fe5-bc9b-0c7e9b6c9b56"
      unitRef="usd">85000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEyLTMtMS0xLTIwOTI1_c5bb555c-0774-49e3-9ca6-8c6bf5f07d66"
      unitRef="usd">68000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEyLTUtMS0xLTIwOTI1_b830d5ce-4564-4e09-8965-292d078eee0d"
      unitRef="usd">48000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEzLTEtMS0xLTIwOTI1_aa4b824b-7715-47c6-85a2-7305769ced83"
      unitRef="usd">2002000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEzLTMtMS0xLTIwOTI1_89f615bd-e380-4f1a-a88a-25894edca624"
      unitRef="usd">1449000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjMvZnJhZzpkMGZmYTI1YzBhNWE0ZTY5YmVmZDIyZmVmM2VjMDllYy90YWJsZTphNWJjMzliYjE0NmE0NDc0YmY1NTgyYmNhNWNlZTY4Zi90YWJsZXJhbmdlOmE1YmMzOWJiMTQ2YTQ0NzRiZjU1ODJiY2E1Y2VlNjhmXzEzLTUtMS0xLTIwOTI1_e7aa9565-a4a6-481e-a7e3-f4e68942ac69"
      unitRef="usd">878000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzItMS0xLTEtMjA5MjU_0e50e4d3-53b1-4fe5-847b-8fdbc8a889cb"
      unitRef="usd">2080000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzItMy0xLTEtMjA5MjU_11e60c18-65f9-4310-aaca-bdcdbffd79c5"
      unitRef="usd">1499000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzItNS0xLTEtMjA5MjU_977f41d2-c7ba-4820-bd45-fba682f0411f"
      unitRef="usd">906000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQtMS0xLTEtMjA5MjU_8ac66da0-2bba-433b-a723-b9ea37f448e8"
      unitRef="usd">408000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQtMy0xLTEtMjA5MjU_bfe0290a-4b4f-423f-95cd-b966e5e5a88f"
      unitRef="usd">361000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQtNS0xLTEtMjA5MjU_44fee77d-fe62-4be8-b76b-fe097b8ba6b5"
      unitRef="usd">329000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUtMS0xLTEtMjA5MjU_06a1f676-f4b8-459f-b8d4-1a10385fe2a1"
      unitRef="usd">4000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUtMy0xLTEtMjA5MjU_7ac06791-56cc-4f54-9c00-796b2c6dc275"
      unitRef="usd">19000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUtNS0xLTEtMjA5MjU_8a044799-dbb6-4142-8f07-915d15757d02"
      unitRef="usd">11000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzYtMS0xLTEtMjA5MjU_1e3fbf3a-bf3d-453b-87f2-b6d844381d7b"
      unitRef="usd">-57000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzYtMy0xLTEtMjA5MjU_dac73c5a-f3d0-48af-bf15-c1120f749642"
      unitRef="usd">85000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzYtNS0xLTEtMjA5MjU_83d96d12-f3d3-46ec-a37e-5034c0ad1a31"
      unitRef="usd">15000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzctMS0xLTEtMjA5MjU_bbeed6f0-e9e0-47bd-aae3-cd9ec0486682"
      unitRef="usd">79000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzctMy0xLTEtMjA5MjU_672a8dc6-86a6-4da8-b395-6199b31c0c56"
      unitRef="usd">97000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzctNS0xLTEtMjA5MjU_2173d1eb-da0f-4c32-a618-18e56a3cb32b"
      unitRef="usd">56000000</us-gaap:ShareBasedCompensation>
    <dgx:GainLossOnDispositionOfJointVenture
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzgtMS0xLTEtMjA5MjU_f3ba734d-5f38-455b-99f8-fb76d19b2660"
      unitRef="usd">314000000</dgx:GainLossOnDispositionOfJointVenture>
    <dgx:GainLossOnDispositionOfJointVenture
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzgtMy0xLTEtMjA5MjU_f34936e9-ac6c-4ed4-be70-143227d0943f"
      unitRef="usd">0</dgx:GainLossOnDispositionOfJointVenture>
    <dgx:GainLossOnDispositionOfJointVenture
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzgtNS0xLTEtMjA5MjU_ba96bbf5-9858-41ea-ba95-19a9a6778719"
      unitRef="usd">0</dgx:GainLossOnDispositionOfJointVenture>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzEzLTEtMS0xLTIwOTI1_a60231d9-0a31-4dca-b4ae-89ed9a4506a4"
      unitRef="usd">-9000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzEzLTMtMS0xLTIwOTI1_b5bcde4a-b58d-4b71-b097-fe5a3d5352f3"
      unitRef="usd">-3000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzEzLTUtMS0xLTIwOTI1_d422117b-0af7-4dd4-aef3-52dde697567f"
      unitRef="usd">70000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE0LTEtMS0xLTIwOTI1_67f4ea97-5c2d-4ca7-86ab-407bd68fd670"
      unitRef="usd">63000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE0LTMtMS0xLTIwOTI1_9bcc13e2-2b56-453a-9d1e-a0205ff7781b"
      unitRef="usd">81000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE0LTUtMS0xLTIwOTI1_7ff3391a-37de-4d11-ab86-cec0ebafd71e"
      unitRef="usd">39000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE2LTEtMS0xLTIwOTI1_05a41b9d-5325-434b-8555-7f5532877888"
      unitRef="usd">-81000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE2LTMtMS0xLTIwOTI1_d271bfc8-9660-4896-b2e5-16f1990a64e6"
      unitRef="usd">455000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE2LTUtMS0xLTIwOTI1_637507f3-9ca1-404c-a3a4-567fa2b959da"
      unitRef="usd">63000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE3LTEtMS0xLTIwOTI1_330ee71c-bcda-4cb8-bf4a-c3ed81d105f4"
      unitRef="usd">35000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE3LTMtMS0xLTIwOTI1_dd51723b-0d8b-43ba-85a3-dd374ae13216"
      unitRef="usd">452000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE3LTUtMS0xLTIwOTI1_67525285-215f-48e2-8e61-9d93c3f68414"
      unitRef="usd">73000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE5LTEtMS0xLTIwOTI1_567e2b25-d250-4dc6-806c-54891d449cd1"
      unitRef="usd">-20000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE5LTMtMS0xLTIwOTI1_3b560535-b352-4683-978c-5faa38ecb741"
      unitRef="usd">22000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzE5LTUtMS0xLTIwOTI1_1caf9319-563b-4e85-970b-3d7140c3fe1a"
      unitRef="usd">29000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <dgx:TerminationOfInterestRateSwapAgreements
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIwLTEtMS0xLTIwOTI1_4f046bb4-d350-4052-954b-ad72fc258256"
      unitRef="usd">0</dgx:TerminationOfInterestRateSwapAgreements>
    <dgx:TerminationOfInterestRateSwapAgreements
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIwLTMtMS0xLTIwOTI1_c3aeaf8c-953a-4ef2-a573-05afc90edc47"
      unitRef="usd">40000000</dgx:TerminationOfInterestRateSwapAgreements>
    <dgx:TerminationOfInterestRateSwapAgreements
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIwLTUtMS0xLTIwOTI1_c8fd44f0-67b0-4c5a-a46d-3ce9ffbbc44b"
      unitRef="usd">0</dgx:TerminationOfInterestRateSwapAgreements>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIxLTEtMS0xLTIwOTI1_5267ea6d-8dcb-48f6-8adf-5b21fa30bb5b"
      unitRef="usd">9000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIxLTMtMS0xLTIwOTI1_d67b458f-4fd1-4672-9765-9ef07ba23fc1"
      unitRef="usd">37000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIxLTUtMS0xLTIwOTI1_f6c5435b-0c5b-4a62-8edb-462447982b4b"
      unitRef="usd">4000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIyLTEtMS0xLTIwOTI1_96c52340-6c90-4b8b-9eba-b3172cd427bf"
      unitRef="usd">2233000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIyLTMtMS0xLTIwOTI1_bdf493c9-bd47-4656-9cc5-aa40d861249b"
      unitRef="usd">2005000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzIyLTUtMS0xLTIwOTI1_d073cf09-d4a3-4afe-9608-6b845231908c"
      unitRef="usd">1243000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI1LTEtMS0xLTIwOTI1_4c916d76-7fc8-415b-932f-2a246060f6fa"
      unitRef="usd">331000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI1LTMtMS0xLTIwOTI1_13d76a5c-78f7-4972-b88d-9b97aec925a4"
      unitRef="usd">330000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI1LTUtMS0xLTIwOTI1_dfa57b8b-cb86-4bf7-88fd-b583cdead3e7"
      unitRef="usd">58000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI2LTEtMS0xLTIwOTI1_c669d53f-f11e-4578-a53a-f79dbce40948"
      unitRef="usd">755000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI2LTMtMS0xLTIwOTI1_4dfbeaeb-2bcc-491b-9a40-12d6b3e22dca"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI2LTUtMS0xLTIwOTI1_df204f7d-99a7-4177-85e5-2ec4a776b1ae"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI4LTEtMS0xLTIwOTI1_4313a850-1b97-4297-b109-39428cdaea7a"
      unitRef="usd">3000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI4LTMtMS0xLTIwOTI1_6874530e-e668-4425-a12d-aff178b97ad3"
      unitRef="usd">3000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI4LTUtMS0xLTIwOTI1_f78c8ecd-2dcb-4914-8b42-f9dccc56fa91"
      unitRef="usd">91000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI5LTEtMS0xLTIwOTI1_2e7b3c59-b9d3-4940-8f5e-e989581dcc63"
      unitRef="usd">403000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI5LTMtMS0xLTIwOTI1_ca28a7b2-84f5-453d-b54a-a65d858cfce4"
      unitRef="usd">418000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzI5LTUtMS0xLTIwOTI1_6c2d6312-7586-420c-ba3a-9b691b75c455"
      unitRef="usd">400000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMxLTEtMS0xLTIwOTI1_55c489a3-2477-4592-97ab-c5d1295a0cd7"
      unitRef="usd">3000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMxLTMtMS0xLTIwOTI1_7ca55139-6d01-44b4-9e63-67cbb5bc6f45"
      unitRef="usd">27000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMxLTUtMS0xLTIwOTI1_da5afc3d-a33b-46ab-b4f6-5999c8ed2984"
      unitRef="usd">44000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMyLTEtMS0xLTIwOTI1_1cf6e6d5-6033-4fde-a61e-7bd48f3b50c6"
      unitRef="usd">21000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMyLTMtMS0xLTIwOTI1_df430de0-1b3f-47d8-a3fd-430d5a35b93d"
      unitRef="usd">-772000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzMyLTUtMS0xLTIwOTI1_6c48973a-73e9-4acf-a259-9395b0f2e8d0"
      unitRef="usd">-411000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM1LTEtMS0xLTIwOTI1_6fa79c9c-5dff-4ec1-8b75-9dea668052c1"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM1LTMtMS0xLTIwOTI1_9b127c63-bc77-4c21-a2eb-f8701921d2b8"
      unitRef="usd">749000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM1LTUtMS0xLTIwOTI1_0ba837d9-683a-4b16-906e-b78afc235fc6"
      unitRef="usd">2281000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM2LTEtMS0xLTIwOTI1_62d89d33-51a6-4f41-a30f-a00f851449a1"
      unitRef="usd">2000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM2LTMtMS0xLTIwOTI1_e662faa0-5dac-497f-a5c2-e08d306d4d59"
      unitRef="usd">1554000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM2LTUtMS0xLTIwOTI1_e8790db1-7990-4f5b-885f-bc649091e1e0"
      unitRef="usd">1449000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM3LTEtMS0xLTIwOTI1_a7678973-a3bb-4d3b-b81e-21460f00fab9"
      unitRef="usd">2199000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM3LTMtMS0xLTIwOTI1_d5568e43-7164-46f4-9a6b-401c824b2813"
      unitRef="usd">325000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM3LTUtMS0xLTIwOTI1_a9762389-4cad-4e71-80de-2519abfe9e1d"
      unitRef="usd">353000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM4LTEtMS0xLTIwOTI1_5e0edeff-3e54-455b-8866-784a717e12fa"
      unitRef="usd">129000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM4LTMtMS0xLTIwOTI1_37eb3c12-a5ee-4cf8-95eb-4ea6001888b0"
      unitRef="usd">189000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM4LTUtMS0xLTIwOTI1_8f860127-6f54-46d1-822f-38873ec056bc"
      unitRef="usd">119000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM5LTEtMS0xLTIwOTI1_2581b4ad-0fba-46ca-87ec-372845997095"
      unitRef="usd">22000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM5LTMtMS0xLTIwOTI1_d57f1a34-e251-473e-a7bf-463cf8c3bf1a"
      unitRef="usd">15000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzM5LTUtMS0xLTIwOTI1_08dda805-d67b-403c-b5f4-1eeb0f2a9bf8"
      unitRef="usd">16000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQwLTEtMS0xLTIwOTI1_0b79e354-a335-404a-97d2-4460a034296f"
      unitRef="usd">309000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQwLTMtMS0xLTIwOTI1_e14b47b3-6929-41c4-852f-cc3294fc313d"
      unitRef="usd">297000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQwLTUtMS0xLTIwOTI1_ccbe9699-ec86-4c36-885d-8663ef3bafb5"
      unitRef="usd">286000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQxLTEtMS0xLTIwOTI1_eee4cc24-395f-4a62-ad62-bd6d112d59b7"
      unitRef="usd">99000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQxLTMtMS0xLTIwOTI1_ea774910-ca0a-4960-9298-b42164cc0187"
      unitRef="usd">58000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQxLTUtMS0xLTIwOTI1_398913c7-5087-4024-8e6e-0c2f15dcb063"
      unitRef="usd">54000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ1LTEtMS0xLTIwOTI1_28ca22b7-f73a-45fa-8055-67d756143dbd"
      unitRef="usd">-38000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ1LTMtMS0xLTIwOTI1_fba268e7-9fce-4a4e-bc32-3009b03f86ed"
      unitRef="usd">44000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ1LTUtMS0xLTIwOTI1_e5204d5f-a37d-42ff-bf89-55caa107a680"
      unitRef="usd">-17000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ2LTEtMS0xLTIwOTI1_829dfa44-a4ce-44a6-8e96-613ad4a38f57"
      unitRef="usd">-2540000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ2LTMtMS0xLTIwOTI1_05f0d608-54c0-4025-b15c-226f4b378577"
      unitRef="usd">-1267000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ2LTUtMS0xLTIwOTI1_fea48a33-73e2-42cf-85d3-cb7a0c852636"
      unitRef="usd">225000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ4LTEtMS0xLTIwOTI1_87f21e91-0516-4ef2-b586-9b0f36c92892"
      unitRef="usd">-286000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ4LTMtMS0xLTIwOTI1_82bc7c57-7beb-466b-81f7-ab02a8571dec"
      unitRef="usd">-34000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzQ4LTUtMS0xLTIwOTI1_84b14b10-e129-4e6f-bdb6-eaf0135b1b6d"
      unitRef="usd">1057000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUwLTEtMS0xLTIwOTI1_e0c21a93-951b-4815-815f-3f2d524c4f6f"
      unitRef="usd">1158000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUwLTMtMS0xLTIwOTI1_b98e25e3-6987-46f6-994e-fb413cdea8b2"
      unitRef="usd">1192000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i751cd9d2a9c24eeb80a337f22c577eed_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUwLTUtMS0xLTIwOTI1_1513394e-441e-4a53-943e-c7ff9dfb6557"
      unitRef="usd">135000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUxLTEtMS0xLTIwOTI1_f435af79-ae39-4b88-98a6-87642783235d"
      unitRef="usd">872000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUxLTMtMS0xLTIwOTI1_6a9ee05f-6503-4cdf-a05e-f68db692fce5"
      unitRef="usd">1158000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjYvZnJhZzoxMzgwZWYyM2FiZmM0NGI5YmRlNTZiOTczN2JjMDZkZC90YWJsZTpiNjhiY2MwYzkzZmY0YzU4OTY2ZTE2MzA3MjhhMTIxNC90YWJsZXJhbmdlOmI2OGJjYzBjOTNmZjRjNTg5NjZlMTYzMDcyOGExMjE0XzUxLTUtMS0xLTIwOTI1_d2d62b7e-b6c7-4f86-ae0d-5e7acd8e10ac"
      unitRef="usd">1192000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4b6f2cccffed48a8b1dceaea5ff25de2_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItMS0xLTEtMjA5MjU_8d7e5578-80e0-464b-8903-46bb5badb3c0"
      unitRef="shares">135000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b6f2cccffed48a8b1dceaea5ff25de2_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItMi0xLTEtMjA5MjU_8eaab544-c117-4db6-a722-9e1825626a8f"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idda5f95daad049caab9cbe2bfb827136_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItMy0xLTEtMjA5MjU_73e60ed6-06a2-49a6-bc6e-2bed4b499d79"
      unitRef="usd">2667000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5299549fc0c64e619315ae69e3a2d208_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItNC0xLTEtMjA5MjU_9c348a5f-c8e8-4dc4-a934-960175f1b649"
      unitRef="usd">7602000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6aab3fa36e3d4c9784c83bb58dbc0467_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItNS0xLTEtMjA5MjU_e81eda18-604a-48d4-bc72-eb11487f64ef"
      unitRef="usd">-59000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f2e5616f9864fd5b5916bfd56220c6d_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItNi0xLTEtMjA5MjU_c82a50c0-3339-4e3c-9c07-fe965ff055bd"
      unitRef="usd">-4996000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1066f069691a446899ccc794445c6f7e_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItNy0xLTEtMjA5MjU_efed68e0-4610-4912-808c-10bed0c89dd8"
      unitRef="usd">51000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i751cd9d2a9c24eeb80a337f22c577eed_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItOC0xLTEtMjA5MjU_55bc5750-d482-475a-bc5e-d3bb342ad078"
      unitRef="usd">5267000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i751cd9d2a9c24eeb80a337f22c577eed_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzItMTEtMS0xLTIwOTI1_176551bf-5157-4b01-ae1b-406669298696"
      unitRef="usd">77000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i88b348bf53ef45a6b79322e9729d0498_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMtNC0xLTEtMjA5MjU_3d5b88f7-5805-440a-aa30-c1c1de74283a"
      unitRef="usd">858000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ic1c4749bcaac4d619fd98fd7d8f56cf3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMtNy0xLTEtMjA5MjU_02786fc7-97cf-4d72-a359-3f4f013b7306"
      unitRef="usd">42000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMtOC0xLTEtMjA5MjU_6874cd46-1c7d-4f4c-bd61-862b675fe05b"
      unitRef="usd">900000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMtMTEtMS0xLTIwOTI1_c64e7182-593d-4513-8a5b-6e8fc4858f7d"
      unitRef="usd">6000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i267bcc57d1894a25886a84780745fe3f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQtNS0xLTEtMjA5MjU_682dfdab-0aeb-4b36-8e34-080c803552b9"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQtOC0xLTEtMjA5MjU_f0ebc4eb-3aae-46fc-aa40-593d08230015"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i88b348bf53ef45a6b79322e9729d0498_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzUtNC0xLTEtMjA5MjU_7c9c79a8-7beb-4fe5-991a-0abca1c4d4de"
      unitRef="usd">286000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzUtOC0xLTEtMjA5MjU_e4d2427b-e292-4e8b-8ac4-997e89ffc98f"
      unitRef="usd">286000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic1c4749bcaac4d619fd98fd7d8f56cf3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzYtNy0xLTEtMjA5MjU_0c70e1e7-f987-43ba-8d25-346d2b1470ff"
      unitRef="usd">47000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzYtOC0xLTEtMjA5MjU_6f9efbec-e7f2-48d8-bb16-f071d16dd4c1"
      unitRef="usd">47000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzYtMTEtMS0xLTIwOTI1_7b56637f-4749-47cf-9891-58901738cffc"
      unitRef="usd">7000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie209ef77b3d74e11bcf8556dd3482d4a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzctMy0xLTEtMjA5MjU_65374d4d-5eca-4d5f-bd6b-1403839a8b1f"
      unitRef="usd">9000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzctNi0xLTEtMjA5MjU_106ee7c3-9bb5-4faf-9bbc-f716e5423b27"
      unitRef="usd">15000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzctOC0xLTEtMjA5MjU_d4107280-bc87-4f3d-867e-7881ed7e502f"
      unitRef="usd">24000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie209ef77b3d74e11bcf8556dd3482d4a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzgtMy0xLTEtMjA5MjU_e7cb9261-7ef1-46a9-9160-2aa120cc389e"
      unitRef="usd">55000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzgtNi0xLTEtMjA5MjU_3e0026ba-11d1-4e2e-8439-cd79655ac921"
      unitRef="usd">1000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzgtOC0xLTEtMjA5MjU_4858b230-6a10-4740-9308-acb3c810f1d7"
      unitRef="usd">56000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3be5ad04ae5542ecb8f3b50fb4e30464_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzktMS0xLTEtMjA5MjU_44b44174-0878-4060-95d9-075b44592cda"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie209ef77b3d74e11bcf8556dd3482d4a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzktMy0xLTEtMjA5MjU_b4c0f2ab-23b1-4884-b1d9-918a0d58b35a"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzktNi0xLTEtMjA5MjU_3b3e6c68-f074-4e2e-91ca-7b95b3f4f8f9"
      unitRef="usd">112000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzktOC0xLTEtMjA5MjU_bda04db7-86b4-4f6b-8650-59528d0ae1d2"
      unitRef="usd">119000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie209ef77b3d74e11bcf8556dd3482d4a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzEwLTMtMS0xLTIwOTI1_50fb771f-4373-4c5e-8bb8-3c0a52c710e8"
      unitRef="usd">16000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzEwLTgtMS0xLTIwOTI1_996c4f75-4f5d-4356-93bb-733ba53b02bc"
      unitRef="usd">16000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3be5ad04ae5542ecb8f3b50fb4e30464_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzEyLTEtMS0xLTIwOTI1_37611c75-efd0-47c6-a3e8-0f2bcb1a1dd3"
      unitRef="shares">4000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzEyLTYtMS0xLTIwOTI1_376520cf-aa0a-405b-b125-2c05780f1d42"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzEyLTgtMS0xLTIwOTI1_447720a9-4e90-4c0c-9569-87dc9d648bcc"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idf54f2e101be444fae80a5c5c2d3c804_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTEtMS0xLTIwOTI1_ae0c8c00-5225-42a6-aec2-9ac87e1e6a85"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idf54f2e101be444fae80a5c5c2d3c804_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTItMS0xLTIwOTI1_10944c51-1f28-4f7a-b4a7-f3af7d060fe1"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae81071de369404b8afd4d5fc92817db_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTMtMS0xLTIwOTI1_d4e53cb2-b378-4302-a351-4bebbdae696b"
      unitRef="usd">2722000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67c2565c4020431eab3d950ad045cb6d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTQtMS0xLTIwOTI1_614b18bc-ea51-42bd-a3e7-3410fd66a785"
      unitRef="usd">8174000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if98d4882c785427cb6359a1c4887bd59_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTUtMS0xLTIwOTI1_2a8c7c8a-a163-4dfd-ba53-bb22a6e6b396"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb7782dfdbdd41bcb0c2a7ce6d9fc4e9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTYtMS0xLTIwOTI1_b8f951bd-d85e-4217-8d67-b42ee6070bd3"
      unitRef="usd">-5218000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7887c43e3ff4c0eaa862aa8feccb3a5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTctMS0xLTIwOTI1_177870ef-efd1-4360-8aa8-ed205c2301b7"
      unitRef="usd">46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTgtMS0xLTIwOTI1_b867f0e7-e57a-4848-b31d-d7162f0ca0a1"
      unitRef="usd">5687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE2LTExLTEtMS0yMDkyNQ_7f55234d-eddc-4193-8879-8c31c403dbcc"
      unitRef="usd">76000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i7109a9f8e79b43adaac841ce00ee330f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE3LTQtMS0xLTIwOTI1_fe1b798d-65ed-44f0-a118-a12d73a2ca8f"
      unitRef="usd">1431000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i100aacd303a1475289f1b48d599c5544_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE3LTctMS0xLTIwOTI1_8c0157b1-ff74-4ec3-9670-beb342daeb1c"
      unitRef="usd">53000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE3LTgtMS0xLTIwOTI1_e86e3849-e90a-4a0b-847b-a4743bfe1274"
      unitRef="usd">1484000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE3LTExLTEtMS0yMDkyNQ_ee89386c-97a2-46f8-886c-a3c8873dae71"
      unitRef="usd">15000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i873b50b7201e479895a613c8644d45a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE4LTUtMS0xLTIwOTI1_49504acd-729d-48cc-ac40-d6c36833dac2"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE4LTgtMS0xLTIwOTI1_2e1abea0-1426-484a-b612-618c9a330b71"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7109a9f8e79b43adaac841ce00ee330f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE5LTQtMS0xLTIwOTI1_218eb813-ae4c-4f15-81cf-e3e2a33ab2bf"
      unitRef="usd">302000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzE5LTgtMS0xLTIwOTI1_e8c946fa-136b-4817-8b09-099a82f70474"
      unitRef="usd">302000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i100aacd303a1475289f1b48d599c5544_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIwLTctMS0xLTIwOTI1_58b6d7a8-47e5-46b8-b88b-1a4b48ba0990"
      unitRef="usd">49000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIwLTgtMS0xLTIwOTI1_cd8f444b-569a-4e60-bf66-9cf617d85287"
      unitRef="usd">49000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIwLTExLTEtMS0yMDkyNQ_6c0a2f03-f73b-4e1e-921a-e09583092c85"
      unitRef="usd">9000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9a6dfcd580714f519c23752e3e04312e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIxLTEtMS0xLTIwOTI1_d8a45ec2-cf55-463b-89f8-74407945b5e1"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0aa4482609c643a18d09f0c105d38575_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIxLTMtMS0xLTIwOTI1_8af8bd2f-fe0b-4709-8d2c-754eaff75b2a"
      unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIxLTYtMS0xLTIwOTI1_8519d8d2-3b77-48f0-a323-35bcc5cc4ebd"
      unitRef="usd">14000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIxLTgtMS0xLTIwOTI1_6b543cf6-0260-41aa-95d0-90e6f06e8bd7"
      unitRef="usd">25000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0aa4482609c643a18d09f0c105d38575_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIyLTMtMS0xLTIwOTI1_d41a5e43-f2ad-4e6c-be4e-bdeadb226fa3"
      unitRef="usd">97000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIyLTgtMS0xLTIwOTI1_9de3bb2a-3467-4baf-861d-c43d43afe0d5"
      unitRef="usd">97000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9a6dfcd580714f519c23752e3e04312e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIzLTEtMS0xLTIwOTI1_dc7c2251-75f8-4007-a4e8-663aeece5307"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0aa4482609c643a18d09f0c105d38575_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIzLTMtMS0xLTIwOTI1_ce55c92f-aa82-4fb7-9f11-f5d5559eae57"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIzLTYtMS0xLTIwOTI1_c373c1a9-e12d-452e-961a-d359c6ec6f52"
      unitRef="usd">163000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzIzLTgtMS0xLTIwOTI1_3264f1ed-eed8-4266-969c-35496fbc1749"
      unitRef="usd">189000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0aa4482609c643a18d09f0c105d38575_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzI0LTMtMS0xLTIwOTI1_d3279c98-221a-423d-90ad-60aa12b56958"
      unitRef="usd">15000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzI0LTgtMS0xLTIwOTI1_fbcff4fe-0ede-40bc-9d53-79d286516459"
      unitRef="usd">15000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i9a6dfcd580714f519c23752e3e04312e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzI2LTEtMS0xLTIwOTI1_e268019c-7fea-497b-95a4-2013d2039ea3"
      unitRef="shares">3000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzI2LTYtMS0xLTIwOTI1_16a06bf1-4a0b-46b1-a381-8d795fcf1740"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzI2LTgtMS0xLTIwOTI1_b2442f16-02f6-4f79-aff4-edc2a0eb221b"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3b3040c4c16442589b2b35eb56972716_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTEtMS0xLTIwOTI1_d70e6156-b7be-4f45-af31-700b6aa8c081"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b3040c4c16442589b2b35eb56972716_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTItMS0xLTIwOTI1_5cee590b-2137-4fe4-ad76-83f109bdd614"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib47828d248b649a69973dd77b69d8e47_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTMtMS0xLTIwOTI1_41462c4f-bd2d-4559-bfb7-8a153e30f48e"
      unitRef="usd">2841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ed179caf3f3462791e29a68b26fdab2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTQtMS0xLTIwOTI1_54b47db6-6af2-414c-9534-a4098b7b5bb5"
      unitRef="usd">9303000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icf17d00ced53485da1e88eb50e730ada_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTUtMS0xLTIwOTI1_cdfc6142-ba9b-4000-aa03-7395e0dd74d1"
      unitRef="usd">-21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84e35541023d468e8cb0c202d383eddc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTYtMS0xLTIwOTI1_2a66ec54-3263-4764-a032-503394820750"
      unitRef="usd">-5366000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b11d3e18df649ec889a7fa850cc7e67_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTctMS0xLTIwOTI1_be65b9b3-4507-437e-929a-0062a660e261"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTgtMS0xLTIwOTI1_99284ce9-9a47-4b7c-9374-159eb5fdb573"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMwLTExLTEtMS0yMDkyNQ_502d4c14-9f15-49da-9548-cc83984b33e7"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i7215d41c21ea4fbdb2f7240f3cc276ee_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMxLTQtMS0xLTIwOTI1_51d6454e-ea9f-4c5e-b2e0-5b12cfb183d0"
      unitRef="usd">1995000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i184e53e381dc4d5bb40497f1d9fc9b8d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMxLTctMS0xLTIwOTI1_a4b2ed65-5d02-4362-9654-ebf877c25457"
      unitRef="usd">72000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMxLTgtMS0xLTIwOTI1_24dc2ea6-729c-42ef-9d43-c17d854d2be0"
      unitRef="usd">2067000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMxLTExLTEtMS0yMDkyNQ_60453ed7-09c4-490d-b709-003dc1f539a3"
      unitRef="usd">13000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iecc4fcf7570e403c98d584e438978f0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMyLTUtMS0xLTIwOTI1_39164077-2fee-4b14-8ba8-a1ac73b080be"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMyLTgtMS0xLTIwOTI1_d7b30aa1-1e1d-40b0-baee-0382b015c31a"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7215d41c21ea4fbdb2f7240f3cc276ee_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMzLTQtMS0xLTIwOTI1_6a440b44-ef09-43f3-8659-ac9644e37917"
      unitRef="usd">307000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzMzLTgtMS0xLTIwOTI1_20b14989-4c9a-463e-b9a8-a2705ef17fec"
      unitRef="usd">307000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i184e53e381dc4d5bb40497f1d9fc9b8d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM0LTctMS0xLTIwOTI1_3844bbf4-47c6-4f49-aee3-324978a9cb26"
      unitRef="usd">83000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM0LTgtMS0xLTIwOTI1_ff58a0e2-eaa2-4fdd-9b7d-ab8bba76ff32"
      unitRef="usd">83000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM0LTExLTEtMS0yMDkyNQ_302d6c34-6b9f-4e2d-8eac-98ec04c6fbe2"
      unitRef="usd">16000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM1LTMtMS0xLTIwOTI1_a6662fbb-5b9d-4542-b5a5-35045f4f1638"
      unitRef="usd">-21000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM1LTYtMS0xLTIwOTI1_6907129f-2208-4562-9e49-01388ae19bf9"
      unitRef="usd">47000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM1LTgtMS0xLTIwOTI1_3943ff84-66e0-44d2-afba-c049ef56eafa"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM2LTMtMS0xLTIwOTI1_cf8f8729-c10b-4db1-8613-20c9a8f7b0b5"
      unitRef="usd">79000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM2LTgtMS0xLTIwOTI1_dde37df3-2f6f-4bdc-b3ff-2174f72498d5"
      unitRef="usd">79000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i6174bff25adb42cdbd66e7fb9ff9c37d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM3LTEtMS0xLTIwOTI1_7f464a1f-c09c-42ce-9c1c-1d40011c7d21"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM3LTMtMS0xLTIwOTI1_60c48f0c-d8d2-48ad-a56b-fc31c72c056b"
      unitRef="usd">20000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM3LTYtMS0xLTIwOTI1_e61361d9-9db1-4ca0-9305-4cdbea1982ab"
      unitRef="usd">109000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM3LTgtMS0xLTIwOTI1_1fd6fb2c-09a1-432e-9a3d-daecbfcba2d5"
      unitRef="usd">129000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM4LTMtMS0xLTIwOTI1_95b60c6d-f541-4fd4-b22a-1ecbdf0cd8f0"
      unitRef="usd">10000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM4LTYtMS0xLTIwOTI1_ee975a5b-a367-4fa2-bb61-3c69dda008d4"
      unitRef="usd">12000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM4LTgtMS0xLTIwOTI1_9782504f-dbb6-4f58-b267-644610f3803c"
      unitRef="usd">22000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6174bff25adb42cdbd66e7fb9ff9c37d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM5LTEtMS0xLTIwOTI1_db2c971e-8ea9-4cb4-ab12-801bf63a6209"
      unitRef="shares">16000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM5LTYtMS0xLTIwOTI1_edabec67-d735-464f-a51e-58e31147d943"
      unitRef="usd">2222000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzM5LTgtMS0xLTIwOTI1_78a7104f-6eca-4465-aa2b-ba34892e2f53"
      unitRef="usd">2222000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ie3f6b571b38240d390aa08232e44b88e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQxLTMtMS0xLTIwOTI1_8bb7063c-f9ab-4053-9fdb-4430afa8323a"
      unitRef="usd">649000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i7215d41c21ea4fbdb2f7240f3cc276ee_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQxLTQtMS0xLTIwOTI1_a787bf79-e1d5-45df-a544-259ad89482c8"
      unitRef="usd">3342000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQxLTYtMS0xLTIwOTI1_7c88cdbf-9ae0-413f-bbba-06f6ef2efae7"
      unitRef="usd">-3991000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQxLTgtMS0xLTIwOTI1_df2b49a2-203a-4e37-8808-0037349b153d"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i38edfda579db45e2b38455c17b62991c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTEtMS0xLTIwOTI1_1a93108f-e7ac-41bd-9152-6a44fe6386f4"
      unitRef="shares">119000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38edfda579db45e2b38455c17b62991c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTItMS0xLTIwOTI1_304ee863-acb3-40a1-8f85-4f349bafb737"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6273937e3079404bac24531420de0b6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTMtMS0xLTIwOTI1_9e5d551a-7748-469b-a230-a008b0cda424"
      unitRef="usd">2260000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id617ebe9e53c430eab235ef5b09c5eb1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTQtMS0xLTIwOTI1_20707dc9-bd7e-4b38-9fc6-87d34f99be31"
      unitRef="usd">7649000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie250c2a689ff4ef885295f77abd96941_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTUtMS0xLTIwOTI1_d0396055-c47d-4518-a17b-41c31c26b36c"
      unitRef="usd">-14000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7d076d028664d249c58ef5ec036b46f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTYtMS0xLTIwOTI1_b95b296a-c1a3-4431-9128-bb429a69b405"
      unitRef="usd">-3453000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23a7255d9f5c4ffa878e62ba379a4038_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTctMS0xLTIwOTI1_c72b34e3-a107-4079-90af-ab680d94dabb"
      unitRef="usd">39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTgtMS0xLTIwOTI1_ff4e5041-ea42-4c7a-bd1c-d26423cb5a56"
      unitRef="usd">6483000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNjkvZnJhZzowYThlOTFjZmI4MDc0ZWZhYWQzMmY2YjQ4M2I3ODQxZS90YWJsZTo4ZTdhNWJhNTQyZTA0NzU1YjNiMmFjY2ViMmUwM2M4MC90YWJsZXJhbmdlOjhlN2E1YmE1NDJlMDQ3NTViM2IyYWNjZWIyZTAzYzgwXzQzLTExLTEtMS0yMDkyNQ_83cfed9c-e0e7-495f-b98b-848285267647"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NatureOfOperations
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzUvZnJhZzoxOTM5YzY2ZDY0MWI0MGQ5YjI5YjEwN2E2YmQ5MDIzYy90ZXh0cmVnaW9uOjE5MzljNjZkNjQxYjQwZDliMjliMTA3YTZiZDkwMjNjXzE2OTc_7e3fd8ee-c76e-4f3d-b4d1-e3450acc8889">DESCRIPTION OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Background&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzUz_b7c48048-3ae0-442e-a30b-e89728c1de8a">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The consolidated financial statements include the accounts of all entities controlled by the Company through its direct or indirect ownership of a majority voting interest.  Additionally, the consolidated financial statements include the accounts of variable interest entities (&#x201c;VIEs&#x201d;) in which the Company has a variable interest and for which the Company is the &#x201c;primary beneficiary&#x201d; as it has both: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.  All significant intercompany accounts and transactions are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Income attributable to the minority interest in the Company's majority owned and controlled consolidated subsidiaries is recorded as net income attributable to noncontrolling interests in the consolidated statements of operations and the noncontrolling interest is reflected as a separate component of consolidated stockholders' equity in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  The accompanying consolidated statements of operations and related disclosures report the results of NID as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  See Note 20 for a further discussion of discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Investments in entities which the Company does not control, but in which it has a substantial ownership interest (generally between 20% and 49%) and can exercise significant influence, are accounted for using the equity method of accounting.  These investments are classified as investments in equity method investees in the consolidated balance sheet.  The Company records its pro rata share of the earnings, adjusted for accretion of basis difference, of these investments in equity in earnings of equity method investees, net of taxes in the consolidated statements of operations.  The Company reviews its investments in equity method investees for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes as revenue the amount that reflects the consideration to which it expects to be entitled in exchange for goods sold or services rendered primarily upon completion of the testing process (when results are reported) or when services have been rendered (see Note 3).  Net revenues from Medicare and Medicaid programs were approximately 10%, 11% and 15% of the Company's consolidated net revenues for the years ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Taxes on Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year.  Current and deferred income taxes are measured based on the tax laws that are enacted as of the balance sheet date of the relevant reporting period.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.  Tax benefits from uncertain tax positions are recognized only if the tax position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan (&#x201c;ELTIP&#x201d;) and its Amended and Restated Non-Employee Director Long-Term Incentive Plan (&#x201c;DLTIP&#x201d;), as well as the dilutive effect of accelerated share repurchase agreements ("ASRs"), if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards.  As such, the Company recognizes stock-based compensation cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants.  The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.  The terms of the Company's performance share units allow the recipients of such awards to earn a variable number of shares based on the achievement of the performance goals, which are based on the financial performance of the Company and the total shareholder return of the Company relative to an index of peer companies ("relative TSR"), specified in the awards.  For performance share units with a goal based on the financial performance of the Company, stock-based compensation expense is recognized based on management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned.  The cumulative effect on current and prior periods of a change in the estimated number of performance share units expected to be earned for these awards is recognized as compensation cost in earnings in the period of the change.  For performance share units with a market-based relative TSR goal, stock-based compensation expense is recognized based on the estimated fair value of the award regardless of the actual number of shares earned.  For further details regarding stock-based compensation, see Note&#160;17.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy.  The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company predominately uses the U.S. dollar as its functional currency.  The functional currency of the Company's foreign operating subsidiaries generally is the applicable local currency.  Assets and liabilities denominated in non-U.S. dollars are translated into U.S. dollars at exchange rates as of the end of the reporting period.  Income and expense items are translated at the average monthly exchange rates during the year.  Resulting translation adjustments are recorded as a component of accumulated other comprehensive loss within stockholders' equity.  Gains and losses from foreign currency transactions, which are denominated in a currency other than the functional currency, are included within other operating (income) expense, net in the consolidated statements of operations.  Foreign currency transaction gains and losses have historically not been material.  The Company may be exposed to market risk for changes in foreign exchange rates primarily under certain intercompany receivables and payables.  From time to time, the Company uses foreign exchange forward contracts to mitigate the exposure of the eventual net cash inflows or outflows resulting from these intercompany transactions.  The Company's foreign exchange exposure is not material to the Company's consolidated financial condition.  The Company does not hedge its net investment in non-U.S. subsidiaries because it views those investments as long-term in nature.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Cash and cash equivalents include all highly-liquid investments with original maturities, at the time acquired by the Company, of three months or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash, cash equivalents, short-term investments, accounts receivable and derivative financial instruments.  The Company's policy is to place its cash, cash equivalents and short-term investments in highly-rated financial instruments and institutions.  Concentration of credit risk with respect to accounts receivable is mitigated by the diversity of the Company's payers and their dispersion across many different geographic regions, and credit risk is concentrated among certain payers who are large buyers of the Company's services.  To reduce risk, the Company routinely assesses the financial strength of these payers and, consequently, believes that its accounts receivable credit risk exposure, with respect to these payers, is limited.  While the Company has receivables due from federal and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent on submitting appropriate documentation timely.  As of both December&#160;31, 2021 and 2020, receivables due from government payers under the Medicare and Medicaid programs represented approximately 6% of the Company's consolidated net accounts receivable.  The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.  As of December&#160;31, 2021 and 2020, receivables due from patients represented approximately 21% and 11%, respectively, of the Company's consolidated net accounts receivable.  The Company applies assumptions and judgments including historical collection experience (including the period of time that the receivables have been outstanding) for assessing collectability and determining net revenues and accounts receivable from patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Accounts receivable are reported net of allowances for credit losses.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;When estimating its allowance for credit losses, the Company pools its trade receivables based on the following customer types: healthcare insurers, government payers, client payers and patients, which are described in Note 3.&#160; The Company principally estimates the allowance for credit losses by pool based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period of time that the receivables have been outstanding.&#160; To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the customers from their respective pools and establishes allowances based on the individual risk characteristics of such customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Inventories, which consist principally of finished goods testing supplies and reagents, are valued at the lower of cost (first in, first out method) or net realizable value.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Property, plant and equipment is recorded at cost.  Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.  Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and expensed as incurred for preliminary project activities and post-implementation activities.  Capitalized costs include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with the internal-use software project, and interest costs incurred, when material, while developing internal-use software.  Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose.  Costs for maintenance and training are expensed as incurred.  The Company capitalizes interest on borrowings during the active construction period of major capital projects.  Capitalized interest is added to the cost of the underlying assets and is amortized over the expected useful lives of the assets.  Depreciation and amortization are provided on the straight-line method over expected useful asset lives as of December&#160;31, 2021 as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;buildings and improvements, ranging up to thirty-one and a half years; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;laboratory equipment and furniture and fixtures, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1MDYw_1d199ab7-3192-43a9-a2e6-2c9e9839ee94"&gt;five&lt;/span&gt; to twelve years; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;leasehold improvements, the lesser of the useful life of the improvement or the remaining life of the building or lease, as applicable; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;computer software developed or obtained for internal use, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1Mjcw_88e6f6e4-a789-4494-8767-bda409fe0bc3"&gt;five&lt;/span&gt; to ten years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Goodwill represents the excess of the fair value of the acquiree (including the fair value of non-controlling interests) over the recognized bases of the net identifiable assets acquired and includes the future economic benefits from other assets that could not be individually identified and separately recognized.  Goodwill is not amortized, but instead is periodically reviewed for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of goodwill exceeds its fair value.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On a quarterly basis, the Company performs a review of its business to determine if events or changes in circumstances have occurred which could have a material adverse effect on the fair value of the Company and its goodwill.  If such events or changes in circumstances were deemed to have occurred, the Company would perform an impairment test of goodwill as of the end of the quarter and record any noted impairment loss.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The goodwill test is performed at least annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired.  The annual impairment test includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative test may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company is required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, the Company's policy is to update the fair value calculation of its reporting units and perform the quantitative goodwill impairment test on a periodic basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  The Company calculates the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  The Company assesses the valuation methodology based upon the relevance and availability of the data at the time that the valuation is performed.  The Company compares the estimate of fair value for the reporting unit to the carrying value of the reporting unit.  If the carrying value is greater than the estimate of fair value, an impairment loss will be recognized in the amount of the excess. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company performs its annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2021, the Company performed a qualitative impairment test and, based on the totality of information available for the reporting units, the Company concluded that it was more-likely-than-not that the estimated fair values of the reporting units were greater than the carrying values of the reporting units and, as such, no further analysis was required.  For the year ended December&#160;31, 2020, in accordance with its policy to perform the quantitative test on a periodic basis, the Company updated the fair value calculation of its reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets are recognized at fair value, as an asset apart from goodwill if the asset (i) arises from contractual or other legal rights, or (ii) is separable.  Intangible assets, principally representing the cost of customer-related intangibles, non-competition agreements and technology acquired, are capitalized and amortized on the straight-line method over their expected useful lives, which generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE5MTMy_22152b9e-6ae5-4ec5-ae0f-101ca8483d0a"&gt;five&lt;/span&gt; to twenty years.  Intangible assets with indefinite useful lives, consisting principally of acquired tradenames, are not amortized, but instead are periodically reviewed for impairment.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company reviews indefinite-lived intangible assets periodically for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of an indefinite-lived intangible asset is more than its estimated fair value.  The indefinite-lived intangible asset impairment test is performed at least annually, or more frequently in the case of other events that indicate a potential impairment.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Based upon the Company&#x2019;s most recent annual impairment tests completed during the fourth quarters of the years ended December&#160;31, 2021 and 2020, the Company concluded that indefinite-lived intangible assets were not impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company reviews the recoverability of its long-lived assets (including amortizable intangible assets), other than goodwill and indefinite-lived intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.  Evaluation of possible impairment is based on the Company's ability to recover the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations.  If these cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's investments (except for those accounted for under the equity method of accounting) include:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity investments with readily determinable fair values, including investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries (such investments, which previously did not have readily determinable fair values, became publicly-traded during the year ended December 31, 2021); as well as participant-directed investments of deferred employee compensation and related Company matching contributions held in trusts pursuant to the Company's supplemental deferred compensation plans (see Note 17).  These investments are measured at fair value with both realized and unrealized gains and losses recorded in current earnings within other income, net in the consolidated statements of operations.  For the years ended December&#160;31, 2021, 2020 and 2019, gains from all equity investments with readily determinable fair values totaled $56 million, $8 million, and $10 million, respectively.  The carrying values of these investments was $121 million at December 31, 2021, of which $44 million was included in prepaid expenses and other current assets and $77 million was included in other assets in the consolidated balance sheet.  The carrying values of these investments was $67 million at December 31, 2020, which was included in other assets in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity investments that do not have readily determinable fair values, which consist of investments in preferred and common shares of privately held companies.  These investments are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  The Company regularly evaluates these equity investments to determine if there are any indicators that the investment is impaired; no impairment charges were recognized related to these investments for the years ended December&#160;31, 2021, 2020 and 2019.  The carrying value of these investments was $4 million and $25 million at December&#160;31, 2021 and 2020, respectively.  Such amounts were included in other assets in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Available-for-sale debt securities of privately-held companies.  These investments are measured at fair value with unrealized gains and losses presented in other comprehensive income (loss).  The carrying amount of these investments was $1 million and $12 million at December&#160;31, 2021 and 2020, respectively.  Such amounts were included in other assets in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit risk-related contingent features or requirements to post collateral.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate debt instruments and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company accounts for these derivatives as either an asset or liability measured at its fair value.  The fair value is based upon model-derived valuations in which all significant inputs are observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.  For a derivative instrument that has been formally designated as a fair value hedge, fair value gains or losses on the derivative instrument along with offsetting fair value gains or losses on the hedged item that are attributable to the risk being hedged are reported in other income, net in the consolidated statements of operations.  For derivatives that have been formally designated as a cash flow hedge, the change in the fair value of the derivatives is recorded in accumulated other comprehensive loss.  Upon maturity or early termination of an effective interest rate swap agreement designated as a cash flow hedge, unrealized gains or losses are deferred in stockholders' equity, as a component of accumulated other comprehensive loss, and are amortized as an adjustment to interest expense over the period during which the hedged forecasted transaction affects earnings, which is when the Company recognizes interest expense on the hedged cash flows.  At inception and quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item.  After the initial quantitative assessment, this analysis is initially performed on a qualitative basis and, if it is determined that the hedging relationship was and continues to be highly effective, no further analysis is required.  All components of each derivative financial instrument's gain or loss are included in the assessment of hedge effectiveness.  If it is determined that a derivative ceases to be a highly effective hedge, the Company discontinues hedge accounting and any deferred gains or losses related to a discontinued cash flow hedge shall continue to be reported in accumulated other comprehensive loss, unless it is probable that the forecasted transaction will not occur.  If it is probable that the forecasted transaction will not occur by the originally specified time period, the Company discontinues hedge accounting and any deferred gains or losses reported in accumulated other comprehensive loss are classified into earnings immediately.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Comprehensive income (loss) encompasses all changes in stockholders' equity (except those arising from transactions with stockholders) and includes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Notes 15 and 16); and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Advertising costs are expensed as incurred.  For the years ended December 31, 2021, 2020 and 2019, advertising costs were $78&#160;million, $38&#160;million and $18&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Standards &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;New Accounting Standards To Be Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of &lt;/span&gt;&lt;/div&gt;the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjgw_a5567d13-0c1a-4ab4-bdc3-d2c022f75d5f">The consolidated financial statements include the accounts of all entities controlled by the Company through its direct or indirect ownership of a majority voting interest.  Additionally, the consolidated financial statements include the accounts of variable interest entities (&#x201c;VIEs&#x201d;) in which the Company has a variable interest and for which the Company is the &#x201c;primary beneficiary&#x201d; as it has both: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.  All significant intercompany accounts and transactions are eliminated in consolidation.&#160;&#160;&#160;&#160;Income attributable to the minority interest in the Company's majority owned and controlled consolidated subsidiaries is recorded as net income attributable to noncontrolling interests in the consolidated statements of operations and the noncontrolling interest is reflected as a separate component of consolidated stockholders' equity in the consolidated balance sheet.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzI5_76406a6a-2f79-4406-bad3-00b73aa64a37">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  The accompanying consolidated statements of operations and related disclosures report the results of NID as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  See Note 20 for a further discussion of discontinued operations.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjY4_8e67826d-fc1c-4504-b060-668d5f76e083">Investments in entities which the Company does not control, but in which it has a substantial ownership interest (generally between 20% and 49%) and can exercise significant influence, are accounted for using the equity method of accounting.  These investments are classified as investments in equity method investees in the consolidated balance sheet.  The Company records its pro rata share of the earnings, adjusted for accretion of basis difference, of these investments in equity in earnings of equity method investees, net of taxes in the consolidated statements of operations.  The Company reviews its investments in equity method investees for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i0ef869edccf349a68f85c65c81e97770_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIwNjQ_f7a53746-645d-4360-9fc3-cd99ab4e751e"
      unitRef="number">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ice911685201a460b8af3f58815059f82_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIwNzE_c24a5049-7ba5-4870-b93f-64e48313ef46"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:UseOfEstimates
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzU3_bd0d12d8-3e21-41a8-981c-5398737fec7f">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzU4_61a18e5e-7e6f-4eed-bd2f-d09a68f7e46f">The Company recognizes as revenue the amount that reflects the consideration to which it expects to be entitled in exchange for goods sold or services rendered primarily upon completion of the testing process (when results are reported) or when services have been rendered (see Note 3).  Net revenues from Medicare and Medicaid programs were approximately 10%, 11% and 15% of the Company's consolidated net revenues for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i641831615df34b538199d475b2c51f92_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzM1NjU_82d1f534-6eff-48c2-a9ac-b8a39bc0668e"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i89f3081e1b5445c6bfec2edf60f2f909_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzM1Njk_2bbb8339-a0c2-4570-a121-2052771e65a8"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia5e542d0dfea43e2af9118d20432c274_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzM1NzY_e47b4e18-4d88-47d8-a388-ef4487258d4e"
      unitRef="number">0.15</dgx:PercentageofNetRevenues>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzgx_c8c64078-f6ad-4e41-bfdc-c03ce1172ae8">The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year.  Current and deferred income taxes are measured based on the tax laws that are enacted as of the balance sheet date of the relevant reporting period.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.  Tax benefits from uncertain tax positions are recognized only if the tax position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjY0_c5bf8709-5ea7-42b1-b051-0f1509e25e25">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan (&#x201c;ELTIP&#x201d;) and its Amended and Restated Non-Employee Director Long-Term Incentive Plan (&#x201c;DLTIP&#x201d;), as well as the dilutive effect of accelerated share repurchase agreements ("ASRs"), if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjg1_af177c62-ef3a-48ba-abc0-b7832bd60e00">The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards.  As such, the Company recognizes stock-based compensation cost&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants.  The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.  The terms of the Company's performance share units allow the recipients of such awards to earn a variable number of shares based on the achievement of the performance goals, which are based on the financial performance of the Company and the total shareholder return of the Company relative to an index of peer companies ("relative TSR"), specified in the awards.  For performance share units with a goal based on the financial performance of the Company, stock-based compensation expense is recognized based on management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned.  The cumulative effect on current and prior periods of a change in the estimated number of performance share units expected to be earned for these awards is recognized as compensation cost in earnings in the period of the change.  For performance share units with a market-based relative TSR goal, stock-based compensation expense is recognized based on the estimated fair value of the award regardless of the actual number of shares earned.  For further details regarding stock-based compensation, see Note&#160;17.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjU5_43fed4d0-f8f9-46b8-b8b9-e1fb4634baff">The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market.&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy.  The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzQ3_43cf6c55-72ca-42b3-a603-62852c4ba143">The Company predominately uses the U.S. dollar as its functional currency.  The functional currency of the Company's foreign operating subsidiaries generally is the applicable local currency.  Assets and liabilities denominated in non-U.S. dollars are translated into U.S. dollars at exchange rates as of the end of the reporting period.  Income and expense items are translated at the average monthly exchange rates during the year.  Resulting translation adjustments are recorded as a component of accumulated other comprehensive loss within stockholders' equity.  Gains and losses from foreign currency transactions, which are denominated in a currency other than the functional currency, are included within other operating (income) expense, net in the consolidated statements of operations.  Foreign currency transaction gains and losses have historically not been material.  The Company may be exposed to market risk for changes in foreign exchange rates primarily under certain intercompany receivables and payables.  From time to time, the Company uses foreign exchange forward contracts to mitigate the exposure of the eventual net cash inflows or outflows resulting from these intercompany transactions.  The Company's foreign exchange exposure is not material to the Company's consolidated financial condition.  The Company does not hedge its net investment in non-U.S. subsidiaries because it views those investments as long-term in nature.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjk2_e5adaabe-60d8-4a51-98e3-1b68c8b0c5fc">Cash and cash equivalents include all highly-liquid investments with original maturities, at the time acquired by the Company, of three months or less.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzI1_2df7f6e9-95ac-40a8-a60b-c832c059ea16">Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash, cash equivalents, short-term investments, accounts receivable and derivative financial instruments.  The Company's policy is to place its cash, cash equivalents and short-term investments in highly-rated financial instruments and institutions.  Concentration of credit risk with respect to accounts receivable is mitigated by the diversity of the Company's payers and their dispersion across many different geographic regions, and credit risk is concentrated among certain payers who are large buyers of the Company's services.  To reduce risk, the Company routinely assesses the financial strength of these payers and, consequently, believes that its accounts receivable credit risk exposure, with respect to these payers, is limited.  While the Company has receivables due from federal and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent on submitting appropriate documentation timely.  As of both December&#160;31, 2021 and 2020, receivables due from government payers under the Medicare and Medicaid programs represented approximately 6% of the Company's consolidated net accounts receivable.  The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.  As of December&#160;31, 2021 and 2020, receivables due from patients represented approximately 21% and 11%, respectively, of the Company's consolidated net accounts receivable.  The Company applies assumptions and judgments including historical collection experience (including the period of time that the receivables have been outstanding) for assessing collectability and determining net revenues and accounts receivable from patients.</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i37a9f450d5fc42bd8a4cedc5a182bb1d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzExOTQz_646ce812-164c-4ac2-9eb4-a4a80ea0b577"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i93a20c5e9811442496e0ddbc0d32b35f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzExOTQz_9d9b707a-c902-43fe-8302-4a01065fbde0"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="icb3cd0ebcab8404c8e2d53703218de07_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NzIyMTM_69834b97-aabb-416b-a00f-133c527d00c4"
      unitRef="number">0.21</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ie5d364f684594c5783514a961ba1cb23_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NzIyMTc_f62bb49c-80f7-4eb7-bcc4-789af4bb0969"
      unitRef="number">0.11</dgx:PercentageofNetAccountsReceivable>
    <dgx:AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzQz_2bda7281-4438-46a2-8073-a7f625d3df45">Accounts receivable are reported net of allowances for credit losses.  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;When estimating its allowance for credit losses, the Company pools its trade receivables based on the following customer types: healthcare insurers, government payers, client payers and patients, which are described in Note 3.&#160; The Company principally estimates the allowance for credit losses by pool based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period of time that the receivables have been outstanding.&#160; To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the customers from their respective pools and establishes allowances based on the individual risk characteristics of such customers.&lt;/span&gt;&lt;/div&gt;</dgx:AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjYy_c87350cf-7aa2-48d8-845a-464bd10a6caa">Inventories, which consist principally of finished goods testing supplies and reagents, are valued at the lower of cost (first in, first out method) or net realizable value.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjc4_f157c25f-9df7-42b3-8c21-9fec372414e0">Property, plant and equipment is recorded at cost.  Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.  Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and expensed as incurred for preliminary project activities and post-implementation activities.  Capitalized costs include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with the internal-use software project, and interest costs incurred, when material, while developing internal-use software.  Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose.  Costs for maintenance and training are expensed as incurred.  The Company capitalizes interest on borrowings during the active construction period of major capital projects.  Capitalized interest is added to the cost of the underlying assets and is amortized over the expected useful lives of the assets.  Depreciation and amortization are provided on the straight-line method over expected useful asset lives as of December&#160;31, 2021 as follows: &lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;buildings and improvements, ranging up to thirty-one and a half years; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;laboratory equipment and furniture and fixtures, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1MDYw_1d199ab7-3192-43a9-a2e6-2c9e9839ee94"&gt;five&lt;/span&gt; to twelve years; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;leasehold improvements, the lesser of the useful life of the improvement or the remaining life of the building or lease, as applicable; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;computer software developed or obtained for internal use, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1Mjcw_88e6f6e4-a789-4494-8767-bda409fe0bc3"&gt;five&lt;/span&gt; to ten years.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ifb8e5cfafc1a42d58d6cad9058f4760e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1MDY2_db87dfb5-c1e0-402a-b13a-556f2db29fb5">P12Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0b00f7e1bf43453099ed71ff43d6717f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE1Mjc2_a3e84db4-49f0-4fc2-8ddd-bb740870bae2">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzQw_2f733cbc-0bec-441b-ac17-7f77e0632d76">Goodwill represents the excess of the fair value of the acquiree (including the fair value of non-controlling interests) over the recognized bases of the net identifiable assets acquired and includes the future economic benefits from other assets that could not be individually identified and separately recognized.  Goodwill is not amortized, but instead is periodically reviewed for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of goodwill exceeds its fair value.  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On a quarterly basis, the Company performs a review of its business to determine if events or changes in circumstances have occurred which could have a material adverse effect on the fair value of the Company and its goodwill.  If such events or changes in circumstances were deemed to have occurred, the Company would perform an impairment test of goodwill as of the end of the quarter and record any noted impairment loss.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The goodwill test is performed at least annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired.  The annual impairment test includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative test may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company is required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, the Company's policy is to update the fair value calculation of its reporting units and perform the quantitative goodwill impairment test on a periodic basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  The Company calculates the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  The Company assesses the valuation methodology based upon the relevance and availability of the data at the time that the valuation is performed.  The Company compares the estimate of fair value for the reporting unit to the carrying value of the reporting unit.  If the carrying value is greater than the estimate of fair value, an impairment loss will be recognized in the amount of the excess. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company performs its annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2021, the Company performed a qualitative impairment test and, based on the totality of information available for the reporting units, the Company concluded that it was more-likely-than-not that the estimated fair values of the reporting units were greater than the carrying values of the reporting units and, as such, no further analysis was required.  For the year ended December&#160;31, 2020, in accordance with its policy to perform the quantitative test on a periodic basis, the Company updated the fair value calculation of its reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzIx_4ecffd48-51bf-4b2a-a776-ac11d341ca41">Intangible assets are recognized at fair value, as an asset apart from goodwill if the asset (i) arises from contractual or other legal rights, or (ii) is separable.  Intangible assets, principally representing the cost of customer-related intangibles, non-competition agreements and technology acquired, are capitalized and amortized on the straight-line method over their expected useful lives, which generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE5MTMy_22152b9e-6ae5-4ec5-ae0f-101ca8483d0a"&gt;five&lt;/span&gt; to twenty years.  Intangible assets with indefinite useful lives, consisting principally of acquired tradenames, are not amortized, but instead are periodically reviewed for impairment.  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company reviews indefinite-lived intangible assets periodically for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of an indefinite-lived intangible asset is more than its estimated fair value.  The indefinite-lived intangible asset impairment test is performed at least annually, or more frequently in the case of other events that indicate a potential impairment.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Based upon the Company&#x2019;s most recent annual impairment tests completed during the fourth quarters of the years ended December&#160;31, 2021 and 2020, the Company concluded that indefinite-lived intangible assets were not impaired.&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;The Company reviews the recoverability of its long-lived assets (including amortizable intangible assets), other than goodwill and indefinite-lived intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.  Evaluation of possible impairment is based on the Company's ability to recover the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations.  If these cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzE5MTM4_da541fe1-7e9f-4433-bdf1-fe6561c59787">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzM1_8e51b19c-2327-4d70-94e1-a74f02086ba9">The Company's investments (except for those accounted for under the equity method of accounting) include:&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity investments with readily determinable fair values, including investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries (such investments, which previously did not have readily determinable fair values, became publicly-traded during the year ended December 31, 2021); as well as participant-directed investments of deferred employee compensation and related Company matching contributions held in trusts pursuant to the Company's supplemental deferred compensation plans (see Note 17).  These investments are measured at fair value with both realized and unrealized gains and losses recorded in current earnings within other income, net in the consolidated statements of operations.  For the years ended December&#160;31, 2021, 2020 and 2019, gains from all equity investments with readily determinable fair values totaled $56 million, $8 million, and $10 million, respectively.  The carrying values of these investments was $121 million at December 31, 2021, of which $44 million was included in prepaid expenses and other current assets and $77 million was included in other assets in the consolidated balance sheet.  The carrying values of these investments was $67 million at December 31, 2020, which was included in other assets in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity investments that do not have readily determinable fair values, which consist of investments in preferred and common shares of privately held companies.  These investments are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  The Company regularly evaluates these equity investments to determine if there are any indicators that the investment is impaired; no impairment charges were recognized related to these investments for the years ended December&#160;31, 2021, 2020 and 2019.  The carrying value of these investments was $4 million and $25 million at December&#160;31, 2021 and 2020, respectively.  Such amounts were included in other assets in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Available-for-sale debt securities of privately-held companies.  These investments are measured at fair value with unrealized gains and losses presented in other comprehensive income (loss).  The carrying amount of these investments was $1 million and $12 million at December&#160;31, 2021 and 2020, respectively.  Such amounts were included in other assets in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjA2NDI_5eb2bd92-ebfe-422a-a568-687f6b3a8ec3"
      unitRef="usd">56000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIxMzg4_334d11ed-f10e-4970-94c0-403b5b54db33"
      unitRef="usd">8000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIxMzk2_a79db7f3-8b3b-4c11-b6dc-555629c3fb6d"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjA3MDU_16dbedea-ec01-43a1-b373-3b94945ba8cf"
      unitRef="usd">121000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i972899ce7ba6442aaf147d47867cd482_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0Mzk2NjY_8a1dfacd-0f50-4d18-9485-e2c0cec73554"
      unitRef="usd">44000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0Mzk2NzE_89b800bc-9267-4c2b-bfd6-a40fd29241c2"
      unitRef="usd">77000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="iba604be725684156a3eb0ffeedf8b741_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0Mzk2NzE_95262d48-dbba-41c8-a1a3-54958278022c"
      unitRef="usd">77000000</us-gaap:TradingSecurities>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i6abd46db2a6b4225801b044e7620dd70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIxNDY3_213d6389-5c82-4b3c-94b7-fa5dfc45fc04"
      unitRef="usd">67000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjI4NzQ_42c3bc9f-49b7-4c78-9f4d-1fbf2c392c95"
      unitRef="usd">0</dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment>
    <dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjI4NzQ_6f096a30-4208-4c3a-bbda-925431946772"
      unitRef="usd">0</dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment>
    <dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjI4NzQ_fc1e9aa1-2b6f-40d2-b5fd-4598e78598dc"
      unitRef="usd">0</dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjE0Mzg_162581fd-dc34-4b4d-a8ab-5791abb40c4c"
      unitRef="usd">4000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIyMDY2_c64e42bf-67b1-4a9e-8fad-485f15247471"
      unitRef="usd">25000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzEwOTk1MTE2NjA3MTY_1d16ff35-0335-4a76-bc0f-c17aaa618f06"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzIyMzI1_6f75c0f3-8d7b-4acd-be2f-fcf109e9091d"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMjcz_a48e3d59-cbb8-472a-b601-f93d30f82fc4">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit risk-related contingent features or requirements to post collateral.&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate debt instruments and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;The Company accounts for these derivatives as either an asset or liability measured at its fair value.  The fair value is based upon model-derived valuations in which all significant inputs are observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.  For a derivative instrument that has been formally designated as a fair value hedge, fair value gains or losses on the derivative instrument along with offsetting fair value gains or losses on the hedged item that are attributable to the risk being hedged are reported in other income, net in the consolidated statements of operations.  For derivatives that have been formally designated as a cash flow hedge, the change in the fair value of the derivatives is recorded in accumulated other comprehensive loss.  Upon maturity or early termination of an effective interest rate swap agreement designated as a cash flow hedge, unrealized gains or losses are deferred in stockholders' equity, as a component of accumulated other comprehensive loss, and are amortized as an adjustment to interest expense over the period during which the hedged forecasted transaction affects earnings, which is when the Company recognizes interest expense on the hedged cash flows.  At inception and quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item.  After the initial quantitative assessment, this analysis is initially performed on a qualitative basis and, if it is determined that the hedging relationship was and continues to be highly effective, no further analysis is required.  All components of each derivative financial instrument's gain or loss are included in the assessment of hedge effectiveness.  If it is determined that a derivative ceases to be a highly effective hedge, the Company discontinues hedge accounting and any deferred gains or losses related to a discontinued cash flow hedge shall continue to be reported in accumulated other comprehensive loss, unless it is probable that the forecasted transaction will not occur.  If it is probable that the forecasted transaction will not occur by the originally specified time period, the Company discontinues hedge accounting and any deferred gains or losses reported in accumulated other comprehensive loss are classified into earnings immediately.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:StockholdersEquityPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzcz_abd2b61d-4569-4da1-a43d-f499e74858e3">Comprehensive income (loss) encompasses all changes in stockholders' equity (except those arising from transactions with stockholders) and includes:&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Notes 15 and 16); and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzI3NDg3NzkxMTU5MDU_8c663574-6be7-4d09-b40d-605ee26f0c06">Advertising costs are expensed as incurred.  For the years ended December 31, 2021, 2020 and 2019, advertising costs were $78&#160;million, $38&#160;million and $18&#160;million, respectively.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0NDA2OTI_0144c67b-33de-4977-99ae-021ab6ab2080"
      unitRef="usd">78000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0NDA3MDU_e9e5a3d0-21f3-4d89-8862-0317beb85c30"
      unitRef="usd">38000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1Xzc2OTY1ODE0NDA3MTg_fcc67c12-13dd-46c8-aa88-24ff777e1b7d"
      unitRef="usd">18000000</us-gaap:AdvertisingExpense>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xNzgvZnJhZzo1NmI2ZmFiZTEwZjI0ZTEyYTFlY2FjYmNhZmFhZDc1NS90ZXh0cmVnaW9uOjU2YjZmYWJlMTBmMjRlMTJhMWVjYWNiY2FmYWFkNzU1XzMxMzIy_3999ebc2-d02a-4427-9d20-565ed9404f2b">New Accounting Standards To Be Adopted&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of &lt;/span&gt;the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzc5MDM_76444456-d301-4c8b-9cef-740f2a05a71b">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DIS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues in the Company&#x2019;s DIS business accounted for greater than 95% of the Company&#x2019;s consolidated net revenues for the years ended December&#160;31, 2021, 2020 and 2019 and are primarily comprised of a high volume of relatively low-dollar transactions.  The DIS business, which provides clinical testing services and other services, satisfies its performance obligation and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions, as discussed below. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.  Contracts with customers in the DIS business do not contain significant financing components based on the typical period of time between performance of services and collection of consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The process for estimating revenues and the ultimate collection of accounts receivable involves significant judgment and estimation.  The Company follows a standard process, which considers historical denial and collection experience and other factors (including the period of time that the receivables have been outstanding), to estimate contractual allowances and implicit price concessions, recording adjustments in the current period as changes in estimates.  Further adjustments to the allowances, based on actual receipts, may be recorded upon settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following are descriptions of the DIS business&#x2019; portfolios:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Healthcare Insurers &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reimbursements from healthcare insurers are based on negotiated fee-for-service schedules and on capitated payment rates.  Under fee-for-service arrangements, healthcare insurers are billed at the Company's list price.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and the terms of the Company&#x2019;s contractual arrangements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Collection of the Company's net revenues from healthcare insurers is normally a function of providing complete and correct billing information to the healthcare insurers within the various filing deadlines and generally occurs within 30 to 60 days of billing.  Provided the Company has billed healthcare insurers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and if so, it will reserve accordingly for the billing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under capitated arrangements with healthcare insurers, the Company recognizes revenue based on a predetermined monthly reimbursement rate for each member of an insurer's health plan regardless of the number or cost of services provided by the Company.  Healthcare insurers typically reimburse the Company under capitated arrangements in the same month services are performed, essentially giving rise to no outstanding accounts receivable at the end of a reporting period.  If any capitated payments are not received on a timely basis, the Company determines the cause and makes a separate determination as to whether or not the collection of the amount from the healthcare insurer is at risk and, if so, would reserve accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Payers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reimbursements from government payers are based on fee-for-service schedules set by governmental authorities, including traditional Medicare and Medicaid.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and other factors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Collection of the Company's net revenues from government payers is normally a function of providing the complete and correct billing information within the various filing deadlines and generally occurs within 30 days of billing.  Provided the Company has billed government payers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and, if so, it will reserve for the billing accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Client Payers &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Client payers include physicians, hospitals, ACOs, DCEs, IDNs, employers, other commercial laboratories and institutions for which services are performed on a wholesale basis, and are billed based on negotiated fee schedules.  Credit risk and ability to pay are more of a consideration for these payers than healthcare insurers and government payers.  Collection of consideration the Company expects to receive generally occurs within 60 to 90 days of billing.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company principally estimates the allowance for credit losses for client payers based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period of time that the receivables have been outstanding. To the extent that any individual client payers are identified that have deteriorated in credit quality, the Company establishes allowances based on the individual risk characteristics of such customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patients&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Uninsured patients are billed based on established patient fee schedules or fees negotiated with physicians on behalf of their patients.  Insured patients (includes coinsurance and deductible responsibilities) are billed based on fees negotiated with healthcare insurers.  Collection of billings from patients is subject to credit risk and ability of the patients to pay.  Net revenues consist of amounts billed net of discounts provided to uninsured patients in accordance with the Company&#x2019;s policies and implicit price concessions.  Implicit price concessions represent differences between amounts billed and the estimated consideration the Company expects to receive from patients, which considers historical collection experience (including the period of time that the receivables have been outstanding) and other factors including current market conditions. Patient billings are generally fully reserved for when the related service reaches 210 days outstanding.  Balances are automatically written off when they are sent to collection agencies.  Allowances are further adjusted for estimated recoveries of amounts sent to collection agencies based on historical collection experience, which is regularly monitored.  Collection of consideration the Company expects to receive generally occurs within 30 to 60 days of billing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#x2019;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered.  Collection of consideration the Company expects to receive generally occurs within 30 to 60 days of billing.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, substantially all of the Company&#x2019;s services were provided within the United States, see Note 19.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer as of December&#160;31, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table summarizes the activity for the Company's allowance for credit losses during the years ended December&#160;31, 2021 and 2020, which principally relates to client payers:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs of accounts receivable, net of recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs of accounts receivable, net of recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i3a090f7f88f3481086c45baf1ec6dabd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzEwNg_1bba286c-e189-4c6c-8928-18cc793c40ef"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ice4e3139e0ba4820be8e5d8cf02f15fe_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzEwNg_b772228e-2d00-4882-bf30-053997a344d0"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="idb62d67015ba418c9bcc8c4ca149ca60_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzEwNg_fa70d45a-a659-4270-9351-c52fcc12d971"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="ie799399ba4554af3b75c1e5d805f52c7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzI2MTE_e08454a6-829f-49a8-8f15-7f56e28e45d7">P30D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i88dd508f2a244b859dab8f3eb925f23a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzI2MTc_0959028c-64a2-4c98-9b62-b88506b4a1eb">P60D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i3dd2fa8993ba4765a061aa8753907429_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzQ0MTE_481c93c1-051c-409d-80bd-b1bd99a9115b">P30D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i886f4c78cd9c49dda5f59730477bd7a8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzUyNTY_da1f876d-2181-4f4a-bba3-581da53bc0f5">P60D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="ic7db216ea09e4faf817a70826756f79f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzUyNjI_d901fb1a-10d9-4d11-a28c-a874620486c3">P90D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:PeriodofBillingFullyReserve
      contextRef="i5b66d5c815234d649c202faa47b0836f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzY3NDI_8f66d6b9-648f-46cb-85c3-97a218b4c2e9">P210D</dgx:PeriodofBillingFullyReserve>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="iceca007bdcd64d67a3cfc72359b58092_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzcxMDA_06077ad7-6489-4f4a-af79-2cd51b74d5ef">P30D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i24c4e46338874112b41b05ba07c69b13_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzcxMDY_d3ee48f2-2d87-4581-b995-b5a1fbc757bb">P60D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i3e8e2db9ab7a4c3c8b0971c8eb34874d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzczNzU_31d68954-2b6b-46ff-9f16-8a3c8c27209a">P30D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i5bed9502f4964d15af65cfe68d0a3389_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzczODE_a94ef9f6-6511-4e8f-a274-4a379e1f53f3">P60D</dgx:RevenueCollectionofConsiderationPeriod>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzc5MDA_f7cdb27b-f44d-4607-94aa-99b138e2e6c8">The approximate percentage of net revenue by type of customer was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i7008d482a62245bb9875f7b05fec3156_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzMtMS0xLTEtMjA5MjU_953297e6-8dff-4007-99f9-1e5d50f50cb4"
      unitRef="number">0.39</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0bb294ef9720428da49024b4cc1c015e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzMtMy0xLTEtMjA5MjU_bf98645a-022b-4210-8359-a819aefdcadd"
      unitRef="number">0.34</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i58580a51b19549c984bf823f6103da97_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzMtNS0xLTEtMjA5MjU_3207a7de-b714-4354-92e3-d8cbb4a5e8d2"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ib3c0596ed88949319f741c4098014adc_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzQtMS0xLTEtMjA5MjU_7701ef61-4998-4938-9fab-b6f96f71b5f1"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i53e0c40604dc436dac0d5316b6aa3124_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzQtMy0xLTEtMjA5MjU_ded4e208-02db-4380-a6cd-04aecbc2710c"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i17c7defe77e94feca925988ab94659bc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzQtNS0xLTEtMjA5MjU_61b27f6f-d00f-4db4-87c8-db2c8d0ab493"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="if59d0382710d43bd95feee9461a26bdc_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzUtMS0xLTEtMjA5MjU_a085d58e-3960-4302-a2cf-4154e6c95492"
      unitRef="number">0.42</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0c17eb1dddb643999d1956c1832f752a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzUtMy0xLTEtMjA5MjU_cd737a86-0405-4ce4-b0bb-932ad0bd3168"
      unitRef="number">0.37</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i7b5e5b177ae448c083554c9494be58aa_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzUtNS0xLTEtMjA5MjU_b1adc0e9-2a98-4026-b82f-a3e977b94531"
      unitRef="number">0.36</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i641831615df34b538199d475b2c51f92_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzYtMS0xLTEtMjA5MjU_82d1f534-6eff-48c2-a9ac-b8a39bc0668e"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i89f3081e1b5445c6bfec2edf60f2f909_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzYtMy0xLTEtMjA5MjU_2bbb8339-a0c2-4570-a121-2052771e65a8"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia5e542d0dfea43e2af9118d20432c274_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzYtNS0xLTEtMjA5MjU_e47b4e18-4d88-47d8-a388-ef4487258d4e"
      unitRef="number">0.15</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3a09d850f846426d9dfd70228809d98a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzctMS0xLTEtMjA5MjU_a30191e3-1b0b-4019-998b-7cc38269d3a3"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i101444f4d55c4f7face8b6cbb4ad8c7c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzctMy0xLTEtMjA5MjU_69e33470-03d2-4f6d-8b7a-02a350e7ba16"
      unitRef="number">0.38</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i67a12fbdd2794793bdbac9d69717453a_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzctNS0xLTEtMjA5MjU_aafff747-807d-474c-804d-b8490832c7e9"
      unitRef="number">0.32</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i5b66d5c815234d649c202faa47b0836f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzgtMS0xLTEtMjA5MjU_dfd7b8f8-90df-4e9b-98b5-40f0840ba010"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i842c67659a084bca972b57a09beab75c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzgtMy0xLTEtMjA5MjU_937adcd0-edcc-48ba-b73c-b567c4dd4617"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia0bd2018f1ae4210af8adb65d7d4adec_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzgtNS0xLTEtMjA5MjU_e05a2c7a-012f-4caf-afd3-a013f3c3eff6"
      unitRef="number">0.13</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="id6815212460d4587af042592f64aaf60_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzktMS0xLTEtMjA5MjU_cf94eddd-f8f7-4563-93b2-7823b656ff6a"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="id22f162e49514311adf2fd36a699bba9_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzktMy0xLTEtMjA5MjU_9ca6eb9a-2e66-4c2e-b1cf-f3b8839305a9"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzktNS0xLTEtMjA5MjU_151dd063-4293-466a-bf61-4465c5cd1d1c"
      unitRef="number">0.96</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i4d589ca3abf844d78f270902170a0189_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzEwLTEtMS0xLTIwOTI1_ad50f797-3270-4ed1-b33e-a0850a5ad751"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i41ddf51214fb499e84fddd91bbb595d0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzEwLTMtMS0xLTIwOTI1_1809cb6d-b699-4cc6-ba0e-5822809a5d40"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i62d8cd061af34ddda090b2a1ed70a859_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzEwLTUtMS0xLTIwOTI1_5196c82d-7625-4d57-8154-af5a2b63d305"
      unitRef="number">0.04</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzExLTEtMS0xLTIwOTI1_2900795e-1820-4964-aa35-6c524261e06c"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzExLTMtMS0xLTIwOTI1_db914fe8-99cd-4499-9b5a-c2354a6dff09"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTphOWJhMGIxN2U4ZjQ0M2Q2OWVkNDI1ODkzZjI2MjY5ZS90YWJsZXJhbmdlOmE5YmEwYjE3ZThmNDQzZDY5ZWQ0MjU4OTNmMjYyNjllXzExLTUtMS0xLTIwOTI1_082bc0b6-f652-4f44-ab4b-a04cf155a65d"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:AccountsReceivableDisaggregationTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzc5MDI_2af55120-b91e-4a68-bf99-e1b515b83151">The approximate percentage of net accounts receivable by type of customer as of December&#160;31, 2021 and 2020 was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:AccountsReceivableDisaggregationTableTextBlock>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i4a05287b4f02418c82cd5f2e6e79c6dc_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzItMS0xLTEtMjA5MjU_d47a07ee-c7f9-49da-a91f-b2c95997e6b5"
      unitRef="number">0.32</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i2add5ec575124eaa815d9e79f4d20f0e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzItMy0xLTEtMjA5MjU_35667e76-c57b-4412-8253-cae0ed8865f4"
      unitRef="number">0.34</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i37a9f450d5fc42bd8a4cedc5a182bb1d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzMtMS0xLTEtMjA5MjU_646ce812-164c-4ac2-9eb4-a4a80ea0b577"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i93a20c5e9811442496e0ddbc0d32b35f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzMtMS0xLTEtMjA5MjU_9d9b707a-c902-43fe-8302-4a01065fbde0"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i37a9f450d5fc42bd8a4cedc5a182bb1d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzMtMy0xLTEtMjA5MjU_79109e28-05be-4e5f-bcd0-c9dd3cdee6e3"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i30f9993ad61e49b8889d85cebdd9a0ca_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzQtMS0xLTEtMjA5MjU_e1f842cf-169c-4fe5-9fbc-3757edb821dd"
      unitRef="number">0.38</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ia36c52a54f80476e9f66b1b0b7134265_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzQtMy0xLTEtMjA5MjU_7dcea6e6-7142-4812-bc2e-187b2e12f0ee"
      unitRef="number">0.46</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="icb3cd0ebcab8404c8e2d53703218de07_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzUtMS0xLTEtMjA5MjU_69834b97-aabb-416b-a00f-133c527d00c4"
      unitRef="number">0.21</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ie5d364f684594c5783514a961ba1cb23_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzUtMy0xLTEtMjA5MjU_f62bb49c-80f7-4eb7-bcc4-789af4bb0969"
      unitRef="number">0.11</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i1d0d6530dd894b1c87f220eb4e22a87b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzYtMS0xLTEtMjA5MjU_2d813632-dae2-4c19-986f-53e15273c5f7"
      unitRef="number">0.97</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="if86384a0f5614da3a89e030848de8448_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzYtMy0xLTEtMjA5MjU_018c3039-88e1-4447-a81f-212e33f01f19"
      unitRef="number">0.97</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i47fc543fa62f457495efbed248f47831_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzctMS0xLTEtMjA5MjU_2d67464c-b188-4076-a830-4d9773f62676"
      unitRef="number">0.03</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i618e3edc7d0e472db6505e306cf617c9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzctMy0xLTEtMjA5MjU_586ac0ee-e208-4b1f-a5bb-706cd898558a"
      unitRef="number">0.03</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzgtMS0xLTEtMjA5MjU_5b04d555-98e2-4621-bb6d-621d107b013f"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTowYTI2Y2Q5ZDgyMDY0YzVlYTQ2OWExZWY3YzE4NGFiZC90YWJsZXJhbmdlOjBhMjZjZDlkODIwNjRjNWVhNDY5YTFlZjdjMTg0YWJkXzgtMy0xLTEtMjA5MjU_6519a9ff-d698-4230-9d87-33e8582c692c"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90ZXh0cmVnaW9uOjU1Y2RhZDk2NmFiMzQ5ODQ5YmJiOTBiZDc3NzZiYzQyXzc4OTc_6ef67cae-8683-4995-892c-08e2f8431199">The following table summarizes the activity for the Company's allowance for credit losses during the years ended December&#160;31, 2021 and 2020, which principally relates to client payers:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs of accounts receivable, net of recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs of accounts receivable, net of recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzItMS0xLTEtMjk3NTk_5ff0081f-6eac-4eba-80e9-6c7613764187"
      unitRef="usd">15000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzMtMS0xLTEtMjk3NTk_4d281567-d29b-4361-aca1-9f7be584ba1f"
      unitRef="usd">19000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzQtMS0xLTEtMjk3NTk_46ac5010-574b-42c5-bffc-3e851d04e1dc"
      unitRef="usd">6000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzItMS0xLTEtMjA5MjU_edb0e477-84da-4658-b31f-00da7769c3e1"
      unitRef="usd">28000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzMtMS0xLTEtMjA5MjU_06a1f676-f4b8-459f-b8d4-1a10385fe2a1"
      unitRef="usd">4000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzQtMS0xLTEtMjA5MjU_78703cc5-25bb-4322-a73d-73d585113670"
      unitRef="usd">1000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODQvZnJhZzo1NWNkYWQ5NjZhYjM0OTg0OWJiYjkwYmQ3Nzc2YmM0Mi90YWJsZTozOGNiNjA5MmE0NWE0Zjk3OGYzYjVkZWNhNDljMTE4OS90YWJsZXJhbmdlOjM4Y2I2MDkyYTQ1YTRmOTc4ZjNiNWRlY2E0OWMxMTg5XzUtMS0xLTEtMjA5MjU_86ab5ea1-2eb1-4a17-8025-711a1bfef0b2"
      unitRef="usd">31000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90ZXh0cmVnaW9uOmUyZTZhYWNiNzg0OTRkMThhYjllYzY4M2IyNWZjNGE1XzI5OA_cca66c28-7d64-4e74-86f1-6dace904cc96">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics' common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders - basic:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders - diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company entered into ASRs with several financial institutions to repurchase $1.5&#160;billion of the Company's common stock as part of the Company's share repurchase program. See Note 16 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90ZXh0cmVnaW9uOmUyZTZhYWNiNzg0OTRkMThhYjllYzY4M2IyNWZjNGE1XzI5Mw_120151ad-17d3-4679-9a3b-7c7ce2ff9d2e">The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics' common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders - basic:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders - diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzItMS0xLTEtMjA5MjU_4c79b348-7d6b-4267-b3c7-c4fb41306426"
      unitRef="usd">1995000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzItMy0xLTEtMjA5MjU_44066cc6-da0c-4b95-853f-9fb1939d81f8"
      unitRef="usd">1431000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzItNS0xLTEtMjA5MjU_8e61a124-ba2f-41db-ac0c-f530a6a98223"
      unitRef="usd">838000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzMtMS0xLTEtMjA5MjU_65d16c9d-aaa4-466a-a87a-8998cdc275dd"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzMtMy0xLTEtMjA5MjU_b773ada2-3fc6-4a12-aac7-3b3e140fe85f"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzMtNS0xLTEtMjA5MjU_1ea047f3-2882-476b-93c0-4853d40ffd0d"
      unitRef="usd">20000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzQtMS0xLTEtMjA5MjU_da70d4f9-abf5-4267-88d5-be952522fcdb"
      unitRef="usd">1995000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzQtMy0xLTEtMjA5MjU_2f667f06-19a1-4adb-8b72-8a800cf54fbc"
      unitRef="usd">1431000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzQtNS0xLTEtMjA5MjU_38de0e6f-3ef7-4984-870d-b2775fe3c239"
      unitRef="usd">858000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzYtMS0xLTEtMjA5MjU_5b53be52-f27c-444a-90d6-9917f0c2e16e"
      unitRef="usd">1995000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzYtMy0xLTEtMjA5MjU_e6126962-490a-433d-90c3-3362ec879754"
      unitRef="usd">1431000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzYtNS0xLTEtMjA5MjU_5fdbf774-5c6d-4a99-ad99-bc6477f3441e"
      unitRef="usd">838000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzctMS0xLTEtMjA5MjU_a02551ea-6366-4022-b333-b17afea0ac9e"
      unitRef="usd">7000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzctMy0xLTEtMjA5MjU_8474e519-04bf-44ff-91d5-8362c4de595e"
      unitRef="usd">6000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzctNS0xLTEtMjA5MjU_c19bd3d9-31c3-454b-8291-5aa31c28d3f3"
      unitRef="usd">3000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzgtMS0xLTEtMjA5MjU_6d4ef409-3092-44d5-8afe-ce46717bc377"
      unitRef="usd">1988000000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzgtMy0xLTEtMjA5MjU_fdf640ce-4fda-466b-bafe-0fdbb85b5f46"
      unitRef="usd">1425000000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzgtNS0xLTEtMjA5MjU_b552cdba-ea2b-4454-84cc-b14ccf1a64aa"
      unitRef="usd">835000000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEwLTEtMS0xLTIwOTI1_076abeb7-b8ea-4ac7-80e8-527901c23d08"
      unitRef="shares">125000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEwLTMtMS0xLTIwOTI1_6c9ac131-3f5c-40db-9bf6-ebc80e88e5b5"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEwLTUtMS0xLTIwOTI1_ffa53ebd-9f50-4666-9ff1-e126236841fe"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEyLTEtMS0xLTIwOTI1_901f4d28-545e-4601-8ae8-5772c9acc019"
      unitRef="shares">3000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEyLTMtMS0xLTIwOTI1_fb74402c-67a7-4461-870e-2aff07b8ba10"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEyLTUtMS0xLTIwOTI1_3efda3d6-6344-4920-8ab5-3fa094d68845"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEzLTEtMS0xLTIwOTI1_9b058f1d-48cb-470d-bf30-926a92351163"
      unitRef="shares">128000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEzLTMtMS0xLTIwOTI1_6dc48790-f27e-470a-b688-d21bd4a5a685"
      unitRef="shares">136000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzEzLTUtMS0xLTIwOTI1_a7ac9a8b-7a86-4565-b4cd-fcb0710b45fa"
      unitRef="shares">136000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE2LTEtMS0xLTIwOTI1_953ed003-e6d3-40ed-955e-043a10bd2a69"
      unitRef="usdPerShare">15.85</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE2LTMtMS0xLTIwOTI1_1e03e1c2-ed95-45b0-ad44-d0451a37ce0e"
      unitRef="usdPerShare">10.62</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE2LTUtMS0xLTIwOTI1_64651a85-ad9e-46d5-be60-2ab6b80be41c"
      unitRef="usdPerShare">6.21</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE3LTEtMS0xLTIwOTI1_cbbd7fa1-afa7-456b-b4ec-adbf4aa5cc1f"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE3LTMtMS0xLTIwOTI1_82de0d56-0a83-417a-b5ee-5fee0ba19a84"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE3LTUtMS0xLTIwOTI1_bfea90f3-55bd-43b8-acfd-88d209fa2251"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE4LTEtMS0xLTIwOTI1_a64d5008-dda3-4b76-860c-ffda7eb08ac8"
      unitRef="usdPerShare">15.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE4LTMtMS0xLTIwOTI1_c9aba9b3-0623-4bb9-9e23-2e6972871f1d"
      unitRef="usdPerShare">10.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzE4LTUtMS0xLTIwOTI1_9d1cb49b-ffa7-4877-941e-ddfd09d324de"
      unitRef="usdPerShare">6.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIxLTEtMS0xLTIwOTI1_80e055a0-cd53-4a2b-8cb9-22f57aa7aaf6"
      unitRef="usdPerShare">15.55</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIxLTMtMS0xLTIwOTI1_b33059a8-60a7-402c-b92f-1e93a8d77795"
      unitRef="usdPerShare">10.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIxLTUtMS0xLTIwOTI1_28d05ca0-a8d5-4fa6-a2a5-22c16e096b0e"
      unitRef="usdPerShare">6.13</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIyLTEtMS0xLTIwOTI1_c53a973f-e19f-4efa-bab6-f241309fc6de"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIyLTMtMS0xLTIwOTI1_a8bc936e-feaa-465e-b2f8-d94930a77cdd"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIyLTUtMS0xLTIwOTI1_89b1df81-335f-47f0-8b93-05ef35f2f95e"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIzLTEtMS0xLTIwOTI1_878ace95-b408-460f-9c89-b7fb20e305fc"
      unitRef="usdPerShare">15.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIzLTMtMS0xLTIwOTI1_95907647-caf3-45fa-b544-ba9796956b57"
      unitRef="usdPerShare">10.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZToyN2Y5YTI1MmViMGQ0NzE0OTdlOTZiYTZlYmZhODlkYi90YWJsZXJhbmdlOjI3ZjlhMjUyZWIwZDQ3MTQ5N2U5NmJhNmViZmE4OWRiXzIzLTUtMS0xLTIwOTI1_c120066b-7d4b-4ae7-b8e9-0da9340a9bb8"
      unitRef="usdPerShare">6.28</us-gaap:EarningsPerShareDiluted>
    <dgx:AcceleratedShareRepurchasesPayment
      contextRef="i1dc63d78467b4990a09bb4edf33bc0d9_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90ZXh0cmVnaW9uOmUyZTZhYWNiNzg0OTRkMThhYjllYzY4M2IyNWZjNGE1Xzc2OTY1ODEzOTUxODQ_6893c306-c02f-42f1-a141-faeaa6e1c1a2"
      unitRef="usd">1500000000</dgx:AcceleratedShareRepurchasesPayment>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90ZXh0cmVnaW9uOmUyZTZhYWNiNzg0OTRkMThhYjllYzY4M2IyNWZjNGE1XzI4Nw_c567f37c-84bd-4f10-b1cf-703074816f4f">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZTpiODFlMjRkZWQ0YWI0ZDBkODM2MzE0YWVmN2NiN2QyMS90YWJsZXJhbmdlOmI4MWUyNGRlZDRhYjRkMGQ4MzYzMTRhZWY3Y2I3ZDIxXzItMS0xLTEtMjA5MjU_48eeb61b-b45d-4649-aad8-38f5b97d4f28"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZTpiODFlMjRkZWQ0YWI0ZDBkODM2MzE0YWVmN2NiN2QyMS90YWJsZXJhbmdlOmI4MWUyNGRlZDRhYjRkMGQ4MzYzMTRhZWY3Y2I3ZDIxXzItMy0xLTEtMjA5MjU_45a4e44a-8608-4b51-ac88-91482b2ec72b"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xODcvZnJhZzplMmU2YWFjYjc4NDk0ZDE4YWI5ZWM2ODNiMjVmYzRhNS90YWJsZTpiODFlMjRkZWQ0YWI0ZDBkODM2MzE0YWVmN2NiN2QyMS90YWJsZXJhbmdlOmI4MWUyNGRlZDRhYjRkMGQ4MzYzMTRhZWY3Y2I3ZDIxXzItNS0xLTEtMjA5MjU_750d4b95-66ac-4243-8e19-4078ef890027"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwNjU1_57fe6800-5db8-42d7-9a03-5ed3a8ce6a26">BUSINESS ACQUISITIONS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;2021 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, the Company completed acquisitions for an aggregate purchase price of $336&#160;million, net of cash acquired, including the acquisitions discussed below.  The 2021 acquisitions resulted in goodwill of $228&#160;million, of which $223&#160;million is deductible for tax purposes.  These acquisitions also resulted in $104&#160;million of intangible assets, principally comprised of customer-related intangible assets.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of the outreach laboratory services business of Mercy Health&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2021, the Company completed the acquisition of the outreach laboratory services business of Mercy Health ("Mercy Health"), which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $225&#160;million.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $54&#160;million of customer-related intangible assets and $171&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of assets of Labtech Diagnostics, LLC ("Labtech")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 13, 2021, the Company completed the acquisition of assets of Labtech, an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South Carolina, North Carolina, Florida and Georgia, in an all cash transaction for $85&#160;million, which consisted of cash consideration of $80&#160;million and contingent consideration initially estimated at $5&#160;million. The contingent consideration arrangement is dependent upon the achievement of certain testing volume benchmarks.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $41&#160;million of intangible assets, $40&#160;million of goodwill (of which $35&#160;million is tax deductible), $11&#160;million of property, plant and equipment, $9&#160;million of finance lease liabilities, $6&#160;million of operating lease right-of-use assets, $6&#160;million of operating lease liabilities, and $2&#160;million of inventories. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;2020 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company completed acquisitions for an aggregate purchase price of $330&#160;million, net of cash acquired, including the acquisitions discussed below.  The 2020 acquisitions resulted in goodwill of $247&#160;million, of which $210&#160;million is deductible for tax purposes.  These acquisitions also resulted in $146&#160;million of intangible assets, principally comprised of customer-related and technology intangible assets.  Net revenues attributable to the 2020 acquisitions were $127&#160;million for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Blueprint Genetics Oy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 21, 2020, the Company completed the acquisition of Blueprint Genetics Oy ("Blueprint Genetics"), in an all cash transaction for $108&#160;million, net of $3&#160;million cash acquired.  Blueprint Genetics is a leading specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing and proprietary bioinformatics.  Through the acquisition, the Company acquired all of Blueprint Genetics' operations.  Based on the purchase price allocation, the assets acquired and liabilities assumed primarily consist of $66&#160;million of tax-deductible goodwill, $43&#160;million of intangible assets, and $2&#160;million of property, plant and equipment and working capital.  The intangible assets primarily consist of technology and customer-related assets which are being amortized over a useful life of 10 years and 15 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of the Outreach Laboratory Services Business of Memorial Hermann Health System&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 6, 2020, the Company completed the acquisition of select assets which constitute substantially all of the operations of Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System ("Memorial Hermann"), in an all cash transaction for $120&#160;million.  Memorial Hermann is a not-for-profit health system in Southeast Texas.  Based on the purchase price allocation, the assets acquired primarily consist of $27&#160;million of customer-related intangible assets and $93&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of 15 years.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of the Remaining 56% Interest in Mid America Clinical Laboratories, LLC&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On August 1, 2020, the Company completed the acquisition of the remaining 56% interest in Mid America Clinical Laboratories, LLC ("MACL") from its joint venture partners in an all cash transaction for $93&#160;million, net of $18&#160;million cash acquired.  MACL is the largest independent clinical laboratory provider in Indiana.  Prior to the acquisition, the Company accounted for its 44% interest in MACL as an equity method investment, which was remeasured to its fair value of $87&#160;million on the acquisition date, resulting in a gain of $70&#160;million that was recognized in other income, net in the consolidated statements of operations.  The fair value of the previously held equity interest was determined using a discounted cash flow analysis that took into account, among other items, MACL's expected future cash flows, long-term growth rate (1.5%), and a discount rate commensurate with economic risk (7.5%).  Based on the purchase price allocation, the assets acquired and liabilities assumed consist of $84&#160;million of goodwill (of which $47&#160;million is tax-deductible), $74&#160;million of intangible assets, $11&#160;million of working capital and $11&#160;million of property, plant and equipment.  The intangible assets consist of customer-related assets which are being amortized over a useful life of 15 years.  As a result of the acquisition, MACL became a wholly owned subsidiary of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;2019 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During 2019, the Company completed acquisitions for an aggregate purchase price of $63 million, including the acquisition discussed below.  The 2019 acquisitions resulted in goodwill of $43 million, of which $36 million is deductible for tax purposes.  These acquisitions also resulted in $21 million of intangible assets, principally comprised of customer-related intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of the Clinical Laboratory Services Business of Boyce &amp;amp; Bynum Pathology Laboratories, P.C.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On February 11, 2019, the Company completed the acquisition of certain assets of the clinical laboratory services business of Boyce &amp;amp; Bynum Pathology Laboratories, P.C. in an all cash transaction for $61 million, which consisted of cash consideration of $55 million and contingent consideration initially estimated at $6 million.  The contingent consideration arrangement was dependent upon the achievement of certain testing volume benchmarks.  During 2019, the liability was reduced to $0 as a result of updated testing volume forecasts for the earn-out period compared to the testing volume target included in the contingent consideration arrangement, resulting in a $6 million gain recorded in other operating (income) expense, net.  Based on the purchase price allocation, the assets acquired principally consist of $41 million of goodwill (of which $35 million is tax deductible) and $20 million of customer-related intangible assets.  The intangible assets are being amortized over a useful life of 15 years.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;General Information&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;The acquisitions described above were accounted for under the acquisition method of accounting.  As such, the assets acquired and liabilities assumed are recorded based on their estimated fair values as of the closing date.  Supplemental pro forma combined financial information has not been presented as the impact of the acquisitions is not material to the Company's consolidated financial statements.  The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entities with those of the Company and the value associated with an&#160;assembled workforce and other intangible assets that do not qualify for separate recognition.  All of the goodwill acquired in connection with these acquisitions has been allocated to the Company's DIS business.  For further details regarding business segment information, see Note 19.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI3NDg3NzkwODc4MjA_42224ad9-daf0-4393-95c9-414f9147a6f5"
      unitRef="usd">336000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI3NDg3NzkwODc4MzI_5df41ea2-b500-42d3-8532-85d1ccdd99af"
      unitRef="usd">228000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI3NDg3NzkwODc4NDQ_6b833ed8-1954-434d-898a-43b48ec7b709"
      unitRef="usd">223000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI3NDg3NzkwODc4NTY_7162166d-eb8f-477e-a740-f017bdb9e7a5"
      unitRef="usd">104000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="icbd86fbda26d4940870279bbf2723a39_D20210601-20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwOTk1MTE2NDYwOTc_30a74be3-d624-4176-b8d0-66c39d90bf00"
      unitRef="usd">225000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1aee2bd26ebb41528a08b0155d7985b1_I20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwOTk1MTE2NDYxMTE_d584a68f-01ab-40ea-8c45-8317cc27a295"
      unitRef="usd">54000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="iaade8f13b4c24c27921a397d61fbbfce_I20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwOTk1MTE2NDYxMjQ_0296b93e-02c3-4546-86d1-6fa7de986af8"
      unitRef="usd">171000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="iaade8f13b4c24c27921a397d61fbbfce_I20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwOTk1MTE2NDYxMjQ_9021595a-9a51-4000-b043-07a5f324948a"
      unitRef="usd">171000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3ede7ec3a11842568aa070ef6416d46f_D20210601-20210601"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEwOTk1MTE2NDYxMzc_e4889d75-b0bc-4375-93fc-8ab0c12ebb08">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i15009b0e1117479090ce699335523d61_D20211213-20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzM2MTU_fc4087bb-fbf7-41c2-857a-a98075b0c2eb"
      unitRef="usd">85000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i15009b0e1117479090ce699335523d61_D20211213-20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzM2MzE_47176286-e407-4ab8-8a88-40c5c9e6429f"
      unitRef="usd">80000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i81a78a06e59d4de0972e28a1dee3dbe4_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzM2NDc_1856c63a-0561-412e-aaf4-38b94046d4bb"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ0MTc_092ceef0-989f-44de-a8a6-f06da65594c7"
      unitRef="usd">41000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ0MzA_c547b736-a44e-4ae6-b22e-070a003f6ea7"
      unitRef="usd">40000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzcxNDY4MjU2MDg1MDQ_cf87e1f5-4ca1-4975-9c07-755aa12b2b03"
      unitRef="usd">35000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ4NDA_2bc786be-fb3e-4546-a4c2-640f8f93519f"
      unitRef="usd">11000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities
      contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ5Mjc_6f629ea3-e0a7-47a8-b994-6339da798471"
      unitRef="usd">9000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ4NTU_8e4a1aaa-d16a-4bb2-b6a3-6c4b02fcd83f"
      unitRef="usd">6000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ4Njg_707d61ff-be34-4f44-94ca-d9674ff937b7"
      unitRef="usd">6000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i74efea8f8cea4927b3e90d3cbac4d97b_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzgyNDYzMzcyMzQ1MDM_12fe71ce-bcf5-40d7-b0f9-b38cbc5853d1"
      unitRef="usd">2000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i31f1113940444a80a3c10cf968e6c6ce_D20211213-20211213"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI3NDg3NzkwOTY3OTE_f23557f2-0eba-4c7c-9c94-89acfab26fb9">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzEzNQ_3b65f4f0-ff0c-4b7b-a948-d0d93a3ce05b"
      unitRef="usd">330000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI1Mg_2bf79805-a571-433f-a383-1c7927bbcf5b"
      unitRef="usd">247000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI2NQ_a8b86446-2da9-45d6-8a11-8e9a51a58f70"
      unitRef="usd">210000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzMzNw_97bb25f0-7c95-46e1-9eb2-0369d7e7806b"
      unitRef="usd">146000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1>
    <dgx:BusinessAcquisitionPostacquisitionRevenue
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQ5NQ_6c6d9e24-773e-455b-acef-e3cbb8cd3ed9"
      unitRef="usd">127000000</dgx:BusinessAcquisitionPostacquisitionRevenue>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ie3246f22b780495da5706a912cfe9e8f_D20200121-20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzcxNg_6b827098-1a5e-46ef-8550-ae85775539b9"
      unitRef="usd">108000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ie3246f22b780495da5706a912cfe9e8f_D20200121-20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzcyNw_78f218d1-1a52-41ec-9333-55273dbc3afd"
      unitRef="usd">3000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:Goodwill
      contextRef="ib9011e0276964d49be24c92eb49f6aab_I20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE0NTA_0d4912aa-c147-46ba-8144-6f756fa5a976"
      unitRef="usd">66000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="ib9011e0276964d49be24c92eb49f6aab_I20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE0NTA_da0e6b4b-b0b9-43cc-b8ae-2c0ce31eb40e"
      unitRef="usd">66000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib9011e0276964d49be24c92eb49f6aab_I20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE0ODE_62a18240-accf-4478-9faa-5d0b65564413"
      unitRef="usd">43000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital
      contextRef="ib9011e0276964d49be24c92eb49f6aab_I20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE1MTA_db64bc2e-531a-4fde-bbd5-68dcb059b128"
      unitRef="usd">2000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iba6f3990b67144cba1d435606505c8f4_D20200121-20200121"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE2OTg_c4ca1f1b-4053-4da7-aa75-145e3dd6732c">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic51e744f4f2e4bcaa5294155d679de88_D20200121-20200121"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzE3MDQ_4aa0c388-225e-4de9-813c-1bca13a953ff">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i60b68dc1052845acade8ae63bf8e6344_D20200406-20200406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzIxMDg_4980cb4f-65a8-4f90-9a83-2cfaa5761625"
      unitRef="usd">120000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4617473021984d69adc99b7ffdf6247a_I20200406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzIzNzQ_10918aee-16d3-41d9-8ee4-8166f760cddf"
      unitRef="usd">27000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i8776f0149dc24a4fb8b364ad4db1ebb4_I20200406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI0MTk_11f0113a-d660-4b5c-b515-f997fa595ba9"
      unitRef="usd">93000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i8776f0149dc24a4fb8b364ad4db1ebb4_I20200406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI0MTk_d7a99b44-e447-4e82-b468-aefd449c1f7e"
      unitRef="usd">93000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7e2e808f5d17421891028da702156879_D20200406-20200406"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI1MTU_e2f36e88-1508-430e-96c1-ec658c340898">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI1NTI_69e26cd5-45f4-48f9-bdb7-0fd3d60baf6e"
      unitRef="number">0.56</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI2ODI_cb1af06e-ef59-4cc3-981c-72c5030455c8"
      unitRef="number">0.56</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i4f962685f1e94c24ad92c8ab20b848a9_D20200801-20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI4MDg_e122ea1f-4519-4b78-8c4c-04380c8f97e7"
      unitRef="usd">93000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i4f962685f1e94c24ad92c8ab20b848a9_D20200801-20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI4MTk_67894816-9615-4c4b-aefa-126460a0ee60"
      unitRef="usd">18000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i0e0666473465402491e5adb9a61aa8a9_I20200731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzI5Njg_f76040d0-6e20-4d50-9c9a-81e917fb6793"
      unitRef="number">0.44</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="id6481d3eb8e74ecb8e9190ad66be0074_D20200731-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzMwNjI_ad43ca3e-96ca-439d-a268-0f4c5faae7b3"
      unitRef="usd">87000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i45f309f68fd843a48e8af03cd2f2fd0f_D20200801-20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzMxMTM_e4c7263f-dac0-4d27-9b34-a5f74daef749"
      unitRef="usd">70000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue
      contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzMzOTg_e6abb48f-b182-4944-83ea-e5a1d507e788"
      unitRef="number">0.015</dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue>
    <dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue
      contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM0NTY_3731b356-1c3e-4d28-8eb9-8a059828c0f9"
      unitRef="number">0.075</dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue>
    <us-gaap:Goodwill
      contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM2NjU_2c2a0032-a6d4-4eca-ad9b-d60305b5cdfe"
      unitRef="usd">84000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM2OTA_0b784792-ff71-49ac-b17f-a609d753eb2f"
      unitRef="usd">47000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib4508da7ee96473cacb0e8b34be9019b_I20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM3MTM_6cc6475d-1271-4d32-a8af-c24f540d2d7b"
      unitRef="usd">74000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital
      contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM3Mzg_cb01b410-2160-439d-aee1-bca52628adb3"
      unitRef="usd">11000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i91ecb9e9aa0543a9b24df0457649804e_I20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM3NjQ_f172bc45-f98d-4cd6-80a4-7c6089653fa6"
      unitRef="usd">11000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie3555bc8ae0b4b1cbeefc4ba15b1ff96_D20200801-20200801"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzM5MDc_78b678cf-2adf-4d79-ad44-85ef52700cbb">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQxMDM_50132951-a726-497c-b64c-58e52dc6341d"
      unitRef="usd">63000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQxOTc_4e6bbe9e-0b08-44d7-9655-d7b412b50786"
      unitRef="usd">43000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQyMTA_a2338e7f-179e-4e4d-9ae0-3e75e8b7e87d"
      unitRef="usd">36000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQyODI_8dfc8cbe-c851-44f6-a4a0-2bbfb3cd53bb"
      unitRef="usd">21000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic42d65a53e2e4f8caac33c19b3fe9550_D20190211-20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQ2ODg_d8519b63-bc9b-4cfe-8d4b-22b8af3b3dc5"
      unitRef="usd">61000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ic42d65a53e2e4f8caac33c19b3fe9550_D20190211-20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQ3MzM_6ce0654c-0b61-4e87-9d98-9c4c8d5cbea5"
      unitRef="usd">55000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ibf8a6d03f13d4234a113977f48f0640c_I20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQ3ODg_a9de2e6c-4b74-495f-a14c-931e5ee5595b"
      unitRef="usd">6000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i30539b4ef73742fd917103c75f8a131d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzQ5NTA_49c12934-7ff2-41ea-af91-c32fd122203f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0443eda130d94868aa628f929fc4e6bd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzUxMzI_96df517a-fa30-48d0-a924-cd90f188bc66"
      unitRef="usd">6000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:Goodwill
      contextRef="i423ce88d5a4046c7b9394f997e1e0db6_I20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzUyNzU_6a7ce0af-f80a-4323-8b1a-c9ca0779d291"
      unitRef="usd">41000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i423ce88d5a4046c7b9394f997e1e0db6_I20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzUzMDA_dece51e4-c427-4922-bc70-2ec30a7a3e9a"
      unitRef="usd">35000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7356ad2d38bf4e7e85b6c706c139d415_I20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzUzMjY_dc95db08-c097-4150-b9af-cfa517ac0f1a"
      unitRef="usd">20000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i31f33c5e991148e899c59f925d85d5b1_D20190211-20190211"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTMvZnJhZzo1OGUzN2Y1N2MyOGM0ODQ5YmE1NjFiNDhlNTYyNjUwZS90ZXh0cmVnaW9uOjU4ZTM3ZjU3YzI4YzQ4NDliYTU2MWI0OGU1NjI2NTBlXzU0MzM_cbaa8f1b-9c26-4e8a-a57b-ef47c4bcdd13">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8yNzQ4Nzc5MDcxMDcw_906faf03-9a10-46ee-a776-a62ee477c1bf">DISPOSITION&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q2 Solutions&#xae; ("Q2 Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner, for $760&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the year ended December&#160;31, 2021, the Company recorded a $314&#160;million pre-tax gain in other income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the year ended December&#160;31, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Solutions' clients, providing a range of lab testing capabilities to augment Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Solutions' core offerings and extend its industry leading suite of services.&lt;/span&gt;DISCONTINUED OPERATIONS&#160;&#160;&#160;&#160;Discontinued operations, net of taxes, for the year ended December 31, 2019 includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.  In addition, net cash provided by operating activities in the consolidated statement of cash flows for the year ended December 31, 2019 included a $28 million refund from the taxing authorities related to discontinued operations.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="i9c1e96cb7a8540ba9373cdf8a930af85_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMTE2_2a21501e-4072-44f9-992b-0af37774b0dc"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross
      contextRef="iff8c10fa9efa4acb8369a234686c91ff_D20210401-20210401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMTIx_74a31cf5-0ed1-470f-a17e-daa4c01f4d35"
      unitRef="usd">760000000</dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i8e96757089434161b4f6a911623f3a76_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMTcx_df83eec6-702e-4fef-857f-012576d8947a"
      unitRef="usd">-314000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3b20ad37382b4dbd949a4bd8cd17fa6c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMTg1_481e04ed-e51c-4b3c-ba5d-46c877738151"
      unitRef="usd">20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMjQ4_6c4d9251-4331-4fb5-92d4-97b73735923f"
      unitRef="usd">55000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMjYx_6c0b8832-3c0d-4c3f-962f-d282e099d20c"
      unitRef="usd">127000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDE1L2ZyYWc6ZTk4NWNhMjhkMzY4NDYwN2JmNmY0OGNmODQ1MzkwN2YvdGV4dHJlZ2lvbjplOTg1Y2EyOGQzNjg0NjA3YmY2ZjQ4Y2Y4NDUzOTA3Zl8xNjQ5MjY3NDQzMjc1_77d3da73-6712-4fa3-adaf-11637e7c049e"
      unitRef="usd">72000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzU1NzY_5ada3e85-f4eb-4591-8c09-67e72062ea2e">FAIR VALUE MEASUREMENTS &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:72pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#x201c;invested&#x201d; at the direction of the employee in &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries. Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  During the year ended December 31, 2021, certain of the Company's equity investments became publicly traded. Such equity investments are now classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the acquisition of Labtech (see Note 5), the Company has a contingent consideration obligation of up to $20&#160;million that is to be paid based on the achievement of certain testing volume benchmarks.  As of December&#160;31, 2021, the fair value of the contingent consideration liability totaled $5 million, which was measured at fair value using an option-pricing method and classified within Level 3 of the fair value hierarchy as the fair value was determined based on significant inputs that are not observable.  Significant inputs include management&#x2019;s estimate of volume and other market inputs, including comparable company revenue volatility (7.5%) and a discount rate (2.5%).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value adjustments included in earnings - realized/unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, additions and issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The $1 million net gain included in earnings associated with the changes in the fair value of contingent consideration for the year ended December&#160;31, 2020 is reported in other operating (income) expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of December&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long-term growth rates, and a discount rate commensurate with economic risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, the Company recorded an $8&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of December&#160;31, 2021 and 2020, the fair value of the Company&#x2019;s debt was estimated at $4.4 billion and $4.6 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzU1ODY_7db7ef40-74cb-4d93-a3cf-fc7990f1a7e5">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:TradingSecurities
      contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzUtMS0xLTEtMjA5MjU_b24c55f2-3b58-4696-a23e-68f61b6b690f"
      unitRef="usd">77000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzUtMy0xLTEtMjA5MjU_fe958796-a307-4c58-a3ef-b751cae8f269"
      unitRef="usd">77000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzUtNS0xLTEtMjA5MjU_9b0e2d5a-685a-4a2f-8609-666c5052aa2a"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzUtNy0xLTEtMjA5MjU_df933b15-9b1c-4f7d-86d7-383f5f656057"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzYtMS0xLTEtMjA5MjU_48cdfda7-a160-46e0-ba57-2eaa141f5291"
      unitRef="usd">57000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzYtMy0xLTEtMjA5MjU_6511f864-8676-4584-8604-70ab973721ff"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzYtNS0xLTEtMjA5MjU_25cf11f9-8e0e-43c7-9d70-ae1a4b9c403b"
      unitRef="usd">57000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzYtNy0xLTEtMjA5MjU_b32271cd-d977-40d0-ae6d-45c22fb55af9"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtMS0xLTEtMzAyODg_520f7558-53da-4103-9368-bef7a8cede10"
      unitRef="usd">44000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtMy0xLTEtMzAyODg_33511dab-0611-4092-a448-53e36a722697"
      unitRef="usd">44000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtNS0xLTEtMzAyODg_073aee19-138b-4aec-bdcb-7639e9379a32"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtNy0xLTEtMzAyODg_235232c5-deeb-4a11-8045-f58cd3d0b3fc"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtMS0xLTEtMjA5MjU_72f63a2a-2cfe-4c07-a8b8-9059d46c1da9"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtMy0xLTEtMjA5MjU_ffd7b14d-776a-4346-b370-97c87893abbb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtNS0xLTEtMjA5MjU_7d0f5cfb-28a9-4ede-92a6-436cf04ca39a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzgtNy0xLTEtMjA5MjU_4b2afbf3-aa3a-48d5-9d96-56ef2bcd3940"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzExLTEtMS0xLTIwOTI1_3d41c50f-05b6-42e2-b916-94313ddb4238"
      unitRef="usd">179000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzExLTMtMS0xLTIwOTI1_7ff624cd-105f-4690-a976-003d0b8d6235"
      unitRef="usd">121000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzExLTUtMS0xLTIwOTI1_016a00cb-885b-4237-a848-730e6c16dd47"
      unitRef="usd">57000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzExLTctMS0xLTIwOTI1_919e929a-50cf-4b7c-8ca0-701209ca9ce8"
      unitRef="usd">1000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE0LTEtMS0xLTIwOTI1_2382237b-f697-4773-8596-803211cba71c"
      unitRef="usd">143000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE0LTMtMS0xLTIwOTI1_077c50c0-8f1e-45b9-a61f-76d3eb1bad0e"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE0LTUtMS0xLTIwOTI1_54439aa4-d5d1-45f5-b3c8-2d8a190e0315"
      unitRef="usd">143000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE0LTctMS0xLTIwOTI1_0e960b97-9f57-425f-970e-220cec884c10"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE2LTEtMS0xLTIwOTI1_f9dfccdb-5785-44ec-bbb5-28e228fddc23"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE2LTMtMS0xLTIwOTI1_b3b85424-964f-4a68-b1c8-7b8877ee7d8c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE2LTUtMS0xLTIwOTI1_f29f01ea-2ca3-449e-bcc9-3903a6f17328"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE2LTctMS0xLTIwOTI1_3c6bba74-26e0-4766-bb03-3021e22b0e40"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE5LTEtMS0xLTIwOTI1_4eef1597-b065-4674-b9c1-81d9b46e490f"
      unitRef="usd">148000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE5LTMtMS0xLTIwOTI1_adb3b40e-d702-4100-9db6-92017c54ffeb"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0766501a28ea42ae98034d9409e0ed9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE5LTUtMS0xLTIwOTI1_6ef48e5b-7cfa-4f4c-9244-95f98ad5e90e"
      unitRef="usd">143000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzE5LTctMS0xLTIwOTI1_b0a67201-7ded-4bf4-9345-b9919eff0009"
      unitRef="usd">5000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ifc4866c6aa2449f9b1ec282011ec5b46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzIxLTEtMS0xLTIwOTI1_50ba2c7f-a03f-42fc-a3e4-00f34e421f5a"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="id22911e2cc294cebbfc441d94dfaf441_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzIxLTMtMS0xLTIwOTI1_3e817dbe-0bbf-4ee6-b65a-53cfae5b8c0c"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ib83ba03755a844f2aacb5ab477db26dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzIxLTctMS0xLTIwOTI1_342346c1-c549-4715-a2f5-f63812536182"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:TradingSecurities
      contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI1LTEtMS0xLTIwOTI1_3f0a5f50-93ca-4b45-8224-1d55dfdf902d"
      unitRef="usd">67000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI1LTMtMS0xLTIwOTI1_a14498c6-372f-4fda-bc95-b0502a3a99c3"
      unitRef="usd">67000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i38f5b3d3498744299e5a0aef9e2f770b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI1LTUtMS0xLTIwOTI1_17be89ed-8e6d-4539-beca-b3123c187020"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI1LTctMS0xLTIwOTI1_cf66bef4-614f-4e5a-b8f7-6caf934a9c5a"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI2LTEtMS0xLTIwOTI1_c5801219-6fce-4c61-be89-a45a6f334b03"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI2LTMtMS0xLTIwOTI1_a22eff39-1c4c-42e0-a603-cd586f12f51d"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i38f5b3d3498744299e5a0aef9e2f770b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI2LTUtMS0xLTIwOTI1_50b71854-4e1b-4622-b41f-591c6ae0f772"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI2LTctMS0xLTIwOTI1_cc20c7ce-af76-4344-a172-7c802b407cfa"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI5LTEtMS0xLTIwOTI1_b6404971-ba8e-4051-8152-df30e22ceaf6"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI5LTMtMS0xLTIwOTI1_1c7c072e-8107-4b5a-b256-3bfd7b0f652e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i38f5b3d3498744299e5a0aef9e2f770b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI5LTUtMS0xLTIwOTI1_93253c76-a21c-40bf-a402-44a9d19d4f6e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzI5LTctMS0xLTIwOTI1_b1f364cc-be7c-4747-8c8c-3bf769aa9583"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzMxLTEtMS0xLTIwOTI1_e31da381-6a1c-4fcd-bdf2-607c978a00d8"
      unitRef="usd">129000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzMxLTMtMS0xLTIwOTI1_07eaf8ce-83a7-43ba-8a97-435bc27cecd7"
      unitRef="usd">67000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i38f5b3d3498744299e5a0aef9e2f770b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzMxLTUtMS0xLTIwOTI1_9c9fcecf-ff8d-47b5-a8c7-ee39c4176a8e"
      unitRef="usd">50000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzMxLTctMS0xLTIwOTI1_8faa0f0e-eef1-4dba-b2ff-3ed0e5366c3d"
      unitRef="usd">12000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzM0LTEtMS0xLTIwOTI1_e99dfd3e-4aba-4c13-8c17-06aead9a2abc"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzM0LTMtMS0xLTIwOTI1_b7e2f699-3beb-420c-9bb8-96a975ef387c"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i38f5b3d3498744299e5a0aef9e2f770b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzM0LTUtMS0xLTIwOTI1_4dda59c1-7291-4317-921a-fd9dbf057f25"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzM0LTctMS0xLTIwOTI1_710c1707-9fb7-439e-894c-854d7d58cb43"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i5ad83b4de96747abb8cb8781622ee947_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzQxLTEtMS0xLTIwOTI1_828d3f74-fb30-42cb-a684-506104e782ed"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i81f60e6780e640a694005a30b6a5abe5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzQxLTMtMS0xLTIwOTI1_75b2f679-7ad3-49cf-addc-8301584d7321"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i073fd4818f044aef89256b4a52dcbf2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplMGJhODYxY2Q3MWE0YzdmODYxMjcxZGJhM2NiMTRlNy90YWJsZXJhbmdlOmUwYmE4NjFjZDcxYTRjN2Y4NjEyNzFkYmEzY2IxNGU3XzQxLTctMS0xLTIwOTI1_fa5043af-c294-4b2d-a8f8-a19d4877be25"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ie17bd574ae9c4ff8ae0d21265f27f20e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzc2OTY1ODE0MDkyNzM_e2a9b03d-33fb-45cc-bad7-caf38d18249e"
      unitRef="usd">20000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i434a8ab4e7b34865bb3ce497565a2bf6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzEwOTk1MTE2MzczODA_3cf2bec9-4d27-4678-9a52-80e0e502b2b1"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i617406ef61a34f3aa8f1d1f3c8941262_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzc2OTY1ODE0MDkzNjM_bd8241d4-caf4-4967-b073-a63fa47d9191"
      unitRef="number">0.075</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i124355337c804541809469ff7ef7f47f_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzc2OTY1ODE0MDkzNjk_6f28f162-c22c-4061-b6e8-0415867b4f1a"
      unitRef="number">0.025</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzU1NzQ_e4927615-a683-4054-aa5a-fb7cee421a4c">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value adjustments included in earnings - realized/unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, additions and issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i66a58a0ecc1d462f851c119a2540a972_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzItMS0xLTEtMjA5MjU_9b7ffb59-27a1-48b2-a7ce-05d1889fe76b"
      unitRef="usd">7000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ibc94c6adc50e45d1a843a6310b57c833_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzQtMS0xLTEtMjA5MjU_b30a1d52-8547-4e58-ac2d-a0d490a6473e"
      unitRef="usd">6000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ibc94c6adc50e45d1a843a6310b57c833_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzUtMS0xLTEtMjA5MjU_e2c944ef-8f92-43b8-b2bc-07fd31bacd15"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i67b969149f9b4fee96f681a629e8e1bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzktMS0xLTEtMjA5MjU_0cd1ec02-ba0d-4439-b17d-e0ae14da1f45"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <dgx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances
      contextRef="i021bad29b33a4e059cf6ee59d7e0df44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzExLTEtMS0xLTMwMzU4_ff21e248-83d6-4c84-87b4-a281349373fe"
      unitRef="usd">5000000</dgx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i434a8ab4e7b34865bb3ce497565a2bf6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90YWJsZTplYzk4MTc2MTk5YmI0N2Y0OGFkOGUxNGIzODBkYjEwZi90YWJsZXJhbmdlOmVjOTgxNzYxOTliYjQ3ZjQ4YWQ4ZTE0YjM4MGRiMTBmXzEzLTEtMS0xLTIwOTI1_3cf2bec9-4d27-4678-9a52-80e0e502b2b1"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i9c47ea6a797a43599cb7fc4368a7daa1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzQwMzg_205e62eb-ba93-4000-a378-887e31da4c39"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i10c8c1d0f30246589418e5588a96ce94_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzQyNDg_6bfa891b-5a98-4e58-a53c-f02adbf1a1d9"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i41d87f6d82ea49589aa5d33a9546d817_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzc2OTY1ODE0MDgwNjQ_02d3d1ad-9dc9-4518-a2dd-5c7407d614c1"
      unitRef="usd">8000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzUyMDg_c27f3a69-6c4c-49c4-a1b8-4fa09c4a1a21"
      unitRef="usd">4400000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTYvZnJhZzo4NDNjMzNhN2YwMzg0MjNlYjNiNDYzZmU4Mzg0ODcyZC90ZXh0cmVnaW9uOjg0M2MzM2E3ZjAzODQyM2ViM2I0NjNmZTgzODQ4NzJkXzUyMTU_88db4277-5ec6-4eff-8ab2-757e81339c2d"
      unitRef="usd">4600000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzYwNjg_cef5ba6e-92ab-46f9-96a9-97a2dcf21bf7">TAXES ON INCOME&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's pre-tax income from continuing operations before equity in earnings of equity method investees consisted of approximately 2.5 billion, $1.9 billion and $1.1 billion from U.S. operations and pre-tax income (loss) of $148 million, $(7) million and $15 million from foreign operations for the years ended December&#160;31, 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;Pre-tax income from continuing operations before equity in earnings of equity method investees for U.S. and foreign operations include pre-tax gains of $171&#160;million and $143&#160;million, respectively, from the sale of the Company's 40% ownership interest in Q2 Solutions.  During the year ended December&#160;31, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The components of income tax expense (benefit) for 2021, 2020 and 2019 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:42.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A reconciliation of the federal statutory income tax rate to the Company's effective income tax rate for 2021, 2020 and 2019 was as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess tax benefits on stock-based compensation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision true-ups &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of equity earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in reserves for uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowances associated with certain net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December 31, 2019, the Company recognized a $12 million net income tax benefit due to the release of valuation allowances associated with certain net operating loss carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) as of December&#160;31, 2021 and 2020 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities not currently deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basis differences in investments, joint ventures and subsidiaries &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(633)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(604)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2021 and 2020, non-current deferred tax liabilities of $290 million and $350 million, respectively, are included in other liabilities in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2021, the Company had estimated net operating loss carryforwards for federal and state income tax purposes of $31 million and $676 million, respectively, which expire at various dates through 2041.  Estimated net operating loss carryforwards for foreign income tax purposes are $70 million as of December&#160;31, 2021, some of which can be carried forward indefinitely while others expire at various dates through 2041.  As of December&#160;31, 2021 and 2020, deferred tax assets associated with net operating loss carryforwards of $71 million and $94 million, respectively, have each been reduced by valuation allowances of $29 million and $33 million, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Income taxes payable, including those classified as long-term in other liabilities in the consolidated balance sheet as of December&#160;31, 2021 and 2020, were $106 million and $135 million, respectively.  Prepaid income taxes were $36 million and $2 million as of December&#160;31, 2021 and 2020, respectively, and were recorded in prepaid expenses and other current assets in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The total amount of unrecognized tax benefits as of and for the years ended December&#160;31, 2021, 2020 and 2019 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For tax positions of current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in judgment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expirations of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The contingent liabilities for tax positions primarily relate to uncertainties associated with the realization of tax benefits derived from the allocation of income and expense among state jurisdictions, the characterization and timing of certain tax deductions associated with business combinations, certain tax credits and the deductibility of certain expenses and settlement payments.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The total amount of unrecognized tax benefits as of December&#160;31, 2021, that, if recognized, would affect the effective income tax rate is $90 million.  Based upon the expiration of statutes of limitations, settlements and/or the conclusion of tax examinations, the Company believes it is reasonably possible that the total amount of unrecognized tax benefits may decrease by up to $15 million within the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Accruals for interest expense on contingent tax liabilities are classified in income tax expense in the consolidated statements of operations.  Accruals for penalties have historically been immaterial.  Interest (income) expense included in income tax expense in each of the years ended December&#160;31, 2021, 2020 and 2019 was approximately $(2) million, $6 million and $5 million, respectively.  As of December&#160;31, 2021 and 2020, the Company had approximately $20 million and $21 million, respectively, accrued, net of the benefit of a federal and state deduction, for the payment of interest on uncertain tax positions.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The recognition and measurement of certain tax benefits includes estimates and judgment by management and inherently involves subjectivity.  Changes in estimates may create volatility in the Company's effective tax rate in future periods and may be due to settlements with various tax authorities (either favorable or unfavorable), the expiration of the statute of limitations on certain tax positions and obtaining new information about particular tax positions that may cause management to change its estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the regular course of business, various federal, state, local and foreign tax authorities conduct examinations of the Company's income tax filings and the Company generally remains subject to examination until the statute of limitations expires for the respective jurisdiction.  The Internal Revenue Service has either completed its examinations of the Company's consolidated federal income tax returns or the statute of limitations has expired up through and including the 2016 tax year.  At this time, the Company does not believe that there will be any material additional payments beyond its recorded contingent liability reserves that may be required as a result of these tax audits.  As of December&#160;31, 2021, a summary of the tax years that remain subject to examination, awaiting approval, are under appeal, or are otherwise unresolved for the Company's major jurisdictions are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;United States - federal&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2017 - 2020 &lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;United States - various states&#160;&#160;&#160;&#160;2002 - 2020</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5Xzc2OTY1ODE0MDQwMzA_0ec1415e-36f3-46f7-9b1d-4268e02be323"
      unitRef="usd">2500000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzE3NA_b5c99915-a88e-4600-b437-e23af161307d"
      unitRef="usd">1900000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzE4MQ_7edb36db-dac6-46b3-a854-64142f5f60ba"
      unitRef="usd">1100000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIzNA_fa3ea408-2a2f-4f07-bc9e-ace7be45b3a1"
      unitRef="usd">148000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIzOA_0a43fac2-6be4-4068-9951-522f1e9335e5"
      unitRef="usd">-7000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI0NQ_3e9112db-9d86-4048-a4f7-a16730d279e4"
      unitRef="usd">15000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i20d31ae01df141748e29ec7263dbe9c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzMyOTg1MzQ4OTI1NTU_e067190f-88a8-4399-a1d7-17be8bfb21f5"
      unitRef="usd">171000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i8c9bfd94887a4b799eb75fdf00ff90c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzMyOTg1MzQ4OTI1Njk_f7cf79a9-8533-4839-af8a-f84b1005ccd2"
      unitRef="usd">143000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="i9c1e96cb7a8540ba9373cdf8a930af85_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzMyOTg1MzQ4OTI1ODM_d51d9326-513b-4ece-9cb2-587f369c5e1a"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzEwOTk1MTE2Mjg2NDQw_6c4d9251-4331-4fb5-92d4-97b73735923f"
      unitRef="usd">55000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzEwOTk1MTE2Mjg2NTAx_6c0b8832-3c0d-4c3f-962f-d282e099d20c"
      unitRef="usd">127000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9edb4026ff5f4e66868ef5e753c20e30_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzEwOTk1MTE2Mjg2NTU2_77d3da73-6712-4fa3-adaf-11637e7c049e"
      unitRef="usd">72000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzYwNDg_4f1fba5e-de1d-4ad2-8b9a-292c36352f17">The components of income tax expense (benefit) for 2021, 2020 and 2019 were as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzItMS0xLTEtMjA5MjU_47efca21-58ee-4007-aa0d-f37818e29e45"
      unitRef="usd">528000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzItMy0xLTEtMjA5MjU_a5fb9d22-d1bf-4982-9d3f-c1a46767a33e"
      unitRef="usd">300000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzItNS0xLTEtMjA5MjU_d21594ed-bbec-4e83-8624-fb0adc79130b"
      unitRef="usd">176000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzMtMS0xLTEtMjA5MjU_c95b2930-3f9e-4121-9028-9d4e8187d8d1"
      unitRef="usd">123000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzMtMy0xLTEtMjA5MjU_fff584fc-4ecf-47e9-b3ee-21e4978724de"
      unitRef="usd">74000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzMtNS0xLTEtMjA5MjU_9b8d84e4-6c9a-412d-bcfa-a9fcc0453e4a"
      unitRef="usd">53000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzQtMS0xLTEtMjA5MjU_683877a7-4a9e-4c34-a5af-0a0919a1f092"
      unitRef="usd">3000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzQtMy0xLTEtMjA5MjU_08c303c0-06c9-48d1-9cac-d12df6924813"
      unitRef="usd">1000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzQtNS0xLTEtMjA5MjU_9a822124-8f1a-4bfc-b765-1559c2402583"
      unitRef="usd">3000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzYtMS0xLTEtMjA5MjU_755e5aca-d898-45dc-a45e-28721ef3fe9c"
      unitRef="usd">-61000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzYtMy0xLTEtMjA5MjU_73d17487-c57a-4ff5-bec1-2ab4744d7f93"
      unitRef="usd">55000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzYtNS0xLTEtMjA5MjU_f35b3464-539f-49ec-a949-fcc910fc8364"
      unitRef="usd">21000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzctMS0xLTEtMjA5MjU_370507c3-89de-40c9-abb2-c6732ed7526d"
      unitRef="usd">5000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzctMy0xLTEtMjA5MjU_5988e830-0e0f-4961-a03a-4045ed4cbd0f"
      unitRef="usd">29000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzctNS0xLTEtMjA5MjU_a761c228-bf89-423f-90a8-cf9bc1d9e539"
      unitRef="usd">-4000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzgtMS0xLTEtMjA5MjU_93bedf58-22be-416f-9472-55044f52347a"
      unitRef="usd">-1000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzgtMy0xLTEtMjA5MjU_86785b20-ecaf-4842-836a-39197a193db3"
      unitRef="usd">1000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzgtNS0xLTEtMjA5MjU_9c1d8a6a-4a69-474a-9432-388b26a97181"
      unitRef="usd">-2000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzktMS0xLTEtMjA5MjU_90b7512f-bd92-4c45-b03a-a9712fe28357"
      unitRef="usd">597000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzktMy0xLTEtMjA5MjU_432850c3-dd7a-4c2a-ab8b-d71ee501c96e"
      unitRef="usd">460000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxZThlZjE0OGRhODA0ZDIwYTFlZDE5NWQwYmVkMmRiNC90YWJsZXJhbmdlOjFlOGVmMTQ4ZGE4MDRkMjBhMWVkMTk1ZDBiZWQyZGI0XzktNS0xLTEtMjA5MjU_6a4b2b2b-5f81-4722-af13-51851a341368"
      unitRef="usd">247000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzYwNjA_93868015-e3e9-475e-b146-97b1ce029298">A reconciliation of the federal statutory income tax rate to the Company's effective income tax rate for 2021, 2020 and 2019 was as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess tax benefits on stock-based compensation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision true-ups &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of equity earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in reserves for uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowances associated with certain net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzItMS0xLTEtMjA5MjU_599d6fe4-abbf-4016-b0bb-a65ae9cfa478"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzItMy0xLTEtMjA5MjU_b8b665e2-862b-4aab-919f-472f63fff6d0"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzItNS0xLTEtMjA5MjU_ced5fdcd-a88a-4e81-b049-a2ca318d0e30"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzMtMS0xLTEtMjA5MjU_84035bf2-3011-4df6-adde-f0b587fdcd02"
      unitRef="number">0.041</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzMtMy0xLTEtMjA5MjU_5abaabfe-d014-41e1-b569-c0493648d57e"
      unitRef="number">0.045</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzMtNS0xLTEtMjA5MjU_10a8032a-d4b1-410f-a81d-03d6797b764b"
      unitRef="number">0.046</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzgtMS0xLTEtMjA5MjU_37304853-5b66-455e-be56-2f37550a8d1d"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzgtMy0xLTEtMjA5MjU_63882977-d90a-47d7-90e8-c49d72573a6c"
      unitRef="number">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzgtNS0xLTEtMjA5MjU_76fece90-1ba4-411f-a65f-82c373a3a7f6"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzEwLTEtMS0xLTIwOTI1_4bc1594a-ab63-4de7-9418-9be390a76ce3"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzEwLTMtMS0xLTIwOTI1_62fa9d97-ce1b-4c12-baee-9a5d07f958aa"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzEwLTUtMS0xLTIwOTI1_ab209774-0a19-436e-adcb-95ad2fb5d6c7"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzExLTEtMS0xLTIwOTI1_ccb26ded-a8e7-4eef-81bd-e09c1f846939"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzExLTMtMS0xLTIwOTI1_a52e4bae-84ca-435a-9620-90bb779d4379"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzExLTUtMS0xLTIwOTI1_18a7500e-07da-429c-9055-d1c10406a7cc"
      unitRef="number">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE0LTEtMS0xLTIwOTI1_b7d5b748-52f6-4b88-802c-0e67f6b3cd81"
      unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE0LTMtMS0xLTIwOTI1_71e83e72-8d9e-4807-82cc-0f3b1e426ff3"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE0LTUtMS0xLTIwOTI1_c6a693e5-1fdf-4b51-baec-d37ffda535d6"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE1LTEtMS0xLTIwOTI1_a45c1c0d-b9c3-41cf-a8d1-cd487144b6f0"
      unitRef="number">0.004</dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition>
    <dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE1LTMtMS0xLTIwOTI1_8c3b1d00-c059-4129-acaa-3a9727d2d295"
      unitRef="number">0.009</dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition>
    <dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE1LTUtMS0xLTIwOTI1_e7550ca4-5c0e-439f-83f8-1cc7ef31a3c7"
      unitRef="number">0.017</dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE2LTEtMS0xLTIwOTI1_ad6b0857-b154-4f4c-8c14-27018726cbba"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE2LTMtMS0xLTIwOTI1_8541b9df-168f-4e7a-865d-4256a31d5ef4"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE2LTUtMS0xLTIwOTI1_c7b57f49-c371-40f6-9144-2be531cea428"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE3LTEtMS0xLTIwOTI1_d89ab5c2-e777-4d80-80aa-92f00f7fd008"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE3LTMtMS0xLTIwOTI1_70c0adb5-b448-45b7-a4c5-66854442b44e"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE3LTUtMS0xLTIwOTI1_9b427497-f4a6-42ff-adc0-0bdea9ea91fc"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE4LTEtMS0xLTIwOTI1_ad8cfbd8-679f-448c-8929-1b9885d48c58"
      unitRef="number">0.230</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE4LTMtMS0xLTIwOTI1_7cee863f-ecf2-4c9c-87e3-38cb8b8596fc"
      unitRef="number">0.245</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZToxYzBkMjA3NGIyMDI0YmFmOWY5Mjg0YTc3ODNmNWYyYy90YWJsZXJhbmdlOjFjMGQyMDc0YjIwMjRiYWY5ZjkyODRhNzc4M2Y1ZjJjXzE4LTUtMS0xLTIwOTI1_c4d9c7b6-03fb-47ed-a5ae-008de2f339f2"
      unitRef="number">0.230</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <dgx:IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5Xzk4Nw_c4741c64-5e02-4025-84a1-bdc87965aed1"
      unitRef="usd">12000000</dgx:IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzYwNTY_3fbddf1b-033a-415d-8f1a-4694f22bb0c3">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) as of December&#160;31, 2021 and 2020 were as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities not currently deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basis differences in investments, joint ventures and subsidiaries &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(633)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(604)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzItMS0xLTEtMjA5MjU_8bcb27be-0aec-4166-ab7b-13dfb1db496c"
      unitRef="usd">89000000</dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables>
    <dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzItMy0xLTEtMjA5MjU_c1d57e66-3281-4375-a9f1-55e9c0703ddb"
      unitRef="usd">71000000</dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzMtMS0xLTEtMjA5MjU_3df9ad5e-fdbc-49b0-8949-b34574bbf400"
      unitRef="usd">180000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzMtMy0xLTEtMjA5MjU_a19c4b90-8ada-431d-a5b9-47eea83c1c46"
      unitRef="usd">146000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzQtMS0xLTEtMjA5MjU_ee6343d4-a7d7-42fb-894c-138e956fc81a"
      unitRef="usd">32000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzQtMy0xLTEtMjA5MjU_d33f0fde-9b1d-4afc-8443-c9ee2cfa7556"
      unitRef="usd">47000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzYtMS0xLTEtMjA5MjU_89cd3ec0-d773-4461-bdc6-28886e0c0f84"
      unitRef="usd">12000000</dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments>
    <dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzYtMy0xLTEtMjA5MjU_661a5fad-2aba-4a38-9dad-120236ff8ec1"
      unitRef="usd">81000000</dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments>
    <dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzctMS0xLTEtMjA5MjU_19f724fb-651f-4b04-abee-3bfaee711fe7"
      unitRef="usd">42000000</dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance>
    <dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzctMy0xLTEtMjA5MjU_98e67cca-9129-4ed3-a65c-aa51e3edff7b"
      unitRef="usd">61000000</dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzgtMS0xLTEtMjA5MjU_a3028895-36a8-48a0-8951-815555b0080c"
      unitRef="usd">150000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzgtMy0xLTEtMjA5MjU_25520c95-a3ac-49dd-aca5-f76706c7a82b"
      unitRef="usd">151000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzktMS0xLTEtMjA5MjU_b7602944-59e3-4be1-bf17-b9f53b52f633"
      unitRef="usd">162000000</dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent>
    <dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzktMy0xLTEtMjA5MjU_e09f274b-dc04-4f47-b62c-14b0e80ff3a2"
      unitRef="usd">161000000</dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzEwLTEtMS0xLTIwOTI1_dcfacb50-52ab-47e1-9342-452894c87426"
      unitRef="usd">633000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzEwLTMtMS0xLTIwOTI1_fc212036-27d2-47ee-b042-7072ba788cac"
      unitRef="usd">604000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzExLTEtMS0xLTIwOTI1_e7626aef-bfbe-4f24-b450-b430ff5c1ada"
      unitRef="usd">290000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTpkZDZiZWY5NmY2YzU0MDVjODUyZTVjOGMyNDNiNTYyOS90YWJsZXJhbmdlOmRkNmJlZjk2ZjZjNTQwNWM4NTJlNWM4YzI0M2I1NjI5XzExLTMtMS0xLTIwOTI1_7feefe2c-e4d2-45c8-854e-13cf30b6767b"
      unitRef="usd">350000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ieaadd96b316f4fe3aa85d0828713bc7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIxNDA_676948f4-4a30-4c6c-bc87-259258e2a77c"
      unitRef="usd">290000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i83edf4f54cea471cb6078513f0ebb62d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIxNDc_59b122f2-1462-459e-ad4b-4804d23fa3f5"
      unitRef="usd">350000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ie38bc8aadde34be2a92c9c3930883626_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIzNTE_2e3d1240-c8a9-45c7-93ea-4d49ad5a3770"
      unitRef="usd">31000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i2b96d806bd364953ade441ac89234392_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzIzNTg_bec21013-42be-466f-9ca6-3ab0002790a4"
      unitRef="usd">676000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i5fe0a4d10c264c40b9e40c8f509f7adc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI0OTg_c32c2041-6c75-4db5-88f5-4b654b6c6493"
      unitRef="usd">70000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI3MDA_a4bdf4e5-02e6-4179-be3f-9445152c1996"
      unitRef="usd">71000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI3MDc_e77bc776-c9d6-4c54-8526-bbfb31c7d274"
      unitRef="usd">94000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI3NzU_04047834-d0e9-4620-a0e4-5fa3b5bd928c"
      unitRef="usd">29000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI3ODI_f021292e-19a6-48c0-bb4e-22169be14110"
      unitRef="usd">33000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:AccruedIncomeTaxes
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI5NDQ_b0a3a147-5ab4-4403-ab53-46a65408d368"
      unitRef="usd">106000000</us-gaap:AccruedIncomeTaxes>
    <us-gaap:AccruedIncomeTaxes
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI5NTE_97070937-de05-43ce-8814-f75e34474325"
      unitRef="usd">135000000</us-gaap:AccruedIncomeTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzI5OTY_838bf6ae-00ec-4f8b-a8b9-58f2631f3dae"
      unitRef="usd">36000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzMwMDM_879b48a3-3eb0-4807-9c39-ea94206c4409"
      unitRef="usd">2000000</us-gaap:PrepaidTaxes>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzYwNTI_3a0aff88-05e2-41c3-aecb-e9cfcf1aa9e8">The total amount of unrecognized tax benefits as of and for the years ended December&#160;31, 2021, 2020 and 2019 consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For tax positions of current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in judgment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expirations of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzItMS0xLTEtMjA5MjU_4da343a9-fa26-4168-8e4b-587f7d9fdbe2"
      unitRef="usd">93000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzItMy0xLTEtMjA5MjU_c663d440-1ee4-4320-a5ff-87b2700ae140"
      unitRef="usd">88000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i751cd9d2a9c24eeb80a337f22c577eed_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzItNS0xLTEtMjA5MjU_3ec179af-42f3-4ef7-a746-bbcad7b06ca7"
      unitRef="usd">107000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzQtMS0xLTEtMjA5MjU_1d328875-7d4e-4abe-aaf5-c35c808108eb"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzQtMy0xLTEtMjA5MjU_0c909d3a-a944-480c-a450-c264206407a4"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzQtNS0xLTEtMjA5MjU_ec7e97bb-7a57-441c-9d44-84927fe0a33a"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzUtMS0xLTEtMjA5MjU_e787e835-4138-4b68-b5ab-2b2f7b5f1a04"
      unitRef="usd">30000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzUtMy0xLTEtMjA5MjU_95553cf8-d99a-4808-8e42-dd081b05c7bf"
      unitRef="usd">25000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzUtNS0xLTEtMjA5MjU_75143594-e52e-47a3-b381-93b8aa7318da"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <dgx:ReductionsForChangesInJudgment
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzctMS0xLTEtMjA5MjU_64e75432-e9fa-4280-81dc-33207938a73e"
      unitRef="usd">6000000</dgx:ReductionsForChangesInJudgment>
    <dgx:ReductionsForChangesInJudgment
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzctMy0xLTEtMjA5MjU_baf2278e-3acf-4ba3-8ec3-49d632cbdec7"
      unitRef="usd">9000000</dgx:ReductionsForChangesInJudgment>
    <dgx:ReductionsForChangesInJudgment
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzctNS0xLTEtMjA5MjU_922e2f66-2a8a-4b4c-8078-9eeadaf4bf9b"
      unitRef="usd">3000000</dgx:ReductionsForChangesInJudgment>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzgtMS0xLTEtMjA5MjU_0097e02f-dc3e-49c1-9ea9-df8b9e7a40b1"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzgtMy0xLTEtMjA5MjU_b11b382f-cc57-41df-b0a5-41032bf357e8"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzgtNS0xLTEtMjA5MjU_278a89d8-6866-48b5-a867-a6a5f4087194"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzktMS0xLTEtMjA5MjU_b7487a84-fbc0-42b9-a6f6-634a10c71b73"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzktMy0xLTEtMjA5MjU_c0e27fba-0df3-4ed8-8735-fb6ebb858f29"
      unitRef="usd">9000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzktNS0xLTEtMjA5MjU_a8f3fdfc-916e-4869-9cc9-c85588112955"
      unitRef="usd">32000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzEwLTEtMS0xLTIwOTI1_4bf95934-fce8-4116-b0b4-5099f278322c"
      unitRef="usd">110000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzEwLTMtMS0xLTIwOTI1_c8ebd81e-6844-47c9-a3bb-8399a046f4c8"
      unitRef="usd">93000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90YWJsZTo3ZDFmNzFlY2M1YjQ0NzJjYTI2YmRmYzNiMDFjOTdkMi90YWJsZXJhbmdlOjdkMWY3MWVjYzViNDQ3MmNhMjZiZGZjM2IwMWM5N2QyXzEwLTUtMS0xLTIwOTI1_d0f76695-9c78-48ba-9110-06b54b6e3c79"
      unitRef="usd">88000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzM3Nzc_3c404966-4f8e-4633-8423-6af6f6ea559c"
      unitRef="usd">90000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQwMTE_f137560c-e69c-479e-abbb-ce89402a7280"
      unitRef="usd">15000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQzNTc_1389cfc2-62b5-44ad-8b95-5c6f845f876a"
      unitRef="usd">-2000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQzNjE_21bd1e8d-4d4f-4eb4-ac3c-8b66ca574142"
      unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQzNjg_b1ec9da6-4f99-4fb2-899f-59ccb627bb54"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQ0MzQ_8a9daf59-2c87-4508-87c3-04ba563ea563"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8xOTkvZnJhZzplMjMzNWM4MzllYTY0MTAzODgxYzJkN2MxNTFjZjRiOS90ZXh0cmVnaW9uOmUyMzM1YzgzOWVhNjQxMDM4ODFjMmQ3YzE1MWNmNGI5XzQ0NDE_361c49f4-fc24-43a4-973a-15f98cc771bd"
      unitRef="usd">21000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90ZXh0cmVnaW9uOmMxMzI2MWM0ZTFhZTQ4MzhhMDg0Y2U2MTZmNDA2ZjQ3XzQ0Mg_7ac06c39-26d8-4317-b0c9-9e90fd72b18e">SUPPLEMENTAL CASH FLOW AND OTHER DATA &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the years ended December&#160;31, 2021, 2020 and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with purchases of treasury stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends received from equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90ZXh0cmVnaW9uOmMxMzI2MWM0ZTFhZTQ4MzhhMDg0Y2U2MTZmNDA2ZjQ3XzQ0Ng_d90fdff8-fb7e-4058-8ec0-fa3fc6d7c3b4">Supplemental cash flow and other data for the years ended December&#160;31, 2021, 2020 and 2019 was as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with purchases of treasury stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends received from equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:Depreciation
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzItMS0xLTEtMjA5MjU_e1498cb6-6204-41bf-a1bf-14a7c0c245f9"
      unitRef="usd">305000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzItMy0xLTEtMjA5MjU_0a3e1d69-33ef-458a-9826-4a3ac6e00d75"
      unitRef="usd">258000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzItNS0xLTEtMjA5MjU_b2130837-e649-4d95-a8c6-c976b96a8442"
      unitRef="usd">233000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzMtMS0xLTEtMjA5MjU_4666f20e-7c60-4549-b86e-1dc5bcf8d8b3"
      unitRef="usd">103000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzMtMy0xLTEtMjA5MjU_71679faa-c9be-46c7-adf3-bd25d0e65775"
      unitRef="usd">103000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzMtNS0xLTEtMjA5MjU_8557f45c-6b6a-48ee-b0c4-4615051dee11"
      unitRef="usd">96000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzQtMS0xLTEtMjA5MjU_f2f4aed0-0d70-4700-9001-286841a3e5b6"
      unitRef="usd">408000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzQtMy0xLTEtMjA5MjU_c482e9c8-92b5-42dd-8732-d51e25d15385"
      unitRef="usd">361000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzQtNS0xLTEtMjA5MjU_f7378668-610f-4292-860f-a96b3d7e4943"
      unitRef="usd">329000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzYtMS0xLTEtMjA5MjU_55c57946-eefa-4423-801a-e64cd139d3db"
      unitRef="usd">152000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzYtMy0xLTEtMjA5MjU_18ec39f2-2ff8-4057-9482-8cddf4ac6cf2"
      unitRef="usd">166000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzYtNS0xLTEtMjA5MjU_cd6a1ab3-256d-4f15-a763-6803e172143f"
      unitRef="usd">180000000</us-gaap:InterestExpense>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzctMS0xLTEtMjA5MjU_f61a4aa2-0de1-4c74-ae81-7289db3f6d3d"
      unitRef="usd">1000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzctMy0xLTEtMjA5MjU_797d3f80-5216-4a36-8693-5e5c6403c667"
      unitRef="usd">3000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzctNS0xLTEtMjA5MjU_31bf9a11-a4ad-4523-ab65-958dc15d71b5"
      unitRef="usd">5000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzgtMS0xLTEtMjA5MjU_fa9cecf4-a4eb-476b-8828-4590d53e63e6"
      unitRef="usd">-151000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzgtMy0xLTEtMjA5MjU_27c04739-1233-44cf-a692-5e826058fd3d"
      unitRef="usd">-163000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzgtNS0xLTEtMjA5MjU_36b994cb-e7e9-47b5-9f84-6cc9ae91ee52"
      unitRef="usd">-175000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestPaidNet
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEwLTEtMS0xLTIwOTI1_28094966-8db8-4800-aa84-f208c721425f"
      unitRef="usd">159000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEwLTMtMS0xLTIwOTI1_8f1fe47d-4e6e-4648-a2ea-1960d1ac166b"
      unitRef="usd">201000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEwLTUtMS0xLTIwOTI1_2a8f6448-c59b-43d3-a26e-cb0efcbdb042"
      unitRef="usd">192000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzExLTEtMS0xLTIwOTI1_c58de435-ac07-4fb3-8e7d-99097a21c61c"
      unitRef="usd">709000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzExLTMtMS0xLTIwOTI1_615cd4d1-fcfc-41bd-85a9-c15ffad88948"
      unitRef="usd">360000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzExLTUtMS0xLTIwOTI1_a36219df-fe3d-43d8-8eb8-24b161cb9492"
      unitRef="usd">202000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEzLTEtMS0xLTIwOTI1_4c552fab-1c8d-4470-9460-06d5520763b9"
      unitRef="usd">26000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEzLTMtMS0xLTIwOTI1_72e88c3f-3a9d-4bdf-9ea7-d5257452f523"
      unitRef="usd">46000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzEzLTUtMS0xLTIwOTI1_7389c1bd-75b1-47c1-a0d0-ea2bb9ee8b4f"
      unitRef="usd">26000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE0LTEtMS0xLTIwOTI1_c9a80683-95a2-4f7a-9677-1d75d0b1ea01"
      unitRef="usd">23000000</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE0LTMtMS0xLTIwOTI1_08a2c1a1-45a3-4f05-8ab9-92ee743fde46"
      unitRef="usd">0</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE0LTUtMS0xLTIwOTI1_e43e5ce4-2954-4c4e-b07f-34a2331e7987"
      unitRef="usd">0</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE1LTEtMS0xLTIwOTI1_e77b87cc-a537-4e31-839b-5bcdbf268b28"
      unitRef="usd">74000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE1LTMtMS0xLTIwOTI1_c208bc88-52d6-43c6-9506-a4336230aedc"
      unitRef="usd">76000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE1LTUtMS0xLTIwOTI1_b1ef5b26-fde9-476f-a3bc-ce4b0ed880d2"
      unitRef="usd">71000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE3LTEtMS0xLTM1NDI5_96109d34-ae68-487c-a438-87a451d9c144"
      unitRef="usd">60000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE3LTMtMS0xLTM1NDI5_66476b13-bdc5-4ae8-a685-2aa0e2f028f7"
      unitRef="usd">54000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE3LTUtMS0xLTM1NDI5_332b3fad-79a5-410a-90bd-4724fa424673"
      unitRef="usd">48000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE4LTEtMS0xLTIwOTI1_792853f3-ec84-4fb0-b0d9-6244ee244d3a"
      unitRef="usd">354000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE4LTMtMS0xLTIwOTI1_d652b282-dce9-4f5c-8a19-c900b8914c59"
      unitRef="usd">368000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE4LTUtMS0xLTIwOTI1_5842f3d9-a3bf-4caf-a44f-27795a8044f7"
      unitRef="usd">63000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE5LTEtMS0xLTIwOTI1_43d6dd43-f2ff-4884-a17b-64a4b66e618c"
      unitRef="usd">18000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzE5LTMtMS0xLTIwOTI1_90156b9a-e13f-4bb7-8f92-208ee4c3dc65"
      unitRef="usd">17000000</us-gaap:LiabilitiesAssumed1>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIwLTEtMS0xLTIwOTI1_e4db5f9a-a9a3-49ce-b26a-f4f28276c0fb"
      unitRef="usd">336000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIwLTMtMS0xLTIwOTI1_69d48c04-cbdb-4317-88e7-1fac773ae220"
      unitRef="usd">351000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIwLTUtMS0xLTIwOTI1_cfc103df-25df-4b7f-9194-0f34996a16ba"
      unitRef="usd">63000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIxLTEtMS0xLTIwOTI1_cf4aa290-37e6-4b0b-b41d-0df6cc9b7d16"
      unitRef="usd">-5000000</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIxLTMtMS0xLTIwOTI1_4d003093-cf3d-457c-bfa2-c7af0e11c220"
      unitRef="usd">0</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIxLTUtMS0xLTIwOTI1_921716bb-83da-43c9-aa65-e5d7daa305f6"
      unitRef="usd">-5000000</dgx:Mergerconsiderationpaidpayablenet>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIyLTEtMS0xLTIwOTI1_08c999db-8fea-4f58-9a80-a71f81c33eeb"
      unitRef="usd">331000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIyLTMtMS0xLTIwOTI1_4b170ce8-80fd-4cbb-b39f-80a399af94a0"
      unitRef="usd">351000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIyLTUtMS0xLTIwOTI1_aedb017e-56d8-4df2-86ec-a7c1f6709cdb"
      unitRef="usd">58000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzIzLTMtMS0xLTIwOTI1_8a03994d-891f-46a1-8a62-e3c672b2ccd4"
      unitRef="usd">21000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzI0LTEtMS0xLTIwOTI1_77336c64-55ab-41e9-85c8-136d5dec2640"
      unitRef="usd">331000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzI0LTMtMS0xLTIwOTI1_1f73c962-ca64-4757-9208-17be04eac95a"
      unitRef="usd">330000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTplNThlM2I3NDIwZGQ0NTMxYjEwN2NiNmM3ODI3NDI5ZS90YWJsZXJhbmdlOmU1OGUzYjc0MjBkZDQ1MzFiMTA3Y2I2Yzc4Mjc0MjllXzI0LTUtMS0xLTIwOTI1_9bbfb226-3760-4d2f-a173-07480957ca8d"
      unitRef="usd">58000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:OperatingLeasePayments
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzMtNC0xLTEtMjA5MjU_0c53c3b3-49dc-4e09-bd15-7b0bdb1e9dbc"
      unitRef="usd">185000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzMtNi0xLTEtMjA5MjU_698ac39e-d98d-44ff-887b-4d7ec9da41f7"
      unitRef="usd">185000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzMtOC0xLTEtMjM5MTE_a970e085-cf41-439f-bb34-4db461f71597"
      unitRef="usd">180000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzQtNC0xLTEtMjA5MjU_f0ded040-f7cd-4a89-9511-a33bc7479a57"
      unitRef="usd">2000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzQtNi0xLTEtMjA5MjU_2c8ce3dd-0c91-48a7-9ed7-8977d5237480"
      unitRef="usd">3000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzQtOC0xLTEtMjM5MTE_ab3685d4-01dd-45f7-8df3-4fd3279dde07"
      unitRef="usd">3000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzUtNC0xLTEtMjA5MjU_f47cdfc6-f9ac-45d3-8c72-288e1d188d3a"
      unitRef="usd">2000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzUtNi0xLTEtMjA5MjU_f9ebbcc5-2705-4be8-a3f7-0a29a586b9e5"
      unitRef="usd">3000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzUtOC0xLTEtMjM5MTE_eba27e70-dcbe-4f35-ada4-0b06b1e9fc52"
      unitRef="usd">4000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzYtNC0xLTEtMjA5MjU_30076094-e1f3-4141-bb2f-8897b34805e7"
      unitRef="usd">150000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzYtNi0xLTEtMjA5MjU_dd2bd175-f667-49b6-9858-c6e1c4e9513f"
      unitRef="usd">219000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzYtOC0xLTEtMjM5MTE_5df7e5cf-96e0-4dd9-9d95-6e37305f1548"
      unitRef="usd">164000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzctNC0xLTEtMjA5MjU_9acee96b-a743-4c55-a7aa-1185b4c016d6"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzctNi0xLTEtMjA5MjU_2d9f44a6-80c6-4207-94e8-539a962008fa"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDIvZnJhZzpjMTMyNjFjNGUxYWU0ODM4YTA4NGNlNjE2ZjQwNmY0Ny90YWJsZTozMjA5ZjMwNmYwMGU0MzJlOTI1MzIzNGI2ZjkwZDQ3NS90YWJsZXJhbmdlOjMyMDlmMzA2ZjAwZTQzMmU5MjUzMjM0YjZmOTBkNDc1XzctOC0xLTEtMjA5MjU_ec145839-eccd-4b4c-9d8d-00b5a9f803cb"
      unitRef="usd">1000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90ZXh0cmVnaW9uOmMzZGFkNjgwZmU0ZDQ5NWViMTdiZGZlODhkNmFiNzM0XzIyOA_d033dbcd-e11c-4a7f-8fb3-fb17928b3d49">PROPERTY, PLANT AND EQUIPMENT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Property, plant and equipment as of December&#160;31, 2021 and 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment and furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software developed or obtained for internal use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December 31, 2019, the Company recognized a $73&#160;million gain in other operating (income) expense, net on the sale and leaseback of a property.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90ZXh0cmVnaW9uOmMzZGFkNjgwZmU0ZDQ5NWViMTdiZGZlODhkNmFiNzM0XzIzMQ_2fb7bef8-9a5d-4b45-ac6d-299467f55f80">Property, plant and equipment as of December&#160;31, 2021 and 2020 consisted of the following: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment and furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software developed or obtained for internal use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5ee54bfafa2142ab925140ee00165fea_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzItMS0xLTEtMjA5MjU_2bfc91fb-9cfa-464c-87a4-94111dcf245e"
      unitRef="usd">43000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i95334650a7794ede9d0240487ccf5b99_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzItMy0xLTEtMjA5MjU_c73d508f-ad01-4a9a-a447-59b9bd65ba5a"
      unitRef="usd">42000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8d5ebce76e5d403e9298f0728ff53d6e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzMtMS0xLTEtMjA5MjU_c4a48f23-f6c0-4d0c-803a-c9c1001438b8"
      unitRef="usd">532000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i82c68c29716a45b6ae635ee994106a2f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzMtMy0xLTEtMjA5MjU_3a790b21-e0c5-45b1-a6af-03914d85e3d3"
      unitRef="usd">526000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9b876c41bbc04618b47e5868c157a986_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzQtMS0xLTEtMjA5MjU_27dca9b7-9dd7-468b-ada5-c57456863feb"
      unitRef="usd">2009000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib69a77afcc7848b9bcdb721d263b8590_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzQtMy0xLTEtMjA5MjU_ebdf2d25-b426-443f-8105-4a62ee003927"
      unitRef="usd">1974000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2dc448c5c6a4434ca848bbf1bcbbdbab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzUtMS0xLTEtMjA5MjU_48e96a7d-db9a-4f45-99b8-55834a65b304"
      unitRef="usd">705000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib0550e1e6602405196f7a86f02932b05_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzUtMy0xLTEtMjA5MjU_3a7b9dea-247d-4364-8e71-e5637baa8c89"
      unitRef="usd">666000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i850a9e2e7a37450487c5434158c02aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzYtMS0xLTEtMjA5MjU_2edd65d1-d1af-469d-a881-f979aafd6239"
      unitRef="usd">1292000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3445b8f4bd484038bb1c8dba887da7aa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzYtMy0xLTEtMjA5MjU_5cf6eefc-8276-4cb4-a69b-0aee4eed4dbe"
      unitRef="usd">1209000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9051075426f64d9fb6d5c2874af92f58_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzctMS0xLTEtMjA5MjU_cb7d8f2e-8d3c-494d-9d96-26504fcfb9f1"
      unitRef="usd">214000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i703f397efc54465491f61111e9d00225_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzctMy0xLTEtMjA5MjU_e5efab70-69bb-4e05-909b-ae62949b9f92"
      unitRef="usd">202000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzgtMS0xLTEtMjA5MjU_4fa2a11f-128e-4ad3-8603-7f5646bf430b"
      unitRef="usd">4795000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzgtMy0xLTEtMjA5MjU_263dfdc4-38ff-4147-a0d2-18c69cb78c71"
      unitRef="usd">4619000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzktMS0xLTEtMjA5MjU_2e12e776-b21c-47ca-94fa-3c5711153481"
      unitRef="usd">3088000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzktMy0xLTEtMjA5MjU_6ccaae57-49db-4939-a676-fc31be738b09"
      unitRef="usd">2992000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzEwLTEtMS0xLTIwOTI1_882312cd-2425-4b0c-b192-8793d44e9c29"
      unitRef="usd">1707000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90YWJsZTo1YTY4OWNkZGQ4NWI0NTZiYWZmNmZlMGE1NzlmMDVkZC90YWJsZXJhbmdlOjVhNjg5Y2RkZDg1YjQ1NmJhZmY2ZmUwYTU3OWYwNWRkXzEwLTMtMS0xLTIwOTI1_3a0e1407-7751-45bb-b2f6-295235715357"
      unitRef="usd">1627000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i75cf772afd4440dbabbaa7a8d8609ebd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDUvZnJhZzpjM2RhZDY4MGZlNGQ0OTVlYjE3YmRmZTg4ZDZhYjczNC90ZXh0cmVnaW9uOmMzZGFkNjgwZmU0ZDQ5NWViMTdiZGZlODhkNmFiNzM0Xzc2OTY1ODEzOTQ5NTA_db751913-b17c-4b7c-a22c-52c0265b53b1"
      unitRef="usd">73000000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90ZXh0cmVnaW9uOjJiM2I4MTI1ZWVlOTQ1OWViYjE4NmM0ZGIwOTZlZDBmXzEwNDg_27d6a42e-3c17-4161-8663-1a054a21fd50">GOODWILL AND INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The changes in goodwill for the years ended December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Principally all of the Company&#x2019;s goodwill as of December&#160;31, 2021 and 2020 was associated with its DIS business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, goodwill acquired during the period was principally associated with the acquisitions of the assets of Mercy Health and assets of Labtech (see Note 5). For the year ended December&#160;31, 2021, adjustments to goodwill related to foreign currency translation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, goodwill acquired during the period was principally associated with the acquisitions of Blueprint Genetics, assets of Memorial Hermann and MACL (see Note 5). For the year ended December&#160;31, 2020, adjustments to goodwill related to foreign currency translation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets as of December&#160;31, 2021 and 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:39pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90ZXh0cmVnaW9uOjJiM2I4MTI1ZWVlOTQ1OWViYjE4NmM0ZGIwOTZlZDBmXzEwMjk_bdbc1e68-b0db-4dcb-999a-449ea3b20f7e">The changes in goodwill for the years ended December&#160;31, 2021 and 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzItMS0xLTEtMjA5MjU_8d4dec95-af68-4535-be1e-b2e88a746a0d"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0cadea5752cf4f50bc45f8f371d2168d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzItMy0xLTEtMjA5MjU_9e9b258d-cb51-4e01-830a-8cee5e5fc111"
      unitRef="usd">6619000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzMtMS0xLTEtMjA5MjU_25417167-96cc-4c31-a7f9-d14361ea1661"
      unitRef="usd">228000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzMtMy0xLTEtMjA5MjU_a8595fd8-67e6-4097-b035-9c92c03f2670"
      unitRef="usd">247000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzQtMS0xLTEtMjA5MjU_e39b5ec6-b366-4e55-894f-3868e325973c"
      unitRef="usd">-6000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzQtMy0xLTEtMjA5MjU_262dee17-2e07-4a10-96fd-a1d1abefae11"
      unitRef="usd">7000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzUtMS0xLTEtMjA5MjU_27d44ca8-cb65-4ac4-a985-3a0e4ed48eda"
      unitRef="usd">7095000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZToyZmE5YWFmNTc1Yzc0NWMyYmUwNzBlZGQyOWQyNGI0OS90YWJsZXJhbmdlOjJmYTlhYWY1NzVjNzQ1YzJiZTA3MGVkZDI5ZDI0YjQ5XzUtMy0xLTEtMjA5MjU_44211a6c-2b26-4716-8353-f5a7c2af0411"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90ZXh0cmVnaW9uOjJiM2I4MTI1ZWVlOTQ1OWViYjE4NmM0ZGIwOTZlZDBmXzEwNDM_631f3edb-4b69-4b16-b123-29f6007ec206">Intangible assets as of December&#160;31, 2021 and 2020 consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:39pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie440f7efd91b4288b67e34da88f9d851_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtMS0xLTEtMjA5MjU_5c8933bc-cbf3-4a4a-a12e-14d3ef9a7e21">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9b6430db74f74cdba668c4da15ce72f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtMy0xLTEtMjA5MjU_eae215af-c1b2-46cc-a178-e4b125632192"
      unitRef="usd">1581000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9b6430db74f74cdba668c4da15ce72f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtNS0xLTEtMjA5MjU_33aa3626-b733-4614-ab83-8c6cb464ab58"
      unitRef="usd">726000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9b6430db74f74cdba668c4da15ce72f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtNy0xLTEtMjA5MjU_ccdf86d9-15f1-442f-839e-c431fd53dea3"
      unitRef="usd">855000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i19172532941b40db90a9673c0a833751_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtOS0xLTEtMjA5MjU_2285e4cc-3c22-4252-981d-1108c8ebde94"
      unitRef="usd">1479000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i19172532941b40db90a9673c0a833751_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtMTEtMS0xLTIwOTI1_1454cd6b-a20d-402a-8425-1f9b741ba68b"
      unitRef="usd">638000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i19172532941b40db90a9673c0a833751_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzMtMTMtMS0xLTIwOTI1_a8d7fc35-29a8-4c17-bb51-16ae14f5e952"
      unitRef="usd">841000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i2ac379b1564746b29091a6803b4e237e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtMS0xLTEtMjA5MjU_072d616b-fc3c-482d-bbf5-e1b3ed369a76">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic96f44c6128f47809c839fe1a70df50d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtMy0xLTEtMjA5MjU_fa7a3d20-20ea-4d9b-a414-9dd2895fa942"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic96f44c6128f47809c839fe1a70df50d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtNS0xLTEtMjA5MjU_bdb2aadc-788e-48cb-8b38-5a6ae75bc4cc"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic96f44c6128f47809c839fe1a70df50d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtNy0xLTEtMjA5MjU_bfbdd9cc-7b15-4619-9c19-f1a90e1e716c"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i01eaebddea0d433ea24e6c5ef38bd564_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtOS0xLTEtMjA5MjU_0230708b-5e84-456b-bfb2-59289cb0505d"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i01eaebddea0d433ea24e6c5ef38bd564_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtMTEtMS0xLTIwOTI1_042019b8-bb9f-4bff-8c3c-81ee0a191fa1"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i01eaebddea0d433ea24e6c5ef38bd564_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzQtMTMtMS0xLTIwOTI1_7a48aaf7-3b3a-4503-be47-5baa2da042d1"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic8c4fd41a16d47c691063b053f0f15a1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtMS0xLTEtMjA5MjU_666e2b5a-bef6-4598-8a24-d78c7c565adc">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="id49dc7dd9f1c473ba5418fbddca06d3f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtMy0xLTEtMjA5MjU_304d637a-64ab-4cf3-a945-c46b6b0bfa6c"
      unitRef="usd">141000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id49dc7dd9f1c473ba5418fbddca06d3f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtNS0xLTEtMjA5MjU_61e423d0-bcc3-4949-aec1-e93ae6bc8017"
      unitRef="usd">74000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id49dc7dd9f1c473ba5418fbddca06d3f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtNy0xLTEtMjA5MjU_aa49f4fb-d689-4fac-b19c-dfedd6407dc4"
      unitRef="usd">67000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ibf12734ab0ab46498369e1f89b24439b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtOS0xLTEtMjA5MjU_1efacf86-7987-4816-b92c-8e866e32a69a"
      unitRef="usd">141000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibf12734ab0ab46498369e1f89b24439b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtMTEtMS0xLTIwOTI1_6b85644a-c444-4404-b173-60bfc039af26"
      unitRef="usd">65000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibf12734ab0ab46498369e1f89b24439b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzUtMTMtMS0xLTIwOTI1_6b9e4108-07c8-430b-8255-e6cefc62a660"
      unitRef="usd">76000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i662626ed24964bfba9dc3b27519b5804_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtMS0xLTEtMjA5MjU_94ed333a-3ad9-4330-88e2-a5e96beda494">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3a7ac3e799d44879aad973d51eb36f14_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtMy0xLTEtMjA5MjU_960fdce5-bf58-401a-af4b-bf55a293fee2"
      unitRef="usd">109000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3a7ac3e799d44879aad973d51eb36f14_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtNS0xLTEtMjA5MjU_e5641315-3bd1-4ac2-9540-dd614aa0e2b4"
      unitRef="usd">101000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3a7ac3e799d44879aad973d51eb36f14_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtNy0xLTEtMjA5MjU_61563b45-2a66-4b43-9040-b400ed9f0486"
      unitRef="usd">8000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if0367af741674c3fb7c7d805734fd8e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtOS0xLTEtMjA5MjU_caad149e-9599-4419-ab0e-7a5593350d5e"
      unitRef="usd">108000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if0367af741674c3fb7c7d805734fd8e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtMTEtMS0xLTIwOTI1_bec99483-227a-4058-8a11-f51e5443aa56"
      unitRef="usd">95000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if0367af741674c3fb7c7d805734fd8e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzYtMTMtMS0xLTIwOTI1_9bf437ca-06c9-4753-bb21-5c6a02af0344"
      unitRef="usd">13000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6a08e02b7c23441cb6f556cdb634cb88_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctMS0xLTEtMjA5MjU_ce9ac79b-d462-4d6f-a3be-030e6ea3dd21">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i97af82c328c645e99f19d0e2e6ce85e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctMy0xLTEtMjA5MjU_489c229b-6ae3-491a-8879-a1fc9cb6ee62"
      unitRef="usd">1834000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i97af82c328c645e99f19d0e2e6ce85e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctNS0xLTEtMjA5MjU_caed961d-446d-4cfd-aa80-cdcd2b1ac1de"
      unitRef="usd">903000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i97af82c328c645e99f19d0e2e6ce85e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctNy0xLTEtMjA5MjU_42d732e8-88aa-4ef6-803b-a7d636979b99"
      unitRef="usd">931000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i05d194442c87432d9686414335afe7cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctOS0xLTEtMjA5MjU_d58bb44e-a9b7-4408-9665-b807461c1b7f"
      unitRef="usd">1731000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i05d194442c87432d9686414335afe7cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctMTEtMS0xLTIwOTI1_271a0f3e-fb86-4563-8b69-0ea3df972bce"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i05d194442c87432d9686414335afe7cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzctMTMtMS0xLTIwOTI1_c078fa3e-08ef-4af2-b4fe-1e7a888c45f6"
      unitRef="usd">931000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i1456547e481a4de1a93ec35f388b1295_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEwLTMtMS0xLTIwOTI1_a48179c6-04b3-4177-8903-473565535bdb"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1456547e481a4de1a93ec35f388b1295_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEwLTctMS0xLTIwOTI1_94359647-333c-4fed-a23d-524039386a10"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i70b2a42da95c4ef2a98b0f15b9f4b9c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEwLTktMS0xLTIwOTI1_31d279ad-fcda-4ff1-a8e8-8d5c34fd6d1e"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i70b2a42da95c4ef2a98b0f15b9f4b9c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEwLTEzLTEtMS0yMDkyNQ_c08b823e-b99f-49d5-8de7-ff54e85afd4a"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="id5164e43d9194c4eb7704645ad2ab56a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzExLTMtMS0xLTIwOTI1_222f1f2f-d281-4429-9c1f-10fb041df11b"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id5164e43d9194c4eb7704645ad2ab56a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzExLTctMS0xLTIwOTI1_e6a17e7c-d333-4de3-b99d-4b4942d57b92"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ideb21621cd5b4062b5cb405b6542855f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzExLTktMS0xLTIwOTI1_3f708403-245f-4ebc-ad3f-3a8ffccc91ab"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ideb21621cd5b4062b5cb405b6542855f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzExLTEzLTEtMS0yMDkyNQ_d46d965a-49f3-4331-8dbe-dfcd3b1efc18"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTMtMS0xLTIwOTI1_e78a1e3a-1cd7-42a0-9b77-14471ce9eabb"
      unitRef="usd">2070000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTUtMS0xLTIwOTI1_9e328a6f-bbf4-4b60-a10e-632476dca4d9"
      unitRef="usd">903000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTctMS0xLTIwOTI1_2bbea2bd-e926-4b0a-ac93-26c87fa60448"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTktMS0xLTIwOTI1_dc257220-30d3-41d7-837b-2c0f705ddc99"
      unitRef="usd">1967000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTExLTEtMS0yMDkyNQ_644241fa-9a14-476f-a0e7-d0c0f0a5c8e9"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTo1YjkxNzI2MDQzNjA0NDMzYmY5ZjE0ZTNkMjliMTViOC90YWJsZXJhbmdlOjViOTE3MjYwNDM2MDQ0MzNiZjlmMTRlM2QyOWIxNWI4XzEyLTEzLTEtMS0yMDkyNQ_6e01ef76-f86a-4a29-96fa-c167d9c43af7"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90ZXh0cmVnaW9uOjJiM2I4MTI1ZWVlOTQ1OWViYjE4NmM0ZGIwOTZlZDBmXzEwMjI_f2246eb4-53fa-4d9d-822b-b9514f567c37">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December&#160;31, 2021 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzEtMS0xLTEtMjA5MjU_24905cf7-b60b-4fc9-a2cb-edc468cf215b"
      unitRef="usd">105000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzItMS0xLTEtMjA5MjU_1ddc47a2-1f7e-4df3-8d36-6ab589342b69"
      unitRef="usd">103000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzMtMS0xLTEtMjA5MjU_48cb3bd0-4fb0-44bc-a84a-a48f1a789423"
      unitRef="usd">100000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzQtMS0xLTEtMjA5MjU_d23ba4e9-5144-4a42-9ed1-9684ba2e59cf"
      unitRef="usd">98000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzUtMS0xLTEtMjA5MjU_5c8e7f9d-ff4c-42d0-9522-4deab8559c34"
      unitRef="usd">93000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzYtMS0xLTEtMjA5MjU_8b613026-3a6d-48a2-85b8-da07ea112e44"
      unitRef="usd">432000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <dgx:FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDgvZnJhZzoyYjNiODEyNWVlZTk0NTllYmIxODZjNGRiMDk2ZWQwZi90YWJsZTozYzJhMTZkZTgzYzU0M2Q5YjcxYTA1ZWM0NzQyMzliZS90YWJsZXJhbmdlOjNjMmExNmRlODNjNTQzZDliNzFhMDVlYzQ3NDIzOWJlXzctMS0xLTEtMjA5MjU_0ee75d2c-e2e1-41f4-8222-f57723814765"
      unitRef="usd">931000000</dgx:FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90ZXh0cmVnaW9uOjExNThmOTJhYjg1NDQ4MTU4ZjlhNmJhOGNlZDJmZGMyXzEzOA_014a0830-24b8-409e-a741-43163c552bdb">ACCOUNTS PAYABLE AND ACCRUED EXPENSES &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Accounts payable and accrued expenses as of December&#160;31, 2021 and 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued wages and benefits (including incentive compensation)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Overdrafts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90ZXh0cmVnaW9uOjExNThmOTJhYjg1NDQ4MTU4ZjlhNmJhOGNlZDJmZGMyXzE0Mw_1add2c2b-cd11-4479-8356-52a742202e10">Accounts payable and accrued expenses as of December&#160;31, 2021 and 2020 consisted of the following: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued wages and benefits (including incentive compensation)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Overdrafts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzItMS0xLTEtMjA5MjU_b24b3594-6da5-411f-affc-8528df409fca"
      unitRef="usd">518000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzItMy0xLTEtMjA5MjU_46020abe-2e12-4965-a9a7-3ccf3ae98a32"
      unitRef="usd">502000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzMtMS0xLTEtMjA5MjU_39777870-3306-46f9-bf1f-c498315de6b9"
      unitRef="usd">460000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzMtMy0xLTEtMjA5MjU_f19a1f9a-8e40-4295-bdc4-fce916f00345"
      unitRef="usd">356000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzQtMS0xLTEtMjA5MjU_f5c9269e-e1a3-46f4-a674-1d4abff046b5"
      unitRef="usd">357000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzQtMy0xLTEtMjA5MjU_5446a75b-8927-4c5e-b149-ff3cf5204f18"
      unitRef="usd">446000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:BankOverdrafts
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzUtMS0xLTEtMjA5MjU_eac85bfa-0292-4eb9-944a-1356619a589a"
      unitRef="usd">116000000</us-gaap:BankOverdrafts>
    <us-gaap:BankOverdrafts
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzUtMy0xLTEtMjA5MjU_f15939ef-9a8a-40ec-81be-a4639ae7ef2c"
      unitRef="usd">153000000</us-gaap:BankOverdrafts>
    <us-gaap:DividendsPayableCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzYtMS0xLTEtMjA5MjU_a766c1e3-eeee-4ffa-81ca-e3f4bd25c889"
      unitRef="usd">74000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzYtMy0xLTEtMjA5MjU_62e0b7b8-20ec-451d-ac0e-51064312e9a6"
      unitRef="usd">76000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzctMS0xLTEtMjA5MjU_fe014513-0bce-4576-bb69-776a49b5b5d5"
      unitRef="usd">34000000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzctMy0xLTEtMjA5MjU_d90e1565-b9f7-4c89-9427-d3d8c0c2264b"
      unitRef="usd">31000000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzgtMS0xLTEtMjA5MjU_b16c331d-7863-4956-9c18-c029313f872b"
      unitRef="usd">26000000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzgtMy0xLTEtMjA5MjU_a20b8eec-c462-459d-9baa-9a63397d171b"
      unitRef="usd">26000000</us-gaap:InterestPayableCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzktMS0xLTEtMjA5MjU_dc93e125-b3f8-460a-983d-8015b766df37"
      unitRef="usd">10000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzktMy0xLTEtMjA5MjU_47545c0e-f194-489d-bb40-2e4fb4c7052e"
      unitRef="usd">43000000</us-gaap:AccruedIncomeTaxesCurrent>
    <dgx:MergerConsiderationPayableCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzEwLTEtMS0xLTIwOTI1_3d947ac5-513e-4bfd-bc92-4f69ecd17f29"
      unitRef="usd">5000000</dgx:MergerConsiderationPayableCurrent>
    <dgx:MergerConsiderationPayableCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzEwLTMtMS0xLTIwOTI1_b604ffd5-b377-4376-a91f-8bae0b66653a"
      unitRef="usd">0</dgx:MergerConsiderationPayableCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzExLTEtMS0xLTIwOTI1_f582b23b-cab3-4053-b31c-e4f40bd626ce"
      unitRef="usd">1600000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTEvZnJhZzoxMTU4ZjkyYWI4NTQ0ODE1OGY5YTZiYThjZWQyZmRjMi90YWJsZTpkYWE4MTMyM2E4OWI0ZGEyYWY5YjEyYjBmNTU4Mjc4Yi90YWJsZXJhbmdlOmRhYTgxMzIzYTg5YjRkYTJhZjliMTJiMGY1NTgyNzhiXzExLTMtMS0xLTIwOTI1_2a767f8c-003b-4289-bfb6-57903b595804"
      unitRef="usd">1633000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzY5ODA_5271e66f-dfc5-4614-9afd-ef0ac11379d5">DEBT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Long-term debt (including finance lease obligations) as of December&#160;31, 2021 and 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.25% Senior Notes due April 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50% Senior Notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.45% Senior Notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20% Senior Notes due June 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95% Senior Notes due June 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80% Senior Notes due June 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.95% Senior Notes due July 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75% Senior Notes due January 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% Senior Notes due March 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Secured Receivables Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During October 2021, the Company amended its $600&#160;million secured receivables credit facility (the &#x201c;Secured Receivables Credit Facility&#x201d;), previously amended in October 2020, to extend the maturity dates for each underlying commitment by one year, while maintaining the borrowing capacity under the facility at $600&#160;million.  Under the Secured Receivables Credit Facility, the Company can borrow against a $250&#160;million loan commitment maturing October 2022 and a $250&#160;million loan commitment maturing October 2023, and can issue up to $100&#160;million of letters of credit (see Note 18) through October 2023.  Borrowings under the Secured Receivables Credit Facility are collateralized by certain domestic receivables.  As of December&#160;31, 2021, interest on the borrowings under the Secured Receivables Credit Facility was based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.725% to 0.80%.  The Secured Receivables Credit Facility is subject to customary affirmative and negative covenants and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility.  As of both December&#160;31, 2021 and 2020, there were no outstanding borrowings under the Secured Receivables Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Unsecured Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During November 2021, the Company amended and restated the agreement for its $750&#160;million senior unsecured revolving credit facility (the &#x201c;Credit Facility&#x201d; or "Senior Unsecured Revolving Credit Facility") to extend the maturity date to November 2026 while maintaining the borrowing capacity under the facility at $750&#160;million.  Under the Credit Facility, the Company can issue letters of credit totaling $150&#160;million (see Note 18).  Issued letters of credit reduce the available borrowing capacity under the Credit Facility.  Interest on the Credit Facility is based on certain published rates plus an applicable margin based on changes in the Company's public debt ratings.  At the option of the Company, it may elect to lock into LIBOR-based interest rates for periods up to six months.  Interest on any outstanding amounts not covered under LIBOR-based interest rate contracts is based on an alternate base rate, which is calculated by reference to the prime rate, the federal funds rate or an adjusted LIBOR rate.  As of December&#160;31, 2021, the Company's borrowing rate for LIBOR-based loans under the Credit Facility was LIBOR plus 1.00%.  The Credit Facility contains various covenants, including the maintenance of a financial leverage ratio, which could impact the Company's ability to, among other things, incur additional indebtedness.  As of both December&#160;31, 2021 and 2020, there were no outstanding borrowings under the Senior Unsecured Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Notes Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, the Company completed a senior notes offering, consisting of $550&#160;million aggregate principal amount of 2.80% senior notes due June 2031 (the &#x201c;2031 Senior Notes&#x201d;), which were issued at an original issue discount of $1&#160;million.  The Company incurred $5&#160;million of debt issuance costs associated with the 2031 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During November 2020, the net proceeds from the 2031 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under the Company's senior notes due April 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During January 2020, the Company redeemed in full the outstanding indebtedness under the Company's senior notes due January 2020 and senior notes due March 2020, using the net proceeds from the issuance, in December 2019, of the senior notes due June 2030.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, the Company recorded a loss on retirement of debt, principally comprised of premiums paid, of $9&#160;million in other income, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;All of the senior notes are unsecured obligations of the Company and rank equally with the Company's other senior unsecured obligations.  None of the Company's senior notes have a sinking fund requirement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company may redeem its outstanding senior notes prior to scheduled maturity, as a whole or in part, at a redemption price equal to the present value of the remaining scheduled payments of principal and interest, except for certain notes for which the Company also has an option to redeem such instruments at par value on or after dates specified in the indentures governing the notes ("the par value redemption option"). &#160;For notes with the par value redemption option, if such notes are redeemed prior to the specified dates, the redemption price calculations exclude any interest that would have been due after such dates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Maturities of Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2021, long-term debt matures as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:297.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:235.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value basis adjustments attributable to hedged debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzY5NzI_b82e176e-134b-4432-9e26-86ab60b96922">Long-term debt (including finance lease obligations) as of December&#160;31, 2021 and 2020 consisted of the following: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.25% Senior Notes due April 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50% Senior Notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.45% Senior Notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20% Senior Notes due June 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95% Senior Notes due June 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80% Senior Notes due June 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.95% Senior Notes due July 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75% Senior Notes due January 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% Senior Notes due March 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id0594f257da04350b8a4a4b497e30e2e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzUtMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjo3MzI4YjBiNmI4ODU0MzRmOGI5YTQwMTk0NjA2OTU4Zl80_3ae33500-b561-4a5a-9f2c-6a515c12a7f0"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id0594f257da04350b8a4a4b497e30e2e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzUtMS0xLTEtMjA5MjU_72cded29-1baa-404d-b316-98fdfb735b9a"
      unitRef="usd">311000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2c6fef0c959f4836b6be1689a5919adf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzUtMy0xLTEtMjA5MjU_6a6e4568-39f5-4e1d-82f2-a693eef52c0b"
      unitRef="usd">316000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7fadb78c01474e89b32f31ed14c21f18_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzYtMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjo1YTM4OTNjNDBjMTg0YzRiOGIyY2JjNzUyYWY4NTk2OV80_73a1476c-985a-4578-a2c6-b1baf8e799f5"
      unitRef="number">0.0350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7fadb78c01474e89b32f31ed14c21f18_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzYtMS0xLTEtMjA5MjU_c93dc983-b41a-4f1a-8eb2-b4aea835dac9"
      unitRef="usd">616000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie8b7492430de4dbfa02f30eb630168d1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzYtMy0xLTEtMjA5MjU_0a2786de-8cbb-48ea-a69f-2ef332e35d6a"
      unitRef="usd">622000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5202c6f3e7cf486b94bb890d000fb968_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzctMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjowNDY1MTliMzA5OWI0YzY3YWUzMzQ1ZTI2NzdkMjgyNl80_96b6fb29-f88a-4e3a-9146-a0fc6bde942a"
      unitRef="number">0.0345</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5202c6f3e7cf486b94bb890d000fb968_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzctMS0xLTEtMjA5MjU_4f954833-e8ff-4e82-8c12-db6bfd1f7294"
      unitRef="usd">510000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i82cb0de9768a4944bc7de354bb2821b1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzctMy0xLTEtMjA5MjU_e468f8cc-ce7f-4674-8813-29e7b84567da"
      unitRef="usd">512000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie5df62b2adde478ea217430cd360e7e5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzgtMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjoyN2VhYjBhODk1ZDk0OWIxYjZmMzAwZDAzY2VlMTZlY180_3252c1f0-496b-41e7-a6fa-9d8dbdc69610"
      unitRef="number">0.0420</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ie5df62b2adde478ea217430cd360e7e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzgtMS0xLTEtMjA5MjU_c3fcf4f4-ef18-4f9e-980d-4e78476b0737"
      unitRef="usd">499000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ida0ded49fab44741b80d31af3ba70aae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzgtMy0xLTEtMjA5MjU_fc93b499-5d99-4b2a-9c72-7f2d3ac50b49"
      unitRef="usd">499000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i766f928a9c9346038b77495a2d20fb42_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzktMC0xLTEtMjA5MjUvdGV4dHJlZ2lvbjpkZTg3MTk3NWQyOWQ0OTkyOTQ3NmM0NzQ1M2ZhNDA4NF80_dafea6a8-c710-42f2-98f7-825f54123979"
      unitRef="number">0.0295</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i766f928a9c9346038b77495a2d20fb42_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzktMS0xLTEtMjA5MjU_051a8acf-cc8a-4e60-b611-d0007eecec43"
      unitRef="usd">798000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icc060a500fe64aac9a2a927778e50857_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzktMy0xLTEtMjA5MjU_1d8da4e9-769c-4cf7-ab6d-14913e8eb341"
      unitRef="usd">798000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i378672f20c0d4618a6b6e81143b6720a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEwLTAtMS0xLTIwOTI1L3RleHRyZWdpb246MmQ1NDAzYjg5YWYyNDIwNDgxZTdiYjQwYzlhNWY1YWFfNA_c50326da-e990-42ab-ac29-cfeb2a7b9f04"
      unitRef="number">0.0280</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i378672f20c0d4618a6b6e81143b6720a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEwLTEtMS0xLTIwOTI1_4eee246f-3394-4407-8c48-b6e2c16fbb91"
      unitRef="usd">549000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i88cc643b6da843ffa1c10a9f855203c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEwLTMtMS0xLTIwOTI1_b302fd9f-68a6-4a22-8477-6e2c67cd9600"
      unitRef="usd">549000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie4ce1f1f310449c2b6c89c7e62ade9b8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzExLTAtMS0xLTIwOTI1L3RleHRyZWdpb246ZjQ1ZjU1MGM0NGU4NDUxYWFlZmRiMDNjMDVkMWY4OGRfNA_0f1ca107-a969-476c-8872-490ae4b5880e"
      unitRef="number">0.0695</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ie4ce1f1f310449c2b6c89c7e62ade9b8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzExLTEtMS0xLTIwOTI1_bd51526f-2a6c-4ade-aa2b-ba55b3261273"
      unitRef="usd">175000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5df76549d2994abd97388a4720896161_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzExLTMtMS0xLTIwOTI1_e1906bb5-e1d4-4ff0-b72e-42b7b9387f24"
      unitRef="usd">175000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3b9881c9daf746ff96ea2d9b6927e946_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEyLTAtMS0xLTIwOTI1L3RleHRyZWdpb246Y2IwNmFmYTRkYzNiNDU0NGJiYzY3YzM0N2NhYjYzODBfNA_496e6c97-8eb4-4d3b-9f24-d6f6f9d3c5db"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3b9881c9daf746ff96ea2d9b6927e946_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEyLTEtMS0xLTIwOTI1_be7fe12c-864b-4142-993a-7161c170db75"
      unitRef="usd">245000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i82a4a8a3b9d14622adefe38f6d57418f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEyLTMtMS0xLTIwOTI1_37db42cf-688f-48b6-abca-450b9fa6824e"
      unitRef="usd">245000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i09bbac6d7bf04160afe3a6e074127aba_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEzLTAtMS0xLTIwOTI1L3RleHRyZWdpb246MzU0ZDJkMjA4M2UxNDYxNzg4ZWRhOTY1ZjI0YmNkMjRfNA_c1a02949-d1b3-4dea-820d-47230febeedf"
      unitRef="number">0.0470</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i09bbac6d7bf04160afe3a6e074127aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEzLTEtMS0xLTIwOTI1_dbcc8c94-f531-4601-b1bb-4befb36e3c73"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic73df93e889f4d69ac6970fe52f080ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzEzLTMtMS0xLTIwOTI1_e6893972-1371-49cb-ae9b-dac42aac13f4"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="i9a32e3b91ca84b89b38c8ba51a6735ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE0LTEtMS0xLTIwOTI1_a75e02ec-1f31-4e07-a343-3aa1d18a6f7b"
      unitRef="usd">34000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="i72472dddee4a401c94ec4e9a3d939bc5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE0LTMtMS0xLTIwOTI1_c2518b8a-779f-4d82-a6a8-709201c21b8c"
      unitRef="usd">27000000</us-gaap:OtherLongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE1LTEtMS0xLTIwOTI1_3bcbc82e-6f79-45c4-a37d-ef13fdc0112c"
      unitRef="usd">25000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE1LTMtMS0xLTIwOTI1_b1367545-612c-45a4-9a64-04e3b3acfe0b"
      unitRef="usd">28000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebt
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE2LTEtMS0xLTIwOTI1_28de68cc-dc60-4d72-af83-a5ccdc7d8e2e"
      unitRef="usd">4012000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE2LTMtMS0xLTIwOTI1_8f6393ad-d9f6-4be8-a3d3-7f708749383f"
      unitRef="usd">4015000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE3LTEtMS0xLTIwOTI1_f95e4f2f-d6c4-4b82-8beb-0719828233ed"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE3LTMtMS0xLTIwOTI1_4915bbf9-0b05-4ac1-a2a5-6b0fbe5cf9e4"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE4LTEtMS0xLTIwOTI1_6f95de1e-41c8-4d41-8c14-b9dc9d84af8f"
      unitRef="usd">4010000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpmZGFkMTRiNTZkNTQ0MTk2YmVkMmY0MzhkYmRkYTUzMC90YWJsZXJhbmdlOmZkYWQxNGI1NmQ1NDQxOTZiZWQyZjQzOGRiZGRhNTMwXzE4LTMtMS0xLTIwOTI1_695151f6-245b-4c1e-8e60-60eb55075d9d"
      unitRef="usd">4013000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ife8fa0dbace2463781c162f0d572554e_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzIyMg_68dd077e-65c4-40da-bed3-978fb0e8f8c1"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dgx:DebtInstrumentExtensionPeriod
      contextRef="i9f138175e3a44f5ebf659b1a78903b5d_D20211001-20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzQwNQ_59045671-dfcf-4c80-876f-c19977c292ca">P1Y</dgx:DebtInstrumentExtensionPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ife8fa0dbace2463781c162f0d572554e_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzQ3Mg_351f4d70-635f-4735-b0b2-57d480c2d6ba"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8413e7af478b4f60b3be63a14fc02040_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzU1Nw_533ab308-8afb-4313-a248-de50b34be824"
      unitRef="usd">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id7273399a8b249109c5141327f9e2f70_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzU5NA_dfa6eb99-0475-471c-82fd-efd80186e8dc"
      unitRef="usd">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if0f0ea4be7af4410af0e10d2186e1e37_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzY0Ng_7a0728cf-be44-4948-b4e0-b602dbc7647f"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if5bd74de8e5d42bd9ceb6ea699aa16ca_D20211231-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzk4NQ_d21543cf-a573-48ab-9710-04a062716b76"
      unitRef="number">0.00725</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1730f3f4c2874eff9f3ca20705fbdfce_D20211231-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzk5MQ_d6e88ef4-5a7d-4430-9923-b090dc4e721d"
      unitRef="number">0.0080</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i90044be8ca1a4466aea5fb0404e36a2d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzEyNzI_5dabe0ce-7867-4321-9557-a7971001de11"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8e4a6015d1ef460f9e8ae76bf0c3381f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzEyNzI_9f8295dc-734d-4e28-8d46-ba34b9fe398c"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia3d6de33f3ed4d19a2ec16d2ece3dab0_I20211130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzE0MjA_77e3683d-539b-47e2-8b9a-f3dae7c307d9"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia3d6de33f3ed4d19a2ec16d2ece3dab0_I20211130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzc2OTY1ODE0MTkwMzI_7294fc74-5e71-4cd1-abe0-f7f0e15c3f9d"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="icaa60f894264418b86cad34928e740c7_I20211130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzE2MzY_1cad676a-4ff3-453c-9fa6-42a81ef02b38"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib618186b3e3648a0a5c22c9e567fe03f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzIzNzg_bf2840f9-6875-4fb7-8ed3-7a2350743c21"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iae8c124c79124e13a5f8a65b35a85a2d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzM0Mjc_5d166b84-de90-47c5-8370-3b3a54409300"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8f48d5ae19c347f5a146cb05e040a26f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzM0Mjc_f32ba37b-c798-4ed0-8e45-a8ff07324ce4"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if8194949fa694c51b9a86b2aa1a10860_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzI3NDg3NzkwODMyMzU_463891c9-1ff8-4ad9-9fb2-6ff2fcb79865"
      unitRef="usd">550000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if8194949fa694c51b9a86b2aa1a10860_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzI3NDg3NzkwODMyNzg_a1cb6d9c-b139-4180-b380-4a18360fe73f"
      unitRef="number">0.0280</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="if8194949fa694c51b9a86b2aa1a10860_I20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzI3NDg3NzkwODMyNjA_48443fd9-724e-4eb4-8d3d-1cecb6563f4d"
      unitRef="usd">1000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="if8194949fa694c51b9a86b2aa1a10860_I20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzQxMTE_313d24a8-b1a8-4e5a-8867-29661eb733e0"
      unitRef="usd">5000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i754db448c4a141e587eb41b3530387d7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzYwMzI_a4687e92-8de5-4132-8242-1aa6cf88150a"
      unitRef="usd">-9000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90ZXh0cmVnaW9uOjU3MGNkZTc1MWJhODQ2ODJhYWE5NDEyMDU4NmZlNjYyXzY5Nzg_93f9bc4e-70fe-43b5-bd7c-e92454237533">As of December&#160;31, 2021, long-term debt matures as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:297.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:235.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value basis adjustments attributable to hedged debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzEtMS0xLTEtMjA5MjU_a1aae57e-d563-40ba-aff7-a0444f77852b"
      unitRef="usd">2000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzItMS0xLTEtMjA5MjU_533cb66b-fb2e-402c-89ab-12287301ee87"
      unitRef="usd">2000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzMtMS0xLTEtMjA5MjU_a8d5dc12-9eda-46f5-834d-c007b68fe4cf"
      unitRef="usd">303000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzQtMS0xLTEtMjA5MjU_246b4c4d-1e39-4bee-8fbe-b56c7f45faa5"
      unitRef="usd">603000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzUtMS0xLTEtMjA5MjU_736725b9-714c-4ac8-bd98-c9052e997545"
      unitRef="usd">503000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzYtMS0xLTEtMjA5MjU_ecb4e626-24b0-4a75-b0d3-908a37758f33"
      unitRef="usd">2596000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <dgx:LongTermDebtMaturitiesGross
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzctMS0xLTEtMjA5MjU_d19cc462-8bcf-4f64-937c-2968a9e9c969"
      unitRef="usd">4009000000</dgx:LongTermDebtMaturitiesGross>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzgtMS0xLTEtMjA5MjU_45474569-e487-4794-bfba-6dfdf4065efe"
      unitRef="usd">10000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzktMS0xLTEtMjA5MjU_3bcbc82e-6f79-45c4-a37d-ef13fdc0112c"
      unitRef="usd">25000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <dgx:DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzEwLTEtMS0xLTIwOTI1_f362d223-6a0f-428e-97ba-9ec0d37c8130"
      unitRef="usd">-38000000</dgx:DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt>
    <us-gaap:LongTermDebt
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzExLTEtMS0xLTIwOTI1_3bdbc927-b829-4c1c-be2c-bd7da82fd656"
      unitRef="usd">4012000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzEyLTEtMS0xLTIwOTI1_0e976754-b5d4-4290-9db9-5f85325d58e0"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTQvZnJhZzo1NzBjZGU3NTFiYTg0NjgyYWFhOTQxMjA1ODZmZTY2Mi90YWJsZTpkNDU5MWNhOTg2NWY0OTExYjU2OTcwMzdlMjJhNzAyNC90YWJsZXJhbmdlOmQ0NTkxY2E5ODY1ZjQ5MTFiNTY5NzAzN2UyMmE3MDI0XzEzLTEtMS0xLTIwOTI1_c4c0d88f-43c5-4f5c-bdb4-25437c39209d"
      unitRef="usd">4010000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTQ_65124396-17a5-40e8-a6dc-e079c12ec392">LEASES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_50c95c33-a401-4066-8573-e62f6ca75cd3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_6f7e233a-96d4-4732-aa53-9f719523830d"&gt;right-of-use asset&lt;/span&gt;&lt;/span&gt;, representing the underlying asset during the lease term, and a lease &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_1997e471-5c97-4a99-87d8-0ad010e8dfa3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_2b9b9016-510b-480e-96bb-962223d0e820"&gt;liability&lt;/span&gt;&lt;/span&gt;, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_375a58c6-c5ec-4296-b7ed-b111e088fff7"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_b44b257f-98c9-4e44-912d-5c75a894370c"&gt;liability&lt;/span&gt;&lt;/span&gt; is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.  For the years ended December&#160;31, 2021, 2020, and 2019, lease expense associated with short-term leases was not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company primarily uses its collateralized incremental borrowing rate in determining the present value of lease payments as the Company's leases generally do not provide an implicit rate.  Such incremental borrowing rates, which take into account interest rates offered to companies that have similar credit ratings to the Company, are determined using a portfolio approach which groups the Company&#x2019;s leases based on tenor.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has lease agreements with (i) right-of-use asset payments and (ii) non-lease components (i.e., payments related to maintenance fees, utilities, etc.) which have been combined and accounted for as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's leases have remaining terms of less than 1 year to 15 years, some of which include options to extend the leases for up to 15 years. The Company's lease terms may include renewal options that are reasonably certain to be exercised and termination options that are reasonably certain not to be exercised. Certain leases also include options to purchase the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Certain of the Company's lease agreements include rental payments adjusted periodically for inflation or a market rate which are included in the lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's assets and liabilities for its lease agreements as of December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_0ffa204f-63da-4cb5-97eb-2b95e023c547"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_47976c32-56f0-4b24-a8fa-f838f8d5f156"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Finance lease assets as of December&#160;31, 2021 and 2020 were recorded net of accumulated amortization of $8&#160;million and $14&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Components of lease cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:247.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $140 million, $120&#160;million and $120&#160;million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The maturity of the Company's lease liabilities as of December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:365.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:163.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Lease term and discount rate as of December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:363.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's discount rates for its operating leases were primarily determined using the Company's incremental borrowing rate.  The Company's weighted-average discount rate for its finance leases principally reflects the implicit interest rate on a lease obligation assumed in a business combination.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;See Note 9 for cash flow information on cash paid for amounts included in the measurement of lease liabilities, leased assets obtained in exchange for new operating lease liabilities, and leased assets obtained in exchange for new finance lease liabilities for the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTU_c5eb06e6-3884-4350-9af7-12e75e02e52f">LEASES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_50c95c33-a401-4066-8573-e62f6ca75cd3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_6f7e233a-96d4-4732-aa53-9f719523830d"&gt;right-of-use asset&lt;/span&gt;&lt;/span&gt;, representing the underlying asset during the lease term, and a lease &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_1997e471-5c97-4a99-87d8-0ad010e8dfa3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_2b9b9016-510b-480e-96bb-962223d0e820"&gt;liability&lt;/span&gt;&lt;/span&gt;, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_375a58c6-c5ec-4296-b7ed-b111e088fff7"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_b44b257f-98c9-4e44-912d-5c75a894370c"&gt;liability&lt;/span&gt;&lt;/span&gt; is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.  For the years ended December&#160;31, 2021, 2020, and 2019, lease expense associated with short-term leases was not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company primarily uses its collateralized incremental borrowing rate in determining the present value of lease payments as the Company's leases generally do not provide an implicit rate.  Such incremental borrowing rates, which take into account interest rates offered to companies that have similar credit ratings to the Company, are determined using a portfolio approach which groups the Company&#x2019;s leases based on tenor.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has lease agreements with (i) right-of-use asset payments and (ii) non-lease components (i.e., payments related to maintenance fees, utilities, etc.) which have been combined and accounted for as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's leases have remaining terms of less than 1 year to 15 years, some of which include options to extend the leases for up to 15 years. The Company's lease terms may include renewal options that are reasonably certain to be exercised and termination options that are reasonably certain not to be exercised. Certain leases also include options to purchase the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Certain of the Company's lease agreements include rental payments adjusted periodically for inflation or a market rate which are included in the lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's assets and liabilities for its lease agreements as of December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_0ffa204f-63da-4cb5-97eb-2b95e023c547"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_47976c32-56f0-4b24-a8fa-f838f8d5f156"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Finance lease assets as of December&#160;31, 2021 and 2020 were recorded net of accumulated amortization of $8&#160;million and $14&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Components of lease cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:247.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $140 million, $120&#160;million and $120&#160;million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The maturity of the Company's lease liabilities as of December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:365.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:163.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Lease term and discount rate as of December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:363.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's discount rates for its operating leases were primarily determined using the Company's incremental borrowing rate.  The Company's weighted-average discount rate for its finance leases principally reflects the implicit interest rate on a lease obligation assumed in a business combination.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;See Note 9 for cash flow information on cash paid for amounts included in the measurement of lease liabilities, leased assets obtained in exchange for new operating lease liabilities, and leased assets obtained in exchange for new finance lease liabilities for the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4ODg_8cbd7a52-7a01-4843-b2c2-f638a08ef8c3">The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_50c95c33-a401-4066-8573-e62f6ca75cd3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODg_6f7e233a-96d4-4732-aa53-9f719523830d"&gt;right-of-use asset&lt;/span&gt;&lt;/span&gt;, representing the underlying asset during the lease term, and a lease &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_1997e471-5c97-4a99-87d8-0ad010e8dfa3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODc_2b9b9016-510b-480e-96bb-962223d0e820"&gt;liability&lt;/span&gt;&lt;/span&gt;, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_375a58c6-c5ec-4296-b7ed-b111e088fff7"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI3NDg3NzkwNzM4ODY_b44b257f-98c9-4e44-912d-5c75a894370c"&gt;liability&lt;/span&gt;&lt;/span&gt; is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.</us-gaap:LesseeLeasesPolicyTextBlock>
    <dgx:LeaseRemainingLeaseTerm
      contextRef="i5e3f8aa3f21c4630b2c2d3a505ba4881_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzE5NjE_618eebf7-bbda-4b20-91c3-3d9e2f600c0b">P1Y</dgx:LeaseRemainingLeaseTerm>
    <dgx:LeaseRemainingLeaseTerm
      contextRef="i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzE5Njc_8544fdc6-eb81-4a20-bf96-ce4b1b794d60">P15Y</dgx:LeaseRemainingLeaseTerm>
    <dgx:LeaseRenewalTerm
      contextRef="i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzIwMzI_63181fd7-3ab0-4387-bb80-5def1e5abd16">P15Y</dgx:LeaseRenewalTerm>
    <dgx:ScheduleOfLeaseByAssetTypeTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4ODk_d533d52d-8894-43a2-b53e-419746233673">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's assets and liabilities for its lease agreements as of December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_0ffa204f-63da-4cb5-97eb-2b95e023c547"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTItMS0xLTQzNjg4_47976c32-56f0-4b24-a8fa-f838f8d5f156"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Finance lease assets as of December&#160;31, 2021 and 2020 were recorded net of accumulated amortization of $8&#160;million and $14&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</dgx:ScheduleOfLeaseByAssetTypeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzItNC0xLTEtMjA5MjU_7f5dba9b-a2e1-42a1-8994-78632d838697"
      unitRef="usd">597000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzItNi0xLTEtMjA5MjU_7dc651ce-2a7b-4f9b-b497-77b4437d0008"
      unitRef="usd">604000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzMtNC0xLTEtMjA5MjU_e1d47e11-f4f7-4864-89bf-9d2cf14ad413"
      unitRef="usd">29000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzMtNi0xLTEtMjA5MjU_e0e4b2c6-8ae9-4f09-84cf-f40176a47293"
      unitRef="usd">22000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <dgx:LeaseRightofUseAsset
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzQtNC0xLTEtMjA5MjU_a918e34a-7355-4d66-92c6-a41583bcff46"
      unitRef="usd">626000000</dgx:LeaseRightofUseAsset>
    <dgx:LeaseRightofUseAsset
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzQtNi0xLTEtMjA5MjU_9a8e277e-27a8-434b-92b8-3f14ae5d2a32"
      unitRef="usd">626000000</dgx:LeaseRightofUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzgtNC0xLTEtMjA5MjU_d515ec79-9f4a-4ea5-83e9-a33e45140dcd"
      unitRef="usd">151000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzgtNi0xLTEtMjA5MjU_57e7b086-4a4a-4e1f-96c1-c63b7d24dbfb"
      unitRef="usd">141000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzktNC0xLTEtMjA5MjU_c5740090-212f-48c9-8a82-5f9487df5f76"
      unitRef="usd">2000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzktNi0xLTEtMjA5MjU_ad31ac78-55ee-47f6-8ab7-f3e873686d31"
      unitRef="usd">2000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzExLTQtMS0xLTIwOTI1_0dfe896d-44f1-46a9-b8a1-9a7e389474c0"
      unitRef="usd">494000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzExLTYtMS0xLTIwOTI1_0e8557c5-ba1e-452e-af65-757192537d21"
      unitRef="usd">499000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTQtMS0xLTIwOTI1_796b3a4b-0b1b-4906-9c65-354cb5172c6a"
      unitRef="usd">32000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEyLTYtMS0xLTIwOTI1_a8f12235-cbc9-4263-b4cd-4f1c02d99d04"
      unitRef="usd">25000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <dgx:LeaseLiability
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEzLTQtMS0xLTIwOTI1_4aa30422-9469-4e55-881a-038a0c20d9f6"
      unitRef="usd">679000000</dgx:LeaseLiability>
    <dgx:LeaseLiability
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo0NTFhMmU1MDdlN2U0MWMyOWFjMjdhYTAyNTZjNDdlMS90YWJsZXJhbmdlOjQ1MWEyZTUwN2U3ZTQxYzI5YWMyN2FhMDI1NmM0N2UxXzEzLTYtMS0xLTIwOTI1_f5b9fe93-8566-40dd-b8a5-31aa2dbac33b"
      unitRef="usd">667000000</dgx:LeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI2Njc_27f8e6c2-4598-4ab1-9f23-4ded32c5f645"
      unitRef="usd">8000000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI2NzQ_5d71cecb-f833-4e48-aef6-cfb7b0e1e915"
      unitRef="usd">14000000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTA_ea8b5cf8-d064-4a91-83c9-86d94479642d">Components of lease cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:247.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $140 million, $120&#160;million and $120&#160;million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <dgx:OperatingLeaseFixedAndVariableCost
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzItMi0xLTEtMjA5MjU_b4a664ae-9bd5-4e9d-bfde-9da009a36984"
      unitRef="usd">321000000</dgx:OperatingLeaseFixedAndVariableCost>
    <dgx:OperatingLeaseFixedAndVariableCost
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzItNC0xLTEtMjA5MjU_3295f5b1-37d1-426c-8d9c-8b779eb672f4"
      unitRef="usd">300000000</dgx:OperatingLeaseFixedAndVariableCost>
    <dgx:OperatingLeaseFixedAndVariableCost
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzItNS0xLTEtMzAyMjE_ef4ebf63-e69b-4c74-8b05-92a3c889f884"
      unitRef="usd">294000000</dgx:OperatingLeaseFixedAndVariableCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzUtMi0xLTEtMjA5MjU_7f2090c3-3344-4ae2-91c3-d2ed6f9e962d"
      unitRef="usd">2000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzUtNC0xLTEtMjA5MjU_b9895e73-d280-49eb-80e0-602eccd61a0c"
      unitRef="usd">6000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzUtNS0xLTEtMzAyMjc_a812e998-5cd5-4c75-abc2-6b55b32065c8"
      unitRef="usd">7000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzYtMi0xLTEtMjA5MjU_0d42ab2a-eb8d-4d06-8e62-bac37ffa4348"
      unitRef="usd">2000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzYtNC0xLTEtMjA5MjU_6c2fd261-2a4f-457b-8baa-09b31e45cc1e"
      unitRef="usd">3000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzYtNS0xLTEtMzAyNTE_8e5de20b-7c48-434d-86fb-5748ab396a63"
      unitRef="usd">3000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LeaseCost
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzctMi0xLTEtMjA5MjU_b3578c74-73f6-46a8-ac18-02edcdfb5170"
      unitRef="usd">325000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzctNC0xLTEtMjA5MjU_8eb045f7-215a-4d80-a076-bfd041801f46"
      unitRef="usd">309000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTpiODg3NTQ4OTQ0MDI0Y2E5OTk4NGI2NGY2YzQyZmZhNi90YWJsZXJhbmdlOmI4ODc1NDg5NDQwMjRjYTk5OTg0YjY0ZjZjNDJmZmE2XzctNS0xLTEtMzA3MDg_563a0e45-be86-45bb-8347-69dd1ff423b7"
      unitRef="usd">304000000</us-gaap:LeaseCost>
    <dgx:ShorttermLeaseandVariableLeaseCost
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzI5NzI_7c6bae93-0c02-4056-aa96-88196d1077cf"
      unitRef="usd">140000000</dgx:ShorttermLeaseandVariableLeaseCost>
    <dgx:ShorttermLeaseandVariableLeaseCost
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4Xzc2OTY1ODEzOTg3MzI_7077beb3-7f64-41f4-8fb4-1a518397428f"
      unitRef="usd">120000000</dgx:ShorttermLeaseandVariableLeaseCost>
    <dgx:ShorttermLeaseandVariableLeaseCost
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4Xzc2OTY1ODEzOTg3MTg_129b7133-3fe9-4f64-bf79-556341d1c25f"
      unitRef="usd">120000000</dgx:ShorttermLeaseandVariableLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTE_01e1f8df-3a99-4662-9af5-c13c72e31a58">The maturity of the Company's lease liabilities as of December&#160;31, 2021 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:365.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:163.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTI_a36fe7f5-9325-4c3d-8e50-07628db4eeec">The maturity of the Company's lease liabilities as of December&#160;31, 2021 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:365.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:163.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzEtMi0xLTEtMjA5MjU_25e4e268-2e01-48e3-a285-b109f053752e"
      unitRef="usd">169000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzEtNC0xLTEtMjA5MjU_385acc19-602e-469b-911c-f3e20035c71c"
      unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzEtNi0xLTEtMjA5MjU_8048813d-0fe1-463e-9fd0-899d4b1d6876"
      unitRef="usd">173000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzItMi0xLTEtMjA5MjU_59ae882e-bafb-40b2-906e-0f55be110872"
      unitRef="usd">153000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzItNC0xLTEtMjA5MjU_236d9bf8-fe99-46ac-8389-20455bf15f9f"
      unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzItNi0xLTEtMjA5MjU_5fb79ed9-5b63-43c3-93fd-0b6998ba7aa3"
      unitRef="usd">157000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzMtMi0xLTEtMjA5MjU_d1befc27-b5e8-4c38-8dee-dc3bab8ef0ab"
      unitRef="usd">116000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzMtNC0xLTEtMjA5MjU_fc0b2942-719c-469f-a79f-b99593361f96"
      unitRef="usd">5000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzMtNi0xLTEtMjA5MjU_796b18c0-5704-4483-890f-7b4122da172a"
      unitRef="usd">121000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzQtMi0xLTEtMjA5MjU_906592db-6007-4ad6-8683-f484f310e55b"
      unitRef="usd">83000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzQtNC0xLTEtMjA5MjU_ef8f9f55-cc88-46d9-804b-e7f4333a52b1"
      unitRef="usd">5000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzQtNi0xLTEtMjA5MjU_4cb3cf99-8f79-465d-9e80-33f1a58569c0"
      unitRef="usd">88000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzUtMi0xLTEtMjA5MjU_c2a3c5a6-9951-4988-bbee-cca4303dbb7d"
      unitRef="usd">54000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzUtNC0xLTEtMjA5MjU_584fd2c3-114f-4f60-b857-95020360cf20"
      unitRef="usd">5000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzUtNi0xLTEtMjA5MjU_9d76abbf-67bc-41ea-b555-a9823fd56703"
      unitRef="usd">59000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzYtMi0xLTEtMjA5MjU_d72b6d71-531c-4ba6-b085-db21aaa2ef6a"
      unitRef="usd">139000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzYtNC0xLTEtMjA5MjU_cf040a6b-e655-4e7a-a47e-6a1e2e387d67"
      unitRef="usd">27000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzYtNi0xLTEtMjA5MjU_d319c59d-0b07-4977-831c-8e27cbeec520"
      unitRef="usd">166000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzctMi0xLTEtMjA5MjU_f917b905-758f-4638-94a9-ad407f557f71"
      unitRef="usd">714000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzctNC0xLTEtMjA5MjU_cf9e2f63-3cb6-4636-845e-f1d492469471"
      unitRef="usd">50000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDue
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzctNi0xLTEtMjA5MjU_16be4322-3e61-4d3a-b090-35e4d63b3164"
      unitRef="usd">764000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzgtMi0xLTEtMjA5MjU_12a721cc-0290-4b58-aa49-b11177f60039"
      unitRef="usd">69000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzgtNC0xLTEtMjA5MjU_925d2135-f2f5-4068-af0e-5a31bcff3c22"
      unitRef="usd">16000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzgtNi0xLTEtMjA5MjU_ff0bc29b-850a-48a3-a9ee-8de4fe1d9932"
      unitRef="usd">85000000</dgx:LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzktMi0xLTEtMjA5MjU_f5df9e9b-956e-4219-8200-42a3f61309b4"
      unitRef="usd">645000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzktNC0xLTEtMjA5MjU_aa0cfc21-62c0-4963-92d1-0cf70086361a"
      unitRef="usd">34000000</us-gaap:FinanceLeaseLiability>
    <dgx:OperatingandFinanceLeaseLiability
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo1MWIyNTMxNjRhZTc0ZTMzOGVhOGQxYmExM2FjMThjNy90YWJsZXJhbmdlOjUxYjI1MzE2NGFlNzRlMzM4ZWE4ZDFiYTEzYWMxOGM3XzktNi0xLTEtMjA5MjU_95796fd6-1f50-4f03-97b5-4f67f59bd432"
      unitRef="usd">679000000</dgx:OperatingandFinanceLeaseLiability>
    <dgx:ScheduleofLeaseTermandDiscountRateTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90ZXh0cmVnaW9uOmM3NGI0OWI3OTA2MzQwZDNiMGMxZTMxYWNhM2NkYjk4XzM4OTM_6f05616b-a903-49a3-8d06-cf41827ffdf6">Lease term and discount rate as of December&#160;31, 2021 and 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:363.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleofLeaseTermandDiscountRateTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzItMS0xLTEtMjA5MjU_d9b20c18-b79b-44a9-a442-c94de53a7043">P6Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzItMy0xLTEtMjA5MjU_10d26d72-7e16-4271-8672-b6a849825c23">P6Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzMtMS0xLTEtMjA5MjU_6ea8c742-4088-40c5-8373-a82ce7f722d7">P11Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzMtMy0xLTEtMjA5MjU_1ce17e67-0671-4c01-92f5-fe6c6ce8cc39">P13Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzYtMS0xLTEtMjA5MjU_00a77682-a5c7-4d96-879b-e686f27521bf"
      unitRef="number">0.030</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzYtMy0xLTEtMjA5MjU_477d1474-df96-473d-81a4-8286e7d72ea4"
      unitRef="number">0.032</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzctMS0xLTEtMjA5MjU_9474ce18-4cae-4530-9bc4-0854bb2cf40d"
      unitRef="number">0.069</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMTcvZnJhZzpjNzRiNDliNzkwNjM0MGQzYjBjMWUzMWFjYTNjZGI5OC90YWJsZTo2NWE4OTBiNDM4YWM0YWVjOTE5ZTU0N2I3NTQzODEwNi90YWJsZXJhbmdlOjY1YTg5MGI0MzhhYzRhZWM5MTllNTQ3Yjc1NDM4MTA2XzctMy0xLTEtMjA5MjU_06134764-e588-45bb-90d2-811c18328432"
      unitRef="number">0.081</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90ZXh0cmVnaW9uOmRhNWViYjdjZDFlZDQxOTU4YjIwZDU2MTFmZTgwYTdhXzMxMjQ_5ec8142f-4fba-4dc6-96f1-7381d011482e">FINANCIAL INSTRUMENTS &#160;&#160;&#160;&#160;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest Rate Derivatives &#x2013; Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Fair Value Hedges &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt. All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2021 and 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Amount of Hedged Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Amount of Hedged Long-Term Debt &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both December&#160;31, 2021 and 2020, the entire balance is associated with remaining unamortized hedging adjustments on discounted relationships. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the years ended December&#160;31, 2021, 2020 and 2019, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total for line item in which the effects of fair value hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items (Long-term debt)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90ZXh0cmVnaW9uOmRhNWViYjdjZDFlZDQxOTU4YjIwZDU2MTFmZTgwYTdhXzI3NDg3NzkwNzY1NDM_57bd99bb-7bed-46a8-a9b3-85967c4de3d0">As of December&#160;31, 2021 and 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Amount of Hedged Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Amount of Hedged Long-Term Debt &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both December&#160;31, 2021 and 2020, the entire balance is associated with remaining unamortized hedging adjustments on discounted relationships. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the years ended December&#160;31, 2021, 2020 and 2019, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total for line item in which the effects of fair value hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items (Long-term debt)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedge
      contextRef="i088cf7af90a4499da82634db3e749425_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZToxMWE3MGU0OTBiZGQ0ZjM0OGVkZjY4NTM1NTFiYmRlYy90YWJsZXJhbmdlOjExYTcwZTQ5MGJkZDRmMzQ4ZWRmNjg1MzU1MWJiZGVjXzItMy0xLTEtMjA5MjU_dc12d775-a961-496a-8385-412165a36098"
      unitRef="usd">0</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="i088cf7af90a4499da82634db3e749425_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZToxMWE3MGU0OTBiZGQ0ZjM0OGVkZjY4NTM1NTFiYmRlYy90YWJsZXJhbmdlOjExYTcwZTQ5MGJkZDRmMzQ4ZWRmNjg1MzU1MWJiZGVjXzItNS0xLTEtMjA5MjU_89bedb0f-29d3-4497-bd43-54fb39957662"
      unitRef="usd">38000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedge
      contextRef="i8b611f9fb71a4871a95107ddf00e5972_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZToxMWE3MGU0OTBiZGQ0ZjM0OGVkZjY4NTM1NTFiYmRlYy90YWJsZXJhbmdlOjExYTcwZTQ5MGJkZDRmMzQ4ZWRmNjg1MzU1MWJiZGVjXzItNy0xLTEtMjA5MjU_81e2fe5d-f8c2-4613-8742-b015ab22fc09"
      unitRef="usd">0</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="i8b611f9fb71a4871a95107ddf00e5972_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZToxMWE3MGU0OTBiZGQ0ZjM0OGVkZjY4NTM1NTFiYmRlYy90YWJsZXJhbmdlOjExYTcwZTQ5MGJkZDRmMzQ4ZWRmNjg1MzU1MWJiZGVjXzItOS0xLTEtMjA5MjU_02bee02d-c566-481f-a508-4a995295761c"
      unitRef="usd">51000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzMtMy0xLTEtMjA5MjU_c54a1a02-6958-48f2-8a59-f40669f04b2a"
      unitRef="usd">369000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzMtNS0xLTEtMjA5MjU_29df900c-126b-4be3-96ff-7c52249cea07"
      unitRef="usd">76000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzMtNy0xLTEtMjA5MjU_f9213044-7e22-4814-8cb5-da01d3dbcf3d"
      unitRef="usd">20000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i11c302abd9aa427ba7d0156fe01460ec_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzYtMy0xLTEtMjA5MjU_792f3ae2-467e-4795-b9e2-5cf591abb949"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i3cc5031c24924569b75aea0f1da108a1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzYtNS0xLTEtMjA5MjU_cac9daa8-4bbb-4719-843b-1095dda82683"
      unitRef="usd">-68000000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i003a13fe51aa4e869629249e6bbb90d5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzYtNy0xLTEtMjA5MjU_8c64acfe-8dc7-4bf5-a7b7-98a7e3dc3f0e"
      unitRef="usd">-65000000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic8afa4ad788744a6a80595836c35781a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzctMy0xLTEtMjA5MjU_4a264888-31c0-4932-9347-8add26efa4e1"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia36018d33c604038aa1aa14c366c4dd2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzctNS0xLTEtMjA5MjU_9143b2fe-ae2d-43b8-9f9b-cc540cc970c5"
      unitRef="usd">68000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia85aba486145433bbe90c96b488714b9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjAvZnJhZzpkYTVlYmI3Y2QxZWQ0MTk1OGIyMGQ1NjExZmU4MGE3YS90YWJsZTpmOTVhODM5Y2U0MTQ0M2Y3OGNlYzdhZDZjZjk3NTY2NS90YWJsZXJhbmdlOmY5NWE4MzljZTQxNDQzZjc4Y2VjN2FkNmNmOTc1NjY1XzctNy0xLTEtMjA5MjU_6fd216e1-54a5-42a8-a091-c626781b6d37"
      unitRef="usd">65000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzQ2OTI_231639b3-baa3-40e3-aad6-528e642729cd">STOCKHOLDERS&#x2019; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Stockholders' Equity&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Series Preferred Stock &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Quest Diagnostics is authorized to issue up to 10 million shares of Series Preferred Stock, par value $1.00 per share.  The Company's Board of Directors has the authority to issue such shares without stockholder approval and to determine the designations, preferences, rights and restrictions of such shares.  No shares are currently outstanding.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under the Company's Restated Certificate of Incorporation the number of authorized shares of common stock, par value $0.01 per share, is 600 million shares.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Changes in Accumulated Other Comprehensive Loss by Component&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Comprehensive income (loss) includes:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 15); and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020, and 2019, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The changes in accumulated other comprehensive loss by component for 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Changes in Available-for-Sale Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Losses on Cash Flow Hedges, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions, its clinical trials central laboratory services joint venture, to IQVIA, its joint venture partner.  As a result of the transaction, during the year ended December&#160;31, 2021, $20&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other income, net.  See Note 6 for further details. &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Additionally, for the year ended December 31, 2020, $3&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other operating (income) expense, net as a result of the sale of foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, the gross deferred losses on cash flow hedges were reclassified from accumulated other comprehensive loss to interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During each of the four quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.56 per common share.  During each of the four quarters of 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.53 per common share.  On February&#160;3, 2022, the Company announced that its Board of Directors authorized a 6.5% increase in its quarterly cash dividend from $0.62 to $0.66 per share, or $2.64 per share annually, commencing with the dividend payable in April 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In each of February 2021 and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion.  As of December&#160;31, 2021, $0.7 billion remained available under the Company&#x2019;s share repurchase authorization.  In February 2022, the Company's Board of Directors authorized the Company to repurchase an additional $1&#160;billion of the Company's common stock.  The share repurchase authorization has no set expiration or termination date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, the Company repurchased 16.0 million shares of its common stock for $2.2 billion, including shares repurchased under ASRs.  The repurchases during the year included an accrual of $23 million recorded in accounts payable and accrued expenses in the consolidated balance sheet for share repurchases not settled until after December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase its common stock as part of a share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount, and was accounted for as two transactions: (1) a treasury stock repurchase and (2) a forward contract.  During the year ended December&#160;31, 2021, the Company paid $1.5&#160;billion to the financial institutions and received 10.7&#160;million shares of its common stock under the ASRs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;For the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020, the Company repurchased 2.7 million shares of its common stock for $325 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, the Company repurchased 3.5 million shares of its common stock for $350 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Shares Reissued from Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, the Company reissued 2 million shares, 3 million shares and 2 million shares, respectively, from treasury stock for shares issued under the Employee Stock Purchase Plan ("ESPP") and stock-based compensation program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Treasury Stock Retirement &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, the Company retired 55&#160;million shares of treasury stock.  In accordance with the Company's policy, the amount paid to repurchase the shares in excess of par value was allocated between retained earnings and additional paid-in capital based on a pro-rata allocation of additional paid-in capital at the time of the share retirement.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redeemable Noncontrolling Interest&lt;/span&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  The Company records changes in the fair value of the noncontrolling interest immediately as they occur.  As of December&#160;31, 2021 and 2020, the redeemable noncontrolling interest was $79 million and $82 million, respectively, and was presented at its fair value.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ice911685201a460b8af3f58815059f82_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzE2OQ_c5a88470-0403-40df-a9a6-f8e2486f1f45"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIxNg_a9d23929-a1c9-4b80-8d38-825303960489"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzQyMQ_c86e5d72-9815-4a27-91d9-774f49592077"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzU5NQ_5310ed32-a0ea-4f1d-8419-a94196aced37"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzYxMg_537bfc02-ccd5-43a7-a2f8-7b1b4d575c81"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzQ2ODI_51e0b6da-838c-4239-a4d6-afcc6b32d9a9">The changes in accumulated other comprehensive loss by component for 2021, 2020 and 2019 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Changes in Available-for-Sale Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Losses on Cash Flow Hedges, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4f78e9964d4545d0b470900cf41790eb_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzItMS0xLTEtMjA5MjU_fb91fb0d-1726-4090-b2f4-4031f6641c9f"
      unitRef="usd">-49000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibaf3d2d6da574aad843e8c47db812bde_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzItMy0xLTEtMjA5MjU_00682929-4afb-4f77-8e72-50b7ab3f1147"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2e6f13795fa643d4a934ef2779cf20c8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzItNS0xLTEtMjA5MjU_a81d6862-491d-443d-9450-7e83c49ef911"
      unitRef="usd">-9000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icedac86dbdd94e328db0b81523eb9490_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzItNy0xLTEtMjA5MjU_0420dbbd-c2f7-4ea3-9848-87679183e278"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6aab3fa36e3d4c9784c83bb58dbc0467_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzItOS0xLTEtMjA5MjU_2674ddf1-e4e7-452c-bf14-4c513d4035c1"
      unitRef="usd">-59000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i172b86f75b754578b0023e98bbdbb60a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzMtMS0xLTEtMjA5MjU_7be3c214-098f-4540-92fa-4161d1acc126"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i854a8c819539479993d7ec23a433969f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzMtMy0xLTEtMjA5MjU_1946acfc-16cb-454f-9fc2-b9b172263024"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6ee641cc51754d1cb00d4f664780d7e8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzMtNS0xLTEtMjA5MjU_0df3f23f-e289-41d4-bffa-faa97fccbede"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9be9b6bedf67403391fbe4666a7b7789_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzMtNy0xLTEtMjA5MjU_2cd7b7f1-861c-4944-b856-600b9568328e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i267bcc57d1894a25886a84780745fe3f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzMtOS0xLTEtMjA5MjU_5c34eea1-dc7b-4a66-b362-ab96e8ada0a0"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i172b86f75b754578b0023e98bbdbb60a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzQtMS0xLTEtMjA5MjU_a5c89ea0-3ab2-4d28-ae7e-974cb12a13cd"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i854a8c819539479993d7ec23a433969f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzQtMy0xLTEtMjA5MjU_d764d6db-d3da-4d5f-af7e-064b6f70bea3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6ee641cc51754d1cb00d4f664780d7e8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzQtNS0xLTEtMjA5MjU_4543ae97-9da6-4d93-8c23-7fd1ef7ea953"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9be9b6bedf67403391fbe4666a7b7789_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzQtNy0xLTEtMjA5MjU_b352da52-cc7e-4240-b5f8-8c93ee11b384"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i267bcc57d1894a25886a84780745fe3f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzQtOS0xLTEtMjA5MjU_446470dd-a320-46ad-94be-2d3fe447e346"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i172b86f75b754578b0023e98bbdbb60a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzUtMS0xLTEtMjA5MjU_93c4e812-8967-4c4b-a6e0-ea77c8e94425"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i854a8c819539479993d7ec23a433969f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzUtMy0xLTEtMjA5MjU_a41ad402-6f8d-4afc-97b5-487d4e4e6eb0"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ee641cc51754d1cb00d4f664780d7e8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzUtNS0xLTEtMjA5MjU_ced18d3e-17ca-49e9-8351-9077bed7e05c"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9be9b6bedf67403391fbe4666a7b7789_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzUtNy0xLTEtMjA5MjU_03d198b6-1031-424e-8f42-f96b2970bad8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i267bcc57d1894a25886a84780745fe3f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzUtOS0xLTEtMjA5MjU_dda037a1-232c-40f0-8402-2241214d3c7e"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i46c2e1b5de824befa49ed510987e9918_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzctMS0xLTEtMjA5MjU_c07b5100-f28f-4ea2-bef9-d9d788831e6d"
      unitRef="usd">-42000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i586f4c60ec0941b798835a56c0a9126d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzctMy0xLTEtMjA5MjU_816df2dc-63b8-4590-83bb-ce88fff67c44"
      unitRef="usd">8000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9d895060707c4feab2cdb2374be33e9e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzctNS0xLTEtMjA5MjU_7417cdfc-3235-4fb8-b1a0-fc8eaea5fef5"
      unitRef="usd">-4000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i20f21fbe58224ed6b3cf27749d03f137_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzctNy0xLTEtMjA5MjU_6c124eec-14cf-4e78-b0e6-a8db2e73f30c"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if98d4882c785427cb6359a1c4887bd59_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzctOS0xLTEtMjA5MjU_726c8c38-5729-487e-b3ec-c938aedebbab"
      unitRef="usd">-39000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i823d173be3fb47b8a4246a64c03b0a01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzgtMS0xLTEtMjA5MjU_0f33c485-3519-4ff8-a592-0096d9765a0f"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3aa0eae48f174f9b9a05ca9da0eab655_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzgtMy0xLTEtMjA5MjU_631cb8e5-01c0-4213-9c2f-01172ff3a129"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifcd6a47fcc964ce4a5dc370e77b30cbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzgtNS0xLTEtMjA5MjU_b862f14b-41c1-4b85-9bcf-8b9dff0ab0f9"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i455a47bd993d476393c8224860c4376d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzgtNy0xLTEtMjA5MjU_b786b2c2-d8ce-4bf3-aeef-af3030271fc7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i873b50b7201e479895a613c8644d45a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzgtOS0xLTEtMjA5MjU_21934578-045c-4254-9cc5-4440c4a4da73"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i823d173be3fb47b8a4246a64c03b0a01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzktMS0xLTEtMjA5MjU_08f77ea7-194d-46c9-a262-4d8c9010f241"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3aa0eae48f174f9b9a05ca9da0eab655_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzktMy0xLTEtMjA5MjU_58783721-6555-4d54-b84c-a36d734cb7e4"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ifcd6a47fcc964ce4a5dc370e77b30cbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzktNS0xLTEtMjA5MjU_96271e66-8bf0-46c1-b31f-191a421f0a47"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i455a47bd993d476393c8224860c4376d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzktNy0xLTEtMjA5MjU_6e38eb13-b6a7-4f6a-833f-0c970ee27c7e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i873b50b7201e479895a613c8644d45a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzktOS0xLTEtMjA5MjU_0f67c6d3-2b20-4a8f-ad0b-f93d9c21cbc1"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i823d173be3fb47b8a4246a64c03b0a01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEwLTEtMS0xLTIwOTI1_52cd2899-ab50-4d68-97c4-d3d88580ecac"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3aa0eae48f174f9b9a05ca9da0eab655_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEwLTMtMS0xLTIwOTI1_873dbb0d-9f33-4910-ba84-640920fbe94e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifcd6a47fcc964ce4a5dc370e77b30cbe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEwLTUtMS0xLTIwOTI1_eb0bb8c2-4b82-44b8-9c1e-e265e7adf750"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i455a47bd993d476393c8224860c4376d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEwLTctMS0xLTIwOTI1_3be230d0-eef5-4961-88be-98848045efb1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i873b50b7201e479895a613c8644d45a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEwLTktMS0xLTIwOTI1_09501579-9352-49fa-bb7b-ae9c07817ba8"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia2ea7757788d44a2a8005c4e5c5e5d8d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEyLTEtMS0xLTIwOTI1_48925c80-dd45-42c4-93d2-704c904d8c6f"
      unitRef="usd">-27000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6a589942e02b472d8d4555b653f21c8e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEyLTMtMS0xLTIwOTI1_c1a06607-b3b5-48bb-bdf2-90bc717f5815"
      unitRef="usd">8000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2e3a08874f20424ebeb0772967620d16_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEyLTUtMS0xLTIwOTI1_d4784d90-7f37-4758-ad9c-e88fab30af9a"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia329d4330d184f4db61e55f388db1e37_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEyLTctMS0xLTIwOTI1_b43df60d-3b92-4a46-84ef-57d90301244a"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icf17d00ced53485da1e88eb50e730ada_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEyLTktMS0xLTIwOTI1_9dd59daa-655a-4b2e-a855-ef224e119041"
      unitRef="usd">-21000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib08a3f5f05e8446a81e70c779986707e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEzLTEtMS0xLTIwOTI1_a0f137ea-f0cb-4c01-b6a0-84d58ccda499"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7b0ee439d5e042c0ad07cb7eea297ef4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEzLTMtMS0xLTIwOTI1_95e99e78-6169-4cdd-9178-e92cdf31e390"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i131d1f6ef78b4ccda288b254ef8513eb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEzLTUtMS0xLTIwOTI1_c23cee72-a2ab-4496-b23b-92bb6ec83335"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i614f87384bc04f7eb3b659a197d00719_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEzLTctMS0xLTIwOTI1_dac49463-1f82-4250-914f-ae204a19c59d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iecc4fcf7570e403c98d584e438978f0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzEzLTktMS0xLTIwOTI1_3d352b29-88dd-456e-97e3-2c0ab713f4a0"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib08a3f5f05e8446a81e70c779986707e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE0LTEtMS0xLTIwOTI1_5d7bd131-ef99-4d2a-9383-884a8db16538"
      unitRef="usd">20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7b0ee439d5e042c0ad07cb7eea297ef4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE0LTMtMS0xLTIwOTI1_1f07bb5a-8039-4843-b162-aa123dd28668"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i131d1f6ef78b4ccda288b254ef8513eb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE0LTUtMS0xLTIwOTI1_ae57f3e0-475f-4f6f-a2ae-8538e7e05df6"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i614f87384bc04f7eb3b659a197d00719_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE0LTctMS0xLTIwOTI1_ea2eb45d-66be-46c4-8237-e988ab53d9c4"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iecc4fcf7570e403c98d584e438978f0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE0LTktMS0xLTIwOTI1_84edfb2a-11fb-4e18-9f0b-58c22ba4ca0a"
      unitRef="usd">21000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib08a3f5f05e8446a81e70c779986707e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE1LTEtMS0xLTIwOTI1_f1947fd2-f044-4b6c-85a9-cd196216acb4"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7b0ee439d5e042c0ad07cb7eea297ef4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE1LTMtMS0xLTIwOTI1_daaf8985-c5ea-4007-b87f-111a2a40566b"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i131d1f6ef78b4ccda288b254ef8513eb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE1LTUtMS0xLTIwOTI1_485df642-5eee-4fa3-bdfb-685f8c33bede"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i614f87384bc04f7eb3b659a197d00719_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE1LTctMS0xLTIwOTI1_a2ecc307-122c-43ea-8ef9-cd634fcab4a9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iecc4fcf7570e403c98d584e438978f0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE1LTktMS0xLTIwOTI1_49053554-172d-472f-8791-cd103ae5349c"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if8c928ba4d594c0d8a8bc43cc0eaff7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE3LTEtMS0xLTIwOTI1_ad4d7bef-785b-41b5-9435-3a9dc92476d4"
      unitRef="usd">-14000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i172575bb71684d5b977ed5b5efb382cf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE3LTMtMS0xLTIwOTI1_675ab81f-c0e1-431d-8140-a72edd0d9794"
      unitRef="usd">1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6be47c24890a4321b9eab67a24b8a937_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE3LTUtMS0xLTIwOTI1_b4e76efa-c194-4325-914c-a4774aadd48b"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie014908da8a24f6e98f6bd987c799a93_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE3LTctMS0xLTIwOTI1_b3d69325-542c-4ea1-920d-a22c1eee8519"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie250c2a689ff4ef885295f77abd96941_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90YWJsZTozNWM2YmQzYmNkNDk0ZWEyOTI5MjQzMjA1ODk1MGY5My90YWJsZXJhbmdlOjM1YzZiZDNiY2Q0OTRlYTI5MjkyNDMyMDU4OTUwZjkzXzE3LTktMS0xLTIwOTI1_11cf0b9f-5762-48f1-85af-299f694e7885"
      unitRef="usd">-14000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="i9c1e96cb7a8540ba9373cdf8a930af85_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3Xzc2OTY1ODE0MDQzMjk_2a21501e-4072-44f9-992b-0af37774b0dc"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3b20ad37382b4dbd949a4bd8cd17fa6c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3Xzc2OTY1ODE0MDUwOTI_ea192b7b-25e1-48a8-bdc4-d93451955c51"
      unitRef="usd">20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i823d173be3fb47b8a4246a64c03b0a01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3Xzc2OTY1ODE0MDU1MDM_d0079b5b-67c5-4b30-b7ec-e00391e11725"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i037da802480a40f1aceb3032d77fd42d_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIxMzQ_72087200-0da4-4681-a1c2-01811c0e9c37"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ifc7daa98ed14443ba924d16779e53a1b_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIxMzQ_74a92618-8b95-4a75-8a31-e744f9fec7e8"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i46b7967df9714e9abdb47bd55a82bb99_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIxMzQ_c50723ef-4d61-43df-b67d-07a5de2d1e94"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i256fbf2ceee847e3a69e9615a1382681_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIxMzQ_f3a1f697-14bc-4cc0-9c1b-d7640bd4c3c7"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i4c85169bb26d4f7487f2139697536c87_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIyNjk_4f0d2788-23fc-4f2b-8290-36be7580a41a"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i80051b14fe464495a4d017e6d935f7b4_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIyNjk_84aac8de-53df-496d-9389-fc6f6b154c37"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i75da353bc1d84ecf943ea64892e87557_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIyNjk_d9cd9963-62ae-439a-9272-8e1a0a3f4fcd"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i1a65b7fef56742dfa223a86fcbbc87ed_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzIyNjk_f4981d04-a9fc-40d5-820c-254e8b98d906"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i920aa1cda167443c8b0444671613bbf4_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI0MTE_2952aef2-fc0f-4039-889b-7ad2a3845215"
      unitRef="usdPerShare">0.53</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ieda553b13ff74c3c8adddf0770a90cb1_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI0MTE_707052ce-2caf-4196-86f8-b236fcd6f1da"
      unitRef="usdPerShare">0.53</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iea6463b11ecf4c00a41fca1508914f0f_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI0MTE_b431d16d-bbd5-4ec2-a1bd-68b242638d34"
      unitRef="usdPerShare">0.53</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i83a23412d4724363966c8ea6e44ab909_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI0MTE_cfea337a-6222-4407-bea9-22e419cb135b"
      unitRef="usdPerShare">0.53</us-gaap:CommonStockDividendsPerShareDeclared>
    <dgx:IncreaseDecreaseinCommonStockDividendsDeclaredasPercent
      contextRef="i2bc256f3969842e6a0da1ee27ff4d814_I20220203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA5NzQ_e2570722-b6aa-4088-95bd-86270431e7ee"
      unitRef="number">0.065</dgx:IncreaseDecreaseinCommonStockDividendsDeclaredasPercent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ifc7daa98ed14443ba924d16779e53a1b_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA5ODI_d71935e1-e290-43d0-8c11-d8b7506cb5b5"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iab2af8571ad549cc8ca5ad0958512f11_D20220203-20220203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA5Nzg_5afdf40f-b95a-4d29-8306-d7a84c8065a2"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i27c3f506bf6b40788ce7094bb62e2e2d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA5ODY_38dab282-b85b-4bef-bc8c-e945d4de2e34"
      unitRef="usdPerShare">2.64</us-gaap:CommonStockDividendsPerShareDeclared>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i2bbace4627094c78b2e45eaf382e646d_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzE2NDkyNjc0NDc4MzQ_7dfde363-ab36-45f4-bf84-f9269a98596b"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i23fa7d555abb409cb510e5e698113fc5_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzE2NDkyNjc0NDc4MzQ_e3bbc035-24c5-490e-8ea5-c34f56dfc926"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI4MzE_839f3060-e541-4e61-9b30-ef3b91a27afe"
      unitRef="usd">700000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i0f71fea2861045d2bc904b3d6d15ea55_D20220201-20220228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3Xzc2OTY1ODE0MDg0MjY_f4f12007-92d2-4f97-94ad-625cdaa62bf6"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMDQ_e0a8bbd6-9bed-4d8d-bd91-2d9a29282f4e"
      unitRef="shares">16000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0db211db68ce4f9ea4c4885932bee85a_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMTA_395839ad-b2b3-45b8-8458-add40a02fd8a"
      unitRef="usd">2200000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA2NDg_c9a80683-95a2-4f7a-9677-1d75d0b1ea01"
      unitRef="usd">23000000</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <dgx:AcceleratedShareRepurchasesPayment
      contextRef="i1dc63d78467b4990a09bb4edf33bc0d9_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzI3NDg3NzkwODIzNDc_4dcf407a-79f4-4a43-b7eb-e680a83a45a2"
      unitRef="usd">1500000000</dgx:AcceleratedShareRepurchasesPayment>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1dafd9b95c6842e2b8662b418c9af1b3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDA2OTg_49d5c665-eb87-46c8-b81d-1979884cc5f9"
      unitRef="shares">10700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMTY_5d842041-73db-42d4-a57d-e160f87f447c"
      unitRef="shares">2700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i121f4e383fce42bf856f42599ddd385c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMjE_3fb18a5b-c61d-4231-976b-3d376cd0a53b"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMjY_4bfabcab-ef18-4f5a-8050-e2cd2bbddce5"
      unitRef="shares">3500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic99adc4854d64a2dbb3bc25137041c4a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDAxMzE_2ec05886-eaa5-45e7-bfaa-547a5ccb2591"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzM2ODc_955fb5c8-c584-45ce-96e5-af9443bb13e9"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzM2OTg_64cfb8ca-6f2d-486f-ae9e-ed91644cf1d8"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzM3MTI_1dfe07e3-413c-4d64-a6e4-f6a29de182fa"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2MzU2MTQ_78bc1234-b047-46f1-ba7b-9d687d0c66b0"
      unitRef="shares">55000000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i10c8c1d0f30246589418e5588a96ce94_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzM5MjA_f45b24bc-9ce3-4a79-9bb5-1a2b831533c8"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDEwMDY_83cfed9c-e0e7-495f-b98b-848285267647"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjMvZnJhZzo1Mjc2MjAzZjZhZTU0NzZiYTZiNGYwNjU4OTg2ZGY0Ny90ZXh0cmVnaW9uOjUyNzYyMDNmNmFlNTQ3NmJhNmI0ZjA2NTg5ODZkZjQ3XzEwOTk1MTE2NDEwMTA_502d4c14-9f15-49da-9548-cc83984b33e7"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwOTA1_c68413e3-006f-4b41-8467-3cdcda00b56d">STOCK OWNERSHIP AND COMPENSATION PLANS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee and Non-employee Directors Stock Ownership Programs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;The ELTIP provides for three types of awards: (a) stock options, (b) stock appreciation rights and (c) stock awards.  The ELTIP provides for the grant to eligible employees of either non-qualified or incentive stock options, or both, to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Grants of stock appreciation rights allow eligible employees to receive a payment based on the appreciation of Company common stock in cash, shares of Company common stock or a combination thereof.  The stock appreciation rights are granted at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Stock options and stock appreciation rights granted under the ELTIP expire on the date designated by the Board of Directors but in no event more than ten years from date of grant.  No stock appreciation rights have been granted under the ELTIP.  Under the ELTIP, awards are subject to forfeiture if employment terminates prior to the end of the vesting period prescribed by the Board of Directors.  For all award types, the vesting period is generally over three years from the date of grant.  For performance share units, the actual amount of shares earned is based on the achievement of the performance goals specified in the awards.  The performance goals for awards granted for 2019 were based on the financial performance of the Company.  The performance goals for awards granted in 2020 and 2021 were based on the financial performance of the Company, as well as relative TSR.  The maximum number of shares of Company common stock in respect of which awards may be granted under the ELTIP is approximately 79 million shares.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The DLTIP provides for the grant to non-employee directors of non-qualified stock options to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  The DLTIP also permits awards of restricted stock and restricted stock units to non-employee directors.  Stock options granted under the DLTIP expire on the date designated by the Board of Directors but in no event more than ten years from date of grant.  For all award types, the vesting period is generally over three years from the date of grant, regardless of whether the award recipient remains a director of the Company.  The maximum number of shares that may be issued under the DLTIP is 2.4 million shares.  For the years ended December&#160;31, 2021, 2020 and 2019, grants under the DLTIP totaled 12 thousand shares, 14 thousand shares and 14 thousand shares, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  See Note 16 for further information regarding the Company's share repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The fair value of each stock option award granted was estimated on the date of grant using a Black-Scholes option-valuation model.  The expected volatility under the Black-Scholes option-valuation model was based on historical volatilities of the Company's common stock.  The dividend yield was based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the expected holding period of the related award.  The expected holding period was estimated using the historical stock option exercise behavior of employees. The Black-Scholes option-valuation model also incorporates the average market price of the Company's common stock at the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The weighted average assumptions used in valuing stock options granted in the periods presented were:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21.82&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$17.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected holding period, in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following summarizes the activity relative to stock option awards for 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.459%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Average Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited and canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company's closing common stock price on the last trading day of 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December&#160;31, 2021.  This amount changes based on the fair market value of the Company's common stock.  Total intrinsic value of options exercised in 2021, 2020 and 2019 was $83 million, $113 million and $62 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2021, there was $7 million of unrecognized stock-based compensation cost related to nonvested stock options which is expected to be recognized over a weighted average period of 1.6 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The fair value of restricted stock awards and restricted stock units is the average market price of the Company's common stock at the date of grant.  For performance share units with a goal based on the financial performance of the Company, the fair value is based on the average market price of the Company's common stock at the date of grant, adjusted for the present value of dividends expected to be paid on the Company's common stock during the vesting period.  For performance share units with a market-based relative TSR goal, the fair value is estimated on the date of grant using a Monte Carlo valuation model.  The expected volatility under the Monte Carlo valuation model is based on the historical volatility of the common stock of the Company and the common stock of the companies in the peer index.  The dividend yield is based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the performance period of the related award. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The weighted average assumptions used in valuing performance share units with a market-based relative TSR goal in the periods presented were:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.353%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$150.15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$144.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following summarizes the activity relative to stock awards, including restricted stock units and performance share units, for 2021, 2020 and 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center;text-indent:31.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares forfeited and canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2021, there was $27 million of unrecognized stock-based compensation cost related to nonvested stock awards, which is expected to be recognized over a weighted average period of 1.5 years.  Total fair value of shares vested was $59 million, $37 million and $40 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.  For performance share units with a goal based on financial performance of the Company, the amount of unrecognized stock-based compensation cost is subject to change based on changes, if any, to management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned at the end of the performance periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2021, 2020 and 2019, stock-based compensation expense totaled $79 million, $97 million and $56 million, respectively.  Income tax benefits recognized in the consolidated statements of operations related to stock-based compensation expense totaled $32 million, $39 million and $27 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively, which includes excess tax benefits associated with stock-based compensation arrangements of $19 million, $23 million and $13 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under the Company's ESPP, substantially all employees can elect to have up to 10% of their annual wages withheld to purchase Quest Diagnostics common stock.  The purchase price of the stock is 95% of the market price of the Company's common stock on the last business day of each calendar month.  Under the ESPP, the maximum number of shares of Quest Diagnostics common stock which may be purchased by eligible employees is 9 million.  Approximately 200 thousand shares, 225 thousand shares and 269 thousand shares of common stock were purchased by eligible employees in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Contribution Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company maintains qualified defined contribution plans covering substantially all of its employees.  The maximum Company matching contribution is 5% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions for certain qualified defined contribution plans; matching contributions were reinstated in the third quarter of 2020.  The Company's expense for contributions to its defined contribution plans aggregated $93 million, $64 million and $84 million for 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplemental Deferred Compensation Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has a supplemental deferred compensation plan that is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to 50% of their salary in excess of their defined contribution plan limits and for certain eligible employees, up to 95% of their variable incentive compensation.  The maximum Company matching contribution is 5% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions; matching contributions were reinstated in the third quarter of 2020.  The compensation deferred under this plan, together with Company matching amounts, are credited with earnings or losses measured by the mirrored rate of return on investments elected by plan participants.  Each plan participant is fully vested in all deferred compensation, Company match and earnings credited to their account.  The amounts accrued under the Company's deferred compensation plans were $77 million and $67 million as of December&#160;31, 2021 and 2020, respectively.  Although the Company is currently contributing all participant deferrals and matching amounts to a trust, the funds in this trust, totaling $77 million and $67 million as of December&#160;31, 2021 and 2020, respectively, are general assets of the Company and are subject to any claims of the Company's creditors. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company also offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  The Company matches employee contributions equal to 25%, up to a maximum of $5 thousand per plan year.  A participant's deferrals, together with Company matching credits, are &#x201c;invested&#x201d; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  Each participant is fully vested in their deferred compensation and vests in Company matching contributions over a period of four years at 25% per year.  This plan was amended effective January 1, 2018 so that future deferrals under the plan may only be made by participants who made deferrals under the plan in 2017.  The amounts accrued under this plan were $66 million and $59 million as of December&#160;31, 2021 and 2020, respectively.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  The cash surrender value of such life insurance policies was $57 million and $50 million as of December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;  For each of the years ended December&#160;31, 2021, 2020 and 2019, the Company's expense for matching contributions to these plans was not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans
      contextRef="i069088e9e79e44e78b230470438a9c05_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwMDE_7cc5f5ee-4a60-4266-a156-e55b875b2dbe">P10Y</dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEzMDE_ee4b9c25-345c-4572-8590-eb193b4c9213">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i34ff8916a5f444ccb368b1089fe044ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzE4NDY_6d8c6b0c-f3f9-4f06-be1b-60c7f8853d10"
      unitRef="shares">79000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans
      contextRef="i89212b0997f444118e64670ec656f232_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzIzMjg_d6f5f318-883f-43e8-94fb-c66f2f4e80d6">P10Y</dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i89212b0997f444118e64670ec656f232_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzI0MTA_1f60e838-e314-4bf1-bfc1-fde0e0dd0e2b">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i57198eacfa274bdda46d180bc4e3f05d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzI1ODI_4b9ca539-cbf8-44ef-a991-c4dacb4f690c"
      unitRef="shares">2400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i89212b0997f444118e64670ec656f232_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzI2NjA_962c0e36-7897-499a-88d7-6a012d74acfc"
      unitRef="shares">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iad5bf5052c604fa2982645d51ef2f9bf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzI2NzE_972d98dc-6734-4180-ae6c-8172a12f538a"
      unitRef="shares">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3b1d357b32ce4113917ff628a45e0a1b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzI2ODU_4e88e57e-714b-43b9-b2fa-3fa35953264a"
      unitRef="shares">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwOTEw_4764423f-643a-45f8-92f4-09e8d443411f">The weighted average assumptions used in valuing stock options granted in the periods presented were:  &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21.82&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$17.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected holding period, in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzItMS0xLTEtMjA5MjU_d7872b90-b386-485f-8dc1-efb75c7d05d0"
      unitRef="usdPerShare">21.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzItMy0xLTEtMjA5MjU_d3864095-3494-43aa-9637-a61c5ac07d5f"
      unitRef="usdPerShare">17.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzItNS0xLTEtMjA5MjU_37947643-20c3-4f8d-aebc-c6cbf322eb7e"
      unitRef="usdPerShare">14.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzMtMS0xLTEtMjA5MjU_445ab187-e4a3-4306-bc8e-29c04359456d"
      unitRef="number">0.256</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzMtMy0xLTEtMjA5MjU_71d4a51d-9237-4d9c-a13f-38a4a07cbf2f"
      unitRef="number">0.203</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzMtNS0xLTEtMjA5MjU_bbde0767-b69d-404f-aa78-a1232d00c3e5"
      unitRef="number">0.204</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzQtMS0xLTEtMjA5MjU_92dfe293-db50-4f0a-be5a-e4cfb0d7aa7a"
      unitRef="number">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzQtMy0xLTEtMjA5MjU_1e41c48a-e87f-4a90-8ed3-4762e028aee8"
      unitRef="number">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzQtNS0xLTEtMjA5MjU_00287948-2f4c-4de0-b9cd-5756a2ef45bd"
      unitRef="number">0.024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzUtMS0xLTEtMjA5MjU_8cf88af2-656c-4a7b-8e56-322615735fc6"
      unitRef="number">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzUtMy0xLTEtMjA5MjU_ef927958-d5c3-4fa0-aba4-1e8c1f1cdfa6"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzUtNS0xLTEtMjA5MjU_edafee37-8532-41bb-88b1-3800038b61be"
      unitRef="number">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzYtMS0xLTEtMjA5MjU_3274e9e6-92ac-42de-b2ab-8bcde29ff846">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzYtMy0xLTEtMjA5MjU_31ff67b3-f3f5-47c7-bb96-6198528084fc">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo2NTRmYTc4ZGM1ZjE0Nzg4YjBlYzgzNzZiYjM0NTViYi90YWJsZXJhbmdlOjY1NGZhNzhkYzVmMTQ3ODhiMGVjODM3NmJiMzQ1NWJiXzYtNS0xLTEtMjA5MjU_6961151b-0dcd-47be-8a81-9be4792d8a9b">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwODk2_b76a7ba4-4cc8-44b8-b23b-0e30f366a02b">The following summarizes the activity relative to stock option awards for 2021: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.459%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Average Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited and canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i30b7bc67e7bb4a52a97e03ff7b345782_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzItMS0xLTEtMjA5MjU_05d6706e-ecc7-47c5-adca-ef0d1a0295e8"
      unitRef="shares">6500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i30b7bc67e7bb4a52a97e03ff7b345782_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzItMy0xLTEtMjA5MjU_b430372e-fb82-47cb-812e-9d2fa8ec9139"
      unitRef="usdPerShare">90.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzMtMS0xLTEtMjA5MjU_01487205-e640-4426-9df2-7d8856e50327"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzMtMy0xLTEtMjA5MjU_8b799da6-3a1c-4732-aee4-d6f033dabd0d"
      unitRef="usdPerShare">122.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzQtMS0xLTEtMjA5MjU_4b4ad2d4-d2ad-4aa8-b1aa-552fcf639070"
      unitRef="shares">1500000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzQtMy0xLTEtMjA5MjU_cdc4f179-85ef-45d8-af6b-851e06c2195f"
      unitRef="usdPerShare">84.09</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzUtMS0xLTEtMjA5MjU_c3a6d78f-0041-4a9f-979a-6d6fd0629e78"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzUtMy0xLTEtMjA5MjU_01d11704-ef53-4acd-ab39-d3d1fa0ecc3d"
      unitRef="usdPerShare">107.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzYtMS0xLTEtMjA5MjU_c9918b72-2c40-4390-90b2-94197737e69a"
      unitRef="shares">5700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzYtMy0xLTEtMjA5MjU_5bb3795f-18f0-4dd2-9355-c46cba7b1ca7"
      unitRef="usdPerShare">96.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzYtNS0xLTEtMjA5MjU_4b52f567-7796-4c26-bc38-d0a882d53e7f">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzYtNy0xLTEtMjA5MjU_a3bd37ea-8d56-4006-86fc-42a6e1b676d9"
      unitRef="usd">433000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzgtMS0xLTEtMjA5MjU_8dc7597f-f981-4631-9c8d-ba7ad796f028"
      unitRef="shares">3700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzgtMy0xLTEtMjA5MjU_4fee40ee-e3aa-4c43-9c8e-0ad6f178fccd"
      unitRef="usdPerShare">89.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzgtNS0xLTEtMjA5MjU_493ec4be-b199-40cb-89c1-4d91fd5e3702">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzgtNy0xLTEtMjA5MjU_184eb798-700d-4b60-8f73-687f0c298e78"
      unitRef="usd">309000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzktMS0xLTEtMjA5MjU_17f4a8f1-a724-4ed2-baa5-aee92bedc04c"
      unitRef="shares">5600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzktMy0xLTEtMjA5MjU_c1746dc4-852e-4717-b196-b149e83a3070"
      unitRef="usdPerShare">96.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzktNS0xLTEtMjA5MjU_8ede43ff-3dc8-4139-a7b2-dee84454f617">P6Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTpiMGU2MzdmNzg0N2I0NjYxYWRjNDdiMjJiMTIyYWVmYS90YWJsZXJhbmdlOmIwZTYzN2Y3ODQ3YjQ2NjFhZGM0N2IyMmIxMjJhZWZhXzktNy0xLTEtMjA5MjU_8143ad9a-318e-4e1a-b7dd-79ae3bf59c28"
      unitRef="usd">430000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzQ0Mzk_780ee14c-134b-4e2a-a9c0-e226ca92c7e4"
      unitRef="usd">83000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ie07834d81a9d4a88aaf80835b2bb5156_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzQ0NDM_1e261d7e-1d01-42f4-9030-8563b39242e7"
      unitRef="usd">113000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i0edf8a3dee0e4be4a7970782a11e919b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzQ0NTA_1fd44ffa-fe98-489b-b136-8bcba1e79bcc"
      unitRef="usd">62000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i3da8fc0aa3404c2db542e20d7df2b6e6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzQ0OTI_3d0ff69f-f75c-4db4-8f64-444e949280a3"
      unitRef="usd">7000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzQ2NDU_d8b7e6ca-52ea-45d3-91ab-a09ca63aade9">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <dgx:ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwOTAx_f6a81011-03e0-433d-8104-09e8dc4c5964">The weighted average assumptions used in valuing performance share units with a market-based relative TSR goal in the periods presented were:  &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.353%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$150.15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$144.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic601ee56a8d64d41a238221625b7f525_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzAtMS0xLTEtMjA5MjU_5757a59c-daa6-4440-85e4-01ef4121fdd9"
      unitRef="usdPerShare">150.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i71d3304ab3de4fac88d8ba9dc1cdc015_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzItMy0xLTEtNDA4OTQ_b1f45dad-f627-4d9a-ad65-715494d3241b"
      unitRef="usdPerShare">144.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ic601ee56a8d64d41a238221625b7f525_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzEtMS0xLTEtMjA5MjU_e3a21929-d9fa-47e1-bd61-fa5a08235a37"
      unitRef="number">0.302</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i71d3304ab3de4fac88d8ba9dc1cdc015_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzMtMy0xLTEtNDA5MDE_5f9aef8e-0b3c-4c6b-8c74-af141e54afae"
      unitRef="number">0.201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic601ee56a8d64d41a238221625b7f525_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzItMS0xLTEtMjA5MjU_fd5007af-c0d3-4c82-a84b-1f8dc2ce3e95"
      unitRef="number">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i71d3304ab3de4fac88d8ba9dc1cdc015_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzQtMy0xLTEtNDA5MDg_fb0f0048-e0a8-43ef-a350-2c6428da8498"
      unitRef="number">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic601ee56a8d64d41a238221625b7f525_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzMtMS0xLTEtMjA5MjU_9fe772cd-14b1-4669-887f-6de2098e60a2"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i71d3304ab3de4fac88d8ba9dc1cdc015_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZToyYjRlZjAyYTg4ZjI0MTQ1ODkwNzE2N2E0MDZiOTBlZC90YWJsZXJhbmdlOjJiNGVmMDJhODhmMjQxNDU4OTA3MTY3YTQwNmI5MGVkXzUtMy0xLTEtNDA5MTU_d95d7172-d87a-49f1-aa81-22fccc4e7669"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwOTE3_3d0d2f49-4d52-4789-aeab-3e5b4c8d9295">The following summarizes the activity relative to stock awards, including restricted stock units and performance share units, for 2021, 2020 and 2019: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares forfeited and canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic50d104c1f2e4df4a4f6e3d9ae3c0287_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtMS0xLTEtMjA5MjU_15d31335-dc72-45d1-a867-b9e3f05b5439"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic50d104c1f2e4df4a4f6e3d9ae3c0287_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtMy0xLTEtMjA5MjU_d5ff7db4-bf6d-46dc-abea-25214ac98817"
      unitRef="usdPerShare">100.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iaeeaf4706c6e49b7a86e967f2bd3443a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtNS0xLTEtMjA5MjU_2ec54b9d-b274-4cf8-b034-0b345886aed6"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iaeeaf4706c6e49b7a86e967f2bd3443a_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtNy0xLTEtMjA5MjU_bf97757c-4763-4936-8dae-dc38925d915e"
      unitRef="usdPerShare">93.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i58ae2069c994411b8ad5cf3e9fd7f728_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtOS0xLTEtMjA5MjU_3ab985e0-c984-4272-a58f-e5043a3f4bc6"
      unitRef="shares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i58ae2069c994411b8ad5cf3e9fd7f728_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzMtMTEtMS0xLTIwOTI1_1c8d13f5-6219-43d6-abc9-78f03405ba40"
      unitRef="usdPerShare">88.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtMS0xLTEtMjA5MjU_3a79e0d0-65f4-4808-a69c-858174bbcbc4"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtMy0xLTEtMjA5MjU_157a6333-6808-4997-9e20-bdaf76fdd881"
      unitRef="usdPerShare">122.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtNS0xLTEtMjA5MjU_48876dca-a3b3-4107-b1bf-7852a291fccc"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtNy0xLTEtMjA5MjU_391a4739-4466-4864-9f11-976431c1ad43"
      unitRef="usdPerShare">112.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtOS0xLTEtMjA5MjU_1ea28192-efb4-4d2c-b2cf-d06d58772b12"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzQtMTEtMS0xLTIwOTI1_d6db2025-3c7d-42fe-a392-f34309ab90c2"
      unitRef="usdPerShare">86.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtMS0xLTEtMjA5MjU_a0c78e60-369f-48f1-a051-ae4d169348fc"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtMy0xLTEtMjA5MjU_29b55959-73e7-49ac-9cb5-a8db9f1f1e8e"
      unitRef="usdPerShare">103.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtNS0xLTEtMjA5MjU_a4041c9c-31bf-4dfd-8993-48ed86e4cc33"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtNy0xLTEtMjA5MjU_83e9a2c0-de6e-4b27-b4e8-2c2108278a4b"
      unitRef="usdPerShare">96.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtOS0xLTEtMjA5MjU_2f5a3012-6ad2-425c-ad75-4231cb73f4c5"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzUtMTEtMS0xLTIwOTI1_9ebb5326-3ad8-4a51-8ed9-9a71d2cd916b"
      unitRef="usdPerShare">75.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtMS0xLTEtMjA5MjU_91a7ac10-f1fa-4f31-a4f7-d4c1165736cb"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtMy0xLTEtMjA5MjU_1c6292ad-8130-4ad1-b096-8fe2fac277c3"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtNS0xLTEtMjA5MjU_7afe3109-ec72-4df6-af85-b05e156908d5"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtNy0xLTEtMjA5MjU_22626e30-1824-41ae-b3a3-e962590a6f0b"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtOS0xLTEtMjA5MjU_d5b84b39-4301-46c8-b432-78f31e9e9fc1"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzYtMTEtMS0xLTIwOTI1_8b2971e7-7b55-40ca-936b-eed9e5cbb80e"
      unitRef="usdPerShare">94.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i152aaa9d36b34e3496329cdd1df55d76_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtMS0xLTEtMjA5MjU_32b66fab-f16b-4828-807b-e6f22bb3e716"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i152aaa9d36b34e3496329cdd1df55d76_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtMy0xLTEtMjA5MjU_cc860f34-7af4-4eb8-87d5-7fa8d899f8d0"
      unitRef="usdPerShare">107.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic50d104c1f2e4df4a4f6e3d9ae3c0287_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtNS0xLTEtMjA5MjU_4cf1aef7-2e08-4426-b334-a48f378ee6f1"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic50d104c1f2e4df4a4f6e3d9ae3c0287_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtNy0xLTEtMjA5MjU_4c52f96c-75cf-4e3a-84c7-879d1fde8909"
      unitRef="usdPerShare">100.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iaeeaf4706c6e49b7a86e967f2bd3443a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtOS0xLTEtMjA5MjU_94f90088-8220-483e-9ff4-009b82c5ad80"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iaeeaf4706c6e49b7a86e967f2bd3443a_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90YWJsZTo0MTZiNjhkYmIyOGE0ZDBlYTA0ODU4ZDgxMzc2YWQwYy90YWJsZXJhbmdlOjQxNmI2OGRiYjI4YTRkMGVhMDQ4NThkODEzNzZhZDBjXzgtMTEtMS0xLTIwOTI1_f37215df-9664-4a91-90c4-ad16a728f643"
      unitRef="usdPerShare">93.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i152aaa9d36b34e3496329cdd1df55d76_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzYxMjM_8d2ddb70-9ac7-47af-acf5-a8bface2d158"
      unitRef="usd">27000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzYyNzY_ce8ffc15-d29f-47d5-aa72-6e4c06fd5f56">P1Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i736bcca082424f64bf26eff1b324c5c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzYzMjU_916466c4-542b-4e5d-ae39-1f2dd9a93e0d"
      unitRef="usd">59000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i5d8f1d62ecad4c2abc3374f530739b78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzYzMjk_6ce08163-bdf4-40da-a638-bffec5a172ce"
      unitRef="usd">37000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i990c0865fcfd44a28790f743293ae4b6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzYzMzY_254b1740-df6f-46fb-9de6-a9ac8a02f39b"
      unitRef="usd">40000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzY4NTI_dbeb1835-9e75-42e2-87e1-32c76013f8fc"
      unitRef="usd">79000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzY4NTY_0aec1745-1672-4f05-94b3-6f1ed44ad7cb"
      unitRef="usd">97000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzY4NjM_c97104de-ced3-4992-a4ad-0323f890f92c"
      unitRef="usd">56000000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcwMTA_0e5671d8-3d52-46a5-9f5e-c26773ccc4f7"
      unitRef="usd">32000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcwMTQ_53fc8062-4095-4f23-841d-db62d12a9463"
      unitRef="usd">39000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcwMjE_c1fc52e8-20cd-41fb-a3f4-f8be6faea593"
      unitRef="usd">27000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcxNjU_75ddc601-f0bb-4a29-b76b-d02b0da061c1"
      unitRef="usd">19000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcxNjk_5b19f0e3-f719-45e2-ac22-9171616d9fcb"
      unitRef="usd">23000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzcxNzY_d58605c2-c551-4271-818f-f81d60f8057c"
      unitRef="usd">13000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i186f5b12f07149329dc5f3bd351174d2_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzczNDA_9507f56a-e890-4259-915b-98a4a8cc8dc8"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <dgx:MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp
      contextRef="ifaf57f30a4d148c7832fab56a16d3c67_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzc0NTQ_bbaff4f3-3253-4078-b21a-df3b2c618f0d"
      unitRef="number">0.95</dgx:MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i186f5b12f07149329dc5f3bd351174d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzc2ODQ_f685f30b-35dc-4f50-be44-862e11c1689e"
      unitRef="shares">9000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ifaf57f30a4d148c7832fab56a16d3c67_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzc3MDM_33d9ba27-2c10-49e1-a8c2-73dc4852a4b8"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i133ed156b2ae4c0cb1ccbd97cc19199f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzc3MTQ_aff04e78-f340-48d7-bb92-3855fc863074"
      unitRef="shares">225000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if54829fa59064ad3adf7093c5e760b0e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzc3Mjg_26b9bef8-b1bb-4b25-92da-0e23f02245e7"
      unitRef="shares">269000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzgwMDc_ba964fc7-3e32-4ae3-b266-c92400ce2693"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzgzMjE_bb1f0104-3263-4f09-b9f6-03ecc4c4b4b2"
      unitRef="usd">93000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzgzMjU_1ac104f1-ccf5-4347-be9c-97f34335e61e"
      unitRef="usd">64000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzgzMzI_484d1a23-b868-46c4-b292-1c1cffdaf2c3"
      unitRef="usd">84000000</us-gaap:DefinedContributionPlanCostRecognized>
    <dgx:SupplementalDeferredCompensationPlanSalaryDeferral
      contextRef="i946d409692054dddb8d20bf8697e64db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzg1OTc_3f5e1f62-e613-49db-b4d3-356ababd7449"
      unitRef="number">0.50</dgx:SupplementalDeferredCompensationPlanSalaryDeferral>
    <dgx:SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral
      contextRef="i946d409692054dddb8d20bf8697e64db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzg3MTA_f4cf3ca2-6140-4497-affc-08e23d93bf97"
      unitRef="number">0.95</dgx:SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i33d716f8929d432d844c17e2ba676a0b_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzg4MDE_4061fe24-c10a-4c95-8391-14ec1e0a29c5"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="i8fc7b757284449cebf65a284bd73bd8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzkzODM_2a9faefe-057b-4107-afaa-370f1f277317"
      unitRef="usd">77000000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="i9e961edb5fcd410ea3ec16b2c6c74476_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzkzOTA_b4f4888d-2a6d-41ba-84b6-d7c1fb9addc6"
      unitRef="usd">67000000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP
      contextRef="i8fc7b757284449cebf65a284bd73bd8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzk1NjU_b5c79425-f119-4422-af6a-46430c0e4d2f"
      unitRef="usd">77000000</dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP>
    <dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP
      contextRef="i9e961edb5fcd410ea3ec16b2c6c74476_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzk1NzI_a59d3f13-231b-438e-8283-b4f227aa8979"
      unitRef="usd">67000000</dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i037161dc8162495a912293e3e9a40ec4_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzk4Nzc_625bc735-626a-4e43-9aa2-0a45ac3a9b9b"
      unitRef="number">0.25</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="i61c9407736c741d0ab822ef30250f2a8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzk5MDA_8c901af8-5000-45ad-94e7-5620b66f5d48"
      unitRef="usd">5000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="i037161dc8162495a912293e3e9a40ec4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwMjQy_44481283-2379-4883-946a-4d11fc55d8f6">P4Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <dgx:SdcpIiGradedVestingPercentage
      contextRef="i037161dc8162495a912293e3e9a40ec4_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwMjQ4_d5f89645-f41f-45a6-bd80-d37b13c91285"
      unitRef="number">0.25</dgx:SdcpIiGradedVestingPercentage>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="i8095617a570e4c32b5ffb3c1434f3dc7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwNDY4_fedbe7e1-c135-4eba-8ff5-a8753ede4777"
      unitRef="usd">66000000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="icb5c138d0e66484badc0c6cfaeb41e0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwNDc1_a5affdd4-f397-44f1-8607-72092d048f8b"
      unitRef="usd">59000000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i8095617a570e4c32b5ffb3c1434f3dc7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwNzI2_a030499f-1820-4354-85f3-f2c73b08fcf9"
      unitRef="usd">57000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="icb5c138d0e66484badc0c6cfaeb41e0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjYvZnJhZzplMjNkMmU0NmQ2OGM0MzUyYjA2NjNjZTA0ZDAyZmEyZS90ZXh0cmVnaW9uOmUyM2QyZTQ2ZDY4YzQzNTJiMDY2M2NlMDRkMDJmYTJlXzEwNzMz_f915f04b-0a47-4271-b54a-975a374dc296"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwNzkw_98badd20-b21e-4ba1-932b-748b174aeb6e">COMMITMENTS AND CONTINGENCIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letters of Credit and Contractual Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company can issue letters of credit under its Secured Receivables Credit Facility and Senior Unsecured Revolving Credit Facility (see Note 13).  In support of its risk management program, to ensure the Company&#x2019;s performance or payment to third parties, $70 million in letters of credit under the Secured Receivables Credit Facility were outstanding as of December&#160;31, 2021.  The letters of credit primarily represent collateral for current and future automobile liability and workers&#x2019; compensation loss payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has certain noncancelable commitments, primarily under take-or-pay arrangements, to purchase products or services from various suppliers, mainly for consulting and other service agreements, and standing orders to purchase reagents and other laboratory supplies.  As of December&#160;31, 2021, the approximate total future purchase commitments are $252 million, of which $53 million are expected to be incurred in 2022, $87 million are expected to be incurred in 2023 through 2024 and the balance thereafter. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Billing and Collection Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In September 2016, the Company entered into a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzExMzc_708f737c-5f7e-406e-a9c5-dbbc99a6dcd3"&gt;ten&lt;/span&gt;-year agreement with a third party to outsource its billing and  related operations for the majority of the Company&#x2019;s revenues.  Services under the agreement commenced during the fourth quarter of 2016.  The agreement includes an annual fee, which is subject to adjustment based on certain changes in the Company's requisition volume and the achievement of various performance metrics.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Lease Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases, including real estate leases that were entered into by certain predecessor companies of a subsidiary prior to the Company's acquisition of the subsidiary.  While over the course of many years, the title to certain properties and interest in the subject leases have been transferred to third parties and the subject leases have been amended several times by such third parties, the lessors have not formally released the subsidiary predecessor companies from their original obligations under the leases and therefore remain contingently liable in the event of default.  The remaining terms of the lease obligations and the Company's corresponding indemnifications range up to 26 years.  The lease payments under certain leases are subject to market value adjustments and contingent rental payments and therefore, the total contingent obligations under the leases cannot be precisely determined but are likely to total several hundred million dollars.  A claim against the Company would be made only upon the current lessee's default and, in certain cases, after a series of claims and corresponding defaults by third parties that precede the Company in the order of liability.  The Company also has certain indemnification rights from other parties to recover losses in the event of default on the lease obligations.  The Company believes that the likelihood of its performance under these contingent obligations is remote and no liability has been recorded for any potential payments under the contingent lease obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;401(k) Plan Lawsuit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#x2019;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;In re: Quest Diagnostics ERISA Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;AMCA Data Security Incident&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#x201c;AMCA&#x201d;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#x2019;s system between August 1, 2018 and March 30, 2019 (the &#x201c;AMCA Data Security Incident&#x201d;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#x2019;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#x2019;s nor the Company&#x2019;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#x2019; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, certain federal and state statutes, including the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of the government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of December&#160;31, 2021, the Company does not believe that material losses related to legal matters are probable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reserves for legal matters totaled $4 million and $1&#160;million as of December&#160;31, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reserves for General and Professional Liability Claims&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $159 million and $138 million as of December&#160;31, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i041613d64bbb4a13a8721a2ee2352a92_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzM0OQ_97c84d1d-5fbd-4987-9c8b-b1839615d368"
      unitRef="usd">70000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzkyNg_dc8d228e-7918-47d4-9273-7edcbdd656ae"
      unitRef="usd">252000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzkzOQ_b9c52d8e-ce17-4c75-90b9-912ea81dd0ad"
      unitRef="usd">53000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary>
    <dgx:UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzk3Nw_179be4ae-4c78-4d9f-b576-e16fa6dd2791"
      unitRef="usd">87000000</dgx:UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears>
    <dgx:RemainingTermsofContingentLeaseObligationsMaximum
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzIzMjI_01ad971a-2f2d-46dd-88cd-6f9300d6325c">P26Y</dgx:RemainingTermsofContingentLeaseObligationsMaximum>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwOTk1MTE2NDAxNTk_eb43b23e-4495-43dd-af05-9054ef9f3652"
      unitRef="claim">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwOTk1MTE2NDAxNjA_93d5dbf6-c1eb-46d0-935d-df80f48c0159"
      unitRef="claim">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LitigationReserve
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzk1MTY_d955bc2d-34bd-4e4b-aba9-bbef71494644"
      unitRef="usd">4000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwOTk1MTE2NDg3OTM_63f8458e-b687-46c5-a14b-54a69d7bfeab"
      unitRef="usd">1000000</us-gaap:LitigationReserve>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwNjE2_a4ed279b-4f5b-48f2-b891-c9703a71239c"
      unitRef="usd">159000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMjkvZnJhZzoxN2FmMWNiZmQ0NzU0OWU1YjM5YzhjMjk4YTM0ODFlMi90ZXh0cmVnaW9uOjE3YWYxY2JmZDQ3NTQ5ZTViMzljOGMyOThhMzQ4MWUyXzEwNjIz_cf625def-f4a1-40a9-81c8-e9fdf320813f"
      unitRef="usd">138000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90ZXh0cmVnaW9uOjQ1OTQzYTMwNDA5ZjQ1MDhhYzNmYzlhOWY2MTc0OGNlXzI0NTc_ff842dfd-a9e7-4ce5-bf82-81e672ac11a1">BUSINESS SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs, and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2021, substantially all of the Company&#x2019;s services were provided within the United States, and substantially all of the Company&#x2019;s assets were located within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table is a summary of segment information for the years ended December&#160;31, 2021, 2020 and 2019. Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangibles assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from continuing operations before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Depreciation and amortization expense for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Capital expenditures for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues by major service for the years ended December&#160;31, 2021, 2020 and 2019 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing and other services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i3a090f7f88f3481086c45baf1ec6dabd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90ZXh0cmVnaW9uOjQ1OTQzYTMwNDA5ZjQ1MDhhYzNmYzlhOWY2MTc0OGNlXzgwOA_1bba286c-e189-4c6c-8928-18cc793c40ef"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ice4e3139e0ba4820be8e5d8cf02f15fe_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90ZXh0cmVnaW9uOjQ1OTQzYTMwNDA5ZjQ1MDhhYzNmYzlhOWY2MTc0OGNlXzgwOA_b772228e-2d00-4882-bf30-053997a344d0"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="idb62d67015ba418c9bcc8c4ca149ca60_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90ZXh0cmVnaW9uOjQ1OTQzYTMwNDA5ZjQ1MDhhYzNmYzlhOWY2MTc0OGNlXzgwOA_fa70d45a-a659-4270-9351-c52fcc12d971"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90ZXh0cmVnaW9uOjQ1OTQzYTMwNDA5ZjQ1MDhhYzNmYzlhOWY2MTc0OGNlXzI0NDQ_b52ccd11-1928-40e5-8796-b1ff0febbc66">The following table is a summary of segment information for the years ended December&#160;31, 2021, 2020 and 2019. Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangibles assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from continuing operations before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Depreciation and amortization expense for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Capital expenditures for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues by major service for the years ended December&#160;31, 2021, 2020 and 2019 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing and other services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6815212460d4587af042592f64aaf60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzItMS0xLTEtMjA5MjU_1b91c3ba-e0b9-4f6a-a2e4-82b583e85d2e"
      unitRef="usd">10494000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id22f162e49514311adf2fd36a699bba9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzItMy0xLTEtMjA5MjU_348b57f9-84ef-4116-bc32-3d490a5d79de"
      unitRef="usd">9139000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzItNS0xLTEtMjA5MjU_1625ca59-a739-45be-8d2d-c56aa0231ff7"
      unitRef="usd">7405000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id980e16d89514f7aa100a29c06e97763_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzMtMS0xLTEtMjA5MjU_d33eb413-d6e7-4b27-87c0-8b1f59df1a47"
      unitRef="usd">294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i744ee99a69fd4003b8a54a40eb3c8813_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzMtMy0xLTEtMjA5MjU_53ffc58b-7e6d-45f6-b992-5924a4ca7a57"
      unitRef="usd">298000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if013d02c91354f9286988eda03c628e0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzMtNS0xLTEtMjA5MjU_5acbb4f9-4121-447f-929f-05f47593f287"
      unitRef="usd">321000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzQtMS0xLTEtMjA5MjU_b8eeed38-5f89-44be-8f2d-513a55631a98"
      unitRef="usd">10788000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzQtMy0xLTEtMjA5MjU_9101bf7a-36ff-425f-9086-efb6c8146171"
      unitRef="usd">9437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzQtNS0xLTEtMjA5MjU_bfc8a698-2e29-439e-85cf-a012c7a8407f"
      unitRef="usd">7726000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="id6815212460d4587af042592f64aaf60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzctMS0xLTEtMjA5MjU_cafc99f7-dd3c-4163-ad83-227e27f4d2a4"
      unitRef="usd">2646000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id22f162e49514311adf2fd36a699bba9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzctMy0xLTEtMjA5MjU_fc456cb0-41a1-4f6a-8737-c3c9d29f3e0a"
      unitRef="usd">2201000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzctNS0xLTEtMjA5MjU_a7054b1e-9748-4c36-959e-f93910ff93e2"
      unitRef="usd">1298000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id980e16d89514f7aa100a29c06e97763_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzgtMS0xLTEtMjA5MjU_067d3ae7-f29c-4696-96bd-47379cf82b88"
      unitRef="usd">29000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i744ee99a69fd4003b8a54a40eb3c8813_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzgtMy0xLTEtMjA5MjU_320402c1-7b45-4f74-ba3f-bf06c1ce9de0"
      unitRef="usd">39000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if013d02c91354f9286988eda03c628e0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzgtNS0xLTEtMjA5MjU_c6217f67-9bcf-4a7a-a662-d0e16a59b3c2"
      unitRef="usd">42000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6bb108bc797e4252abac7baa59a2e9d4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzktMS0xLTEtMjA5MjU_57f00678-1bcf-4f6a-807e-e3f01a51b84c"
      unitRef="usd">-294000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6cd1adca053c4d6580c37c9b0bff2f37_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzktMy0xLTEtMjA5MjU_0cc25b1b-152f-48f8-b868-f50269bffaa7"
      unitRef="usd">-269000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i73cec06921db4ba883aa7b2610ace433_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzktNS0xLTEtMjA5MjU_6bcd0f2e-a78a-4339-85c9-083164288be5"
      unitRef="usd">-109000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEwLTEtMS0xLTIwOTI1_37a33017-9aeb-4a60-9793-adfa3deeb619"
      unitRef="usd">2381000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEwLTMtMS0xLTIwOTI1_6e0d0f50-173c-4bb2-b769-d449bfe810ad"
      unitRef="usd">1971000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEwLTUtMS0xLTIwOTI1_9faaebb3-5447-4d38-a770-37db10415628"
      unitRef="usd">1231000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzExLTEtMS0xLTIwOTI1_9c3b09bd-3a7c-4ced-ad34-bce1442334ec"
      unitRef="usd">218000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzExLTMtMS0xLTIwOTI1_31bb6a8f-a79c-4aab-8772-5820fb650988"
      unitRef="usd">-87000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzExLTUtMS0xLTIwOTI1_fec60e26-8d73-4368-a127-8d0a17f47965"
      unitRef="usd">-155000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEyLTEtMS0xLTIwOTI1_66958641-b546-49c9-a51d-ba1af5faf2a5"
      unitRef="usd">2599000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEyLTMtMS0xLTIwOTI1_7574e637-c1aa-4884-ac2d-68d9ead65ba9"
      unitRef="usd">1884000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEyLTUtMS0xLTIwOTI1_76a07075-9ad5-4ae6-95d2-fd1e5009eaf5"
      unitRef="usd">1076000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEzLTEtMS0xLTIwOTI1_6b6adecc-b48f-48fe-90a8-ec9b01b991fa"
      unitRef="usd">597000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEzLTMtMS0xLTIwOTI1_8b0908a2-0366-4ba2-8c8d-5e9ee64c1512"
      unitRef="usd">460000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzEzLTUtMS0xLTIwOTI1_e6d5014b-1ddb-4b7a-bb74-c0bffdc7e8aa"
      unitRef="usd">247000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE0LTEtMS0xLTIwOTI1_14f94a7d-78f2-4681-b861-fae8284b4c11"
      unitRef="usd">78000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE0LTMtMS0xLTIwOTI1_547dacc5-0b6c-4361-906d-b3b33075e3ca"
      unitRef="usd">75000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE0LTUtMS0xLTIwOTI1_930c1114-9ebc-4e94-a9a2-850a67a0b8c6"
      unitRef="usd">57000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE1LTEtMS0xLTIwOTI1_0ded4108-2726-4e60-a141-ce5e7c2d6238"
      unitRef="usd">2080000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE1LTMtMS0xLTIwOTI1_dfabc4b0-b27f-48db-886b-630ed697a414"
      unitRef="usd">1499000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE1LTUtMS0xLTIwOTI1_5b782a79-e946-40d4-b7ce-44965d573eb7"
      unitRef="usd">886000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE2LTEtMS0xLTIwOTI1_f2588ba8-744b-4936-9ad2-8f07390a700b"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE2LTMtMS0xLTIwOTI1_250c12a9-d848-4672-bb22-2bbcc9a003c4"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE2LTUtMS0xLTIwOTI1_1416bd74-5b94-47ae-9d29-6a8f72ad2bd6"
      unitRef="usd">20000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE3LTEtMS0xLTIwOTI1_6674bd49-c4b0-410b-bfde-a25301e2859a"
      unitRef="usd">2080000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE3LTMtMS0xLTIwOTI1_db78103c-0c95-4f69-9f94-bbb293e50b99"
      unitRef="usd">1499000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE3LTUtMS0xLTIwOTI1_ab79e4e6-0a8a-4b79-be90-216b6f61c4f6"
      unitRef="usd">906000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE4LTEtMS0xLTIwOTI1_c5abae76-1eb3-472c-a7f9-267f3deb3c09"
      unitRef="usd">85000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE4LTMtMS0xLTIwOTI1_97d9a95c-2a8c-4d37-8925-05a8aac073f2"
      unitRef="usd">68000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE4LTUtMS0xLTIwOTI1_c3a1a0fb-280b-417c-b542-e9af5b0041ed"
      unitRef="usd">48000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE5LTEtMS0xLTIwOTI1_4c399235-ed45-41f8-b511-eeb8db66d178"
      unitRef="usd">1995000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE5LTMtMS0xLTIwOTI1_6c31afe0-f480-490a-a017-441163c5608d"
      unitRef="usd">1431000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZToxMDhmN2NmN2FmNmQ0NzUzYTAzYjRmYzk0YjUzOTIyOC90YWJsZXJhbmdlOjEwOGY3Y2Y3YWY2ZDQ3NTNhMDNiNGZjOTRiNTM5MjI4XzE5LTUtMS0xLTIwOTI1_3554eb6e-b8e5-47b8-873f-a83b28f6ed22"
      unitRef="usd">858000000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id6815212460d4587af042592f64aaf60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzItMS0xLTEtMjA5MjU_8740769e-0bd0-4bde-8137-1aac9b710c75"
      unitRef="usd">294000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id22f162e49514311adf2fd36a699bba9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzItMy0xLTEtMjA5MjU_79940b3a-ec10-48b1-85b5-b6047aa9e7c3"
      unitRef="usd">249000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzItNS0xLTEtMjA5MjU_639dcf4a-6a13-4786-9aed-253efc113f83"
      unitRef="usd">226000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id980e16d89514f7aa100a29c06e97763_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzMtMS0xLTEtMjA5MjU_61b5aa9e-95a0-41d4-ac4b-b05491849aff"
      unitRef="usd">10000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i744ee99a69fd4003b8a54a40eb3c8813_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzMtMy0xLTEtMjA5MjU_068c80d6-4f9a-49af-bd71-9399e4abe927"
      unitRef="usd">8000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if013d02c91354f9286988eda03c628e0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzMtNS0xLTEtMjA5MjU_36f234aa-cf8a-403a-b4eb-596b8e27c52b"
      unitRef="usd">6000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6bb108bc797e4252abac7baa59a2e9d4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzQtMS0xLTEtMjA5MjU_0906a2f0-facc-445f-9e2f-0d37beeff866"
      unitRef="usd">104000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6cd1adca053c4d6580c37c9b0bff2f37_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzQtMy0xLTEtMjA5MjU_8a5f8a24-708f-4466-8051-d12f84616316"
      unitRef="usd">104000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i73cec06921db4ba883aa7b2610ace433_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzQtNS0xLTEtMjA5MjU_d11234af-aed7-4343-868e-16083afc67fa"
      unitRef="usd">97000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzgtMS0xLTEtMjA5MjU_142d9af6-f176-4125-ba95-0fac0bc6acfb"
      unitRef="usd">408000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzgtMy0xLTEtMjA5MjU_d3d1e282-ce3d-4337-abf0-d68dc59108e1"
      unitRef="usd">361000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTowNGU5MmRhZDlkMWI0YWQxYThkYTc2MzA0ZjAzMjU2ZS90YWJsZXJhbmdlOjA0ZTkyZGFkOWQxYjRhZDFhOGRhNzYzMDRmMDMyNTZlXzgtNS0xLTEtMjA5MjU_c402d0bd-c337-4318-bb28-788a99832dea"
      unitRef="usd">329000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id6815212460d4587af042592f64aaf60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzItMS0xLTEtMjA5MjU_888b7b66-83ed-4d51-95d1-67546bef79bf"
      unitRef="usd">379000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id22f162e49514311adf2fd36a699bba9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzItMy0xLTEtMjA5MjU_b1f0af80-0fca-4a38-b3fe-498a483b7070"
      unitRef="usd">394000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i83535508818d4ed9b24c6c32a5dc5160_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzItNS0xLTEtMjA5MjU_6d26921b-5c13-4d6e-9c7a-73368022f5e0"
      unitRef="usd">373000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id980e16d89514f7aa100a29c06e97763_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzMtMS0xLTEtMjA5MjU_dc3df5f0-2861-4f72-a8a1-fc1be6a7f9fd"
      unitRef="usd">14000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i744ee99a69fd4003b8a54a40eb3c8813_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzMtMy0xLTEtMjA5MjU_ee821331-0f4d-455f-bf53-fce0b4f8c6ae"
      unitRef="usd">15000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if013d02c91354f9286988eda03c628e0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzMtNS0xLTEtMjA5MjU_b9732339-d7a6-4147-90e1-d0fc4fd738ee"
      unitRef="usd">20000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6bb108bc797e4252abac7baa59a2e9d4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzQtMS0xLTEtMjA5MjU_cce9d6cd-665f-4552-a1ef-91bc1b41df1c"
      unitRef="usd">10000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6cd1adca053c4d6580c37c9b0bff2f37_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzQtMy0xLTEtMjA5MjU_1d38e490-7b90-4d54-a775-a03acfb1474b"
      unitRef="usd">9000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i73cec06921db4ba883aa7b2610ace433_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzQtNS0xLTEtMjA5MjU_377f254b-3470-4cb5-89fc-a74e06080bd5"
      unitRef="usd">7000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzgtMS0xLTEtMjA5MjU_36a19f8a-5469-4080-b60a-651ad62f410c"
      unitRef="usd">403000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzgtMy0xLTEtMjA5MjU_4cf70a37-b54b-412c-abd7-fd4cfb84254f"
      unitRef="usd">418000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTozMmY4YThiYTRhMzk0NTUyYTIxN2YzZTA1OTZhMjMyNy90YWJsZXJhbmdlOjMyZjhhOGJhNGEzOTQ1NTJhMjE3ZjNlMDU5NmEyMzI3XzgtNS0xLTEtMjA5MjU_6c65e884-7bfa-417f-aa88-3588805d6401"
      unitRef="usd">400000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3764f252b9f84910a98e8576a15f1852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzItMS0xLTEtMjA5MjU_d78b400a-d4ff-4017-9aa4-447f2384a990"
      unitRef="usd">4293000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98112ec95e1d4aab9f4cde79cf53b385_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzItMy0xLTEtMjA5MjU_7ae308b8-d158-4f9e-8bc8-7aba90d5e435"
      unitRef="usd">3836000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc9427fc9d114228a3d3efa6bcb432e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzItNS0xLTEtMjA5MjU_f9baa7f3-71ed-4647-886c-c49697fa51db"
      unitRef="usd">4206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i208fa7e6f0334944b10d285de0b70711_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzMtMS0xLTEtMjA5MjU_aee3f4e9-c9ea-4495-a773-212690d9d14d"
      unitRef="usd">2770000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f08a738c5804d11b70644f0148c895c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzMtMy0xLTEtMjA5MjU_136af7ec-46f7-40a9-a7c8-8cc81edffc18"
      unitRef="usd">2723000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib527ecaf883c4b36bb71ff0a85b4d81a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzMtNS0xLTEtMjA5MjU_021f8a7a-5e26-4af9-b358-075f4a0436d3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i338f15fece2f4712847fd4e04333fc1d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzQtMS0xLTEtMjA5MjU_56b61550-ae53-4fcb-b76d-c98d03be3de4"
      unitRef="usd">2878000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i975831888a86459eb1bac2b48531332d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzQtMy0xLTEtMjA5MjU_45e735f9-01c4-4b48-91b0-b27ce4a77615"
      unitRef="usd">2098000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19a2acf57ffa4509ab771b661fcea999_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzQtNS0xLTEtMjA5MjU_e9a916c9-25db-4bd9-8004-7545d7f417ae"
      unitRef="usd">2620000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c039428d6d84b189717417daf0d8fe3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzUtMS0xLTEtMjA5MjU_28564203-8408-461d-84b2-ae5b0b09bb11"
      unitRef="usd">553000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a494abcac9c47fca32926023c31eae6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzUtMy0xLTEtMjA5MjU_7c3123fe-82e2-4f01-aad9-2fc79a5558bf"
      unitRef="usd">482000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f07a6ecd11b4fb5b1eaf5f119c9eb51_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzUtNS0xLTEtMjA5MjU_9ae3d459-30be-435e-bef0-06ef3cbf0239"
      unitRef="usd">579000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4766ba2728754ca5b737ca40088cd12b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzYtMS0xLTEtMjA5MjU_9e640221-1344-424e-a35f-d6549da9d7ef"
      unitRef="usd">294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5343cf8aa45f4acc956a10119ecd34d5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzYtMy0xLTEtMjA5MjU_bf8237a6-5841-4da2-9813-33510f017655"
      unitRef="usd">298000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5096412349bf441a965c02745c0985c1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzYtNS0xLTEtMjA5MjU_42667143-48db-429a-bb4f-4991f0f0d33e"
      unitRef="usd">321000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzctMS0xLTEtMjA5MjU_6caba892-353f-49d7-9b31-fe8e74d19e16"
      unitRef="usd">10788000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i462eab522eb649e1a4b46ade84e4f310_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzctMy0xLTEtMjA5MjU_438a0abc-79d9-4cbf-9589-6d71fe71f311"
      unitRef="usd">9437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40e7161d44294f15a49f8b3bf407ed2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzIvZnJhZzo0NTk0M2EzMDQwOWY0NTA4YWMzZmM5YTlmNjE3NDhjZS90YWJsZTo0ZTVlZWY5NWZlZGQ0M2JiYmI1MGNkZGI4NWRkMTdkMS90YWJsZXJhbmdlOjRlNWVlZjk1ZmVkZDQzYmJiYjUwY2RkYjg1ZGQxN2QxXzctNS0xLTEtMjA5MjU_ce19a8a7-24e7-4fcc-99db-326110898896"
      unitRef="usd">7726000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits
      contextRef="i3694f852a462494f91d7c0a3b1211df9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzgvZnJhZzpmYTQ4OTc4MmE2YjM0ZTNmOWE2NTVjM2ZkMzg0ZWNjZC90ZXh0cmVnaW9uOmZhNDg5NzgyYTZiMzRlM2Y5YTY1NWMzZmQzODRlY2NkXzE0Ng_d0815ab5-6340-4446-afc4-dfaf63172ea8"
      unitRef="usd">20000000</dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="i3694f852a462494f91d7c0a3b1211df9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMzgvZnJhZzpmYTQ4OTc4MmE2YjM0ZTNmOWE2NTVjM2ZkMzg0ZWNjZC90ZXh0cmVnaW9uOmZhNDg5NzgyYTZiMzRlM2Y5YTY1NWMzZmQzODRlY2NkXzM4Mw_2e8ca490-11d9-43e5-b5b4-24d6e1d5cd8f"
      unitRef="usd">28000000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDk2L2ZyYWc6ODM3Nzc0Y2FlNzA5NGExMDlhMTMxODE0M2FlNzRiZGIvdGV4dHJlZ2lvbjo4Mzc3NzRjYWU3MDk0YTEwOWExMzE4MTQzYWU3NGJkYl8yNzQ4Nzc5MDcyMjcx_8e19d342-6f63-4f88-ae65-f052563b412b">SUBSEQUENT EVENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisition of Pack Health, LLC&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On February 1, 2022, the Company acquired Pack Health, LLC ("Pack Health"), a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $105&#160;million with up to $20&#160;million of contingent consideration if certain revenue benchmarks are achieved. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preliminary purchase price allocation for the acquisition, which will be accounted for as a business combination, is not provided as the appraisal necessary to assess the fair values of assets acquired and liabilities assumed is not yet complete, but a significant portion of the purchase price is expected to be allocated to intangible assets and goodwill.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i6e7331c77972481e85855c53b18546a4_D20220201-20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDk2L2ZyYWc6ODM3Nzc0Y2FlNzA5NGExMDlhMTMxODE0M2FlNzRiZGIvdGV4dHJlZ2lvbjo4Mzc3NzRjYWU3MDk0YTEwOWExMzE4MTQzYWU3NGJkYl8yNzQ4Nzc5MDc0NzU4_6d865623-91e4-4eaa-bc6b-d87a3f2350db"
      unitRef="usd">105000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i8a6f1832ce5e4035a5b9b14f52d94a3f_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yMDk2L2ZyYWc6ODM3Nzc0Y2FlNzA5NGExMDlhMTMxODE0M2FlNzRiZGIvdGV4dHJlZ2lvbjo4Mzc3NzRjYWU3MDk0YTEwOWExMzE4MTQzYWU3NGJkYl8yNzQ4Nzc5MDc0Nzcy_3a05f946-2a57-4c2a-9415-4e6d0d9f195d"
      unitRef="usd">20000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i7dfddcac3e494696bd29405872d37f33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90ZXh0cmVnaW9uOmQ0MDdhM2Y4ZGQ2ZTRmMDc5YmZkZTVjZDA1YzhlYjBjXzIwMw_7c46584b-3ba0-4636-84cc-ab4ea68b2cd1">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II - VALUATION ACCOUNTS AND RESERVES&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Provision for Credit Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deductions&lt;br/&gt;and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;End of Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Doubtful accounts and allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)Primarily represents the write-off of accounts receivable, net of recoveries.</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="icbfee6ac293a4d0693346eada0d23f20_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzItMS0xLTEtMjA5MjU_b645aa5b-a29b-4fa7-918a-702a1a675ace"
      unitRef="usd">28000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i38a07547d99340ac959c9e338dbbd36c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzItMy0xLTEtMjA5MjU_18239910-2d36-43bc-a8e4-926d9d9f8508"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i38a07547d99340ac959c9e338dbbd36c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzItNS0xLTEtMjA5MjU_8a806109-4a9b-49b8-a120-e534d4418984"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2934d884c7734d478ccf8f3700348ced_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzItNy0xLTEtMjA5MjU_ae4bc8b5-e9ec-4643-aa08-3d4fec3c2755"
      unitRef="usd">31000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i66fc5387af244c48b34e4b6ff0662c58_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzUtMS0xLTEtMjA5MjU_8baf79b8-c8a4-424f-98ce-0425eaf7133c"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ib4c6d71b26c14be794b19fdcba867621_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzUtMy0xLTEtMjA5MjU_d9e6359f-07a9-46c0-8fcf-232862d8140d"
      unitRef="usd">19000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib4c6d71b26c14be794b19fdcba867621_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzUtNS0xLTEtMjA5MjU_5508dee3-26fe-419a-aa76-d5e2b6f753ec"
      unitRef="usd">6000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="icbfee6ac293a4d0693346eada0d23f20_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzUtNy0xLTEtMjA5MjU_950734e0-aca2-4205-ad84-b52fe6e4e3fd"
      unitRef="usd">28000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i33dd72fa523b4d1d80a0eabd16074f43_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzgtMS0xLTEtMjA5MjU_d579a410-2036-4966-8125-44e5f59ba66b"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="if6f1ed6fbd9646ca9077dc5312767b5f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzgtMy0xLTEtMjA5MjU_9d42dbbb-9cc2-4e51-b087-9b7860c78b19"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="if6f1ed6fbd9646ca9077dc5312767b5f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzgtNS0xLTEtMjA5MjU_ca6feb81-e67f-4156-a12c-1f25aabddf8a"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i66fc5387af244c48b34e4b6ff0662c58_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0MDAxY2Y4NzY4MjQ0Y2NhM2Y3NzJiZmMwOGY4NjViL3NlYzpiNDAwMWNmODc2ODI0NGNjYTNmNzcyYmZjMDhmODY1Yl8yNDQvZnJhZzpkNDA3YTNmOGRkNmU0ZjA3OWJmZGU1Y2QwNWM4ZWIwYy90YWJsZTpkZGM0MmQ3Y2FmMDU0NDE1OTczODUyYmZmNWJmNTViNC90YWJsZXJhbmdlOmRkYzQyZDdjYWYwNTQ0MTU5NzM4NTJiZmY1YmY1NWI0XzgtNy0xLTEtMjA5MjU_fd999ff2-8f61-406d-b997-19c717ca1f0c"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>107
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M?;>P;R.@"[#K>Z7,:> VZ%[;Y"]02P,$%     @ KH%<5&]K$/%_!@  #AH
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M"\4DP2533WQ]0^IZ+K1?Q)DTOVA=QSH6BDJI>%:+@2"C>?6/W^H^M 1N]X#
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M+.4$28Q4B)2:B<9([.L)0:=O-(Z5TCUA/->(90\;2;66APN*/$?./0TJ]()
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M9Q_:F;@6(/FCDV0FL=/=SK1-IFYWGV49VVQEX06<C_WU"\B1;+@BR;XDLGQ
MG'OAG@/6^8.0O]2&,8T>MV6E+GH;K7<?!P-5;-@V5Q_$CE7FFY60VUR;CW(]
M4#O)\J5KM"T')$F&@VW.J][EN;MW)R_/Q5Z7O&)W$JG]=IO+IVM6BH>+'NX]
MW_C.UQMM;PPNSW?YFLV9_KF[D^;3H.EER;>L4EQ42++51>\*?YS1B6W@$']R
M]J".KI&ELA#BE_WP>7G12^R(6,D*;;O(S;][-F5E:7LRX_CGT&FO>:9M>'S]
MW/LG1]Z06>2*347Y%U_JS45OW$-+MLKWI?XN'OY@!T*9[:\0I7)_T<,!F_10
ML5=:; ^-S0BVO*K_YX^'0!PUP,..!N30@/@-THX&]-" OK9!>FB0NLC45%P<
M9KG.+\^E>$#2HDUO]L(%T[4V]'EE\S[7TGS+33M].;W]-K_]\GEV]>-FAN8_
MS+^O-]]^S-'M)S2]FO^!/GVY_6N.^NCG?(;>_?8>_89XA;[RLC1)4^<#;89@
M.QH4A\==UX\C'8_#!'T5E=XH=%,MV?*T@X$9>T. /!.X)M$>9ZSX@"@^0R0A
M&!C0]/7-$Z#Y[-7-\23"AC;IH*X_VI6.7&W0RBQ&A592;)%9WS+7O%K7"X1K
MSM3'R'/2YCFI>T[:\9QOIJ+PJA!;!N6P;CMR;6WAN+\DR=A$Y_XXKB$(IY/)
M*6@6@B;)L,&<##UKAIY%0W2U_-LL"U-ZM$):F-I3B*K@)4-5P\G>MY\*&\V=
M%/?<S#6T>'IS.(?-F(;1<,Z8*;H%S^M25BU1OA52\W_=#2C"=7?#H[BDR=@+
M<(BA0^S%%\"0"1S?4<-E%.5R9^/ERKI1%51(MN0:E4(I!J[W4<C$XQ$BL#]-
M  B&68P;%N,7,K)BTHR]F1'Y8ST35$=&QL$0^MG(8Q)BQIG')(3@#&8R:9A,
MHDSF6A2_^E;;ELA0,8*OZGG&'NTUN( GP2A&7LBG(63BT9V%D*QC[>*DE9LD
MRN9W8T60&?R2JYU0W!$1*_2WX)5&]V91[R7(Z-#M27XH]J<:@/+*UBP*.25U
MI*$X2NJ+6QWHW=J04^\M/96;@F1XF2EG2HY^.D.[,C<,;6U@_^SYSM8OD"<.
M\^*3#"'4)QE"^J,NFJ2E2:(T;_6&R3-;6<&1D_"90^J/'0"-_:(&@6A'5<.M
MLN(7I'635VN3)3O_6ADPB3,Z8M-2\GS!RQ<E ;<2B^,:>U448F]5RD@#X_?Y
MHH1G=AI6%>R'+<3TT\RO/1#J* .G-%JYQ=GK:.SR)\NAUK>BD'M3D XU"':"
M63A/,Y]8B$DSXO,*0:,N6JUBX[AD?VYT@3740!:AQ/:)[X4 $ E8 )BN2=UJ
M-8Z+]0\FS:8@?RZCIH@RR91&9GHSI![R'<K7DC'GED!VH?(&W "%#XIJK)M3
M:JV X[B"NVK3L4"[BQ @XT']!##4USX(E'90:I4<QZ7\VVL]*4@ME&-":%!@
M 522!)4B1&&2=JPITHH[2=ZT>^'5O9F,K[?;I%5<$E?<Z[TR=Y29&(51T]I'
MU+/"+@,78_>-]/>8ARTEH(^4^E471OES'T)EXXY0MEI+XEIK7'C!V/(0R+>Z
M)1(JZ,B7BRD "KC%(*?,6ATF]/\S\_S2V<N&Z?"TB!N:O@R9 9!)QPZ$M :
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M120/SM_MC8G27N+67G=W3$QUM&P_4>I(W.KX)BT8,66N;]D&LC.,OF8:!2L
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M)%6L LC_W^:Y^'Y1O7J[?;_\Y']02P,$%     @ KH%<5+1SOT?8!   "PL
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M[SJ[D9<!@HUI^']U+7A(7GAVLN>%,WGAC.#FC0C*UZI3/__8VEW1XM.P&OY
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MF*]'KV7@39QOV$_ ]S]J<D"KX@WX3?8&7)M?;;,Z_J3;#;H#"#M \P$L9'#
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MCM0U,:^1;A+*Z6C1DR,YTY3:EZ&)B&NMZFY=LJA*.P'^LNPI\PZ\=AN<PB6
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M%]3K\^0%Q*"FKK@/9Z#)P(U5S0I/WV\9/08TY3&F\0EV,&GUDKN@7X3E:K5
M\V9!)T0]2J.0?=MP+P3]9J[QYV0/#OJ0K&$I9%G,Z Z@(LN \6X;".5QO@RI
MO.25,%RH-\*3Z8/^_)P04IB!Q41TR.)S5<7#]*T*>,9'^P7L(%7,PP])9S>S
M49FX01/E74YOC7SX_$G,ZDV._1U%AAT4E\.>E",4WX5=9V%]GUACU45:6A(.
M Z<K;[CEA+<L(NVG6)&5QN'HBV ))?I,K-QYB+!.6HU ;P3<2<(T2*.?_'(=
MJ"V*MDDG2):;YW\\;>)4#_%RDWXB#5.I]<_: 9*:EL<D/10ZQ0,A5AY4I*N6
M$:M(JWGQ&Q859%01)\^PG#H();C/ &LC? )<%Y=98)<L,@N5<Z6(C$UV]YA.
M(F?4EF+,O0^'9*%O5$Q"JXIZS)-&CFG&3+MUJ!E23@ZNH]BA>X!%@QH5=@Z2
M/LZ@S+'"57W!S8!\-)B9(G^R&N;G0V,?'3GSC?6M<+(:1CILJ\)ZG1@.V9Z=
M0]0=R$Q-SY/IOM*Y;'V2[9ZT&4^.L6K?T&ST0@MPWH+RCJ/S!PG%SH6MGP0*
M").0@[/$','[1B%P$4AD[YH64$E!$5M?OL\:.C#K1\R)[W Z.16.%YX& 0B"
M6DI-$;'<*=19PJ>BTT!8C&I56KQF_F&RTK@B3C7QMX%@ ^0@3\ZD!SEF+T*/
MF>2,$U*E]!DD'&,WBR1.;T?:6'B&:+P+<[1_-DC.BDJT<T)DP?!]\/$;4GQG
MJ/QH0Q^0 N-U@_T=R093%S#L*27TV\H7VI(C^\9U<5%-YP8(R)JL[W\(;E7Q
M&I\U*4M(]OI83JYPF-E/SL&W$ 7';.18T0VH!><<TVCHVTJKOIM8DEIC!FOR
M^(.T AV:(S@735#S2#%59+@2&0CDQSI 5U/# QGD\&"87*+6 85I[A5&%'%-
MGPYGL&2RT.+FM+O4>RGA"? .4I-I\2%V@+"O:FN[NAFV:,F,ET0*ZDJ9VN<,
M_;@13B"G9;T@/'&#5 $/$$YD%(A\,HOR$1'UR^ 4#LE)C#"RY.-GR;)-/&QP
M$D"C_8SM =- S :&2]H9N*$RGWPB,R!D62:>XB")YWT%EJ))PY"$44N+@I[>
ME,#U(X?I.V[A>)L.INT==9SP5] H9OI]" ?5H/+QIT3YFH:OH**XB!FDWD<T
M-[S;P;=<>(V\4ZR2CUDE'R-9CC.5/-51Z:;)+E[*B,0Y%^Q]F8ZM?#?]E++=
MJ53;WH, )S-NUD(?AJ2*DA TS,_J^#:;L$]U#AHLMERK^&I=/DOX8;3W!$L,
MJ1>T/6(%21:=GXNFP] 1^4(:JY)/?-"23_5E8Q4S[T^0=Z6P=]/7R+R%2:)W
MUL-<:**G?%=)S^UZ'.;4>D5)59RCFP4%BCD6"F6HK#."<I:E34- Z*749R1\
M-C;DIDQ8""])H)!OL]4=SRDF$SB4CL%^/%;&/I";C9*"24;B/AD(SD)/)CY\
M7CAVQ[7<DA."_%1MA9L9@+TQ9=RAI%YE)_0$S2*Z_\5 3@8);H4N>'[!<YM2
M*ZRQ[['8T%'YAGC#:R:^4()95-Q:UHT^U%"QFR79F(8M4\,M! O715$K,A9.
MFFZ/N7')53M[+4]0EK=.U"<UVMO4_=T\1/H[UR53W.@Y@N[E"-X)DI4:GWAU
M63+)QOB4GMP%EN]]-$L;!V. 2BF5NP"7Q/ ]0DB*F0<D'M]#DB>6.,;<<R7)
MF^AVX20&^"D$5T)L,Z@Q)65\01[?ZA7R3[QAN-9K.*$/2O"8IO2CMWM(XWO>
M946<H:&S?9=DTDG@,<T5;A/@YM&D6_+"-\.DCG2KDZ KPU+TNG@\!L&>=-SR
M@0WOJL3Y_>Q2@<D1#FZ.&^T;L#7/;D7ZE&$Y[<,Z1-]PZV\5P,Z]P85$H>7C
ME@N)CGP*(::*W_A[>P9->5@EX)86#H;95XN.U"QI3DA?]JT;%2D2+ADZZIY:
M@1N"F5\_BA/'MK(6*U%PE,YUI9%;$IHJ+YY7/<Y\XL@743#KH9/+L%#F;>]H
M8)A3DY1[NOM@V"F)ER;T"_"TT+7$<G\U;(7>I]*.7J3#JLGTR#'7EG3> 8GC
MKOX^!5^.&LQ[)C>'Q?;=KES+Y6,\^TKU\+6N&8%MCVIZV[>N3V[-2YK1L%JK
MI>TJ[)]MB[53E]S2<OKT:-]]5N'.D'S$E?B(6IK\31)TEKX)OX[ZF%.3'IH$
M_/A6UFW-+=;?V%E]MV$:7?7"H))JH\LQOU%L."""'1_\\*38@)V@@:L'S^+/
MN.6#TY/XP>"2F;UAR8 PZ%P_. 43*PLA<2:.2<E!E)<'CQ^'1W<J%&V)%'11
ME4DN3$(@I7G?CP#&8MJ#IT_WKI15#NYYI=G]C_ODZ6VG/?&JX1\%ZA;=21:Y
MLE^C;O)N"XJ3L_9;0+[()\=2V:T)2XPSKKB>0M(?M.I]A)7"$ "J=XGEXZ'^
MAMHG>O))^ GOF0Q:Y9/Q(I[0D^>&#M@*@DHLAVAV.SB3X_24) V+'T@>;G?P
MK3DE5B-=]'_2!G@7?, 7&(N/0@?G;SP,=CVY$'',6-]R,]04W]["ME'P2'S.
M?KA59K.^QE0U7)(O(VE!.N-?P>3G/E.#U\H<.T5M"XLNO<8AY<+CK^?"H<FX
MS4#$3LUPI'Q\2"Y*.<3GCP9TR-RO2769$^+T[/\"(5['UO\XN7"1--^G<D93
M,W<-"\S$1<]G;ZP,H!<R@,T#+/EDD!N.!@4OO0TW! X&L80),%_";N!-7FGN
M.9#-%BK<3FV3=,?,S_T<@UEOL\NC]SR??UWC=2^#[,EH7FQZM&@/2D)G6(H#
MTL]^N9;O DR)@WWQL9>OXE1>:*O">_4JNE0$<<S3)+&(YUL=*5]_A2U$,2O'
M(Z(09EKR4,FEO)4#LGXM%M  "RR_-@N\8=6&'@KC7$\7\]S!6#PT"Y+@KPJ0
MIJ(!'D)'/TIRRQ6,.Y?.;KE*^K^3MJYP@>12T^02&2])NP;+@NUKU,>*J5X<
MB[OPY/N(K$(30BFPQJ53<CE?$9%L$T9KID>A?/F<U&:\;-LE6XO6DGL.<)9\
M[VH8SB_K'I.4F.1Q0Q%DX7P!Y-OA57(S:GAGRT;]I4P9G&_"@9]LYJJ;HA%/
MFK'"C'/0O%IB=K,*%K-JO'MF FN#P;CA_-(05ZE_M#37NJ)Q)'YL,(@TJ=W\
MS2?3KXVFI^3Z=DL38&16',\IK64"Q0^C4]84 P*?T<4A$A05WR *ZL-'C0Q#
MN'Z ,!8&$"6X48U<W\J7M_'5%!=R44$. EZ8[>'+:8=Z)AL&)3G3,F9\J^9,
M>'+J:U]:3?*M>'&;'WM$1X#G8ES(XTA=*SR0-.#%VQ"PT]?*K*T83KX3%/BM
MJ_VE$.D%CI3Z:"F\'E\1*46 ,)2<26XZE#NH>OHA@WC12%1+U($G]=OTEHEX
MI43JTPQ[@C[E11:377'Q3QOO3W(T?F8M5:Y).0XUC3R1CJ/$VT*VRG6S4%/F
MYC]*ZHEW$+OR.<)6J49/+(_TS3MNQ2<(Z$XWC<=3X:[Y!%>D@&;I)^P5(N[E
MCQ3(75J3&RK,[,J@Z7*)_$2ARYVKT;85S<X7X6*&J;\)0.ILH6E*A]_)!E/^
MHHQ%RHAQ]N!V),9F <$A[9E=RC/NA4@W&A19[C.Z/R\^$TNS6;DI^!)"[)GA
M\-?GFY6_)Y7)M5_GW'VJ4;P0:<G-G.&NV\D+!6;?>$D!IVJ(*T)][3Z*)[9K
M2GNS)!9CS4K8"#U4."Q%ILGP/U^X[9+[V^4NZ*03?.(VMS$8&9]'^STOSLDA
MT=N@&F(S(X7BU&65FYS @Z%SQ+><#7DJR)*_T@8!"/=)I'^D@^>.,S9)13B)
M0H:<W*;NB/!U(L]PPF4GH&%U!K5A5L2.?O>,#6W:-25OU&E;A&T&G1%\APYY
M(V8I'63)K4 A<>$/SWX9G!S_?L%..5\WI[^OX"_W'B+D/HU=Y)H(9[O0G'2'
MMPTN$$J2%Z3).V#S!D/V$@-D#;6Q7.P[>68<9(J!CZC&5$]T5W!.X]^><+)U
M<BD^UXQOHN /M4*2[U'YW[$8Z!9,LQ$"^7N!,57M]U,4?4.%*"/CPG;!]B,T
M#TX+>KB+F4I_"3J_<04_1>_O6\ 8(%P51^ZROV[Q+\7UUR%K>&45N:SQ!K<-
M2)NA1-.<((POR[TWAS@P>C3X+DL*@3=,Z2DV$$C>J$@F_WZ-+[U)V0WL?;PG
M)-59Y&.D*QQE??6QYC9]M\OX*ITX@8&N\ #%AXS@HQ M1K8-)B'.Q.]Y.?U#
M'#.*9%-+'$+K.X/SW$:/P?'3N9LPQ!LI/&4B0]G)%:<_\ CVDZ-\:@-1DE!.
MW9FF'",E<1Q\LN,.]-R]"_;28L<F,PG/4J6?\.36_@&J;ZM.J=$.E'9\\#0I
M+#UX]&R0WGRVK\CT7N^*Y"_K7>*T+%VXN/>+3[9XJ>&@EO[P" 2L[_ 6N*2U
M(Z8N)]]_:3'UAGDF:C)L8)]$RSAY+I1V:: *AT_!LK44J6\E>ESUAAOF2&TX
M?[>P;X19].#,-KZW3I:G?)OV)7W.46AJK8NY$\GU+ OLT Q>[-0?&'R8_"W'
MC6Y7]!<K'4>L_&<=PZ>%_Z.8Y_RW(./C_!<U 8DKY,=:+^'5D_G3'PZX$<W_
MTMDM_67(A>TZNZ$?UUJ!N.(#\/W2PLGE%]P@_*G0G_\'4$L#!!0    ( *Z!
M7%0R!JC!$ P  + F   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;.U:
M;9/;MA'^*YAKW<8S\MU).I_MJ^T9^VPGUVD<CYV7Z73Z 2)!"3%), !YLOKK
M^^P"($$=I<1)FD\=>W02"2SVY=EG%R"?;HW]Z#9*M>)35=;NV<FF;9NKLS.7
M;50EW:EI5(T[A;&5;/'3KL]<8Y7,>5)5GBW.SR_/*JGKD^=/^=H[^_RIZ=I2
MU^J=%:ZK*FEW+U5IML].YB?QPGN]WK1TX>SYTT:NU0?5?M>\L_AUUDO)=:5J
MITTMK"J>G;R87[V\H/$\X'NMMB[Y+LB2E3$?Z<=-_NSDG!12I<I:DB#QYU9=
MJ[(D05#CIR#SI%^2)J;?H_0W;#ML64FGKDWY@\[;S;.3QR<B5X7LRO:]V7ZE
M@CT/25YF2L>?8NO'7CPZ$5GG6E.%R="@TK7_*S\%/R03'I\?F+ ($Q:LMU^(
MM7PE6_G\J35;86DTI-$7-I5G0SE=4U ^M!9W->:US]^__O[UV^]>B_>OK[_Y
M\NW-MS??O'UZUD(PW3[+@I"77LCB@)#Y0GQMZG;CQ.LZ5_E8P!DTZM5:1+5>
M+HY*?*6R4[&<S\3B?#$_(F_9F[ED><M#9JI;57=*%-94XAJZ6L !KFXWXIJ=
MK*SXUXN5X^O_/K+@1;_@!2]X\=O\>E0()>25:V2FGIT@XYRRM^ID2K)X=?-!
MO$4&6V^F$[H6[4;!TJJ1]>XO?WJ\F#_ZF^-QJ\YA&>>0$)GIZE;E KDMUDCI
M%EYH-[(63Q[>$Z:8%)&9VIE2YY(FUNF:)(5F[)2T3BA"@D <5;6"V!A+_CP7
MLL[Q9?Z$OTBK1&,U2$&7.RQ0X8?#9&@@Q09I)6Y-V56*+EA52LIC# 2?/,A-
M64HL:V7M).>Y.Q7?0HG4TIG8;G2VP1KF5N?0-(.C=29+T2K7ZGHMR+4ZPQU2
MQ\ (VU^:"8<%7:')JZT3C;),A74&?5:E7DO/+IAH56;6M?X/1O9.&>SJ&@PC
MXTK%,X)_HPI0+J.H?+'=**([!UIQ[!JK&F/A[?L"#N:[O;H;>:O$2O$$^-NJ
MW%L?@B9(-I@+(VDI65&\:6$*(CQAO>ZZ%>I3 YK$, -QB%VKVQ(1P$\8I>!O
MGSE9S)6U-5W#,%.?,B!FK3C\WL,CCU(,UKP\65$ .D;(!@-EMF%EG4K4U'56
M=KGB\1HV9%%=3LP.(9,EXD[>AZO\:/:>W$&K7-5:EN[^C,/1P#I80B% K""#
M_$L(P6TG<NU@#<%L197)^ZU7$?<5L@&$BP''3/"N=&T,)^Y"&HT/+B+U@]?<
ME=@H6;:;C,*J:]=97)R)M;E5MJY85[(#EGVM<LVCR!#_0^?DWK65%1D(""?C
M$W.!_\AOSA-<OWQDA1$+Y$;4IF47HX0+IX'@ LM!>*%K.)IL(=B:FJ1S"42.
M>$GMKN$\0E)HPPF+0!(BVRV!<I0KQ3C+4+AB9=X'9(A%2 C"50 (J=)G%@DA
M'9 G#)X]B8'=7 "P7)7D<A#)+>:F5O[8Y6OV/0F,"T4E8B+YL&)1X5J,DS:/
M^D5RB18@*0$'8]DO'I#[]E*R6<0J4PG?% B8L2-0,^+&G@4[MWQ]L"IE 71=
MK!]F R/(WIA9AU*(UD>>E3K3DXE"E&99&9G_"!Q5C(& HZRSED'H=412>2KP
MO!!S^E2\Z2R;F(J ;DQ)O2JS 5E!33:Q:7&GDCNB):\,)211J5,M.(JD^5 -
MF4=Y YK/+&:3&3$W4]R'>I9D_)7X:DC.FY"<XKW2U:JS3GFUF04GDIC7[ VH
MU=JTFBMDH=0#(/A!P+Z@KCKOREAJ4!%DHUL>BEQF'%KOM>^(T._,E]:2BUF;
MV6%-=$GT'; 20/Q7)TIB*@[SZ;A?Z$M7GA*:+Q@NBJ-J?YB-*4]S712H0OP[
MDL">D)BV$1_Y7C%JT_(U5*51&7(=57.FOM^>?KX(V\H=Z7@&>Q/W$]&FC#-V
M];@U.@0;C8'$D"4:!"F*KNZE#:4T] PJV(&<0U4D;])-7?N-&;O.Y]34.E0(
M0M;>HATQ'732+"#'3H[Z3@_(M:H1"-+&9$CO?N+RG*1?GHM<[MA18?U3\<XW
M5?DH<!O9QWL2HB0;L<<ROD)%"U-K %-J*$U$"[A.8Y^3[RL^HP&03FL.L2]W
MGA%+32Q!8FHC,C1(X#ETEQ]/Q4V13.2Q$C)+4 WL#>;-1E;U+0'B5B0=%?/=
M3QTA&GIO,17+?B3KU@8P=3X+[ZC-W(NJ:&;4@?&TT.1S\6+:+7=]6]U[W!/#
MP!LI)KT_)[N,U)*[G6K"OO"\2KJ?BG9V)<U)F)!)RI=F:H(JW^039=1Q2>2
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M%>^/\3]&;CA^LZA?T9!+VLAEM#L)<QM)A$JFB08O"8"@#":5YI:3KA,80?_
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M!?A\9(POWY""Y>\T+OX+4$L#!!0    ( *Z!7%1N.]A+>P0  *P)   9
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M',EPMT N8QE^D^@]%@*7$ %$H'76]O[9Y/2G@TU.*_;G]&KRT&"5)JFHO6#
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ME)P=_R$:OG)S$@[$%X,$%W>X0"/IVQE7S9U.M;2D03^B]+P$+C\\$<2&9@Y
M0TQB,8W$QW8ZX\C2-N/,+,XJIQJG11<CRO +RI"]\1U_BF@:XR]"Z-!7)('&
M27V9$PC^\#?ZT_$8TJ:C25T,BF-!ZPCWIIR@A%Q!%WR/2:>;)Z R^"[97/PA
M=[?QP0+'&A]I5=U"47D7AFAC1R)Q&)?XPIE,IYQ_<YFQXWDW-3RF^RXSK&0J
M@ QNC=,GDY99M"XIC!NN01T&65<6O!I,'N^U>E.T T<LWJQTLJ+&1%/J 9V
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M#D#O"Z7LR\(EZ/]HBW\!4$L#!!0    ( *Z!7%2K_UD)T00  +D+   9
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MR9JXK,G_+O=96-NY7;UF&?8]:DV-:HO>O^6"I@[KDSJP0QUP3\VOJ0A,@RR
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MN["788:-_=+U!D\LL"<&6F-T1^F_!I9*]-R8*!?L3N6A,LR&PIJ(*$:H@7"
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M1Q>_=398-AR6T)?#HKGZUX9RU%TE1"E<YV$4O%B3$79&4\S3-]'&RK 5>JU
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M"XOG^<,5W:C/K@\9F.F/\!T=U333\]6L1SCX/J$&=7/DI2L3&NBDD8EM_L3
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MTF,%LNQE [XOG8N[%W&PO[B=_P502P,$%     @ KH%<5!;1E-!E P  %0<
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M <%[< 3>95G:ONE,LR[\.8O_O%RZK@7&^:^)!1Z&!1[2 @^/+/"N-4UI=C7
MM:OBA6T<+%,IYLVF*IXK9^BK=ZUVNNGHFS%,3R_S<:.+,@#75;$RC8*%55TX
M@*E!HCI7P%;JOM)%!T\K/CFMK>JZ@ =,A\<',%UKZQJ +&_HT1=VNU,-_MS:
M?KTI#+Q5F18DK+ M /4_[QO=NHW9$4A@US]M:[J;XMH2?DW3:3AC=UX4EU5E
M\)RP[LV,EOCZO5^KUJAEK0/\>))[?__;]XO%Q;,_KEXY^G'^[!0>*_8;4VZR
MDVV4@QT?@D(*@0X<>0.(AK_*"KO6H'8KEKK1*^ B^%D6+ "RZ6B!I>TV3XM[
M\U-Z<V?WNBTZZS')YP)EQ7N'D^$GL'7X7W7%UL)VG%DW!N"KIJMA"[ 3>1$>
MP_7F3YZY0@,N[=:4Q4ZWI+^;4M-![BUX9;NLS9HY$)972V?;95%;YT:6W=D.
MT8F$ AKU-?"$3K>!$/P+@"?\L46-B)_#L33H7D$*4&O5VNU7@T>V 39-OR0R
ME4*0P!-X5!#?QBFR /!!JPM=&U"CQ%W  &4JAN=__]O\\<6SPW^O&H -J.NZ
MUBS[CCA#]@.PF+<#IP#4A#V^<Y']42PJVE4B61F_NW[I3 5,@X0'Q@+$V;;"
MEUS1:(0]NI'&-AYB*E_.[R5?(TH2T!C,>ZL$.X@N>/H(--[/"LTI;T@53N\4
MO(T+;'>V 9@(<K":+3]M;%V!0OBNT'_UC*O#;2U53?Q)INQ\0M\^"OKVT:0B
MO+,^G0;SLF\1"[C?;F/:JOBK5RU@!"&CZS/+E $BHM9X'OQT#QJQJ(#L^/!;
M4!Q@K(NKQH%6Z@%K+XU:-R#-I@0-=?+VZN7)Z0RPVB&R/X&J ('M5\"[O(/
M&S<@ !]%]]&J^.W=2=SJFAZJC"M!UGO #GRVLRTK$/@5'!IZ$7:$=,8'+5K&
M'MY*@'DCL+B8_P#[[D0W[BQP3%'JM@.?T'-LISX7#&2M&[*M?AO OK@.J$!:
MV];7NH(#?M"Z> LZ :"3WE7%JF]A?RUMIW?D%<(>CVQNBH$>!P9Z/$GY5\RL
M;W2WL160[1KH0D@=8Z)I4,G+R/S!+AU:D\K"QXWMO(J8%2#GT52) 5'$#9TB
MC9F8VR"K]P#-@ O4IDO=[;5N )'?$OT?_O#M*2LA!3OY#'K3.#W0IJNZ!S+I
M&6E,T:>:#6#OO#B(,&\9/VCI@PO%'.K0?L:#(ZRR5D"ZE6$-8@9HR0#REUJ/
M:[%<7;! >!RRUG3DG>Q:,#_@&,.#N+Y8-:W:!K;IX(#5G^!DR]G@ *WNA+.6
MI#\JLUH!2@D9_/+@5''?^)/ Q4>/G&9&BAQ!J<]'SG9,? ^.>8TQ"AWSCIC$
M0Z*S8%I\%'@*N.0:9 K^H=7:HMPH$%$"4IJV[+?(925]4 %W=)K-->U9M2WI
M'K5E>[M5-\2Z2TTD ,!HH*9$\4D0Q2>3\O.[(]*] ET)@9@>E<!I"(@X"%O)
M7@F!CSB72 OTEA"!>]-M$K8&",&'CP(&W^N=^!.(E]\;@[]]0*#1]?SE\O)=
M<#U;)! J7E#Q$/L2,4 1;M4GX$U_2!)2$)=^N_,*%S"O@!]+KZI1:Z,H;:,#
M#\Z;N#XUN+"F9D6#OT>%+U::M7%W]!U>!7G2R\THRKS?,+:=%CFKEPWHSSL(
MY^&7*MI4?HEPJUMC4?5?@L6#%;PA8F^0Y= [CM8E>)IBL.\#@WT_R1[O>9_%
M>^!;4(3'7(5I($,=!(#^&X_N/!K8M2?L,#'%GW)!!YA*A!W9(:A\1!P]95&V
MR'K4S&_Z,PLL2?;:6M!ZH$<JE&2GVVM3DJ6%D+N%YSDV,<"R/7AKWE<1:2 '
M!W%*;&[A1>!=5!"!$*J--#XM*!:";\,R&T4>/KT@"]YSWHH_. 7"OM5=9 BB
MY!N-2J7EJ(1_,;A/NV[5UK%3H';P^V<B->Q\?O'MK)C/V93-'WWKMQ[=[4R5
M-MF2$I?<@)J&Z @3$<5+"$VV2]VRH^_S"?3O!:W!W@W@ $D 04Q],\5O/P1^
M^V&:54CY ^8YM!CCM5L D#ZSUX8<(=+KP=-BAXZ]7I=_OD/\PL,[=4/!@T=)
MV;<MJ@)$3;&K>^%(YBW@LTJ#]"%)&4PBP/@&T/:% "!%XQ_.ED8R;[5"_5-1
M(JW"\Q/;@7-8J[U7<!BD-<I'&4+?S-YG.@D<27V-;LN(*GF9;/NHFFMUE-8J
M8(1E#C_H.U29XL$ZT-R:#"(YG]XY<,'-&K6,TXH97C%MPF*T%F+(>6\+?F_)
M)*#(LP%(F3E/9:2[(F3ZDU D#E;9:=2RQ;6J>TD_U;7=$WJ-8ZY"T2#Q-A3W
M;2W J<TGE$ @4D-FGJCED,"$=U0C+260A##5"/+W!KX//H*J$>7BULBY;#/Z
MXA!OE%B*_)E@R*74C!&(&&=F#3Y;RN+.\QSN!M&?I2KZQL<SN-#..A,3"LEJ
MML%DS"HPM7_P. I)H3OP0 $V ""]K#\KRE#@BYAW4Y^)E7HP>RT?/I<>76X:
M4)PU2%=KNB Q?O$I=36_B&GBB^E@R'NV[\ *?T!?>C0)/ WD8Z:H>W9+,2)U
M76O*D"Z ;TPGV@#=%,1[8YLS8/F5-ISUH-R2XZP9LFM3,37 P8-XVNP4*0*G
M0;$%0:-0'4PN4((C&\DD!L\MN.\H$"53P+"A[ E>> #82"**& ]U>WM&\8WX
MW<!)F(,H\[< V!; \LO %T"XLN=0&(A-AT& $]F>?^\QPDN2!X,H9G@*EOQC
MB)GYW.Z>"ABH=-%Q!YEH>C2,["O&/0-_]1T&!17'>2]-W>-;_W\/"2XWYGO6
ML&MD ?&_+:FZ-&U9(290?1^'E-C-8*/>W0XBS7B'1[R^7&4KL #97<SWI,E?
M85D2+W"Q**COT5D;^%"76_:.\/WWFGS]JG@%[J*] 8_N5]NLSS[J=HO>"^X=
M=O,.S'.(=5[]^O$J!CL(!!<<!?H6Y#H ?DD)<*#NK2N\3%>8H9^PUT .Y8[A
M"(.T&GUK5#(;<67[%M0_A!)JW6H)9NZ=7'YX[S 1!WH<7,\:-"L&L47Q*N<X
MX=.C^B:E6;"/JT1;51J41<M.3KKYY&$@C7$L%ZF$'7#1W;8T:0B2>N%\4H=_
M0 8[>TX6"!D&(KJCF=5;0*7QDGB&CAGXC"U<F<!GJ>>\AMHKS.^ >5@I\)S0
MD='>''K7D-A;$IZ<#CH*F1)JP GMFO 7\.P3-9L8;%:^UH+Y S9'2$':SWEQ
M"8OTY29/"2>1X-$=E%C3(>^!W3J,;].'Y<#1/P[;@?U"<.:C(S2H!29>@D\)
M" ,W0/LP31AFEKL0US'NXX B.!&8]0&&Q7B<$ J'I )COT5UGHI8$V((4CJP
M2BN+'3IK&4(%C>AC4RTA=^"4&\%4FFG+_3K9-J_%>P7=O76'8>(QM4B^L 06
M($3&I^&0L($.S"1IH3#:$='9&8)5N3'@>6^E0B(;#NNOK:K!1K$+CUO)7HY)
ME_2=_$ A"=/9#K,SN >NNL Q +?-\'E*OU.L 88,O9Q*?\9G=IK--SQ$A=.3
M\.#'#^]1+6*0P@E<P;QG_M=,\%&D<AZ-SOGE9YL=EQO)* UX)JP0LVO?88"&
M%>&07),U[D*9_,PI(\34%Z9(R*49\@')+(4]2W8P,<3X5\M07/48!=(@,&S$
M!Y'.4_%?*GQW8(BM:C_I3BB;<AHA_NL)/] PB9%819Z%-]?P7XV9KL -E'H\
M(**G&QXIU*$T!":U$RC!]QK9+9S#Y\'F3R:M\"):X<6DZ7R-1_J#CO2&+>?1
MRM0MD%(C#$<"90D/N!1GVV0!"'<DJNX&F;;1U##C@J):SJF8#MFZE"K"WA?Z
MI4& N-.1+]1PX,^Y*D-?4"D?D\ J9 *HZ*(P\0":#@/K6.T/"1GFL>@5-20-
MX)PYY#44JR9_$;G<D4\9\$%A"QBIC7C*4@? F)NA2S*&>C-4A>DH4#RV=_+]
M.?BQ$$)&])'5#?D7#N'_PAPE!K0@3;"S2(&#TEG@<X5%6*W/:E!A=0&:K%7@
MTMZP@N$"%HKX,6)R( 7JC-]'H92]!5 H895V)3BAN#!V\;'P_DJOS#'MZYW1
M#<16J&1)<9&?!EJ,GWN0/@<PJ/M'0#R%8,]VG)_F2I/TZ@GRI&Q581R :0[)
M",%G24+(0UL,H>&[SFP-^-KC;QZN]ZSXZP!$7#Z!9QKPSOM0./+;#6X:IG@8
M]#/"Q=96NCYC^E:1_B[F[]1!8PNQ#94NE^C#25?28,?^] ^>DE(0J'XA2F&-
M<EM8US8:#T9)JB/K]TW<P:02BQUW\P?32@Q6@[4D=US>C&JO:1"I]MI!,&6Y
MMP=+'$YS//7[^8?SHK(U,P IKE7?E-QU)@:W]#T5(]\<NHXKV;=49M/>#)-5
M!J4U+(:1!89IV:*7X^E-X#:;M"EA]BLY!Q.$=%8MCX#>R!_H8FV($Z,QEP[A
M9TR>'^3,?;-3+-@!SO3V8$TI#_I$RA;;.^',@U4/*P7O@Z_D@5$,1LF=V"B0
M=CZIO+\(0GEVG5 'DDK&K\'?Q5[A:TT-;%Z7C;4?P1Y^44:R(]+M1B+BZ1HH
MGS:/I>[Y@#HJX14Q$4K<VT-V&F0>99_\7F2H>YP6._4DF$FN[(N:!5Y/G*=8
M#U% ];N- 8RUJ.=J7\LG$PIV$$S[H $!Z_U+JB]8Q[9;K&%KW"?2FDDW@4?N
M@#^2FB3EH6+?4-+1Q^X!"I"DM+AZ16>D@K#9<D,>_)\'WZ0%#I:&#\@!I!X;
M)975+4C>FAL<Y$Q]TC""#1+D&L+Q2N4VU"1C]V1,;-_QSS$,\ V.3N<G23DJ
MQ^9W(_L,NS#<$^3IX)L/CQ0]HRL&'W-_[8!RH<MHHRN,)SK?7NB[2#*EDVFW
MI2Y53SJAX/83SE9DC3X.>*I9GZ'S1( 41O>3-B,V4<^GVYM?(.Z1!^@';-$"
MPW;4];TC+"*HCK!"\@[-,7HU]<U9#1;35-DYR0\":5F;ACS!+F2;13<27ZJ2
M>CV&/=323@3>&ZM.=DL@%IG$4VQ^G$^W+;ZPE#B-W2XO8 M L_<@FJ.HF@;W
M.K!4ZO,<=.X"I_SINU-"K[A%-HR;(3U5\FY(45#9QCO4V/X+U)@=T 2"J V8
M*L]4@0JSV.\;U824H<']X8AR-;;] _G;8=\_6VU;[&I5LF2,[X>6&-\2\KQP
M33L0R!1[E!>79E#1!P=42_%$["958DK;C)P;"XVBQP+#509KOM2 ?) $4S>Z
M38O0E0'PK>-YF18-Z9;TA924.W!NL#=C!Z80 U\VC"1"R4:-2RC._4#8H2J:
M7=;<;RQ1OJ:TZ[*G#P\VZ+M+D%98O:[Z4M,B@QRKQ?H<NGWHXCOO^J4Q*>Q^
MC>+J>_CBT6>QKM_A% ($.9@2$O:FG. (IM,#>ST].Z!1NM8,$8/=YUQE_L?&
MU#H[Q4:YS-15$*^Q8Z*Q+:AFED-[7ZPQR=L@'^''TE.;XR3H>#F/U.LQ>Y4N
M$CI%T(U)SN1,4VK?8$%DW&A5=YN2Q54Z=/"754]E'>"VJ7T*GP JV+ZDIK_2
M.RP--90" QT"*"(K2JT_\!A"JFQ)<B,Q#&C6FOUGZM4$_^E(*X\T\2PN9N.X
MC3OT+!$+8K>T)P74(8]G74J/[]*7-,)5HI*2$E .8XP1PTFPX$.*A=QAXX6
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M>N0E_\W$^#C_Z4F0@S7BO-8K>/7B_ E(7<M_S9%_Z>R._H+BTG:=W=*/&ZW
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MGM-^H^M[2MVPJO1W@XFRM%'X3]JF,]1N HU/E;+KAG.PN2P.?P%02P,$%
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MRSDVD-+P KR?:NU6-ZR@V9*>_PM02P,$%     @ KH%<5$RE$&QD!   50H
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M>\*FM!V0<;(R5N759(H@ET7Y+YZK/&Q-&/I[)H35A-#%70*Y**^$%>>G6FU
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M<R]S:&5E=#0U+GAM;+U76V_;-A3^*X17# G@VKI:4I8$R*U=@"7IXK1[&/9
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MSZ<.^W3*9FND!"(BS(A1UO(\5^O:D5BI4N;D.BC=\+-QF&Z!$T=2I(SH=IW
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MO:5;0]'T+H-S2,N<[30?!$YW<<OQ652@X/O"V7T)/45C04%G-$Y@TE'-<3L
MV(JC'Y5J\?!<*HY#%&V ;I1M!/=[3ZF7OHO'&W>/2NB%NV$9YL[QYAK2K_:7
MN*/F[O*XO;D!7G"]D#5]H\TAZHV2>,!T<ZMJ7JQ:N9O,3%E8[J9+7$2%I@WX
M?Z[(O<T+*>BOMH=_ U!+ P04    " "N@5Q4!O7T2!$(  #.+@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T-BYX;6R]6FUO&KD6_BL6NE?J2DF9\;Q!E40B
MT'21F@25=E>KU?U@P("U,V/6]D B[8^_GI=@AC$VD"[]T###.<?GS<]C&]]L
M*/N++S$6X"6)4W[;6@JQ^M1N\^D2)XA_I"N<RF_FE"5(R$>V:/,5PVA6*"5Q
M&SI.V$X025MW-\6[$;N[H9F(28I'#/ L21![O<<QW=RVW-;;BV]DL13YB_;=
MS0HM\!B+'ZL1DT_MK94927#*"4T!P_/;5L_]-(@*A4+B-X(W?.<SR$.94/I7
M_C"<W;:<W",<XZG(32#Y9XW[.(YS2]*/ORNCK>V8N>+NYS?K#T7P,I@)XKA/
MX]_)3"QO6YT6F.$YRF+QC6Y^Q55 06YO2F->_ \VI6SHM< TXX(FE;+T("%I
M^1>]5(G847 [!Q1@I0#W%8(#"EZEX!VKX%<*?I&9,I0B#P,DT-T-HQO <FEI
M+?]0)+/0EN&3-*_[6##Y+9%ZXF[\X_&Q]^T/\/P QL,O3\.'8;_W]!WT^OWG
M'T_?AT]?P.CYZ[ __#P&'P98(!+S7\ U^#$>@ __^>6F+:0/N:7VM!KOOAP/
M'AC/A>"1IF+)P>=TAF=U VWI_#8"^!;!/31:'.#I1^"Y5P ZT-4XU#]>W=&H
M#XY6=[N&:+QM/;S"GG? 7F\ZI5DJ2+H (QJ3*<$<_-F;<,'D#/F?80!_.X!?
M#. ?&F"VQDP0GH\PI5SH2EA:B H+.7"L[Z*.4_R[::]W4]L4]+2"@Z:@NR]8
MBR;81A,8TS4NX0K0.1B314KF9(I2 ;19_"IUP5#@A)OR&&Y'#HUY_/QW1L0K
M2+!8TAD@Z1IS(?%0<#!%C+WF0Z]1G&%=?L-F-GQ7F^"F9 #W)6ON1UOW(Z/[
M(\RFTEL)[7GN4DDP#*]QFF&N<]AL2SKTT7'^JYM[YRH.SE"LY:&SS4/':&F\
M1*Q( 2[KB1%+9>TXF#.:U,I*)$G-YR0F2.B3U#EVUF@$ ^VL:0H&D:GXW6W0
MW1.+C\H)PV473#%9HTFL;5RS64,?G*%8B\QU%)\Y1EO/*\Q0,?-).J4)!A]B
MRKF>J9Q&?J'7T4]$C:S;C;2R@THVW)6%GG':NCM\[1KC>Y+5*B/3AN0VAH9.
MU86-D)JRKM_MZD-JRG:=T!@15!%!8T3?&9KE]:IF(,?3C!&10_9"KEL!9:82
MPH9?P;Y;5;1-23U5:03=_036(U7<[GI'1:I"U,;D:=K'W#V*_%TS^P^3%2(L
M!S0PE<BW.."!W_"@D4ZKR,!MDOXA_Q7=N\$QK#M6/;(ADH"SG+YD;N-7N>87
MF,F%<@YA8"Z#/4S#U5B[,?CZWFD*PGW$K@>D5A&N>1G16\LE=>[KM=S#77,D
MG9[AB;"U2'BH1_<]UPA"H^=J >&:.5@!;8SEQ@NP?(=U3>?7F7Q G&.A=SUJ
MSMCN/JM5SC=%0V>_0G7O%>V[9M[?\_X*2%Z?2'(7KUJG.TU/?','*"YVS>3W
M+:\TRSVY1YQPTXY(D2!T+KPLAHJ@H)F@SNMHJ"$C;5/H!(T=#14103,15>"R
ML^C3>MKD!]_8E%#Q S3SPP#/,6-X)C=FR0JG'!5'(^(HUH!-UHCTTTHC&1J7
ME5#1"S33R[-88@9ZFLE?-ZCP'EYZ?P<5-$,S-!_%UGW8W*)9LJD0%EH0=B>;
MX!]P E H&(2=2^=7 1\T ]^[NKUK[_;Z^8O"3L^\@1@Q+-=(,_#Y)7=*!H[2
M&2A+T9?YSY=.9Y3$4_CIN1<NB:<0T/L9"%@9B8Y&0&_G],N"@,,QF&1<ON7&
M;"I$\OQ+9U.!EV=>K)YVQF(QUHT.[:W/51S8%$/+IMQ34.J9H?3L P>+74-2
M3E>LQZ90VCMV'6P]<*@LU0X<0E^_7]7)0D=_X*"1=6'7>,#J*8KPS"OEW2DI
M(>\+76.6%CO(%7K%S#A-%1=XW0M/4U\!OF\!_).FJ<68>_ (S*;H'IJF-L7
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M(IF/2!R@!0L310/T=?XDE8!*\&_'EH-BRX'><M"RY6WL\XBBM> 1\B&T+$[
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ME0L\Z5&'79, >VX'QW<CM^WQG0O0<X^&WLB5H>>A)_DN0,_%H=>ZZAZY\I-
M.KHG<X&++EZ4/;!D*H:?+AB)Y^0YSD_M!#)8PE*>EF8JK<(UV\ZYIOV,K"87
ML.KB6/THC."OI5GBQ9MA3 13Z8'J4< :S9959R1 U\6YB!HYIT%"GJDH6I5&
MRIMN#U]TE6=J<,"B5H5QM#@37ZS(0BCF2R)0Q;+T,",\%N3(OLK B%H_JK%
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M-1AO36S^(5_]'$WK)93?*!-GZ*T@G!M<G5_?P?WYS70$X]'Y9'HW&H^^?I]
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MI<7PK04+2Y,7(;7+D-J5(>5+O/)+#'I.I>G![1-?<'1V_+9:8?A*_AZC3GA
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MC[NT1TS1O!<#I].\.WW0CGK=_'%)'SQHO &]GVOMG@?>0?D)-?@/4$L#!!0
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M=',O<VAE970U-2YX;6R]6VUOVS@2_BM$L NT0!SKW7:1!DCL+*Z+ON22]NZ
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M:N-$>IJ?6:AK)+-\Y,[R=P1,7)(LA?"<[9J0C=5X(CHM:4TK8"P;$0QKT;B
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M6/=J5?>%TW7[[M ]Y9R6[<<53G/,A #\?4DIWWX1$^Q><+OX+U!+ P04
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MJE%],EM-WH"%P?\S/FA%^\STP0%(X1=HW0&',&]64GV+.FR2$XLM/+J$PE;
M>Q K$/IXT\^#'(0]WUI!PP9$I\[9- E.8/Z_(\*H_2SA"E,G3]0X4\,T:)3.
M9177B^<?7>;F)76/Q4JO=D1AJ=V"JZX^@T3Y."D[BF_L_;[@2K\6;'.M'W0@
MC('^ON1<O7;,DZ%Z(@[_ 5!+ P04    " "N@5Q4A+!# O$$  #W&@  &0
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M_NGHLHEW20Q=:UK71/@DDK#>A]S>M[<D2'N0'0Z;DFB/D]6@.D7KE,@]4'Y
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METK>H.L9*$RH'MVBU_D,75_=H"M$&'HBE.HZR8&K]*Z&ZR;E#I-BA^#,#GZ
MGCA3F40/+(7T6,#5X58Q!_N8)T&KX@R2.Q3Z'U#@!7Y#0-/+Z5X#?78QW8];
MW(15!4*K%YZK .AC*]&/\4(JH:_!SQ;-J-*,K&9T1O/K&@16A*T0->HHT=5M
MJERATK,JY@6Q'84FH]O#9#9@/.\8,SO%!'%488XL="H+G0O2<M^2C&ZEU&U-
MQCCG0I$_V+YG^+)(28JPE* :SW,AUSUT4\O)*:);R\@IHM><CU[EHM?JXI$I
M$" 5TB:*HE*"%X021:#11>^_+DX18<U%&^+(1;]RT6]U\44WLO8CV3_=,NC4
M F_ >'$M]";,F2,95\''K<'/,WV0;G49\L*#1)BE:(N%+@2% U^-]8A/[H@?
MU>[1M $3U.]:.Z8PYAXTA!S$RC96J6/;,%6\9ZO5JG>/;<NJK4]T3R]:\#^9
MXH/@"8L585*[7FI)[ZZGK[,HFFPQ47QMV\Z"*]W$[##3WR4@#$ _7W*N]A.S
M0?6E,_H+4$L#!!0    ( *Z!7%3DS<_6\P,  )L1   9    >&PO=V]R:W-H
M965T<R]S:&5E=#8X+GAM;+6876_C*!1 _PJRYJ&5NK6!V$ZK)-),V]&.U&JB
MR<[NPVH?2$(2--AD#6G:?[_@N"8=P*[2G9?$7_<>+IAC[-%>5#_DAE(%G@I>
MRG&T46I['<=RL:$%D9=B2TM]9B6J@BB]6ZUCN:TH6=9!!8]1DF1Q05@934;U
ML6DU&8F=XJRDTPK(75&0ZOD3Y6(_CF#T<N ;6V^4.1!/1ENRIC.JOF^GE=Z+
MVRQ+5M!2,E&"BJ[&T4=X?8.1":BO^)/1O3S:!J:4N1 _S,Z7Y3A*3(LHIPME
M4A#]]TAO*.<FDV['OTW2J&6:P./ME^R?Z^)U,7,BZ8W@?[&EVHRC8026=$5V
M7'T3^]]I4U!J\BT$E_4OV#?7)A%8[*0211.L6U"P\O!/GIJ.. J PT  :@+0
M6P-P$X#K0@\MJ\NZ)8I,1I78@\I<K;.9C;IOZFA=#2O-,,Y4I<\R':<F]W<?
M9W<S</9 U*YBZOD<G-U211B7Y^ W\'UV"\X^G(,/@)7@@7&N>UZ.8J7!)CQ>
M-)!/!P@*0&[IXA)@> %0@J G_.;MX<GK\%B7V]:,VII1G0\'\GW=THHH5JX!
MI_H.D!TI<9L2URD'@92Z9<C7+X>HO(XR,^IQ K.K4?SH00U:U* /A7VH0U1V
MC$JQ'Y6VJ+0/-?"A4A<%,S\J:U%9'RKUH3('-0P4E;>DO(^4^4BY0TH'?M*P
M)0T[27]LJ#;K2M'*QQNZG8@#M\95"[SJ!@I%^.&F!EORK&VKO+/URD'G,% K
M3*Q(DD[X/97R&GPI=;E4*J\D$H<;F@SPR%^P$SO5-%TG>"1\1X%8->5S1N:,
M,\5^GMY-4Z#;E$$::(OU"NP6RV=6DG)!^[4"K5?@:6)IPHX+"(V@%0L\S2S0
M54N(9<T"3U,+=-T2&A:K%GB:6Z KEQ#+R@6>9A?HT4N 9?4"W^,7Z H&Y0&D
M%0S\?PP#7<6DB1^.K&'0>PW3)'C]O U@K6%0MV%>9O6]J?H"W#=F>;X ,T44
M-7U@O'.XC.GNF0K)ZC7JWW=/RJQXYYR"NW)7U,L.4?[C;7IW([XJ/=@]5KMY
M7X[7W7.TF$*_0,!-TN.1P@&I("M+A#O]6]^=7459%:)>%7JUBSRKK#RP($%6
MAJA7AE[Q(L]"*PW,861UB'IUZ%4O<G4(S7+=2[-"1+U"],H7N4(<#@,P:T34
M;<20?9'KPC2P\D#6A:C'A9WZ1:X!819P$;8*Q-T*?*M_L;O4RK/ _,+6A+A;
M(/T"QNZZ:AAXSF%K&/PK#(-=PV3YSX,>'[TYF\\6#Z1:LU)JPDI')9>YGH'5
MX4O 84>);?TR/1=*OYK7FQM*EK0R%^CS*R'4RXYY/V^_QTS^ U!+ P04
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MZ7EEEY'^!D%A#/3]G'.UW1@'^5=-YQ]02P,$%     @ KH%<5-Z>#(K,!P
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MD='_7HJD5\M_13I+ZJH(@$H)."1P5/<NCT>OB .;8/13&/W/%P552"K*H5_
MT>GE<$1[N+C(7#.#%.S@_]AJ%_ :$IM:/=Y1KH@:TCJ9<M>A\&,\%Y*KQEVU
M#U$[8XOV;]B)L$]0D1@535!M-*K25AX9[A_LF::%!KF_\AR@'->A.N@ODJU[
M$L[(Q""'$V'<1'T#.)R!P[5"FT X#1TNH.O;S;8I<AE3(.N_[/F3H%K%0+9[
MS8X!:L85Z 2RR/6%D[#:Q>+L-FW[J'.4+:M9PQGYH'KL4]\]3O7WO]Z>COH:
MTKU@2SR0E/NEKE:;[X9&!'3!#S^MJKI*1FVHFMM^Z1-9K3A=$4G5!Z'DKCIU
M.+ CWK8\69&Q7BX+MF49XIZ1'JIFO;BODKE'#[&9V1<5:<_JF9@$9;R'JHG/
MB.24PNX7*K8_:**> 6-&=VCPFS!^LCJKS7;J5R?.. ]7<Y[1ET]596PD7Y66
MJ2_CC-%P-:-]IR)IQO1]H\[2:B 9[-1TW2J-+1Q\%'5-58HS.L/5=%8;V0E5
M&YL^:L<8&S!G+(>K6>YTS)^KXE_ 2'JL'5<Q8!L6Y*.RFC-ZQ-7T6-O'SU6W
M7=)S3364<1VN)IMG)E44C\QK@.SX6ZD44_$4UK>.&#M>D\>-T-&B2<FBKJG6
M,L[#U9QW< H(F%1!EZJ,'+8*W'^H^MX_..25^E?D.4/?QAG+X6J6>PDR"!&"
M^##BY.$Z3,CB'MA0[K+R3%0;15'!]9)R[QJKO96[Z/(I7X47AD+AV08RNL5)
M9]-+R7%X%7<T?X.N)M'58J8FNNF\)UR=9@1X=*E4MIL]E7P>71Y& \DVX77:
MG$G)_/!Q3<F"<KU O5\R)I.!-I!>X8[^!5!+ P04    " "N@5Q4\O&R[5,%
M  "&%0  &0   'AL+W=O<FMS:&5E=',O<VAE970W."YX;6S-6-]SFS@0_E=V
M/'U(9QR, /_J))YQ0GK-W,7QQ$W[T+D'&62;"2!7DN/D_OJ3@  &@=W+/?3%
M!O'M2M_N:G>EBSUE3WQ#B("7*(SY96<CQ/93K\>]#8DP-^B6Q/++BK(("_G*
MUCV^903[B5 4]BS3'/0B',2=R44R-F>3"[H381"3.0.^BR+,7J](2/>7'=1Y
M&W@(UANA!GJ3BRU>DP41C]LYDV^]7(L?1"3F 8V!D=5E9XH^N9:E!!+$MX#L
M>>D9%)4EI4_JY=:_[)AJ120DGE JL/Q[)M<D#)4FN8Z?F=)./J<2+#^_:?^<
MD)=DEIB3:QI^#WRQN>R,.N"3%=Z%XH'NOY",4%_I\VC(DU_89UBS ]Z."QIE
MPG(%41"G__@E,T1)  T:!*Q,P*H*. T"=B9@GRK@9 ).8IF42F('%PL\N6!T
M#TRAI3;UD!@SD9;T@UCY?2&8_!I(.3%9?+V__A/NO\]N'A9?;N<PG;EP?7\W
MOYDMIE]O[V<P_VLZ6\#95/DG$ 'A\$!"+(@/@L)"4.\)IGO,?/X1SEPB<!#*
MIW-X7+AP]N$C?( >\ UF4BZ(X3$.!.^6!NZ",)3NEV,?RJ\7/2&YJ17VO(S'
M5<K#:N"!++BCL=APN(E]XA\JZ$FCY):QWBQS9;5J=(EG@(VZ8)D6TBSH^G1Q
M4R/NGBR.QBUL[-S/=J+/;O*S,OFYVB$^7--(I@V.DXTW90S':R*WLH#E*Y1Q
M<_R:#"?^[<+-SUT@7N$VYH+MU <.]V)#&(@-CN%^*U)'SFC\3+@,D"Y\3W:=
MU#1])DQF$?A#SB5 !BJ!SSA@\ V'.P(_IDNI4F: OUN(.CE1)R'J-!%5(9D1
M\,I$R8MZ)KK02C4.$XTJ43Y/AM+FSV5GUR'CX2'$K4/Z@QQRP*6?<^FW<KF-
M)0," K_ DL1D%0B9:O/-Q_\#TW2^06F-ME5AJH%4C.'6(=90SW20,QVT>ZT4
M=F4N74G&(YR7;= %'-%=+'3\!C4?H*HGZQ#+KO#3:+'U_(8YO^'QJ,P294N0
MCW)UH]]O-\]VT5)^IZM4+8<?#S0,099?I;%M[XYS6N/C4<!!MB=<X-@/XG57
M.GT=Q+%\5!._$LQT;A_7 A)5O'X4X:8(9)8A!M*['9E%>35/H;16B:]:EK*Z
M9M8G-HU^9?UZE%/A< QU2*+4(Z!32*2!H.6 ZO.>:TCH8346QV"'-*R"AG4*
M#=DLKTB@DJB,,?!P[,FNLX&750L;L\KI*,3-(%4^3;%5E'1D__)V(9)2RT;)
M-+;ME.,0MQ5R2*8HV\CY_5+:_]F@H**JH_:R?E*:@_W;VG"VMB2'@*_6ME)K
M>U9KTSHYG7Y4=H\IXZU:Z36XL6U4BZ$&-1H93041%14?G5#R\\QX(ETXDZ<$
M7Y8=S#ALI6N3H\1'K172Z<=E*UB6,1Q5K:#!(<MP:G:HXT8#PQHUV*'H#-"1
MUJ"<7-_C]6&=AVD;3FU_UW'C@6$/JG3KL&'?Z#?1+3H7-'I'$GX/_]'Q7'T4
MXF:0 ^LXACENH%UT-NC76YM2KGX/[[%FMP\-9U EK\/5LX*KP1UDA</#=-$(
M6>V-T&/,B$?7<?"/)-EX=/$HU_;UF?*#KKWAR&$5;8W5WM:<OJ2Z>V3N":BV
M9S@R*4K]/8 HN:YHNZ@H&ANKO;'Y2@4.RUE21A4_UK-E.@_.J]6SD@9C5X^]
M&HQC5ES3*UU0182MDXL^+DTKCW'IC4P^FE\F3I,KM,KX%?KDIE>"A9KTAO(.
M,UE!.81D)56:QE"6+99>^J4O@FZ3:[ E%8)&R>.&8)\P!9#?5Y2*MQ<U07[U
M.OD74$L#!!0    ( *Z!7%1I@ =(T@,  ,<+   9    >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;,U6VV[;.!#]E8'0Q:9 &]UL)RYL XZ=18,VCA"E[4.Q
M#[1$6T0D44M2<?SW.Z1D64YL)8]]L4EJYO#,A3,SVG#Q*!-*%3QG:2['5J)4
M\<6V9930C,AS7M <OZRXR(C"K5C;LA"4Q$8I2VW/<09V1EAN34;F+!"3$2]5
MRG(:")!EEA&QO:(IWXPMU]H=W+-UHO2!/1D59$U#JGX4@<"=W:#$+*.Y9#P'
M05=C:^I^F;N^5C 2/QG=R-8:M"E+SA_UYB8>6XYF1%,:*0U!\.^)SFB::B3D
M\5\-:C5W:L7V>H?^CS$>C5D226<\_<5BE8RM2PMBNB)EJN[YYBNM#>IKO(BG
MTOS"II9U+(A*J7A6*R.#C.75/WFN'=%2< <G%+Q:P7NIT#NAX-<*_GL5>K5"
MSWBF,L7X84X4F8P$WX#0THBF%\:91AO-9[F.>Z@$?F6HIR;AP]WL&]S]6ES?
MAU]O I@NYC"[NPVN%^'TX>9N <'WZ2*$L^NL2/F64@@5CQXA*$64H+LA2 D&
M+X]A3E<('<.,YTJP96FBJK_*CW VIXJP%%>?X4<XA[,/'T$F1% )+(>'A)<2
M(>0G^*#WMRQ-45F.;(4&:IIV5!MS51GCG3#&]> 6KT\D7.<QC0\!;/1,XQYO
MYYXKKQ-Q3J-S\-U/X#F>>X30[/WJSA'U^;O5W6&'-7X3;-_@^:>"K7W^63\3
M':<,:X<D)DY3(4B^IOB>%2RWT)8+R-8<3S=$Q/#[.T+"C:*9_+>#4*\AU#.$
M>B<(:1(DW_XM@3YK-A2PDD'42B$)B@-34K]EDU_MCU#H_#J6)]6U%^9:7?J>
M)D-_9#^U(_=:9- [%)F_%KG<BQP8W&\,[G<:?$N>659F':X;-$B#/R.6%PVA
MBT[3I@@=FP"9F&*14E$"!1417HDM!/@*Z*Z*'(3X6 "[[^J?.\Y?'9PO&\Z7
MG3A=5:T#?MC #_^,&+G.OMP[G18'!_'(JG3$ IZ7!%L/'DML0"JA:6R>(J[@
M.@R"H[6X^R;7>2-(;JM'N6^\&O&((U A6&1H[U),FJ@Q*4MT'%% (&8RXB6Z
MK\1<?(-^]YW#MW+,]?;TO4ZH19DMD0P2KYL>><)N2)9I5>Z(CO11AA7LH%W%
M',<Y7H'<?1-P_4XZ846BJ),]UAE(4[9FFM#NA<K:@R>]Y[_BYK6H527VF)#7
M?U%DCPD-AB^,M%L33D;%VDR*$DRLJV[>G#;3Z-3,8"_.K_24:B:G/4PUXF*2
MK1GVFY2N$-(YO\!*+JJIL=HH7I@Y:LD53F5FF>"D3846P.\KSM5NHR]H9O?)
M_U!+ P04    " "N@5Q4^ZZI9W $  #^$0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970X,"YX;6S56-MNVS@0_96!T05:H(TNOB6%8\"Q4]38)C'B=/M0[ ,M
MC2VBE*@E*3L!]N-W*"N2G<BR'Q8%\F*+TLSA&<YPCJC!1JI?.D(T\!B+1%^V
M(F/2SXZC@PACIL]DB@D]64H5,T-#M7)TJI"%N5,L'-]U>T[,>-(:#O)[,S4<
MR,P(GN!,@<[BF*FG*Q1R<]GR6L\W[ODJ,O:&,QRD;(5S--_3F:*14Z*$/,9$
M<YF PN5E:^1]'OL=ZY!;_,5QHW>NP8:RD/*7'4S#RY9K&:' P%@(1G]K'*,0
M%HEX_%. MLHYK>/N]3/ZESQX"F;!-(ZE^,%#$UVVSEL0XI)EPMS+S5<L NI:
MO$ *G?_"IK!U6Q!DVLBX<"8&,4^V_^RQ6(@=!Z]WP,$O'/R7#IT##NW"H9T'
MNF66AS5AA@T'2FY 66M"LQ?YVN3>% U/;!KG1M%33GYF.'^X&_\)=S]NK^_G
M7Z<S&-U.8'QW,[N^G8\>IG>W,/LVNIW#^WF6I@(I?X8)F. 2E<(0QC*F>M(L
MS\A,L$1_@/<3-(P+NOH$W^<3>/_N [P#GL!#)#/-DE /'$/,[?Q.4+"\VK+T
M#[#T?+B1B8DT7"<AAOL #H5<QNT_QWWE-R).,#B#MO<1?-?W:@B-3W=W&^BT
MRS2T<[S. ;P;]LCC+&Y ZI1(G1RI?9!976Y&2K%DE>>/"LQ$,$U"ON9AQL1'
MN'X,1!;R9 7SB"G\9+=%"#/V9,TU4,I@)K51:+C:0EQA@DM.SWY^H^EA:C#6
M?S>0[Y;DNXW+,")TRB\$Q)TE3U3H)H@@1178PELAR"5@G KYA$A&B5%\D=D
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MQY//X[A_X.*'W (H]#..$CEH;)7:W7J>#+<04WG#=Y#H)VLN8JIT4VP\N1-
M5Q841Q[Q_<"+*4L:P[Z]]RB&?9ZJB"7P*)!,XYB*EWN(^&'0P(WCC2>VV2IS
MPQOV=W0#"U!?=X]"M[R"9<5B2"3C"1*P'C3N\.V$^ 9@>WQC<) GU\A,9<GY
M#].8K@8-WRB""$)E**C^V<,(HL@P:1W_Y*2-8DP#/+T^LG^VD]>365()(QY]
M9RNU'32Z#;2"-4TC]<0/?T(^H;;A"WDD[7]TR/JVVPT4IE+Q. =K!3%+LE_Z
M,S?B!(#K "0'D#, P36 9@YHG@."&D K![3>.D([!]BI>]G<K7%CJNBP+_@!
M"=-;LYD+Z[Y%:[]88@IEH81^RC1.#4</L]GT>3:9/R_0W7R,1@_SY^G\C\E\
M-)TLT-48%&61_-3WE![,0+PP)[[/B$D-,48SGJBM1)-D!:L*_.@5/'$0>'J6
MQ53)<:KWQ,FX@-T-:OK7B/@XJ!+DAH\AU'!LX 1_78S1U6]5MHS?SN+G+&%$
M65Q!-7%3/83J%4&_V-0L*J)I:9NU"I<*31.I1*H#0:&_ON@.:*H@EG\[Z%L%
M?<O2MVKH'U,1;O7*1GP9L0TU:5'U+C*2CB4Q8;<?DK8./_/7]_85X[>+\=OO
M'=\Z2*I49%3!B8IVTR4B*$0$_TM$$ZFMX.EF:QJM*D7!A2_=CDM1IU#4<2JZ
MVP@ ^[X51WI#D5Q+!+1DD>ZY0319(1TUQWA?ITE8\^;NW>-@'[T %=)12=U"
M<M=)]01F(S3J%(A8(KY&$?QJJKPV6<GBM&IYC=ST)'A5::]0VG-2S?5^:1>Y
M1&L6P0I=L01%]"!3IN0G]"^J2X!Q[Z( 2?5[QGX9^+Y3S!>F<G?T1B]![$%6
MIK-_46FMLT++)%9TQ*Z*Q"=;$W8J74"T_ITE,A4TT;7H5(LOC,+M7K5>?*FW
MV74J)J5BXO86E*Y%4XDC 2NF'+6#RSS&'Q+(N$QD[([D3+5=0*&5;0- Z36O
M%]<UHC%/$U7I^F5*YV%4YV29TM@=TPL(4ZT%/4$(;$^7$<C<4_29ABQBZL4U
M]S*(<? AYI:YBMV!EXM>YZ)12'?Z\EQ]MM_G5*=^!K[;T#(LL3O.WF"H#J+W
M%'"9?KCW$1Z3,M*(.]+>XS&IC:L+C[V3S^H8Q,:>9Z3>!_5RR#X[B[O%F>G.
MGA3.[H_P[3@[^90TV4%L1L5&)YS>N-::TK_IZ%4ALK--UE!\9S_>EUSIHX"]
MW.KS( C303]?<ZZ.#3- <<(<_@=02P,$%     @ KH%<5/FU+[F/!P  =B<
M !D   !X;"]W;W)K<VAE971S+W-H965T.#(N>&ULO5IM;]LX$OXKA+$'I$!3
M2R1E2442((FR>P8V:2]N]SX<[H,B,[:PDNB5Z*0][(]?ZB6F30X9)=?-E\26
MGQGJX9#S#$<Z>>3U[\V:,8&^E475G$[60FP^3J=-MF9EVGS@&U;)7^YY7:9"
M?JU7TV93LW39&97%%'O>;%JF>34Y.^FN?:[/3OA6%'G%/M>HV99E6G^_8 5_
M/)WXDZ<+M_EJ+=H+T[.33;IB"R:^;C[7\MMTYV69EZQJ<EZAFMV?3L[]CTE
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MID(?TQHE0#MQ1F<Z&0"%/?VT :#\_;UY2$;I!G$7Z"\^/Q&@%VC&!P!1(SP
MR-:V)DJ9R!AE&GM^(J:ND%!O;$(@G7(">B(P&ZH4BHY5*+7>FCZQN;(D55I%
MWT"KJ-(J^B.TB@)=*V.-@2!=JP"05:NHTBHZYH Q)@-0X/B@+R\ 8Z0R $.Q
MA<;>4SSW">/%>Y^:/2I?/S !&",H0#O,PD7)+QWST&WLMJ=0QTHG F#TYCB
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MI1V\B#>J^+TR'U<V'=G,H479M68%7S?S==$*P-C[.#NM*K'Y(/A"ELPE_^R
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MH %#DJ39!P_VHWB[3\7=[UN3GU!+ P04    " "N@5Q4EXJ[',     3 @
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M^165/)XF61J6I'EIKC32=*/9L+K99=E4'@MRKTC6QQ^C'7](]_D_4$L#!!0
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MR[GU=OGK\FOGY(:ZXASN*X;GOU!+ P04    " "N@5Q4B6[,?BL"  "[,
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M<',O87!P+GAM;%!+ 0(4 Q0    ( *Z!7%1#@IQZ[0   "L"   1
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M965T,BYX;6Q02P$"% ,4    " "N@5Q4;VL0\7\&   .&@  &
M    @(&:$   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
MKH%<5 I-0Z&M @  + <  !@              ("!3Q<  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( *Z!7%1*Z2J#E 8  *@>   8
M          " @3(:  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    " "N@5Q4D0<EU](#   E#   &               @('\(   >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ KH%<5'$EK.JT!P  Q"$
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( *Z!7%1 V/GM200  %D+   9
M      " @>QI  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ KH%<5)%713S5"0  LR$  !D              ("!;&X  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "N@5Q4;CO82WL$  "L"0
M&0              @(%X>   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( *Z!7%0P6C3$:@L  !,D   9              " @2I]  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ KH%<5'73P6^Z
M"P  ]R   !D              ("!RX@  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    " "N@5Q4"SZ+JUX$  !R"@  &0
M@(&\E   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( *Z!
M7%3^H6MU4P,  -T&   9              " @5&9  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ KH%<5*O_60G1!   N0L  !D
M         ("!VYP  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    " "N@5Q4LJ[T!>P"  !:!@  &0              @('CH0  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( *Z!7%2:=(XPR@D  '\;
M   9              " @0:E  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ KH%<5'A&6Y;V!P  #B4  !D              ("!!Z\
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "N@5Q46$1,
M3! %  "R#   &0              @($TMP  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( *Z!7%0E#>(@4@H  !(?   9
M  " @7N\  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
MKH%<5&SVMS_<#P  PC8  !D              ("!!,<  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    " "N@5Q4J+#!,TD/  !6*   &0
M            @($7UP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( *Z!7%3Q];*/R0<  $84   9              " @9?F  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ KH%<5)L"4ER.!
MQ D  !D              ("!E^X  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    " "N@5Q4%M&4T&4#   5!P  &0              @(%<
M\P  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( *Z!7%2E
M=DHNU (   P&   9              " @?CV  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ KH%<5+UB^\CH(0  7W,  !D
M     ("! _H  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *Z!7%1,I1!L9 0  %4*   9              "
M@7HO 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ KH%<
M5%L9MCT, P  / 8  !D              ("!%30! 'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    " "N@5Q4&I8LNU<$   \"@  &0
M        @(%8-P$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( *Z!7%1:#=@2]P(  $P&   9              " @>8[ 0!X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ KH%<5(/UO,2[ P  30D
M !D              ("!%#\! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    " "N@5Q4PLG/[TL%  #I#P  &0              @($&0P$
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( *Z!7%0@AVWJ
M#00  (L)   9              " @8A( 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ KH%<5.,NV6F9 P  * D  !D
M ("!S$P! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " "N
M@5Q4)"&4U14%  !2#0  &0              @(&<4 $ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( *Z!7%1OXM\R^@4  .8.   9
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M970T.2YX;6Q02P$"% ,4    " "N@5Q4SV3$;O<#   I#@  &0
M    @(&I>@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M *Z!7%3M2L C:@4  .,=   9              " @==^ 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ KH%<5%R\VIJ) @  C08  !D
M             ("!>(0! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    " "N@5Q40:/A1N #  !.#0  &0              @($XAP$ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( *Z!7%3:*][\*@,
M  0(   9              " @4^+ 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ KH%<5 L>Z'C0"@  [#8  !D              ("!
ML(X! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " "N@5Q4
M8::A'K,%  "9&   &0              @(&WF0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    ( *Z!7%3/*FOI2P0  %T1   9
M      " @:&? 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ KH%<5,KS'&*]!@  X20  !D              ("!(Z0! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " "N@5Q4YNW8FC\#   N"@
M&0              @($7JP$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    ( *Z!7%2$L$,"\00  /<:   9              " @8VN 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ KH%<5#)DU22#
M P  Y@T  !D              ("!M;,! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    " "N@5Q44 J.%$4#  !D#   &0
M@(%OMP$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( *Z!
M7%3B)-Y+50,  (8,   9              " @>NZ 0!X;"]W;W)K<VAE971S
M+W-H965T-C,N>&UL4$L! A0#%     @ KH%<5/6&N"]# P  M0H  !D
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M=#8X+GAM;%!+ 0(4 Q0    ( *Z!7%0D]LEF30(  #@'   9
M  " @8'/ 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @
MKH%<5*7[D*,M @  F 0  !D              ("!!=(! 'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6Q02P$"% ,4    " "N@5Q4P3E]"%<"  !.!0  &0
M            @(%IU $ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4
M Q0    ( *Z!7%2DY19!_@(  .$(   9              " @??6 0!X;"]W
M;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ KH%<5-Z>#(K,!P
MERH  !D              ("!+-H! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX
M;6Q02P$"% ,4    " "N@5Q46/ <Q34&  !$(0  &0              @($O
MX@$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( *Z!7%0#
MRV9HG0,  !8,   9              " @9OH 0!X;"]W;W)K<VAE971S+W-H
M965T-S4N>&UL4$L! A0#%     @ KH%<5"2& H($!   A0X  !D
M     ("!;^P! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *Z!7%0Q?8O=_P,  &T.   9              "
M@5L$ @!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ KH%<
M5/FU+[F/!P  =B<  !D              ("!D0@" 'AL+W=O<FMS:&5E=',O
M<VAE970X,BYX;6Q02P$"% ,4    " "N@5Q4374[>YL"  "+!0  &0
M        @(%7$ ( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0
M   ( *Z!7%2?C583DP(  $H'   9              " @2D3 @!X;"]W;W)K
M<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ KH%<5#M7(^[O @  5P@
M !D              ("!\Q4" 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q0
M2P$"% ,4    " "N@5Q4A-,P\RD#  #L$@  #0              @ $9&0(
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *Z!7%27BKL<P    !,"   +
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4!08     70!= ((9   H*0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>361</ContextCount>
  <ElementCount>610</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>104</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2105103 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2108104 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2111105 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2113106 - Disclosure - DISPOSITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISPOSITION</Role>
      <ShortName>DISPOSITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2115107 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2121108 - Disclosure - TAXES ON INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOME</Role>
      <ShortName>TAXES ON INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2124109 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW AND OTHER DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2127110 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2130111 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2133112 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2136113 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2143114 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2150115 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2155116 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2159117 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2167118 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2169119 - Disclosure - BUSINESS SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2172120 - Disclosure - DISCONTINUED OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS</Role>
      <ShortName>DISCONTINUED OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2174121 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2176122 - Disclosure - Schedule II - Valuation Accounts and Reserves</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves</Role>
      <ShortName>Schedule II - Valuation Accounts and Reserves</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITION</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables</Role>
      <ShortName>EARNINGS (LOSS) PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - TAXES ON INCOME (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOMETables</Role>
      <ShortName>TAXES ON INCOME (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/TAXESONINCOME</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2325305 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2328306 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2331307 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2334308 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2337309 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBT</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2344310 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASES</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2351311 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2356312 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2360313 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2370314 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - EARNINGS (LOSS) PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails</Role>
      <ShortName>EARNINGS (LOSS) PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2412404 - Disclosure - BUSINESS ACQUISITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - DISPOSITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISPOSITIONDetails</Role>
      <ShortName>DISPOSITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DISPOSITION</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2417406 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2418407 - Disclosure - FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2419408 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - TAXES ON INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOMEDetails</Role>
      <ShortName>TAXES ON INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/TAXESONINCOMETables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2426411 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2429412 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2432413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2435414 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2438415 - Disclosure - DEBT (Long-Term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTLongTermDebtDetails</Role>
      <ShortName>DEBT (Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBTTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2439416 - Disclosure - DEBT (Secured Receivables Credit Facility) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails</Role>
      <ShortName>DEBT (Secured Receivables Credit Facility) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBTTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2440417 - Disclosure - DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails</Role>
      <ShortName>DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBTTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2441418 - Disclosure - DEBT (Senior Notes Offering) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails</Role>
      <ShortName>DEBT (Senior Notes Offering) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBTTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2442419 - Disclosure - DEBT (Maturities of Long-Term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails</Role>
      <ShortName>DEBT (Maturities of Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBTTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2445420 - Disclosure - LEASES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASESTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2446421 - Disclosure - LEASES (Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESLiabilitiesDetails</Role>
      <ShortName>LEASES (Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASESTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2447422 - Disclosure - LEASES (Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESCostsDetails</Role>
      <ShortName>LEASES (Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASESTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2448423 - Disclosure - LEASES (Maturity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESMaturityDetails</Role>
      <ShortName>LEASES (Maturity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASESTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2449424 - Disclosure - LEASES (Term and Rate) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESTermandRateDetails</Role>
      <ShortName>LEASES (Term and Rate) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASESTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2452425 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2453426 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2454427 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Income Statement) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2457428 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2458429 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2461430 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2462431 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2463432 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2464433 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2465434 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2466435 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2468436 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2471437 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2473438 - Disclosure - DISCONTINUED OPERATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails</Role>
      <ShortName>DISCONTINUED OPERATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2475439 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="dgx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2477440 - Disclosure - Schedule II - Valuation Accounts and Reserves (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails</Role>
      <ShortName>Schedule II - Valuation Accounts and Reserves (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves</ParentRole>
      <Position>85</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="dgx-20211231.htm">dgx-20211231.htm</File>
    <File>dgx-20211231.xsd</File>
    <File>dgx-20211231_cal.xml</File>
    <File>dgx-20211231_def.xml</File>
    <File>dgx-20211231_lab.xml</File>
    <File>dgx-20211231_pre.xml</File>
    <File>dgx12312021ex211.htm</File>
    <File>dgx12312021ex22.htm</File>
    <File>dgx12312021ex231.htm</File>
    <File>dgx12312021ex311.htm</File>
    <File>dgx12312021ex312.htm</File>
    <File>dgx12312021ex321.htm</File>
    <File>dgx12312021ex322.htm</File>
    <File>dgx12312021ex9910.htm</File>
    <File>dgx12312021ex999.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dgx-20211231_g1.jpg</File>
    <File>dgx-20211231_g2.jpg</File>
    <File>dgx-20211231_g3.jpg</File>
    <File>dgx-20211231_g4.jpg</File>
    <File>dgx-20211231_g5.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="1388">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>113
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dgx-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 30,
   "contextCount": 361,
   "dts": {
    "calculationLink": {
     "local": [
      "dgx-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dgx-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dgx-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dgx-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dgx-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dgx-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 788,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 12,
    "http://questdiagnostics.com/20211231": 1,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 17
   },
   "keyCustom": 71,
   "keyStandard": 539,
   "memberCustom": 52,
   "memberStandard": 51,
   "nsprefix": "dgx",
   "nsuri": "http://questdiagnostics.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://questdiagnostics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105103 - Disclosure - REVENUE RECOGNITION",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108104 - Disclosure - EARNINGS PER SHARE",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111105 - Disclosure - BUSINESS ACQUISITIONS",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113106 - Disclosure - DISPOSITION",
     "role": "http://questdiagnostics.com/role/DISPOSITION",
     "shortName": "DISPOSITION",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115107 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121108 - Disclosure - TAXES ON INCOME",
     "role": "http://questdiagnostics.com/role/TAXESONINCOME",
     "shortName": "TAXES ON INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124109 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA",
     "shortName": "SUPPLEMENTAL CASH FLOW AND OTHER DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127110 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "role": "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130111 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://questdiagnostics.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133112 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
     "role": "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136113 - Disclosure - DEBT",
     "role": "http://questdiagnostics.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143114 - Disclosure - LEASES",
     "role": "http://questdiagnostics.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150115 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2155116 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2159117 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2167118 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2169119 - Disclosure - BUSINESS SEGMENT INFORMATION",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION",
     "shortName": "BUSINESS SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2172120 - Disclosure - DISCONTINUED OPERATIONS",
     "role": "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS",
     "shortName": "DISCONTINUED OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2174121 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://questdiagnostics.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2176122 - Disclosure - Schedule II - Valuation Accounts and Reserves",
     "role": "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves",
     "shortName": "Schedule II - Valuation Accounts and Reserves",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2306301 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)",
     "role": "http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables",
     "shortName": "EARNINGS (LOSS) PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - TAXES ON INCOME (Tables)",
     "role": "http://questdiagnostics.com/role/TAXESONINCOMETables",
     "shortName": "TAXES ON INCOME (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325305 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables",
     "shortName": "SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328306 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "role": "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331307 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334308 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)",
     "role": "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337309 - Disclosure - DEBT (Tables)",
     "role": "http://questdiagnostics.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleOfLeaseByAssetTypeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344310 - Disclosure - LEASES (Tables)",
     "role": "http://questdiagnostics.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleOfLeaseByAssetTypeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351311 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2356312 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2360313 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2370314 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AdvertisingCostsPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AdvertisingCostsPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - REVENUE RECOGNITION (Details)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - EARNINGS (LOSS) PER SHARE (Details)",
     "role": "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
     "shortName": "EARNINGS (LOSS) PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412404 - Disclosure - BUSINESS ACQUISITIONS (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
     "shortName": "BUSINESS ACQUISITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414405 - Disclosure - DISPOSITION (Details)",
     "role": "http://questdiagnostics.com/role/DISPOSITIONDetails",
     "shortName": "DISPOSITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "iff8c10fa9efa4acb8369a234686c91ff_D20210401-20210401",
      "decimals": "-6",
      "lang": "en-US",
      "name": "dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417406 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "ifc4866c6aa2449f9b1ec282011ec5b46_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashSurrenderValueFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "ie17bd574ae9c4ff8ae0d21265f27f20e_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418407 - Disclosure - FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "ie17bd574ae9c4ff8ae0d21265f27f20e_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419408 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i67b969149f9b4fee96f681a629e8e1bf_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i66a58a0ecc1d462f851c119a2540a972_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - TAXES ON INCOME (Details)",
     "role": "http://questdiagnostics.com/role/TAXESONINCOMEDetails",
     "shortName": "TAXES ON INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426411 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails",
     "shortName": "SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429412 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)",
     "role": "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435414 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)",
     "role": "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438415 - Disclosure - DEBT (Long-Term Debt) (Details)",
     "role": "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
     "shortName": "DEBT (Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i9a32e3b91ca84b89b38c8ba51a6735ec_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "ife8fa0dbace2463781c162f0d572554e_I20211031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439416 - Disclosure - DEBT (Secured Receivables Credit Facility) (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
     "shortName": "DEBT (Secured Receivables Credit Facility) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i9f138175e3a44f5ebf659b1a78903b5d_D20211001-20211031",
      "decimals": null,
      "lang": "en-US",
      "name": "dgx:DebtInstrumentExtensionPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "ia3d6de33f3ed4d19a2ec16d2ece3dab0_I20211130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440417 - Disclosure - DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
     "shortName": "DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "ia3d6de33f3ed4d19a2ec16d2ece3dab0_I20211130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441418 - Disclosure - DEBT (Senior Notes Offering) (Details)",
     "role": "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
     "shortName": "DEBT (Senior Notes Offering) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i754db448c4a141e587eb41b3530387d7_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442419 - Disclosure - DEBT (Maturities of Long-Term Debt) (Details)",
     "role": "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails",
     "shortName": "DEBT (Maturities of Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5e3f8aa3f21c4630b2c2d3a505ba4881_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:LeaseRemainingLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445420 - Disclosure - LEASES (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5e3f8aa3f21c4630b2c2d3a505ba4881_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:LeaseRemainingLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dgx:ScheduleOfLeaseByAssetTypeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446421 - Disclosure - LEASES (Liabilities) (Details)",
     "role": "http://questdiagnostics.com/role/LEASESLiabilitiesDetails",
     "shortName": "LEASES (Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dgx:ScheduleOfLeaseByAssetTypeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:OperatingLeaseFixedAndVariableCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447422 - Disclosure - LEASES (Costs) (Details)",
     "role": "http://questdiagnostics.com/role/LEASESCostsDetails",
     "shortName": "LEASES (Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:OperatingLeaseFixedAndVariableCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448423 - Disclosure - LEASES (Maturity) (Details)",
     "role": "http://questdiagnostics.com/role/LEASESMaturityDetails",
     "shortName": "LEASES (Maturity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449424 - Disclosure - LEASES (Term and Rate) (Details)",
     "role": "http://questdiagnostics.com/role/LEASESTermandRateDetails",
     "shortName": "LEASES (Term and Rate) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "dgx:GainLossOnDispositionOfJointVenture",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452425 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i088cf7af90a4499da82634db3e749425_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453426 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i088cf7af90a4499da82634db3e749425_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454427 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Income Statement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i11c302abd9aa427ba7d0156fe01460ec_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457428 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "ifc7daa98ed14443ba924d16779e53a1b_D20211001-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "ide7d8c567bcc4f5c8e62e8a21b9045c2_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458429 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i4f78e9964d4545d0b470900cf41790eb_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461430 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462431 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i30b7bc67e7bb4a52a97e03ff7b345782_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463432 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i55cf1cdf81da407d87a1dc53435b843a_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464433 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465434 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i751cd9d2a9c24eeb80a337f22c577eed_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i751cd9d2a9c24eeb80a337f22c577eed_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i53478dbdef6c4f4da03d5763e9b3c86a_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466435 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i946d409692054dddb8d20bf8697e64db_D20210101-20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "dgx:SupplementalDeferredCompensationPlanSalaryDeferral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468436 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i5dc2e07c6f7f43bfbdd8a74b68e9fdaa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471437 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i3764f252b9f84910a98e8576a15f1852_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i3694f852a462494f91d7c0a3b1211df9_D20190101-20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473438 - Disclosure - DISCONTINUED OPERATIONS (Details)",
     "role": "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails",
     "shortName": "DISCONTINUED OPERATIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i3694f852a462494f91d7c0a3b1211df9_D20190101-20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2475439 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "role": "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i6e7331c77972481e85855c53b18546a4_D20220201-20220201",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "icbfee6ac293a4d0693346eada0d23f20_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2477440 - Disclosure - Schedule II - Valuation Accounts and Reserves (Details)",
     "role": "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails",
     "shortName": "Schedule II - Valuation Accounts and Reserves (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i33dd72fa523b4d1d80a0eabd16074f43_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20211231.htm",
      "contextRef": "i7dfddcac3e494696bd29405872d37f33_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 104,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r732",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r732",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r732",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r732",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r732",
      "r733",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dgx_AcceleratedShareRepurchaseAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase Agreements",
        "label": "Accelerated Share Repurchase Agreements [Member]",
        "terseLabel": "Accelerated Share Repurchase Agreements"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseAgreementsMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AcceleratedShareRepurchasesPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Payment",
        "label": "Accelerated Share Repurchases, Payment",
        "terseLabel": "Accelerated share repurchases, payment"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPayment",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable and Allowance for Credit Losses Policy",
        "label": "Accounts Receivable and Allowance for Credit Losses Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Credit Losses"
       }
      }
     },
     "localname": "AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_AccountsReceivableDisaggregationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Disaggregation [Table Text Block]",
        "label": "Accounts Receivable Disaggregation [Table Text Block]",
        "terseLabel": "Accounts Receivable Disaggregation"
       }
      }
     },
     "localname": "AccountsReceivableDisaggregationTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_AgreementtoOutsourceBillingandCollectionFunction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement to Outsource Billing and Collection Function",
        "label": "Agreement to Outsource Billing and Collection Function",
        "terseLabel": "Agreement to outsource billing and collection function"
       }
      }
     },
     "localname": "AgreementtoOutsourceBillingandCollectionFunction",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_AllotherservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other services [Member]",
        "label": "All other services [Member]",
        "terseLabel": "All other services"
       }
      }
     },
     "localname": "AllotherservicesMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AnatomicpathologytestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anatomic pathology testing services [Member]",
        "label": "Anatomic pathology testing services [Member]",
        "terseLabel": "Anatomic pathology testing services"
       }
      }
     },
     "localname": "AnatomicpathologytestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]",
        "terseLabel": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://questdiagnostics.com/20211231",
     "xbrltype": "stringItemType"
    },
    "dgx_BlueprintGeneticsOyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blueprint Genetics Oy [Member]",
        "label": "Blueprint Genetics Oy [Member]",
        "terseLabel": "Blueprint Genetics Oy"
       }
      }
     },
     "localname": "BlueprintGeneticsOyMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) [Member]",
        "label": "Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) [Member]",
        "terseLabel": "Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum)"
       }
      }
     },
     "localname": "BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_BusinessAcquisitionPostacquisitionRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Post-acquisition Revenue",
        "label": "Business Acquisition, Post-acquisition Revenue",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionPostacquisitionRevenue",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finance Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finance Lease Liabilities",
        "terseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinanceLeaseLiabilities",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles1",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles1",
        "terseLabel": "Finite-lived intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment and Working Capital",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment and Working Capital",
        "terseLabel": "Property, plant, and equipment and working capital"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital",
        "terseLabel": "Working capital"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Dicount Rate used to determine fair value",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Dicount Rate used to determine fair value",
        "terseLabel": "Equity interest in acquiree, discount rate used to determine fair value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Long-term Growth Rate used to determine fair value",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Long-term Growth Rate used to determine fair value",
        "terseLabel": "Equity interest in acquiree, long-term growth rate used to determine fair value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_COVID19TestingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Testing Services",
        "label": "COVID-19 Testing Services [Member]",
        "terseLabel": "COVID-19 testing services"
       }
      }
     },
     "localname": "COVID19TestingServicesMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CapitatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitated [Member]",
        "label": "Capitated [Member]",
        "terseLabel": "Capitated"
       }
      }
     },
     "localname": "CapitatedMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ClientPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Client Payers [Member]",
        "label": "Client Payers [Member]",
        "terseLabel": "Client payers"
       }
      }
     },
     "localname": "ClientPayersMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) [Member]",
        "label": "Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual life of stock options and other awards under the Shared-based compensation plans",
        "label": "Contractual life of stock options and other awards under the Shared-based compensation plans",
        "terseLabel": "Contractual life of stock options and other awards under the shared-based compensation plans"
       }
      }
     },
     "localname": "ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_DSBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DS Businesses [Member]",
        "label": "DS Businesses [Member]",
        "terseLabel": "DS"
       }
      }
     },
     "localname": "DSBusinessesMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DebtInstrumentExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, Extension Period",
        "label": "Debt instrument, Extension Period",
        "terseLabel": "Extension period"
       }
      }
     },
     "localname": "DebtInstrumentExtensionPeriod",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, fair value basis adjustment attributable to hedged debt",
        "label": "Debt Instrument, fair value basis adjustment attributable to hedged debt",
        "negatedTerseLabel": "Fair value basis adjustments attributable to hedged debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease Liabilities, Noncurrent",
        "label": "Deferred Tax Assets, Operating Lease Liabilities, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Receivables",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Receivables",
        "terseLabel": "Accounts receivable reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liability, Investments, Investments in Subsidiaries and Equity method investments",
        "label": "Deferred Tax Liability, Investments, Investments in Subsidiaries and Equity method investments",
        "negatedTerseLabel": "Basis differences in investments, joint ventures and subsidiaries"
       }
      }
     },
     "localname": "DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_DiagnosticInformationServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Information Services Business [Member]",
        "label": "Diagnostic Information Services Business [Member]",
        "terseLabel": "DIS business"
       }
      }
     },
     "localname": "DiagnosticInformationServicesBusinessMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discontinued Operation, Gain on Settling Uncertain Tax Benefits",
        "label": "Discontinued Operation, Gain on Settling Uncertain Tax Benefits",
        "terseLabel": "Gain on settling uncertain tax benefits"
       }
      }
     },
     "localname": "DiscontinuedOperationGainonSettlingUncertainTaxBenefits",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change for uncertain tax position",
        "label": "Effective Income Tax Rate Reconciliation, Change for uncertain tax position",
        "terseLabel": "Changes in reserves for uncertain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_EmployeeLongTermIncentivePlanEltipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Long-Term Incentive Plan (ELTIP) (Member)",
        "label": "Employee Long Term Incentive Plan Eltip [Member]",
        "terseLabel": "Employee Long Term Incentive Plan ELTIP"
       }
      }
     },
     "localname": "EmployeeLongTermIncentivePlanEltipMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_EquityMethodInvestmentOwnershipPercentDisposedOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Ownership Percent Disposed Of",
        "label": "Equity Method Investment, Ownership Percent Disposed Of",
        "terseLabel": "Percent of ownership interest sold"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentDisposedOf",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities",
        "label": "Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances",
        "terseLabel": "Purchases, additions and issuances"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FairValueOfNetAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of net assets acquired",
        "label": "Fair value of net assets acquired",
        "totalLabel": "Fair value of net assets acquired"
       }
      }
     },
     "localname": "FairValueOfNetAssetsAcquired",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FeeforserviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fee-for-service [Member]",
        "label": "Fee-for-service [Member]",
        "terseLabel": "Fee-for-service"
       }
      }
     },
     "localname": "FeeforserviceMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FinanceLeaseObligationsandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Obligations and Other [Member]",
        "label": "Finance Lease Obligations and Other [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "FinanceLeaseObligationsandOtherMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance and Operating Lease Liabilities, Payments, Due [Abstract]",
        "label": "Finance and Operating Lease Liabilities, Payments, Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived intangible assets, estimated amortization expense, total.",
        "label": "Finite-lived intangible assets, Estimated amortization expense, total",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FivePointSevenFivePercentSeniorNotesDue2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Point Seven Five Percent Senior Notes Due 2040 [Member]",
        "label": "Five Point Seven Five Percent Senior Notes Due2040 [Member]",
        "terseLabel": "5.75% Senior Notes due January 2040"
       }
      }
     },
     "localname": "FivePointSevenFivePercentSeniorNotesDue2040Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ForeignCurrencyTranslationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation",
        "label": "Foreign Currency Translation [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Seven Zero Percent Senior Notes due March 2045 [Member]",
        "label": "Four Point Seven Zero Percent Senior Notes due March 2045 [Member]",
        "terseLabel": "4.70% Senior Notes due March 2045"
       }
      }
     },
     "localname": "FourPointSevenZeroPercentSeniorNotesdueMarch2045Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Two Zero Percent Senior Notes due June 2029 [Member]",
        "label": "Four Point Two Zero Percent Senior Notes due June 2029 [Member]",
        "terseLabel": "4.20% Senior Notes due June 2029"
       }
      }
     },
     "localname": "FourPointTwoZeroPercentSeniorNotesdueJune2029Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FourpointtwofivepercentSeniorNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four point two five percent Senior Notes Due 2024 [Member]",
        "label": "Four point two five percent Senior Notes Due 2024 [Member]",
        "terseLabel": "4.25% Senior Notes due April 2024"
       }
      }
     },
     "localname": "FourpointtwofivepercentSeniorNotesDue2024Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funds in a trust pertaining to all participant deferrals and company matching amounts related to the Supplemental Deferred Compensation Plan.",
        "label": "Funds in a trust pertaining to all participant deferrals and company matching amounts related to the SDCP",
        "terseLabel": "Funds in a trust pertaining to all participant deferrals and company matching amounts related to the SDCP"
       }
      }
     },
     "localname": "FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_GainLossOnDispositionOfJointVenture": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Disposition of Joint Venture",
        "label": "Gain (Loss) on Disposition of Joint Venture",
        "negatedTerseLabel": "Gain on disposition of joint venture"
       }
      }
     },
     "localname": "GainLossOnDispositionOfJointVenture",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_GenebasedandesoterictestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gene-based and esoteric testing services [Member]",
        "label": "Gene-based and esoteric testing services [Member]",
        "terseLabel": "Gene-based and esoteric (including advanced diagnostics) testing services"
       }
      }
     },
     "localname": "GenebasedandesoterictestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GovernmentPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Payers [Member]",
        "label": "Government Payers [Member]",
        "terseLabel": "Government payers"
       }
      }
     },
     "localname": "GovernmentPayersMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_HealthcareInsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Insurers [Member]",
        "label": "Healthcare Insurers [Member]",
        "terseLabel": "Healthcare insurers:"
       }
      }
     },
     "localname": "HealthcareInsurersMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards",
        "label": "Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards",
        "negatedTerseLabel": "Income tax benefit due to release of valuation allowances associated with net operating loss carryforwards"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Common Stock, Dividends, Declared as Percent",
        "label": "Increase (Decrease) in Common Stock, Dividends, Declared as Percent",
        "terseLabel": "Increase in quarterly dividends as percent"
       }
      }
     },
     "localname": "IncreaseDecreaseinCommonStockDividendsDeclaredasPercent",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment without Readily Determinable Fair Value, Impairment",
        "label": "Investment without Readily Determinable Fair Value, Impairment",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "InvestmentwithoutReadilyDeterminableFairValueImpairment",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment and furniture and fixtures [Member]",
        "label": "Laboratory Equipment And Furniture And Fixtures [Member]",
        "terseLabel": "Laboratory Equipment and Furniture and Fixtures"
       }
      }
     },
     "localname": "LaboratoryEquipmentAndFurnitureAndFixturesMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LaboratoryEquipmentFurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory Equipment, Furniture and Fixtures [Member]",
        "label": "Laboratory Equipment, Furniture and Fixtures [Member]",
        "terseLabel": "Laboratory Equipment, Furniture and Fixtures"
       }
      }
     },
     "localname": "LaboratoryEquipmentFurnitureAndFixturesMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LabtechDiagnosticsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Labtech Diagnostics, LLC",
        "label": "Labtech Diagnostics, LLC [Member]",
        "terseLabel": "Labtech Diagnostics, LLC"
       }
      }
     },
     "localname": "LabtechDiagnosticsLLCMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LeaseRemainingLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Remaining Lease Term",
        "label": "Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LeaseRemainingLeaseTerm",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_LeaseRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Renewal Term",
        "label": "Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LeaseRenewalTerm",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_LeaseRightofUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Right-of-Use Asset",
        "label": "Lease, Right-of-Use Asset",
        "totalLabel": "Total lease assets"
       }
      }
     },
     "localname": "LeaseRightofUseAsset",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 1.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due Next Twelve Months",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due Next Twelve Months",
        "totalLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 5.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Five",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Five",
        "totalLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 4.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Four",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Four",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 3.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Three",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Three",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Two",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Two",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 6.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due after Year Five",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due after Year Five",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount",
        "label": "Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount",
        "totalLabel": "Less: Interest"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LoanCommitmentMaturingOctober2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan commitment maturing October 2022",
        "label": "Loan commitment maturing October 2022 [Member]",
        "terseLabel": "Loan commitment maturing October 2022"
       }
      }
     },
     "localname": "LoanCommitmentMaturingOctober2022Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LoanCommitmentMaturingOctober2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan commitment maturing October 2023",
        "label": "Loan commitment maturing October 2023 [Member]",
        "terseLabel": "Loan commitment maturing October 2023"
       }
      }
     },
     "localname": "LoanCommitmentMaturingOctober2023Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LongTermDebtMaturitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date. May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer, and before deducting unamortized discount or premiums, if any.",
        "label": "Long-term Debt, Maturities Gross",
        "totalLabel": "Total maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesGross",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Element represents the discounted market value of the Company stock on offering date or purchase date that participants pay for shares. Typically, the participant's per share cost is the lower of the prices on the two dates.",
        "label": "Market price of Company stock issued at a discount under the ESPP",
        "terseLabel": "Market price of company stock issued at a discount under the ESPP"
       }
      }
     },
     "localname": "MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_MeasurementInputComparableCompanyRevenueVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Comparable Company Revenue Volatility [Member]",
        "label": "Measurement Input, Comparable Company Revenue Volatility [Member]",
        "terseLabel": "Comparable Company Revenue Volatility"
       }
      }
     },
     "localname": "MeasurementInputComparableCompanyRevenueVolatilityMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MemorialHermannMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Memorial Hermann [Member]",
        "label": "Memorial Hermann [Member]",
        "terseLabel": "Memorial Hermann"
       }
      }
     },
     "localname": "MemorialHermannMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MercyHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mercy Health",
        "label": "Mercy Health [Member]",
        "terseLabel": "Mercy Health"
       }
      }
     },
     "localname": "MercyHealthMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MergerConsiderationPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Consideration Payable, Current",
        "label": "Merger Consideration Payable, Current",
        "terseLabel": "Merger consideration payable"
       }
      }
     },
     "localname": "MergerConsiderationPayableCurrent",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_Mergerconsiderationpaidpayablenet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger consideration paid (payable), net",
        "label": "Merger consideration paid (payable), net",
        "terseLabel": "Merger consideration payable"
       }
      }
     },
     "localname": "Mergerconsiderationpaidpayablenet",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_MidAmericaClinicalLaboratoriesLLCMACLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mid America Clinical Laboratories, LLC (MACL)",
        "label": "Mid America Clinical Laboratories, LLC (MACL) [Member]",
        "terseLabel": "Mid America Clinical Laboratories, LLC (MACL)"
       }
      }
     },
     "localname": "MidAmericaClinicalLaboratoriesLLCMACLMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Net operating loss carryfowards, net of valuation allowance",
        "terseLabel": "Net operating loss carryfowards, net of valuation allowance"
       }
      }
     },
     "localname": "NetOperatingLossCarryfowardsNetOfValuationAllowance",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_NidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NID [Member]",
        "label": "NID [Member]",
        "terseLabel": "NID"
       }
      }
     },
     "localname": "NidMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_OperatingLeaseFixedAndVariableCost": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Fixed and Variable Cost",
        "label": "Operating Lease, Fixed and Variable Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseFixedAndVariableCost",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_OperatingandFinanceLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating and finance leases.",
        "label": "Operating and Finance Lease, Liability",
        "totalLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingandFinanceLeaseLiability",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_OtherEquityComponentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Equity Components [Member]",
        "label": "Other Equity Components [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherEquityComponentsMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_OtherIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income (Expense)",
        "label": "Other Income (Expense) [Member]",
        "terseLabel": "Other Income (Expense)"
       }
      }
     },
     "localname": "OtherIncomeExpenseMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PackHealthLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pack Health, LLC",
        "label": "Pack Health, LLC [Member]",
        "terseLabel": "Pack Health, LLC"
       }
      }
     },
     "localname": "PackHealthLLCMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PatientMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient [Member]",
        "label": "Patient [Member]",
        "terseLabel": "Patients"
       }
      }
     },
     "localname": "PatientMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PercentageofNetAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Accounts Receivable",
        "label": "Percentage of Net Accounts Receivable",
        "terseLabel": "Percentage of net accounts receivable"
       }
      }
     },
     "localname": "PercentageofNetAccountsReceivable",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Revenues",
        "label": "Percentage of Net Revenues",
        "terseLabel": "Percentage of net revenues",
        "verboseLabel": "Percentage of net revenues from the DIS business"
       }
      }
     },
     "localname": "PercentageofNetRevenues",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance share units with market-based relative TSR goal",
        "label": "Performance share units with market-based relative TSR goal [Member]",
        "terseLabel": "Performance share units with market-based relative TSR goal"
       }
      }
     },
     "localname": "PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PeriodofBillingFullyReserve": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of Billing Fully Reserve",
        "label": "Period of Billing Fully Reserve",
        "terseLabel": "Period of billing fully reserve"
       }
      }
     },
     "localname": "PeriodofBillingFullyReserve",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Sale of Equity Method Investments, Gross",
        "label": "Proceeds from Sale of Equity Method Investments, Gross",
        "terseLabel": "Gross proceeds from disposition of joint venture"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestmentsGross",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_Q2SolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 Solutions",
        "label": "Q2 Solutions [Member]",
        "terseLabel": "Q2 Solutions"
       }
      }
     },
     "localname": "Q2SolutionsMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ReductionsForChangesInJudgment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross amount of decreases in unrecognized tax benefits resulting from changes in judgment.",
        "label": "Reductions for changes in judgment",
        "negatedTerseLabel": "Reductions for changes in judgment"
       }
      }
     },
     "localname": "ReductionsForChangesInJudgment",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_RemainingTermsofContingentLeaseObligationsMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining Terms of Contingent Lease Obligations, Maximum",
        "label": "Remaining Terms of Contingent Lease Obligations, Maximum",
        "terseLabel": "Remaining terms of lease obligations, maximum"
       }
      }
     },
     "localname": "RemainingTermsofContingentLeaseObligationsMaximum",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_RestatedDirectorLongTermIncentivePlanDltipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restated Director Long-Term Incentive Plan (DLTIP) (Member)",
        "label": "Restated Director Long Term Incentive Plan Dltip [Member]",
        "terseLabel": "Restated Director Long-Term Incentive Plan (DLTIP)"
       }
      }
     },
     "localname": "RestatedDirectorLongTermIncentivePlanDltipMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_RevenueCollectionofConsiderationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Collection of Consideration Period",
        "label": "Revenue, Collection of Consideration Period",
        "terseLabel": "Collection of consideration"
       }
      }
     },
     "localname": "RevenueCollectionofConsiderationPeriod",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_RoutineclinicaltestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Routine clinical testing services",
        "label": "Routine clinical testing services [Member]",
        "terseLabel": "Routine clinical testing and other services"
       }
      }
     },
     "localname": "RoutineclinicaltestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ScheduleOfLeaseByAssetTypeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Lease By Asset Type [Table Text Block]",
        "label": "Schedule Of Lease By Asset Type [Table Text Block]",
        "terseLabel": "Schedule Of Lease By Asset Type"
       }
      }
     },
     "localname": "ScheduleOfLeaseByAssetTypeTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Share-based Payment Award, Performance Share Units, Valuation Assumptions",
        "label": "Schedule of Share-based Payment Award, Performance Share Units, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used in Valuing The Company's Performance Share Units"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleOfShareholdersEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Shareholders' Equity [Table]",
        "label": "Schedule of Shareholders' Equity [Line Items]",
        "terseLabel": "Stockholders\u2019 Equity and Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfShareholdersEquityLineItems",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleOfShareholdersEquityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Shareholders' Equity [Table]",
        "label": "Schedule of Shareholders' Equity [Table]",
        "terseLabel": "Schedule of Shareholders' Equity [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareholdersEquityTable",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Lease Term and Discount Rate [Table Text Block]",
        "label": "Schedule of Lease Term and Discount Rate [Table Text Block]",
        "terseLabel": "Schedule of Lease Term and Discount Rate"
       }
      }
     },
     "localname": "ScheduleofLeaseTermandDiscountRateTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_SdcpIiGradedVestingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SDCP II graded vesting percentage",
        "label": "SDCP II graded vesting percentage",
        "terseLabel": "SDCP II graded vesting percentage"
       }
      }
     },
     "localname": "SdcpIiGradedVestingPercentage",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_SdcpIiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SDCP II [Member]",
        "label": "Sdcp Ii [Member]",
        "terseLabel": "SDCP II [Member]"
       }
      }
     },
     "localname": "SdcpIiMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_SeniorunsecuredrevolvingcreditfacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior unsecured revolving credit facility [Member]",
        "label": "Senior unsecured revolving credit facility [Member]",
        "terseLabel": "Senior unsecured revolving credit facility"
       }
      }
     },
     "localname": "SeniorunsecuredrevolvingcreditfacilityMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_Sharebasedcompensationexcesstaxbenefitamount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation, excess tax benefit, amount",
        "label": "Share-based compensation, excess tax benefit, amount",
        "terseLabel": "Share-based compensation, excess tax benefit, amount"
       }
      }
     },
     "localname": "Sharebasedcompensationexcesstaxbenefitamount",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_ShorttermLeaseandVariableLeaseCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term Lease and Variable Lease, Cost",
        "label": "Short-term Lease and Variable Lease, Cost",
        "terseLabel": "Short-term leases and variable lease costs"
       }
      }
     },
     "localname": "ShorttermLeaseandVariableLeaseCost",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_SixPointNineFivePercentSeniorNotesDue2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Six Point Nine Five Percent Senior Notes Due 2037 [Member]",
        "label": "Six Point Nine Five Percent Senior Notes Due2037 [Member]",
        "terseLabel": "6.95% Senior Notes due July 2037"
       }
      }
     },
     "localname": "SixPointNineFivePercentSeniorNotesDue2037Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_StockAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement - Equity Instruments Other than Options.",
        "label": "Stock Awards [Member]",
        "terseLabel": "Stock Awards"
       }
      }
     },
     "localname": "StockAwardsMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_StockRepurchaseProgramAdditionalAmountAuthorized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Additional Amount Authorized",
        "label": "Stock Repurchase Program, Additional Amount Authorized",
        "terseLabel": "Additional amount authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAmountAuthorized",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies Line Items",
        "label": "Summary of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies [Table]",
        "label": "Summary of Significant Accounting Policies [Table]",
        "terseLabel": "Summary of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SupplementalDeferredCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Deferred Compensation Plan [Member]",
        "label": "Supplemental Deferred Compensation Plan [Member]",
        "terseLabel": "Supplemental Deferred Compensation Plan"
       }
      }
     },
     "localname": "SupplementalDeferredCompensationPlanMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_SupplementalDeferredCompensationPlanSalaryDeferral": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of salary deferral under the Supplemental Deferred Compensation Plan. This plans is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to this percentage of their annual salary in excess of their defined contribution plan limits.",
        "label": "Supplemental Deferred Compensation Plan Salary Deferral",
        "terseLabel": "SDCP salary deferral"
       }
      }
     },
     "localname": "SupplementalDeferredCompensationPlanSalaryDeferral",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferral percentage of the variable incentive compensation under the Supplemental Deferred Compensation Plan. The plan is an unfunded, non-qualified plan that provides for certain management and highly compensated eligible employees to defer up to this percentage of their variable incentive compensation.",
        "label": "Supplemental Deferred Compensation Plan Variable Incentive Compensation Deferral",
        "terseLabel": "SDCP variable incentive compensation deferral"
       }
      }
     },
     "localname": "SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TerminationOfInterestRateSwapAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination Of Interest Rate Swap Agreements",
        "label": "Termination Of Interest Rate Swap Agreements",
        "terseLabel": "Termination of interest rate swap agreements"
       }
      }
     },
     "localname": "TerminationOfInterestRateSwapAgreements",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Point Five Zero Percent Senior Notes due March 2025 [Member]",
        "label": "Three Point Five Zero Percent Senior Notes due March 2025 [Member]",
        "terseLabel": "3.50% Senior Notes due March 2025"
       }
      }
     },
     "localname": "ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Point Four Five Percent Senior Notes due June 2026 [Member]",
        "label": "Three Point Four Five Percent Senior Notes due June 2026 [Member]",
        "terseLabel": "3.45% Senior Notes due June 2026"
       }
      }
     },
     "localname": "ThreePointFourFivePercentSeniorNotesdueJune2026Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_TotalAmortizingIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Amortizing Intangible Assets [Member]",
        "label": "Total Amortizing Intangible Assets [Member]",
        "terseLabel": "Total Amortizing Intangible Assets"
       }
      }
     },
     "localname": "TotalAmortizingIntangibleAssetsMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_TreasuryStockPurchasedbutNotyetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Purchased but Not yet Paid",
        "label": "Treasury Stock Purchased but Not yet Paid",
        "terseLabel": "Accounts payable associated with purchases of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockPurchasedbutNotyetPaid",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Point Eight Zero Percent Senior Notes due June 2031",
        "label": "Two Point Eight Zero Percent Senior Notes due June 2031 [Member]",
        "terseLabel": "2.80% Senior Notes due June 2031"
       }
      }
     },
     "localname": "TwoPointEightZeroPercentSeniorNotesDueJune2031Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Point Nine Five Percent Senior Notes due June 2030 [Member]",
        "label": "Two Point Nine Five Percent Senior Notes due June 2030 [Member]",
        "terseLabel": "2.95% Senior Notes due June 2030"
       }
      }
     },
     "localname": "TwoPointNineFivePercentSeniorNotesdueJune2030Member",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_UMassJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UMass Joint Venture [Member]",
        "label": "UMass Joint Venture [Member]",
        "terseLabel": "UMass Joint Venture"
       }
      }
     },
     "localname": "UMassJointVentureMember",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecorded Unconditional Purchase Obligation, Due within Two and Three Years",
        "label": "Unrecorded Unconditional Purchase Obligation, Due within Two and Three Years",
        "terseLabel": "Purchase obligation, 2023 through 2024"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears",
     "nsuri": "http://questdiagnostics.com/20211231",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r334",
      "r375",
      "r425",
      "r428",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r713",
      "r715",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/LEASESNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r334",
      "r375",
      "r425",
      "r428",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r713",
      "r715",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/LEASESNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r246",
      "r407",
      "r409",
      "r660",
      "r712",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r246",
      "r407",
      "r409",
      "r660",
      "r712",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r334",
      "r375",
      "r414",
      "r425",
      "r428",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r713",
      "r715",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/LEASESNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r334",
      "r375",
      "r414",
      "r425",
      "r428",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r713",
      "r715",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/LEASESNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r179",
      "r426",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r179",
      "r184",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r169",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SCHEDULE II - VALUATION ACCOUNTS AND RESERVES"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r179",
      "r184",
      "r314",
      "r426",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r167",
      "r168",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date of execution of accelerated share repurchases.",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date upon which the accelerated share repurchase agreement was executed.",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities [Abstract]",
        "terseLabel": "Accounts Payable and Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r33",
      "r61"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Trade accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r27",
      "r45",
      "r251",
      "r252"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $31 and $28 as of December\u00a031, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxes": {
     "auth_ref": [
      "r40",
      "r42",
      "r485",
      "r666",
      "r692"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due.  This amount is the total of current and noncurrent accrued income taxes.",
        "label": "Accrued Income Taxes",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r40",
      "r666",
      "r693"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedInsuranceCurrent": {
     "auth_ref": [
      "r32",
      "r33",
      "r65"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Insurance, Current",
        "terseLabel": "Accrued insurance"
       }
      }
     },
     "localname": "AccruedInsuranceCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r59",
      "r299"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r81",
      "r88",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Net Deferred Losses on Cash Flow Hedges, net of tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r82",
      "r83",
      "r84",
      "r88",
      "r96",
      "r97",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Net Changes in Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r48",
      "r86",
      "r87",
      "r88",
      "r695",
      "r720",
      "r721"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Accumulated other comprehensive (loss) income",
        "verboseLabel": "Accumulated net loss from designated or qualifying cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r85",
      "r88",
      "r96",
      "r97",
      "r98",
      "r171",
      "r172",
      "r173",
      "r555",
      "r716",
      "r717",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r80",
      "r88",
      "r96",
      "r97",
      "r98",
      "r555",
      "r608",
      "r609",
      "r610",
      "r611",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r464",
      "r465",
      "r466",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r429",
      "r431",
      "r469",
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r473"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising cost"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r216",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All other operating segments"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r167",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Credit Loss"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r253",
      "r265",
      "r266",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r52",
      "r253",
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs of accounts receivable, net of recoveries"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r139",
      "r283",
      "r291"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options and performance share units not included due to their antidilutive effect"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r156",
      "r228",
      "r235",
      "r242",
      "r263",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r549",
      "r556",
      "r605",
      "r642",
      "r644",
      "r664",
      "r690"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r29",
      "r31",
      "r77",
      "r156",
      "r263",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r549",
      "r556",
      "r605",
      "r642",
      "r644"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r255",
      "r256",
      "r271",
      "r671"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r433",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r569",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BankOverdrafts": {
     "auth_ref": [
      "r65",
      "r317"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.",
        "label": "Bank Overdrafts",
        "terseLabel": "Overdrafts"
       }
      }
     },
     "localname": "BankOverdrafts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Building Improvements",
        "verboseLabel": "Building and Improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r424",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r424",
      "r427",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill deductible for tax purposes"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r533",
      "r534",
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r138",
      "r541"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration arrangements"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Maximum Contingent Consideration Payment",
        "verboseLabel": "Contingent consideration arrangements, range of outcomes, value, high"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r532",
      "r535",
      "r538"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "netLabel": "Contingent consideration, liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r526",
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Finite-lived intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r526",
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r526",
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Equity interest in acquiree, fair value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Equity interest in acquiree, percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Equity interest in acquiree, remeasurement gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r144",
      "r145",
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accounts payable associated with capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash acquired from acquisition",
        "verboseLabel": "Less: cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r25",
      "r55",
      "r141"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r36",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r134",
      "r141",
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, end of year",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r134",
      "r606"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW AND OTHER DATA"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r16",
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations",
        "terseLabel": "Refund from taxing authorities related to settlement of the uncertain tax benefits"
       }
      }
     },
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash surrender value of life insurance policies"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "auth_ref": [
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "terseLabel": "Hedged items (Long-term debt)"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r70",
      "r313",
      "r672",
      "r700"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r309",
      "r311",
      "r312",
      "r316",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r171",
      "r172",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]"
       }
      }
     },
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r44",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares",
        "terseLabel": "Common stock, shares, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r44",
      "r644"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share; 600 shares authorized as of both December 31, 2021 and 2020; 162 and 217 shares issued as of December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r91",
      "r93",
      "r94",
      "r108",
      "r681",
      "r708"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r91",
      "r93",
      "r107",
      "r547",
      "r548",
      "r560",
      "r680",
      "r707"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r91",
      "r93",
      "r106",
      "r546",
      "r560",
      "r679",
      "r706"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "General corporate income (expenses), Net"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r115",
      "r156",
      "r263",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r605"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Operating costs and expenses and other operating expense (income):"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs and expenses, net"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r502",
      "r510"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Current federal tax expense (benefit)"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r502"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Current foreign income tax expense"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r502",
      "r510",
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Taxes payable, current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r502",
      "r510"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "Current state and local income tax expense"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer - related"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r153",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r348",
      "r355",
      "r356",
      "r358",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r39",
      "r40",
      "r41",
      "r155",
      "r162",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r338",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r361",
      "r362",
      "r363",
      "r364",
      "r620",
      "r665",
      "r668",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rate in excess of LIBOR",
        "verboseLabel": "Interest rate in excess of LIBOR"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r41",
      "r359",
      "r668",
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r331",
      "r361",
      "r362",
      "r618",
      "r620",
      "r621"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r346",
      "r361",
      "r362",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r67",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r68",
      "r155",
      "r162",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r338",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r361",
      "r362",
      "r363",
      "r364",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r68",
      "r155",
      "r162",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r338",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r357",
      "r361",
      "r362",
      "r363",
      "r364",
      "r388",
      "r389",
      "r390",
      "r391",
      "r617",
      "r618",
      "r620",
      "r621",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r344",
      "r617",
      "r621"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Unamortized discount",
        "terseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]",
        "terseLabel": "Debt Instruments [Abstract]"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Significant change in unrecognized tax benefits is reasonably possible, estimated range of change, upper bound"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain": {
     "auth_ref": [
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.",
        "label": "Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain]",
        "terseLabel": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]"
       }
      }
     },
     "localname": "DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.",
        "label": "Deferred Compensation Arrangement with Individual, Contributions by Employer",
        "terseLabel": "Deferred compensation arrangement with individual, employer contribution"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis": {
     "auth_ref": [
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.",
        "label": "Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]",
        "terseLabel": "Deferred Bonus and Profit Sharing Plan, Type of Deferred Compensation [Axis]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]",
        "terseLabel": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the liability as of the balance sheet date to an individual under a deferred compensation arrangement. This amount may be the result of periodic accruals made over the period of active employment, or reflect termination benefits resulting contractual terms or a death benefit.",
        "label": "Deferred Compensation Arrangement with Individual, Recorded Liability",
        "terseLabel": "SDCP accrual"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRecordedLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1": {
     "auth_ref": [
      "r413",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Deferred Compensation Arrangement with Individual, Requisite Service Period",
        "terseLabel": "SDCP II vesting period"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r503",
      "r510"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Defered federal income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r60",
      "r344",
      "r619"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r503",
      "r510"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Deferred foreign income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r139",
      "r157",
      "r503",
      "r510",
      "r511",
      "r512"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax provision",
        "verboseLabel": "Deferred income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r503",
      "r510"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Deferred state and local income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r500",
      "r501"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r500",
      "r501"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r500",
      "r501"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Liabilities not currently deductible"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r495"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "verboseLabel": "Deferred tax assets, valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r477",
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTerseLabel": "Total non-current deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r500",
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r500",
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Non-current deferred tax liability - depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Company's expense for contributions to its defined contribution plans"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Amended company match percentage of employee contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r139",
      "r297"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r139",
      "r223"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivatives designated as hedging instruments"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r585",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r567",
      "r570",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r563",
      "r564",
      "r565",
      "r567",
      "r568",
      "r573",
      "r575",
      "r579",
      "r581",
      "r584",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r161",
      "r563",
      "r564",
      "r567",
      "r568",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK OWNERSHIP AND COMPENSATION PLANS"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r296",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by Sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r23",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "netLabel": "DISPOSITION",
        "verboseLabel": "DISCONTINUED OPERATIONS"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS",
      "http://questdiagnostics.com/role/DISPOSITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r424",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r33",
      "r65"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividend payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r40",
      "r42",
      "r667",
      "r691"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividend payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Country"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r109",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r185",
      "r188",
      "r196",
      "r197",
      "r198",
      "r202",
      "r203",
      "r587",
      "r588",
      "r682",
      "r709"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Net income (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Earnings per share attributable to Quest Diagnostics\u2019 common stockholders - basic:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings Per Share, Basic and Diluted [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r109",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r188",
      "r196",
      "r197",
      "r198",
      "r202",
      "r203",
      "r587",
      "r588",
      "r682",
      "r709"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Net income (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Earnings per share attributable to Quest Diagnostics\u2019 common stockholders - diluted:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r159",
      "r479",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Tax provision at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r479",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowances associated with certain net operating losses"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther": {
     "auth_ref": [
      "r479",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Other, Percent",
        "negatedTerseLabel": "Excess tax benefits on stock-based compensation arrangements"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": {
     "auth_ref": [
      "r479",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent",
        "terseLabel": "Impact of equity earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r479",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent",
        "terseLabel": "Impact of noncontrolling interests"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r479",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r479",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Return to provision true-ups"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r479",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued wages and benefits (including incentive compensation)"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized stock-based compensation cost weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation not yet recognized, stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit related to stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r96",
      "r97",
      "r98",
      "r171",
      "r172",
      "r173",
      "r175",
      "r181",
      "r183",
      "r206",
      "r264",
      "r387",
      "r392",
      "r464",
      "r465",
      "r466",
      "r506",
      "r507",
      "r586",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r613",
      "r716",
      "r717",
      "r718",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r102",
      "r133",
      "r139",
      "r701"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Dividends received from equity method investees"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Other than temporary impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r111",
      "r112",
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "verboseLabel": "Gain on sale of investment, before tax"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r56",
      "r229",
      "r260"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investments in equity method investees",
        "verboseLabel": "Equity method investments carrying value"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r56",
      "r133",
      "r262",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": {
     "auth_ref": [
      "r601"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Trading securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Trading equity securities gain or (loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity Securities without readily determinable fair value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r590",
      "r603",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r346",
      "r361",
      "r362",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r591",
      "r649",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r598",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r590",
      "r591",
      "r593",
      "r594",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r346",
      "r415",
      "r416",
      "r421",
      "r422",
      "r591",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r346",
      "r361",
      "r362",
      "r415",
      "r416",
      "r421",
      "r422",
      "r591",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r346",
      "r361",
      "r362",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r591",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r595",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r595",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Liability Balances Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r596"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Total (gains)/losses included in earnings - realized/unrealized",
        "terseLabel": "Total (gains)/losses included in earnings - realized/unrealized"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r346",
      "r361",
      "r362",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r649",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r598",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r144",
      "r145",
      "r146"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r625",
      "r631",
      "r639"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r627",
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r623",
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "dgx_OperatingandFinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r623"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "dgx_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease, Liability, Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r623"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "dgx_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Noncurrent finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability.",
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r626",
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "dgx_LeaseRightofUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [
      "r625",
      "r631"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "terseLabel": "Right-of-use asset, accumulated amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r625",
      "r631",
      "r639"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of leased assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r636",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate, Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTermandRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r635",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term,Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTermandRateDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible asset, useful life",
        "verboseLabel": "Weighted average amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization, intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 6.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 1.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 5.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 4.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 3.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 2.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r284",
      "r286",
      "r290",
      "r294",
      "r661",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Future amortization expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r284",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Country"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Losses (gains) on sale of property, plant and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r139",
      "r365",
      "r366"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Losses on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r277",
      "r278",
      "r644",
      "r663"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, balance at end of year",
        "periodStartLabel": "Goodwill, balance at beginning of year",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired during the year"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Adjustments to goodwill"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedge": {
     "auth_ref": [
      "r576"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability hedged in fair value hedging relationship.",
        "label": "Hedged Liability, Fair Value Hedge",
        "terseLabel": "Carrying Amount of Hedged Long-Term Debt"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Hedge Accounting Basis Adjustment"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]",
        "terseLabel": "Amounts attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r114",
      "r140",
      "r176",
      "r177",
      "r178",
      "r179",
      "r194",
      "r198",
      "r545"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r158",
      "r513"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Income (loss) from continuing operations - domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r158",
      "r513"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Income (loss) from continuing operations - foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r228",
      "r234",
      "r238",
      "r241",
      "r244"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from continuing operations before income taxes and equity in earnings of equity method investees"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r156",
      "r174",
      "r228",
      "r234",
      "r238",
      "r241",
      "r244",
      "r263",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r546",
      "r588",
      "r605"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income from continuing operations",
        "totalLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r100",
      "r109",
      "r174",
      "r176",
      "r177",
      "r178",
      "r179",
      "r188",
      "r196",
      "r197",
      "r588",
      "r674",
      "r676",
      "r682",
      "r702"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Income from continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r100",
      "r109",
      "r174",
      "r176",
      "r177",
      "r178",
      "r179",
      "r188",
      "r196",
      "r197",
      "r198",
      "r588",
      "r682",
      "r702",
      "r705",
      "r709"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Income from continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r19",
      "r22",
      "r517",
      "r703"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income from discontinued operations, net of taxes",
        "verboseLabel": "Income (loss) from discontinued operations, net of taxes"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r15",
      "r19",
      "r546"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income from discontinued operations, net of taxes"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r103",
      "r109",
      "r192",
      "r196",
      "r197",
      "r682",
      "r703",
      "r705",
      "r709"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Income from discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r192",
      "r196",
      "r197",
      "r561"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Income from discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r102",
      "r139",
      "r225",
      "r260",
      "r675",
      "r701"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity in earnings of equity method investees, net of taxes",
        "verboseLabel": "Share of equity earnings from investments in affiliates"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r424",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails",
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r2",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r17",
      "r20",
      "r21",
      "r22",
      "r303",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails",
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r301",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r485",
      "r492",
      "r494",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r159",
      "r480",
      "r493",
      "r498",
      "r508",
      "r515",
      "r518",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r182",
      "r183",
      "r226",
      "r478",
      "r509",
      "r516",
      "r711"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense",
        "negatedTotalLabel": "Total",
        "terseLabel": "Income tax (benefit) expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r95",
      "r475",
      "r476",
      "r493",
      "r494",
      "r497",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Taxes on Income"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r136",
      "r143"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r198"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r285",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r285",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets Excluding Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible assets, gross excluding goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r282",
      "r288"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "verboseLabel": "Total intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "auth_ref": [
      "r683"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.",
        "label": "Interest and Dividend Income, Operating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndDividendIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r101",
      "r222",
      "r616",
      "r619",
      "r685"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r684"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest expense, net",
        "totalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r131",
      "r135",
      "r143"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r33",
      "r34",
      "r65"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r26",
      "r75",
      "r644"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r35",
      "r76",
      "r150",
      "r205",
      "r272",
      "r273",
      "r274",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r262",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r637",
      "r639"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Net lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Leases:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 1.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 1.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r51",
      "r156",
      "r263",
      "r605",
      "r644",
      "r670",
      "r698"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r144",
      "r145",
      "r146"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "terseLabel": "Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r66",
      "r156",
      "r263",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r550",
      "r556",
      "r557",
      "r605",
      "r642",
      "r643",
      "r644"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r70",
      "r313"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserves"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r41",
      "r345",
      "r360",
      "r361",
      "r362",
      "r668",
      "r694"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Less: Current portion of long-term debt",
        "verboseLabel": "Less: current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r162",
      "r318",
      "r350"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r162",
      "r318",
      "r350"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 6.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r162",
      "r318",
      "r350"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r162",
      "r318",
      "r350"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r162",
      "r318",
      "r350"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r162",
      "r318",
      "r350"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 5.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Total long-term debt, net of current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r68",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "New claims filed (in lawsuits)"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MalpracticeLossContingencyAccrualUndiscounted": {
     "auth_ref": [
      "r313"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.",
        "label": "Malpractice Loss Contingency, Accrual, Undiscounted",
        "terseLabel": "Self-insurance reserves"
       }
      }
     },
     "localname": "MalpracticeLossContingencyAccrualUndiscounted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r74",
      "r156",
      "r263",
      "r320",
      "r324",
      "r325",
      "r326",
      "r329",
      "r330",
      "r605",
      "r669",
      "r697"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r207",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r134",
      "r137",
      "r140"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r22",
      "r89",
      "r92",
      "r98",
      "r104",
      "r140",
      "r156",
      "r174",
      "r176",
      "r177",
      "r178",
      "r179",
      "r182",
      "r183",
      "r194",
      "r228",
      "r234",
      "r238",
      "r241",
      "r244",
      "r263",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r588",
      "r605",
      "r677",
      "r704"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r89",
      "r92",
      "r98",
      "r182",
      "r183",
      "r552",
      "r559"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: net income attributable to noncontrolling interests",
        "verboseLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": {
     "auth_ref": [
      "r186",
      "r198"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic",
        "totalLabel": "Earnings available to Quest Diagnostics\u2019 common stockholders \u2013 basic and diluted"
       }
      }
     },
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete Agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r392",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Non-operating expenses, net",
        "totalLabel": "Total non-operating income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r228",
      "r234",
      "r238",
      "r241",
      "r244"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating income",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r623"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 1.0,
       "parentTag": "dgx_OperatingandFinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease, liability",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r623"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "dgx_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of long-term operating lease liabilities",
        "verboseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r623"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "dgx_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities",
        "verboseLabel": "Noncurrent operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r628",
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "dgx_LeaseRightofUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Operating lease assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r636",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate, Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTermandRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r635",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Weighted-average remaining lease term, Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTermandRateDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r24",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Principles of Consolidation and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r569",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r82",
      "r83",
      "r86"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net change in available-for-sale debt securities, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r88",
      "r96",
      "r97",
      "r99",
      "r607",
      "r609",
      "r613"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive (loss) income before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r81",
      "r86"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net deferred gain on cash flow hedges, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r90",
      "r93",
      "r96",
      "r97",
      "r99",
      "r105",
      "r387",
      "r607",
      "r612",
      "r613",
      "r678",
      "r705"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Net current period other comprehensive income",
        "totalLabel": "Other comprehensive income",
        "verboseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other Income"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets, Subject To Amortization"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r569",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r41",
      "r668",
      "r694"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-term Debt",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other Operating Income (Expense)"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other operating (income) expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic": {
     "auth_ref": [
      "r193",
      "r195"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic",
        "terseLabel": "Less: Earnings allocated to participating securities"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r121",
      "r124"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Increase in investments and other assets, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r122",
      "r537"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "netLabel": "Cash paid for business acquisitions",
        "terseLabel": "Cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired",
        "totalLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures",
        "verboseLabel": "Total capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r43",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r29",
      "r53",
      "r54"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r28",
      "r30",
      "r275",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r127",
      "r130"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from disposition of joint venture"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from disposition of property, plant, and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r125",
      "r463"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r22",
      "r89",
      "r92",
      "r98",
      "r132",
      "r156",
      "r174",
      "r182",
      "r183",
      "r228",
      "r234",
      "r238",
      "r241",
      "r244",
      "r263",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r546",
      "r551",
      "r553",
      "r559",
      "r560",
      "r588",
      "r605",
      "r686"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r59",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r305",
      "r723",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY, PLANT AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r58",
      "r298"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r37",
      "r38",
      "r300",
      "r644",
      "r687",
      "r699"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r57",
      "r300",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r37",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r37",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r110",
      "r267"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r88",
      "r96",
      "r97",
      "r99",
      "r607",
      "r611",
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Amounts reclassified from accumulated other comprehensive loss"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r47",
      "r392",
      "r467",
      "r644",
      "r696",
      "r719",
      "r721"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r171",
      "r172",
      "r173",
      "r175",
      "r181",
      "r183",
      "r264",
      "r464",
      "r465",
      "r466",
      "r506",
      "r507",
      "r586",
      "r716",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r219",
      "r220",
      "r233",
      "r239",
      "r240",
      "r246",
      "r247",
      "r249",
      "r406",
      "r407",
      "r660"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues",
        "verboseLabel": "Total net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r408",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r151",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r634",
      "r639"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r634",
      "r639"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleAndLeasebackTransactionGainLossNet": {
     "auth_ref": [
      "r632",
      "r639",
      "r641"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.",
        "label": "Sale and Leaseback Transaction, Gain (Loss), Net",
        "terseLabel": "Gain on sale recognized"
       }
      }
     },
     "localname": "SaleAndLeasebackTransactionGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow and Other Data"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Components of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]",
        "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of the Federal Statutory Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location"
       }
      }
     },
     "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r280",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Goodwill, Net"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Summary of Transactions Under Stock Awards Other than Options"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r59",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r228",
      "r231",
      "r237",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r228",
      "r231",
      "r237",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r433",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r438",
      "r450",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Transactions Under The Company's Stock Option Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used in Valuing The Company's Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Future Amortization Expense Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "verboseLabel": "Secured Receivables Credit Facility"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r216",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r249",
      "r307",
      "r308",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r228",
      "r232",
      "r238",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Shares forfeited and cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Shares forfeited and cancelled weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Shares granted weighted average grant date fair value (in dollars per share)",
        "verboseLabel": "Fair value at grant date (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Shares outstanding, end of year",
        "periodStartLabel": "Shares outstanding, beginning of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Shares outstanding, end of year weighted average grant date fair value",
        "periodStartLabel": "Shares outstanding, beginning of year weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Shares vested weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Percentage of maximum annual wages witheld for the ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares available for award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable, end of year shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable, end of year weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Options forfeited and cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options forfeited and cancelled weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Fair value at grant date (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r462"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options outstanding, end of year aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r440",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, end of year",
        "periodStartLabel": "Options outstanding, beginning of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding, end of year weighted average exercise price",
        "periodStartLabel": "Options outstanding, beginning of year weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest, end of year aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest, end of year shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest, end of year weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r430",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, granted weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r433",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r456",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected holding period, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r462"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable, end of year aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable, end of year weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options outstanding, end of year weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest, end of year weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r149",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software and Software Development Costs",
        "verboseLabel": "Computer Software Developed or Obtained for Internal Use"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r8",
      "r216",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r249",
      "r280",
      "r302",
      "r307",
      "r308",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r73",
      "r96",
      "r97",
      "r98",
      "r171",
      "r172",
      "r173",
      "r175",
      "r181",
      "r183",
      "r206",
      "r264",
      "r387",
      "r392",
      "r464",
      "r465",
      "r466",
      "r506",
      "r507",
      "r586",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r613",
      "r716",
      "r717",
      "r718",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r206",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r43",
      "r44",
      "r387",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares purchased by eligible employees under ESPP"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r43",
      "r44",
      "r387",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans, sharers"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r43",
      "r44",
      "r387",
      "r392",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercise of stock options, shares",
        "terseLabel": "Exercise of stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": {
     "auth_ref": [
      "r44",
      "r387",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Shares, Treasury Stock Reissued",
        "terseLabel": "Reissuance of shares for employee benefit plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r43",
      "r44",
      "r392",
      "r432",
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r73",
      "r387",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Equity Option"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r44",
      "r49",
      "r50",
      "r156",
      "r254",
      "r263",
      "r605",
      "r644"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Quest Diagnostics stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Quest Diagnostics stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r97",
      "r156",
      "r171",
      "r172",
      "r173",
      "r175",
      "r181",
      "r263",
      "r264",
      "r392",
      "r464",
      "r465",
      "r466",
      "r506",
      "r507",
      "r543",
      "r544",
      "r558",
      "r586",
      "r605",
      "r607",
      "r608",
      "r613",
      "r717",
      "r718",
      "r740"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r154",
      "r374",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r392",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "StockholdersEquityPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r614",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r614",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r614",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r614",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r645",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r482",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets",
        "verboseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r71",
      "r156",
      "r263",
      "r605"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Intangible Assets Not Subject to Amortization - Tradenames"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r673"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Deferred compensation trading securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r72",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock, at Cost"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r44",
      "r387",
      "r393"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Retirement of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r72",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r44",
      "r387",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock, shares",
        "verboseLabel": "Purchases of treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r44",
      "r387",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "terseLabel": "Shares retired (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r72",
      "r395",
      "r396"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 43 and 84 shares as of December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r387",
      "r392",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchases of treasury stock, value",
        "terseLabel": "Treasury stock value acquired cost method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTerseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.",
        "label": "Unclassified Indefinite-lived Intangible Assets [Member]",
        "terseLabel": "Intangible Assets Not Subject to Amortization - Other"
       }
      }
     },
     "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r474",
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits, ending balance",
        "periodStartLabel": "Unrecognized tax benefits, beginning balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Reductions for settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for tax positions of current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense accrued for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued",
        "terseLabel": "Unrecognized tax benefits, interest on income taxes accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense",
        "terseLabel": "Unrecognized tax Benefits, interest on income taxes expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r490"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions for expirations of statutes of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Purchase obligation, 2022"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).",
        "label": "Unrecorded Unconditional Purchase Obligation",
        "terseLabel": "Purchase obligation"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r163",
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Provision for doubtfull accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "Net deductions and other"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r167",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r167",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r187",
      "r198"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average common shares outstanding - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r185",
      "r198"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Weighted average common shares outstanding - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2740-109256"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=124268079&loc=d3e32787-111569"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21459-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409961&loc=d3e20487-108367"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123417830&loc=SL77919786-209982"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1-5)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r728": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r729": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r731": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r732": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r733": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r734": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r735": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r736": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r737": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r738": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r739": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e526-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>114
<FILENAME>0001022079-22-000027-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001022079-22-000027-xbrl.zip
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M!J=3EL9C)O"4#?H,QKBH=%8 '+Q11.?#YTN=3%T>5.:X"AR#U;8 :L'",D9
M2C8F@"HH>=L!R?>70K)[)WVYZ_! SKMXN7ET/!Z]/NO15Y$Q6%T9:E$E54.-
ML5J(6D4)'R3&JYJ+)^GV'1C/_<N!WJ7IN;S#)(L?O"T,+&8HL6J9 :,R1W84
M2U6F:E>[F@?_(0FT$ M$V1OR0>F66M*QI%Q*+%!0MRWLO.K Z/\-@18ZU!]2
MLBD)>YP#K#8'5W2S0<I59TKH@ 7ZPS'_?S$.IH<%QQ)CMKCE^R>0_%BIT1B)
MG(K5H&G+:%T272-JAW,RKAJ[TJG1:V9>)_EAB4S%*$9$3$CP#I77B#$XFU0
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M"__511G(I>[1?[AY4@/PO%SGM>V7U&"Z;*5'-;=86,58:L":E(3"*1%&XZV
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M'R>'#P>C-\W@7VW-Q3FB69BP1$^9* %;$RDKZ8+.6,X)DNH\FN\''3X_W!&
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MVTB*O0>1L4A%B6ZIR!DT*[S1+LN#^AS5";126N0AM_G_VF(,1J-A-K8M!NC
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M7KV/@]C /FWVW*H'\FD$%M.H-1KA%).:&:6L3_&=,V1"JCA#@;XL.EY "FX
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MNR"9&-P;H;X^K\-.KL!' <%YT:^3*,#!-!]P+$Z<$+3W*4Z+B9U/6>Q.1,(
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M6NYR<-P"F$2![U$6<BW6@DY3GD5I&7][1IP+!'#/T>^>G\P",7\31D3_-U#
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MPE7A;2DP-&)$R0I;LNH57)(Z6$- EFK%#CE%%@PMA2'F%'5 T0+"#'\$VU>
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M11J**Q;@#-);# 7-[=47%"9.F@0BZ!!U UCM#Y1K=G&:08@6 8/J_I37CI"
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M:'9?6"OJ5L?7?K1!&PU\=Z+G$3#HK\+!)00 ,&]Q,)7_5R9QG%@@"ZAKA*C
M7:S>%2A+D(\)F[B4(V7[$KZ#,%8B5O# ZZV8 M0ZPQ6K48S_U!VQJ,KR290T
M+U+KM;+O]0'[7H\TD;S/B43UO X>HN?U47:,V7];DZ$1U@+<G\3-P+*K.!\D
M"&H<U,IC&T(O<F.?3=_-NX>>AM*VO&]@.\<V:M;#D==^[80>[O=37F7V1569
M?3_%[-=6',?9V/G PWWU&(J+Z)OO+O//"R*0TY!&-^-4[&.0R$(7)YZB7_Y
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MAK=?,;S+U(VHI^3K26#_JW]E((_]5/&%9 >,U9AN-&*!ZGO<KF3FB*GIE_B
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M"$,,#/&_X&%:Y4(%<0>;2/Y=@>I=&NND,!M8W0QQ5!%'4CQJG@C1[UX>@*6
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M\Q1^2T-JG(7;&>8-[;A4I:Z( V!.G_]5M@B[EULZGZ>^WU%,V/?5,"-!>SC
M(3BKD0R)B?FT.I/C[J!I_UH[9*M']&U#LL'&^TIP+8K8>49$&6B1E%D#1IUP
M# *G:U28%$SX5]DZF^(:Z9P%4(*?!.I(Q/HES=4=O*1OZ30X#0)^4E/U;:AU
MY<;U5,JZMAB[6[M?=@Y^Y?"<BHG+N5-:B4I)/MWH*R[:-;^[-&X-0_<DHJM(
M!V<#@\HM'>2W)5/Q$MR"X&Y3[C3[\NO*'_QK?V5)4DB%!$$=XVEQ_1GMU9^_
MJCXQC;FEJ^Z=P_H77-R+@2HG4.QZ?D)I_3/=_#4/S)FMIAA@4YL"14I8I%+U
MQ19NQV@1_&"CANO@'AVOD;/U^-'&<8+<6/1OTK4&3AO*2A'[7N@F;G9I:/9*
MJ]G-8(5^C]6STEVV9><,T0C]J^_]Z!&78,4%-Z]%%IQH_)S.:*O6+@DT\A1#
M!,K(02SEL@R:)"M[29W/4SR)',FVB@IB/B*9S#(;U%Q2IG])%VE_COPCQ%:Y
M<).2RKJWI2\\Z*2N5'?5%A)]U],]RX;?=*/UT:[1>A.>Y>LU6F^V=60TQ=V%
MTPF\O&+;)Z-:2; RP<L$H5\&J5P[D0P/4NN^S]1?!\*5RZ*>CA*7TT#3E2P%
M+![Q1"COY6'!+I=.=(&)^[,#21.]]^<!H$@!5LG04;P:7NP*<UAII!UA%.-;
M^*6L2J;9!\>MGGHIH0SW8:H*NRF??Q"TX'D02!/99C+(OMC2I.A'&EEN]"B0
M)K<H><1\SFW1"SVDA+\1K"UR'2.#+A< (F!/.D&8U^)&<%4 =PGY,0,2 WN'
M*;WU/",N(W@HQ&K.HQ(]:N(<W\NKVC61+8;U$:[S$FFU/J:(G2=$F!$-6"&N
MQU)PEZE2]Y)_*0IO9GQ9<&75&/3D$K=!;VZX1(MP.A >60[]1@M5%_]OX"<6
M3L=A@"E:KJ?;!,HW',Q_HPE\?R^H8X40#Y@/WE[*4!6\HQZE]X01#ITIX893
MN!I^VFH%WD_./$Q0A!%D4]550Y(GW,<XHL$W(V/&=K)J;NFD8&/;]W;1 /=>
M-+%PZ%!FW-T%<^4Q<]2IV",>]ERWCW!MXKJT[^'7EKY,<\^O&(ONBXB^=-#'
MB0RCBN6H=O<-D,R>IY!%2C_JAT?&4B8)T\O3F9#F+>L;E%.#0@EG0*H38OR[
M]0HJZ!(0@79KGW@^P$ND3.VZ&CPH<L#C*],JQ/\-\JS4*!'T>OS & *%;=^L
MQ,F//4Q5Y;LY+F\MNLH6)H!EZ5;"C[7[T2)W,;C"V8#AY'.7OX2KB/T,+SD>
M(KC09FEOC*%;^TH3HO L@]@Y/XIN&_%&FJ]MJ094ZL28[#2Y9G2:=GWYP-!$
M>*']ZY+Z7<KXK<<IMON&;W&GF6?\2X,*.YP[4W9RPA!TOL6=)VJ)[^7#\!!S
MTE88%_1@C7X?W[SLE5YXX]&!/2[*%13XP9 JE)H\) BWZUE2$32ZPQNX;U";
MC?[[P>W1Q/'A@WM __[L)H:?SG\]?W?Z>JLMR#J;0'ZNX1*8GJ2C]A??@;;>
MCI#D#.T/UR^POCOGD\13V>)A7^2>-8\[,8;2ON"8(;<G/BA\%?^>C$K*J>+W
MK4MZ20,@=,NF!0],Q7D(UHRR(/P^_HVWD2P%,T?K@XX_^6,?')MM>%HB'R5-
M&"$I&D*\4F.L(XSU^+S(;MH?..D?D4Y^3W%/<A&F0Q"<::+^[47=L633:TJO
MH2%#/H*<72KL$OFQ2$OJ67SAE1!C.0IN2<>B$;&GZB"O&JB&Z!6VW63$+QR)
MF6&@21U@." DG-937A0]ADSF&\.)T'$?T;H2O^I-SW/#96F"KM)L*E+CO!CR
MO"80H*Z>2'EM*<]^ S^U+?(?/]FN5/0I>60O8,ZH'GU\V$N.#HX.@Y =;96/
M$"(O<'T\>MZ#YPS4SSUV&XI9\WL']#VBEJYA05-)2$ELN?N*'0&6&^//D?\I
M[R-K!4P_+56_[DV9)),@8H0:-!11IWR,_[9_L<\UOZ+$=#52^XJX#CSAE 2;
MHH=\>O@W7=N!RWHR+0:4OLA&E,Y>$B\_.$CY2>,='X>?TZW#->Q/YZZ0<(2F
MFE2CK&!G?'?BW8I%H@*C/?4*E;IL&]'W2W?-DE-YTO5:*2D%HB0>M[O!1DV3
M&MOG5\C':<W8"[N%IXFO.BF*#L'W+=H"&T-YQ4V9?":L\_1M4MR*9YMJ.<<?
M6X,ZFY)F&*Z*LX)CW7,X<8<^'5@Z,MY#.7@Q#.;N=U:=0J]?TVGD3)IEQ@ID
M/48MP 69]AZ_.2CAO^4T8P:$X+<D%Z3QV$M6:0T\ZVGQE1_)C<?$,%$8!5YX
M9?@MOAEIS1B?G<>&,@#^.S@,(\5:Q'S\AJWMRO6\S9)V-]'%DO'$C<V#AOLN
MWF3P-ZF%H9AEFLDUY!WA?S'>A\N =:QJ.?=HW$9& +C"1L')XA(=BA 4$NPK
MS_Y=4VR"_8-\5#[$P?'OR$^N4R7/SM8X#/2X+JF'&XQ)<;W'0^4YCAJF \ES
MU.O (R!#N54?DV6ESQ-GVC!IN$!(>$)_0XO$T'Z$,BD&)O0NI)9G?R"+YQQE
MS%!W]?SC$/PN)\1&Z'6IDP8G0LVU6=&$55UB>AVX?NDB(6%;W#?!:$=!51GJ
MYUGIXH$9*/_\ -<VINV7*!+;X[W!?V<=$'89P[_ZVY#&+%/+GZBD'[]6%9=3
M@ZXTA:0AF!<-1=CQ"S01X2Q&9>4K>">D0EH@)U,YT@;D=VY83').U?+&?"NW
MO=$.E/RS_SC=JKC'W;)@S+^O#$M2V3)HDSA%<<V)CVOATNXE7M."[ J<VM@4
M2]D^O#@3#9"KBCI0)>9<W-0-RM0(^ES#:]%R,C\AA1X^HQ?%Q.&_;3[WYQ:=
M?1<A#/H=PZ ?,0Q:\TGX/L@MDA'B1VSY5YFH0,!:+^J<BG=#5XISA;I3J8@/
MPQH;]BAQ)G2R-A95."X2IA:,?!B2,XEBQDA J6DNK[;C"=; 4L'QR0?$!^?F
MC><C81BPK<@=HT^OIY$*42*0@P,S@0(S;Y(7T>#\VHCY=.&/8&\7WJX$/P&M
MC4_G4S90[A?(W32IF39P*L.Z+/$<8[E,"<QDR$.H:X2R]!]ILV/NWK_QK>QN
M9(:0D:UOWA]7()B#WV&+XT_?RRY/+A:.#Y4S,ESPMS#@DMUCNBN< ,K&81,\
M)A#Q8/6,!4,WPGHR]>%SX5@I75TZJ?D#6V@E4U/1,W&5$P^Q0"]JATY9M[1N
M1W_.JZ"%PCQYK&Z'TT AGJ&2,L @&S$W2+A,>J(=8_B2WPX_8_$SQSO\S"8\
MRU\-/T,797%K$16#W<B=?DMVOF2GJW9142*88"%YT^B;&;ME/X+WA&[N@NPI
MGL%DOX/%H/!$@I%JY?8?.3 ]HZ;,;SA(^. KJ,S(MBD#IQ7\O"&?..P87V4+
M>CDWXU,+B7P(NX.230R 5#/55F[BZHA $X6TEA_#1'!L^-BWZSQ(.1UJC_D\
M)(*MG),-0-)F<YYA4K1Q3"!PU=/> Y."=BH+'_:(EDYN2F=M.BKF"[EY1B$7
M.^5R2O,C2"V*:U +@VT*B*:0BF;-1&?8=:5QD-.P1N44^U6.$)\ UW=5E D>
MPE+,81H_9*/<(?%CA:@7<LA'&1PO$"F"PQW^_3^N+/J$ML*E8"4U Y$-4>OU
M[#_Z(:0X#&).Y**$NU;(X%^R TD/CR%-&>06L6I(@K""K2 O@4 W1P='1ZR!
MR%@:UD",UDT(+"/QNUWJZXNY_Z]\5H%01)IQ6'\JC*6@%IJ_QBUI9"X1=&*T
M>Z^)HRF8#()(E,%@4"X:>5C$NV+J4;))V8Q%9DO1BG2:F)EE'UD_/C018'Y[
MBB:VI_DC^!-E<<=5H_VQVU/3IP\I<RE.511?2U\KI<)]VFI!J:D@O8R/:),?
M9%;"873V_BQY":;$D1_[D)))'%,G9YI#?$]O04]TILC />%>ICH:I@5,]BF0
M*$ORA8<AF680<2R'")SS#,I>*%/L!0GWA40+/VF0ZT,[20"T!2<O$!9720R!
M2GW@?!/W !U/DN*GUXG4,RCM,)31>)6'<HHZ]B..E22QED6+/KRH)/+T;#?\
MTU',HTW>P<;9",B?=/[>9G3XY _,+Q58PCH?24*-/\5;B+K:^;]K@FHPD9X]
M>8DRE9B^?*B,]%EIR0."TL5&2\WD]7:V\XO9SG-?&%ZSN;S M&MR^/SYTU!#
MK)B0H)$B\$_,YHKB825WCLQ53PCSKYS)V,'&O')+.:CCM#*E,&5/A[M@/;]=
M1K<\>N*""BI(L@\^B\PRT#[S^]$-:_IGAMJA"CR]^='!X;'?^ <T!M.TSH>7
MF"E@>*&J@>"U)BEN6FN8D"!UA/Q5;(Y9S5R1DV-$U>%C^V_S.+!#A]5MS29E
ML2=+-0IBW)X@UV8HX:@K+A8"O:/X <8U&?M\4@@E"%HH*0ER,5X--<Z4R27W
M&H:1"!-(4*#'2=^*"A8X\EAE01^<?TPVU:;4);=!B9=19. BX'5LT%<P^M,R
M HN%2 OW 5'?X#QG??D+*HZ3$ ZS*5Z"X2I%N9WYQI?>XH;5K.!N;]N&\MCA
MK-(?P_J5O/*BF*/)9?)*3!4:G6VVW<G&IY8/C[;!/M)3OO?9PQ<-H,Q% ,J\
M%:#,FDPH/:@RSHK KY[U1)W,6O<*GI05)*+W+;\&/"))"Q;$89DPAB:FR(]U
MOPRBER-($MO@J[$YG14#-!\CIR*E<2AM:0<CNOZ6A]0P\!I;XK>+4F- ="EX
M*P4HE(FSU6R$KRUJKCV5+IL-:O X9H(Q9\WZU-3W.KIO=-!EAV/711C_UAL8
M;]JZQ?$3<FP,7ZXJ9N.K3(Z;?:G7<#?\,CM<%U@PO,HJJ5W](K\_*UB9D-,P
M0[3P%B$68<$X9RNU7B121MM,>//P7M6';#JU\S=RN%SB&>Q,4% (CDV>FC5G
M35O""O",]&T]46O;%+U#9#-W?+I&[+(84/'5\1$9?F+MOXC),<I <?2]Y&66
M\SGS-C0(O/NO=#8_><$NPUMI>3#H@-=A#&0XJSV#LDY5,4*BB@:DNP-4QVE]
MSO? 'V<%Q%0>!BV'JD"<_;)8A#Y=6!89N?&X=DX8K>@O30U8^0<>&JXW1S[3
MRM@AY.][D=>%S,6,=]@XS'TW.G75X7*13L6C^(6ZK1#=N%[ *I:_;V/1].OB
MDE!I=<[RU:8W)%KV%".R=T8M%"EGI&G=M.6B7V'1L4#G@D2%AE.8[ A#IFTG
M8^1*@G6&&(\F2":H<%V*67JU3G"RE*0"<<0ZYG9/<#VRSMH)#[=R!F$#8_3
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MB.@+ @0(-] ,/D#@:==.BEI$46S)DCM@A(/^IH<G<0IO-C,[4=H)O%1+3 S
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MI$=(OI?4+-6%1Y/G9^#Y4>%9K/[C7M-> 4Z-JM\L*2M]?G^SAYO5B>KVUZO
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M=2:LJC-X49*F1V"/- E)0J_BA-XWNS)"TC-,,2594DRS2+JU8@L><BQ@X_6
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MS9*A',2(:BN.@T0Q^_>&S'Z3]9_#7?UG$YYE5__9U7^V,!XKX41+SB=3E"M
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MY,R0\\1H(.J& 0>&]Z?9ZM0E@YPTB\BD.7 %,NV0&;E\R:%?FLUX2VO:PO_
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ME3W1T$U'WJD9R83=EX1T2[7%M;1D4A()B0/O.$R\W..*"V-)7[Q.F2?E#4G
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M5$_L.WLR9S_&<J,PGS&BJ:;R-,]DM*H<LYYC[E8YYC*L9=MRS)0&DJ%QE4V
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M\IV8ZFZE3JB)I6@*0* S4=6,U-@NBB;GU>!,(JAL!@;#4 2Z 4@R-\(A\J&
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MU(?UFXSVB5W5$=R'B0J_"HP#=3VI%"R%KTF3/%21_PP/S#?TE76Y@&?T_IZ
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M$25!.G2=>222\%#X'$\Q1O*07@X:00*V?_9^&ZDH_K/\,4AI].E\;DN]M@)
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MC+@3.-0FHG)EUV:&JI/E(BTCEV<TSA\XIWLZ&.>/P&79IIC^_7PQ%QAT>BE
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M87RDT:-B#KD5R[4#H6K?0PQ\*QJ%/1#CSI=[YP<GU B&2Y6#Z/%Q_$_89#?
M" D/LN]/X5,<X>K[8$?BS.H@C%=4:.N1WBM:*KY6:ACB272*SJ3/UA]2R;B
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MU>(@(6:KTZB.FG4*3;,2FM(+37-YH?G.DZ93"<V30M/KU<TMBRV_89A&T>A
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M;"L!P7"!S>DYL74+KD3H&"CQ Y3E!S<>J7ND"Y+/RQ!\6YCIO_Z/N=]XM3%
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M<]H(?/3AC\NS2^?BO?/^[/ST_,W9Z0?GS<7YV[//ZCN?WEW^Z\-G^LK%K^^
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MA^L^DT..]$^N7,\+(CF#P4MBB9%.R_]=4"B-9GJ,14$%E\RP6WUGAT;&862
MH*_I LC?*O!^CP>&R=$4 0^_X6$ADBMY(XP?K6Q=/GE>D4IE3%R/S<8 92U2
MC:#LS72PJMT7A^F0_8N!$*0Q6\ D,#D5%*3ZE]9$@Z7CY._@GC(2M7(A043?
MPWL BEM.^:*)/3Q33$W=PL!6C).I FE6R]M@AX_;SCN\;FZZ@NPHBIGWD8.(
M\'J]&G.(IIS$=-'] #-3G@R*(A0_1]IXUM^U6(JM6M%"I0R8#L2==O:'PM /
M(G6 #A3"IO!?&$?30[!OYC9/JB&$Q!AZ>HJ>-K-\;3'W%WC!@NC++(B+TV^A
M2*@,>^' %+K80%]K<@IKZSF/V<$!#8Q]3K8#K)',B60.4HL$)&O_J,"W]  ]
M!8:%*_*R)CRG$-%TBQ>+.,EP/H6T;G #X#LQYYAG4  J7,#5GBD5$22V+8/)
MV$Q, W635K"1)09<G>/W7'@'T(^-7WVT,GE1,IK*LY'J8@*LGY6KK-1+<$\$
MT0IV5Z^5W\U4^;3DM>@]ZO!!<6J5'/MD$E/[J4V, PI9O)35-WCH/^?^5&04
MT4GBT#GE(H9>IXM9@5**\$9&.SB2JAT_L"SS=(&ZBJV%PAOMD 1?4Y;V\*.Y
M2_9()"8!K3W76H:FW$FG:XUU4'(N"E$5,\,F9@D33O")FG[\7I!<6'M@AA3J
M A5V?$A=%C9G'8"U2TH-J)M&TPE]\I)X9"$G5V7)"P<LT$LEBF#.D>SS[DL6
M7M(MD]^%#RCST^_P'UHL,XA(.699^+SA2 NY2*81TGLN-23XAAA 7761ZV^N
M/[%P^0QNVZ]83.%<LA"N&#Y=+^%1\^7AC%'TA:E"16FV&SVSU>1[X3Z A0&V
M8<H%A2+UDF#,4L07F K'_]I[JO$YU;L^0SL%1.C/TIYZ2J=SCYP#D^XB0Q"\
MJ8QSDP728[81!P:N/@/?A(G1DIW$-+KI54W4[,ICJK[5*PO@3-Y7>4D7:G*F
M#D"JLV6UD'@WSM_)5+T;*9YU%O"DR0+682V/.7RE5CHG8FM*![:OA8[QRFJF
MY8NO1^;:CMC2N/N2#%!F+WY1I'HZEQQ=;D5V3Y.OL%$7'+K_*__OQR#%">4!
M??7B:^C.@"!4B8 A\# \).>:2M1<3T_4>]'K#7F3$F=>%O70AFBJI%HICF/D
M&<:D0N/2K.^:N7I+!]SMK3G@0E$[V08I5YB?QZ#MABH&Y^8^52,7(APFE$$!
M/:X^JCDQMFB@8$FEGJ:IX'#2!W>,&1*[U;[E?/CPQMG?DQ_M'6SS,8#0T5YE
MM[^IY''+].&:2!#9"T'%%&9HL7&#4UM&Z8F )*S0B%,%JB4I9/(!( XN0=S-
MG#=N O<B K%S'B>%?[\'8L*%H2?\(N)D&MBRR:F63<=%T605(F+H35#2DGY)
M?_&%R3R\..X4?JI&+*-52D0H_(!+>[$B <,!<P[X9LZ+LF2D.>"K'F)5'Z*L
M- 3'&;[RJ"@^IQ*0*I-<*E0>B\B; 6&_IO<6Q36;D]C(XG7$Z(RV01;3*L^*
M?2RGGB="SMG\0H6=#S17LEYRV!IMJK(=$8XI#2DM$L$G6'U/'\D$5G$,\[7=
MH".+0ZR*A%)OD&MHRL6R+9FVP"0FBUJNGK]RJ7;%%N+V&/E#V:Y@%8NX6#PB
M1:A5Y&J&U6(&@_(7JDZWF(! D9Q;,4]62#22OK@)8"<4H O0)-](FL*Z7XPZ
MCB6+6U8\H%?Q$(S8<!&7K$(P#W->P*DXQEJM^?5>*^MJ<[UIE9<N.V@7UQ&X
M'+-@X9RADR_+7O[Y*(L]:@_OM=J*0 =._3KLMRN&;6+)$3O/O7I1?'E&]@\G
M;A7#WI.XP-.CP6NG9B3>WVLX]S$Y=^\ !?39/W\[.W7^'H=86@%:[RSRVD!Z
M^G.%'[8+AL%%5$BZL7,&MB@G(@:=ETZL!6GP(P7INF#>/9GOL2_UV@/0K,85
MQ=J!S;"Y-'4P%)W /ZOB;%\H2X1%.6"DM32C\H,*'ZKBBA:[GJ.CD@.Y.HXF
MW;34#2EBARV<Q>0Z]V5B20E0/SM4S9FN_R67]@X\XM<$2UFD<V,]G=O9/>KW
M%J:R?AY$7%2J.<M% ]#!"FOXZUQDL]BW3"IX W7G<RY=Q2@+[[&ZD"J@%Y@:
M?9O7L?$O\:G5]T6_.RC2"XS*P\S]YDS1Q44GE1RZ@/ 46TXD,F7*%APX[;85
M"X:H:-A757FJQLQ#(S:[%K+2!I^I#B'VA/!37>SB@7-^P^558:Z[" QU[+*P
M%[W2R:.KGL]SOBY,,MF0BXVNPIC4B2FV!8M74P<YQY-/$ :_P*[4PP<9PWKS
M$Z!R'?VB%\/ATLJ9X Z>!+DK5'O-"Y&\A@?44C$5:AJ>@(G=&U40(:'"ON5'
M2A^%(BCQ9)+"08S1Y.\M/<,7<'()$44_1)9RK&YTVV8E\2^JF'&=.1::,2B*
M[KVD(Z0"L$3,%0B$JM7RD)<DL:JB<R@(ME&3/*4B,4;+7V0=,?9F$D49'80B
M>,BG0/%"D\4X"'45GIM/24(UU/\.ZE-]HVXBIDIF*G^B%@95/NB$PJ6324&I
M":X18\5>]Z#>=T0XCQXLPOGT7L*6UAC5QM62&3 5$O2=2X*A_206>>+-L)'J
MU#3R[^^=7GY*:Y_T6LL8=F<?FSA49T(& T:<88-<R4C-" 2+H.Y#$(&XSB1H
M!.&R:")Q+\Q\'N,^8^\KVLH*"(I*F8BJU@] )TP3=PXFV3O,X$M[D=\.OP79
MA(VK$H@ K-1Y@"U<] _U"'HF]I,@4@O'0$T)9D"]:.9M@6IMC<TO03+@@R/3
M'<@)(DE8-+MES97^_=(^+9/>WAV<6>RW9,\:K.8;!9)3\C':=[="%]A?^:+;
MEM;G6)I[4HRM."&NO_=$@'UFW4Z[9&]*(E1MRA0AXX'LFB; OA@WT0TJQ'.J
MN-&<825E+"72O8<6J4LD_8%J\<ZBJV :4R;E5[[.3\\,VUQX^SNCZHEHZDY5
M+;[EU4B1B3VJF/TQU%=9^Z 2-HMY.,V,3.4Z]SF:Y?RQ+,G'?!=W]TM'%"2J
M&\QE*3O\@[)GW &3NE?:KH0'487[%45+^+FL,+%<HI"DZK\TURK-%.P7UZP2
MU )&%53#^#1VP[H+GTTOR(Q1ETQ5A5:OH3NE *8\WE0V$E@:<!%B90B0"8O=
M*,1&[:&%,U#':1VEW8BH@,MD>(8 ":G: I35T@I4Z<,K)Z8967]R+ 8/)R20
MB-?8?(=OH;\WA;,6*QQUFL+9.JQEUPIG+:@"^QYB'!9D!$5+[+]/ A%R2ZV^
M^=*Q+WP-@S#VOVW,:!WA-U\@7!"[5",C 6))+EF)$6 D,8!%^,Y70:;U7.*9
M,E;8++ZV^Y%M'&O0) S0$U'JP:J'DU8X2%'90IJ^MG"2I["H/RFX:C7+OD;K
M"_$<?"7$"!8VQV0!_I-WC#")<_4%&X125GXAE2*1(89B83V*HBQPU%>HIZ.
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M,T*=1MY-H:Y3&@(MHL;$O0)9*%'A2^O8Y@OU=\/ 6 @OL@)TATT\@YF32I*
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M3)L;67+%96-8G^?J  X%+X#@*9O9:-)'\ >]7*ZXVVAE*TP!9>P+.0AZC4E
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M[F5Y@JJH\ 3X-ZI.!21 *JA.K+<;XLAFO,$Z5E.< G*I4K581B&:%VAW>/2
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MFRHBWUI3%T+;"Y!#VYVGN+/GM.K"EQJLE_H-*\K?L$?0Q4(<U2J(A 8Y<16
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MV B@G=/H<CT\N^+E;I[-XH1'<SM'[6%Q"*:UCZ4UD:YCJJ!Q#O_!RZ-UT=3
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M\[6VP>]H(E\VXAF.G:N,M'*^/-_SY>N4F':OZTI6S+<P IK:;&U@-!HM@.9
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MPRE!;0A/^[KSP 4.B6"$ NN, ,*04PHS%TW:V/&Z)(T_Y_CA #EW05T N01
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M6$=@(1JPQ@J()+=OT=&)["$O,8O-ANJ2@XL+5!<"U9I]891UFHH ,1@#3/
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M=R1MP\[('!QB(;&Y]4)%+R1:VQ#3^W Y=UK>%CSO<*N"K_GAJR9SM74.TT"
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M2J$&6A,(+++(>4&Q)'KOJ=RA9@FMJ*X0U;B<5%!EK-:6.HY4<$H&)YP,C-M
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M7Z;6Y$&(;U)+SO QFY:/T/&'M^\E=B@P0@'W(8J*M!AHI2TP4A-E+.1<1N%
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MF. LL)!8CY# VLO5EI?!QVX.D,O.Q$D$7@GT*V&]P_F_7R8&&"^^U-?9$=+
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M8K SF?QYRYK:7V- WV*_-S&J^*<SJK/.X0Z\T^LC3CUS/I<*&)?QF@)XGWA
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M,\&$P%J3G%\0C*/<2\^H%<$+4NV:#7J_9]5<1.]$D! P[)6<&O@A);C'A12
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MG;W-O5<[FW^UWA[ 'W:W]P[>MDK?*/);OO)@9^_=]M;:O]PO[6X+'ML!*1T
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MJ%SKN$C#>_I$ZCG^COV"TVXW.$.O3SP& RFY3/5H:J2(&Z1X%:1(EV,S@L6
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MPF\T2J.H5B21<*,SE\;N-';G*3B)C=VY';NSX ":0+SCQ@' R:%3K10RG$2
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MFZ&9*SL-OCG8=?I9"D52H(?/JZ7!G?)N+IL($/,D301P5$02D&IJ>"+"<I.
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M *Z)UT"+F":"3(V)3^G352T5K$P-OJV:O8-MZ,7A.=DJ]C52^VMTK]A>+?9
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M_SS;.WL;NXV]G<:[G>W=G3\VUZO'>+^YO;;];G/MC\;N'KRQM;&]MUOA%P'
M@BOW-K<_;:PO_</] M )MVV!E/: S[1BK]?H9+C^UNQE7 W@C  2__IX9J^Z
MXYLFT.:FO\4#W,[KJ/^.&86!?XR3$<I:ZIGB1'IMHW36B.!I,AZ3VJV'[\2P
MEH.UV'"GN?-)$<&CHX;JG-9+L7=$^4AN@, '!7K;.#H_S<M7^9"-;.%3!]8V
M8TAM5#/7[#6^'37]465Q@2KY+S6WA>': .#>[,&;_4YWP .'%OOT#*@;\.7>
MK/:*KVH+WQ_Y3HYD5+Z#B^V8X"K;/1\:[ZNO9>I;O7/6!=M: 5YV1#([J-ZN
M6<:_>I?D\QR&]NZZ;^!GM(+,G\T8;_7\M0=P!H2\$6VW#;_9J[RB,=?CVOUJ
M-#^OMX@O)W5R3/-3[VL<^/%<F,%*3YW#/!FW'OI2>@/75.+:@JT/66J]I+6T
M@5/>&.3&MC)/!8%MM_(@X76(^3=&J&Y6I4[]09AU,Y@%BHEZW9B!H<_-K_A7
M;V061S &5@D6 X8$'X,O'&!0L8I-7H.>+#[=9I;9$W"*6Q4<5( 3#YN^<=1I
MA4H'F^WJ2MO.B@H G(UDONC2Q:V4N@=ZW,YZD:7T*-I6_\C7L9  ?G6W"E%L
M3([A%W#6XVEV*C+<6.\[9^U\ZPQ$5XLW&/P)>"^=4'GU]859*RO$ZE0R"\X)
M>/2@8O68VU65!SOJI@S<F?AK#9# KT.>I1#![ />5F)\I1AC@0RX_8C2-+/3
M%4]M,S3B]ZR&@V>O3/90; %P<_68X4Q=+=O5Z#(4V%8%A[VC&/N  %/FJ7JX
MT %?L-\XL@ Z-P[]E]JRY!\",S)N=NK1#W"D0MG.R0G,4^\('KE7Q:I X;,+
M>KGVOT[,1HZE &5IG\']X*)F-]_[5:-915U>@<K!![ \]15#&*]7**_<.'[4
M6#FX#J9A_:P[-#SG8!$:&0L#((6/%60R\@JTF<+?H5L]6.2K69XB]!GA3K*!
M [CTK2HV!'=]W=@]@\F:<GU^YG;GVT.&T'K#6SQD!*U:V!_:G\'2WSJ&]G(P
MU-[85.E'0%"O3FCVAMA5&>_4ZGP;6//>->$8W.5*NF9)%ONA9-G>^&?-$1'H
M@3<#M_1@%X=6_#*4G"'D2NM@B+N3%P_,QLBC9.YW7,=\:IRSEX_<R-9@IDU=
MEB5?\N%M5A:K/8BJ7=)WZP&2ZB!7%H<_K.M' *I?>C$VM@$/&N+75]=X/O@%
ML#2UGW28+5!E ,"03K#$3#E/,S/[QQQ;J9$H%X3B-AK/4P(/#0=*J!2)JD1Q
MK+92R<U;J6^SUH"'"\-V8+SRS[Z['/.[T2&O 9.#=RM]^9A?[:2=LSY8I=BK
M=EG_%R;W>@(/0!H*G2KJDW__V6_#?O[O$?8G?[7MW^9LYQBNI5L76W2#?3Y>
MN]A9_W"^1?]J;E'X[>/MD\][A_D]&/]_OOSW L:TMT]VUC?@N;Z<;U]L'41J
MC<,L(,:20USDS@<V*.1M8CH03;F)*ZMT5DG'07RB!A, ') >8.,5";IF?JP'
MI/I:+5J6LZ&![H-9S6#YM=,Z R,,KJ@_RI:JVI"IS.#0NM<_=V7BISMQ,\7\
MTCV%$?9A\<-<0LX9M]HZ'I5C/$< '?.1&R6DL-0E>5LAO\P$V+K"_+]!LS^U
MK_!WLP+<CS$3:QAQ-?S\3^"/\&1O+9"WRT.#4Y+5BJP/97WCV\[>%[*UMP'?
M\/#^V@'SB0(!,X@'JA"72B-C!44:1QP%IHXZLK(J)D1]&(5[-0C.? -(_:'M
M!RO2.<U?19EOY7<&GDI%K!=DWO,HAF0_AL6;>K!LMH;9*G2J?@/Z#-IZDGT
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M\O!2LL&VUPZ<\,:87'14ZPB"@3%RG"D4*;.)2,*P HI)INQ5W]FE 'Q6<.?
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MB\:3Q[#T\W'&GT^7M\YW]@[)UL4'GH_C;.]].HA8*@#8A+2V&G%F#.AT4(B
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M%Q;"\U9[ZPN-+!#*,8)%,-DD4\BP:!$//!>UL4PI#$(X'VZ[,^129V306+K
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ME3/D$4!'6?K;+SV,Z4L"":.&1D0,V.5<>PQHP2.BE$CC(N&$9$XVG\1T/62
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M$]8AZFA23B1B,6A]-G\HN:C]YVR&%W%<DCC.-M,30C"?- K&V&R$5Y%5BD(
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M>!JQ\C*IQ $)70C:*NZDCB8%:[]L_YQ=A8-OK]K3C;";]\'[Z18)K@+ LP*
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M=LY=[9Q>'/W*$7S-3OF]/I3UVT:K,(+R,=-+G*D51X4V_094;\]WT8H\.)$
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M!1P> 7LKX/"[X#!+VJ*S5$6%4? N E5C ME@@<,Y+'/63O*"KJWSNI.V6@-
MM77#1<^XOAM9N*1*S(W?_*'M'<0J<[<'WS:3,GDY0;?PN(+&J^=Q'_,X=M*G
M8:R:!^U,-_-V;VNZE=_T!U<S)HJ#[6Y8O3?'\AC&2F+#4239K48X0<[1G$]E
ME&-<8Q%SRH180<I$,>6>('@LG><5\'A \)AA@2%0%X@2*$FI$#=.(J.%1EY&
MXGDT@K"4RP&: AX%/.K( PMX/!QXS+)$$9**PB=D9,R%.8)!)AB!9&0J=V(A
M@FNP/&3AB0_$$Z^$^ I++%C]^%CB9;_>):1^TGWL'@K!_1QW--;'""N+K.+
M';T0\)NUB! M'/>8R" ?31N[ BN/ E96PA\+K-PKK,QFA@:3.+<2:>PEXA0K
M9'C42#!CC83%U<D66"FP\NB9Y0VP4N!C(?C8F;%*HB=<:&90]/GX"1@BP"MU
M0!@[86%5,?,.>.6*6.75DHUY#'D?=GKCJAK4=7^I+IP,ZMKZC;<O[MCIA=@;
MO6+RMB4AI]+$<]KJ27_2(N'5('9A9'_'/RYJZ56B=NFN:<E'_.,6ZX;][GAT
M\RW7U9Y\8,2@5?XKHO+J;%S^F0=<B:2#NXE/6DE-.?<^I[XHZI('U:2E<%\H
M%FL7=QT.?FRB@XC<(-JOR"9XR5>V>VK/AFO_NEJ[L].[&)14+_/4S\[:C7.3
MTKW-S<_JEOVWK<U8&H>#C.?_]>LE4FOK[:JZ:3\U7F=5T!L-__M?]A<B]*![
M=*Y^7+5'/WS:VFTW-K<WWK9V=MO;KW<;VZW7.Q_?[WS<:&]M-C9:FXW=3W_N
M;L,5'[>W=FO_/JV=]M9NH[W3>+W3VMUYM[U9O<:;[=9&Z_7VQKO&;AO^T-QJ
MM7<;E<U'_LA7MK=;G[8V:_]R_^CT&O#8;NXM _9'-_>;Z8\.X^"T,XP- &30
M%J,8_GD#JM_#<*LGONJ,8'+\+5Y@HA7G?UZ'DO<Y[)\.DN"7-XYSHN5;XV-X
MM%^"BVJFEO<@9]>,SMYW;6^TT0M;_SONG.0LLLW.T'?[N3I>&[[OSV[??UVY
M/??IASU'/Q[N;\)WO-WOMMY^P#OMO[I[1UML[_CC\7[[@.]O[A_N'?GSUFN#
M]_]SB/WQ7SW[V8QWP"K;?_OF:^OHX'3_^!,&^TVT/O_5:;9#9Q^>M;-Y^+5U
M_*;3.F_BW.!Q9^-+P(P%!Y98),0C;E5".CF&DB/*4+"Q S<38QQ,GA@V,I^.
MABH2@G;1>AX!PA/C6GHF*0M21+O6B& DGV0Y'XQ! ;W_N/-^ZV-[[T7C_;N-
M5KO"P*T/G[;?9]BX,/2F6V 1 VK&%INLWR\']R""<+W]4C<I>,9[_[SYX0M-
M3KF8<DMP45$1@:R7 5$#,ZV2$,!&9O>^CE9BL%2$ 1X3C;9!1\$HK(8TQF,S
MM_>G<_^B<9)GOV%[H1$OYK]AA]F^V8P^'KLXF&P&1EXT\DI6EV8G61[!L#,$
M/90OSH4]4[_;[9]FPM/XI?C\3.5>*T"_?,/UAZ\[K["Z2]UYQ>'.6]>=O_5C
M<WUR=O/'OU-,_6XEVG\YV-L-:'G%U!];.>M2SORZ<MXS?@96O76I%?WS]3T:
M#T>==%8K3^L[4"6W\1<7SW?M/-\B1L%=LLE2PJEUA@K"<8P8$RE2M%^V;]FA
M\B8;\.V@/ZS3F9J[68)3KS;9:^_QG<^MK_MO/_#69_BN]GYG[_/^<>MXO]M\
MNT5:Y]WCYN9?7_=?SWJU_SH$RU'LT8]?]S</R-[1!](ZAG$<[U&P)D_WVI_8
MSN>]T];GCU_!>ISV,+H4%'/)&Y(<,CY9Q"7W2"O+D>&$D. 3Y0*,05Y.W!54
M6 8J&+ 4N138*F5X#-$$3#GF6GF?A#.F0H7;='0LJ+!45#B[B@I>L2"P3L@&
MH.?<&HLLYPH)XXP+4CB;6SCR%1S2?UKVS9_C3C>/=UAQYL[QR:#_=]7VXN;<
MR$?=67X!I-!!1.>CDE$$CEDTU.@$]%ZG)%B0L=@/*T"*YIS]X+GE.E&&DO0Y
MVQJ#_8"91=YX6'+"F79Z;5VPVM?S>'X"1KW4GAI%I.7"21LE Z/=@.6'I:6I
MJ.+5"-B,*F96&>PH01%[@6"A"++2)H29(3QH$5E@(& YOZ#HXM_S-;@<]^\/
MSB[[N4$MI_$ I&@\B)/_ZGS+OQ<%;9Q6TG/BG,=<$NVXBD(#I!"AK-%R60KZ
M<C9L;WR,0K_*T<C/*^"R$+A\F&?_*GAKG$(F! 7L7[M<44,@+Q074DN6HEM;
MIR\PKOU1RV<G?TX:8-$V>:\TU\#+?'"*DD E<UH8O"S]7>1OB?(WH]RC"XD&
M*I#C5"+.64*:Y,)75M+L*F6&YBH)+XQZ5*<5:ZG><S;T8;];:/85%*'!<ZZ]
M\$ "../>9BQQB3CO7'#6%9J] J#X-*>HN8Y&6A50<,8BGKA !@PP)(1F !;"
M,<S7UA6N?6>J9R=@#@N!(XE29D^W($8F9;5,F!I&X<-"LU<C8/,TVYD0+:(<
MI(PSR9&."EBWD$PY:[779FU=RD*S?[<#=/_X9#R*@\:PGT:G%EAUB'_'+FSN
MT.@/?E02R-4#.CGCI&>[C?$P/GM-K06V)M*H+ -R5L7,!&AL(K3'U$9?^';=
M4&9OGF_'$*0(! 5B$_!M$Y#5FJ!DE+$V!4F9R?8^-<5?7C?Y8YP+IQ-W@6N.
M&5C)Q&LPD;56(9<G*'R[AO(WH^6%3S+&Y)&F"OBV=QQ9:1S"-D8>8^#!Q4K^
M5N'O>FIZOC<<#<;5W*%.#P'G/AC$86'<!D@ 5H)3F20/)CD9A*=:<9L,34(7
MQKT"J/#S@6VG@DXT(AV81]SPD,N(240EV%[))V<2R34(5^"8*XKZYQ6B,$O,
M*(!YP;D4W) D"?R3D\TPI85QKTC 9GW?(B;K%$:@@!WB$0MD,.AB&R4UW(!\
M&5JE^-=6$]]"TFZ5P/\TQ5 $3R-67B:5.'/)A:"MXD[J:%*P2TL +_;RLF3T
M8-[MG"RUA"1$J(Z(V]RK26*&5!*22P?KBMW:.G^AS(*.YUO+Q<ITY#.6W!#!
M]/%"*N<]3\)K0.2H+27.8 ZV:F&Z-93<&>U*)0LI>(Z83BG7WU?(XD 1T5X:
ML&VU5R1+KERTB/:]2^[3HL'O@/*^:FQX/SX>=W-)#I"8DP%L\LG!Y9Q19H_[
M,-[SZ@]/DQW_8P5FPZ4IW[PTX_![-^9? (\V+DW\C5A58&IY,/7U&H<XH5$I
MB1S-53R4M\B T8&8%PHHFV!< TRQ%UCK.9CZ9Z'8*Y/299D(14IK*:4SQH3T
MWMHH<BN. %3=,(.L!*%-GA$7%=,N5]>@+\PU8:O[E-*GV2R[W1_9[L^MKVD5
M$CIG@/T>:ZG=5-QT.'9YTU!O2*Z3NZ45"\HN$66W3BN$K>RA[=-<P/:+UK Z
MU =$.<W-;[%'CAB*M#(L<!Z-IU5V@,+J3ISM]\7E0<_R%ZPK6+<B!U7!NJ5C
M7?,JUC&+(^%8(:4$R<<:'5# )!$U@C+@?@)^9*R3]+%AW=5RW/.%N&]57[M>
M91[?] =5^;ZS: >-V LQ?"_]UYA4_2/F175%SNZTO;,&,+G^00^^.C1LX_\L
M$KP5/A=4M@D4'L?Y!(*S5ED=M,0FNK!PP?Q=D%,0[>KXA[/^:WL $S09QUO;
MZ;WK#X=/7MKO7FX2QM3>(SN;6^<[;;BNO?$E.!!80QB8)LJ#D0(_+*4>">HQ
ME<()YLC:NKJI8-"T:''C .8^=PNKBA9?:B7]CT[/]X_C/QOQVTGL#>.+1B^.
M&G!#WEU#6(7*9=J]6,U<6-(V3J8X_G*F>O#"->]O789=KSV@L-Y0G)BLJCCQ
MVWX_G,(Z@EAM]T:V=] !K*O:40SK6)[X8"HS_;.]HU8']O(9[/?N?OLK:+MN
M=^]X^]O.YOY1Z^W'3G/S*]W__.%TOS,C,T?_[C3I-F^"YMJ'>T$6R [(#,@;
M;QTW\?[;K-7VN_N;?QYG;=?:/,A':Z7E-"+FB4*<2(*TE P1BP4'4R4%,5>C
MU3NCO-,B":RY%]1X[TB$O:>),,K&V1JM;W=V-C]OOWM7%2;>!NELO=W^\]U6
M8V-W=ZN]N^P"Q;\>W<S;I$"=<RI9&[CQUE!)14A.,8R-,^09%C3>]8<QC+MQ
M)UW(T',6D^;1UR\N.$^BU,CA[%H,WB%C\A$W;J)ECN*DYC:6I=$&DGR,"I8"
MYW[BB1M'!<$\>LQFQ:0-JF/2'&>85<[!=.JK(R879LUPQJZYJ:3Q:<QU((;3
M2L;#5[\A9)=[<TR*"V>C=,8[^?.2Q[^<B8<N>0Q4[B6>T+F[U#Q6ZC[*" LC
M[J7F\=TJ*?]RL+K4/"XUCTO-XX>H>;P*)V#UQ.L:I=Q0(M!V<S.W%PT7 8Q[
MF2,!Y\DJJQ1&KL\KK,!Y>6%!/A;7Q=WLRZFC\FS_>$OL?7YSW&I[LG?N<>MS
M$[[CTVGK_,_N_ML/9SN?/YP!^\$[<UW__GV\U^X>[GW>(ZWSOXY:YQ_@?GB?
M]@9KOOWKZ_[FMH#_X;VC#^*Z^L@Z<)A*(Y!-8*1RP01RD43D8,UR?$U:'-;6
MY0M]H\>C-EDJ!1\>!3Y@;T.T0@GJ$^ #=IZ+I!-3)% B=<CX<!O'9\&'>\&'
MF=08$S/=T@%YE^,8$<B_9M@B#9Q,1)$\(23CP\)YMJM-I:T=!ESLYH;U_SON
M#'(>[7B0C:$+ O\T,V<7B9S<Q3UU&P#9F,[X9C7A[^%%^J'@QD*X,5\WF0I.
M%)$*&>D]XIX19%4R*!#.)(F62)F/E]+YM->:617/3LXXF.O6"4JCD]Q$8KD#
M*S!$S2-/C.!*SO"%G"U@R!<Y6X:<S>AGJX41*6@D592(8Z.0PV#$&V^HQRQ1
MJ3#(&5\PRZ!HYROBLQ'RV9NJHF)CU/_N87^:.GF1//DE*.4AO##\=A-J3'!B
MN^<'.2:^&2?_+KBQ$&[,5T:.S#@1O42.2<"-* 32AB?$M-2146$4\V#7ET,I
MST Q%Q%;CHC-'5&E(4:B4,Y;1]P2#,9P"LB20*R+R<9,G8MBOJ=X0NR%7T02
M2@)V2<"^W\,FQ4>Y?*"=+QY-5>"YLC?R3N;:\IXC:[1 .0>;Q\!U#!: ]@6^
M8Q6/<JZDP-J3@+42FJTUK,W8CYR#BK'2(^IR\PQ%)-),,)2$59[:A/DD]+)P
M:';EL/8$CY"\'W1ZOG-BN]VS!OS(EN>E\R+_[[\T)>J/X8_<3#O,E_PR&Q,N
ML\-A/Y<-B*%QVAD=-CJC86-S>[?AQD,8W7#X<K&4S'I-VT].WER=DQ>7INZ:
M"-E)16&K^3JYO!(S<Y<OK6X?=O)6&UXLDZV2^_-_->/ GS7^)]HN7%Y5K_G^
MT3OK1M$?-OXQC+'1ZH]B0_SS96.!-[#7>Q$;@SBIG -_ SR%:>LU_'@PB#T8
MR2@?Y^E6@O&R\1Q6&M_?2O_9'<=\SZCQ-O8BP-/PQ965/^X/.K8+BP\ZK3>I
M7=3<>/WNC@N.[V_!Z[*F=1_>_1YV*&>#KC\;U/PB&4DLYO,.3AKX 9:+@QE$
MU"2)L8J>8CE[Z$&RF&2*6A%+N8E".V\PTUH" \=<B]E##S]F_T*&;Z=2X5N'
MG6&6OBGV3TXZ9)/FYV<=KCUM-Y.5S/,A@I/^!'->56+>^3O^.#OP?]>NW#6U
MP/"/6ZP#:VL\NOF6ZXY.K$+FWJ!\</G*_%SZ>3CXP54/(G*#:+\BFV"XKVSW
MU)X-U_YU]7Q(IW?Q>*E>YDF<??\;WS*E>WO+B54+=";W3<VK,P:T'^2K8$RV
M-F-I' XRI/W7K\]UJK7U=G5<!K;^ZXR&58<X>_.YG8??;=>?!?WP:6NW#5;O
MQMO6SFY[^_5N8[OU>N?C^YV/&^VMS>IXX.ZG/W>WX8J/VUN[M7^?UDY[:[?1
MWFF\WFGM[KS;WJQ>X\UV:Z/U>GOC76.W#7]H;K7:NXV*.I _\I7M[=:GK<W:
MO]P_.KW&]!CTL#'N=8&C3(Y!GW:&L='I!>"%@+__?#CKX<80PO4O<#MSYV<G
M26]U,O3ZPW$W'87[I7Y\1$?A"'\I.%O^Z3+RTI"['G=[Z*-PYB6G\I&,%2:6
M/9K!/J:)?4QC?6R;@-UNK#<<+S2_>;YPT#^]H>+Z%&-_Z5FM^3G-S]5_Q%#Y
MGC9@9&#H3WZ_7.XY_V&27I(KGTQ.HL^E$-UEBHEXO.=;EW*^]S%/P&T.^%*^
MG!.^BY_,O5% %XF+U'P17O>'HUOLPF4=CWY",W>IHO,\W)49O<.,MN)MMN+S
MG)LBIT5.ZS*CLW)Z;1HIN3X;NSY)1#?LELGNR$'&SFQ@X=4*T&G5)4?*5Y9:
M+K]*/'L]'L*7P^M/P]D+B$G= .^GF777QH\CY[ET6PJ&.$ZU=E)%QH/5.IF@
M!;E%_/A-I]<9Q7>=O^-LF<E/PYC&W7>=%*]DV,%[^%=A/,@L^I%&EK_793[Z
M^JUUODV;FQ_.6T<;N+79/-\[WA/[1UMXO]WZVCSJ=IKMOSH[\W69.SOM+=8\
MVLN1YGP_;IZW.OM'W>-F^V.W27,^WO:WUN=M?MVQ9.&U8<QYY%UBB%MND24T
M(L(#B\E8%2E96R?JQE!P*4OR1,N2&"<YP\$IGA3WP5DIM0>!)L)'19.X;<K_
M;%9(U0MPZYOOCO.D/:O,V8>3\MG6NQ;$6-B$/'$4\5R!P!*E4>2.4"$9);GU
M+GDA-*E[^8&"'H_C(/2RX.-FHV!XB=%>)K,%+19$B]:,3<"8M4Q2B9QB8!-(
MPI%UFB'MI7=<<NN$7EM7M,Z'H0M,/&LCHQ5'UY@8!1<6PX49*\+[D+0,!A&1
M".*<)J29B<ASEJO;LQ M6UO78L%#A04<"CA<"P[$$$4%HX83EUO#&&R-5,QC
MJQE3@MSV=%YA( ^/'3NS1Y*I%I$#[V"> @.A@B*C24"$8.UU="$:GAD(5RLH
MFUC0X[&@QR(,9%GP41C(_?LK9CMC$B[ ')0.68H#XIA:I'./3)(,V(H$[$3M
MUM8EJW.3\((3S]K**!1D*< PTT;2ZJ"29P)18S7BN=66RX68B;21\"2B$10X
M"%^!'_,)13);_1[R_>.3.(H->S"(\7AR,NH9Q3.I]4P91X3DBDM'#38$M YF
MCD?*5"SQS!H Q'P91ZQHD 0,!P )C[BF ? A"12)8S$P::R2:^MFB>',9U=V
MT1N9./>24)VXTMAXS4R*Q"H<DL!AV8'!HC(7DX@9KUVRRK) ,<!4M(@' T8U
M)QR9$*@V(EG#06/6OIG)TQ"S1?CKLN2L\-=[E[G9")H+CEH;/%):1]!"WB'M
MF$;"@IFJA//<^[5U6F/R^C3$K09:K=# 9<C7C$ZK"I :#_(%!GJ.4!MD//Q(
MQ!H<251$@GS5/I?EV0D9)M%&6+IH<>",14MYE%[$Q+0+P+26'=$I8K:0F,T&
M;3!E6&'MD(B:(RZ 5H'D420,6([>88%%**9C#4W'9<E9,1WOGZ[-ACXPS^W^
MG$;.F82X2PGI[,O0)$9LB2')DF([/@NU5FS'I0C83 A!6:ZM30HQQRQH-<R0
MBUPAX:REP8+\!;(2X_$)!1#:T1_VX+L.SIY5T,!KSU/@Q!(9N/+2$"P9V$DL
MX42$+8>@Z@ )\_T2I)21.F$!!Y($1# ::<!P%)3VR@LI;,ATDI>HP6^4VN<F
M> 6L/1'/%7-6<*(SC?<6R\!2B1JL5B1F/"P,\R"9LBBG^R/N$T/6<($\ETXZ
M[)*M/"RKB+,_1T%;A/PM2](*^;MWJ9N-&T@2.64!(^<]0]QP@VST!$7#;)3.
M:TS4VKKBA?P]?<56R-\R!&RV.[#E)O'D4)#:()ZL1XX8CT**(4B.5?!\;5VN
MH =AD;*?2IE+A"H&M@BV^0BBT4R:2)(VCG+.C"N1@Y7*V6SD@$00K:0E4D8K
MQ'5N>&"H1SIJX%J,6FEL,1]K:3XN2]**^7C_I&TV=B"=%I)S"S2-<\0YYJ#>
M%$,2YZ8'S-A$):BW^0.:Q7Y\<IJMV(]+D;#FK(29R G6""NO$6?8(4V%0%'Z
MF+P$Q28Q,+3YT@@E>G![Z=G)S3&>5>! 2@K_%P/E1G*7G 5.R1Q5@A@G-.8E
M<% #.-B;"QP8'@-CS")F ]!)QC#2.E)D1332Q0!L$^BD*'&#NZM'9E5N2J>,
M"9QK92S,M&)!D.B83(27N,%J)6+&P6(D3L%'@5P2H!\QL<@FGO/&A+#4L!1C
MKC2&:W_*_VD(VB+$;UF25HC?O4O=;-P@ NLCC C$7""(6T^1$1RC$"3AUN)(
M7:ZN@>?=+87X/3G-5HC?,B3L;#8R)R1S7*#,\!!WG"&#0<)RB\D83,)<R[7U
M^7(41:NM5L@29E+9I#B1BGN6G/(J:"P4XRGHN/0:4D7,%A*SV;B!!Q DW$10
M7P8(%2<&68<C4E8(PYC 0<2LR(J@U<Y\7):D%?/Q_DG;;-S 16\,UPQ1JBS*
M;=^1MH2@!,:(X)Q9*W+5A!(W> ::K9B/2Y&PF;B!<8DSY2W"TH-B4X(AYRA!
MPDN+J87%Y)FAK> LW6)Q@^HKU$LE:AY":/='MON\0@@6ZX@IP "%O42\DTD(
MZ8.3C'NG=0DAU  9_%P(P4=CO3(.!2XIXD$F9)F+"#,<9;0LA*4W8+E&5=ZZ
M*]O3TZ,&E*BFGE'M)1?1F$1,P)'FB*X6$9<^)S46IADO#=?&4PK")&W,^=/$
M(JT5<$B2O %$C%%6?4XTFT^A_JFB7:1KX6J,W:<FP0OU&EF2"!?J>>\2.QNY
M\#8&(TE G,N0SQD%9*W&R <?J"/6DQ"!>>)YP_@FZEE$]1DJVT):ER&;L]J4
M!L5HU*!#K44\GXW-]4^154$R:<!H-09DDRV8Q%T$M,8"BD4@AG-.O5:<4<!F
M+3GAC F;HO*I]-RHK_S.!E."T,YQ'I$U3N5L<(V,E (YC167Q!.G4K:&59'@
MNDOP0L6?EB3"Q1J^?_XZ&XBABEB<6$3)Z5R)0C*DG30(9T]0,HHZ#^:PQKB8
MP[65U1IHVV(.+T4X9V(X'BN=+ @GUC$A;A-%CJ>(2%16:^VY2+*.]O TPG/Q
M?1>;E5>">4?Q+9>62W]QZ;6!1:)_X+[U7P\&_7$OH"DTI^J?V3U_ZSACZ/P]
M,R"4KW]E+I[1Z878&[U"IAKD_>H&=:UN^ '4#5LA=:/7!Y$?NZ/H1XU1OV$O
MF5.OO@,&O-FREVJUJE3?2I->#YOE_<O[/]OWOZ=3GK6"SALR.@8VQ,KN'2Z,
MBX]TL4L&W,\[]P$_%EQ%KHGE(1)K6/1,)*:U(]3<N7EXR>U> G_:.GTWU[L/
M%DH9+Q'FCB%.E$+:8/A-,5A(P80+;FV=LMKW#W\:DO;__DM30O\H<_LT4:SX
M@):"87XFCY<S8217B+'<7S#%@"QE 0G*,3-,2TMPP; ZRIG"CEI.@S7"\YBH
M-=KEJMS.).Z,5^4DV(HE[>M526,D4&5L0,D'"Y*6"+(Z)R,$X?,1!QE(+))6
MK(4G,+<U0+%B+2P%P[;.WTU"NC#FKV>M#U\\UDY3%I$SN9N/"0( +"J4DN!1
M"YL"MRM"L5(PK/B#GA0V!D$DCYP%0PP'='1*82ZYL(%:)Z0M_J!5HN.W.7\0
MI3211!,*5!/$.:VZ>"9$<'*8DY (<:6+9['O'OW<U@##BGVW% 2;\09%:8F*
MRJ-<!1+Q$%FV\T*N#V3 2!?*&5H0K(92%ATEDA(?A.-84B<\_%LX*3C50BP]
MR[W(V8)R-NL+2@IKCAFB7 "+BLXC&UA"S.J4O/>&V&(I%$OA\<]M#3"L6 I+
M0; Y3U#@,A@I+.(FL5PKFB =7$0A^< <B<D3_93:SMZ44D3$I>HQ-4@KRH5B
M&IW9O,S[3+V<O?1J'OAD F&Z9U/!?^^<1.U\=O_GY^GP2YB&)P/U(G@:L?(R
MJ<29R\WEM%7<21U-"G;ICJUR*'-IFN!LSNL5E;8D,HM <RO$J<7( ,M'A'-%
M?#31NIP%]0*K^4->MSE'\ON"\S &6T&]YXAZBQQD71;LE8.L#X!RGV;RI"*C
MVLJ$G$L<P9IA9 F.2#+*E0S>\F#N5->EP%N!M_K"6PV,NNOY>S'IE@EV,V$
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MDH^&R(0QXV)MG0E9].YO)JT,;(C93W[%>5ZT[_*T[^4(437;!2/N@A'SV?,
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M9V(Y6KB%3[6CG78G"T"[.X3_YY7. N'.4*'F1[!0RD+QX;F$VF$%9V]6>!C
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MBA46R8&C$ZN5?I:5%G58:;"U.B:.A%4!<<XP,H8R< P,#IY'14G(*WU=@PW
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MF0\ K8R1/=#M'>"J'9C3LYS>3R6%/=KI=8HDIYR'9ON >]FM+FZ^7V:+P3V
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M6G)@B2XA$ZA/A-O 2>YK,V5#B9<GB1].N9Z*;E7*]83*-4:V(H[<42^1MM$
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M_LOS?5'Q_=GF^U][A_T*"J>"PM4)NF^P%(8&AR3&"G$;)-(2\#!Q71S5CD(
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M-6M?FHVUYO>5I>(U+L!YK06_*+'YO_^AP<+^D:]LK336EY=F_N5^ VX'M^V
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MWA0S?-!9M]N"AX5^-GK=\W)5*X6J+I='#=])C/!@O]GZ>Z>Y5!<;=!VNA^_
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M=PZT;0RU4[>&#=S.?B9N- F8(VNROL4!V#K%'N7>5T#@=3!89C8@Y,.R@7&
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MK*$09YXE&7F6C1F\Y]K"SWCGR\>#Q!/)R3_(T$ 13P;^QFU D@H/FD92=]$
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MYAIJJ>(^J (0BQ51**4\82;'+%B+[1]L3GSA:+3:8.;AVK/\.JJXIB1N[3M
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M:%40[90EV(Y+YU1ZGJNU9\4UP+?L74GF2$HW(?/D<.Q/S^U:,%T;Z,OO/!O
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MR65NNNBK+U07A%9#L?/YYW7[P2HP>PII*DJ;$8:#JK#C9.PYPJ^%1[J(NU:
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MS#[WZWKGM":9V=&FX!3 $D*T2U^6_&IX$5 OK7XA',L!JIG*SU5#9O2B-4N
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MG[ O-@-9K9.Z;_\)%BT<=\->7/2D;$\Y\(_S^LN?VJ>R^>K(2N:<IY10Q,"
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MI6N40MT2U]SF?OW[^4-;6?6CRJIO["#?RJK5DU4+!IB&L[.Q,(3G,1+!)"#
M3.4D1)L[145.4[K<NN!%*ZI:4;7"HBH+!<VI%P+@5*32"!V5Y3:*K B>Q?;2
MY[&)JD5CU4:G3*X588$!K.(:8)5TD1C0.ZXP"@XZXJ5/P?(5$U6U+;M0MHZ*
M)*'N,JZ0W2RN\.=XY:.\A[L\2/G*E*^;1"S_['&W[?I_%.9H0XM_T(B=.P\M
MG@C,[93%B36*6W!V=^#,+?F\G(E.ZU@0[[DC@N:<&*\X8:P(K(C",R/6GK'U
M7-P2G+51?JW,^#Z1PZW,N&^9L>![BD[(W-D,Q 46/L=T U7P@CCNM&<Z\I 9
ME!EP>*W,:&7&*D8&MS+CGF7&HA/(%)D4E@:B"Z&(<#PG6NI HN::9A'^$]C:
M,[K^("%#/Y!1U4;^?L_(WTO%2"LI;B$ICI<LDBPO/#>A(!%.AF"D!<%@"R(
M8F@7%;-*86CAJD.+GXZ[[CRPM^6N.^"NQ:P^EHF,.4H**R1@]T(0:W@D-F:Y
MHRYH'[*U9ZN?TO?3<=>=Q^VVW/7MW+6(<N$H:!'S@FCK(A&FP'+&.2,>88>1
M&B0AH%S!6HC[#4QS7:G"'Q/B_G(+.9%;2S-E7:&+()ADQAI76 /$9QA(=W$#
MC(M-/N%OK<"X:X'Q80GLRB)F '@5H4E@)%=:5@02.,A[(ZE5PEV>QO9KJXH?
MCL><I\8[DTGNA,^ERAPOG+:9C9%%7MP Z;8\=G\\M@!Y,^>8M-02*EG$=JV*
M6)4K$F7&<@U'9@SFJN7+F+?EL8?CL8*[X+)<,^JML$8I#L=D64XSXX*HTBV^
M@'=;'KLW'EL$OKEU/HLL$&PT1N!X-,;X:9(I3G/!E+)!8NK$]^6Q'SD7;;'@
M]0V0[[<%4:^>.'G(Y*WV NE>)<S6IR1=DI39_@3CT2->&,XS"K:U"19LZSPC
MNM 8KA(-]R'8G&J\=>;JEK?.*Y;QT#+NO68RM8Q[[XR[,\^X><@ &\B,T )#
MS*QEQ!:Y)EX(0-]! :+S>/6KBY9Q?R#&O>N\GI9Q[YUQW\PSK@;+.%C+B12B
M( (SHTU19(07WM),4)DSE6(V^*HQ[J/T=E]1Y[[?(\MM?.K.-K^FSC8_IM/[
M(=$];'I_7MQL51O>"I7;"97/2S!>.VXS;3WAIG#8G=T#@N>"6!<HZ K.14"/
M-VTK1ZV<2^X.L/@5+KF6W^Z.WQ;0-Z?6YD9%4-T83F6,):HH&)&*9='F,M,8
M3J66JP2TSN\'Y+1O!\\MI]T[IRW Y1A<G@66$^4+3@3/ 2Y3K$OJ,T.+* J=
MHP]<+I<V7AT?^(VA\$RSP7H(@K]_JILQZL:S1$^ZSGYOY%R1=R<.^J=-VT*$
MT#7Y8P=F&\!^# VH'IG/=7/I\-\QMH(L>].T;6S167UZ&D8G?6R%^3$,1V$F
MY"0U86R= =\%H$]] $V=C^IT]R:'^T<ZV^IW!WBR.V6O/X #W,8V;7!T&ST_
M/\I6.M^==+S;Z713U'SK9+A#J7F^9 _DN98J%Y18*7(BM-/$2.J)-=1$&4UD
M1J);7^I;QJ2VWL$5%@AW[M9O!<*C%0@+!DLA"Q%R3">EQA"AE"#&,4]RY74P
M/I?6:/0ZPA>M0/AQ!,)=7Q>T N'1"H0%NZK(359DA23:>$F$"9@ZZAF)G@:9
M92 4(MI5ZUFQHO7#?H1KB.V)C=2I[QY^S%N'6X4HWH]5 [*H]LG\$7HAEJ-6
MA-Q.A%PL&QD6P:5SQ J50H #T9E1)&#0-K5:TVC6GDG=>D%7B;_NR4AH^>O;
M^6L!LRN;Z4P91C*>@Q%OX6_**4]DT"'DPE%),>\MSUK^6B7^NA_,W?+7M_/7
M @0.N9<9%990[RWP5V&(M84@#C..O"N",EAQ27Q?_?4#P=NMVWC\4] -?I]N
M#'Y,'/SP,/B+1G<K5&XC5+(E4$Q%U,(4GA0J,B)R13$OC@(]!<448"U'Z=JS
MH@W$636&NV?G><MP=\5P"RA9BL(;YR3);.XP0(""%9I[ I"+\ZR0@3O0XL4#
MM#YN&>XAG=,MP]T5PRT&L/,,=!@51 <+#!>T($:C;2HSDQ<FL\KE:\_D+3OD
MM-#Y=F$V;6;JBH7&P"^J%CA_]P?XP<9H-"CM>&1L-QST=_L]G."@W^VF&,'J
M+JR]X[I#2467L'CF@Q<T4X05+ =)E6?$4$&)"S(4COF<<2QZN)ZI91=:>^G]
M6'G_ :)@6MY_>-Y?, M\--8)FQ'+"KR<\I8HE5N2\RSX7!=&4('WVZ*-@/N1
M>/_[![Q\'>^W['U+]EXP0J0M%#.%)F!^@&K/O""V<($(H7/I9<&#+=:> <>O
M&'/_H":*+X>UE1+\C)'2^O2_IU6R.7,(4_FT&T9[<:D=9RP_!T\NPJ#?RJ+;
MR2*V9&9$)I6R1I%""$N$QBX,QC.B8E9PG1E@'XO-[!2C[/?6#;EB3'G/YD++
ME-^)*1?P/Y.9H\QHXA6V1LD+1JQEC#!KG=,FR[@3+5.N+%/>+X[_$E.VS'=+
MYGNS> E. =P4@DBK!1&%"01[F!%,F2\8Z$;K\[5G[)9>MQ9_S]>P 6C=5JE\
M -3]]Z ?RU%;*NN.Q0B_)(NU$-8+39(C3]#,$AM]((9)GM' E-2F]=__:/QZ
MYX"\Y=?[XM=%G[LM% 5@33*GL0U2KHF.   L(&_-@\RLUJW/_8?CU[O&ZK/\
MVK+D+5ER 8D;6^@@0DXR@R7DX5_$!IT1!@ ]CSEUP*5KSW36^LGO#:?_%8;#
MIYTI6N^8F1NBSJC?Z<W=$<&OJDNBUE]^]Q4HPVCJ"&@OZNY> (DE#.^DL284
M.:'!<B(*YH@IHB8LAQ/TV,4R TR@VO#<56.^.X?A+?/=/_,M ')=>&VT=(09
MY;#6=$&49I)D$M" <5G!(UM[EK?)*"O'?'>-J5OFNW_F6X#>CAMJLF@)4YDE
M@A8.J[$Q$K2)TF:9H,&O/1,/P'P_$+B^!E:_&@,9=S9+<]SK#V'"2WAZWI:I
ME@&+7C1GOLVT7[E&5_]S[]OPPTCA^[4_6F?D'8I?N61X",>U9ER2X+$G.\4&
ME9)2$H)5WN:YIT7JLZ'U+6V/.V.4[X.=6BG72KD'-/1:*7>W4FZQ#9CCU,20
MD2A41H3.##'8SD\(2G/N9)ZIU 9,?&4WH5;*M5+NQY!R]VI1MX+LUH)LP5KF
M4@I00(%8%0"N%5815?!(C.*6J9C#&3'T$]_27'YP,99L[=^24?HL3;T./$PA
MAY/^!DN?IX^K%=G!;\_FVR',M(FHV4%@>^6S_K#$IY\.0A>&^1A^_U3ZT4G#
M*S-/U=N131\Q%I8^'EW]R,RJ74 ?T?=G>89S>D$$6V@.,?/GR6"J*(Z!E@;!
M?" FPG2?FNXG<SY<^VUN5:=EKQD^+Y[@)BZN_\I5QGAOJZQ(#(1/OXI,?3KN
M 9'BKV!.9F7FTCD9H&C]?Z6%!ZF+JL@5$\(YPV-1,!M=IJ+*I3TJUIX=)+=,
M/W8PAPX+<?S?;^9JLO[^U+;D7DK4]NK-UOY!9W-[X^7NWO[!]O/]SO;N\[W7
M?^^]WCC8VNQL[&YV]M_\L;\-OWB]O;6_\NO9W3O8VN\<['6>[^WN[_VUO9F6
M\6)[=V/W^?;&7YW] _A@9VOW8+^30N/I[_C+@^W=-UN;*[^X7\I>!X;MIBXT
MXUXW#(>=_N@D##Z50^Q'XT%(CX+_=6DA]S;=-.+3<@2;XVZP@$J3+?]YF;Q;
MT!@5ZLB-*K)"16Z\$DX(HUDTA3*.:RDC+=:N>,[++,^"DI9Q(Y06QC*:R9QF
M.BCJ O^"*+Q7@7_5IFR&LP' LVH5V%_(G&("[D7U05U.&XW/#I! YSR8P; 3
M0';YSF9PX=2&034.I^L=]-ZE/[,T$@+ SJ<P"!TSA!&ZW?ZGX=/O1S5?M1U7
M<N>I&1R#ED.$(^?-F0FS5B[S><0$Z^F:LV%XVOSE=U\.S[KF_&G92[-*#_U>
MCUX#"GS! AI*[ZN^KG6KUD^4Y*A>ZRN(^L6UYGV2-.\"C*N^R]D3IO,KO\Z>
MT"N_NVY8FCW)*?^J8:__3G+63I:*&PU[PSNI*V^&;W1]55'\2EU@H>BY,M#K
MYUA_]G.OG^JY]=>,L&#@\;3J;]Z;&YF[M]CC'^65C_)&_'*?V.;V?L>.A_#Y
M\*H;[Q_'T?EC^BI]KJADE(D\\T*JPL1,, E8/A?&Q#R[];WS+%:&OW=#*E33
M\QLSD/E'<6%^VGWY1NZ<OCYYM]G]L/-V&SY_]?GPX.3#X8%C.Q<;V;OW&Q<[
M[]^PR3,3%R9\=_#A_-W+%Q_V\)GW.,:+D[V7KT]@G3"'UZ<[FSOGNP?ONO^Y
MV*[=EUNCG?<;$L8[4H7(BEP'DEF?$6%]((KR@E!CG+8%S5R!/1?U+1NL/=A=
M2BLE5EQ*,!9ISH+0D@I.J?&11<]SDVMMK=&WOK=MI<1]2(GS>2E1:"TRRPT)
MCH*44)82):TD-L]$88P.A>/8=.*6&7*ME&BEQ*520G')I<R4HLJ+X+5EPN6.
M,R.]D[3"$K>Z]VREQ#U(B=T%+)%S[5T4AN2&8M:,PI)2P1,F>8B.4AX52@EV
MR[2]GS9X^'(VVNAVJPN"IF1=[[@S#,>GU?743YY\Y[7* LV]0G@1037!"(9I
ME^5!%T5^^^#75G#<N>#863)"<FHEH@BBI<&2&1[[/ M+;":%IDIH$^/:,_H
ME7?:C)_K8\V%"$%K ._1PV#<*B.%$1EF2(+RYBV:7PEV6T#S6:Z<RGQ.1-2&
M('<1ZPM*--<Z"&.#9EB&MN6V%>.VF%'N,^8TY1*.CJE<*Q6\R;C+F0HM*EX)
M;EM$Q3R/C MCB(M8S"(#*]J*8(G4N56!%4XRN_:LQ<3?PD0O0P^@<!>6,3C#
MD*\?M"/Y+61%;BW-E'6%+H)@DAEK7&&-D=JPH+UH@?##RXI72T XTUEN6,R
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M(? H@B9.!P,6D):8I, )HRP'W +*1?BU9VR]*-KDH%7C3A4S90JNG%29 !0
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M#AH;E$*]'DXVS!. 8BYO5+[I7HS+/?8[@4=JU3%!C?'*D=4M6F/'P<X:--S
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MW#4.%6M$-5/V55-XW91]Y92H=C6V4(14?T5XO8$IL_N J+%&7=?UMSM6NKN
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M'K/:%T &]>"KN?%T"^ISA07+K,IXLBHF1NB.,>L]DA40NTOW[+15L824AI%
M-L 2#.Z.8+/*X,FT?0OHFR$+ULJL:NF+.Y'160E.6LF(MH<GW*5[I"(S.T&<
M2=+U<-)=#5/ ?F4P)#1XVX/QBEP^T3X'_\W?=CX%M"0;TJ7W.\8 /G]$]@.Z
M![G?"/:M3P MZ32\][QY9.)[+FA)$]UBK@&@F3W0!8@?'A[ZCADPF"5(I8%.
M+C;!-U&F0BL<\_DS,FQOD[>MGT@HP?1PV. D^PU.@0BG)9;3I9#G%>J\SJG4
MD8C#GK'#[/)+*\<1^#*9!%4'P\$/[A5@L\3&<-;(U9R_^=9:&/B5ETW2*9B%
M+&DP%JC/OAX\>>R.+^),>;VRK7%QKA^N 8LMV4>P2&58[NM6_C&8-VIXT35_
MH P1D_,H4(1M3^4HSY3T/YQ IN=@<L*&S;;2W!6AGT''V\_LDZ6YKH^H2^B(
M.!:@,8M^:3C?^%-BB+\<,-)N)[.\38@3%B&!WJH6%\,]#">.M0DQ);4,4YQ3
MNH=V?+$4^#8#OW6T4-2<<!V%HC!/J,JCMV$RP&XMFI,HMO<0V%O&,_8&A4L0
M!A%=BQ%5&U;HS.WWP"_L&-@>WHE'9_'\$@R]^*"8+&V\YL6Q(']^?6:.!Z=8
M9@F:R?=V>&B*&;N* CV9(-">\;0,?&X&#Y3-CK,M!2*IU50J,#;7S*B*]H.M
M#>Z.9JY''3T@1Q"=IC;S1D!I( E&0^!SG!M/@R<FQBAT.4-%/3*#Q"#B)&6_
M&U@D8'2 C?$5>YN,#7/*=\P%ATS>OFA)1]Z, )Z#S# (M%1D7;&\$HA6Q1!G
MXM,36W(!I*2&W'%$_! _<?7YQ:!\:Y$]C9?9&T6R2CH HNN@8/1'YRZ>HN]"
M=1 =^0.28;5*?6AYTATNV&H[70ER^N&B:!6RVB]YV15R;(<16L!,ZY)GVXH#
MR;&E\';G4KYW=("@=$FUUF"U8AL&#V@_B3,Y81W@L ?L>7<$[L,AH?$M[6D8
M>9,=+O]ZY#<4S\(KQ][DB]9OW<R#V5DO-+.+\T@PHW=!SLD6FSO#VQ";K)]+
M&2Y%<TO0T#OR@*BS+7@F("NU! U9.!1&#K60M6#A ]$QT.A^S\-*'4PE=M0;
M1M(C >W/G5_,=LI6@*> EE2[<9=%X,(ZO"DBE@%A%@D$(79-<<Y9K61"":K/
M5G^LAPMJFHS4$C0D=^V2;^UGYY1T.,V80\1'AR@#LCJ.*Q=OTQ7-_L.W>XK<
MNZM#C]/GX%?#SK;)*T#)8/8<;ZGNG?FWAHO=KO5_?G#XL>L%IZ#XLH)\1M::
MO=RPS%[IOA96SA7<G)T+\^GST57@%C1@3+QG!,8$SAX4A?)*J@]B\<!@Y_\O
MHB0U'OC>@%:UF^V+PM'%I= DF PJ;DP^DE-O=3)$285E<6^X;OR4AE@:,I-+
M0'=%EX&1YC+X2N@W(#@(/<J>1]ZR2#F5ZBE;/$S;P');WZ6W,\N6U*/;-4WX
MBK)]&;XY>KB$R VUC2C*.3>KK&'N,->L"'.8LC?5H>X+8,UE&U,PWWQ#WBV;
ME?E3+4#D7)_=$<,6*[!7 $J@X@K./PO'"MW+S!G/-LV[XOWV5^-*.KMI3G Y
M0'1) .:QL2R<!LRZ/GZ 18[#'A8RP=0'1>&&IHUH3[4:G@3!-O?<HN7?:<[.
M]]AZQZ#!5A;\Y3R'"\$OA$F_S2]5$<>%5\638"#MXQG9=HS+5[SA90,O0VSN
MC2>\];/#(RL@_?B5]/%);*[TPJF NZ92E>0A5.#P(E_IZQU/7)X<.V5%O DY
M7L$2"!*,GBDE)D*6.Z1DJQN,U_1;F')NQ"P+(ZEI-CV^7BU4>X)F9Z67P<,T
M@SYGEF+TQ&MJ:&4_/S2S/(X$<KV_+>Z9">*.ZR<PA7P*^@BF.O8W?F)_I3C(
MC^VITD!RMKY8TU]<150&1(9FE_;IG- ])*WE')[Z<-"C81<Y'A)+^,/-F^"P
MH@F&A.8P$S5O@SD[O03BN??&Q^QMMEY=.&3)-N!8];C][1X'<< GG[(87>[%
M/\A>M/2/+BUV630Q6%A,IK+GK.]<"UG=$:(KC/(/BA7+_(,#MF.!?7NZ8J98
M[$_LZ% \MK#!;E<%91<T9<NM-WQ(5R2&\&1%2:I.YX^$[Z$,V"'D]$V4?G1%
M2Z>5LR-3"4L"55;]7%,?[X,EO^-IJD*E2N#9&1**\-H)+HXSG_FKY\&C&GG7
MPN3EDT!H"H9O_)/$:B3"IC-C4]F%-#EW"%8#DW-?:>@[ELN&)_5=;Q=$G4)#
M/&+8]LZ@'C;Q#NIDA>$8; XP S?CUO#,#;.VN2O:I='+\=X&Z?W>--ND>;L2
MY>QBW3)W&LYQ1!VED6+XEUU2&2M0TF_P0, +7$D53/9FW^&:Z9SHOA(($@A(
M8/7XCLM6&LBBZ('8#\!HT,LKPRRPE5$.0X)&!S%Y9!7>,33T;?LY/&XC<CMF
MY_GA:_;(2HN995,"X^?P,?23YMIY!1!D75XFCT?UL6NL8=@%6T@%MUO*PDBR
MB[(AU&/V-=? QN&D'?\L/*E7)*NDFP?L\"1?S<&J+C.X+KRZ\R;_EL?24!(H
MLZX/(TIS^ X@W^\+6Y<Y066F_]%GW2,"^!'UO%!)-2?PLBJ:!(SV]4@9YVT7
MI*64H %#A$"\PO,-.32E)96@"46VE",UN=^4BR<X21!]P1)DV/D,O$ Z,P'Y
MFGGX9:SM+XI-:]^<&A8_2!CER'FCZ'70<JXI(U]D]M-3^SFGDW/!1R4H"08:
M"_AAK?$->X17S+O/@L$FNVA;@Q]="TY\+1P+4;ZHLG@,S,O1DBU!IRWDAUO[
M4T@'GW-"-8\324#U&.=<51E+($%U;VT?[<!T\=AK8>Q5H$G..EB008+FA X:
M=N=5EI\SYJ[)LR*KHOU@&W-JF-^"_>K<5Z%2DTK XRUY-M'ML^-OI]%1]?@S
MC=,/O0^')#D"6P5*@BY(/7T0^/ '4-Z6.=^Z6UC4XG_PBH0WJLR)Z##*ZT#E
MM"_^WM:)';SG)I:$E(02\'S*$RM32M@NQ3.;P[UP"YS'5\'?/^"X4IGJR"E;
MP8F/*85UVV05QJQSLXK?ZVIUO>B.'FY1#=S=+OO1IPI0,JQYN-D8W 03:H,"
MUS"DII=@L'%%%BJXX V/(QV8L_HHEEF"9AY>>8SYP*+;;*(1GN-U*0,A09.#
M7<D[6!0CZTMPJ\TAB#K;/R'.]7W'WR_GT"[7W*"M\>M/_P]02P,$%     @
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M6-)0+@.X\CNZ55+:Z-(O/79_UWYOKZ'1Q=^;IXU<!170U3.*>I4[V3JR(S/
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MC ,GK8:DHM0Y<9YRIZX'JP$-(93?-U5:R*:]LS(_G]7N;%=@?-1&YI3 AR)
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M6=]6#NV$T?(6<LT=KP14I'+$T !6U6O1 @-X$1"T]"Z:7)(/W;J$W =J,+F
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M6XB+ -[$MC6 6/5DJ@'(W1Q1M:[@901J63L5#BF:0'4T<E662E-._*4LR77
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M2E(-L@\-+?SB:C#RO=^'@\G5"!_1FR0TN,OO3-/%)K<5Z]$N.[Y-)7)!&AM
M$_"\5!3,DOB$?P01:*2:9\Z@RFS>XB W.1Z8I49_@/'%8%H=?30N:$_^Z,.P
MG)[/B_/,<.'+<P>=F8Q[!!"1$NX11D_O" W)3GF:N,DJLF>HO\Y[=^XROAB6
MWCV<J*J]EF/./PT'$2"-2G'',U\\JL7HYRU++4@'62G"0JE)%@3ZSQQ]MI H
M%<99P523XZG5WOJ398M85E%S%6R[Q=A.P?=*RGTIEW.,*$_Z-T+L.,=SMLF1
M4DJ42"EXR<A@A''FK,G>V$J-'5=%^I.=RVS(JCJO$%9W"K%<>W=S=W8..2MX
M&R>7DQZ*.DW/% \'EU=#N"@>WE>8*>)P,ASBN&;=53_"^"2?^V\=):AQC@GB
MLD7!Y:Q(X-01326+3K'('H;^M\3?-D?QD]O+N+TSKE2[U48@\Q/R-]!'38]+
M':C@LM<$G<C2Q%Z4EL$A$&V%5MDHFU2=T.0E@'ZR\>E[SLTT6.%,>L[V9>AB
M9+D,C 09 Y$N.N*X#,0 =XIZ+6FLXP4^C>LGS99'<K6FSPI9%V\A ^)+R^ I
ME3WZ4HQ "@JM"Q9(L)$2G HT16# %*]"MV> _>3;,KZUJ=$6N\YN3XRSRTOK
MG,FRF <>.)%6X PSQI!,10:NH]=:5-R'JP]P6]6-?A3:OT1>O90:2_5E,[US
M8X%Q79KZ^6@3D;04"2C'<B+H*%*.)NHZ>\5VQK>KN(T7R>RMS[Z5&5;A/&XE
MP'<2 9K KAHXLB;P%Q']_"*X]-#&VB(17A"/(0@;76*E!!2:CCI:-!U+U1^A
M!&,\*<7B_O-WM;#L?:+O*OIO.?;[/_G9H#>9 IH'5!13,2KGB>+3?A9"H)TH
M'$'7)F3/E.*N2:6N1P_>OF>Y%74,VI)EA0#P>P(XO'=$/.4ZE&Q>;C5)4A@<
M:#;$:314K-0@<1+H\+"#7(UUYS&PGQ;A<HNP39U6N+9Z M[-[&H <'M&VR*(
MNS'/6E5L<])LH)7:%M1"H$IIQX2.1#L;B009<'_.N5Q/):,DM=35.7_:$6V>
ML8IVRYI5E%&;+=]#F-Y<EQ"4CX/QXC7X9F]F*E$N*?$44#*\7$<9*DF(TF3*
M\2>F3HW:35#OV(C:G 1/4:RF!BM85T_EB5(AC8_*$)Q\:/AI14E0"8C(R5+A
MK 3S:O+U?P2KJBU=;CW-OPFXGVG^:RISM03N-32Q]31_HX154.HU2?!$(BIB
M:>*$08[)!P;>UBDX\V.E^==CR2H*J,"..ZGJ\TU4N1S!&$ID+C7HJ4% N( 2
MCBA+\KK/LD[<RR,H.P\]V$15BU*^UY9S!6/E=I"S.-@2#3CHEX#L*=^%X)93
MYXAFQ9*261$/.&CGJ3)<"Q"JCE/U)*R?!LMR@Z4]?58(M7N :3Z?FH"J:JHL
MA+4;$Z5%]2V,<V]#]M42+QZ"XPH5YE()L@\!YP$M95)T(I%1RSFWEO(ZQ]!;
M),0SQLBV^;"*R%N^<7H_&$+W2W\6OAFOSX>^/YK5XIOOE$RIA&)71* 91M#)
M#\2:($O%46LEAYS"<YFS3=ZS?7.C!54,*LEQ>YG1[P^.3O]V</SYW8=W!V>?
M3_&OC^=GW_N=SLH^WN]MZL>W">#K)U.W\]Z6\J\K".%!RK91SEN?F%,RRNB8
MRT)3-#8R\YI'[3OM0&BK[M =$VMJ0*'E]+[;Q^]U?>]V;3ST5P\"&R%*G9*3
M1$?#<.Z@QQ:4=(1Q3[4Q$'.N5-9Y0^0;UR8>^F)=GD&<#*>ZZ8#1Z$6X2%R4
MZ&1$G.U!1L O,R MM/*I3FF31U!V6(EB&SQZ5(1X(U74*#CL1Q=GTUT!GS<5
MR_=I>^NQ=")C22GJ"2^W0](;A[N#=24E)V7JI=*Q3DIK(WBOC$/MJZQEHVUF
MNGSG^/N_?3QZ]^W&QYUG1A3+!NW=J0WR>%88",(QM&YTX,4<B90$JCS1M@#G
M7+O8I/W4YDA>";=VH+8*\20'7]'.**<E:.Z6.\'OR-Y"&-_!B7:-"2%G0J-$
MG))S8JFSA#&EK1')Z$HGVTT1OA+:555<A>NUF:&[:+EU6LA,<T%B.9$4(3JM
M@+ (,8A4/*@Z%M522*^-0JVHIL+YYJ*5\\9/NKZ)D8#T<="/LR35CHQ,:O2Z
MB?=<$:DH)4Y$380$P3-(:D*EJ*55H;XRCM55987$XIL:LP@XH&P*WL/I!<.7
M(AN42S?-;QENA]%1FEI#DR5<HFP0<B16R5*6VF=F<,DUO,[>N ;85\:_VNJL
MD&E\YT1HT=I,=2[=603)-%I<FX'A3 F*).>L4"Y3^[ J5TMD>QK7*^-5BTIZ
M3"&S>7&C!'!9K,.RL"+?4:Z]:6WT,0QA-+\%N07>41"0X=R16/)QI 0@#J(B
MC+J0F/ ,_ZO"J16!OC*2U53C8];9%LO<+Y+6[%)>>28=[N^$)5_*'P;<Z)7$
M.>* FAQ=]M15/E)>CFY;Q0EVRJK6U?12R@7<&=B=DLGOA_#/2;G!FU[U*J$T
M2S019IPG:%(:XE(P)*4LF$TNZERG4EL#<+N*QVF?$,L9UXIBME3G_A;@32!^
M XA;[Z/P .3.NR>TH^ &E>W;T,Z.B)1=YBG(DDEAT<'PF1.GHB!,&6K!0S"^
M<J.7;1.H>7.$G?%G%:5LJ]'&:3G&'>(:?%.,7T>?0'D24BCMT2@0[Z@C2603
MO2W')G4*&31!]S(Z)&RDUB8--3;1287;Z(9]173PY>#,HF)=Z81$2Z8\UX1:
MP3@H96VE&,"7W5MJFZ9/6^JI< NX6JN1)F!_]I-J7^\;M?M91VF[[R=%M?2*
M"R*GG=P2Z#+S M$N:*\2]X+7":)Y 0QKIY_4]@BVBJZVU$^*W;1_--XHM!-)
MC%H2J1E"\Q'W:2-TSLYG1BN',3X&]3*LI9;4V:"?U#JZJ&DNW8'&Y]""Y @L
MHTOAP)5VLI1XAE^JG'S( 2>,J6Q=/P;UVFBRCBZVW)U.@=%BUES%!B(5<&*Y
M<(7+0BF.'H"J4WO@1^Y.US)-UM'%4KMY.SD8"YK7MIQM\<0;:N95-!W8@PP*
MAWZS2#(8%:BD-OGLH]7@'0#369O%&11/O*R=N(\[#_Y^W2(5RU:C2\D+<R63
MF;A(/8E"X<H$00"O4R'X*53;BW0Y& X]?G=V_%$^G>23R;@D\8[FL_W+14=:
M2;ESC 2/YJ:,4I&@C"8LLVE+GX!:W7$03)-Q;'\E;8UYZ\>^M*[@"I;;&I$\
M=[:FZ=[1"6A1Y-*O0IA2=\+'1!REDJ2(/_!21^/KU*1J ?RK)&8[JJQ@(*[<
ME%Y;D1P:0233[-$,"FC01BZ)L4;Q1!.SE2)45T6ZK1B(:NRJJIJ7$NNP8&C3
M\YY,%4?/VA"1 AK:@EL2M*9$)5!!)N&]JA/?L 30K@[VZY)@R7JVB3(JK%&+
M8)6/0[BIQ-P$8-63_&<A[N;TOA6%-B#)YMK8"6ULQK48O30BK2NUEDJ]4\]P
MPH3 HHX.3<,ZF3L[HLLS1_&[8<LJ2F@Y6_78AS'$B[??CPB.CP]OJF) Y#EE
M2Z*SZ"4$PXC-U!"05)=27%K1!]Q8F(;ZQ"M>A"&\B3(&[4NR@K_UT.(^QW\W
MI;6U44A6^C8H8$3J%(CS*I&H!%K@7GM9J4+T,D2OPL9H11T50@<6X;J9% V0
M5;4NEF/;C5G1C@X;$&,#!50P*)Y F ('$"H3P9G#==,JXKWS9?$,0H#CJE)8
MTK:I\8P)L6UFK"+WEHV'AZA*9J@?EO5Q^JE_?0I?H3^!OPU*M:W9V<]T/]2L
MW!=D5BI\VE+-BQ%/.1"&>R'C.1LF8@/+8MWW;]_L:$M_@RT+?PO&R+3LYZ0_
M/O7CFP*P3JFD@I($DA<EY8X2G#N1Q,"D",E(K>H$>3R/[8>G3B4U+%U9MG,C
M^]$/RRGSU[:KWCUZ;LW;UZ<'\>#.->!>[QDPI[.1'.>TD2E**92W2F6 Q7>N
MCUZQXZITWDEF>+!$VY)<:RU2S"6TI97AC >.(ZJ</K&CJG2/R@U]_=C]'>?T
M\6 TZJ Q$+)QBE ORFF#5\2IS'%R*_#4A^29K"*5IU#]@ F[J[!K<3'8%A14
M80N=8?L XXM!.NI_Q46FC']:2/W\PO?/X?)J,/3#ZR.T [K#\K-.%#A<'2)J
MW)2C#:5(R)$3):-&YU5H]_ LIU5*K8+U51*MFC(KGBJO4H@C<9NMCPHQHKV"
M-F<@-AA)N%>2)ZX]=74OL_:[KLHF!*RMSBTEN?R].[[XW!^$$0R_%B]H%F)8
MRO2B\'K=Z0!N$[[>^%%W=#N<FW5]UHH <!J^\\,^_AJN] IM7^<YNNHH78F>
M$_')9V*H]IPIYQW?7GYGE2&^,K:_3.I4J-;WH=L?H.ER?5-AY.2//@Q'%]VK
M3S",.&C_!=Y<WR]&,ON5#H2,0(MADT1)DA.XO5BG28A1>-QQO%&FCON]+N17
MQN'MJ+9*-< P/NJ/QL/)-+_WMMH-M9%)1CW1T3HB5<C$ BTE+K7."KA,H4XE
MF26 7AF?VE!+A?I]C3)Z73)H"1M.3#9(:RF!.(LV20[<>G X=E>G*==>%2%J
M94=M2TTO)3"O85ZF59!U9)SHK$O/,HYKJL=/3!DA*34QL#J7Z'N0C[\2+=;+
MQU]%/3O/DFX"]F<^?OMZWRA=>AVEO0"F\9@9SC<$F8B$R'&QSYZPXI90"<Q#
MG3/F%\"P=O+QMTFPYKK:<@9MR#$ !$EH8H;(6'J FNQ(\L!!^RBIK>,K_L 9
MM"NI<X4,VE5T4;=\T?VRX-/9PC+5MI3:$4:AA<DI[O2B'&$G:8.W$)6M7K7H
M,:S78!QMJ(R:Q[=W2B_/9TXZ>7#2]NA<[OZQW,/AW22I-QC@=NRH6D/<N>VU
M*:V6$?9%<:+F;EIMH,(D)R1#%SY8W%^\BL0[W >,U3$DSBS^_9/TZYB#/QSG
M5Z%"R\&A2^X0Y[8*U4[JQ!SQ,4HBG4=@)396 YK4697>K@]*#"R, 'WR)3NT
M U^&0@<UM%'!<GS01?ZX_(.;S*LD%(N9!\)U::HFE$2CUDB2C<?!<\IBK)/G
M_P2HO;4:VU)$A>O,)=!N(F$;@*MJ[ST);S>V6FO*;$:2#311P<IZ&J2)R<08
M%>[7$>>(2XY892-QVGHFH@\FU DPWP%-GK%N=L.25110@1W3Z+J3J^DF6'JP
M%*COOI6N9C>Q[\8I;DKK%9-P 95&RW(AQDFR/@ME.5>NSG'%L]"V;]6TJ,I!
M33VT:)F,AN/.;53%="Y0&X16:&Z%F-'PPA$3#Z5RM$C6\60"V$9.%3[Y#AGP
MJX=$>/3JO;,V-A-NBV$I]X#,Z=P$RBJ6Q&KZWH6]L*$Z%BEU UFVN-HO@N1Q
M\9  &=&@DRY!4A),1KY*H,98PQ-KM/._'+4NV=_K:745$;9\IO#Y WK"_S%
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MM'N2A(I!<$Y3I=:0C2'N'W'J:*="[-;AH#\:#V>5?8_*G<877/YNL/&0,Y3
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MGX' =1R71RV*8EB'(A6Z*&,=12 )5;0NY^1CQC;=@&Y!.9E\N5XZNI4OMX^
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M(%T=K,5] ;^L>G,N1*FY5>D@HRX;K>_\++03Y,6 ;?>V[MR' +\+7Z\2$KO
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MZQU;[428]KCV4BHJ,&T<>"53]0XRQ( *9/8FAJ"236WZLCRV/?1 C<W3%AJ
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M("+?'(AC;\'2"P))R8W7RD@C4Q\:N]]>%"7 TIJ]Q^+06S[(XR3H%&+D\"!
M5$> KZ .@8WAD/+289X' OE"=6^K"3I8[GQK06]!SCX,[T%?/ V';D)8V1+8
M=:0=J!RV"P%N!T4+[O<*#WB?&,N%1XI;^"!XT,@(>!=:;@P02#BW928!] R+
M;<6RO:)B%Z:71\.B;P2C20B)G!.@%37G2!LP@ 3\Q-S ;6O*^/16DG-PJW1?
M<6T&P1Z\+O@0FCW3Z@>^9K2[$*2@)F<)&Y'1SO,9<Q.1F @\WL"N*@.!-03]
M-%9#%PPOT"QC%5D/+_='Z#<AL*CUL)7$PU@1G0BT 4C:2Z/ _;&=4$FC9AZT
MFK4VUR%'!>]HJ1%1G%"AD@Z\3*+9@>"RQ;HX#%IV$4+'09KWUO_S-MKAY/;B
MXG1^YWF?>&1:(LEH[DOM$W*>J9S0[AFQ1)+E/*S5<S*?+]V_K= Q\ZON.-=C
ML&9>EGY^GKUF#YXU[ZOI:%+;4?@0<RE#K%N$<'9:OZO SOZ'6@KW@*F(H^,N
MXN0Y#M0IS$P(AABM3<+I>K>M]B^??EI]%/Z>VN$@?9MEASYL]11\?O*L4:#7
M*N^1]P+4$@.UI)WQ.4(H.-<B6=LH,M2HK'IG\MK>7G]5]S,?W/GH:>OAL/J:
M@_.YHN>1\Q^JX?#/:OS5CL.U""&9D"*BCB:P_31'+@6'/(9WH16<<5XF5K8'
ML?V60I5%U_*E5UIV!=Y:FPF=)X5<<T55BIXBQ7([+D[R_..@D$\8JY T)[I,
M+*D1>?U?L,4%79664@&[>S.1I[=V?!/#I^JTFHUY?!QK2CS%& N/@LUC^X 7
MR)D\\U9AQP6QWJHRH8"]R/W5H=:%% MX"C83_3KF<MA948G428(V=R@8DW(;
M$H<L#@EYZ50T##.%#X&V)PI_=8#M*:L" X^;Z5P+KYS@# 5S06+@!-@,.D:/
MHA&*,R$UHV4"%'O<C&4,\P?W8V['S8*)R 1@!F=Y;)A*%AZ!CAAO*-:^T5RV
M3HWR7C(!^C,SRTKE6'(&-@-[$?KB4N#<&R97!BK$#8%#&I8K7:,Q6$8N31D?
M7C/Z^HX-%,;&3CI\+QGU;I ^]J1L0&/1$$(3*@\312@AY=V,@?U%="@X)1U(
M<E' RRMW*8LF@-%"-%"=E/!66E6HU>OA8+0ENG L*-I%,@70LR -;.C3<0P/
MXU873; 24<QB)'E.Y_2@ZW5B(&,P<<& M-*+,OZ5353U_Q3I7H[/VT5W(X2N
MXQC/)#AC6XSA[O>S[+BO!W!EGXVF=_,DX8M!/6D0M=@!)7G#>ADFF8#=8A<=
M'&01J6CYP=5UG-0GKIZ,K2]S=2]MT5)#+%IC7$1;QP^#F]O)9;JJXVR7(O1O
MWK'WSW^UQ):_X49L*N IOQA8-QC..I84!=6J?=HB*_=N^V[=/)IY.A[GQUH1
M6*W?KG=,;9#:,V!MY=*N6G_^Z_PC-\/\X[?_ %!+ P04    " "N@5Q4*];0
MUSI5  "F<P  $P   &1G>"TR,#(Q,3(S,5]G,2YJ<&?LNP547,O2+[XGR! T
M$-PUN+N[A:#!W5V"NP=W"!#<@UMP3X#@KF%P#^YNCW.NG7N_>]_WM_5_;ZUW
M:E:MZ;UW3U=755?UK[OW//U\6@%>O960E@! (!"@__P!GE918<7=+$P!0%86
MH $   Z !O$"+YY+Z,\7;T,L .CG,NBYK)N>\=LW0 4 KV9V\0'P\SW$YVN!
M9P;P=W__[9_T)_U)?]*?]"?]2?^'DIR%D;F=M2,=L8*!DX.%D84!L20 P,1"
M_0U5O"J+A?Y[^5M\W.]E*&96 (B/_T?Y'P@#+ONW5O]$&'_2G_0G_4E_TI_T
M?S:Q,+$P\3 Q\[ P$3-Q\;"P\[!R_]M[SU@$L ", '/ #K &' $Z@!A0  P
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M/2X<R 9)>W%K6EZ5E+!(\P,8>P+PUYZ8F7&[/!M6]-M(^/0#78?>6C<^M4\
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M5X0*BN=YBD)^ E8YONC/,M1>65,,:4T1'14?7+^^42N?'?7![. Q"Z^]*SM
M8%(5"%^F?E8@AV?LWX37:_\$(<*7ZVF5==?S2K%.&M!&\Y9!CX95-(=UC!F5
MNVB9K@M]RVFX!4(P%FX.HW>BW<W>U3J#%)UVA"7(\K^03&?5CF>@.*/IM1%O
MJ,FR[C8J'X>%")?_28:# .&)2VG)+R.]::=R0;EQV=9D6/,+',H45,<901))
M(7E$7]P/UQFK$BA?'S<'>MXHR_)LIII'^WJBA9[1^5(/A>)(XO!%^CE_4F,O
MNA<^'DDACEY7B%>S(I]Z =&4=? 9FJ_F().X$1!-^L72U+,YU)P5[<6?WXBE
M-DQ\Q]7L6EN?M$GZ\3Q)(DQ=XN,+46; 3\Z-#32FJ)[@UBO4T-"<:2..22M3
M5/[&)E)DD"9/ A9,'*9PB*.-OQT8\ 3T\!"FL0]Q<MJ:U3?*F 7@69C&#IR$
M8:"BRO!:\X8J?.#F0@<UB#O6N%UU5<W-:;/O5S .1=B@<SA*LT7AO!!#I<%:
MRC\M<$7DD!RPQW/;DZZ-EIBF5 ^;(J_RIU]/=4T2TYEW"?V^[.>C@.T"G1 .
M[!15..@1N3D0L$#NE^3)U>1IQ/$YW@]R&))+?U9!C*B*Y-C$DP/UB%N9W[9E
MMN5!=INU^BDR%@RER..Q0IL)H^J^61-FQ_411\-E(]3^+9>L=V#L?R2D"M[$
M>K&U@"E0EA]X:U-I6,EYW0%KP];T!#2?4FZ!GJ&Z.=2@^?-$":+Y%AC #=L>
M7]6$E>K<-G#\)DS;AXS]S,8;M'+C=02[8Y.^-H=UBOWX"?1?DK=4%XUD44&N
M'Y_I^FI6Z%93DCS-\K;#\EZ(H^)SAJ@\(;H_;7@".CK;2L*!$[UKE4>R)R!3
M]0FXNE:361&$V86 0PG/E*22R&S[X*4;#RE\O\WFCO]UDE65#Z];OI;P(BNQ
MRC*[4[OT+EUPY[UT3Y.P;P'C7'S/1K*D3:PYB4RZ#2XU66O1XJ<^'^0Z*LA<
MNEX0(7%8WS*-9BE#M.E9DF"2%X:M/J&5GO3B=RV&?/=VI,@?ZZ+/3\)B>I=I
M!)3UC=NID+E@5TRHF7.O^3&U"A[?*4YXL7L6$"%?F\X<;LLUUGH;SFRVCS-_
ML&_USI![.9^5?C[*59$ZVL69='N1>#8("E\6?1SY@'W(8BL:U[MX(\_O7<*K
M%XJ)Y<-J V-=A]W[,Z]9*Z5V[_.W):U@I%=P@((K,Q1YI0II&>3ZKBLY5D<6
MZ3R75DNRS8*B)I4]?E'@O!I3B$(X[DRRT6OP8346&4M\_%XVQRV*C9^>K;1E
M7AYL<:D&N[LFM8[X5;O(V0 /$P@\3=0.$##I05YL"*A;1M88+G1SD.4YG3AZ
MVS"YD?HH&2Z%B^T51ZPB@1;0R/M23ABOW99G7A!5?=>#H*>TX*9F7JRL[U28
MG)8)H9$%2[$-C@RYZ?W/U%$]K,/C)R"87;!J_<Y'QNGT_NB"T%KBW;;=<*11
M]F@=H*]]SYHJ*X*@7OGJ5\><A14/+Q%[8?1+?6D "IN:0WI$.(IY3V'X^$JC
M<=QIK[3X8&O68.I->ZLZ.T($UR%BN!&DIALZK [:B%>*%XX8JE?';)T?_@E0
MQ74N7XAB90O#C[*AZ6*5S&(V^EP4+:'-(5)-9N7KM,ZH<AWR)0;):M8#O<?J
M@?-MEJ(_0_F;<.[I5XE.="44D;$"QN3ZT>ZP?B3C7GCVA;NI%+N0^9_E:;K]
MKO"[[Y=J6N>9.C6465\W4+HP9[)*6ZT,2Q"AJB^WSGRA]?8Y>O^!H &[H#Z>
M FKS[GLZ&H\17^:GP9@P^ ;<RRRDH(&E'0_#)4G6N1']N"$E;L3Y%R4Q=/K)
M-Z<BZ8%: M@G22EKZFO!$!?.#N/HS?'R@C =K:@3UB*T-VX+02%R[CC F1VF
MQ6P[T0E]GFR%Y@X*6W/YD)JC)>J<F%&FNGSBM@QBG@^L5U5&A!W>AZ64%7?B
MY&^IG#_WM>0;9,2B:4T=[E EIKM>(5 #K[I?"$/[IRLW"-"/':!M5MA]-)RY
MY1>P[KF17B!1[N$-0S_<"4P_MH<YBF2[L[&DY\%1LA"?U%P@UI#)BS"RK\,P
M,B"S!M;) J?JT?V<T-4R"G^HVSK)H^Q6SXU:(.>4>(?O\D9P#\*<%AIL;*+W
M;>8*O0C>K%]WH:T?OR@E\)2_LTVFE4;Y?,(43QDV/A[^]2L78AD<WRLD0/>W
M%5H%RMI/HN-(".':,<J]?6EKI>!U"Q4N1J3&3>I&%>%WJ<=:T,9O^0KC\!&P
M60)/]C_NH?2'5L)5>AS3N/N\G PI\^Q@D06<_H:/_A-CA*SK8&YW9\+..%EA
MA?.FW7$3AWTA)S95 I&_L#^';: E^Z&Y?FW7A95:JUKJ<KGJTCEQ8S#(I)C4
M9529DXU,J!?LFGP)J57X:;Z$$7SX0U^&']?,[4N*B0::!3,^%VV-.0VGP?P6
M-H9)*XRO8\Z>U SFC$?&@NH.XNEUP)G2F9A2B@I!823V%.>5J/<EUWI&F)>)
M;_ZBC-F:#<VL?),5SA$]1<#-(?V75Y'-K#=O?WU[Y3M=1>/ ^4I9)ZT'0I\\
MAZ709+ZT2D)W/#],QY0B!4>HD&8$7=7ST-3W/-%DN:XNFBF<X"TOB!KAXR;%
M/*3YA+GLSW2S1>*2&KZ0O_CH-<]C!JFB:\>WM,A9_*FKJ<4^-E[!MJ<C?B_L
MZ< IC?WN(5.%%JT>1*)1OP)*W;/E\US=T[%G"V.PU3V4R3%MEPWJKDX9.#R]
MGQ9)"SB5./H$E:X_6;M,<.VJ-I53/7F4'V\!$0N**NO'KTAAB""CDG"&[R[B
M!@BYLI&(JF2> +CE2Y^-,Y_^#=O^^1;3A0=6;9.0SF'!=Y-\;ZS9,C!G529,
M&^)O3Q%,)-.,Q8V[/B[\^!QX9L0OZ^0BP'U\F5=<$%5^ED+! F?B::&$$$CH
M&OK%!+7?[^4-]G'^.6P-NUU8LVQ,<'"-@571\GS=<"U5EVQS%+E&O@H:V>>J
MO=HD& ?L P6'O5C$+!0OGK;Q2NN53+A#_<G-)!E9X8OY7G/U,G]\#9;/HL"=
M'#:R>J29C9GD\6SW%?,N?;&.%OOP;' E6R!;<]OT<H8]9W)8?9^_@8ABF%0/
M&'NQA]=_79:#<ZJ@+=&FG,[F8-LTGCO)ZYTZ32T]-DF8 H:P*?FZ.1?L164H
MW042YI[BY/VVEO[J6N9+^@U5E<6Z>''$0FA"21&49^B6UG:<^142W$POT'G9
M/!-!$"%-=Q@#/9X_ *>(@Q@RI.OZ@LF-O<!H=7!>[_6OYHC!EP%=8LGRB2II
MCE*C4+!0V+2A:0F!?>L5M(7=Y; $;SJWE>.M/$O;&.@5#^@/3)O-]9W)FT['
M[L.%8:J =:X%UK(EF@F):N04],F%A6%\!Y2OFC)\YC$9D:>DGX1<TC')B,T*
M ,=VDF.,I8:UB+D?0\P[:O620S&.+Y7VQ>D02%><3C?WT@-Q8WDG:T=A=\?E
M5_<.)#PYV^NF;>OH97--(0=TK\5*"97-S-UF,UH9O$N.[NGX,6<E@Z]4&G].
MXL6350>L[7\,$(G>H!/NC$0:4J:BQ"&#WLX*NS4F)&V)OI1^+:U#,Z\88%+5
M:.'2\HY@0R$_W[(Z9V$@VW;CE K4;!98U^))A**^Z.UO,%:7PC"A?DB0ZH;H
M"L_RA;GNC.6^B2S U0EC_-I1LFF"8D9S5VI!S])!IY/,T"6/!D 6^CZ0F4)X
MD9XI.-FQRM8Q]B9@BVM_?ZV%\PDP^]PI^O+EX/[/(DR^$/JZ,&*'?-69B(HY
MJTO3/3FM[\@2N+L]5C9S.#!B107!*(IQ0KALO^67S2RL0Y5*IT$%'_-U=VQ/
M9L#WUYLVN5;6-<*<RR< =_' IM\6$^82PDUT-6X);/VV\4#[*P99]-(.T:(J
M+B"INOCV .?!:GL/3[5]RJ;\]9$\38] F?V#U0ZY0ER)OU\V +8$-/_3DIT:
M 6"1(M(L?U-HA'4[V*A\BP-K_F(:(WV)>&+V47?L@<4BK]M#D>M.\PE8IKRG
M@I*K:K7(6]Q[1&F?=%J':_Y,F;S=I#S0W$#^0E)>5&U2<U*O8)_L81OJ9KJH
M@B3#$;&8^$(5UH^K7*V+D/CD78+VGI%<E1O;7JD,K99,"J5JDM-/XWB)*#@
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MJ.NOO1U)=S_(51'K^-K&+N<)V'L">(#UHN?)2=DE6MR)RX0;VH5]QP7+RML
M8\ ISD$RYU"0YXQGIY6D&&[3\Z4\LJMDEN[Z_=T86.?OF0%CNYUCG.&P506=
MHYY5WF2-5VS2F9I$E1;??HB(01(>EYH!G?E06>%Y,:3+_Y!0;JE)L)57;M%P
MAJ=6/5%QD/1&@Y'N8-ZY*]?9*2[?NNAN]S.>/U#>&X)Y=1"68ZZFZH/7,L.6
M1Q ^)VW)\M5P2_$E_'B.DE]\:4:D.Y@<:O*@KM2S$E7OUWA^[E8G'&7B9Z0@
M$Q888)N;\+T9L3.!I_ELW%X[7E/UR<'&93/>Z*J,IPXWPWFI# O:)L;A!R,5
M[%BQH;(Q/U=80G_-\)\02]SV"CHGK1TO,3XYPE$E+6EXK>XW4?D"/O#=+=!I
ML;%:@LX-B'X>,U'E6GL?=&3,XW,A2[*FC^9 <M@ ,S9E9#1_"_Q8)=&4M>W:
MI";D"1#"PJRQNDT_HKB,LB^6\!OH8;U4#Z5O15,5/2T"WZWE3+ E$*9E]ZXO
M(^]J%N1KOFJH;^! TT[S+$@,?%':V+W)E_V5&8 1Y#H$[7FH)IOE6F VFR:C
MQ)E9H'5!:T58BV-#T4D+AI4ZK[L2$G4D]R8[[(J7'6FI!GOB/2_-)1DJS=1!
MD27T&P[8:R)09+0 M\,<4N,=!8 14G+-*SYCE]_2'OQ+ALV0^G'8F[]Y))!+
M XU3)=8@],9_9;W 0L<R257OY,P1E^APF_(4?T:V-Y(NKZ\A7#K&*"K["=";
M\./,BR(),PK#(!.'+\H#"?T"]JFG>P?7>9.> $4K--_V'QV=)1WA%YQ\;!:/
MNPI@9_$/X&Y(@U6Z[SS[$P#O<)VGK%M#ZZV@ /84MU>\[KFQWQ)'B,F!?JSS
M0,&5T,+BB R<X5R\Q5< RXN;:KE%O&OZAD6+1SB!U%&\5IN8.(5!'#@6*(3P
M[R8L1>WY@NFRV+<L7ZG?*XT+$1HXVEXF*PDS+D6%9WF$-W=@6:2H3)'H?M:P
MOR7:N5&C%H+AX2;$497Z69J#F._"!J&"&J^-DF67P4CY0(XOE;4HN*I6.L*6
M(2=+<RY+-!02]EK0S3?* ZE\2JV^G[_%5@*?2-X22/UC_)6H6R2EFD%\NE 2
M+TN#F]*V*)VBHH;[U[GPD6D6T0$E5AIJ,Q)EQ'CYM\/3SO,Z]"Y-9V_(0C^=
M7=^JX17M<7JDH?(>Q/")M3Z#1ET_'F_1'RXN<S**ERE@9R[%ZZM[VK36$]@\
M#RF+(7/? ,9//MY6'.$ S\6_GJF58C9<J<JF:2P)ZKL)AKRM% ><,0F93#HM
MF6V)SB8$.D(KXB=N(;?\ES5T@>TH9+N\:BE3L=HR-DQ)2Q)1O1+OA0ASQ!UY
MU"(P1:IVA<B<T"I%+PA*"U01<SYMH,9*>OR7,W\<-FD^1O02'/Q7WZXPMCWJ
M4V]USD3FJ-RC.EIIQW>#JPO>E!H;DM-%#-G]\NWTX]L-]SJ6MN'M8DF,0\;&
M-0$P\O*M7ENP;OJXJ=^?),PN>,X\@[:=>M=8O7FZRQ$"E"V4G*OBO6$Z9X0,
M'E^.&=G"YDQ1;W&75+70 ^=7U7UB6 0<S*LQU8^?0)6*H_8$M;K&^Z@L(*,Q
MXQ7EQ)0U]N75NYQ]E(UO8[ 9&/UNCMV\''-Z'8,3U"]W]KU+R[-?-&4X=C^^
M9Z]/%Q642"O2,U"]5Z0X]W"QOHYXU&)Y6!'LFFFT!-1<X@9;,$VYR=,3I/]P
MFO#"#Y[6M+?SZDJ?+5NKQ[/_JH/QY(>=YO7;SE=(/7?!1XTK/B)^7.&IO+S%
MP0;UJ<*[U0FZ,3")Y55/@&1#M*"S HT'<&908 E^U+85/!K_4I_F%4AO\@'<
M*ON(L>.D $YB^<J!C2'P44FMF$^:)C$.8^K2('6DZ?@PQ3'>YJ.U9[?+^O&.
M$*&WN--L.W(BRPQK&/B*?.71^PEXNUUA0UF3/-@<EFLG0>"360O"^.V@S'('
M]Z'G\W<\EOG,(OG%6U659TO/)']8>K;T(0'>^65QZ8A3FZ8WS;H7I0/G<F0F
MMF],F^NE6NPRI.!'BPE>PP=O)$#^7T$B1UL.0R%*&C+F)AA\MSXVBT1NAUB.
M7Z(XM5),0#M52J8Y9CC]VLM8_$->2"_2OCE40&Y!<UWJR&I.DTAT6XROO>)?
MFJG/6)/9 UXU9+UZ?(E"]LO*=+T[B2<ZSA'A,, T=%7;^'5TMZ^V&HDX@#%U
M[=K--6?B=>\4+N(KJEV'#MK]"(O-%ZAM%NK%9X.@,\>@S]>,LG)%N#Q0_IO'
MZY\]/CQ!C>)KI",-\H<VQ@5.FVES3E!"HG*L6BB&P,G"]X3K\S?OSQF1\/P:
M- ,2(TK$/!J:+K,1#VA%FJ>1-QX6<+XGAIP2[%5/UFKQLTLF$.XP#U4.$AV7
M[I:$8Z#3^/L!W]!KGX>%0]9K&W:KCA"/O&N'RZU1Y;I(':VVVB <"&MK(8$H
MH$: ; Y5FMM:*'LR<9WUX_@Z .^FO)5W]0E 01)YY"HPD6QLE/U.KKU:+_$Q
M<ANF[4S[JLL7;T$P3&"TR"W'68-/OD"FF.+K<M@34&.KLB1J6QIO]()2+SG:
MB,_^&[AE7/>U]QJ2M4^O3%EOJ5Z45E]8U.E"1]830!2>?Y.R>.7 <[[6/$JP
MVQQ5^$,03NNGGG:7%7]T,?FX."W<)C5 -92]6B4GS(\$>*A@K+4#@=T\1YV"
M]3N^\R=NP=OO$O9OZPO*V"XG^]1CDLAX#ZR1L7L:>[>GO)AFH!.6?VD&U3<5
M[B6]^C8[HUEWIENA3K3T@]ET 2_23R2@E8HW##BGB?9TL\UE7I#X2K+?Q4Z!
M#NK;;4<SOY+]@K8WU=D;=\Z_EV)"\T/]U;>5 !ZU$E6YFFS1$I(X9HP^? $N
M.Z-'-M"W<:6%>1F+#V,+)-+HITCB0C#FYK>US2HS%X-B"U*9>;-[&N<*X*(N
M-M=7^555QO:QX@*-HPA[1":-F.\;#HT%22@/&PK'GO'/_J]_?1'AQ9><+_.6
M"NYJU%F'C7>#Y^P_=MN)FB>E/_#]$MS.C6EYSH =V9&1A.90 [\JMA6/VS*V
M=%'.+>2=B:AOPS>/:O'NT-[%II 1]1(-"=Y.@3+^%A\ZOB%\PMLP7]M]EYRB
M17RNJJ\>G?M4E_RSVW.(&QMAZ#^=_&RZO+S*1MYX;EP<'>3_CWU\AWI?Q'NR
MPFL]Q>.#Z%CZ\W(Y4?K%5E>T&.;&1_IYOQO) 3@"MXV9BN+5##*-9+D$Q:\:
M1.^2AVMI#H@^S;N<U$9&XF-P@R?JS+.1C62N75?+B=XEO*NI:;+A4<==++-U
M1HB(\(YT$ J7QGEV!,#OOC$%4?/W$LS39KM,2NAGKK\C[7?UY!^41+D_$Z6M
M%K] B%SQ@/]E2>O9XEE-4I=)_5&)30E[@:/W?4 A =PAKP*8T^!XN4O3]C/$
M.1UKS]"0&4%MNF*)7'N;*HH:[IN?*!4TH3!L;:T\@@4A0>JA-\N2L*/'P"PG
M)R?+@BS#>)VH-"WK*[!P.O(';O;*?UC!=$^3SZ.\@DMCS.?@"<BYK'AA;MR0
MLI;RE@>?)7-ZEWWT.D\22W7K<M'7^]7-M\=GC($JA*_SG.O ;X_N^4M\+2RZ
MAJQ'L08I.W+NK?S*Z5\\ 7>"JE$_UZ@%)&\)GP#_;!21__!GS1=!6V$&7C+R
MMBVC)Y4#OG)U48XKW=P<KN_X,86SIM2>.^?N/81DY4B.]DJ3@T;JE[WB3'![
M&OM>]>.2+Q.2[O$3$ )Y"!K^26N-,M"V\8R\%:"<D$!UL%A80N55?,C!\H]U
M+K\B<*'%X4N8 'R02$END!"&T#? J>"?4#T*:>#;X\."XP:U$XX.1"C=R,6V
MD>(W,(N)$U+?%<GOQC_1A(?F.VDCN[<5N77H3GI1K^-<(/PZJ$-B%*]O\F.1
MX$O9:+!.1QTQ40*L(R-1WAZP$\%<:ZFW>RYJ=6F*7RQ\1N$?_J@D]1,;QU1)
M#GB1\/BJ ZF5XV31O-[U"^1-  YC'A8+N4UZMCLGQP(SGF,DOM.:'U?E:[=!
MU:\S]P<T9PKQ"/PB/3U;; UU6NP6J?0[)([;K4$F"[C$Z"8@?&ZFG2B2$X+$
M6H:JNMZP"[?[$V@[<L'&3\%1&5I6QL@9'O@!PN>\68CF6*GQNYP>A&G\IS (
MSO3Y-C1!W KXD<="9!-E7Q(+>UED"8)*!O$K>7@Z<Y(DH7D#HW'\B3,+*=E
MFTL84Y5\>,=7G;<_+NOL!2(GV7 _JC%W8BYJ?\VC5I\.GA,)C/>Y&16.$3D.
MZBGT7-7B/;"/F6>$TJX5Q_#Z&!>1KPYU_:ID8R.>1;HD]<C_O%RKJP'"GUB>
MF09;8(\_VX,G3F3^0MQU 99E"+UB/9XUT^J?'80,U<UC=FF;[U4=:G*S?GE!
M%'*MJN*Z1%Z%U2P6F7<5^WCBBYQW6@'[.UCB!W====B.K[EPQPFZ/$/F)V#F
MA\4LP<I>6W*"9O6:^$+'\ZV]!]KJ_[C*0_:Q0WGHZ'Z_J&-O#;_JVRX2,]$P
M+4*E E!A \B?:O\9$ZLPLFOQ"^SV0$[M&'1$C&"^'E .?8C<,$864#9*\.^M
MH%ET>*2K;6HZH0PL:&A(4C^X,(LW$Z,CU?NJS;!%EKTPP.(9RSL&5E1A&Y8;
M59^<N))-&VF(2U&Y3.Q7I5EXA:)"VMHE=NQ777><<?M++C42\F.*)[W2ND>B
MUJD9SZ1O-#$.$\HK^Z!748-Z-:GVF#\J*-BO/LRL7.:A!3H5NJ9@R*#P5740
M!U[C=.0[#E: HQY.B0IJ@:H2=IKMS 8S3']&P>J2_B'O0[/.3)2[%5+[.OR7
M06'TB2*1"1O#%B#6;^!MX,0U;Z>F6'-A<+>+O66J:L;JSWB$PEKJETW23=Z1
M3%^W[;N0=F7,TL? .:*5.V>Z&IHOWT1OW5*;-@1[6I"Z2*6H]"-F5R!4:IMQ
MXV 4Z/+G71M"_D<CUQD.Y]JM7]$2)7:*F@A!0M1HHPVC)$I$#89HB1:B]SH,
M(GH/H@21B"A#"$891(E1@QEFH@:C,Z(;T8Z]]]GG^ZYS<GW7^;'^O-?[_EKK
M6?=:SWO?]P_]#86WY23G#W=; UT%$PNK!^@0[M=,,]HNPZV4V3\QN\NP(D2H
ME_?I"9&#PEQ/B_S$-.+?<C[M[^IOAJSF"/&$1.4SZ/Q[-^'FID+A']4<,A7)
MURTE^!S+)F*:^.M:6$P/ MY[DH4*!ATF_UD(@.?.65<Q'UI7Z"TSU<RAG]'8
M W,L6B1:&%V@N-1Z-DP)S5\9^\JWM'1M^RK9K=]I>QE9ZT.-7V;=5:-@OJX/
M*_EQ$OCU%(#% .DQL42C4V![2N1P31_1(3RN;V"]Q,(&I/R+XY:]61';,G,)
M>[,N4@?V8/89K':HNS+.O1/3,SV]<\_IXMQ'@@091L^X(2_6RYGKFH9PN6TJ
M,3G3&8/!F6;RQ &:+Z)-:N&]Z9U4,P-<62?B@QF&L3JFZ'0'<$7N-7^;"+J6
ME9$%0]%W(%7&UU?JW12>)M'W".15;0Y$[K)K"#J+V#C<VJ:X+%E63-^:*-?Q
M2"QJGO.<6YP?Q0Y5V3BI5+6A!BO,B9ID0I";F4B](O3'<7I,)&;,<TY/#YY;
M.6'%2O9&N8@8K<A%74KF_=R4A5.,4^*WX#7B?Q >YIY$;X'=.307T'F)UHEX
M4AOJ@V;;XWC4+=\-3NTN#\;/BD1*TD*SM>KKZD\!%<?ORM\G&*KOU77'WCGL
M8])5=N',5?Q8'1+58/1NAEW<M#[L9+1B1HTINFBBE^^VI,_WTAO+W.;3_B6-
M%]7 LW#9L2+;0I/E?2B>*6DM6S?'S*S>QYK[A0%UBMNY C@5@-:NZ9TX4L4B
M4/<=6;.);%I3*9+G;U?79,V:B)&ZC-O90_UY7=F["C>9$YEZ-5H:!J<Z?W9C
M9H:=YX2)"X(IC!0?=1O5+<X'+9:$ABG*R0K$X9JYQNTSKMR7S,FP,$)<S&K[
M)K-@,Q4U_UJ0EXX"_D)_O*[UF^*8)=-2D78N:;)*Q=DC/?4"9S+[;8]0:SX#
M$&&!E^7DIN(UB7_H WTDC.#86.\Q7N @[FR16"XE[^26!5M@$X\I/Y+'_%G-
M%?<'Y[8EY)0#59FW9E$K3>3MSQ0X:A7ZS_#YDB+;J]]P$OR;RT&K4B&[(XFK
M!JLZ'7H' <==:^I/2:$FKP"CHI<)8!7G4^ ,F@>U;$?ZN2QYC:N#"/LE%_9X
M.7!P>:Y_:K1>R+KM<0*2<&_$U#3O84UU)0A7:I?4M88!V0G?CAX^=YGSKGB[
M9WC,JGT^@_0@BG6V@D:M")0-RBYI?N.HD$GSPZS[DJ.E!)C.W,I)]B--#S,U
M\)(%$4M_I>.Q46-QK'7AA,-8TX2O+[,8.+F?UE\/S5^FI.[6QFF0269^%#F^
M[7TV79*_(TF9Q?QH#U H]YHI]'/8-YT8?TB4G%;/90GOU#W?K"'6(3<71T=N
MN&-)Z9<RZ!?P[;BZL'+C. ?GKD&' 2-O%FP-C3X@8_UB]E%H>'HS?&E8EYKQ
M@Y_8"0;=BML><#T%+FO=7!/N<T('5HNB7W6QLBK[HUT$Q"#G2?5@WIE^GFZ[
M*VJUASRXO8:1D:Q)ROC+=^*&5'DHG(.^[FMO^%XN:.** ;9A5UJG^#>J[+>6
M+;_O8TWLWVFERV5G6AFYWX2MS(*DK[NI:NMP7T?SM@NI"EV$R>*V<%HG'+58
M)@VIV\O6F7,^_%>)*BT)1<BF -NK9&W/%>A&ILRMUK^NO:_+LZP907!E/;OG
M%2.ME_R=^RIO;] ?UTBP3>U%M:Q]@N%[I\W"XLI(Z+"0'I+,DXGT5.8+#_M<
M>&A_U<ZR1>*_L50&2%T$]:B ;Y =IO*P^A VS2@B%W6Q'?=RZ+$6X.'UYRM+
M"M>O>=$^7=-9<1PH'=KQ.T*P#04>/- 9CAND_)U7@'0%B\IGHP1%Z92; \44
MI\!NZ;E&$99Q_ZP@*<"F@Z3PY>S1EW(0G(8QYI.M-.<<V]EPI5.38S9V7W8G
MF9S!*2;]$XK7?R^>[PMZ$>D4\D6'^]>)8>/_-%>6W+NX<C!DIEZ25B)ZWC36
M/JSG@ID&V!VI+-.>$SC[^0,IW/9BL:>3%T(/L?:3@%UWQ?$=1=G!0L4SII3$
M.'N*._V_.OIEJYP"+Q*585)$#KM)\.6#;"E";R9/IYCL&MI"/.]Y=\,&9,RK
MR67@4,5UKQS!5-AR!J*5;^5$&W,.V/T.)Z7G@%,@(MSVN&2O9?1Q?FVB'IM-
M0VB,*(4O7:NAS@ JK.^=1S'PB2+![2=)9TUAHD2">&\Y'G:<(PE//LX8F)PG
M'I[8@0<F?XXB?8,\M>HV('F%4R:G@+WSH5']C8J6KF^3J6HB&?$3B[V=/X,(
M<0:TTW*('Z,81[X3=K:,O93OV2J+D=NH4T!PH(4*(K> SFAD,9^P@PN/DGYJ
M-E=AA#G#=A-*>._0M+$94]Q$3:Z\SRD5;F-VG^@!9,I"+@6IUV/!XA43CTG!
M)W@HIHQRY;%EE+K]N)N)AD84'PUH?H(C(2<&R=!>'6ZTR3X74-.A6=HJ 8JE
MH8!)]V]K#]7)W)JCY54*D\-I1;;Q.5<?^^!,$:!)[W@^A[(&[11!0AS]]U<5
MK[_^6)Q+_4;] )C,[BQ^"KN#0ZQ+U-W$LNV9FDQKW'ZH.9^8>\?<./=NS/N<
MQ&R($,@U*MT'A-]R?*R *.RWM4<BG-VOZ_!\2A^M!Q>S:]"WZJO0)<A<'3\%
MR"=6G27&ILH2/14R]YA3>H;;&%\T6_6\?;.A1+N5HL0].)L_#*;\Z%B[_W.6
MWN/"SW6G^R_$'W]GL7H)N:N.[A43M;,J3:VCX_MR/86L_BTI2_Z9+NI3AE8S
M5L29.\8.V6S<#M9WN<#URH?EMA0+SQ_0) &7*JM!5 6;^>I9C@;&O$B"J/@\
MW]X4Z&0C>+&_4[1S"K6)^!?^NTT)UFW7O&-9IJ$\TH$,0UT%8^E$!"//QY@D
MYC,N0*'TWKZ"/_??>W0$V,&YSGHYF1Y="C]GKRC $+#+,JAVN6#CZA-H'BGX
M!U%VOB$W:GR@5H:C7&#PM\8VY\J+'/:(H,#@]181_,=CQWYUSB35\RL"(P+P
MS5O153@>SN!UURD1PG"P%UG:GS<\%9'>#)^>=Z-F[S2K[>U WOCNSGM/D7P-
M3H:P;5VCN1QIVT<JE?GT 7\=YW)K= 8^/4L^OB9BW 146&QJW.WUFH'.0X'E
M+2=\+JA$75I0[@QM P02AV<S6G&#:OEFDSKNI18JMC3/\5CSKRZ+[F(+JF(<
MKSB2I"E*" ZW2FF-1G;E$(\'U/#T[Y$!SZ*<SM=_CBY(L$EFS9BS\R@[_T25
MD,O ^A4(<&:<:]")KI" 4"I197@[,O9E-*!.3)>1LB\2+O_2._E Q_CP4]^+
MZ>MT[*-71I\W[$<%F5-5SN"P9<^:-^+35FE)N5[Z6P_;[C)BKR-%&N-;O!;Y
MR5:\H#FC?H2.&[P8VV&4S(U,:\8/:90[E9:=VQ);FLQ9W'3EN8_AHJC(;HCO
M_,)>\NRQJ=E(N1U2UCDAV:%H[$?W7DV(Z(LA<:)(G>!3GZUYT[BCIB7RN@*4
MY^/-A;/-#_H5A$,.J0G*DJ\8(0>7I7P$PQ?HBA?JA-VKRTH4J=\4%;JNY/(.
MHT2"/Z\LL#]P=+TX,=4RVE<[U-,KH<1L_6 )!:)-ZI/I).-7E+\<LQWOVZG
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M@^A-U1*#K#U9SJU39!\7RNF0H'+W =\__)!:KX)WNB^< @[B1Y^AUKB=;JA
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M.4+TL3B: 1K$CWM_TD_Z23_I)_VDG_0_E!Y90BWL;9S9Z)2-79PLH9;&=+(
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MNTM9Y#[KY]S\,J?N4FRX+E=/JMO2[7MNOEE[A *H,Q[=MV14#W_ >YF,:'$
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MPZNBXQ<UNR.PB;SVR1'[H06AY&0L$?[H&OZ_YZNG_S!#4!/_"U!+ P04
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M7ZN0K:F$D2\GK#9;K\'H2K,Y+&L:O[!E*;\AS5>C@.YZ0+]TO8QLP;N=4-Q
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M.([AJ5#.;V5"G*SL5C_*815)->&3/1N;S$<GL+?C<43_A=26TZ*C"MN.@&S
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MV*+Z2:K<-(1C#2"XJ"XMYIE*?%[8U%1?69.T>^%Y<+#Z\F24Y:/\-%82JR>
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M+FK&VR"-B),7?MWBPL+VS%HALFN".W'RM$CCL3T.U"QXRZPMR)1X=F6"<&"
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MDW*'OW8-C\#N'B='J-ZJRBWB8S?S^V,68O^#8L9C&_/64  .R*T\4K/T1X^
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M29&G(!GE>JL+B00FW32KO8;ZCXV,G3.77/#(-Q0E6V? ]"DC^]QF^%D'58?
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MA'W34K>/\^4AZ'0E3<?P\=T2@7<B(#79&P.VC3%[>F>P]X".->1Z"9K%812
M$UAN?8.:G&^\;+0S8^W@Y#,TR_[QX:RH V1)B2.>F"L#F-5_/'M>/Y7U,/+!
M9'+CU"Y75>NMOQ92.^,I'W L$)+\QA9EXF!F>H01GXE6CM:T,R$S+@1TU[#K
M:^L7 8P&=3<IUV43G?'+UW.6SZV ]M>M:9\&R*^+R1_I:ZI)HA#^5^2O8QE+
MWI_1#1#_];](M_;_\I?$3PC&JNUUDV?7%0YY7."._ W'_+JB74<$P=)6CCX_
MZAD/?TN;N"'M14/(VP%]FNO?V0&L:;ZK\>I754(%QWX5**4$!BI\:95RA-*L
M(P.:N".SB=8/3V%$,U]61:T]O'TR*([O>UN[JY&AUAM!IKW4,X.=9$MQPF^W
M L2@70^SFE-E1V?726LS6WQ)9!JYN5B!$AB51BR6$!@JQ3AJ<,T,?<00"_)T
MI,&+Z Z<ZL /(4XG4+"3*-%"4(;'ZQF^5GL)?-V=!]J9"K[.@E&J-(Q+SB_;
M)&2GR4Z:4<',S9KQ4?=,2+^'6/I+2WWLV;9C-OGJIG3 "D;\31+6T.^=4?1'
MB\#G=T7T,6E.VC5+]/T,-1]G+-J:&I(53S@J'2?DD-LTUF3>.9;W5(5@-2XB
ML6"IHN5CFZD(IY%[+[^:]<!K@;TJ@_[.0S79QT2XFJZ_O+BQR.0[V/M\\,OP
M1/#E@EPY\+Q%L;M[662*5XQN1;IF&N) >]PR,[YM<!C-(=HK:CZ 7-PV*8A<
MH7@F#['/O;(MEJ(D'SE=E.*,65&-4Q*N+N!'2DM$AC4D1)U&J:(IY-E<"!\F
M$^?FC5]$*H28?F)A<MKE1I5KE1((=WWOC]>9/5KT,B5MKTG$U,^4L_\W-U$8
M6OG4CA&'4X[GX4*7,$I2K'7YO++YZB!;?L3\1D^))\:U'D*'&$7FF[;$LB+/
M]STG5\T]PFWIA2O=?$OEGY$?+&;='F-307[L*/&""X#=Z=+S(NQ/Z\3UYGA.
M7FH>W[=ENY2#K<==BDI/P$9$4$Q+FM\Y&@V'CEZ#BW)D?.GBB>MY,)1.E2L%
M\I'=V1Y(JQV%-( '",!NOZN0TL\'B+5]7=J]\?T8)^?A1:CBY,AFJFVOKRZ
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MLK3 )#5(DQ^HQ$ZU)#5'.H0HEEAU>!M^%!J]+90\)<7:!-80JGR([.R2:TF
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M?DA"ZYL[Q"[0QW*C7U0<3=2.>6Q EA/@D$E=3RDG:4;0V_L+$3--G[8'M 8
M@<DK6<SLJ7>)0J5HGVT<@8-A3O:EG?GL2NP/10W>IP8 0)6X],!(4=RS<UPV
M!351&5#_'IQ<#)WVYN:0L.AZ[33;.+8G$4;84#2I_<*!-?X9C1KW_7QM?.<R
M3, #Q0CX3[2@6:"19"7T;#.>2T;$K*O2JL,5SM;+K7H*:/ODQ#G@Q[7;&9@9
M"9I*<4SI+5;EJLM0K-<S[Y62Y;<15J73Y\^&X]Z$WGR44(4V'I6&0S5BU$?A
M22R79U:$WL4^3(#)!#R#M SJ$GUJ\2!V7'\I0>&^GD*P\XU*.O87)5OM.J)=
M9OY-]J.\3&YI'_#=N^C3-O-FWVGT@K0%@MR(7 FS!A?4UK?34S._S<9YS5:C
M+7Y]8&\P^9=Y:;T_?K-R/M+ []/N^3F4R9?K#@BZR*)JV,HW/%IVY66&5M'X
M2"2\L"#7.[#8#.;T03K3,?!^^.W8S;(XH[",1U4*E9SM 8Q_IJR:_&5378WV
MMY,_#2SH4?T3]:/4XZ_NZ+^O8?X;0MM3FF]YAJ9(0$;;BNU.VC<+3KH]6IKM
M#U_TSMB0!<R5$?N<%$#J1(9_-0!I0]QT/>4\T<M()JB]!-YCRW/68PAN,<_4
MJ]@;="?(Q[$=ET]DG%X"Z&6KV$-_U+$M!2 ,EQU4#(&.[())[S_?!HS;5T\4
M$10 L#UVZ=\ZX?ZE_LWV^&H_.Y6%]Z9?"078) 03I?V3PTZL\%#8/0K 9NR2
M=7;.>Y[\$[UXG0*8QRH3ZC.7KWR0UCL=7'%O;N!>\P3957 'G)4@0-]BYN=\
M57-5URSGF00%^%Q  3**#R]"_U.9_!\<9_3>39A>TMH68V ),9?6H[+L;.-&
MLYJ3[AHNX&!@S,UX=MK\*%XV>2<;Z?,BU,"#O34K)6=W!:9T/+V?[=@#5^,Y
M[ZH7"2:_7/-3@MCE4RROAX9H4EKQL1R6KG,\7YYT-KZ^)W:2*;17H2/RME+1
M&19:1(^]<>1#E41=O+#7 ")B"O+Q[O47%E<LUC>QPBC:KY-%_><\\L<<U*:^
M7E,1.3], 1RGCA/H/44.9#?0%R_(S3"I0LB=D)T,?X)1"5DJ=YJP0_#9ERC(
ME>.'A4"6K@B"O>AHL^(D?5"[68Q_](8@!X:D$.%,8J#.,&-_\8A'6Y(D?\T[
M@QVWKN<QV=KIN5C8!]E&MG5G8C)98-O51 *ZCYI^/.,?V3/2>2ZY !&:]U0&
M[;\ 9;99\UJ;P+[NAS/.XP1,ZM/*^A-\-^9KY07W%E+LD$I;/6ZMAA>1X5N6
M]1-O)Q W-\UDI18:)._;%VH#2YCKJ"X(]..,J_F=\ /=I'$IGFWPS-TCHRC>
MYBX^WTV+"+QC B&V /-\H61TDBZL=-0G[K"?HU2B8^/=!V,*P "Y[&J/</;,
M>UA9\_)*_KV*'M]KNC40QVW9C.</7@XI,PPQ%4Q'[ <<YY?I1%DRMD/*%IRI
M>I"U3;,QNU3MMX@=+;I*G@Y#Z-P7']<WHW8$Y,)=R<\"]I@T+Z411TIN$;G6
M9?K=.K0\]A0'UR/*/G]6C[XA4&EF*N8<IR+HL7*-IMZ=^<4EA@N-SB?=K[NW
M67'...?.-['?^(-.0DYL-TUL%BE >(9_(5R)?(@^O7,'7,!*U[*^<[YR^>X<
MTXBDPM#?_"(Z0)/G7.#'B8\@-?TCYK?IO*-SXH<^,;\..=!2SM@+\R:^TL8,
M2:?;5AR5NQ>Q\BPCZ.G4[U0-]MWB(7:<00P9HZ.1O- H0Y67/:;9$=I?#-;'
MEKR=C8RMWO=V0641:40#*[+4UHOUDA),1TR!F$YPN5HQI!BKA+_#^U%JY]F4
MO/R*-%4'*1DO6]=J<-(;\4- ARA3D)3/Q5NJ_W+3@/.!PXUFSDZ>O9((4FM!
M],6YG^*RWS7]P!NE? S962^G[X&-![PZ?544CDQN^R]<9YR'>1TH!%ZHKHW9
MMTN6+#C\R@E3-N9!,9=2R="2'BVJ%K;;'R>F^J'R[\]HPUC31T05RWK:'(J%
M8.LJ/-A4XB4\\WGW\7)(31["S0<[K51%=^D4-L<^J>E0I;N[>_5J)QD<#5YP
M7;DSLK%Q^[O%S;[>2QT9AJQ%-)NVB97P 8FY&G\DS6*WA\<&]SU^]^JOU4GJ
M58FF.A?7-0RXERX_M4GF>312#?==M%J>C]K%S3,1#%U\%)ZPJ)ZNSTM5UT;!
M#K7CI@;?KS2X4.=N;:)P;1?SYS*DJ\4]'H+SL'4Q9F\J%(VT&VB,@F98UDQ]
M0>R-Y9A&EN:BM79X12T!KCS9*;R2X7J?)3Z&1GZ?NAI?D\F\6KXV8FWC%NTN
M6QRP< \!YT@25.]"G0M\(<-[$ I1+!H,EOF6@A;.%C28N9'XI2+^JSV*!1-.
MTU<%\<YB<" E,U3Z[+=JUH:Z_KA(%*CCG\UTJW90F4<6W^%Y3"W:(5_Z>!1?
MF@6O*+$QP";(Y6\M=Z#%4=Q<0F?7PNK(/4UL(4,K&8FKT8MP?ITBL'!E@K]X
M\S:9$"6HIYTX8_0V=-*).W)0)*4/R@@1AN=4*M@?ZDW5A_+5OJ7R6!$'S:_Z
MD2.RLAA<&L!3,&<!7OXUL/$^O4S(D@I="K,\9X-7KE/  1Z30_PA298-ZP!-
M5?+/^8WHTQA'<WVNC^2Y I(0D*.&C)M$-;!/S:T:3)+L7"O>@3UL4[[K^XJZ
MJKOHGS&MXN36G(5<V3U3HT33BC EJ8UJC&/$2K1-:?J?C$IJ^0LRKE5LR0UR
MM0,.S43)CI4VV93;F.CVOM%;IQ*Z'ZH/MZZ<D5A.YD/W]CX!8I%.TV0KBTSF
M:?>2Q0\DZ=17D0ONW8ZQ#K>_N53RL'IQ:=R%1IH8NBZ@F2>M5;UM;??-LD+$
MOS1+QX='PZYRGJ':@O%A[]YUA==Q+![9G.U=+*K8>N+O2U.18.)].08OV18_
MJ!0P1"/Z 0D[:25*HS\(M5W0=RD@/ARV?R0ETQ3%"3W%%B<QROC:G*.1%3_J
M32^N0 %N?;'_ CZ_E#3&UN>28Z9N_0"7OI#4U?G@'@\UYKV?2.OTV.Y$0$%:
MI62_TT.'>8'U&\X^_5GK/#MI#I<0VDCN;$Q[?JO%'8]KP[GA"-^;[SY_KN8Z
M\/"6 XFQRF6=\;-OC_=+6C$(5S3&!"G_"I5U^';NAVKVI9OPG>%:".<427MR
M/K-PU?SI.W^EV;1K8/!Y YA#XI+=>YC1Z:B6T/ZFIJ7Q%W_.T/Z:"9<F5#=&
M@+9U(**_H@\+Z/&Y-X#I7\8EQ5+_B;[ZKU=__7^4?V,=&;O'GNDN*$HA?>PX
MHVC_P%P7Y=7KG#\S*R"IZV,%>RD+A/#S\ 0MFC0N0D:@*X-M(-)=-Q#9[N];
MC2G \QTM"I )/1>\*%\4_,<([6_0;]!OT&_0;]!OT/\!"+U@<:2DN#@1<0U#
M7R7NL5[QP=2Y,D,E09W &FYLV/.)+Y29[R7A:DP\!;@D&3PQUGD2$P!0IOX#
M4$L#!!0    ( *Z!7%3'\Y&3"H\  -'H   3    9&=X+3(P,C$Q,C,Q7V<T
M+FIP9^RZ!50=^Y,_V+B[NTL2W%V28"%H<(+KQ=T)%B2X!$AP=W=W=X?@%MSU
MXG_>;VSGS9R7M[NSLW/.I#A][K>[JTL_755?[GV:>UH%T-^)2XD#$! 00.3S
M'_"TA@$KY@(R!@ 9&> E  #P #0$/P#YO,)^/GD7" *@G]<0SVOMI.0_/@%Z
M $"?V2,&X)ZO(3^?"ST? /'>/Y[]3;_I-_VFW_2;?M/_4I(%&9A:6]@SD,OK
M.=B!#$!ZY!(  !,)]2]3!7I1)/2_KMNBH_ZQAN+A 8#HZ'];_]N$ 9_VA]3?
M$\9O^DV_Z3?]IM_TOYO86-C8^%C8^%@YR5EX^-AX^#C9_]-KS[,(  (, %/
M&K  [ $&@!R0!_0 !\#N']=!SVMRX'DZ 9[6D&A-'1QL^)B9K>R9] RM]8V8
M#*PMF5WT;)A9F5B8 0%A%QL] W,C!W)](Q.0E2#=<6,K'3G(4)!.E5.&1<;F
MC9$I2-+-SNB#FZR2@9NY :\AG; 0"J* "Y^+I8VED8,>N8NEA94]GXL@Y3^D
M\SVO_[C,3"DD8&=HS*?X5OR?.9[/!"G_V19G9V<F9W8F:SL39E9>7EYF%C9F
M-C;&9PY&>U<K!ST71BM[JG\6\-;(WL .9., LK8B_^-<3]_:T4&0TM$19,AG
MK&?,J6]HR,FHK\=NR,C*:JC'J&?(SLIHR,YNR,W)RL-FS*I/^<_J#0W^5;N-
MHYW%/W0;&C ;61A9&EDYV#]'@Y69DOF_5N=SB/Y5Z7\:_F<?GWGXWM@9Z3D8
MO7T^A/Y(-R,+&R,KI]*_I)N)AYM;@/E/? +,?S+T_X=H"0D8&O 9_&&3M=T_
MJ?]@9/O_+ML6(*'_9,S^)V>?[_W3XEG+,P01$! $F/^O!OS'B##_,P*?5_^*
MU^<GR?\;Z+>2WTI^*_FMY+>2WTI^*_F?I>3?9EXCJ^=!U_EYHGU: -X <# P
ML##0<+ PL/!P</"(&$C/,P8B#AHZ,@8^#B$!/@X^'A$I'041"0T)'CXE$R4-
M_8M7#*\(R9G9F5^RT;U\]?(/(1!P\/"("(C82$C8+XGQB5_^WZ:G-@ #'F(1
MVA *@A* Q(" PH!XZ@+(   "!N(?]"^;!0A(*&@86#AX!$2D9X9J=  2 @H*
M$AH*!@8:^OFNY_-] !H#!I."51062T$/CM(6F\TG*AV>ZG5Y.X[B^ DUN[Z=
M+P(B+AX^ 2$-+1W]BY<<G%S</+Q\;]Z*B4M(2KW[H*2LHJJFKF%@:&1L8@HR
MLW=P=')V<77S^^P?$!CT)3@ZYFML7/RW[PD9F5G9.;EY^045E575-;5U]0T=
MG5W=/;U]_0,3DU/3,[-S/^;7UC<V?VYM[^SNG9Z=7UQ>78-O;O_P"P* @O@7
M^D_]PGCV"Q(:&@H:[@^_(""=_V# @(:A8(7%%%6 T[/%HF3S@<=^'95>WHY
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MO#&GCFR;Q7P974X%?+PUC(3;4/^$?HH(KNP@M&J(ZYFV7L,,DCZF1Q P@>*
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ML6MX85D6.S]\5PV$^DW4% M@I:N[1!]KUU8GF>&5WZBB7L?P229_[1GY8'K
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M<&:,9H%PWR<XMAO0%%UC+E(L70=0&[?Q\D+YI9A"?3O9^KZ>B$:@KB/G:99
M<]F859.K53<5>F:Y'-UEZ/_:!O5U9!8IW+OZ4[ZK:[F(C@HU[46-[TW2!I8L
M :\SU);EOA.1B/:P7A:GHKI0=;9@NA)UWMI4LT'FLDO1=M/1J+J3A$2B3K>M
MVG9+K<O![;0P:8K-IM4E6V2?IV%H#\/V\W0^'LXRL+;S4B49T'KSNGL)]Z0(
MG*HD.Q;N<6'L6,(T9^'B64*HN#1U\A]2?9)J4QG0<R-.V+AG+]@+;!=&]>#-
M">K2B/LN, $WM5G&7N7.2CA,R.X7R.C?SK/O+7H9,@IGZCR_Z-9T9<4)OXZ>
M&%1"\R4[U LZ$=\UY. &1_9Y",:,[\1=)O7$93X8E#AG7,?D,4V]&R2W7+WS
M2P#.'^0>,1_@WHX?5&MYQJV"6T9FN"J:HYVEU=4E ]1).<_QT10&HI*V2O><
M9G%K5] =$!RU9(_EM&#Y=^+6K\1=#/58+$N3V^7BLDJ<+O';*1N)GH! (?RI
MJD84OKT>6_/<P>V%7I2+4\MXWG,$"9A%C,@A*0(>@82XE;8$F)IFVZ(L/&M/
M1P1?5]HI*QIU@W8B L+7V>*RL#PC8H#KHK20WTGFVM<$V?0\$>MJ$A(KT>;8
MKI"7.1<WWP[?5*&$^!/P$"?,S#@02:?.XTF!:*>P!S,_RBYK9]OB(U=T 1 ?
M+764\#],^9JGQZ]9?S:>L'#HF2S!G.BP%IKGJ2;Z=B7)6EU1 ?GN$,).=KQC
M@]-JHXT/9O9+YBGRN Z)(CD.$YY2@U8!ZYD_IN6\#5M=^Q&J#&!C[U*H-B[
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M0$;LV)P+V^/9#%)(2**@$'_0LFG+#ZH7II&8$[HO*%S:Z$K$V6=^F>97&=:
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M9PHUUB2<OJMP;SK+X9?S8U"WS+40>F:77+S+Y.<BZOAY+51XBF^E!V4"7:B
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MIK<F9\DI9^R\D!$B:U\]'>S3D_G4 YC+ C5'CLEUEK^613_0?_?8/ZKJ8=R
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M[:=+$V8DT*G(O42-Y/TW_O=_+?U]N\^$PO^8J\P>HT+68*Z0K$9J&B<,T]9
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M($_-6-]%?GK[\!) @SQJG/<)%W10T9;%%8K0\NRBJD+VV!LT[6*TZ!GYD4I
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MN$F><-'T31XC:3UMW8,1TL<<*M5V"_.L'_)CK1S]KXI<7F:&KWV4O\M7NU'
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MIH9J7KJ&$_ F+H0-BVKLNJY?I*.N$(9]V&DG&#:6!,5^IV2"?E(5>Q0$8[3
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M>\__KHGW;,27@AA/=H_"$A)%+[CUS ?D+=L$%C_N4C(X+[?(=,,KA,?@=8;
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M\QAJ?D(OUF9)QBSFJ\$9R7JM0@%8"^9>%E6<9QN]A0ML__!,C/$"#H;2WBJ
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MHDDYT?,H^U33OEG=M"X)Q"=%OI;*4ZCP(ZS!Q+&@M_X_EH\@)R5[D)^D_+E
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M-%05B?@Z3[$;0>U*(R[3F1?VJKSK>Y,1"@  PS?_S[5A)'?X3U!+ P04
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ML<]V8?WY6E!DBC]ZWU)4[G"<Q86V[CT/%;K&%TQ=E;$$%+TV:*TRX"7WK6-
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M560$D( 46N7FEKP=L<&#SF]6&(?.6;D^N^4C^DG@$P">$H=VX%%["Z<P94
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MEH]S&"+SH3G<8T*1(LO$UHP$DWSIR=<^N9&*%[O]BHT/J7S-%P4:S\^6DZL
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M)'Q&T3F&SE@>^DWRF9.\4-RTF$KEB+3B9*=X/&%$)_V,S;F,@VD\.;RW\3L
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M4VR W_(OPM[:G@5'M:-)#M!A%XHVL+T&9;P'=OVU>KTEZNB O[YQG5+@8--
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ME!PIM?J%.R/9*"' 3?H)<71Z $J"=\5 =]3<)SM:T1\S(:Y*O)]04*"WH(W
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M6UD.6@SY&];U4QWAZB.UCI-,"$T4- V[JP#,1($Z@2L<=MWLDKZN5:E=JN9
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MA16B\;R0\L_[>LD%:^<WT^0)2_$/B^=BON;>QI;PY\]2#?U7[TGWIX_AO*"
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MEY>7?3:P"G#)ZL\;[!T*GXF2JG<544_IF;AK2EQ3[/B]#$F:&GEI7 A((LF
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MW5O[55%E1%[2V4V[E?8 -!5UR<%HQH58 EJQ)6"%>ME-Q_L!@QO5!6I- T[
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M>8$1=M6\<(HPB$1AE:P-YOC%//O'<56_VU;S?8)A3J.&<4P4V3L\!Y;6ACK
M1!3]S/" S7E7VPR''0[5T((D?]UOZL;F--)3"=2[2\5&M<T\YT@4W%A2=PO]
MO=U)IA6-F^+MG6XZ\:#B<>1M7\(^A;F%N74<%9J !FYY@_*$5JOW'@\2HG%"
M:EJP>W7>SU<8Z9X> [CG@V,7KAFPV0(/9.J!X0JPR>/Z!"Z5>V%=?3Z%4?8(
M=6*&ZO;CH.U':P[ ]FC<:QBT?%DZ]ANQGO SC3ZV"7F:CKN]-!:Q@!0'H#$G
M=4U+S]9J=,H7*'\@(W^HN4=I3;V,,W5N0YY%CL. ^UP="<0392NF^\=_!8C:
M%CP;*D0S-$S,?GJ^=DJBA.K.:G /;$%5;P)X0J-]R+V4/8A4!!*:%V0\B]P?
M,9K?_^HJSBJMS@R2T-'K.J7+1X"]@5<8,D5E-R$[/[#0R.Y2IEL%S;!=PDVB
M;(G:>&UL-N_LA,)\0P.&P6]T:B:+,. 0B.78U@O@+;.D34A:TN52Q,NBVJ-,
MRE7>]6^6>U <2?IY1M"\"L&LC[E?$C+%U7=LVKQ@@+D (T:PN;D8=\%RI$2(
M3$R;:$WN(W9^RR9DWWVMR8"=Y,<U7<L?9PXI&(0Z,(YS(*88!]SL(SZD0@\R
M+8'4""#_4KV# F$3<D M>^WWD5_=SF['7L(9*NNR),+&2U %X"([S\]25 '8
M)]C3'&'@:HRD<B%H>0[[X?&+4X<*]N1FLO*3_/S<RS [5'K]/7YAJSL(V58!
M65FELP'%>7I,S+&NTY?U.Y3P+2\?G9/36*T866\T[<"-2;%Y^SEPA PYRE#$
M,JXS+6BHML:K"B(K/PO9+8/W]"XIV^C8HJ^P"K;#PW$F<*>^KVBZ 2M^10DT
MQ#DNC>&:)W<_R>/KTXBH.G3[8^T.]J.KPCU9@%;B*T +<RVO86CH_\)A\':C
MIK3PI[9=>W6IVP&B%?'<X+=OW_X!.UH!B*!*EFM;U]5.M_&?,H.6=]PVFM(H
M+,4I6X+:'D^%A2.N7EY>TMR)1V-3[P1"N$$N>BVK3/<LXP+X'"G!U#%^PU21
M&.SP]#RHD?W.I)Y[,3^[MOWSQHKLCT\WMNR@>RF*'DZ#@ ^ 6:]\X$O Y50Z
M32J(6,6!I"ZM\2R/A#(?4TV>)41YP+R=*Q V"(M"'9S/1[?Q=]2-CGSH+,R5
MX+JKS+4+%[$8_WT3HD:#\<WH*SJ;4YK$DL-W0]=6-XP>VE'978V_].Q>9Z)D
M8SA (]\@PT?,X"BYH>[E%0F&,+N-CN)Z3P&3:3)=6DP+7:N:FC\0[/6\XV%*
M)HC\N6@Z<-T,40\0]CF*R[X\K]B=V[UG<:/+;DO(,9.,_GH;SV-K%Z_WQ;^(
M%?C[CMY_^QT]6U*;:2QZ3],N\+*W)-,#+*20N'X^W(3,K:(%W*_=LNYH]W',
M'CG+=%]^1\=RS#"'>9.32941Q"K$<[82C:MMPH\WCPB*&9VX4['_R9+7%[,*
M%!:2B3G?"X%?=8N(:K"@H'>Y:-B?H*5%SJO&G>Z2.O:CL&3R6,.!P[_ZI%Z\
MT>O<CDN'$TELZ);WX5D(@G$SBJ$0H@Q$M.B=MHU4VQW!"+ \VP_3GA;ZZMNK
M_^42O VQ-Y#3#L[3KSD6T*CZ)_,&+;E]$\*'/"S5_<-Z$JR_]<IU=+WW"H^.
M M_QSG4',\*3GH>W_9A(9SNSYL$4HZ;$F&1&DL=4AY,6TO(LH?UFW'&E:JWC
MF,:JA-G,/QJ9A2*_0%<$$*O>;$)<G,#D,ALOV%<<CP>N^CQ?A_#SI&Z,^-5+
M*YCNI:UZ6[**0]SII3OHIUCINFID&XTN PS8OK :=P;C>O 0\]41;[KM59P]
M21K9A0;.P(D\]">$O$%%I24U^5@,497$-=OC^_WI)D3/JXA'0#(S_?),([(&
MV8H#7''S#&!N'BG+RO6<)]XG+A1?G"NQ2X+C5+L\*;=1,R]-".&"JRD?A252
MSIIJ8TSW8*=?UKZMGKXL/HB@;T*.+@[\5@U<WI;1,]1Y_'I;8VVNI+71^DA)
MM_ FQ,N_J1,="1= N6W=G,W%% RP$Y5-8,LS3<&TW?E^!_6X.R=)ALM&E)N#
MWPR<XG(TSP32,1C4'12HL@EA<V]CG&4EM)*J,#$KB&?6.\?M+V%RW5FWBGU.
MFB6:X>8*8N;Z4+-29-GY1(8V\DO&E6#+9L1S:_OXV3U1U;LBOM0G^L:J+J6-
MLS\?,;PM/S#'H=A^UI(_#AXL86VD)O18Q#Q<'\[XK1_!8ZR#69J2%45]*PX*
MR38J?, 6]7&O76]DB*.:WW&$;,+8C9-J.%&F' ZLI<J'QA.+6S-)5<2]D/6P
M6=J>!>O30>.GKUSD^A+4]Q,1%L)%1H4C1:H!2WS";E=]V,!["\?4Y#S7 6OK
M<<R:^?$4,ZX/VZO?8&3,_0*<,8?>O#N<%RUW^?_28_U&S<3"I']E;#7N#EO>
MQOB6M4UF^O=_PI/]JZ=?.@B?T#FVM8E8KF9G>:6_JCO.V0H7/CHX*I3ZXP?U
M3,G!XYU.LH\AF,<X=Q)QR8[U>I4"S%'Z:Q/PRA-R9W=>FGQ8JCXO7Q'_<$9,
M:B[KH,KC=PP$FT D+6PK0[5\!'T4[P)?+.42#?X1H>;SL],Y")4<+J7)LX@K
M=YZW\0121Z%1)/[W4IFMRX9U73V?' ?[$SY_,;1@ZG'YH3(UDZ-4T$*5Z1P9
MTI>\"[H6S9+&5#UJFT]=A;G(D#JIM,#8I0/ *T,W=VH:RE2IKQ_Q%4M7K 8-
M7;E:^Z)2E7NH45,3KB[DT[,NAM^=#O\FX?L#9'_^.HZ9^.@<[A=_L.M(FF/_
M]+, E)OYENL(%1XEG60\>^K5Y7^,C("I<W3"HYE+?\_1_M\P1[M\WR;$#4,T
MI'3,HQB:X! ]&\2BZ"AHH!1^3;0HM_IQ$+.:]8UOYJE"A4 45T"B83#DE\)?
MJB(V$D5^@@/\-)[,LX^$^-=L79/-]*\!IM,BJ^O1HJ"-U;!Y$*7*]<>-VL'#
MEQ*_'W_< ER(OCJ,)C8^^L."#Z'N02-PKOVHNYBQJ38$'V;HA!"6:D0X/[1W
MX>@)*R_''74-/LE#4J40Y+!E#F<J5&/G<0P9T)M]D$2\2W\"1#SQ$#T-=%-#
MD3P7/W:XF%^$JOBVO';2>XXZ":]R9HKC.=.H@/61>7X3PKU$0;0&A4!WOSL2
MW<WAZKNK1 XWOLIYHNBO1@M!]9VXQM\[T'XB9#^G6OYP<B6ZIKU$HVTISGX'
M^E.-,&E6%!/7I!V8.+_(O>J<(:([/O^D]UZ4(>-\EFI6=BKUY4L+SS&I5<(?
MK>*@'#D3MTM_) _98\]+0[5+6"M$>GDL[(\IJ-]_RLMKJ&]NPC/]TG?)=&8+
MZQV*O+ $RI$6CCU0>MZTVQ;TIRBF!<DF>WJ2)\3M?_F]$]_I7E]^A)0$<9%Z
M7G>G484SUL!Y&'@,-=]<X4U4H:-I 1U]_&>_Y(B#WKS!0H^3]I>;H&2S56?9
M$[7G_/LMRYA:DH< @Q7[G:PHE!.4-T2=<4V=SADK:)4LVK;^G/)T=TF7X[#B
M:964Y7/BZ.0,EF$X\\@4+UNNVMI]GV& =M-B]C!2MJBD*F\3\HJ)B0JY0YZ$
M)>=?SF\='3N7UHAQ5GKN7ICLA^A"6H*9]$M;]XTC"9/RB$A2U=/ KJ5K=2+L
M"; >8WMRLETL)56^QCV?W[<ZZ73V*5_[-*"#O6<VU^;0DOXIYJV/=;HB"KIZ
M'D>O^7Y>+N2]Y<QZKKG2!^-PF<H9)E\F/16LEK8_ C:CO,F>IYTFYY#Z0V^Z
MH%H'Y"'/EM'*(T_8_(B'R#X8<&5I3(/^\+>:B>PG8^H^+W$-^DP4?>)R&3Q:
MLRLR[_"*W).(AVJK@CZ2^X$+GI$E"MT'ZPR(&<CRD)K%VK=PJ6F7*:;C5%I/
M1+%X)>]&IWV^?9(M87[8%:-"ZZ#+<)HG/"=Y6CVCH]E[++KC2KGG^YS3M&<>
M_+#E02VO'9_)'/NS2VH640RK[&#RP<FR^#XI6W :,P&.FU]1N54T9Z(G5J8N
M%91$7G/F?E3LQK@.V0W):[+1I"$BE>]+\LL].Z6)^I[W$M'K*HO2_+T!LTP&
MC?!?+\\)9UX-G#=<)G@93^\F8E_6EG[[ B0\U3U"WK<;RA,HW+*!C"L:YSWK
M4#A6<*!CY0*$>R@OFME>:#22F37N^6M\!&>Q*GI_=C#LV4$CEZ2!8]_#HH^_
M4?A_O'#A]?"JGL[%H>*1U4<_2TL]\UR]%&5?'+T0?=HJB@S1ZKE2>,B H]YV
MN,I_&%'3T[DP5#RJ%O.SU/.D T>Y.?_QX!>.RA/_T;23]0'NL<]]:FO]<),H
MM1P$Y?OVUE#\4HN=M>?7FX[B\[WJAL-9RB(<Z?8!YR'A/#59@10+47=_Q506
M_'SA5N*SNH;<#^^[M,8XNJU$\X[*XR820Y#=EDKB+BUE'V>:#0TB#G[)?.]Q
M;UN:L;EV3OL=;33EIU8GYL?D,:KM3%O6#UL5O,7WYO.L*;Y!XW7+P$9SH\G\
MA9WCZPKVBDT!D8%7I*K5:,8;L^L;//_XWI.WP5R:?K,,375@L;SBQ6Z[DY>8
ML:T/X/A^_V3$I0$#Y"Q>7/FE3[P9;[UBA()4/<,\S<IH-9F1RH%0PP$R</^4
MZA^R3:F>0T::'O_Z\PB\/\M"^U<QWCN^0_]&<"&[#_4O(M[?[%AC_ VAAH.@
M_H6D^S>#TG?\B^U ^[\%J_]_7O@1#>GY&TZWDK^9./@,__^9=R\P8"&.@RRR
MK'#4;3W('+H:O7""@MM[N7^]IDYZS6GJ>KU]N]BA'=\NJ[1/G\N7DK[&]7$$
MQ@_FX_7W BQ2C*XC57Z?U.4AL@KB5W VT69\_*)V0Y(6=[2>T7;<#IP7#M0S
MZQO7%>/TY#PK\X.^"Y76T3K45P3>GW.%DR__[INM4\S#:8:AFOU0Y*9)>!_3
M%AWSL//1,!6/%[V 7N<RK;X-K8KEHO&=@37 L0BFQ!/.J]I8R?IC%-13_2--
MX!CU7>CG5/O=#TQ.2$OLS,C*[[H')V%MXAOE@3XV-V?DN X@OR& &_"])L#=
M#B$B- PIJEXH.,,\8B^,==+PYCNYMZ'^9;HBM_(WP0MF0M?O2GXWAY_#.9B"
MI]]#RT'..TXP+LTL=BH]88M 6Z6)<5]0@-"EUZOC2N<1V75I3+X<XK)9SF(W
M_:GQ)<?T#+%;S*-?/N1J[>&Q3SW,RYMDU"&=L9$C1FZ2ID[?F%;5*ZZ8_K&6
M*^;O;S/UTAMH3$BA>JE1RJ I@ID$NCTA,VTB"]/=C0H[C6W%ZA_$C$/!HP3F
M02GVGG%:#&77S((@PQ4<LAM=J.J64/\Q.7Z3YC.T,F%0MJLY,&FP5[7^](5^
MP7LV42I9@H=FIA"@WQK+-HUM16*-(0)0S5(H<C*B2CAZ99\W1?@Q\OALW8^8
M?-+Y![YOW491#B;2ME'PAWR.Z3_V.R0^OK'MECI5XRDB_YZ]P-2' ZW&T< F
MQ!+O5[S *E6?53O.>C7L9C]@STU+*: .PM7Z&JP^.?'C.YZ5PVZU+JO-ZZ5<
M>%LL$EIB<56_AYA?-158(M-7<W=+;[/;-B'E:1'%H#]G'#^S8AN.40*O(*\W
M'=:'13=[*0^,'=W^*+]_*<? 2\O"7B6HC,UAVH!9 G^F-.H@V**:A<H;/XX=
M?&]30U:W:?5E7CE_0#N#T4?G<.6PT\@>%'=#G#>UK8>0H.8"M"D1YC>"-:KK
ME)6^(6ECIFL&H9ZOP4=G@+)$K@BF4N[8;(U0206QO67L2+C@RO4S@H8?!'_B
M#NCJDU/F0<MM"^^4UE$W-R'!.-ROM$K#;!@TY/Q4Q((FYM1]%]RZ[T62/[;V
M)ZD:Z3Q3/,^Q/#L5S;Z[DZIF6K-6G("UYPE3-<;IPH!<U IR=0W:G#"&)WO/
MK^9O0NXPQ4'GPI\NGX7<8UPT;*]R,5>SEZ71@(S:N!DBS5=6@F8IV+D)<;ES
MC\*,F0CC:(.;\1/3 3^0)7C;'2TALH*L[/!H]'+W9";GKYRWK'S'[QSA$O*$
M?N3?B]$+[L]_\]55B-^MKG3^YNCH@"I6F/\SGY2!B).3+@32*?/RG[#P\'#U
M2;CAT,Q(M?O7?X&9NXW4 *6%*(8#1_%+JCT%")1WWPPID67;MQT\E7;SI;I@
M>C '"67-?5J=MUG2VU@?5KWCB?4AJJ#[L5;DH6BR[&+*%A(VW90G=/>J%__Q
M7&@Q_00KF@PBO+UI%M2BK*3 ^.O08M??CRVOF.LO!W\Q9-'Z_9/@F9J94?YH
MP>5TGS[>OC0NV%JLX<6Z=J7W]IVRP0G5JAPD=%+BR[XC"=VS8!)BSJY#(I_B
M[F"^EI$HGHVX-GBT=; QU<@"B78XS%MGG3A,5^$;YIB1L[TFH2<,!!EH7I]V
MLQ:M"Z?GZ\0_Q"\M7+9SE!W!U<I+)QG!#)\V]W_JOUXB?VP-._%<P QQ[L&_
M[D/ZTTCOOXK2^$](FK]M?8QF2%]FY7*$%)0H1D4W(\:&IG:G *2+H#SMW2<V
MS["(JC+J_5Q <'RA6YJP^7JR@L\MQ;7G1_DJ;8/\DN5.C"%LD9\G%5C%U8VR
M[4U0UKOW#5HR. I4O+O U?X(4)3F>]>1*G'JJY7=."DFZ$=Z[@M6*251R- @
M=?+,^S.8<([4J(0!E\<7;*C(& XDR;,>ZQ_#/M;7P\8QE0OMS_U>[-=U\'G@
MKO-(^>WY<+'<]-O>*NYA)X=/"]U(W#J\&&:*:C8(03""0U1IJ'!]':98,F6F
M'?:L25;_$%A*IBAE>GJ_D?.RR;324)\+>NQTQBJ2^$DUIL(2PM'DSJ;C ?0J
MVA)32(J:-L]I,+Z)>Y!YC$QZMH&*"M$3?O[]8^W''.-W;Y(?M'V9DZ2^_IQK
M?IQ0^\TWP8KSY4CD\.01UBO]738)SXF$9YY(*7#)'@M@\<=HO85T.VFWM2/C
M"\+Q^@Z>WCLMOGWF5YSC2GU<_QJNSH1N0E+2D9JHL7*0,PVNRB-,V40T<!7]
M=8C-#:.$;DFD&MEF'82(E4L1I<I!OSC _5C,EP.7:'I5Y17E?,5:;)C_"Z@^
M*RQ$C]-EV>5@U-M?*, <$06O_%%(D<J;.E,!ZCB^9949_TC9DQ3DG1]W4S!2
MD_M)C$I)UW.\'V(GRAU#Q' PCJH4.ZG.BM,_&FC3S.8"+:=T2+L#9:9L@<[A
MA#BU\4.)BXN*Z-[8YJ+UBHZ==T@'/RX?.YV0>N0'&KBB%(83X0Q>!@(PVX2(
M;T*:%5828D378ME<;O"]_%39EH<T@X':>B#1[JJ>_I31LH\*OVJ1P;7M"[$'
M=E05;@4N% L)URDQ#R8R=3#Y1?5%(;=HQS!1=])8]P)F=9%W.DD/U9UU^[D(
M*, $-Y[<@@/,8&,\>'@5*8*I(_,\%.FEN@D1 -V"&CI5[>Q';X8O#F3N\+$2
MJ%"&5'F+'>"Y_8ACI%'-94(;!;@*>(<2O_:'0;4^(J:-,"EQ=TVRO\U!\OM"
MY9=XLXX';BSEU]NC.VF$IU6X2'T^'&"/]0W85Y2_+3Q(P<M:),6(Z_A<5XYV
M]&\8&(!KAF^(A7 8YO.4/K!_)_R?WR^1P>F3+/:N@2F0OZ0%:_DQICVCX++)
M^+UG+X[WE7P2T>M36T+_Q9G<,V("-__T3.XPQS3_Z6G>OY?\AY+_',Y0_V:F
M LBOG^__),? FQUWHO\\.0&'N?^]X)\6E/D;*J5V$W(0-+Y2WN]51OE8=U+\
MPN,U!4.J7$]:V$J)!S6ES/OTP G-.H_[K_<1Y6%_\:6_^@I')I9O0O[B4PE_
M4;_7^Z+_RY5LX*=_9%6B'%!?#?$P((4]BJYJBB%_S.$_61J>_[Z2-'F\UZ0Q
MRV9141O5K3DN,4<;IW,$Y],.W5U%8GV[.991!^5<:FCQTBM>28QIW!#HV3S;
M)*$]:7KZ3/ [8]5[M[TB5UY#2:7N-@,-&@6V<^RC(PL>"@H45XR2MY?0\=MQ
M%ZTFOCZ_L2/)Z!.F5VD<P][/@?<P6V0'S@/ X3&2=B'W:(Y-W^UD*6-&]\'O
M$KH31I^Q1)^SIT2^!E@S=]33(IA"<VR>YBDLP,[B#"!2GEA*GBAR+:'#]\V:
M9F%><:7<]?AT%WIB_QD1)[4-*08WI\HI.<='=J%C<>0\1%5(L*VL1Q(H17G-
M;\M'N$=\WA+DFSB0>OP>EZQ'?BDD!,-PX908YL@STW'GFZ@(6.7T"FK/BIZY
M=^6MG^C]1Y-"W>:"6MJ)3T]D=28_]DS]EJ.I9DC7XG21 XY<BL+6-.B?"+G?
M_QV\F_]KF55\C6;8YEZ2:=DPT:W]E4DPE3V\"2D(.H+#(0;ZYCDV9.=+3O-1
MR.:,.];L;G1E>S*E>Q,BV_V1QG?2_^VW6#_IQE=5;::RMV\_E>7F$IS/48R@
MS#S6U?.GDL0#:^_'*?9H3+B)QK_[CC^PYG08.F=Y->M7S[F]-2M&;N/SB5M)
M$;BTJI)&L'G&]<XS"?,G.#PL%]6L#+^'*0>+IX0CE)K4P+<D]^JU^$3+RT9<
M%D+I?+_3H6N*HE-SB-?VZF 4P$^_#GKN(L2H9?,TYX@..1QP';W6DDH[^H8J
M]B@P_-:30<UAM!OH3R_EM.-3H/!Y#7THZV553*GU=T>QMN#AI&,5DNEA.R*2
MQPJ(VV"^;2%]0#W=C[7E0LV35/<6KAVN=K$W59QK:Y+ZZ#)_TE(W3_V4#VKZ
MI9PONHY+C2$+#83'ESQC#U*UNW<]MVYR2KE8;S4KMO*C 4,7 7%\@9V/BV/8
M7RAOE22B@Q6O3Z@R)MQ5ZWX3U1DN:SAB/9O'>0K*SRIN)E74/-L0C''2H%TL
MY6Z<SR]R>#9]1#)V?'RG^!%!0 WYB?T%!ESJ&QLG7U"?/$+K3VY''DN TED7
M#Z?6]&JQ>G"';Z\X*XZ)B 5;#N(_;6@>$M9XO/_I@B?"ZAG-.4Q3"%04[<Z^
M'.Q__>7Z,?6:X!:_I!$BLZ:^RMRY\PY3:BI'=[K#5_U>R75":I9#WR'9ND&?
M6/MH^H_&E.]$>$XTZQ"G\[9M0GHXS.TCE/W=?7$<P3T[&%CTJ[FX=DRBRJ/
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M*I2FI31^S;I_2/"K&2*5Y@RC:1P:02%*W0(&LT*_*J41D7Z>=.=?#<<H2SR
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M-P[,L<@;9_Z/I?;?C[#]1QQAD_]! N5G%H8HF*U3#_S+'9N0JB:,6OVOFN
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MT V ^$3 &;^<&J_#N%975G]:4JLV0YE72YQZ_'RN[F6??0&P+6(3Q;@68L*
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M8;<B=NIW4#D(?9XJ4TY#V<5X).02TP95CY/*!A.U:C\245%%%QS6\F8$-W"
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MU\)FK&(!!02M)%:;$W=VITVL-Y=B&-(6322:2!R1Q3M/\_$<98,"8%_K>7'
ME8U16Q;*:3DSA(EC'>X+(*YLXPQ&)\Q2'14&A&M+8;YA6-<X(:NEHQ+->><:
MUVHI@%"3]Y.PG25D!>B;?@IN?)])1,B_HTVY[A <;0RZ\BVE,N3AC738:S7J
MXC-H'G'>C^X)O*^6 )[[ $7#%\ZM)9VE/NGB4V>#NO<1M1IWGMMU=K>S;/$J
ME+$_BP9B)E::4F3J<$53];#=N/U.<96ESDC;K/G(QJ8OE7'#AG5AE^IU/[U5
M <% ?%%KE8^:=COM/IUY]#A/YBF0&$@ 6/ A@_<"F*!Z.TW)9V$G&Z^]F/FZ
MY-!0]-TK_G6DTQ6'Q].4JH[^QQ"P:E2]IC9$A<QXDFF28*MZS?]#PMVH*S<S
M].32\+)>Q4!R_O+B'(=5;__.3,#8^9?V93^! @::)OMVHXQR+^12H3F5-U,)
M^<*H0T+*FT*#H^LEKG%3GYI"VF0,<_1[KW @:XE1@8%D)X1@)RQO^G*TEU\A
M6>1ZWZ4LU.!P]7P)T9R#R+T"/_X:J]L\HF)HN0"$8G*WA(H,.XHS"<-\@5RN
M7U-;L>/BC/#/+2'+R[)]LLUY>'YL#J?8@837\(\5U<V.&\+F.?K@O=Z1)M;]
M/U>_,BX"A10B23N6B:?R-YJK7Y?@%QDRHC<_ZC\F[*'=L@=E2PUD\9A188T[
MK:5)+M'@@.SXD_+Q_".J;)!G^*NI;R>.%<*E*8LTW<TIAON^IJS]5>Y="[V\
M!2+./@W\7T1,9C+[(Z^H[^,81Y$,5;.[\>>]@VE/28<.4(L)\3&&<<NE]7T>
M"O<(E2BFRQ$S^[D\I6$#CVD6YM4LCD.2TW=5NT11]&OHY>F]RL6?-U)X,/LL
MJK-LCMB1.&XLF5;7YT__F$_>8;&+;MWM97XVK;K+O0%"SSSCN\?7CN+#XB92
MC$A]T1E HYJF6884M[/N5LLL3"%(@F]NHBD/[UE04-CM?"RO.^=HZ?,#O =.
M-?+QZ9\#C8(=1P,#4+Y-BF:?FDX]F=;R]1?,KDRLJN_SN8X9.6.A9_^F^H&O
ME?ZZ+=-J>54;#FAQ[*".4ATUX4@405W;R![;490H&2?ST%?$-/ 1ZR<L W\1
MP-.Y4-N!J ^6TQO0P+XZN/EI+_?2<@G#^%BU^G0]R:G$IDDVR+'J8PA391L)
MLV5B_6;> <J^AY%%";%*$Y.3S(G<S':+>=N^M*B)HO1RP[C"D0T"P74<OQU3
M<P;%:SMF(<MPH(JP0>:%)>&2=.6<D &O,JA;O$^"]WS-RM'J=,IBX!,H]WWW
M:A%*;^R>:/_71V6LK)X,O'KW$\2J,ACO,?K=VFJ5RZ'1:B'2P78[U1M=KL,C
MUZ*6)J->YTSX>(F2SC#$=[)J>536"54S'&/T/?_CGW1P[%^9K7IQS1O3,>@&
M3+Y\F!M^ $^+Y]!3S,-[@;">U2=TWY:]%(N/L\&L5XV-3[70(0QS9AX'K*W@
M^T5)G>64J3EKNC802];=$+R$.D^VT M.M0?LPGF:W<YL)#=M61-81])AG+9Q
M.L8".UAA@=D*P,?DUI[/*:LLS5=*4IR,8FH=N%5Y2G=U(=0.CZ;'.[ 6E4W"
MTB0/9I5<3OLM1:<'-'US_+%X>.G[6?7>.HYL4+']O,;HIB2O1*M@8N;,%^3"
M/H^ KUI]_&S0H.H 00ZZ24L5:5< E N'E@JB.[0E@%#TBQ2;P]3+=;I=RP.7
MQNIC%17H>V.FAN 3:W.;:Q&<KJJYQ08Y5UFCD&3""R%QKNY5BTIZQP&4^7>;
M+J_0QW:G3OF4<7]];"N\BO^._['&VEW-?%DMRHRMAY:H-"'Y4'K?39W:/]SG
MN,2[#O&!9O=V3$7[UC6MY*;Z)6!")<%P/&LK7G+9P"N!8/V"#?(3@NJFL;;/
M"RTYK[N@X>C?*&GI)B6E]DI05 )82H[:X+SO;YJ0)(B?]]UR5.3=L5N?PII]
MI<Z#\$G7V2"/N"B:.:<<)\[GP!-*&C.KE:C2-;/8[=,#*2.^Q&#6<41Q2C=2
M[<RZ7/7D-=>$UU.]A R%_D#:5F8HP59,1$N(=HL9ASHV.AHD@%>JDM3NYP#7
MC[$*Y0[0T2M.?=/+HPZHTZZ8D37XL""Q(]';(^FR+R+$D)=>O;Q)I2/7'T-M
MB*&0_#6&,(8NB5(3K#["S*_6\/0C"[Z+MW06JFMF1G]<@-0BY)1"@53T!]8F
M)R;\R**=Z3K6R0;=@_4GU]KP+7T'ETP/7!,M7?.)'9;A7^B9NVXBBY9LJ 5'
M*J3 3SH5EA1PN$2\;03"W]0T;BJR=PG5KCVSH<\:-MAQP.2F_OU?B,5ZX>:=
MZ58.D$+W5\X?'>*>6,8&K1X/BS&_5L:GLT]U.;5)X_$NGE,W_+[4*"_I]G$0
M-_WRR.S+615QF?R[I?%M(4UT\2V[M-\.5F(!0=_9I6I9:JB?)U2)U=%@Z'8R
MR_7DHVOCU5EORW1M!OJM<].I^64+V[99]1N7RI=8><]@.\ME&CDF@!L8O,1,
M>1*:J&C:_:$;I?^Q7J*J(+@YY'YP4Z*@UV#D%M/(E(@KY_%W\=5?EMOP04OE
M7@$(DRNO>[%(J3COCTGABEUUY./DGYE%B>3:D./X&T-_5[+N*2@@ V4D;YX=
M6>.@P.Z<1%]A7>^W4G;,\,3;A7NO(&VO":@AG98,#/L*B^>=^@<+-;.795D#
MS:<M,%#IDC1U5"]!0?,FTBEK8*VXAYZ\WO&!\'[QEZ=5-F184E!6*F8=P09]
MPGV%4.40J\H<> 9A_EB?8G&?YO _!H6+V8!9F?5"Z)GH8M2GO&)I7]V"V]34
M?(L-OD]4S7=(R]BTT*KP=N@O+.R7I8ZYFU&\L<O+=)&':>U.KH]U]6@5Q?,^
MUH.;.=DK"WO^:N9<1K$A28D2^W3%HX_A0#:2DV^!5KGZ/LS/]=T)D_ZVUQC5
MOPDI'HTF<K5W5>\!7(Q=QN_*IZ5GG7=,ZS$-EA!OLN^MM@I6[?,'#+':#L'A
M*N41R^B7\*C5XHJB1^3EW>([57*4*LN9@SB3H:'!_L&JX:'I R89#A*OGF>F
MSQAH;K$1WJR EZ)(PL5_!!Q7&:89'\_Y&3RBN2%I:6HW,9\@TP@))W$U9@8;
MY,1\\K.S-6LVN!(RUZZN<+*%F,3[+*A/+$D'YTU#^''@ [VY,@<QYA%:+U,G
M!KEXJV/%Z\TM[WV9OG$$\0PR1NQ1E;Z.W^,I$1\?[PP+KRQZ<&X?QS66>RJH
MMKD*M3Y-M6-TL7+6-\1O4V5HWY@IVIHS4$HHX#(S9EQ2X?SR?K5P,*/_&4O0
MK:W@D!O('SJ<ZT?B8O!CR&L1EEH(LO&*S<'\Q\(?WG O2HAA>OR*%5G==S%/
M^@8@>]"[&0K ^33,/88ZQ3KF3?9[NZ3C:\8<=^%BWDH@&S]9'8P!)&6[#^0S
M;D<DG2E=.J%L[(4P4)X0,/82,2%-6:+[Q$R^Q[K@IM9N+$/\.+1%Z#/A>:U,
MQU[ 0,%--4\/GT7V>4H<N?DT'[<FX-2=_H'PH&4I#"]1FWUVZPL'4^MC @(S
M\Q4+(_B,%:7[)G5UD:^OPU^:Z K\C//_NR6[_@F:T_]:DCL"X[ABR/P$79C5
MH"[<1W#$#R!J6%PZ+O>>MUKV'K,:3.':7G,_->W3AJZH^(F4D5IGN0ZK#P2A
MWV*Q$$T-<'1AJ-&%&3NHT/KA"V<]27V5YZ5IXI&>ZW;AUG?+W]A'8@]LQY+%
M"'*_;?($U* L7@6ZZZSQ*&P' U%!48[(.!S278O;690AZR)I^]FLW#R2^<;O
M>=8I4V9G5YQ?5,%0K+* 1^D0QH18+#U/I0NQZC>.]$$="0/V-:Q=IEOB>,7L
M;YSW?>)7*1A<3AZ;/O3 :6F05L>)H)QHQ'G3@,G%.EP^]K,"/\KH^S'9E[.L
MHZ_O>YM ZV3OMTI^K],R(3_%+?(PJC8/10\@ %F/^:H<K)@GD72(M2V_Q_[,
M")!&IJ5))K:U><GWUAMXSV$J.T&8*D0&)'^1(>Q+%V4HT:6#" \P$1S>^C:]
M*7_RVXJ$B'QT!9!\)T>R+6OP<3.W]O/2C0ILXW=?#WKTP'K60>9MH]$K-O&^
M"\V,Q(Y6R "&M7=3T*4-/>S=[<E?PP8=Q*/X;#.^'"NFX&IRY*VX)Z2?9CWF
M8/+(O3S!);B%B&CIN6*.:7# 1<T=C'/[7<^Q1NBN-(I<0(9*HA<9&^H=U3]T
MV2KJF-4KR?$P[XD/H,U4\1G@?C_:'F8X],X\WQ.%?GN:(R7P^57=B6:/Y/L_
M2Z/P*:571+RJ"S3@.28= 0'-K7VZ:W*8);OIX<=WTBI?^RIC?#CU2:*K"$(8
M6R)PAD[3!)QH"#[T#S9(#&5 E3;!;N*DT^&B1L/#PM%)9+,U,)]V]$8X_12Z
M!I*/G4-\^!A(ET>W:_-1++-]Q)<O=>VSN0R=SNE>B$, HG&K3O/ZL*Y1%<OH
ME;/4O06PX[J08'*9F \M N B);9F,^Y0QET(WA(]'R+/LT$@/;D-N*"*5NWH
M"4(VW/_@>LLI\^4*^'K)Q?31G\7J.6?+FT=&'#<4HE\-F-C(X#D==1YJU\[_
M>! @3YFXS<2(7)YB@\3=S*#/<F4X@>YY*D.Z:*A:!/ B\W:IBY8$#,/(XCH;
M\'K;RBL4-DB!4-R6H8&1+6.#5B)L3[YMM# BYT"B"!.NTQLRY!P,BR=K3#2\
MKI8-VK72"EN(9QH:8=N.-MTTK]J$L\R/;N'$_HVD\%3[M!]*T0]\-9<E40$:
M38M[*;$TLY-FG'O.$E:J=0+2^.VN]I=Y*RSG;P@82+RJ#["X>3*]5?$02&;9
MB26$F,^G:K)!]6D-VF>KE]7W\/3>J-GP?2N8@"N8FH^B'JD?P#]#Z3RY,5Y=
MD9Y]UP=7=&D/QV=0Q;(X)&3<)/*.#-&9,PA3]-X';C2?)'RN^XKHB[0GEK-!
MC02_:L$A37VJ:5W)Y2K;3[VWX8P#);")F^8$NANZ%0T9BD1=#9DYWZ7!RQM<
MN&)G3,A!E6WJ#2IR^'HBW,DQ%@WI^LXDN:57Y#&.AM<P9DN^849?;R3$(QH@
MPK="Z9TW[L]+H<.6Y*&+<= ^C*@B;&UWB%(4&X3+X;C@9U=B)Y; \^)'<ABR
M9VP(%$L-7Q\6#X:B !L6#R1A^&;VJJOTOP]0!(KB"=0!,L?P@9,-RPO8376I
MVUAZ 7%6<GGU8I M:R.W8_, #X*Q-V]0JHK<L?EDYI#.;GL*7PP;U)15\@UZ
M&]+O=&Y@FM(L/PY9ZN)0L$^Q4#.%TI5DNLHT;QS#LU);6*O+!#GAZ 9=29T1
M;PV10:K6+;!!TNNX;0PDT$Q&8B'[7+2/ )F] R-D3UM_N>RZ71_"A4#RD])1
M,9JKMEUE(DP>YGOH+6( AI]Q8@>A3DO4B%*2?_O30+O#W?RZQWO/1+T0UMH)
MB:RDG&] 5;EQ?#4;Q/PH6_SCB1.6YT?0@M02F2!2*;7?]U&%)X2RNV^484^"
M!WGN7G [V9DDUX/ZFJ-:EF%HV?I6TK.(GE+A4-I^3UC> ;9OZ,-4>TY7-9Y@
M&P1P4W$6G'^DNLGRH6GZGM]T9!7[C4_H)JE<XXE4.ZAZNR]:8#76#S/*P1F\
M;L8O@;'/ZHVOCCV\6QBI\2EV*&JB1#O$R6,4R>"?(L&>58J>Q5&M#(NH9W-0
M9KEIMZ8%\H3K'[[4V9NF4..B>K !3HUE\*N,RE=5(WEFO'O]C]!?U;G+'T%D
MMO#BZ N$JR1Y'FJAW^,;FKDYDL*E:E<3XZ^Y6Y:*6J?D)IM(,%:U$O8BZE5W
MJ]/.A"?E*A"&-Y("1XD#BS0DM;>^$RWG8&+(V*6LMB=^ZAMW[3A3T2;8P<LA
MW4IRPO^[:]WA%B/> '/Q=Q%[4.?'% !)0OV\(JIZ)_ L>>9+9=#BA\@NG3G0
MLA#47& J%E/8,1].N4!:7,'P>";5W1[JLQ&I=#B_#0@N><PQ&T^P]P82"-&6
MN"MBO[X]SNIKJ(M,!\P)PD@4PPP*EX@RIW8S;9G* "[E.WQ*/X" ! \DDY@=
M-!<\V>T[RB^@L&^EYQY7Y]L+!NO%WCA.WV9&AK]$G0<NI[&\K>\/!$"/IW*Q
M03IXY$GJXM/3BU%\ZF^\W#.XG#;J<-32Q(@03:,8LR[GAG7\4AE-4H",WL.Q
MY.>LMFJY?C%BJ'R1!2Y%O3%I>KW2YQM:5J8')4/=]CE)S6]>>S<U*3I+:BBF
M&S\6OXUX6Y7AM-*6%:+JJFE$API?R9H7;B D(-V6]?'ZPB_JV2 >1YMPD143
M79^T7ZH)_M\Y?^)_E0S/]!>YLY]*_?&LG;K;NZTA2[ P: GA,])OQ-F?&!Q0
MF*G_BAG[0>!M3Y78<H&F^+L2$K,;(;.YB/0\ /48>*OX,VFK+J4A;+Y M:CV
M;F64)NC>L<,K33&9ONUHVP8;^8=P'K5K&8A!<\320G3*XL 51OZR,;' _E5X
MQQF&4/E$NWPK MA%AY%Q31TO<#MEVYOJH2(#%H:F3\Q/CMBU5<??N9S/U0?R
M?H600VT>UTD"8J^?F8;NT#P9=U?ZB)NSM;G5<RWSPX9'.&9 ^ 8'4PII8.8[
MUFD;,)]GK?0WV05$6_S5OE;EMK*9VD.+ML2IX^ <7R.*#VT? *:DM7Q'%NF0
MM:YI0DJ=' N.EF;JK DEZ>F<8JVBN&CXL*2CTT\_%+1)5 _AYT66G%W7TP[6
M8%#+6B6^<9S/H=T(SB(R6.-5,&RE',66ELS,+BZF*K=7IV7HGVBB+50][!QH
M3%GBB\_$+M2GB4>O8&L6 2EL'93'RQ+?X'P'R3>2>[!?IYQ72?O%MNK+XN/I
M6KW5L1<O?=,7V6%VT,SD*5>JG"]L#R!9ZZ6+S)G4_#&DT].2FT] &Q6Q0?-K
M4--"[KH?)_=/9=&;/6*('NM#J:3%/8!/K>5U2R'_(@UC]1:^H!Q9Y][CW3\S
M05E%)HB\[K0KX<H\#L=S]EM*5$CX9!S_31RT\??S:O^Y%"K_9VU?AT_9-T &
M.VB!S'3H?60(9@?&'A8F J_S%1W%-^*W 0I7[WYK8!7F#,^H1V?>M#::O)Q?
M<ZMBY$"07ONCB9;+Z6EVOH_HQSP+:4F]*S@1 $K++:",<RSKA::K_*M4S\#:
M..N&\-B@)W6W[3R0:+FIN'L!.K32@(L68H)67EOSMS[5<@D!2FE/F*48)YCX
M)J#4/H&NY40@C=$<A5J;/0 L#8BMZ_2T,0J-#QXO+P]6N7GS:_["R=TA D?#
M?1*;#LYR^")TT*F1R*$=]SO\<'GV<S-*>, 2(N+&NV[;JURA5U9$:?1+&RQN
MH*5*[/II_R;S30Y9/F@I\L8K87W01D3(NM$H<3Z0JD B, [(;"8-=$1W5Q_K
M7IV'PRE;/?M(R(@'*\5YSO<:I'U\AK47MML>K'Q^<=F,S!-Y;OUXN+!",XJ/
MF4MP) #'TX*J%3T':4I , G)!4!(B+!%E/!H?+AKG?0U;:6^!W?T*SZ58]05
M=\9/MA[B"T49CK6];M&^\91K\#K\!>?=SW+>!;:YRG81<U=A-ZL;#:',Q0FL
MKG_J9IB2,B:7)3K=?"PL12OT'NRIN7OM2_W6SLH'Y^2>+7P'P;]B*#0,(#W%
M%%ID%+LA6+KX9)GU"&9ZM2J']A1VU(@YD:U;]?K,*5[JNI6XI9$E6(QDTT-P
M&W$N6;QGHRF@4J@NP?19VR.O!L?7TR1;;IN],GJ9:HBX_83/.4YN1)TE&+_G
M8+"GJ5C,Z)*CTLSU!L-'1=^3,KI-2F7'G)8K1IAGOS-]F)R7V#ROGH?WTQ:8
MK1:E@IO2CU654'MS:$&WOA5S,S[8[18(,Y\3R-.[GA"VM,/W-F4;K9")(SA"
MYY& B0V4-<RJ78(68\AF'D[C7B/VT6P0A$^_0OLZSD-U\.L91<9M5C.QU".,
M<,^'P-^>_A-&OE&IQP8YW9='MFDHK+FJ.><DMC0]! F>3 B#>]AOGI3C?,^H
MD?-9#'5F$OKTK,V.$NK-WEG?CRB5\'F\2YOV?7_S"17KK=N[[NH?W3G<DB"O
M^0 M6H=910R29. WIHK5'K?P%<T-I60TKOD/3$1_SW&S[?],9AA@#Z@?'+B!
M2=>U_HY5LE=XS)IQDW2ZTKRL-Y11M("Q)A8+S1/IHN@&2SXJU[P9W1" ?J;&
MNVH*>H\4BM@,'U9M$PRYO'9H*N@5EJN+(/\;G>7G&,Z]/O0A9CAZNR>.C$X6
MU7PX.[""^V%I,#8><VI6\GMKDJ'FJ?VJ0XI-Y*9:#"#AP3@@1(OK)3:B-2CU
M+'%K/5.YR2HJK\F3\K=8V78^XN.OOM8@::"\KY]82&"(#E(@YSX]GQU3"./
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MNUMRT7$73[-!6[;B.]F@?;;!KF*N+D?P)EICXG>K;_:(L$'-5S&W[G L2U1
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M9IW[EG^DC6&5%8^&,P2^CAI_JJ(5A*6^=IKM%3U=]WGN<TS?R_8CKG/9$;W
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MS^<C-4\KB+\U:ULRD9JYN'D@\IR&_0W\YHDK>\\:G%Z.T8TY/"5RB-?N,.1
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M1!*S81Q^ER9'NCRA\ZU>4V3-]HA:1<D#N9AC 2N63Q]^/GCH1C5?:J3/9RB
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M\A(+Q'NH&!F#XTW4K^/N94B7^5!/*;/D0C.!4J_ GD?D"+CG'&A5B\ATQ!T
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M<N)MGM^[$]CXG3P,[G#^KIT+POU39K\S2X C54"A<)RL(:?@'EN:(=AC4)J
MU_@!LWV-[*2BJL8M]AN:C;LGG%A.4&\WBRM+V+G4;E0<=94KH L.XA'G#4:
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M*+4]_Q0D)-C9)(.+06L6$KV:_'#W,IE2CZ-KNGCK0/-_>OF<N,@UR"$(!"(
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MW?':TO'#1V+0.@]/_]R#=\47O;PO]'N=G0?(<PA YQPABGP$_P%9/1;#A;]
M9UY/<U4!PN:0T7$EZ'L-E5&C/WNBET:7#MM;N<3IOA%J+$&%#&R](8';QLN<
MI=O&FYQD13*.$U58I':,M#/5&9O048%^XRTV0?U=,&E;7F41@/86MPU0?._J
M*&L3YVKMX?6!Q3,&!;^P"#1,'%EC$M^!K#1-I"&%N.BQ5RR!6+ULYY8AGV/
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M,OW?0+YA H073,7Z*V:U4^!26(1PJ5R__U'+ORWPC6-;I;1A@WHH8?S,5JO
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M4[<+.4A'#Z](E3]6,L4]/J:1L"LK& ZH>"]GTV>EL.D,@58"<(&,P$:^=SU
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M;D^,-S4'=RVN7')+>6>@J/=YLXW(9M[N*;SU/%Z+* X\P6P O*T!;#;*KS0
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M]THCP-3)@I Z@6>EU%2R$HW>+\V=QTD(.R4>'RVCL0/0#+00@08C4($$%$I
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MHM!Q:%079""$)I %L8B2*. AB<^(GE\/-#DVW0H&+\#OK:CGA<YOH-4,,[
MV-!!!'VP.C=L?@>((:/F-X.]9=#\CLHG8N9WKS\S3_E*U(=:%U1RD"2LN5 E
MA@7'T/$\ 9%'&<1AR"&+PIC&)(A<-^F5JKP]TM3HH<K'71</JP-6 6Z$[9FX
MO(.N'D%8P6Q@ANBD+TNXFE/PBU-P]4]@/@3%,#G,.Z.]31KS(:4/9C(?O*$?
M3:C$:,[691->)4SSN1M0E[N2&UP'R26<*ER8.&$$H]@/7(8Y1:&1(W%TM*G1
MQ7N<YR]5+%VUI%8?02T_>-U<P(PYC@.NQQ[68!R805JX-E5FMDHB6,P<UL+$
M*I4<'W%4.M%2?IM2]&[J1ROO5D6ZY$7-4O69[,6WM)@G'%$L_0M(2>Q Y#H,
MQCAQ(,,(!<P1(7:-@O\.C#,U*FG%!!TYI;\M)35<EQS"58\W+* U,&/T <J8
M*D[ 8)4D#HTU*CV<4'B;&$Y=;D8)JA/W^VQ9K6E6>/$Y%:IAJSKH:FIA7BQ9
M%=):U<<L?EVR9B>;[=37O);O2C&G(4<A\D+HA-B#B",."?,Y5&L:FC#*!=%:
MO]@6;&JDT]$-+*1RRH$I=@X8,Z4AP)6*8*5T5.>(]5DC:TKOTN[VZ)/258^U
MK)O^.,V]I4$'YL6S;'D[25NRC%:=@*M?3=*FKR3\;V9;[4ES* /4LZQ\>C5S
MNEXS;UH?;I2)=BB0VIEYL.</U#GA8+OUNN>Z'%4*K"3Y(K^+IB8-0;%'_*I!
M>AQ Q%1O2"Q4NP0B)W4O2#PLK'9*Z"'DU*;X2M*S2@0-84G-,Y(WML_ ,[:)
M:>QW(3@#NW&[#O01=%I=!LZ VKBKP#EC]3Q&JK*D/N_+DOJT*E=5O-$Z.;&I
M"K<^+,4X$5'B^M -7 R1'S%)Z2&''$<<AY[\CUFQE'.$F1IUUP*K+/DS*WR<
M92'-TZJ1<!_Z0*M.\/R\/\%S!K[P<O8ZV;;1908^I065[GG5.[AM)3S(@;D-
MJ.T>F)TCT+AG:A:@VSEVL_%,P_TRGLX_R_=D<?V0+?F7596.S7TO(BP,(4U4
MV2D/2><XI!YDL>_[;A@%#M7* ]WW\*DQ8R4?J 0$M82:.Q3[@#NQ8W0F' ,3
ME@$2^NOY(RKO(8Z"TQ_OL^>?Y&T59_R)U(^P_K%>L>][X#BK[B.JK%?.QZ[I
MF0]#*5^H#!S.*F=L4U*C^"!_V2R"L.M%'B8>I''L0N32JJ10))>S08 "-_2I
M:U3O6VO4J7W*':'KG:I.,1HYX2K!>RY<]8R@Y]Y8AW;HI:4-5,TS2$Q0LILA
MHC7RN!D@)F#L9'@8W?RFS4U5UY5F)HT22OW08] 5TO% U L@CE1E"DRP%R4"
MR17=&W0RW4@X-?+K"#@#7&WABZH,17VV9ICR;-^>EG;IAK32P#PZ0!?2VMBV
M?+7!C3#%#J,=*:>UT=<7Y(%ZA^X9J&^R7]MI^U#EC>)&_GNVE".^7&=%H=;
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M-/E-OM!M+09<^55MUD&V*HL2+U6@]0P0?I\NU7Y2VXQ]I"[LQF^$B\,0XXC
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MG\&GYF>UK28S ;)6:) VU>% D2TT([=Z&>+T)L"0\ [,1X<[W:W%7S?Z;!4
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M@(X^,Z TZA;<Z63P;\QVL3;;]6FS&5.@39RM$J85P4:E5YM0;I.QU6>?U_]
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M9%+H5*1JC#I@M^TY(J7O+,#DOTE?K)5J>?^9XX+?I/</Y97XM6ANG=,X4H>
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MM7G(^S%V_@>H)0:5R("M.%!" R6U_@93+W.<WOP;&N2!)P4I/JCD!Y4"0&D
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MD"01@H'O^B)&8>P(H^"?TT-.C02:A8DR7A5[4\L+LK7 ?2KF'L5<SZ>QB^3
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MHSB(N1,YCNNY)L0YKOA3(]Y7C8L.GEU2J=YN6DG=D\KP+'/<ET7S&'2RK\#
MD\'>A)#-.?4,K)5N\T24ENLB&AM%JXE"54\760XZREH\7WT3&]D]FAU7A7%/
M==_$/#L'PF\CQ<C%3.I3F\ME4>;5QFY]LGWW@)=--LM:PZVY_V?YZ%+%<7["
M:5ZOFIW0\5U&5'*)JDJ( A\FW(N@(]R$1L*52Y'(O,?D%%0SH=GQ&EHVO7M>
MY6YN.ED>S."\5^H!IF);A%2PWL<9J4R*S=<M#",OBH(8"A;%$%$4P)AQ"B-,
M/(&)XU/JF';7G()BYB_;\*T\][UJ1].$_[N\9'I.WQ1$G:@KV#.'N 8&=)"I
MH^U *;'99!BOX=FS^U!!5*>'*)#J7= )%/H9P.;3J )D4[&_CQ)! YC26OV@
M(63K>7:&BP?U_THB.0\H650%_CRE<E#U#Q=+]OH7G2MK;_ER255!0/Z!UW]^
M_$87*S4-R1\>%!)J"ZH.X9P'7A(%7%"8N"K:W$D223'R/PQ3D02"DY"A>:D\
M=<V3N5'%-]K462LQ')>K8_!:1I N 97:54=NU0]\HV?URWR-0O7OAH=PX[XE
MFD=\D[7]T >(4A45PRFMW-%H!C;*UO^HS+[]NU<W-'LY+0K@^Q:''U2%O@8*
MT&)1A]S7:%@\J'P3*]H]!AU7A7$/6=_$/#M'N&\CA7F=\?>+5 XIIWJ>%TT%
M?<^+78^Y\JU!3!T ^R&,<:QZD'F.RSTG\;A6C;[]CY_:.4,MH:HA+@?3KV>]
M![?CD\#Y: Q-TC40M70]&C3L042_H/=YR(Q4O]L0(:-BW8<!.%*;>\]-HY7B
M/BQPM_+VD:O.:7_U.ANUVP#+<:C/8P$)=4*(J)S[8M4_,0ZBF&.">606O')\
MN*EQ6?\66 <!U?-L[<$T,,FU;;"V4LJ';81U"I<!6F$='/(-FF&=4G]_.ZR3
M=YT?#'>C=BJNQ*\%OY CEA>/65ZF_U5/5FZ <4Q1#(FO.C6'(8.)@V-( U]0
MX1!"S0KM:XX[-4;IRK:N5*'B9Z7<9T2['4/>/,S-$I[CQK=50L-,0"DVJ.2>
M@:[DPP2V:4 U6$3;L;'?+)1- Y!C,6PZM_<CJG>K(EU*)GR?/1(Y8)4QGA9T
MD16KG&_F9R=T.19. $/$Y6(M<&+)4Y1 $HG0)0'BV#=*X=8;=FHT]>[7V\LO
M'V]OP<7[?__U\O;R[O+JBZ$?I(FW'CO91W%@<FH%!AV)P4;D@=PC,YBL$I/F
MT*/RDAD<V[1D>+=Y$O4E%?G%BJ72IA=E674]EF-\6N#[>4Q)[#"?0!ZKG '&
M H@]CT,_<C#%<8!"JE4C[?@P4V.=R_>?;D C*NC("I2P^KG41W ]L:5D#:V!
MV:4?4$8IU:=QZ)U4?>31HZ55GU:OFUBM<77/R$#ZP-EJP:_$_F/B*F>I.1%6
MA[WU\7)1K![KW]VIG-?-9!J@@ 5N)'G"3WR(1"@D;7 *>9101P0QCY'1;HU=
M\:9&-ZUV:AW6$1K\JE9DZ;(*25$[&G</O J4P<N7?RJ:7H.-TH8Q4W:MK><Z
MO9T-!R;!KOF.Q"J]LE>=;=F$.W5,_GNE)1C$*1O& ':#BNR*.&YXT"#P[@3Z
M##.*V:Q1Y.7\ZNM24N-#^E15E$Y$'!(>(DGS D/D, YCC%V8(,&Y[XF(NEJM
MYG>>/#6N7@MG5)Q[%[#CG'D6# /3G38"V@1U4-MCW")OZO"*_-LVI^P^=10Z
M.*A,^R4?OJ"?Z_:!"Y[G7*6*\/1^N2Y,N-5K J$XXL)SH A]M>_-0A@3CT(_
M]$(4.7&,$R.73&_8J7V^K=0J:TR)+=VKJM*+A68?FG;0<Y;LHSLP*ZR!;23N
M%D@=L 6(&4Y6?17-H4?U0<S@V/8M#._N7<0KKR*2JQ0X50ZC2AKIUDZZRW9]
MFTXIX[D?HMBC+().%#.YNDRDLQ$A#"D.6> YF-)$R]FP)]+4:*Y>:V3-HD)%
M7S[Q7%+>8W50597, :ME:GK29\%V>O0WKD6&WB3;* /:BCMUHM1VP; /Z6)5
M59>NH_\.+BAUZGKWJ2YF"7/;U<?.%6OLZF268-Q3O<S6D\_S-.644!V*RL7D
MM_9WS1QQPPN>/TNAENR"TGR%%T7U)V>?-TTPY@PSU8:508RY U$48[E:9(DT
M/6,L0B&5%-['%SU7L*G1>$<TL,Q*0.O&78L7P.H:X]+D_9S4LTUHYL:.:9BQ
M'%WEV=9*S:J?U__0*%9E052J51-PJ]P,-.J!SQIM87H[Q+80'\1E/ENX-W&J
M;4%ZR.VV]OR^CGE=H;MV^YN!O_!R[D0.832(H&"N@(A0#A,<"!A0[@@?$^HZ
M1I$HAP::&ONV<K8; S.PY(8] @YB*DCBAP2%,(K\!")/+F$(BRE,A$.B((EC
M-PQ,L@^M8#I"GN"0F.HN+<Y':O %0P-26X:XD?*'JMRP38__.!26_?@#@XWL
MG1]7>=?G/G&]>6+65A2T] VZ<8?K!ER-^UY\6/'_X#C_)-^N.6(()3'WH<MB
M E$<>9 $D8!AZ/AA+ 3#@NBPQGEB3(U3Y L7Z&<SG0'_<8(9#]2!Z6<WE4+Y
MKUM1SFM=9NVVA&JRNN) *0241J.81#\1;1S3C)2P-K2)C#+<SD?V2";<&0\?
M+6/N? "ZF746GF8^*>V),=V4HKMD<J!4I&J'J5ZA7- _5ZE<GDCA.@N0*LR
M*W'34@KZ+.^47\+R7FU3%.X<\SA!+A=0Q,*#"","<2003!@.J$BPS_12^$:2
M=VK+D5I,N%!RJI9EK:#Z/#N&D4_/D1,SW<"3Z;[X^UFGC"GH:MSL)X%6YXK5
MNYN C=I5=7+U,E2:@Z[JTWH;]*?GB;T5(\WCDWD[C";\$6UUQ#,80XK17(@1
M(>WZ&F,.>T[/KSO\K>[6<\^7].6SE/FRY(_%G"2Q[S&20"8PALA##HQ1&$%7
M$->3B^$HP8EYNZ\#HTW-(>A$V'3$!;\K@4$EL69THA[6VB?W=A <_E"^-W@]
M&W>= &6 GEV'1GR#=ETGE-_?J>O433US75:/CSA_N1)[!DF[)3((<D6,:0)Y
M+!R(2$@EN_@N1#$-<.1PWS'KHJP[\-2(IIO@\*I[0Q,19II]HHN_'N,,@>K
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M/N9#]J@2"Y#G8H_Q $I2(A#YV(>8L0221(C$C7D<QT;)(H>'FAH%=20%E:A
MR0I^KZ4UI)\C".M1CAW<!J:9OI 94\QI-*S2RI'A1J62TVIOTX?&'?THXS><
M5[5";G#)JYF3QHYPO#" 'O="B#PG@3&A"10.H2B)B6!)8$(4VP-,C1Y:^8 2
ML)=+L@.A'A.< \S W[\1)L8?_2'%K7[J.X.,^H$?4G'[LSYX7<\B&?Q>,<0-
M?U*-[Y?W^UJF(\8H3@2'(@@3B!SAP1AAU<8A1(Z'8A?Y1FT<-,:<VB>_[D]_
M^_'G7SY^N0.77SY=W?QRH?K4&U;%T !<CPTLPS@P0332@K6XPW>G-P#(;N4+
MC7''+7JA#\1.O0N#6\]/;OP;3^\?2LXNGN4RYU[E44IW18Y:_>,=SQ_=>4!]
MC*6C 1."!41<PD]\A\*("11&G+ @[IW=>'KXJ?%2*S'$M<@J,[V6&2R4T$ *
M\3AK$_BJ7QE&#1B:1W,793#0A]Y->9T*V<H.&N'!6OKZ"J#D'R834A^VP5(A
M-41XLUQ(?7B.)4,:/*5/@P!<['GDG D7!P$-('<##A%E(4Q"N9SR1)SX"0D#
M'FNY6T?&F!J-W>QA+9.Z\ON!/,Y%EN 9F' :HC'B%?TWS:"J_ME C58RWQPP
MPS+X1Z$X6N-^_YTC%K _*OKKZO3'+^VYVEQWM;_.LR>>ER_7TGCEQ9*I\[8G
M]7I4Y?#FH4M$+$(."97_04F20"RH!U&(A"<(CGP_-%IR:@X\-6+LEF1L)9^!
M2O;J$&<M?5-'T' ?2ML>FBO2 5 >F%_/ ]5\26J(D-UUJ>[@XRY.#2'96:&:
MWG]&/VO)@A]X_>=EG='TD"WD,XHZ7. F6RP^9?E7G+.YSWV1$!?!R*411(2Y
M,/:Q!T-,F._@(*'$:%/<</RI$5DK/OB^5> '586KJ\,_M66Z?E=Z@$81\Q*/
M1F;2([8!P1^8WP; O5_':7/T[+>7-I!A_%[2Y@#M;1S=XS&&2U>>SC\TOORG
MM*!X4?<EHJMBCA@7./01=!TN28_Q&&*&(_E7ZB>8)4P(3VOI>GB,J1%;*R:H
MY6R;;DE)-==G1^ \L8"U ]+ !-0#'_WEV&D$]I!(P>F/]]GS3_+NBC_^1.I'
M6/]8+]:./'><Q=IIQ=:+-8U+>_0)6ZSX4YXNRY_YDI<I+:Y>FE(D3A*+P$$!
M3%SL0N0Q"G'@4N@RS_=9Z :NXVIW]SHTRM0^\K6@H)447+T8M& ZB.;I+2HK
M& W\C>^%IT<1G,,X&328LH'76&VA^N%FUL3I%!['6B\=O'>\ADFGQ'_5YNCD
MQ7UK%AY86*ZS"43 (AXZ#N0!22#B+H;$5=6U11+*55^(_,0H=/ODB%-CR!/[
M*#US-DX#K[=^LPKGV^Y(#9#PH8V.Y3J%IT8=N4JA)@B[-0IU;SP_W+*)&Z8^
M(LQ1&;]AH@*RJACMP(?<\;$3NL+S(Z.B-KM#3(U>ML(+>P5B[P%2CSW.@V=@
MNC!$YJS0RP'CK/<,\V;AE\?CJH]<V;-X%6-5-7F\4(6T+Y?O\5-:XD7C^;HX
M2(*8"!A[<021Z\B5E^]A&$4^II3'W#,+OCPZVM0^^XVP59'Q_X^\=VV.&\>R
M1?\*(N:<.541B1J"!$EPYI-LV36:<-D:6]5SY]2'##PE3J<RU<E,E]6__@)\
M9#+? ).@V/>>1[4LD<#>"^0B@+VQ-KR;@]I>1SFKLQ#;L4!OP'DFA'W,\@UF
M/:XLG$#I5^'J;(_#JES9.'^@=&5U4U>UJY=:M/V+NI5L-16<I7%FA-1#$NAE
M219 1E4$$9<\2A*6)*&8SN6CIC+QX*)HM=N/U=.?54__06_^WH2MF29\+K2A
MKH))>W#:$44G=(:2.FHC<GL.D0X*1L?=[EF>:*^3@;6'CKMX*"QTXKINK_6G
MQ?S19,29IEJG!R,:!<),"A(A]<N=!APR01(8(Z100GF, R=IW>/=C&U*8*R$
MQLSR\9U<<S+S!*YV;_GU:'E^U[L!Y?S:G\>AUY?_1%>#4L!Y=_>)X,+5W>B@
M*LVK;Q"_S[75F^F$?G">:"&_L%G^6&Y<OZ,SD\G\[4G*U<WS8CU?37$81 @+
M!%&(!<1$,D@3%4/)&(\5PX1E5@':'FP9&[$T-H/%QF@W.KEF7.PX9R"T/1/3
MU@NPXP;8C,"7RR/@S%,]8-<KF5UCSZ",UP-P^[381Y/N,>V-B,87]5DW5TIZ
MU17[Q#1@L4RCE,,$&[&+)"4P2S($:9JD(E,9$:$F1J/ >IX8+W7DQ'J;[OR]
MC*4\S/=2'D:O"(RX;%56JBEV>EI.WPW?\P37)VJ>V6LHP.PCWGT!-U#0NSN
M3G%O&U3.A+[/WCY8]-O&B78 W.KZ:Z0'?Y.KIX6XFW^7Q:I<X-XO9CE_G9*8
M$!4$*0Q,HC..T@AF$0Z@PF$4AH0DTBXKR*JWL<T<Z_39REK0,K>+0.$IA.UF
MB+WAYIE%3T(&_JAL!5X4 :S@\:!T>*K'-Q ^O.#\<1W$2S=UHY16,;\Z$J."
M)$I8R*$40:*7ITI!0I5FE222J<2I1,BI\.=!#V.CCG8-2C>V. 3/CB&N@L0S
M*[31\!"L.NEZKV_\82^#ON4GG=Q_LT]?>,7;_'DQ-]DPU$B%W.FUW;.LE9*G
M">6)5&D(4QXIB!D.(>49A5F@4$#3 "?(*8Y]OKMQON=Y:>+$3'H[O.RGL75X
M\WM!;! ::%L**E/!3[6Q/_=,"A=1Z9\A3G<Y/%U<=/\H=UR^JXLFAB8D^:5I
MEL[%I=KDM%V;?(ICDLDXUA.(,#&5PV,,*2,$A@2A"*% QF%BNXUSI2UCV^EY
MT$-66>@B'''=<%S>]1D09-_QMM*3"=CX4F;N[@D&;1R:@,:E"=!.@=*K^G"4
M]FNX(7+1 !ELJ ;3"AEBR!S517H!^:P*R74]#*A6T@L4NZHF_339<0M-*<E7
MNIWJ:_E ?Y@<TJ_28*'[+1_V:KU]-_] ET9XI?BT,,6GOJ@R4%+H5;<PV5/?
MUJS(14Z7KU-*8R%%2"%C:01Q$!AE/+UDCD*9A7&B9)8ZZ>'Y,')LL_&[YQ=3
MXFVA@*SVH63MB..&G8_QM-SG>^-1\KT]V+C73/Q-Z:<RP7W7Q4DC79#/0>,F
M^*ER]&<SOKN^@JVS9>EHWFNE5Y]CTN^>I ]#A]W*] CUP0ZHS[XZGD>LOT\?
M%\O[Y8)+*0I3Q+!<E56;M*9JH3&Z+*4[I3R+2!!BJ/\3FZR? !))&(PR$1":
M!DS_ODD#MOM*.%I@12V["<*^/P&-+HIFCKP5?C 3P$6Y_T#KJG/.FS6NHV/'
M^#X0'^A 8Y-RK!9+\%-C?%EN]6=0[?5L' !;#WH\W]@-NGY/.SK:,.S9QVX
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M2JP$K!SZ'!MEMLPV6\=Y;3A8FGWG0IL.Z,9V^_BL[0!<#I5[@-4S_;41_:)
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MA%CI557*.%1Z<04Q3Q+(F'[541P$@9Y9922VRA+KT/?87OO:?+.9VW( ;#T
MC0L=]G2ZC,WE8*!'Q#VSR>C =JA;Z _TH>H6;L$O6N#3+?@O#?A;['LJ6=@-
MO',E"QU;'*YD83=7=TH6=FS"SY'2_Y9T^:!'0DY)&!&9AA*F2E*(62@@54I
MO1!/.<MH*H33>MRZY[%],_33B/L]5+H%^8K@W[70O5% <&*2'YD$]S07$V L
M!Z7IPQTX/4!KT).GV][?/J!X#A37LZB'#?@C*),5,25$CX">OD*6X0!BR1 D
M2&8P%2C$,5,T)4YG'VP['B$]Q?W34PEQ?^SD"MQXR,E8/BPWM;$:G)K*SD?'
M3&U(NA#3SOW=>.E0^JFXF8NOTI0QD<7MIB35%-$L2+-40(*5A%C0$%)S.HL$
M6%(LB4*2NO"2;<=CXR6COB:VY>B,*O3"5'%VXRIKV.VXR@>8OE?1']Z#IC3O
M!* 0!MGDF/Q=!7'CR@1LG.F/O5S1ZY6]K#L?E+U<(=EG+^?[W;<+2Y&<FV=S
M>/WO>D6Y7P*E3HP.&:()CQE4TDRGDEA!R@,*HRR+,TRSA(=V 0#;'L?&5Y66
MT-;JPQJ_]AM3=I!?WOOK'4C/7'49PPYI_G9@VN_M]0[J4%5)>P#7:1_/":@S
MNW=V[0RV9^?D5GNGSNW&:Q+F#@^B)W$64L(5#*G4],Q$"DF$.40)#A0-(Q5@
MXJ!'?J$[JZ?_387$.YV2/05NBI(X",,8HHC%^MLG,YB%IC*.P%&819PHZ72Z
MX1]$/Z$%YT^LD5KN%=@H8H(D3$&A4 )QJ"<5)$8,<IZ0,$T2R3G>/+7V,H4]
M/K5#B13V@Z?=(F?\.A3#Z$\,*3PQ"L4)1ZD)/QH3=>RJ^"JYS+\;:9;/<E6K
M6DQY+$,5"0'#.#%)GL)(5',!12))P-, B=CIY,BYSL9&MXVM8+DQ=E)5M%#;
MFA=E.3^^E")?E?4MJO*(_RM"Y>K^?X4$T/(WM[H-,]WXYW]"2?!O$9J8<YO5
M169;?&(*T;](O7;\+F>G#V&Y#Z = _4U+)YI:#,B7ULC0I5^&%I5!<R O*\&
MQ$BZ3\#[OD68;=#JE:S.=C@H8]FXOD];5O=T38O4;'@G=$-E(-ZLYSZOR^5E
MS.*(T8S !!,*L33;(R@E$&L>0YQA$D=6Q:,O]C0VUJI3 LVG>M=<4-GKFC)Y
M"N +FR%]PN:953HCUB&=\@(:5^95GFI]X 3+"TX>9EI>NL&='&[K+9Z/><'I
M[%XN\X7XJ']73!.,2*(H@WHUPR F+(4L2!FD8<Q$F$J,D=5)MK.]C(T4&D-!
M92FH3 6EK?:$<!K4RV30"U2>B: 32DXD<!&%S@1PNN7!7OZ+SK5?_,L7=\BS
M?EHL5Z:<3!E;UE/KO]!E;N8;Y;_?+XK5-.%)G* L-+47]'^B.(+4Y%<G>CH0
MAB%3$;4*]MIU-S8:*"VN"NZ4TAA5"/)[;78ME\&UX0ZA$PO0+\=-^H72=X!W
MBV)I7@EB8W"3HF)L[A5$AUSH7L$<*OWY:E#=4IZM,3J7Y7RYD>$2FZT=VLEE
MMK^KX^92&6EI-B-$&H;E4;4TU-,N'& )&5(!3%(D J'2 "'F4OYFIW4GLAVL
MUDU398LZ1*2/@V>YD],5$M];-Z5=/C9CCCG<[^[+3@_#;K<<<^Y@?^7H1=W>
MUT]2-R9/U,EJEUG"5!(E1 @1-KLJE$8P0YDT$;E(2HZ1C)3+JVS;\3C?\FLJ
M6EE#;D< /H#TS V5R1-PKIC>-L^W/^IPA:I75K'N?%#"<85DGXN<[^]&4\=5
M?%L2T.]>MY?4W=Z8HJ[5Z?QMX8?BBTEQ?7BB\R\O9=[>Q\52R7PEQ=V\6I1.
M918JB12#*$X"B$D<P@PS!%F8TE1&C,LH:&+B=EPWH/4=0NS>UZ#4E&=2C:7E
M1)^;R,UL)D^_W&_^&-BQ[]B&=G@]]K;?;5%VP%[!4=UVX_T$U,HE+0! B0!8
M:0A C<$$;% PVCL5#OU]#]Y@\'K]I QI_Z!?I3<8F/T/VUN8T.>WL>KL9JY[
M,8+$^7=YKU_AHCRN_#KE2JJ4QK%^J)">S:LHA"SE(:1$",H"GL3"*:&N@PVC
MVRLMZWV\.^"T/KY0YP?CFB]-;Q /^,4X4L$#_%%9#![DCQ5XI[G@KSWJ"%X!
MW0!\?=Z.$?"N%5!V_&G75$<>;'00OZCJR&%.9_>+2BYUH[^9!"I4<19#@@)J
M)O<<,C/-3W'*A$"1Y*E3J4:;3L?'=(UHYT*!C=6@,;NSYJG5 %B27<^P^F:W
MZQ%U)S4'B/IE,9N.AZ4M!R@.>,KE7C=B*I:KUO'!N?C/-9WERDA9-AERF[<"
MD1C%DH0P9B0UZGX,$BPT2W&9!)*P+$7<AI;LNQP=*9T_16LV#;;.@$UBJ"M7
M.8S)>:;R@[1OGO(&LC5]N>-VCKQT:RWBTO_:)RV'[@:A+'?W&\+J<*=[1LV]
M;EUS85.5+%%I$(8"!@SIR1*G&-) A##4?$0Q)XPSZZID.RV/C7QJXQRR8':!
M.D\55[GOF1%JNSJ<^MU%P#Y;I3,2 R6F6"/BE']RU.LSJ2:[UP^657+4S'8"
MR?$+.BI)T7QI&$W^)FFQ7I:SL&HE6/W7[ 646P'3-(EBE1$*$4M#B%/"81:F
M"":A2H4(9"!I["0E9=OSV(C*&%Y^L"5HF>Y:YLH:=[O%FA<T/?/><2 GH-Z&
M\KH=Y8Q7OR)3UKT/JS+E"LJ!S)1S QY+=']>5(4A1!D2*,JDD?;?3:;=Y\7J
MO^7JJ^2+QWG^=RG*#>@Z1C!E(L8I#F/(9**G7H(I2#*E8'DL6Z4H54KV7L'[
M6JO'QI8[H<GY8@5>I2GQW9@^J6I\@T5EO8>"WE<_!G8$/+K!?=M@P@1L?&VB
MS94/54*QJ:=:/@E?6T_"S;-90@U<,KRO(1F^HOC5EH^OX'A?@]&I'GEOG7?,
M EW,'Q_D\OE6LLU!<LEC'"G)H<PH@Y@B!$E %424QRH)$A(S)YG$(WV,[7MA
MDMG^M<E8!B]&1TA_.$Q=66U[=59!:.L=TSV/8!N2"-$T(C!3)B]>!0PRP0AD
M899)#7*FHLRMSM.5Z Y3XZG"E_O'U^ZS>25FGC]RGS:8&/LVB?3@-[I:+\\7
M-W9/C#V-1+\YL$?Z&3;=];2C!YFM9R[MQK+WR\6+7*Y>3<A[=3,O,X5>S(3E
M0;=WNWBF^7P:(!JHC$8P)C2&6"H),Q3%,,!41!D-!2)..QT6?8Z-A1N3]6)\
M5E;$F NP,7L"C.'@C\ITQP"US0#844?/L Y!)9_R[WH^_+ C2'@91V<J<4"F
M5VJQZ7=0JG$ 8I]Z7&Z]<NOUW>L[.C/)V-^>I%S]NERL7W+->^9(X)2$*H@R
M@2"*I>8BGB609D) P7'*]2R09BCLM.MZIM.QD=%VGW!B$IIKNT%I.&@L!W^4
MMCNRD=48..[ ]H3L8)NOUX#:?=_5 B4_6Z[G.GZ;W58+*$YNM-K<._!QGWHY
M_*LIXE<T^=7_)?/')[.VUJL<^BC+/][2E=PX,I6)RH32ZS%FMEPQ%P22.$ZA
M2 1A(D-QFD77IT-[LW^4I%E6ZP5T!1[+.I5"&PQ^RN= +&8SNBR _L*!PH!P
M6E!R%,^&'0./>,0'W(SM>!9H<]JG0F%[U&<"&B1 #45U"3!@@.UG9 1'@JX;
MQW$<"^KHPPA2U+T/4&_'@ZXTHV/,LCR39"Q=S+4A]5)7?]5HBC"&J<!&&2VD
MD(0\A";G*XK,M@-URH4_VLO8ODWUN<.-E1VW$HXC:AFNNQ8GSXSN#E''HO(G
M(/!04GZ_IS<H*'_"V>/EY$]=W'$Z36?R9B[*P_F,\K\^:'XI:%FWYE?=NE'-
M_2Q74Y9QI1B*86@RT3&* LA(E,"49BJ5(E"()4ZS8*MNQT80QC2@IR^%MKZ5
M+. X2;5#W')NV3N.OJ>$!CJS;;LQ&;1LUM,\ _%/QNZ?)T";WN/TS0FJ?F==
M=ET/.UER@N-@CN-VMWNV>7DRNA*YKQ7NFUI7&<Z"($R-CK,IT2<#2(7",!+Z
MT0M9D 2!M6KCJ4[&QCN5^D%=>.&GVE3+M?%9,,^33%\0>::4X^AT2%L_"9-]
M!GL?< V4S.[X4#FEM%^"X4QV^\E;!TMTOV1\.^?]XK7NS/=N7>1S611ZGL?R
M>?D0?%O)EQNN9W_5V<-&1D)3CRQ6=_/R3TLIF[#TK\O%GZNGKWJ1^'MARN3<
M2I,KH!O=[ES%+$8)$@&,8OVYPI(12#A)(<&9#$,2R8!9Q9*',GALC%RO@_+:
M);,M16NG)JV4E<?2,; T6U)KL[NU6@#1. ?49B_4GJ,&>3HN?Q;&-N:>/S&-
MNZ#E[P08CT'+Y99RT?:QN-D\%MNLG<IW\/4?[+&P_PR.[?$8Z),ZML?$Z9L]
MY)B=^?X/8L9@<XDA06W/2P;MUZ^\[&?Y8_7PIYQ]E[\MYJNG8DI(Q*B,$.1!
MIN<N018:W7X"N<H8"1 -5>A4AZRK(6.;D^A7*?0C-WLP!':;4T, Z_G#[R9'
M.P'_+>D2?)GW&'6\%L0W$:H],&:4PK6G(.LJ9'NRO6X$>9L7+XN"SLKLF4(O
M,F=KH;O7O]8X:$/64M0V+>;%9_T0UY&FC+.04"1A(K"$.,T"F%&,8!P01!(A
M&59658VNM&-L]-BX4661 6-HQP!?UX&Q8\T!X/9,FIV0=B;&*W'JE1>[VC(H
M+5X)V#XK7MM<5R6_!?_KTV*F[RBJ*>R^,($P9] RDD 9DPQBP0-(4F)"E8J&
M:1PG 7>BOXL]CHWH3(!X*9_DO,B_R\T&;QE2<Q7MNX2U99"R3P1]QR=;MOZ?
M>J$^C/2#-4H]*_9=ZG5@N3Y+$ ZU^FQO[)@FI515D7E3>-LLC<V)VSG7\\#J
M).Z3R?"ZF]]*)9=+O6BF/ZIZ+%MMKJ8R\91D@@4HI##F32R39@F%$4T(9BD7
MB;#2S_)DW^@XK33=;)1]WTK2-<86IJ+2@N>F8@'X,U\] 2Z7*Y-(4%;HWBS=
MJIK<CLE</8^['6.^X6AZYM>-9\V'R93:+7<X=[V;@.V0-QZ6UU8^MI0)-UY.
M3&:PD0[N,1?-SSCTF\76LXW#YK_Y ?@@<\Y3-]V^)0_+4H;HM?QF?96K?&E2
MA8O5;W+UM!"5W,@4L133#.G):X(YQ)'4JW@981A0RGB<$:77\4VIF0?[[X1-
MWU9TL5LHYF& ;T!E;2.EO*H=J81ZW$C=:@#LF+HW/(>AW\9<4-H[ ;7%M?I-
M973_BC<N(/7*C58=#TIX+E#LLYC3O7Z#,F:?^Z-^*J<A0I&,DPAF:5@&8V+(
M3"W/6$0!25&$B$Q]!&,: \8V4=4/8NPG"+.!O-_@2Q<@QQAT,3X,'W791^]-
MHBT;(T899=F'J&MTY:"=;@QW-U_5.A?5[.[7I5X5?OA1[U[^NEB(/_/9;)HA
MRIA(%:0181"S+-"\%D0PRE@:$JG"-!0NO&;7[=C8;&MU7;1X8E+:B@+(QG+P
M6)ON1GJ6HV!'=?UCZYG@6K VM9!+FTT:;H-K8W8/&;G=<.J5RBR['I3 W.#8
MIRW'NSMJL91E1^0N)S9*9C&)4X226'-21"#.$KU"%$:>().A(H&DJ7!2X3O7
MV=B(J5$\4Y7-=='E66WU.0$T=YSM2*@O]#Q33VWFD1E5[]78;1#I5TOE7(?#
M:JA8N'Z@G6)SSY623G?SE_6J^"2_RUE8GVW!28($(::D,37ATHSIB0[)8,*4
MC)@@2,9.X=(S?8V-1$K;@&/.W#DL+9FB'X1\$T5+B*DR5+-%!5B/]2\<,/$C
MNW2DO[=16SKM^$F1I3.W.!X[DOGT1L];]!A],D-5IO<S3,- +WM4QO7L(E%,
M+X6" "8!37E$,A0S9'5"Z+#ML?% ;1YH[+,\=G$$M/,$<"44GE]X:Q3L3Q6<
M]O?(RUQ(_LOCXON_Z+O*]_AOV/P(JQ^KXP%'VALFD_^T(YND^S.7=)2$I<M5
MSO.7<E?DF^2ULN]M7JR6.5L;29BY^'TNMO_^0)=S?6UA4GW>T2+GTS0->,82
M!C/S2<>A3&#&4@E)%$D2,Y4Q29PD8Z^W:6PO?R4\W9A9)A7P,I%@M0 O;7=!
ML?'745JVAX&TFUD,/#R>"6G'&[!U9P):#I5:$CLN;<>RD9$H'>M1QK8_E/N5
MN>W!KF%E</L#\D FM\>F.V;ORV7^G9J<@T80X\M\^SNC\*)76#A*F(0(Q7J&
ME7(!,X6,VA;/<"BR+$R=R/EBCV.CWJUQ!1"RR!_G)?'2 CQ)\6A>^GRNQV?=
MH8[99?3M&+573#WSY=:N'1D=(UC4_E.OHCK6^/2;;G^QUV$3ZVU!.$BAM[ZQ
M8[*\?#3OSE=9UM.8/V[J%W,<9)0)!A.!(H@I5Y RAF%$(X(R$7#%G:CG5$=C
M8YS:3K QM'M!^U/0VO%*'X!YII-.6+EGO5\ HM]D]U.=#9OC?L'E@]3V2]=W
MCBWE*UF6?MB+9?U>2+6>?<J5G%)"E" HA"0V9ZVC5!BBB&&<XC1**0M5XI3>
M8]/IV$BCLAG.RB(9^5Y$?&*4&;3A8*8M=PXZ71Z F$295'$"58JD7L%3 ADB
M(>0LDEAAAC!3;N6@^AZ"8>I#;<2>:2WV3)_-V_#W*@?\I93*]0"_=>RO5TC]
MQP#- UU5?=G/19B RF;PZ=P#W248: U1WT'!RQT/'1RTAN)(D-#^WNMS#AIY
MD%K;3'\.!)$HE)#()(,XH"%DD4I@3%E,4X)C29RRHL[T-;:OP$:L1]--C]D&
M^PA;$TX?N/GGF7:NP0;!VE(_F08GX/"6:+#?WYOE&9QP_%R:P:E;W$4+VZU^
M8;/\L3KV3>>B5$BLX^,JBQ!6"8<R235]8",XR)(4IBS@$8M0D@;<;C)CW>?X
M9C*E<?;*;G;(7@@\^D!K2/( +8O+'?]*O-1=XM4.37NAN]Y1'4BIKA=TG>3E
MG) ZHP]GU\Y@ F].;K45VMQN[#:5TW/"+^I#L<J?Z4H64QE)%48BA;%2*<0L
M() BF4"241$F0L3,[:S.;O-CF[!IZ\PYP8U];G.T/>CLIF7= ?%,IOM8#*-H
M<1R.7F=B>UT,.ODZ[M[^?.O$51TW]/F3%.N9:;$.5][+95-,*.<W<W&;STPT
MLZRTU];$21AF202E0&;=EBI(5""@(DD0A)'YKUOYCFYVC(TB&C?*=Z/)&M">
M5 7)ZL2!\HM8N^,8(^@X6I8A!/]CX#O"X I_7??3D_[.=7CV&ZCH:,NP<8SK
M #L(<US97'\G;')9M,X=;B)[3 8DBWD*,V:F3UDJH'["8QC10)(@R:3@KK$0
MRZ['QIL?VZ=N>CAJ<P)P][VP_F <=FNL=0RGMGL"M.%>(J[N>'D_I'.B^S<_
MLG,>%IL#/!=:Z,99Y0*QT>F^E6PUI2&-9!1E$"6(0\PQAXPP!DG,,(XH29E=
MLO[)'L;&0 Z;:*=1L^.7J[#P3"/51LVV8H QKS^F..EYKX1PV,N@[_U))_=?
M[],7NA^VJ3-27U'('O+53$ZYXHBR0*_-4J$@QK& E 0<4AY+G&4LXI3;GK;9
M;WQL[VYIE)GSH_ G]G.3V/UJ?^KF +T+N]]78N+Y'7:%P^GXS2F_.Y^_.6AP
ML ,XIUQIG\ Y>8U[1.O#\\ML\;JMAW$W-]*"^7=YKT?OPVR5O]3! HGT2H!(
M!64688@3KC^[29S ),Y"QF5,@C2T+:5EV^G87NG&[O)3!(SE8&,Z,+:##Y\>
M[N[MXS36Z%\.?/G U#,E6,!I[.X0_[+&U3X$Y@/?@:)@.SC#8SC_5#ZW/X.?
M*A]Z*H_H"MF9<)AU4X-%Q%R=:P?%G._MMH!ZOWA^-@61%OROY093<;->/2V6
MII;SE-*,":0D5"&B$"M,829( &G,1!!)O;8BTF4I=::OL;%X96HEJ#D!16DM
MH!MSW99;YS"V6WCUA)QGKJY!J_4T*T/!S670G%=C%G#TNBX[U]^@*S0+Q_?7
M:C:WN$\)[Y<++J4H/FH330'L+ZI2FJ_T-^_FWV6Q*K=Z2BVH*>*9%)@%, V#
M&&(6"4B8"*'^_QDF62:QL#IDX][UV(BE$C=[J7T 9HB!*,N'E*7HS.+G?Q;Y
M? 6^:Q?62X>ZEXY#<GFVZ ]HSSQTOX.N,;T,JU65)BOK0<O\6G'.&]+V\T=_
MB \TB^P9>:>99#?PSLPG'1L<;%;9S='VW+)C"^Z;>[?U8_>@;YVF-$ABK!CD
M,5(0AV$*6<QCR"+$19*$@>*9[<9>N^&Q47QC&S#&V6_E[6!U>1NO*P*>N=?.
M>:>-NV.>=MZTVVELL V[8RZT-^N._MWM=2N6*_->BS5?%3=S\4TNO^=<%G6]
M/2.IP%"0F+F77LJE,H,$(0RS- B0*;D3!5:;ZF=[&=N+6!M:ILW4ECJ6.3P/
MZOF7M#>H_,^6W%&R?H&M4#BW6-,-M!9J^E_[B[3S/0SRBELYV;SO=A>[+\F^
MR7F^6*[GI3:3%$OY?3'[GL\?N?Y'OE*4EUD5]9ZF_MBB#%,!]3P@@SA.4D@(
MEE!@P1(9QHJF=M]BQX['1A&5[6!C/-A8#RKS06.__?+ :2 N+\-\P>N95NR1
M[;!W[P2Q_?K+%]0#K;[ZA-QIZ=4%MS,++Z?F!EMV=7&RO>CJ=']7P2VVNMOH
M135'&TV=KV\KHRM5%X>CCW**HB!*@D1"FI!4?PB(A(S$",:)7I11PI!"5A-#
M]Z[']BDPEK=4MB9&WZ(ZI+O4AKMJ;ED/@%T P ^LOM>"!M&[%J*;8\_&\ FH
M3 =;V_L4XW+%JV=5+NON!Y;G<H7E4*?+N85N'/99KJH*A48+[&95:1.6Z>Z+
MS]K9Q7RE'=?W/S8V3!4-A I9!F5@1 11'$*",P(1$AE-4J:PC-ST89QM<'GY
MACEB76FZ:D<TG95%1FG+#2/L.M]Q9$-ZCJGL[J.%59P1R@,81A)!G*D09BQ2
M,-7K$D3U3ZF;[IK7L1I.?7<^OI&R^T)YQ=_SA\J\'CO%X<'-'O:[+FP^9/U]
ML#K#U^MWR]V*03]?G4':_XIU;ZC;Q^S=NLCG^OU^OWAF^;RJL:L[T1WH;Z7^
MJ<A%6?-M,=\<?YDJ&;,XRBC$,C5R9V:+)L(*\C2.@X"E0E*GFD8=;!@;16[M
M!;QML!L#=AD,%"<)3L(0BE@OCC!'&20)8C"+@B0*"*5F;J&Y^VV'8E.(>/5&
M S'9*$%9[I==,R9VWR7/C[WG+U-C/6B9;RH4;^!_OPO_IXOP.W^9K@"PUV]3
M%SL&_3I= =3^]^F:ICK**=2GBTT9Y6<C@565>5\N325XL]1[][J]I#['=_,G
M78I/VM"[E7PNI@*C0"I&8!2*2'^P8@$S'$K]3R4"$6(NA%5,H3^3QO;]*LV%
MS-@+VCZ!EE. O8+V=;5CH/0,_&%\ Z5SKBK-UP^P'>$..VR^HQC#C)B[0D-O
M(/<KUG"]6</J-O0&XX&$0W\M7UGH\-WK;Y(6ZV79Z\>E_-M:SOGKS8^\F"*1
M!B).8A@$*8988 :IDAS&48Q"0;&0R$W#]'*?8Z/DEIU@8RCXPYCJ2+ V@-LQ
M:,\P>J;(3@AVKXIX&1,_U1'/]/LV51(O W&R6J+%K=U(YV8V*\^&USK]11V!
M9P+3@(81%#Q,-,^$,<Q2DD#."6(I#0(2.VUE'.]F;-2BK02+4I5@\5+.ULO"
M:8\=2OB<@-6.3:X'RS.!5,H-C7D>*JJ>1Z!7NCC1U: ,<=[=?5*X<'4W'BB%
M7]XOBM6>G%NLHA#3*(199"JIHBB##"D.32PHC%*&E7 2WSO1S]B8H)8V,H:Z
MO?BG<+1[\WM Q_.KWP+&JZ#=!21ZI8!3?0W* 1<<WB>!2Y=W8X$/2B\FS)'E
M*M;R0'^8/(&OTOB0S_)R1?1;/E\8F8HFT%)=VI0 2!(:$"PQC&,40,QC!EF"
M$$0!24TU'JR"V(4OKK9H;,QR]ZS_L#*'K/J)#E\_9';4-.A >":QC2]-#%E[
M4V8X@5U_)J>BR+NQYTF3$-4?_?6&=J]$>;U5@U)J;R#NDV]_#7?<^C>)6S=S
M88IUS_YCO<P+D?.RTUK51_ @Y"2 ,@HU"9. 0%(>XZ,DE7KFEL3<20;B0G]C
MH]C2W/)T3&DP:%OLN 5_ 6C+_?7^X/.]>7X&.0_+/$M@^MWPOM#GL+O9=@ <
M;%5;WG9M\>=MVFC1U'A]]_KO57GCKW)6%7UXRE_*G=*0<H5HED(5Z>D?SF(%
M"2)EM:V8J1A1YI;]TLV,L7%1;29HV]EIL[KCJ-@QE'^L/1-7%YBOJ!?=!25/
M1:2=3'FCRM)=X#I=;KI3:SVDM!OMA2JG8ZU[^O)2YW,4-]]I/JM2$6OI'A,F
M?%K,=#]%*?\^32(2!4F 81I0!;'2LS*&HS)1,&&4B20EP72U6-&9'3?V9)<3
M66ZL\[@N:^HHT,9TD\G[GVNSXKK-Z>-\4:QR7OSS/Y$0I?\&>$ORJW8+E']#
M_P;8IOR"Z%+]HJ^!MZ/?-QA.SWQ\F)]=ZLML_0);Q\!->[0;2;*6<W4Q#4^I
MV]?C[2^A^PK;WB[-^WI SR9_]]!\UU6WYIF[HEA+<:OGW//'^[)P<Z71]K L
MX[.OY45?95Y>-D4DPR(1*63<5-U(%864T@BBC(0Q%DAB$;DMQ%U-&-M\N+*K
M+!^Q4(U,HUHL@6SD3)F<2Y6OP(N^SW6U[CQ M@MXG[![7]-KNT!E/:C,!Y7]
MC>+C!#0^5$J0H/&BSY5^5P1[7OP[FS'P?D!7F ZW"#JWU)$=UZPHTU)6'XP0
M8K$-?29A%D6HJN\A(<8FF*PX@RE#*DU4F@KA%!(ZV=/8N.[;[^^^??C/WS]\
M?@ ?_J+_^\V1SDXB:LE:?>#DFYPV-H+*2/"'G_IHE[#HEV9.]C8LFUQR^H T
M+M[00>1H_?(R*]/6Z.Q6*KE<[B;8&G'LO]!E;F9N&\7L]@75370V#8BB*HT0
MQ!$Q.6E)4%88@3QFC-- )"JQEJ3MS:K1<<[M^WOPO;;<G$NN3#=KY6TJO*B-
M=Y#OZ6T4SW/7FXV-=Y[;^@0:IW;/)Y22_8U?+2G_G8MNWW#D'%29WF($!Y)L
M:DP#+QO=#+.263W)BZ_=>JXIL[S2\G'X!3SHB\U"".2FN+EN09E&],Q]OIC#
MOZWI+%>YOK.\9/5$5T:G^GLNZC45E\L5S>?@F<YI??+%[(@]Y8]/L]>M;;H!
M.<L?<V-ZLPPKS%Y,R1-@_6)^7CUI$PY\SI>7O/ZE)\&JOA^I<VI6O?4UG-15
MW_#LZ&#UWKC[-.+3@L[-MDY>RAS_1E?EHN8+7RV87.H1C.J(/%(LEDD40!$R
M6M4Y)4S%$&'.$X)9F(16.RX.?8YM"F#,+O?&*[OUVU\9#FK+@3'=_@-BB_SE
M#[L'/#U_MJV@[*"&:(NI_2?7 [8#?5"O>UR=/B*.()WY1-BV--@'P-&U-KV[
MWMJU;%&Q^J*^2KVP7,LI2Z20,<>0Q9$Y>1ZDD**00,9)(%"0(L=RU#NMCXV0
MRV1YL]M="P>[UB)J V>W]=,9#L]\VB!16]9G?:$C#O=<4:C=P\ UA(XX=U@U
MZ-A%W=[5;3V)^\4LYZ^MO5Q,E<)(01IG&<0T$9#B4$$>$J%H%L8".YT_/MG3
MV-[A5HD-M]?W-)9VKW(O"'E^K;<V3D!E)?BC_E\ON[D7,>GUS3_=VZ L<-'I
M?4:X?$/7+_GR96$4=C?9YB(*HS2&,M&?<9QE%%)%8LAC+"@/)(D2)T'BO?;'
MQ@2_RKDT^S^\,;-1?_Q)5LG]YD#(9^EX;G ?5-OO?&>HO'_I&W3J8ZH>TL=/
M>-_S9W^WCX$__$<=//ST'[_L.N7#&_ZW=5[5N+O73\43+>3]4D]?;V;ER.A?
M_[I8B#_SV<P<:N$K*1[HCUMIJF28G<2;Y\5ZOIJR..!)FD0PD:&>Z!N&H"H-
M("5)DG%%6,B=R*%7ZT9'+;7)0&P,+?=Q5_0'>%GK02Y<%P_]#J8=*;W9$'FF
MM(VR7\NQ"6A\F(#&B_(TX=8/4#G2O[Q?K_AZ$?[KQ\(WD03L%=Q38H']=M(Y
MQ?T]+9[NJ[B1>/?Z>R'%W?QC/J=SGL\?;\Q!1VVB+*8L8Z%*)8&A%$ASN8P@
M"V,&B8I"DL9)BE7LF,5NV;4340^0J&[2F[DV'?RT-OIQ^?SG)O FC+:<:CP
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MI\R>=/5(ANSI:Z^-Q!Z7P_RVTO12RUK>&+V=?/6Z%]0C6<R",#!16$)-/#:
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M#"=QF,$XX(&F!);"3*02AFFDUT JE4ALRC=8DT(OIEF]+;NU'3R3B2G!\:^
M;OT#HN5@>3::MCQSYIE^1M2:G88;I<$X;3,P;9\F8.-5=7Z]Y==D4RIB4M6*
MF)27>"@8T3?@?3-I/\8-S;^]0GJ$M?MMOQO7?Y8KLQ&NF_^>"RG>O?Y>F$_)
MIA10G:F1MU33$REP+(SZ8UP*5L<,,J+7>8FI/H=Y@(1T.HGD;L+8)H)EC$>5
M,9[RT,MB6P!K8_N_NC%VAW&QXV:_:'MF86U\%5!KS ?L%?QD/ #Y_.=6X;&M
M%UZB;MU![)59.Y@Q*(=VAVF?+:]HJ>ONUK<G.9O5.:A3A6C,HLQ$_C.C_T$4
M9%)S'B9Q2FFH8H2M])6.-S\V/JMW:4H3FS1<USVL'?AL-Z^Z@C+,KI4='AUV
MJHZY?>46U4Z3 ^]-'7/G<%/JZ%4=<WA,PBG;3SAMY2J_>]U>4J<RW_Q)E^(C
MS9=_H;.UV25?/U>YJ1]^O$A>U?)[1M,TB# +8PR3E!AA-48@2R6!J1))9,)Y
M3%KM9_LW=70D4AL'GA:S4II"<W6^$!.3Y?@JZ=(UA]_?&-M-G,8Q<IZ9KIWS
MWW:SG?AOYEQ'SP889R? N M*?T'+X0G8/ _&YQX3H+P/2[_I4_[,'3;YRCOL
M!ZE;_GOL>%)T*TA7Z2>9C<] 44HDC#-D5,)Y"!D**!0J"G'"4205<]$O.NS"
MB>T'*VK.*^/ K*N2YA$L[=CY.H0\LVK+N$FM8M;CYM]IU_L]%GK8S;"'0D^Z
M>7 D]/25W=[P#\\OL\6KE.41ID814@4D$PQ!'F$.,98)I*%,(<\H5P1AD0:Q
MR\3P2!^CF]'5)M;G,>]UNT^:;,N];;?7_!B@=N_YE3#Y7BCN(M1_9:4S[O?Z
MLA_K9]"W_8RC^Z_[N4L[IG(_F3G%W?SW^5+26?YW*;9%I/]=BD<I[E;R^6Z^
MF5F4OT334"*)68*@0 1!G&01I)D,82JE0)0$-*16<OU7VC$VWJA,!;FVM3#B
M4(U8@I!L];-C;GC'D;$CEP'P]DQ E0=FB;WU >R5LZ^'P[AB+FRMU\J_])B2
M?AV<_>:M=[1EV.3VZP [R("_LKENY%DOO8JOL@QN/BP>Z(__RE=/]3;0Q\7R
M^/GPJ1")BHEFSS@* HA%(*%^R!44/!1(_P>CB#79(@_V)-K5G@XI(@]#3L)>
MZ*ON>V;2S\#_R]V[+L>-8^FBKX*('>=,541B-B\@">S]2Y;E:NUM6QI;51U]
MZD<&KC)[4IGJ9*9MS=,?@&1F4GD%2()B37>$RY9(8JT/Y(>%A77YL=.G;*E;
ME.9'KO>[^D-?EQ4URA_5'AO>].P\N]?3:#W%=C3L=<:&X>%:A4E9-:PA^^2X
MYVSGQ.B/?;NBV"O]MA9F4/[M"MD^ 7=^7NOXO6;KA(<E%7+C35$B85)$$B:(
M)A#A((9$9:9.D0JCF#$<<J?^=6?&&IL96LIF(NRJKB-M W9/0FM';CT!YIF_
M]GNS3$ IJ ?OE04>?4>CG1QOZ "S2XH?B1F[>(M[\Y.=45AUN<L-!=VI_[/(
MYZL_]*/72SDEE&>1C#',"->T0:((XIA')I<QCC$FA$OB8)M9#CM2$ZS<3VG+
M2>SD-IG^_S22@^^5Z/:]/6S@OQ _T2.: S7W?;TC??\:R%)H\(</(.W[I/0,
MZ$"M4OH UJESB@-,9YJGV#QEL/XI#BHU6ZBXW-:VP)G*Y\92G*^6.5N78<%Z
M]NL=X?(37?%OVJQ\]7NI7RQMFR0JB4)!& Q4$)GN 012S#C$IL"-0+$*N%,8
M2WM1QF857NFO4M1[8CI_ 4]&=!.K8H0UG3_T=R,W>V[>T,=QS]QA\NP,RV&F
MQ//"4"L!FE*6YTL3L%$$;#1Y==$$U,J8^=KX2(I_,]V5B]**[;/65U>@>Z[^
MU5J<@>N!=87ML$)8YR=VB#<\V+4?AJ*\VP]%J<M?_B$+TW-F+K9A* OSHT:C
MF:O'QV5IT-X:V>=%SDL'[92A)$ACE<$XX3%$(4D@SF0 "<;"_"J(.',.1WP+
M3<:V#%2*E/E9<A.HMEIH:[Y838!>(0RMF*A%0#?Z@'RC$/AN-&H1SO@FKY#=
M:O*7>#$\+T8]!$/>;:(?&^_73>/]^J-\OU[U$MOB K; 5,=S/<=,ON7D]A]2
M^2;:#!]Q^9:3=C0@\TT%<D_MJ;UE'_*"T]D_-)_?S,5[/<!4AHBD-!(PB&($
MD=X501P''"9Q2+*$IS1EPC;!Y]0@8UOS:CE!)2@PD@(M*GA_KC2N/:07G%8]
M >4[H*(-1DXI0)= :)T(=/+!@Z4#75*MF11T\=J.Y7W+4O-30I0B* NA9&D*
M4<8%) PK& F:)CQ+0^56I.;UX\?V@>\*T5:=&=I6[*VPLS0<6R/BVYJS!J-]
M$=Y7.OLINUL-\3:%=E^I=[*T[NNKW,^C3"44*;>IO=H4^)#/J9;TH]26Q":X
M^V5SN/Y^+0U=?,B_RRDFC-&89Q %@D'$60J)% @*$@5)HC(L$FJ3=]%-#"<:
M&" W0[]2J?TQ2@?X+Q]3#0.J9R:IE)@TR@V8;5VM""@UF8"M+I/-GM"T.%W+
MRH0P&@TR)?8'7L-,S4#G8+ZGR.F,K#NR9X[..CQ\L!.U[@ T#]IZ>%K;6CD_
MZ@@,/>S]<C'7?^7EDE?<+V8Y?ZG^W#4-4P*'<:2WD@&3%"(:AY H%FEK,V4L
M2A*F=Y9NE7+<!!B;/:KE!SL%P%>SS:=+X7B2YCP-=H:K3W ]+TA[N+X67I-;
M*3CXL_ZOE_9L;='KN1Z.HQ #5\-I!]%A+9R6S^F8_"B7WW,NCWO]/B_FWRMW
MGG'P%64V<//WUXMB]7FQ^H=<?9%\\3@WR0A300+,:*CY,#*]MZ5(-#T*"D64
MAI(H++3IWBJ%LF])Q\:C)J%C(]OIP'ZN-6F9EMG[5-M1\"@F<,!#I:-=-;?Z
M;<Z0C$+ZIROP(E=@I]/$U)I<]QF*ZQU^/RFJO4O[-HFNOD _F2[K;< V+I^F
MY3X-%%$9H0H&."80A:9S2DQ3F' 594HF(@J(O1NG^>BQN6:JLADS(Z-[T8PC
MR-EX8-KBX=VK\GI3WAH#%Y='6RP&<V-88N+HCSBF]ED?PZL;!O0;'!/TM2_@
MZ!4M"_DLBL($BVFS6L[YB[:SKV<T?RH^Y#,I/J_+*A4THDFB60@R8@I!,I1!
MJM(,JLR4_. :->[4V-UBS+%9GV:WR4LA@3)2@E_R.9C1'\4Z7Q6.^?PVD-O9
MCCT#Z9OL3%1J0UQM]FE4*XE!*;+^22ETCW6"[!'JMW"0Q;C#5A*R!^*@M)##
MK6XD5"Q7TR]F%U V/*012A,1<AA(S34HPPED :>&=9(890H%D56-[5=/'1N1
MF!/#O%CE)K#BDR;R];(^GW5H&OD:MO-4T1J, 4ZF6^!@30!']3[WB>L;&I^W
M_M?^I_WZB8-\O$>5V'R>QW_IO@\I2PA56YZZ*I62/$ HT'N/6"80!11!3+!>
M_I,H$C)004*Q55S8L:>/[X,T92,J">W-[T/0+N]".D'A_7/<H7"YA)<%'/8;
MDDZP#+0GL8J*AF67D]4+V'5P+\#=ZIM<@M4W.M_$1?][/QN:D["=V=,<WC/8
MMN:DN,V=S>F+6G>O/3PC;;3#KGZ?T]E]G;IX\W.EI]:TD/RH%Z=I2EF*,&8P
MCK/8-'8DD*!4&RAAD"@11IEBQ+&;;1=YQD:=IT,+7G6#WVH%-FJ!/W>*@9NY
M_E26Y>?DWO:VT_3:;;(&G#3/)#_@?+7IE]L'RGWWS^TDT]#]=/L \$A_W5X>
MVS*2><T*^:^U'NG&U)BH;0L496D@F&G!1/5&D<0QI#%7,,)9&)MP2(&L\A;.
MCC(VLMT)"4HI'<.:CP)I1X"=X?%MN^XAXZ$$[5D(^HUY/CK2L*'/YY0]B( ^
M>W&/9MMG+7Q==$HD49P(O2M5B4CU]R]"R$*50:Q9@8@LPCAP\D=?&&]L3+"3
M#*AZ16]YF&8+> =#J1V,;V8([<3U;-H<XN+?=&F,^?:FR2$ 5J;'D=O:D<QO
MBX7XD<]FTP QC(244*5EP*JB$,LL@31D4<(0BM/8RMNU_^"QT<9&+C=JV,(4
MHR3@C&(HL>EKS&,$*<$$8LY0D@0JEBR;5NV.M'FX7/D#:W\0_Y!- *.SDC'H
M"C#YF,_G)N:T+H_0$E#];J44IQ',:*!7,:D!)?KM@S(," I0%(=I6 -Z,[=L
M%=T>SLT0 X/9J#+1$D:[M:D-,)X7H8O?H_-"LZ]DKRO*]N&#+AW[*NVO$0>_
M;[<8?,KGBZ5>76[GFHEEL9I&(LLDBU.815*S'4HPI('$,"(!QR%""@NG3B?[
M XQM<3#+JBD9M)C-#+/EM9B.=N0!C'8?9Q=PAC@7,:6+]1S\V\:_?[6J:BN9
MG$]3T&0/O(T:_7W8IP#J]0,_&&30#_V4BOL?_,GK6CJ8^#<IUC-YIS9,LDNA
MH4D2IUR%,&,1AR@+(LBH8#")!%,!)5EFU__68JRQT4'51:$PK3)VR_9GZ>IT
M.@.NI>NI'\A\DT0MI;%D-G+6"?=^$H\L8.G7*75FO&%=4Y<5/W!06=SB'K7T
ME<LYU7;S[_/B6?)<Y5*\7SS1?#XE.*%QI@0,"<(0)<(4U=$[)AG%-,C2*(EE
M:!O%='*4L?'%1E#P9R6?0R#3:23/4T1O^'@G!UMHG&*;+JK>.=;I] B#Q3Y=
M5+(9"W7YXE[.H![T4\JXNSC$02I9!@.$$VT>) EDA%&(HRAFBB8H2&2'4ZC-
M.*/[U/=/6XR@3N&+EX!M=2K5!JZASZ5LD.IZ-+6/@\_#J>U8;WD\M:_PA0.J
M@\M;ER67RZ44MWKG]R0?Z$]3SV]>R'=R+E6^FJ(DDRF5"@8DI1"%3$"2( 8C
M'D2,)30*0Z<CZ@OCC8TD-N+J#821M^S7];Q<?,^+?.'8-O42TFD2I"$C&+*4
M,FUOQ2FD89C!.*6I2D.:X8!.O\LE6[P!ULUQAT5;5C*#7U@EM6..RB74[3BZ
M1R0]<_46PDK4LH79S0;"=Y<@;%-.W0:8OFNFGQUSZ,+H-@ <J7YN=5N'$N?L
M<G%7UKJXZ]]E_OC-7*.)@3[*+]+8IYMR[92OUE3O3I=/X92)6!""(JA4HED-
M1Q)BR1B4/.%*)&D01DZ'DN-1;6Q+E741]!^U@H!6&H+E1L6J14:E(S!=?EN4
M11_%W+C421^%P"-:0=ZF</H&*% C!;90@096X.'<2]FNE/JHYK__VNKC4&_X
M8NOCT/O47FY\$G;;/IY0P_1+O=7R?,^%'O#F)Y^MC7 'E>4+K<K]HE@MY2JO
M\B=K0ZAX]V(VNG?JZ$#&R9+10% LM8'!0PR1( (R(C*S04WC,.4ISJR2;4>C
MT=CLBNV.XMUBOBY*+K]?+K0FY0I0EJPK6SR53B%M8VRO?[5XM/&KO?E4..X.
M_Q*OS%#[SY-O2P,9;2'L@-FN\T7'=ZGU)O;-Y\_+-OGMM'J3C?B;3^*IK?[;
M"]:RA*12VL3(O\NMK^(+74E3.6S.\UE>#;/Z(/43Z<PD5*WUU_;RZN*IPC2(
ML@1#R5 "D7X@)"+F,(HP84B&E,5.G<]ZD&ELR^Q#T[-L(DJ+C=A@:=W2I<\Y
MLUO[!IX)SZO75INF^]3("%YK-#$35"L%MEKMW[1M:]ECE<?^X.ZWGF,/<@U;
MN;$_( ]J-/;XZ):439=FKU?HUZ]<1_9K:J.,)5F  RAII""BJ81$:G96*!!1
M1+"0@5,CG0OCC8UJ-^*:S[-R8SFRZP5X+9FS/]!\L^(!7L.4);=$J%\BNS#F
ML"1E!\ ! 5G>UC*IE>;+LI-?H]I5L?WAWW+-:DO^[64311@GPA1]A1@K E&,
M"*0"I9 'E FI:4@B)\O/:?2Q$8^1LVH'"K:2EEODSU=_.$8<MIL-.V;RAK%G
MGNH&KWLZ;!N8^DV.=9)@V%39-N <),ZV>DC;_C"KR@0S52*G048S',69MHLT
M\DC(")(D-(4ZDH"&&>=I&-H4L3[Z="=:&J".M19N$W%#]S*"_F,MBQ5XG]/'
M^<(4.73N]M($U8Y]6D/EF5T,2O4&[Q<CVJ\'Z5/WM-]\^Z-(]-QSI3G"P U5
MCBAWV"WEV$7M/O!MSZDR#_^+.1Z[4[\7\JHHY&H:R4 &*$X@2M-,_Z$HI %3
M, T(YR'#0H2!BYUR=K2QV26[1FM5_8VE$1<N%%SK?U CL>-W?Q[K@&N+,*4$
M8H0X1"C46(=1!K. 95QA'(6(3^?2,O.^.]*D0GHSXG X]P^M'<7V]G)ZIMP=
M7G6!DR^;%U,+"TII^V-;*U!Z9=_S(P[*QE;*[[.SW4TM75AEAO(GN?JV$+=E
M.Q-C_'V1=&:ZE?RF[3VS)-S-W^?%\Z*@LRF/62 Q83 .A()("019K# ,@T1&
M))-I&#N&3[N*,+YX:B,C6,R!%JX\3LVW6DP DVJQ+$.L'9U?KA-CZ0WS"+9O
M]UB53%_)#FX;&&_$!^5$U%:CGH^-$CVZREK"UZ_OS%6(89UI+2$Z\*ZU?4X[
M(JR[!1;W],7L,Z[F0O]DN9;BXZY(VG552$K_;E=5ZHH5933%E,LX(E12B-.,
M0B19 *E(]'X6AREF@G(:9"Z6;5>!QF;\;O0!M4*EQZA6"31T G]N-'!TT76>
M03L&'7)>/#-JGU/B3*5]X=@KM786:E"J[0O"?>KM[;G=@ET?Z,_2Q"UV!K#I
M+$.7RQ=M4Y55WZ?:"N4II3'DL8P@(EA!F@09Q+$4,0I%Q)!3WHO#V&,CV,:N
MUS1.XDU9VP6$VDR '6EZ@M4S/V[#(DVD226W2;K8;I;+_E16,+>.E70 S$M4
MH\WX;Q)_Z #,J4A!ET=T:PO]1<[HZAA]3@-M,^K_(QB2E)C2Y R2+ P@IB+4
M.^T@CMU*DU\<<6RLM3$W?E!3/\H8('4"<F%:YM51FN;81,MN L::W9L=<Y0O
MSX;E'KI/C'UOFFM9X;(2MFG63<!UWZ6+K:'QTN7X]*AOTJWX(@BGN@Y?OK$=
M'55G/-MF#!_-=&Y2,!(6H31+,8PYQ7K[&B3:AJ(!1%F8R50F,J1.-=+/C#4V
M"JI/&W<]33;"MLJF.0>R';_T!)UG9FF-FC.I6.#1*YV<&V]0(K%0?)]";&YI
MW60A7\F/>@T6M_.5?A-,RY;*?M)K^/II77+6U=-BN<K_J^KBQJE,62@DY*G0
MFS,N8ZB-'0Q-R3NNH@!AQ:9S^5B2G5W(E+,0;B>3.U&\6CP;00%M2#HQ571K
ME5H=6;:8(3M"\H3Z8+T;M/"PE![LQ-_NYYK3T52AUWX.+>'KN\6#JQA#=WUH
M"=.11A!MG]2R'W'='XEDF%":1C B<0A1(@7$@<A@C'F:\0#S"%.GCL0C;2UU
MJA>O<S'/)GCGN:@#))X)IC4:[KV)[?M(V7<G'K)CU E%#CH4]](5ZIH6W[Z6
M^R9]3QG)N@UI?9\7?+8P,S7%!&5!EE&HB%00(9Y!QE &L0PS(82*.7<JW&\U
MZM@^:",T*#92@^]E;/="@5FNI+9*]&_*_AO/)L'!N5F4W3S862*]H^N9&TI@
MMP)70?,3T B@WTG=G[WA!%*O)H;=R(-:%4Y@[!L2;C=W[2CPB:[6R]+=<Z<^
M+N:/IG#,>\E696'X1IL!PC&*(@*E3!%$489-MW4,&0Y#@50<A!%OUV; 3H"Q
MD5>SFOY. _,OHP,T]=6 T:)M+P++:;$C,)]@^[9S+'$>J).!&WZ>VAM8"O%&
M/0_<(#K=",'Q.6X\:/JXFX?=SHO5<FTLY[HC\&)^7W8:FV(5!$K&# 8XUH2'
M20RIT%LK1%D892R05%KE#%P<:6S,MA4/5#W7[!CL,J#GJ:I7F+R?T#.34[41
M= )VD-WW"IE8\/+GE=ML$.A>#3E&"*W)VQJ6BJ7UY27SAE'-NY?O'X1@K=78
M,*G]#>Z4^3HIX$/^LZQ3^ ==YH:4KQ?%:IID' 6A6;ZX2:Y$FC(I(2FD*LOB
MC,I04*O8 KOAQD:>^TE ?'&FPUH;>"^S:+^@>:;2@R2@4MXR(F,C,;CN&T-[
M6NT7RX&XM3.F3A1K#]$9GK5XR&!D:Z]0DW$=[G*D79E/;^:KLID@7RR?%\OR
M]2D/6Z]-P.SRY7HAY#1BJ4!4<*@2KNU50D)(1(*@(DE",ZZ-6&:U0;<<;VS$
M6XD,7LD\J>($-,R@EAP8T2VYQ!+W"X3</YJ>&;D/(.T)Q V>(_OI0O)_?UQ\
M_Y_Z2>56^E_(_!56?ZWXQ7*,80C&3>$MPSC>ULXI>+]<<"E%\4&+^Y6:/;C^
MB>:UU8LI FRB[DUZU+-9PJ8L(5RE-(:9B .((B0ABX,8DD@%G(124!:Y^ ,=
MQAX;]6Q$!V::@2@SP_(R)FFA3-7'4HL)>#9Z3*H6#AM5W+R#+O-CYQCTA+IG
MBGH-^-<Z__5^B_3]#NF;BT@[.P-;8-:K']!E_$%=@"V V??^M7E$.Z[[(K_+
M^5J:@3:EJ4VQWNMUL5H\R>4V/8\&*)8)RB!A:0Q1H!2D*4,PC"-$(XX43:T:
MI3J..S:.J\6NOKB-X."'EAQL1&^=0FD[%7:4Y@%@SW36$[;.1.:(5*\D9COV
MH 3F",@^>;G>WC)E7(C2N*"S>YJ+V_DU?<Y7=':]>'HR!F%5 5;_3V42JBR5
M$&$-/\MP#(7,1!;',@I3)]OL\I!CHZN=Q.!9BPSS.>"5T([9W9?!MF.E?B'T
M3$@-](RT0*-7RSL!E<2@%+G'M&QK>/I-O+X\[+"IU=8P'"1/V]_I[O7?G<F6
M%6>_+6;ZOJ(JE?$QG\O;E7PJIHH@P4@80IX1 E$HM*44< 8)22/$%4]":GU@
M:C7BV$BGA+D6]?_]'S@*L_\-ZO(Q9BOR10HIGTKOJTE>-RO$8C8S;MK;N1;/
ME&+\T^@&2N4L;2C[Z;E\<- [Z)YIJAD:TI3XWS:H^X33_@RA=U@'.D9HH@?4
M8@DNXUV&9O1@H3K#=N9HP>XY@YTN.*G5/&!PN[%E%<W5-VVGEBD+N_H:4[WG
MI2E.&&2A0!!E-((X"16,592%61BF<6R57W!VE+&1>2EDNQJ.1T&T,Q,[0^/[
MN+9$99/$M!.QQT*-YQ#HMT#CT9&&+<QX3MF#@HQG+VX9!KQ)V7RW+C2'%,57
M^5CUHS*)PXID1 @>0"Y#$\K!*60!)Y JD6ICAL5AXE0FXNQH8R. C6RMTK'/
MXVK'!;VAY=L,LP3*/>K6!H!^0VS/CCAL/*V-\@?!LU8W=6@[_^YR5]MF6[NR
MJ^TV>4%SU_JI:G&[Z6S[WG3&DW-1]B03(0^D(!(*E"B(XD1"')$0T@@'BJ<,
M2>*4%.5=XK%1UD8V\)++F640ZG#3:\EZ8YHTW\S9O1E[(ZFKH?=DUY!]^TY\
M.==GL%US]2&FJ?^>Z5ZE'KX5^A"3<+3#^2 #]Q7(<KRNKS9Q:11SJ2@,!<9Z
M;RM5&:@,"1.8$D$X2YU,7.N1Q[9VG UB^><BUY3S7<M]+F6TXU38K0]> /;,
M\\?C54Y5%N^QGJ,S6)X#54Z-_L9A*A= N1RD<ND!;2-^/^0S^7E=UJF(>)C1
M0$4P"E.JB0K'D!"%H>0I)RQ#%$FK2FG''CXV+JI#4(V H)+0-62W =R%<X^.
M<'AF#@<D6L3<'JK<,<"V\<"!HVD/53D,G3UR3=O8L<U)WNN#O,TY7D4'6UMG
MFJ:1S,(L@0E*"$11R"%F*(09$8HE01B3S"EWWG'\L7W>C8/0^>N#T+Q6P#5^
MS&TZ[ P-CR![)HW+!\V3VOAH[A_[C"MKA5S/\65N,@P<9]8*H,-XLW:/:5G8
M:!=*4I%H?1!9W--Z2S<7Y1'%KD9)L0W=3%G*(F7: Z=1#!$+34W&0,(L2SG'
M:9:H@#C5.^H@S-CHL!E1-:E7^>T1>S$QC2=K#X^)(JE.X!IJM0Z[[32A=APZ
MU#1Y)M0!9LB]W%(/T/9;A:F+0,,69^H!NH.:37T\LVU \#_7]8;S87$B#K"4
MA>T[[+Z8/*0B7\FO<OD]Y[(J#_!%\L7CO'Q*92]E$4HQ(4B;KRB"IM83).9
M.,D$222*590X=7GW+?#8"+Y\*VKW?;.1 ) _S=\='6K>I]N.VL<TB9[I_^K^
M]GIR_!!FY_&>F(S995GS095ILL4*-'3J,U1Z&.![#K3V+/3 8=K#3,%AD/=
MXPX<(7!7'01]6"R5S%?ETC@7-S^?\RK+N;C=U$-2*N09HQP&04@ABKF$F)KN
M$7$H)0M9(DBX*>W^,$"@@*W@5F3VNAS\PQ QCI7XAK",_'6-$&ZJKLYF<J@
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M*2?XPR6?YQR.YY>'GM#Q3.%'@ %_5E(ZU XZA9!]M: >D!JH/E KQ)Q* %W
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M%!%QG+# ;)<# A&*,61<OU@)33$/>"H%<LI;&XUF8[/ZJCXJU8NDE^D?M?R
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MW:P&'YS17" YQF).][<,G:QWK0^+VCVW\>E)$Y5^ITHRW;BV(YZ%6)BLDCC
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M/7\]:92F<:PX#)(XA$@%&33H0X4#%E")(A'B>B9NYI8Y?-[G82.)OUFX*<]
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MLP;;]SBA0'N?X]2?[3^RCXL?8KG-)PY"E$<R#F""6 11QD)(\BR% 6,I(D%
MLL HE?OHR6/[T$KA3!*-KP!V_7-SAJ'G#\X8 :N/[J2VSI_=_M,&^_!.*M'^
M]$Y?X%Y308>:U:DWJRF5H4!,I)!R79DGQ0P20G7%0I$&>8ZE8-@F9?%P *M/
M<;!,Q<6%>@H.N71'J)HYQUVPZOU[;6!IA/-;'.&4VM[K(NP-,GA)A%,JGJJ&
M</(ZMZ_[TO'D!R$72_%-L#VGN1V]@A*U=DXA%[HQ+(D5)6#U3Q$G*!$)%XQ8
MU4CH(,O8IN_[:[%@@)8*@>6A1G8TTL5\9HPSD%%Z)B>#>(O:($?:]!.)X0%6
MK^3719Y!>=(#<(>4ZN.1CNTGBKG>[BS++7XI""UFQ?JM/BCYOB;KLKW1O:PN
M*\CL8;$J]/BW/]=:4#I3=ZW64TX"$NFB\P%32R.$<P9Q2B1,*.<"R3PE(;/J
M5.%%K+%Q<JT5J(L';Q7;GCE.P%8Y_;UOU0.-?N"/G8;@=KYY*5W"Q=QRG]23
MU<WX>WA;]DSE[V%&^ZX=7E'WV^##CVC#]@+Q"N=1VQ"_3W=<9I/5LT[H4O]S
M^Z]-\8/,=(K743)Y3% N9 A9&DO=5#B">19@2 01<1RI;R>S.N,V&G5L1*ZE
MK=(1]0\MN2V7X$:(&Z[+?>/8]V+]'(3#Y)1;P>5WD6\T\K K?QLPCK8#K&YV
MHZ;'I6+&S?*M['I2=E9<346& XZ#!,99'$&DZ B2C"N_4S=&H[$426"51WYB
MC+'13B,B6&D9)V!52FG'.:>@-&.8C@#US"=;;+Y7V'R_C(TU85S0WBL]G!IG
M4#*XH.CAIW_ITBY]/+:5@_<=HM_GO%B507V"W_YDZM*Z;&<F4YHD-(9ICO0V
M8!1#2DD(<Y1@'G%)4FQ%!4Y2C(TLM!+_79<E%^JIUH527<Q@1B.]@]LST31]
M0W;EK8_7@6TU0*5'#[56.^#80[<16TG>H0^)(UBG.Y2X/LQ]<?:P7.@></S#
MV^\K7;U^*\$-6Q<_U()0K'1GZK(@QT;P^L^+^6H:1FD@4![#& E=XY4@2$E&
MH6)']6LFDB2V"C3L),W8B/*;D!NU#BFC<=?DI_ZBR6;]O%B6.H!EU=0;K!=@
M)=;KV79;1U<DW*BW;[DFQ5S?":B8"UFXK +=36N^.AS$8$.L&AM% 'T#OVA=
M0#'_2XN/=_I,0%LCL%/)[T*R,[+>%YCN$@V^\.P,WJD%:?>'VK>8>A!+N5B^
MZ(V\TA?^?:ZHX!_%^ODWLORG6']0LP3_ILFD^"$>OW_[=4%F=6]JD88R1C&&
M,DN)[E#'%#U'6#FQ28ZE3J"-S&+*ND@Q-EIN*5(M=!79*E7 GTH7\%(JHU#2
M7_^R5@<H?<"34LB\\Y&[S2[S[F"6Z)EO.QCA>B=RC]8P;T<UB%4&ZDK5QR=B
MU96J,Y@7FE.Y/WNP'E6=U6^WJNK^,/LIJVYI\W$QFPFFW]6%_*@F035S5M-A
M72B;!8ED#$E(.$\@BHA4KY5:320H3W(29DE"C<Y\S(<<VV2T$[?L1],6V)S>
M#-&^/K/XQ[#G::066+>6;^.X)_2U.N6N<)I/#?YA'6@>\ &O%>_;(76!Y T?
M-!BCVRG6IF_+.SU&:YW=CXUB@6(6Y)!Q77TG0#FD"<U@S$+*<AK+W"PCS&GT
ML3%XE^UP.]C-=F1Z [-G*C\?_#3$IK<3:OT'+XUCD]L)'*-0),^;VIHO'Y55
MQ,.BF*\_*X?V_Q7+A6)(IN.=Q+Q8++\NUF+%-T(YO^Q9F2)I%GH$A9)Q E-,
M$41)C&$>1PPR0FA "$Z96:"INPAC([;XKTGP7T E,BAE!DIH4$H-M-CF'I6C
M3:X[K/TCW7=T@58 E!H K0+0.H!:B4O@.^R"N'X9QGYN_]88R._MT2I6[G W
M0"^XQXX/'LQ=[J9XVWWN^"3[^>?[YN6%+-_NY??B:5ZF5<S7!TU1"E$WNX_3
ME 69B&%"=)I9'@4PSW$,211DH>24!GEH.NE8C#NVF:8672\M6\*WV@&!1GR[
M?@6VYK@^W_0$<L^3S%CP-9])>L)YH.FCA?>JA3?9X?UJBK?5=.& VH4YPN9I
M@TT,#BJV9P.7VQU;Z&U6Q5RM9SXN7JA:^>@7[OM:O);-^NH<"_73^JW9.+B;
MUWW\Q&=2+/].9AL13F4J"4.9@'E(,S4_" )S1"BDE">IC-*0)JE5@ST/0HUM
M\J@D!D4MLOJA:?$I)D JL<$/+;=E0SX?UC/;KQG:)CW/-8TZH*6/3EL3KZ"E
MT@349KMKF>UF:S:M&?C[1;/9-_OSB+/?5H ^!!NV4:!'*(_:"/I\ML?-\ ?R
M5G8F^[01_R[(4B\FIBCD<11)!JD,$XCB#$&"L( HC 2.48(RUCTY^<3 8Z-@
M]6*G'C:^3T'<8<^[(W#OMMV]7@ JP ,I^ 1HP<L=B)YWNB]@U?\F]ZG!WW]_
M^P(D1EO;E^YW;WZJV7#!_EEOS66IX(*E$J8T9! 1I*A(,1(D/%,,1$D>I'8Y
MLX<CC(UI*@&K5"S[OJ;[X)E12R=(>N:0-AH>=QZOJNZ]8^G^*(/W*3VIY*GN
MI*<O=/N:=X58='GHJMOI1BU"=R'#58&6ZKI'\E.L/JM_JG7KE!&<B#!%$.="
M+0NS,(0440%3*7C"2<I#F=A\]NZBC(T?FL)'53VJ,O.";=5I"MTI?0#4[1FT
M!G8LTL%H9G0SC"EZYJ6]\E.5%7::M)(EFL)4]?6E-FKQ=\4PUCS6'5.OA-=!
MG$&9L3MLAQ3JX8F.I0";+(V=!-,L3#-$*(6"*X\)!5D$\X 3&".>I4'(94!3
MFUJ?)\:P8L<!RGWN,IE<NK:> C%&)(W#G$ <AKHQ2:8/L)07*K-$,IX3(8/(
MKC-K1QB'Z;YZ"&0]X7C 4R:(8%WN+$R(;N\B(491 *GZ)V<Q"\+0*I^RZTLY
M1.V)@QJTOEY-L_FV(T ]3Z2[]VQO2O58J_&\^GYK,)X89]C:BN<5/:J9>.%2
MAW  ]BSX9B86LMP>>!0Z$X-_JJ/>OI&U*$^;=E69I$PQR9CZYB,IU;Q$,T@)
M2V#,<_6^) $7Q#@GPG;PL7%#([\^22TU %J%LKI3HP306E@<5]N:PR FH$>0
M^PX,,,2W/J8VJIC5'7*+,($>H1\J5J '$]@%#3AB>"ERP/:1PX4/."J[%T/@
M^HR.:Y>311RG,J,QYFH9HSSN2)<H"I7'R'79Q(QDB?+/41(X>8PGAQO;!%&+
M!5X7RR8Y:;:8/\&U_H9V/N6L_+!FM3*%;6FS*R8($*,!3B-=+)Y"E*MIF^(0
M02ICF@8X9%&>.2Z".AMAF/508X:A$+?T[3NC.)B;?[;R;P\N_T54^O'^3P_Y
M/@N!B^J?71-<OLLYWJ!8JX?^T 5%UNK%T'5W;U8KL=;9,(K8_H-4-7G+MACZ
M,/'QS\54)"R0*8VA1+HR>H"(+E/)8181@1'E5,W)EL$']E*,;3Y0+V!L'8G@
M +X9 ?4.:<^\5,D/2P7 3@-0JC IF^$PG9/75J:.65"*> U9<,?1=_R"@R1#
M!S.X@W4BLJ'#P]SHL"Q245:ET(TKU'.K=6!*\BS,E%7R))$01?KX,]1=*1EG
M0D0!H=2HEM'E8<9&:.5Y<UUKA;7D;!ITV9'=&6C-V*P[8'WO9F@!:ZSJZ!MP
MLURJ2\K2>A/P57U!95'P*]A9$]1E:+PRT)FA!J68R^H><LB5JQWK^:I5GEYY
MZV;:=3Q/D.4H"B,),6$Q1#)7B^ TB!2 &6<X"A)$<ZMBO4=#C(T<OFR7NA<;
MO)L":$8#W6#IF0+V$>DA)NJ\]GXKWQX/,VQ9V[-J'M6L/7^ESVXA-^N/9+E\
M4RNP,L1[FN4BR5,F(<TRI/=<"*0XRJ%R T1.0B&S2'3O%G(PZMB^_VVKBW)6
M$WZ[A1PB;L8.WG'LF3 N= LA:]!([3L7Q0JE 9J$'(X\@B8A9\ P:Q)R[F8W
M1OHD7I>"%96OC E->( #&)>=03'*8,X%AR2*2)BF41@R*R^C_?"Q\4M;-K<%
MQQYT9@SB"DC/1-$6RQ\1G%+6Z_>^-\"@G_4IU0Z_WI/7.';R$>QYOI@MGM[*
MI<;A;D53$#FA"0WS&+(048@R%*LU0DY@&,9)@I($2Q1;]?8Q&75LG_5.:%A*
M?;2U9]OYQPCZ-,F59T81E(3K7BH!ACG#$HH@SAE+$QP);'=*YAW\80[+=F+W
M ;,9R7J'KF?VO?[*]K#6LP+);Z\FHY&'[=YD \91/R>KFSVT<FNVA%"( QJG
M$ >(*[K'!.8XRR!!88Q($D646M5/.#'&Z,C]H%V97L4L;.M2GL+2D%BZ(=0W
MC>R!TP=EG%>_OV9N[T('YQ6]V,S-RZ?^24BQ7.[O)^_.Y.MVYH+K[?XZ8"2-
M\H#+*(-1'&00T4A"RD(&<QDCM6[#DC&KPR-K"<9&$XT"^X=*SO$Z]A8Q70SV
MB'/O*\8:XK;P>Z$]6_FKHRG?D3[.X'E>@=I*,? RU1&DX[6LZX.ZY ^727*Z
M5L0T2T(NDR2"G.M:44+JC:DPA9R0C.,P"Z6T*D9R\/RQ$5B=$+/6\H%7):!+
M(N\./3,ZZH!)SV333J$M:X?X3I\]4KJ'G-C=&.^0Z'JDX.GLU>/+W#[?ICS(
MXZ*N7_2PU-&SZ[>'F:Y)-^=Z._OUI71>]!(FE3'DD79>1$YAGO),-TT1B> R
MI41.Y^))=Q,T^[;-!S=ZQ7'UBK=%Z//$YK70&8/E?C0OUAOK3M46T(<Z?)L&
M,0Q)GD 4A!&D41C &.>"!%$2D,0RM-LS],/N7)6IFFQ( YCQ<C^@]DS9C="Z
MX%,M-FCDGH!2\DEY-+D5WA^GVP/FE>XMAA]T)K"'Y7"2<'B"?4[I_?I9+*LR
M>-K;7,SUB-N6CP'%0J8P#8G.R(\0I#P0,,YS%,=1&,?"N.7CA7'&Y@Z6HIKG
M)%Y"\#+E>,2E9WXII6SJ;.[D=&@<< DM\V1-3Z@-E)?IC)Y5\J4!)A?R+"_=
M/5A*I8$*[>Q)D\M=3X#5XY9D^58]_:M85Q[[-"5)+"6-892%RG].M?],$85,
M$)JB+,)QP.T.?4\/-#9.5((Y5=,X"Z3IV6)W>'H_3JQ%K#_P"=!8W5W&RN'\
M\#(0GH\,SPPV\"GA996/#P:O7&_O'*EG[++U%JM5&0DF%W^2)5_IOTD=$E9.
M'C>SF?JUTFL:Q'F** MAF%(.49Y07="(P00E/$X$DVJI9^HT.8P_1N)HI?(J
M)=2B;Z?%!,SU!;(LK%[M:I-&%7.GPL5.UUVSGM'OF9=&"[RYE]>S 0;R_JHN
M=(!(];F5&#/2U!<X@?U*_YXWQSUK\A,0'=< R'J]+.AF71;N4*M\+OB&K<N@
ME=-67I8P_=6/;]G!$A=\3I>G#N:+=E"Y[:-V>8S#:KX9BLSYR4K24YJS.&51
M )4I0HBX6M@3PG-(<H08%E'.(VY2JM!H-*O):("BA0_J83J3K^SB41;X<"LM
M80:UP>+?)X!];P%L64;O(YXK.>\3/XOM )\X#C0MG'@7%=&+?UN!5H?:!9T5
M3]4,H1B]?EU?F\W>LAKN8L\NLK9+>:4O]C>&]]+^PM5G#+?+8*K.WEZ#\4WV
MK/WQ_N]WGT+\*%9Z@.]B^:-0CD"]*4;R7,HTT15E)8,HI CB+"8PCG 0Q9A2
MEAAOPEX::&P+AU)6&&*PKJ0%JUI<<XJYB.MU=O:%5L_$O 6J%A0TDCKLSEY$
MS)R/?2$W$!6?1= /?9J@<8$Y+]X^&&F:*-'F2Z/KAZAQ]%7\7#_^*68_Q&^+
M^?IY-<6(L!!)";,DD!!AD4.<4@DCP1+"9!*F*>ZOV-&A.&.C7?7Z17U6/3HR
MA]E&\' @]\S6'>H@W<_]MF[R .@[%D0Z$FG$E9'.P=>M1-+9I_JLE=0J>K/Z
M\+:[I@Y.N-$;&?>O9<.%7]65Z]7=_$$LBP7_ARB>GM6;?/-#.<Y/XO:G6+)B
M)1Z6A=XDESC@$4X@"V6B.)AED*01A4& ):(Q94%@U75F0-G'1MBU A/PI%50
MS/%G+3P@E?1 U.*#5RV_CRI/_;P49C/!2$W=\[31KD>UEP/05AS0-W"R<)76
M?@*V;TJ%@&Z36F$P 0T*H(8!-#B AXOOC*?J5KU:;X"26?W(/X(Z7+T:QJRX
M5[\B]#157A'T?K->J>F=EXTAULMBOBI851F'1'D2B5#"-$%J<9*G N9IB&""
MB$@DY@EGQ.O$Z"KI2*=!L-@)/ %BSO7.ZIOVGLG3T[(,*M?MO2M%7+IY]V=Z
M3]/?$ 8=P61G.M?=M]^'K<:^BS#U;I5A)S%G:<<U974%W7J"ZCR@EVC%IEY5
M%7AP-V>SC1[RH>IK<-,*)'A<Z!1"M7A4L,\JJ<I&Z.4F61IPAB )0@)11!FD
MC*50,AY@1IE:L673UW*>_;XFR[79;.1?4!O6.A2W/P+[0&;Z@&CB,L'T8$P>
M2H&R $,:! @BE@8PIRF'/*4B36(L8Q[6QKR=&Z9]C<&4C;#_OS&DF8OPOJ;I
MV3<X#K?=%E:L%-2S?*TBJ'4$-P?!4_MJ@JV>O<7K>K1!GY&^/L1\SQAACS!?
MB2[V.9+;I/];60FE=#ONYJ^;]:-ZS,W/8C653"11PB*HR#Z#B"<AI%' 88Y2
M'JHIG6&9V2PASPTTMA5@2TY0"@JTI. /+:OA$?A5;,T(V =B/=.H&UC6-'@-
M":]D=G:P02GIFLJ'Q'+U^JZMWG9!IU5(\!1%>4)C&4$>L1RB. \@$;F$F?J]
M)#)/LL"J@-'YH<9&$>=CXBMY71N+'4%LQA-^@.N9*5H-Q31>'XWPZM!)[!P4
M/741.QKNG3J(G5/[?/>PLW<XULI?O+PLYF5AM7(38W6W6FT$GY*$$$F5)T&R
ME.C>8 G,LR"""<$QDX'@06BU(WUFG+%1124F6%65#U>EI* H1;6LB'\&5S.*
M\(!6S_Q0 U67B*R$5&NPRTC95[F_C(/?NO9GQAJVDOUEA8]JUU^YW#'2CA3+
M<H.RY:3\HU@__SY?4!V.J]<WI=.R^B:T7L6LJK^M_K59+A5)?2"K8K4-D?XN
MUNM9=9(WY5D<L AA2'1A,<0H5;1",ZC6)RG+$<ISS)I"1(\6P7B]26STR>U7
M+WH<@*=:$EJ&[?5G6S-J>V=3#13NIY2L#ILFH+WF^E,I"MJ:5JNP%=C7=0*V
MVH)2W;U^KB:VMP\,[-TL?H,&^Q-WV(#"WF$_"C;L?T3[5)BF(?J]+*>QY\5,
MW;>J]MS*5NC3F& I><B5/QI0B(C D/*<P3@/><+C($*149-RH]'&YI4V NNH
MAK;(_]94E_FC%-LBX^,ZX)?9W#N,?<<6O ."YHDS7I$<*'NF,Z)6R33&"%W(
MJ+G^C,'2:HS5:>?6F-]D2<"BF-[.U^HI-YRK5V3U4?UXOWQ<_#F?QC'A!(D
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MW;ROI6'3R(_K=@9'_?F.[7G0TZ_NAP2TQJ!4N8\R93U8I)^Z9CX%?9]":#U
M?;9R6A]CN4T]#\L%4U/#ZK,"IMS=O:_<[]N?8LD*Y:=/$Y)F*%:^<)JQ%")*
M)*0BE!"'8<8EEVF:8IMYY.J(8YL4&L'T=% VD@:+2F([@K^.M!E;>\6O9^IM
M9 7ZNZL/D&IQP59>?[1I#(U7#KP^ZJ"$9@S"(3N9W]A/!: FKR+& 8\BE"J:
MH3E$DH601'D,,X;2(!9IKA;B/@O_N*05#5/OQS"MR!9@0Z_P/UWJD$5U'R\I
M*(Y(#5K49]"D%$= ;$OX=$L\T=&,'S8KM71?K3XN7J@:K.Z'O'B:%_\A^!U7
MXQ2RT)[7S6HEUJL;]J]-H7PTM01L>6[E9J7@_U@L_ZF<MH_DM5B3V31,@Q G
M7$ 9I67&.((T$@',<A+))*,XD$:!/OV*.3:RJZ4#K!+//"*Z1TM>.4D?C7UZ
M9M5&2=#2LNJ$5>D)VHJ"2E/0J%KNFK07W;6V$]!8_..(+&X>.3\.RP\4;__.
M;X!5T'[_AKD0ZM_CX(,E"/0/8#NM8(#1G!<KQ5IY'S^4&.H#FY<1J940']Y^
M(_][L?PX(ZM5V=$E%#251# 8QKE:L*0QAC@7.4PR01@.HBA$B>6"Q73LL<WC
ME>BPE!WLA&](@;Z!4GY0*N#45\?&,,8+G3[@[G^QXP]IER6/+6:^ESW&XP^]
M]+$%YL3RQ_H1'9(9]K(D[N9LMM%G7 ^+91F\L5XO"[I9:PI^7'Q5&"SF:X6'
M>NA3$YDQ%0%C- D$S&B$%?\A"2GC''(6!2(281C*R*0JC%^QK*AQ@#(QCWJ,
M:@-YFU8D2NT<<AJZ&RW":4"C,(>Q(+SJO*!^@Z$(XH3G>4(5.-/7*@9\39;K
ML9KN4,0>W>#JK'<"?N@CG'<Q&D]%$E"10"EY !'*I#(:CJ!@/,NS0.2Q9+71
M;N>&K7#>RV2-@/]'&\S, QG>!#T[)Z>2)R=@JQ2HM0)MM?0F[;YBVRA5SUE&
MWI#VGW347;3A<Y"\P7DR)<G?T^TSE&Y>Q)R7[<UFY&F*$!*4AA1&2:++$(41
MS#$.( E3E$B4\913T]RDO2>/;1&W%0YHZ<S3D?;ANK)]V@6$GMG+4'^KW*.3
MNCIG'>T_;;!\HY-*M#.-3E_0L1Q$]>GKD/+%7)\ E4O[/(E9'D0)Y!E*(,J2
M&&*181@1@01B.$E2J[ZC%T<;VP=:5R/8">FTDW(98%//Q1-L/7_2UHBYEW&X
MA$0_Y1M.CO@^91LN*7^V7,/%F]S(X[?%C_+1=W,=;U?EH<QFBS_+8-V;.?\F
M=&R=6'U3OL+GQ5(GH4SS2-(DB#E,1$ @XB*$5/ 8"I(A@:. 2VH5,.T@P]B(
MYOOM1_"=/0N^F:EEE')X CP!C5Z@F(.M9F"G6GGBTR@'_M#J@5H_2X9RL:(9
M;_5LF[Z75X.9Q9H&.P#KE1Q=Y!B4,CL =4BD71[EV$9!2+%<"OYA,=_H$1Z6
M"UFL=7J,6GBU$O[NYERWPMF0V4>],"-L_:@&O)?-_>T\P;J[>1($,F"$PYCR
M%*)($3#.LQC*- SB,!"(!D85&/L7=6QD74VCL,RN;"<+K_3.2Z,<:+13O]4*
MZJ#F1L7]=&.W!O8]OAEFS#X.>_<\ 6PM5FI9,GNE)Z@5;=O_I/D[6]^^CT3O
MAO';<J(_<8?M3M$[[$>-+/H?L6.:I6ZU,5OHM)M=&YE4Q$S0/(%,33'*^T=8
MM[8(( HRE)(P97%J->]<&FQL,T>K7D1+6N<:DA=Q-HS)\(1>WT$8SL"YIP1>
M0*2?U+Y3 [Y/BMX%U<^FVEVZQ[F,1%.5_*M8_ZIXZ<MB56;-?!*KXFFN_W"_
M_%^*UPKY5@:DK9X_*W?\;X(_;8LT*U*144!2F"6)HAL9"IC'1#<V("R(1)*(
MS"IFS(=08Z,EI<C..]'JJ$]+N29:=*!E!Y7P$S 79<G6-?EI78^BNR7-"&UH
M^_1]1-)JI*#-I!4"OVB5_E+E^AT:Z>BH]X$L]6;%U1KH+F4OO"'MNRQ&=\&&
M+IOA#<H3937\/=NU=_</]0HNEF]*@"DED6[2G4,9!C%$*<]@CK"$$9,<<\DI
MS:T.E-H/'QNQ-K(5IET<3B)F1GRN./1,8%NQ)IJ_?+;1/E;7<\/LU@ #M\8^
M5NVX"?:):QS/?^L-[GOY73SI]>(W\:JC/G1DAUPL7\IUX8>W^H^[FB<T3#G-
M1*H^7YE!Q&0 <QG'D-(P"*E:QM',*GW848ZQ??.-&F5M^TI6L-4$M%29E,4%
MJRLL#Y0=+69XU-R_'?H^MG$Q0:]U9CIBZO<XVU&680^ZNP%V= 3>\7'=3F\^
M"W4/F=W-V>)%/)*?MS_U?IOX(.9"%NMI&*,\RS-%I(0E$.&$P)SB7*U8><9X
MFB8AL6J[9S;LV'BSE%JM<F0E-2A*L?5:$XA*</ +K40_WTJNBQGLCCW\@3O4
M$48M,:A$!DIF<-L ^^$:L,ZG$&8X]7*B<&7H=SD=,(/CW$Z_X=UN;'70F/1L
M58@;J>A EX;X7/P0TY"D68YT!09%7&HYER@',$@0I$12EL@@0)%5U2HG*<;&
M98_/BLJ(EM".J=Q,8$9<O0/;,X\=]T.^7'ZFA+\J0J,U\<=LG8#T2G1ND@S*
M>YW .J3!;@^S8\75<JT+=?$-6]\OOU?M]\IXW2Q&1&0)5>O<+(0HQ"$D 48P
MS#.48QY$:1R8$-ZY <;&9;6,9>Q#+:95%/19("_3E@]X>F8D!V2,R>::^I=X
M1-W;XA#UKT/^./OP0:CAFFK-5W_U.L=3Q29B[_-B^6FQH6NYF=TPMM@H[O@F
MF"C*2J ZA$_6D:XI2[-09@QFL?K.D0Q#F",4PR1.T@PG </4JJ6<M01CHX1&
M6+"3=K(+@ 525T-0WFJQ+@\3.T4FVUO+\)BP3QOT?R;8 _SVYW^N$/H][+.6
M8MB3/5>0CH[QG!_D6J^X7G-6K>C(4G&PSB/A9;#'@UB6-?JG>GLJ37(,LYQ+
MB*(X@SC.<IC3)*$D$PD/0KNBQ2;#CHT0MU)792<FX%6M.AR2X0U!-Z,X_U#V
M[D\U*'ZO4%0RJW<65%+7X5]*[JJQA\]JQC9 >2YI;#3TP'6-;> X+FYL=;<;
M.541^-]U'?>R,-D_BO7S0E=N)[R8O7T2ZIM_*>::$'<=CUXT54XQX3@F>0Y9
M$A'ERZ%<E]"A, QXDJ=8H$18[;4[2S(V"JL3-W>:@#\K5<"RT@7PEC) ZH!,
M!X9SMYP9Z0UBCYYY\+PI:C5 6P_0;KM1Z>*/&CO#Z94MW:49E$ [@W;(J=T?
MZ-HT^&%#9P7[/%N0]91AG*0TBI15TAPBRB2D.8I@JM[B-""(RL2X+,?1TT='
MAU5WW$I"4(IHVRZXC=UE\NJ,2-^$9 &&0Z/@$TIW;!/<?N+ 38)/*'/<(OC4
M1?:?Z*>Z*O%*GP<N7Q=EZ[0/;]_*@W0E;BM4B\4L54LRF(D\@4AD1'?[)C#"
M49(G8982\V[?QJ..[9/>"@[:DNL(H*WLYI^X.?;7/_U>$.T[JN ZF. /KZ%4
M3D@Y\XCY2(/QB[7R;=ZQO[E#I=.[U6HC^*>-SD-\J,I&ZD7?ZG3?VJG@)&01
MRF":IU*?J,40,Z0CPM.,JG493KE5"(&##&/C*BU]N9F[D( M7EX6\[HCUF:N
M; 'J."CPJFY:3<!*Z[2T##%WL939&JQG_'MFMDI,4,D_J?::5I/37<#;N=]5
MO,'GQ5**8KWQN3_5 4__A1,MY1B^2J(;4"=+(CH^RHTY[]?/8JF?MQ3/ZI'%
M#U&%>979.HNE*)[F'S=+3=9OC^JU6Q%6UA^9\_)?LZH:"?_?F]5:OX]?Q?I>
M/I*?4Y$QSF.90D02Y?K%+-/IUAE,@D!@&2 4958;7OV(.3;^K34!K%8%K'?2
M [(5WXYQ>[*P&2F_O]UZYNU20;"G81/J6N5+3D!CU491T-*TC.)HZ0IVRI:9
M2WHF?KR0]VK-ZOT:Q"OQ]R3JH'-#OW ?3A\]CV;?B$UGYR_FZV*N)K0Z@&XQ
MU\F@B_EWL5ZKNYY^5S@NU^I7:J0ZHG@U%2*.HD2J5R+%NA8O2R'.(JZFCXA&
M@J8YE\RTRYJC#&.;&\H4;.V0US(KG[P6NDQ6J'US0V^\BVVN["P,@WC?^PPM
M#<!6A0EHC-"H ;9ZE(D-'P8S@GDKLP&,,5"?LKZ,8M6 K".<%[J+N3YYL-9A
M'55O]P7K^BC[F>@WL61O?Q-DMGZN"WNP.(EQGB:0Z>D%A3R$A&8IY*F( K5V
MR4-AE$A\\NECFSU* 4$EH3D['8-VG?P[0=$SK;=1N%Z:Q  .<QKN!,M !&OT
MDEBQY5FM+_#@\3V#,=Q9<=O<=?ZBCH7POQ1S<:=^7$V3*$N$8 02Q&.(:))
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MEKZ_I.Q1I?N+%SM6?/U!BEE9'6>Q_$YF8E=(YY.@Z]V_IB@)*6()UB?B'*(
MAQ"')()I%J8B)E$8Y%:YDJ8#CXTAMG)#Y:3"E9(<<"4P6&TEMBSB:FH ,QKI
M ]:^F47#MY-L HXA]EB8U1(?O_5830<?M@RK)21'U5=M[W=CJA-;Q1_+[(PG
M?1:MUI<%KU,T6H[QZIO^Z5ZJM:=.,5R53M3?U.)S&D=4H) 'RDPDAHA':LV7
MZNK5$48Q)BF)0ZM-5K_BC8WU?B,_BY?-"]BI!/9T:A8E=MSGV:24I(+H_/U4
MDAPB&:L5D_H2U5H>L33.948",OTAEG0Q?J.VQ>S/K"USLCUSDI8Z$U#^K#<
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M0G3D$KL^QXT6?Y\OM\G3K8+$=VJ1KM[A]?V\*K2O_B24(&RY$7R:YG$:DE3
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M(JFD4B<K2*NXTTN#C8T&E*RP)>SV-;><C"_B:\8/OE#KF2SVQ=R=DOM?$9@
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MUTY.M;*M!#4\ K@(Y?4)R = /4\K+6P:&1W:\9[%R)S\?6 U$*4[869%T=?
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M(BC"( I( '&$8DBR-,82\3#FJ<U1XH6QQG:<N"=J<[!X-8C+CIDN06_&2)X
M[9F)]K&L6\[]\F6Q6OU%T9!8:X92$D_ S0&^#\J_]E&-P (NKTQT:;Q!&<A
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M!!=1JI[%+8//;,8?&^E5[<]D(R@@6TG+JAW686M6MC#CN1X1[IGG&LF!_M;
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M,2'JW[$DTQ]B21>F'H-OR-N#OP?HX)=9E=R]6^'U8(>(TBC,=*!,0'-=84'
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M130XPPQ@S)BB4M[8%QO<;HZH9P@:J)MI!13U(?$&@',G'OPTFX8KQ]\&1UG
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M2[D[A&VECA:1=;A87" ;WEAN:?9@33')6B9PADM *HE*!-U;4^^>R!,$#5V
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M0P*\=PTWX&2\P.Z(:72/&'.@22I'KS2 3Y)#EIQ8GJC*N5;SZF>):F:0VI!
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M^.3@?_]V>/I?]SG::J++$P^O/MKE1PSU/^-EE?(JJ5B,L];%\#?8C<J$D(F
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M1:6)8C;3:.K<DWJ:GF%K$?N'4 ]2;P [>R%<G%^L:H&>&V)_Q1@51CE!"/A
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M/2-N .TT8/?*D<@4/_*(CRBX<40Y$)HH$+%<7DFE&U_(RLA <N1UIIH^1]'
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M4#EI>93:\1A5:Q\B1%KN-J[FH<N0RB"ZG+Q""Z[J5*\]3U,W,+VU<XB>=-
MFAZW67I<WTFMRX)#DF7^,=$H)R,8*!&#))Z$I.K$FS\DK5O5[5L[2.A7(PU
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M_0#NTHW<P(Y.PO$<P>@H0*44(-1)!T$R2XZ!2:E1]\@G"-L*9/9D03:(/CJ
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M;3XGR7 7G:7EPHRK00TMH2)%+>#WF!/:Y-M ;1OJQDW(/*H%&T1!(_;&OCF
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M4T]26E(JHS'@A,WDT20+GB4$E,R(D$7VH4U?SCT)'O<T]ZCXW#")I[F*>V[
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M5MR=Q1-Y])F1-Y!*O;@L04*H12$N&:],"2J$.WV*-F;2//FBK9#D?RLD#:^
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M:0RLUO(JX&DK-!*?3UD 5UE6%BWWMRK+[BQ<W>?;/0%H7XTOCRC^3N#U=K[
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M&/D2M9JBKJV+$;PKTF4CZ8"UF6$XE-*NJ@B:6<!#5=0!!!\X8'=QITR4"3&
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MBXUH]!_\M9AO=CGKF%6A8#H _4T&%77M=8H(T8@BT1>3G'S$8VE(WK352A.
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M,@@*#Y:-#-%+!Z!JDBA!CAZ99R"-JZ,4 [F-LECP(EJ?G?*13?30?^)E(X/
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MR @I*V$P)B7#1(GM<1A\,D]O37 ^S;$<!+K3>:R[-^^V2Y/C30%Q[9P3O,Y
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MFB1%Y7W)@:LVFRS^O8ME*'[;[6(9 H(.O*R;:QF0+JPL@H*H>'U@5'1A83;
M+&<V.C3<M0DRGN0NED%0>' 7RQ"]= "J_07WP Z&''14*#60@T?AB_4,@J\>
MH%:QI%#'T/DVUK4!-SWM8AD$KF/L8AFBZ0G13L[J[)IG=[G<0YM8>"04V5H!
MH;@I$%E)9 .B9CE+AT(_XO3>^<.=3S1JKN?E6$(_!?OX>!3LLLO1%@':!KI;
M##IP+GL(4G.3*>@LHLWBQ,-I?RH;50ZYWH^,@%/&_,O_.9]OOK]>D)=_OM7*
MN\UG7'W\'!:7#YL_WFNNCP&-6EL4)@,JF<BB)$V"40$":N<UVN1#9QG@O?CL
M_%88&<5C':+VD/K?<> NRS^MELQSX8#731P*%=G K! P&6/0.*5Y9^-;A[)X
MHL?L"#@__I'< W2G,TQR;_'<'/0W8R):4I6!XK9O85:!MP;!V8+"HPY,-GJ*
M/!*')SI&\BF=R ,@]Z2OQXMBLA]RR1)3E-H N3.*8E.OP5.  (FAUEJ63*(Z
ML:-XD\,3'97SE([B 9 [[54XCTKF<DC?->$$YD26B4Z,5@84"XE,%"OD1XAD
MBDW18V<[.(<S>:(3=Y[2D3P,>$_\5-YVYDV.L38W@"PE@RK<0##:0E+5D[<D
M&^QL/W23"+*_LJNG="(/ 5U/4Q_;"N=6,]+6R7]!)N55F*^VY=G7%8W")FZ8
MA,RQYEW(F@6;!-@BG?3>"\XZRT*T$<2)1J,G\PS;#)1/.A#=77RSR#*++D:P
MR=3@W3D(R2(D$X(72C(RAT_V(#_YU]UVQZ=#4S (R__K7H8?%Y_,7&#D&1R/
M"E3R=7ABU,!U"%'Q(%PYM3M]H A.]#;_7V4/6J+Z23L%-Y\*'Q<<\^BD(<TS
MYF3U# MX$R)D9;*53CCN3RTT'RB")_^^_03,04M4/VES<&V)S>-24\X4%,J!
MX3K52F%/46)!R/7)Q'*GG#ZU*&$(_T_^5?T)&()F>'[25F! =&5LLCDS Y%%
M#DK4C>:V&,@R.>&3Y"CDB=F D5\*3OD5_PE8@$98[B0#T*R#?1:+$H@*(: +
MM9Q=TM^5!,79X+S*1;LV)6/-6#I1QWV<5_D^@-+!K7GDF0\A!\98=E"2CZ"B
M*.!DEH#.\L2+S]FYTSI&^\\1Z<\7[OQL'0ZI#@[<L:+\K42OO?"50E>Y3X!>
M9U#)!(BF6JF2C!2.F71R)<\/\7NBKFCO*>?1(-;M09R9E*WFF$$$4T#YE,%+
M%,!+LBH4IP,_9D'RR6]M&A_(@U34 =!VN@\_AK^?XP++?/.*M'#]3^K0U<4:
M9\&54FS=AAUDK/NE-,3H"WBMZX(!E[7(T[E.C])_\JN0FKM$XT)@ZM$/E<58
M64S7&,&_$Z[7F_!WO& T?%F>+S8SSQ(/%FN"0='-83F#P+*MM9&!8XPIJ5NS
MM>Z>"C'@FR>_2V@?.#95S&F/Z/MQ0NOTC#_/5^DSB:A.Y B+_((DLJBJJH-X
MXWDEJ/Y)T\%]A]!SQ'%^HXFMCR%_6B247'F0S!/>O2,#*UD@^&-Q/DA5DFIR
MQSZ5(7\:K;:2#(9'2S>4(M?,Z<S <]194S2N0IL1:?\>\C<4O^V&_ T!00?^
M^<UY7P53G;#$(><Z;"D83FQX#I$SY!D3=ZQ-1<^3'/(W" H/#OD;HI<.0+6_
MX!X8"6:,C=P5!C%83NY8EB2#.AR,1QUDYDS(B8I/3WS(WR!P'6/(WQ!-=X#V
M&V[@Y=0YSS6SQ ;=0$(!W3P)@D8.P243%0JE>!M7X YB.N]A:(Z0^YXC]E37
MA(A;KS:S]U5N%\,Y!8O*88:2#07!@8OJ[Q@0G&Z9+#1%R#LMBZ1?O88O^J?;
MV+KQV:<RHF^?RWE_^?< FDNL2Z:Q[ON F!!!.2O 24P0/0_6:6:8W>DI=7?8
M3&F&#E#9;:7O(;^)U?Y'^'O^Y?S+)>$L"I44*R T<\1\,4 "B."LRQFMU4SL
M%-_OI/@;GYY8]?LH;CF&%#MP3D9X;,T8',O2@-6.+&50#EP2&GBR1LM,%S'K
M;&?;FT'S9-N5>74121X9 :>,^<N3_L-#/(_KM)IOL__OPP9GW#O4##58;E(=
MTU(H2"H.8LWNBUB4LIWU/S["4>>AP<C('.M@C F3B3.5?X35/W&S701^\>8:
M%M^W@='K]?H<\[--?9.MV;"_%H2%E^NO7V?"I&!4%!"RI8A+<0V14<#DK5(^
M2Y70W_(?[\Q7#O_RB?;>'@;6(RCIE"WVQ;R>RPMV_>Q\\WFYNJA$IC-HE6"0
MA0J@="0/S10%'%FQKA3/99M:V]%9.?E2]4EL]"C Z.%D_#SG+\Y7\\6GB^K#
M"[;N34"O9\REO"T.TZ(6!FNO(23%H0@*>3!DE5RC?LS]"#[YHO&#4'X$)7>
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M>PB] ^A\P$3&-U<F+BN6#9>UN] "(M)ADG2B7! *M)'&*L^$X6V67OY"2E^
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MS&0NN#4W!^X?((H#"#W=3K,*F/I^ ]ZQE-=TTWB0MSB@E;S7\X_L!&NTG??
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M+^*09M[V!^6+AU7ZYS_^!U!+ P04    " "O@5Q4/&?,4:0.    + $ %
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M2;"#OG$J;_U#"C+P)58QLU&]TZ$NE8\?O,<SO"DG?OU4W"L<SO^,!5\G<'"
M> >=D[8_P/X0%7="JS:GPN,C@=LNB:5J<]\F?DX*Y^)^0 [B_QS:-.B[>'A
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M1X6_5C;1!\8NY8QMI634]E\'L:Q7SD'\\1',9W+\<4,L0A]4_5N0I=@#LE5
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MY)LT'/LT%$F_ 2_ZV3S+G?A88LTG\QD3K>EB]53ZCJ&ZA6WBK3;-K0$.XM$
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MI=&8DU4N((VQ0M,[;J"C@8782* '?FA$JW^G;"DW1.Y>'^' Z;N M&ILDF7
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M"Q[C9:9RPU3*SE6>,*]9^X6ID/V[$-JP,\DGJ=)&^IH-4U_ED*5\#P <_G4
M['#L6CL7N]=<(V((3S)G-ZF:Q2*8B*H+81F[0,&$5*$:8P0N4X1VSHK4Y(7
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MX@.;AJ6U9H%H,>:6R9KH"K&UM>6VG%!68..D$07B+SZV48$UP%+<B4A!2V)
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M[_($]K/VZ:Y#VHN9)W\"4$L#!!0    ( *^!7%3B)L/Q0 @  )\I   4
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M  (R2 2%EJ',\2"19DSB))8B@U(6I>=(FC!1ID _RJU:)1X[N5:AB/#:L*>
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M7<"[Y(%,I)T1(=@T+*TU!T2',;],UD17F*VK+;>E0WF!G9-!%(C A-A'1<X
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M"OMPET?PE;5/?W717:(\_0-02P,$%     @ KX%<5%9;E<RW!   J!,  !0
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MLVNPL2#NGA?N5DA9'/_^""Z".-*M<GC0;/=NVF7K_O,\BVGT=3DVIK[(B=A
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MC6'KF6E_FQ.K*;O5[[_UKGO=FY8WA'UCFH.&2B7M1M,DO@LHGJ(T$OX%UZ#
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M)V-A]D,UW8E(8;!8=24MBGYM%9E0E!=5I/BHGQ>FK-#EU6P+5<.5JG$3:\T
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M0BY5V*7\K7W7MAFV/ISLAH$QES#0P]0%57F<ZUN+BZ;%GJDP;,9=3WE+3W/
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M21LC9(:U2/B_2_N%<CES9F$2AKSG;$[DJ/ZY&U]%EJ25GQM%!5 E!+R$AUB
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MT)[()9E94\%#19RF^F=;$EZT"4Y/X7U^]\/3IT$T7\\[FFW\DQ%N"SWK0NN
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MB6Y3EG)S%\V)M%EXB@3O*I2/;W!Y+'YS*EU48,'GT3YT?$SG,]B?&>=EW:*
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M%R3;+G%>4T$0C_D$C5\J;^MW;6/J,SM.A%N/J(V9[,TR^(>$_2B8;R3D?LD
M#XV4EEIFU1H#15-]".%H!_$ZN)\\BQ;8$KNEK ^EA\']8!)'!-NJMK;4.APN
M4U.2#0+YV$5RA'P#:HJ5)?&CR;_ !G#>-C<E^L7)8(]@L..29 5;$$E4S,AR
M88Q$B$]VJA!;V>&9J^4J0L1"7"KRJ*2,8=,+E.P0$55A?.I2;PW*KTZ&>13#
M;##O. ;C[);U5W".+)Q(UICCB_GIR<U4SS^&>50(R!I5=]]]G6_<T)ICAKR
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M&E,]<^X?22^ZG1XE4S8!%#Q(.RR>L"?6.#U!N2&LL<C6]ZD7>,&;8MP9!+5
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M"Y O7Y[_K&^Z9L-#=\6/(I>K[9 ]/6Z6=K=_2S 6095GHL<ED>F(KZ8O6(?
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M"CX&VR32KMR6I-*P(50E:@!C!P1$;.OH-XX9M"<+]LH8]APKX.:.[R2K)*#
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M9YV&9"H(+@;_;GK.\!*[P=B=Z3Q]&O@SR;A@K$AEF\;$3V:K528,@FO5W(,
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M"G-A^8L]>O]&7TGT<3K_;C1F>1_2WR/V,N8I^,WH;D)>??EC_-K5S]O#\V-
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M_.GR_>7%]==1D#Z;GXYERN_'B9IN<3S>36B$KZ\-]O#7#T>6-9PU<(MZ4$-
MGEBOOL';J7#!<5M^[2A:*,C6;G,(.246$#P[\=E>CYW/4?."=FXE%<$D!K$)
M$N:V-EW!G;71WYA]0 G\BWC\*R;2'B:\#%7(CO%:L,]%N9Y%=KX,[.'#G02V
MW5 :%$V&QS8JPB\Z(Z8FP2G]_"C3S\^F]/.?)OUL@*K,@MGI[PF#I*T442Z\
M-()*2P*_-6 /9P#6RL0I=K^C/N-GE*_$<\1KC:6YISV"S2(5WBA1B+6^R56:
M4:YE5@SI]$#,IO[S_580CG1N;CC-_[!3@]FC<"?^^MY]D/&7ZX!RX3,N&:Q6
M*"S<N*AO2E3V^,?[%_2:_<?YUC9Y^Z#1/,LG??)$(P[^K2%LF2;ZL(G>,]/7
MM"9^0IV(ONG:0AL* :1='ESV\NC.N=O%(NR^:/%0"V+G/1\D(#'0U.&,_:\P
M'^%3_E]P@J,9-_@3#@D0>EC@^35":&"^QP )W74$VYW1=$]&C/.F?X3"E\U0
M<*'1[AC$UW+P'QTWR3[S^YD F?A"7YJ=$Y.M8TH(!<'++>7&+9<G[MZGIX1,
MAE4>S=?S$ :*.HGO*53NB( PZD'I#??%"%R?TIHGT3%"#/L2D_M41)! PI:#
MS2 VO4$T-ZAU?R![ZY<,;Q"A,=SR$O(^(6,_\P>/+^S_2KC"*RI C.\AD"2&
M>VQ.LMN^!0R-?UFV8,UOKH[Q"'B;P7$KTKKC'PTM)$&([BK<9 M"^<2I@%<:
MZ1I<1A_#(%TC<R65P<&/JB2G89\=K+9I(U)94=@[SDWPXB.U:0=G\],'=9\8
M1I65J>F[-,=[K6'76D/\<9JGFYNRR&*&;QGMS;@LEAGA:0V^"Z7U_O1&P*[I
MX2UA%AH*=6Z?]5^DR&/0G_2E_<*_]S930?)+BOKDW$$12<QL/ [XYI?R9ZV&
MJNZ99VWL-HB4T('K"9;=;%6*Q\/P",QG+_#&?,JKEGM_\4KG)Z]TG!V@VEXW
M.>3A^?X=ECJW@]  VTY>_U[WQ&<SKKJG:V98<4R)_^1"[HQ@ [.";?N U6"+
M:FZ$%*9H;ENG@=:,Z?/07L_G9XPM>S/K>9QN%<"Z'[M!P;.SL%LJ.U>V7K15
MS7F_'>WP3C[.$0 _FY^=)#.>"D;>-T;9][*N6X^;/6KH04EU)AEN9]?. _JC
MK)8UV!%W<L0IM=3NH9KO4K=SLN:>0,1.C.[G7;\=BH90+? 1QC00ZDN!!)\0
M2@7<*V)X1JOZ,ZX!H]@37'[Y,W_>$TJ<Q2F%0R*H^^?>"8X83PGQFT3I!WRY
M,T=?RU%Q;/QF>Q,5(N6K3.L/?"2DKAY'NR$:VGT/IV1G&!##1E7VJ?:3'HVO
M2N%I45"A^-#B[2<>-:PZVCTAWC5B8F%M!OBJ:@T(\,^85E),W7F2(#N583D>
MVOJZRAF[S[@>_$W6L^LG^M() Z])\*=^#M'.3G=":&]OD.76G+VZ4V2VY'V;
M#$&%$?LV(*<*@\6HCFVHPU?5(XCIO;%JU[B&QO$'.;/]/)!3U7_,5?]OIJK_
M Q.J/F!4\$OI[RW<_<P=4GEJ_+9JW%"S61YM%=7*H&"Y@@"H'>V#7:@FH[0R
MU>>G^OP7U>=]ZUQVQ%>7;;[$_=LW2U>)U5;T8#_*4NG\\\P:NR=W?1]C0Z:2
MNR?VLX 53LSUI&*]$XZ*:!C@>"?2LS26\FW3],BT!U9DY+!P#AYO4U8N><,
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M6254\KI$%'D=#>'FAS6(]#E/TH]:@Z8A6&DM[V-8+VZRIFWXK*:B2)I%G K
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M%TV;6_76E_DR1>(9XUX) ;SZFV(7Y)]S:L%65>.I",D8+HNZ:<EP4 0;V[\
MFT<!+<I7$G_2Z3-H9ZG-&8@7X![*!;A_60IXTC6R0@%=*(1'99ZB @>D/?6>
M:_:X[S$%L0_XON*6_HQ,*82DOF,11C[&&%625M):W#3I4;>#O6?SKT[ BG<T
MW\P]1U^[/?B*W8A Q\-:6E&-K^V>IX:,8$'P@0J )^@_%]%7O@Q\-WQ(IL02
M9X:D0_;)CQ7KZ#'8T7J+S!+074BJL;RS(<==-^G#V3=DC[FU_?C6'4CMP)F
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M()&#H 2Z36@M^\Y/KFL P0"3+P0OPA(Y&-^PW0*:0-O=J",3?\/JC0;W.*(
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M4S/V(PFD3:,JXY%Z_$YR.N]'7*4@0)U.!4F6IUMS7*:8A"=GIK=9F.7'#N0
MSL=T &-RZ<U0<+'G6FPX*]3MWJ*7C6@'[% +7<QOL3)S"VL:O'+0=(-[/SKJ
M1#C_^JN1;75-!*;D3R,);F;[4&=LT%U?:A'RX[H0<"/J]A;!WLU8!)VI?"PJ
M)A6OTRA5F81('P_8]*0ODD4\F"][S\/D>6N2?AVA+WZ43P6-]B8OK8\1;]M2
M;*T[W[CQ$(ZUG4=9V_GQ6-OYT[3OF, <$QJ]Q)G[.1T]]BSJ7NUUMAR*Q[$<
MC\?QE+F>HB+S ;XLQ(9P'\/]4&"18A5!!'Q?(XA]0M H.T&$B_ 2G@@/['2)
M,6D9N0R(U(GFB#NW48X80;(+(@WH_++[H(>R6*_'LU@UC'2@<QJ@W\L[K_'/
MMOQA@%<;#ZS8M(,Y6EYA#".GJ%2OJ#I?YK70-:R[N6T.^7;Z[I['[M5PT@PR
MG]SL8TG4EQS_MJ0T*K0^P!,1I ^^-&R(MKL/!)9QKS!J_"EPU/.C?=H]ZQ/2
M-OIB>C!8[;.3'T>SR78T7EY)80S>8 _H\JB^=XA-F*\!Y*J0QI/3,U+?;50G
M3G\C8X*:[(B<I9^?/^$F26@*LCB$P<[&(PQEAQZV=T2)WF_^V1CLPA;CX5=*
M**_]9 ZX6=+Y*2=#]VBBG>HV,'O2=D_AF>N01>WF'^[,<G*5]NY9XK]][.&!
M$Y(.DZD9^ZA!N\Y2OJ.G'@-^]PCGVK>AMF\9*A5MXN,R#HO;315$RAAMW!G[
M^ .IDV]$E/R?Q'G=:8E4G8P$>W#BX)U5Q %4*.TD>VVP:]WN;Q%[,C87FS1:
M 0TXTMS.C66?"[R J_]0&:"6 _-PF"V4^"B@],%.0JS@<H).M17.&(<O!3$(
MHJB<ZD3?S3P[6T'MDE"J0#3<([ $F?..1V (7):>IYSZ/F7.B5%LO\D?]]R#
ML,<(YW_&C34\^U2SH"/.842#'EU/!RVR/XM:"=H8^R&;7-.<;>K\MJBV@."[
M23/'&R\75+,4H8J47W=O[C\.,<PVFXJNQU3_&.\1Q8_-I6"%EQO 0RP(-NY6
M5*7G9Z?@,&Z?N#5R(#$0\TTZ1$)!I!THP=!3-?FAJ-..M4NX[_1UZ!PY>U%X
MHA#7,= MG!HCM=@2(C'_K$4%NSR)6"Z3,*1;A:,VNS)=,*9&H6<VP)R"W!),
MEA)9LS"\V)(%-(*KED9.>VAHKPA6=PM:&E/F4.EM>"1@<;B;H4YW?_M MF$2
M,Z*S)/(R^$&=#G41BL^BS]]7Z5P+(%W!;Z<X/%1^@V_W+0PZD]JQ4Y*X%^Q'
MQV,XDAP8:X_U!>\JMBP2BXL%+?=!3]K%<I;',G9%/S?0-X'L77OG%2XGNYZC
MU_YT4Z&F\5[''PFTM[%=.K^3Y0QP0-[YB=K4^LJNGQYW-=<[O$!81Q0Y;AKS
M@+$G:/SYEC\2T_;0[*N*C1RI%A!D0B!FFD$@%M;\NCTMEC"J&U_(F$"; T4_
M"1[QB?U+_VX!<@-%8WWT!N>YU[8-6+Z V@@.W4@%'D\MH:JML(QHUDAH%9_.
M*'D#UI:(#!9OY-KDG:- F N/QI9/H_UP'E)W@RE5Z1"/:(9QI^C,R/T!<AI_
M%)T\UP6*Q&,9"&GL"11BL6OT.$P %8OK0BZ70G,"!U?3S>Q*B*^M@E+(D"_7
ML]BL<V<VW[*H5S*E1[S)H\2;_'3$F_QI\";V)"-/;[]\<"(D:>+W"5P2K\)&
M@"SI^)GJG$=QJ0<^%L\P&72]'!C9Q@%]3D=,8:5S;D$NH7' $SAL%WGF)2?M
M(HGVV'$2=;AH(4TI.>2<&06>;MN;JF8>&ZA6I$O[,LC/\'O-!FG<(66CNL-L
MZ4.<[%1WF75:4S.A+.$/!E;(!(G+"*6YGESP,Y@_O*&NMLZUZ;Z\<5+( "TK
MYNH?ZJ8,)GU'IROT)AN/U!<A>4Y5?3-2P)W6C[JM=L=;.8!F6\T@>RCYKO%1
M2;RN6C"+%CAN%@BD2Z_%?,%&JADN[L&,SDY^3)RG?9]Z52>T[2KKZ(926G%"
MJZS:2V/*+X[,$L^WI@5Q'EQ8CMO28I6(D"IR^X#SRDNEV1VD#)+K,8Q=QRH)
M23HYZ.?#"-+OC , 8J U9%O;VINZVE[?A,#'G3DJ/B;A6&G];F<3AKG[=Q6
M6/@'&Z5 "RBJ #0%FNCN\P:=C*UC#VMTMQX:EVYO (Y#Y46I1]ELB2!;%)S
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M(U3^\*#R^[SWR;N'[I.83%3/GZ+^FLYG%$YCVNMGR"O!6*D+B,D#, 9P(8
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MP[\3#>\*BB;F807L:'RJ8L%DWJD=;Z#3U59..AP2FWG)C\WPL"Q'=Z5!Z?7
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MM(]RZ)V\K3Z&.0UIZ<0609[K S$RYK@9#6GAKN/F%:P*2+\>#Y=O4A?>]).
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M3?1R_]5CL:2?2[6@&'7LLC0_@#4C&@YK!FFFM1CU@"S=M8DVC=/U/H\R4^<
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MO@LCIQ_G8YNQQPNNFTT:YJ;C-$>; ](D")HCZ>CS87HM![-Q(Y&YB(@XSI0
M@H].?^%%?(4D*(7PY]SP*!T,KQ#>T5SE338>^TQM3,N<9H.U*6^*%BI-!9$J
MC_S*!5\G63"UD6N6I4[P^PI&,TL,6:BR8M?5 CQVH?V7L.4A'H092+D3T4.I
M.(0$JOPTWO'?/=*4ZI-=2G5'@/?'Y#)>#<5K6,O*W=&I=@J&\M1HU0;'XMGM
M<AW?_1C__/@A+ZZBK*4.24$'Y9Q34K2@3@!DZVOAWVM"'Q51#6<KG1RLO8"_
M908 >(?(:A%<5OGTBU9DA9>7!%NN,/H5JHDO":8YYU0%I2P $1Q[>5"$!N7%
MG72[2+NNS;MJ<M4Z(CT56 Z]B"[)S,\M-GQ06K_+.VQC+7/:/UUO4?"2#!BO
M==$H=HE1CF[#2EW,PL%TD$,7>HH?!GMU(T3-YE&$!:7VIK5WR\U0H\1)872E
MW>1Q[0*.-^1^G]Q, 5)"(/>[.%[PQ',B T^$@]EAJ* &TIN\:,M8<])%[^IX
MLFLR^X:](LMKY!6:S)>JBC-R\C\70B#M>HWXY*(<8V;40>[B4,IH$;NZUD**
MWEL"*MM+7<()YA"_-Z]K5RN6X[YIG9K^)R&$%URO=>MK*B.R!/4O0H)I)T1R
M!U9?W$;CVV$WX51]_5A.U4OM8N,%L#LU_U@*OX($);IH+KD,_O0@F(%;+ &S
M<Q[X)\!IC^ NWZ;7JH3M,'6V5J* (2T%BUR,O#E<;/-CG98]\KH=] LC/G"L
MK@K8E$FIB1?BZ[>-'"W-&]("9D\)KZ_0/PQ"*5-V_-G'+F-ZUF#X\00F_:F<
MM*6CNW@VYHG.\G5/G)3Z>*[J&3V=\D7!6[6]CX4HBSAYH/842R\86VZIVN3"
MJZC*SHVN5G^:UK_%UK</,_)Y*=2R/@B3.ECM.Y:D<-\=G"9?2>CV?EQRB"P9
MIT)9-)MT[H6N\(F2V>IT5PDUOW1BCO5\VX3RF<>QB*-LHV'KY7L'8?)CWBYI
M/E"7Z3#>C%%_G\&;.C(B\IO=W%V6CGO:Q<K;3-K5*;!QY/+/DLN'^!OXX;6,
MV$77P'\Y,<AJ.41O[B!D%;2XCE40/9WK! GU*BJ*]!#%M9K&3?<\YHE-HVIM
MX;?>4W*I9 ?82,'=Q=P[4G'1AB_+=E8YKRV\QU)SW[:81<S/PP6T&0U6P))(
M@0CP84V9+FG_V%!F.8>DWM^&G1 <?AO<N,)B(@2]4O7.J*,37L\ISY1=R2OP
M. 0I,;LE'@9JJ0U&O^[UFJP-O8T/T1VG4=_AMOQ8Y/F<V?>QYKGS.7^,MJM5
M(V*P)3-."DLHAN\%:N5@F:#,TQO\.U:984?-Q'!@!J58+2O\0Q%3L"8*T+ #
MF5Q>?+<9/C__C#4<R?[;C,KO$.Y3Z@7VH,J[:C6A@07WX6:7JTF9S)*H2'J9
M*48HV&:X.."[VBS!1Y*J9<L$$(;"2&AEU-914V2.2J4Y%8 AEVHF2.\U32.5
M[71UIB@YU#.,=8V\II-F%B\(JY=Y$S-N8:DCZID%>05(M8:''191T&&6?@]6
M6K/3[H[XO__K^:MN(>Y=#6C0-:"GNQK0 ]> ' -_[QJ0=V;BA09\F@P0XPAG
MQAQ=![+8!4E2,V#*I!INKW/\^\)E5[#G */_M1&8O6SJE":, _%C<1)7$^U&
MI]L2)KEJW08CT;B6X/%IM&2+Z_AU2Q]@X?@486C_,A$B"X>,21O3PY:U.H!Q
MPSN.2+]_TILN!QY P:4,#P^]5;67S_>6^92D^N!XC[-2O !%$H38>$B@-MM<
M 0] =%+W&F,KLQ9+3W#_@*,=8=^$XB/P#-_T5F/\/IR;,W-(MC@I1F)]:[?V
M %%B5/1)4^64U5H3]<3FF2H2T8L7WNT[X[5QI@Y]6_YG9L&!LF-D/\YP.2 T
MR59AZ&5_G___0&]1^>](1Q-\92(59A<_E#;H. Y5Z=5Z^3GFV9A#K\!_V8DE
M%N&H8!$ [B*V,]GFS2>E"B@8462",WGD8&Y;DD"+^WN*F="1W>#XQH.S]SC3
M3F<XX\*XTVI>NS$S7%CHG^'>V0 +[D#CT>C\/"O::34IV=HPE-(?;*J%=4O9
MFPJ+&^UE6Q(>G^4LS-90M&AI\C?+N7N^O$\Y17KA>&-H QWI.?Z0J?"W!J-:
MP04SED89Y^\VBK;Y9C;>CC@?)_GY<U]DV>;%:S?FTL1FSTETC4WWB'T)_[*N
MQ;"&8DM6$*;<#H=R<JY)N1V+JH:\EPN/I@*,SDDUW:7<MC%(<N'V3C,V@8N8
MF:0,G3XA*D/0=I6^C$D\17"*H9!C(1GFS@V9HC/SM=\-T/P^E]*#MO&E:2QT
MQEP$:1V%GKQ:'5IW3.(?$Z%M(<N810ONEF+%35\Y,]Q(AY,NW"K%N4YXLS7<
MJ;-[9'EEGS.ZR9.9%EAG^6K"U7#1!&J9B0W3JAB^5D$*,XXGE,D<VR)4HCT,
M4E4L5IP^O&?#S*,*CI+A;.EG^R]>XT2XG1X)MZ6P:H*4J<F#P'Z"R@"N1EC[
M%R<::]3B##]Y'1R_NP@PE?GR;\&3YZCMMW=X<$@F80%A!/6W@ MOVD-&SYY0
M_]_)Q>GE$?U$*Z6 3Q>PT&3=?4PCAN8U1=MBIV^Q#+=WV0QHW1SN\TQ4/M,/
MX@072R[T&C4Z3#0Y+_3CIY-2<!BP(N!?P:MG>X?/@A&EVLK2N0;Q)(N;X?$)
M.0VIDSM/AN7?*WAYM,3 .9PS6P FYG#IHN1=A/9W'-)]7S_?>W%PK_LFF;;+
M@K%?%60PT5-&"RC 8<4?FYL<[!W^L'LL\QS+,V6\Q$I1W+C7X=[35]]X,V)W
MD@0)8W"1WX/"@3EX?25U']%-7NP]>?I=;VOO.E]A7:O^3A)7I+F=J['6Y!6C
MYC5.$')$A)9.7ZI4H0>HT);065WBK69!Y/AL [/MBEJ/LZCU;%?4>L2-38_L
ME![.,7WX:O_@*4[%"/RJFHM'"'G/Q(LIYG91=?S^UYRG']WS](AL]P>VW6L\
M0NR7#?YU2C_J:8\=K6]D3)O<@D$,'&6901N^0"_WY34MNT2"[OD0>Z>#MG4+
MKFSS\R 8'8\YB_QS#R(C4U%*?I@ :T;*#@D+2D5#H@*P*J^/KL;FC?@OA!N8
MWXX-/1=6,!U:?&]>PZZ[RDU)K;GK/D5=9&-HASPX.MMKG6Z&9)R<V%-)17W-
M2L-TZV:$G-(VL>Q0J56[[29Q=8L*A-U(=^D+*K&.C[RVB&%E\K^9N_RV)7\X
MP$KL*:IP,E&<4:1@Q@/BX9#-FBP6L#'!5)/B6#SE@B &/E=%M"1,,V:+^DR(
M:=C33DAAW#"0W2B[Y[HSWS0D#<SZL-F8/1(F)!+T;[[U.=0>H&5_$K4_41JV
M9TGSHI9V?1P)TW[TY*,_@(9CCC3WF3F)Z>YN54,D]?/2_)W+E5=8UVIE69QY
M,EM-$T1]U0TD+5]*Y=;=9:^%NC71BH:JN#$@9=,6K AP+@0+WXS8B@VT'RUL
M32G($)3&)B@7F>$J'^]RNS\[MRNO4+ N]XZ_VI;>SPZ5DM)+$-^G;/'DD!O\
M:4-A@C3DL-FD9>&H3KASW9T7PEARZ^.DR+_$Q=XLCM+8P4$M1:.!9 WS=%82
MHQVZ)[Q9.!)WA-.K(D_Q@*DTE\UH"RVM_?7Y00@KA/Z'6Y?@4=2J$=68I3J>
M<S0=CP['8)U'1^.]T<E6[[3A;#63G]F>K88<"P21G ?Q392NF$K->9(B*;]X
M.Q+94F$U49W(U% RDQI ]@^&SN'@5X@>](H+5D6#$R/X+/$5>E.[9/WC3-8_
MWR7K=\GZ/V\Z;'O. C<(8;^&(!Z*&CW.9S'Y/6C]F]I\F]]*7#2CDY R<EJ"
M$SY_K /X^VIVI=+RSA%50S*4-67XK=T"P]D!)C^8Y2A^:[UE%]:.+YJS3M0&
M50?;#SQ^5^:*MCBX+Z*?$Y6W%V# ?AQA@G#)=*\8*'.+!<3GJ&XRW@ KQ;=M
MHZ;8DN3W=$B+FU44AH,BO<?RE!X<T?)Q>^$HA*5PTTT/*X00/R,:1 [37;*@
MTX?:?VIK.I2V@2MJS>)ECHA_YR11%K>P:X%OICQGQ:0=T<G(H7,T?9R2+%AW
M6?Y<[:),=&=V,F>R8)JQSN$S'FK3J$D1:#_1-Y^+0AHMM\FO,NS"B *DS4?&
M$_@HB^<)W;A[3=;RT%8D86F)A(R)?^D88?ET?<+<"T[NZG49)K)VYX $SYO/
M_XUOV6,D<.4N8=^MIM6*:&OPEL0MH:H7_ NG+T9^,X<E1SR1_,_5<E[DYH\>
MW2?_"GRK+_9?V$ UU>^V<OQ0EB?%\5/X>V7O#)8@E88=^0U^?;%:!*L2]RS_
MCNE07394'C:.THX#TU![$80AM"Y3^$9&B](!<,H8X=%GSN-3HTU9.L^'%%9(
M([HLXD6R6I1,Z^%4[1W.+OX*Q4)D9?05QU&!)[<02>G=J8:"_]5F05GS1L!A
M6PZGV9 .)_:\T"RY[1W:>REB-FC=1E_':#TZG2UDBT)@"F<2&@H"G=]C_50%
MBO*WVTOUTE8 'AT!4ZW(>,W(F)+G&J>PSB.KW"IT'H@9PBT0JVP-*:68?\QM
M_[_EQ@]]:R:L**__YM"1IEI=5L@MR08I[FJ8HC<?^:$?LJ]+P&9C9IF-"[!P
M<;Y"G3XR8Y:JS2MLZ3L5740$-F6U#XW9+V"2',55P3F1F>A:GI[%80*4#N35
MJ$)3[AV%J0R6X)(SG"LZ%R&TX89C,O5\J&+Y\8UR0[^-[OB*E#0*=0C]"LDN
M(85ICG1'6Q^KL-TQ.1Q#\94=Z%:UM[%O%8$!LT@V&M8?KG@:Z10VYSU?-:LU
M<))32%\F?D=*T^H97,,4](T4Q].UPQOH!)D&2@:0:]+;;,U3![8MDK,3_WGV
MV[N+-\$%H>NQQSD@H+T/8>^\)+JJ4]@XC R@61*^<-SX</Z _UJLTIB<;YH_
M@=T[ 2Z;+1+7ROF_F*B@%EQ>H:,[@](369DECJU2I0\+H4^CV[952:(SI W"
M%Q0K?QO!@S#LI&?:0LOR$5([.#R$:DK%<]6=HD(P;9P8&]3G;#/AXTMZTVTR
M*+S^0FWZ+;R+]\ZZ;9/7[4K59W4@=?5XFN>N9DXD.J)WY@F,NJM88SQ\KL&Y
MX,02)HUB!;VJ4)0X*[-\6L%Q$",IIL.<V-OD;9N;VQ58#@]1E\8TD:-F9PKV
MXB8V]+8P<\D<MR+:PQ[HVJ[R,>C*QXM=Y6-7^?CS DY:(@_%2+H1".4N>+N*
M:2])E8N=B&_U^K^.Y>HE)YQF"1RY!?D)[%2@KT;IJ=S_,WD?+"S"Z1\XU+B=
M@:YCSP"-&,AB]ZK'=8URW YV-?[3XX@>@C.:DD$$$9B(NI,W?VO0P0C<%0FU
M*;=>)MH6XS]#:,7=)T0+E>FO,R<IBD <;8;/^(BF<'>"0'7RM?M>ZSXO=2\N
M=[9#Z[VP7$ 9/LLBRMS*L%-NL0,CZG>Z,2U'G' TQ%*K93CROC"'@_^>E:V1
M5#XE_5!TDLGG(_9G"4!Z-[ SX;O8:A=;_<#8ZEY9Q4=VU _GK#>(MT\N)+XK
MS>@RM(GEI&3/FOTGZD,8;]X@@;'NDCLO$WGM+O[U>\67-^_I9##'0;F:%/F5
MHIE]#8EUB UWQVG,WSH#-J(']T*SE&$@_[%QJ\<HS?UW#-+VZ+QN[1ZT A[Q
M5\SD^[C2L):!H/$V1Y=(ZP1F<-,.)+JQKAW7$*^,*<"+A +S>4OJ]_X^GSEI
M]%FWV 8,!^9A@$[DT%#+D"D:N2ILZW,AY:JX282XUA.ZH?Q\&DUCS="O6QN4
M.I[S0:4;M/!&@V5CDV9RKQV:]B>V"6XYJP4P9:^AA07>C%)^0Z)1NV?G9#7.
M&Y."0ZYQ*-YKZ<JOJGS9"(H?-%MS>7+\Z?3\+!@.!]X+"4TI%P#_^W!Z>7SR
M_OW1V<GYY\OMJ$,>'NX/9KK7R<AQU+4C%]Q6<L&^=_\+]P8\Z&L/@L_<KFQ]
M*9'QH(9?Z0UFUM<P$,\,5RQY00;-N%AE@M&JR0=9C2+C13J][4Y['J;&HBD5
M'6(M?!)Q!BK)':6B;H1?!/?,#,)<=!$E*7M-2-C$V2HZ-5G-/I[1)Q#V\C56
MG;J$?6EUVVR5"5XCSD#HC"A;+28"\W'4]"Q!A C;3\<PF#2_'0<QUL#!\TNF
M=&=[365D7SN/SGLPU3 [G2S=A:@RDNZJX'[+:TP..%,RBUL>SGZ2GXG*8TQ?
M6.XZ=7^2;=!.7<2=Y+7H1%]9UR(,N]86N6*UM^LD;[6H:/NVLV"8:=7+Z74\
M6Z4Q;ZJ'/<[_\G<!<#JD'C_HU42ERZ/-WKZ3MF+N 3?E+BM#X81%1:BD/C+^
M77ETT.71E[ORZ*X\^N<MC]K3KRN5(7^^)&;E]W!5FYG(K3#Z\34VAK^A=O:S
M_:/],#@\X.U]F:^JZ^!M'!63O  ']EV:(XG*DS"X7"55')R^/]P[>/;J((1K
M@']TE8?PJ^#%P8N#IWM/GF+O^1'ZFYK[N 03GD7!Y74^SQ"$=X(VGMF=2_K3
M?LE_^N__>O'L;U,<UCYX=5+EG.;+NU$Y7C/T#\EL!@?*AZA  8Q+:GZ!I]_X
MF?A#\&#W>"[,YV!K69324'"R?RGRU3(8O3,GW%F^'XQ>/7LV#IZ]/MA[_N+%
MT[$W ;\O%_L,"]^?%@E- /R*GA+G@,&BSH=*?;+]P\:'Q_>6F'ED>W$XF]'4
M+W@SZL(TK&+:G$+@X2PX+<L5[<4?N0V_9<F^/R8K,;T+/L71(AA],MX5+]2#
M@W'P],6SO</7+UZ/F^OX^8MQ\.3UL[WG3UZ\]-?QE.^^GTYUI6(F\P:F8+^"
M.^E:M9N;5_;V+M8!)MIYK<JRNZRB+(WOO(6W\>+MN0;<_R!X'V73B/@T+ZLB
MCJL0/I)6"?)^@ZE^&SPY?'( R_ASEJ#K#I<A<BUOI=9N09*JQJPW5N;+PU>P
M,I\BA<FS W]E+LH4U?7TJ[02V6:6?.T_PW(<SFHT/2:R&I/_K*YS64'OJ]F]
M5F'SNX=@P5 BX#\1&#@PF?\@VUEBM^$[T]%W7!7PT7_&10D+ZYA:",_^&1R
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M,;+QI<QV*W2,<T%?.9NNE1G&?(%0=W6W^TUK2IFX[V,Z7&!?$='W]R5/!A]
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M,2]@+3J4T.^Q?OW<^G2LFJUZ@#>P 6;BL0@J-)HPP3?E F'Z5W"1.R76@8A
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M,:/[LTK!%:G*<7-;7/$E?2='O)A;B/=AO"&Q#16K*38IXO*SH7S$VT;&A74
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M_("@RFE6R;2H\%P2M,2P8.Y#%+9S,F]#_$XJ)4QU4,%,)]T\)&&S!;Y)?%>
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M6<DF7SAF<3\TX3B)\W&IS[T2O+9L>%B!N,S@4+MQ"L5ZBZP]]CRVT"K@>+'
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MN($5K,DKW0ZFR[2,U=(T]*!&Y*F$J]89_V[RJ4^9LI0T9H(I0WR#?Y_"*GO
M>0)3OB+;?"R6W&G-7,,H6SW4*B,:CE+( GTFN$8+E)W07X;EUU_N;>/1$):N
M% 5;U]=R)) B!2''7B8&8$C]G&R-O9 7BQ\TE&IUTH]$GDL? V$&94-)?AYY
M?:@EP2SN>Y?LNGMQ>R>+8G)!T]EKU2)R/B5T*V24"A@FC&J!N6VP&@RY)[>#
M/#>8*&H9<CJJ\K"4[]/9P!+>F'ORN33"%//,4]P>GI^G!2@6[G+#<VP*7408
M.:)5+K16\S #EN*X&%&;XG@\-3MRT8:/EC29F#)Z?X/0HB&G8+*(:N2J[X+M
MBT[?L&UG9IM$4F--%SFKZ[B!>+-EV)"CA$11(BGDD4>B-JG+@E*.L@P790<K
M=*E? 8CHK_!@9U@T3"$U^._%HO]!1%:"?$%;5J"$F>9Q5J @Q7=-[;I4MX6"
MJ,COB##FAJ<>.$S5J-$P&N#K(D=5>)$0&"@:F<<R[4#2C"/SC7"*+/ZC#Y7D
M A1&HS\5G2*.@X+2I%8&M"^/"4V2JH4$-!X2.,4[8JOUA-&M.A=[*G=E9OE&
MG -KA:%6G9TGGQW8S\W.CC(OY=>P]X_"F4EM61X".AL[H<+Q\JMPX=8FE#E)
M?<5H;_=3A;2*-M)HGGWT@H0R.+0A8$;J<Y,)URPIH6FESJP>=U$A?P!2=;YQ
M9:K\FZ)PDEL-Z"J)NJ@CJWGDKC9VI7,6#L4L4!,Z,]<9.I9EN.S:@87 :ZZ_
M=._4)[A)V:KZ6:J6@'H.6D@S5QO+*Z:174-KI^*[1U5\MXKO[E9\]Y6%&876
M1L!_M,638*#:N!FBTX; +13>"QF<JFHU#GBK;&:6PVH53XPPVY8%.V2C<G$!
MA"=]^L14=T*=&&V3.H%[4U"D*CM4-72X]'/,#=<U5*C41#\O.<XQ@5U)UQ$Z
MS@F*&&"WB)Z1BL/:Z$F7^YZ*W$0KR)%.0!;41'B>4A%B(5JPWWQR!DCWJ,:A
MA6!.O!3+L#LV32*T7:B4C7P<NEQ0/QIQ5X'+5'V;],O)#Z].$[D>J,R[J\W<
ML.$4N7)TR9R]>/PAPU.U9'''C;GP&?.QK,RF%#@M>.C<CV$P)HP/5E&80?2+
M&,CZXTZ,-\/XU:S+$T"&AJN!I%/0XF8*$^L98-U@I0-Z"Y"^[4R$R=#_#]^J
M6 G=%8 :Y"V@.DWH'BNHWVZH>G/9J[<7CP#6ESR);GRY-HL,[@2O?"@_K[QV
M["'L'MG[ ZSI?SL:$1"5Q-KJ%.-79JJW-OMBN'#\3F3#44G$W78G,M16G.]1
M2U)0QXY?RGVQH8>E>]$J8O%H!:07:]DIC5\J2A !)3B*$EP"'.CR=U?"-FP3
MNP?"H0;6!$;$S!\[5-.@;$M]U2Y\J=.C VK)@13J@1^3T@63_G^O=&O:BKA=
M"U&MY.HRA<''1#C;L.)!DF1,@Z KA!08D6"KL2:\@W\CHC[<G\ [Q_GTKWSI
MD4Q4*:TO.:P$%FD\TAV0 Q>\ R:#C>.NP]OH%75VI/\X52_%JYL_-(*_SVS.
MC@[H[4<4<XSH'_&#KF-20'84$! H&&6Y2%W6-[:[2HE-E-!2A9 0<A$62PJW
M(_8$5$MGEJIBD@1ZY".OEM3:E3PJ 8#@JFHCG;48-%&R,A4N<X!N'F+%IE*5
M=GBD I7A37I)EN-Y2]-(B[;H7-\*HY%PFT@[)S3@/1BAAP2ZKKIXOL7:XKC\
MVF);%;B]5"5/,>A?E'W=4@59B;-4)VFIA.WY"X?K5N3C;?5!?5K0M!7$Z F!
M]"I!TQ)E16*98Z^N"M\1'),@GZ,$0E1C().R/2N). &25E5GUL8HU?-!,:@/
M+FIA->>ZDN\+TA2F,KPU(I"#BHB;AF7.I)-,34,G2R]ERB\-7L(4*!:GT*+$
MPO#Y>I&D9YLSB]L/_EB!7Q/A^&6H9ZQ<J=9* FPL.@X#)U0]Q":EI(_F+I8>
M/BV\CJ1+A%4%9UA3Q<G LU?ZX _4+?L9A4EPZG94C! K 6M@40_1I+M7]""#
MB4A&O)6I2XFZ(TE-(-AKIH14;FV1<I!"(2<V@S+H]*Q7<T7I7<#_ @1E3@[I
MF!"D]'FH4758,F807+WD@PEKG57B;3/QME.PJ>,*-E7!IK8/-O4"2N<F53%^
M:ITWI;QDD;JH3M](.'C6[49>[JU:669[*:4W!O-8"GC 6J7JE745K7.!@4;
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M:IE?+OA]5-/X'>$YF(QI&_#WS)U,N2^\+!UEV]8_HHBD3W3;)A13G;X8MO%
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M,#(Q,3(S,2YX<V102P$"% ,4    " "N@5Q4XJP>6/8Q  !N"0( %
M        @ '5L@0 9&=X+3(P,C$Q,C,Q7V-A;"YX;6Q02P$"% ,4    " "N
M@5Q4 9FSX+:F  !U;P< %               @ ']Y 0 9&=X+3(P,C$Q,C,Q
M7V1E9BYX;6Q02P$"% ,4    " "N@5Q4*];0USI5  "F<P  $P
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M,#(Q,3(S,5]P<F4N>&UL4$L! A0#%     @ KX%<5#QGS%&D#@   "P! !0
M             ( !2=H* &1G>#$R,S$R,#(Q97@R,3$N:'1M4$L! A0#%
M  @ KX%<5'K!M-$L!@  UUP  !,              ( !'^D* &1G>#$R,S$R
M,#(Q97@R,BYH=&U02P$"% ,4    " "O@5Q4PK%<QSD$   +#P  %
M        @ %\[PH 9&=X,3(S,3(P,C%E>#(S,2YH=&U02P$"% ,4    " "O
M@5Q4E2A:<TD(  #S*0  %               @ 'G\PH 9&=X,3(S,3(P,C%E
M>#,Q,2YH=&U02P$"% ,4    " "O@5Q4XB;#\4 (  "?*0  %
M    @ %B_ H 9&=X,3(S,3(P,C%E>#,Q,BYH=&U02P$"% ,4    " "O@5Q4
M5EN5S+<$  "H$P  %               @ '4! L 9&=X,3(S,3(P,C%E>#,R
M,2YH=&U02P$"% ,4    " "O@5Q4]CLJA[ $  "O$P  %
M@ &]"0L 9&=X,3(S,3(P,C%E>#,R,BYH=&U02P$"% ,4    " "O@5Q4$1Z3
MV+@# @ %51$ %0              @ &?#@L 9&=X,3(S,3(P,C%E>#DY,3 N
M:'1M4$L! A0#%     @ KX%<5)$X=3"&+   X<$! !0              ( !
MBA(- &1G>#$R,S$R,#(Q97@Y.3DN:'1M4$L%!@     4 !0 &P4  $(_#0
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
